PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Mackenbach, JP; Murphy, A; McKee, M				Mackenbach, Johan P.; Murphy, Adrianna; McKee, Martin			Ukraine: not only a matter of geopolitics	LANCET			English	Editorial Material							HEALTH-POLICY; LIFE EXPECTANCY; EUROPE; EPIDEMIOLOGY; LESSONS		[Mackenbach, Johan P.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands; [Murphy, Adrianna; McKee, Martin] London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, London WC1, England	Erasmus University Rotterdam; Erasmus MC; University of London; London School of Hygiene & Tropical Medicine	Mackenbach, JP (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands.	j.mackenbach@erasmusmc.nl	McKee, Marc D/E-2187-2011; Mckee, Martin/E-6673-2018	McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683				Figes O, 2003, NATASHAS DANCE CULTU; Gilmore ABC, 2002, SOC SCI MED, V55, P2177, DOI 10.1016/S0277-9536(01)00361-6; Gilmore ABC, 2001, PREV MED, V33, P453, DOI 10.1006/pmed.2001.0915; Kentikelenis A, 2014, LANCET, V383, P748, DOI 10.1016/S0140-6736(13)62291-6; Mackenbach JP, 2013, INT J EPIDEMIOL, V42, P1100, DOI 10.1093/ije/dyt122; Mackenbach JP, 2013, SOC SCI MED, V93, P166, DOI 10.1016/j.socscimed.2013.05.010; Mackenbach JP, 2013, EUR J PUBLIC HEALTH, V23, P195, DOI 10.1093/eurpub/cks192; Mackenbach JP, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f533; Marshall Monty G., 1800, POLITY 4 PROJECT POL; Max-Planck-Gesellschaft, HUM LIF TABL DAT; McKee M, 2000, HEALTH POLICY PLANN, V15, P263, DOI 10.1093/heapol/15.3.263; McKee M, 2004, BRIT MED J, V329, P1428, DOI 10.1136/bmj.329.7480.1428; Mesle F., 2012, MORTALITY CAUSES DEA; Murphy A, 2013, INT J PUBLIC HEALTH, V58, P837, DOI 10.1007/s00038-013-0457-2; Murphy A, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-38; Riegert B, 2014, DTSCH WELLE     0225; Sung HE, 2004, CRIME LAW SOCIAL CH, V41, P179, DOI 10.1023/B:CRIS.0000016225.75792.02; Transparency International, CORR PERC IND 2013; Webb CPM, 2005, ALCOHOL ALCOHOLISM, V40, P327, DOI 10.1093/alcalc/agh152; WHO, 2013, EUR HLTH DAT HFB DB; Wilson A., 2000, UKRAINIANS UNEXPECTE	21	5	5	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 8	2014	383	9920					848	850		10.1016/S0140-6736(14)60425-6	http://dx.doi.org/10.1016/S0140-6736(14)60425-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AC3FC	24612752	Green Submitted			2022-12-28	WOS:000332399500005
J	Bass, C; Glaser, D				Bass, Christopher; Glaser, Danya			Early recognition and management of fabricated or induced illness in children	LANCET			English	Article							MUNCHAUSEN-BY-PROXY; BORDERLINE PERSONALITY-DISORDER; FAMILY-BASED INTERVENTION; FACTITIOUS DISORDER; INTERGENERATIONAL TRANSMISSION; MULTIMODAL REHABILITATION; MIND-BODY; ATTACHMENT; ADOLESCENTS; BEHAVIOR	Fabricated or induced illness (previously known as Munchausen syndrome by proxy) takes place when a caregiver elicits health care on the child's behalf in an unjustified way. Although the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders specifies deception as a perpetrator characteristic, a far wider range is encountered clinically and is included in this Review. We describe the features of fabricated or induced illness, its effect on the child, and the psychosocial characteristics of caregivers and their possible motives. Present evidence suggests that somatoform and factitious disorders are over-represented in caregivers, with possible intergenerational transmission of abnormal illness behaviour from the caregiver to the child. Paediatricians' early recognition of perplexing presentations preceding fabricated or induced illness and their management might obviate the development of this disorder. In cases of fully developed fabricated or induced illness, as well as protection, the child will need help to return to healthy functioning and understand the fabricated or induced illness experience. Management of the perpetrator is largely dependent on their capacity to acknowledge the abusive behaviour and collaborate with helping agencies. If separation is necessary, reunification of mother and child is rare, but can be achieved in selected cases. More collaborative research is needed in this specialty, especially regarding close study of the characteristics of women with somatoform and factitious disorders who involve their children in abnormal illness behaviour. We recommend that general hospitals establish proactive networks including multidisciplinary cooperation between designated staff from both paediatric and adult mental health services.	[Bass, Christopher] John Radcliffe Hosp, Dept Psychol Med, Oxford OX3 9DU, England; [Glaser, Danya] Great Ormond St Hosp Sick Children, London WC1N 3JH, England	University of Oxford; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Bass, C (corresponding author), John Radcliffe Hosp, Dept Psychol Med, Oxford OX3 9DU, England.	christopher.bass@oxfordhealth.nhs.uk						Adshead G, 2005, BRIT J PSYCHIAT, V187, P328, DOI 10.1192/bjp.187.4.328; Adshead G, 2001, Attach Hum Dev, V3, P77; Adshead G., 2003, CHILD ABUSE REV, V12, P227, DOI DOI 10.1002/CAR.803; Adshead G, 2001, CHILD ABUSE REV, V10, P398; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; [Anonymous], 2013, CHILD PROTECTION COM; [Anonymous], 2009, FABRICATED INDUCED I; Ayoub Catherine C, 2002, Child Maltreat, V7, P105, DOI 10.1177/1077559502007002002; Ayoub Catherine C, 2002, Child Maltreat, V7, P149, DOI 10.1177/1077559502007002007; Barber MA, 2002, ARCH DIS CHILD, V86, P230, DOI 10.1136/adc.86.4.230; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Bass C, 2007, ADV PSYCHIAT TREATME, V13, P169; Bass C, CLIN TOPICS IN PRESS; Bass C, 2011, BRIT J PSYCHIAT, V199, P113, DOI 10.1192/bjp.bp.109.074088; Bateman AW, 2012, AM J PSYCHIAT, V169, P560, DOI 10.1176/appi.ajp.2012.12030341; Berg B, 1999, ARCH DIS CHILD, V81, P465, DOI 10.1136/adc.81.6.465; Black D, 1996, CLIN CHILD PSYCHOL P, V1, P89, DOI DOI 10.1177/1359104596011008; BOOLS C, 1994, CHILD ABUSE NEGLECT, V18, P773, DOI 10.1016/0145-2134(94)00044-1; Bools C., 2007, INCREDIBLY CARING FA, P29; Bools C, 2001, MUNCHAUSENS SYNDROME, P219; Bools C, 2007, INCREDIBLY CARING FA, P95; BOOLS CN, 1992, ARCH DIS CHILD, V67, P77, DOI 10.1136/adc.67.1.77; BOOLS CN, 1993, ARCH DIS CHILD, V69, P625, DOI 10.1136/adc.69.6.625; Brooke D, 2001, MUNCHAUSENS SYNDROME, P209; Bryk M, 1997, PEDIATRICS, V100, P1, DOI 10.1542/peds.100.1.1; Cavendish C, 2012, REMOVE VEIL SECRECY; Ciechanowski PS, 2002, PSYCHOSOM MED, V64, P660, DOI 10.1097/01.PSY.0000021948.90613.76; Craig TKJ, 2002, PSYCHOL MED, V32, P805, DOI 10.1017/S0033291702005846; Crittenden PM, 2013, J FORENSIC PRACT, V15, P237, DOI 10.1108/JFP-08-2012-0002; Davies KA, 2009, PAIN, V143, P200, DOI 10.1016/j.pain.2009.02.013; Day DO, 2010, J FORENSIC PSYCHOL P, V10, P13, DOI 10.1080/15228930903172981; Deimel GW, 2012, PSYCHOSOMATICS, V53, P294, DOI 10.1016/j.psym.2011.04.006; Denny SJ, 2001, J PAEDIATR CHILD H, V37, P240, DOI 10.1046/j.1440-1754.2001.00651.x; Dike CC, 2005, J AM ACAD PSYCHIATRY, V33, P342; Ehrlich S, 2008, PSYCHOSOMATICS, V49, P392, DOI 10.1176/appi.psy.49.5.392; Eminson M, 2003, CHILD ABUSE NEGLECT, V27, P413, DOI 10.1016/S0145-2134(03)00028-0; Eminson M, 2000, CHILD ABUSE REV, V9, P68; Eminson M, 2000, MUNCHAUSEN SYNDROME, P17; Farnfield Steve, 2010, Clin Child Psychol Psychiatry, V15, P313, DOI 10.1177/1359104510364315; Feldman Kenneth W, 2002, Child Maltreat, V7, P125, DOI 10.1177/1077559502007002004; Feldman MD, 2006, INT J CLIN PRACT, V60, P1675, DOI 10.1111/j.1742-1241.2006.00975.x; Feldman MD, 2002, CHILD ABUSE NEGLECT, V26, P509, DOI 10.1016/S0145-2134(02)00327-7; Ferrara P, 2013, J CHILD HEALTH CARE, V17, P366, DOI 10.1177/1367493512462262; First M. B., 1997, STRUCTURED CLIN INTE; Frye EM, 2012, EDUC PSYCHOL REV, V24, P47, DOI 10.1007/s10648-011-9180-9; General Medical Council, 2012, PROT CHILDR YOUNG PE; George C, 1996, INF MENTAL HLTH J, V17, P198, DOI 10.1002/(SICI)1097-0355(199623)17:3<198::AID-IMHJ2>3.0.CO;2-L; George C, 1994, ADULT ATTACHMENT INT; GODDING V, 1991, ARCH DIS CHILD, V66, P956, DOI 10.1136/adc.66.8.956; Gray J, 1996, CHILD ABUSE NEGLECT, V20, P655, DOI 10.1016/0145-2134(96)00055-5; Gray J, 1995, TRUST BETRAYED MUNCH; Gregory J., 2003, SICKENED MEMOIR MUNC; Griffin DW, 1994, ATTACHMENT PROCESSES, P17, DOI DOI 10.1037//0022-3514.67.3.430; Halligan P, 2003, MALINGERING ILLNESS, P3; HM Government, 2008, SAF CHILDR WHOM ILLN; Hobson RP, 2009, BRIT J PSYCHIAT, V195, P325, DOI 10.1192/bjp.bp.108.060624; Jones D, 2000, MUNCHAUSEN SYNDROME, P276; JUREIDINI J, 1993, J NERV MENT DIS, V181, P135, DOI 10.1097/00005053-199302000-00010; Kozlowska K, 2013, AM J FAM THER, V41, P212, DOI 10.1080/01926187.2012.677723; Kozlowska K, 2012, FAM PROCESS, V51, P570, DOI 10.1111/famp.12000; Kozlowska K, 2012, AM J FAM THER, V40, P399, DOI 10.1080/01926187.2012.677715; Kucuker H, 2010, PEDIATR DIABETES, V11, P572, DOI 10.1111/j.1399-5448.2009.00631.x; Leichsenring F, 2011, LANCET, V377, P74, DOI 10.1016/S0140-6736(10)61422-5; Libow JA, 2002, CHILD ABUSE NEGLECT, V26, P525, DOI 10.1016/S0145-2134(02)00328-9; LIBOW JA, 1995, CHILD ABUSE NEGLECT, V19, P1131, DOI 10.1016/0145-2134(95)00073-H; Loader P, 1996, CLIN CHILD PSYCHOL P, V1, P353; Marcus A, 1995, EUR CHILD ADOLES PSY, V4, P229, DOI 10.1007/BF01980487; Marshall T, 2007, BRIT J PSYCHIAT, V191, P449, DOI 10.1192/bjp.bp.107.035261; McClure RJ, 1996, ARCH DIS CHILD, V75, P57, DOI 10.1136/adc.75.1.57; McCulloch V, 2011, CHILD ABUSE NEGLECT, V35, P965, DOI 10.1016/j.chiabu.2011.05.020; MCGUIRE TL, 1989, PEDIATRICS, V83, P289; McNicholas F., 2000, CHILD ADOL MENT H-UK, V5, P69; Meadow R, 1998, ARCH DIS CHILD, V78, P210, DOI 10.1136/adc.78.3.210; MEADOW R, 1977, LANCET, V2, P343; Mitchell I, 2001, MUNCHAUSENS SYNDROME, P185; Moran P, 2003, BRIT J PSYCHIAT, V183, P228, DOI 10.1192/bjp.183.3.228; Morrell B, 2012, J PEDIATR NURS, V27, P328, DOI 10.1016/j.pedn.2011.03.008; National Institute for Health and Clinical Excellence (NICE), 2009, BORD PERS DIS TREATM; NICE, 2009, SUSP CHILD MALTR NIC; PARKER G, 1987, J AFFECT DISORDERS, V13, P75, DOI 10.1016/0165-0327(87)90076-0; Parnell T., 1998, MUNCHAUSEN SYNDROME, P47; Pulman A, 2012, J MED INTERNET RES, V14, P188, DOI 10.2196/jmir.2011; Puri BK, 2006, INT J CLIN PRACT, V60, P1527, DOI 10.1111/j.1742-1241.2006.00983.x; Roesler T, 2009, MED CHILD ABUSE MUNC, P165; Roesler T, 2009, MED CHILD ABUSE MUNC, P259; Roesler T, 2009, MED CHILD ABUSE MUNC; Roesler T, 2009, PHYS PART PROBLEM ME, P279; Roesler T, 2009, MED CHILD ABUSE MUNC, P239; ROESLER TA, 1994, ARCH PEDIAT ADOL MED, V148, P1150, DOI 10.1001/archpedi.1994.02170110036006; ROSENBERG DA, 1987, CHILD ABUSE NEGLECT, V11, P547, DOI 10.1016/0145-2134(87)90081-0; ROTH D, 1990, ISRAEL J PSYCHIAT, V27, P160; Royal College of Psychiatrists, 2013, CR183 ROYAL COLL PSY; Sanders Mary J, 2002, Child Maltreat, V7, P112, DOI 10.1177/1077559502007002003; SANDERS MJ, 1995, CLIN PSYCHOL REV, V15, P423, DOI 10.1016/0272-7358(95)00024-J; Seibel M, 1998, MUNCHAUSEN PROXY SYN, P68; Shapiro M, 2011, CHILD ABUSE NEGLECT, V35, P87, DOI 10.1016/j.chiabu.2010.10.005; Shaw RJ, 2008, HARVARD REV PSYCHIAT, V16, P215, DOI 10.1080/10673220802277870; Sheridan MS, 2003, CHILD ABUSE NEGLECT, V27, P431, DOI 10.1016/S0145-2134(03)00030-9; Siegel DM, 2009, FAM SYST HEALTH, V27, P113, DOI 10.1037/a0015030; Stirling J, 2007, PEDIATRICS, V119, P1026, DOI 10.1542/peds.2007-0563; Tyrer P., 2005, PERSONALITY ASSESSME; Waller E, 2004, J NERV MENT DIS, V192, P200, DOI 10.1097/01.nmd.0000116463.17588.07; WARNER JO, 1984, ARCH DIS CHILD, V59, P151, DOI 10.1136/adc.59.2.151; Watson S, 2000, MUNCHAUSEN SYNDROME, P17	105	58	59	0	52	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 19	2014	383	9926					1412	1421		10.1016/S0140-6736(13)62183-2	http://dx.doi.org/10.1016/S0140-6736(13)62183-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AG3LI	24612863				2022-12-28	WOS:000335318400027
J	Bass, C; Halligan, P				Bass, Christopher; Halligan, Peter			Factitious disorders and malingering: challenges for clinical assessment and management	LANCET			English	Article							MEDICALLY UNEXPLAINED SYMPTOMS; CHRONIC REGIONAL PAIN; MINOR HEAD-INJURY; MUNCHAUSENS-SYNDROME; COMPENSATION NEUROSIS; PERFORMANCE VALIDITY; ETHICAL IMPLICATIONS; RISK-FACTORS; ILLNESS; LITIGATION	Compared with other psychiatric disorders, diagnosis of factitious disorders is rare, with identification largely dependent on the systematic collection of relevant information, including a detailed chronology and scrutiny of the patient's medical record. Management of such disorders ideally requires a team-based approach and close involvement of the primary care doctor. As deception is a key defining component of factitious disorders, diagnosis has important implications for young children, particularly when identified in women and health-care workers. Malingering is considered to be rare in clinical practice, whereas simulation of symptoms, motivated by financial rewards, is regarded as more common in medicolegal settings. Although psychometric investigations (eg, symptom validity testing) can inform the detection of illness deception, such tests need support from converging evidence sources, including detailed interview assessments, medical notes, and relevant non-medical investigations. A key challenge in any discussion of abnormal health-care-seeking behaviour is the extent to which a person's reported symptoms are considered to be a product of choice, or psychopathology beyond volitional control, or perhaps both. Clinical skills alone are not typically sufficient for diagnosis or to detect malingering. Medical education needs to provide doctors with the conceptual, developmental, and management frameworks to understand and deal with patients whose symptoms appear to be simulated. Central to the understanding of factitious disorders and malingering are the explanatory models and beliefs used to provide meaning for both patients and doctors. Future progress in management will benefit from an increased appreciation of the contribution of non-medical factors and a greater awareness of the conceptual and clinical findings from social neuroscience, occupational health, and clinical psychology.	[Bass, Christopher] John Radcliffe Hosp, Dept Psychol Med, Oxford OX3 9DU, England; [Halligan, Peter] Cardiff Univ, Sch Psychol, Cardiff CF10 3AX, S Glam, Wales	University of Oxford; Cardiff University	Bass, C (corresponding author), John Radcliffe Hosp, Dept Psychol Med, Oxford OX3 9DU, England.	christopher.bass@oxfordhealth.nhs.uk	Halligan, Peter W/A-1669-2010	Halligan, Peter W/0000-0003-2784-6690				American Psychiatric Association, 2000, DIAGN STAT MAN MENT; American Psychiatric Association (APA), 2013, DIAGN STAT MAN MENT; Angell M, 2011, NEW YORK REV BOOKS, V58, P14; Aronoff Gerald M, 2007, Pain Pract, V7, P178, DOI 10.1111/j.1533-2500.2007.00126.x; ASHER R, 1951, LANCET, V260, P339; BARSKY AJ, 1983, AM J PSYCHIAT, V140, P273; BASS C, 1995, J PSYCHOSOM RES, V39, P403, DOI 10.1016/0022-3999(94)00157-Z; Bass C, 2014, LANCET; Bass C, 2009, NEW OXFORD TXB PSYCH, P1049; Bass C, 2007, J ROY SOC MED, V100, P81, DOI 10.1258/jrsm.100.2.81; Bass C, 2013, PERSONAL MENT HEALTH, V7, P80, DOI 10.1002/pmh.1223; Bass C, 2011, BRIT J PSYCHIAT, V199, P113, DOI 10.1192/bjp.bp.109.074088; Berry DTR, 2010, PSYCHOL INJ LAW, V3, P295, DOI 10.1007/s12207-010-9087-7; Binder LM, 2012, CLIN NEUROPSYCHOL, V26, P116, DOI 10.1080/13854046.2011.633563; British Psychology Society (BPS) Professional Practice Board, 2009, ASS EFF CLIN TEST CO; Burke FD, 2008, J HAND SURG-EUR VOL, V33E, P103, DOI 10.1177/1753193408087230; Burkett B., 1998, STOLEN VALOR VIETNAM; Bush S.S., 2013, MILD TRAUMATIC BRAIN, P73; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carone D. A., 2013, MILD TRAUMATIC BRAIN, P101; Cassidy JD, 2011, INJURY, V42, P428, DOI 10.1016/j.injury.2010.11.027; Chafetz M, 2013, ARCH CLIN NEUROPSYCH, V28, P633, DOI 10.1093/arclin/act038; Creed F, 2011, MED UNEXPLAINED SYMP, P1, DOI DOI 10.1017/CBO9780511977862; Crittenden Patricia M., 2011, ASSESSING ADULT ATTA; Croft, 2010, CHRONIC PAIN EPIDEMI, P3; Cunningham JM, 2011, PSYCHOSOMATICS, V52, P185, DOI 10.1016/j.psym.2010.11.005; de Asla R, 2011, J BONE JOINT SURG AM, V93, p[e116, 1], DOI DOI 10.2106/JBJS.K; DeWitt DE, 2010, MED J AUSTRALIA, V192, P55, DOI 10.5694/j.1326-5377.2010.tb03411.x; DeWitt DE, 2009, MED J AUSTRALIA, V191, P213, DOI 10.5694/j.1326-5377.2009.tb02755.x; Drob SL, 2009, J AM ACAD PSYCHIATRY, V37, P98; Dyer C, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3226; Eastwood S, 2008, PSYCHOTHER PSYCHOSOM, V77, P209, DOI 10.1159/000126072; Ehrlich S, 2008, PSYCHOSOMATICS, V49, P392, DOI 10.1176/appi.psy.49.5.392; Eisendrath S, 1996, SPECTRUM FACTITIOUS, P65; Eisendrath SJ, 2004, PSYCHOSOMATICS, V45, P350, DOI 10.1176/appi.psy.45.4.350; Eisendrath SJ, 2002, J AM ACAD PSYCHIATRY, V30, P391; Eisendrath SJ, 1996, SPECTRUM FACTITIOUS, P195; Eisendrath SJ, 2008, ANN PLAS SURG, V60, P64, DOI 10.1097/SAP.0b013e318049cc41; Farnfield Steve, 2010, Clin Child Psychol Psychiatry, V15, P313, DOI 10.1177/1359104510364315; Fehnel CR, 2006, AM J PSYCHIAT, V163, P547, DOI 10.1176/appi.ajp.163.3.547-a; Feldman MD, 2006, INT J CLIN PRACT, V60, P1675, DOI 10.1111/j.1742-1241.2006.00975.x; Ferrari R, 2011, J NEUROL NEUROSUR PS, V82, P826, DOI 10.1136/jnnp.2010.213520; Ferrari R, 2012, J RHEUMATOL, V39, P655, DOI 10.3899/jrheum.110970; FINK P, 1992, J PSYCHOSOM RES, V36, P125, DOI 10.1016/0022-3999(92)90021-S; Fliege H, 2007, PSYCHOSOMATICS, V48, P60, DOI 10.1176/appi.psy.48.1.60; Ganis G, 2009, SOC NEUROSCI, V4, P465, DOI 10.1080/17470910802507660; Gervais RO, 2001, J RHEUMATOL, V28, P1892; Gieler U, 2004, DERMATOL PSYCHOSOM, V5, P93; Goebel RA, 2012, COMPLEX REGIONAL PAI; Goldstein AB, 1998, INT J PSYCHIAT MED, V28, P221, DOI 10.2190/8LRP-5YTD-3VP2-3HC6; Granacher R. P., 2008, CLIN ASSESSMENT MALI, P145; Green P., 2005, US MAN LAMOTTE AIR S; Greiffenstein M, 2005, LEG CRIMINOL PSYCHOL, V10, P1; Greiffenstein M, 2013, CLIN NEUROPSYCHOL, V27, P138, DOI 10.1080/13854046.2012.722686; Greve K. W., 2012, COPING PSYCHIAT PSYC, P587, DOI DOI 10.1093/MED:PSYCH/9780195174113.003.0026; Greve KW, 2013, CLIN NEUROPSYCHOL, V27, P108, DOI 10.1080/13854046.2012.739646; Greve KW, 2009, ARCH PHYS MED REHAB, V90, P1117, DOI 10.1016/j.apmr.2009.01.018; Hadeed V, 1998, ANN INTERN MED, V129, P73, DOI 10.7326/0003-4819-129-1-199807010-00027; Hall RCW, 2007, J FORENSIC SCI, V52, P717, DOI 10.1111/j.1556-4029.2007.00434.x; Hall RCW, 2006, GEN HOSP PSYCHIAT, V28, P525, DOI 10.1016/j.genhosppsych.2006.08.011; Hall RCW, 2012, J AM ACAD PSYCHIATRY, V40, P390; Hallett M, 2010, J CLIN NEUROSCI, V17, P959, DOI 10.1016/j.jocn.2009.11.021; Halligan P, 2003, MALINGERING ILLNESS, P3; Halligan P.W., 2011, PSYCHOGENIC MOVEMENT, P120; Hamilton JC, 2013, PSYCHOSOMATICS, V54, P142, DOI 10.1016/j.psym.2012.08.013; Hamilton JM, 2009, JOURNALISM'S ROVING EYE: A HISTORY OF AMERICAN FOREIGN REPORTING, UPDATED EDITION, P27; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Hoertel N, 2012, PSYCHIAT RES, V200, P1077, DOI 10.1016/j.psychres.2012.05.004; Holm LW, 2008, PLOS MED, V5, P760, DOI 10.1371/journal.pmed.0050105; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Iverson GL, 2006, APPL NEUROPSYCHOL, V13, P77, DOI 10.1207/s15324826an1302_3; Iverson Grant L, 2007, Pain Pract, V7, P94, DOI 10.1111/j.1533-2500.2007.00116.x; Johnson-Greene D, 2013, CLIN NEUROPSYCHOL, V27, P148, DOI 10.1080/13854046.2012.733732; Jung B, 2007, PAIN MED, V8, P433, DOI 10.1111/j.1526-4637.2007.00315.x; Kanaan RAA, 2010, HIST HUM SCI, V23, P68, DOI 10.1177/0952695109357128; Kanaan RAA, 2010, PSYCHOSOMATICS, V51, P47, DOI 10.1176/appi.psy.51.1.47; Kapfhammer HP, 1998, NERVENARZT, V69, P401, DOI 10.1007/s001150050289; Kendell R, 2003, AM J PSYCHIAT, V160, P4, DOI 10.1176/appi.ajp.160.1.4; Kozlowska Kasia, 2007, Clin Child Psychol Psychiatry, V12, P487, DOI 10.1177/1359104507080977; Krahn LE, 2003, AM J PSYCHIAT, V160, P1163, DOI 10.1176/appi.ajp.160.6.1163; Krahn LE, 2008, PSYCHOSOMATICS, V49, P277, DOI 10.1176/appi.psy.49.4.277; Lamberty G. J., 2008, UNDERSTANDING SOMATI; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2004, DIFFERENTIAL DIAGNOSIS IN ADULT NEUROPSYCHOLOGICAL ASSESSMENT, P243; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; LIBOW JA, 1995, CHILD ABUSE NEGLECT, V19, P1131, DOI 10.1016/0145-2134(95)00073-H; LUCIRE Y, 2003, CONSTRUCTING RSI BEL; Mailis-Gagnon A, 2008, CLIN J PAIN, V24, P176, DOI 10.1097/AJP.0b013e31815ca278; Main CJ, 1998, SPINE, V23, P2367, DOI 10.1097/00007632-199811010-00025; McCullumsmith CB, 2011, PSYCHIAT CLIN N AM, V34, P621, DOI 10.1016/j.psc.2011.05.013; MECHANIC D, 1961, AM SOCIOL REV, V26, P51, DOI 10.2307/2090512; MENDELSON G, 1995, J PSYCHOSOM RES, V39, P695, DOI 10.1016/0022-3999(94)00154-W; Merckelbach H, 2012, CLIN NEUROPSYCHOL, V26, P1217, DOI 10.1080/13854046.2012.710252; Merten T, 2013, PSYCHOL INJ LAW, V6, P122, DOI 10.1007/s12207-013-9155-x; Merten T, 2009, PSYCHOL INJ LAW, V2, P284, DOI 10.1007/s12207-009-9057-0; MILLER H, 1972, LANCET, V1, P580; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Mohandas P, 2013, BRIT J DERMATOL, V169, P600, DOI 10.1111/bjd.12416; Morel K., 2010, DIFFERENTIAL DIAGNOS; Nicholas MK, 2011, PHYS THER, V91, P737, DOI 10.2522/ptj.20100224; Nimnuan C, 2000, QJM-INT J MED, V93, P21, DOI 10.1093/qjmed/93.1.21; O'Connor EA, 2013, J HAND SURG-AM, V38A, P1590, DOI 10.1016/j.jhsa.2013.04.047; Ochoa JL, 2010, J NEUROPSYCH CLIN N, V22, P278, DOI 10.1176/appi.neuropsych.22.3.278; Pankratz L, 1998, PATIENTS WHO DECEIVE; Pearce JMS, 2005, SPINAL CORD, V43, P263, DOI 10.1038/sj.sc.3101709; Pearce S, 2010, J MED ETHICS, V36, P831, DOI 10.1136/jme.2010.035865; Peebles R, 2005, CLIN PEDIATR, V44, P237, DOI 10.1177/000992280504400307; Petrie KJ, 2012, CURR DIR PSYCHOL SCI, V21, P60, DOI 10.1177/0963721411429456; Poole CJM, 2010, OCCUP MED-OXFORD, V60, P127, DOI 10.1093/occmed/kqp170; Raab S, 2005, MAFIA LEADER WHO FEI; REICH P, 1983, ANN INTERN MED, V99, P240, DOI 10.7326/0003-4819-99-2-240; Resnick PJ, 2008, CLIN ASSESSMENT MALI, P109; Rief W, 2004, J PSYCHOSOM RES, V57, P367, DOI 10.1016/S0022-3999(04)00047-9; Rief W, 2003, J PSYCHOSOM RES, V54, P405, DOI 10.1016/S0022-3999(02)00401-4; Robertson MD, 2009, MED J AUSTRALIA, V191, P217, DOI 10.5694/j.1326-5377.2009.tb02756.x; Rogers R, 1990, Bull Am Acad Psychiatry Law, V18, P323; Rogers R, 2009, LAW HUMAN BEHAV, V33, P213, DOI 10.1007/s10979-008-9145-9; Ronson G, 2009, LEADING FRONT; Rosen GM, 2007, J ANXIETY DISORD, V21, P201, DOI 10.1016/j.janxdis.2006.09.011; Salmon P, 2007, PATIENT EDUC COUNS, V67, P246, DOI 10.1016/j.pec.2007.03.008; Singh HP, 2006, J HAND SURG-BRIT EUR, V31B, P611, DOI 10.1016/j.jhsb.2006.08.009; Spence SA, 2004, PHILOS T R SOC B, V359, P1755, DOI 10.1098/rstb.2004.1555; Stone J, 2012, J NEUROL NEUROSUR PS, V83, P67, DOI 10.1136/jnnp-2011-300125; Suchy Y, 2012, CLIN NEUROPSYCHOL, V26, P1296, DOI 10.1080/13854046.2012.722230; Sullivan K., 2007, J FORENSIC NEUROPSYC, V4, P49, DOI DOI 10.1300/J151V04N04_04; Sullivan MJL, 2012, CLIN J PAIN, V28, P484, DOI 10.1097/AJP.0b013e3182527d13; Sweet J. J., 2013, MILD TRAUMATIC BRAIN, P145; Sweet JJ, 2013, J EXP PSYCHOPATHOL, V4, P6, DOI 10.5127/jep.022311; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Torres L, 2012, PSYCHOL INJ LAW, V5, P1, DOI 10.1007/s12207-012-9118-7; Trivers Robert, 2011, DECEIT SELF DECEPTIO; Tyrer P, 1999, J PSYCHOSOM RES, V46, P177, DOI 10.1016/S0022-3999(98)00072-5; Van Dinter TG, 2009, AM J MED, V122, pE4, DOI 10.1016/j.amjmed.2009.03.035; Vranceanu AM, 2011, J HAND THER, V24, P118, DOI 10.1016/j.jht.2010.12.002; Vranceanu AM, 2009, J BONE JOINT SURG AM, V91A, P2014, DOI 10.2106/JBJS.H.01512; Vrij A., 2008, DETECTING LIES DECEI; Wade DT, 2007, CLIN REHABIL, V21, P291, DOI 10.1177/0269215507077799; Wade DT, 2004, BMJ-BRIT MED J, V329, P1398, DOI 10.1136/bmj.329.7479.1398; Wade DT, 2003, CLIN REHABIL, V17, P349, DOI 10.1191/0269215503cr619ed; Walters GD, 2009, J CLIN EXP NEUROPSYC, V31, P584, DOI 10.1080/13803390802363728; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; World Health Organisation, 1993, ICD 10 CLASSIFICATIO	142	121	125	1	58	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 19	2014	383	9926					1422	1432		10.1016/S0140-6736(13)62186-8	http://dx.doi.org/10.1016/S0140-6736(13)62186-8			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AG3LI	24612861				2022-12-28	WOS:000335318400028
J	Moyer, VA				Moyer, Virginia A.		US Preventive Serv Task Force	Vitamin, Mineral, and Multivitamin Supplements for the Primary Prevention of Cardiovascular Disease and Cancer: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							BETA-CAROTENE; LUNG-CANCER; RISK; PHYSICIANS; HEALTH; TRIAL	Description: Update of the 2003 U.S. Preventive Services Task Force (USPSTF) recommendation on vitamin supplementation to prevent cardiovascular disease and cancer. Methods: The USPSTF reviewed the evidence on the efficacy of multivitamin or mineral supplements in the general adult population for the prevention of cardiovascular disease and cancer. Population: This recommendation applies to healthy adults without special nutritional needs (typically aged 50 years or older). It does not apply to children, women who are pregnant or may become pregnant, or persons who are chronically ill or hospitalized or have a known nutritional deficiency. Recommendation: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of multivitamins for the prevention of cardiovascular disease or cancer. (I statement) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of single- or paired-nutrient supplements (except beta-carotene and vitamin E) for the prevention of cardiovascular disease or cancer. (I statement) The USPSTF recommends against beta-carotene or vitamin E supplements for the prevention of cardiovascular disease or cancer. (D recommendation)	[Moyer, Virginia A.; US Preventive Serv Task Force] US Prevent Serv Task Force, Rockville, MD USA		Moyer, VA (corresponding author), US Prevent Serv Task Force, Rockville, MD USA.			Pignone, Michael/0000-0002-6657-7342				Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; American Academy of Family Physicians, 2014, CLIN RECOMM VIT SUPP; American Heart Association, 2013, VIT MIN SUPPL; Bailey RL, 2013, JAMA INTERN MED, V173, P355, DOI 10.1001/jamainternmed.2013.2299; Bolland MJ, 2011, AM J CLIN NUTR, V94, P1144, DOI 10.3945/ajcn.111.015032; Denham BE, 2011, JAMA-J AM MED ASSOC, V306, P428, DOI 10.1001/jama.2011.982; Dickinson A, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-29; Fortmann SP, 2013, AHRQ PUBLICATION, V14-05199-EF-1; Fortmann SP, 2013, ANN INTERN MED, V159, P824, DOI 10.7326/0003-4819-159-12-201312170-00729; Gahche J., 2011, NCHS Data Briefs; Gaziano JM, 2012, JAMA-J AM MED ASSOC, V308, P1871, DOI 10.1001/jama.2012.14641; Hercberg S, 2004, ARCH INTERN MED, V164, P2335, DOI 10.1001/archinte.164.21.2335; Hoyert Donna L, 2012, Natl Vital Stat Rep, V61, P1; Kushi LH, 2012, CA-CANCER J CLIN, V62, P30, DOI 10.3322/caac.20140; Lappe JM, 2007, AM J CLIN NUTR, V85, P1586, DOI 10.1093/ajcn/85.6.1586; Lichtenstein AH, 2006, CIRCULATION, V114, P82, DOI 10.1161/CIRCULATIONAHA.106.176158; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Marra MV, 2009, J AM DIET ASSOC, V109, P2073, DOI 10.1016/j.jada.2009.10.020; National Institutes of Health State-of-the-Science Panel, 2007, AM J CLIN NUTR, V85, p257S; Nutrition Business Journal, 2011, NBJS SUPPL BUS REP A; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Otten J.J., 2006, DIETARY REFERENCE IN, DOI DOI 10.17226/11537; Tanvetyanon T, 2008, CANCER-AM CANCER SOC, V113, P150, DOI 10.1002/cncr.23527; USDA, 2010, DIET GUID AM, DOI DOI 10.HTTP://WWW.CNPP.USDA.G0V/PUBLICATI0NS/DIETARYGUIDELINES/2010/P0LICYD0C/P0LICYD0C.PDF; Wactawski-Wende J, 2006, NEW ENGL J MED, V354, P684, DOI 10.1056/NEJMoa055222; World Cancer Research Fund & American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P	26	96	97	3	32	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 15	2014	160	8					558	+		10.7326/M14-0198	http://dx.doi.org/10.7326/M14-0198			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG0ZE	24566474				2022-12-28	WOS:000335143700006
J	Newton, K; Dugger, DL; Wickliffe, KE; Kapoor, N; de Almagro, MC; Vucic, D; Komuves, L; Ferrando, RE; French, DM; Webster, J; Roose-Girma, M; Warming, S; Dixit, VM				Newton, Kim; Dugger, Debra L.; Wickliffe, Katherine E.; Kapoor, Neeraj; de Almagro, M. Cristina; Vucic, Domagoj; Komuves, Laszlo; Ferrando, Ronald E.; French, Dorothy M.; Webster, Joshua; Roose-Girma, Merone; Warming, Soren; Dixit, Vishva M.			Activity of Protein Kinase RIPK3 Determines Whether Cells Die by Necroptosis or Apoptosis	SCIENCE			English	Article							NECROSIS; DEATH; COMPLEX; ALPHA; PHOSPHORYLATION; INFLAMMATION; RECEPTORS; CASPASE-8; FADD	Receptor-interacting protein kinase 1 (RIPK1) and RIPK3 trigger pro-inflammatory cell death termed "necroptosis." Studies with RIPK3-deficient mice or the RIPK1 inhibitor necrostatin-1 suggest that necroptosis exacerbates pathology in many disease models. We engineered mice expressing catalytically inactive RIPK3 D161N or RIPK1 D138N to determine the need for the active kinase in the whole animal. Unexpectedly, RIPK3 D161N promoted lethal RIPK1-and caspase-8-dependent apoptosis. In contrast, mice expressing RIPK1 D138N were viable and, like RIPK3-deficient mice, resistant to tumor necrosis factor (TNF)-induced hypothermia. Cells expressing RIPK1 D138N were resistant to TNF-induced necroptosis, whereas TNF-induced signaling pathways promoting gene transcription were unperturbed. Our data indicate that the kinase activity of RIPK3 is essential for necroptosis but also governs whether a cell activates caspase-8 and dies by apoptosis.	[Newton, Kim; Dugger, Debra L.; Wickliffe, Katherine E.; Kapoor, Neeraj; Dixit, Vishva M.] Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA; [de Almagro, M. Cristina; Vucic, Domagoj] Genentech Inc, Dept Early Discovery Biochem, San Francisco, CA 94080 USA; [Komuves, Laszlo; Ferrando, Ronald E.; French, Dorothy M.; Webster, Joshua] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Roose-Girma, Merone; Warming, Soren] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Newton, K (corresponding author), Genentech Inc, Dept Physiol Chem, 1 DNA Way, San Francisco, CA 94080 USA.	knewton@gene.com; dixit@gene.com	Warming, Soren/ABD-5729-2021; dixit, vishva m/A-4496-2012	dixit, vishva m/0000-0001-6983-0326; Warming, Soren/0000-0002-5721-0741				Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Duprez L, 2011, IMMUNITY, V35, P908, DOI 10.1016/j.immuni.2011.09.020; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Lee TH, 2004, J BIOL CHEM, V279, P33185, DOI 10.1074/jbc.M404206200; Lee TH, 2003, MOL CELL BIOL, V23, P8377, DOI 10.1128/MCB.23.22.8377-8385.2003; Moriwaki K, 2013, GENE DEV, V27, P1640, DOI 10.1101/gad.223321.113; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Park YH, 2013, BBA-PROTEINS PROTEOM, V1834, P292, DOI 10.1016/j.bbapap.2012.08.013; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; Sun XQ, 2002, J BIOL CHEM, V277, P9505, DOI 10.1074/jbc.M109488200; Takahashi N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.176; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308	18	439	456	8	168	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2014	343	6177					1357	1360		10.1126/science.1249361	http://dx.doi.org/10.1126/science.1249361			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD3AI	24557836				2022-12-28	WOS:000333108500038
J	Cruz-Martin, A; El-Danaf, RN; Osakada, F; Sriram, B; Dhande, OS; Nguyen, PL; Callaway, EM; Ghosh, A; Huberman, AD				Cruz-Martin, Alberto; El-Danaf, Rana N.; Osakada, Fumitaka; Sriram, Balaji; Dhande, Onkar S.; Nguyen, Phong L.; Callaway, Edward M.; Ghosh, Anirvan; Huberman, Andrew D.			A dedicated circuit links direction-selective retinal ganglion cells to the primary visual cortex	NATURE			English	Article							LATERAL GENICULATE-NUCLEUS; MOUSE; MOTION; MICE; IDENTIFICATION; PREFERENCES; PROJECTIONS; EXPRESSION; EXCITATION; REVEALS	How specific features in the environment are represented within the brain is an important unanswered question in neuroscience. A subset of retinal neurons, called direction-selective ganglion cells (DSGCs), are specialized for detecting motion along specific axes of the visual field(1). Despite extensive study of the retinal circuitry that endows DSGCs with their unique tuning properties(2,3), their downstream circuitry in the brain and thus their contribution to visual processing has remained unclear. In mice, several different types of DSGCs connect to the dorsal lateral geniculate nucleus (dLGN)(4-6), the visual thalamic structure that harbours cortical relay neurons. Whether direction-selective information computed at the level of the retina is routed to cortical circuits and integrated with other visual channels, however, is unknown. Here we show that there is a di-synaptic circuit linking DSGCs with the superficial layers of the primary visual cortex (V1) by using viral trans-synaptic circuit mapping(7,8) and functional imaging of visually driven calcium signals in thalamocortical axons. This circuit pools information from several types of DSGCs, converges in a specialized subdivision of the dLGN, and delivers direction-tuned and orientation-tuned signals to superficial V1. Notably, this circuit is anatomically segregated from the retino-geniculo-cortical pathway carrying non-direction-tuned visual information to deeper layers of V1, such as layer 4. Thus, the mouse harbours several functionally specialized, parallel retino-geniculo-cortical pathways, one of which originates with retinal DSGCs and delivers direction-and orientation-tuned information specifically to the superficial layers of the primary visual cortex. These data provide evidence that direction and orientation selectivity of some V1 neurons may be influenced by the activation of DSGCs.	[Cruz-Martin, Alberto; El-Danaf, Rana N.; Dhande, Onkar S.; Nguyen, Phong L.; Huberman, Andrew D.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Cruz-Martin, Alberto; El-Danaf, Rana N.; Sriram, Balaji; Dhande, Onkar S.; Nguyen, Phong L.; Huberman, Andrew D.] Univ Calif San Diego, Div Biol Sci, Neurobiol Sect, La Jolla, CA 92093 USA; [Osakada, Fumitaka; Callaway, Edward M.; Huberman, Andrew D.] Salk Inst Biol Studies, La Jolla, CA 92097 USA; [Ghosh, Anirvan] F Hoffmann La Roche & Cie AG, Neurosci Discovery, CH-4070 Basel, Switzerland; [Huberman, Andrew D.] Univ Calif San Diego, Dept Ophthalmol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Salk Institute; Roche Holding; University of California System; University of California San Diego	Huberman, AD (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.	ahuberman@ucsd.edu	Callaway, Edward/D-4336-2011; Cruz Martin, Alberto/ABE-7562-2021; Cruz-Martín, Alberto/AAO-5320-2020	Callaway, Edward/0000-0002-6366-5267; Osakada, Fumitaka/0000-0002-9078-1458; Cruz-Martin, Alberto/0000-0002-3271-7220; dhande, onkar/0000-0001-7584-9672	Vision Core [P30 EY019005]; Knights Templar Eye Foundation; Japan Society for the Promotion of Science; Kanae Foundation; Uehara Memorial Foundation; Naito Foundation; NINDS Circuits Training Grant; Gatsby Charitable Trusts; NIH [EY022577, MH063912, R01EY022157]; Whitehall Foundation; Ziegler Foundation for the Blind; Pew Charitable Trusts; McKnight Foundation; NATIONAL EYE INSTITUTE [P30EY019005, R01EY022157, R01EY022577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063912] Funding Source: NIH RePORTER	Vision Core; Knights Templar Eye Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kanae Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); NINDS Circuits Training Grant; Gatsby Charitable Trusts; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehall Foundation; Ziegler Foundation for the Blind; Pew Charitable Trusts; McKnight Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank the Kleinfeld laboratory for helpful advice, F. Rieke and M. Turner for example DSGC recording, and the Salk Viral Vector and Biophotonics staff. This work was supported by Vision Core P30 EY019005, the Knights Templar Eye Foundation (O.S.D.), Japan Society for the Promotion of Science (F.O.), Kanae Foundation (F.O.), Uehara Memorial Foundation (F.O.), Naito Foundation (F.O.), NINDS Circuits Training Grant (R.N.E.), Gatsby Charitable Trusts (E. M. C. and A. G.), NIH EY022577 and MH063912 (E. M. C.), Whitehall Foundation (A. D. H.), Ziegler Foundation for the Blind (A. D. H.), Pew Charitable Trusts (A. D. H.), The McKnight Foundation (A. D. H.), and NIH R01EY022157 (A.D.H.).	Atallah BV, 2012, NEURON, V73, P159, DOI 10.1016/j.neuron.2011.12.013; BARLOW HB, 1963, SCIENCE, V139, P412, DOI 10.1126/science.139.3553.412; Beier KT, 2013, J NEUROSCI, V33, P35, DOI 10.1523/JNEUROSCI.0245-12.2013; Bokil H, 2010, J NEUROSCI METH, V192, P146, DOI 10.1016/j.jneumeth.2010.06.020; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Chalupa L.M., 2003, VISUAL NEUROSCIENCES; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Dhande OS, 2013, J NEUROSCI, V33, P17797, DOI 10.1523/JNEUROSCI.2778-13.2013; Grubb MS, 2004, VISION RES, V44, P3365, DOI 10.1016/j.visres.2004.09.003; Hioki H, 2007, GENE THER, V14, P872, DOI 10.1038/sj.gt.3302924; Huberman AD, 2008, NEURON, V59, P425, DOI 10.1016/j.neuron.2008.07.018; Huberman AD, 2009, NEURON, V62, P327, DOI 10.1016/j.neuron.2009.04.014; KATZ LC, 1984, NATURE, V310, P498, DOI 10.1038/310498a0; Kay JN, 2011, J NEUROSCI, V31, P7753, DOI 10.1523/JNEUROSCI.0907-11.2011; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; Krahe TE, 2011, J NEUROSCI, V31, P17437, DOI 10.1523/JNEUROSCI.4370-11.2011; Land PW, 2004, BRAIN RES, V996, P251, DOI 10.1016/j.brainres.2003.10.032; Lee SH, 2012, NATURE, V488, P379, DOI 10.1038/nature11312; Li YT, 2013, NAT NEUROSCI, V16, P1324, DOI 10.1038/nn.3494; Lien AD, 2013, NAT NEUROSCI, V16, P1315, DOI 10.1038/nn.3488; Livingstone MS, 1998, NEURON, V20, P509, DOI 10.1016/S0896-6273(00)80991-5; Marshel JH, 2012, NEURON, V76, P713, DOI 10.1016/j.neuron.2012.09.021; Morin LP, 1999, VISUAL NEUROSCI, V16, P1037, DOI 10.1017/S0952523899166069; Murphy GJ, 2006, NEURON, V52, P511, DOI 10.1016/j.neuron.2006.09.014; Osakada F, 2013, NAT PROTOC, V8, P1583, DOI 10.1038/nprot.2013.094; Osakada F, 2011, NEURON, V71, P617, DOI 10.1016/j.neuron.2011.07.005; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Piscopo DM, 2013, J NEUROSCI, V33, P4642, DOI 10.1523/JNEUROSCI.5187-12.2013; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; RAFOLS JA, 1973, J COMP NEUROL, V150, P303, DOI 10.1002/cne.901500305; Rivlin-Etzion M, 2012, NEURON, V76, P518, DOI 10.1016/j.neuron.2012.08.041; Rivlin-Etzion M, 2011, J NEUROSCI, V31, P8760, DOI 10.1523/JNEUROSCI.0564-11.2011; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Volgyi B, 2005, J COMP NEUROL, V492, P66, DOI 10.1002/cne.20700; Wei W, 2011, TRENDS NEUROSCI, V34, P638, DOI 10.1016/j.tins.2011.08.002; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; ZACK GW, 1977, J HISTOCHEM CYTOCHEM, V25, P741, DOI 10.1177/25.7.70454	39	204	205	3	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2014	507	7492					358	+		10.1038/nature12989	http://dx.doi.org/10.1038/nature12989			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD1YG	24572358	Green Accepted			2022-12-28	WOS:000333029000034
J	Tang, RY; Li, G; Yu, JQ				Tang, Ri-Yuan; Li, Gang; Yu, Jin-Quan			Conformation-induced remote meta-C-H activation of amines	NATURE			English	Article							CARBON-HYDROGEN BONDS; ROOM-TEMPERATURE; OLEFINATION; OXYGENATION; SELECTIVITY; REACTIVITY; CATALYSTS; TEMPLATE; ARENES	Achieving site selectivity in carbon-hydrogen (C-H) functionalization reactions is a long-standing challenge in organic chemistry. The small differences in intrinsic reactivity of C-H bonds in any given organic molecule can lead to the activation of undesired C-H bonds by a non-selective catalyst. One solution to this problem is to distinguish C-H bonds on the basis of their location in the molecule relative to a specific functional group. In this context, the activation of C-H bonds five or six bonds away from a functional group by cyclometallation has been extensively studied(1-13). However, the directed activation of C-Hbonds that are distal to(more than six bonds away) functional groups has remained challenging, especially when the target C-H bond is geometrically inaccessible to directed metallation owing to the ring strain encountered in cyclometallation(14,15). Here we report a recyclable template that directs the olefination and acetoxylation of distal meta-C-H bonds-as far as 11 bonds away-of anilines and benzylicamines. This template is able to direct the meta-selective C-H functionalization of bicyclic heterocycles via a highly strained, tricyclic-cyclophane-like palladated intermediate. X-ray and nuclear magnetic resonance studies reveal that the conformational biases induced by a single fluorine substitution in the template can be enhanced by using a ligand to switch from ortho- to meta-selectivity.	[Tang, Ri-Yuan; Li, Gang; Yu, Jin-Quan] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	Scripps Research Institute	Yu, JQ (corresponding author), Scripps Res Inst, Dept Chem, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	yu200@scripps.edu	Tang, Ri-Yuan/J-5332-2015; Li, Gang/I-2960-2012; Li, Gang/ABF-3486-2021	Tang, Ri-Yuan/0000-0002-5764-8858; Li, Gang/0000-0001-5229-554X; Li, Gang/0000-0001-5229-554X	Scripps Research Institute; NIH (NIGMS) [1R01 GM102265]; National Natural Science Foundation of China [21202121]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102265] Funding Source: NIH RePORTER	Scripps Research Institute; NIH (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge The Scripps Research Institute and the NIH (NIGMS, 1R01 GM102265) for their financial support. R.-Y.T. is a visiting scholar from Wenzhou University and is sponsored by the National Natural Science Foundation of China (21202121).	Ackermann L, 2011, ORG LETT, V13, P4153, DOI 10.1021/ol201563r; Banks JW, 1999, J CHEM SOC PERK T 2, P2409, DOI 10.1039/a907452j; Boele MDK, 2002, J AM CHEM SOC, V124, P1586, DOI 10.1021/ja0176907; BRESLOW R, 1980, ACCOUNTS CHEM RES, V13, P170, DOI 10.1021/ar50150a002; Cho JY, 2002, SCIENCE, V295, P305, DOI 10.1126/science.1067074; Colby DA, 2010, CHEM REV, V110, P624, DOI 10.1021/cr900005n; Das S, 2006, SCIENCE, V312, P1941, DOI 10.1126/science.1127899; Daugulis O, 2009, ACCOUNTS CHEM RES, V42, P1074, DOI 10.1021/ar9000058; Desai LV, 2004, J AM CHEM SOC, V126, P9542, DOI 10.1021/ja046831c; Duong HA, 2011, ANGEW CHEM INT EDIT, V50, P463, DOI 10.1002/anie.201004704; Engle KM, 2012, ACCOUNTS CHEM RES, V45, P788, DOI 10.1021/ar200185g; Flemming JP, 2008, ORG BIOMOL CHEM, V6, P1215, DOI 10.1039/b716954j; Guimond N, 2011, J AM CHEM SOC, V133, P6449, DOI 10.1021/ja201143v; Hartung C. G., 2004, MODERN ARENE CHEM, P330, DOI DOI 10.1002/3527601767.CH10; Hofmann N, 2013, J AM CHEM SOC, V135, P5877, DOI 10.1021/ja401466y; Hull KL, 2007, J AM CHEM SOC, V129, P11904, DOI 10.1021/ja074395z; Ishiyama T, 2002, J AM CHEM SOC, V124, P390, DOI 10.1021/ja0173019; Jun CH, 1999, SYNLETT, P1; KAKIUCHI F, 1995, B CHEM SOC JPN, V68, P62, DOI 10.1246/bcsj.68.62; Leow D, 2012, NATURE, V486, P518, DOI 10.1038/nature11158; Park SH, 2011, ORG LETT, V13, P2372, DOI 10.1021/ol200600p; Paul S, 2010, ORGANOMETALLICS, V29, P4424, DOI 10.1021/om100789n; Rakshit S, 2011, J AM CHEM SOC, V133, P2350, DOI 10.1021/ja109676d; Saidi O, 2011, J AM CHEM SOC, V133, P19298, DOI 10.1021/ja208286b; Satoh T, 2010, CHEM-EUR J, V16, P11212, DOI 10.1002/chem.201001363; SCHWARZ H, 1989, ACCOUNTS CHEM RES, V22, P282, DOI 10.1021/ar00164a004; Wan L, 2013, J AM CHEM SOC, V135, P18056, DOI 10.1021/ja410760f; Wang DH, 2010, SCIENCE, V327, P315, DOI 10.1126/science.1182512; Ye MC, 2011, J AM CHEM SOC, V133, P6964, DOI 10.1021/ja2021075; Zhang YH, 2009, J AM CHEM SOC, V131, P5072, DOI 10.1021/ja900327e	30	400	406	13	373	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2014	507	7491					215	220		10.1038/nature12963	http://dx.doi.org/10.1038/nature12963			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC6RJ	24622200	Green Accepted			2022-12-28	WOS:000332651800035
J	Anderson, AS; Craigie, AM; Caswell, S; Treweek, S; Stead, M; Macleod, M; Daly, F; Belch, J; Rodger, J; Kirk, A; Ludbrook, A; Rauchhaus, P; Norwood, P; Thompson, J; Wardle, J; Steele, RJC				Anderson, Annie S.; Craigie, Angela M.; Caswell, Stephen; Treweek, Shaun; Stead, Martine; Macleod, Maureen; Daly, Fergus; Belch, Jill; Rodger, Jackie; Kirk, Alison; Ludbrook, Anne; Rauchhaus, Petra; Norwood, Patricia; Thompson, Joyce; Wardle, Jane; Steele, Robert J. C.			The impact of a bodyweight and physical activity intervention (BeWEL) initiated through a national colorectal cancer screening programme: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LIFE-STYLE INTERVENTION; WEIGHT-LOSS; PRIMARY-CARE; BODY-SIZE; REDUCTION; RISK; HEALTH; BREAST; ASSOCIATION; PROSTATE	Objective To evaluate the impact of a diet and physical activity intervention (BeWEL) on weight change in people with a body mass index >25 weight (kg)/height (m) 2 at increased risk of colorectal cancer and other obesity related comorbidities. Design Multicentre, parallel group, randomised controlled trial. Setting Four Scottish National Health Service health boards. Participants 329 overweight or obese adults (aged 50 to 74 years) who had undergone colonoscopy after a positive faecal occult blood test result, as part of the national bowel screening programme, and had a diagnosis of adenoma confirmed by histopathology. 163 were randomised to intervention and 166 to control. Intervention Participants were randomised to a control group (weight loss booklet only) or 12 month intervention group (three face to face visits with a lifestyle counsellor plus monthly 15 minute telephone calls). A goal of 7% reduction in body weight was set and participants received a personalised energy prescription (2508 kJ (600 kcal) below that required for weight maintenance) and bodyweight scales. Motivational interviewing techniques explored self assessed confidence, ambivalence, and personal values concerning weight. Behavioural strategies included goal setting, identifying intentions of implementation, self monitoring of body weight, and counsellor feedback about reported diet, physical activity, and weight change. Main outcome measures The primary outcome was weight change over 12 months. Secondary outcomes included changes in waist circumference, blood pressure, fasting cardiovascular biomarkers, and glucose metabolism variables, physical activity, diet, and alcohol consumption. Results At 12 months, data on the primary outcome were available for 148 (91%) participants in the intervention group and 157 (95%) in the control group. Mean weight loss was 3.50 kg (SD 4.91) (95% confidence interval 2.70 to 4.30) in the intervention group compared with 0.78 kg (SD 3.77) (0.19 to 1.38) in the control group. The group difference was 2.69 kg (95% confidence interval 1.70 to 3.67). Differences between groups were significant for waist circumference, body mass index, blood pressure, blood glucose level, diet, and physical activity. No reported adverse events were considered to be related to trial participation. Conclusions Significant weight loss can be achieved by a diet and physical activity intervention initiated within a national colorectal cancer screening programme, offering considerable potential for risk reduction of disease in older adults.	[Anderson, Annie S.; Craigie, Angela M.; Caswell, Stephen; Macleod, Maureen; Steele, Robert J. C.] Ninewells Med Sch, Ctr Res Canc Prevent & Screening, Canc Div, Med Res Inst, Dundee, Scotland; [Treweek, Shaun] Univ Aberdeen, Hlth Serv Res Unit, Aberdeen, Scotland; [Stead, Martine] Univ Stirling, Inst Social Mkt, Stirling FK9 4LA, Scotland; [Daly, Fergus] Frontier Sci Scotland, Kingussie, Inverness, Scotland; [Belch, Jill] Ninewells Med Sch, Med Res Inst, Vasc Dis Res Unit, Dundee, Scotland; [Rodger, Jackie] Univ Dundee, Ninewells Hosp & Med Sch, Dundee DD1 9SY, Scotland; [Kirk, Alison] Univ Strathclyde, Sch Psychol Sci & Hlth, Phys Act Hlth Res Grp, Glasgow, Lanark, Scotland; [Ludbrook, Anne; Norwood, Patricia] Univ Aberdeen, Hlth Econ Res Unit, Aberdeen, Scotland; [Rauchhaus, Petra] Univ Dundee, Ninewells Hosp & Med Sch, Tayside Med Sci Ctr, Tayside Clin Trials Unit, Dundee DD1 9SY, Scotland; [Thompson, Joyce] Kings Cross Hosp, Directorate Publ Hlth, NHS Tayside, Dundee, Scotland; [Wardle, Jane] UCL, Inst Epidemiol & Publ Hlth, Hlth Behav Res Ctr, London, England	University of Dundee; University of Aberdeen; University of Stirling; University of Dundee; University of Dundee; University of Strathclyde; University of Aberdeen; University of Dundee; University of London; University College London	Anderson, AS (corresponding author), Ninewells Med Sch, Ctr Res Canc Prevent & Screening, Canc Div, Med Res Inst, Dundee, Scotland.	a.s.anderson@dundee.ac.uk	Treweek, Shaun/AAE-8006-2019; Belch, Jill/AAE-9189-2019	Treweek, Shaun/0000-0002-7239-7241; Belch, Jill/0000-0001-8280-6689; Steele, Robert JC/0000-0003-4248-6785; anderson, annie/0000-0002-0047-4500; Macleod, Maureen/0000-0002-7536-8198; Stead, Martine/0000-0002-3066-4604	MRC National Prevention Research Initiative [G0802030]; Alzheimer's Research Trust; Alzheimer's Society; Biotechnology and Biological Sciences Research Council; Cancer Research UK; Chief Scientist Office, Scottish Government Health Directorate; Department of Health; Economic and Social Research Council; Engineering and Physical Sciences Research Council; Health and Social Care Research and Development Office for Northern Ireland; Medical Research Council; Welsh Assembly Government; World Cancer Research Fund; NHS Research Scotland; Chief Scientist Office of the Scottish Government Health Directorates; Diabetes UK; Cancer Research UK [14133] Funding Source: researchfish; Medical Research Council [G0802030] Funding Source: researchfish; Chief Scientist Office [HSRU1, HERU1] Funding Source: researchfish; MRC [G0802030] Funding Source: UKRI	MRC National Prevention Research Initiative(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer's Research Trust; Alzheimer's Society; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Chief Scientist Office, Scottish Government Health Directorate; Department of Health; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Health and Social Care Research and Development Office for Northern Ireland; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Welsh Assembly Government; World Cancer Research Fund(World Cancer Research Fund International (WCRF)); NHS Research Scotland; Chief Scientist Office of the Scottish Government Health Directorates; Diabetes UK(Diabetes UK); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the MRC National Prevention Research Initiative (www.npri.org.uk), grant award No G0802030. National Prevention Research Initiative is a national research initiative administered by the Medical Research Council made up of the following funding partners: Alzheimer's Research Trust; Alzheimer's Society; Biotechnology and Biological Sciences Research Council; Cancer Research UK; Chief Scientist Office, Scottish Government Health Directorate; Department of Health; Diabetes UK; Economic and Social Research Council; Engineering and Physical Sciences Research Council; Health and Social Care Research and Development Office for Northern Ireland; Medical Research Council; Welsh Assembly Government; and World Cancer Research Fund. Further financial support was provided by NHS Research Scotland to carry out this work. The Health Services Research Unit, University of Aberdeen, is core funded by the Chief Scientist Office of the Scottish Government Health Directorates.	American Institute of Cancer Research and the World Cancer Research Fund, 2007, FOOD NUTR PHYS ACT P; Anderson AS, 2013, CANCER PREV RES, V6, P165, DOI 10.1158/1940-6207.CAPR-12-0385; [Anonymous], 2013, NHS ROL PUBL HLTH NH; Babor TF, 1992, AUDIT ALCOHOL USE DI; Birks S, 2012, OBES REV, V13, P868, DOI 10.1111/j.1467-789X.2012.01010.x; British Heart Foundation, 2009, SO YOU WANT LOS WEIG; Cancer Research UK, 2013, BOW CANC STAT; Cappuccio FP, 2003, NUTR METAB CARDIOVAS, V13, P12, DOI 10.1016/S0939-4753(03)80163-1; Caswell S, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001276; Caswell S, 2009, BRIT J NUTR, V102, P1541, DOI 10.1017/S0007114509990808; Craigie AM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-184; de Bruijn KMJ, 2013, BRIT J SURG, V100, P1421, DOI 10.1002/bjs.9229; Dowswell G, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-255; Gollwitzer P.M., 1993, EUR REV SOC PSYCHOL, V4, DOI [10.1080/14792779343000059, DOI 10.1080/14792779343000059]; Health Promoting Health Service, 2013, OV 2009; Jacobs ET, 2007, CLIN GASTROENTEROL H, V5, P982, DOI 10.1016/j.cgh.2007.03.022; Jolly K, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6500; Kitahara CM, 2013, J CLIN ONCOL, V31, P2450, DOI 10.1200/JCO.2012.48.4691; Klabunde CN, 2007, ANN EPIDEMIOL, V17, P584, DOI 10.1016/j.annepidem.2007.03.011; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Larsen IK, 2007, CLIN GASTROENTEROL H, V5, P477, DOI 10.1016/j.cgh.2006.12.011; Mackey DC, 2011, J GERONTOL A-BIOL, V66, P1108, DOI 10.1093/gerona/glr101; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McBride CM, 2000, PSYCHO-ONCOLOGY, V9, P418, DOI 10.1002/1099-1611(200009/10)9:5<418::AID-PON474>3.0.CO;2-E; Miles A, 2003, CANCER EPIDEM BIOMAR, V12, P651; National Health Service, 2011, 5 DAY PORT SIZ; NHS National Service Division, 2013, SCOTT BOW SCREEN PRO; Robertson DJ, 2013, GUT; ROE L, 1994, FAM PRACT, V11, P375, DOI 10.1093/fampra/11.4.375; Rollnick S, 2010, BMJ-BRIT MED J, V340, P1242, DOI DOI 10.1136/BMJ.C190020423957; Romaguera D, 2010, AM J CLIN NUTR, V92, P912, DOI 10.3945/ajcn.2010.29482; Ross HM, 2008, BRIT J GEN PRACT, V58, P548, DOI 10.3399/bjgp08X319710; Royal College of Physicians, 2013, ACT OB COMPR CAR ALL; ScotCen Social Research, 2013, SCOTT HLTH SURV 2012; Sedjo RL, 2007, CANCER EPIDEM BIOMAR, V16, P526, DOI 10.1158/1055-9965.EPI-06-0229; Stead M, 2012, PREV MED, V54, P97, DOI 10.1016/j.ypmed.2011.10.017; Steele RJC, 2012, GUT, V61, P576, DOI 10.1136/gutjnl-2011-300535; Steele RJC, 2009, GUT, V58, P530, DOI 10.1136/gut.2008.162883; Steele RJC, 2004, BMJ-BRIT MED J, V329, P133, DOI 10.1136/bmj.38153.491887.7C; The Scottish Government, 2012, SCOTT IND MULT DEPR; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; Witham MD, 2010, AGE AGEING, V39, P176, DOI 10.1093/ageing/afp251; World Cancer Research Fund (WCRF)/American Institute for Cancer Research, 2013, CANC PREV EST BOD FA; World Health Organisation, 2004, STAND HLTH PROM HOSP; Yamaji Y, 2008, AM J GASTROENTEROL, V103, P2061, DOI 10.1111/j.1572-0241.2008.01936.x	45	52	52	0	29	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 7	2014	348								g1823	10.1136/bmj.g1823	http://dx.doi.org/10.1136/bmj.g1823			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC6JC	24609919	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000332627300003
J	Hamnvik, OPR; Becker, CB; Levy, BD; Loscalzo, J				Hamnvik, Ole-Petter R.; Becker, Carolyn B.; Levy, Bruce D.; Loscalzo, Joseph			Wasting Away	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HIV-INFECTED PATIENTS; TENOFOVIR; TOXICITY; HYPOPHOSPHATEMIA	A 40-year-old woman presented to the emergency department with pain, weakness, and poor oral intake. In the 3 months preceding presentation, she had noted the gradual onset of bilateral diffuse flank pain that progressed to affect her lower back, abdomen, and both arms and legs. ForewordIn this Journal feature, information about a real patient is presented in stages (boldface type) to an expert clinician, who responds to the information, sharing his or her reasoning with the reader (regular type). The authors' commentary follows.StageA 40-year-old woman presented to the emergency department with pain, weakness, and fatigue. During the 3 months before presentation, she noted the gradual onset of bilateral diffuse flank pain that spread to her lower back, abdomen, and both arms and legs. The pain was worse with movement, and she eventually became homebound. She had been unable to walk without assistance for the preceding 2 weeks. There were no other aggravating or relieving factors. The patient also reported poor appetite and reduced food intake and had lost approximately 4 kg. Nausea developed 2 days before presentation, and the patient became ...	Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Levy, BD (corresponding author), Brigham & Womens Hosp, Harvard Inst Med Bldg, Boston, MA 02115 USA.	blevy@partners.org	Loscalzo, Joseph/ABD-8980-2021; Hamnvik, Ole-Petter/D-1719-2011	Hamnvik, Ole-Petter/0000-0002-3600-2628	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007609] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32 HL007609] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adolescents PoAGfAa, 2013, GUIDELINES USE ANTIR; [Anonymous], 2011, NEW ENGL J MED, V365, P1625; Dienstag JL, 2008, NEW ENGL J MED, V359, P1486, DOI 10.1056/NEJMra0801644; Dienstag JL, 2010, NEW ENGL J MED, V363, P298; Gupta SK, 2005, CLIN INFECT DIS, V40, P1559, DOI 10.1086/430257; Hall AM, 2011, AM J KIDNEY DIS, V57, P773, DOI 10.1053/j.ajkd.2011.01.022; Haque SK, 2012, NEPHROL DIAL TRANSPL, V27, P4273, DOI 10.1093/ndt/gfs493; Jonsson KB, 2003, NEW ENGL J MED, V348, P1656, DOI 10.1056/NEJMoa020881; Labarga P, 2009, AIDS, V23, P689, DOI 10.1097/QAD.0b013e3283262a64; Malik Amyn, 2005, J Infect, V51, pE61, DOI 10.1016/j.jinf.2004.08.031; Nelson MR, 2007, AIDS, V21, P1273, DOI 10.1097/QAD.0b013e3280b07b33; Rodriguez-Novoa S, 2010, EXPERT OPIN DRUG SAF, V9, P545, DOI 10.1517/14740331003627458; Weisinger JR, 1998, LANCET, V352, P391, DOI 10.1016/S0140-6736(97)10535-9; Woodward CLN, 2009, HIV MED, V10, P482, DOI 10.1111/j.1468-1293.2009.00716.x	14	7	9	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 6	2014	370	10					959	966		10.1056/NEJMcps1305773	http://dx.doi.org/10.1056/NEJMcps1305773			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC2EB	24597870				2022-12-28	WOS:000332309800014
J	Khaleel, M; Puliyel, M				Khaleel, Maha; Puliyel, Mammen			Neonatal Lupus	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A baby boy born to apparently healthy parents had a bright red rash over his face within 2 hours after birth. He also had clinical features consistent with trisomy 21, which was confirmed by karyotyping. A baby boy born to apparently healthy parents had a bright red rash over his face within 2 hours after birth (Panel A). He also had clinical features consistent with trisomy 21, which was confirmed by karyotyping. The initial laboratory tests showed a hemoglobin level of 14 g per deciliter and a platelet count of 24,000 per cubic millimeter. An electrocardiogram at 4 weeks of age showed normal sinus rhythm, and the rash was reduced (Panel B). A complete blood count showed a white-cell count of 4500 per cubic millimeter with a normal differential count; the hemoglobin level was 8.8 ...	[Khaleel, Maha; Puliyel, Mammen] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA	Children's Hospital Los Angeles	Khaleel, M (corresponding author), Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA.	mkhaleel@chla.usc.edu	Puliyel, Mammen/I-7477-2017	Puliyel, Mammen/0000-0003-0700-5341					0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 6	2014	370	10					958	958		10.1056/NEJMicm1307809	http://dx.doi.org/10.1056/NEJMicm1307809			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC2EB	24597869				2022-12-28	WOS:000332309800013
J	Wynia, MK; Kishore, SP; Belar, CD				Wynia, Matthew K.; Kishore, Sandeep P.; Belar, Cynthia D.			A Unified Code of Ethics for Health Professionals Insights From an IOM Workshop	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Wynia, Matthew K.] Amer Med Assoc, Chicago, IL 60611 USA; [Wynia, Matthew K.] Univ Chicago, Chicago, IL 60637 USA; [Kishore, Sandeep P.] Rockefeller Univ, Weill Cornell Med Coll, New York, NY 10021 USA; [Kishore, Sandeep P.] Sloan Kettering Inst, New York, NY USA; [Kishore, Sandeep P.] Young Profess Chron Dis Network, New York, NY USA; [Belar, Cynthia D.] Amer Psychol Assoc, Washington, DC 20036 USA	American Medical Association; University of Chicago; Cornell University; Rockefeller University; Memorial Sloan Kettering Cancer Center	Wynia, MK (corresponding author), Amer Med Assoc, 330 N Wabash Ave, Chicago, IL 60611 USA.	matthew.wynia@ama-assn.org	Wynia, Matthew/T-2210-2019					Cuff PA, 2013, EST TRANSD PROF IMPR; Hafferty FW, 2013, ABMS PROFESSIONALISM; Huber SJ, 2004, AM J BIOETHICS, V4, pW5; McGraw DK, 2004, J INFORM COMMUNICATI, V2, P235; Rousseau Jean--Jacques, 1762, SOCIAL CONTRACT PRIN; Sullivan WM, 2000, CAN MED ASSOC J, V162, P673; Wynia MK, 2012, JAMA-J AM MED ASSOC, V308, P1327, DOI 10.1001/jama.2012.12601	7	11	11	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 26	2014	311	8					799	800		10.1001/jama.2014.504	http://dx.doi.org/10.1001/jama.2014.504			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB4XQ	24570240				2022-12-28	WOS:000331793700017
J	Kamata, H; Akagi, Y; Kayasuga-Kariya, Y; Chung, U; Sakai, T				Kamata, Hiroyuki; Akagi, Yuki; Kayasuga-Kariya, Yuko; Chung, Ung-il; Sakai, Takamasa			"Nonswellable" Hydrogel Without Mechanical Hysteresis	SCIENCE			English	Article							DOUBLE-NETWORK HYDROGELS; MODULUS	Hydrogels are three-dimensional polymer networks that contain a large amount of water inside. Certain hydrogels can be injected in solution and transformed into the gel state with the required shape. Despite their potential biomedical applications, the use of hydrogels has been severely limited because all the conventional hydrogels inevitably "swell" under physiological conditions, which drastically degrades their mechanical properties. We report the synthesis of injectable "nonswellable" hydrogels from hydrophilic and thermoresponsive polymers, in which two independently occurring effects (swelling and shrinking) oppose each other. The hydrogels can endure a compressive stress up to 60 megapascals and can be stretched more than sevenfold without hysteresis. Our results demonstrate that the suppression of swelling helps retain the mechanical properties of hydrogels under physiological conditions.	[Kamata, Hiroyuki; Akagi, Yuki; Kayasuga-Kariya, Yuko; Chung, Ung-il; Sakai, Takamasa] Univ Tokyo, Sch Engn, Dept Bioengn, Bunkyo Ku, Tokyo 1138656, Japan; [Chung, Ung-il] Univ Tokyo, Sch Med, Div Clin Biotechnol, Ctr Dis Biol & Integrat Med,Bunkyo Ku, Tokyo 1130033, Japan; [Chung, Ung-il] Tokyo Univ Hosp, Div Tissue Engn, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Sakai, T (corresponding author), Univ Tokyo, Sch Engn, Dept Bioengn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	sakai@tetrapod.t.u-tokyo.ac.jp	Kamata, Hiroyuki/AAW-9435-2020	Kamata, Hiroyuki/0000-0002-5933-8677; Sakai, Takamasa/0000-0001-5052-0512	Japan Society for the Promotion of Science (JSPS); Center for Medical System Innovation (CMSI); Graduate Program for Leaders in Life Innovation (GPLLI); International Core Research Center for Nanobio; Core-to-Core Program; A. Advanced Research Networks; Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST program); Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT) through the Center for NanoBio Integration (CNBI); MEXT [23700555, 24240069]; Japan Science and Technology Agency (JST) through the S-innovation program; COI STREAM	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Center for Medical System Innovation (CMSI); Graduate Program for Leaders in Life Innovation (GPLLI); International Core Research Center for Nanobio; Core-to-Core Program; A. Advanced Research Networks; Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT) through the Center for NanoBio Integration (CNBI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (JST) through the S-innovation program; COI STREAM	This work was supported by the Japan Society for the Promotion of Science (JSPS) through the Grants-in-Aid for Scientific Research, the Center for Medical System Innovation (CMSI), the Graduate Program for Leaders in Life Innovation (GPLLI), the International Core Research Center for Nanobio, Core-to-Core Program, A. Advanced Research Networks, and the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST program); the Ministry of Education, Culture, Sports, Science, and Technology in Japan (MEXT) through the Center for NanoBio Integration (CNBI) and Grants-in-Aid for Scientific Research from MEXT (23700555 to T. S. and 24240069 to U. C.); the Japan Science and Technology Agency (JST) through the S-innovation program and COI STREAM.	Appel EA, 2012, CHEM SOC REV, V41, P6195, DOI 10.1039/c2cs35264h; Chung JE, 1998, J CONTROL RELEASE, V53, P119, DOI 10.1016/S0168-3659(97)00244-7; Cui J, 2012, MACROMOLECULES, V45, P6104, DOI 10.1021/ma300593g; Gong JP, 2003, ADV MATER, V15, P1155, DOI 10.1002/adma.200304907; Haraguchi K, 2002, ADV MATER, V14, P1120, DOI 10.1002/1521-4095(20020816)14:16<1120::AID-ADMA1120>3.0.CO;2-9; Haraguchi K, 2011, MACROMOL RAPID COMM, V32, P1253, DOI 10.1002/marc.201100248; Heskins M., 1968, J MACROMOL SCI CHEM, V2, P1441, DOI DOI 10.1080/10601326808051910; Hoffman AS, 2012, ADV DRUG DELIVER REV, V64, P18, DOI 10.1016/j.addr.2012.09.010; JANMEY PA, 1994, J BIOL CHEM, V269, P32503; Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x; Li J, 2006, BIOMATERIALS, V27, P4132, DOI 10.1016/j.biomaterials.2006.03.025; Mithieux SM, 2004, BIOMATERIALS, V25, P4921, DOI 10.1016/j.biomaterials.2004.01.055; Nakajima T, 2013, SOFT MATTER, V9, P1955, DOI 10.1039/c2sm27232f; Nicodemus GD, 2008, TISSUE ENG PT B-REV, V14, P149, DOI 10.1089/ten.teb.2007.0332; OBUKHOV SP, 1994, MACROMOLECULES, V27, P3191, DOI 10.1021/ma00090a012; Okumura Y, 2001, ADV MATER, V13, P485, DOI 10.1002/1521-4095(200104)13:7<485::AID-ADMA485>3.0.CO;2-T; Phadke A, 2012, P NATL ACAD SCI USA, V109, P4383, DOI 10.1073/pnas.1201122109; Reinicke S, 2009, SOFT MATTER, V5, P2648, DOI 10.1039/b900539k; Sakai T, 2008, MACROMOLECULES, V41, P5379, DOI 10.1021/ma800476x; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Sun JY, 2012, NATURE, V489, P133, DOI 10.1038/nature11409; Wang Q, 2010, NATURE, V463, P339, DOI 10.1038/nature08693	22	426	435	55	974	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 21	2014	343	6173					873	875		10.1126/science.1247811	http://dx.doi.org/10.1126/science.1247811			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB1LG	24558157				2022-12-28	WOS:000331552600042
J	Shi, PY				Shi, Pei-Yong			Unraveling a Flavivirus Enigma	SCIENCE			English	Editorial Material							NONSTRUCTURAL PROTEIN NS1; WEST-NILE-VIRUS; COMPLEMENT		Novartis Inst Trop Dis, Singapore 138670, Singapore	Novartis	Shi, PY (corresponding author), Novartis Inst Trop Dis, 10 Biopolis Rd,05-01 Chromos, Singapore 138670, Singapore.	pei_yong.shi@novartis.com						Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749; Alcon-LePoder S, 2005, J VIROL, V79, P11403, DOI 10.1128/JVI.79.17.11403-11411.2005; Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949; BRANDT WE, 1970, J VIROL, V6, P500, DOI 10.1128/JVI.6.4.500-506.1970; Chung KM, 2006, P NATL ACAD SCI USA, V103, P19111, DOI 10.1073/pnas.0605668103; Gutsche I, 2011, P NATL ACAD SCI USA, V108, P8003, DOI 10.1073/pnas.1017338108; Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813; Lindenbach BD, 1999, J VIROL, V73, P4611, DOI 10.1128/JVI.73.6.4611-4621.1999; Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008; Rathore APS, 2011, ANTIVIR RES, V92, P453, DOI 10.1016/j.antiviral.2011.10.002; WINKLER G, 1989, VIROLOGY, V171, P302, DOI 10.1016/0042-6822(89)90544-8; Youn S, 2012, J VIROL, V86, P7360, DOI 10.1128/JVI.00157-12	12	11	11	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 21	2014	343	6173					849	850		10.1126/science.1251249	http://dx.doi.org/10.1126/science.1251249			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB1LG	24558152				2022-12-28	WOS:000331552600035
J	Neumann, I; Brignardello-Petersen, R; Guyatt, G				Neumann, Ignacio; Brignardello-Petersen, Romina; Guyatt, Gordon			Review: Novel oral anticoagulants reduce stroke more than ASA in nonvalvular atrial fibrillation	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Neumann, Ignacio] Pontificia Univ Catolica Chile, Santiago, Region Metropol, Chile; [Brignardello-Petersen, Romina] Univ Toronto, Toronto, ON, Canada; [Guyatt, Gordon] McMaster Univ, Hamilton, ON, Canada	Pontificia Universidad Catolica de Chile; University of Toronto; McMaster University	Neumann, I (corresponding author), Pontificia Univ Catolica Chile, Santiago, Region Metropol, Chile.		Neumann, Ignacio/ABB-5013-2020					GUYATT G, 2011, INT J SURG, V64, P383, DOI DOI 10.1016/J.JCLINEPI.2010.04.026	1	2	3	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 18	2014	160	4							JC3	10.7326/0003-4819-160-4-201402180-02003	http://dx.doi.org/10.7326/0003-4819-160-4-201402180-02003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC8RF	24534937				2022-12-28	WOS:000350635100002
J	KONDO, S; ASAI, R				KONDO, S; ASAI, R			A REACTION-DIFFUSION WAVE ON THE SKIN OF THE MARINE ANGELFISH POMACANTHUS	NATURE			English	Article							SPOTS	IN 1952, Turing proposed a hypothetical molecular mechanism, called the reaction-diffusion system(1), which can develop periodic patterns from an initially homogeneous state. Many theoretical models based on reaction-diffusion have been proposed to account for patterning phenomena in morphogenesis(2-4), but, as yet, there is no conclusive experimental evidence for the existence of such a system in the field of biology(5-8). The marine angelfish, Pomacanthus, has stripe patterns which are not fixed in their skin. Unlike mammal skin patterns, which simply enlarge proportionally during their body growth, the stripes of Pomacanthus maintain the spaces between the lines by the continuous rearrangement of the patterns. Although the pattern alteration varies depending on the conformation of the stripes, a simulation program based on a Turing system can correctly predict future patterns. The striking similarity between the actual and simulated pattern rearrangement strongly suggests that a reaction-diffusion wave is a viable mechanism for the stripe pattern of Pomacanthus.	KYOTO UNIV,SETO MARINE BIOL LAB,SHIRAHAMA,WAKAYAMA,JAPAN	Kyoto University	KONDO, S (corresponding author), KYOTO UNIV,CTR MOLEC BIOL & GENET,SAKYO KU,SHOGOIN KAWAHARACHO 53,KYOTO,JAPAN.			Kondo, Shigeru/0000-0003-0192-5526				BUNNING E, 1948, Z NATURFORSCH B, V3, P203; DAWES EA, 1956, QUANTITATIVE PROBLEM; KAUFFMAN SA, 1984, PATTERN FORMATION, P73; LACALLI TC, 1981, PHILOS T R SOC B, V294, P547, DOI 10.1098/rstb.1981.0118; LENGYEL I, 1991, SCIENCE, V251, P650, DOI 10.1126/science.251.4994.650; MEINHARDT H, 1992, REP PROG PHYS, V55, P797, DOI 10.1088/0034-4885/55/6/003; Meinhardt H., 1982, MODELS BIOL PATTERN; MELNHARDT H, 1989, DEVELOPMENT S, V107, P169; MURRAY JD, 1988, SCI AM, V258, P80, DOI 10.1038/scientificamerican0388-80; OUYANG Q, 1991, NATURE, V352, P610, DOI 10.1038/352610a0; POOL R, 1991, SCIENCE, V251, P627, DOI 10.1126/science.1992515; SEGEL LA, 1972, J THEOR BIOL, V37, P545, DOI 10.1016/0022-5193(72)90090-2; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Wigglesworth VB, 1940, J EXP BIOL, V17, P180; WINFREE AT, 1991, NATURE, V352, P568, DOI 10.1038/352568a0	15	573	595	2	100	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	AUG 31	1995	376	6543					765	768		10.1038/376765a0	http://dx.doi.org/10.1038/376765a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	RR836	24547605				2022-12-28	WOS:A1995RR83600037
J	Razumilava, N; Gores, GJ				Razumilava, Nataliya; Gores, Gregory J.			Cholangiocarcinoma	LANCET			English	Article							PRIMARY SCLEROSING CHOLANGITIS; STEREOTACTIC BODY RADIOTHERAPY; IN-SITU HYBRIDIZATION; C VIRUS-INFECTION; INTRAHEPATIC CHOLANGIOCARCINOMA; RISK-FACTORS; HILAR CHOLANGIOCARCINOMA; BILIARY-TRACT; UNITED-STATES; HEPATITIS-C	Cholangiocarcinoma represents a diverse group of epithelial cancers united by late diagnosis and poor outcomes. Specifi c diagnostic and therapeutic approaches are undertaken for cholangiocarcinomas of different anatomical locations (intrahepatic, perihilar, and distal). Mixed hepatocellular cholangiocarcinomas have emerged as a distinct subtype of primary liver cancer. Clinicians need to be aware of intrahepatic cholangiocarcinomas arising in cirrhosis and properly assess liver masses in this setting for cholangiocarcinoma. Management of biliary obstruction is obligatory in perihilar cholangiocarcinoma, and advanced cytological tests such as fluorescence in-situ hybridisation for aneusomy are helpful in the diagnosis. Liver transplantation is a curative option for selected patients with perihilar but not with intrahepatic or distal cholangiocarcinoma. International efforts of clinicians and scientists are helping to identify the genetic drivers of cholangiocarcinoma progression, which will unveil early diagnostic markers and direct development of individualised therapies.	[Razumilava, Nataliya; Gores, Gregory J.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA	Mayo Clinic	Gores, GJ (corresponding author), Mayo Clin, Rochester, MN 55905 USA.	gores.gregory@mayo.edu			US National Institutes of Health [DK59427, T32 DK007198]; Mayo Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK059427, R56DK059427, T32DK007198] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by US National Institutes of Health grants DK59427 (GJG) and T32 DK007198 (NR), and the Mayo Foundation. We thank Konstantinos Lazaridis for contributing to the discussion of cholangiocarcinoma treatment in the context of personalised medicine, and Courtney Hoover for secretarial support.	Akiba J, 2013, AM J SURG PATHOL, V37, P496, DOI 10.1097/PAS.0b013e31827332b0; Andersen JB, 2012, GASTROENTEROLOGY, V142, P1021, DOI 10.1053/j.gastro.2011.12.005; Anderson CD, 2004, J GASTROINTEST SURG, V8, P90, DOI 10.1016/j.gassur.2003.10.003; Liberato MJA, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-103; Barney BM, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-67; Bergquist A, 2002, J HEPATOL, V36, P321, DOI 10.1016/S0168-8278(01)00288-4; Berman DM, 2003, NATURE, V425, P846, DOI 10.1038/nature01972; Beuers U, 2009, J HEPATOL, V51, P237, DOI 10.1016/j.jhep.2009.04.009; Blechacz B, 2008, HEPATOLOGY, V48, P308, DOI 10.1002/hep.22310; Blechacz B, 2011, NAT REV GASTRO HEPAT, V8, P512, DOI 10.1038/nrgastro.2011.131; Boberg KM, 2002, SCAND J GASTROENTERO, V37, P1205, DOI 10.1080/003655202760373434; Borger DR, 2012, ONCOLOGIST, V17, P72, DOI 10.1634/theoncologist.2011-0386; Chaiteerakij R, 2013, HEPATOLOGY, V57, P648, DOI 10.1002/hep.26092; Chalasani N, 2000, HEPATOLOGY, V31, P7, DOI 10.1002/hep.510310103; Chang WH, 1998, GASTROINTEST ENDOSC, V47, P354, DOI 10.1016/S0016-5107(98)70218-4; Chapman MH, 2012, EUR J GASTROEN HEPAT, V24, P1051, DOI 10.1097/MEG.0b013e3283554bbf; Chapman R, 2010, HEPATOLOGY, V51, P660, DOI 10.1002/hep.23294; Charatcharoenwitthaya P, 2008, HEPATOLOGY, V48, P1106, DOI 10.1002/hep.22441; Chong YS, 2012, CLIN RADIOL, V67, P766, DOI 10.1016/j.crad.2012.01.004; Chung JY, 2009, CLIN CANCER RES, V15, P660, DOI 10.1158/1078-0432.CCR-08-1084; Claessen MMH, 2009, J HEPATOL, V50, P158, DOI 10.1016/j.jhep.2008.08.013; DeOliveira ML, 2007, ANN SURG, V245, P755, DOI 10.1097/01.sla.0000251366.62632.d3; DeOliveira ML, 2011, HEPATOLOGY, V53, P1363, DOI 10.1002/hep.24227; DEVIERE J, 1988, GASTROINTEST ENDOSC, V34, P95, DOI 10.1016/S0016-5107(88)71271-7; Dill MT, 2013, HEPATOLOGY, V57, P1607, DOI 10.1002/hep.26165; Donato F, 2001, CANCER CAUSE CONTROL, V12, P959, DOI 10.1023/A:1013747228572; El Khatib M, 2013, HEPATOLOGY, V57, P1035, DOI 10.1002/hep.26147; El-Serag HB, 2009, HEPATOLOGY, V49, P116, DOI 10.1002/hep.22606; Endo I, 2008, ANN SURG, V248, P84, DOI 10.1097/SLA.0b013e318176c4d3; Erez N, 2013, NATURE, V500, P37, DOI 10.1038/nature12459; Everhart JE, 2009, GASTROENTEROLOGY, V136, P1134, DOI 10.1053/j.gastro.2009.02.038; Fan B, 2012, J CLIN INVEST, V122, P2911, DOI 10.1172/JCI63212; Fingas CD, 2011, HEPATOLOGY, V54, P2076, DOI 10.1002/hep.24588; Fingas CD, 2010, HEPATOLOGY, V52, P550, DOI 10.1002/hep.23729; Fritcher EGB, 2011, AM J GASTROENTEROL, V106, P2023, DOI 10.1038/ajg.2011.272; Galassi M, 2013, LIVER INT, V33, P771, DOI 10.1111/liv.12124; Geynisman DM, 2012, DISCOV MED, V14, P41; Gonda TA, 2012, GASTROINTEST ENDOSC, V75, P74, DOI 10.1016/j.gie.2011.08.022; Han W, 2012, CANCER LETT, V318, P124, DOI 10.1016/j.canlet.2012.01.011; Heimbach JK, 2011, HPB, V13, P356, DOI 10.1111/j.1477-2574.2011.00298.x; Hemming AW, 2011, J AM COLL SURGEONS, V212, P604, DOI 10.1016/j.jamcollsurg.2010.12.028; Hezel AF, 2010, J CLIN ONCOL, V28, P3531, DOI 10.1200/JCO.2009.27.4787; Hoffmann RT, 2012, CARDIOVASC INTER RAD, V35, P105, DOI 10.1007/s00270-011-0142-x; Hofmann JJ, 2010, DEVELOPMENT, V137, P4061, DOI 10.1242/dev.052118; Hong YK, 2011, EJSO-EUR J SURG ONC, V37, P237, DOI 10.1016/j.ejso.2010.12.010; Honjo S, 2005, INT J CANCER, V117, P854, DOI 10.1002/ijc.21146; Huang MH, 2005, J GASTROEN HEPATOL, V20, P141, DOI 10.1111/j.1440-1746.2004.03523.x; Hwang J, 2012, J MAGN RESON IMAGING, V36, P881, DOI 10.1002/jmri.23728; Iavarone M, 2013, J HEPATOL, V58, P1188, DOI 10.1016/j.jhep.2013.02.013; Isayama H, 2004, GUT, V53, P729, DOI 10.1136/gut.2003.018945; Ishida Masaharu, 2013, Curr Anesthesiol Rep, V1, P63; Jinawath A, 2007, J CANCER RES CLIN, V133, P271, DOI 10.1007/s00432-006-0166-9; Kaewpitoon N, 2008, WORLD J GASTROENTERO, V14, P666, DOI 10.3748/wjg.14.666; Kahaleh M, 2005, GASTROINTEST ENDOSC, V61, P528, DOI 10.1016/S0016-5107(04)02593-3; Katabi N, 2012, AM J SURG PATHOL, V36, P1647, DOI 10.1097/PAS.0b013e3182684d4f; Khan SA, 2012, GUT, V61, P1657, DOI 10.1136/gutjnl-2011-301748; Khan SA, 2012, J HEPATOL, V56, P848, DOI 10.1016/j.jhep.2011.11.015; Kiefer MV, 2011, CANCER-AM CANCER SOC, V117, P1498, DOI 10.1002/cncr.25625; Kim JH, 2011, AM J ROENTGENOL, V196, pW205, DOI 10.2214/AJR.10.4937; Kim SH, 2012, J COMPUT ASSIST TOMO, V36, P704, DOI 10.1097/RCT.0b013e3182706562; Kipp BR, 2012, HUM PATHOL, V43, P1552, DOI 10.1016/j.humpath.2011.12.007; Kisiel JB, 2012, CANCER-AM CANCER SOC, V118, P2623, DOI 10.1002/cncr.26558; Ko KS, 2013, CURR OPIN GASTROEN, V29, P312, DOI 10.1097/MOG.0b013e32835d6a3e; Komuta M, 2012, HEPATOLOGY, V55, P1876, DOI 10.1002/hep.25595; Kopek N, 2010, RADIOTHER ONCOL, V94, P47, DOI 10.1016/j.radonc.2009.11.004; Krokidis M, 2010, CARDIOVASC INTER RAD, V33, P97, DOI 10.1007/s00270-009-9604-9; Kuhlmann JB, 2012, EUR J GASTROEN HEPAT, V24, P437, DOI 10.1097/MEG.0b013e3283502241; Kullman E, 2010, GASTROINTEST ENDOSC, V72, P915, DOI 10.1016/j.gie.2010.07.036; Lan BY, 2012, AM J SURG, V204, P232, DOI 10.1016/j.amjsurg.2011.07.025; Lee D, 2012, MODERN PATHOL, V25, P131, DOI 10.1038/modpathol.2011.133; Lee J, 2012, LANCET ONCOL, V13, P181, DOI 10.1016/S1470-2045(11)70301-1; Lee TY, 2008, AM J GASTROENTEROL, V103, P1716, DOI 10.1111/j.1572-0241.2008.01796.x; Levy C, 2005, DIGEST DIS SCI, V50, P1734, DOI 10.1007/s10620-005-2927-8; Levy MJ, 2012, CURR OPIN GASTROEN, V28, P244, DOI 10.1097/MOG.0b013e32835005bc; Lewis JT, 2010, AM J SURG PATHOL, V34, P27, DOI 10.1097/PAS.0b013e3181bc96f9; Li YY, 2011, J GASTROINTEST SURG, V15, P608, DOI 10.1007/s11605-011-1419-8; McLean L, 2006, LIVER INT, V26, P1047, DOI 10.1111/j.1478-3231.2006.01350.x; Mertens JC, 2013, CANCER RES, V73, P897, DOI 10.1158/0008-5472.CAN-12-2130; Mouly C, 2013, HPB, V15, P638, DOI 10.1111/hpb.12035; Murad SD, 2012, HEPATOLOGY, V56, P972, DOI 10.1002/hep.25629; Nagorney David M, 2006, Adv Surg, V40, P159, DOI 10.1016/j.yasu.2006.05.009; NAGORNEY DM, 1993, ARCH SURG-CHICAGO, V128, P871; Nakanuma Y, 2010, WORLD J HEPATOL, V2, P419, DOI 10.4254/wjh.v2.i12.419; Nehls O, 2004, SEMIN LIVER DIS, V24, P139, DOI 10.1055/s-2004-828891; Ong CK, 2012, NAT GENET, V44, P690, DOI 10.1038/ng.2273; Oseini AM, 2011, HEPATOLOGY, V54, P940, DOI 10.1002/hep.24487; Palmer WC, 2012, J HEPATOL, V57, P69, DOI 10.1016/j.jhep.2012.02.022; Park SY, 2011, CLIN RADIOL, V66, P322, DOI 10.1016/j.crad.2010.11.002; Patel AH, 2000, AM J GASTROENTEROL, V95, P204; Polistina FA, 2011, RADIOTHER ONCOL, V99, P120, DOI 10.1016/j.radonc.2011.05.016; Rafi S, 2013, CARDIOVASC INTER RAD, V36, P440, DOI 10.1007/s00270-012-0463-4; Raju RP, 2011, DIGEST DIS SCI, V56, P1557, DOI 10.1007/s10620-010-1550-5; Razumilava N, 2013, CLIN GASTROENTEROL H, V11, P13, DOI 10.1016/j.cgh.2012.09.009; Razumilava N, 2012, HEPATOLOGY, V55, P465, DOI 10.1002/hep.24698; Razumilava N, 2011, HEPATOLOGY, V54, P1842, DOI 10.1002/hep.24570; Razumilava N, 2011, J HEPATOL, V54, P577, DOI 10.1016/j.jhep.2010.10.010; Reitman ZJ, 2010, CANCER CELL, V17, P215, DOI 10.1016/j.ccr.2010.02.024; Rimola J, 2009, HEPATOLOGY, V50, P791, DOI 10.1002/hep.23071; Rohle D, 2013, SCIENCE, V340, P626, DOI 10.1126/science.1236062; Rosen CB, 2010, TRANSPL INT, V23, P692, DOI 10.1111/j.1432-2277.2010.01108.x; Roskams T, 2006, ONCOGENE, V25, P3818, DOI 10.1038/sj.onc.1209558; Ruys AT, 2012, BRIT J RADIOL, V85, P1255, DOI 10.1259/bjr/88405305; Sangchan A, 2012, GASTROINTEST ENDOSC, V76, P93, DOI 10.1016/j.gie.2012.02.048; Sansone P, 2012, J CLIN ONCOL, V30, P1005, DOI 10.1200/JCO.2010.31.8907; Sapisochin G, 2011, LIVER TRANSPLANT, V17, P934, DOI 10.1002/lt.22307; Schnitzbauer AA, 2012, ANN SURG, V255, P405, DOI 10.1097/SLA.0b013e31824856f5; Sekiya S, 2012, J CLIN INVEST, V122, P3914, DOI 10.1172/JCI63065; Shaib Y, 2004, SEMIN LIVER DIS, V24, P115, DOI 10.1055/s-2004-828889; Shaib YH, 2005, GASTROENTEROLOGY, V128, P620, DOI 10.1053/j.gastro.2004.12.048; Shen WF, 2011, WORLD J SURG, V35, P2083, DOI 10.1007/s00268-011-1171-y; Shin HR, 1996, INT J EPIDEMIOL, V25, P933, DOI 10.1093/ije/25.5.933; Sia D, 2013, ONCOGENE, V32, P4861, DOI 10.1038/onc.2012.617; Sia D, 2013, GASTROENTEROLOGY, V144, P829, DOI 10.1053/j.gastro.2013.01.001; Sinakos E, 2011, CLIN GASTROENTEROL H, V9, P434, DOI 10.1016/j.cgh.2011.02.007; Sirica AE, 2012, NAT REV GASTRO HEPAT, V9, P44, DOI 10.1038/nrgastro.2011.222; Soderlund C, 2006, GASTROINTEST ENDOSC, V63, P986, DOI 10.1016/j.gie.2005.11.052; Soreide K, 2004, BRIT J SURG, V91, P1538, DOI 10.1002/bjs.4815; Stone JH, 2012, NEW ENGL J MED, V366, P539, DOI 10.1056/NEJMra1104650; Takahashi K, 2013, CLIN BIOCHEM, V46, P946, DOI 10.1016/j.clinbiochem.2013.01.025; Tocchi A, 2001, ANN SURG, V234, P210, DOI 10.1097/00000658-200108000-00011; Tyson GL, 2011, HEPATOLOGY, V54, P173, DOI 10.1002/hep.24351; Valle J, 2010, NEW ENGL J MED, V362, P1273, DOI 10.1056/NEJMoa0908721; van der Gaag NA, 2010, NEW ENGL J MED, V362, P129, DOI 10.1056/NEJMoa0903230; Venkatesh PGK, 2013, DIGEST DIS SCI, V58, P850, DOI 10.1007/s10620-012-2401-3; Vienne A, 2010, GASTROINTEST ENDOSC, V72, P728, DOI 10.1016/j.gie.2010.06.040; Vilgrain V, 2008, HPB, V10, P106, DOI 10.1080/13651820801992617; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Vogl TJ, 2012, INT J CANCER, V131, P733, DOI 10.1002/ijc.26407; Wadsworth CA, 2013, CURR OPIN GASTROEN, V29, P305, DOI 10.1097/MOG.0b013e32835faacc; Wang F, 2013, SCIENCE, V340, P622, DOI 10.1126/science.1234769; Wang P, 2013, ONCOGENE, V32, P3091, DOI 10.1038/onc.2012.315; Welzel TM, 2007, INT J CANCER, V120, P638, DOI 10.1002/ijc.22283; Welzel TM, 2011, HEPATOLOGY, V54, P463, DOI 10.1002/hep.24397; Wu YM, 2013, CANCER DISCOV, V3, P636, DOI 10.1158/2159-8290.CD-13-0050; Xu HX, 2012, BRIT J RADIOL, V85, P1078, DOI 10.1259/bjr/24563774; Yamamoto S, 2004, CANCER SCI, V95, P592, DOI 10.1111/j.1349-7006.2004.tb02492.x; Yamasaki Susumu, 2003, J Hepatobiliary Pancreat Surg, V10, P288, DOI 10.1007/s00534-002-0732-8; Yeoh KG, 1999, GASTROINTEST ENDOSC, V49, P466, DOI 10.1016/S0016-5107(99)70044-1; Yoshikawa D, 2008, BRIT J CANCER, V98, P418, DOI 10.1038/sj.bjc.6604129; Zabron A, 2013, DIS MODEL MECH, V6, P281, DOI 10.1242/dmm.010561; Zhou YM, 2008, WORLD J GASTROENTERO, V14, P632, DOI 10.3748/wjg.14.632	141	1045	1147	12	182	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 21	2014	383	9935					2168	2179		10.1016/S0140-6736(13)61903-0	http://dx.doi.org/10.1016/S0140-6736(13)61903-0			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ7VG	24581682	Green Accepted			2022-12-28	WOS:000337906600031
J	He, B; Doubrovinski, K; Polyakov, O; Wieschaus, E				He, Bing; Doubrovinski, Konstantin; Polyakov, Oleg; Wieschaus, Eric			Apical constriction drives tissue-scale hydrodynamic flow to mediate cell elongation	NATURE			English	Article							PARTICLE-TRACKING MICRORHEOLOGY; DROSOPHILA GASTRULATION; ADHERENS JUNCTIONS; MORPHOGENESIS; EMBRYO; INVAGINATION; MECHANICS; TRANSPORT; MEMBRANE; CLEAVAGE	Epithelial folding mediated by apical constriction converts flat epithelial sheets into multilayered, complex tissue structures and is used throughout development inmost animals(1). Little is known, however, about how forces produced near the apical surface of the tissue are transmitted within individual cells to generate the global changes in cell shape that characterize tissue deformation. Here we apply particle tracking velocimetry in gastrulating Drosophila embryos to measure the movement of cytoplasm and plasma membrane during ventral furrow formation(2,3). We find that cytoplasmic redistribution during the lengthening phase of ventral furrow formation can be precisely described by viscous flows that quantitatively match the predictions of hydrodynamics. Cell membranes move with the ambient cytoplasm, with little resistance to, or driving force on, the flow. Strikingly, apical constriction produces similar flow patterns in mutant embryos that fail to form cells before gastrulation ('acellular' embryos), such that the global redistribution of cytoplasm mirrors the summed redistribution occurring in individual cells of wild-type embryos. Our results indicate that during the lengthening phase of ventral furrow formation, hydrodynamic behaviour of the cytoplasm provides the predominant mechanism transmitting apically generated forces deep into the tissue and that cell individualization is dispensable. [GRAPHICS] .	[He, Bing; Doubrovinski, Konstantin; Wieschaus, Eric] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Polyakov, Oleg] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Wieschaus, Eric] Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA	Princeton University; Princeton University; Howard Hughes Medical Institute; Princeton University	Wieschaus, E (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	efw@princeton.edu			National Institutes of Health (National Institute of Child Health and Human Development) [5R37HD15587]; Howard Hughes Medical Institute; New Jersey Commission on Cancer Research Fellowship; National Institutes of Health [P50 GM 071508]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD015587] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD015587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER	National Institutes of Health (National Institute of Child Health and Human Development)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); New Jersey Commission on Cancer Research Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Thiberge (Imaging core facility) for two-photon microscopy. We thank N. Wingreen, C. Brangwynne, C. Brody, H. Stone, S. Little, S. Di Talia, Y.-C. Wang and Y. Yan for their suggestions on the manuscript. We thank all members of the Wieschaus and Schupbach laboratories for discussions. This work was supported by the National Institutes of Health (National Institute of Child Health and Human Development grant 5R37HD15587) to E.F.W. and by the Howard Hughes Medical Institute. B.H. was supported by the New Jersey Commission on Cancer Research Fellowship. The Imaging core facility was supported by National Institutes of Health Grant P50 GM 071508.	Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427; Brodland G. Wayne, 2007, Computer Methods in Biomechanics and Biomedical Engineering, V10, P121, DOI 10.1080/10255840601124704; BRODLAND GW, 1994, J BIOMECH ENG-T ASME, V116, P146, DOI 10.1115/1.2895713; Brodu V, 2006, GENE DEV, V20, P1817, DOI 10.1101/gad.375706; Clarkson M, 1999, DNA CELL BIOL, V18, P457, DOI 10.1089/104454999315178; Conte V, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034473, 10.1371/journal.pone.0037062]; Conte V, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/016010; Davidson LA, 2011, CURR TOP DEV BIOL, V95, P215, DOI 10.1016/B978-0-12-385065-2.00007-4; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Glotzer JB, 1997, CURR BIOL, V7, P326, DOI 10.1016/S0960-9822(06)00156-4; Goldstein RE, 2008, P NATL ACAD SCI USA, V105, P3663, DOI 10.1073/pnas.0707223105; Happel J., 2012, LOW REYNOLDS NUMBER, V1; HARDIN J, 1988, DEVELOPMENT, V103, P211; KAPLAN DR, 1991, BIOSCIENCE, V41, P693, DOI 10.2307/1311764; Kolsch V, 2007, SCIENCE, V315, P384, DOI 10.1126/science.1134833; Lecuit T, 2000, J CELL BIOL, V150, P849, DOI 10.1083/jcb.150.4.849; Lecuit T, 2002, DEV CELL, V2, P425, DOI 10.1016/S1534-5807(02)00141-7; LEPTIN M, 1991, GENE DEV, V5, P1568, DOI 10.1101/gad.5.9.1568; LEPTIN M, 1990, DEVELOPMENT, V110, P73; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Mason TG, 1997, PHYS REV LETT, V79, P3282, DOI 10.1103/PhysRevLett.79.3282; MERRILL PT, 1988, DEVELOPMENT, V104, P495; Niwayama R, 2011, P NATL ACAD SCI USA, V108, P11900, DOI 10.1073/pnas.1101853108; Oda H, 2001, J CELL SCI, V114, P493; ODELL GM, 1981, DEV BIOL, V85, P446, DOI 10.1016/0012-1606(81)90276-1; PARKS S, 1991, CELL, V64, P447, DOI 10.1016/0092-8674(91)90652-F; PEIFER M, 1994, DEVELOPMENT, V120, P369; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; Pouille PA, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015005; Pozrikidis C, 2001, J COMPUT PHYS, V169, P250, DOI 10.1006/jcph.2000.6582; Royou A, 2002, J CELL BIOL, V158, P127, DOI 10.1083/jcb.200203148; Sadler TW, 2005, AM J MED GENET C, V135C, P2, DOI 10.1002/ajmg.c.30049; Savin T, 2005, BIOPHYS J, V88, P623, DOI [10.1529/biophysj.104.042457, 10.1529/biophysj.104.04245]; Sawyer JM, 2010, DEV BIOL, V341, P5, DOI 10.1016/j.ydbio.2009.09.009; SWEETON D, 1991, DEVELOPMENT, V112, P775; Welte MA, 1998, CELL, V92, P547, DOI 10.1016/S0092-8674(00)80947-2; Wirtz D, 2009, ANNU REV BIOPHYS, V38, P301, DOI 10.1146/annurev.biophys.050708.133724	37	137	137	1	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					392	+		10.1038/nature13070	http://dx.doi.org/10.1038/nature13070			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF0KP	24590071	Green Accepted			2022-12-28	WOS:000334403000051
J	Warren, TK; Wells, J; Panchal, RG; Stuthman, KS; Garza, NL; Van Tongeren, SA; Dong, L; Retterer, CJ; Eaton, BP; Pegoraro, G; Honnold, S; Bantia, S; Kotian, P; Chen, XL; Taubenheim, BR; Welch, LS; Minning, DM; Babu, YS; Sheridan, WP; Bavari, S				Warren, Travis K.; Wells, Jay; Panchal, Rekha G.; Stuthman, Kelly S.; Garza, Nicole L.; Van Tongeren, Sean A.; Dong, Lian; Retterer, Cary J.; Eaton, Brett P.; Pegoraro, Gianluca; Honnold, Shelley; Bantia, Shanta; Kotian, Pravin; Chen, Xilin; Taubenheim, Brian R.; Welch, Lisa S.; Minning, Dena M.; Babu, Yarlagadda S.; Sheridan, William P.; Bavari, Sina			Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430	NATURE			English	Article							SMALL-MOLECULE INHIBITOR; EBOLA-VIRUS INFECTION; NONHUMAN-PRIMATES; HEMORRHAGIC-FEVER; MARBURG-VIRUS; POSTEXPOSURE PROTECTION; ANTIVIRAL ACTIVITY; MOUSE MODEL; REPLICATION; CHALLENGE	Filoviruses are emerging pathogens and causative agents of viral haemorrhagic fever. Case fatality rates of filovirus disease outbreaks are among the highest reported for any human pathogen, exceeding 90% (ref. 1). Licensed therapeutic or vaccine products are not available to treat filovirus diseases. Candidate therapeutics previously shown to be efficacious in non-human primate disease models are based on virus-specific designs and have limited broad-spectrum antiviral potential. Here we show that BCX4430, a novel synthetic adenosine analogue, inhibits infection of distinct filoviruses in human cells. Biochemical, reporter-based and primer-extension assays indicate that BCX4430 inhibits viral RNA polymerase function, acting as a non-obligate RNA chain terminator. Post-exposure intramuscular administration of BCX4430 protects against Ebola virus and Marburg virus disease in rodent models. Most importantly, BCX4430 completely protects cynomolgus macaques from Marburg virus infection when administered as late as 48 hours after infection. In addition, BCX4430 exhibits broad-spectrum antiviral activity against numerous viruses, including bunyaviruses, arenaviruses, paramyxoviruses, coronaviruses and flaviviruses. This is the first report, to our knowledge, of non-human primate protection from filovirus disease by a synthetic drug-like small molecule. We provide additional pharmacological characterizations supporting the potential development of BCX4430 as a countermeasure against human filovirus diseases and other viral diseases representing major public health threats.	[Warren, Travis K.; Wells, Jay; Panchal, Rekha G.; Stuthman, Kelly S.; Garza, Nicole L.; Van Tongeren, Sean A.; Dong, Lian; Retterer, Cary J.; Eaton, Brett P.; Pegoraro, Gianluca; Honnold, Shelley; Welch, Lisa S.; Bavari, Sina] US Army Med Res Inst Infect Dis USAMRIID, Therapeut Discovery Ctr, Div Mol & Translat Sci, Ft Detrick, MD 21702 USA; [Bantia, Shanta; Kotian, Pravin; Chen, Xilin; Taubenheim, Brian R.; Babu, Yarlagadda S.; Sheridan, William P.] BioCryst Pharmaceut Inc, Durham, NC 27703 USA; [Minning, Dena M.] MedExpert Consulting Inc, Indialantic, FL 32903 USA		Bavari, S (corresponding author), US Army Med Res Inst Infect Dis USAMRIID, Therapeut Discovery Ctr, Div Mol & Translat Sci, Ft Detrick, MD 21702 USA.	sina.bavari.civ@mail.mil	Eaton, Brett/G-1796-2019; Bavari, Sina/L-3642-2019; Panchal, Rekha/None; Pegoraro, Gianluca/K-4233-2016	Eaton, Brett/0000-0002-3060-2913; Bavari, Sina/0000-0001-8424-5635; Panchal, Rekha/0000-0001-8621-9078; Sheridan, William/0000-0001-8320-1323; Pegoraro, Gianluca/0000-0003-2843-9464	Science and Technology Office for Chemical and Biological Defense of the Defense Threat Reduction Agency [TMTI0048_09_RD_T, CB3675]; National Institute of Allergy and Infectious Diseases (NIAID) [HHSN272201100019I]; BioQual Inc. under NIAID [HHSN27220110005I]; University of Alabama Birmingham under NIAID [HHSN272201100016I]	Science and Technology Office for Chemical and Biological Defense of the Defense Threat Reduction Agency; National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); BioQual Inc. under NIAID; University of Alabama Birmingham under NIAID	J. Kuhn and J. Huggins provided insightful discussions and critically reviewed the manuscript. R. Kincaid and G. Feuerstein provided advice and guidance for BCX4430 development efforts. These studies were in part supported by The Joint Science and Technology Office for Chemical and Biological Defense of the Defense Threat Reduction Agency (proposal #TMTI0048_09_RD_T and CB3675) to S. Bavari. S. Radoshitzky assisted with the EBOV minigenome replicon assay. J. Reifman was essential to algorithm development of HCI image assessments. C. Basler provided the BHK-21-derived cell line constitutively expressing the T7 RNA polymerase. Plasmids encoding viral products and the EBOV minigenome replicon were provided by P. Kranzusch and S. Whelan. Neutral-red uptake antiviral assays were conducted by: D. L. Barnard, G. W. Day, B. Gowan, J. G. Julander, B. Tarbet, D. F. Smee and J. D. Morrey of Utah State University under National Institute of Allergy and Infectious Diseases (NIAID) contract HHSN272201100019I, BioQual Inc. under NIAID contract HHSN27220110005I, and at the University of Alabama Birmingham under NIAID contract HHSN272201100016I. Cell-based metabolism studies were conducted by C. Parker, X. Cheng, R. Upshaw and Y. Luo. A. Nalca, E. E. Zumbrun, H. Bloomfield, D. Dyer and J. Yeager assisted with virus aerosolization. C. Cooper provided assistance with the culture of human macrophage cell culture and R. Zamani provided assistance with high-content image assessments. S. Tritsch assisted with Nipah virus antiviral assays. Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the US Army.	Alves DA, 2010, VET PATHOL, V47, P831, DOI 10.1177/0300985810378597; Aman MJ, 2009, ANTIVIR RES, V83, P245, DOI 10.1016/j.antiviral.2009.06.001; Barnard DL, 2001, ANTIVIR CHEM CHEMOTH, V12, P241, DOI 10.1177/095632020101200405; Bausch DG, 2007, J INFECT DIS, V196, pS142, DOI 10.1086/520545; Bente D, 2009, DIS MODEL MECH, V2, P12, DOI 10.1242/dmm.000471; Bray M, 1998, J INFECT DIS, V178, P651, DOI 10.1086/515386; Bray M, 2002, ANTIVIR RES, V55, P151, DOI 10.1016/S0166-3542(02)00018-9; Bray M, 2000, ANTIVIR RES, V45, P135, DOI 10.1016/S0166-3542(00)00066-8; Dye JM, 2012, P NATL ACAD SCI USA, V109, P5034, DOI 10.1073/pnas.1200409109; Geisbert TW, 2010, LANCET, V375, P1896, DOI 10.1016/S0140-6736(10)60357-1; Geisbert TW, 2008, VACCINE, V26, P6894, DOI 10.1016/j.vaccine.2008.09.082; Hevey M, 1998, VIROLOGY, V251, P28, DOI 10.1006/viro.1998.9367; HUGGINS JW, 1989, REV INFECT DIS, V11, pS750; Kinch MS, 2009, AM J TRANSL RES, V1, P87; Kobinger GP, 2011, J INFECT DIS, V204, P200, DOI 10.1093/infdis/jir077; Kortepeter MG, 2011, J INFECT DIS, V204, pS810, DOI 10.1093/infdis/jir299; Kuhn JH, 2008, FILOVIRUSES COMPENDI; Lou H, 2003, VIROLOGY, V317, P65, DOI 10.1016/j.virol.2003.08.038; Muhlberger E, 1999, J VIROL, V73, P2333; Panchal RG, 2012, ANTIVIR RES, V93, P23, DOI 10.1016/j.antiviral.2011.10.011; Panchal RG, 2010, J BIOMOL SCREEN, V15, P755, DOI 10.1177/1087057110374357; SMITH DH, 1982, LANCET, V1, P816; Smither S. J., 2014, ANTIVIRAL RES; Sullivan NJ, 2000, NATURE, V408, P605, DOI 10.1038/35046108; Towner JS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000212; Warfield KL, 2007, J INFECT DIS, V196, pS430, DOI 10.1086/520583; Warfield KL, 2009, J VIROL, V83, P6404, DOI 10.1128/JVI.00126-09; Warren TK, 2010, NAT MED, V16, P991, DOI 10.1038/nm.2202; Warren TK, 2010, ANTIMICROB AGENTS CH, V54, P2152, DOI 10.1128/AAC.01315-09	29	387	430	5	176	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 17	2014	508	7496					402	+		10.1038/nature13027	http://dx.doi.org/10.1038/nature13027			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF0KP	24590073	Green Published, Bronze			2022-12-28	WOS:000334403000053
J	Lucifora, J; Xia, YC; Reisinger, F; Zhang, K; Stadler, D; Cheng, XM; Sprinzl, MF; Koppensteiner, H; Makowska, Z; Volz, T; Remouchamps, C; Chou, WM; Thasler, WE; Huser, N; Durantel, D; Liang, TJ; Munk, C; Heim, MH; Browning, JL; Dejardin, E; Dandri, M; Schindler, M; Heikenwalder, M; Protzer, U				Lucifora, Julie; Xia, Yuchen; Reisinger, Florian; Zhang, Ke; Stadler, Daniela; Cheng, Xiaoming; Sprinzl, Martin F.; Koppensteiner, Herwig; Makowska, Zuzanna; Volz, Tassilo; Remouchamps, Caroline; Chou, Wen-Min; Thasler, Wolfgang E.; Hueser, Norbert; Durantel, David; Liang, T. Jake; Muenk, Carsten; Heim, Markus H.; Browning, Jeffrey L.; Dejardin, Emmanuel; Dandri, Maura; Schindler, Michael; Heikenwalder, Mathias; Protzer, Ulrike			Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA	SCIENCE			English	Article							LYMPHOTOXIN-BETA-RECEPTOR; GENE-EXPRESSION; HEPATOCELLULAR-CARCINOMA; CYTIDINE DEAMINASES; HUMAN HEPATOCYTES; TRANSGENIC MICE; HBV INFECTION; FOREIGN DNA; IN-VITRO; REPLICATION	Current antiviral agents can control but not eliminate hepatitis B virus (HBV), because HBV establishes a stable nuclear covatently closed circular DNA (cccDNA), Interferon-alpha treatment can clear HBV but is limited by systemic side effects. We describe how interferon-alpha can induce specific degradation of the nuclear viral DNA without hepatotoxicity and propose lymphotoxin-beta receptor activation as a therapeutic alternative. Interferon-alpha and lymphotoxin-beta receptor activation up-regulated APOBEC3A and APOBEC3B cytidine deaminases, respectively, in HBV-infected cells, primary hepatocytes, and human liver needle biopsies. HBV core protein mediated the interaction with nuclear cccDNA, resulting in cytidine deamination, apurinic/apyrimidinic site formation, and finally cccDNA degradation that prevented HBV reactivation. Genomic DNA was not affected. Thus, inducing nuclear deaminases-for example, by lymphotoxin-beta receptor activation-allows the development of new therapeutics that, in combination with existing antivirals, may cure hepatitis B.	[Lucifora, Julie; Xia, Yuchen; Reisinger, Florian; Zhang, Ke; Stadler, Daniela; Cheng, Xiaoming; Sprinzl, Martin F.; Koppensteiner, Herwig; Chou, Wen-Min; Schindler, Michael; Heikenwalder, Mathias; Protzer, Ulrike] Tech Univ Munich, Helmholtz Zentrum Munchen, Inst Virol, D-81675 Munich, Germany; [Lucifora, Julie; Dandri, Maura; Protzer, Ulrike] German Ctr Infect Res DZIF, Munich, Germany; [Lucifora, Julie; Dandri, Maura; Protzer, Ulrike] German Ctr Infect Res DZIF, Hamburg Sites, Germany; [Sprinzl, Martin F.] Univ Hosp Mainz, Dept Med 1, D-55131 Mainz, Germany; [Makowska, Zuzanna; Heim, Markus H.] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland; [Volz, Tassilo; Dandri, Maura] Univ Med Ctr Hamburg Eppendorf, Dept Internal Med, D-20246 Hamburg, Germany; [Remouchamps, Caroline; Dejardin, Emmanuel] Univ Liege, GIGA Res Lab Mol Immunol & Signal Transduct, B-4000 Liege, Belgium; [Thasler, Wolfgang E.] Univ Munich, Grosshadern Hosp, Dept Gen Visceral Transplantat Vasc & Thorac Surg, D-81377 Munich, Germany; [Hueser, Norbert] Tech Univ Munich, Univ Hosp Rechts Isar, Dept Surg, D-85748 Munich, Germany; [Durantel, David] Univ Lyon, LabEx DEVweCAN, Canc Res Ctr Lyon, INSERM,U1052,CNRS,UMR 5286, F-69007 Lyon, France; [Liang, T. Jake] NIDDK, Liver Dis Branch, Bethesda, MD 20892 USA; [Muenk, Carsten] Univ Dusseldorf, Fac Med, Clin Gastroenterol Hepatol & Infectiol, D-40225 Dusseldorf, Germany; [Browning, Jeffrey L.] Biogen Idec Inc, Dept Immunobiol, Cambridge, MA 02142 USA	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; German Center for Infection Research; German Center for Infection Research; University Hospital Mainz; University of Basel; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Liege; University of Munich; Technical University of Munich; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Heinrich Heine University Dusseldorf; Biogen	Heikenwalder, M (corresponding author), Tech Univ Munich, Helmholtz Zentrum Munchen, Inst Virol, D-81675 Munich, Germany.	heikenwaelder@helmholtz-muenchen.de; protzer@tum.de	Protzer, Ulrike/D-5915-2015; Durantel, David/I-4639-2018; LUCIFORA, Julie/L-7449-2017; Heikenwalder, Mathias/AAA-2269-2020; Heim, Markus/A-7526-2008; Dandri, Maura/ABG-4773-2021; Volz, Tassilo/U-1942-2019; Xia, Yuchen/H-8546-2019; Dejardin, Emmanuel/AAE-9076-2021; Schindler, Michael/C-1647-2015	Protzer, Ulrike/0000-0002-9421-1911; Durantel, David/0000-0002-9226-3419; LUCIFORA, Julie/0000-0003-0482-7809; Heim, Markus/0000-0002-7523-4894; Dandri, Maura/0000-0002-0073-6689; Xia, Yuchen/0000-0001-8460-3893; Schindler, Michael/0000-0001-8989-5813; Volz, Tassilo/0000-0003-3120-8958; Stadler, Daniela/0000-0002-7342-9751	Federation Beige Contre Le Cancer; European Research Council; German Research Foundation [SFB 841, SFB TR 36, SFB TR 22]; Peter-Hans Hofschneider Foundation; Helmholtz Alliances HAIT; PCCC; HTCR; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK054500] Funding Source: NIH RePORTER	Federation Beige Contre Le Cancer; European Research Council(European Research Council (ERC)European Commission); German Research Foundation(German Research Foundation (DFG)); Peter-Hans Hofschneider Foundation; Helmholtz Alliances HAIT; PCCC; HTCR; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank R. Rester, T. Asen, K. Ackermann, K. Kappes, M. Feuerherd, R. Barer, R. Hillermann, U. Finkel, A. Krikoni, and F. Zhang for technical support; L. Terracciano for analysis of acute hepatitis patients; F. Chisari for HBV transgenic mice (HBV 1.3.32); T. Buch arid O. Prazeres da Costa for help with array analysis and data discussions; L. Allweiss and A. Groth for help in generating and treating humanized uPA-SCID mice; and Siemens Healthcare Diagnostics for reagents. Supported by grants from Federation Beige Contre Le Cancer (E.D.), a European Research Council starting grant (LiverCancerMechanism) (M.H.), the German Research Foundation (SFB 841 to M.D. SFB TR 36 to M.H. and SFB TR 22), the Peter-Hans Hofschneider Foundation and the Helmholtz Alliances HAIT (U.P.), and PCCC (M.H.). We acknowledge the support of the nonprofit foundation HTCR, winch holds human tissue on trust, making it broadly available for research on an ethical and legal basis. Patent application EP12006XXX has been filed at the European patent office: "Lymphotoxin signaling activation and its downstream mediators eliminate HBV ccc DNA." Microarray data have been submitted to the GEO database (www.ncbi.nlm.nih.gov/geo/) with accession number GSE46667. Human liver chimeric uPA-SCID mice were handled in accordance with protocols approved by the ethical committee of the city and state of Hamburg (permission number G12/015). Experiments with HBV-transgenic mice were performed in accordance with German legislation governing animal studies and the Principles of Laboratory Animal Care guidelines, NIH (55.1-1-54-2531.3-27-08). The study protocol for the animal experiment in fig. S128 was approved at the Southwest Foundation for Biomedical Research, San Antonio, TX (IACUC 869 PT, approved in 2004).	Aynaud MM, 2012, J BIOL CHEM, V287, P39182, DOI 10.1074/jbc.M112.372722; Belloni L, 2012, J CLIN INVEST, V122, P529, DOI 10.1172/JCI58847; Berger G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002221; Bock CT, 2001, J MOL BIOL, V307, P183, DOI 10.1006/jmbi.2000.4481; Bonvin M, 2006, HEPATOLOGY, V43, P1364, DOI 10.1002/hep.21187; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Carpenter MA, 2012, J BIOL CHEM, V287, P34801, DOI 10.1074/jbc.M112.385161; Dejardin E, 2002, IMMUNITY, V17, P525, DOI 10.1016/S1074-7613(02)00423-5; Doehle BP, 2005, VIROLOGY, V339, P281, DOI 10.1016/j.virol.2005.06.005; Friedman JI, 2010, BIOCHEMISTRY-US, V49, P4957, DOI 10.1021/bi100593a; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; GRIPON P, 1988, J VIROL, V62, P4136, DOI 10.1128/JVI.62.11.4136-4143.1988; GUIDOTTI LG, 1994, P NATL ACAD SCI USA, V91, P3764, DOI 10.1073/pnas.91.9.3764; Guidotti LG, 1999, SCIENCE, V284, P825, DOI 10.1126/science.284.5415.825; Guo YH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-563; Haybaeck J, 2009, CANCER CELL, V16, P295, DOI 10.1016/j.ccr.2009.08.021; Hu XL, 2013, CARCINOGENESIS, V34, P1105, DOI 10.1093/carcin/bgt014; Huang Y, 2007, GASTROENTEROLOGY, V132, P733, DOI 10.1053/j.gastro.2006.11.045; Jost S, 2007, J VIROL, V81, P10588, DOI 10.1128/JVI.02489-06; Kitamura K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003361; Krebs K, 2013, GASTROENTEROLOGY, V145, P456, DOI 10.1053/j.gastro.2013.04.047; Landry S, 2011, EMBO REP, V12, P444, DOI 10.1038/embor.2011.46; LEE TH, 1995, J VIROL, V69, P1107, DOI 10.1128/JVI.69.2.1107-1114.1995; Lukashev M, 2006, CANCER RES, V66, P9617, DOI 10.1158/0008-5472.CAN-06-0217; McClary H, 2000, J VIROL, V74, P2255, DOI 10.1128/JVI.74.5.2255-2264.2000; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Munk C, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-71; Pasquetto V, 2002, J VIROL, V76, P5646, DOI 10.1128/JVI.76.11.5646-5653.2002; Protzer U, 2012, NAT REV IMMUNOL, V12, P201, DOI 10.1038/nri3169; Rang A, 1999, J HEPATOL, V31, P791, DOI 10.1016/S0168-8278(99)80279-7; Smith HC, 2012, SEMIN CELL DEV BIOL, V23, P258, DOI 10.1016/j.semcdb.2011.10.004; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Suspene R, 2005, P NATL ACAD SCI USA, V102, P8321, DOI 10.1073/pnas.0408223102; Turelli P, 2004, SCIENCE, V303, P1829, DOI 10.1126/science.1092066; Uprichard SL, 2003, P NATL ACAD SCI USA, V100, P1310, DOI 10.1073/pnas.252773599; Wieland SF, 2000, J VIROL, V74, P4165, DOI 10.1128/JVI.74.9.4165-4173.2000; Wieland SF, 2004, P NATL ACAD SCI USA, V101, P2129, DOI 10.1073/pnas.0308478100; Wolf MJ, 2010, ONCOGENE, V29, P5006, DOI 10.1038/onc.2010.260; Wursthorn K, 2006, HEPATOLOGY, V44, P675, DOI 10.1002/hep.21282; Zhang TW, 2013, HUM MOL GENET, V22, P1262, DOI 10.1093/hmg/dds513; Zoulim F, 2011, LIVER INT, V31, P111, DOI 10.1111/j.1478-3231.2010.02399.x	41	633	696	5	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2014	343	6176					1221	1228		10.1126/science.1243462	http://dx.doi.org/10.1126/science.1243462			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC7RG	24557838	Green Submitted, Green Accepted			2022-12-28	WOS:000332728500030
J	Sinha, A; Hughes, KR; Modrzynska, KK; Otto, TD; Pfander, C; Dickens, NJ; Religa, AA; Bushell, E; Graham, AL; Cameron, R; Kafsack, BFC; Williams, AE; Llinas, M; Berriman, M; Billker, O; Waters, AP				Sinha, Abhinav; Hughes, Katie R.; Modrzynska, Katarzyna K.; Otto, Thomas D.; Pfander, Claudia; Dickens, Nicholas J.; Religa, Agnieszka A.; Bushell, Ellen; Graham, Anne L.; Cameron, Rachael; Kafsack, Bjorn F. C.; Williams, April E.; Llinas, Manuel; Berriman, Matthew; Billker, Oliver; Waters, Andrew P.			A cascade of DNA-binding proteins for sexual commitment and development in Plasmodium	NATURE			English	Article							MALARIA PARASITE; TRANSCRIPTION-FACTOR; BERGHEI; MICROARRAYS; GENERATION; FALCIPARUM; SELECTION; SEQUENCE; TOOLKIT; GENES	Commitment to and completion of sexual development are essential for malaria parasites (protists of the genus Plasmodium) to be transmitted through mosquitoes(1). The molecular mechanism(s) responsible for commitment have been hitherto unknown. Here we show that PbAP2-G, a conserved member of the apicomplexan AP2 (ApiAP2) family of DNA-binding proteins, is essential for the commitment of asexually replicating forms to sexual development in Plasmodium berghei, a malaria parasite of rodents. PbAP2-G was identified from mutations in its encoding gene, PBANKA_143750, which account for the loss of sexual development frequently observed in parasites transmitted artificially by blood passage. Systematic gene deletion of conserved ApiAP2 genes in Plasmodium confirmed the role of PbAP2-G and revealed a second ApiAP2 member (PBANKA_103430, here termed PbAP2-G2) that significantly modulates but does not abolish gametocytogenesis, indicating that a cascade of ApiAP2 proteins are involved in commitment to the production and maturation of gametocytes. The data suggest a mechanism of commitment to gametocytogenesis in Plasmodium consistent with a positive feedback loop involving PbAP2-G that could be exploited to prevent the transmission of this pernicious parasite.	[Sinha, Abhinav; Hughes, Katie R.; Dickens, Nicholas J.; Religa, Agnieszka A.; Graham, Anne L.; Cameron, Rachael; Waters, Andrew P.] Univ Glasgow, Wellcome Trust Ctr Mol Parasitol, Glasgow G12 8QQ, Lanark, Scotland; [Modrzynska, Katarzyna K.; Otto, Thomas D.; Pfander, Claudia; Bushell, Ellen; Berriman, Matthew; Billker, Oliver] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Kafsack, Bjorn F. C.; Williams, April E.; Llinas, Manuel] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Williams, April E.; Llinas, Manuel] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA	University of Glasgow; Wellcome Trust Sanger Institute; Princeton University; Princeton University	Billker, O (corresponding author), Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.	OB4@sanger.ac.uk; Andy.Waters@glasgow.ac.uk	Bushell, Ellen/AAA-9295-2019; Berriman, Matthew/A-7618-2011; Otto, Thomas/ABE-7632-2020; Dickens, Nicholas/G-1445-2013; Cameron, Rachael/E-9331-2013	Berriman, Matthew/0000-0002-9581-0377; Kafsack, Bjorn F.C./0000-0003-0089-1096; Pfander, Claudia/0000-0002-9574-9553; Otto, Thomas/0000-0002-1246-7404; Dickens, Nicholas/0000-0003-0492-5855; Cameron, Rachael/0000-0002-7793-857X; Billker, Oliver/0000-0003-1716-168X; Hughes, Katie/0000-0002-3597-1056; Williams, April/0000-0001-9281-8528	Wellcome Trust [083811/Z/07/Z, 085349, 098051]; Evimalar [242095]; Medical Research Council [G0501670]; National Institutes of Health [R01 AI076276]; Centre for Quantitative Biology [P50GM071508]; Howard Hughes Medical Institute fellowship of the Damon Runyon Cancer Research Foundation; MRC [G0501670] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076276] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007388, P50GM071508] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome Trust); Evimalar; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centre for Quantitative Biology; Howard Hughes Medical Institute fellowship of the Damon Runyon Cancer Research Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. McBride for technical assistance with mosquito transmissions; A. R. Gomes, J. Tripathi, D. Vaughan and the III flow cytometry facility for assistance; C. Cairney and N. Keith at the Beatson Institute for use of their Agilent microarray scanner; and A. Cortes and D. Baker for reading of the manuscript. A. P. W. is funded by the Wellcome Trust (ref.083811/Z/07/Z). The Wellcome Trust Centre for Molecular Parasitology is supported by core funding from the Wellcome Trust (085349). A. S. was a student of the University of Glasgow Wellcome Trust 4-year PhD Programme Molecular Functions in Disease. A. P. W., O.B. and M. B. are members of Evimalar (ref. 242095), which funds the work of T.D.O. Work at the Sanger Institute was funded by grants from the Wellcome Trust (098051) and the Medical Research Council (G0501670). M. L. is funded by the National Institutes of Health (R01 AI076276) and the Centre for Quantitative Biology (P50GM071508). B. F. C. K. was supported by a Howard Hughes Medical Institute fellowship of the Damon Runyon Cancer Research Foundation.	Assefa S, 2009, BIOINFORMATICS, V25, P1968, DOI 10.1093/bioinformatics/btp347; Balaji S, 2005, NUCLEIC ACIDS RES, V33, P3994, DOI 10.1093/nar/gki709; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Berger MF, 2009, NAT PROTOC, V4, P393, DOI 10.1038/nprot.2008.195; BRUCE MC, 1990, PARASITOLOGY, V100, P191, DOI 10.1017/S0031182000061199; Burrill DR, 2011, GENE DEV, V25, P434, DOI 10.1101/gad.1994911; Cameron A, 2013, EVOL APPL, V6, P365, DOI 10.1111/eva.12005; Campbell TL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001165; DEARSLY AL, 1990, PARASITOLOGY, V100, P359, DOI 10.1017/S0031182000078628; Flueck C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000569; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Heo JB, 2011, SCIENCE, V331, P76, DOI 10.1126/science.1197349; Ikadai H, 2013, P NATL ACAD SCI USA, V110, pE1676, DOI 10.1073/pnas.1217712110; Iwanaga S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047557; Janse CJ, 2006, NAT PROTOC, V1, P346, DOI 10.1038/nprot.2006.53; JANSE CJ, 1991, ACT LEIDENS, V60, P43; JANSE CJ, 1992, EXP PARASITOL, V74, P1, DOI 10.1016/0014-4894(92)90133-U; Kafsack BFC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-187; Khan SM, 2005, CELL, V121, P675, DOI 10.1016/j.cell.2005.03.027; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lopez-Rubio JJ, 2009, CELL HOST MICROBE, V5, P179, DOI 10.1016/j.chom.2008.12.012; Mair GR, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000767; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Orr RY, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-103; Otto TD, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1268; Otto TD, 2010, BIOINFORMATICS, V26, P1704, DOI 10.1093/bioinformatics/btq269; Painter HJ, 2011, MOL BIOCHEM PARASIT, V176, P1, DOI 10.1016/j.molbiopara.2010.11.014; Pfander Claudia, 2013, Methods Mol Biol, V923, P127; Pfander C, 2011, NAT METHODS, V8, P1078, DOI [10.1038/NMETH.1742, 10.1038/nmeth.1742]; Ponzi M, 2009, CELL MICROBIOL, V11, P1272, DOI 10.1111/j.1462-5822.2009.01331.x; Quail MA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-341; R Development Core Team, 2012, R LANG ENV STAT COMP; Shiels BR, 1999, PARASITOL TODAY, V15, P241, DOI 10.1016/S0169-4758(99)01451-9; Sinden R., 1997, MOL BIOL INSECT DIS; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Swain MT, 2012, NAT PROTOC, V7, P1260, DOI 10.1038/nprot.2012.068; Tsai IJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r41; van Dijk MR, 2001, CELL, V104, P153, DOI 10.1016/S0092-8674(01)00199-4; Workman CT, 2005, NUCLEIC ACIDS RES, V33, pW389, DOI 10.1093/nar/gki439; Yuda M, 2010, MOL MICROBIOL, V75, P854, DOI 10.1111/j.1365-2958.2009.07005.x; Yuda M, 2009, MOL MICROBIOL, V71, P1402, DOI 10.1111/j.1365-2958.2009.06609.x; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	44	247	249	0	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2014	507	7491					253	+		10.1038/nature12970	http://dx.doi.org/10.1038/nature12970			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC6RJ	24572359	Green Accepted			2022-12-28	WOS:000332651800043
J	Becker, JE; Krumholz, HM; Ben-Josef, G; Ross, JS				Becker, Jessica E.; Krumholz, Harlan M.; Ben-Josef, Gal; Ross, Joseph S.			Reporting of Results in ClinicalTrials.gov and High-Impact Journals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							TRIALS		[Becker, Jessica E.; Ben-Josef, Gal] Yale Univ, Sch Med, New Haven, CT 06520 USA; [Krumholz, Harlan M.; Ross, Joseph S.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA	Yale University; Yale University	Ross, JS (corresponding author), Yale Univ, Sch Med, Dept Internal Med, POB 208093, New Haven, CT 06520 USA.	joseph.ross@yale.edu	, Harlan/AAI-2875-2020	Becker, Jessica/0000-0003-0522-2836; Ross, Joseph/0000-0002-9218-3320	NHLBI NIH HHS [1U01HL105270-02, U01 HL105270] Funding Source: Medline; NIA NIH HHS [K08 AG032886] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG032886] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Mathieu S, 2009, JAMA-J AM MED ASSOC, V302, P977, DOI 10.1001/jama.2009.1242; Ross JS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000144; Turner EH, 2008, NEW ENGL J MED, V358, P252, DOI 10.1056/NEJMsa065779; Zarin DA, 2005, NEW ENGL J MED, V353, P2779, DOI 10.1056/NEJMsa053234; Zarin DA, 2011, NEW ENGL J MED, V364, P852, DOI 10.1056/NEJMsa1012065	5	70	70	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2014	311	10					1063	1065		10.1001/jama.2013.285634	http://dx.doi.org/10.1001/jama.2013.285634			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC5QO	24618969	Green Accepted, Bronze			2022-12-28	WOS:000332575800025
J	Finlay, SN				Finlay, Shauna N.			Patient commentary: my experience of gestational diabetes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2014	348								g1976	10.1136/bmj.g1976	http://dx.doi.org/10.1136/bmj.g1976			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD1ZL	24620361				2022-12-28	WOS:000333032100009
J	Caburet, S; Arboleda, VA; Llano, E; Overbeek, PA; Barbero, JL; Oka, K; Harrison, W; Vaiman, D; Ben-Neriah, Z; Garcia-Tunon, I; Fellous, M; Pendas, AM; Veitia, RA; Vilain, E				Caburet, Sandrine; Arboleda, Valerie A.; Llano, Elena; Overbeek, Paul A.; Luis Barbero, Jose; Oka, Kazuhiro; Harrison, Wilbur; Vaiman, Daniel; Ben-Neriah, Ziva; Garcia-Tunon, Ignacio; Fellous, Marc; Pendas, Alberto M.; Veitia, Reiner A.; Vilain, Eric			Mutant Cohesin in Premature Ovarian Failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHROMATID COHESION; GENES; EXPRESSION; ANEUPLOIDY; MUTATIONS; EVOLUTION; SYNAPSIS; MEIOSIS; STAG3; REC8	Premature ovarian failure is a major cause of female infertility. The genetic causes of this disorder remain unknown in most patients. Using whole-exome sequence analysis of a large consanguineous family with inherited premature ovarian failure, we identified a homozygous 1-bp deletion inducing a frameshift mutation in STAG3 on chromosome 7. STAG3 encodes a meiosis-specific subunit of the cohesin ring, which ensures correct sister chromatid cohesion. Female mice devoid of Stag3 are sterile, and their fetal oocytes are arrested at early prophase I, leading to oocyte depletion at 1 week of age. Few genes have been implicated in sporadic premature ovarian failure. This study implicates STAG3, which encodes a cohesin, a protein that mediates chromosome pairing during meiosis. Premature ovarian failure, the end point of primary ovarian insufficiency, affects approximately 1% of women worldwide. Patients with premature ovarian failure present with at least a 6-month history of amenorrhea and elevated plasma levels of follicle-stimulating hormone (>40 mIU per milliliter). The disorder can result from premature depletion of the follicle pool, follicular atresia, follicle growth arrest, or ovarian dysgenesis. Although a majority of cases are idiopathic, premature ovarian failure can be caused by infectious agents, chemotherapy, pelvic surgery, autoimmune disease, environmental factors, or genetic conditions.(1) The disorder is observed in syndromic diseases for example, Turner's syndrome and BPES ...	[Caburet, Sandrine; Fellous, Marc; Veitia, Reiner A.] Univ Paris Diderot, Inst Jacques Monod, Paris, France; [Vaiman, Daniel; Fellous, Marc] Univ Paris Diderot, Inst Cochin, INSERM, CNRS,Unite Mixte Rech 8104, Paris, France; [Arboleda, Valerie A.; Vilain, Eric] Univ Calif Los Angeles, Dept Human Genet, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Llano, Elena] Univ Salamanca, Dept Fisiol & Farmacol, E-37008 Salamanca, Spain; [Llano, Elena; Garcia-Tunon, Ignacio; Pendas, Alberto M.] Inst Biol Mol & Celular Canc, Salamanca, Spain; [Overbeek, Paul A.; Oka, Kazuhiro; Harrison, Wilbur] Baylor Coll Med, Dept Mol Cellular Biol, Houston, TX 77030 USA; [Luis Barbero, Jose] CSIC, Ctr Invest Biol, Madrid, Spain; [Ben-Neriah, Ziva] Hadassah Univ Hosp, Dept Genet, IL-91120 Jerusalem, Israel	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); Baylor College of Medicine; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Hebrew University of Jerusalem	Vilain, E (corresponding author), Univ Calif Los Angeles, Dept Human Genet, 695 Charles E Young Dr,Gonda 5506, Los Angeles, CA 90095 USA.	amp@usal.es; evilain@ucla.edu	Llano, Elena/AAS-5517-2021; Llano, Elena/K-1723-2014; Vaiman, Daniel/O-6030-2015; Caburet, Sandrine/AAH-3435-2019; Pendas, Alberto M/L-1017-2014; Barbero, Jose Luis/J-9833-2014; García-Tuñón Llanio, Ignacio/K-9901-2014; Arboleda, Valerie/C-9608-2011	Llano, Elena/0000-0002-2626-5723; Llano, Elena/0000-0002-2626-5723; Vaiman, Daniel/0000-0002-1915-0717; García-Tuñón Llanio, Ignacio/0000-0003-4758-2151; Caburet, Sandrine/0000-0002-7404-8213; Pendas, Alberto M/0000-0001-9264-3721; Overbeek, Paul/0000-0001-9784-2084; Arboleda, Valerie/0000-0002-9687-9122; BARBERO, JOSE LUIS/0000-0002-1226-0323	University Paris Diderot-Paris; Ligue Nationale contre le Cancer; Centre National de la Recherche Scientifique; GIS (Groupement d'Interet Scientifique) Institut des Maladies Rares; Doris Duke Charitable Foundation; National Institute of Child Health and Human Development (NICHD) [RO1HD068138, R01HD044513]; NICHD [F31HD068136]; UCLA Medical Scientist Training Program; Ministerio de Economia y Competitividad [SAF2011-25252]; Junta de Castilla y Leon; Ocular Development Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD044513, R01HD068138] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F31HD068136] Funding Source: NIH RePORTER	University Paris Diderot-Paris; Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); GIS (Groupement d'Interet Scientifique) Institut des Maladies Rares; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); UCLA Medical Scientist Training Program; Ministerio de Economia y Competitividad(Spanish Government); Junta de Castilla y Leon(Junta de Castilla y Leon); Ocular Development Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Supported by grants from the University Paris Diderot-Paris 7 (to Drs. Caburet, Veitia, and Fellous), the Ligue Nationale contre le Cancer and the Centre National de la Recherche Scientifique (to Drs. Caburet and Veitia), the GIS (Groupement d'Interet Scientifique) Institut des Maladies Rares (to Drs. Caburet and Fellous), the Doris Duke Charitable Foundation and National Institute of Child Health and Human Development (NICHD) (RO1HD068138 and R01HD044513, to Drs. Arboleda and Vilain), the NICHD (F31HD068136) and the UCLA Medical Scientist Training Program (both to Dr. Arboleda), and the Ministerio de Economia y Competitividad (SAF2011-25252) and Junta de Castilla y Leon (both to Drs. Llano and Pendas). The lentiviral mutagenesis studies were supported by the Ocular Development Fund (to Dr. Overbeek).	Bachelot A, 2009, EUR J ENDOCRINOL, V161, P179, DOI 10.1530/EJE-09-0231; Barber TD, 2008, P NATL ACAD SCI USA, V105, P3443, DOI 10.1073/pnas.0712384105; Bardhan A, 2010, CHROMOSOME RES, V18, P909, DOI 10.1007/s10577-010-9169-0; Baudot A, 2010, EMBO REP, V11, P805, DOI 10.1038/embor.2010.133; Bertini V, 2012, GENE, V503, P123, DOI 10.1016/j.gene.2012.04.071; Bolor H, 2009, AM J HUM GENET, V84, P14, DOI 10.1016/j.ajhg.2008.12.002; Caburet S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033412; Chiang T, 2010, CURR BIOL, V20, P1522, DOI 10.1016/j.cub.2010.06.069; Christin-Maitre S, 2010, ANN ENDOCRINOL-PARIS, V71, P218, DOI 10.1016/j.ando.2010.02.014; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Garcia-Cruz R, 2010, HUM REPROD, V25, P2316, DOI 10.1093/humrep/deq180; Goswami D, 2005, HUM REPROD UPDATE, V11, P391, DOI 10.1093/humupd/dmi012; Herran Y, 2011, EMBO J, V30, P3091, DOI 10.1038/emboj.2011.222; Hodges CA, 2005, NAT GENET, V37, P1351, DOI 10.1038/ng1672; Houmard B, 2009, BIOL REPROD, V81, P438, DOI 10.1095/biolreprod.108.075747; Kervestin S, 2012, NAT REV MOL CELL BIO, V13, P700, DOI 10.1038/nrm3454; Kon A, 2013, NAT GENET, V45, P1232, DOI 10.1038/ng.2731; Lister LM, 2010, CURR BIOL, V20, P1511, DOI 10.1016/j.cub.2010.08.023; Llano E, 2008, GENE DEV, V22, P2400, DOI 10.1101/gad.475308; Llano E, 2012, J CELL BIOL, V197, P877, DOI 10.1083/jcb.201201100; Mandon-Pepin B, 2008, EUR J ENDOCRINOL, V158, P107, DOI 10.1530/EJE-07-0400; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; Mehta GD, 2012, BBA-MOL CELL RES, V1823, P1324, DOI 10.1016/j.bbamcr.2012.05.027; Miyamoto T, 2003, LANCET, V362, P1714, DOI 10.1016/S0140-6736(03)14845-3; Nagaoka SI, 2012, NAT REV GENET, V13, P493, DOI 10.1038/nrg3245; Nasmyth K, 2011, NAT CELL BIOL, V13, P1170, DOI 10.1038/ncb2349; Nishiyama S, 2011, MOL HUM REPROD, V17, P266, DOI 10.1093/molehr/gaq098; Nogues C, 2009, FERTIL STERIL, V92, P578, DOI 10.1016/j.fertnstert.2008.06.034; Notaridou M, 2011, INT J CANCER, V128, P2063, DOI 10.1002/ijc.25554; Persani L, 2010, J MOL ENDOCRINOL, V45, P257, DOI 10.1677/JME-10-0070; PETERS H, 1969, ACTA ENDOCRINOL-COP, V62, P98, DOI 10.1530/acta.0.0620098; Pezzi N, 2000, FASEB J, V14, P581, DOI 10.1096/fasebj.14.3.581; Remeseiro S, 2013, CURR OPIN CELL BIOL, V25, P63, DOI 10.1016/j.ceb.2012.10.013; Shelling AN, 2010, REPRODUCTION, V140, P633, DOI 10.1530/REP-09-0567; Solomon DA, 2011, SCIENCE, V333, P1039, DOI 10.1126/science.1203619; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Xu HL, 2005, DEV CELL, V8, P949, DOI 10.1016/j.devcel.2005.03.018; Zhao H, 2013, MOL HUM REPROD, V19, P644, DOI 10.1093/molehr/gat040	38	193	206	4	50	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 6	2014	370	10					943	949		10.1056/NEJMoa1309635	http://dx.doi.org/10.1056/NEJMoa1309635			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC2EB	24597867	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000332309800011
J	Kessler, RC; Duncan, GJ; Gennetian, LA; Katz, LF; Kling, JR; Sampson, NA; Sanbonmatsu, L; Zaslavsky, AM; Ludwig, J				Kessler, Ronald C.; Duncan, Greg J.; Gennetian, Lisa A.; Katz, Lawrence F.; Kling, Jeffrey R.; Sampson, Nancy A.; Sanbonmatsu, Lisa; Zaslavsky, Alan M.; Ludwig, Jens			Associations of Housing Mobility Interventions for Children in High-Poverty Neighborhoods With Subsequent Mental Disorders During Adolescence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OPPORTUNITY; PREVALENCE; SAMPLE; YOUTH	IMPORTANCE Youth in high-poverty neighborhoods have high rates of emotional problems. Understanding neighborhood influences on mental health is crucial for designing neighborhood-level interventions. OBJECTIVE To perform an exploratory analysis of associations between housing mobility interventions for children in high-poverty neighborhoods and subsequent mental disorders during adolescence. DESIGN, SETTING, AND PARTICIPANTS The Moving to Opportunity Demonstration from 1994 to 1998 randomized 4604 volunteer public housing families with 3689 children in high-poverty neighborhoods into 1 of 2 housing mobility intervention groups (a low-poverty voucher group vs a traditional voucher group) or a control group. The low-poverty voucher group (n=1430) received vouchers to move to low-poverty neighborhoods with enhanced mobility counseling. The traditional voucher group (n=1081) received geographically unrestricted vouchers. Controls (n=1178) received no intervention. Follow-up evaluation was performed 10 to 15 years later (June 2008-April 2010) with participants aged 13 to 19 years (0-8 years at randomization). Response rates were 86.9% to 92.9%. MAIN OUTCOMES AND MEASURES Presence of mental disorders from the Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) within the past 12 months, including major depressive disorder, panic disorder, posttraumatic stress disorder (PTSD), oppositional-defiant disorder, intermittent explosive disorder, and conduct disorder, as assessed post hoc with a validated diagnostic interview. RESULTS Of the 3689 adolescents randomized, 2872 were interviewed (1407 boys and 1465 girls). Compared with the control group, boys in the low-poverty voucher group had significantly increased rates of major depression (7.1% vs 3.5%; odds ratio (OR), 2.2 [95% CI, 1.2-3.9]), PTSD (6.2% vs 1.9%; OR, 3.4 [95% CI, 1.6-7.4]), and conduct disorder (6.4% vs 2.1%; OR, 3.1 [95% CI, 1.7-5.8]). Boys in the traditional voucher group had increased rates of PTSD compared with the control group (4.9% vs 1.9%, OR, 2.7 [95% CI, 1.2-5.8]). However, compared with the control group, girls in the traditional voucher group had decreased rates of major depression (6.5% vs 10.9%; OR, 0.6 [95% CI, 0.3-0.9]) and conduct disorder (0.3% vs 2.9%; OR, 0.1 [95% CI, 0.0-0.4]). CONCLUSIONS AND RELEVANCE Interventions to encourage moving out of high-poverty neighborhoods were associated with increased rates of depression, PTSD, and conduct disorder among boys and reduced rates of depression and conduct disorder among girls. Better understanding of interactions among individual, family, and neighborhood risk factors is needed to guide future public housing policy changes.	[Kessler, Ronald C.; Sampson, Nancy A.; Zaslavsky, Alan M.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Duncan, Greg J.] Univ Calif Irvine, Sch Educ, Irvine, CA USA; [Gennetian, Lisa A.; Katz, Lawrence F.; Kling, Jeffrey R.; Sanbonmatsu, Lisa; Ludwig, Jens] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Katz, Lawrence F.] Harvard Univ, Dept Econ, Cambridge, MA 02138 USA; [Kling, Jeffrey R.] Congress Budget Off, Washington, DC USA; [Ludwig, Jens] Univ Chicago, Harris Sch Publ Policy, Chicago, IL 60637 USA	Harvard University; Harvard Medical School; University of California System; University of California Irvine; National Bureau of Economic Research; Harvard University; Congressional Budget Office; University of Chicago	Kessler, RC (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	kessler@hcp.med.harvard.edu			US Department of Housing and Urban Development (HUD) [C-CHI-00808]; National Science Foundation [SES-0527615]; National Institute for Child Health and Human Development [R01-HD040404, R01-HD040444]; US Centers for Disease Control and Prevention [R49-CE000906]; National Institute of Mental Health [R01-MH077026]; National Institute on Aging [P30 AG012810, R01-AG031259, P01-AG005842-22S1]; National Opinion Research Center's Population Research Center from the National Institute of Child Health and Human Development [R24-HD051152-04]; University of Chicago Center for Health Administration Studies; US Department of Education/Institute of Education Sciences [R305U070006]; John D. and Catherine T. MacArthur Foundation; Smith Richardson Foundation; Spencer Foundation; Annie E. Casey Foundation; Bill & Melinda Gates Foundation; Russell Sage Foundation; Robert Wood Johnson Foundation; LIEPP (Interdisciplinary Research Center for the Evaluation of Public Policies) at Sciences Po.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD051152] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD040444, R01HD040404] Funding Source: NIH RePORTER; NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL [R49CE000906] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG031259, P30AG012810, P01AG005842] Funding Source: NIH RePORTER	US Department of Housing and Urban Development (HUD); National Science Foundation(National Science Foundation (NSF)); National Institute for Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Opinion Research Center's Population Research Center from the National Institute of Child Health and Human Development; University of Chicago Center for Health Administration Studies(University of Chicago); US Department of Education/Institute of Education Sciences(US Department of Education); John D. and Catherine T. MacArthur Foundation; Smith Richardson Foundation; Spencer Foundation; Annie E. Casey Foundation; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Russell Sage Foundation; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); LIEPP (Interdisciplinary Research Center for the Evaluation of Public Policies) at Sciences Po.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Support for the current report was provided by a grant from the US Department of Housing and Urban Development (HUD) (C-CHI-00808). Additional funders include: the National Science Foundation (SES-0527615), the National Institute for Child Health and Human Development (R01-HD040404, R01-HD040444), the US Centers for Disease Control and Prevention(R49-CE000906), the National Institute of Mental Health (R01-MH077026), the National Institute on Aging (P30 AG012810, R01-AG031259, P01-AG005842-22S1), the National Opinion Research Center's Population Research Center (through R24-HD051152-04 from the National Institute of Child Health and Human Development), the University of Chicago Center for Health Administration Studies, the US Department of Education/Institute of Education Sciences (R305U070006), the John D. and Catherine T. MacArthur Foundation, the Smith Richardson Foundation, the Spencer Foundation, the Annie E. Casey Foundation, the Bill & Melinda Gates Foundation, and the Russell Sage Foundation. The work of Dr Duncan was additionally supported in part by a Robert Wood Johnson Foundation Investigator in Health Policy award, while the work of Dr Ludwig was additionally supported in part by a Robert Wood Johnson Foundation Investigator in Health Policy award, a Russell Sage Foundation visiting scholar award, and a visiting scholar award from LIEPP (Interdisciplinary Research Center for the Evaluation of Public Policies) at Sciences Po.	[Anonymous], 2008, SAS STAT SOFTWARE CO; [Anonymous], 2009, SUDAAN COMPUTER PROG; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhui KS, 2012, INT J EPIDEMIOL, V41, P791, DOI 10.1093/ije/dys007; Briggs X, 2010, MOVING TO OPPORTUNIT; Carter PL, 2003, SOC PROBL, V50, P136, DOI 10.1525/sp.2003.50.1.136; Centers for Disease Control and Prevention, HEALTHY COMMUNITIES; Clampet-Lundquist S, 2011, AM J SOCIOL, V116, P1154, DOI 10.1086/657352; Congressional Budget Office, GROWTH IN MEANS TEST; DeLuca HF, 2012, ARCH BIOCHEM BIOPHYS, V523, P1, DOI 10.1016/j.abb.2012.05.009; Feins J, 1995, IMPLEMENTATION ASSIS; Feins JD, 1996, MOVING TO OPPORTUNIT; Galster GC, 2012, NEIGHBOURHOOD EFFECT, DOI [DOI 10.1007/978-94-007-2309-2_2, 10.1007/978-94-007-2309-2_2]; Gebler N, 2012, CITYSCAPE, V14, P57; Gennetian LA, 2012, CITYSCAPE, V14, P137; Goering J, 1999, MOVING TO OPPORTUNIT; Goering J, 2003, CHOOSING BETTER LIFE, P3; Gravel J, 2007, CLIN TRIALS, V4, P350, DOI 10.1177/1740774507081223; Hosmer D. W., 2001, APPLIED LOGISTIC REG; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Kessler RC, 2012, ARCH GEN PSYCHIAT, V69, P372, DOI 10.1001/archgenpsychiatry.2011.160; Kessler RC, 2009, J AM ACAD CHILD PSY, V48, P386, DOI 10.1097/CHI.0b013e31819a1cbc; Kling JR, 2007, ECONOMETRICA, V75, P83, DOI 10.1111/j.1468-0262.2007.00733.x; Lee MA, 2008, POPUL BULL, V63, P3; Leventhal T., 2009, HDB ADOLESCENT PSYCH, P411, DOI [10.1002/9780470479193.adlpsy002013, DOI 10.1002/9780470479193.ADLPSY002013]; Leventhal T, 2011, SOC SCI MED, V73, P737, DOI 10.1016/j.socscimed.2011.06.042; Ludwig J, 2012, SCIENCE, V337, P1505, DOI 10.1126/science.1224648; Ludwig J, 2011, NEW ENGL J MED, V365, P1509, DOI 10.1056/NEJMsa1103216; Maercker A, 2004, BRIT J PSYCHIAT, V184, P482, DOI 10.1192/bjp.184.6.482; McLaughlin KA, 2012, ARCH GEN PSYCHIAT, V69, P1151, DOI 10.1001/archgenpsychiatry.2011.2277; Olsen EO, 2003, NBER CONF R, P365; Orr L, 2003, MOVING TO OPPORTUNIT; Osypuk TL, 2012, ARCH GEN PSYCHIAT, V69, P1284, DOI 10.1001/archgenpsychiatry.2012.449; Roux AVD, 2010, ANN NY ACAD SCI, V1186, P125, DOI 10.1111/j.1749-6632.2009.05333.x; Sareen J, 2007, ARCH GEN PSYCHIAT, V64, P843, DOI 10.1001/archpsyc.64.7.843; Shroder M, 2002, J URBAN ECON, V51, P315, DOI 10.1006/juec.2001.2247; The American Association for Public Opinion Research, STANDARD DEFINITIONS; US Bureau of the Census, CENSUS TRACTS AND BL; US Department of Housing and Urban Development, PUBLIC HOUSING IMAGE; Wolter KM, 1985, INTRODUCTION TO VARI	41	84	84	1	49	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2014	311	9					937	947		10.1001/jama.2014.607	http://dx.doi.org/10.1001/jama.2014.607			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AC0FS	24595778	Green Published, Green Accepted			2022-12-28	WOS:000332170800022
J	Brass, D; Mckay, P; Scott, F				Brass, Dawn; Mckay, Pam; Scott, Fiona			Investigating an incidental finding of lymphopenia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Brass, Dawn] Ninewells Hosp, Dept Haematol, Dundee DD1 9SY, Scotland; [Mckay, Pam] Gartnaval Gen Hosp, Beatson Oncol Ctr, Dept Haematol, Glasgow, Lanark, Scotland; [Scott, Fiona] Western Gen Hosp, Dept Haematol, Edinburgh EH4 2XU, Midlothian, Scotland	University of Dundee; Beatson Oncology Centre; University of Edinburgh	Scott, F (corresponding author), Western Gen Hosp, Dept Haematol, Edinburgh EH4 2XU, Midlothian, Scotland.	fiona.m.scott@luht.scot.nhs.uk						[Anonymous], UK NAT GUID HIV TEST; CAIRD F I, 1972, Age and Ageing, V1, P239, DOI 10.1093/ageing/1.4.239; Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612; Castelino DJ, 1997, AUST NZ J MED, V27, P170, DOI 10.1111/j.1445-5994.1997.tb00934.x; Hogan S, 2010, HIV MED, V11, P40; Krishna MT, 2008, ARCH DIS CHILD, V93, P90, DOI 10.1136/adc.2007.123497; Ray-Coquard I, 2009, CANCER RES, V69, P5383, DOI 10.1158/0008-5472.CAN-08-3845; STEPHAN JL, 1993, J PEDIATR-US, V123, P564, DOI 10.1016/S0022-3476(05)80951-5; UKPIN Primary Immunodefiency Network, SEV COMB IMM SCID IN	9	22	23	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 3	2014	348								g1721	10.1136/bmj.g1721	http://dx.doi.org/10.1136/bmj.g1721			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC6HK	24591476				2022-12-28	WOS:000332622000002
J	Hoffecker, JF; Elias, SA; O'Rourke, DH				Hoffecker, John F.; Elias, Scott A.; O'Rourke, Dennis H.			Out of Beringia?	SCIENCE			English	Editorial Material							DISPERSAL; AMERICA		[Hoffecker, John F.] Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA; [Elias, Scott A.] Royal Holloway Univ London, Dept Geog, Egham TW20 0EX, Surrey, England; [O'Rourke, Dennis H.] Univ Utah, Dept Anthropol, Salt Lake City, UT 84112 USA	University of Colorado System; University of Colorado Boulder; University of London; Royal Holloway University London; Utah System of Higher Education; University of Utah	Hoffecker, JF (corresponding author), Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA.	john.hoffecker@colorado.edu		HOFFECKER, JOHN/0000-0001-6132-3012; Elias, Scott/0000-0002-1498-1060				[Anonymous], 1937, OUTLINE HIST ARCTIC; Battaglia V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071390; Brubaker LB, 2005, J BIOGEOGR, V32, P833, DOI 10.1111/j.1365-2699.2004.01203.x; Dulik Matthew C, 2012, Proc Natl Acad Sci U S A, V109, P8471, DOI 10.1073/pnas.1118760109; Elias SA, 2008, QUATERNARY SCI REV, V27, P2473, DOI 10.1016/j.quascirev.2008.09.011; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Hoffecker J. F., 2007, HUMAN ECOLOGY BERING; Pitulko Vladimir, 2013, PALEOAMERICAN ODYSSE, P13; Raghavan M, 2014, NATURE, V505, P87, DOI 10.1038/nature12736; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Schroeder KB, 2007, BIOL LETTERS, V3, P218, DOI 10.1098/rsbl.2006.0609; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Thery-Parisot I., 2005, ZOOARCHAEOLOGY FATS, P50; Westbrook R., 2012, GSA ANN M CHARL NC 4, P180; Willerslev E, 2014, NATURE, V506, P47, DOI 10.1038/nature12921	15	46	48	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2014	343	6174					979	980		10.1126/science.1250768	http://dx.doi.org/10.1126/science.1250768			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC2DZ	24578571				2022-12-28	WOS:000332309600030
J	Egan, AG; Blind, E; Dunder, K; de Graeff, PA; Hummer, BT; Bourcier, T; Rosebraugh, C				Egan, Amy G.; Blind, Eberhard; Dunder, Kristina; de Graeff, Pieter A.; Hummer, B. Timothy; Bourcier, Todd; Rosebraugh, Curtis			Pancreatic Safety of Incretin-Based Drugs - FDA and EMA Assessment	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								After evaluating a safety signal regarding pancreatitis and pancreatic cancer in patients using incretin-based drugs, the Food and Drug Administration and the European Medicines Agency conclude that assertions of a causal association are inconsistent with the data. With approximately 25.8 million diabetic patients in the United States and 33 million in the European Union alone, the growing prevalence of diabetes worldwide poses a major public health challenge. Both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) are committed to ensuring the safety of drug products marketed for the treatment of diabetes, and postmarketing reports of pancreatitis and pancreatic cancer in patients taking certain antidiabetic medications have been of concern to both agencies. Working in parallel, the agencies have reviewed nonclinical toxicology studies, clinical trial data, and epidemiologic data pertaining to blood glucose-lowering ...	[Egan, Amy G.; Hummer, B. Timothy; Bourcier, Todd; Rosebraugh, Curtis] US FDA, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA; [Blind, Eberhard] European Med Agcy, London, England; [Dunder, Kristina] Lakemedelsverket, Uppsala, Sweden; [de Graeff, Pieter A.] Dutch Med Evaluat Board, Utrecht, Netherlands	US Food & Drug Administration (FDA); Medical Products Agency	Egan, AG (corresponding author), US FDA, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA.			Blind, Eberhard/0000-0003-4359-4198				Butler AE, 2013, DIABETES, V62, P2595, DOI 10.2337/db12-1686; Engel SS, 2013, DIABETES THER, V4, P119, DOI 10.1007/s13300-013-0024-0; European Medicines Agency, 2013, ASS REP GLP 1 BAS TH; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889	5	350	363	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 27	2014	370	9					794	797		10.1056/NEJMp1314078	http://dx.doi.org/10.1056/NEJMp1314078			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB8AR	24571751				2022-12-28	WOS:000332013000004
J	Ehn, M; Thornton, JA; Kleist, E; Sipila, M; Junninen, H; Pullinen, I; Springer, M; Rubach, F; Tillmann, R; Lee, B; Lopez-Hilfiker, F; Andres, S; Acir, IH; Rissanen, M; Jokinen, T; Schobesberger, S; Kangasluoma, J; Kontkanen, J; Nieminen, T; Kurten, T; Nielsen, LB; Jorgensen, S; Kjaergaard, HG; Canagaratna, M; Dal Maso, M; Berndt, T; Petaja, T; Wahner, A; Kerminen, VM; Kulmala, M; Worsnop, DR; Wildt, J; Mentel, TF				Ehn, Mikael; Thornton, Joel A.; Kleist, Einhard; Sipila, Mikko; Junninen, Heikki; Pullinen, Iida; Springer, Monika; Rubach, Florian; Tillmann, Ralf; Lee, Ben; Lopez-Hilfiker, Felipe; Andres, Stefanie; Acir, Ismail-Hakki; Rissanen, Matti; Jokinen, Tuija; Schobesberger, Siegfried; Kangasluoma, Juha; Kontkanen, Jenni; Nieminen, Tuomo; Kurten, Theo; Nielsen, Lasse B.; Jorgensen, Solvejg; Kjaergaard, Henrik G.; Canagaratna, Manjula; Dal Maso, Miikka; Berndt, Torsten; Petaja, Tuukka; Wahner, Andreas; Kerminen, Veli-Matti; Kulmala, Markku; Worsnop, Douglas R.; Wildt, Juergen; Mentel, Thomas F.			A large source of low-volatility secondary organic aerosol	NATURE			English	Article							MASTER CHEMICAL MECHANISM; MASS-SPECTROMETER; SULFURIC-ACID; HIGH-RESOLUTION; ALPHA-PINENE; ATMOSPHERIC CHEMISTRY; PHASE; GAS; SIZE; OXIDATION	Forests emit large quantities of volatile organic compounds (VOCs) to the atmosphere. Their condensable oxidation products can form secondary organic aerosol, a significant and ubiquitous component of atmospheric aerosol(1,2), which is known to affect the Earth's radiation balance by scattering solar radiation and by acting as cloud condensation nuclei(3). The quantitative assessment of such climate effects remains hampered by a number of factors, including an incomplete understanding of how biogenic VOCs contribute to the formation of atmospheric secondary organic aerosol. The growth of newly formed particles from sizes of less than three nanometres up to the sizes of cloud condensation nuclei (about one hundred nanometres) in many continental ecosystems requires abundant, essentially nonvolatile organic vapours(4-6), but the sources and compositions of such vapours remain unknown. Here we investigate the oxidation of VOCs, in particular the terpene alpha-pinene, under atmospherically relevant conditions in chamber experiments. We find that a direct pathway leads from several biogenic VOCs, such as monoterpenes, to the formation of large amounts of extremely low-volatility vapours. These vapours format significant mass yield in the gas phase and condense irreversibly onto aerosol surfaces to produce secondary organic aerosol, helping to explain the discrepancy between the observed atmospheric burden of secondary organic aerosol and that reported by many model studies(2). We further demonstrate how these low-volatility vapours can enhance, or even dominate, the formation and growth of aerosol particles over forested regions, providing a missing link between biogenic VOCs and their conversion to aerosol particles. Our findings could help to improve assessments of biosphere-aerosol-climate feedback mechanisms(6-8), and the air quality and climate effects of biogenic emissions generally.	[Ehn, Mikael; Pullinen, Iida; Springer, Monika; Rubach, Florian; Tillmann, Ralf; Andres, Stefanie; Acir, Ismail-Hakki; Wahner, Andreas; Mentel, Thomas F.] Forschungszentrum Julich, Inst Energy & Climate Res IEK 8, D-52425 Julich, Germany; [Ehn, Mikael; Thornton, Joel A.; Sipila, Mikko; Junninen, Heikki; Rissanen, Matti; Jokinen, Tuija; Schobesberger, Siegfried; Kangasluoma, Juha; Kontkanen, Jenni; Nieminen, Tuomo; Petaja, Tuukka; Kerminen, Veli-Matti; Kulmala, Markku; Worsnop, Douglas R.] Univ Helsinki, Dept Phys, FIN-00014 Helsinki, Finland; [Thornton, Joel A.; Lee, Ben; Lopez-Hilfiker, Felipe] Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA; [Kleist, Einhard; Wildt, Juergen] Forschungszentrum Julich, Inst Bio & Geosci IBG 2, D-52425 Julich, Germany; [Jokinen, Tuija; Berndt, Torsten] Inst Tropospher Res TROPOS, D-04318 Leipzig, Germany; [Nieminen, Tuomo] Univ Helsinki, Helsinki Inst Phys, FIN-00014 Helsinki, Finland; [Kurten, Theo] Univ Helsinki, Dept Chem, FIN-00014 Helsinki, Finland; [Nielsen, Lasse B.; Jorgensen, Solvejg; Kjaergaard, Henrik G.] Univ Copenhagen, Dept Chem, DK-2100 Copenhagen O, Denmark; [Canagaratna, Manjula; Worsnop, Douglas R.] Aerodyne Res Inc, Billerica, MA 01821 USA; [Dal Maso, Miikka] Tampere Univ Technol, Dept Phys, FIN-33101 Tampere, Finland	Helmholtz Association; Research Center Julich; University of Helsinki; University of Washington; University of Washington Seattle; Helmholtz Association; Research Center Julich; Leibniz Institut fur Tropospharenforschung (TROPOS); Helsinki Institute of Physics; University of Helsinki; University of Helsinki; University of Copenhagen; Aerodyne Research; Tampere University	Ehn, M (corresponding author), Forschungszentrum Julich, Inst Energy & Climate Res IEK 8, D-52425 Julich, Germany.	mikael.ehn@helsinki.fi	Worsnop, Douglas R/D-2817-2009; Jorgensen, Solvejg/A-1246-2011; Kontkanen, Jenni/AAL-1368-2020; Tillmann, Ralf/I-9203-2012; Nieminen, Tuomo J/D-1618-2011; Tillmann, Ralf/AAM-5619-2021; Schobesberger, Siegfried/L-4454-2014; Sipilä, Mikko/G-3024-2010; kangasluoma, juha/W-7450-2019; Kurtén, Theo C/G-2120-2012; Acir, Ismail/AAQ-1770-2020; Jokinen, Tuija/B-3365-2014; Kerminen, Veli-Matti/M-9026-2014; Ehn, Mikael/N-2571-2016; Kulmala, Markku T/I-7671-2016; Lee, Ben H/G-7007-2014; Dal Maso, Miikka/A-7980-2008; Kangasluoma, Juha/AAY-7941-2021; Kjaergaard, Henrik G/H-4333-2014; Wahner, Andreas/J-4129-2012; Nieminen, Tuomo/AAB-8686-2020; Mentel, Thomas F/A-3576-2011; Thornton, Joel A/C-1142-2009; Petäjä, Tuukka/A-8009-2008; Junninen, Heikki/C-2157-2014	Worsnop, Douglas R/0000-0002-8928-8017; Jorgensen, Solvejg/0000-0002-0255-1338; Kontkanen, Jenni/0000-0002-5373-3537; Tillmann, Ralf/0000-0003-0648-6622; Tillmann, Ralf/0000-0003-0648-6622; Schobesberger, Siegfried/0000-0002-5777-4897; Sipilä, Mikko/0000-0002-8594-7003; Kurtén, Theo C/0000-0002-6416-4931; Acir, Ismail/0000-0001-7250-1427; Jokinen, Tuija/0000-0002-1280-1396; Ehn, Mikael/0000-0002-0215-4893; Kulmala, Markku T/0000-0003-3464-7825; Lee, Ben H/0000-0002-5057-2168; Dal Maso, Miikka/0000-0003-3040-3612; Kangasluoma, Juha/0000-0002-1639-1187; Kjaergaard, Henrik G/0000-0002-7275-8297; Wahner, Andreas/0000-0001-8948-1928; Nieminen, Tuomo/0000-0002-2713-715X; Mentel, Thomas F/0000-0003-0810-3541; Thornton, Joel A/0000-0002-5098-4867; Petäjä, Tuukka/0000-0002-1881-9044; Junninen, Heikki/0000-0001-7178-9430; Rissanen, Matti/0000-0003-0463-8098; Rubach, Florian/0000-0002-6144-2799	Emil Aaltonen foundation; US Department of Energy, Office of Science [DE-SC0006867]; ERC Advanced Grant EU-FP7-ATMNUCLE [227463]; EU-FP7 project PEGASOS [265148]; Academy of Finland [251427, 266388]; Academy of Finland Center of Excellence programme [1118615]	Emil Aaltonen foundation; US Department of Energy, Office of Science(United States Department of Energy (DOE)); ERC Advanced Grant EU-FP7-ATMNUCLE; EU-FP7 project PEGASOS; Academy of Finland(Academy of Finland); Academy of Finland Center of Excellence programme(Academy of Finland)	M.E. was supported by the Emil Aaltonen foundation; J.A.T. was supported by the US Department of Energy, Office of Science (DE-SC0006867). This work was supported by the ERC Advanced Grant EU-FP7-ATMNUCLE (project no. 227463), the EU-FP7 project PEGASOS (project no. 265148), the Academy of Finland (project no. 251427 and 266388) and by the Academy of Finland Center of Excellence programme (project no. 1118615). We thank M. Kajos, S. Schallhart and T. Ruuskanen for measurement support, O. Kupiainen for collision rate calculations, and the tofTools team for analysis tools for mass spectra.	Atkinson R, 1997, J PHYS CHEM REF DATA, V26, P521, DOI 10.1063/1.556011; Berndt T, 2005, SCIENCE, V307, P698, DOI 10.1126/science.1104054; Bertram TH, 2011, ATMOS MEAS TECH, V4, P1471, DOI 10.5194/amt-4-1471-2011; Capouet M, 2006, ATMOS CHEM PHYS, V6, P1455, DOI 10.5194/acp-6-1455-2006; Carslaw KS, 2010, ATMOS CHEM PHYS, V10, P1701, DOI 10.5194/acp-10-1701-2010; Crounse JD, 2013, J PHYS CHEM LETT, V4, P3513, DOI 10.1021/jz4019207; Crounse JD, 2012, J PHYS CHEM A, V116, P5756, DOI 10.1021/jp211560u; Crounse JD, 2011, PHYS CHEM CHEM PHYS, V13, P13607, DOI 10.1039/c1cp21330j; DeCarlo PF, 2006, ANAL CHEM, V78, P8281, DOI 10.1021/ac061249n; Donahue NM, 2012, ATMOS CHEM PHYS, V12, P615, DOI 10.5194/acp-12-615-2012; Ehn M, 2012, ATMOS CHEM PHYS, V12, P5113, DOI 10.5194/acp-12-5113-2012; Ehn M, 2011, AEROSOL SCI TECH, V45, P522, DOI 10.1080/02786826.2010.547890; EISELE FL, 1993, J GEOPHYS RES-ATMOS, V98, P9001, DOI 10.1029/93JD00031; Gautrois M, 1999, J CHROMATOGR A, V848, P239, DOI 10.1016/S0021-9673(99)00424-0; Grieshop AP, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029987; GUENTHER A, 1995, J GEOPHYS RES-ATMOS, V100, P8873, DOI 10.1029/94JD02950; Hall WA, 2012, AEROSOL SCI TECH, V46, P983, DOI 10.1080/02786826.2012.685114; Hallquist M, 2009, ATMOS CHEM PHYS, V9, P5155, DOI 10.5194/acp-9-5155-2009; Hari P, 2005, BOREAL ENVIRON RES, V10, P315; Hildebrandt L, 2009, ATMOS CHEM PHYS, V9, P2973, DOI 10.5194/acp-9-2973-2009; Jang MS, 2002, SCIENCE, V298, P814, DOI 10.1126/science.1075798; Jayne JT, 2000, AEROSOL SCI TECH, V33, P49, DOI 10.1080/027868200410840; Jenkin ME, 1997, ABSTR PAP AM CHEM S, V214, P116; Jimenez JL, 2009, SCIENCE, V326, P1525, DOI 10.1126/science.1180353; Johnson D, 2008, CHEM SOC REV, V37, P699, DOI 10.1039/b704260b; Jokinen T, 2012, ATMOS CHEM PHYS, V12, P4117, DOI 10.5194/acp-12-4117-2012; Junninen H, 2010, ATMOS MEAS TECH, V3, P1039, DOI 10.5194/amt-3-1039-2010; Kalberer M, 2004, SCIENCE, V303, P1659, DOI 10.1126/science.1092185; Kangasluoma J, 2013, AEROSOL SCI TECH, V47, P556, DOI 10.1080/02786826.2013.773393; Kirkby J, 2011, NATURE, V476, P429, DOI 10.1038/nature10343; Kokkola H., 2013, ATMOS CHEM PHYS DISC, V13, P14613; Kulmala M, 2013, SCIENCE, V339, P943, DOI 10.1126/science.1227385; Kuwata KT, 2007, J PHYS CHEM A, V111, P5032, DOI 10.1021/jp0704113; Kwan AJ, 2012, ATMOS CHEM PHYS, V12, P7499, DOI 10.5194/acp-12-7499-2012; Lindinger W, 1998, INT J MASS SPECTROM, V173, P191, DOI 10.1016/S0168-1176(97)00281-4; Matsunaga A, 2010, AEROSOL SCI TECH, V44, P881, DOI 10.1080/02786826.2010.501044; Mauldin RL, 2012, NATURE, V488, P193, DOI 10.1038/nature11278; Mauldin RL, 1999, J GEOPHYS RES-ATMOS, V104, P5801, DOI 10.1029/98JD02612; Mentel TF, 2009, ATMOS CHEM PHYS, V9, P4387, DOI 10.5194/acp-9-4387-2009; Mereau R, 2001, PHYS CHEM CHEM PHYS, V3, P4712, DOI 10.1039/b105824j; Naik V, 2013, ATMOS CHEM PHYS, V13, P5277, DOI 10.5194/acp-13-5277-2013; Nieminen T, 2010, ATMOS CHEM PHYS, V10, P9773, DOI 10.5194/acp-10-9773-2010; Paasonen P, 2013, NAT GEOSCI, V6, P438, DOI [10.1038/NGEO1800, 10.1038/ngeo1800]; Pankow JF, 2003, ATMOS ENVIRON, V37, P3323, DOI 10.1016/S1352-2310(03)00346-7; Parrish DD, 2012, ATMOS CHEM PHYS, V12, P11485, DOI 10.5194/acp-12-11485-2012; Pathak RK, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007436; Peeters J, 2009, PHYS CHEM CHEM PHYS, V11, P5935, DOI 10.1039/b908511d; Peeters J, 2012, J PHYS CHEM A, V116, P6134, DOI 10.1021/jp211447q; Raatikainen T, 2010, ATMOS CHEM PHYS, V10, P2063, DOI 10.5194/acp-10-2063-2010; Riipinen I, 2011, ATMOS CHEM PHYS, V11, P3865, DOI 10.5194/acp-11-3865-2011; Saunders SM, 2003, ATMOS CHEM PHYS, V3, P161, DOI 10.5194/acp-3-161-2003; Sharma S, 2010, J PHYS CHEM A, V114, P5689, DOI 10.1021/jp9098792; Shilling JE, 2008, ATMOS CHEM PHYS, V8, P2073, DOI 10.5194/acp-8-2073-2008; Shiraiwa M, 2013, P NATL ACAD SCI USA, V110, P11746, DOI 10.1073/pnas.1307501110; Silva G., 2010, ENVIRON SCI TECHNOL, V44, P250, DOI DOI 10.1021/ES900924D; Sipila M, 2010, SCIENCE, V327, P1243, DOI 10.1126/science.1180315; Solomon S., 2007, PHYS SCI BASIS WORKI; Spracklen DV, 2011, ATMOS CHEM PHYS, V11, P12109, DOI 10.5194/acp-11-12109-2011; Spracklen DV, 2008, PHILOS T R SOC A, V366, P4613, DOI 10.1098/rsta.2008.0201; SU T, 1973, J AM CHEM SOC, V95, P7609, DOI 10.1021/ja00804a011; Tobias HJ, 2001, J PHYS CHEM A, V105, P6129, DOI 10.1021/jp004631r; Vaden TD, 2011, P NATL ACAD SCI USA, V108, P2190, DOI 10.1073/pnas.1013391108; Vanhanen J, 2011, AEROSOL SCI TECH, V45, P533, DOI 10.1080/02786826.2010.547889; Vereecken L, 2007, PHYS CHEM CHEM PHYS, V9, P5241, DOI 10.1039/b708023a; Vereecken L, 2004, CHEM PHYS LETT, V393, P432, DOI 10.1016/j.cplett.2004.06.076; Vereecken L, 2010, PHYS CHEM CHEM PHYS, V12, P12608, DOI 10.1039/c0cp00387e; Vereecken L, 2012, CHEM SOC REV, V41, P6259, DOI 10.1039/c2cs35070j; Viggiano AA, 1997, J PHYS CHEM A, V101, P8275, DOI 10.1021/jp971768h; Virtanen A, 2010, NATURE, V467, P824, DOI 10.1038/nature09455; Wang L, 2010, NAT GEOSCI, V3, P238, DOI 10.1038/NGEO778; Worsnop D. R., 2011, AEROSOL SCI TECHNOL, V45, pi; Yatavelli RLN, 2012, AEROSOL SCI TECH, V46, P1313, DOI 10.1080/02786826.2012.712236; Yatavelli RLN, 2010, AEROSOL SCI TECH, V44, P61, DOI 10.1080/02786820903380233; Young PJ, 2009, ATMOS CHEM PHYS, V9, P2793, DOI 10.5194/acp-9-2793-2009; Zhao J, 2013, ATMOS CHEM PHYS, V13, P7631, DOI 10.5194/acp-13-7631-2013; Ziemann PJ, 2002, J PHYS CHEM A, V106, P4390, DOI 10.1021/jp012925m	76	1037	1061	64	1447	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2014	506	7489					476	+		10.1038/nature13032	http://dx.doi.org/10.1038/nature13032			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0DN	24572423				2022-12-28	WOS:000332165100035
J	Wolfe, SM				Wolfe, Sidney M.			THE WASHINGTON BRIEF Increased heart attacks in men using testosterone: the UK importantly lags far behind the US in prescribing testosterone	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EVENTS		Publ Citizen, Hlth Res Grp, Washington, DC 20009 USA		Wolfe, SM (corresponding author), Publ Citizen, Hlth Res Grp, Washington, DC 20009 USA.	Swolfe@citizen.org						[Anonymous], 2014, COMMUNICATION; Avorn J, 2005, POWERFUL MED BENEFIT; Baillargeon J, 2013, JAMA INTERN MED, V173, P1465, DOI 10.1001/jamainternmed.2013.6895; Basaria S, 2010, NEW ENGL J MED, V363, P109, DOI 10.1056/NEJMoa1000485; Finkle WD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085805; Layton JB, 2014, J CLIN ENDOCR METAB; US Food and Drug Administration, 2014, FDA EV RISK STROK HE; Xu L, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-108	8	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 27	2014	348								g1789	10.1136/bmj.g1789	http://dx.doi.org/10.1136/bmj.g1789			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC0UF	24578515	Green Published, Bronze			2022-12-28	WOS:000332210200003
J	Doshi, P				Doshi, Peter			TRANSPARENCY IN THE DRUG INDUSTRY From promises to policies: is big pharma delivering on transparency?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TRIAL DATA		BMJ, London WC1H 9JR, England		Doshi, P (corresponding author), BMJ, London WC1H 9JR, England.	pdoshi@bmj.com						Barron H, 2014, NEW ENGL J MED, V370, P485, DOI 10.1056/NEJMc1315673; Clinical Study Data Request Site, 2014, IT WORKS; Clinical Study Data Request Site, 2014, SPONS SPEC INF SAN 2; Doshi P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g63; Doshi P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6754; F Hoffmann-La Roche Ltd, 2013, ROCH GLOB POL SHAR C; Helterbrand J., 2014, WHY INCREASED DATA S; Johnson & Johnson, 2014, JOHNS JOHNS ANN CLIN; Marciniak TA, 2010, CARDIOVASCULAR EVENT; Moscicki R., 2014, RESPONSIBLE SHARING; The Editorial Board, 2013, NY TIMES	11	8	8	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 26	2014	348								g1615	10.1136/bmj.g1615	http://dx.doi.org/10.1136/bmj.g1615			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC0UC	24574476	Green Published			2022-12-28	WOS:000332209900006
J	Haines, CS; Lima, MD; Li, N; Spinks, GM; Foroughi, J; Madden, JDW; Kim, SH; Fang, SL; de Andrade, MJ; Goktepe, F; Goktepe, O; Mirvakili, SM; Naficy, S; Lepro, X; Oh, JY; Kozlov, ME; Kim, SJ; Xu, XR; Swedlove, BJ; Wallace, GG; Baughman, RH				Haines, Carter S.; Lima, Marcio D.; Li, Na; Spinks, Geoffrey M.; Foroughi, Javad; Madden, John D. W.; Kim, Shi Hyeong; Fang, Shaoli; de Andrade, Monica Jung; Goktepe, Fatma; Goktepe, Ozer; Mirvakili, Seyed M.; Naficy, Sina; Lepro, Xavier; Oh, Jiyoung; Kozlov, Mikhail E.; Kim, Seon Jeong; Xu, Xiuru; Swedlove, Benjamin J.; Wallace, Gordon G.; Baughman, Ray H.			Artificial Muscles from Fishing Line and Sewing Thread	SCIENCE			English	Article							POLYMERS; MEMORY; SHAPE; ACTUATORS; NANOCOMPOSITES; PERFORMANCE; ELASTOMERS; HYBRID	The high cost of powerful, large-stroke, high-stress artificial muscles has combined with performance limitations such as low cycle life, hysteresis, and low efficiency to restrict applications. We demonstrated that inexpensive high-strength polymer fibers used for fishing line and sewing thread can be easily transformed by twist insertion to provide fast, scalable, nonhysteretic, long-life tensile and torsional muscles. Extreme twisting produces coiled muscles that can contract by 49%, lift loads over 100 times heavier than can human muscle of the same length and weight, and generate 5.3 kilowatts of mechanical work per kilogram of muscle weight, similar to that produced by a jet engine. Woven textiles that change porosity in response to temperature and actuating window shutters that could help conserve energy were also demonstrated. Large-stroke tensile actuation was theoretically and experimentally shown to result from torsional actuation.	[Haines, Carter S.; Lima, Marcio D.; Li, Na; Fang, Shaoli; de Andrade, Monica Jung; Lepro, Xavier; Oh, Jiyoung; Kozlov, Mikhail E.; Xu, Xiuru; Swedlove, Benjamin J.; Baughman, Ray H.] Univ Texas Dallas, Alan G MacDiarmid NanoTech Inst, Richardson, TX 75083 USA; [Spinks, Geoffrey M.; Foroughi, Javad; Naficy, Sina; Wallace, Gordon G.] Univ Wollongong, ARC Ctr Excellence Electromat Sci, Intelligent Polymer Res Inst, Wollongong, NSW 2522, Australia; [Madden, John D. W.; Mirvakili, Seyed M.] Univ British Columbia, Dept Elect & Comp Engn, Vancouver, BC V6T 1Z4, Canada; [Madden, John D. W.; Mirvakili, Seyed M.] Univ British Columbia, Adv Mat & Proc Engn Lab, Vancouver, BC V6T 1Z4, Canada; [Kim, Shi Hyeong; Kim, Seon Jeong] Hanyang Univ, Ctr Bioartificial Muscle, Seoul 133791, South Korea; [Kim, Shi Hyeong; Kim, Seon Jeong] Hanyang Univ, Dept Biomed Engn, Seoul 133791, South Korea; [Goktepe, Fatma; Goktepe, Ozer] Namik Kemal Univ, Corlu Engn Fac, Dept Text Engn, Corlu Tekirdag, Turkey; [Xu, Xiuru] Jilin Univ, Alan G MacDiarmid Inst, Changchun 130012, Peoples R China	University of Texas System; University of Texas Dallas; University of Wollongong; University of British Columbia; University of British Columbia; Hanyang University; Hanyang University; Namik Kemal University; Jilin University	Baughman, RH (corresponding author), Univ Texas Dallas, Alan G MacDiarmid NanoTech Inst, Richardson, TX 75083 USA.	ray.baughman@utdallas.edu	Naficy, Sina/E-7544-2011; Wallace, Gordon G/H-1123-2011; Baughman, Ray/A-8628-2018; Spinks, Geoffrey/E-5612-2011; GÖKTEPE, FATMA/ABA-5614-2020; Kim, Seon Jeong/AAR-8127-2021; Li, Na/M-9852-2015; Madden, John DW/B-8948-2009; Foroughi, Javad/A-1439-2012; Spinks, Geoffrey/T-6363-2019; Naficy, Sina/M-7357-2019; GÖKTEPE, ÖZER/ABA-5620-2020; de Andrade, Monica Jung/N-3963-2019; Lepro, Xavier/G-1021-2012	Naficy, Sina/0000-0001-9168-6746; Wallace, Gordon G/0000-0002-0381-7273; Baughman, Ray/0000-0001-5845-5137; Spinks, Geoffrey/0000-0003-4656-9473; GÖKTEPE, FATMA/0000-0002-8586-9164; Kim, Seon Jeong/0000-0002-2867-6737; Li, Na/0000-0002-1909-6378; Madden, John DW/0000-0002-0014-4712; Foroughi, Javad/0000-0003-1979-5213; Spinks, Geoffrey/0000-0003-4656-9473; Naficy, Sina/0000-0001-9168-6746; GÖKTEPE, ÖZER/0000-0002-4849-9483; de Andrade, Monica Jung/0000-0003-0411-4008; Lepro, Xavier/0000-0002-0166-3127	Air Force Office of Scientific Research [FA9550-12-1-0211]; Air Force [AOARD-10-4067, AOARD-13-4119]; Office of Naval Research MURI [N00014-08-1-0654]; Robert A. Welch Foundation [AT-0029]; Creative Research Initiative Center for Bio-Artificial Muscle; Korea-U.S. Air Force Cooperation Program [2012-00074]; Australian Research Council; Australian National Fabrication Facility, China National 973 Project [2007CB936203, S2009061009]; NSF China [51003036]; Natural Sciences and Engineering Research Council of Canada	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Air Force; Office of Naval Research MURI(MURIOffice of Naval Research); Robert A. Welch Foundation(The Welch Foundation); Creative Research Initiative Center for Bio-Artificial Muscle; Korea-U.S. Air Force Cooperation Program; Australian Research Council(Australian Research Council); Australian National Fabrication Facility, China National 973 Project; NSF China(National Natural Science Foundation of China (NSFC)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	We thank C. Mozayan, D. B. Hagenasr, Y. Zhang, D. A. Tolly, D. E. Wait, and P. E. Javidnia for assistance with sample preparation and measurements. Support is largely from Air Force Office of Scientific Research grant FA9550-12-1-0211, with additional support from Air Force grants AOARD-10-4067 and AOARD-13-4119, Office of Naval Research MURI grant N00014-08-1-0654, Robert A. Welch Foundation grant AT-0029, the Creative Research Initiative Center for Bio-Artificial Muscle, the Korea-U.S. Air Force Cooperation Program grant 2012-00074 (Korea), Centre of Excellence funding from the Australian Research Council and the Australian National Fabrication Facility, China National 973 Project (nos. 2007CB936203 and S2009061009), NSF China (no. 51003036), and a Natural Sciences and Engineering Research Council of Canada Discovery grant. Correspondence and requests for materials should be addressed to ray.baughman@utdallas.edu. A provisional patent application (61784247) and an international patent application (PCT/US2013/053227) have been filed by N. Li et al. on "Coiled and non-coiled twisted nanofiber yarn and polymer fiber torsional and tensile muscles."	Baughman RH, 1996, SYNTHETIC MET, V78, P339, DOI 10.1016/0379-6779(96)80158-5; Carpi F, 2010, SCIENCE, V330, P1759, DOI 10.1126/science.1194773; Cheng ZY, 2008, MRS BULL, V33, P183, DOI 10.1557/mrs2008.43; CHOY CL, 1981, J POLYM SCI POL PHYS, V19, P335, DOI 10.1002/pol.1981.180190213; Cui J, 2006, NAT MATER, V5, P286, DOI 10.1038/nmat1593; Foroughi J, 2011, SCIENCE, V334, P494, DOI 10.1126/science.1211220; FULLER FB, 1971, P NATL ACAD SCI USA, V68, P815, DOI 10.1073/pnas.68.4.815; Grant D, 1997, IEEE CONTR SYST MAG, V17, P80, DOI 10.1109/37.588180; Huber JE, 1997, P ROY SOC A-MATH PHY, V453, P2185, DOI 10.1098/rspa.1997.0117; Hunter I., 1992, ROBOT REV, P299, DOI [10.5555/146312, DOI 10.5555/146312]; JOSEPHSON RK, 1993, ANNU REV PHYSIOL, V55, P527, DOI 10.1146/annurev.ph.55.030193.002523; KOBAYASHI Y, 1970, POLYMER, V11, P114, DOI 10.1016/0032-3861(70)90030-3; Koerner H, 2004, NAT MATER, V3, P115, DOI 10.1038/nmat1059; KOJIMA Y, 1993, J APPL POLYM SCI, V49, P1259, DOI 10.1002/app.1993.070490715; Leng JS, 2011, PROG MATER SCI, V56, P1077, DOI 10.1016/j.pmatsci.2011.03.001; Lima MD, 2012, SCIENCE, V338, P928, DOI 10.1126/science.1226762; Love A. E., 1944, MATH THEORY ELASTICI, P414; Madden JDW, 2004, IEEE J OCEANIC ENG, V29, P706, DOI 10.1109/JOE.2004.833135; Miaudet P, 2007, SCIENCE, V318, P1294, DOI 10.1126/science.1145593; Pelrine R, 2000, SCIENCE, V287, P836, DOI 10.1126/science.287.5454.836; Phillips WF, 2004, MECH FLIGHT; Smela E, 2003, ADV MATER, V15, P481, DOI 10.1002/adma.200390113; Song YT, 2013, NATURE, V502, P85, DOI 10.1038/nature12532; Tangorra J, 2007, BIOINSPIR BIOMIM, V2, pS6, DOI 10.1088/1748-3182/2/2/S02; Treloar L. R. G., 1975, RUBBER ELASTICITY; van der Heijden GHM, 2000, NONLINEAR DYNAM, V21, P71, DOI 10.1023/A:1008310425967; Zhang M, 2005, SCIENCE, V309, P1215, DOI 10.1126/science.1115311	27	747	781	88	1120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 21	2014	343	6173					868	872		10.1126/science.1246906	http://dx.doi.org/10.1126/science.1246906			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB1LG	24558156				2022-12-28	WOS:000331552600041
J	Hoeksma, J				Hoeksma, Jon			The NHS's care. data scheme: what are the risks to privacy?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									E Hlth Insider, London, England		Hoeksma, J (corresponding author), E Hlth Insider, London, England.	jon@e-health-media.com							0	12	12	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2014	348								g1547	10.1136/bmj.g1547	http://dx.doi.org/10.1136/bmj.g1547			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB9ZG	24535332				2022-12-28	WOS:000332153700005
J	Pershing, S; Enns, EA; Matesic, B; Owens, DK; Goldhaber-Fiebert, JD				Pershing, Suzann; Enns, Eva A.; Matesic, Brian; Owens, Douglas K.; Goldhaber-Fiebert, Jeremy D.			Cost-Effectiveness of Treatment of Diabetic Macular Edema	ANNALS OF INTERNAL MEDICINE			English	Article							RANIBIZUMAB PLUS PROMPT; INTRAVITREAL BEVACIZUMAB; DEFERRED LASER; VISUAL IMPAIRMENT; RANDOMIZED-TRIAL; UTILITY VALUES; FOLLOW-UP; TRIAMCINOLONE; PHOTOCOAGULATION; RETINOPATHY	Background: Macular edema is the most common cause of vision loss among patients with diabetes. Objective: To determine the cost-effectiveness of different treatments of diabetic macular edema (DME). Design: Markov model. Data Sources: Published literature and expert opinion. Target Population: Patients with clinically significant DME. Time Horizon: Lifetime. Perspective: Societal. Intervention: Laser treatment, intraocular injections of triamcinolone or a vascular endothelial growth factor (VEGF) inhibitor, or a combination of both. Outcome Measures: Discounted costs, gains in quality-adjusted life-years (QALYs), and incremental cost-effectiveness ratios (ICERs). Results of Base-Case Analysis: All treatments except laser monotherapy substantially reduced costs, and all treatments except triamcinolone monotherapy increased QALYs. Laser treatment plus a VEGF inhibitor achieved the greatest benefit, gaining 0.56 QALYs at a cost of $ 6975 for an ICER of $ 12 410 per QALY compared with laser treatment plus triamcinolone. Monotherapy with a VEGF inhibitor achieved similar outcomes to combination therapy with laser treatment plus a VEGF inhibitor. Laser monotherapy and triamcinolone monotherapy were less effective and more costly than combination therapy. Results of Sensitivity Analysis: VEGF inhibitor monotherapy was sometimes preferred over laser treatment plus a VEGF inhibitor, depending on the reduction in quality of life with loss of visual acuity. When the VEGF inhibitor bevacizumab was as effective as ranibizumab, it was preferable because of its lower cost. Limitation: Long-term outcome data for treated and untreated diseases are limited. Conclusion: The most effective treatment of DME is VEGF inhibitor injections with or without laser treatment. This therapy compares favorably with cost-effective interventions for other conditions.	Stanford Univ, Stanford Hlth Policy, Ctr Hlth Policy, Stanford, CA 94305 USA; Stanford Univ, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Byers Eye Inst, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; Univ Minnesota, Sch Publ Hlth, Minneapolis, MN USA	Stanford University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; University of Minnesota System; University of Minnesota Twin Cities	Pershing, S (corresponding author), 2452 Watson Court, Palo Alto, CA 94303 USA.	pershing@stanford.edu		Enns, Eva/0000-0003-0693-7358; Goldhaber-Fiebert, Jeremy/0000-0002-4007-5192	Agency for Healthcare Research and Quality; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000028] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R21CA094303, R33CA094303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG037593] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Agency for Healthcare Research and Quality.	Ahmadieh H, 2008, GRAEF ARCH CLIN EXP, V246, P483, DOI 10.1007/s00417-007-0688-0; Alcon, TRIES SUSP TRIAMC AC; [Anonymous], 1987, Int Ophthalmol Clin, V27, P265; Arevalo JF, 2007, OPHTHALMOLOGY, V114, P743, DOI 10.1016/j.ophtha.2006.12.028; Arias Elizabeth, 2010, Natl Vital Stat Rep, V58, P1; Bandello F, 2011, 47 EUR ASS STUD DIAB; Beck RW, 2009, ARCH OPHTHALMOL-CHIC, V127, P245, DOI 10.1001/archophthalmol.2008.610; Brown MM, 1999, AM J OPHTHALMOL, V128, P324, DOI 10.1016/S0002-9394(99)00146-4; Brown MM, 2001, BRIT J OPHTHALMOL, V85, P327, DOI 10.1136/bjo.85.3.327; Browning DJ, 2010, DIABETIC RETINOPATHY: EVIDENCE-BASED MANAGEMENT, P141, DOI 10.1007/978-0-387-85900-2_7; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Centers for Medicare & Medicaid Services, MED OUTP ADD A B UPD; Centers for Medicare & Medicaid Services, MED ASP DRUG PRIC FI; Clark A, 2008, CLIN EXP OPHTHALMOL, V36, P526, DOI 10.1111/j.1442-9071.2008.01827.x; Curtis LH, 2010, ARCH OPHTHALMOL-CHIC, V128, P1273, DOI 10.1001/archophthalmol.2010.223; Day S, 2011, AM J OPHTHALMOL, V152, P266, DOI 10.1016/j.ajo.2011.01.053; Dewan V, 2012, OPHTHALMOLOGY, V119, P1679, DOI 10.1016/j.ophtha.2012.01.049; Do DV, 2012, OPHTHALMOLOGY, V119, P1658, DOI 10.1016/j.ophtha.2012.02.010; Elman MJ, 2012, OPHTHALMOLOGY, V119, P2312, DOI 10.1016/j.ophtha.2012.08.022; Elman MJ, 2011, OPHTHALMOLOGY, V118, P609, DOI 10.1016/j.ophtha.2010.12.033; Elman MJ, 2010, OPHTHALMOLOGY, V117, P1064, DOI 10.1016/j.ophtha.2010.02.031; Enns EA, 2013, 34 ANN M SOC MED DEC; Faghihi H, 2008, EUR J OPHTHALMOL, V18, P941, DOI 10.1177/112067210801800614; Fong DS, 2007, ARCH OPHTHALMOL-CHIC, V125, P469; Frazier AL, 2000, JAMA-J AM MED ASSOC, V284, P1954, DOI 10.1001/jama.284.15.1954; Freeman JV, 2011, ANN INTERN MED, V154, P1, DOI 10.7326/0003-4819-154-1-201101040-00289; Gangnon RE, 2008, INVEST OPHTH VIS SCI, V49, P5041, DOI 10.1167/iovs.08-2231; Gaspoz J, 2002, NEW ENGL J MED, V346, P1800, DOI 10.1056/NEJM200206063462309; Genentech, 2013, LUC PACK INS; Genentech, 2012, LUC PACK INS; Gillies MC, 2006, OPHTHALMOLOGY, V113, P1533, DOI 10.1016/j.ophtha.2006.02.065; Gold MR, 1996, COST EFFECTIVENESS H; Goldie SJ, 2005, NEW ENGL J MED, V353, P2158, DOI 10.1056/NEJMsa044278; Googe J, 2011, RETINA-J RET VIT DIS, V31, P1009, DOI 10.1097/IAE.0b013e318217d739; Goyal S, 2011, GRAEF ARCH CLIN EXP, V249, P15, DOI 10.1007/s00417-010-1452-4; Hurley Susan F, 2008, Cost Eff Resour Alloc, V6, P12, DOI 10.1186/1478-7547-6-12; Ip MS, 2008, OPHTHALMOLOGY, V115, P1447, DOI 10.1016/j.ophtha.2008.06.015; Javitt JC, 2007, OPHTHALMOLOGY, V114, P238, DOI 10.1016/j.ophtha.2006.07.054; KLEIN R, 1991, OCULAR PROBLEMS DIAB, P1; Klein R, 2009, OPHTHALMOLOGY, V116, P497, DOI 10.1016/j.ophtha.2008.10.016; Knudtson MD, 2006, ARCH OPHTHALMOL-CHIC, V124, P243, DOI 10.1001/archopht.124.2.243; Levinson DR, 2011, DEP HLTH HUMAN SERVI; Lloyd A, 2008, DIABETIC MED, V25, P618, DOI 10.1111/j.1464-5491.2008.02430.x; Lovestam-Adrian M, 2007, DIABETES RES CLIN PR, V77, P141, DOI 10.1016/j.diabres.2006.10.026; Martin DF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.053; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Massin P, 2010, DIABETES CARE, V33, P2399, DOI 10.2337/dc10-0493; Michaelides M, 2010, OPHTHALMOLOGY, V117, P1078, DOI 10.1016/j.ophtha.2010.03.045; Mitchell P, 2012, BRIT J OPHTHALMOL, V96, P688, DOI 10.1136/bjophthalmol-2011-300726; Mitchell P, 2011, OPHTHALMOLOGY, V118, P615, DOI 10.1016/j.ophtha.2011.01.031; National Institute for Health and Clinical Excellence 2011 Hypertension, 2011, NAT I HLTH CLIN EXC; Nguyen QD, 2009, OPHTHALMOLOGY, V116, P2175, DOI 10.1016/j.ophtha.2009.04.023; Ockrim ZK, 2008, BRIT J OPHTHALMOL, V92, P795, DOI 10.1136/bjo.2007.131771; PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015; Physicians' Desk Reference, 2010, PHYS DESK REF RED BO; Pollack A., 2011, NY TIMES; Nguyen QD, 2012, OPHTHALMOLOGY, V119, P789, DOI 10.1016/j.ophtha.2011.12.039; Quan DN, 2010, OPHTHALMOLOGY, V117, P2146, DOI 10.1016/j.ophtha.2010.08.016; RUIZ MS, 2001, NO TIME LOSE GETTING; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Sanders GD, 2005, NEW ENGL J MED, V353, P1471, DOI 10.1056/NEJMsa051989; Schmier JK, 2006, RETINA-J RET VIT DIS, V26, P1056, DOI 10.1097/01.iae.0000254890.48272.5a; Scott IU, 2007, OPHTHALMOLOGY, V114, P1860, DOI 10.1016/j.ophtha.2007.05.062; Sharma S, 2005, CAN J OPHTHALMOL, V40, P369, DOI 10.1016/S0008-4182(05)80079-1; Sharma S, 2000, Curr Opin Ophthalmol, V11, P175, DOI 10.1097/00055735-200006000-00004; Sharma S, 2000, CAN J OPHTHALMOL, V35, P267, DOI 10.1016/S0008-4182(00)80077-0; Sharma S, 2001, CURR OPIN OPHTHALMOL, V12, P230, DOI 10.1097/00055735-200106000-00016; Shea AM, 2008, ARCH OPHTHALMOL-CHIC, V126, P1748, DOI 10.1001/archopht.126.12.1748; Soheilian M, 2009, OPHTHALMOLOGY, V116, P1142, DOI 10.1016/j.ophtha.2009.01.011; Solaiman KAM, 2010, RETINA-J RET VIT DIS, V30, P1638, DOI 10.1097/IAE.0b013e3181e1ed07; U. S. Bureau of Labor Statistics, 2009, EMPLOYMENT EARNINGS; U.S. Census Bureau, 2012, CONS PRIC IND CPIO M; Van der Reis MI, 2011, RETINA-J RET VIT DIS, V31, P1449, DOI 10.1097/IAE.0b013e3182278ab4; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Williams R, 2004, EYE, V18, P963, DOI 10.1038/sj.eye.6701476; Xu L, 2008, GRAEF ARCH CLIN EXP, V246, P923, DOI 10.1007/s00417-008-0773-z; Yilmaz T, 2009, OPHTHALMOLOGY, V116, P902, DOI 10.1016/j.ophtha.2009.02.002	77	46	47	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 7	2014	160	1					18	+		10.7326/M13-0768	http://dx.doi.org/10.7326/M13-0768			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	297IS	24573663	Green Accepted			2022-12-28	WOS:000330249700003
J	Nayak, RK; Pearson, SD; Miller, FG				Nayak, Rahul K.; Pearson, Steven D.; Miller, Franklin G.			Cost-Related Motivations for Conducting Research Participants Should Be Informed	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BEVACIZUMAB		[Nayak, Rahul K.; Pearson, Steven D.; Miller, Franklin G.] NIH, Ctr Clin, Dept Bioeth, Bethesda, MD 20892 USA; [Pearson, Steven D.] Inst Clin & Econ Review, Boston, MA USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Miller, FG (corresponding author), NIH, Ctr Clin, Dept Bioeth, 10 Ctr Dr,Bldg 10,Rm 1C118, Bethesda, MD 20892 USA.	fmiller@nih.gov		Nayak, Rahul/0000-0001-6725-7634				[Anonymous], 2011, COMP AGE RELATED MAC; Avery RL, 2006, OPHTHALMOLOGY, V113, P363, DOI 10.1016/j.ophtha.2005.11.019; Avery RL, 2006, OPHTHALMOLOGY, V113, pe5, DOI DOI 10.1016/J.OPHTHA.2005.11.019; Levine RJ, 1988, ETHICS REGULATION CL, P100; Levine RJ, 2003, ETHICAL REGULATORY A, P197; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Martin DF, 2010, NEW ENGL J MED, V363, P105, DOI 10.1056/NEJMp1001201; Office of Inspector General, 2011, A011000514 US DEP HL	8	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 16	2014	311	15					1491	1492		10.1001/jama.2014.1821	http://dx.doi.org/10.1001/jama.2014.1821			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE9DX	24615527				2022-12-28	WOS:000334306000012
J	Zhu, SY; Rezvani, M; Harbell, J; Mattis, AN; Wolfe, AR; Benet, LZ; Willenbring, H; Ding, S				Zhu, Saiyong; Rezvani, Milad; Harbell, Jack; Mattis, Aras N.; Wolfe, Alan R.; Benet, Leslie Z.; Willenbring, Holger; Ding, Sheng			Mouse liver repopulation with hepatocytes generated from human fibroblasts	NATURE			English	Article							PLURIPOTENT STEM-CELLS; NUCLEAR RECEPTORS; DEFINED FACTORS; IN-VIVO; EXPRESSION; MICE; TRANSPLANTATION; CONVERSION; INDUCTION; DIFFERENTIATION	Human induced pluripotent stem cells (iPSCs) have the capability of revolutionizing research and therapy of liver diseases by providing a source of hepatocytes for autologous cell therapy and disease modelling. However, despite progress in advancing the differentiation of iPSCs into hepatocytes (iPSC-Heps) in vitro(1-3), cells that replicate the ability of human primary adult hepatocytes (aHeps) to proliferate extensively in vivo have not been reported. This deficiency has hampered efforts to recreate human liver diseases in mice, and has cast doubt on the potential of iPSC-Heps for liver cell therapy. The reason is that extensive post-transplant expansion is needed to establish and sustain a therapeutically effective liver cell mass in patients, a lesson learned from clinical trials of aHep transplantation(4). Here, as a solution to this problem, we report the generation of human fibroblast-derived hepatocytes that can repopulate mouse livers. Unlike current protocols for deriving hepatocytes from human fibroblasts, ours did not generate iPSCs but cut short reprogramming to pluripotency to generate an induced multipotent progenitor cell (iMPC) state from which endoderm progenitor cells and subsequently hepatocytes (iMPC-Heps) could be efficiently differentiated. For this purpose we identified small molecules that aided endoderm and hepatocyte differentiation without compromising proliferation. After transplantation into an immune-deficient mouse model of human liver failure, iMPC-Heps proliferated extensively and acquired levels of hepatocyte function similar to those of aHeps. Unfractionated iMPC-Heps did not form tumours, most probably because they never entered a pluripotent state. Our results establish the feasibility of significant liver repopulation of mice with human hepatocytes generated in vitro, which removes a long-standing roadblock on the path to autologous liver cell therapy.	[Zhu, Saiyong; Ding, Sheng] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Rezvani, Milad; Mattis, Aras N.; Willenbring, Holger] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Harbell, Jack; Willenbring, Holger] Univ Calif San Francisco, Div Transplantat, Dept Surg, San Francisco, CA 94143 USA; [Mattis, Aras N.; Willenbring, Holger] Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94110 USA; [Mattis, Aras N.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Wolfe, Alan R.; Benet, Leslie Z.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Ding, Sheng] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Willenbring, H (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, 35 Med Ctr Way, San Francisco, CA 94143 USA.	willenbringh@stemcell.ucsf.edu; sheng.ding@gladstone.ucsf.edu	Benet, Leslie Z/K-8286-2016; Mattis, Aras/C-5558-2014; Wolfe, Alan R./A-6853-2009	Wolfe, Alan R./0000-0002-0932-4146; Rezvani, Milad/0000-0002-9550-8725	California Institute for Regenerative Medicine (CIRM) [RN2-00950]; National Institutes of Health (NIH) [P30 DK26743]; CIRM [TG2-01160, TG2-01153]; NIH; Gladstone Institutes; German Academic Exchange Service; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD064610] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH2TR000487, UH3TR000487] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gladstone Institutes(University of California System); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the Gladstone Institutes' Bioinformatics Core for data analysis, A. Grimm for discussion, and P. Derish for manuscript editing. H. W. is supported by funding from the California Institute for Regenerative Medicine (CIRM; RN2-00950) and the National Institutes of Health (NIH; P30 DK26743). S. D. is supported by funding from CIRM, NIH and the Gladstone Institutes. S.Z. is supported by CIRM research training grant TG2-01160. M. R. is a research fellow in the Biomedical Exchange Program funded by the German Academic Exchange Service. J.H. is an Ethicon-Society of University Surgeons Fellow. A.N.M. is supported by CIRM research training grant TG2-01153.	Andreou ER, 1998, ARCH BIOCHEM BIOPHYS, V357, P137, DOI 10.1006/abbi.1998.0792; Aninat C, 2006, DRUG METAB DISPOS, V34, P75, DOI 10.1124/dmd.105.006759; Azuma H, 2007, NAT BIOTECHNOL, V25, P903, DOI 10.1038/nbt1326; Basma H, 2009, GASTROENTEROLOGY, V136, P990, DOI 10.1053/j.gastro.2008.10.047; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chen AA, 2011, P NATL ACAD SCI USA, V108, P11842, DOI 10.1073/pnas.1101791108; Cheng X, 2012, CELL STEM CELL, V10, P371, DOI 10.1016/j.stem.2012.02.024; Clotman F, 2005, GENE DEV, V19, P1849, DOI 10.1101/gad.340305; Espejel S, 2010, J CLIN INVEST, V120, P3120, DOI 10.1172/JCI43267; Hasegawa M, 2011, BIOCHEM BIOPH RES CO, V405, P405, DOI 10.1016/j.bbrc.2011.01.042; Kodama Y, 2004, GASTROENTEROLOGY, V127, P1775, DOI 10.1053/j.gastro.2004.09.004; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kurian L, 2013, NAT METHODS, V10, P77, DOI [10.1038/NMETH.2255, 10.1038/nmeth.2255]; Lee JM, 2011, NATURE, V474, P506, DOI 10.1038/nature10111; Leeder JS, 2005, J PHARMACOL EXP THER, V314, P626, DOI 10.1124/jpet.105.086504; Li J, 2013, ARTERIOSCL THROM VAS, V33, P1366, DOI 10.1161/ATVBAHA.112.301167; Li WL, 2011, P NATL ACAD SCI USA, V108, P8299, DOI 10.1073/pnas.1014041108; LIEBER A, 1995, P NATL ACAD SCI USA, V92, P6210, DOI 10.1073/pnas.92.13.6210; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/NMETH.1393, 10.1038/nmeth.1393]; Liu H, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002376; Ma XC, 2013, STEM CELL TRANSL MED, V2, P409, DOI 10.5966/sctm.2012-0160; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Martinez-Jimenez CP, 2006, MOL PHARMACOL, V70, P1681, DOI 10.1124/mol.106.025403; Mwinyi J, 2010, MOL PHARMACOL, V78, P886, DOI 10.1124/mol.110.065540; Puppi J, 2012, CELL TRANSPLANT, V21, P1, DOI 10.3727/096368911X566208; Rashid ST, 2010, J CLIN INVEST, V120, P3127, DOI 10.1172/JCI43122; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Song ZH, 2009, CELL RES, V19, P1233, DOI 10.1038/cr.2009.107; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wang P, 2011, CELL STEM CELL, V8, P335, DOI 10.1016/j.stem.2011.01.017; Wang X, 2002, AM J PATHOL, V161, P565, DOI 10.1016/S0002-9440(10)64212-5; Willenbring H, 2008, CANCER CELL, V14, P59, DOI 10.1016/j.ccr.2008.05.004; Woo DH, 2012, GASTROENTEROLOGY, V142, P602, DOI 10.1053/j.gastro.2011.11.030; Xie CQ, 2009, MOL ENDOCRINOL, V23, P724, DOI 10.1210/me.2008-0465; Zhang XZ, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-4; Zhu SY, 2010, CELL STEM CELL, V7, P651, DOI 10.1016/j.stem.2010.11.015	37	186	205	1	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					93	97		10.1038/nature13020	http://dx.doi.org/10.1038/nature13020			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD9UL	24572354	Green Accepted, Green Submitted			2022-12-28	WOS:000333609900049
J	Urbach, DR; Govindarajan, A; Saskin, R; Wilton, AS; Baxter, NN				Urbach, David R.; Govindarajan, Anand; Saskin, Refik; Wilton, Andrew S.; Baxter, Nancy N.			Introduction of Surgical Safety Checklists in Ontario, Canada	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSTOPERATIVE ADVERSE EVENTS; QUALITY IMPROVEMENT PROGRAM; PATIENT SAFETY; IMPLEMENTATION; MORTALITY; OUTCOMES; SURGERY; POPULATION; INDICATORS; CARE	BackgroundEvidence from observational studies that the use of surgical safety checklists results in striking improvements in surgical outcomes led to the rapid adoption of such checklists worldwide. However, the effect of mandatory adoption of surgical safety checklists is unclear. A policy encouraging the universal adoption of checklists by hospitals in Ontario, Canada, provided a natural experiment to assess the effectiveness of checklists in typical practice settings. MethodsWe surveyed all acute care hospitals in Ontario to determine when surgical safety checklists were adopted. Using administrative health data, we compared operative mortality, rate of surgical complications, length of hospital stay, and rates of hospital readmission and emergency department visits within 30 days after discharge among patients undergoing a variety of surgical procedures before and after adoption of a checklist. ResultsDuring 3-month periods before and after adoption of a surgical safety checklist, a total of 101 hospitals performed 109,341 and 106,370 procedures, respectively. The adjusted risk of death during a hospital stay or within 30 days after surgery was 0.71% (95% confidence interval [CI], 0.66 to 0.76) before implementation of a surgical checklist and 0.65% (95% CI, 0.60 to 0.70) afterward (odds ratio, 0.91; 95% CI, 0.80 to 1.03; P=0.13). The adjusted risk of surgical complications was 3.86% (95% CI, 3.76 to 3.96) before implementation and 3.82% (95% CI, 3.71 to 3.92) afterward (odds ratio, 0.97; 95% CI, 0.90 to 1.03; P=0.29). ConclusionsImplementation of surgical safety checklists in Ontario, Canada, was not associated with significant reductions in operative mortality or complications. (Funded by the Canadian Institutes of Health Research.) Public reporting of adherence to surgical safety checklists was mandated for all hospitals in Ontario, beginning in July 2010. In this study of administrative data, checklist introduction was not associated with significant reductions in operative mortality or complications. A study published in 2009 showed that implementation of the 19-item World Health Organization (WHO) Surgical Safety Checklist substantially reduced the rate of surgical complications, from 11.0% to 7.0%, and reduced the rate of in-hospital death from 1.5% to 0.8%.(1) The WHO estimated that at least 500,000 deaths per year could be prevented through worldwide implementation of this checklist.(2) This dramatic effect of a relatively simple and accessible intervention resulted in its widespread adoption. In the United Kingdom, a nationwide program was implemented by the National Health Service within weeks after publication of the WHO study,(3) and almost 6000 hospitals ...	[Urbach, David R.; Govindarajan, Anand; Saskin, Refik; Wilton, Andrew S.; Baxter, Nancy N.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Urbach, David R.; Govindarajan, Anand; Baxter, Nancy N.] Dept Surg, Toronto, ON, Canada; [Urbach, David R.; Baxter, Nancy N.] Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Urbach, David R.] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada; [Govindarajan, Anand] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Baxter, Nancy N.] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Dept Surg, Toronto, ON M5B 1W8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Urbach, DR (corresponding author), 200 Elizabeth St,10-214, Toronto, ON M5G 2C4, Canada.	david.urbach@uhn.ca	Callahan, Charles D/L-1641-2013; Baxter, Nancy N/E-7020-2015	Baxter, Nancy N/0000-0003-4793-4620	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Funded by the Canadian Institutes of Health Research.	[Anonymous], SURG SAF CHECKL HOW; [Anonymous], 2003, CAN CLASS HLTH INT; [Anonymous], SURG SAF CHECKL; [Anonymous], PATIENT SAFETY; [Anonymous], 2009, PAT SAF AL WHO SURG; [Anonymous], 2013, PUBL REP PAT SAF PER; [Anonymous], 2008, J HOPK ACG CAS MIX S; Auerbach AD, 2007, NEW ENGL J MED, V357, P608, DOI 10.1056/NEJMsb070738; Best WR, 2002, J AM COLL SURGEONS, V194, P257, DOI 10.1016/S1072-7515(01)01183-8; Bliss LA, 2012, J AM COLL SURGEONS, V215, P766, DOI 10.1016/j.jamcollsurg.2012.07.015; Borchard A, 2012, ANN SURG, V256, P925, DOI 10.1097/SLA.0b013e3182682f27; Cima RR, 2011, SURGERY, V150, P943, DOI 10.1016/j.surg.2011.06.020; Conley DM, 2011, J AM COLL SURGEONS, V212, P873, DOI 10.1016/j.jamcollsurg.2011.01.052; de Vries EN, 2010, NEW ENGL J MED, V363, P1928, DOI 10.1056/NEJMsa0911535; Deyo RA, 2010, JAMA-J AM MED ASSOC, V303, P1259, DOI 10.1001/jama.2010.338; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; Helmio P, 2011, CLIN OTOLARYNGOL, V36, P242, DOI 10.1111/j.1749-4486.2011.02315.x; Hu JC, 2009, JAMA-J AM MED ASSOC, V302, P1557, DOI 10.1001/jama.2009.1451; Kaafarani HMA, 2009, AM J SURG, V198, pS63, DOI 10.1016/j.amjsurg.2009.08.008; Levy SM, 2012, SURGERY, V152, P331, DOI 10.1016/j.surg.2012.05.034; Neily J, 2010, JAMA-J AM MED ASSOC, V304, P1693, DOI 10.1001/jama.2010.1506; Nilsson L, 2010, ACTA ANAESTH SCAND, V54, P176, DOI 10.1111/j.1399-6576.2009.02109.x; North Carolina Quality Center, WHO SURG SAF CHECKL; Oregon Association of Hospitals and Health Systems, SPRINT SURG SAF; Schermerhorn ML, 2008, NEW ENGL J MED, V358, P464, DOI 10.1056/NEJMoa0707348; Sewell M, 2011, INT ORTHOP, V35, P897, DOI 10.1007/s00264-010-1112-7; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; Takala RSK, 2011, ACTA ANAESTH SCAND, V55, P1206, DOI 10.1111/j.1399-6576.2011.02525.x; Tu JV, 1998, CAN MED ASSOC J, V159, P221; van Klei WA, 2012, ANN SURG, V255, P44, DOI 10.1097/SLA.0b013e31823779ae; Vogts N, 2011, NEW ZEAL MED J, V124, P48; World Health Organization, PAT SAF SURG SAF WEB; World Health Organization, IMPL MAN SURG SAF CH; World Health Organization, SAF SURG SAV LIV; Yinong YX, 2011, ARCH SURG-CHICAGO, V146, P1368, DOI 10.1001/archsurg.2011.762; ZEGER SL, 1989, BIOMETRICS, V45, P347; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	37	394	403	2	45	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 13	2014	370	11					1029	1038		10.1056/NEJMsa1308261	http://dx.doi.org/10.1056/NEJMsa1308261			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC7ED	24620866	Bronze			2022-12-28	WOS:000332689100010
J	Blyth, A				Blyth, Andrew			Thoracic Trauma	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	8	9	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 7	2014	348								g1137	10.1136/bmj.g1137	http://dx.doi.org/10.1136/bmj.g1137			25	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC6JC	24609501				2022-12-28	WOS:000332627300001
J	Fairfax, BP; Humburg, P; Makino, S; Naranbhai, V; Wong, D; Lau, E; Jostins, L; Plant, K; Andrews, R; Mcgee, C; Knight, JC				Fairfax, Benjamin P.; Humburg, Peter; Makino, Seiko; Naranbhai, Vivek; Wong, Daniel; Lau, Evelyn; Jostins, Luke; Plant, Katharine; Andrews, Robert; Mcgee, Chris; Knight, Julian C.			Innate Immune Activity Conditions the Effect of Regulatory Variants upon Monocyte Gene Expression	SCIENCE			English	Article							GENOME-WIDE ASSOCIATION; INTERFERON-GAMMA; DISEASE; RESPONSES; LOCI; RISK; POPULATION; IDENTIFICATION; METAANALYSIS; INDUCTION	To systematically investigate the impact of immune stimulation upon regulatory variant activity, we exposed primary monocytes from 432 healthy Europeans to interferon-gamma (IFN-gamma) or differing durations of lipopolysaccharide and mapped expression quantitative trait loci (eQTLs). More than half of cis-eQTLs identified, involving hundreds of genes and associated pathways, are detected specifically in stimulated monocytes. Induced innate immune activity reveals multiple master regulatory trans-eQTLs including the major histocompatibility complex (MHC), coding variants altering enzyme and receptor function, an IFN-beta cytokine network showing temporal specificity, and an interferon regulatory factor 2 (IRF2) transcription factor-modulated network. Induced eQTL are significantly enriched for genome-wide association study loci, identifying context-specific associations to putative causal genes including CARD9, ATM, and IRF8. Thus, applying pathophysiologically relevant immune stimuli assists resolution of functional genetic variants.	[Fairfax, Benjamin P.; Humburg, Peter; Makino, Seiko; Naranbhai, Vivek; Wong, Daniel; Lau, Evelyn; Jostins, Luke; Plant, Katharine; Knight, Julian C.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Andrews, Robert; Mcgee, Chris] Univ Cambridge, Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England	University of Oxford; Wellcome Centre for Human Genetics; University of Cambridge; Wellcome Trust Sanger Institute	Fairfax, BP (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	bfairfax@well.ox.ac.uk; julian@well.ox.ac.uk	Lau, Evelyn/HGU-8290-2022; Knight, Julian/C-7242-2009; Humburg, Peter/A-4191-2009; Knight, Julian Charles/W-2399-2019	Lau, Evelyn/0000-0003-3281-8360; Knight, Julian/0000-0002-0377-5536; Humburg, Peter/0000-0002-3331-6496; Knight, Julian Charles/0000-0002-0377-5536; Naranbhai, Vivek/0000-0003-4281-8882; Fairfax, Benjamin/0000-0001-7413-5002	Wellcome Trust [074318, 088891, 090532/Z/09/Z]; European Research Council (ERC) under the European Union [281824]; Medical Research Council [98082]; National Institute for Health and Research Oxford Biomedical Research Centre; MRC [G1001708] Funding Source: UKRI; Medical Research Council [G1001708] Funding Source: researchfish; National Institute for Health Research [CL-2012-13-004, ACF-2008-13-017] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); European Research Council (ERC) under the European Union(European Research Council (ERC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health and Research Oxford Biomedical Research Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Gene expression and ChIP-seq data are available through ArrayExpress. Genotyping data have been deposited at the European Genome-phenome Archive (EGA) and are available on request (EGAS00000000109). We are very grateful to all the volunteers who participated in this study together with members of the Knight laboratory for their support. We also thank G. McVean and D. Kwiatkowski for support of this study and helpful suggestions. This work was supported by the Wellcome Trust [grants 074318 (J.C.K.), 088891 (B.P.F.), and 090532/Z/09/Z (core facilities Wellcome Trust Centre for Human Genetics including High-Throughput Genomics Group)], the European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC grant agreement no. 281824 (J.C.K.), the Medical Research Council (98082, J.C.K.), and the National Institute for Health and Research Oxford Biomedical Research Centre.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amisten S, 2007, EUR HEART J, V28, P13, DOI 10.1093/eurheartj/ehl410; Bandiera S, 2005, MOL PHARMACOL, V67, P435, DOI 10.1124/mol.104.006056; Baron JM, 1998, BIOCHEM PHARMACOL, V56, P1105, DOI 10.1016/S0006-2952(98)00105-1; Biswas S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-244; Chevillard G, 2011, CELL MOL LIFE SCI, V68, P3337, DOI 10.1007/s00018-011-0747-x; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Crosslin DR, 2012, HUM GENET, V131, P639, DOI 10.1007/s00439-011-1103-9; Cullell-Young M, 2001, IMMUNOGENETICS, V53, P136, DOI 10.1007/s002510100312; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Escoubet-Lozach L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002401; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Fairfax BP, 2012, NAT GENET, V44, P502, DOI 10.1038/ng.2205; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gaffney DJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003501; Gaulton KJ, 2010, NAT GENET, V42, P255, DOI 10.1038/ng.530; Gregory AP, 2012, NATURE, V488, P508, DOI 10.1038/nature11307; Grossman SR, 2013, CELL, V152, P703, DOI 10.1016/j.cell.2013.01.035; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Hao K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003029; HARADA H, 1989, CELL, V58, P729, DOI 10.1016/0092-8674(89)90107-4; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kalliokoski A, 2009, BRIT J PHARMACOL, V158, P693, DOI 10.1111/j.1476-5381.2009.00430.x; Kirino Y, 2013, NAT GENET, V45, P202, DOI 10.1038/ng.2520; Kroger A, 2002, J INTERF CYTOK RES, V22, P5, DOI 10.1089/107999002753452610; Kruger E, 2012, CURR OPIN IMMUNOL, V24, P77, DOI 10.1016/j.coi.2012.01.005; Leek J. T., COMBAT SVA SURROGATE; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Manry J, 2011, J EXP MED, V208, P2747, DOI 10.1084/jem.20111680; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Marinho S, 2012, ANN ALLERG ASTHMA IM, V108, P402, DOI 10.1016/j.anai.2012.03.002; MATSUYAMA T, 1993, CELL, V75, P83, DOI 10.1016/S0092-8674(05)80086-8; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Metz R, 2007, CANCER RES, V67, P7082, DOI 10.1158/0008-5472.CAN-07-1872; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Orozco LD, 2012, CELL, V151, P658, DOI 10.1016/j.cell.2012.08.043; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Rotival M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002367; Sasaki M, 2008, FREE RADICAL RES, V42, P625, DOI 10.1080/10715760802244768; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Small KS, 2011, NAT GENET, V43, P561, DOI 10.1038/ng.833; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sokol H, 2013, GASTROENTEROLOGY, V145, P591, DOI 10.1053/j.gastro.2013.05.047; Watling D, 2008, P NATL ACAD SCI USA, V105, P6051, DOI 10.1073/pnas.0710814105; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Xu JF, 2012, NAT GENET, V44, P1231, DOI 10.1038/ng.2424; Yin TF, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r77; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou KX, 2011, NAT GENET, V43, P117, DOI 10.1038/ng.735	65	466	469	2	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2014	343	6175					1118	+	1246949	10.1126/science.1246949	http://dx.doi.org/10.1126/science.1246949			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2LB	24604202	Green Accepted			2022-12-28	WOS:000332331500041
J	Friedberg, MW; Schneider, EC; Rosenthal, MB; Volpp, KG; Werner, RM				Friedberg, Mark W.; Schneider, Eric C.; Rosenthal, Meredith B.; Volpp, Kevin G.; Werner, Rachel M.			Association Between Participation in a Multipayer Medical Home Intervention and Changes in Quality, Utilization, and Costs of Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LONGITUDINAL DATA-ANALYSIS; STRUCTURAL CAPABILITIES; TRANSFORMATION; EFFICIENCY; WILL	IMPORTANCE Interventions to transform primary care practices into medical homes are increasingly common, but their effectiveness in improving quality and containing costs is unclear. OBJECTIVE To measure associations between participation in the Southeastern Pennsylvania Chronic Care Initiative, one of the earliest and largest multipayer medical home pilots conducted in the United States, and changes in the quality, utilization, and costs of care. DESIGN, SETTING, AND PARTICIPANTS Thirty-two volunteering primary care practices participated in the pilot (conducted from June 1, 2008, to May 31, 2011). We surveyed pilot practices to compare their structural capabilities at the pilot's beginning and end. Using claims data from 4 participating health plans, we compared changes (in each year, relative to before the intervention) in the quality, utilization, and costs of care delivered to 64 243 patients who were attributed to pilot practices and 55 959 patients attributed to 29 comparison practices (selected for size, specialty, and location similar to pilot practices) using a difference-in-differences design. EXPOSURES Pilot practices received disease registries and technical assistance and could earn bonus payments for achieving patient-centered medical home recognition by the National Committee for Quality Assurance (NCQA). MAIN OUTCOMES AND MEASURES Practice structural capabilities; performance on 11 quality measures for diabetes, asthma, and preventive care; utilization of hospital, emergency department, and ambulatory care; standardized costs of care. RESULTS Pilot practices successfully achieved NCQA recognition and adopted new structural capabilities such as registries to identify patients overdue for chronic disease services. Pilot participation was associated with statistically significantly greater performance improvement, relative to comparison practices, on 1 of 11 investigated quality measures: nephropathy screening in diabetes (adjusted performance of 82.7% vs 71.7% by year 3, P<.001). Pilot participation was not associated with statistically significant changes in utilization or costs of care. Pilot practices accumulated average bonuses of $92 000 per primary care physician during the 3-year intervention. CONCLUSIONS AND RELEVANCE A multipayer medical home pilot, in which participating practices adopted new structural capabilities and received NCQA certification, was associated with limited improvements in quality and was not associated with reductions in utilization of hospital, emergency department, or ambulatory care services or total costs over 3 years. These findings suggest that medical home interventions may need further refinement.	[Friedberg, Mark W.; Schneider, Eric C.] RAND Corp, Boston, MA USA; [Friedberg, Mark W.; Schneider, Eric C.] Brigham & Womens Hosp, Div Gen Internal Med, Boston, MA 02115 USA; [Friedberg, Mark W.; Schneider, Eric C.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Schneider, Eric C.; Rosenthal, Meredith B.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Volpp, Kevin G.; Werner, Rachel M.] Philadelphia VA Med Ctr, Ctr Hlth Equ Res & Promot, Philadelphia, PA USA; [Volpp, Kevin G.] Univ Penn, Perelman Sch Med, Ctr Hlth Incent & Behav Econ, Philadelphia, PA 19104 USA; [Volpp, Kevin G.; Werner, Rachel M.] Univ Penn, Div Gen Internal Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Volpp, Kevin G.] Wharton Business Sch, Dept Hlth Care Management, Philadelphia, PA USA; [Volpp, Kevin G.] Penn Med Ctr Hlth Care Innovat, Philadelphia, PA USA	RAND Corporation; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania	Friedberg, MW (corresponding author), 20 Pk Plaza,Ste 920, Boston, MA 02116 USA.	mfriedbe@rand.org	Friedberg, Mark William/Y-2607-2019	Friedberg, Mark William/0000-0002-7907-8358; Werner, Rachel/0000-0003-3435-4221; Volpp, Kevin/0000-0003-1423-4599; Rosenthal, Meredith/0000-0003-3410-0184; Schneider, Eric/0000-0002-1132-5084	Commonwealth Fund; Aetna; NATIONAL INSTITUTE ON AGING [K24AG047908] Funding Source: NIH RePORTER	Commonwealth Fund; Aetna; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was sponsored by the Commonwealth Fund and Aetna.	[Anonymous], PATIENT CENTERED MED; [Anonymous], OPTUM NORMALIZED PRI; [Anonymous], THE BREAKTHROUGH SER; [Anonymous], IMPROVING PERFORMANC; [Anonymous], 2007, JOINT PRINCIPLES OF; [Anonymous], STATEMENTS OF SUPPOR; Bitton A, 2010, J GEN INTERN MED, V25, P584, DOI 10.1007/s11606-010-1262-8; Boult C, 2011, ARCH INTERN MED, V171, P460, DOI 10.1001/archinternmed.2010.540; Buntin MB, 2004, J HEALTH ECON, V23, P525, DOI 10.1016/j.jhealeco.2003.10.005; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clarke RMA, 2012, HEALTH AFFAIR, V31, P627, DOI 10.1377/hlthaff.2011.0908; Crabtree Benjamin F, 2010, Ann Fam Med, V8 Suppl 1, pS80, DOI 10.1370/afm.1107; Diedhiou A, 2010, MED CARE RES REV, V67, P450, DOI 10.1177/1077558710367735; Fifield J, 2013, J GEN INTERN MED, V28, P778, DOI 10.1007/s11606-013-2386-4; Flottemesch TJ, 2012, AM J MANAG CARE, V18, P677; Friedberg MW, 2009, ANN INTERN MED, V151, P456, DOI 10.7326/0003-4819-151-7-200910060-00006; Friedberg MW, 2009, AM J MANAG CARE, V15, P137; Friedberg MW, 2009, J GEN INTERN MED, V24, P162, DOI 10.1007/s11606-008-0856-x; Gabbay RA, 2013, ANN FAM MED, V11, pS99, DOI 10.1370/afm.1473; Gabbay RA, 2011, JT COMM J QUAL PATIE, V37, P265, DOI 10.1016/S1553-7250(11)37034-1; Gilfillan RJ, 2010, AM J MANAG CARE, V16, P607; Graubard BI, 1999, BIOMETRICS, V55, P652, DOI 10.1111/j.0006-341X.1999.00652.x; Hoff T, 2012, MED CARE RES REV, V69, P619, DOI 10.1177/1077558712447688; Jackson GL, 2013, ANN INTERN MED, V158, P169, DOI 10.7326/0003-4819-158-3-201302050-00579; Jaen Carlos Roberto, 2010, Ann Fam Med, V8 Suppl 1, pS57, DOI 10.1370/afm.1121; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; McWilliams JM, 2013, HEALTH SERV RES, V48, P1526, DOI 10.1111/1475-6773.12032; National Committee for Quality Assurance, 2008, STANDARDS AND GUIDEL; Nutting PA, 2009, ANN FAM MED, V7, P254, DOI 10.1370/afm.1002; Peikes D, BUILDING THE EVIDENC; Peikes D, 2012, AM J MANAG CARE, V18, P105; Reid RJ, 2010, HEALTH AFFAIR, V29, P835, DOI 10.1377/hlthaff.2010.0158; Reid RJ, 2009, AM J MANAG CARE, V15, pE71; Roby DH, 2010, MED CARE RES REV, V67, P412, DOI 10.1177/1077558710368682; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Rosenthal MB, RECOMMENDED CORE MEA; Rosenthal MB, 2013, JAMA INTERN MED, V173, P1907, DOI 10.1001/jamainternmed.2013.10063; Rosenthal MB, 2010, MED CARE RES REV, V67, P476, DOI 10.1177/1077558710368412; Setodji CM, 2012, HEALTH SERV OUTCOME, V12, P62, DOI 10.1007/s10742-012-0082-1; Song Z, 2011, NEW ENGL J MED, V365, P909, DOI 10.1056/NEJMsa1101416; Werner RM, 2013, MED CARE, V51, P487, DOI 10.1097/MLR.0b013e31828d4d29; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	42	258	258	1	48	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 26	2014	311	8					815	825		10.1001/jama.2014.353	http://dx.doi.org/10.1001/jama.2014.353			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AB4XQ	24570245	Green Accepted, Bronze			2022-12-28	WOS:000331793700021
J	Frisch, S				Frisch, Suzy			Indian medicine, coming soon to an island near you	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												suzyfrisch@yahoo.com						Anand G., 2009, WALL STREET J 1125; Cortez N, 2011, SOUTH CALIF LAW REV, V84, P859; Govindarajan V, 2013, WASHINGTON POST; Govindarajan V., 2013, HARVARD BUS REV; Richman BD, 2008, HEALTH AFFAIR, V27, P1260, DOI 10.1377/hlthaff.27.5.1260	5	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 25	2014	348								g1740	10.1136/bmj.g1740	http://dx.doi.org/10.1136/bmj.g1740			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AC0TW	24569600				2022-12-28	WOS:000332209200011
J	Werfel, J; Petersen, K; Nagpal, R				Werfel, Justin; Petersen, Kirstin; Nagpal, Radhika			Designing Collective Behavior in a Termite-Inspired Robot Construction Team	SCIENCE			English	Article								Complex systems are characterized by many independent components whose low-level actions produce collective high-level results. Predicting high-level results given low-level rules is a key open challenge; the inverse problem, finding low-level rules that give specific outcomes. We present a multi-agent construction system inspired by mound-building termites, solving such an inverse problem. A user specifies a desired structure, and the system automatically generates low-level rules for independent climbing robots that guarantee production of that structure. Robots use only local sensing and coordinate their activity via the shared environment. We demonstrate the approach via a physical realization with three autonomous climbing robots limited to onboard sensing. This work advances the aim of engineering complex systems that achieve specific human-designed goals.	[Werfel, Justin; Petersen, Kirstin; Nagpal, Radhika] Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA; [Petersen, Kirstin; Nagpal, Radhika] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Werfel, J (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Cambridge, MA 02138 USA.	justin.werfel@wyss.harvard.edu		Petersen, Kirstin H./0000-0002-7813-5621	Wyss Institute for Biologically Inspired Engineering	Wyss Institute for Biologically Inspired Engineering	Supported by the Wyss Institute for Biologically Inspired Engineering.	ANDERSON PW, 1972, SCIENCE, V177, P393, DOI 10.1126/science.177.4047.393; Arkin R. C., 1998, BEHAV BASED ROBOTICS; Bar-Yam Y., 1997, DYNAMICS COMPLEX SYS; Bolger A, 2010, IEEE INT C INT ROBOT, P5085, DOI 10.1109/IROS.2010.5651495; Bonabeau E DdRDF, 1999, SWARM INTELLIGENCE N; Brooks R. A., 1989, Journal of the British Interplanetary Society, V42, P478; BROOKS RA, 1986, IEEE T ROBOTIC AUTOM, V2, P14, DOI 10.1109/JRA.1986.1087032; Grasse P. P., 1959, Insectes Sociaux Paris, V6, P41, DOI 10.1007/BF02223791; Ijspeert AJ, 2001, AUTON ROBOT, V11, P149, DOI 10.1023/A:1011227210047; Khoshnevis B, 2004, AUTOMAT CONSTR, V13, P5, DOI 10.1016/j.autcon.2003.08.012; Lindsey Q, 2012, ROBOTICS: SCIENCE AND SYSTEMS VII, P177; Mitchell M., 2009, COMPLEXITY GUIDED TO; Nigl F, 2013, IEEE ROBOT AUTOM MAG, V20, P60, DOI 10.1109/MRA.2012.2201579; Quinn RD, 2001, CLIMBING AND WALKING ROBOTS, P69; SHOHAM Y, 1995, ARTIF INTELL, V73, P231, DOI 10.1016/0004-3702(94)00007-N; SMITH JM, 1974, J THEOR BIOL, V47, P209, DOI 10.1016/0022-5193(74)90110-6; THERAULAZ G, 1995, SCIENCE, V269, P686, DOI 10.1126/science.269.5224.686; Thrun S., 2005, PROBABILISTIC ROBOTI; Werfel J., 2006, THESIS MIT; Willmann J, 2012, INT J ARCHIT COMPUT, V10, P439, DOI 10.1260/1478-0771.10.3.439; Wismer S, 2012, IEEE INT C INT ROBOT, P5436, DOI 10.1109/IROS.2012.6386278; Worcester J., 2011, 2011 IEEE/RSJ International Conference on Intelligent Robots and Systems (IROS 2011), P4790, DOI 10.1109/IROS.2011.6048806	24	308	314	33	261	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 14	2014	343	6172					754	758		10.1126/science.1245842	http://dx.doi.org/10.1126/science.1245842			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB1NB	24531967				2022-12-28	WOS:000331557800035
J	Hanmer, J; Lu, X; Rosenthal, GE; Cram, P				Hanmer, Janel; Lu, Xin; Rosenthal, Gary E.; Cram, Peter			Insurance Status and the Transfer of Hospitalized Patients An Observational Study	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; EMERGENCY-DEPARTMENT; CHEST-PAIN; PREFERENCES; TRIAGE; EMTALA; RACE; REVASCULARIZATION; CENTERS; NEED	Background: There is little objective evidence to support concerns that patients are transferred between hospitals based on insurance status. Objective: To examine the relationship between patients' insurance coverage and interhospital transfer. Design: Data analyzed from the 2010 Nationwide Inpatient Sample. Patients: All patients aged 18 to 64 years discharged alive from U.S. acute care hospitals with 1 of 5 common diagnoses (biliary tract disease, chest pain, pneumonia, septicemia, and skin or subcutaneous infection). Measurements: For each diagnosis, the proportion of hospitalized patients who were transferred to another acute care hospital based on insurance coverage (private, Medicare, Medicaid, or uninsured) was compared. Logistic regression was used to estimate the odds of transfer for uninsured patients (reference category, privately insured) while patient-and hospital-level factors were adjusted for. All analyses incorporated sampling and poststratification weights. Results: Among 315 748 patients discharged from 1051 hospitals with any of the 5 diagnoses, the percentage of patients transferred to another acute care hospital varied from 1.3% (skin infection) to 5.1% (septicemia). In unadjusted analyses, uninsured patients were significantly less likely to be transferred for 3 diagnoses (P < 0.05). In adjusted analyses, uninsured patients were significantly less likely to be transferred than privately insured patients for 4 diagnoses: biliary tract disease (odds ratio, 0.73 [95% CI, 0.55 to 0.96]), chest pain (odds ratio, 0.63 [CI, 0.44 to 0.89]), septicemia (odds ratio, 0.76 [CI, 0.64 to 0.91]), and skin infections (odds ratio, 0.64 [CI, 0.46 to 0.89]). Women were significantly less likely to be transferred than men for all diagnoses. Limitation: This analysis relied on administrative data and lacked clinical detail. Conclusion: Uninsured patients (and women) were significantly less likely to undergo interhospital transfer. Differences in transfer rates may contribute to health care disparities.	Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15213 USA; Univ Iowa, Carver Coll Med, Ctr Comprehens Access & Delivery Res & Evaluat, Iowa City, IA USA; Iowa City Vet Affairs Med Ctr, Iowa City, IA USA; Univ Toronto, Toronto, ON, Canada; [Cram, Peter] Univ Hlth Network, Mt Sinai Hosp, Toronto, ON M5G 2C4, Canada	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University Health Network Toronto	Hanmer, J (corresponding author), Univ Pittsburgh, Med Ctr, Montefiore Hosp, Suite W93,200 Lothrop St, Pittsburgh, PA 15213 USA.	hanmerjz@upmc.edu	Cram, Peter/K-4472-2014	Cram, Peter/0000-0002-1910-346X	National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000442] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR062133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033035] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Institutes of Health.	American Hospital Association, 2008, AM HOSP ASS ANN SURV; Babu MA, 2011, NEUROSURGERY, V69, P659, DOI 10.1227/NEU.0b013e31821bc667; Barnett H, 2010, PROF CASE MANAG, V15, P280, DOI 10.1097/NCM.0b013e3181e2d114; Boulware LE, 2005, AM J TRANSPLANT, V5, P1503, DOI 10.1111/j.1600-6143.2005.00860.x; Constantinescu F, 2009, ARTHRIT RHEUM-ARTHR, V61, P413, DOI 10.1002/art.24338; Cooke CR, 2011, MED CARE, V49, P662, DOI 10.1097/MLR.0b013e31821d98b2; Cram P, 2008, MED CARE, V46, P467, DOI 10.1097/MLR.0b013e31816c43d9; Durbin DR, 1997, PEDIATRICS, V100, part. no., DOI 10.1542/peds.100.3.e8; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Gurwitz JH, 2002, AM J MED, V112, P528, DOI 10.1016/S0002-9343(02)01072-0; HCUP Nationwide Inpatient Sample (NIS), HLTH CAR COST UT PRO; Healthcare Cost and Utilization Project (HCUP), HEALTHC COST UT PROJ; Healthcare Cost and Utilization Project National Institutes of Health, 2013, DESCR DAT EL HEALTHC; HIMMELSTEIN DU, 1984, AM J PUBLIC HEALTH, V74, P494, DOI 10.2105/AJPH.74.5.494; Houchens R, 2001, HCUP METHOD SERIES R; Institute of Medicine Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, 2003, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Kamoie B E, 2000, J Health Law, V33, P25; Kao DP, 2012, ARCH INTERN MED, V172, P891, DOI 10.1001/archinternmed.2012.1290; KELLERMANN AL, 1990, AM J PUBLIC HEALTH, V80, P864, DOI 10.2105/AJPH.80.7.864; KELLERMANN AL, 1988, AM J PUBLIC HEALTH, V78, P1287, DOI 10.2105/AJPH.78.10.1287; Koval KJ, 2006, J BONE JOINT SURG AM, V88A, P2124, DOI 10.2106/JBJS.F.00245; Lee Tiana Mayere, 2004, Ann Health Law, V13, P145; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; Lopez L, 2010, ACAD EMERG MED, V17, P801, DOI 10.1111/j.1553-2712.2010.00823.x; McCarthy JJ, 2013, COMMON PROBLEMS ACUT; Mumma BE, 2011, ANN EMERG MED, V57, P551, DOI 10.1016/j.annemergmed.2010.09.026; Nathens AB, 2001, J TRAUMA, V50, P776, DOI 10.1097/00005373-200105000-00002; Popescu I, 2007, JAMA-J AM MED ASSOC, V297, P2489, DOI 10.1001/jama.297.22.2489; Ravn-Fischer A, 2012, AM J EMERG MED, V30, P1515, DOI 10.1016/j.ajem.2011.12.020; Rosenbaum S, 2012, HEALTH AFFAIR, V31, P1749, DOI 10.1377/hlthaff.2012.0517; Rosenberg AL, 2003, ANN INTERN MED, V138, P882, DOI 10.7326/0003-4819-138-11-200306030-00009; SCHIFF RL, 1986, NEW ENGL J MED, V314, P552, DOI 10.1056/NEJM198602273140905; Smith JM, 2002, J NATL MED ASSOC, V94, P426; Strickler Jeffery, 2006, JONAS Healthc Law Ethics Regul, V8, P77, DOI 10.1097/00128488-200607000-00005; Thakur NA, 2010, J ORTHOP TRAUMA, V24, P336, DOI 10.1097/BOT.0b013e3181b18b89; White A, 2011, SEEING PATIENTS UNCO; Wong MD, 2004, AM J MED, V116, P613, DOI 10.1016/j.amjmed.2003.09.051	37	19	19	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 21	2014	160	2					81	+		10.7326/M12-1977	http://dx.doi.org/10.7326/M12-1977			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	297SQ	24592493	Green Accepted			2022-12-28	WOS:000330275600014
J	Greenwood, B; Koram, K				Greenwood, Brian; Koram, Kwadwo			Malaria control in Africa: progress but still much to do	LANCET			English	Editorial Material									[Greenwood, Brian] Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1E 7HT, England; [Koram, Kwadwo] Noguchi Mem Inst Med Res, Accra, Ghana	University of London; London School of Hygiene & Tropical Medicine; University of Ghana	Greenwood, B (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Keppel St, London WC1E 7HT, England.	brian.greenwood@lshm.ac.uk						Cotter C, 2013, LANCET, V382, P900, DOI 10.1016/S0140-6736(13)60310-4; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Noor AM, 2014, LANCET; Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; Tatem AJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-133; Tusting LS, 2013, LANCET, V382, P963, DOI 10.1016/S0140-6736(13)60851-X; van Eijk AM, 2013, LANCET INFECT DIS, V13, P1029, DOI 10.1016/S1473-3099(13)70199-3; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2013, EV REV GROUP MAL BUR	12	11	11	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 17	2014	383	9930					1703	1704		10.1016/S0140-6736(14)60044-1	http://dx.doi.org/10.1016/S0140-6736(14)60044-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH6UO	24559538	hybrid, Green Submitted			2022-12-28	WOS:000336267300008
J	Chatterjee, S; Naik, S; John, S; Dabholkar, H; Balaji, M; Koschorke, M; Varghese, M; Thara, R; Weiss, HA; Williams, P; McCrone, P; Patel, V; Thornicroft, G				Chatterjee, Sudipto; Naik, Smita; John, Sujit; Dabholkar, Hamid; Balaji, Madhumitha; Koschorke, Mirja; Varghese, Mathew; Thara, Rangaswamy; Weiss, Helen A.; Williams, Paul; McCrone, Paul; Patel, Vikram; Thornicroft, Graham			Effectiveness of a community-based intervention for people with schizophrenia and their caregivers in India (COPSI): a randomised controlled trial	LANCET			English	Article							GLOBAL MENTAL-HEALTH; PSYCHOEDUCATIONAL INTERVENTION; PRIMARY-CARE; RURAL INDIA; DISCRIMINATION; DISORDERS; COUNTRIES; SERVICES; ILLNESS; STIGMA	Background Observational evidence suggests that community-based services for people with schizophrenia can be successfully provided by community health workers, when supervised by specialists, in low-income and middle-income countries. We did the COmmunity care for People with Schizophrenia in India (COPSI) trial to compare the effectiveness of a collaborative community-based care intervention with standard facility-based care. Methods We did a multicentre, parallel-group, randomised controlled trial at three sites in India between Jan 1, 2009 and Dec 31, 2010. Patients aged 16-60 years with a primary diagnosis of schizophrenia according to the tenth edition of the International Classification of Diseases, Diagnostic Criteria for Research (ICD-10-DCR) were randomly assigned (2:1), via a computer-generated randomisation list with block sizes of three, six, or nine, to receive either collaborative community-based care plus facility-based care or facility-based care alone. Randomisation was stratified by study site. Outcome assessors were masked to group allocation. The primary outcome was a change in symptoms and disabilities over 12 months, as measured by the positive and negative syndrome scale (PANSS) and the Indian disability evaluation and assessment scale (IDEAS). Analysis was by modified intention to treat. This study is registered as an International Standard Randomised Controlled Trial, number ISRCTN 56877013. Findings 187 participants were randomised to the collaborative community-based care plus facility-based care group and 95 were randomised to the facility-based care alone group; 253 (90%) participants completed follow-up to month 12. At 12 months, total PANSS and IDEAS scores were lower in patients in the intervention group than in those in the control group (PANSS adjusted mean difference -3.75, 95% CI -7.92 to 0.42; p=0.08; IDEAS -0.95, -1.68 to -0.23; p=0.01). However, no difference was shown in the proportion of participants who had a reduction of more than 20% in overall symptoms (PANSS 85 [51%] in the intervention group vs 44 [51%] in the control group; p= 0.89; IDEAS 75 [48%] vs 28 [35%]). We noted a significant reduction in symptom and disability outcomes at the rural Tamil Nadu site (-9.29, -15.41 to -3.17; p=0.003). Two patients (one in each group) died by suicide during the study, and two patients died because of complications of a road traffic accident and pre-existing cardiac disease. 18 (73%) patients (17 in the intervention group) were admitted to hospital during the course of the trial, of whom seven were admitted because of physical health problems, such as acute gastritis and vomiting, road accident, high fever, or cardiovascular disease. Interpretation The collaborative community-based care plus facility-based care intervention is modestly more effective than facility-based care, especially for reducing disability and symptoms of psychosis. Our results show that the study intervention is best implemented as an initial service in settings where services are scarce, for example in rural areas.	[Chatterjee, Sudipto; Naik, Smita; Balaji, Madhumitha; Patel, Vikram] Sangath, Goa, India; [John, Sujit; Thara, Rangaswamy] Schizophrenia Res Fdn, Madras, Tamil Nadu, India; [Dabholkar, Hamid] Parivartan, Satara, India; [Koschorke, Mirja; Thornicroft, Graham] Kings Coll London, Inst Psychiat, London SE5 8AF, England; [Williams, Paul; McCrone, Paul] Ctr Global Mental Hlth, London, England; Hlth Serv & Populat Res Dept, London, England; [Varghese, Mathew] Natl Inst Mental Hlth & Neurosci, Dept Psychiat, Bengaluru, India; [Weiss, Helen A.] London Sch Hyg & Trop Med, Med Res Council, Trop Epidemiol Grp, London WC1, England; [Patel, Vikram] London Sch Hyg & Trop Med, Ctr Global Mental Hlth, London WC1, England; [Patel, Vikram] Publ Hlth Fdn India, New Delhi, India	University of London; King's College London; National Institute of Mental Health & Neurosciences - India; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Public Health Foundation of India	Thornicroft, G (corresponding author), Kings Coll London, Inst Psychiat, Ctr Global Mental Hlth, London SE5 8AF, England.	graham.thornicroft@kcl.ac.uk	Varghese, Mathew/AAG-8341-2019; weiss, helen/ABC-7823-2021; Thornicroft, Graham/B-4027-2010; Williams, Paul/C-8914-2013	Varghese, Mathew/0000-0001-5670-5710; weiss, helen/0000-0003-3547-7936; Thornicroft, Graham/0000-0003-0662-0879; Balaji, Madhumitha/0000-0002-7399-8057; Patel, Vikram/0000-0003-1066-8584; John, Sujit/0000-0001-7157-3533; McCrone, Paul/0000-0001-7001-4502; Williams, Paul/0000-0001-6259-0390	Wellcome Trust; Medical Research Council [MR/K012126/1] Funding Source: researchfish; National Institute for Health Research [RP-PG-0606-1053, NF-SI-0611-10053] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Wellcome Trust.	Adams G, 2004, J CLIN EPIDEMIOL, V57, P785, DOI 10.1016/j.jclinepi.2003.12.013; Balaji M, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-42; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Brohan E, 2013, PSYCHIAT RES, V208, P33, DOI 10.1016/j.psychres.2013.03.007; Brohan E, 2010, EPIDEMIOL PSICHIAT S, V19, P326; Chatterjee S, 2003, BRIT J PSYCHIAT, V182, P57, DOI 10.1192/bjp.182.1.57; Chatterjee S, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-12; Chatterjee S, 2009, BRIT J PSYCHIAT, V195, P433, DOI 10.1192/bjp.bp.108.057596; Chaudhury Pranit K, 2006, Indian J Psychiatry, V48, P95, DOI 10.4103/0019-5545.31597; Chisholm D, 2000, BRIT J PSYCHIAT, V176, P581, DOI 10.1192/bjp.176.6.581; Collins PY, 2011, NATURE, V475, P27, DOI 10.1038/475027a; Dua T, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001122; Farooq S, 2011, BRIT J PSYCHIAT, V199, P467, DOI 10.1192/bjp.bp.110.085340; Gaebel W, 2012, EUR PSYCHIAT, V27, P87, DOI 10.1016/j.eurpsy.2011.12.001; Hackshaw A, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3340; Hamilton S, 2011, INT REV PSYCHIATR, V23, P47, DOI 10.3109/09540261.2010.545367; Haro JM, 2003, ACTA PSYCHIAT SCAND, V107, P16, DOI 10.1034/j.1600-0447.107.s416.5.x; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kulhara P, 2009, ACTA PSYCHIAT SCAND, V119, P472, DOI 10.1111/j.1600-0447.2008.01304.x; Lund C, 2011, LANCET, V378, P1502, DOI 10.1016/S0140-6736(11)60754-X; Paranthaman V, 2010, ASIAN J PSYCHIATR, V3, P206, DOI 10.1016/j.ajp.2010.07.002; Ritsher JB, 2003, PSYCHIAT RES, V121, P31, DOI 10.1016/j.physchres.2003.08.008; Roberts C, 2005, CLIN TRIALS, V2, P152, DOI 10.1191/1740774505cn076oa; Sartorius N, 1996, SOC PSYCH PSYCH EPID, V31, P249; Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251; Sharif F, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-48; Thara R, 2002, IDEAS INDIAN DISABIL IDEAS INDIAN DISABIL; Thornicroft G, 2013, PSYCHOL MED, V43, P849, DOI 10.1017/S0033291712001420; Thornicroft G, 1998, BRIT J PSYCHIAT, V173, P423, DOI 10.1192/bjp.173.5.423; Thornicroft G, 2009, LANCET, V373, P408, DOI 10.1016/S0140-6736(08)61817-6	30	136	138	0	23	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 19	2014	383	9926					1385	1394		10.1016/S0140-6736(13)62629-X	http://dx.doi.org/10.1016/S0140-6736(13)62629-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AG3LI	24612754	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000335318400024
J	Paolino, M; Choidas, A; Wallner, S; Pranjic, B; Uribesalgo, I; Loeser, S; Jamieson, AM; Langdon, WY; Ikeda, F; Fededa, JP; Cronin, SJ; Nitsch, R; Schultz-Fademrecht, C; Eickhoff, J; Menninger, S; Unger, A; Torka, R; Gruber, T; Hinterleitner, R; Baier, G; Wolf, D; Ullrich, A; Klebl, BM; Penninger, JM				Paolino, Magdalena; Choidas, Axel; Wallner, Stephanie; Pranjic, Blanka; Uribesalgo, Iris; Loeser, Stefanie; Jamieson, Amanda M.; Langdon, Wallace Y.; Ikeda, Fumiyo; Fededa, Juan Pablo; Cronin, Shane J.; Nitsch, Roberto; Schultz-Fademrecht, Carsten; Eickhoff, Jan; Menninger, Sascha; Unger, Anke; Torka, Robert; Gruber, Thomas; Hinterleitner, Reinhard; Baier, Gottfried; Wolf, Dominik; Ullrich, Axel; Klebl, Bert M.; Penninger, Josef M.			The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells	NATURE			English	Article							MOUSE NK CELLS; TYROSINE KINASES; IN-VIVO; CELLULAR TARGETS; IDENTIFICATION; ACTIVATION; WARFARIN; GROWTH; AXL; IMMUNOTHERAPY	Tumour metastasis is the primary cause of mortality in cancer patients and remains the key challenge for cancer therapy(1). New therapeutic approaches to block inhibitory pathways of the immune system have renewed hopes for the utility of such therapies(2). Here we show that genetic deletion of the E3 ubiquitin ligase Cbl-b (casitas B-lineage lymphoma-b) or targeted inactivation of its E3 ligase activity licenses natural killer (NK) cells to spontaneously reject metastatic tumours. The TAM tyrosine kinase receptors Tyro3, Axl and Mer (also known as Mertk) were identified as ubiquitylation substrates for Cbl-b. Treatment of wild-type NK cells with a newly developed small molecule TAM kinase inhibitor conferred therapeutic potential, efficiently enhancing anti-metastatic NK cell activity in vivo. Oral or intraperitoneal administration using this TAM inhibitor markedly reduced murine mammary cancer and melanoma metastases dependent on NK cells. We further report that the anticoagulant warfarin exerts anti-metastatic activity in mice via Cbl-b/TAM receptors in NK cells, providing a molecular explanation for a 50-year-old puzzle in cancer biology(3). This novel TAM/Cbl-b inhibitory pathway shows that it might be possible to develop a 'pill' that awakens the innate immune system to kill cancer metastases.	[Paolino, Magdalena; Pranjic, Blanka; Uribesalgo, Iris; Loeser, Stefanie; Ikeda, Fumiyo; Fededa, Juan Pablo; Cronin, Shane J.; Nitsch, Roberto; Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1030 Vienna, Austria; [Choidas, Axel; Schultz-Fademrecht, Carsten; Eickhoff, Jan; Menninger, Sascha; Unger, Anke; Klebl, Bert M.] Lead Discovery Ctr GmbH, D-44227 Dortmund, Germany; [Wallner, Stephanie; Gruber, Thomas; Hinterleitner, Reinhard; Baier, Gottfried; Wolf, Dominik] Med Univ Innsbruck, A-6020 Innsbruck, Austria; [Jamieson, Amanda M.] Brown Univ, Dept Microbiol & Immunol, Providence, RI 02912 USA; [Langdon, Wallace Y.] Univ Western Australia, Sch Pathol & Lab Med, Perth, WA 6009, Australia; [Torka, Robert; Ullrich, Axel] Max Planck Inst Biochem, Dept Mol Biol, D-82152 Martinsried, Germany; [Wolf, Dominik] Univ Hosp Bonn, D-53127 Bonn, Germany	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Lead Discovery Center GmbH (LDC); Medical University of Innsbruck; Brown University; University of Western Australia; Max Planck Society; University of Bonn	Penninger, JM (corresponding author), Austrian Acad Sci, Inst Mol Biotechnol, IMBA, A-1030 Vienna, Austria.	josef.penninger@imba.oeaw.ac.at	Paolino, Magdalena/AAN-9417-2020; Nitsch, Roberto/AAT-3666-2020; Hinterleitner, Reinhard/N-7091-2019; Penninger, Josef M/I-6860-2013; Ikeda, Fumiyo/AAD-3770-2020; Jamieson, Amanda/U-7169-2019	Nitsch, Roberto/0000-0001-8766-6267; Penninger, Josef M/0000-0002-8194-3777; Ikeda, Fumiyo/0000-0003-0407-2768; Jamieson, Amanda/0000-0002-5781-9231; Gruber, Thomas/0000-0002-5796-7090; Uribesalgo, Iris/0000-0001-9492-1000; Paolino, Magdalena/0000-0001-9724-9029; Baier, Gottfried/0000-0002-2085-8325; Torka, Robert/0000-0003-4030-3535	European Research Council (ERC); Era of Hope/DoD Innovator Award; Institute of Molecular Biotechnology (IMBA); Austrian National Foundation; Austrian Academy of Sciences; GEN-AU (AustroMouse); EU ERC; Austrian Science Fund (FWF) [P 25044] Funding Source: researchfish	European Research Council (ERC)(European Research Council (ERC)); Era of Hope/DoD Innovator Award; Institute of Molecular Biotechnology (IMBA); Austrian National Foundation; Austrian Academy of Sciences; GEN-AU (AustroMouse); EU ERC(European Research Council (ERC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank T. Hanada, R. Hanada, R. Karim and all other members of the Penninger laboratory for discussions and technical support. We thank all members of the IMP-IMBA BioOptics service facility for assistance in cell sorting and image quantification, and S. Soto and H. Popper for pathology analysis of tumour metastases. We thank A. L. Prieto, E. Vivier, D. Raulet and C. Melief for providing us with critical reagents and C. Martinez, A. Majoros and P. C. Esk for sharing reagents and for discussions. We also thank G. Keri, L. Orfi and colleagues from Vichem Kft., Budapest, for their initial synthetic work on the quinoline-based Axl inhibitors, which served as the basis for the current rationale design of LDC1267. M. P. is supported by the European Research Council (ERC) and Era of Hope/DoD Innovator Award. J.M.P. is supported by grants from the Institute of Molecular Biotechnology (IMBA), the Austrian National Foundation, the Austrian Academy of Sciences, GEN-AU (AustroMouse), an Era of Hope/DoD Innovator Award and an EU ERC Advanced Grant.	Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Brabletz T, 2013, NAT MED, V19, P1104, DOI 10.1038/nm.3327; Brehmer D, 2004, MOL CELL PROTEOMICS, V3, P490, DOI 10.1074/mcp.M300139-MCP200; BROWN JM, 1973, CANCER RES, V33, P1217; Caraux A, 2006, NAT IMMUNOL, V7, P747, DOI 10.1038/ni1353; Carlyle JR, 2006, J IMMUNOL, V176, P7511, DOI 10.4049/jimmunol.176.12.7511; Caspi RR, 2008, NAT REV IMMUNOL, V8, P970, DOI 10.1038/nri2438; Cerwenka A, 2001, P NATL ACAD SCI USA, V98, P11521, DOI 10.1073/pnas.201238598; Chiang JY, 2007, J CLIN INVEST, V117, P1029, DOI 10.1172/JCI29472; Godl K, 2003, P NATL ACAD SCI USA, V100, P15434, DOI 10.1073/pnas.2535024100; Haglund K, 2012, J CELL SCI, V125, P265, DOI 10.1242/jcs.091280; HARSHAN KV, 1991, INFECT IMMUN, V59, P2818, DOI 10.1128/IAI.59.8.2818-2821.1991; Hasanbasic I, 2005, J THROMB HAEMOST, V3, P2790, DOI 10.1111/j.1538-7836.2005.01662.x; Jamieson AM, 2002, IMMUNITY, V17, P19, DOI 10.1016/S1074-7613(02)00333-3; KASAI M, 1981, NATURE, V291, P334, DOI 10.1038/291334a0; Kojo S, 2009, P NATL ACAD SCI USA, V106, P17847, DOI 10.1073/pnas.0904078106; LACOUR F, 1957, Bull Assoc Fr Etud Cancer, V44, P88; Lee-MacAry AE, 2001, J IMMUNOL METHODS, V252, P83, DOI 10.1016/S0022-1759(01)00336-2; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Linger RMA, 2008, ADV CANCER RES, V100, P35, DOI 10.1016/S0065-230X(08)00002-X; Loeser S, 2007, J EXP MED, V204, P879, DOI 10.1084/jem.20061699; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; MAKINO Y, 1995, INT IMMUNOL, V7, P1157, DOI 10.1093/intimm/7.7.1157; MCCULLOCH P, 1989, BRIT J CANCER, V59, P179, DOI 10.1038/bjc.1989.37; Nagai K, 2003, J BIOL CHEM, V278, P18229, DOI 10.1074/jbc.M213266200; Nagata K, 1996, J BIOL CHEM, V271, P30022, DOI 10.1074/jbc.271.47.30022; Oksvold MP, 2008, MOL IMMUNOL, V45, P925, DOI 10.1016/j.molimm.2007.08.002; Pannellini Tania, 2004, Breast Dis, V20, P33; Paolino M, 2011, J IMMUNOL, V186, P2138, DOI 10.4049/jimmunol.1003390; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Pirmohamed M, 2006, BRIT J CLIN PHARMACO, V62, P509, DOI 10.1111/j.1365-2125.2006.02806.x; Pulaski B.A., 2001, CURR PROTOC IMMUNOL, V20; Roepstorff K, 2009, TRAFFIC, V10, P1115, DOI 10.1111/j.1600-0854.2009.00943.x; RYAN JJ, 1968, ANN SURG, V168, P163, DOI 10.1097/00000658-196807000-00021; Schultz-Fademrecht C., 2012, Patent No. [EP 2 423 208 A1, 2423208]; Valverde P, 2005, BIOCHEM BIOPH RES CO, V333, P180, DOI 10.1016/j.bbrc.2005.05.086; Walzer T, 2007, P NATL ACAD SCI USA, V104, P3384, DOI 10.1073/pnas.0609692104; Yanagita M, 2001, AM J PATHOL, V158, P1423, DOI 10.1016/S0002-9440(10)64093-X	38	291	327	7	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 27	2014	507	7493					508	+		10.1038/nature12998	http://dx.doi.org/10.1038/nature12998			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD6WN	24553136	Green Accepted			2022-12-28	WOS:000333402000043
J	Plucain, J; Hindre, T; Le Gac, M; Tenaillon, O; Cruveiller, S; Medigue, C; Leiby, N; Harcombe, WR; Marx, CJ; Lenski, RE; Schneider, D				Plucain, Jessica; Hindre, Thomas; Le Gac, Mickael; Tenaillon, Olivier; Cruveiller, Stephane; Medigue, Claudine; Leiby, Nicholas; Harcombe, William R.; Marx, Christopher J.; Lenski, Richard E.; Schneider, Dominique			Epistasis and Allele Specificity in the Emergence of a Stable Polymorphism in Escherichia coli	SCIENCE			English	Article							TERM EXPERIMENTAL EVOLUTION; EXPERIMENTAL POPULATIONS; BALANCED POLYMORPHISM; KEY INNOVATION; CONTINGENCY; ADAPTATION; EXPRESSION; DYNAMICS	Ecological opportunities promote population divergence into coexisting lineages. However, the genetic mechanisms that enable new lineages to exploit these opportunities are poorly understood except in cases of single mutations. We examined how two Escherichia coli lineages diverged from their common ancestor at the outset of a long-term coexistence. By sequencing genomes and reconstructing the genetic history of one lineage, we showed that three mutations together were sufficient to produce the frequency-dependent fitness effects that allowed this lineage to invade and stably coexist with the other. These mutations all affected regulatory genes and collectively caused substantial metabolic changes. Moreover, the particular derived alleles were critical for the initial divergence and invasion, indicating that the establishment of this polymorphism depended on specific epistatic interactions.	[Plucain, Jessica; Hindre, Thomas; Le Gac, Mickael; Schneider, Dominique] Univ Grenoble 1, Inst Jean Roget, Lab Adaptat & Pathogenie Microorganismes, F-38041 Grenoble, France; [Plucain, Jessica; Hindre, Thomas; Le Gac, Mickael; Schneider, Dominique] CNRS, UMR5163, F-38041 Grenoble, France; [Tenaillon, Olivier] Univ Paris 07, INSERM, UMR 1137, F-75018 Paris, France; [Tenaillon, Olivier] Univ Paris Diderot, IAME, UMR 1137, Sorbonne Paris Cite, F-75018 Paris, France; [Cruveiller, Stephane; Medigue, Claudine] CNRS, UMR 8030, F-91057 Evry, France; [Cruveiller, Stephane; Medigue, Claudine] CEA DSV IG Commissariat Energie Atom & Energies A, Direct Sci Vivant, Inst Genom, Genoscope LABGeM Lab Anal Bioinformat Genom & Met, F-91057 Evry, France; [Leiby, Nicholas; Harcombe, William R.; Marx, Christopher J.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Leiby, Nicholas] Harvard Univ, Syst Biol Program, Cambridge, MA 02138 USA; [Marx, Christopher J.] Harvard Univ, Fac Arts & Sci, Ctr Syst Biol, Cambridge, MA 02138 USA; [Lenski, Richard E.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Lenski, Richard E.] Michigan State Univ, BEACON Ctr Study Evolut Act, E Lansing, MI 48824 USA	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; CEA; UDICE-French Research Universities; Universite Paris Saclay; Harvard University; Harvard University; Harvard University; Michigan State University; Michigan State University	Schneider, D (corresponding author), Univ Grenoble 1, Inst Jean Roget, Lab Adaptat & Pathogenie Microorganismes, F-38041 Grenoble, France.	dominique.schneider@ujf-grenoble.fr	Tenaillon, Olivier/L-9857-2017; Hindré, Thomas/M-6026-2014; Schneider, Dominique/M-6019-2014	Tenaillon, Olivier/0000-0002-3796-1601; Lenski, Richard/0000-0002-1064-8375; Le Gac, Mickael/0000-0001-6451-5781	Agence Nationale de la Recherche (ANR) [ANR-08-BLAN-0283-01]; Centre National de la Recherche Scientifique; Universite Joseph Fourier; U.S. National Science Foundation [DEB-1019989]; BEACON Center for the Study of Evolution in Action [DBI-0939454]; ANR; U.S. National Science Foundation; U.S. National Institutes of Health; French Ministry of Research	Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Joseph Fourier; U.S. National Science Foundation(National Science Foundation (NSF)); BEACON Center for the Study of Evolution in Action; ANR(French National Research Agency (ANR)); U.S. National Science Foundation(National Science Foundation (NSF)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); French Ministry of Research(Ministry of Research, FranceEuropean Commission)	We are grateful to the late Evelyne Coursange, our dear laboratory manager and beloved friend. This work was Supported by grants from the Agence Nationale de la Recherche (ANR) (Program Blanc, grant ANR-08-BLAN-0283-01 to D.S.), the Centre National de la Recherche Scientifique (to D.S.), the Universite Joseph Fourier (to D.S.), the U.S. National Science Foundation (DEB-1019989 to R.E.L.), and the BEACON Center for the Study of Evolution in Action (DBI-0939454 to R.E.L.). For fellowships, J.P. thanks the French Ministry of Research and Universite Joseph Fourier, M.L.G. the ANR Program Blanc, N.L. the U.S. National Science Foundation, and W.R.H. the U.S. National Institutes of Health. R.E.L. and D.S. will make strains available to qualified recipients, subject to completion of a material transfer agreement that can be found at www.technologies.msu.edu/inventors/mta-cda/mta/mta-forms. Genomic data have been deposited to the ENA (European Nucleotide Archive) Short Read Archive (PRJEB5328). Other data are archived at the Dryad Digital Repository (www.datadryad.org, doi: 10.5061/dryad.12c6b).	Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; Blount ZD, 2012, NATURE, V489, P513, DOI 10.1038/nature11514; Cooper TF, 2003, P NATL ACAD SCI USA, V100, P1072, DOI 10.1073/pnas.0334340100; Doebeli M, 2000, AM NAT, V156, pS77, DOI 10.1086/303417; Elena SF, 1997, EVOLUTION, V51, P1058, DOI 10.1111/j.1558-5646.1997.tb03953.x; Herron MD, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001490; Hindre T, 2012, NAT REV MICROBIOL, V10, P352, DOI 10.1038/nrmicro2750; Jeong H, 2009, J MOL BIOL, V394, P644, DOI 10.1016/j.jmb.2009.09.052; Laland KN, 1999, P NATL ACAD SCI USA, V96, P10242, DOI 10.1073/pnas.96.18.10242; Le Gac M, 2012, P NATL ACAD SCI USA, V109, P9487, DOI 10.1073/pnas.1207091109; Losos JB, 1998, SCIENCE, V279, P2115, DOI 10.1126/science.279.5359.2115; Malpica R, 2006, ANTIOXID REDOX SIGN, V8, P781, DOI 10.1089/ars.2006.8.781; Peekhaus N, 1998, J BACTERIOL, V180, P3495, DOI 10.1128/JB.180.14.3495-3502.1998; Rozen DE, 2009, ECOL LETT, V12, P34, DOI 10.1111/j.1461-0248.2008.01257.x; Rozen DE, 2000, AM NAT, V155, P24, DOI 10.1086/303299; Rozen DE, 2005, J MOL EVOL, V61, P171, DOI 10.1007/s00239-004-0322-2; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; Spencer CC, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030015; Spiers AJ, 2002, GENETICS, V161, P33; Tenaillon O, 2012, SCIENCE, V335, P457, DOI 10.1126/science.1212986; Treves DS, 1998, MOL BIOL EVOL, V15, P789, DOI 10.1093/oxfordjournals.molbev.a025984; Wiser MJ, 2013, SCIENCE, V342, P1364, DOI 10.1126/science.1243357	24	81	81	2	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2014	343	6177					1366	1369		10.1126/science.1248688	http://dx.doi.org/10.1126/science.1248688			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD3AI	24603152				2022-12-28	WOS:000333108500041
J	He, J; Li, SH; Deng, YQ; Fu, HY; Laforteza, BN; Spangler, JE; Homs, A; Yu, JQ				He, Jian; Li, Suhua; Deng, Youqian; Fu, Haiyan; Laforteza, Brian N.; Spangler, Jillian E.; Homs, Anna; Yu, Jin-Quan			Ligand-Controlled C(sp(3))-H Arylation and Olefination in Synthesis of Unnatural Chiral alpha-Amino Acids	SCIENCE			English	Article							C-H BONDS; COUPLING REACTIONS; FUNCTIONALIZATION; HYDROGENATION; ACTIVATION; DERIVATIVES	The use of ligands to tune the reactivity and selectivity of transition metal catalysts for C(sp(3))-H bond functionalization is a central challenge in synthetic organic chemistry. Herein, we report a rare example of catalyst-controlled C(sp(3))-H arylation using pyridine and quinoline derivatives: The former promotes exclusive monoarylation, whereas the latter activates the catalyst further to achieve diarylation. Successive application of these ligands enables the sequential diarylation of a methyl group in an alanine derivative with two different aryl iodides, affording a wide range of beta-Ar-beta-Ar'-alpha-amino acids with excellent levels of diastereoselectivity (diastereomeric ratio > 20:1). Both configurations of the beta-chiral center can be accessed by choosing the order in which the aryl groups are installed. The use of a quinoline derivative as a ligand also enables C(sp(3))-H olefination of a protected alanine.	[He, Jian; Li, Suhua; Deng, Youqian; Fu, Haiyan; Laforteza, Brian N.; Spangler, Jillian E.; Homs, Anna; Yu, Jin-Quan] Scripps Res Inst, La Jolla, CA 92037 USA	Scripps Research Institute	Yu, JQ (corresponding author), Scripps Res Inst, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	yu200@scripps.edu	He, Jian/R-9985-2016; He, Jian/F-6399-2014; Deng, Youqian/B-9333-2012	He, Jian/0000-0002-3388-3239; 	Scripps Research Institute; NIH (National Institute of General Medical Sciences) [2R01GM084019]; Bristol-Myers Squibb; Sichuan University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084019] Funding Source: NIH RePORTER	Scripps Research Institute; NIH (National Institute of General Medical Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Bristol-Myers Squibb(Bristol-Myers Squibb); Sichuan University(Sichuan University); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge The Scripps Research Institute, the NIH (National Institute of General Medical Sciences, grant 2R01GM084019), and Bristol-Myers Squibb for financial support. H. F. is a visiting scholar sponsored by Sichuan University. J.H. developed C(sp3)-H arylation and olefination and conducted most of the experiments; S. L. synthesized quinoline ligands; Y.D., H. F., B.N.L., and J.E.S. performed large-scale reactions; A. H. obtained the crystal structures shown in Fig. 6; and J.-Q.Y. directed the project. Metrical parameters for the structures of 7f, intermediate A, and intermediate B are available free of charge from the Cambridge Crystallographic Data Centre under reference numbers CCDC-985675, -985676, and -985677, respectively. A provisional patent application has been filed and is available under patent application no. U.S. 61/946165.	Baudoin O, 2011, CHEM SOC REV, V40, P4902, DOI 10.1039/c1cs15058h; Burk MJ, 1998, J AM CHEM SOC, V120, P657, DOI 10.1021/ja9731074; Chen X, 2009, ANGEW CHEM INT EDIT, V48, P5094, DOI 10.1002/anie.200806273; Ferreira PMT, 2008, EUR J ORG CHEM, V2008, P4676, DOI 10.1002/ejoc.200800602; Giri R, 2005, ANGEW CHEM INT EDIT, V44, P2112, DOI 10.1002/anie.200462884; Gutekunst WR, 2011, J AM CHEM SOC, V133, P19076, DOI 10.1021/ja209205x; Hasegawa N, 2011, J AM CHEM SOC, V133, P8070, DOI 10.1021/ja2001709; Jazzar R, 2010, CHEM-EUR J, V16, P2654, DOI 10.1002/chem.200902374; Tran LD, 2012, ANGEW CHEM INT EDIT, V51, P5188, DOI 10.1002/anie.201200731; Lyons TW, 2010, CHEM REV, V110, P1147, DOI 10.1021/cr900184e; NOYORI R, 1990, ACCOUNTS CHEM RES, V23, P345, DOI 10.1021/ar00178a005; Reddy BVS, 2006, ORG LETT, V8, P3391, DOI 10.1021/ol061389j; Rodriguez N, 2013, CHEM SCI, V4, P175, DOI 10.1039/c2sc21162a; Roseblade SJ, 2007, ACCOUNTS CHEM RES, V40, P1402, DOI 10.1021/ar700113g; Shang R, 2013, J AM CHEM SOC, V135, P6030, DOI 10.1021/ja402806f; Simmons EM, 2012, NATURE, V483, P70, DOI 10.1038/nature10785; Tang WJ, 2003, CHEM REV, V103, P3029, DOI 10.1021/cr020049i; Wang DH, 2008, J AM CHEM SOC, V130, P7190, DOI 10.1021/ja801355s; Wang LQ, 2009, ORG LETT, V11, P1079, DOI 10.1021/ol802865c; Wasa M, 2012, J AM CHEM SOC, V134, P18570, DOI 10.1021/ja309325e; Wasa M, 2010, ISR J CHEM, V50, P605, DOI 10.1002/ijch.201000038; Wasa M, 2009, J AM CHEM SOC, V131, P9886, DOI 10.1021/ja903573p; Wildemann D, 2006, J MED CHEM, V49, P2147, DOI 10.1021/jm060036n; Zaitsev VG, 2005, J AM CHEM SOC, V127, P13154, DOI 10.1021/ja054549f; Zhang SY, 2013, J AM CHEM SOC, V135, P12135, DOI 10.1021/ja406484v	25	379	381	5	345	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2014	343	6176					1216	1220		10.1126/science.1249198	http://dx.doi.org/10.1126/science.1249198			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC7RG	24626923	Green Accepted			2022-12-28	WOS:000332728500029
J	Holmes, CD				Holmes, Christopher D.			Air pollution and forest water use	NATURE			English	Letter							TROPOSPHERIC OZONE; CLIMATE; GROWTH; RESPONSES; TREES		Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA	University of California System; University of California Irvine	Holmes, CD (corresponding author), Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA.	cdholmes@uci.edu	Holmes, Christopher D/C-9956-2014	Holmes, Christopher D/0000-0002-2727-0954				Ainsworth EA, 2012, ANNU REV PLANT BIOL, V63, P637, DOI 10.1146/annurev-arplant-042110-103829; Calatayud V, 2007, WATER AIR SOIL POLL, V185, P239, DOI 10.1007/s11270-007-9446-5; Chappelka AH, 1998, NEW PHYTOL, V139, P91, DOI 10.1046/j.1469-8137.1998.00166.x; Cooper OR, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD018261; Franks PJ, 2013, NEW PHYTOL, V197, P1077, DOI 10.1111/nph.12104; Hoshika Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039270; Karlsson PE, 2004, ATMOS ENVIRON, V38, P2283, DOI 10.1016/j.atmosenv.2004.01.027; Keenan TF, 2013, NATURE, V499, P324, DOI 10.1038/nature12291; Lombardozzi D, 2012, BIOGEOSCIENCES, V9, P3113, DOI 10.5194/bg-9-3113-2012; McLaughlin SB, 2007, NEW PHYTOL, V174, P109, DOI 10.1111/j.1469-8137.2007.02018.x; Sitch S, 2007, NATURE, V448, P791, DOI 10.1038/nature06059; Skarby L, 1998, NEW PHYTOL, V139, P109, DOI 10.1046/j.1469-8137.1998.00184.x; Torseth K, 2012, ATMOS CHEM PHYS, V12, P5447, DOI 10.5194/acp-12-5447-2012; WHO, 2000, AIR QUAL GUID EUR, P219; Wittig VE, 2009, GLOBAL CHANGE BIOL, V15, P396, DOI 10.1111/j.1365-2486.2008.01774.x	15	22	24	1	88	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 13	2014	507	7491					E1	E2		10.1038/nature13113	http://dx.doi.org/10.1038/nature13113			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC6RJ	24622206				2022-12-28	WOS:000332651800001
J	Cordier, P; Demouchy, S; Beausir, B; Taupin, V; Barou, F; Fressengeas, C				Cordier, Patrick; Demouchy, Sylvie; Beausir, Benoit; Taupin, Vincent; Barou, Fabrice; Fressengeas, Claude			Disclinations provide the missing mechanism for deforming olivine-rich rocks in the mantle	NATURE			English	Article							ELASTOPLASTIC THEORY; GRAIN-BOUNDARIES; DEFORMATION; DISLOCATION; CREEP; CONSTRAINTS; ORIENTATION; DIFFUSION; STRENGTH	Mantle flow involves large strains of polymineral aggregates. The strongly anisotropic plastic response of each individual grain in the aggregate results from the interactions between neighbouring grains and the continuity of material displacement across the grain boundaries. Orthorhombic olivine, which is the dominant mineral phase of the Earth's upper mantle, does not exhibit enough slip systems to accommodate a general deformation state by intracrystalline slip without inducing damage. Here we show that a more general description of the deformation process that includes the motion of rotational defects referred to as disclinations can solve the olivine deformation paradox. We use high-resolution electron backscattering diffraction (EBSD) maps of deformed olivine aggregates to resolve the disclinations. The disclinations are found to decorate grain boundaries in olivine samples deformed experimentally and in nature. We present a disclination-based model of a high-angle tilt boundary in olivine, which demonstrates that an applied shear induces grain-boundary migration through disclination motion. This new approach clarifies grain-boundary-mediated plasticity in polycrystalline aggregates. By providing the missing mechanism for describing plastic flow in olivine, this work will permit multiscale modelling of the rheology of the upper mantle, from the atomic scale to the scale of the flow.	[Cordier, Patrick] CNRS, UMR 8207, Unite Mat & Transformat, F-59650 Villeneuve Dascq, France; [Cordier, Patrick] Univ Lille 1, F-59650 Villeneuve Dascq, France; [Demouchy, Sylvie; Barou, Fabrice] CNRS, UMR 5342, Geosci Montpellier, F-34095 Montpellier, France; [Demouchy, Sylvie; Barou, Fabrice] Univ Montpellier 2, F-34095 Montpellier, France; [Beausir, Benoit; Taupin, Vincent; Fressengeas, Claude] CNRS, UMR 7239, Lab Etud Microstruct & Mecan Mat, F-57045 Metz, France; [Beausir, Benoit; Taupin, Vincent; Fressengeas, Claude] Univ Lorraine, F-57045 Metz, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Universite de Montpellier; Arts et Metiers Institute of Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Lorraine; Universite de Lorraine	Cordier, P (corresponding author), CNRS, UMR 8207, Unite Mat & Transformat, F-59650 Villeneuve Dascq, France.	patrick.cordier@univ-lille1.fr	DEMOUCHY, sylvie/A-2502-2009; Cordier, Patrick/D-2357-2012; Fressengeas, Claude/B-9083-2013	DEMOUCHY, sylvie/0000-0001-5023-4655; Cordier, Patrick/0000-0002-1883-2994; Fressengeas, Claude/0000-0002-2436-6037; Barou, Fabrice/0000-0002-8382-0826; TAUPIN, Vincent/0000-0002-2469-0179	European Research Council under the Seventh Framework Programme (FP7-ERC) [290424-RheoMan]; Marie Curie fellowship [FP7-PEOPLE-20074-3-IRG, 230748-PoEM]; Agence Nationale de la Recherche [ANR-11-JS09-007-01]	European Research Council under the Seventh Framework Programme (FP7-ERC); Marie Curie fellowship(European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR))	We acknowledge financial support from the European Research Council under the Seventh Framework Programme (FP7-ERC grant number 290424-RheoMan), from a Marie Curie fellowship (FP7-PEOPLE-20074-3-IRG, grant number 230748-PoEM) and from the Agence Nationale de la Recherche (grant number ANR-11-JS09-007-01, NanoMec).	Adjaoud O, 2012, PHYS CHEM MINER, V39, P749, DOI 10.1007/s00269-012-0529-5; Arndt NT, 2010, J PETROL, V51, P573, DOI 10.1093/petrology/egp080; ASHBY MF, 1970, PHILOS MAG, V21, P399, DOI 10.1080/14786437008238426; Barreiro JG, 2007, EARTH PLANET SC LETT, V264, P188, DOI 10.1016/j.epsl.2007.09.018; Beausir B, 2013, INT J SOLIDS STRUCT, V50, P137, DOI 10.1016/j.ijsolstr.2012.09.016; Demouchy S, 2011, PHYS EARTH PLANET IN, V184, P91, DOI 10.1016/j.pepi.2010.11.001; Demouchy S, 2013, PHYS EARTH PLANET IN, V220, P37, DOI 10.1016/j.pepi.2013.04.008; Demouchy S, 2012, PHYS EARTH PLANET IN, V202, P56, DOI 10.1016/j.pepi.2012.05.001; Demouchy S, 2010, EARTH PLANET SC LETT, V295, P305, DOI 10.1016/j.epsl.2010.04.019; Detrez F., J MECH PHYS SOLIDS S; DeWit R., 1970, Proceedings of the conference on fundamental aspect of dislocation theory, P651; Falus G, 2011, J STRUCT GEOL, V33, P1528, DOI 10.1016/j.jsg.2011.09.010; Fressengeas C, 2011, INT J SOLIDS STRUCT, V48, P3499, DOI 10.1016/j.ijsolstr.2011.09.002; Friedel J., 1967, DISLOCATIONS; Hansen LN, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2011JB008220; HIRTH G, 1995, J GEOPHYS RES-SOL EA, V100, P1981, DOI 10.1029/94JB02128; Hirth G., 2003, INSIDE SUBDUCTION FA, V138, P83, DOI [10.1029/138GM06, DOI 10.1029/138GM06]; HUTCHINSON JW, 1977, METALL TRANS A, V8, P1465, DOI 10.1007/BF02642860; KOHLSTEDT DL, 1995, J GEOPHYS RES-SOL EA, V100, P17587, DOI 10.1029/95JB01460; Langdon TG, 2006, J MATER SCI, V41, P597, DOI 10.1007/s10853-006-6476-0; MINDLIN RD, 1963, ARCH RATION MECH AN, V11, P415; Miyazaki T, 2013, NATURE, V502, P321, DOI 10.1038/nature12570; Pantleon W, 2008, SCRIPTA MATER, V58, P994, DOI 10.1016/j.scriptamat.2008.01.050; Paterson MS, 2000, J STRUCT GEOL, V22, P1341, DOI 10.1016/S0191-8141(00)00042-0; ROMANOV AE, 1992, DISLOCATIONS SOLIDS, V9, P191; Romanov AE, 2009, PROG MATER SCI, V54, P740, DOI 10.1016/j.pmatsci.2009.03.002; Seront B., 1993, THESIS; Soustelle V, 2010, J PETROL, V51, P363, DOI 10.1093/petrology/egp085; Taupin V, 2013, J MECH PHYS SOLIDS, V61, P370, DOI 10.1016/j.jmps.2012.10.001; Upadhyay MV, 2013, PHILOS MAG, V93, P794, DOI 10.1080/14786435.2012.733829; Varadhan SN, 2006, MODEL SIMUL MATER SC, V14, P1245, DOI 10.1088/0965-0393/14/7/011; Volterra V., 1907, ANNLS SCIENT EC NORM, V24, P401; von Mises R, 1928, Z ANGEW MATH MECH, V8, P161, DOI 10.1002/zamm.19280080302; WEBB SL, 1989, PHYS CHEM MINER, V16, P684	34	73	74	4	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					51	+		10.1038/nature13043	http://dx.doi.org/10.1038/nature13043			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0ZQ	24572356				2022-12-28	WOS:000332224400040
J	Koelle, K; Rasmussen, DA				Koelle, Katia; Rasmussen, David A.			INFLUENZA Prediction is worth a shot	NATURE			English	Editorial Material							VACCINE		[Koelle, Katia; Rasmussen, David A.] Duke Univ, Dept Biol, Durham, NC 27708 USA	Duke University	Koelle, K (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	katia.koelle@duke.edu; david.rasmussen@duke.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD040372] Funding Source: NIH RePORTER; NICHD NIH HHS [T32 HD040372] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; Luksza M, 2014, NATURE, V507, P57, DOI 10.1038/nature13087; Medlock J, 2009, SCIENCE, V325, P1705, DOI 10.1126/science.1175570; Russell CA, 2008, VACCINE, V26, pD31, DOI 10.1016/j.vaccine.2008.07.078; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Stohr K, 2002, LANCET INFECT DIS, V2, P517, DOI 10.1016/S1473-3099(02)00366-3	6	5	5	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					47	48		10.1038/nature13054	http://dx.doi.org/10.1038/nature13054			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0ZQ	24572355				2022-12-28	WOS:000332224400038
J	Parker, JL; Newstead, S				Parker, Joanne L.; Newstead, Simon			Molecular basis of nitrate uptake by the plant nitrate transporter NRT1.1	NATURE			English	Article							PEPTIDE TRANSPORTERS; CRYSTAL-STRUCTURE; PROTEIN; MECHANISM; ARABIDOPSIS; SYSTEM; CHL1; OVEREXPRESSION; RECONSTITUTION; OPTIMIZATION	The NRT1/PTR family of proton-coupled transporters are responsible for nitrogen assimilation in eukaryotes and bacteria through the uptake of peptides. However, in most plant species members of this family have evolved to transport nitrate as well as additional secondary metabolites and hormones. In response to falling nitrate levels, NRT1.1 is phosphorylated on an intracellular threonine that switches the transporter from a low-affinity to high-affinity state. Here we present both the apo and nitrate-bound crystal structures of Arabidopsis thaliana NRT1.1, which together with in vitro binding and transport data identify a key role for His 356 in nitrate binding. Our data support a model whereby phosphorylation increases structural flexibility and in turn the rate of transport. Comparison with peptide transporters further reveal show the NRT1/PTR family has evolved to recognize diverse nitrogenous ligands, while maintaining elements of a conserved coupling mechanism within this superfamily of nutrient transporters.	[Parker, Joanne L.; Newstead, Simon] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Newstead, Simon] Rutherford Appleton Lab, Didcot OX11 0FA, Oxon, England	University of Oxford; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Parker, JL (corresponding author), Univ Oxford, Dept Biochem, Oxford OX1 3QU, England.	joanne.parker@bioch.ox.ac.uk; simon.newstead@bioch.ox.ac.uk		Newstead, Simon/0000-0001-7432-2270; Parker, Joanne/0000-0003-2964-2720	Medical Research Council (MRC) [G0900399]; Royal Society [RG110211, IE111401]; MRC [G0900399] Funding Source: UKRI; Medical Research Council [G0900399] Funding Source: researchfish; Wellcome Trust [102890/Z/13/Z] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank R. Flaig for help with additional access to beamline IO4 and we thank Diamond Light Source for access to beam lines I02, I03, I04 and I04-1 (MX7345) that contributed to the results presented here. This research was funded through the Medical Research Council (MRC) Career Development Award grant G0900399 and Royal Society grants (RG110211 and IE111401) to S.N.	Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; [Anonymous], PYMOL MOL GRAPHICS S; Baaske P., 2011, J BIOMOL TECH, V22, pS55; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Boursiac Y, 2013, TRENDS PLANT SCI, V18, P325, DOI 10.1016/j.tplants.2013.01.007; Chandrasekaran A, 2006, J NEUROCHEM, V98, P1551, DOI 10.1111/J.1471-4159.2006.03975.X; Chen XZ, 1999, J BIOL CHEM, V274, P2773, DOI 10.1074/jbc.274.5.2773; Chiang CS, 2004, J BIOL CHEM, V279, P30150, DOI 10.1074/jbc.M405192200; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; CRAWFORD NM, 1995, PLANT CELL, V7, P859, DOI 10.1105/tpc.7.7.859; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; Daniel H, 2006, PHYSIOLOGY, V21, P93, DOI 10.1152/physiol.00054.2005; Dechorgnat J, 2011, J EXP BOT, V62, P1349, DOI 10.1093/jxb/erq409; Doki S, 2013, P NATL ACAD SCI USA, V110, P11343, DOI 10.1073/pnas.1301079110; Drew D, 2008, NAT PROTOC, V3, P784, DOI 10.1038/nprot.2008.44; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; FEI YJ, 1994, NATURE, V368, P563, DOI 10.1038/368563a0; FOUCAUD C, 1992, J BIOL CHEM, V267, P22087; Guettou F, 2013, EMBO REP, V14, P804, DOI 10.1038/embor.2013.107; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Knol J, 1996, J BIOL CHEM, V271, P15358, DOI 10.1074/jbc.271.26.15358; Krouk G, 2010, DEV CELL, V18, P927, DOI 10.1016/j.devcel.2010.05.008; Leran S, 2014, TRENDS PLANT SCI, V19, P5, DOI 10.1016/j.tplants.2013.08.008; Liu KH, 2003, EMBO J, V22, P1005, DOI 10.1093/emboj/cdg118; Liu KH, 1999, PLANT CELL, V11, P865, DOI 10.1105/tpc.11.5.865; Madej MG, 2013, P NATL ACAD SCI USA, V110, pE4831, DOI 10.1073/pnas.1319754110; Nakajima H, 1997, APPL ENVIRON MICROB, V63, P2213, DOI 10.1128/AEM.63.6.2213-2217.1997; Newstead S, 2008, PROTEIN SCI, V17, P466, DOI 10.1110/ps.073263108; Newstead S, 2007, P NATL ACAD SCI USA, V104, P13936, DOI 10.1073/pnas.0704546104; Newstead S, 2011, EMBO J, V30, P417, DOI 10.1038/emboj.2010.309; Nour-Eldin HH, 2012, NATURE, V488, P531, DOI 10.1038/nature11285; Orsel M, 2006, PLANT PHYSIOL, V142, P1304, DOI 10.1104/pp.106.085209; Pedersen BP, 2010, ACTA CRYSTALLOGR D, V66, P309, DOI 10.1107/S0907444909053244; Radestock S, 2011, J MOL BIOL, V407, P698, DOI 10.1016/j.jmb.2011.02.008; Reddy VS, 2012, FEBS J, V279, P2022, DOI 10.1111/j.1742-4658.2012.08588.x; Seresht AK, 2013, APPL MICROBIOL BIOT, V97, P3939, DOI 10.1007/s00253-012-4263-1; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Smirnova I, 2007, P NATL ACAD SCI USA, V104, P16504, DOI 10.1073/pnas.0708258104; Solcan N, 2012, EMBO J, V31, P3411, DOI 10.1038/emboj.2012.157; STEINER HY, 1995, MOL MICROBIOL, V16, P825, DOI 10.1111/j.1365-2958.1995.tb02310.x; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; Tsay YF, 2011, PLANT CELL MONOGR, V19, P223, DOI 10.1007/978-3-642-13431-9_9; TSAY YF, 1993, CELL, V72, P705, DOI 10.1016/0092-8674(93)90399-B; Tsay YF, 2007, FEBS LETT, V581, P2290, DOI 10.1016/j.febslet.2007.04.047; Ugolev Y, 2013, J BIOL CHEM, V288, P32160, DOI 10.1074/jbc.M113.502971; Wang YY, 2012, TRENDS PLANT SCI, V17, P458, DOI 10.1016/j.tplants.2012.04.006; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Winter G, 2010, J APPL CRYSTALLOGR, V43, P186, DOI 10.1107/S0021889809045701; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; Yan HC, 2013, CELL REP, V3, P716, DOI 10.1016/j.celrep.2013.03.007; Yan N, 2013, TRENDS BIOCHEM SCI, V38, P151, DOI 10.1016/j.tibs.2013.01.003; Yang Z, 2012, J STRUCT BIOL, V179, P269, DOI 10.1016/j.jsb.2011.09.006; Zheng HJ, 2013, NATURE, V497, P647, DOI 10.1038/nature12139	57	242	264	9	238	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					68	+		10.1038/nature13116	http://dx.doi.org/10.1038/nature13116			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0ZQ	24572366	Green Accepted			2022-12-28	WOS:000332224400043
J	Doran, T; Kontopantelis, E; Reeves, D; Sutton, M; Ryan, AM				Doran, Tim; Kontopantelis, Evangelos; Reeves, David; Sutton, Matthew; Ryan, Andrew M.			Setting performance targets in pay for performance programmes: what can we learn from QOF?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							FOR-PERFORMANCE; QUALITY; INCENTIVES; ENGLAND; IMPACT; CARE		[Doran, Tim; Sutton, Matthew] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England; [Kontopantelis, Evangelos] Univ Manchester, Ctr Hlth Informat, Inst Populat Hlth, Manchester, Lancs, England; [Reeves, David] Univ Manchester, Inst Populat Hlth, Ctr Biostat, Manchester M13 9PL, Lancs, England; [Sutton, Matthew] Univ Manchester, Inst Populat Hlth, Ctr Hlth Econ, Manchester M13 9PL, Lancs, England; [Ryan, Andrew M.] Weill Cornell Med Coll, Div Outcomes & Effectiveness Res, New York, NY USA	University of York - UK; University of Manchester; University of Manchester; University of Manchester; Cornell University	Doran, T (corresponding author), Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England.	tim.doran@york.ac.uk	Reeves, David/H-6203-2014; Kontopantelis, Evangelos/H-2966-2019	Reeves, David/0000-0001-6377-6859; Kontopantelis, Evangelos/0000-0001-6450-5815; Sutton, Matt/0000-0002-6635-2127	National Institute for Health Research [CDF-2011-04-016] Funding Source: researchfish; Medical Research Council [MC_PC_13042, MR/K006665/1] Funding Source: Medline; Department of Health [CDF-2011-04-016] Funding Source: Medline; MRC [MR/K006665/1] Funding Source: UKRI	National Institute for Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		British Medical Association, 2013, GEN MED SERV CONTR C; Caley M, 2014, BRIT J GEN PRACT, V64, pE54, DOI 10.3399/bjgp14X676465; Chien AT, 2013, NEW ENGL J MED, V369, P2076, DOI 10.1056/NEJMp1311957; Doran T, 2008, LANCET, V372, P728, DOI 10.1016/S0140-6736(08)61123-X; Eijkenaar F, 2013, EUR J HEALTH ECON, V14, P117, DOI 10.1007/s10198-011-0347-6; Flodgren G, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009255; Gillam SJ, 2012, ANN FAM MED, V10, P461, DOI 10.1370/afm.1377; Health & Social Care Information Centre, QUAL OUTC FRAM; Kontopantelis E, 2012, HEALTH SERV RES, V47, P1117, DOI 10.1111/j.1475-6773.2011.01362.x; Lester H, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a3017; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; Meacock R, 2014, HEALTH ECON, V23, P1, DOI 10.1002/hec.2978; National Institute for Health and Clinical Excellence, 2009, PRIM CAR QUAL OUTC F; National Institute for Health and Clinical Excellence, 2010, QOF ADV COMM REC IND; NHS Employers, 2003, INV GEN PRACT NEW GE; NHS Employers, CHANG QOF 2014 15; NHS Employers, 2013, 2013 14 GEN MED SERV; Roland M, 2004, NEW ENGL J MED, V351, P1448, DOI 10.1056/NEJMhpr041294; Roland M, 2012, ANN INTERN MED, V157, P912, DOI 10.7326/0003-4819-157-12-201212180-00014; Rosenthal MB, 2005, JAMA-J AM MED ASSOC, V294, P1788, DOI 10.1001/jama.294.14.1788; Scott A, 2011, COCHRANE DB SYST REV, V9, DOI DOI 10.1002/14651858.CD008451.PUB2	21	31	31	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2014	348								g1595	10.1136/bmj.g1595	http://dx.doi.org/10.1136/bmj.g1595			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC6HV	24594910				2022-12-28	WOS:000332623400005
J	Honeyman, JN; Simon, EP; Robine, N; Chiaroni-Clarke, R; Darcy, DG; Lim, IIP; Gleason, CE; Murphy, JM; Rosenberg, BR; Teegan, L; Takacs, CN; Botero, S; Belote, R; Germer, S; Emde, AK; Vacic, V; Bhanot, U; LaQuaglia, MP; Simon, SM				Honeyman, Joshua N.; Simon, Elana P.; Robine, Nicolas; Chiaroni-Clarke, Rachel; Darcy, David G.; Lim, Irene Isabel P.; Gleason, Caroline E.; Murphy, Jennifer M.; Rosenberg, Brad R.; Teegan, Lydia; Takacs, Constantin N.; Botero, Sergio; Belote, Rachel; Germer, Soren; Emde, Anne-Katrin; Vacic, Vladimir; Bhanot, Umesh; LaQuaglia, Michael P.; Simon, Sanford M.			Detection of a Recurrent DNAJB1-PRKACA Chimeric Transcript in Fibrolamellar Hepatocellular Carcinoma	SCIENCE			English	Article							PROTEIN-KINASE-A; COMPARATIVE GENOMIC HYBRIDIZATION; GROWTH-FACTOR RECEPTOR; PAIRED-END; CLINICOPATHOLOGICAL FEATURES; CANCER GENOMICS; BREAST-CANCER; LIVER; PHOSPHORYLATION; SURVIVAL	Fibrolamellar hepatocellular carcinoma (FL-HCC) is a rare liver tumor affecting adolescents and young adults with no history of primary liver disease or cirrhosis. We identified a chimeric transcript that is expressed in FL-HCC but not in adjacent normal liver and that arises as the result of a similar to 400-kilobase deletion on chromosome 19. The chimeric RNA is predicted to code for a protein containing the amino-terminal domain of DNAJB1, a homolog of the molecular chaperone DNAJ, fused in frame with PRKACA, the catalytic domain of protein kinase A. Immunoprecipitation and Western blot analyses confirmed that the chimeric protein is expressed in tumor tissue, and a cell culture assay indicated that it retains kinase activity. Evidence supporting the presence of the DNAJB1-PRKACA chimeric transcript in 100% of the FL-HCCs examined (15/15) suggests that this genetic alteration contributes to tumor pathogenesis.	[Honeyman, Joshua N.; Simon, Elana P.; Chiaroni-Clarke, Rachel; Darcy, David G.; Lim, Irene Isabel P.; Gleason, Caroline E.; Murphy, Jennifer M.; Teegan, Lydia; Takacs, Constantin N.; Botero, Sergio; Belote, Rachel; Simon, Sanford M.] Rockefeller Univ, Lab Cellular Biophys, New York, NY 10065 USA; [Honeyman, Joshua N.; Darcy, David G.; Lim, Irene Isabel P.; Murphy, Jennifer M.; LaQuaglia, Michael P.] Mem Sloan Kettering Canc Ctr, Dept Surg, Div Pediat Surg, New York, NY 10065 USA; [Simon, Elana P.] Dalton Sch, New York, NY 10128 USA; [Robine, Nicolas; Germer, Soren; Emde, Anne-Katrin; Vacic, Vladimir] New York Genome Ctr, New York, NY 10013 USA; [Rosenberg, Brad R.] Rockefeller Univ, Whitehead Presidential Fellows Program, New York, NY 10065 USA; [Bhanot, Umesh] Mem Sloan Kettering Canc Ctr, Pathol Core Facil, New York, NY 10065 USA	Rockefeller University; Memorial Sloan Kettering Cancer Center; Rockefeller University; Memorial Sloan Kettering Cancer Center	Simon, SM (corresponding author), Rockefeller Univ, Lab Cellular Biophys, 1230 York Ave, New York, NY 10065 USA.	simon@rockefeller.edu		Lim-Beutel, Irene Isabel/0000-0002-1711-443X; Botero, Sergio/0000-0002-9298-8006; Rosenberg, Brad/0000-0002-5885-1276; Belote, Rachel/0000-0002-3001-0002; Bhanot, Umeshkumar/0000-0001-6656-1239; Simon, Elana/0000-0003-2433-4390; Vacic, Vladimir/0000-0001-6571-2293; Robine, Nicolas/0000-0001-5698-8183; Simon, Sanford/0000-0002-8615-4224	Fibrolamellar Cancer Foundation; Rockefeller University Center for Clinical and Translational Science [2UL1RR024143]; Howard Hughes Medical Institute International Student Predoctoral Fellowship; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000043] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143] Funding Source: NIH RePORTER	Fibrolamellar Cancer Foundation; Rockefeller University Center for Clinical and Translational Science; Howard Hughes Medical Institute International Student Predoctoral Fellowship; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Two coauthors on this study are patients with FL-HCC. We thank S. Tavazoie and H. Goodarzi for trouble-shooting, recommending protocols and software, and for helpful discussions of the data and the manuscript. We thank R. Darnell for support, insightful discussions of the data, and critical comments on the manuscript. We also thank the Pathology core facility at Memorial Sloan-Kettering Cancer Center (MSKCC), the Molecular Cytology core facility (MSKCC), and members of the fibrolamellar community for support. This work was funded by a grant from The Fibrolamellar Cancer Foundation, The Rockefeller University Center for Clinical and Translational Science grant 2UL1RR024143, and by an anonymous donor. We thank J. Panda for fund-raising efforts. C.N.T was supported by a Howard Hughes Medical Institute International Student Predoctoral Fellowship. The New York Genome Center and the authors (N.R., S. G., A.-K.E., and V. V.) have filed a patent application related to the use of the chimeric transcript in the detection of human cancers. Sequence data have been deposited into the database of Genotypes and Phenotypes, dbGaP (accession no. phs000709.v1.p1).	Adams DG, 2002, ARCH BIOCHEM BIOPHYS, V407, P103, DOI 10.1016/S0003-9861(02)00464-2; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Ang Celina S, 2013, Gastrointest Cancer Res, V6, P3; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Barretina J, 2010, NAT GENET, V42, P715, DOI 10.1038/ng.619; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bouchard MF, 2005, ENDOCRINOLOGY, V146, P4905, DOI 10.1210/en.2005-0187; Buckley AF, 2006, HUM PATHOL, V37, P410, DOI 10.1016/j.humpath.2005.12.009; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen DS, 1999, MOL CELL BIOL, V19, P1002; CRAIG JR, 1980, CANCER, V46, P372, DOI 10.1002/1097-0142(19800715)46:2<372::AID-CNCR2820460227>3.0.CO;2-S; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Edgren H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r6; EDMONDSON HA, 1956, AMA J DIS CHILD, V91, P168, DOI 10.1001/archpedi.1956.02060020170015; El-Serag HB, 2004, HEPATOLOGY, V39, P798, DOI 10.1002/hep.20096; Emde AK, 2012, BIOINFORMATICS, V28, P619, DOI 10.1093/bioinformatics/bts019; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Ho AS, 2013, NAT GENET, V45, P791, DOI 10.1038/ng.2643; Kakar S, 2005, MODERN PATHOL, V18, P1417, DOI 10.1038/modpathol.3800449; Kakar S, 2009, MODERN PATHOL, V22, P134, DOI 10.1038/modpathol.2008.178; Katzenstein HM, 2003, CANCER-AM CANCER SOC, V97, P2006, DOI 10.1002/cncr.11292; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Marchio AS, 2000, ONCOGENE, V19, P3733, DOI 10.1038/sj.onc.1203713; Mavros MN, 2012, J AM COLL SURGEONS, V215, P820, DOI 10.1016/j.jamcollsurg.2012.08.001; Muramori K, 2011, J PEDIAT HEMATOL ONC, V33, pE195, DOI 10.1097/MPH.0b013e3182011676; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nesterova MV, 2006, CANCER RES, V66, P8971, DOI 10.1158/0008-5472.CAN-06-1049; Patonai A, 2013, PATHOL ONCOL RES, V19, P63, DOI 10.1007/s12253-012-9558-0; Rausch T, 2012, BIOINFORMATICS, V28, pI333, DOI 10.1093/bioinformatics/bts378; Shaikh D, 2012, CELL SIGNAL, V24, P2396, DOI 10.1016/j.cellsig.2012.08.007; Stipa F, 2006, CANCER-AM CANCER SOC, V106, P1331, DOI 10.1002/cncr.21703; Torbenson M, 2007, ADV ANAT PATHOL, V14, P217, DOI 10.1097/PAP.0b013e3180504913; Tortora G, 1997, ONCOGENE, V14, P923, DOI 10.1038/sj.onc.1200906; Ward SC, 2011, SEMIN LIVER DIS, V31, P61, DOI 10.1055/s-0031-1272835; Weeda VB, 2013, EUR J CANCER, V49, P2698, DOI 10.1016/j.ejca.2013.04.012; Wilkens L, 2000, AM J CLIN PATHOL, V114, P867, DOI 10.1309/BMTT-JBPD-D13H-1UVD	39	265	277	3	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2014	343	6174					1010	1014		10.1126/science.1249484	http://dx.doi.org/10.1126/science.1249484			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2DZ	24578576	Green Accepted			2022-12-28	WOS:000332309600042
J	Rorth, P				Rorth, Pernille			Reach Out and Touch Someone	SCIENCE			English	Editorial Material							LATERAL INHIBITION; PRIMARY CILIUM; DROSOPHILA; TRANSPORT; CYTONEMES		Inst Mol & Cell Biol, Singapore 138673, Singapore	Agency for Science Technology & Research (ASTAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Rorth, P (corresponding author), Inst Mol & Cell Biol, 61 Biopolis Dr, Singapore 138673, Singapore.	prorth@imcb.a-star.edu.sg						Bischoff M, 2013, NAT CELL BIOL, V15, P1269, DOI 10.1038/ncb2856; Cohen M, 2010, DEV CELL, V19, P78, DOI 10.1016/j.devcel.2010.06.006; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; de Joussineau C, 2003, NATURE, V426, P555, DOI 10.1038/nature02157; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Roy S, 2014, SCIENCE, V343, P852, DOI 10.1126/science.1244624; Roy S, 2011, SCIENCE, V332, P354, DOI 10.1126/science.1198949; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Sanders TA, 2013, NATURE, V497, P628, DOI 10.1038/nature12157; Wang X, 2010, P NATL ACAD SCI USA, V107, P17194, DOI 10.1073/pnas.1006785107; Watkins SC, 2005, IMMUNITY, V23, P309, DOI 10.1016/j.immuni.2005.08.009	13	3	3	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 21	2014	343	6173					848	849		10.1126/science.1250885	http://dx.doi.org/10.1126/science.1250885			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB1LG	24558151				2022-12-28	WOS:000331552600034
J	Mechanic, R				Mechanic, Robert			Post-Acute Care - The Next Frontier for Controlling Medicare Spending	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							COST		Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA 02454 USA	Brandeis University	Mechanic, R (corresponding author), Brandeis Univ, Heller Sch Social Policy & Management, Waltham, MA 02454 USA.							Chandra A, 2013, HEALTH AFFAIR, V32, P864, DOI 10.1377/hlthaff.2012.1262; Gage B., 2011, POSTACUTE CARE EPISO; Kramer A, 2011, COMMUNITY DISCHARGE; Newhouse JP, 2013, NEW ENGL J MED, V368, P1465, DOI 10.1056/NEJMp1302981; Taheri PA, 2000, J AM COLL SURGEONS, V191, P123, DOI 10.1016/S1072-7515(00)00352-5	5	177	177	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 20	2014	370	8					692	694		10.1056/NEJMp1315607	http://dx.doi.org/10.1056/NEJMp1315607			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AB1DO	24552315				2022-12-28	WOS:000331531900003
J	Reuben, DB; Tinetti, ME				Reuben, David B.; Tinetti, Mary E.			The Hospital-Dependent Patient	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Reuben, David B.] Univ Calif Los Angeles, David Geffen Sch Med, Div Geriatr, Los Angeles, CA 90095 USA; [Tinetti, Mary E.] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Tinetti, Mary E.] Yale Univ, Sch Epidemiol & Publ Hlth, New Haven, CT USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Yale University; Yale University	Reuben, DB (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Geriatr, Los Angeles, CA 90095 USA.							Carson SS, 2012, RESP CARE, V57, P848, DOI 10.4187/respcare.01736; Jencks SF, 2011, NEW ENGL J MED, V364, P1582; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Mor V, 2010, HEALTH AFFAIR, V29, P57, DOI 10.1377/hlthaff.2009.0629; Robert Wood Johnson Foundation, 2013, REV DOOR REP US HOSP; Shepperd S, 2005, COCHRANE DB SYST REV, V3, DOI DOI 10.1056/NEJMP1315568	6	30	30	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 20	2014	370	8					694	697		10.1056/NEJMp1315568	http://dx.doi.org/10.1056/NEJMp1315568			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AB1DO	24552316	Green Published			2022-12-28	WOS:000331531900004
J	Di Nisio, M; Middeldorp, S				Di Nisio, Marcello; Middeldorp, Saskia			Treatment of Lower Extremity Superficial Thrombophlebitis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							VEIN-THROMBOSIS		[Di Nisio, Marcello] Univ G dAnnunzio, Dept Med Oral & Biotechnol Sci, I-66013 Chieti, Italy; [Di Nisio, Marcello; Middeldorp, Saskia] Univ Amsterdam, Acad Med Ctr, Dept Vasc Med, NL-1105 AZ Amsterdam, Netherlands	G d'Annunzio University of Chieti-Pescara; University of Amsterdam; Academic Medical Center Amsterdam	Di Nisio, M (corresponding author), Univ G dAnnunzio, Dept Med Oral & Biotechnol Sci, Via Vestini 31, I-66013 Chieti, Italy.	mdinisio@unich.it	Middeldorp, Saskia/ABI-8197-2020	Middeldorp, Saskia/0000-0002-1006-6420				Cosmi B, 2012, J THROMB HAEMOST, V10, P1026, DOI 10.1111/j.1538-7836.2012.04727.x; Decousus H, 2010, NEW ENGL J MED, V363, P1222, DOI 10.1056/NEJMoa0912072; Decousus H, 2010, ANN INTERN MED, V152, P218, DOI 10.7326/0003-4819-152-4-201002160-00006; Di Nisio M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004982.pub5; Kearon Clive, 2012, Chest, V141, pe419S, DOI 10.1378/chest.11-2301; Prandoni P, 2005, J THROMB HAEMOST, V3, P1152; Wichers IM, 2005, HAEMATOLOGICA, V90, P672	7	8	8	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 19	2014	311	7					729	730		10.1001/jama.2014.520	http://dx.doi.org/10.1001/jama.2014.520			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA8ZO	24549553				2022-12-28	WOS:000331383700025
J	Tremoulet, AH; Jain, S; Jaggi, P; Jimenez-Fernandez, S; Pancheri, JM; Sun, XY; Kanegaye, JT; Kovalchin, JP; Printz, BF; Ramilo, O; Burns, JC				Tremoulet, Adriana H.; Jain, Sonia; Jaggi, Preeti; Jimenez-Fernandez, Susan; Pancheri, Joan M.; Sun, Xiaoying; Kanegaye, John T.; Kovalchin, John P.; Printz, Beth F.; Ramilo, Octavio; Burns, Jane C.			Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial	LANCET			English	Article							CORONARY-ARTERY ABNORMALITIES; TUMOR-NECROSIS-FACTOR; INTRAVENOUS IMMUNOGLOBULIN; OPEN-LABEL; RHEUMATOID-ARTHRITIS; T-CELLS; CORTICOSTEROIDS; CHILDREN; GAMMA; METAANALYSIS	Background Kawasaki disease, the most common cause of acquired heart disease in developed countries, is a self-limited vasculitis that is treated with high doses of intravenous immunoglobulin. Resistance to intravenous immunoglobulin in Kawasaki disease increases the risk of coronary artery aneurysms. We assessed whether the addition of infliximab to standard therapy (intravenous immunoglobulin and aspirin) in acute Kawasaki disease reduces the rate of treatment resistance. Methods We undertook a phase 3, randomised, double-blind, placebo-controlled trial in two children's hospitals in the USA to assess the addition of infliximab (5 mg per kg) to standard therapy. Eligible participants were children aged 4 weeks-17 years who had a fever (temperature >= 38.0 degrees C) for 3-10 days and met American Heart Association criteria for Kawasaki disease. Participants were randomly allocated in 1: 1 ratio to two treatment groups: infliximab 5 mg/kg at 1 mg/mL intravenously over 2 h or placebo (normal saline 5 mL/kg, administered intravenously). Randomisation was based on a randomly permuted block design (block sizes 2 and 4), stratified by age, sex, and centre. Patients, treating physicians and staff, study team members, and echocardiographers were all masked to treament assignment. The primary outcome was the difference between the groups in treatment resistance defined as a temperature of 38.0 degrees C or higher at 36 h to 7 days after completion of the infusion of intravenous immunoglobulin. Analysis was by intention to treat. This trial is registered with ClinicalTrials.gov, NCT00760435. Findings 196 patients were enrolled and randomised: 98 to the infliximab group and 98 to placebo. One patient in the placebo group was withdrawn from the study because of hypotension before receiving treatment. Treatment resistance rate did not differ significantly (11 [11.2%] for infliximab and 11 [11.3%] for placebo; p=0.81). Compared with the placebo group, participants given infliximab had fewer days of fever (median 1 day for infliximab vs 2 days for placebo; p<0.0001). At week 2, infliximab-treated patients had greater mean reductions in erythrocyte sedimentation rate (p=0.009) and a two-fold greater decrease in Z score of the left anterior descending artery (p=0.045) than did those in the placebo group, but this difference was not significant at week 5. Participants in the infliximab group had a greater mean reduction in C-reactive protein concentration (p=0.0003) and in absolute neutrophil count (p=0.024) at 24 h after treatment than did those given placebo, but by week 2 this difference was not significant. At week 5, none of the laboratory values differed significantly compared with baseline. No significant differences were recorded between the two groups at any timepoint in proximal right coronary artery Z scores, age-adjusted haemoglobin values, duration of hospital stay, or any other laboratory markers of inflammation measured. No reactions to intravenous immunoglobulin infusion occurred in patients treated with infliximab compared with 13 (13.4%) patients given placebo (p<0.0001). No serious adverse events were directly attributable to infliximab infusion. Interpretation The addition of infliximab to primary treatment in acute Kawasaki disease did not reduce treatment resistance. However, it was safe and well tolerated and reduced fever duration, some markers of inflammation, left anterior descending coronary artery Z score, and intravenous immunoglobulin reaction rates.	[Tremoulet, Adriana H.; Jimenez-Fernandez, Susan; Kanegaye, John T.; Printz, Beth F.; Burns, Jane C.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Jain, Sonia; Sun, Xiaoying] Univ Calif San Diego, Dept Family & Prevent Med, La Jolla, CA 92093 USA; [Tremoulet, Adriana H.; Jimenez-Fernandez, Susan; Pancheri, Joan M.; Kanegaye, John T.; Printz, Beth F.; Burns, Jane C.] Rady Childrens Hosp San Diego, San Diego, CA USA; [Jaggi, Preeti; Kovalchin, John P.; Ramilo, Octavio] Nationwide Childrens Hosp, Columbus, OH USA; [Jaggi, Preeti; Kovalchin, John P.; Ramilo, Octavio] Ohio State Univ, Columbus, OH 43210 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University	Tremoulet, AH (corresponding author), Univ Calif San Diego, Sch Med, Dept Pediat, 9500 Gilman Dr, La Jolla, CA 92093 USA.	atremoulet@ucsd.edu	Burns, Jane C/J-6167-2015		US Food and Drug Administration; Robert Wood Johnson Foundation; Janssen Biotech; FOOD AND DRUG ADMINISTRATION [R01FD003514] Funding Source: NIH RePORTER	US Food and Drug Administration; Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Janssen Biotech(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services)	US Food and Drug Administration, Robert Wood Johnson Foundation, and Janssen Biotech.	Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Boschetti G, 2011, INFLAMM BOWEL DIS, V17, P160, DOI 10.1002/ibd.21308; Burns JC, 2013, CLIN EXP IMMUNOL, V174, P337, DOI 10.1111/cei.12182; Burns JC, 2008, J PEDIATR-US, V153, P833, DOI 10.1016/j.jpeds.2008.06.011; Burns JC, 2005, J PEDIATR-US, V146, P662, DOI 10.1016/j.jpeds.2004.12.022; Burns JC, 1998, PEDIATR INFECT DIS J, V17, P1144, DOI 10.1097/00006454-199812000-00009; Chen SJ, 2013, HEART, V99, P76, DOI 10.1136/heartjnl-2012-302126; Choueiter NF, 2010, J PEDIATR-US, V157, P960, DOI 10.1016/j.jpeds.2010.06.014; Dallaire F, 2012, J AM SOC ECHOCARDIOG, V25, P859, DOI 10.1016/j.echo.2012.05.019; de Zorzi A, 1998, J PEDIATR-US, V133, P254, DOI 10.1016/S0022-3476(98)70229-X; Franco A, 2010, AUTOIMMUNITY, V43, P317, DOI 10.3109/08916930903405891; FURUKAWA S, 1988, CLIN IMMUNOL IMMUNOP, V48, P247, DOI 10.1016/0090-1229(88)90088-8; Gunn L, 2002, HARRIET LANE HDB; Inoue Y, 2006, J PEDIATR-US, V149, P336, DOI 10.1016/j.jpeds.2006.05.025; Jimenez-Fernandez SG, 2012, PEDIATR INFECT DIS J, V31, P1087, DOI 10.1097/INF.0b013e31826108c2; Kobayashi T, 2012, LANCET, V379, P1613, DOI 10.1016/S0140-6736(11)61930-2; Margossian R, 2011, J AM SOC ECHOCARDIOG, V24, P53, DOI 10.1016/j.echo.2010.10.015; MATSUBARA T, 1990, CLIN IMMUNOL IMMUNOP, V56, P29, DOI 10.1016/0090-1229(90)90166-N; Mori M, 2012, J RHEUMATOL, V39, P864, DOI 10.3899/jrheum.110877; Nadkarni S, 2007, J EXP MED, V204, P33, DOI 10.1084/jem.20061531; Newburger JW, 2007, NEW ENGL J MED, V356, P663, DOI 10.1056/NEJMoa061235; Newburger JW, 2004, CIRCULATION, V110, P2747, DOI 10.1161/01.CIR.0000145143.19711.78; Ogata S, 2012, PEDIATRICS, V129, pE17, DOI 10.1542/peds.2011-0148; Oharaseki T, 2013, MOD RHEUMATOL, DOI [10.1007/s10165-013-0865-4, DOI 10.1007/S10165-013-0865-4]; Okada Y, 2003, J PEDIATR-US, V143, P363, DOI 10.1067/S0022-3476(03)00387-1; Saji T, 2006, J PEDIATR-US, V149, P426, DOI 10.1016/j.jpeds.2005.07.039; Sleeper LA, 2011, J PEDIAT, V158, P831; Son MB, 2011, J PEDIATR-US, V158, P644, DOI 10.1016/j.jpeds.2010.10.012; Son MBF, 2009, PEDIATRICS, V124, P1, DOI 10.1542/peds.2008-0730; Song Min Seob, 2010, Korean Circ J, V40, P334, DOI 10.4070/kcj.2010.40.7.334; Sundel RP, 2003, J PEDIATR-US, V142, P611, DOI 10.1067/mpd.2003.191; Tremoulet AH, 2008, J PEDIATR-US, V153, P117, DOI 10.1016/j.jpeds.2007.12.021; Weiss JE, 2004, J RHEUMATOL, V31, P808	33	168	180	1	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 17	2014	383	9930					1731	1738		10.1016/S0140-6736(13)62298-9	http://dx.doi.org/10.1016/S0140-6736(13)62298-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH6UO	24572997	Green Published			2022-12-28	WOS:000336267300026
J	Doria-Rose, NA; Schramm, CA; Gorman, J; Moore, PL; Bhiman, JN; DeKosky, BJ; Ernandes, MJ; Georgiev, IS; Kim, HJ; Pancera, M; Staupe, RP; Altae-Tran, HR; Bailer, RT; Crooks, ET; Cupo, A; Druz, A; Garrett, NJ; Hoi, KH; Kong, R; Louder, MK; Longo, NS; McKee, K; Nonyane, M; O'Dell, S; Roark, RS; Rudicell, RS; Schmidt, SD; Sheward, DJ; Soto, C; Wibmer, CK; Yang, YP; Zhang, ZH; Mullikin, JC; Binley, JM; Sanders, RW; Wilson, IA; Moore, JP; Ward, AB; Georgiou, G; Williamson, C; Karim, SSA; Morris, L; Kwong, PD; Shapiro, L; Mascola, JR				Doria-Rose, Nicole A.; Schramm, Chaim A.; Gorman, Jason; Moore, Penny L.; Bhiman, Jinal N.; DeKosky, Brandon J.; Ernandes, Michael J.; Georgiev, Ivelin S.; Kim, Helen J.; Pancera, Marie; Staupe, Ryan P.; Altae-Tran, Han R.; Bailer, Robert T.; Crooks, Ema T.; Cupo, Albert; Druz, Aliaksandr; Garrett, Nigel J.; Hoi, Kam H.; Kong, Rui; Louder, Mark K.; Longo, Nancy S.; McKee, Krisha; Nonyane, Molati; O'Dell, Sijy; Roark, Ryan S.; Rudicell, Rebecca S.; Schmidt, Stephen D.; Sheward, Daniel J.; Soto, Cinque; Wibmer, Constantinos Kurt; Yang, Yongping; Zhang, Zhenhai; Mullikin, James C.; Binley, James M.; Sanders, Rogier W.; Wilson, Ian A.; Moore, John P.; Ward, Andrew B.; Georgiou, George; Williamson, Carolyn; Karim, Salim S. Abdool; Morris, Lynn; Kwong, Peter D.; Shapiro, Lawrence; Mascola, John R.		NISC Comparative Sequencing	Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies	NATURE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODIES; HIV-1-NEUTRALIZING ANTIBODIES; VACCINE EFFICACY; STRUCTURAL BASIS; BROAD; RECOGNITION; IMMUNOGLOBULIN; GENERATION; INFECTION	Antibodies capable of neutralizing HIV-1 often target variable regions 1 and 2 (V1V2) of the HIV-1 envelope, but the mechanism of their elicitation has been unclear. Here we define the developmental pathway by which such antibodies are generated and acquire the requisite molecular characteristics for neutralization. Twelve somatically related neutralizing antibodies (CAP256-VRC26.01-12) were isolated from donor CAP256 (from the Centre for the AIDS Programme of Research in South Africa (CAPRISA)); each antibody contained the protruding tyrosine-sulphated, anionic antigen-binding loop (complementarity-determining region (CDR) H3) characteristic of this category of antibodies. Their unmutated ancestor emerged between weeks 30-38 post-infection with a 35-residue CDR H3, and neutralized the virus that superinfected this individual 15 weeks after initial infection. Improved neutralization breadth and potency occurred by week 59 with modest affinity maturation, and was preceded by extensive diversification of the virus population. HIV-1 V1V2-directed neutralizing antibodies can thus develop relatively rapidly through initial selection of B cells with a long CDR H3, and limited subsequent somatic hypermutation. These data provide important insights relevant to HIV-1 vaccine development.	[Doria-Rose, Nicole A.; Gorman, Jason; Ernandes, Michael J.; Georgiev, Ivelin S.; Pancera, Marie; Staupe, Ryan P.; Altae-Tran, Han R.; Bailer, Robert T.; Druz, Aliaksandr; Kong, Rui; Louder, Mark K.; Longo, Nancy S.; McKee, Krisha; O'Dell, Sijy; Roark, Ryan S.; Rudicell, Rebecca S.; Schmidt, Stephen D.; Soto, Cinque; Yang, Yongping; Kwong, Peter D.; Shapiro, Lawrence; Mascola, John R.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Schramm, Chaim A.; Zhang, Zhenhai; Shapiro, Lawrence] Columbia Univ, Dept Biochem, New York, NY 10032 USA; [Moore, Penny L.; Bhiman, Jinal N.; Nonyane, Molati; Wibmer, Constantinos Kurt; Morris, Lynn] NHLS, Natl Inst Communicable Dis, Ctr HIV & STIs, ZA-2131 Johannesburg, South Africa; [Moore, Penny L.; Bhiman, Jinal N.; Wibmer, Constantinos Kurt; Morris, Lynn] Univ Witwatersrand, Fac Hlth Sci, ZA-2050 Johannesburg, South Africa; [Moore, Penny L.; Garrett, Nigel J.; Williamson, Carolyn; Karim, Salim S. Abdool; Morris, Lynn] Univ KwaZulu Natal, CAPRISA, ZA-4013 Congella, South Africa; [DeKosky, Brandon J.; Georgiou, George] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA; [Kim, Helen J.; Wilson, Ian A.; Ward, Andrew B.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Kim, Helen J.; Wilson, Ian A.; Ward, Andrew B.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, La Jolla, CA 92037 USA; [Kim, Helen J.; Wilson, Ian A.; Ward, Andrew B.] Scripps Res Inst, IAVI Neutralizing Antibody Ctr, La Jolla, CA 92037 USA; [Crooks, Ema T.; Binley, James M.] Torrey Pines Inst, San Diego, CA 92037 USA; [Cupo, Albert; Moore, John P.] Cornell Univ, Weill Med Coll, New York, NY 10065 USA; [Hoi, Kam H.; Georgiou, George] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Sheward, Daniel J.] Univ Cape Town, Inst Infect Dis & Mol Med, Div Med Virol, ZA-7701 Cape Town, South Africa; [Sheward, Daniel J.] NHLS, ZA-7701 Cape Town, South Africa; [Mullikin, James C.] NIH, NISC Comparat Sequencing Program, Bethesda, MD 20892 USA; [Mullikin, James C.] NHGRI, NIH Intramural Sequencing Ctr, NIH, Bethesda, MD 20892 USA; [Sanders, Rogier W.] Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, NL-1105 AZ Amsterdam, Netherlands; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Georgiou, George] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Karim, Salim S. Abdool] Columbia Univ, Dept Epidemiol, New York, NY 10032 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Columbia University; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand; University of Kwazulu Natal; University of Texas System; University of Texas Austin; Scripps Research Institute; Scripps Research Institute; International AIDS Vaccine Initiative; Scripps Research Institute; Torrey Pines Institute for Molecular Studies, California; Cornell University; University of Texas System; University of Texas Austin; University of Cape Town; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Amsterdam; Academic Medical Center Amsterdam; Scripps Research Institute; University of Texas System; University of Texas Austin; Columbia University	Morris, L (corresponding author), NHLS, Natl Inst Communicable Dis, Ctr HIV & STIs, ZA-2131 Johannesburg, South Africa.	lynnm@nicd.ac.za; pdkwong@nih.gov; lss8@columbia.edu; jrmascola@nih.gov	Bhiman, Jinal/ABA-6029-2021; Shapiro, Lawrence/AAE-7172-2019; Karim, Salim Abdool/P-3117-2019; Schmidt, Stephen/AAC-6967-2019; Gorman, Jason/AGG-9417-2022; Schmidt, Stephen/B-5398-2012; Zhang, Zhenhai/GRX-5887-2022; Wibmer, Constantinos Kurt/AAH-8669-2019; Cheng, Yushao/E-6256-2011; Mascola, John/AAI-7193-2021; Sheward, Daniel/GSJ-0708-2022; Morris, Lynn/V-3941-2018; Ward, Andrew B/F-9203-2014; Ward, Andrew/ABD-7728-2021; Wibmer, Constantinos Kurt/AAO-3035-2021; Karim, Salim Abdool/AAE-7118-2019	Bhiman, Jinal/0000-0001-6354-4003; Karim, Salim Abdool/0000-0002-4986-2133; Zhang, Zhenhai/0000-0002-4310-0525; Sheward, Daniel/0000-0002-0227-5636; Morris, Lynn/0000-0003-3961-7828; Ward, Andrew B/0000-0001-7153-3769; Ward, Andrew/0000-0001-7153-3769; Wibmer, Constantinos Kurt/0000-0003-2329-2280; Hoi, Kam Hon/0000-0003-4158-0446; Roark, Ryan/0000-0003-0586-103X; Ernandes, Michael/0000-0001-8218-0145; Staupe, Ryan/0000-0003-0793-524X; Moore, Penny/0000-0001-8719-4028; Gorman, Jason/0000-0002-3775-6560; Kim, Helen/0000-0003-0096-7740; , Carolyn/0000-0003-0125-1226	Vaccine Research Center; NIAID; Fogarty International Center; NHGRI; NIGMS of the National Institutes of Health, USA; International AIDS Vaccine Initiative; National Science Foundation; Scripps CHAV-ID; South African Department of Science and Technology; Wellcome Trust; Hertz Foundation; Donald D. Harrington Foundation; Poliomyelitis Research Foundation; National Research Foundation of South Africa; US Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG000196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005089, P01AI082362, ZIAAI005022, UM1AI100663, ZIAAI005095, ZICAI005111, ZIAAI005010, R01AI100790] Funding Source: NIH RePORTER	Vaccine Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS of the National Institutes of Health, USA; International AIDS Vaccine Initiative; National Science Foundation(National Science Foundation (NSF)); Scripps CHAV-ID; South African Department of Science and Technology; Wellcome Trust(Wellcome TrustEuropean Commission); Hertz Foundation; Donald D. Harrington Foundation; Poliomyelitis Research Foundation; National Research Foundation of South Africa(National Research Foundation - South Africa); US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the participants in the CAPRISA 002 study for their commitment. For technical assistance and advice, we thank: K. Mlisana, S. Sibeko, N. Naicker, the CAPRISA 002 clinical team, N. Samsunder, S. Heeralall, B. Lambson, M. Madzivhandila, T. Khoza, C. Mitchell Scheepers, E. Turk, C.-L. Lin, M. Roederer, J. Stuckey, B. Hartman, G. Loots, J. H. Lee, G. Ippolito, B. Briney, S. Hunicke-Smith and J. Wheeler, and members of the WCMC HIVRAD Core and the NIH Vaccine Research Center HIMS, HIMC, SBS and SBIS sections. We thank J. Baalwa, D. Ellenberger, F. Gao, B. Hahn, K. Hong, J. Kim, F. McCutchan, D. Montefiori, J. Overbaugh, E. Sanders-Buell, G. Shaw, R. Swanstrom, M. Thomson, S. Tovanabutra and L. Zhang for contributing the HIV-1Envelope plasmids used in our neutralizationpanel. Funding was provided by the intramural research programs of the Vaccine Research Center and NIAID, the Fogarty International Center, NHGRI, and NIGMS of the National Institutes of Health, USA; the International AIDS Vaccine Initiative; the National Science Foundation; Scripps CHAV-ID; the South African Department of Science and Technology; and fellowships from the Wellcome Trust, Hertz Foundation, Donald D. Harrington Foundation, Poliomyelitis Research Foundation and the National Research Foundation of South Africa. Use of sector 22 (Southeast Region Collaborative Access team) at the Advanced Photon Source was supported by the US Department of Energy, Basic Energy Sciences, Office of Science, under contract number W-31-109-Eng-38.	Alamyar E., 2012, IMMUNOME RES, V8; Ashkenazy H, 2012, NUCLEIC ACIDS RES, V40, pW580, DOI 10.1093/nar/gks498; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; Briney BS, 2012, GENES IMMUN, V13, P469, DOI 10.1038/gene.2012.20; Briney BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036750; Burton DR, 2012, CELL HOST MICROBE, V12, P396, DOI 10.1016/j.chom.2012.09.008; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DeLano W.L, PYMOL MOL GRAPHICS S; Doria-Rose N, 2013, PROTOCOL EXCHANGE; Doria-Rose NA, 2012, J VIROL, V86, P8319, DOI 10.1128/JVI.00696-12; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gao F, 1996, J VIROL, V70, P7013, DOI 10.1128/JVI.70.10.7013-7029.1996; Georgiev IS, 2013, SCIENCE, V340, P751, DOI 10.1126/science.1233989; Glanville J, 2009, P NATL ACAD SCI USA, V106, P20216, DOI 10.1073/pnas.0909775106; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Huang JH, 2013, NAT PROTOC, V8, P1907, DOI 10.1038/nprot.2013.117; Huang JH, 2012, NATURE, V491, P406, DOI 10.1038/nature11544; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003342; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Kabat EA, 1991, SEQUENCES PROTEINS I; Kong Leopold, 2012, J AIDS Clin Res, VS8, P3; Kraus MH, 2010, VIROLOGY, V397, P346, DOI 10.1016/j.virol.2009.11.019; Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lefranc MP, 2003, DEV COMP IMMUNOL, V27, P55, DOI 10.1016/S0145-305X(02)00039-3; Li WZ, 2001, BIOINFORMATICS, V17, P282, DOI 10.1093/bioinformatics/17.3.282; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Lynch RM, 2011, J VIROL, V85, P905, DOI 10.1128/JVI.02006-10; Lyumkis D, 2013, SCIENCE, V342, P1484, DOI 10.1126/science.1245627; Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; Moore PL, 2013, J VIROL, V87, P4882, DOI 10.1128/JVI.03424-12; Moore PL, 2011, J VIROL, V85, P3128, DOI 10.1128/JVI.02658-10; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Overbaugh J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007039; Pancera M, 2005, VIROLOGY, V332, P145, DOI 10.1016/j.virol.2004.10.042; Pancera M, 2013, NAT STRUCT MOL BIOL, V20, P804, DOI 10.1038/nsmb.2600; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piantadosi A, 2009, J VIROL, V83, P10269, DOI 10.1128/JVI.01149-09; Pond SLK, 2008, MOL BIOL EVOL, V25, P1809, DOI 10.1093/molbev/msn123; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Shu Y, 2007, VACCINE, V25, P1398, DOI 10.1016/j.vaccine.2006.10.046; Sorzano COS, 2010, J STRUCT BIOL, V171, P197, DOI 10.1016/j.jsb.2010.03.011; Soto CS, 2008, PROTEINS, V70, P834, DOI 10.1002/prot.21612; Souto-Carneiro MM, 2004, J IMMUNOL, V172, P6790, DOI 10.4049/jimmunol.172.11.6790; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Tong T, 2012, J VIROL, V86, P3574, DOI 10.1128/JVI.06938-11; Tran EEH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002797; van Loggerenberg F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001954; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Waddell PJ, 1997, MOL PHYLOGENET EVOL, V8, P398, DOI 10.1006/mpev.1997.0452; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zhu J, 2013, P NATL ACAD SCI USA, V110, P6470, DOI 10.1073/pnas.1219320110; Zhu J, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00315	83	522	536	1	93	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					55	+		10.1038/nature13036	http://dx.doi.org/10.1038/nature13036			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24590074	Green Accepted, Green Submitted			2022-12-28	WOS:000335199100038
J	Kozlowska, K				Kozlowska, Kasia			Abnormal illness behaviours: a developmental perspective	LANCET			English	Editorial Material							SOMATIC SYMPTOMS		[Kozlowska, Kasia] Childrens Hosp, Westmead, NSW 2145, Australia; [Kozlowska, Kasia] Univ Sydney, Sch Med, Discipline Psychiat, Sydney, NSW 2006, Australia; [Kozlowska, Kasia] Univ Sydney, Sch Med, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney; University of Sydney	Kozlowska, K (corresponding author), Childrens Hosp, Westmead, NSW 2145, Australia.	kkoz6421@uni.sydney.edu.au						Administration for Children and Families US Department of Health and Human Services, CYCL AB; [Anonymous], 2008, RAISING PARENTS ATTA; Bass C, 2014, LANCET; Crittenden PM, 2006, CAMB ST SOC, P388, DOI 10.1017/CBO9780511499869.014; Crittenden PM, 1999, MONOGR SOC RES CHILD, V64, P145; Damasio A.R., 2005, DESCARTES ERROR EMOT; Farnfield Steve, 2010, Clin Child Psychol Psychiatry, V15, P313, DOI 10.1177/1359104510364315; Flaviola G, 2013, ADAPTIVE MALADAPTIVE; HARLOW HF, 1958, AM PSYCHOL, V13, P673, DOI 10.1037/h0047884; Kozlowska K, 2013, HARVARD REV PSYCHIAT, V21, P314, DOI 10.1097/HRP.0000000000000008; Kozlowska K, 2012, FAM PROCESS, V51, P570, DOI 10.1111/famp.12000; Rask CU, 2013, J PEDIATR-US, V162, P335, DOI 10.1016/j.jpeds.2012.08.001; Schore A.N., 2003, AFFECT DYSREGULATION	13	9	10	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 19	2014	383	9926					1368	1369		10.1016/S0140-6736(13)62640-9	http://dx.doi.org/10.1016/S0140-6736(13)62640-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG3LI	24612862				2022-12-28	WOS:000335318400008
J	Zhou, Q; Neubauer, J; Kern, JS; Grotz, W; Walz, G; Huber, TB				Zhou, Qian; Neubauer, Jakob; Kern, Johannes S.; Grotz, Wolfgang; Walz, Gerd; Huber, Tobias B.			Calciphylaxis	LANCET			English	Editorial Material									[Zhou, Qian] Univ Heart Ctr Freiburg, Dept Cardiol, Freiburg, Germany; [Neubauer, Jakob] Univ Hosp Freiburg, Dept Radiol, D-79106 Freiburg, Germany; [Kern, Johannes S.] Univ Hosp Freiburg, Dept Dermatol, D-79106 Freiburg, Germany; [Walz, Gerd; Huber, Tobias B.] Univ Hosp Freiburg, Dept Nephrol, D-79106 Freiburg, Germany; [Grotz, Wolfgang] Alfred Krupp Hosp, Dept Internal Med, Essen, Germany; [Huber, Tobias B.] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany	Universitats Herzzentrum Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg	Huber, TB (corresponding author), Univ Hosp Freiburg, Dept Nephrol, D-79106 Freiburg, Germany.	tobias.huber@uniklinik-freiburg.de	Zhou, Qian/ABC-7574-2021	Huber, Tobias B./0000-0001-7175-5062					0	13	15	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 22	2014	383	9922					1067	1067		10.1016/S0140-6736(14)60235-X	http://dx.doi.org/10.1016/S0140-6736(14)60235-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD8MV	24582472				2022-12-28	WOS:000333521200032
J	Brown, JR; Sox, HC; Goodman, DC				Brown, Jeremiah R.; Sox, Harold C.; Goodman, David C.			Financial Incentives to Improve Quality Skating to the Puck or Avoiding the Penalty Box?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		[Brown, Jeremiah R.; Sox, Harold C.; Goodman, David C.] Geisel Sch Med Dartmouth, Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA	Dartmouth College	Brown, JR (corresponding author), Dartmouth Hitchcock Med Ctr, Dartmouth Inst Hlth Policy & Clin Practice, Geisel Sch Med Dartmouth, One Med Ctr Dr,HB 7505, Lebanon, NH 03756 USA.	jbrown@dartmouth.edu	Goodman, David/AAG-7497-2020		AHRQ HHS [K01 HS018443] Funding Source: Medline; NHLBI NIH HHS [R01 HL119664] Funding Source: Medline	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Brock J, 2013, JAMA-J AM MED ASSOC, V309, P381, DOI 10.1001/jama.2012.216607; Calikoglu S, 2012, HEALTH AFFAIR, V31, P2649, DOI 10.1377/hlthaff.2012.0357; Lyu H, 2013, JAMA SURG, V148, P362, DOI 10.1001/2013.jamasurg.270; The Medicare Payment Advisory Commission, C MED HLTH CAR DEL S	4	20	20	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2014	311	10					1009	1010		10.1001/jama.2014.421	http://dx.doi.org/10.1001/jama.2014.421			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC5QO	24618957	Green Accepted			2022-12-28	WOS:000332575800013
J	Willyard, C				Willyard, Cassandra			POLIO The eradication endgame	NATURE			English	Editorial Material							VACCINE											Burns CC, 2013, J VIROL, V87, P4907, DOI 10.1128/JVI.02954-12; Mangal TD, 2013, AM J EPIDEMIOL, V178, P1579, DOI 10.1093/aje/kwt203; Resik S, 2013, NEW ENGL J MED, V368, P416, DOI 10.1056/NEJMoa1202541	3	5	6	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					S14	S15		10.1038/507S14a	http://dx.doi.org/10.1038/507S14a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC0ZQ	24611172	Bronze			2022-12-28	WOS:000332224400007
J	Spence, D				Spence, Des			Statins for all	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CHOLESTEROL; DISEASE					destwo@yahoo.co.uk						Mihaylova B, 2012, LANCET, V380, P581, DOI 10.1016/S0140-6736(12)60367-5; Nago N, 2011, J EPIDEMIOL, V21, P67, DOI 10.2188/jea.JE20100065; NICE, 2014, CONS LIP M IN PRESS; Spence D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3566	4	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 3	2014	348								g1899	10.1136/bmj.g1899	http://dx.doi.org/10.1136/bmj.g1899			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC6HK	24589618				2022-12-28	WOS:000332622000019
J	Johnson, JS; Bentley, MJ; Smith, JA; Finkel, RC; Rood, DH; Gohl, K; Balco, G; Larter, RD; Schaefer, JM				Johnson, J. S.; Bentley, M. J.; Smith, J. A.; Finkel, R. C.; Rood, D. H.; Gohl, K.; Balco, G.; Larter, R. D.; Schaefer, J. M.			Rapid Thinning of Pine Island Glacier in the Early Holocene	SCIENCE			English	Article							ANTARCTIC ICE-SHEET; WEST ANTARCTICA; SEA EMBAYMENT; STABILITY; RETREAT	Pine Island Glacier, a major outlet of the West Antarctic Ice Sheet, has been undergoing rapid thinning and retreat for the past two decades. We demonstrate, using glacial-geological and geochronological data, that Pine Island Glacier (PIG) also experienced rapid thinning during the early Holocene, around 8000 years ago. Cosmogenic Be-10 concentrations in glacially transported rocks show that this thinning was sustained for decades to centuries at an average rate of more than 100 centimeters per year, which is comparable with contemporary thinning rates. The most likely mechanism was a reduction in ice shelf buttressing. Our findings reveal that PIG has experienced rapid thinning at least once in the past and that, once set in motion, rapid ice sheet changes in this region can persist for centuries.	[Johnson, J. S.; Bentley, M. J.; Smith, J. A.; Larter, R. D.] British Antarctic Survey, Nat Environm Res Council, Cambridge CB3 0ET, England; [Bentley, M. J.] Univ Durham, Dept Geog, Durham DH1 3LE, England; [Finkel, R. C.; Rood, D. H.] Lawrence Livermore Natl Lab, Ctr Accelerator Mass Spectrometry, Livermore, CA 94550 USA; [Finkel, R. C.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Rood, D. H.] Univ Calif Santa Barbara, Earth Res Inst, Santa Barbara, CA 93106 USA; [Gohl, K.] Helmholtz Ctr Polar & Marine Res, Alfred Wegener Inst, D-27568 Bremerhaven, Germany; [Balco, G.] Berkeley Geochronol Ctr, Berkeley, CA 94709 USA; [Schaefer, J. M.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Schaefer, J. M.] Columbia Univ, Dept Earth & Environm Sci, New York, NY 10027 USA	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; Durham University; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Santa Barbara; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Berkeley Geochronolgy Center; Columbia University; Columbia University	Johnson, JS (corresponding author), British Antarctic Survey, Nat Environm Res Council, Madingley Rd, Cambridge CB3 0ET, England.	jsj@bas.ac.uk	Bentley, Michael J/F-7386-2011; Smith, James/N-1836-2013	Bentley, Michael J/0000-0002-2048-0019; Gohl, Karsten/0000-0002-9558-2116; Johnson, Joanne/0000-0003-4537-4447	Natural Environment Research Council; Columbia University Earth Institute/Lamont-Doherty Earth Observatory; NERC [NE/J005673/1, NE/F014260/1] Funding Source: UKRI; Natural Environment Research Council [NE/J005673/1, bas0100027, NE/F014260/1] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Columbia University Earth Institute/Lamont-Doherty Earth Observatory; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The data presented here are archived in the supplementary materials. The project was conceived and developed by M.J.B. and R. D. L. Fieldwork and sampling were planned and undertaken by M.J.B., J.A.S., and J.S.J. K. G. led the cruise (RV Polarstern Expedition ANT-XXVI/3). J.S.J. processed the samples and interpreted the data, with direction from J.M.S., and analyses were performed by R. C. F. and D. H. R. G. B. developed the Monte Carlo simulations for Fig. 2 and fig. S4. M.J.B. and J.S.J. wrote the first draft, and all authors contributed to the interpretation and writing of the paper. This work forms part of the British Antarctic Survey program "Polar Science for Planet Earth," funded by the Natural Environment Research Council, and was made possible by a Marie Tharp Fellowship in Earth, Environmental, and Ocean Sciences at Columbia University Earth Institute/Lamont-Doherty Earth Observatory, awarded to J.S.J. The fieldwork was supported by the research program PACES, Topic 3 "Lessons from the Past" of the Alfred Wegener Institute. This is LDEO publication 7577.	Bentley MJ, 2010, GEOLOGY, V38, P411, DOI 10.1130/G30754.1; Gladstone R. M., 2012, EARTH PLANET SC LETT, V333-334, P191; Graham AGC, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001482; Gudmundsson GH, 2012, CRYOSPHERE, V6, P1497, DOI 10.5194/tc-6-1497-2012; Hillenbrand CD, 2013, GEOLOGY, V41, P35, DOI 10.1130/G33469.1; Jacobs SS, 2011, NAT GEOSCI, V4, P519, DOI [10.1038/NGEO1188, 10.1038/ngeo1188]; Jakobsson M, 2012, QUATERNARY SCI REV, V38, P1, DOI 10.1016/j.quascirev.2011.12.017; Jamieson SSR, 2012, NAT GEOSCI, V5, P799, DOI [10.1038/ngeo1600, 10.1038/NGEO1600]; Jenkins A, 2010, NAT GEOSCI, V3, P468, DOI 10.1038/NGEO890; Johnson JS, 2008, GEOLOGY, V36, P223, DOI 10.1130/G24207A.1; Joughin I, 2011, NAT GEOSCI, V4, P506, DOI [10.1038/ngeo1194, 10.1038/NGEO1194]; Joughin I, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044819; King MA, 2012, NATURE, V491, P586, DOI 10.1038/nature11621; Kirshner AE, 2012, QUATERNARY SCI REV, V38, P11, DOI 10.1016/j.quascirev.2012.01.017; Lowe AL, 2002, QUATERNARY SCI REV, V21, P1879, DOI 10.1016/S0277-3791(02)00006-9; Park JW, 2013, GEOPHYS RES LETT, V40, P2137, DOI 10.1002/grl.50379; Payne AJ, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021284; Pritchard HD, 2012, NATURE, V484, P502, DOI 10.1038/nature10968; Pritchard HD, 2009, NATURE, V461, P971, DOI 10.1038/nature08471; Rignot E, 2011, MEASURES INSAR BASED; Rignot E, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033365; Schaefer JM, 2009, SCIENCE, V324, P622, DOI 10.1126/science.1169312; Shepherd A, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021106; Shepherd A, 2001, SCIENCE, V291, P862, DOI 10.1126/science.291.5505.862; Shepherd A, 2012, SCIENCE, V338, P1183, DOI 10.1126/science.1228102; Solomon S., 2007, PHYS SCI BASIS WORKI; Stone JO, 2003, SCIENCE, V299, P99, DOI 10.1126/science.1077998; Thomas R, 2004, SCIENCE, V306, P255, DOI 10.1126/science.1099650; Tinto KJ, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL049026; Wingham DJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039126	30	47	47	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2014	343	6174					999	1001		10.1126/science.1247385	http://dx.doi.org/10.1126/science.1247385			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2DZ	24557837	Green Accepted, Green Published			2022-12-28	WOS:000332309600039
J	Feldman, HM; Reiff, MI				Feldman, Heidi M.; Reiff, Michael I.			Attention Deficit-Hyperactivity Disorder in Children and Adolescents	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DEFICIT/HYPERACTIVITY DISORDER; FOLLOW-UP; DSM-IV; ADHD; PREVALENCE; METHYLPHENIDATE; MEDICATION; EFFICACY; OUTCOMES; UPDATE	ADHD is characterized by inattention, hyperactivity, impulsivity, or a combination of these symptoms, which compromise functioning. Management includes medications (shown to improve core symptoms but not necessarily functional outcomes) and behavioral therapies. ForewordThis Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they exist. The article ends with the authors' clinical recommendations.StageA 9-year-old boy who received a diagnosis of attention deficit-hyperactivity disorder (ADHD) at 7 years of age is brought to your office by his parents for a follow-up visit. He had had behavioral problems since preschool, including excessive fidgeting and difficulty following directions and taking turns with peers. Parent and teacher rat ings of behavior confirmed elevated levels of inattention, hyperactivity, and impulsivity that were associated with poor grades, disruptions of classroom activities, and poor peer relationships. He was treated with sustained-release methylphenidate. Although parent and teacher rating scales after treatment showed reduced symptoms, he still makes many careless ... Attention Deficit-Hyperactivity Disorder in Children and Adolescents Attention deficit-hyperactivity disorder (ADHD), the most prevalent neurobehavioral disorder in children, is associated with adverse long-term functional outcomes. Diagnostic evaluation relies on the use of validated parent and teacher rating scales that assess the child's behavior in everyday situations in various environments. Adolescents provide self-report as part of the diagnostic evaluation. Coexisting conditions and problems, especially learning disorders, anxiety and depression (internalizing disorders), and oppositional behaviors and conduct disturbance (externalizing disorders), must be considered in the evaluation and management of ADHD. Treatment should address a child's areas of functional disability rather than focus exclusively on ADHD core symptoms. Management plans developed with the child and family members, including parents, should specify measurable target objectives that relate to broader functional outcomes and are monitored in the evaluation of treatment effectiveness. Stimulant medications reduce the symptoms of ADHD without necessarily improving corresponding functional limitations. Behavior management is not as effective as medication in reducing core symptoms, but it improves functioning, which is important for subgroups of children with ADHD, and it increases parental satisfaction.	[Feldman, Heidi M.] Stanford Univ, Dept Pediat, Sch Med, Palo Alto, CA 94304 USA; [Reiff, Michael I.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA	Stanford University; University of Minnesota System; University of Minnesota Twin Cities	Feldman, HM (corresponding author), Stanford Univ, Dept Pediat, Sch Med, 750 Welch Rd,Suite 315, Palo Alto, CA 94304 USA.	hfeldman@stanford.edu		Feldman, Heidi/0000-0002-4435-0913				American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; [Anonymous], 2005, WHAT IS FAM CTR MED; [Anonymous], 2009, PAR TRAIN PROGR INS; Antshel KM, 2008, CHILD ADOL PSYCH CL, V17, P421, DOI 10.1016/j.chc.2007.11.005; Biederman Joseph, 2003, Paediatr Drugs, V5, P833, DOI 10.2165/00148581-200305120-00006; Biederman J, 2012, J CLIN PSYCHIAT, V73, P941, DOI 10.4088/JCP.11m07529; Boyle CA, 2011, PEDIATRICS, V127, P1034, DOI 10.1542/peds.2010-2989; Braun JM, 2006, ENVIRON HEALTH PERSP, V114, P1904, DOI 10.1289/ehp.9478; Carlson CL, 2000, CHILD ADOL PSYCH CL, V9, P499; Castellanos FX, 2012, TRENDS COGN SCI, V16, P17, DOI 10.1016/j.tics.2011.11.007; Clark C, 2012, NOISE HEALTH, V14, P292, DOI 10.4103/1463-1741.104896; Cooper WO, 2011, NEW ENGL J MED, V365, P1896, DOI 10.1056/NEJMoa1110212; Diamond A, 2007, SCIENCE, V318, P1387, DOI 10.1126/science.1151148; Dickstein SG, 2006, J CHILD PSYCHOL PSYC, V47, P1051, DOI 10.1111/j.1469-7610.2006.01671.x; DuPaul GJ, 2012, SCHOOL PSYCHOL REV, V41, P387; Efron D, 1997, PEDIATRICS, V100, part. no., DOI 10.1542/peds.100.6.e6; Faraone SV, 2010, PSYCHIAT CLIN N AM, V33, P159, DOI 10.1016/j.psc.2009.12.004; Faraone SV, 2002, INT J NEUROPSYCHOPH, V5, P121, DOI 10.1017/S1461145702002845; Fergusson DM, 1997, J CHILD PSYCHOL PSYC, V38, P633, DOI 10.1111/j.1469-7610.1997.tb01690.x; Froehlich TE, 2011, CURR PSYCHIAT REP, V13, P333, DOI 10.1007/s11920-011-0221-3; Fulton BD, 2009, PSYCHIAT SERV, V60, P1075, DOI 10.1176/appi.ps.60.8.1075; Garcia CR, 2012, EUR PSYCHIAT, V27, P309, DOI 10.1016/j.eurpsy.2010.08.002; Graf WD, 2013, NEUROLOGY, V80, P1251, DOI 10.1212/WNL.0b013e318289703b; Greenhill, 2007, J AM ACAD CHILD PSY, V46, P141; Greenhill L, 2006, J AM ACAD CHILD PSY, V45, P1284, DOI 10.1097/01.chi.0000235077.32661.61; Hoza B, 2007, J PEDIATR PSYCHOL, V32, P655, DOI 10.1093/jpepsy/jsm024; Jensen PS, 1999, ARCH GEN PSYCHIAT, V56, P1088, DOI 10.1001/archpsyc.56.12.1088; Jensen PS, 1999, ARCH GEN PSYCHIAT, V56, P1073; Lee SI, 2008, J CHILD PSYCHOL PSYC, V49, P70, DOI 10.1111/j.1469-7610.2007.01784.x; Loe IM, 2007, J PEDIATR PSYCHOL, V32, P643, DOI 10.1093/jpepsy/jsl054; Merrell C, 2001, BRIT J EDUC PSYCHOL, V71, P43, DOI 10.1348/000709901158389; Molina BSG, 2009, J AM ACAD CHILD PSY, V48, P484, DOI 10.1097/CHI.0b013e31819c23d0; Neuman RJ, 2005, TWIN RES HUM GENET, V8, P392, DOI 10.1375/twin.8.4.392; Pastor P.N., 2008, VITAL HLTH STAT, V10, P1; Pelham WE, 2007, J PEDIATR PSYCHOL, V32, P711, DOI 10.1093/jpepsy/jsm022; Pelham WE, 2008, J CLIN CHILD ADOLESC, V37, P184, DOI 10.1080/15374410701818681; Perrin JM, 2008, PEDIATRICS, V122, P451, DOI 10.1542/peds.2008-1573; Pliszka S, 2007, J AM ACAD CHILD PSY, V46, P894, DOI 10.1097/chi.0b013e318054e724; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Poulton A, 2005, ARCH DIS CHILD, V90, P801, DOI 10.1136/adc.2004.056952; Reid R, 2002, J AM ACAD CHILD PSY, V41, P906, DOI 10.1097/00004583-200208000-00008; Schachar R, 2002, CAN J PSYCHIAT, V47, P337, DOI 10.1177/070674370204700404; Schwarz A, 2013, NY TIMES; Shaw P, 2007, P NATL ACAD SCI USA, V104, P19649, DOI 10.1073/pnas.0707741104; Sia CJ, 2002, PEDIATRICS, V110, P184; Ustun TB, 2007, AMBUL PEDIATR, V7, P132, DOI 10.1016/j.ambp.2006.05.004; Weber W, 2007, PEDIATR CLIN N AM, V54, P983, DOI 10.1016/j.pcl.2007.09.006; WHO, 2001, WHO INT CLASS FUNCT; Wolraich M, 2011, PEDIATRICS, V128, P1007, DOI 10.1542/peds.2011-2654; World Health Organization, 1993, ICD 10 CLASS MENT BE, V10th ed.; World Health Organization, 2001, INT CLASS FUNCT DIS	52	153	154	4	98	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 27	2014	370	9					838	846		10.1056/NEJMcp1307215	http://dx.doi.org/10.1056/NEJMcp1307215			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AB8AR	24571756				2022-12-28	WOS:000332013000009
J	Linden, D; Courtney, D; Shyamsundar, M; Hewitt, R				Linden, Dermot; Courtney, David; Shyamsundar, Muralis; Hewitt, Richard			Chest pain and neck discomfort in a young man	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SPONTANEOUS PNEUMOMEDIASTINUM		[Linden, Dermot] Ulster Hosp, Dept Intens Care, Belfast BT16 1RH, Antrim, North Ireland; [Courtney, David] Ulster Hosp, Dept Med, Belfast BT16 1RH, Antrim, North Ireland; [Shyamsundar, Muralis; Hewitt, Richard] Ulster Hosp, Dept Resp Med, Belfast BT16 1RH, Antrim, North Ireland		Linden, D (corresponding author), Ulster Hosp, Dept Intens Care, Belfast BT16 1RH, Antrim, North Ireland.	dermotlinden@gmail.com		Linden, Dermot/0000-0003-0552-1115				Baskaran RK, 2010, EMERG MED J, V27, P241, DOI 10.1136/emj.2008.068361; Blencowe NS, 2013, BMJ-BRIT MED J, V346, P38; Caceres M, 2008, ANN THORAC SURG, V86, P962, DOI 10.1016/j.athoracsur.2008.04.067; Campillo-Soto A, 2005, ARCH BRONCONEUMOL, V41, P528, DOI 10.1157/13078656; HERLAN DB, 1992, CHEST, V102, P503, DOI 10.1378/chest.102.2.503; Janes SM, 2004, THORAX, V59, P360, DOI 10.1136/thx.2003.019513; Johnson MK, 2000, THORAX, V55, P340, DOI 10.1136/thorax.55.4.340; Macia I, 2007, EUR J CARDIO-THORAC, V31, P1110, DOI 10.1016/j.ejcts.2007.03.008; MCMAHON DJ, 1976, AM J SURG, V131, P550, DOI 10.1016/0002-9610(76)90008-8; MUNSELL WP, 1967, J AMER MED ASSOC, V202, P689, DOI 10.1001/jama.202.8.689; Newcomb AE, 2005, CHEST, V128, P3298, DOI 10.1378/chest.128.5.3298; Patel A, 2000, CHEST, V117, P1809, DOI 10.1378/chest.117.6.1809; RALPHEDWARDS AC, 1994, ANN THORAC SURG, V58, P1758, DOI 10.1016/0003-4975(94)91683-7; WERNE C, 1985, ANN EMERG MED, V14, P1010, DOI 10.1016/S0196-0644(85)80252-3; YELLIN A, 1983, THORAX, V38, P383, DOI 10.1136/thx.38.5.383	15	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 25	2014	348								g1661	10.1136/bmj.g1661	http://dx.doi.org/10.1136/bmj.g1661			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC0TW	24569524				2022-12-28	WOS:000332209200003
J	Chen, C; Ackerly, DC				Chen, Christopher; Ackerly, D. Clay			Beyond ACOs and Bundled Payments Medicare's Shift Toward Accountability in Fee-for-Service	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Chen, Christopher] Washington Univ, Sch Med, St Louis, MO 63130 USA; [Ackerly, D. Clay] Massachusetts Gen Hosp, Boston, MA 02114 USA	Washington University (WUSTL); Harvard University; Massachusetts General Hospital	Ackerly, DC (corresponding author), Massachusetts Gen Hosp, Nonacute Serv, 55 Fruit St, Boston, MA 02114 USA.	dackerly@partners.org						Bueno H, 2010, JAMA-J AM MED ASSOC, V303, P2141, DOI 10.1001/jama.2010.748; DaVanzo Dobson, CLINICALLY APPROPRIA; Davidson A., THE PRESIDENT WANTS; Health Care Financing Administration, 1999, HEALTH CARE FINANCIN; Kuo YF, 2011, ANN INTERN MED, V155, P152, DOI 10.7326/0003-4819-155-3-201108020-00005; Lemieux J, 2012, AM J MANAG CARE, V18, P96; Medicare Payment Advisory Commission, DAT BOOK HLTH CAR SP; Miller ME, MEDICARE POST ACUTE; Newhouse JP, 2013, JAMA-J AM MED ASSOC, V310, P1227, DOI 10.1001/jama.2013.278139; Rau J., NEARLY 1500 HOSPITAL	10	34	34	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 19	2014	311	7					673	674		10.1001/jama.2014.11	http://dx.doi.org/10.1001/jama.2014.11			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA8ZO	24549543				2022-12-28	WOS:000331383700015
J	Lang, E				Lang, Eddy			In out-of-hospital cardiac arrest, mechanical CPR did not improve survival compared with manual CPR	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Calgary, Calgary, AB, Canada	University of Calgary	Lang, E (corresponding author), Univ Calgary, Calgary, AB, Canada.		Lang, Eddy/AAS-2080-2020; Lang, Eddy/I-4759-2014	Lang, Eddy/0000-0003-0850-4337	Uppsala University and Physio-Control/Jolife AB	Uppsala University and Physio-Control/Jolife AB	Uppsala University and Physio-Control/Jolife AB.	Brooks SC, 2011, COCHRANE DB SYST REV, P1; Taniguchi D, 2012, EMERG MED CLIN N AM, V30, P1, DOI 10.1016/j.emc.2011.09.003; Westfall M, 2013, CRIT CARE MED, V41, P1782, DOI 10.1097/CCM.0b013e31828a24e3	3	0	0	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 18	2014	160	4							JC5	10.7326/0003-4819-160-4-201402180-02005	http://dx.doi.org/10.7326/0003-4819-160-4-201402180-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC8RF	24534939				2022-12-28	WOS:000350635100004
J	Manderscheid, R; Kathol, R				Manderscheid, Ron; Kathol, Roger			Fostering Sustainable, Integrated Medical and Behavioral Health Services in Medical Settings	ANNALS OF INTERNAL MEDICINE			English	Article							PRIMARY-CARE PHYSICIANS; MENTAL-HEALTH; COLLABORATIVE CARE; UNITED-STATES; OLDER-ADULTS; DEPRESSION; OUTCOMES; DISORDERS; ACCESS; PREVALENCE		[Manderscheid, Ron] Natl Assoc Cty Behav Hlth & Dev Disabil Directors, Washington, DC 20001 USA; Univ Minnesota, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities	Manderscheid, R (corresponding author), Natl Assoc Cty Behav Hlth & Dev Disabil Directors, 25 Massachusetts Ave NW,Suite 500, Washington, DC 20001 USA.	rmanderscheid@nacbhd.org						Archer J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006525.pub2; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bradford DW, 2008, PSYCHIAT SERV, V59, P847, DOI 10.1176/ps.2008.59.8.847; Bradshaw LE, 2013, AGE AGEING, V42, P582, DOI 10.1093/ageing/aft074; Colton Craig W, 2006, Prev Chronic Dis, V3, pA42; Cunningham PJ, 2009, HEALTH AFFAIR, V28, pW490, DOI 10.1377/hlthaff.28.3.w490; Druss Benjamin G, 2011, Synth Proj Res Synth Rep, P1; Druss BG, 2011, MED CARE, V49, P599, DOI 10.1097/MLR.0b013e31820bf86e; Goldberg SE, 2012, AGE AGEING, V41, P80, DOI 10.1093/ageing/afr106; Grembowski DE, 2002, J GEN INTERN MED, V17, P258, DOI 10.1046/j.1525-1497.2002.10321.x; Kathol R. G., 2010, INTEGRATED CASE MANA, V1st; Kathol RG, ANN FAM MED IN PRESS; Kathol RG, 2010, PSYCHOSOM MED, V72, P511, DOI 10.1097/PSY.0b013e3181e2c4a0; Katon WJ, 2008, J OCCUP ENVIRON MED, V50, P459, DOI 10.1097/JOM.0b013e318168efb7; Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955; Kessler RC, 2005, NEW ENGL J MED, V352, P2515, DOI 10.1056/NEJMsa043266; Melek S, 2012, DEPRESSION TREATMENT; Melek SP, 2013, EC IMPACT INTEGRATED; Patel V, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001448; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Seelig MD, 2008, J OCCUP ENVIRON MED, V50, P451, DOI 10.1097/JOM.0b013e318169cce4; Simon GE, 2010, PSYCHIAT SERV, V61, P684, DOI 10.1176/ps.2010.61.7.684; Summergrad P, 2011, PSYCHOSOMATICS, V52, P537, DOI 10.1016/j.psym.2011.08.006; Unutzer J, 2008, AM J MANAG CARE, V14, P95; Unutzer Jurgen, 2012, Am J Public Health, V102, pe41, DOI 10.2105/AJPH.2011.300555; Wang PS, 2007, LANCET, V370, P841, DOI 10.1016/S0140-6736(07)61414-7; Wang PS, 2005, ARCH GEN PSYCHIAT, V62, P629, DOI 10.1001/archpsyc.62.6.629; Wang PS, 2002, AM J PUBLIC HEALTH, V92, P92, DOI 10.2105/AJPH.92.1.92; Zuvekas SH, 2007, HEALTH AFFAIR, V26, P249, DOI 10.1377/hlthaff.26.1.249	29	50	50	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 7	2014	160	1					61	+		10.7326/M13-1693	http://dx.doi.org/10.7326/M13-1693			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	297IS	24573665				2022-12-28	WOS:000330249700008
J	Platt, R; Kass, NE; McGraw, D				Platt, Richard; Kass, Nancy E.; McGraw, Deven			Ethics, Regulation, and Comparative Effectiveness Research Time for a Change	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Platt, Richard] Harvard Pilgrim Hlth Care Inst, Boston, MA 02215 USA; [Platt, Richard] Harvard Univ, Sch Med, Boston, MA USA; [Kass, Nancy E.] Johns Hopkins Berman Inst Bioeth, Baltimore, MD USA; [Kass, Nancy E.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [McGraw, Deven] Ctr Democracy & Technol, Washington, DC USA	Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Platt, R (corresponding author), Harvard Pilgrim Hlth Care Inst, 133 Brookline Ave,Sixth Floor, Boston, MA 02215 USA.	richard_platt@harvard.edu						[Anonymous], NIGHTTIME DOSING OF; [Anonymous], DEMONSTRATION PROJEC; DHHS Office of the Secretary, 2011, FED REG         0726, V76, P44; Faden RR, 2013, HASTINGS CENT REP, V43, pS16, DOI 10.1002/hast.134; Huang SS, 2013, NEW ENGL J MED, V368, P2255, DOI 10.1056/NEJMoa1207290; Institute of Medicine (IOM), 2007, THE LEARNING HEALTHC; Kass N, 2012, JAMA-J AM MED ASSOC, V307, P1589, DOI 10.1001/jama.2012.491	7	54	54	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 16	2014	311	15					1497	1498		10.1001/jama.2014.2144	http://dx.doi.org/10.1001/jama.2014.2144			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE9DX	24626256				2022-12-28	WOS:000334306000015
J	Loehlin, DW; Carroll, SB				Loehlin, David W.; Carroll, Sean B.			EVOLUTIONARY BIOLOGY Sex, lies and butterflies	NATURE			English	Editorial Material								Variation in an evolutionarily conserved sexual-differentiation gene, doublesex, has been found to explain how females of one species of butterfly mimic the colour patterns of several toxic species to avoid predation.	[Loehlin, David W.; Carroll, Sean B.] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; [Loehlin, David W.; Carroll, Sean B.] Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Loehlin, DW (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA.	loehlin@wisc.edu; sbcarrol@wisc.edu						Bates H.W., 1862, T LINN SOC LOND, V23, P495; CLARKE CA, 1972, PHILOS T ROY SOC B, V263, P431, DOI 10.1098/rstb.1972.0006; Kopp A, 2012, TRENDS GENET, V28, P175, DOI 10.1016/j.tig.2012.02.002; Kunte K, 2014, NATURE, V507, P229, DOI 10.1038/nature13112; Loehlin DW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000821; Martin A, 2012, P NATL ACAD SCI USA, V109, P12632, DOI 10.1073/pnas.1204800109; Reed RD, 2011, SCIENCE, V333, P1137, DOI 10.1126/science.1208227; Robinett CC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000365; Tanaka K, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001131; Wallace A. R., 1864, T ENTOMOL SOC LOND, V2, P14	10	7	7	2	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2014	507	7491					172	173		10.1038/nature13066	http://dx.doi.org/10.1038/nature13066			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC6RJ	24598543				2022-12-28	WOS:000332651800023
J	Milo, A; Bess, EN; Sigman, MS				Milo, Anat; Bess, Elizabeth N.; Sigman, Matthew S.			Interrogating selectivity in catalysis using molecular vibrations	NATURE			English	Article							GAUSSIAN-BASIS SETS; INFRARED-SPECTRA; HECK ARYLATIONS; ATOMS LI; PARAMETERS	The delineation of molecular properties that underlie reactivity and selectivity is at the core of physical organic chemistry(1-5), and this knowledge can be used to inform the design of improved synthetic methods or identify new chemical transformations(6-9). For this reason, the mathematical representation of properties affecting reactivity and selectivity trends, that is, molecular parameters, is paramount. Correlations produced by equating these molecular parameters with experimental outcomes are often defined as free-energy relationships and can be used to evaluate the origin of selectivity and to generate new, experimentally testable hypotheses(6,10-12). The premise behind successful correlations of this type is that a systematically perturbed molecular property affects a transition-state interaction between the catalyst, substrate and any reaction components involved in the determination of selectivity(10,11). Classic physical organic molecular descriptors, such as Hammett(4), Taft(3) or Charton(5) parameters, seek to independently probe isolated electronic or steric effects(3-6,13,14). However, these parameters cannot address simultaneous, non-additive variations to more than one molecular property, which limits their utility. Here we report a parameter system based on the vibrational response of a molecule to infrared radiation that can be used to mathematically model and predict selectivity trends for reactions with interlinked steric and electronic effects at positions of interest. The disclosed parameter system is mechanistically derived and should find broad use in the study of chemical and biological systems.	[Milo, Anat; Bess, Elizabeth N.; Sigman, Matthew S.] Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Sigman, MS (corresponding author), Univ Utah, Dept Chem, 315 South 1400 E, Salt Lake City, UT 84112 USA.	sigman@chem.utah.edu	Bess, Elizabeth N/P-6570-2018; milo, anat/C-3255-2015	Bess, Elizabeth N/0000-0003-0349-0423; milo, anat/0000-0003-1552-8193	US National Science Foundation [CHE-0749506]; Center for High Performance Computing at the University of Utah; Division Of Chemistry [1110599] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); Center for High Performance Computing at the University of Utah; Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by the US National Science Foundation (CHE-0749506). We thank S.J. Miller and S. Yoganathan for discussions and for providing the peptide catalyst used in these studies. The support and resources of the Center for High Performance Computing at the University of Utah are gratefully acknowledged.	[Anonymous], 1995, DATA ANAL CHEM; [Anonymous], 2009, GAUSS 09 REV C 01; [Anonymous], 2012, MATLAB STUD VERS V 7; Anslyn E. V., 2006, MODERN PHYS ORGANIC; Baldi P., 2001, BIOINFORMATICS MACHI, P5; Benigni R, 2001, J CHEM INF COMP SCI, V41, P727, DOI 10.1021/ci000308+; Benigni R, 1999, J CHEM INF COMP SCI, V39, P558, DOI 10.1021/ci980223x; Bess E. N., 2012, ASYMMETRIC SYNTHESIS, P363; Bess EN, 2013, ORG LETT, V15, P646, DOI 10.1021/ol303465c; CHARTON M, 1975, J AM CHEM SOC, V97, P3694, DOI 10.1021/ja00846a023; CHARTON M, 1976, J ORG CHEM, V41, P2217, DOI 10.1021/jo00874a035; CHARTON M, 1975, J AM CHEM SOC, V97, P3691, DOI 10.1021/ja00846a022; CHARTON M, 1975, J AM CHEM SOC, V97, P1552, DOI 10.1021/ja00839a047; CHARTON M, 1960, CAN J CHEM, V38, P2493, DOI 10.1139/v60-338; CHARTON M, 1977, J ORG CHEM, V42, P2528, DOI 10.1021/jo00434a048; Coates J., 2000, ENCY ANAL CHEM, DOI DOI 10.1002/9780470027318.A5606; Curtin D. Y., 1954, REC CHEM PROG, V15, P110; Dearden J. C., 2006, SMITH WILLIAMS INTRO, P185; Draper NR., 1998, WILEY SERIES PROBABI, V3rd ed.; Dunitz JD, 2008, ANGEW CHEM INT EDIT, V47, P4208, DOI 10.1002/anie.200800063; Goodman S, 2008, SEMIN HEMATOL, V45, P135, DOI 10.1053/j.seminhematol.2008.04.003; Gustafson JL, 2010, ORG LETT, V12, P2794, DOI 10.1021/ol100927m; Hammett LP, 1935, CHEM REV, V17, P125, DOI 10.1021/cr60056a010; Hammett LP, 1937, J AM CHEM SOC, V59, P96, DOI 10.1021/ja01280a022; HANSCH C, 1991, CHEM REV, V91, P165, DOI 10.1021/cr00002a004; Harper KC, 2013, J ORG CHEM, V78, P2813, DOI 10.1021/jo4002239; Harper KC, 2013, J AM CHEM SOC, V135, P2482, DOI 10.1021/ja4001807; Harper KC, 2012, NAT CHEM, V4, P366, DOI [10.1038/nchem.1297, 10.1038/NCHEM.1297]; Harper KC, 2011, SCIENCE, V333, P1875, DOI 10.1126/science.1206997; JACOBSEN EN, 1991, J AM CHEM SOC, V113, P6703, DOI 10.1021/ja00017a069; JAFFE HH, 1953, CHEM REV, V53, P191, DOI 10.1021/cr60165a003; Jensen KH, 2010, J ORG CHEM, V75, P7194, DOI 10.1021/jo1013806; Mei TS, 2013, J AM CHEM SOC, V135, P6830, DOI 10.1021/ja402916z; Meyer MP, 2012, ADV PHYS ORG CHEM, V46, P57, DOI 10.1016/B978-0-12-398484-5.00002-X; Miller JJ, 2008, ANGEW CHEM INT EDIT, V47, P771, DOI 10.1002/anie.200704257; Peng CS, 2013, P NATL ACAD SCI USA, V110, P9243, DOI 10.1073/pnas.1303235110; Pino A, 2003, QSAR COMB SCI, V22, P191, DOI 10.1002/qsar.200390011; SCHAFER A, 1994, J CHEM PHYS, V100, P5829, DOI 10.1063/1.467146; SCHAFER A, 1992, J CHEM PHYS, V97, P2571, DOI 10.1063/1.463096; Shahlaei M, 2013, CHEM REV, V113, P8093, DOI 10.1021/cr3004339; Sigman MS, 2009, J ORG CHEM, V74, P7633, DOI 10.1021/jo901698t; TAFT RW, 1952, J AM CHEM SOC, V74, P3120, DOI 10.1021/ja01132a049; TAFT RW, 1953, J AM CHEM SOC, V75, P4538, DOI 10.1021/ja01114a044; Valero R, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2982923; Verloop A., 1983, PESTIC CHEM HUM WELF, P339; Verloop A., 1976, DRUG DESIGN, V3, P133; Verloop A., 1987, QSAR DRUG DESIGN TOX, P97; Verloop A., 1977, PHARMACOCHEM LIB, V2, P63; Werner EW, 2012, SCIENCE, V338, P1455, DOI 10.1126/science.1229208; Williams A, 2003, FREE ENERGY RELATION; Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x	51	95	96	3	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2014	507	7491					210	+		10.1038/nature13019	http://dx.doi.org/10.1038/nature13019			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC6RJ	24622199				2022-12-28	WOS:000332651800034
J	Daughtridge, GW; Archibald, T; Conway, PH				Daughtridge, Giffin W.; Archibald, Traci; Conway, Patrick H.			Quality Improvement of Care Transitions and the Trend of Composite Hospital Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Daughtridge, Giffin W.] Univ Penn, Philadelphia, PA 19104 USA; [Archibald, Traci; Conway, Patrick H.] Ctr Medicare & Medicaid Serv, Baltimore, MD 21244 USA; [Conway, Patrick H.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA	University of Pennsylvania; Centers for Medicare & Medicaid Services; Cincinnati Children's Hospital Medical Center	Conway, PH (corresponding author), Ctr Medicare & Medicaid Serv, Mailstop S3-02-01,7500 Secur Blvd, Baltimore, MD 21244 USA.	patrick.conway@cms.hhs.gov						Baier RR, 2013, AM J MANAG CARE, V19, P450; Baugh CW, 2013, NEW ENGL J MED, V369, P302, DOI 10.1056/NEJMp1304493; Brock J, 2013, JAMA-J AM MED ASSOC, V309, P381, DOI 10.1001/jama.2012.216607; Centers for Medicare & Medicaid Services (CMS), 2013, QUALITY IMPROVEMENT; Feng ZL, 2012, HEALTH AFFAIR, V31, P1251, DOI 10.1377/hlthaff.2012.0129	5	14	14	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2014	311	10					1013	1014		10.1001/jama.2014.509	http://dx.doi.org/10.1001/jama.2014.509			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC5QO	24618959				2022-12-28	WOS:000332575800015
J	Andrews, CD; Spreen, WR; Mohri, H; Moss, L; Ford, S; Gettie, A; Russell-Lodrigue, K; Bohm, RP; Cheng-Mayer, C; Hong, Z; Markowitz, M; Ho, DD				Andrews, Chasity D.; Spreen, William R.; Mohri, Hiroshi; Moss, Lee; Ford, Susan; Gettie, Agegnehu; Russell-Lodrigue, Kasi; Bohm, Rudolf P.; Cheng-Mayer, Cecilia; Hong, Zhi; Markowitz, Martin; Ho, David D.			Long-Acting Integrase Inhibitor Protects Macaques from Intrarectal Simian/Human Immunodeficiency Virus	SCIENCE			English	Article							ANTIRETROVIRAL-NAIVE ADULTS; ONCE-DAILY DOLUTEGRAVIR; HIV-1 INFECTION; DOUBLE-BLIND; PREEXPOSURE PROPHYLAXIS; RALTEGRAVIR; TRANSMISSION; PREVENTION; CHEMOPROPHYLAXIS; TENOFOVIR	GSK1265744 (GSK744) is an integrase strand-transfer inhibitor that has been formulated as a long-acting (LA) injectable suitable for monthly to quarterly clinical administration. GSK744 LA was administered at two time points 4 weeks apart beginning 1 week before virus administration, and macaques were challenged weekly for 8 weeks. GSK744 LA, at plasma concentrations achievable with quarterly injections in humans, protected all animals against repeated low-dose challenges. In a second experiment, macaques were given GSK744 LA 1 week before virus administration and challenged repeatedly until infection occurred. Protection decreased over time and correlated with the plasma drug levels. With a quarterly dosing schedule in humans, our results suggest that GSK744 LA could potentially decrease adherence problems associated with daily preexposure prophylaxis (PrEP).	[Andrews, Chasity D.; Mohri, Hiroshi; Gettie, Agegnehu; Cheng-Mayer, Cecilia; Markowitz, Martin; Ho, David D.] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA; [Spreen, William R.; Moss, Lee; Ford, Susan; Hong, Zhi] GlaxoSmithKline, Res Triangle Pk, NC 27709 USA; [Russell-Lodrigue, Kasi; Bohm, Rudolf P.] Tulane Natl Primate Res Ctr, Covington, LA 70433 USA	Rockefeller University; GlaxoSmithKline; Tulane University	Ho, DD (corresponding author), Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA.	dho@adarc.org	Russell-Lodrigue, Kasi E/G-7084-2016	Russell-Lodrigue, Kasi E/0000-0003-3719-0779	NIH [R0-AI100724, 1DP1-DA033263]; Tulane National Primate Research Center [2P51-OD11104-52]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI100724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA033263] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tulane National Primate Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded in part by NIH grants R0-AI100724 and 1DP1-DA033263 and Tulane National Primate Research Center grant 2P51-OD11104-52. We thank D. A. Margolis, A. Rinehart, J. C. Pottage Jr., Y. Huang, K. Meyers, and N. Padte for helpful discussions; J. Blanchard for veterinary services; M. Boente-Carrera, L. Tsai, and F. Yu for technical assistance; and G. Bowers, Y. L. Yueh, G. Tabolt, and P. Savina for PK, analytical, and statistical support. W. R. S., L. M., and S. F. are full-time employees of and hold shares in GlaxoSmithKline, Z.H. is a full-time employee of and holds shares in GlaxoSmithKline and serves on the ViiV Healthcare Board, and D. D. H. is a paid consultant to GlaxoSmithKline. The GenBank accession numbers for integrase sequences described in table S3 are KJ415285 to KJ415297.	Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Cahn P, 2013, LANCET, V382, P700, DOI 10.1016/S0140-6736(13)61221-0; Eron JJ, 2013, J INFECT DIS, V207, P740, DOI 10.1093/infdis/jis750; Garcia-Lerma JG, 2008, PLOS MED, V5, P291, DOI 10.1371/journal.pmed.0050028; Garcia-Lerma JG, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000391; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Johns BA, 2013, J MED CHEM, V56, P5901, DOI 10.1021/jm400645w; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Lou Y., 2013, 53 INT C ANT AG CHEM; Marrazzo J.M., 2015, C RETR OPP INF ATL M, P509; Moghimi SM, 2001, PHARMACOL REV, V53, P283; MORDENTI J, 1986, J PHARM SCI, V75, P1028, DOI 10.1002/jps.2600751104; Raffi F, 2013, LANCET INFECT DIS, V13, P927, DOI 10.1016/S1473-3099(13)70257-3; Raffi F, 2013, LANCET, V381, P735, DOI 10.1016/S0140-6736(12)61853-4; Spreen W, 2013, HIV CLIN TRIALS, V14, P192, DOI 10.1310/hct1405-192; Spreen W, 2012, 19 INT AIDS C WASH D; Spreen W., 2013, 7 INT AIDS SOC C HIV; Spreen WR, 2013, CURR OPIN HIV AIDS, V8, P565, DOI 10.1097/COH.0000000000000002; Stellbrink HJ, 2013, AIDS, V27, P1771, DOI 10.1097/QAD.0b013e3283612419; Subbarao S, 2007, J MED PRIMATOL, V36, P238, DOI 10.1111/j.1600-0684.2007.00241.x; Subbarao S, 2006, J INFECT DIS, V194, P904, DOI 10.1086/507306; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; UNAIDS, 2013, 2013 UNAIDS REP GLOB; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; van Lunzen J, 2012, LANCET INFECT DIS, V12, P111, DOI 10.1016/S1473-3099(11)70290-0; Walmsley SL, 2013, NEW ENGL J MED, V369, P1807, DOI 10.1056/NEJMoa1215541; Winner B, 2012, NEW ENGL J MED, V366, P1998, DOI 10.1056/NEJMoa1110855	29	119	138	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2014	343	6175					1151	1154		10.1126/science.1248707	http://dx.doi.org/10.1126/science.1248707			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2LB	24594934	Green Accepted			2022-12-28	WOS:000332331500052
J	Lee, JY; Yang, JG; Zhitnitsky, D; Lewinson, O; Rees, DC				Lee, Jonas Y.; Yang, Janet G.; Zhitnitsky, Daniel; Lewinson, Oded; Rees, Douglas C.			Structural Basis for Heavy Metal Detoxification by an Atm1-Type ABC Exporter	SCIENCE			English	Article							BINDING CASSETTE TRANSPORTER; CRYSTAL-STRUCTURE; P-GLYCOPROTEIN; GLUTATHIONE; MEMBRANE; CFTR; DISRUPTION; LOCALIZES; TOLERANCE; PROTEINS	Although substantial progress has been achieved in the structural analysis of exporters from the superfamily of adenosine triphosphate (ATP)-binding cassette (ABC) transporters, much less is known about how they selectively recognize substrates and how substrate binding is coupled to ATP hydrolysis. We have addressed these questions through crystallographic analysis of the Atm1/ABCB7/HMT1/ABCB6 ortholog from Novosphingobium aromaticivorans DSM 12444, NaAtm1, at 2.4 angstrom resolution. Consistent with a physiological role in cellular detoxification processes, functional studies showed that glutathione derivatives can serve as substrates for NaAtm1 and that its overexpression in Escherichia coli confers protection against silver and mercury toxicity. The glutathione binding site highlights the articulated design of ABC exporters, with ligands and nucleotides spanning structurally conserved elements to create adaptable interfaces accommodating conformational rearrangements during the transport cycle.	[Lee, Jonas Y.; Yang, Janet G.; Rees, Douglas C.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Lee, Jonas Y.; Yang, Janet G.; Rees, Douglas C.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Zhitnitsky, Daniel; Lewinson, Oded] Technion Israel Inst Technol, Fac Med, Rappaport Family Inst Res, Dept Microbiol, IL-32000 Haifa, Israel	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Rees, DC (corresponding author), CALTECH, Howard Hughes Med Inst, Mail Code 114-96, Pasadena, CA 91125 USA.	dcrees@caltech.edu	Yang, Janet/P-2003-2015; Zhitnitsky, Daniel/AAD-6639-2020	Zhitnitsky, Daniel/0000-0002-7360-7247	NIH [GM45162]; Gordon and Betty Moore Foundation; Beckman Institute; Sanofi-Aventis Bioengineering Research Program at Caltech; Office of Basic Energy Research; National Institute of General Medical Sciences [P41GM103393]; National Center for Research Resources [P41RR001209]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM045162, R01GM045162, P41GM103393] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Beckman Institute; Sanofi-Aventis Bioengineering Research Program at Caltech; Office of Basic Energy Research(United States Department of Energy (DOE)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH grant GM45162. We gratefully acknowledge the Gordon and Betty Moore Foundation, the Beckman Institute, and the Sanofi-Aventis Bioengineering Research Program at Caltech for their generous support of the Molecular Observatory at Caltech, and the staff at Beamline 12-2, Stanford Synchrotron Radiation Lightsource (SSRL), for their assistance with data collection. SSRL is operated for the U.S. Department of Energy and supported by its Office of Basic Energy Research and by National Institute of General Medical Sciences grant P41GM103393 and National Center for Research Resources grant P41RR001209. We thank G. Meloni, J. Kaiser, J. Hoy, R. Lill, S. Molik, I. Booth, S. Conway, and A. Laganowsky for stimulating discussions and providing reagents. Coordinates and structure factors have been deposited in the Protein Data Bank of the Research Collaboratory for Structural Bioinformatics, with IDs 4MRN, 4MRP, 4MRR, 4MRS, and 4MRV for NaAtm1 in apo form and in complexes with GSH, selenomethionine, GSSG, and GS-Hg, respectively.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Bekri S, 2000, BLOOD, V96, P3256; Chavan H, 2011, TOXICOL SCI, V120, P519, DOI 10.1093/toxsci/kfr008; Cotten JF, 1999, J BIOL CHEM, V274, P5429, DOI 10.1074/jbc.274.9.5429; Cui GY, 2013, J BIOL CHEM, V288, P20758, DOI 10.1074/jbc.M113.476226; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; FAHEY RC, 1991, ADV ENZYMOL RAMB, V64, P1; Grass G, 2001, J BACTERIOL, V183, P4664, DOI 10.1128/JB.183.15.4664-4667.2001; Herget M, 2009, J BIOL CHEM, V284, P33740, DOI 10.1074/jbc.M109.047779; Hohl M, 2012, NAT STRUCT MOL BIOL, V19, P395, DOI 10.1038/nsmb.2267; Holland I. B., 2003, ABC PROTEINS BACTERI; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; Kispal G, 1997, FEBS LETT, V418, P346, DOI 10.1016/S0014-5793(97)01414-2; Kiss K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037378; Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125; Kuhnke G, 2006, MOL MEMBR BIOL, V23, P173, DOI 10.1080/09687860500473630; Lewinson O, 2009, P NATL ACAD SCI USA, V106, P4677, DOI 10.1073/pnas.0900666106; Li JZ, 2014, PROTEIN SCI, V23, P34, DOI 10.1002/pro.2387; Lill R, 2001, RES MICROBIOL, V152, P331, DOI 10.1016/S0923-2508(01)01204-9; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; Masip L, 2006, ANTIOXID REDOX SIGN, V8, P753, DOI 10.1089/ars.2006.8.753; MEISTER A, 1988, J BIOL CHEM, V263, P17205; Paterson JK, 2007, BIOCHEMISTRY-US, V46, P9443, DOI 10.1021/bi700015m; Pittman MS, 2005, J BIOL CHEM, V280, P32254, DOI 10.1074/jbc.M503075200; Preveral S, 2009, J BIOL CHEM, V284, P4936, DOI 10.1074/jbc.M808130200; Qi WB, 2012, J AM CHEM SOC, V134, P10745, DOI 10.1021/ja302186j; Sauna ZE, 2004, J BIOL CHEM, V279, P48855, DOI 10.1074/jbc.M408849200; Screpanti E, 2007, J STRUCT BIOL, V159, P261, DOI 10.1016/j.jsb.2007.01.011; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Shintre CA, 2013, P NATL ACAD SCI USA, V110, P9710, DOI 10.1073/pnas.1217042110; Sooksa-Nguan T, 2009, J BIOL CHEM, V284, P354, DOI 10.1074/jbc.M806501200; Srinivasan V, 2014, SCIENCE, V343, P1137, DOI 10.1126/science.1246729; Tsuchida M, 2008, BIOCHEM BIOPH RES CO, V369, P369, DOI 10.1016/j.bbrc.2008.02.027; Vatamaniuk OK, 2005, J BIOL CHEM, V280, P23684, DOI 10.1074/jbc.M503362200; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Ye H, 2010, BIOCHEMISTRY-US, V49, P4945, DOI 10.1021/bi1004798; Zutz A, 2009, BBA-BIOENERGETICS, V1787, P681, DOI 10.1016/j.bbabio.2009.02.009	38	117	122	2	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2014	343	6175					1133	1136		10.1126/science.1246489	http://dx.doi.org/10.1126/science.1246489			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2LB	24604198	Green Accepted			2022-12-28	WOS:000332331500047
J	Clancy, CE; Xiang, YK				Clancy, Colleen E.; Xiang, Yang K.			BIOLOGICAL TECHNIQUES Wrapped around the heart	NATURE			English	Editorial Material									[Clancy, Colleen E.; Xiang, Yang K.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA	University of California System; University of California Davis	Clancy, CE (corresponding author), Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA.	ceclancy@ucdavis.edu						Jia ZH, 2011, CIRC-ARRHYTHMIA ELEC, V4, P753, DOI 10.1161/CIRCEP.111.964247; Luther S, 2011, NATURE, V475, P235, DOI 10.1038/nature10216; Xu LZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4329; Zhou X, 2012, METHOD ENZYMOL, V504, P317, DOI 10.1016/B978-0-12-391857-4.00016-1	4	0	0	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					43	44		10.1038/507043a	http://dx.doi.org/10.1038/507043a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0ZQ	24598634				2022-12-28	WOS:000332224400035
J	Schiebinger, L				Schiebinger, Londa			Scientific research must take gender into account	NATURE			English	Editorial Material									Stanford Univ, Stanford, CA 94305 USA	Stanford University	Schiebinger, L (corresponding author), Stanford Univ, Stanford, CA 94305 USA.	schieb@stanford.edu		Schiebinger, Londa/0000-0003-3438-3081					0	36	36	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					9	9		10.1038/507009a	http://dx.doi.org/10.1038/507009a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC0ZQ	24598604	Bronze			2022-12-28	WOS:000332224400014
J	Jones-Smith, JC; Dow, WH; Chichlowska, K				Jones-Smith, Jessica C.; Dow, William H.; Chichlowska, Kristal			Association Between Casino Opening or Expansion and Risk of Childhood Overweight and Obesity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PREVENTION; POVERTY; HEALTH; BMI	IMPORTANCE Economic resources have been inversely associated with risk of childhood overweight/obesity. Few studies have evaluated whether this association is a direct effect of economic resources or is attributable to unmeasured confounding or reverse causation. American Indian-owned casinos have resulted in increased economic resources for some tribes and provide an opportunity to test whether these resources are associated with overweight/obesity. OBJECTIVE To assess whether openings or expansions of American Indian-owned casinos were associated with childhood overweight/obesity risk. DESIGN, SETTING, AND PARTICIPANTS We used repeated cross-sectional anthropometric measurements from fitness testing of American Indian children (aged 7-18 years) from 117 school districts that encompassed tribal lands in California between 2001 and 2012. Children in school districts encompassing American Indian tribal lands that either gained or expanded a casino were compared with children in districts with tribal lands that did not gain or expand a casino. MAIN OUTCOMES AND MEASURES Per capita annual income, median annual household income, percentage of population in poverty, total population, child overweight/obesity (body mass index [BMI] >= 85th age- and sex-specific percentile) and BMI z score. RESULTS Of the 117 school districts, 57 gained or expanded a casino, 24 had a preexisting casino but did not expand, and 36 never had a casino. The mean slots per capita was 7 (SD, 12) and the median was 3 (interquartile range [IQR], 0.3-8). Among districts where a casino opened or expanded, the mean change in slots per capita was 13 (SD, 19) and the median was 3 (IQR, 1-11). Forty-eight percent of the anthropometric measurements were classified as overweight/obese (11 048/22 863). Every casino slot machine per capita gained was associated with an increase in per capita annual income (beta = $541; 95% CI, $245-$836) and a decrease in percentage in poverty (beta = -0.6%; 95% CI, -1.1% to -0.20%) among American Indians living on tribal lands. Among American Indian children, every slot machine per capita gained was associated with a decreased probability of overweight/obesity by 0.19 percentage points (95% CI, -0.26 to -0.11 percentage points) and a decrease in BMI z score (beta = -0.003; 95% CI, -0.005 to -0.0002). CONCLUSIONS AND RELEVANCE In this study, opening or expanding a casino was associated with increased economic resources and decreased risk of childhood overweight/obesity. Given the limitations of an ecological study, further research is needed to better understand the mechanisms behind this association.	[Jones-Smith, Jessica C.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth Human Nutr, Baltimore, MD 21218 USA; [Dow, William H.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of California System; University of California Berkeley	Jones-Smith, JC (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, 615 N Wolfe St,Room E2545, Baltimore, MD 21218 USA.	jjoness@jhsph.edu		Jones-Smith, Jessica/0000-0001-8962-1695; Dow, William/0000-0002-4080-1668	National Institute of Child Health and Human Development [K99 HD073327]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K99HD073327, R24HD042854, R00HD073327] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding for this project was provided by grant K99 HD073327 from the National Institute of Child Health and Human Development.	Akee R, 2013, AM ECON J-APPL ECON, V5, P1, DOI 10.1257/app.5.2.1; Angeles G, 2005, SOCIOL METHOD RES, V34, P76, DOI 10.1177/0049124104273069; Barlow SE, 2007, PEDIATRICS, V120, pS164, DOI 10.1542/peds.2007-2329C; Branas CC, 2011, AM J EPIDEMIOL, V174, P1296, DOI 10.1093/aje/kwr273; Bruckner TA, 2011, INT J EPIDEMIOL, V40, P1083, DOI 10.1093/ije/dyr073; Caballero B, 2003, AM J CLIN NUTR, V78, P1030, DOI 10.1093/ajcn/78.5.1030; California Department of Education, CAL PHYS FITN TEST M; California Department of Education, PFT RES; California Gambling Control Commission, RAT TRIB STAT GAM CO; Cheung YB, 2007, AM J EPIDEMIOL, V166, P1337, DOI 10.1093/aje/kwm223; Costello EJ, 2003, JAMA-J AM MED ASSOC, V290, P2023, DOI 10.1001/jama.290.15.2023; Economos CD, 2013, PREV MED, V57, P322, DOI 10.1016/j.ypmed.2013.06.001; Evans W, 2006, IMPACT LOCAL LABOR M; Evans WN, 2002, 9198 NBER; Fernald LCH, 2008, LANCET, V371, P828, DOI 10.1016/S0140-6736(08)60382-7; Freedman DS, 2009, PEDIATRICS, V124, pS23, DOI 10.1542/peds.2008-3586E; Gelman A., 2007, DATA ANAL USING REGR; Grow HMG, 2010, SOC SCI MED, V71, P584, DOI 10.1016/j.socscimed.2010.04.018; Hruschka DJ, 2012, AM J HUM BIOL, V24, P277, DOI 10.1002/ajhb.22231; Johnston LD, 2013, SCH POLICIES PRACTIC; Kim DH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059316, 10.1371/journal.pone.0070684]; Lakdawalla D., 2002, NBER WORKING PAPERS, V8946; Ludwig J, 2011, NEW ENGL J MED, V365, P1509, DOI 10.1056/NEJMsa1103216; Madsen KA, 2010, PEDIATRICS, V126, P434, DOI 10.1542/peds.2009-3411; Martin J, 2006, IMPACT ANAL TRIBAL G; Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x; Singh GK, 2010, ANN EPIDEMIOL, V20, P40, DOI 10.1016/j.annepidem.2009.09.008; US Census Bureau, GEOGR TIGER LIN SHAP; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wolfe B, 2012, DEMOGRAPHY, V49, P499, DOI 10.1007/s13524-012-0098-8	30	17	17	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2014	311	9					929	936		10.1001/jama.2014.604	http://dx.doi.org/10.1001/jama.2014.604			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AC0FS	24595777	Bronze, Green Accepted			2022-12-28	WOS:000332170800021
J	Daeron, M				Daeron, Marc			Signaling Shifts in Allergy Responses	SCIENCE			English	Editorial Material							MAST-CELL DEGRANULATION; ACTIVATION; SHIP; IGE		[Daeron, Marc] Inst Pasteur, F-75015 Paris, France; [Daeron, Marc] Ctr Immunol Marseille Luminy, F-13009 Marseille, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Daeron, M (corresponding author), Inst Pasteur, F-75015 Paris, France.	daeron@pasteur.fr						Gimborn K, 2005, J IMMUNOL, V174, P507, DOI 10.4049/jimmunol.174.1.507; Gottschalk RA, 2012, P NATL ACAD SCI USA, V109, P881, DOI 10.1073/pnas.1119763109; Huber M, 1998, P NATL ACAD SCI USA, V95, P11330, DOI 10.1073/pnas.95.19.11330; Liu ZJ, 2001, P NATL ACAD SCI USA, V98, P7289, DOI 10.1073/pnas.121171998; Malbec O, 2004, J IMMUNOL, V173, P5086, DOI 10.4049/jimmunol.173.8.5086; Parravicini V, 2002, NAT IMMUNOL, V3, P741, DOI 10.1038/ni817; Rivera J, 2005, TRENDS IMMUNOL, V26, P119, DOI 10.1016/j.it.2005.01.001; Suzuki R, 2014, SCIENCE, V343, P1021, DOI 10.1126/science.1246976; Torigoe C, 1998, SCIENCE, V281, P568, DOI 10.1126/science.281.5376.568; Tsourkas PK, 2012, CELL MOL IMMUNOL, V9, P62, DOI 10.1038/cmi.2011.29; Zhu MH, 2004, J EXP MED, V200, P991, DOI 10.1084/jem.20041223	11	1	1	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2014	343	6174					982	983		10.1126/science.1251425	http://dx.doi.org/10.1126/science.1251425			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2DZ	24578573				2022-12-28	WOS:000332309600032
J	Xu, TD; Dai, N; Chen, JS; Nagawa, S; Cao, M; Li, HJ; Zhou, ZM; Chen, X; De Rycke, R; Rakusova, H; Wang, WY; Jones, AM; Friml, J; Patterson, SE; Bleecker, AB; Yang, ZB				Xu, Tongda; Dai, Ning; Chen, Jisheng; Nagawa, Shingo; Cao, Min; Li, Hongjiang; Zhou, Zimin; Chen, Xu; De Rycke, Riet; Rakusova, Hana; Wang, Wuyi; Jones, Alan M.; Friml, Jiri; Patterson, Sara E.; Bleecker, Anthony B.; Yang, Zhenbiao			Cell Surface ABP1-TMK Auxin-Sensing Complex Activates ROP GTPase Signaling	SCIENCE			English	Article							BOX PROTEIN TIR1; BINDING PROTEIN-1; PLASMA-MEMBRANE; ARABIDOPSIS ROOTS; RECEPTOR; EXPANSION; ENDOCYTOSIS; DIVISION; PATHWAY; TOBACCO	Auxin-binding protein 1 (ABP1) was discovered nearly 40 years ago and was shown to be essential for plant development and morphogenesis, but its mode of action remains unclear. Here, we report that the plasma membrane-localized transmembrane kinase (TMK) receptor-like kinases interact with ABP1 and transduce auxin signal to activate plasma membrane-associated ROPs [Rho-like guanosine triphosphatases (GTPase) from plants], leading to changes in the cytoskeleton and the shape of leaf pavement cells in Arabidopsis. The interaction between ABP1 and TMK at the cell surface is induced by auxin and requires ABP1 sensing of auxin. These findings show that TMK proteins and ABP1 form a cell surface auxin perception complex that activates ROP signaling pathways, regulating nontranscriptional cytoplasmic responses and associated fundamental processes.	[Xu, Tongda; Chen, Jisheng; Nagawa, Shingo; Li, Hongjiang; Yang, Zhenbiao] Univ Calif Riverside, Dept Bot & Plant Sci, Ctr Plant Cell Biol, Riverside, CA 92521 USA; [Xu, Tongda; Cao, Min; Zhou, Zimin] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117604, Singapore; [Xu, Tongda; Nagawa, Shingo; Wang, Wuyi; Yang, Zhenbiao] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Ctr Plant Stress Biol, Shanghai 200032, Peoples R China; [Dai, Ning; Bleecker, Anthony B.] Univ Wisconsin, Dept Bot, Madison, WI 53706 USA; [Li, Hongjiang; Chen, Xu; De Rycke, Riet; Rakusova, Hana; Friml, Jiri] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Li, Hongjiang; Chen, Xu; De Rycke, Riet; Rakusova, Hana; Friml, Jiri] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9052 Ghent, Belgium; [Li, Hongjiang; Chen, Xu; Rakusova, Hana; Friml, Jiri] IST Austria, A-3400 Klosterneuburg, Austria; [Wang, Wuyi; Patterson, Sara E.] Univ Wisconsin, Dept Hort, Madison, WI 53706 USA; [Jones, Alan M.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Jones, Alan M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Friml, Jiri] Masaryk Univ, CEITEC MU, Mendel Ctr Plant Genom & Prote, CZ-62500 Brno, Czech Republic; [Yang, Zhenbiao] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Plant Physiol & Ecol, Shanghai 200032, Peoples R China	University of California System; University of California Riverside; National University of Singapore; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Wisconsin System; University of Wisconsin Madison; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Institute of Science & Technology - Austria; University of Wisconsin System; University of Wisconsin Madison; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Masaryk University Brno; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Yang, ZB (corresponding author), Univ Calif Riverside, Dept Bot & Plant Sci, Ctr Plant Cell Biol, Riverside, CA 92521 USA.	yang@ucr.edu	Xu, Tongda/ABD-9589-2020; Friml, Jiri/D-9511-2012	Friml, Jiri/0000-0002-8302-7596; Chen, Xu/0000-0002-5166-083X; Li, Hongjiang/0000-0001-5039-9660; Xu, Tongda/0000-0003-3398-9217	U.S. National Institute of General Medical Sciences [GM081451, GM065989]; European Research Council [ERC-2011-StG-20101109-PSDP]; CEITEC - Central European Institute of Technology [CZ.1.05/1.1.00/02.0068]; University of Wisconsin HATCH; Agency for Innovation by Science and Technology (IWT); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100130, R01GM081451, R01GM065989] Funding Source: NIH RePORTER	U.S. National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); European Research Council(European Research Council (ERC)European Commission); CEITEC - Central European Institute of Technology; University of Wisconsin HATCH; Agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to X. Chen, N. Raikhel, V. Gonehal, and members of the Yang laboratory for their stimulating discussion and critical comments on this manuscript. This work is supported by grants from the U.S. National Institute of General Medical Sciences to Z.Y. (GM081451) and A.M.J. (GM065989), the European Research Council (project ERC-2011-StG-20101109-PSDP) and CEITEC - Central European Institute of Technology (CZ.1.05/1.1.00/02.0068) to J.F., and University of Wisconsin HATCH support to S. E. P. Requests for tmk mutant seeds described in this work must be sent to N. D. (ning@molbio.mgh.harvard.edu). Predoctoral fellowship from the Agency for Innovation by Science and Technology (IWT) to H.R.	Badescu GO, 2006, TRENDS PLANT SCI, V11, P217, DOI 10.1016/j.tplants.2006.03.001; Braun N, 2008, PLANT CELL, V20, P2746, DOI 10.1105/tpc.108.059048; Chen JG, 2001, PLANT J, V28, P607, DOI 10.1046/j.1365-313x.2001.01152.x; Chen JG, 2001, GENE DEV, V15, P902, DOI 10.1101/gad.866201; Chen X, 2012, CURR BIOL, V22, P1326, DOI 10.1016/j.cub.2012.05.020; Dai N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060990; Dharmasiri N, 2005, NATURE, V435, P441, DOI 10.1038/nature03543; DIEKMANN W, 1995, P NATL ACAD SCI USA, V92, P3425, DOI 10.1073/pnas.92.8.3425; Effendi Y, 2011, PLANT J, V65, P282, DOI 10.1111/j.1365-313X.2010.04420.x; Fu Y, 2005, CELL, V120, P687, DOI 10.1016/j.cell.2004.12.026; Fu Y, 2009, CURR BIOL, V19, P1827, DOI 10.1016/j.cub.2009.08.052; JONES AM, 1993, PLANT PHYSIOL, V101, P595, DOI 10.1104/pp.101.2.595; Jones AM, 1998, SCIENCE, V282, P1114, DOI 10.1126/science.282.5391.1114; JONES AM, 1994, ANNU REV PLANT PHYS, V45, P393, DOI 10.1146/annurev.pp.45.060194.002141; Kepinski S, 2005, NATURE, V435, P446, DOI 10.1038/nature03542; KLAMBT D, 1990, PLANT MOL BIOL, V14, P1045, DOI 10.1007/BF00019401; Leblanc N, 1999, J BIOL CHEM, V274, P28314, DOI 10.1074/jbc.274.40.28314; Lin DS, 2012, CURR BIOL, V22, P1319, DOI 10.1016/j.cub.2012.05.019; Mockaitis K, 2008, ANNU REV CELL DEV BI, V24, P55, DOI 10.1146/annurev.cellbio.23.090506.123214; Nagawa S, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001299; OLIVER SC, 1995, PLANTA, V197, P465, DOI 10.1007/BF00196668; RAY PM, 1977, PLANT PHYSIOL, V59, P357, DOI 10.1104/pp.59.3.357; Robert S, 2010, CELL, V143, P111, DOI 10.1016/j.cell.2010.09.027; Shi JH, 2011, MOL PLANT, V4, P635, DOI 10.1093/mp/ssr050; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; TIAN HC, 1995, J BIOL CHEM, V270, P26962, DOI 10.1074/jbc.270.45.26962; Tromas A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3496; Tromas A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006648; Xu TD, 2010, CELL, V143, P99, DOI 10.1016/j.cell.2010.09.003; Yang ZB, 2008, ANNU REV CELL DEV BI, V24, P551, DOI 10.1146/annurev.cellbio.23.090506.123233	30	186	206	13	201	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2014	343	6174					1025	1028		10.1126/science.1245125	http://dx.doi.org/10.1126/science.1245125			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2DZ	24578577	Green Submitted, Green Accepted			2022-12-28	WOS:000332309600046
J	Furst, MA; McMahon, DP; Osborne, JL; Paxton, RJ; Brown, MJF				Fuerst, M. A.; McMahon, D. P.; Osborne, J. L.; Paxton, R. J.; Brown, M. J. F.			Disease associations between honeybees and bumblebees as a threat to wild pollinators	NATURE			English	Article							DEFORMED-WING-VIRUS; EMERGING INFECTIOUS-DISEASES; APIS-MELLIFERA; VARROA-DESTRUCTOR; NOSEMA-CERANAE; BOMBUS-TERRESTRIS; BEES; PATHOGEN; HEALTH; BIODIVERSITY	Emerging infectious diseases (EIDs) pose a risk to human welfare, both directly(1) and indirectly, by affecting managed livestock and wildlife that provide valuable resources and ecosystem services, such as the pollination of crops(2). Honeybees (Apis mellifera), the prevailing managed insect crop pollinator, suffer from a range of emerging and exotic high-impact pathogens(3,4), and population maintenance requires active management by beekeepers to control them. Wild pollinators such as bumblebees (Bombus spp.) are in global decline(5,6), one cause of which may be pathogen spillover from managed pollinators like honeybees(7,8) or commercial colonies of bumblebees(9). Here we use a combination of infection experiments and landscape-scale field data to show that honeybee EIDs are indeed widespread infectious agents within the pollinator assemblage. The prevalence of deformed wing virus (DWV) and the exotic parasite Nosema ceranae in honeybees and bumblebees is linked; as honeybees have higher DWV prevalence, and sympatric bumblebees and honeybees are infected by the same DWV strains, Apis is the likely source of at least one major EID in wild pollinators. Lessons learned from vertebrates(10,11) highlight the need for increased pathogen control in managed bee species to maintain wild pollinators, as declines in native pollinators may be caused by interspecies pathogen transmission originating from managed pollinators.	[Fuerst, M. A.; Brown, M. J. F.] Royal Holloway Univ London, Sch Biol Sci, Egham TW20 0EX, Surrey, England; [Fuerst, M. A.] IST Austria Inst Sci & Technol Austria, A-3400 Klosterneuburg, Austria; [McMahon, D. P.; Paxton, R. J.] Queens Univ Belfast, Sch Biol Sci, Belfast BT9 7BL, Antrim, North Ireland; [Osborne, J. L.] Rothamsted Res, Dept Agroecol, Harpenden AL5 2JQ, Herts, England; [Osborne, J. L.] Univ Exeter, Environm & Sustainabil Inst, Penryn TR10 9EZ, Cornwall, England; [Paxton, R. J.] Univ Halle Wittenberg, Inst Biol Gen Zool, D-06120 Halle, Saale, Germany; [Paxton, R. J.] German Ctr Integrat Biodivers Res iDiv, D-04103 Leipzig, Germany	University of London; Royal Holloway University London; Institute of Science & Technology - Austria; Queens University Belfast; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of Exeter; Martin Luther University Halle Wittenberg	Furst, MA (corresponding author), Royal Holloway Univ London, Sch Biol Sci, Bourne Bldg, Egham TW20 0EX, Surrey, England.	Apocrite@gmail.com	McMahon, Dino/S-2620-2019; Osborne, Juliet L/I-6776-2012; Paxton, Robert John/D-7082-2015; McMahon, Dino P/F-7006-2012; Fuerst, Matthias/J-8479-2014	McMahon, Dino/0000-0003-1119-5299; Paxton, Robert John/0000-0003-2517-1351; McMahon, Dino P/0000-0003-1119-5299; Fuerst, Matthias/0000-0002-3712-925X	Insect Pollinators Initiative; Biotechnology and Biological Sciences Research Council; Department for Environment, Food and Rural Affairs; Natural Environment Research Council; Scottish Government; Wellcome Trust [BB/I000151/1, BB/I000100/1, BB/I000097/1]; BBSRC [BB/I000097/2, BB/I000151/1, BB/I000097/1, BB/I000100/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I000100/1, BB/I000097/2, BB/I000097/1, BB/I000151/1] Funding Source: researchfish	Insect Pollinators Initiative; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Scottish Government; Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors are grateful to E. Furst for technical support and R. J. Gill for discussions. We thank C. Jones, G. Baron and O. Ramos-Rodriguez for comments on previous versions of the manuscript. They also thank Hymettus Ltd for help with the field collections, K. Liu for help in the laboratory and B. McCrea and S. Baldwin for technical help in the bee laboratory. The study was supported by the Insect Pollinators Initiative (funded jointly by the Biotechnology and Biological Sciences Research Council, the Department for Environment, Food and Rural Affairs, the Natural Environment Research Council, The Scottish Government and The Wellcome Trust, under the Living with Environmental Change Partnership: grants BB/I000151/1 (M. J. F. B.), BB/I000100/1 (R. J. P.) and BB/I000097/1 (J.L.O.).	Alderman DJ, 1996, REV SCI TECH OIE, V15, P603, DOI 10.20506/rst.15.2.943; [Anonymous], 2011, CYBERGEO; [Anonymous], 2012, EPIR R PACK AN EP DA; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bailey L., 1991, HONEY BEE PATHOLOGY; Bates D, 2012, LME4 LINEAR MIXED EF; Binder S, 1999, SCIENCE, V284, P1311, DOI 10.1126/science.284.5418.1311; Blaker H, 2000, CAN J STAT, V28, P783, DOI 10.2307/3315916; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Chen Y, 2008, J INVERTEBR PATHOL, V97, P186, DOI 10.1016/j.jip.2007.07.010; COLE RJ, 1970, J INVERTEBR PATHOL, V15, P193, DOI 10.1016/0022-2011(70)90233-8; Craggs JK, 2001, J VIROL METHODS, V94, P111, DOI 10.1016/S0166-0934(01)00281-6; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; de Bruyn M, 2013, SYST BIOL, V62, P398, DOI 10.1093/sysbio/syt007; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS48, DOI 10.1016/j.jip.2009.06.012; Dobson A, 2004, AM NAT, V164, pS64, DOI 10.1086/424681; Donnelly CA, 2012, NATURE, V485, P582, DOI 10.1038/485582a; Evison SEF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030641; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Genersch E, 2006, J INVERTEBR PATHOL, V91, P61, DOI 10.1016/j.jip.2005.10.002; Genersch E, 2005, VET J, V169, P121, DOI 10.1016/j.tvjl.2004.01.004; GITTLEMAN JL, 1990, SYST ZOOL, V39, P227, DOI 10.2307/2992183; Graystock P, 2013, J APPL ECOL, V50, P1207, DOI 10.1111/1365-2664.12134; Graystock P, 2013, J INVERTEBR PATHOL, V114, P114, DOI 10.1016/j.jip.2013.06.005; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Higes M, 2008, J INVERTEBR PATHOL, V97, P76, DOI 10.1016/j.jip.2007.06.002; Hornakova D, 2010, ANAL BIOCHEM, V397, P118, DOI 10.1016/j.ab.2009.09.019; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Krebs J., 1997, PB3423 HMSO; Martin SJ, 2012, SCIENCE, V336, P1304, DOI 10.1126/science.1220941; Meeus I, 2011, CONSERV BIOL, V25, P662, DOI 10.1111/j.1523-1739.2011.01707.x; Moore J, 2011, J GEN VIROL, V92, P156, DOI 10.1099/vir.0.025965-0; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; Murray TE, 2008, CONSERV GENET, V9, P653, DOI 10.1007/s10592-007-9394-z; Murray TE, 2013, BIOL CONSERV, V159, P269, DOI 10.1016/j.biocon.2012.10.021; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Oldroyd BP, 1999, TRENDS ECOL EVOL, V14, P312, DOI 10.1016/S0169-5347(99)01613-4; Ongus JR, 2004, J GEN VIROL, V85, P3747, DOI 10.1099/vir.0.80470-0; Otterstatter MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002771; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paxton RJ, 2010, J APICULT RES, V49, P80, DOI 10.3896/IBRA.1.49.1.11; R Foundation for Statistical Computing, R LANG ENV STAT COMP; Rambaut A, 2009, TRACER V1 5; Ratnieks FLW, 2010, SCIENCE, V327, P152, DOI 10.1126/science.1185563; Reiczigel J, 2010, EPIDEMIOL INFECT, V138, P1674, DOI 10.1017/S0950268810000385; ROSSI RE, 1992, ECOL MONOGR, V62, P277, DOI 10.2307/2937096; Schielzeth H, 2010, METHODS ECOL EVOL, V1, P103, DOI 10.1111/j.2041-210X.2010.00012.x; Singh R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014357; Smart MD, 2012, J INVERTEBR PATHOL, V109, P148, DOI 10.1016/j.jip.2011.09.009; Therneau T, 2012, COXME MIXED EFFECTS; Vanbergen AJ, 2013, FRONT ECOL ENVIRON, V11, P251, DOI 10.1890/120126; Vitousek PM, 1996, AM SCI, V84, P468; Williams PH, 2009, APIDOLOGIE, V40, P367, DOI 10.1051/apido/2009025; Xie WG, 2011, SYST BIOL, V60, P150, DOI 10.1093/sysbio/syq085; Yanez O, 2012, APIDOLOGIE, V43, P17, DOI 10.1007/s13592-011-0088-7; Yue C, 2005, J GEN VIROL, V86, P3419, DOI 10.1099/vir.0.81401-0	56	402	414	25	654	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 20	2014	506	7488					364	+		10.1038/nature12977	http://dx.doi.org/10.1038/nature12977			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB0JL	24553241	Green Accepted			2022-12-28	WOS:000331477800040
J	Smith, MB; Kelly, C; Alm, EJ				Smith, Mark B.; Kelly, Colleen; Alm, Eric J.			How to regulate faecal transplants	NATURE			English	Editorial Material							MICROBIOTA TRANSPLANTATION; CLOSTRIDIUM-DIFFICILE		[Smith, Mark B.; Alm, Eric J.] MIT, Cambridge, MA 02139 USA; [Smith, Mark B.] OpenBiome, Cambridge, MA USA; [Kelly, Colleen] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA	Massachusetts Institute of Technology (MIT); Brown University	Smith, MB (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ejalm@mit.edu			NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; EISEMAN B, 1958, SURGERY, V44, P854; Evans JM, 2013, J ENDOCRINOL, V218, pR37, DOI 10.1530/JOE-13-0131; Kassam Z, 2013, AM J GASTROENTEROL, V108, P500, DOI 10.1038/ajg.2013.59; Lawley TD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002995; Petrof EO, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-3; Riduara V. K., 2013, SCIENCE; Smits LP, 2013, GASTROENTEROLOGY, V145, P946, DOI 10.1053/j.gastro.2013.08.058; van Nood E, 2014, CURR OPIN GASTROEN, V30, P34, DOI 10.1097/MOG.0000000000000024; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037	10	90	123	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 20	2014	506	7488					290	291		10.1038/506290a	http://dx.doi.org/10.1038/506290a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB0JL	24558658	Bronze			2022-12-28	WOS:000331477800015
J	Feikin, DR; Scott, JAG; Gessner, BD				Feikin, Daniel R.; Scott, J. Anthony G.; Gessner, Bradford D.			Use of vaccines as probes to define disease burden	LANCET			English	Review							INFLUENZAE TYPE-B; PNEUMOCOCCAL CONJUGATE VACCINE; RTS,S/AS01 MALARIA VACCINE; PLACEBO-CONTROLLED-TRIAL; STANDARDIZED INTERPRETATION; STREPTOCOCCUS-PNEUMONIAE; DEVELOPING-COUNTRIES; CHEST RADIOGRAPHS; ROTAVIRUS VACCINE; RANDOMIZED-TRIAL	Vaccine probe studies have emerged in the past 15 years as a useful way to characterise disease. By contrast, traditional studies of vaccines focus on defining the vaccine effectiveness or efficacy. The underlying basis for the vaccine probe approach is that the difference in disease burden between vaccinated and unvaccinated individuals can be ascribed to the vaccine-specific pathogen. Vaccine probe studies can increase understanding of a vaccine's public health value. For instance, even when a vaccine has a seemingly low efficacy, a high baseline disease incidence can lead to a large vaccine-preventable disease burden and thus that population-based vaccine introduction would be justified. So far, vaccines have been used as probes to characterise disease syndromes caused by Haemophilus influenzae type b, pneumococcus, rotavirus, and early infant influenza. However, vaccine probe studies have enormous potential and could be used more widely in epidemiology, for example, to define the vaccine-preventable burden of malaria, typhoid, paediatric influenza, and dengue, and to identify causal interactions between different pathogens.	[Feikin, Daniel R.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Int Vaccine Access Ctr, Baltimore, MD 21205 USA; [Feikin, Daniel R.] Ctr Dis Control & Prevent, Div Preparedness & Emerging Infect, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Scott, J. Anthony G.] KEMRI Wellcome Trust Res Programme, Kilifi, Kenya; [Scott, J. Anthony G.] London Sch Hyg & Trop Med, London WC1, England; [Gessner, Bradford D.] Agence Med Prevent, Ferney Voltaire, France	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Centers for Disease Control & Prevention - USA; University of London; London School of Hygiene & Tropical Medicine; Agence de Medecine Preventive	Feikin, DR (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Int Vaccine Access Ctr, Baltimore, MD 21205 USA.	dfeikin@jhsph.edu			The Wellcome Trust [098532]	The Wellcome Trust(Wellcome TrustEuropean Commission)	JAGS is supported by a research fellowship from The Wellcome Trust (098532). The findings and conclusions in this Review are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.	Aaby P, 2011, HUM VACCINES, V7, P120, DOI 10.4161/hv.7.1.13848; Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; [Anonymous], 2009, WKLY EPIDEMIOL REC; Armah GE, 2010, LANCET, V376, P606, DOI 10.1016/S0140-6736(10)60889-6; Arnoux S, 2007, VACCINE, V25, P7720, DOI 10.1016/j.vaccine.2007.08.063; BALE JR, 1990, REV INFECT DIS, V12, pS861; BENNETT JV, 2002, HAEMOPHILUS INFLUENZ; Black S, 2000, PEDIATR INFECT DIS J, V19, P187, DOI 10.1097/00006454-200003000-00003; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P893; Cherian T, 2005, B WORLD HEALTH ORGAN, V83, P353; Cheung YB, 2010, STAT MED, V29, P328, DOI 10.1002/sim.3783; Cunnington AJ, 2012, NAT MED, V18, P120, DOI 10.1038/nm.2601; Cutts FT, 2005, LANCET, V365, P1139, DOI 10.1016/S0140-6736(05)71876-6; Dagan R, 2009, ADV EXP MED BIOL, V634, P69, DOI 10.1007/978-0-387-79838-7_7; Daza P, 2006, VACCINE, V24, P6232, DOI 10.1016/j.vaccine.2006.05.076; Eskola J, 2001, NEW ENGL J MED, V344, P403, DOI 10.1056/NEJM200102083440602; Feikin DR, 2012, VACCINE, V30, pA52, DOI 10.1016/j.vaccine.2011.08.043; Ferdinands JM, 2013, EPIDEMIOLOGY, V24, P530, DOI 10.1097/EDE.0b013e3182953065; Gessner BD, 2005, LANCET, V365, P43, DOI 10.1016/S0140-6736(04)17664-2; Gessner BD, 2008, PEDIATR INFECT DIS J, V27, P438, DOI 10.1097/INF.0b013e318165f1ba; Gessner BD, 2013, VACCINE, V31, P3222, DOI 10.1016/j.vaccine.2013.05.017; Goldblatt D, 2005, J INFECT DIS, V192, P387, DOI 10.1086/431524; Gupta M, 2010, INDIAN J MED RES, V131, P649; Hament JM, 1999, FEMS IMMUNOL MED MIC, V26, P189, DOI 10.1111/j.1574-695X.1999.tb01389.x; Hansen J, 2006, PEDIATR INFECT DIS J, V25, P779, DOI 10.1097/01.inf.0000232706.35674.2f; Klugman KP, 2007, SCIENCE, V316, P49; Klugman KP, 2003, NEW ENGL J MED, V349, P1341, DOI 10.1056/NEJMoa035060; Lagos R, 1996, PEDIATR INFECT DIS J, V15, P216, DOI 10.1097/00006454-199603000-00008; Leino T, 2012, VACCINE, V31, P176, DOI 10.1016/j.vaccine.2012.10.068; Levine OS, 1999, PEDIATR INFECT DIS J, V18, P1060, DOI 10.1097/00006454-199912000-00006; Lewis RF, 2008, B WORLD HEALTH ORGAN, V86, P292, DOI 10.2471/BLT.07.045336; Lucero MG, 2009, PEDIATR INFECT DIS J, V28, P455, DOI 10.1097/INF.0b013e31819637af; Lucero MG, 2009, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD004977.PUB2; Madhi SA, 2004, NAT MED, V10, P811, DOI 10.1038/nm1077; Madhi SA, 2010, NEW ENGL J MED, V362, P289, DOI 10.1056/NEJMoa0904797; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; Moore DP, 2010, PEDIATR INFECT DIS J, V29, P1099, DOI 10.1097/INF.0b013e3181eaefff; Moore DP, 2012, EXPERT REV RESP MED, V6, P451, DOI [10.1586/ers.12.32, 10.1586/ERS.12.32]; Muganga N, 2007, VACCINE, V25, P7001, DOI 10.1016/j.vaccine.2007.06.032; Mulholland EK, 2004, J HEALTH POPUL NUTR, V22, P257; Mulholland K, 1997, LANCET, V349, P1191, DOI 10.1016/S0140-6736(96)09267-7; Mulholland K, 1999, EPIDEMIOL REV, V21, P43, DOI 10.1093/oxfordjournals.epirev.a017987; O'Brien KL, 2003, LANCET, V362, P355, DOI 10.1016/S0140-6736(03)14022-6; Phrommintikul A, 2011, EUR HEART J, V32, P1730, DOI 10.1093/eurheartj/ehr004; Qureshi H, 2000, VACCINE, V18, P2956, DOI 10.1016/S0264-410X(00)00116-X; Scott JAG, 2011, LANCET, V378, P1316, DOI 10.1016/S0140-6736(11)60888-X; SHANN F, 1984, LANCET, V2, P537; Tate JE, 2009, PEDIATRICS, V123, P744, DOI 10.1542/peds.2008-1200; Viviani S, 2008, CANCER EPIDEM BIOMAR, V17, P3216, DOI 10.1158/1055-9965.EPI-08-0303; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630	52	78	78	1	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 17	2014	383	9930					1762	1770		10.1016/S0140-6736(13)61682-7	http://dx.doi.org/10.1016/S0140-6736(13)61682-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH6UO	24553294	Green Accepted			2022-12-28	WOS:000336267300030
J	Burdett, S; Rydzewska, LHM; Tierney, JF; Auperin, A; Le Pechoux, C; Le Chevalier, T; Pignon, JP				Burdett, Sarah; Rydzewska, Larysa H. M.; Tierney, Jayne F.; Auperin, Anne; Le Pechoux, Cecile; Le Chevalier, Thierry; Pignon, Jean-Pierre		NSCLC Meta-Anal Collaborative Grp	Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data	LANCET			English	Review							RANDOMIZED-TRIAL; PHASE-III; PERIOPERATIVE CHEMOTHERAPY; NEOADJUVANT THERAPY; PLUS SURGERY; CARBOPLATIN; CISPLATIN; FAILURE	Background Individual participant data meta-analyses of postoperative chemotherapy have shown improved survival for patients with non-small-cell lung cancer (NSCLC). We aimed to do a systematic review and individual participant data meta-analysis to establish the effect of preoperative chemotherapy for patients with resectable NSCLC. Methods We systematically searched for trials that started after January, 1965. Updated individual participant data were centrally collected, checked, and analysed. Results from individual randomised controlled trials (both published and unpublished) were combined using a two-stage fixed-effect model. Our primary outcome, overall survival, was defined as the time from randomisation until death (any cause), with living patients censored on the date of last follow-up. Secondary outcomes were recurrence-free survival, time to locoregional and distant recurrence, cause-specific survival, complete and overall resection rates, and postoperative mortality. Prespecified analyses explored any variation in effect by trial and patient characteristics. All analyses were by intention to treat. Findings Analyses of 15 randomised controlled trials (2385 patients) showed a significant benefit of preoperative chemotherapy on survival (hazard ratio [HR] 0.87, 95% CI 0.78-0.96, p=0.007), a 13% reduction in the relative risk of death (no evidence of a difference between trials; p=0.18, I-2 =25%). This finding represents an absolute survival improvement of 5% at 5 years, from 40% to 45%. There was no clear evidence of a difference in the effect on survival by chemotherapy regimen or scheduling, number of drugs, platinum agent used, or whether postoperative radiotherapy was given. There was no clear evidence that particular types of patient defined by age, sex, performance status, histology, or clinical stage benefited more or less from preoperative chemotherapy. Recurrence-free survival (HR 0.85, 95% CI 0.76-0.94, p=0.002) and time to distant recurrence (0.69, 0.58-0.82, p<0.0001) results were both significantly in favour of preoperative chemotherapy although most patients included were stage IB-IIIA. Results for time to locoregional recurrence (0.88, 0.73-1.07, p=0.20), although in favour of preoperative chemotherapy, were not statistically significant. Interpretation Findings, which are based on 92% of all patients who were randomised, and mainly stage IB-IIIA, show preoperative chemotherapy significantly improves overall survival, time to distant recurrence, and recurrence-free survival in resectable NSCLC. The findings suggest this is a valid treatment option for most of these patients. Toxic effects could not be assessed.	[Burdett, Sarah; Rydzewska, Larysa H. M.; Tierney, Jayne F.] UCL, MRC, Clin Trials Unit, Meta Anal Grp, London WC2B 6NH, England; [Auperin, Anne; Le Pechoux, Cecile] Inst Gustave Roussy, Serv Biostat & Epidemiol, Villejuif, France; [Le Chevalier, Thierry; Pignon, Jean-Pierre] Inst Gustave Roussy, Dept Lung Canc, Villejuif, France	Medical Research Council Clinical Trials Unit; University of London; University College London; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy	Burdett, S (corresponding author), UCL, MRC, Clin Trials Unit, Meta Anal Grp, Aviat House,125 Kingsway, London WC2B 6NH, England.	sarah.burdett@ucl.ac.uk	Rydzewska, Larysa/AAA-4242-2020; Rydzewska, Larysa/AAG-7228-2019; DAUTZENBERG, Bertrand/F-4104-2017	Rydzewska, Larysa/0000-0001-6205-7457; Tierney, Jayne/0000-0002-4734-3014; PIGNON, Jean-Pierre/0000-0003-2047-1582; Stewart, Lesley/0000-0003-0287-4724; DAUTZENBERG, Bertrand/0000-0001-6937-8907	Medical Research Council UK; MRC [MC_U122861323] Funding Source: UKRI; Medical Research Council [MC_U122861323] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [U10CA180888, U10CA042777, U10CA180819, U10CA105409, U10CA032102, U10CA038926] Funding Source: NIH RePORTER	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Medical Research Council UK.	Allum WH, 2009, J CLIN ONCOL, V27, P5062, DOI 10.1200/JCO.2009.22.2083; American Cancer Society, 2007, CANC FACTS FIG 2007; Auperin A, 2010, LANCET, V375, P1267, DOI 10.1016/S0140-6736(10)60059-1; Berghmans T, 2005, LUNG CANCER, V49, P13, DOI 10.1016/j.lungcan.2005.01.002; Bunn P, PHASE 3 RANDOMIZED C; Burdett S, 2006, J THORAC ONCOL, V1, P611; Datta D, 2003, CHEST, V123, P2096, DOI 10.1378/chest.123.6.2096; DAUTZENBERG B, 1990, CANCER, V65, P2435, DOI 10.1002/1097-0142(19900601)65:11<2435::AID-CNCR2820651105>3.0.CO;2-2; de Boer RH, 1999, BRIT J CANCER, V79, P1514, DOI 10.1038/sj.bjc.6690241; Depierre A, 2002, J CLIN ONCOL, V20, P247, DOI 10.1200/JCO.20.1.247; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Felip E, 2010, J CLIN ONCOL, V28, P3138, DOI 10.1200/JCO.2009.27.6204; Fisher DJ, 2011, J CLIN EPIDEMIOL, V64, P949, DOI 10.1016/j.jclinepi.2010.11.016; Gilligan D, 2007, LANCET, V369, P1929, DOI 10.1016/S0140-6736(07)60714-4; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Lefebvre C, 2008, COCHRANE HDB SYSTEMA, P95, DOI DOI 10.1002/9780470712184; Lim E, 2009, J THORAC ONCOL, V4, P1380, DOI 10.1097/JTO.0b013e3181b9ecca; Mattson KV, 2003, ANN ONCOL, V14, P116, DOI 10.1093/annonc/mdg009; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Nagai K, 2003, J THORAC CARDIOV SUR, V125, P254, DOI 10.1067/mtc.2003.15; Nakamura H, 2006, LUNG CANCER, V54, P325, DOI 10.1016/j.lungcan.2006.07.019; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; PASS HI, 1992, ANN THORAC SURG, V53, P992, DOI 10.1016/0003-4975(92)90373-C; Pisters KMW, 2010, J CLIN ONCOL, V28, P1843, DOI 10.1200/JCO.2009.26.1685; ROSELL R, 1994, NEW ENGL J MED, V330, P153, DOI 10.1056/NEJM199401203300301; ROTH JA, 1994, J NATL CANCER I, V86, P673, DOI 10.1093/jnci/86.9.673; Scagliotti GV, 2012, J CLIN ONCOL, V30, P172, DOI 10.1200/JCO.2010.33.7089; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X; Song WA, 2010, J THORAC ONCOL, V5, P510, DOI 10.1097/JTO.0b013e3181cd3345; Sorensen JB, 2005, P AN M AM SOC CLIN, V23, P7146, DOI DOI 10.1200/JC0.2005.23.16_; Splinter TA, 2000, P AN M AM SOC CLIN, V19, P495; STEWART LA, 1993, LANCET, V341, P418, DOI 10.1016/0140-6736(93)93004-K; STEWART LA, 1995, STAT MED, V14, P2057, DOI 10.1002/sim.4780141902; Waller D, 2004, EUR J CARDIO-THORAC, V26, P173, DOI 10.1016/j.ejcts.2004.03.041; Westeel V, 2013, EUR J CANCER, V49, P2654, DOI 10.1016/j.ejca.2013.04.013; Wu Y-L, 2002, ANN ONCOL, V13, P140; Yang X, 2005, LUNG CANCER-J IASLC, V49, pS288, DOI 10.1016/S0169-5002(05)81138-9; Yang X-N, 2013, ASCO ANN M, P7537; Yi Xianghua, 2003, Zhongguo Fei Ai Za Zhi, V6, P124, DOI 10.3779/j.issn.1009-3419.2003.02.09; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7	41	374	390	10	59	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 3	2014	383	9928					1561	1571		10.1016/S0140-6736(13)62159-5	http://dx.doi.org/10.1016/S0140-6736(13)62159-5			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG5YO	24576776	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000335495400027
J	Hemani, G; Shakhbazov, K; Westra, HJ; Esko, T; Henders, AK; Mcrae, AF; Yang, J; Gibson, G; Martin, NG; Metspalu, A; Franke, L; Montgomery, GW; Visscher, PM; Powell, JE				Hemani, Gibran; Shakhbazov, Konstantin; Westra, Harm-Jan; Esko, Tonu; Henders, Anjali K.; McRae, Allan F.; Yang, Jian; Gibson, Greg; Martin, Nicholas G.; Metspalu, Andres; Franke, Lude; Montgomery, Grant W.; Visscher, Peter M.; Powell, Joseph E.			Detection and replication of epistasis influencing transcription in humans	NATURE			English	Article							GENOME-WIDE ASSOCIATION; GENETIC-VARIATION; LOCI; GWAS	Epistasis is the phenomenon whereby one polymorphism's effect on a trait depends on other polymorphisms present in the genome. The extent to which epistasis influences complex traits(1) and contributes to their variation(2,3) is a fundamental question in evolution andhuman genetics. Although oftendemonstrated in artificial gene manipulation studies in model organisms(4,5), and some examples have been reported in other species(6), few examples exist for epistasis among natural polymorphisms in human traits(7,8). Its absence from empirical findingsmay simply be due to low incidence in the genetic control of complex traits(2,3), but an alternative view is that it has previously been too technically challenging to detect owing to statistical and computational issues(9). Here we show, using advanced computation(10) and a gene expression study design, that many instances of epistasis are found between common single nucleotide polymorphisms (SNPs). In a cohort of 846 individualswith 7,339 gene expression levels measured in peripheral blood, we found 501 significant pairwise interactions between commonSNPs influencing the expression of 238 genes (P < 2.91 x 10(-16)). Replication of these interactions in two independent data sets11,12 showed both concordance of direction of epistatic effects (P = 55.5 x 10(-31)) and enrichment of interaction P values, with 30 being significant at a conservative threshold of P < 9.98 x 10(-5). Forty-four of the genetic interactions are located within 5 megabases of regions of known physical chromosome interactions(13) (P=1.8x10(-10)). Epistatic networks of three SNPs or more influence the expression levels of 129 genes, whereby one cis-acting SNP is modulated by several trans-acting SNPs. For example, MBNL1 is influenced by an additive effect at rs13069559, which itself is masked by trans-SNPs on 14 different chromosomes, with nearly identical genotype-phenotype maps for each cis-trans interaction. This study presents the first evidence, to our knowledge, for many instances of segregating common polymorphisms interacting to influence human traits.	[Hemani, Gibran; Shakhbazov, Konstantin; McRae, Allan F.; Yang, Jian; Visscher, Peter M.; Powell, Joseph E.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Hemani, Gibran; Shakhbazov, Konstantin; McRae, Allan F.; Visscher, Peter M.; Powell, Joseph E.] Univ Queensland, Princess Alexandra Hosp, Diamantina Inst, Brisbane, Qld 4072, Australia; [Westra, Harm-Jan; Franke, Lude] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Esko, Tonu; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, EE-51010 Tartu, Estonia; [Esko, Tonu] Broad Inst, Cambridge, MA 02142 USA; [Esko, Tonu] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Henders, Anjali K.; Martin, Nicholas G.; Montgomery, Grant W.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Gibson, Greg] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Gibson, Greg] Georgia Inst Technol, Ctr Integrat Genom, Atlanta, GA 30332 USA	University of Queensland; University of Queensland; University of Groningen; University of Tartu; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; QIMR Berghofer Medical Research Institute; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Hemani, G (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia.	g.hemani@uq.edu.au	McRae, Allan F/J-2644-2014; Martin, Nicholas/R-9235-2019; Powell, Joseph/G-3027-2014; Visscher, Peter/ABB-6151-2020; Franke, Lude/P-7036-2016; Montgomery, Grant W/B-7148-2008; Henders, Anjali/E-3126-2017; Yang, Jian/A-5852-2010	McRae, Allan F/0000-0001-5286-5485; Martin, Nicholas/0000-0003-4069-8020; Powell, Joseph/0000-0001-9031-6356; Visscher, Peter/0000-0002-2143-8760; Franke, Lude/0000-0002-5159-8802; Montgomery, Grant W/0000-0002-4140-8139; Hemani, Gibran/0000-0003-0920-1055; Henders, Anjali/0000-0003-3672-1451; Esko, Tonu/0000-0003-1982-6569; Yang, Jian/0000-0003-2001-2474	Australian National Health and Medical Research Council (NHMRC) [389892, 496667, 613601, 1010374, 1046880]; Australian Research Council (ARC) [DE130100691]; National Institutes of Health (NIH) [GM057091, GM099568]; Australian National Health and Medical Research Council [389892, 241944, 389875, 389891, 389938, 442915, 442981, 496739, 496688, 552485]; National Institutes of Health [AA07535, AA10248, AA014041, AA13320, AA13321, AA13326, DA12854]; Georgia Institute of Technology Research Foundation; Celiac Disease Consortium [BSIK03009]; Netherlands Organization for Scientific Research [918.66.620, 916.10.135]; Dutch Digestive Disease Foundation [MLDS WO11-30]; Horizon Breakthrough grant from the Netherlands Genomics Initiative [92519031]; Prinses Beatrix Fonds; VSB fonds; Kersten Foundation; Netherlands ALS Foundation; J. R. van Dijk and the Adessium Foundation; European Communitys [259867]; Estonian Government [SF0180142s08]; Center of Excellence in Genomics (EXCEGEN); University of Tartu [SP1GVARENG]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075091, P01GM099568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA013321, R01AA013326, R01AA007535, R01AA014041, R01AA013320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R56DA012854, R01DA012854] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Institute of Technology Research Foundation; Celiac Disease Consortium; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Dutch Digestive Disease Foundation; Horizon Breakthrough grant from the Netherlands Genomics Initiative; Prinses Beatrix Fonds; VSB fonds; Kersten Foundation; Netherlands ALS Foundation; J. R. van Dijk and the Adessium Foundation; European Communitys(European Commission); Estonian Government; Center of Excellence in Genomics (EXCEGEN); University of Tartu; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We are grateful to the volunteers for their participation in these studies. We thank B. Hill, C. Haley and L. Ronnegard for discussions and comments. This work could not have been completed without access to high performance GPGPU compute clusters. We acknowledge iVEC for the use of advanced computing resources located at iVEC@UWA (http://www.ivec.org), and the Multi-modal Australian Sciences Imaging and Visualisation Environment (MASSIVE) (http://www.massive.org.au). We also thank J. Carroll and I. Porebski from the Queensland Brain Institute Information Technology Group for HPC support. The University of Queensland group is supported by the Australian National Health and Medical Research Council (NHMRC) grants 389892, 496667, 613601, 1010374 and 1046880, the Australian Research Council (ARC) grant (DE130100691), and by National Institutes of Health (NIH) grants GM057091 and GM099568. The QIMR researchers acknowledge funding from the Australian National Health and Medical Research Council (grants 241944, 389875, 389891, 389892, 389938, 442915, 442981, 496739, 496688 and 552485), and the National Institutes of Health (grants AA07535, AA10248, AA014041, AA13320, AA13321, AA13326 and DA12854). We thank A. Caracella and L. Bowdler for technical assistance with the micro-array hybridisations. The CHDWB study funding support from the Georgia Institute of Technology Research Foundation. The funders hadno role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The Fehrmann study was supported by grants from the Celiac Disease Consortium (an innovative cluster approved by the Netherlands Genomics Initiative and partly funded by the Dutch Government (grant BSIK03009)), the Netherlands Organization for Scientific Research (NWO-VICI grant 918.66.620, NWO-VENI grant 916.10.135 to L. F.), the Dutch Digestive Disease Foundation (MLDS WO11-30), and a Horizon Breakthrough grant from the Netherlands Genomics Initiative (grant 92519031 to L. F.). This project was supported by the Prinses Beatrix Fonds, VSB fonds, H. Kersten and M. Kersten (Kersten Foundation), The Netherlands ALS Foundation, and J. R. van Dijk and the Adessium Foundation. The research leading to these results has received funding from the European Communitys Health Seventh Framework Programme (FP7/2007-2013) under grant agreement 259867. The EGCUT study received targeted financing from the Estonian Government SF0180142s08, Center of Excellence in Genomics (EXCEGEN) and University of Tartu (SP1GVARENG). We acknowledge EGCUT technical personnel, especially V. Soo and S. Smit. Data analyses were carried out in part in the High Performance Computing Center of University of Tartu.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Alvarez-Castro JM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000062; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Bloom JS, 2013, NATURE, V494, P234, DOI 10.1038/nature11867; Breen MS, 2012, NATURE, V490, P535, DOI 10.1038/nature11510; Carlborg O, 2006, NAT GENET, V38, P418, DOI 10.1038/ng1761; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; COCKERHAM CC, 1954, GENETICS, V39, P859; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Crow JF, 2010, PHILOS T R SOC B, V365, P1241, DOI 10.1098/rstb.2009.0275; Evans D. M., 2011, NATURE GENETICS, P43; Fehrmann RSN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002197; Hemani G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003295; Hemani G, 2011, BIOINFORMATICS, V27, P1462, DOI 10.1093/bioinformatics/btr172; Hill WG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000008; Ho TH, 2004, EMBO J, V23, P3103, DOI 10.1038/sj.emboj.7600300; Hoffman MM, 2012, NAT METHODS, V9, P473, DOI [10.1038/nmeth.1937, 10.1038/NMETH.1937]; Lan X, 2012, NUCLEIC ACIDS RES, V40, P7690, DOI 10.1093/nar/gks501; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Medland SE, 2009, AM J HUM GENET, V85, P750, DOI 10.1016/j.ajhg.2009.10.009; Metspalu A, 2004, DRUG DEVELOP RES, V62, P97, DOI 10.1002/ddr.10371; Powell JE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003502; Powell JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035430; Preininger M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003362; Rieder Dietmar, 2012, Frontiers in Genetics, V3, P221, DOI 10.3389/fgene.2012.00221; Rietveld CA, 2013, SCIENCE, V340, P1467, DOI 10.1126/science.1235488; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Weir BS, 2008, ANNU REV GENOM HUM G, V9, P129, DOI 10.1146/annurev.genom.9.081307.164347; Westra HJ, 2011, BIOINFORMATICS, V27, P2104, DOI 10.1093/bioinformatics/btr323; WILLIAMS DA, 1976, BIOMETRIKA, V63, P33, DOI 10.2307/2335081; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823	39	128	130	0	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 10	2014	508	7495					249	+		10.1038/nature13005	http://dx.doi.org/10.1038/nature13005			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE4UK	24572353	Green Accepted			2022-12-28	WOS:000333979900045
J	Chen, C; Kang, YJ; Huo, ZY; Zhu, ZW; Huang, WY; Xin, HLL; Snyder, JD; Li, DG; Herron, JA; Mavrikakis, M; Chi, MF; More, KL; Li, YD; Markovic, NM; Somorjai, GA; Yang, PD; Stamenkovic, VR				Chen, Chen; Kang, Yijin; Huo, Ziyang; Zhu, Zhongwei; Huang, Wenyu; Xin, Huolin L.; Snyder, Joshua D.; Li, Dongguo; Herron, Jeffrey A.; Mavrikakis, Manos; Chi, Miaofang; More, Karren L.; Li, Yadong; Markovic, Nenad M.; Somorjai, Gabor A.; Yang, Peidong; Stamenkovic, Vojislav R.			Highly Crystalline Multimetallic Nanoframes with Three-Dimensional Electrocatalytic Surfaces	SCIENCE			English	Article							OXYGEN REDUCTION REACTION; PT-SKIN SURFACES; ALLOY NANOPARTICLES; NANOCRYSTALS; NANOSCALE; EVOLUTION; CATALYSTS; POLYMERS; SIZE	Control of structure at the atomic level can precisely and effectively tune catalytic properties of materials, enabling enhancement in both activity and durability. We synthesized a highly active and durable class of electrocatalysts by exploiting the structural evolution of platinum-nickel (Pt-Ni) bimetallic nanocrystals. The starting material, crystalline PtNi3 polyhedra, transforms in solution by interior erosion into Pt3Ni nanoframes with surfaces that offer three-dimensional molecular accessibility. The edges of the Pt-rich PtNi3 polyhedra are maintained in the final Pt3Ni nanoframes. Both the interior and exterior catalytic surfaces of this open-framework structure are composed of the nanosegregated Pt-skin structure, which exhibits enhanced oxygen reduction reaction (ORR) activity. The Pt3Ni nanoframe catalysts achieved a factor of 36 enhancement in mass activity and a factor of 22 enhancement in specific activity, respectively, for this reaction (relative to state-of-the-art platinum-carbon catalysts) during prolonged exposure to reaction conditions.	[Chen, Chen; Huo, Ziyang; Zhu, Zhongwei; Huang, Wenyu; Somorjai, Gabor A.; Yang, Peidong] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Chen, Chen; Huo, Ziyang; Zhu, Zhongwei; Huang, Wenyu; Xin, Huolin L.; Somorjai, Gabor A.; Yang, Peidong] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Chen, Chen; Li, Yadong] Tsinghua Univ, Dept Chem, Beijing 100084, Peoples R China; [Kang, Yijin; Snyder, Joshua D.; Li, Dongguo; Markovic, Nenad M.; Stamenkovic, Vojislav R.] Argonne Natl Lab, Div Mat Sci, Argonne, IL 60439 USA; [Herron, Jeffrey A.; Mavrikakis, Manos] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA; [Chi, Miaofang; More, Karren L.] Oak Ridge Natl Lab, Div Mat Sci & Technol, Oak Ridge, TN 37831 USA; [Yang, Peidong] King Abdulaziz Univ, Dept Chem, Fac Sci, Jeddah 21589, Saudi Arabia; [Yang, Peidong] Univ Calif Berkeley, Kavli Energy Nanosci Inst, Berkeley, CA 94704 USA; [Yang, Peidong] Lawrence Berkeley Natl Lab, Berkeley, CA 94704 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Tsinghua University; United States Department of Energy (DOE); Argonne National Laboratory; University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); Oak Ridge National Laboratory; King Abdulaziz University; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Yang, PD (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	p_yang@berkeley.edu; vrstamenkovic@anl.gov	CHEN, CHEN/HDM-6657-2022; chen, chen/GRY-7085-2022; Chen, Chen/G-3772-2015; Huang, Wenyu/L-3784-2014; Chi, Miaofang/Q-2489-2015; Xin, Huolin L./E-2747-2010; Stamenkovic, Vojislav/ABD-5466-2021; More, Karren L/A-8097-2016; Stamenkovic, Vojislav/AAF-1435-2019; Zhu, Zhongwei/M-2233-2019; Li, Dongguo/O-6253-2016; Mavrikakis, Manos/D-5702-2012; Chi, Miaofang/Y-3603-2019	Chen, Chen/0000-0001-5902-3037; Huang, Wenyu/0000-0003-2327-7259; Chi, Miaofang/0000-0003-0764-1567; Xin, Huolin L./0000-0002-6521-868X; Stamenkovic, Vojislav/0000-0002-1149-3563; More, Karren L/0000-0001-5223-9097; Li, Dongguo/0000-0001-7578-7811; Mavrikakis, Manos/0000-0002-5293-5356; Chi, Miaofang/0000-0003-0764-1567	U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences (BES), Materials Sciences and Engineering Division [DE-AC02-05CH11231, DE-AC02-06CH11357]; Office of Energy Efficiency and Renewable Energy, Fuel Cell Technologies Program; DOE, Office of Science, BES [DE-FG02-05ER15731]; King Abdulaziz University; Scientific User Facilities Division, BES, DOE	U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences (BES), Materials Sciences and Engineering Division(United States Department of Energy (DOE)); Office of Energy Efficiency and Renewable Energy, Fuel Cell Technologies Program(United States Department of Energy (DOE)); DOE, Office of Science, BES(United States Department of Energy (DOE)); King Abdulaziz University; Scientific User Facilities Division, BES, DOE(United States Department of Energy (DOE))	The research conducted at Lawrence Berkeley National Laboratory (LBNL) and Argonne National Laboratory (ANL) was supported by the U.S. Department of Energy (DOE), Office of Science, Office of Basic Energy Sciences (BES), Materials Sciences and Engineering Division, under contracts DE-AC02-05CH11231 and DE-AC02-06CH11357, respectively. The portion of work related to catalyst mass activity and durability was supported by the Office of Energy Efficiency and Renewable Energy, Fuel Cell Technologies Program. Work at the University of Wisconsin was supported by DOE, Office of Science, BES, under contract DE-FG02-05ER15731; computations were performed at supercomputing centers located at NERSC, PNNL, and ANL, all supported by DOE. We thank King Abdulaziz University for support of the Pt-Co bimetallic nanocatalyst work. Microscopy studies were accomplished at the Electron Microscopy Center at ANL, National Center for Electron Microscopy and Molecular Foundry at LBNL, and the Center for Nanophase Materials Sciences at Oak Ridge National Laboratory, which is sponsored by the Scientific User Facilities Division, BES, DOE. XPS studies were carried out at Advanced Light Source (LBNL). We thank S. Alayoglu for carrying out the site-specific EDX on the alloy nanostructures, H. Zheng for her help on TEM work at LBNL, and Z. Liu for help on XPS analysis.	Mahmoud MA, 2011, NANO LETT, V11, P3285, DOI 10.1021/nl201642r; Cargnello M, 2013, SCIENCE, V341, P771, DOI 10.1126/science.1240148; Choi SI, 2013, NANO LETT, V13, P3420, DOI 10.1021/nl401881z; Cui CH, 2013, NAT MATER, V12, P765, DOI [10.1038/NMAT3668, 10.1038/nmat3668]; DAHMANI CE, 1985, PHYS REV LETT, V55, P1208, DOI 10.1103/PhysRevLett.55.1208; Davis ME, 2002, NATURE, V417, P813, DOI 10.1038/nature00785; Erlebacher J, 2001, NATURE, V410, P450, DOI 10.1038/35068529; Ferreira PJ, 2005, J ELECTROCHEM SOC, V152, pA2256, DOI 10.1149/1.2050347; Guo SJ, 2013, ANGEW CHEM INT EDIT, V52, P8526, DOI 10.1002/anie.201207186; Johnson SA, 1999, SCIENCE, V283, P963, DOI 10.1126/science.283.5404.963; Kang Y, 2013, J AM CHEM SOC, V135, P2741, DOI 10.1021/ja3116839; Macdonald JE, 2010, NAT MATER, V9, P810, DOI [10.1038/NMAT2848, 10.1038/nmat2848]; McEachran M, 2011, J AM CHEM SOC, V133, P8066, DOI 10.1021/ja111642d; Oh MH, 2013, SCIENCE, V340, P964, DOI 10.1126/science.1234751; Skrabalak SE, 2008, ACCOUNTS CHEM RES, V41, P1587, DOI 10.1021/ar800018v; Snyder J, 2010, NAT MATER, V9, P904, DOI [10.1038/NMAT2878, 10.1038/nmat2878]; Snyder J, 2013, ADV FUNCT MATER, V23, P5494, DOI 10.1002/adfm.201301144; Stamenkovic VR, 2007, SCIENCE, V315, P493, DOI 10.1126/science.1135941; Subbaraman R, 2011, SCIENCE, V334, P1256, DOI 10.1126/science.1211934; Tang L, 2010, J AM CHEM SOC, V132, P596, DOI 10.1021/ja9071496; Tao F, 2008, SCIENCE, V322, P932, DOI 10.1126/science.1164170; van der Vliet DF, 2012, NAT MATER, V11, P1051, DOI [10.1038/NMAT3457, 10.1038/nmat3457]; van der Vliet DF, 2012, ANGEW CHEM INT EDIT, V51, P3139, DOI 10.1002/anie.201107668; Wang C, 2011, J AM CHEM SOC, V133, P14396, DOI 10.1021/ja2047655; Wang DL, 2013, NAT MATER, V12, P81, DOI [10.1038/NMAT3458, 10.1038/nmat3458]; Wang DS, 2011, INORG CHEM, V50, P5196, DOI 10.1021/ic200485v; Wang JX, 2011, J AM CHEM SOC, V133, P13551, DOI 10.1021/ja204518x; Yavuz MS, 2009, NAT MATER, V8, P935, DOI [10.1038/NMAT2564, 10.1038/nmat2564]; Yin YD, 2004, SCIENCE, V304, P711, DOI 10.1126/science.1096566; Zhang J, 2010, NANO LETT, V10, P638, DOI 10.1021/nl903717z	30	2010	2043	114	3786	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2014	343	6177					1339	1343		10.1126/science.1249061	http://dx.doi.org/10.1126/science.1249061			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD3AI	24578531	Green Submitted			2022-12-28	WOS:000333108500033
J	Coen, P; Clemens, J; Weinstein, AJ; Pacheco, DA; Deng, Y; Murthy, M				Coen, Philip; Clemens, Jan; Weinstein, Andrew J.; Pacheco, Diego A.; Deng, Yi; Murthy, Mala			Dynamic sensory cues shape song structure in Drosophila	NATURE			English	Article							COURTSHIP SONG; AUDITORY-FEEDBACK; MOTOR CONTROL; BEHAVIOR; NEUROBIOLOGY; MECHANISMS; DECISIONS; GENES	The generation of acoustic communication signals is widespread across the animal kingdom(1,2), and males of many species, including Drosophilidae, produce patterned courtship songs to increase their chance of success with a female. For some animals, song structure can vary considerably from one rendition to the next(3); neural noise within pattern generating circuits is widely assumed to be the primary source of such variability, and statistical models that incorporate neural noise are successful at reproducing the full variation present in natural songs(4). In direct contrast, here we demonstrate that much of the pattern variability in Drosophila courtship song can be explained by taking into account the dynamic sensory experience of the male. In particular, using a quantitative behavioural assay combined with computational modelling, we find that males use fast modulations in visual and self-motion signals to pattern their songs, a relationship that we show is evolutionarily conserved. Using neural circuit manipulations, we also identify the pathways involved in song patterning choices and show that females are sensitive to song features. Our data not only demonstrate that Drosophila song production is not a fixed action pattern(5,6), but establish Drosophila as a valuable new model for studies of rapid decision-making under both social and naturalistic conditions.	[Coen, Philip; Clemens, Jan; Weinstein, Andrew J.; Pacheco, Diego A.; Murthy, Mala] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Coen, Philip; Clemens, Jan; Weinstein, Andrew J.; Pacheco, Diego A.; Murthy, Mala] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Deng, Yi] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University	Murthy, M (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.	mmurthy@princeton.edu	Clemens, Jan/AAE-4983-2019; Deng, Yi/F-9358-2015	Clemens, Jan/0000-0003-4200-8097; Deng, Yi/0000-0002-6822-6343; PACHECO PINEDO, DIEGO/0000-0003-1638-2376; COEN, PHILIP/0000-0003-1495-1061	HHMI International Predoctoral Fellowship; Alfred P. Sloan Foundation; Human Frontiers Science Program; NSF CAREER award; McKnight Endowment Fund; Klingenstein Foundation; Direct For Biological Sciences [1054578] Funding Source: National Science Foundation	HHMI International Predoctoral Fellowship; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Human Frontiers Science Program(Human Frontier Science Program); NSF CAREER award(National Science Foundation (NSF)NSF - Office of the Director (OD)); McKnight Endowment Fund; Klingenstein Foundation(Klingenstein Philanthropies); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank B. Arthur and D. Stern for assistance in establishing the song recording system; P. Andolfatto for wild-type fly strains; S. Kamal and V. Cheng for assistance with selecting and maintaining fly strains; G. Guan for technical assistance; T. Tayler for help with injections; J. Shaevitz for help with the fly tracker; R. da Silveira for early discussions on reverse correlation; and G. Laurent, C. Brody, D. Aronov, I. Fiete, M. Ryan, and the entire Murthy lab for thoughtful feedback and comments on the manuscript. Figure 1a was illustrated by K. Ris-Vicari. P. C. is funded by an HHMI International Predoctoral Fellowship and M. M. is funded by the Alfred P. Sloan Foundation, the Human Frontiers Science Program, an NSF CAREER award, the McKnight Endowment Fund, and the Klingenstein Foundation.	Aronov D, 2011, J NEUROSCI, V31, P16353, DOI 10.1523/JNEUROSCI.3009-11.2011; Arthur BJ, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-11; Baker BS, 2001, CELL, V105, P13, DOI 10.1016/S0092-8674(01)00293-8; BENNETCLARK HC, 1969, ANIM BEHAV, V17, P755, DOI 10.1016/S0003-3472(69)80023-0; BENTLEY D, 1974, SCI AM, V231, P34, DOI 10.1038/scientificamerican0874-34; Calabrese A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016104; Censi A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002891; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Deng Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065769; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; EWING AW, 1979, J COMP PHYSIOL, V130, P87, DOI 10.1007/BF02582977; Fortune ES, 2011, SCIENCE, V334, P666, DOI 10.1126/science.1209867; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Jin DZ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001108; MCFARLAND DJ, 1977, NATURE, V269, P15, DOI 10.1038/269015a0; Mineault PJ, 2009, J VISION, V9, DOI 10.1167/9.10.17; Olveczky BP, 2005, PLOS BIOL, V3, P902, DOI 10.1371/journal.pbio.0030153; Perisse E, 2013, NEURON, V79, P945, DOI 10.1016/j.neuron.2013.07.045; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Sakata JT, 2008, J NEUROSCI, V28, P11378, DOI 10.1523/JNEUROSCI.3254-08.2008; Sakata JT, 2006, J NEUROSCI, V26, P9619, DOI 10.1523/JNEUROSCI.2027-06.2006; Senthilan PR, 2012, CELL, V150, P1042, DOI 10.1016/j.cell.2012.06.043; Sharpee T, 2004, NEURAL COMPUT, V16, P223, DOI 10.1162/089976604322742010; Shirangi TR, 2013, CELL REP, V5, P678, DOI 10.1016/j.celrep.2013.09.039; Simon JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008793; Soon CS, 2008, NAT NEUROSCI, V11, P543, DOI 10.1038/nn.2112; Tinbergen N, 1951, STUDY INSTINCT; Trott AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046025; Verleyen P, 2004, BIOCHEM BIOPH RES CO, V320, P334, DOI 10.1016/j.bbrc.2004.05.173; Von Schilcher F., 1976, Animal Behav, V24, P18, DOI 10.1016/S0003-3472(76)80095-4; Yapici N, 2008, NATURE, V451, P33, DOI 10.1038/nature06483; Ziegler AB, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00072	34	90	90	2	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2014	507	7491					233	+		10.1038/nature13131	http://dx.doi.org/10.1038/nature13131			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC6RJ	24598544				2022-12-28	WOS:000332651800039
J	Sackmann, EK; Fulton, AL; Beebe, DJ				Sackmann, Eric K.; Fulton, Anna L.; Beebe, David J.			The present and future role of microfluidics in biomedical research	NATURE			English	Review							CELL-CULTURE; ENDOTHELIAL BARRIER; ANALYSIS SYSTEMS; FABRICATION; GRADIENTS; POLY(DIMETHYLSILOXANE); ANTIBODY; ASSAYS; MODEL; PAPER	Microfluidics, a technology characterized by the engineered manipulation of fluids at the submillimetre scale, has shown considerable promise for improving diagnostics and biology research. Certain properties of microfluidic technologies, such as rapid sample processing and the precise control of fluids in an assay, have made them attractive candidates to replace traditional experimental approaches. Here we analyse the progress made by lab-on-a-chip microtechnologies in recent years, and discuss the clinical and research areas in which they have made the greatest impact. We also suggest directions that biologists, engineers and clinicians can take to help this technology live up to its potential.	[Sackmann, Eric K.] Univ Wisconsin Madison, Wisconsin Inst Med Res, Dept Biomed Engn, Mat Sci Program, Madison, WI 53705 USA; [Fulton, Anna L.] Univ Wisconsin Madison, Wendt Commons Lib, Madison, WI 53706 USA; [Beebe, David J.] Univ Wisconsin Madison, Wisconsin Inst Med Res, Dept Biomed Engn, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Beebe, DJ (corresponding author), Univ Wisconsin Madison, Wisconsin Inst Med Res, Dept Biomed Engn, 1111 Highland Ave,Room 6009, Madison, WI 53705 USA.	djbeebe@wisc.edu		Sackmann, Eric/0000-0001-5514-1538; Sackmann, Anna Fulton/0000-0002-3852-6951				Abe K, 2008, ANAL CHEM, V80, P6928, DOI 10.1021/ac800604v; Anna SL, 2003, APPL PHYS LETT, V82, P364, DOI 10.1063/1.1537519; Apilux A, 2013, LAB CHIP, V13, P126, DOI 10.1039/c2lc40690j; AUMILLER GD, 1974, J APPL PHYS, V45, P4557, DOI 10.1063/1.1663087; BACH MK, 1970, EXP CELL RES, V61, P387, DOI 10.1016/0014-4827(70)90462-3; Bakkalbasi Nisa, 2006, Biomed Digit Libr, V3, P7, DOI 10.1186/1742-5581-3-7; Becker H, 2000, SENSOR ACTUAT A-PHYS, V83, P130, DOI 10.1016/S0924-4247(00)00296-X; Becker H, 2009, LAB CHIP, V9, P2759, DOI [10.1039/b916505n, 10.1039/b916505]; Becker H, 2009, LAB CHIP, V9, P2119, DOI 10.1039/b911553f; Beebe DJ, 2002, ANNU REV BIOMED ENG, V4, P261, DOI 10.1146/annurev.bioeng.4.112601.125916; Berry SM, 2012, ANAL CHEM, V84, P5518, DOI 10.1021/ac300085m; Berry SM, 2011, BIOMED MICRODEVICES, V13, P1033, DOI 10.1007/s10544-011-9573-z; Berry SM, 2011, LAB CHIP, V11, P1747, DOI 10.1039/c1lc00004g; Berthier E, 2008, LAB CHIP, V8, P852, DOI 10.1039/b717422e; Berthier E, 2013, LAB CHIP, V13, P424, DOI 10.1039/c2lc41019b; Berthier E, 2012, LAB CHIP, V12, P1224, DOI 10.1039/c2lc20982a; Berthier E, 2011, LAB CHIP, V11, P2060, DOI 10.1039/c0lc00539h; Bischel LL, 2013, BIOMATERIALS, V34, P1471, DOI 10.1016/j.biomaterials.2012.11.005; Blow N, 2007, NAT METHODS, V4, P665, DOI 10.1038/nmeth0807-665; BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; Browne AW, 2009, LAB CHIP, V9, P2941, DOI 10.1039/b903755a; Butler KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011921; Carrilho E, 2009, ANAL CHEM, V81, P7091, DOI 10.1021/ac901071p; Chang WJ, 2003, BIOMED MICRODEVICES, V5, P281, DOI 10.1023/A:1027301628547; CHAUDHURY MK, 1991, LANGMUIR, V7, P1013, DOI 10.1021/la00053a033; Chin CD, 2011, NAT MED, V17, P1015, DOI 10.1038/nm.2408; Choi CK, 2010, TRENDS CELL BIOL, V20, P705, DOI 10.1016/j.tcb.2010.09.007; Cressey D, 2011, NATURE, V471, P17, DOI 10.1038/471017a; Cressey D, 2011, NATURE, V470, P154, DOI 10.1038/470154a; deZengotita VM, 1998, CYTOTECHNOLOGY, V28, P213, DOI 10.1023/A:1008010605287; Diaz-Gonzalez M, 2012, ANAL CHEM, V84, P7838, DOI 10.1021/ac301512f; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063; Falagas ME, 2008, FASEB J, V22, P338, DOI 10.1096/fj.07-9492LSF; Fu E, 2012, ANAL CHEM, V84, P4574, DOI 10.1021/ac300689s; Futai N, 2006, LAB CHIP, V6, P149, DOI 10.1039/b510901a; Goral VN, 2011, J MICROMECH MICROENG, V21, DOI 10.1088/0960-1317/21/1/017002; Gorkin R, 2010, LAB CHIP, V10, P1758, DOI 10.1039/b924109d; Hansen C, 2003, CURR OPIN STRUC BIOL, V13, P538, DOI 10.1016/j.sbi.2003.09.010; HARRISON DJ, 1992, ANAL CHEM, V64, P1926, DOI 10.1021/ac00041a030; Henry AC, 2000, ANAL CHEM, V72, P5331, DOI 10.1021/ac000685l; Heo YS, 2007, ANAL CHEM, V79, P1126, DOI 10.1021/ac061990v; Huh D, 2011, TRENDS CELL BIOL, V21, P745, DOI 10.1016/j.tcb.2011.09.005; Huh D, 2010, SCIENCE, V328, P1662, DOI 10.1126/science.1188302; Irimia D, 2006, ANAL CHEM, V78, P3472, DOI 10.1021/ac0518710; Irimia D, 2010, ANNU REV BIOMED ENG, V12, P259, DOI 10.1146/annurev-bioeng-070909-105241; Jang KJ, 2010, LAB CHIP, V10, P36, DOI 10.1039/b907515a; Jeon NL, 2000, LANGMUIR, V16, P8311, DOI 10.1021/la000600b; Jowhar D, 2010, INTEGR BIOL-UK, V2, P648, DOI 10.1039/c0ib00110d; Kamholz AE, 2001, BIOPHYS J, V80, P155, DOI 10.1016/S0006-3495(01)76003-1; Keenan TM, 2008, LAB CHIP, V8, P34, DOI 10.1039/b711887b; Kilby J., 1964, Miniaturized electronic circuits, Patent No. [3138743, US3138743]; Kimura H, 2008, LAB CHIP, V8, P741, DOI 10.1039/b717091b; Kotz KT, 2010, NAT MED, V16, P1042, DOI 10.1038/nm.2205; Lee JN, 2003, ANAL CHEM, V75, P6544, DOI 10.1021/ac0346712; Lee SH, 2010, ANAL CHEM, V82, P2900, DOI 10.1021/ac902903q; Ljunggren HG, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007459; MANZ A, 1990, SENSOR ACTUAT B-CHEM, V1, P244, DOI 10.1016/0925-4005(90)80209-I; Martinez AW, 2010, ANAL CHEM, V82, P3, DOI 10.1021/ac9013989; Martinez AW, 2008, P NATL ACAD SCI USA, V105, P19606, DOI 10.1073/pnas.0810903105; Martinez AW, 2008, LAB CHIP, V8, P2146, DOI 10.1039/b811135a; Martynova L, 1997, ANAL CHEM, V69, P4783, DOI 10.1021/ac970558y; MASUDA S, 1989, IEEE T IND APPL, V25, P732, DOI 10.1109/28.31255; MORRA M, 1990, J COLLOID INTERF SCI, V137, P11, DOI 10.1016/0021-9797(90)90038-P; Muinonen-Martin AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015309; Mukhopadhyay R, 2007, ANAL CHEM, V79, P7249, DOI 10.1021/ac071972t; Nilghaz A, 2012, LAB CHIP, V12, P209, DOI 10.1039/c1lc20764d; Noyce R. N., 1961, Semiconductor device-and-lead structure, Patent No. [US2981877, 2981877]; Olkkonen J, 2010, ANAL CHEM, V82, P10246, DOI 10.1021/ac1027066; Paguirigan AL, 2008, BIOESSAYS, V30, P811, DOI 10.1002/bies.20804; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Quake SR, 2000, SCIENCE, V290, P1536, DOI 10.1126/science.290.5496.1536; Regehr KJ, 2009, LAB CHIP, V9, P2132, DOI 10.1039/b903043c; Reyes DR, 2002, ANAL CHEM, V74, P2623, DOI 10.1021/ac0202435; Reymond N, 2013, NAT REV CANCER, V13, P858, DOI 10.1038/nrc3628; Sackmann EK, 2012, BLOOD, V120, pE45, DOI 10.1182/blood-2012-03-416453; Song JW, 2011, P NATL ACAD SCI USA, V108, P15342, DOI 10.1073/pnas.1105316108; Sung KE, 2011, INTEGR BIOL-UK, V3, P439, DOI 10.1039/c0ib00063a; Toepke MW, 2006, LAB CHIP, V6, P1484, DOI 10.1039/b612140c; Tsai M, 2012, J CLIN INVEST, V122, P408, DOI 10.1172/JCI58753; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; VANLINTEL HTG, 1988, SENSOR ACTUATOR, V15, P153, DOI 10.1016/0250-6874(88)87005-7; von Lode P, 2005, CLIN BIOCHEM, V38, P591, DOI 10.1016/j.clinbiochem.2005.03.008; Walker GM, 2002, LAB CHIP, V2, P131, DOI 10.1039/b204381e; Walsh CL, 2009, LAB CHIP, V9, P545, DOI 10.1039/b810571e; Wang YL, 2011, LAB CHIP, V11, P3089, DOI 10.1039/c1lc20281b; Warner EA, 2011, LAB INVEST, V91, P1787, DOI 10.1038/labinvest.2011.94; Watkins NN, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006870; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Whitesides GM, 2013, LAB CHIP, V13, P11, DOI 10.1039/c2lc90109a; Wood DK, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002738; Wu MH, 2004, BIOTECHNOL APPL BIOC, V40, P41, DOI 10.1042/BA20030170; Yager P, 2006, NATURE, V442, P412, DOI 10.1038/nature05064; Yang MT, 2011, NAT PROTOC, V6, P187, DOI 10.1038/nprot.2010.189; Young EWK, 2013, ANAL CHEM, V85, P44, DOI 10.1021/ac3034773; Young EWK, 2011, ANAL CHEM, V83, P1408, DOI 10.1021/ac102897h; Zervantonakis IK, 2012, P NATL ACAD SCI USA, V109, P13515, DOI 10.1073/pnas.1210182109; ZICHA D, 1991, J CELL SCI, V99, P769; ZIGMOND SH, 1977, J CELL BIOL, V75, P606, DOI 10.1083/jcb.75.2.606	100	1792	1844	106	1908	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2014	507	7491					181	189		10.1038/nature13118	http://dx.doi.org/10.1038/nature13118			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC6RJ	24622198				2022-12-28	WOS:000332651800029
J	Rosenthal, MS				Rosenthal, Marjorie S.			Caregiver-Centered Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SELF-EFFICACY; DISEASE		[Rosenthal, Marjorie S.] Yale Univ, Sch Med, Robert Wood Johnson Fdn, Clin Scholars Program, New Haven, CT 06520 USA; [Rosenthal, Marjorie S.] Yale Univ, Sch Med, Dept Pediat, Div Gen Pediat, New Haven, CT 06510 USA	Robert Wood Johnson Foundation (RWJF); Yale University; Yale University	Rosenthal, MS (corresponding author), Yale Univ, Sch Med, Robert Wood Johnson Fdn, Clin Scholars Program, New Haven, CT 06520 USA.	marjorie.rosenthal@yale.edu						Brodaty H, 2014, AM J GERIAT PSYCHIAT, V22, P756, DOI 10.1016/j.jagp.2013.05.004; Ferrara M, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-93; Gillick MR, 2013, JAMA-J AM MED ASSOC, V310, P575, DOI 10.1001/jama.2013.7310; Harmell AL, 2011, BRIT J HEALTH PSYCH, V16, P317, DOI 10.1348/135910710X504932; Mahoney R, 2005, AM J GERIAT PSYCHIAT, V13, P795, DOI 10.1176/appi.ajgp.13.9.795; Semiatin AM, 2012, AGING MENT HEALTH, V16, P683, DOI 10.1080/13607863.2011.651437; von Kanel R, 2008, GERONTOLOGY, V54, P131, DOI 10.1159/000113649	7	2	2	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2014	311	10					1015	1016		10.1001/jama.2013.285751	http://dx.doi.org/10.1001/jama.2013.285751			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC5QO	24618960				2022-12-28	WOS:000332575800016
J	Paulson, T				Paulson, Tom			DRUG DEVELOPMENT Searching for patterns	NATURE			English	Editorial Material																		Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Rappuoli R, 2011, NATURE, V473, P463, DOI 10.1038/nature10124; Ravindran R, 2014, SCIENCE, V343, P313, DOI 10.1126/science.1246829	5	2	2	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					S10	S11		10.1038/507S10a	http://dx.doi.org/10.1038/507S10a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC0ZQ	24611170	Bronze			2022-12-28	WOS:000332224400005
J	Sun, J; Bankston, JR; Payandeh, J; Hinds, TR; Zagotta, WN; Zheng, N				Sun, Ji; Bankston, John R.; Payandeh, Jian; Hinds, Thomas R.; Zagotta, William N.; Zheng, Ning			Crystal structure of the plant dual-affinity nitrate transporter NRT1.1	NATURE			English	Article							GLUCOSE TRANSPORTERS; CHL1 FUNCTIONS; ARABIDOPSIS; MECHANISM; PROTEIN; MEMBRANE; REVEALS; ENCODES; SYSTEM; DIMER	Nitrate is a primary nutrient for plant growth, but its levels in soil can fluctuate by several orders of magnitude. Previous studies have identified Arabidopsis NRT1.1 as a dual-affinity nitrate transporter that can take up nitrate over a wide range of concentrations. The mode of action of NRT1.1 is controlled by phosphorylation of a key residue, Thr 101; however, how this post-translational modification switches the transporter between two affinity states remains unclear. Here we report the crystal structure of unphosphorylated NRT1.1, which reveals an unexpected homodimer in the inward-facing conformation. In this low-affinity state, the Thr 101 phosphorylation site is embedded in a pocket immediately adjacent to the dimer interface, linking the phosphorylation status of the transporter to its oligomeric state. Using a cell-based fluorescence resonance energy transfer assay, we show that functional NRT1.1 dimerizes in the cell membrane and that the phosphomimetic mutation of Thr 101 converts the protein into a monophasic high-affinity transporter by structurally decoupling the dimer. Together with analyses of the substrate transport tunnel, our results establish a phosphorylation-controlled dimerization switch that allows NRT1.1 to uptake nitrate with two distinct affinity modes.	[Sun, Ji; Payandeh, Jian; Hinds, Thomas R.; Zheng, Ning] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Bankston, John R.; Zagotta, William N.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Zheng, Ning] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Zheng, N (corresponding author), Univ Washington, Dept Pharmacol, Box 357280, Seattle, WA 98195 USA.	nzheng@u.washington.edu	Bankston, John/I-7429-2019	Bankston, John/0000-0002-9478-2335; Sun, Ji/0000-0002-9302-3177	Howard Hughes Medical Institute; National Institutes of Health [R01EY10329, NS074545]; National Science Foundation; NATIONAL EYE INSTITUTE [R01EY010329] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS074545] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the beamline staff of the Advanced Light Source at the University of California at Berkeley. We also thank members of the Zheng laboratory, Zagotta laboratory, Xu laboratory and H. Zheng for discussion and help. This work is supported by the Howard Hughes Medical Institute (N. Z.), National Institutes of Health (R01EY10329 to W. N. Z., NS074545 to J.R.B.) and the National Science Foundation (N.Z.).	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bouguyon E, 2012, SEMIN CELL DEV BIOL, V23, P648, DOI 10.1016/j.semcdb.2012.01.004; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; DiMaio F, 2011, NATURE, V473, P540, DOI 10.1038/nature09964; Doki S, 2013, P NATL ACAD SCI USA, V110, P11343, DOI 10.1073/pnas.1301079110; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Guo FO, 2003, PLANT CELL, V15, P107, DOI 10.1105/tpc.006312; Ho CH, 2009, CELL, V138, P1184, DOI 10.1016/j.cell.2009.07.004; Hou ZJ, 2010, J BIOL CHEM, V285, P4732, DOI 10.1074/jbc.M109.086033; Huang NC, 1996, PLANT CELL, V8, P2183, DOI 10.1105/tpc.8.12.2183; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Krouk G, 2010, DEV CELL, V18, P927, DOI 10.1016/j.devcel.2010.05.008; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Leran S, 2014, TRENDS PLANT SCI, V19, P5, DOI 10.1016/j.tplants.2013.08.008; Liu KH, 2003, EMBO J, V22, P1005, DOI 10.1093/emboj/cdg118; Liu KH, 1999, PLANT CELL, V11, P865, DOI 10.1105/tpc.11.5.865; Munos S, 2004, PLANT CELL, V16, P2433, DOI 10.1105/tpc.104.024380; Nacry P, 2013, PLANT SOIL, V370, P1, DOI 10.1007/s11104-013-1645-9; Newstead S, 2011, EMBO J, V30, P417, DOI 10.1038/emboj.2010.309; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; Pedersen BP, 2013, NATURE, V496, P533, DOI 10.1038/nature12042; PESSINO A, 1991, J BIOL CHEM, V266, P20213; Safferling M, 2003, BIOCHEMISTRY-US, V42, P13969, DOI 10.1021/bi035173q; Slotboom DJ, 2008, METHODS, V46, P73, DOI 10.1016/j.ymeth.2008.06.012; Solcan N, 2012, EMBO J, V31, P3411, DOI 10.1038/emboj.2012.157; Sun LF, 2012, NATURE, V490, P361, DOI 10.1038/nature11524; Taraska JW, 2010, NEURON, V66, P170, DOI 10.1016/j.neuron.2010.02.002; TSAY YF, 1993, CELL, V72, P705, DOI 10.1016/0092-8674(93)90399-B; Tsay YF, 2007, FEBS LETT, V581, P2290, DOI 10.1016/j.febslet.2007.04.047; Veenhoff LM, 2001, EMBO J, V20, P3056, DOI 10.1093/emboj/20.12.3056; Walch-Liu P, 2006, ANN BOT-LONDON, V97, P875, DOI 10.1093/aob/mcj601; Wang RC, 2003, PLANT PHYSIOL, V132, P556, DOI 10.1104/pp.103.021253; Wang RC, 1998, P NATL ACAD SCI USA, V95, P15134, DOI 10.1073/pnas.95.25.15134; Wang YY, 2012, TRENDS PLANT SCI, V17, P458, DOI 10.1016/j.tplants.2012.04.006; Yan HC, 2013, CELL REP, V3, P716, DOI 10.1016/j.celrep.2013.03.007; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629; Zheng HJ, 2013, NATURE, V497, P647, DOI 10.1038/nature12139; Zheng J, 2002, NEURON, V36, P891, DOI 10.1016/S0896-6273(02)01099-1	40	194	212	8	160	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					73	+		10.1038/nature13074	http://dx.doi.org/10.1038/nature13074			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0ZQ	24572362	Green Accepted			2022-12-28	WOS:000332224400044
J	Pass, BJ; Rattner, H				Pass, Bernard J.; Rattner, Herbert			Treatment of Pyoderma With Polymyxin B-Bacitracin Ointment (Reprinted from vol 155, pg 1153, 1954)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		PASS BJ, 1954, JAMA-J AM MED ASSOC, V155, P1153, DOI 10.1001/jama.1954.73690310003007b	1	0	1	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2014	311	9					969	969		10.1001/jama.2013.279369	http://dx.doi.org/10.1001/jama.2013.279369			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC0FS	24595794				2022-12-28	WOS:000332170800037
J	Migliore, M; Signorelli, M; Caltabiano, R; Aguglia, E				Migliore, Marcello; Signorelli, Maria; Caltabiano, Rosario; Aguglia, Eugenio			Flank pain caused by slipping rib syndrome	LANCET			English	Editorial Material									[Migliore, Marcello] Univ Catania, Dept Surg, Sect Thorac Surg, Catania, Italy; [Signorelli, Maria; Aguglia, Eugenio] Univ Catania, Sect Psychiat, Dept Clin & Mol Biomed, Catania, Italy; [Caltabiano, Rosario] Univ Catania, Dept Ingrassia, Sect Human Pathol, Catania, Italy	University of Catania; University of Catania; University of Catania	Migliore, M (corresponding author), Policlin Univ Hosp, Dept Surg, Sect Thorac Surg, Via S Sofi 78, I-95124 Catania, Italy.	mmiglior@unict.it	Caltabiano, Rosario/I-7583-2019; Signorelli, Maria/E-6155-2010; Signorelli, Maria S/A-7422-2016; Migliore, Marcello/O-7545-2017; Signorelli, Maria Salvina/E-6155-2010	Caltabiano, Rosario/0000-0001-8591-8010; Signorelli, Maria/0000-0002-6941-9454; Signorelli, Maria S/0000-0002-6941-9454; Migliore, Marcello/0000-0002-6272-8983; Signorelli, Maria Salvina/0000-0001-5835-4176; aguglia, eugenio/0000-0003-2146-7737				Elwahab SMA, 2012, BMJ CASE REPORTS, DOI [10.1136/bcr-2012-006306, DOI 10.1136/BCR-2012-006306]; HEINZ GJ, 1977, JAMA-J AM MED ASSOC, V237, P794, DOI 10.1001/jama.237.8.794; Migliore M, 2012, JAMA-J AM MED ASSOC, V307, P1746, DOI 10.1001/jama.2012.506; WRIGHT JT, 1980, LANCET, V2, P632	4	9	9	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2014	383	9919					844	844		10.1016/S0140-6736(14)60156-2	http://dx.doi.org/10.1016/S0140-6736(14)60156-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC3EV	24581669				2022-12-28	WOS:000332398700032
J	Ernst, A; Alkass, K; Bernard, S; Salehpour, M; Perl, S; Tisdale, J; Possnert, G; Druid, H; Frisen, J				Ernst, Aurelie; Alkass, Kanar; Bernard, Samuel; Salehpour, Mehran; Perl, Shira; Tisdale, John; Possnert, Goran; Druid, Henrik; Frisen, Jonas			Neurogenesis in the Striatum of the Adult Human Brain	CELL			English	Article							ENHANCED SYNAPTIC PLASTICITY; ROSTRAL MIGRATORY STREAM; NEWLY GENERATED NEURONS; NEURAL STEM-CELLS; HIPPOCAMPAL NEUROGENESIS; HUNTINGTONS-DISEASE; SUBVENTRICULAR ZONE; PATTERN SEPARATION; MACAQUE MONKEYS; GRANULE CELLS	In most mammals, neurons are added throughout life in the hippocampus and olfactory bulb. One area where neuroblasts that give rise to adult-born neurons are generated is the lateral ventricle wall of the brain. We show, using histological and carbon-14 dating approaches, that in adult humans new neurons integrate in the striatum, which is adjacent to this neurogenic niche. The neuronal turnover in the striatum appears restricted to interneurons, and postnatally generated striatal neurons are preferentially depleted in patients with Huntington's disease. Our findings demonstrate a unique pattern of neurogenesis in the adult human brain.	[Ernst, Aurelie; Alkass, Kanar; Frisen, Jonas] Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; [Alkass, Kanar; Druid, Henrik] Karolinska Inst, Dept Oncol Pathol, S-17177 Stockholm, Sweden; [Bernard, Samuel] Univ Lyon, Inst Camille Jordan, CNRS UMR 5208, F-69622 Villeurbanne, France; [Salehpour, Mehran; Possnert, Goran] Uppsala Univ, Dept Phys & Astron Ion Phys, S-75120 Uppsala, Sweden; [Perl, Shira; Tisdale, John] NHLBI, NIH, Bethesda, MD 20892 USA	Karolinska Institutet; Karolinska Institutet; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Centrale de Lyon; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Universite Jean Monnet; Uppsala University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Frisen, J (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden.	jonas.frisen@ki.se	Bernard, Samuel/A-5623-2009	Bernard, Samuel/0000-0002-8442-9968; Druid, Henrik/0000-0002-9198-023X; alkass, kanar/0000-0002-9154-5393	NIHR Cambridge Biomedical Research Centre; Swedish Research Council; Swedish Cancer Society; Karolinska Institute; Tobias Stiftelsen; AFA Forsakringar; Strategic Research Programme in Stem Cells and Regenerative Medicine at Karolinska Institutet (StratRegen); ERC; Knut och Alice Wallenbergs Stiftelse; Stockholm County Council; Karolinska Institutet [ALF 20080508]; Torsten Soderbergs Stiftelse	NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Karolinska Institute(Karolinska Institutet); Tobias Stiftelsen; AFA Forsakringar; Strategic Research Programme in Stem Cells and Regenerative Medicine at Karolinska Institutet (StratRegen); ERC(European Research Council (ERC)European Commission); Knut och Alice Wallenbergs Stiftelse(Knut & Alice Wallenberg Foundation); Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Torsten Soderbergs Stiftelse	We thank the Cambridge Brain Bank, Cambridge (UK), and the NICHD Brain and Tissue Bank for Developmental Disorders, Baltimore, Maryland (USA), for providing tissue. The Cambridge Brain Bank is supported by the NIHR Cambridge Biomedical Research Centre. The staff at the Swedish National Board of Forensic Medicine is acknowledged for cooperation in tissue donation. We thank Marcelo Toro, Sarantis Giatrellis, and Mathilde Chapuis for help with flow cytometry and evaluation of immunostainings and Helena Lonnqvist for help with DNA extraction. We thank Nenad Bogdanovic for anatomical evaluation of human brain sections, Konstantinos Meletis for discussions, and Karl Hakansson for AMS samples preparation. This study was supported by grants from the Swedish Research Council, the Swedish Cancer Society, the Karolinska Institute, Tobias Stiftelsen, AFA Forsakringar, the Strategic Research Programme in Stem Cells and Regenerative Medicine at Karolinska Institutet (StratRegen), the ERC and Knut och Alice Wallenbergs Stiftelse, the regional agreement on medical training and clinical research between Stockholm County Council and the Karolinska Institutet (ALF 20080508) and Torsten Soderbergs Stiftelse.	Androutsellis-Theotokis A, 2009, P NATL ACAD SCI USA, V106, P13570, DOI 10.1073/pnas.0905125106; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bedard A, 2002, NEUROSCI LETT, V328, P213, DOI 10.1016/S0304-3940(02)00530-X; Bedard A, 2002, EUR J NEUROSCI, V16, P1917, DOI 10.1046/j.1460-9568.2002.02263.x; Ben M'Barek K, 2013, J NEUROSCI, V33, P8608, DOI 10.1523/JNEUROSCI.5110-12.2013; Bergmann O, 2012, NEURON, V74, P634, DOI 10.1016/j.neuron.2012.03.030; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bhardwaj RD, 2006, P NATL ACAD SCI USA, V103, P12564, DOI 10.1073/pnas.0605177103; Cicchetti F, 2000, BRAIN RES REV, V34, P80, DOI 10.1016/S0165-0173(00)00039-4; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Curtis MA, 2003, P NATL ACAD SCI USA, V100, P9023, DOI 10.1073/pnas.1532244100; Dayer AG, 2005, J CELL BIOL, V168, P415, DOI 10.1083/jcb.200407053; Eisch AJ, 2012, SCIENCE, V338, P72, DOI 10.1126/science.1222941; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Feldheim DA, 1998, NEURON, V21, P1303, DOI 10.1016/S0896-6273(00)80650-9; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Godin JD, 2010, NEURON, V67, P392, DOI 10.1016/j.neuron.2010.06.027; Goritz C, 2012, CELL STEM CELL, V10, P657, DOI 10.1016/j.stem.2012.04.005; Hou SW, 2008, STROKE, V39, P2837, DOI 10.1161/STROKEAHA.107.510982; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kempermann G, 2012, NAT REV NEUROSCI, V13, P727, DOI 10.1038/nrn3319; Kheirbek MA, 2012, NAT NEUROSCI, V15, P1613, DOI 10.1038/nn.3262; Klempin F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025760; Knoth R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008809; Kohl Z, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-114; Kohler SJ, 2011, P NATL ACAD SCI USA, V108, P10326, DOI 10.1073/pnas.1017099108; Luzzati F, 2006, J NEUROSCI, V26, P609, DOI 10.1523/JNEUROSCI.4371-05.2006; Macas J, 2006, J NEUROSCI, V26, P13114, DOI 10.1523/JNEUROSCI.4667-06.2006; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nacher J, 2002, BRAIN RES, V927, P111, DOI 10.1016/S0006-8993(01)03241-3; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; Plumpe T, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-77; RAKIC P, 1985, SCIENCE, V227, P1054, DOI 10.1126/science.3975601; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Salehpour M, 2013, RADIOCARBON, V55, P865, DOI 10.1017/S0033822200058021; Salehpour M, 2013, NUCL INSTRUM METH B, V294, P97, DOI 10.1016/j.nimb.2012.08.054; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Seki T, 2002, J NEUROSCI RES, V70, P327, DOI 10.1002/jnr.10387; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002; Spalding KL, 2005, CELL, V122, P133, DOI 10.1016/j.cell.2005.04.028; Sulzer D, 2008, J NEUROCHEM, V106, P24, DOI 10.1111/j.1471-4159.2008.05385.x; Tepper JM, 2004, CURR OPIN NEUROBIOL, V14, P685, DOI 10.1016/j.conb.2004.10.003; Tonchev AB, 2005, J NEUROSCI RES, V81, P776, DOI 10.1002/jnr.20604; Tonchev AB, 2003, MOL CELL NEUROSCI, V23, P292, DOI 10.1016/S1044-7431(03)00058-7; Tong J, 2011, NEUROBIOL DIS, V41, P458, DOI 10.1016/j.nbd.2010.10.017; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Walker TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018153; Wang CM, 2011, CELL RES, V21, P1534, DOI 10.1038/cr.2011.83; Wei B, 2011, EUR J NEUROSCI, V33, P819, DOI 10.1111/j.1460-9568.2010.07570.x; Zachrisson O, 2011, J PARKINSON DIS, V1, P49, DOI 10.3233/JPD-2011-0003; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009	52	606	626	2	131	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 27	2014	156	5					1072	1083		10.1016/j.cell.2014.01.044	http://dx.doi.org/10.1016/j.cell.2014.01.044			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AB9BK	24561062	Bronze, Green Submitted			2022-12-28	WOS:000332083900022
J	Kaser, A; Blumberg, RS				Kaser, Arthur; Blumberg, Richard S.			CELL BIOLOGY Stressful genetics in Crohn's disease	NATURE			English	Editorial Material							AUTOPHAGY; VARIANT		[Kaser, Arthur] Univ Cambridge, Addenbrookes Hosp, Dept Med, Div Gastroenterol & Hepatol, Cambridge CB2 0QQ, England; [Blumberg, Richard S.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Gastroenterol Hepatol & Endoscopy,Dept Med, Boston, MA 02115 USA	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Kaser, A (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med, Div Gastroenterol & Hepatol, Cambridge CB2 0QQ, England.	ak729@cam.ac.uk; rblumberg@partners.org			NIDDK NIH HHS [P30 DK034854, R01 DK088199] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854, R01DK088199] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adolph TE, 2013, NATURE, V503, P272, DOI 10.1038/nature12599; Deuring J. J., 2013, GUT; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Khalil H, 2012, MOL CELL BIOL, V32, P4523, DOI 10.1128/MCB.00774-12; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; Murthy A, 2014, NATURE, V506, P456, DOI 10.1038/nature13044; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Uhlig HH, 2013, GUT, V62, P1795, DOI 10.1136/gutjnl-2012-303956	11	6	7	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2014	506	7489					441	442		10.1038/nature13060	http://dx.doi.org/10.1038/nature13060			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0DN	24553137	Green Accepted			2022-12-28	WOS:000332165100027
J	Rahman, A; Underwood, M; Carnes, D				Rahman, Anisur; Underwood, Martin; Carnes, Dawn			Fibromyalgia	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CHRONIC WIDESPREAD PAIN; RHEUMATIC-DISEASES; PREVALENCE; MANAGEMENT; CRITERIA; ACETAMINOPHEN; DIAGNOSIS; EFFICACY; TRAMADOL; TRIAL		[Rahman, Anisur] UCL, Dept Rheumatol, London WC1E 6JF, England; [Underwood, Martin] Univ Warwick, Warwick Clin Trials Unit, Coventry CV4 7AL, W Midlands, England; [Carnes, Dawn] Barts & London Queen Marys Sch Med & Dent, Ctr Primary Care & Publ Hlth, London, England	University of London; University College London; University of Warwick; University of London; Queen Mary University London	Rahman, A (corresponding author), UCL, Dept Rheumatol, London WC1E 6JF, England.	anisur.rahman@ucl.ac.uk	Luciano, Juan V/H-5585-2012; Brauer, Sandra G/D-4519-2011; Ablin, Jacob/V-9716-2019; Guymer, Emma/I-2025-2013; Underwood, Martin/D-6364-2015	Luciano, Juan V/0000-0003-0750-1599; Brauer, Sandra G/0000-0001-9961-4739; Guymer, Emma/0000-0001-6712-1331; Underwood, Martin/0000-0002-0309-1708	National Institute for Health Research University College London Hospitals Biomedical Research Centre; Advantage West Midlands; National Institute for Health Research [NF-SI-0512-10103] Funding Source: researchfish	National Institute for Health Research University College London Hospitals Biomedical Research Centre(General Electric); Advantage West Midlands(General Electric); National Institute for Health Research(National Institute for Health Research (NIHR))	AR is supported by the National Institute for Health Research University College London Hospitals Biomedical Research Centre. MU's contribution benefited from facilities funded through Birmingham Science City Translational Medicine Clinical Research and Infrastructure Trials Platform, with support from Advantage West Midlands.	Ablin J, 2008, JOINT BONE SPINE, V75, P273, DOI 10.1016/j.jbspin.2007.09.010; Annemans L, 2008, ARTHRITIS RHEUM-US, V58, P895, DOI 10.1002/art.23265; Arnold LM, 2013, ARTHRITIS RHEUM-US, V65, P1122, DOI 10.1002/art.37842; Beck J.S., 2011, COGNITIVE BEHAV THER, V(2nd); Bennett RA, 2003, AM J MED, V114, P537, DOI 10.1016/S0002-9343(03)00116-5; Bernardy K, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009796.pub2; Biasi G, 1998, INT J CLIN PHARM RES, V18, P13; Burckhardt C., 2005, APS CLIN PRACTICE GU; Busch A, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003786.pub2; Carville SF, 2008, ANN RHEUM DIS, V67, P536, DOI 10.1136/ard.2007.071522; Cedraschi C, 2004, ANN RHEUM DIS, V63, P290, DOI 10.1136/ard.2002.004945; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; CROFT P, 1993, J RHEUMATOL, V20, P710; Deare JC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007070.pub2; Ferrari R, 2013, J RHEUMATOL, V40, P1590, DOI 10.3899/jrheum.130367; Fitzcharles M.A., 2012, CANADIAN GUIDELINES; Froud R, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X630034; Goldenberg DL, 2004, JAMA-J AM MED ASSOC, V292, P2388, DOI 10.1001/jama.292.19.2388; Hauser W, 2012, CLIN EXP RHEUMATOL, V30, pS78; Hauser W, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010292; Hauser W, 2010, EUR J PAIN, V14, P5, DOI 10.1016/j.ejpain.2009.01.006; Hauser W, 2009, ARTHRIT RHEUM-ARTHR, V61, P216, DOI 10.1002/art.24276; Hauser W, 2009, JAMA-J AM MED ASSOC, V301, P198, DOI 10.1001/jama.2008.944; Haq SA, 2005, J RHEUMATOL, V32, P348; Hughes G, 2006, ARTHRITIS RHEUM-US, V54, P177, DOI 10.1002/art.21545; Julien N, 2005, PAIN, V114, P295, DOI 10.1016/j.pain.2004.12.032; Lunn MPT, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007115.pub3; McBeth J, 2001, ARTHRITIS RHEUM, V44, P940, DOI 10.1002/1529-0131(200104)44:4<940::AID-ANR151>3.0.CO;2-S; Moore A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2690; Moore R Andrew, 2012, Cochrane Database Syst Rev, V12, pCD008242, DOI 10.1002/14651858.CD008242.pub2; Nuesch E, 2013, ANN RHEUM DIS, V72, P955, DOI 10.1136/annrheumdis-2011-201249; Phillips K, 2013, ARTHRITIS RHEUM-US, V65, P291, DOI 10.1002/art.37739; Roskell NS, 2011, PAIN PRACT, V11, P516, DOI 10.1111/j.1533-2500.2010.00441.x; RUSSELL IJ, 1992, ARTHRITIS RHEUM, V35, P550, DOI 10.1002/art.1780350509; RUSSELL IJ, 1994, ARTHRITIS RHEUM-US, V37, P1593, DOI 10.1002/art.1780371106; Tan EM, 1997, ARTHRITIS RHEUM-US, V40, P1601, DOI 10.1002/art.1780400909; Uceyler N, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010782; Valdes M, 2010, ARTHRITIS RHEUM-US, V62, P1829, DOI 10.1002/art.27430; Vincent A, 2013, ARTHRIT CARE RES, V65, P786, DOI 10.1002/acr.21896; Wiffen Philip J, 2013, Cochrane Database Syst Rev, pCD010567, DOI 10.1002/14651858.CD010567.pub2; WOLFE F, 1995, ARTHRITIS RHEUM-US, V38, P19, DOI 10.1002/art.1780380104; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Wolfe F, 2000, ARTHRITIS RHEUM-US, V43, P378, DOI 10.1002/1529-0131(200002)43:2<378::AID-ANR18>3.0.CO;2-2; Wolfe F, 2013, ARTHRIT CARE RES, V65, P777, DOI 10.1002/acr.21931; Wolfe F, 2011, J RHEUMATOL, V38, P1113, DOI 10.3899/jrheum.100594; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140; Wolfe F, 2009, J RHEUMATOL, V36, P671, DOI 10.3899/jrheum.081180	47	44	45	1	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	2014	348								g1224	10.1136/bmj.g1224	http://dx.doi.org/10.1136/bmj.g1224			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC0TP	24566297				2022-12-28	WOS:000332208400001
J	Yuan, JK; Poulin, P				Yuan, Jinkai; Poulin, Philippe			Fibers Do the Twist	SCIENCE			English	Editorial Material							MEMORY; SHAPE; ACTUATION; MUSCLES		[Yuan, Jinkai; Poulin, Philippe] Univ Bordeaux, CNRS, Ctr Rech Paul Pascal, F-33600 Pessac, France	Centre de Recherche Paul Pascal; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Yuan, JK (corresponding author), Univ Bordeaux, CNRS, Ctr Rech Paul Pascal, 115 Ave Schweitzer, F-33600 Pessac, France.	poulin@crpp-bordeaux.cnrs.fr	Yuan, Jinkai/F-3332-2011; Yuan, Jinkai/AGZ-2314-2022	Yuan, Jinkai/0000-0003-2347-5191; Poulin, Philippe/0000-0001-7748-8671				Foroughi J, 2011, SCIENCE, V334, P494, DOI 10.1126/science.1211220; Guo WH, 2012, ADV MATER, V24, P5379, DOI 10.1002/adma.201201845; Haines CS, 2014, SCIENCE, V343, P868, DOI 10.1126/science.1246906; Huber JE, 1997, P ROY SOC A-MATH PHY, V453, P2185, DOI 10.1098/rspa.1997.0117; Lendlein A, 2002, ANGEW CHEM INT EDIT, V41, P2034, DOI 10.1002/1521-3773(20020617)41:12<2034::AID-ANIE2034>3.0.CO;2-M; Lima MD, 2012, SCIENCE, V338, P928, DOI 10.1126/science.1226762; Miaudet P, 2007, SCIENCE, V318, P1294, DOI 10.1126/science.1145593; Ray E. D., 1980, POP SCI, V216, P126; Van Humbeeck J, 2001, ADV ENG MATER, V3, P837, DOI 10.1002/1527-2648(200111)3:11<837::AID-ADEM837>3.0.CO;2-0	9	16	17	7	147	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 21	2014	343	6173					845	846		10.1126/science.1250471	http://dx.doi.org/10.1126/science.1250471			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB1LG	24558149				2022-12-28	WOS:000331552600032
J	Choudhry, N; Rao, RC				Choudhry, Netan; Rao, Rajesh C.			Valsalva Retinopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Choudhry, Netan] Herzig Eye Inst, Toronto, ON, Canada; [Rao, Rajesh C.] Univ Michigan, Sch Med, Ann Arbor, MI USA	University of Michigan System; University of Michigan	Choudhry, N (corresponding author), Herzig Eye Inst, Toronto, ON, Canada.	rajeshr@umich.edu	Rao, Rajesh C./N-1107-2017	Rao, Rajesh C./0000-0002-5776-8366	NATIONAL EYE INSTITUTE [K12EY022299] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))			0	5	5	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 20	2014	370	8					E13	E13		10.1056/NEJMicm1304102	http://dx.doi.org/10.1056/NEJMicm1304102			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB1DO	24552347				2022-12-28	WOS:000331531900001
J	Zimmermann, C; Swami, N; Krzyzanowska, M; Hannon, B; Leighl, N; Oza, A; Moore, M; Rydall, A; Rodin, G; Tannock, I; Donner, A; Lo, C				Zimmermann, Camilla; Swami, Nadia; Krzyzanowska, Monika; Hannon, Breffni; Leighl, Natasha; Oza, Amit; Moore, Malcolm; Rydall, Anne; Rodin, Gary; Tannock, Ian; Donner, Allan; Lo, Christopher			Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial	LANCET			English	Article							QUALITY-OF-LIFE; INTEGRATION; PEOPLE	Background Patients with advanced cancer have reduced quality of life, which tends to worsen towards the end of life. We assessed the effect of early palliative care in patients with advanced cancer on several aspects of quality of life. Methods The study took place at the Princess Margaret Cancer Centre (Toronto, ON, Canada), between Dec 1, 2006, and Feb 28, 2011. 24 medical oncology clinics were cluster randomised (in a 1:1 ratio, using a computer-generated sequence, stratified by clinic size and tumour site [four lung, eight gastrointestinal, four genitourinary, six breast, two gynaecological]), to consultation and follow-up (at least monthly) by a palliative care team or to standard cancer care. Complete masking of interventions was not possible; however, patients provided written informed consent to participate in their own study group, without being informed of the existence of another group. Eligible patients had advanced cancer, European Cooperative Oncology Group performance status of 0-2, and a clinical prognosis of 6-24 months. Quality of life (Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being [FACIT-Sp] scale and Quality of Life at the End of Life [QUAL-E] scale), symptom severity (Edmonton Symptom Assessment System [ESAS]), satisfaction with care (FAMCARE-P16), and problems with medical interactions (Cancer Rehabilitation Evaluation System Medical Interaction Subscale [CARES-MIS]) were measured at baseline and monthly for 4 months. The primary outcome was change score for FACIT-Sp at 3 months. Secondary endpoints included change score for FACIT-Sp at 4 months and change scores for other scales at 3 and 4 months. This trial is registered with ClinicalTrials.gov, number NCT01248624. Findings 461 patients completed baseline measures (228 intervention, 233 control); 393 completed at least one follow-up assessment. At 3-months, there was a non-significant difference in change score for FACIT-Sp between intervention and control groups (3 . 56 points [95% CI -0.27 to 7.40], p = 0.07), a significant difference in QUAL-E (2.25 [0.01 to 4.49], p = 0.05) and FAMCARE-P16 (3.79 [1.74 to 5.85], p = 0.0003), and no difference in ESAS (-1.70 [-5.26 to 1.87], p = 0.33) or CARES-MIS (-0.66 [-2.25 to 0.94], p = 0.40). At 4 months, there were significant differences in change scores for all outcomes except CARES-MIS. All differences favoured the intervention group. Interpretation Although the difference in quality of life was non-significant at the primary endpoint, this trial shows promising findings that support early palliative care for patients with advanced cancer.	[Zimmermann, Camilla; Krzyzanowska, Monika; Hannon, Breffni; Leighl, Natasha; Oza, Amit; Moore, Malcolm; Tannock, Ian] Univ Toronto, Dept Med, Div Med Oncol & Haematol, Toronto, ON, Canada; [Zimmermann, Camilla; Rodin, Gary; Lo, Christopher] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Zimmermann, Camilla; Swami, Nadia; Hannon, Breffni; Rydall, Anne; Rodin, Gary; Lo, Christopher] Univ Hlth Network, Princess Margaret Canc Ctr, Dept Psychosocial Oncol & Palliat Care, Toronto, ON, Canada; [Krzyzanowska, Monika; Leighl, Natasha; Oza, Amit; Moore, Malcolm; Tannock, Ian] Univ Hlth Network, Princess Margaret Canc Ctr, Dept Med Oncol, Toronto, ON, Canada; [Zimmermann, Camilla; Rodin, Gary; Tannock, Ian] Univ Hlth Network, Princess Margaret Canc Ctr, Campbell Family Canc Res Inst, Toronto, ON, Canada; [Donner, Allan] Univ Western Ontario, London, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Western University (University of Western Ontario)	Zimmermann, C (corresponding author), Princess Margaret Canc Ctr, Dept Psychosocial Oncol & Palliat Care, Toronto, ON, Canada.	camilla.zimmermann@uhn.ca	Krzyzanowska, Monika K./ABG-3505-2020; Lo, Chris/AFJ-9787-2022; Harding, Richard/G-9729-2012	Krzyzanowska, Monika K./0000-0001-5533-7418; Lo, Chris/0000-0003-2171-6254; Zimmermann, Camilla/0000-0003-4889-0244; Rodin, Gary/0000-0002-6626-6974; Rydall, Anne/0000-0002-4692-9101; Oza, Amit/0000-0002-9510-8641	Canadian Cancer Society [017257, 020509]; Ontario Ministry of Health and Long Term Care; Rose Family Chair in Supportive Care, Faculty of Medicine, University of Toronto	Canadian Cancer Society(Canadian Cancer Society (CCS)); Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario); Rose Family Chair in Supportive Care, Faculty of Medicine, University of Toronto	Results of this study were presented, in part, at the American Society of Clinical Oncology (ASCO) Annual Meeting; Chicago, IL, USA; June 4, 2012; and at Best of ASCO, 2012. This study was funded by grants 017257 and 020509 from the Canadian Cancer Society (CZ) and by the Ontario Ministry of Health and Long Term Care. CZ is also supported by the Rose Family Chair in Supportive Care, Faculty of Medicine, University of Toronto. The views expressed in the study do not necessarily represent those of the sponsors. We thank the patients who participated in this study, and their caregivers. We thank the medical oncologists who referred patients to this study, and the clinical and administrative staff of the palliative care team at Princess Margaret Cancer Centre. We thank Debika Burman, Nanor Kevork, and Ashley Pope (Department of Psychosocial Oncology and Palliative Care, Princess Margaret Cancer Centre) for their assistance with preparation of study materials, recruitment of patients, and data entry and preparation.	Bakitas M, 2009, JAMA-J AM MED ASSOC, V302, P741, DOI 10.1001/jama.2009.1198; Bruera E, 1991, J Palliat Care, V7, P6; Campbell Marion K, 2012, BMJ, V345, pe5661, DOI 10.1136/bmj.e5661; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Craig Peter, 2008, BMJ, V337, pa1655, DOI 10.1136/bmj.a1655; de Raaf PJ, 2013, J CLIN ONCOL, V31, P716, DOI 10.1200/JCO.2012.44.4216; El Osta B, 2008, J PALLIAT MED, V11, P51, DOI 10.1089/jpm.2007.0103; Fairhurst K, 1996, J Health Serv Res Policy, V1, P77; Follwell M, 2009, J CLIN ONCOL, V27, P206, DOI 10.1200/JCO.2008.17.7568; Giesinger JM, 2011, J PALLIAT MED, V14, P904, DOI 10.1089/jpm.2011.0086; Gilbody S, 2002, BRIT J PSYCHIAT, V180, P13, DOI 10.1192/bjp.180.1.13; Glare P, 2003, BRIT MED J, V327, P195, DOI 10.1136/bmj.327.7408.195; Graham JW, 2007, PREV SCI, V8, P206, DOI 10.1007/s11121-007-0070-9; Harrison JD, 2009, SUPPORT CARE CANCER, V17, P1117, DOI 10.1007/s00520-009-0615-5; Hui D, 2010, JAMA-J AM MED ASSOC, V303, P1054, DOI 10.1001/jama.2010.258; Hwang SS, 2003, J PAIN SYMPTOM MANAG, V25, P225, DOI 10.1016/S0885-3924(02)00641-3; KATZMAN R, 1983, AM J PSYCHIAT, V140, P734; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Lamont EB, 2002, CANCER, V94, P2733, DOI 10.1002/cncr.10530; Lo C, 2009, QUAL LIFE RES, V18, P747, DOI 10.1007/s11136-009-9494-y; Lynch T, 2011, MAPPING LEVELS PALLI; Meier DE, 2008, J PALLIAT MED, V11, P823, DOI 10.1089/jpm.2008.9886; Morrison RS, 2000, ARCH INTERN MED, V160, P743, DOI 10.1001/archinte.160.6.743; Morrison RS, 2004, NEW ENGL J MED, V350, P2582, DOI 10.1056/NEJMcp035232; Morss S, 2008, J AM GERIATR SOC, V56, P124, DOI 10.1111/j.1532-5415.2007.01507.x; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Peterman AH, 2002, ANN BEHAV MED, V24, P49, DOI 10.1207/S15324796ABM2401_06; Rinck GC, 1997, J CLIN ONCOL, V15, P1697, DOI 10.1200/JCO.1997.15.4.1697; SCHAG CAC, 1990, HEALTH PSYCHOL, V9, P83, DOI 10.1037/0278-6133.9.1.83; Sepulveda C, 2002, J PAIN SYMPTOM MANAG, V24, P91, DOI 10.1016/S0885-3924(02)00440-2; Smith TJ, 2012, J CLIN ONCOL, V30, P880, DOI 10.1200/JCO.2011.38.5161; Steinhauser Karen E, 2004, Palliat Support Care, V2, P3; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Webster Kimberly, 2003, Health Qual Life Outcomes, V1, P79, DOI 10.1186/1477-7525-1-79; Wentlandt K, 2012, J CLIN ONCOL, V30, P4380, DOI 10.1200/JCO.2012.44.0248; Whitford HS, 2008, PSYCHO-ONCOLOGY, V17, P1121, DOI 10.1002/pon.1322; World Health Organization, WHO DEF PALL CAR; Zimmermann C, 2008, JAMA-J AM MED ASSOC, V299, P1698, DOI 10.1001/jama.299.14.1698; Zimmermann C, 2006, SUPPORT CARE CANCER, V14, P982, DOI 10.1007/s00520-006-0093-y	40	1024	1037	18	165	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 17	2014	383	9930					1721	1730		10.1016/S0140-6736(13)62416-2	http://dx.doi.org/10.1016/S0140-6736(13)62416-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH6UO	24559581				2022-12-28	WOS:000336267300025
J	Gierisch, JM; Myers, ER; Schmit, KM; Crowley, MJ; McCrory, DC; Chatterjee, R; Coeytaux, RR; Kendrick, A; Sanders, GD				Gierisch, Jennifer M.; Myers, Evan R.; Schmit, Kristine M.; Crowley, Matthew J.; McCrory, Douglas C.; Chatterjee, Ranee; Coeytaux, Remy R.; Kendrick, Amy; Sanders, Gillian D.			Prioritization of Research Addressing Management Strategies for Ductal Carcinoma In Situ	ANNALS OF INTERNAL MEDICINE			English	Article							BREAST; THERAPY; CANCER; RISK	Ductal carcinoma in situ is a common finding in women having mammography screening, and there is considerable uncertainty about the balance of harms and benefits of different management options. This article outlines the process for developing a prioritized research agenda for the Patient-Centered Outcomes Research Institute as informed by a diverse group of stakeholders on the management of ductal carcinoma in situ. Evidence gaps were identified by reviewing existing literature and engaging diverse stakeholders to refine these gaps. Stakeholders ranked evidence gaps by importance from their perspectives using a forced-ranking prioritization method. PubMed was searched for relevant recent studies, and ClinicalTrials.gov was searched for relevant ongoing trials for the 10 highest-ranked evidence gaps. Strengths and limitations of different study designs were assessed to address gaps. Stakeholders prioritized evidence gaps related to incorporation of patient-centered outcomes into future research, development of better methods to predict risk for invasive cancer, evaluation of a strategy of active surveillance, and testing of decision-making tools. The degree to which prioritized evidence gaps may have already been addressed is uncertain because a comprehensive systematic review has not been done.	Duke Clin Res Inst, Duke Evidence Synth Grp, Durham Vet Affairs Med Ctr, Ctr Hlth Serv Res Primary Care, Durham, NC USA; Duke Univ, Sch Med, Durham, NC 27701 USA	Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University	Gierisch, JM (corresponding author), Duke Univ, Med Ctr, Dept Med, Campus Box 104427 DUMC, Durham, NC 27701 USA.	j.gierisch@dm.duke.edu	Gierisch, Jennifer/GLU-1269-2022	Kendrick, Amy/0000-0001-8769-1702; Gierisch, Jennifer/0000-0002-5057-4964	PCORI	PCORI(Patient-Centered Outcomes Research Institute - PCORI)	By a contract from PCORI.	Allegra CJ, 2010, J NATL CANCER I, V102, P161, DOI 10.1093/jnci/djp485; American Cancer Society, 2013, CANCER FACTS FIGURE; Bijker N, 2001, J CLIN ONCOL, V19, P2263, DOI 10.1200/JCO.2001.19.8.2263; Chang SM, 2012, ANN INTERN MED, V157, P439, DOI 10.7326/0003-4819-157-6-201209180-00515; Emdin SO, 2006, ACTA ONCOL, V45, P536, DOI 10.1080/02841860600681569; Fisher B, 1998, J CLIN ONCOL, V16, P2672, DOI 10.1200/JCO.1998.16.8.2672; George WD, 2003, LANCET, V362, P95, DOI 10.1016/S0140-6736(03)13859-7; Goodwin A, 2009, COCHRANE DATABASE SY; Ip S, 2013, FUTURE RESEARCH NEED, V13-EHC016-EF; Kerlikowske K, 2010, JNCI-J NATL CANCER I, V102, P627, DOI 10.1093/jnci/djq101; National Institute for Health and Clinical Excellence, 2009, NICE CLINICAL GUIDEL, V80; National Research Council, 2013, DELIVERING HIGH QUAL; Sanders GD, 2010, FUTURE RESEARCH NEED, V11-EHC006-EF; Staley H, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007847.pub2; Virnig BA, 2009, EVID REP TECHNOL ASS, P1; Virnig BA, 2010, J NATL CANCER I, V102, P170, DOI 10.1093/jnci/djp482	16	27	27	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 1	2014	160	7					484	+		10.7326/M13-2548	http://dx.doi.org/10.7326/M13-2548			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE6IL	24567146				2022-12-28	WOS:000334093800006
J	Kubacka, T; Johnson, JA; Hoffmann, MC; Vicario, C; de Jong, S; Beaud, P; Grubel, S; Huang, SW; Huber, L; Patthey, L; Chuang, YD; Turner, JJ; Dakovski, GL; Lee, WS; Minitti, MP; Schlotter, W; Moore, RG; Hauri, CP; Koohpayeh, SM; Scagnoli, V; Ingold, G; Johnson, SL; Staub, U				Kubacka, T.; Johnson, J. A.; Hoffmann, M. C.; Vicario, C.; de Jong, S.; Beaud, P.; Gruebel, S.; Huang, S. -W.; Huber, L.; Patthey, L.; Chuang, Y. -D.; Turner, J. J.; Dakovski, G. L.; Lee, W. -S.; Minitti, M. P.; Schlotter, W.; Moore, R. G.; Hauri, C. P.; Koohpayeh, S. M.; Scagnoli, V.; Ingold, G.; Johnson, S. L.; Staub, U.			Large-Amplitude Spin Dynamics Driven by a THz Pulse in Resonance with an Electromagnon	SCIENCE			English	Article							FERROELECTRICITY; POLARIZATION; TBMNO3	Multiferroics have attracted strong interest for potential applications where electric fields control magnetic order. The ultimate speed of control via magnetoelectric coupling, however, remains largely unexplored. Here, we report an experiment in which we drove spin dynamics in multiferroic TbMnO3 with an intense few-cycle terahertz (THz) light pulse tuned to resonance with an electromagnon, an electric-dipole active spin excitation. We observed the resulting spin motion using time-resolved resonant soft x-ray diffraction. Our results show that it is possible to directly manipulate atomic-scale magnetic structures with the electric field of light on a sub-picosecond time scale.	[Kubacka, T.; Huber, L.; Johnson, S. L.] ETH, Inst Quantum Elect, CH-8093 Zurich, Switzerland; [Johnson, J. A.; Beaud, P.; Gruebel, S.; Huang, S. -W.; Scagnoli, V.; Ingold, G.; Staub, U.] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland; [Hoffmann, M. C.; de Jong, S.; Turner, J. J.; Dakovski, G. L.; Lee, W. -S.; Minitti, M. P.; Schlotter, W.] SLAC Natl Accelerator Lab, Linac Coherent Light Source LCLS, Menlo Pk, CA 94025 USA; [Vicario, C.; Patthey, L.; Hauri, C. P.] Paul Scherrer Inst, SwissFEL, CH-5232 Villigen, Switzerland; [Chuang, Y. -D.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA 94720 USA; [Moore, R. G.] SLAC Natl Accelerator Lab, Stanford Inst Mat & Energy Sci SIMES, Menlo Pk, CA 94025 USA; [Hauri, C. P.] Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland; [Koohpayeh, S. M.] Johns Hopkins Univ, Inst Quantum Matter IQM, Dept Phys & Astron, Baltimore, MD 21218 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Johns Hopkins University	Kubacka, T (corresponding author), ETH, Inst Quantum Elect, Wolfgang Pauli Str 16, CH-8093 Zurich, Switzerland.	tkubacka@phys.ethz.ch	Hoffmann, Matthias C./N-1082-2019; Patthey, Luc/G-6130-2018; Hauri, Christoph P/B-6192-2013; Moore, Rob/CAG-8039-2022; Staub, Urs/C-4914-2015; scagnoli, valerio/C-6833-2008; Beaud, Paul Alexandre/A-8178-2008; Hoffmann, Matthias C/B-3893-2009; Johnson, Steven Lee/B-3252-2008; scagnoli, valerio/T-1355-2019	Hoffmann, Matthias C./0000-0002-3596-9853; Patthey, Luc/0000-0001-6101-8069; Hauri, Christoph P/0000-0002-8751-0585; Moore, Rob/0000-0002-1608-5411; scagnoli, valerio/0000-0002-8116-8870; Beaud, Paul Alexandre/0000-0001-5028-9138; Hoffmann, Matthias C/0000-0002-3596-9853; Johnson, Steven Lee/0000-0001-6074-4894; scagnoli, valerio/0000-0002-8116-8870; Huber, Lucas/0000-0002-1631-2784; Staub, Urs/0000-0003-2035-3367; Kubacka, Teresa/0000-0002-0968-1311; Chuang, Yi-De/0000-0002-2773-3840; Johnson, Jeremy/0000-0001-9808-7172	LCLS; Stanford University through SIMES; Lawrence Berkeley National Laboratory; University of Hamburg through the BMBF [FSP 301]; Center for Free Electron Laser Science (CFEL); National Center for Competence in Research (NCCR) Molecular Ultrafast Science and Technology; NCCR Materials with Novel Electronic Properties; Swiss National Science Foundation; Swiss National Science Foundation [200021_144115]; DOE [DE-AC02-05CH11231]; DOE, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-FG02-08ER46544]; DOE, Office of Basic Energy Sciences, Materials Sciences and Engineering Division [DE-AC02-76SF00515]	LCLS; Stanford University through SIMES; Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); University of Hamburg through the BMBF; Center for Free Electron Laser Science (CFEL); National Center for Competence in Research (NCCR) Molecular Ultrafast Science and Technology; NCCR Materials with Novel Electronic Properties; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); DOE(United States Department of Energy (DOE)); DOE, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); DOE, Office of Basic Energy Sciences, Materials Sciences and Engineering Division(United States Department of Energy (DOE))	This research was carried out on the SXR Instrument at the LCLS, a division of SLAC and an Office of Science user facility operated by Stanford University for the U.S. Department of Energy (DOE). The SXR Instrument is funded by a consortium including the LCLS, Stanford University through SIMES, Lawrence Berkeley National Laboratory, the University of Hamburg through the BMBF priority program FSP 301, and the Center for Free Electron Laser Science (CFEL). This research was supported by the National Center for Competence in Research (NCCR) Molecular Ultrafast Science and Technology and NCCR Materials with Novel Electronic Properties, funded by the Swiss National Science Foundation, and by the Swiss National Science Foundation (grant no. 200021_144115). Our ultrafast activities are supported by the ETH Femtosecond and Attosecond Science and Technology (ETH-FAST) initiative as part of the NCCR MUST program. The Advanced Light Source is supported by DOE under contract no. DE-AC02-05CH11231. Crystal growth work at IQM was supported by DOE, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering under award DE-FG02-08ER46544. W.-S. L., Y.-D.C., and R.G.M. are supported by DOE, Office of Basic Energy Sciences, Materials Sciences and Engineering Division, under contract DE-AC02-76SF00515.	Aguilar RV, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.047203; Beaurepaire E, 1996, PHYS REV LETT, V76, P4250, DOI 10.1103/PhysRevLett.76.4250; Bodenthin Y, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.027201; Cheong SW, 2007, NAT MATER, V6, P13, DOI 10.1038/nmat1804; Choi YJ, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.097201; Eerenstein W, 2006, NATURE, V442, P759, DOI 10.1038/nature05023; Handayani IP, 2013, J PHYS-CONDENS MAT, V25, DOI 10.1088/0953-8984/25/11/116007; Hoffmann T, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.184404; Johnson SL, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.037203; Kampfrath T, 2011, NAT PHOTONICS, V5, P31, DOI [10.1038/nphoton.2010.259, 10.1038/NPHOTON.2010.259]; Katsura H, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.057205; Katsura H, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.027203; Kenzelmann M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.087206; Kimura T, 2003, NATURE, V426, P55, DOI 10.1038/nature02018; Kirilyuk A, 2010, REV MOD PHYS, V82, P2731, DOI 10.1103/RevModPhys.82.2731; Lottermoser T, 2004, NATURE, V430, P541, DOI 10.1038/nature02728; Lovesey S.W., 1996, XRAY SCATTERING ABSO; Malashevich A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.037210; Mochizuki M, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.147202; Mochizuki M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.177206; Mostovoy M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.067601; Pimenov A, 2006, NAT PHYS, V2, P97, DOI 10.1038/nphys212; Pimenov A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.107203; Rana DS, 2009, ADV MATER, V21, P2881, DOI 10.1002/adma.200802094; Rovillain P, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.027202; Ruchert C, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.123902; Sergienko IA, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.094434; Shuvaev AM, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.097202; Takahashi Y, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.187201; Vicario C, 2013, NAT PHOTONICS, V7, P720, DOI [10.1038/nphoton.2013.209, 10.1038/NPHOTON.2013.209]; Walker HC, 2011, SCIENCE, V333, P1273, DOI 10.1126/science.1208085; Wilkins SB, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.207602; Yamaguchi K, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.237201; Yamasaki Y, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.147204	34	208	209	13	282	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2014	343	6177					1333	1336		10.1126/science.1242862	http://dx.doi.org/10.1126/science.1242862			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD3AI	24603154	Green Accepted			2022-12-28	WOS:000333108500031
J	Beghein, C; Yuan, KQ; Schmerr, N; Xing, Z				Beghein, Caroline; Yuan, Kaiqing; Schmerr, Nicholas; Xing, Zheng			Changes in Seismic Anisotropy Shed Light on the Nature of the Gutenberg Discontinuity	SCIENCE			English	Article							LITHOSPHERE-ASTHENOSPHERE BOUNDARY; UPPER-MANTLE; MELT; PACIFIC; MODEL; SIGNATURE; PLATES; OCEAN	The boundary between the lithosphere and asthenosphere is associated with a platewide high-seismic velocity "lid" overlying lowered velocities, consistent with thermal models. Seismic body waves also intermittently detect a sharp velocity reduction at similar depths, the Gutenberg (G) discontinuity, which cannot be explained by temperature alone. We compared an anisotropic tomography model with detections of the G to evaluate their context and relation to the lithosphere-asthenosphere boundary (LAB). We find that the G is primarily associated with vertical changes in azimuthal anisotropy and lies above a thermally controlled LAB, implying that the two are not equivalent interfaces. The origin of the G is a result of frozen-in lithospheric structures, regional compositional variations of the mantle, or dynamically perturbed LAB.	[Beghein, Caroline; Yuan, Kaiqing; Xing, Zheng] Univ Calif Los Angeles, Dept Earth Planetary & Space Sci, Los Angeles, CA 90095 USA; [Schmerr, Nicholas] Univ Maryland, Dept Geol, College Pk, MD 20742 USA	University of California System; University of California Los Angeles; University System of Maryland; University of Maryland College Park	Beghein, C (corresponding author), Univ Calif Los Angeles, Dept Earth Planetary & Space Sci, 595 Charles Young Dr East,Box 951567, Los Angeles, CA 90095 USA.	cbeghein@ucla.edu	Beghein, Caroline/A-7516-2008; Beghein, Caroline/AAQ-6871-2021; Yuan, Kaiqing/J-8833-2015	Beghein, Caroline/0000-0002-3158-2213; Beghein, Caroline/0000-0002-3158-2213; Yuan, Kaiqing/0000-0002-0125-1093; Schmerr, Nicholas/0000-0002-3256-1262	NSF EAR [0838605, 0949255, 1247608]; Division Of Earth Sciences [0838605] Funding Source: National Science Foundation	NSF EAR(National Science Foundation (NSF)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	C.B. and K.Y. were funded by NSF EAR grants 0838605 and 0949255; N.S. was funded by NSF EAR 1247608. We thank J. Trampert and K. Visser for making their phase velocity maps freely available. Partial derivatives were calculated using fortran code MINEOS (www.geodynamics.org/cig/software/mineos), and figures were made with the Generic Mapping Tools, Gnuplot, and Xmgrace. We thank P. Davis for fruitful discussions. The data used were the phase velocity maps published in (12) and are available at www.geo.uu.nl/-jeannot/My_web_pages/Downloads.html. The models are available in the supplementary materials.	Bagley B, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2008JB005692; Debayle E, 2013, EARTH PLANET SC LETT, V376, P165, DOI 10.1016/j.epsl.2013.06.025; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Gaboret C, 2003, EARTH PLANET SC LETT, V208, P219, DOI 10.1016/S0012-821X(03)00037-2; Gaherty JB, 1999, PHYS EARTH PLANET IN, V110, P21, DOI 10.1016/S0031-9201(98)00132-0; Gripp AE, 2002, GEOPHYS J INT, V150, P321, DOI 10.1046/j.1365-246X.2002.01627.x; Gutenberg B., 1948, B SEISMOL SOC AM, V38, P121, DOI [10.1785/BSSA0380020121, DOI 10.1785/BSSA0380020121]; HAGER BH, 1989, PHILOS T R SOC A, V328, P309, DOI 10.1098/rsta.1989.0038; Hirth G, 1996, EARTH PLANET SC LETT, V144, P93, DOI 10.1016/0012-821X(96)00154-9; Holtzman BK, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2010GC003296; Karato S-I, 1987, HIGH PRESSURE RES MI, P455, DOI [10.1029/GM039p0455, DOI 10.1029/GM039P0455]; Karato SI, 2012, EARTH PLANET SC LETT, V321, P95, DOI 10.1016/j.epsl.2012.01.001; Kawakatsu H, 2009, SCIENCE, V324, P499, DOI 10.1126/science.1169499; Maggi A, 2006, GEOPHYS J INT, V166, P1384, DOI 10.1111/j.1365-246X.2006.03037.x; Matthews KJ, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2011JB008413; Miyazaki T, 2013, NATURE, V502, P321, DOI 10.1038/nature12570; Naif S, 2013, NATURE, V495, P356, DOI 10.1038/nature11939; Nettles M, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2006JB004819; NISHIMURA CE, 1989, GEOPHYS J INT, V96, P203, DOI 10.1111/j.1365-246X.1989.tb04446.x; PARKER RL, 1973, NATURE-PHYS SCI, V242, P137, DOI 10.1038/physci242137a0; Rychert CA, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004194; Rychert CA, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB008070; Sakamaki T, 2013, NAT GEOSCI, V6, P1041, DOI [10.1038/NGEO1982, 10.1038/ngeo1982]; Schmerr N, 2012, SCIENCE, V335, P1480, DOI 10.1126/science.1215433; STEIN CA, 1992, NATURE, V359, P123, DOI 10.1038/359123a0; Tan Y, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004853; Visser K, 2008, GEOPHYS J INT, V172, P1016, DOI 10.1111/j.1365-246X.2007.03685.x; Yuan HY, 2010, NATURE, V466, P1063, DOI 10.1038/nature09332	28	92	93	0	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2014	343	6176					1237	1240		10.1126/science.1246724	http://dx.doi.org/10.1126/science.1246724			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC7RG	24578529	Green Submitted			2022-12-28	WOS:000332728500033
J	Brewster, RC; Weinert, FM; Garcia, HG; Song, D; Rydenfelt, M; Phillips, R				Brewster, Robert C.; Weinert, Franz M.; Garcia, Hernan G.; Song, Dan; Rydenfelt, Mattias; Phillips, Rob			The Transcription Factor Titration Effect Dictates Level of Gene Expression	CELL			English	Article							PLASMID COPY NUMBER; ESCHERICHIA-COLI K-12; EVOLUTION; RETROTRANSPOSONS; RETROACTIVITY; REPLICATION; MECHANISMS; REPRESSION; NETWORK; BIOLOGY	Models of transcription are often built around a picture of RNA polymerase and transcription factors (TFs) acting on a single copy of a promoter. However, most TFs are shared between multiple genes with varying binding affinities. Beyond that, genes often exist at high copy number-in multiple identical copies on the chromosome or on plasmids or viral vectors with copy numbers in the hundreds. Using a thermodynamic model, we characterize the interplay between TF copy number and the demand for that TF. We demonstrate the parameter-free predictive power of this model as a function of the copy number of the TF and the number and affinities of the available specific binding sites; such predictive control is important for the understanding of transcription and the desire to quantitatively design the output of genetic circuits. Finally, we use these experiments to dynamically measure plasmid copy number through the cell cycle.	[Brewster, Robert C.; Weinert, Franz M.; Phillips, Rob] CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA; [Garcia, Hernan G.] Princeton Univ, Dept Phys, Princeton, NJ 08540 USA; [Song, Dan] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Rydenfelt, Mattias] Harvard Univ, Sch Med, Harvard Biophys Program, Boston, MA 02115 USA; [Phillips, Rob] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; Princeton University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; California Institute of Technology	Phillips, R (corresponding author), CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA.	phillips@pboc.caltech.edu		Brewster, Robert/0000-0002-7656-4086; Garcia, Hernan G./0000-0002-5212-3649	NIH [DP1 OD000217, R01 GM085286, 1 U54 CA143869]; La Fondation Pierre Gilles de Gennes; NATIONAL CANCER INSTITUTE [U54CA143869] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008313, R01GM085286] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000217] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); La Fondation Pierre Gilles de Gennes; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to James Boedicker, Michael Elowitz, Ron Milo, Nitzan Rosenfeld, Jon Young, and members of the Phillips group for helpful discussions. We are also grateful to the NIH for support through award numbers DP1 OD000217 (Director's Pioneer Award), R01 GM085286, and 1 U54 CA143869 (Northwestern PSOC Center) and to the La Fondation Pierre Gilles de Gennes (R.P.).	Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Babu MM, 2003, TRENDS GENET, V19, P75, DOI 10.1016/S0168-9525(02)00039-2; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Bremer H, 1996, ESCHERICHIA COLI SAL; Brewster RC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002811; Buchler NE, 2003, P NATL ACAD SCI USA, V100, P5136, DOI 10.1073/pnas.0930314100; Busby S, 1999, J MOL BIOL, V293, P199, DOI 10.1006/jmbi.1999.3161; CESARENI G, 1982, P NATL ACAD SCI-BIOL, V79, P6313, DOI 10.1073/pnas.79.20.6313; Cox RS, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100187; Daber R, 2011, J MOL BIOL, V409, P76, DOI 10.1016/j.jmb.2011.03.057; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Del Vecchio D, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100204; Ebersbach G, 2005, ANNU REV GENET, V39, P453, DOI 10.1146/annurev.genet.38.072902.091252; Elowitz M, 2010, NATURE, V468, P889, DOI 10.1038/468889a; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Gama-Castro S, 2011, NUCLEIC ACIDS RES, V39, pD98, DOI 10.1093/nar/gkq1110; Garcia HG, 2011, P NATL ACAD SCI USA, V108, P12173, DOI 10.1073/pnas.1015616108; Garcia HG, 2010, TRENDS CELL BIOL, V20, P723, DOI 10.1016/j.tcb.2010.07.002; Ghosh SK, 2006, ANNU REV BIOCHEM, V75, P211, DOI 10.1146/annurev.biochem.75.101304.124037; Ghozzi S, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.051916; Guido NJ, 2006, NATURE, V439, P856, DOI 10.1038/nature04473; Hanada K, 2011, MOL BIOL EVOL, V28, P377, DOI 10.1093/molbev/msq204; Kaplan S, 2008, MOL CELL, V29, P786, DOI 10.1016/j.molcel.2008.01.021; Kentner D, 2010, ANNU REV MICROBIOL, V64, P373, DOI 10.1146/annurev.micro.112408.134205; Kim KH, 2011, BIOPHYS J, V100, P1167, DOI 10.1016/j.bpj.2010.12.3737; Kinney JB, 2010, P NATL ACAD SCI USA, V107, P9158, DOI 10.1073/pnas.1004290107; Kuhlman T, 2007, P NATL ACAD SCI USA, V104, P6043, DOI 10.1073/pnas.0606717104; Kuhlman TE, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.42; Lee CL, 2006, J MICROBIOL METH, V65, P258, DOI 10.1016/j.mimet.2005.07.019; Lee C, 2006, J BIOTECHNOL, V123, P273, DOI 10.1016/j.jbiotec.2005.11.014; Lee TH, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.7; Lim WA, 2002, CURR OPIN STRUC BIOL, V12, P61, DOI 10.1016/S0959-440X(02)00290-7; LURIA SE, 1949, GENETICS, V34, P93; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Michelsen O, 2003, MICROBIOL-SGM, V149, P1001, DOI 10.1099/mic.0.26058-0; Mukherji S, 2009, NAT REV GENET, V10, P859, DOI 10.1038/nrg2697; Navarro-Quezada A, 2002, P NATL ACAD SCI USA, V99, P268, DOI 10.1073/pnas.012422299; Ng JW, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.011909; OEHLER S, 1994, EMBO J, V13, P3348, DOI 10.1002/j.1460-2075.1994.tb06637.x; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Paulsson J, 2001, Q REV BIOPHYS, V34, P1, DOI 10.1017/S0033583501003663; PTASHNE M, 2002, GENES SIGNALS; Ricci F, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002171; Rojo F, 2001, CURR OPIN MICROBIOL, V4, P145, DOI 10.1016/S1369-5274(00)00180-6; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Rosenfeld N, 2006, BIOPHYS J, V91, P759, DOI 10.1529/biophysj.105.073098; Rydenfelt M, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.012702; Sanchez A, 2011, EMBO J, V30, P3940, DOI 10.1038/emboj.2011.273; SCHLAX PJ, 1995, J MOL BIOL, V245, P331, DOI 10.1006/jmbi.1994.0028; STUEBER D, 1982, EMBO J, V1, P1399, DOI 10.1002/j.1460-2075.1982.tb01329.x; Teng SW, 2010, BIOPHYS J, V98, P2024, DOI 10.1016/j.bpj.2010.01.031; TWIGG AJ, 1980, NATURE, V283, P216, DOI 10.1038/283216a0; Vilar JMG, 2003, J MOL BIOL, V331, P981, DOI 10.1016/S0022-2836(03)00764-2; Voigt CA, 2006, CURR OPIN BIOTECH, V17, P548, DOI 10.1016/j.copbio.2006.09.001; Wang SP, 1999, P NATL ACAD SCI USA, V96, P6824, DOI 10.1073/pnas.96.12.6824	56	155	158	3	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 13	2014	156	6					1312	1323		10.1016/j.cell.2014.02.022	http://dx.doi.org/10.1016/j.cell.2014.02.022			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AD0ST	24612990	Green Accepted, Bronze			2022-12-28	WOS:000332945100019
J	Colbert, JA				Colbert, James A.			Cardiac Screening before Participation in Sports - Polling Results	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PREVENTION; DEATH	In November, we invited you to share your opinions about whether young athletes should be required to undergo cardiac screening before they participate in organized sports and what tests should be included if screening is performed. We now present the polling results. Millions of high school students participate in organized sports, and a small number of these young athletes will die from sudden cardiac arrest. Whether school-age athletes should be screened for cardiac conditions before they participate in sports remains an area of controversy in the medical community with extremely disparate practices around the world. Even those in favor of screening have differing opinions of the preferred strategy for detecting cardiac abnormalities; some proponents advocate the use of electrocardiography (ECG) or imaging methods, whereas others recommend only a thorough history and physical examination. Recently, as part of our Clinical Decisions series, ...	[Colbert, James A.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Colbert, James A.] Newton Wellesley Hosp, Newton, MA USA	Harvard University; Brigham & Women's Hospital; Newton Wellesley Hospital	Colbert, JA (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.							[Anonymous], 2013, N ENGL J MED, V369, P2049; Corrado D, 2005, EUR HEART J, V26, P516, DOI 10.1093/eurheartj/ehi108; Giese EA, 2007, AM FAM PHYSICIAN, V75, P1008; Zipes DP, 2006, EUR HEART J, V27, P2099, DOI 10.1093/eurheartj/ehl199	4	9	9	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 6	2014	370	10							e16	10.1056/NEJMclde1401118	http://dx.doi.org/10.1056/NEJMclde1401118			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC2EB	24597889				2022-12-28	WOS:000332309800001
J	Shetty, P				Shetty, Priya			PRODUCTION Vaccines from the East	NATURE			English	Editorial Material																		[Anonymous], 2009, CAS STUD GLOB HLTH; Bound K., 2013, CHINAS ABSORPTIVE ST; Cyranoski D, 2005, NATURE, V435, P138, DOI 10.1038/435138a; The Royal Society, 2011, KNOWL NETW NAT GLOB	4	1	1	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					S12	S13		10.1038/507S12a	http://dx.doi.org/10.1038/507S12a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC0ZQ	24611171	Bronze			2022-12-28	WOS:000332224400006
J	Crowe, E; Pandeya, N; Brotherton, JML; Dobson, AJ; Kisely, S; Lambert, SB; Whiteman, DC				Crowe, Elizabeth; Pandeya, Nirmala; Brotherton, Julia M. L.; Dobson, Annette J.; Kisely, Stephen; Lambert, Stephen B.; Whiteman, David C.			Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in Australia	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PARTICLE VACCINE; HPV VACCINATION; YOUNG-WOMEN; INFECTION; LESIONS; IMPACT; DURATION; EFFICACY; DISEASES; CANCER	Objective To measure the effectiveness of the quadrivalent human papillomavirus (HPV) vaccine against cervical abnormalities four years after implementation of a nationally funded vaccination programme in Queensland, Australia. Design Case-control analysis of linked administrative health datasets. Setting Queensland, Australia. Participants Women eligible for free vaccination (aged 12-26 years in 2007) and attending for their first cervical smear test between April 2007 and March 2011. High grade cases were women with histologically confirmed high grade cervical abnormalities (n=1062) and "other cases" were women with any other abnormality at cytology or histology (n=10 887). Controls were women with normal cytology (n=96 404). Main outcome measures Exposure odds ratio (ratio of odds of antecedent vaccination (one, two, or three vaccine doses compared with no doses) among cases compared with controls), vaccine effectiveness ((1-adjusted odds ratio)x100), and number needed to vaccinate to prevent one cervical abnormality at first screening round. We stratified by four age groups adjusted for follow-up time, year of birth, and measures of socioeconomic status and remoteness. The primary analysis concerned women whose first ever smear test defined their status as a case or a control. Results The adjusted odds ratio for exposure to three doses of HPV vaccine compared with no vaccine was 0.54 (95% confidence interval 0.43 to 0.67) for high grade cases and 0.66 (0.62 to 0.70) for other cases compared with controls with normal cytology, equating to vaccine effectiveness of 46% and 34%, respectively. The adjusted numbers needed to vaccinate were 125 (95% confidence interval 97 to 174) and 22 (19 to 25), respectively. The adjusted exposure odds ratios for two vaccine doses were 0.79 (95% confidence interval 0.64 to 0.98) for high grade cases and 0.79 (0.74 to 0.85) for other cases, equating to vaccine effectiveness of 21%. Conclusion The quadrivalent HPV vaccine conferred statistically significant protection against cervical abnormalities in young women who had not started screening before the implementation of the vaccination programme in Queensland, Australia.	[Crowe, Elizabeth; Pandeya, Nirmala; Dobson, Annette J.; Whiteman, David C.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Crowe, Elizabeth] NHS Borders, Dept Publ Hlth Melrose, Melrose, Scotland; [Brotherton, Julia M. L.] Victorian Cytol Serv, Melbourne, Vic, Australia; [Kisely, Stephen] Univ Queensland, Rural Sch, Woolloongabba, Australia; [Kisely, Stephen] Univ Queensland, Southern Clin Sch, Woolloongabba, Australia; [Lambert, Stephen B.] Univ Queensland, Queensland Childrens Med Res Inst, Brisbane, Qld, Australia; [Lambert, Stephen B.] Childrens Hlth Queensland, Brisbane, Qld, Australia; [Lambert, Stephen B.] Queensland Hlth Immunisat Program, Brisbane, Qld, Australia; [Whiteman, David C.] QIMR Berghofer Med Res Inst, Populat Hlth Dept, Brisbane, Qld, Australia	University of Queensland; University of Queensland; University of Queensland; University of Queensland; Queensland Health; QIMR Berghofer Medical Research Institute	Crowe, E (corresponding author), NHS Borders, Dept Publ Hlth Melrose, Melrose, Scotland.	e.crowe1@uq.edu.au	Whiteman, David C/P-2728-2014; Kisely, Steve/B-4680-2012; Lambert, Stephen/N-7819-2019; Pandeya, Nirmala/F-8054-2010	Whiteman, David C/0000-0003-2563-9559; Kisely, Steve/0000-0003-4021-2924; Lambert, Stephen/0000-0002-2709-193X; Pandeya, Nirmala/0000-0003-1462-4968	University of Queensland; NHS Borders; Australian Research Council [FT0990987]; National Health and Medical Research Council [631691, GNT1036231]; Victorian Cytology Service; Children's Health Foundation Queensland [50025]	University of Queensland(University of Queensland); NHS Borders; Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Cytology Service; Children's Health Foundation Queensland	No specific project funding was received but EC was supported by a salary from the University of Queensland and NHS Borders. DCW was supported by a Future Fellowship from the Australian Research Council (FT0990987). NP was supported by an early career fellowship from the National Health and Medical Research Council (631691). SK and AJD were supported by salaries from the University of Queensland. JMLB was supported by salary from the Victorian Cytology Service. SBL was supported by an early career fellowship from the National Health and Medical Research Council (GNT1036231) and is a Queensland Children's Medical Research Institute senior research fellow supported by the Children's Health Foundation Queensland (50025).	Australian Government Department of Health, 2013, NAT CERV SCREEN PROG; Bender R, 2002, J CLIN EPIDEMIOL, V55, P525, DOI 10.1016/S0895-4356(01)00510-8; Bonanni P, 2009, VACCINE, V27, pA46, DOI 10.1016/j.vaccine.2008.10.085; Castle PE, 2012, GYNECOL ONCOL, V127, P437, DOI 10.1016/j.ygyno.2012.10.012; Chief Medical Officer Department of Health and Ageing Australian Government, 2009, GUID REV HPV VACC DO; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Gertig DM, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-227; Gertig DM, 2011, SEX HEALTH, V8, P171, DOI 10.1071/SH10001; Hull Brynley P, 2003, Commun Dis Intell Q Rep, V27, P357; Joura EA, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1401; Markowitz LE, 2012, VACCINE, V30, pF139, DOI 10.1016/j.vaccine.2012.05.039; Munoz N, 2010, JNCI-J NATL CANCER I, V102, P325, DOI 10.1093/jnci/djp534; Nitsch Dorothea, 2006, BMC Med Res Methodol, V6, P15; Paavonen J, 2007, LANCET, V369, P2161, DOI 10.1016/S0140-6736(07)60946-5; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Queensland Government, QUEENSL CERV SCREEN; Queensland Health, 2012, QUEENSL CERV SCREEN; Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527; Villa L, 2007, LANCET, V369, P1861, DOI 10.1016/S0140-6736(07)60852-6; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Wheeler CM, 2009, J INFECT DIS, V199, P936, DOI 10.1086/597309; Winer RL, 2005, J INFECT DIS, V191, P731, DOI 10.1086/427557; Woodman CBJ, 2007, NAT REV CANCER, V7, P11, DOI 10.1038/nrc2050	23	138	144	1	29	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2014	348								g1458	10.1136/bmj.g1458	http://dx.doi.org/10.1136/bmj.g1458			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC6HV	24594809	hybrid, Green Published			2022-12-28	WOS:000332623400003
J	Fu, Y; Lim, S; Urano, D; Tunc-Ozdemir, M; Phan, NG; Elston, TC; Jones, AM				Fu, Yan; Lim, Sungmin; Urano, Daisuke; Tunc-Ozdemir, Meral; Phan, Nguyen G.; Elston, Timothy C.; Jones, Alan M.			Reciprocal Encoding of Signal Intensity and Duration in a Glucose-Sensing Circuit	CELL			English	Article							PROTEIN-KINASE INHIBITORS; HETEROTRIMERIC G-PROTEIN; ARABIDOPSIS-THALIANA; HYPOCOTYL ELONGATION; CELL-PROLIFERATION; INFORMATION; GROWTH; ROOTS	Cells continuously adjust their behavior in response to changing environmental conditions. Both intensity and duration of external signals are critical factors in determining what response is initiated. To understand how intracellular signaling networks process such multidimensional information, we studied the AtRGS1-mediated glucose response system of Arabidopsis. By combining experiments with mathematical modeling, we discovered a reciprocal dose and duration response relying on the orchestrated action of three kinases (AtWNK1, AtWNK8, and AtWNK10) acting on distinct timescales and activation thresholds. Specifically, we find that high concentrations of D-glucose rapidly signal through AtWNK8 and AtWNK10, whereas low, sustained sugar concentration slowly activate the pathway through AtWNK1, allowing the cells to respond similarly to transient, high-intensity signals and sustained, low-intensity signals. This "dose-duration reciprocity" allows encoding of both the intensity and persistence of glucose as an important energy resource and signaling molecule.	[Fu, Yan; Lim, Sungmin; Urano, Daisuke; Tunc-Ozdemir, Meral; Phan, Nguyen G.; Jones, Alan M.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Fu, Yan; Elston, Timothy C.; Jones, Alan M.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Elston, TC (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA.	timothy_elston@med.unc.edu; alan_jones@unc.edu	Phan, Nguyen/I-3381-2013	Phan, Nguyen/0000-0001-7662-9014; Urano, Daisuke/0000-0003-4541-1076	NIGMS [R01GM065989, R01GM079271]; NSF [MCB-0718202]; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy [DE-FG02-05er15671]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065989, R01GM079271] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF(National Science Foundation (NSF)); Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank Ariko Urano, Jing Yang, and Tony Purdue for their technical assistance and Dr. Joshua B. Kelley, Dr. Matthew Pena, Dr. Alejandro Colaneri, Dr. Susanne Wolfenstetter, and Dr. Jianping Huang for useful discussions. This work was supported by grants from the NIGMS(R01GM065989) and NSF (MCB-0718202) to A.M.J. and NIGMS (R01GM079271) to T.C.E. The Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the US Department of Energy through the grant DE-FG02-05er15671 to A.M.J. funded technical support in this study.	Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bonardi V, 2005, NATURE, V437, P1179, DOI 10.1038/nature04016; Booker KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012833; Chen JG, 2004, METHOD ENZYMOL, V389, P338; Chen JG, 2003, SCIENCE, V301, P1728, DOI 10.1126/science.1087790; Chen JG, 2006, PLANT PHYSIOL, V141, P887, DOI 10.1104/pp.106.079202; Chen Y., 2005, FRET DATA ANAL ALGOR; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Deuschle K, 2006, PLANT CELL, V18, P2314, DOI 10.1105/tpc.106.044073; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Gupta A, 2012, PLANT PHYSIOL, V159, P1463, DOI 10.1104/pp.112.195776; Johnston CA, 2007, P NATL ACAD SCI USA, V104, P17317, DOI 10.1073/pnas.0704751104; Jones JC, 2011, J BIOL CHEM, V286, P13143, DOI 10.1074/jbc.M110.190355; Koch KE, 1996, ANNU REV PLANT PHYS, V47, P509, DOI 10.1146/annurev.arplant.47.1.509; Lilley JLS, 2012, PLANT PHYSIOL, V160, P2261, DOI 10.1104/pp.112.205575; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Mariathasan S, 2001, J IMMUNOL, V167, P4966, DOI 10.4049/jimmunol.167.9.4966; Moriyama EN, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r96; Phan N, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.22814; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Rue P, 2012, PROG BIOPHYS MOL BIO, V110, P106, DOI 10.1016/j.pbiomolbio.2012.05.003; Singhania R., 2011, THESIS VIRGINIA TECH; Smeekens S, 2010, CURR OPIN PLANT BIOL, V13, P274, DOI 10.1016/j.pbi.2009.12.002; Ullah H, 2001, SCIENCE, V292, P2066, DOI 10.1126/science.1059040; Urano D, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120186; Urano D, 2012, NAT CELL BIOL, V14, P1079, DOI 10.1038/ncb2568; Urano D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002756; Waltermann C, 2011, BBA-GEN SUBJECTS, V1810, P924, DOI 10.1016/j.bbagen.2011.07.009; Wang Y, 2008, PLANT BIOLOGY, V10, P548, DOI 10.1111/j.1438-8677.2008.00072.x; Yagi YI, 2009, BIOCHEMISTRY-US, V48, P10255, DOI 10.1021/bi900666n; Zhang YQ, 2010, J PLANT PHYSIOL, V167, P1130, DOI 10.1016/j.jplph.2010.03.007	32	57	59	3	34	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 27	2014	156	5					1084	1095		10.1016/j.cell.2014.01.013	http://dx.doi.org/10.1016/j.cell.2014.01.013			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AB9BK	24581502	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000332083900023
J	Hunt, BJ				Hunt, Beverley J.			Bleeding and Coagulopathies in Critical Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							FRESH-FROZEN PLASMA; TRANEXAMIC ACID; TRAUMA PATIENTS; SEVERE SEPSIS; MAJOR TRAUMA; ILL PATIENTS; TRANSFUSION; MANAGEMENT; REPLACEMENT; HEMOSTASIS	In this article, common abnormalities of blood coagulation leading to thrombosis or bleeding in the intensive care unit are reviewed. The definition of coagulopathy is a condition in which the blood's ability to clot is impaired. However, for some clinicians, the term also covers thrombotic states, and because of the complexity of the hemostatic pathways, the two conditions can exist simultaneously. Some practitioners would consider that mildly abnormal results on coagulation screening without bleeding can also indicate a coagulopathy. This review is confined to the original definition of coagulopathy as given above. Such states are common in patients in the intensive care unit (ICU) and require a clinicopathological approach to ensure that the correct diagnosis is made and the appropriate ...	[Hunt, Beverley J.] Kings Coll London, London, England; [Hunt, Beverley J.] St Thomas Trust, London, England	University of London; King's College London	Hunt, BJ (corresponding author), St Thomas Hosp, Thrombosis & Haemophilia Ctr, Westminster Bridge Rd, London SE1 7EH, England.	beverley.hunt@gstt.nhs.uk			Haemonetics	Haemonetics	Dr. Hunt reports receiving consulting fees from Haemonetics and serving as medical director of Lifeblood: the Thrombosis Charity, which receives funds from pharmaceutical companies to help educate health care professionals and the public. No other potential conflict of interest relevant to this article was reported.	Abraham E, 2003, JAMA-J AM MED ASSOC, V290, P238, DOI 10.1001/jama.290.2.238; Afshari A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005370.pub2; Allen DL, 2004, TRANSFUSION MED, V14, P409, DOI 10.1111/j.1365-3148.2004.00536.x; Borgman MA, 2007, J TRAUMA, V63, P805, DOI 10.1097/TA.0b013e3181271ba3; Collins PW, 2006, BRIT J HAEMATOL, V135, P220, DOI 10.1111/j.1365-2141.2006.06281.x; Cuker A, 2009, NEW ENGL J MED, V361, P1887, DOI 10.1056/NEJMcps066546; Desborough M, 2012, TRANSFUSION, V52, p20S, DOI 10.1111/j.1537-2995.2012.03691.x; Franchini M, 2013, BRIT J HAEMATOL, V161, P177, DOI 10.1111/bjh.12272; Hall DP, 2012, BRIT J ANAESTH, V109, P919, DOI 10.1093/bja/aes337; Harper P, 2012, NEW ENGL J MED, V366, P864, DOI 10.1056/NEJMc1112874; Hedges SJ, 2007, NAT CLIN PRACT NEPHR, V3, P138, DOI 10.1038/ncpneph0421; Heilmann C, 2012, INTENS CARE MED, V38, P62, DOI 10.1007/s00134-011-2370-6; Hiippala S, 1998, VOX SANG, V74, P399, DOI 10.1111/j.1423-0410.1998.tb05449.x; Holcomb JB, 2013, JAMA SURG, V148, P127, DOI 10.1001/2013.jamasurg.387; Holmes MV, 2012, BLOOD REV, V26, P1, DOI 10.1016/j.blre.2011.07.002; Hunt BJ, 1997, J CLIN PATHOL, V50, P357; Inaba K, 2010, J AM COLL SURGEONS, V210, P957, DOI 10.1016/j.jamcollsurg.2010.01.031; Innerhofer P, 2013, INJURY, V44, P209, DOI 10.1016/j.injury.2012.08.047; Kaatz S, 2012, AM J HEMATOL, V87, pS141, DOI 10.1002/ajh.23202; Kelton JG, 2013, NEW ENGL J MED, V368, P737, DOI 10.1056/NEJMct1206642; Ker K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3054; Lazo-Langner A, 2013, CRIT CARE, V17, DOI 10.1186/cc12592; Levi M, 2011, NEW ENGL J MED, V365, P1944; Levi M, 2009, BRIT J HAEMATOL, V145, P24, DOI [10.1111/j.1365-2141.2009.07600.x, 10.1111/j.1365-2141.2008.07445.x]; MacLennan S, 2006, J TRAUMA, V60, pS46, DOI 10.1097/01.ta.0000199546.22925.31; Makris M, 2013, BRIT J HAEMATOL, V160, P35, DOI 10.1111/bjh.12107; Mezzano D, 1999, THROMB HAEMOSTASIS, V82, P1250; Nieuwland R, 2000, BLOOD, V95, P930, DOI 10.1182/blood.V95.3.930.003k46_930_935; OSTERUD B, 1983, THROMB HAEMOSTASIS, V49, P5; Ovstebo R, 2012, INNATE IMMUN-LONDON, V18, P580, DOI 10.1177/1753425911428230; Rajasekhar A, 2011, CRIT CARE MED, V39, P1507, DOI 10.1097/CCM.0b013e31820eb517; Ranieri VM, 2012, NEW ENGL J MED, V366, P2055, DOI 10.1056/NEJMoa1202290; Raza I, 2013, J THROMB HAEMOST, V11, P307, DOI 10.1111/jth.12078; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Roberts LN, 2010, BRIT J HAEMATOL, V148, P507, DOI 10.1111/j.1365-2141.2009.08021.x; Rourke C, 2012, J THROMB HAEMOST, V10, P1342, DOI 10.1111/j.1538-7836.2012.04752.x; Scully M, 2012, BRIT J HAEMATOL, V158, P323, DOI 10.1111/j.1365-2141.2012.09167.x; Segal Helen C, 2006, Curr Hematol Rep, V5, P70; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Simpson E, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005011.pub4; Slichter Sherrill J, 2007, Hematology Am Soc Hematol Educ Program, P172, DOI 10.1182/asheducation-2007.1.172; Spahn DR, 2007, CRIT CARE, V11, DOI 10.1186/cc5781; Spahn DR, 2007, CRIT CARE, V11, DOI 10.1186/cc5686; Stanworth SJ, 2011, CRIT CARE, V15, DOI 10.1186/cc10510; Tiede A, 2011, BLOOD, V117, P6777, DOI 10.1182/blood-2010-11-297580; Toh CH, 2007, J THROMB HAEMOST, V5, P604, DOI 10.1111/j.1538-7836.2007.02313.x; Tripodi A, 2011, NEW ENGL J MED, V365, P147, DOI 10.1056/NEJMra1011170; Vanderschueren S, 2000, CRIT CARE MED, V28, P1871, DOI 10.1097/00003246-200006000-00031; Villanueva C, 2013, NEW ENGL J MED, V368, P11, DOI 10.1056/NEJMoa1211801; Zhang ZH, 2012, INTENS CARE MED, V38, P20, DOI 10.1007/s00134-011-2438-3; Ziegler B, 2013, CLIN APPL THROMB-HEM, V19, P453, DOI 10.1177/1076029612458149	51	157	176	2	50	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 27	2014	370	9					847	859		10.1056/NEJMra1208626	http://dx.doi.org/10.1056/NEJMra1208626			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB8AR	24571757				2022-12-28	WOS:000332013000010
J	Stessman, HA; Bernier, R; Eichler, EE				Stessman, Holly A.; Bernier, Raphael; Eichler, Evan E.			A Genotype-First Approach to Defining the Subtypes of a Complex Disease	CELL			English	Article							DE-NOVO MUTATIONS; CLUSTER-ANALYSIS; AUTISM; CHILDREN; DISORDERS; PHENOTYPE; DISCOVERY	Medical genetics typically entails the detailed characterization of a patient's phenotypes followed by genotyping to discover the responsible gene or mutation. Here, we propose that the systematic discovery of genetic variants associated with complex diseases such as autism are progressing to a point where a reverse strategy may be fruitful in assigning the pathogenic effects of many different genes and in determining whether particular genotypes manifest as clinically recognizable phenotypes. This "genotype-first" approach for complex disease necessitates the development of large, highly integrated networks of researchers, clinicians, and patient families, with the promise of improved therapies for subsets of patients.	[Stessman, Holly A.; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Bernier, Raphael] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Eichler, EE (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	eee@gs.washington.edu		Stessman, Holly/0000-0002-0764-3493	U.S. National Institute of Mental Health (NIMH) [MH101221]; Simons Foundation Autism Research Initiative (SFARI) [303241]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH101221] Funding Source: NIH RePORTER	U.S. National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Simons Foundation Autism Research Initiative (SFARI); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in part, by U.S. National Institute of Mental Health (NIMH) grant MH101221 and by the Simons Foundation Autism Research Initiative (SFARI) 303241 to E.E.E. E.E.E. is an investigator of the Howard Hughes Medical Institute. E.E.E. is on the scientific advisory boards (SABs) of DNAnexus, Inc. and was an SAB member of Pacific Biosciences, Inc. (2009-2013) and SynapDx Corp. (2011-2013).	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5th ed., DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; Bitsika V, 2008, J INTELL DISABIL RES, V52, P973, DOI 10.1111/j.1365-2788.2008.01123.x; Buxbaum JD, 2012, NEURON, V76, P1052, DOI 10.1016/j.neuron.2012.12.008; Charman T, 2005, J CHILD PSYCHOL PSYC, V46, P500, DOI 10.1111/j.1469-7610.2004.00377.x; Courchesne E, 2003, JAMA-J AM MED ASSOC, V290, P337, DOI 10.1001/jama.290.3.337; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; Doshi-Velez F, 2014, PEDIATRICS, V133, pE54, DOI 10.1542/peds.2013-0819; Fountain C, 2012, PEDIATRICS, V129, pE1112, DOI 10.1542/peds.2011-1601; Girirajan S, 2013, AM J HUM GENET, V92, P221, DOI 10.1016/j.ajhg.2012.12.016; Halgren C, 2012, CLIN GENET, V82, P248, DOI 10.1111/j.1399-0004.2011.01755.x; Hennekam RCM, 2012, HUM MUTAT, V33, P884, DOI 10.1002/humu.22048; Insel T, 2010, AM J PSYCHIAT, V167, P748, DOI 10.1176/appi.ajp.2010.09091379; Johnson Helen M, 2011, Med Health R I, V94, P124; La Malfa G, 2004, J INTELL DISABIL RES, V48, P262, DOI 10.1111/j.1365-2788.2003.00567.x; Lord C, 2012, J CONSULT CLIN PSYCH, V80, P477, DOI 10.1037/a0027214; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Matson JL, 2009, RES DEV DISABIL, V30, P1107, DOI 10.1016/j.ridd.2009.06.003; McGovern CW, 2005, J CHILD PSYCHOL PSYC, V46, P401, DOI 10.1111/j.1469-7610.2004.00361.x; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Pellicano E, 2012, AJIDD-AM J INTELLECT, V117, P156, DOI 10.1352/1944-7558-117.2.156; PERCY A, 1990, NEUROL CLIN, V8, P659, DOI 10.1016/S0733-8619(18)30341-4; Sacco R, 2012, AUTISM RES, V5, P137, DOI 10.1002/aur.1226; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Santen GWE, 2013, HUM MUTAT, V34, P1519, DOI 10.1002/humu.22394; Schaaf CP, 2011, HUM MOL GENET, V20, P3366, DOI 10.1093/hmg/ddr243; Schulze TG, 2004, HUM HERED, V58, P131, DOI 10.1159/000083539; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Simons VIP Consortium, 2012, NEURON, V73, P1063, DOI 10.1016/j.neuron.2012.02.014; Turner EH, 2009, NAT METHODS, V6, P315, DOI 10.1038/nmeth.f.248; Veltman JA, 2012, NAT REV GENET, V13, P565, DOI 10.1038/nrg3241	35	150	150	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 27	2014	156	5					872	877		10.1016/j.cell.2014.02.002	http://dx.doi.org/10.1016/j.cell.2014.02.002			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology	AB9BK	24581488	Green Accepted, Bronze			2022-12-28	WOS:000332083900006
J	Sherwood, MW; Wang, Y; Curtis, JP; Peterson, ED; Rao, SV				Sherwood, Matthew W.; Wang, Yongfei; Curtis, Jeptha P.; Peterson, Eric D.; Rao, Sunil V.			Patterns and Outcomes of Red Blood Cell Transfusion in Patients Undergoing Percutaneous Coronary Intervention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; CLINICAL-OUTCOMES; RESTRICTIVE TRANSFUSION; INCREASED MORTALITY; CRITICALLY-ILL; IMPACT; RISK; ASSOCIATION; ANEMIA; CRIT	IMPORTANCE Studies have shown variation in the use of red blood cell transfusion among patients with acute coronary syndromes. There are no definitive data for the efficacy of transfusion in improving outcomes, and concerning data exist about possible association with harm. Current transfusion practices in patients undergoing percutaneous coronary intervention (PCI) are not well understood. OBJECTIVE To determine the current patterns of blood transfusion among patients undergoing PCI and the association of transfusion with adverse cardiac outcomes across hospitals in the United States. DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort study of all patient visits from the CathPCI Registry from July 2009 to March 2013 that included PCI, excluding those with missing data on bleeding complications or who underwent in-hospital coronary artery bypass graft surgery (N = 2 258 711 visits). MAIN OUTCOMES AND MEASURES Transfusion rates in the overall population and by hospital (N = 1431) were the primary outcomes. The association of transfusion with myocardial infarction, stroke, and death after accounting for a patient's propensity for transfusion was also measured. RESULTS The overall rate of transfusion was 2.14% (95% CI, 2.13%-2.16%) and quarterly transfusion rates slightly declined from July 2009 to March 2013 (from 2.11% [95% CI, 2.03%-2.19%] to 2.04% [95% CI, 1.97%-2.12%]; P<.001). Patients who were more likely to receive transfusion were older (mean, 70.5 vs 64.6 years), were women (56.3% vs 32.5%), and had hypertension (86.4% vs 82.0%), diabetes (44.8% vs 34.6%), advanced renal dysfunction (8.7% vs 2.3%), prior myocardial infarction (33.0% vs 30.2%), or prior heart failure (27.0% vs 11.8%). Overall, 96.3% of sites gave a transfusion to less than 5% of patients and 3.7% of sites gave a transfusion to 5% of patients or more. Variation in hospital risk-standardized rates of transfusion persisted after adjustment, and hospitals showed variability in their transfusion thresholds. Receipt of transfusion was associated with myocardial infarction (42 803 events; 4.5% vs 1.8%; odds ratio [OR], 2.60; 95% CI, 2.57-2.63), stroke (5011 events; 2.0% vs 0.2%; OR, 7.72; 95% CI, 7.47-7.98), and in-hospital death (31 885 events; 12.5% vs 1.2%; OR, 4.63; 95% CI, 4.57-4.69), irrespective of bleeding complications. CONCLUSIONS AND RELEVANCE Among patients undergoing PCI at US hospitals, there was considerable variation in blood transfusion practices, and receipt of transfusion was associated with increased risk of in-hospital adverse cardiac events. These observational findings may warrant a randomized trial of transfusion strategies for patients undergoing PCI.	[Sherwood, Matthew W.; Peterson, Eric D.; Rao, Sunil V.] Duke Clin Res Inst, Durham, NC 27715 USA; [Wang, Yongfei; Curtis, Jeptha P.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA	Duke University; Yale University	Sherwood, MW (corresponding author), Duke Clin Res Inst, 2400 Pratt St,POB 17969, Durham, NC 27715 USA.	matthew.sherwood@dm.duke.edu	Peterson, Eric David/ABF-5033-2021; Sherwood, Matthew/AAW-5115-2020	Sherwood, Matthew/0000-0002-4305-5883	American College of Cardiology Foundation's NCDR; American College of Cardiology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007101] Funding Source: NIH RePORTER	American College of Cardiology Foundation's NCDR; American College of Cardiology(General Electric); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by the American College of Cardiology Foundation's NCDR. The analytic work for this investigator-initiated study was performed by the Yale Center for Outcomes Research, with financial support from the American College of Cardiology.	Aronson D, 2008, AM J CARDIOL, V102, P115, DOI 10.1016/j.amjcard.2008.03.027; Brindis R G, 2001, J Am Coll Cardiol, V37, P2240, DOI 10.1016/S0735-1097(01)01372-9; Carson JL, 2013, AM HEART J, V165, P964, DOI 10.1016/j.ahj.2013.03.001; Carson JL, 2012, ANN INTERN MED, V157, P49, DOI 10.7326/0003-4819-157-1-201206190-00429; Carson JL, 2011, NEW ENGL J MED, V365, P2453, DOI 10.1056/NEJMoa1012452; Chatterjee S, 2013, JAMA INTERN MED, V173, P132, DOI 10.1001/2013.jamainternmed.1001; Cooper HA, 2011, AM J CARDIOL, V108, P1108, DOI 10.1016/j.amjcard.2011.06.014; Corwin HL, 2004, CRIT CARE MED, V32, P39, DOI 10.1097/01.CCM.0000104112.34142.79; Doyle BJ, 2009, J AM COLL CARDIOL, V53, P2019, DOI 10.1016/j.jacc.2008.12.073; Freudenberger Ronald S, 2003, Curr Opin Crit Care, V9, P356, DOI 10.1097/00075198-200310000-00004; Hebert PC, 2001, CRIT CARE MED, V29, P227, DOI 10.1097/00003246-200102000-00001; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; HILL SR, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002042.PUB2; Jolicoeur EM, 2009, EUR HEART J, V30, P2575, DOI 10.1093/eurheartj/ehp279; Marso SP, 2010, JAMA-J AM MED ASSOC, V303, P2156, DOI 10.1001/jama.2010.708; Mehta SK, 2009, CIRC-CARDIOVASC INTE, V2, P222, DOI 10.1161/CIRCINTERVENTIONS.108.846741; Moscucci M, 1998, AM J CARDIOL, V81, P702, DOI 10.1016/S0002-9149(97)01018-7; Moussa I, 2013, HEART, V99, P297, DOI 10.1136/heartjnl-2012-303379; Nikolsky E, 2009, JACC-CARDIOVASC INTE, V2, P624, DOI 10.1016/j.jcin.2009.05.004; Peterson ED, 2010, J AM COLL CARDIOL, V55, P1923, DOI 10.1016/j.jacc.2010.02.005; Pilgrim T, 2012, CIRC-CARDIOVASC INTE, V5, P202, DOI 10.1161/CIRCINTERVENTIONS.111.965749; Rao SV, 2007, EUR HEART J, V28, P1193, DOI 10.1093/eurheartj/ehm019; Rao SV, 2010, AM HEART J, V159, P710, DOI 10.1016/j.ahj.2010.02.017; Rao SV, 2004, JAMA-J AM MED ASSOC, V292, P1555, DOI 10.1001/jama.292.13.1555; Sabatine MS, 2005, CIRCULATION, V111, P2042, DOI 10.1161/01.CIR.0000162477.70955.5F; Shishehbor MH, 2009, JACC-CARDIOVASC INTE, V2, P46, DOI 10.1016/j.jcin.2008.09.011; Wu WC, 2001, NEW ENGL J MED, V345, P1230, DOI 10.1056/NEJMoa010615; Yang G, 2005, J AM COLL CARDIOL, V46, P1490, DOI 10.1016/j.jacc.2005.06.072	28	59	61	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 26	2014	311	8					836	843		10.1001/jama.2014.980	http://dx.doi.org/10.1001/jama.2014.980			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB4XQ	24570247	Green Accepted, Bronze			2022-12-28	WOS:000331793700023
J	Cheng, C; Hartwig, JF				Cheng, Chen; Hartwig, John F.			Rhodium-Catalyzed Intermolecular C-H Silylation of Arenes with High Steric Regiocontrol	SCIENCE			English	Article							DEHYDROGENATIVE SILYLATION; BOND FUNCTIONALIZATION; ACTIVATION; INSIGHTS	Regioselective C-H functionalization of arenes has widespread applications in synthetic chemistry. The regioselectivity of these reactions is often controlled by directing groups or steric hindrance ortho to a potential reaction site. Here, we report a catalytic intermolecular C-H silylation of unactivated arenes that manifests very high regioselectivity through steric effects of substituents meta to a potential site of reactivity. The silyl moiety can be further functionalized under mild conditions but is also inert toward many common organic transformations, rendering the silylarene products useful building blocks. The remote steric effect that we observe results from the steric properties of both the rhodium catalyst and the silane.	[Cheng, Chen; Hartwig, John F.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Hartwig, JF (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	jhartwig@berkeley.edu			NSF [CHE-1213409]; Direct For Mathematical & Physical Scien [1213409] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank the NSF (CHE-1213409) for financial support, Johnson-Matthey for a gift of [Ir(cod)OMe]<INF>2</INF>, and T. W. Wilson for helpful discussions. A provisional patent application on this work has been submitted.	Alberico D, 2007, CHEM REV, V107, P174, DOI 10.1021/cr0509760; Ball LT, 2012, SCIENCE, V337, P1644, DOI 10.1126/science.1225709; Cheng C, 2013, ANGEW CHEM INT EDIT, V52, P8984, DOI 10.1002/anie.201304084; Choi G, 2013, J AM CHEM SOC, V135, P13149, DOI 10.1021/ja406519u; Eliel EL., 1994, STEREOCHEMISTRY ORGA; Ezbiansky K, 1998, ORGANOMETALLICS, V17, P1455, DOI 10.1021/om980037g; Fleming I., 1989, ORG REACTIONS, V37, P57; Godula K, 2006, SCIENCE, V312, P67, DOI 10.1126/science.1114731; Hartwig JF, 2012, ACCOUNTS CHEM RES, V45, P864, DOI 10.1021/ar200206a; Hofmann N, 2013, J AM CHEM SOC, V135, P5877, DOI 10.1021/ja401466y; Ihara H, 2009, J AM CHEM SOC, V131, P7502, DOI 10.1021/ja902314v; ISHIKAWA M, 1992, ORGANOMETALLICS, V11, P4135, DOI 10.1021/om00060a033; Ishiyama T, 2003, CHEM COMMUN, P2924, DOI 10.1039/b311103b; Ishiyama T, 2003, ANGEW CHEM INT EDIT, V42, P5346, DOI 10.1002/anie.200352399; Kakiuchi F, 2001, CHEM LETT, P422, DOI 10.1246/cl.2001.422; Kuninobu Y, 2013, ORG LETT, V15, P426, DOI 10.1021/ol303353m; Leow D, 2012, NATURE, V486, P518, DOI 10.1038/nature11158; Liskey CW, 2010, J AM CHEM SOC, V132, P11389, DOI 10.1021/ja104442v; Lu B, 2008, ANGEW CHEM INT EDIT, V47, P7508, DOI 10.1002/anie.200802456; Lyons TW, 2010, CHEM REV, V110, P1147, DOI 10.1021/cr900184e; McGlacken GP, 2009, CHEM SOC REV, V38, P2447, DOI 10.1039/b805701j; Mkhalid IAI, 2010, CHEM REV, V110, P890, DOI 10.1021/cr900206p; Murata M, 2007, CHEM LETT, V36, P910, DOI 10.1246/cl.2007.910; Murphy JM, 2007, J AM CHEM SOC, V129, P15434, DOI 10.1021/ja076498n; Oyamada J, 2011, ANGEW CHEM INT EDIT, V50, P10720, DOI 10.1002/anie.201105636; Phipps RJ, 2009, SCIENCE, V323, P1593, DOI 10.1126/science.1169975; Rappoport Y.A.Z., 2003, CHEM ORGANIC SILICON, V2, P1793; Roughley SD, 2011, J MED CHEM, V54, P3451, DOI 10.1021/jm200187y; Saiki T, 2006, ORGANOMETALLICS, V25, P6068, DOI 10.1021/om050968+; SAKAKURA T, 1987, CHEM LETT, P2375, DOI 10.1246/cl.1987.2375; Simmons EM, 2012, NATURE, V483, P70, DOI 10.1038/nature10785; Simmons EM, 2010, J AM CHEM SOC, V132, P17092, DOI 10.1021/ja1086547; Tajuddin H, 2012, CHEM SCI, V3, P3505, DOI 10.1039/c2sc20776a; Ureshino T, 2010, J AM CHEM SOC, V132, P14324, DOI 10.1021/ja107698p; Vanchura BA, 2010, CHEM COMMUN, V46, P7724, DOI 10.1039/c0cc02041a; WILLIAMS NA, 1995, J CHEM SOC CHEM COMM, P1129, DOI 10.1039/c39950001129	36	330	335	8	255	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 21	2014	343	6173					853	857		10.1126/science.1248042	http://dx.doi.org/10.1126/science.1248042			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB1LG	24558154				2022-12-28	WOS:000331552600038
J	Schwitzer, C; Mittermeier, RA; Johnson, SE; Donati, G; Irwin, M; Peacock, H; Ratsimbazafy, J; Razafindramanana, J; Louis, EE; Chikhi, L; Colquhoun, IC; Tinsman, J; Dolch, R; LaFleur, M; Nash, S; Patel, E; Randrianambinina, B; Rasolofoharivelo, T; Wright, PC				Schwitzer, C.; Mittermeier, R. A.; Johnson, S. E.; Donati, G.; Irwin, M.; Peacock, H.; Ratsimbazafy, J.; Razafindramanana, J.; Louis, E. E., Jr.; Chikhi, L.; Colquhoun, I. C.; Tinsman, J.; Dolch, R.; LaFleur, M.; Nash, S.; Patel, E.; Randrianambinina, B.; Rasolofoharivelo, T.; Wright, P. C.			Averting Lemur Extinctions amid Madagascar's Political Crisis	SCIENCE			English	Editorial Material									[Schwitzer, C.] Bristol Zool Soc, Bristol BS8 3HA, Avon, England; [Mittermeier, R. A.; Nash, S.] Conservat Int, Arlington, VA 22202 USA; [Johnson, S. E.] Univ Calgary, Calgary, AB T2N 1N4, Canada; [Donati, G.] Oxford Brookes Univ, Oxford OX3 0BP, England; [Irwin, M.] No Illinois Univ, De Kalb, IL 60115 USA; [Peacock, H.] Golder Associates, Calgary, AB T2A 7W5, Canada; [Ratsimbazafy, J.] Durrell Wildlife Conservat Trust, Antananarivo 101, Madagascar; [Ratsimbazafy, J.; Razafindramanana, J.; Rasolofoharivelo, T.] Grp Etud & Rech Primates Madagascar, Antananarivo 101, Madagascar; [Louis, E. E., Jr.] Omahas Henry Doorly Zoo, Omaha, NE 68107 USA; [Chikhi, L.] Inst Gulbenkian Ciencias, P-2781901 Oeiras, Portugal; [Chikhi, L.] Univ Toulouse 3, CNRS, UMR 5174, Lab Evolut & Divers Biol, F-31062 Toulouse 9, France; [Colquhoun, I. C.] Univ Western Ontario, London, ON N6A 5C2, Canada; [Tinsman, J.] Amer Museum Nat Hist, New York, NY 10024 USA; [Dolch, R.] Assoc Mitsinjo, Andasibe 514, Madagascar; [LaFleur, M.] Univ Vet Med Vienna, A-1210 Vienna, Austria; [Nash, S.; Wright, P. C.] SUNY Stony Brook, Stony Brook, NY 11794 USA; [Patel, E.] Duke Lemur Ctr, Durham, NC 27705 USA; [Randrianambinina, B.] Univ Mahajanga, Mahajanga 401, Madagascar	Conservation International; University of Calgary; Oxford Brookes University; Northern Illinois University; Instituto Gulbenkian de Ciencia; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); Western University (University of Western Ontario); American Museum of Natural History (AMNH); University of Veterinary Medicine Vienna; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Schwitzer, C (corresponding author), Bristol Zool Soc, Bristol BS8 3HA, Avon, England.	cschwitzer@bcsf.org.uk	Irwin, Mitchell Thomas/AAY-1776-2021; Irwin, Mitchell/A-1482-2012	Irwin, Mitchell Thomas/0000-0003-2088-0028; Irwin, Mitchell/0000-0003-2088-0028; Johnson, Steig/0000-0003-2257-8949; Tinsman, Jen/0000-0003-2452-4573; Donati, Giuseppe/0000-0002-4803-0642; Chikhi, Lounes/0000-0002-1140-0718				Barrett MA, 2010, SCIENCE, V328, P1109, DOI 10.1126/science.1187740; Carret J.-C., 2013, MADAGASCAR COUNTRY E; Ganzhorn JU, 1999, CONSERV BIOL, V13, P794, DOI 10.1046/j.1523-1739.1999.98245.x; *GLOB WITN ENV INV, 2009, INV ILL FELL TRANSP; Jenkins RKB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027570; Laurance WF, 2013, TRENDS ECOL EVOL, V28, P261, DOI 10.1016/j.tree.2013.01.017; Mittermeier R.A., 2010, LEMURS MADAGASCAR; ONE DGF FTM MNP CI, 2013, EV COUV FOR NAT MAD; Schwitzer C., 2013, LEMURS MADAGASCAR ST; World Bank, 2013, MAD MEAS IMP POL CRI	10	174	175	0	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 21	2014	343	6173					842	843		10.1126/science.1245783	http://dx.doi.org/10.1126/science.1245783			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB1LG	24558147	Green Submitted			2022-12-28	WOS:000331552600030
J	Porsteinsson, AP; Drye, LT; Pollock, BG; Devanand, DP; Frangakis, C; Ismail, Z; Marano, C; Meinert, CL; Mintzer, JE; Munro, CA; Pelton, G; Rabins, PV; Rosenberg, PB; Schneider, LS; Shade, DM; Weintraub, D; Yesavage, J; Lyketsos, CG				Porsteinsson, Anton P.; Drye, Lea T.; Pollock, Bruce G.; Devanand, D. P.; Frangakis, Constantine; Ismail, Zahinoor; Marano, Christopher; Meinert, Curtis L.; Mintzer, Jacobo E.; Munro, Cynthia A.; Pelton, Gregory; Rabins, Peter V.; Rosenberg, Paul B.; Schneider, Lon S.; Shade, David M.; Weintraub, Daniel; Yesavage, Jerome; Lyketsos, Constantine G.		CitAD Res Grp	Effect of Citalopram on Agitation in Alzheimer Disease The CitAD Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PLACEBO-CONTROLLED TRIALS; NEUROPSYCHIATRIC-SYMPTOMS; BEHAVIORAL DISTURBANCES; ATYPICAL ANTIPSYCHOTICS; CACHE COUNTY; DOUBLE-BLIND; DEMENTIA; OUTCOMES; METAANALYSIS; MULTICENTER	IMPORTANCE Agitation is common, persistent, and associated with adverse consequences for patients with Alzheimer disease. Pharmacological treatment options, including antipsychotics are not satisfactory. OBJECTIVE The primary objective was to evaluate the efficacy of citalopram for agitation in patients with Alzheimer disease. Key secondary objectives examined effects of citalopram on function, caregiver distress, safety, cognitive safety, and tolerability. DESIGN, SETTING, AND PARTICIPANTS The Citalopram for Agitation in Alzheimer Disease Study (CitAD) was a randomized, placebo-controlled, double-blind, parallel group trial that enrolled 186 patients with probable Alzheimer disease and clinically significant agitation from 8 academic centers in the United States and Canada from August 2009 to January 2013. INTERVENTIONS Participants (n = 186) were randomized to receive a psychosocial intervention plus either citalopram(n = 94) or placebo (n = 92) for 9 weeks. Dosage began at 10 mg per day with planned titration to 30 mg per day over 3 weeks based on response and tolerability. MAIN OUTCOMES AND MEASURES Primary outcome measures were based on scores from the 18-point Neurobehavioral Rating Scale agitation subscale (NBRS-A) and the modified Alzheimer Disease Cooperative Study-Clinical Global Impression of Change (mADCS-CGIC). Other outcomes were based on scores from the Cohen-Mansfield Agitation Inventory (CMAI) and the Neuropsychiatric Inventory (NPI), ability to complete activities of daily living (ADLs), caregiver distress, cognitive safety (based on scores from the 30-point Mini Mental State Examination [MMSE]), and adverse events. RESULTS Participants who received citalopram showed significant improvement compared with those who received placebo on both primary outcome measures. The NBRS-A estimated treatment difference at week 9 (citalopram minus placebo) was -0.93 (95% CI, -1.80 to -0.06), P = .04. Results from the mADCS-CGIC showed 40% of citalopram participants having moderate or marked improvement from baseline compared with 26% of placebo recipients, with estimated treatment effect (odds ratio [OR] of being at or better than a given CGIC category) of 2.13 (95% CI, 1.23-3.69), P = .01. Participants who received citalopram showed significant improvement on the CMAI, total NPI, and caregiver distress scores but not on the NPI agitation subscale, ADLs, or in less use of rescue lorazepam. Worsening of cognition (-1.05 points; 95% CI, -1.97 to -0.13; P = .03) and QT interval prolongation (18.1 ms; 95% CI, 6.1-30.1; P = .01) were seen in the citalopram group. CONCLUSIONS AND RELEVANCE Among patients with probable Alzheimer disease and agitation who were receiving psychosocial intervention, the addition of citalopram compared with placebo significantly reduced agitation and caregiver distress; however, cognitive and cardiac adverse effects of citalopram may limit its practical application at the dosage of 30 mg per day.	[Porsteinsson, Anton P.] Univ Rochester, Sch Med & Dent, Rochester, NY 14620 USA; [Drye, Lea T.; Frangakis, Constantine; Meinert, Curtis L.; Shade, David M.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Pollock, Bruce G.] Univ Toronto, CAMH, Campbell Inst, Toronto, ON, Canada; [Devanand, D. P.; Pelton, Gregory] New York State Psychiat Inst & Hosp, Div Geriatr Psychiat, New York, NY 10032 USA; [Devanand, D. P.] Columbia Univ Coll Phys & Surg, New York, NY 10032 USA; [Ismail, Zahinoor] Univ Calgary, Hotchkiss Brain Inst, Dept Psychiat, Calgary, AB, Canada; [Ismail, Zahinoor] Univ Calgary, Hotchkiss Brain Inst, Dept Neurol, Calgary, AB, Canada; [Marano, Christopher; Munro, Cynthia A.; Rabins, Peter V.; Rosenberg, Paul B.; Lyketsos, Constantine G.] Johns Hopkins Bayview, Baltimore, MD USA; [Marano, Christopher; Munro, Cynthia A.; Rabins, Peter V.; Rosenberg, Paul B.; Lyketsos, Constantine G.] Johns Hopkins Sch Med, Baltimore, MD USA; [Mintzer, Jacobo E.] Roper St Francis Healthcare, Clin Biotechnol Res Inst, Charleston, SC USA; [Schneider, Lon S.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Weintraub, Daniel] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Yesavage, Jerome] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Yesavage, Jerome] VA Palo Alto Hlth Care Syst, Stanford, CA USA	University of Rochester; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; New York State Psychiatry Institute; Columbia University; University of Calgary; University of Calgary; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; University of Southern California; University of Pennsylvania; Pennsylvania Medicine; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Porsteinsson, AP (corresponding author), Univ Rochester, Sch Med & Dent, Dept Psychiat, 435 E Henrietta Rd, Rochester, NY 14620 USA.	anton_porsteinsson@urmc.rochester.edu	Weintraub, Daniel/AAD-8309-2020; Weintraub, Daniel/AAC-5232-2020	Weintraub, Daniel/0000-0003-0633-7168; Porsteinsson, Anton/0000-0002-0166-1738	NIA; NIMH [R01AG031348]; NIH [AG05142]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005146, P50AG005142, R01AG031348] Funding Source: NIH RePORTER	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIA and NIMH, R01AG031348 and in part by NIH P50, AG05142 (USC, LSS).	Aalten P, 2005, INT J GERIATR PSYCH, V20, P523, DOI 10.1002/gps.1316; Agresti A., 1990, CATEGORICAL DATA ANA, pXV; Ballard C, 2006, NAT REV NEUROSCI, V7, P492, DOI 10.1038/nrn1926; Ballard CG, 2009, NAT REV NEUROL, V5, P245, DOI 10.1038/nrneurol.2009.39; Bergh S, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1566; Cohen-Mansfield J, 1996, Int Psychogeriatr, V8 Suppl 3, P309; Coupland C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4551; Culang ME, 2009, AM J GERIAT PSYCHIAT, V17, P881, DOI 10.1097/JGP.0b013e3181b4bf4a; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Drye LT, 2012, ALZHEIMERS DEMENT, V8, P121, DOI 10.1016/j.jalz.2011.01.007; FDA Drug Safety Communication, ABN HEART RHYTHMS AS; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fox C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035185; Galasko D, 1997, ALZ DIS ASSOC DIS, V11, pS33; Geda YE, 2013, ALZHEIMERS DEMENT, V9, P602, DOI 10.1016/j.jalz.2012.12.001; Howard R, 2011, INT J GERIATR PSYCH, V26, P812, DOI 10.1002/gps.2607; Howard RJ, 2007, NEW ENGL J MED, V357, P1382, DOI 10.1056/NEJMoa066583; Hurd MD, 2013, NEW ENGL J MED, V368, P1326, DOI 10.1056/NEJMsa1204629; Hurley MV, 1997, ANN RHEUM DIS, V56, P641, DOI 10.1136/ard.56.11.641; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; Lyketsos CG, 2000, AM J PSYCHIAT, V157, P708, DOI 10.1176/appi.ajp.157.5.708; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Munro CA, 2012, AM J GERIAT PSYCHIAT, V20, P1036, DOI 10.1097/JGP.0b013e31826ce4c5; NYTH AL, 1990, BRIT J PSYCHIAT, V157, P894, DOI 10.1192/bjp.157.6.894; NYTH AL, 1992, ACTA PSYCHIAT SCAND, V86, P138, DOI 10.1111/j.1600-0447.1992.tb03242.x; Pollock BG, 1997, AM J GERIAT PSYCHIAT, V5, P70; Pollock BG, 2002, AM J PSYCHIAT, V159, P460, DOI 10.1176/appi.ajp.159.3.460; Pollock BG, 2007, AM J GERIAT PSYCHIAT, V15, P942, DOI 10.1097/JGP.0b013e3180cc1ff5; Ragneskog H, 1996, Int Psychogeriatr, V8, P659, DOI 10.1017/S1041610296002967; Rosenberg PB, 2012, INT J GERIATR PSYCH, V27, P1248, DOI 10.1002/gps.3769; Rosenblum M, 2010, INT J BIOSTAT, V6, DOI 10.2202/1557-4679.1138; Schneider LS, 2006, NEW ENGL J MED, V355, P1525, DOI 10.1056/NEJMoa061240; Schneider LS, 2009, AM J GERIAT PSYCHIAT, V17, pA77; Schneider LS, 1997, ALZ DIS ASSOC DIS, V11, pS22; Schneider LS, 2005, JAMA-J AM MED ASSOC, V294, P1934, DOI 10.1001/jama.294.15.1934; Schneider LS, 2006, AM J GERIAT PSYCHIAT, V14, P191, DOI 10.1097/01.JGP.0000200589.01396.6d; Steinberg M, 2008, INT J GERIATR PSYCH, V23, P170, DOI 10.1002/gps.1858; US Food and Drug Administration, FDA DRUG SAF COMM RE	38	314	323	0	45	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 19	2014	311	7					682	691		10.1001/jama.2014.93	http://dx.doi.org/10.1001/jama.2014.93			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA8ZO	24549548	Green Accepted, Bronze			2022-12-28	WOS:000331383700020
J	Bae, BI; Tietjen, I; Atabay, KD; Evrony, GD; Johnson, MB; Asare, E; Wang, PP; Murayama, AY; Im, K; Lisgo, SN; Overman, L; Sestan, N; Chang, BS; Barkovich, AJ; Grant, PE; Topcu, M; Politsky, J; Okano, H; Piao, XH; Walsh, CA				Bae, Byoung-Il; Tietjen, Ian; Atabay, Kutay D.; Evrony, Gilad D.; Johnson, Matthew B.; Asare, Ebenezer; Wang, Peter P.; Murayama, Ayako Y.; Im, Kiho; Lisgo, Steven N.; Overman, Lynne; Sestan, Nenad; Chang, Bernard S.; Barkovich, A. James; Grant, P. Ellen; Topcu, Meral; Politsky, Jeffrey; Okano, Hideyuki; Piao, Xianhua; Walsh, Christopher A.			Evolutionarily Dynamic Alternative Splicing of GPR56 Regulates Regional Cerebral Cortical Patterning	SCIENCE			English	Article							COUPLED RECEPTOR 56; FRONTOPARIETAL POLYMICROGYRIA; NEOCORTEX; LAMINATION; BRAIN	The human neocortex has numerous specialized functional areas whose formation is poorly understood. Here, we describe a 15-base pair deletion mutation in a regulatory element of GPR56 that selectively disrupts human cortex surrounding the Sylvian fissure bilaterally including "Broca's area," the primary language area, by disrupting regional GPR56 expression and blocking RFX transcription factor binding. GPR56 encodes a heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptor required for normal cortical development and is expressed in cortical progenitor cells. GPR56 expression levels regulate progenitor proliferation. GPR56 splice forms are highly variable between mice and humans, and the regulatory element of gyrencephalic mammals directs restricted lateral cortical expression. Our data reveal a mechanism by which control of GPR56 expression pattern by multiple alternative promoters can influence stem cell proliferation, gyral patterning, and, potentially, neocortex evolution.	[Bae, Byoung-Il; Tietjen, Ian; Atabay, Kutay D.; Evrony, Gilad D.; Johnson, Matthew B.; Asare, Ebenezer; Wang, Peter P.; Walsh, Christopher A.] Harvard Univ, Sch Med, Manton Ctr Orphan Dis, Div Genet & Genom, Boston, MA 02115 USA; [Bae, Byoung-Il; Tietjen, Ian; Atabay, Kutay D.; Evrony, Gilad D.; Johnson, Matthew B.; Asare, Ebenezer; Wang, Peter P.; Walsh, Christopher A.] Harvard Univ, Howard Hughes Med Inst, Boston Childrens Hosp, Sch Med,Broad Inst MIT & Harvard, Boston, MA 02115 USA; [Bae, Byoung-Il; Tietjen, Ian; Atabay, Kutay D.; Evrony, Gilad D.; Johnson, Matthew B.; Asare, Ebenezer; Wang, Peter P.; Walsh, Christopher A.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Bae, Byoung-Il; Tietjen, Ian; Atabay, Kutay D.; Evrony, Gilad D.; Johnson, Matthew B.; Asare, Ebenezer; Wang, Peter P.; Walsh, Christopher A.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Murayama, Ayako Y.; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Tokyo 1608582, Japan; [Im, Kiho; Barkovich, A. James] Harvard Univ, Sch Med, Boston Childrens Hosp,Dept Radiol,Div Newborn Med, Ctr Fetal Neonatal Neuroimaging & Dev Sci, Boston, MA 02115 USA; [Lisgo, Steven N.; Overman, Lynne] MRC Wellcome Trust Human Dev Biol Resource HDBR, Inst Med Genet, Int Ctr Life, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Sestan, Nenad] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA; [Sestan, Nenad] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06520 USA; [Chang, Bernard S.] Beth Israel Deaconess Med Ctr, Comprehens Epilepsy Ctr, Boston, MA 02215 USA; [Barkovich, A. James] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA; [Barkovich, A. James] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Barkovich, A. James] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Barkovich, A. James] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Topcu, Meral] Hacettepe Univ, Fac Med, Dept Pediat, TR-06100 Ankara, Turkey; [Politsky, Jeffrey] Med Coll Georgia, Dept Neurol, Augusta, GA 30912 USA; [Piao, Xianhua] Boston Childrens Hosp, Div Newborn Med, Boston, MA 02115 USA; [Piao, Xianhua] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Keio University; Harvard University; Boston Children's Hospital; Harvard Medical School; Newcastle University - UK; Yale University; Yale University; Harvard University; Beth Israel Deaconess Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Hacettepe University; University System of Georgia; Augusta University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Walsh, CA (corresponding author), Harvard Univ, Sch Med, Manton Ctr Orphan Dis, Div Genet & Genom, Boston, MA 02115 USA.	christopher.walsh@childrens.harvard.edu	Okano, Hideyuki/I-7584-2019; Grant, Peter/HIR-3733-2022; wang, peter/AAD-5851-2020; Ward, Helen/A-1836-2009	Ward, Helen/0000-0001-8238-5036; Tietjen, Ian/0000-0002-8991-6490; Grant, Patricia/0000-0003-1005-4013; BAE, BYOUNG-IL/0000-0002-9958-678X; Evrony, Gilad/0000-0001-7621-2630; Lisgo, Steven/0000-0001-5186-3971; Walsh, Christopher/0000-0002-0156-2238	Medical Research Council [G0700089]; Wellcome Trust Human Developmental Biology Resource [GR082557]; National Institute of Child Health and Human Development, NIH, Brain and Tissue Bank at the University of Maryland [HHSN275200900011C, NO1-HD-9-0011]; Strategic Research Program for Brain Sciences; Ministry of Education, Culture, Sports, Science and Technology (MEXT) Japan; Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program); National Institute of Mental Health, NIH [U01MH081896]; National Institute of Neurological Disorders and Stroke, NIH [2R01NS035129]; Paul G. Allen Family Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH081896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035129] Funding Source: NIH RePORTER; Medical Research Council [MC_PC_15004] Funding Source: researchfish; MRC [G0700089, MC_PC_15004] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Human Developmental Biology Resource; National Institute of Child Health and Human Development, NIH, Brain and Tissue Bank at the University of Maryland; Strategic Research Program for Brain Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology (MEXT) Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Institute of Mental Health, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Neurological Disorders and Stroke, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Paul G. Allen Family Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Research performed on samples of human origin was conducted according to protocols approved by participating institutions, including Boston Children's Hospital and Beth Israel Deaconess Medical Center. The human embryonic and fetal material was provided by the Joint Medical Research Council (grant no. G0700089)-Wellcome Trust (grant no. GR082557) Human Developmental Biology Resource (www.hdbr.org) and the National Institute of Child Health and Human Development, NIH, Brain and Tissue Bank at the University of Maryland (contract no. HHSN275200900011C, reference no. NO1-HD-9-0011). Gpr56 knockout mice are from Genentech. This work was supported by the Strategic Research Program for Brain Sciences and from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) Japan (H.O.); Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program) (H.O.); U01MH081896 from National Institute of Mental Health, NIH (N.S.); 2R01NS035129 from National Institute of Neurological Disorders and Stroke, NIH (C. A. W.); and The Paul G. Allen Family Foundation (C. A. W.). Additional funding support listed in supplementary materials. C. A. W. is an investigator of the Howard Hughes Medical Institute. Gpr56 knockout mice are available from Genentech subject to a Material Transfer Agreement.	Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Baala L, 2007, NAT GENET, V39, P454, DOI 10.1038/ng1993; Bahi-Buisson N, 2010, BRAIN, V133, P3194, DOI 10.1093/brain/awq259; Barkovich AJ, 2010, NEURORADIOLOGY, V52, P479, DOI 10.1007/s00234-009-0644-2; Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553; Golden JA, 2010, NAT REV NEUROL, V6, P471, DOI 10.1038/nrneurol.2010.118; Jeong SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068781; Jeong SJ, 2012, J COMP NEUROL, V520, P2930, DOI 10.1002/cne.23076; Jolma A, 2010, GENOME RES, V20, P861, DOI 10.1101/gr.100552.109; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Li SH, 2008, J NEUROSCI, V28, P5817, DOI 10.1523/JNEUROSCI.0853-08.2008; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Luo R, 2011, P NATL ACAD SCI USA, V108, P12925, DOI 10.1073/pnas.1104821108; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Piao XH, 2005, ANN NEUROL, V58, P680, DOI 10.1002/ana.20616; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Radakovits R, 2009, J NEUROSCI, V29, P7694, DOI 10.1523/JNEUROSCI.5537-08.2009; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Suzuki Y, 2002, NUCLEIC ACIDS RES, V30, P328, DOI 10.1093/nar/30.1.328; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Xu L, 2007, CELL CYCLE, V6, P160, DOI 10.4161/cc.6.2.3760; Zhang DH, 2006, J NEUROCHEM, V98, P860, DOI 10.1111/j.1471-4159.2006.03930.x; Zilles K, 2013, TRENDS NEUROSCI, V36, P275, DOI 10.1016/j.tins.2013.01.006	24	144	149	2	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 14	2014	343	6172					764	768		10.1126/science.1244392	http://dx.doi.org/10.1126/science.1244392			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB1NB	24531968	Green Accepted			2022-12-28	WOS:000331557800038
J	Salas-Salvado, J; Bullo, M; Estruch, R; Ros, E; Covas, MI; Ibarrola-Jurado, N; Corella, D; Aros, F; Gomez-Gracia, E; Ruiz-Gutierrez, V; Romaguera, D; Lapetra, J; Lamuela-Raventos, RM; Serra-Majem, L; Pinto, X; Basora, J; Munoz, MA; Sorli, JV; Martinez-Gonzalez, MA				Salas-Salvado, Jordi; Bullo, Monica; Estruch, Ramon; Ros, Emilio; Covas, Maria-Isabel; Ibarrola-Jurado, Nuria; Corella, Dolores; Aros, Fernando; Gomez-Gracia, Enrique; Ruiz-Gutierrez, Valentina; Romaguera, Dora; Lapetra, Jose; Maria Lamuela-Raventos, Rosa; Serra-Majem, Lluis; Pinto, Xavier; Basora, Josep; Angel Munoz, Miguel; Sorli, Jose V.; Martinez-Gonzalez, Miguel A.			Prevention of Diabetes With Mediterranean Diets A Subgroup Analysis of a Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; LIFE-STYLE INTERVENTION; METABOLIC SYNDROME; RISK-FACTORS; OLIVE OIL; REDUCTION; QUESTIONNAIRE; FREQUENCY; ADHERENCE; OXIDATION	Background: Interventions promoting weight loss can reduce the incidence of type 2 diabetes mellitus. Whether dietary changes without calorie restriction also protect from diabetes has not been evaluated. Objective: To assess the efficacy of Mediterranean diets for the primary prevention of diabetes in the Prevencion con Dieta Mediterranea trial, from October 2003 to December 2010 (median follow-up, 4.1 years). Design: Subgroup analysis of a multicenter, randomized trial. (Current Controlled Trials: ISRCTN35739639) Setting: Primary care centers in Spain. Participants: Men and women without diabetes (3541 patients aged 55 to 80 years) at high cardiovascular risk. Intervention: Participants were randomly assigned and stratified by site, sex, and age but not diabetes status to receive 1 of 3 diets: Mediterranean diet supplemented with extra-virgin olive oil (EVOO), Mediterranean diet supplemented with nuts, or a control diet (advice on a low-fat diet). No intervention to increase physical activity or lose weight was included. Measurements: Incidence of new-onset type 2 diabetes mellitus (prespecified secondary outcome). Results: During follow-up, 80, 92, and 101 new-onset cases of diabetes occurred in the Mediterranean diet supplemented with EVOO, Mediterranean diet supplemented with mixed nuts, and control diet groups, respectively, corresponding to rates of 16.0, 18.7, and 23.6 cases per 1000 person-years. Multivariate-adjusted hazard ratios were 0.60 (95% CI, 0.43 to 0.85) for the Mediterranean diet supplemented with EVOO and 0.82 (CI, 0.61 to 1.10) for the Mediterranean diet supplemented with nuts compared with the control diet. Limitations: Randomization was not stratified by diabetes status. Withdrawals were greater in the control group. Conclusion: A Mediterranean diet enriched with EVOO but without energy restrictions reduced diabetes risk among persons with high cardiovascular risk.			Salas-Salvado, J (corresponding author), Univ Rovira & Virgili, Fac Med & Hlth Sci, Human Nutr Unit, C St Llorenc 21, Reus 43201, Spain.	jordi.salas@urv.cat	Romaguera, Dora/ABE-7004-2020; Salas-Salvado, Jordi/C-7229-2017; perez, miguel/GXF-5077-2022; Lapetra, Jose/F-2552-2015; Bulló, Mònica/F-2925-2016; IBIS, ATENCION PRIMARIA/I-3524-2016; Martinez-Gonzalez, Miguel A./AAE-7669-2019; Pintó, Xavier/AGI-4297-2022; Muñoz, Miguel Angel/X-3511-2019; Estruch, Ramon/AAZ-3723-2020; Sorlí, José V/L-8758-2014; Romaguera, Dora/AAB-2852-2020; Serra-Majem, Lluis/I-6708-2019; Lamuela-Raventos, Rosa M/F-3986-2016	Romaguera, Dora/0000-0002-5762-8558; Salas-Salvado, Jordi/0000-0003-2700-7459; Bulló, Mònica/0000-0002-0218-7046; Pintó, Xavier/0000-0002-2216-2444; Muñoz, Miguel Angel/0000-0002-4083-3248; Sorlí, José V/0000-0002-0130-2006; Serra-Majem, Lluis/0000-0002-9658-9061; Basora, Josep/0000-0003-0278-1149; Lamuela-Raventos, Rosa M/0000-0002-1287-4560; Ros, Emilio/0000-0002-2573-1294; Martinez-Gonzalez, Miguel A./0000-0002-3917-9808	Instituto de Salud Carlos III	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	Instituto de Salud Carlos III.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Martinez-Gonzalez MA, 2012, INT J EPIDEMIOL, V41, P377, DOI 10.1093/ije/dyq250; Bray GA, 2009, LANCET, V374, P1677, DOI 10.1016/S0140-6736(09)61457-4; Bullo M, 2011, CURR TOP MED CHEM, V11, P1797, DOI 10.2174/156802611796235062; Calder PC, 2011, BRIT J NUTR, V106, pS1, DOI 10.1017/S0007114511005460; Cole SR, 2008, AM J EPIDEMIOL, V168, P656, DOI 10.1093/aje/kwn164; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; ELOSUA R, 1994, AM J EPIDEMIOL, V139, P1197, DOI 10.1093/oxfordjournals.aje.a116966; Esfahani A, 2011, J AM COLL NUTR, V30, P285, DOI 10.1080/07315724.2011.10719971; Esposito K, 2010, METAB SYNDR RELAT D, V8, P471, DOI 10.1089/met.2010.0009; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Estruch R, 2006, ANN INTERN MED, V145, P1, DOI 10.7326/0003-4819-145-1-200607040-00004; Fernandez-Ballarth JD, 2010, BRIT J NUTR, V103, P1808, DOI 10.1017/S0007114509993837; Fito M, 2007, ARCH INTERN MED, V167, P1195, DOI 10.1001/archinte.167.11.1195; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Gillies CL, 2007, BMJ-BRIT MED J, V334, P299, DOI 10.1136/bmj.39063.689375.55; InterAct Project, 2011, DIABETES CARE, V34, P1913, DOI 10.2337/dc11-0891; Kastorini CM, 2011, J AM COLL CARDIOL, V57, P1299, DOI 10.1016/j.jacc.2010.09.073; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lindstrom J, 2006, LANCET, V368, P1673, DOI 10.1016/S0140-6736(06)69701-8; Martinez-Gonzalez MA, 2008, BMJ-BRIT MED J, V336, P1348, DOI 10.1136/bmj.39561.501007.BE; Mena MP, 2009, AM J CLIN NUTR, V89, P248, DOI 10.3945/ajcn.2008.26094; Mortimer KM, 2005, AM J EPIDEMIOL, V162, P382, DOI 10.1093/aje/kwi208; Mozaffarian D, 2009, ARCH INTERN MED, V169, P798, DOI 10.1001/archinternmed.2009.21; Phung OJ, 2011, DIABETIC MED, V28, P948, DOI 10.1111/j.1464-5491.2011.03303.x; Riserus U, 2009, PROG LIPID RES, V48, P44, DOI 10.1016/j.plipres.2008.10.002; Rumawas ME, 2009, AM J CLIN NUTR, V90, P1608, DOI 10.3945/ajcn.2009.27908; Salas-Salvado J, 2011, NUTR METAB CARDIOVAS, V21, pB32, DOI 10.1016/j.numecd.2011.03.009; Salas-Salvado J, 2011, DIABETES CARE, V34, P14, DOI 10.2337/dc10-1288; Urpi-Sarda M, 2012, PHARMACOL RES, V65, P577, DOI 10.1016/j.phrs.2012.03.006; Viscogliosi G, 2013, METAB SYNDR RELAT D, V11, P210, DOI 10.1089/met.2012.0168	31	363	374	5	136	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 7	2014	160	1					1	+		10.7326/M13-1725	http://dx.doi.org/10.7326/M13-1725			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	297IS	24573661				2022-12-28	WOS:000330249700001
J	Silove, D; Ward, PB				Silove, Derrick; Ward, Philip B.			Challenges in rolling out interventions for schizophrenia	LANCET			English	Editorial Material							GLOBAL MENTAL-HEALTH; RISK-FACTORS		[Silove, Derrick] Univ New S Wales, Liverpool Hosp, Mental Hlth Ctr, Psychiat Res & Teaching Unit,Sch Psychiat, Sydney, NSW 2170, Australia; [Ward, Philip B.] Univ New S Wales, Liverpool Hosp, Mental Hlth Ctr, Schizophrenia Res Unit,Sch Psychiat, Sydney, NSW 2170, Australia	Liverpool Hospital; University of New South Wales Sydney; Liverpool Hospital; University of New South Wales Sydney	Silove, D (corresponding author), Univ New S Wales, Liverpool Hosp, Mental Hlth Ctr, Psychiat Res & Teaching Unit,Sch Psychiat, Sydney, NSW 2170, Australia.	d.silove@unsw.edu.au	Ward, Philip/E-3959-2010	Ward, Philip/0000-0002-5779-7722				Chatterjee S, 2014, LANCET; Collins PY, 2011, NATURE, V475, P27, DOI 10.1038/475027a; Gore FM, 2011, LANCET, V377, P2093, DOI 10.1016/S0140-6736(11)60512-6; Khandelwal S, 2013, OBES REV, V14, P114, DOI 10.1111/obr.12097; Mitchell AJ, 2013, SCHIZOPHRENIA BULL, V39, P306, DOI 10.1093/schbul/sbr148; Patel Vikarm, 2012, MENTAL HLTH HUMAN RI, P362; Perez-Iglesias R, 2014, INT J NEUROPSYCHOPH, V17, P41, DOI 10.1017/S1461145713001053; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Silove D, 2000, LANCET, V355, P1548, DOI 10.1016/S0140-6736(00)02177-2; Silove D, 2013, BUILDING BACK BETTER, P83; Silove D, 2008, ARCH GEN PSYCHIAT, V65, P1205, DOI 10.1001/archpsyc.65.10.1205; Summerfield D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3509; Wildgust HJ, 2010, J PSYCHOPHARMACOL, V24, P37, DOI 10.1177/1359786810384639	13	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 19	2014	383	9926					1362	1364		10.1016/S0140-6736(14)60085-4	http://dx.doi.org/10.1016/S0140-6736(14)60085-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AG3LI	24612753	hybrid			2022-12-28	WOS:000335318400005
J	Taylor, C; Kavanagh, P; Zuckerman, B				Taylor, Catherine; Kavanagh, Patricia; Zuckerman, Barry			Sickle Cell Trait-Neglected Opportunities in the Era of Genomic Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DISEASE		[Taylor, Catherine] Boston Med Ctr, Boston Combined Residency Pediat, Boston, MA USA; [Taylor, Catherine] Boston Childrens Hosp, Boston, MA USA; [Kavanagh, Patricia; Zuckerman, Barry] Boston Med Ctr, Dept Pediat, Boston, MA USA; [Kavanagh, Patricia; Zuckerman, Barry] Boston Univ, Sch Med, Boston, MA 02118 USA	Boston Medical Center; Harvard University; Boston Children's Hospital; Boston Medical Center; Boston University	Zuckerman, B (corresponding author), Boston Univ, Sch Med, Boston Med Ctr, 771 Albany St,Dowling Third Floor, Boston, MA 02118 USA.	barry.zuckerman@bmc.org			PHS HHS [U38MC2215] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Centers for Disease Control and Prevention National Center on Birth Defects and Developmental Disabilities Divison of Blood Disorders, WHAT YOU SHOULD KNOW; Davis LB, 2010, FERTIL STERIL, V93, P1793, DOI 10.1016/j.fertnstert.2008.12.053; Desposito F, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e22; Kavanagh PL, 2008, AM J MED GENET C, V148C, P15, DOI 10.1002/ajmg.c.30160; NHS Commisioning Board, CLIN COMM POL PREIMP; PAULING L, 1968, UCLA LAW REV, V15, P267; Smith LA, 2006, PEDIATRICS, V117, P1763, DOI 10.1542/peds.2005-1611; Treadwell MJ, 2006, J NATL MED ASSOC, V98, P704	8	22	22	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 16	2014	311	15					1495	1496		10.1001/jama.2014.2157	http://dx.doi.org/10.1001/jama.2014.2157			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE9DX	24604073				2022-12-28	WOS:000334306000014
J	Baruch, J				Baruch, John			Practical science has a global reach and appeal	NATURE			English	Editorial Material									[Baruch, John] Univ Bradford, Bradford BD7 1DP, W Yorkshire, England	University of Bradford	Baruch, J (corresponding author), S China Univ Technol, Guangzhou, Guangdong, Peoples R China.	john@telescope.org		Baruch, John/0000-0001-8177-9914					0	1	1	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2014	507	7491					141	141		10.1038/507141a	http://dx.doi.org/10.1038/507141a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC6RJ	24622169	Bronze			2022-12-28	WOS:000332651800006
J	Truesdale, PE				Truesdale, P. E.			The Hospital versus the Home in the Care of the Sick; An Evolution (Reprinted from vol 59, pg 1671, 1912)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		Truesdale PE, 1912, J AMER MED ASSOC, V59, P1671	1	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2014	311	10					1073	1073		10.1001/jama.2013.279383	http://dx.doi.org/10.1001/jama.2013.279383			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC5QO	24618979				2022-12-28	WOS:000332575800034
J	Eisenstein, M				Eisenstein, Michael			PUBLIC HEALTH An injection of trust	NATURE			English	Editorial Material							VACCINATION; VACCINES; RISK											Atwell JE, 2013, PEDIATRICS, V132, P624, DOI 10.1542/peds.2013-0878; DeStefano F, 2013, J PEDIATR-US, V163, P561, DOI 10.1016/j.jpeds.2013.02.001; European Centre for Disease Prevention and Control, 2013, RISK ASS WILD TYP PO; Kata A, 2012, VACCINE, V30, P3778, DOI 10.1016/j.vaccine.2011.11.112; Larson HJ, 2013, LANCET INFECT DIS, V13, P606, DOI 10.1016/S1473-3099(13)70108-7; O'Leary ST, 2012, PEDIATRICS, V129, P248, DOI 10.1542/peds.2011-1111; Omer SB, 2012, NEW ENGL J MED, V367, P1170, DOI 10.1056/NEJMc1209037; van Panhuis WG, 2013, NEW ENGL J MED, V369, P2152, DOI 10.1056/NEJMms1215400	8	11	11	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					S17	S19		10.1038/507S17a	http://dx.doi.org/10.1038/507S17a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC0ZQ	24611174				2022-12-28	WOS:000332224400009
J	Hirth, G				Hirth, Greg			EARTH SCIENCE Missing link in mantle dynamics	NATURE			English	Editorial Material							CREEP		Brown Univ, Dept Geol Sci, Providence, RI 02912 USA	Brown University	Hirth, G (corresponding author), Brown Univ, Dept Geol Sci, Providence, RI 02912 USA.	greg_hirth@brown.edu						Cordier P, 2014, NATURE, V507, P51, DOI 10.1038/nature13043; Hansen LN, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2011JB008220; HIRTH G, 1995, J GEOPHYS RES-SOL EA, V100, P15441, DOI 10.1029/95JB01292; Hirth JP, 2006, ACTA MATER, V54, P4237, DOI 10.1016/j.actamat.2006.05.017; HUTCHINSON JW, 1977, METALL TRANS A, V8, P1465, DOI 10.1007/BF02642860; Murayama M, 2002, SCIENCE, V295, P2433, DOI 10.1126/science.1067430; Volterra V., 1907, ANNLS SCIENT EC NORM, V24, P401	7	1	2	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					42	43		10.1038/nature13064	http://dx.doi.org/10.1038/nature13064			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0ZQ	24572364				2022-12-28	WOS:000332224400034
J	Treasure, CL; Avorn, J; Kesselheim, AS				Treasure, Carolyn L.; Avorn, Jerry; Kesselheim, Aaron S.			What Is the Public's Right to Access Medical Discoveries Based on Federally Funded Research?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BAYH-DOLE ACT; PATENTS		[Treasure, Carolyn L.; Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Program Regulat Therapeut & Law, Boston, MA 02120 USA; [Treasure, Carolyn L.; Avorn, Jerry; Kesselheim, Aaron S.] Harvard Univ, Sch Med, Boston, MA 02120 USA; [Avorn, Jerry; Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02120 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Kesselheim, AS (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA.	akesselheim@partners.org	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS018465] Funding Source: NIH RePORTER; AHRQ HHS [K08HS18465-01] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Arno Peter S., 2001, TULANE LAW REV, V75, P631; Colaianni A, 2009, MILBANK Q, V87, P683, DOI 10.1111/j.1468-0009.2009.00575.x; LEAHY PJ, COMMUNICATION; Markel H, 2013, NEW ENGL J MED, V369, P794, DOI 10.1056/NEJMp1306553; Rooksby JH, 2013, J LAW EDUC, V42, P313; Stevens AJ, 2011, NEW ENGL J MED, V364, P535, DOI 10.1056/NEJMsa1008268; Varmus H., 1997, DETERMINATION CASE P; Zerhouni EA, 2004, CASE NORVIR MANUFACT	8	7	7	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2014	311	9					907	908		10.1001/jama.2014.404	http://dx.doi.org/10.1001/jama.2014.404			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC0FS	24595771				2022-12-28	WOS:000332170800014
J	Schultz, DM; Yoon, TP				Schultz, Danielle M.; Yoon, Tehshik P.			Solar Synthesis: Prospects in Visible Light Photocatalysis	SCIENCE			English	Review							C-H FUNCTIONALIZATION; BOND-FORMING REACTIONS; PHOTOREDOX CATALYSIS; ELECTRON-TRANSFER; ORGANIC-SYNTHESIS; 9-MESITYL-10-METHYLACRIDINIUM ION; PHOTOCHEMICAL-SYNTHESIS; MICHAEL ACCEPTORS; RADICAL-ADDITION; ENERGY	Chemists have long aspired to synthesize molecules the way that plants do-using sunlight to facilitate the construction of complex molecular architectures. Nevertheless, the use of visible light in photochemical synthesis is fundamentally challenging because organic molecules tend not to interact with the wavelengths of visible light that are most strongly emitted in the solar spectrum. Recent research has begun to leverage the ability of visible light-absorbing transition metal complexes to catalyze a broad range of synthetically valuable reactions. In this review, we highlight how an understanding of the mechanisms of photocatalytic activation available to these transition metal complexes, and of the general reactivity patterns of the intermediates accessible via visible light photocatalysis, has accelerated the development of this diverse suite of reactions.	[Schultz, Danielle M.; Yoon, Tehshik P.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Yoon, TP (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.	tyoon@chem.wisc.edu	昊翀, 谭/AAC-5077-2021		NIH [GM095666]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095666] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge support from the NIH in the form of a research grant (GM095666) and a postdoctoral fellowship to D.M.S.	ALBINI A, 1981, SYNTHESIS-STUTTGART, P249; Alonso F, 2002, CHEM REV, V102, P4009, DOI 10.1021/cr0102967; Bach T, 1998, SYNTHESIS-STUTTGART, P683; Bach T, 2011, ANGEW CHEM INT EDIT, V50, P1000, DOI 10.1002/anie.201002845; Balzani V, 2008, CHEMSUSCHEM, V1, P26, DOI 10.1002/cssc.200700087; BAULD NL, 1989, TETRAHEDRON, V45, P5307, DOI 10.1016/S0040-4020(01)89486-2; Beeson TD, 2005, J AM CHEM SOC, V127, P8826, DOI 10.1021/ja051805f; Beeson TD, 2007, SCIENCE, V316, P582, DOI 10.1126/science. 1142696; Campos KR, 2007, CHEM SOC REV, V36, P1069, DOI 10.1039/b607547a; Chen YY, 2011, NAT CHEM, V3, P146, DOI 10.1038/NCHEM.932; Ciamician G, 1912, Science, V36, P385, DOI 10.1126/science.36.926.385; Condie AG, 2010, J AM CHEM SOC, V132, P1464, DOI 10.1021/ja909145y; DALKO PI, 1995, TETRAHEDRON, V51, P7579, DOI 10.1016/0040-4020(95)00434-A; Du J, 2009, J AM CHEM SOC, V131, P14604, DOI 10.1021/ja903732v; Edmonds DJ, 2004, CHEM REV, V104, P3371, DOI 10.1021/cr030017a; Espelt LR, 2013, J ORG CHEM, V78, P4107, DOI 10.1021/jo400428m; ESSER P, 1994, ANGEW CHEM INT EDIT, V33, P2009, DOI 10.1002/anie.199420091; Fagnoni M, 2007, CHEM REV, V107, P2725, DOI 10.1021/cr068352X; Farney EP, 2014, ANGEW CHEM INT EDIT, V53, P793, DOI 10.1002/anie.201308820; Floreancig PE, 2007, SYNLETT, P191, DOI 10.1055/s-2007-968021; Fors Brett P, 2012, Angew Chem Int Ed Engl, V51, P8850, DOI 10.1002/anie.201203639; Freeman DB, 2012, ORG LETT, V14, P94, DOI 10.1021/ol202883v; FUKUZUMI S, 1990, J PHYS CHEM-US, V94, P722, DOI 10.1021/j100365a039; Fukuzumi S, 2004, J AM CHEM SOC, V126, P1600, DOI 10.1021/ja038656q; Furst L, 2011, ANGEW CHEM INT EDIT, V50, P9655, DOI 10.1002/anie.201103145; Furst L, 2010, ORG LETT, V12, P3104, DOI 10.1021/ol101146f; Guo FH, 2012, EUR J ORG CHEM, V2012, P4881, DOI 10.1002/ejoc.201200665; Hamilton DS, 2012, J AM CHEM SOC, V134, P18577, DOI 10.1021/ja309635w; Hoffmann N, 2008, CHEM REV, V108, P1052, DOI 10.1021/cr0680336; Horton DA, 2003, CHEM REV, V103, P893, DOI 10.1021/cr020033s; Ischay MA, 2008, J AM CHEM SOC, V130, P12886, DOI 10.1021/ja805387f; Ischay MA, 2012, CHEM SCI, V3, P2807, DOI 10.1039/c2sc20658g; Ischay MA, 2012, EUR J ORG CHEM, V2012, P3359, DOI 10.1002/ejoc.201101071; JURIS A, 1988, COORDIN CHEM REV, V84, P85, DOI 10.1016/0010-8545(88)80032-8; KALYANASUNDARAM K, 1982, COORDIN CHEM REV, V46, P159, DOI 10.1016/0010-8545(82)85003-0; Kalyanasundaram K., 1992, PHOTOCHEMISTRY POLYP; Kalyani D, 2011, J AM CHEM SOC, V133, P18566, DOI 10.1021/ja208068w; Kohls P, 2012, ORG LETT, V14, P672, DOI 10.1021/ol202857t; Kotani H, 2004, J AM CHEM SOC, V126, P15999, DOI 10.1021/ja048353b; Leibfarth FA, 2013, ANGEW CHEM INT EDIT, V52, P199, DOI 10.1002/anie.201206476; Lin SS, 2011, J AM CHEM SOC, V133, P19350, DOI 10.1021/ja2093579; Lu Z, 2012, ANGEW CHEM INT EDIT, V51, P10329, DOI 10.1002/anie.201204835; Lu Z, 2011, J AM CHEM SOC, V133, P1162, DOI 10.1021/ja107849y; McNally A, 2011, SCIENCE, V334, P1114, DOI 10.1126/science.1213920; Mitchell EA, 2012, CHEM-EUR J, V18, P10092, DOI 10.1002/chem.201201539; Moeller KD, 2009, SYNLETT, P1208, DOI 10.1055/s-0028-1088126; Mukherjee S, 2007, CHEM REV, V107, P5471, DOI 10.1021/cr0684016; MULLER F, 1993, CHEM REV, V93, P99; Nguyen JD, 2012, NAT CHEM, V4, P854, DOI 10.1038/NCHEM.1452; Nguyen TM, 2013, J AM CHEM SOC, V135, P9588, DOI 10.1021/ja4031616; Nicewicz DA, 2008, SCIENCE, V322, P77, DOI 10.1126/science.1161976; Ohkubo K, 2010, CHEM COMMUN, V46, P601, DOI 10.1039/b920606j; Pham PV, 2011, ANGEW CHEM INT EDIT, V50, P6119, DOI 10.1002/anie.201101861; Pirtsch M, 2012, CHEM-EUR J, V18, P7336, DOI 10.1002/chem.201200967; Prier CK, 2013, CHEM REV, V113, P5322, DOI 10.1021/cr300503r; Protti S, 2009, RSC GREEN CHEM SER, V3, P80, DOI 10.1039/9781847559760-00080; Revol G, 2013, ANGEW CHEM INT EDIT, V52, P13342, DOI 10.1002/anie.201306727; Schmittel M, 1997, ANGEW CHEM INT EDIT, V36, P2550, DOI 10.1002/anie.199725501; Shi L, 2012, CHEM SOC REV, V41, P7687, DOI 10.1039/c2cs35203f; Shih HW, 2010, J AM CHEM SOC, V132, P13600, DOI 10.1021/ja106593m; Sperry JB, 2006, CHEM SOC REV, V35, P605, DOI 10.1039/b512308a; Takeda H, 2010, COORDIN CHEM REV, V254, P346, DOI 10.1016/j.ccr.2009.09.030; THEKAEKARA MP, 1976, SOL ENERGY, V18, P309, DOI 10.1016/0038-092X(76)90058-X; Tucker JW, 2012, J ORG CHEM, V77, P1617, DOI 10.1021/jo202538x; Wallentin CJ, 2012, J AM CHEM SOC, V134, P8875, DOI 10.1021/ja300798k; Weinberg DR, 2012, CHEM REV, V112, P4016, DOI 10.1021/cr200177j; Wenger OS, 2013, ACCOUNTS CHEM RES, V46, P1517, DOI 10.1021/ar300289x; Ye YD, 2012, ORG LETT, V14, P4979, DOI 10.1021/ol3022726; Yoon TP, 2013, ACS CATAL, V3, P895, DOI 10.1021/cs400088e; Yoon TP, 2010, NAT CHEM, V2, P527, DOI [10.1038/NCHEM.687, 10.1038/nchem.687]; YOON UC, 1992, ACCOUNTS CHEM RES, V25, P233, DOI 10.1021/ar00017a005; Zhu SQ, 2013, J AM CHEM SOC, V135, P1823, DOI 10.1021/ja309580a; Zou YQ, 2011, ANGEW CHEM INT EDIT, V50, P7171, DOI 10.1002/anie.201102306	73	1738	1751	75	2362	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2014	343	6174					985	+	1239176	10.1126/science.1239176	http://dx.doi.org/10.1126/science.1239176			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2DZ	24578578	Green Accepted			2022-12-28	WOS:000332309600033
J	Bohadana, A; Izbicki, G; Kraman, SS				Bohadana, Abraham; Izbicki, Gabriel; Kraman, Steve S.			Fundamentals of Lung Auscultation	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							BREATH SOUNDS; SPECTRAL CHARACTERISTICS; DIAGNOSIS; MECHANISM; CRACKLES; DENSITY		[Bohadana, Abraham; Izbicki, Gabriel] Shaare Zedek Med Ctr, Pulm Inst, IL-91031 Jerusalem, Israel; [Bohadana, Abraham; Izbicki, Gabriel] Hebrew Univ Jerusalem, Hadassah Med Sch, IL-91010 Jerusalem, Israel; [Kraman, Steve S.] Univ Kentucky, Sch Med, Lexington, KY 40506 USA	Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; University of Kentucky	Bohadana, A (corresponding author), Shaare Zedek Med Ctr, Pulm Inst, 12 Baiyt St, IL-91031 Jerusalem, Israel.	abraham.bohadana@gmail.com			Novartis; AstraZeneca; Teva; Pfizer; Merck; Sharp; Dohme; Neopharm	Novartis(Novartis); AstraZeneca(AstraZeneca); Teva(Teva Pharmaceutical Industries); Pfizer(Pfizer); Merck(Merck & Company); Sharp; Dohme; Neopharm	Dr. Izbicki reports receiving lecture fees from Novartis; AstraZeneca; Teva; Pfizer; Merck, Sharp, and Dohme; and Neopharm, travel support from Novartis and GlaxoSmithKline, and grant support from Novartis, GlaxoSmithKline, and AstraZeneca - all through his institution; and Dr. Kraman reports providing expert testimony in workers' compensation and medical malpractice cases. No other potential conflict of interest relevant to this article was reported.	ALJARAD N, 1993, THORAX, V48, P347, DOI 10.1136/thx.48.4.347; AUSTRHEIM O, 1985, RESP PHYSIOL, V60, P145, DOI 10.1016/0034-5687(85)90099-4; BAUGHMAN RP, 1989, AM REV RESPIR DIS, V139, P1407, DOI 10.1164/ajrccm/139.6.1407; BOHADANA AB, 1995, THORAX, V50, P955, DOI 10.1136/thx.50.9.955; BOHADANA AB, 1978, THORAX, V33, P345, DOI 10.1136/thx.33.3.345; BOHADANA AB, 1988, CLIN PHYSIOL, V8, P341, DOI 10.1111/j.1475-097X.1988.tb00277.x; Butani L, 1997, ANN ALLERG ASTHMA IM, V79, P91, DOI 10.1016/S1081-1206(10)63094-3; Cottin V, 2012, EUR RESPIR J, V40, P519, DOI 10.1183/09031936.00001612; EARIS JE, 1982, THORAX, V37, P923, DOI 10.1136/thx.37.12.923; EPLER GR, 1978, NEW ENGL J MED, V298, P934, DOI 10.1056/NEJM197804272981703; Flietstra B, 2011, PULM MED, V2011, DOI 10.1155/2011/590506; FORGACS P, 1978, CHEST, V73, P399, DOI 10.1378/chest.73.3.399; Forgacs P., 1978, LUNG SOUNDS; GAVRIELY N, 1981, J APPL PHYSIOL, V50, P307, DOI 10.1152/jappl.1981.50.2.307; GAVRIELY N, 1995, THORAX, V50, P1292, DOI 10.1136/thx.50.12.1292; GAVRIELY N, 1989, J APPL PHYSIOL, V66, P2251, DOI 10.1152/jappl.1989.66.5.2251; KRAMAN SS, 1981, AM REV RESPIR DIS, V124, P292; Kraman SS, 2002, PHYSIOL MEAS, V23, P449, DOI 10.1088/0967-3334/23/2/318; KRAMAN SS, 1980, AM REV RESPIR DIS, V122, P303; Laennec RTH., 1819, DE LAUSCULTATION MED; MIKAMI R, 1987, CHEST, V92, P342, DOI 10.1378/chest.92.2.342; Morris MJ, 2010, CHEST, V138, P1213, DOI 10.1378/chest.09-2944; MUNAKATA M, 1991, THORAX, V46, P651, DOI 10.1136/thx.46.9.651; Murphy R, 2010, NEW ENGL J MED, V363, pE31, DOI 10.1056/NEJMicm0803655; MURPHY RLH, 1984, AM REV RESPIR DIS, V129, P375; Paciej R, 2004, THORAX, V59, P177, DOI 10.1136/thorax.2003.014415; Pasterkamp H, 1996, AM J RESP CRIT CARE, V153, P1087, DOI 10.1164/ajrccm.153.3.8630549; PIIRILA P, 1992, CHEST, V102, P176, DOI 10.1378/chest.102.1.176; Ravenna F, 2002, THORAX, V57, P372, DOI 10.1136/thorax.57.4.372; Vyshedskiy A, 2009, CHEST, V135, P156, DOI 10.1378/chest.07-1562; Yadollahi A, 2010, MED BIOL ENG COMPUT, V48, P1087, DOI 10.1007/s11517-010-0674-2	31	177	185	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 20	2014	370	8					744	751		10.1056/NEJMra1302901	http://dx.doi.org/10.1056/NEJMra1302901			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB1DO	24552321	Green Published			2022-12-28	WOS:000331531900009
J	Laming, JM				Laming, J. Martin			ASTROPHYSICS Lopsided stellar death	NATURE			English	Editorial Material							ADVECTIVE-ACOUSTIC CYCLE; NEUTRINO TRANSPORT; CASSIOPEIA; SIMULATIONS; CORE		Naval Res Lab, Div Space Sci, Washington, DC 20375 USA	United States Department of Defense; United States Navy; Naval Research Laboratory	Laming, JM (corresponding author), Naval Res Lab, Div Space Sci, Washington, DC 20375 USA.	laming@nrl.navy.mil						Arnett D., 1996, SUPERNOVAE AND NUCLE; Brandt TD, 2011, ASTROPHYS J, V728, DOI 10.1088/0004-637X/728/1/8; DeLaney T, 2010, ASTROPHYS J, V725, P2038, DOI 10.1088/0004-637X/725/2/2038; Foglizzo T, 2007, ASTROPHYS J, V654, P1006, DOI 10.1086/509612; Grefenstette BW, 2014, NATURE, V506, P339, DOI 10.1038/nature12997; Hwang U, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/2/130; Ouyed R, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.151103; Scheck L, 2008, ASTRON ASTROPHYS, V477, P931, DOI 10.1051/0004-6361:20077701; Stephenson F.R., 2002, HISTORICAL SUPERNOVA	10	3	3	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 20	2014	506	7488					298	299		10.1038/506298a	http://dx.doi.org/10.1038/506298a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB0JL	24553234				2022-12-28	WOS:000331477800023
J	Wills, AM; Hubbard, J; Macklin, EA; Glass, J; Tandan, R; Simpson, EP; Brooks, B; Gelinas, D; Mitsumoto, H; Mozaffar, T; Hanes, GP; Ladha, SS; Heiman-Patterson, T; Katz, J; Lou, JS; Mahoney, K; Grasso, D; Lawson, R; Yu, H; Cudkowicz, M				Wills, Anne-Marie; Hubbard, Jane; Macklin, Eric A.; Glass, Jonathan; Tandan, Rup; Simpson, Ericka P.; Brooks, Benjamin; Gelinas, Deborah; Mitsumoto, Hiroshi; Mozaffar, Tahseen; Hanes, Gregory P.; Ladha, Shafeeq S.; Heiman-Patterson, Terry; Katz, Jonathan; Lou, Jau-Shin; Mahoney, Katy; Grasso, Daniela; Lawson, Robert; Yu, Hong; Cudkowicz, Merit		MDA Clinical Res Network	Hypercaloric enteral nutrition in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled phase 2 trial	LANCET			English	Article							BODY-MASS INDEX; ALS PATIENTS; ENERGY-EXPENDITURE; SURVIVAL; DYSLIPIDEMIA; MANAGEMENT; PREDICTOR; NEUROLOGY; BENEFIT; DEATH	Background Amyotrophic lateral sclerosis is a fatal neurodegenerative disease with few therapeutic options. Mild obesity is associated with greater survival in patients with the disease, and calorie-dense diets increased survival in a mouse model. We aimed to assess the safety and tolerability of two hypercaloric diets in patients with amyotrophic lateral sclerosis receiving enteral nutrition. Methods In this double-blind, placebo-controlled, randomised phase 2 clinical trial, we enrolled adults with amyotrophic lateral sclerosis from participating centres in the USA. Eligible participants were aged 18 years or older with no history of diabetes or liver or cardiovascular disease, and who were already receiving percutaneous enteral nutrition. We randomly assigned participants (1:1:1) using a computer-generated list of random numbers to one of three dietary interventions: replacement calories using an isocaloric tube-fed diet (control), a high-carbohydrate hypercaloric tube-fed diet (HC/HC), or a high-fat hypercaloric tube-fed diet (HF/HC). Participants received the intervention diets for 4 months and were followed up for 5 months. The primary outcomes were safety and tolerability, analysed in all patients who began their study diet. This trial is registered with ClinicalTrials.gov, number NCT00983983. Findings Between Dec 14, 2009, and Nov 2, 2012, we enrolled 24 participants, of whom 20 started their study diet (six in the control group, eight in the HC/HC group, and six in the HF/HC group). One patient in the control group, one in the HC/HC group, and two in the HF/HC group withdrew consent before receiving the intervention. Participants who received the HC/HC diet had a smaller total number of adverse events than did those in the other groups (23 in the HC/HC group vs 42 in the control group vs 48 in the HF/HC group; overall, p=0.06; HC/HC vs control, p=0.06) and significantly fewer serious adverse events than did those on the control diet (none vs nine; p=0.0005). Fewer patients in the HC/HC group discontinued their study diet due to adverse events (none [0%] of eight in the HC/HC group vs three [50%] of six in the control group). During the 5 month follow-up, no deaths occurred in the nine patients assigned to the HC/HC diet compared with three deaths (43%) in the seven patients assigned to the control diet (log-rank p=0.03). Adverse events, tolerability, deaths, and disease progression did not differ significantly between the HF/HC group and the control group. Interpretation Our results provide preliminary evidence that hypercaloric enteral nutrition is safe and tolerable in patients with amyotrophic lateral sclerosis, and support the study of nutritional interventions in larger randomised controlled trials at earlier stages of the disease.	[Wills, Anne-Marie; Mahoney, Katy; Grasso, Daniela; Lawson, Robert; Yu, Hong; Cudkowicz, Merit] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Wills, Anne-Marie; Mahoney, Katy; Grasso, Daniela; Lawson, Robert; Yu, Hong; Cudkowicz, Merit] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Neurol Clin Res Inst, Boston, MA 02114 USA; [Hubbard, Jane] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Harvard Catalyst Massachusetts Gen Hosp,Clin Res, Boston, MA 02114 USA; [Macklin, Eric A.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Biostat, Boston, MA 02114 USA; [Glass, Jonathan] Emory Univ, Sch Med, Atlanta, GA USA; [Tandan, Rup] Univ Vermont, Burlington, VT USA; [Simpson, Ericka P.] Methodist Neurol Inst, Houston, TX USA; [Brooks, Benjamin] Neuromuscular ALS MDA Ctr, Med Ctr, Charlotte, NC USA; [Gelinas, Deborah] St Marys Hlth Care, Grand Rapids, MI USA; [Mitsumoto, Hiroshi] Columbia Presbyterian Med Ctr, New York, NY 10032 USA; [Mozaffar, Tahseen] Univ Calif Irvine, Irvine, CA USA; [Hanes, Gregory P.] Sarasota Mem Hosp, Sarasota, FL USA; [Ladha, Shafeeq S.] St Josephs Hosp, Barrow Neurol Inst, Phoenix, AZ USA; [Heiman-Patterson, Terry] Drexel Univ, Philadelphia, PA 19104 USA; [Katz, Jonathan] Univ Calif San Francisco, Calif Pacific Med Ctr, San Francisco, CA 94143 USA; [Lou, Jau-Shin] Oregon Hlth & Sci Univ, Portland, OR 97201 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Emory University; University of Vermont; The Methodist Hospital System; The Methodist Hospital - Houston; Columbia University; NewYork-Presbyterian Hospital; University of California System; University of California Irvine; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; Drexel University; California Pacific Medical Center; University of California System; University of California San Francisco; Oregon Health & Science University	Wills, AM (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Boston, MA 02114 USA.	awills@partners.org	Ladha, Shafeeq/AAW-6829-2020; Macklin, Eric A/E-2955-2013; Mozaffar, Tahseen/AAE-6971-2020; CUDKOWICZ, MERIT/GWM-6585-2022; Ladha, Shafeeq S/A-4948-2010	Ladha, Shafeeq/0000-0003-1955-4292; Macklin, Eric A/0000-0003-1618-3502; CUDKOWICZ, MERIT/0000-0002-7075-1681; Ladha, Shafeeq S/0000-0003-1955-4292	Muscular Dystrophy Association; National Center for Research Resources; National Institutes of Health; Harvard NeuroDiscovery Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000170] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758, M01RR000109] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard NeuroDiscovery Center; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Muscular Dystrophy Association, National Center for Research Resources, National Institutes of Health, and Harvard NeuroDiscovery Center.	Aldrich T K, 1993, Monaldi Arch Chest Dis, V48, P327; Andersen PM, 2012, EUR J NEUROL, V19, P360, DOI 10.1111/j.1468-1331.2011.03501.x; Berry JD, AMYOTROPH LATERAL SC, V14, P162; BOUCHARD C, 1983, AM J CLIN NUTR, V37, P461, DOI 10.1093/ajcn/37.3.461; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; Silva LBD, 2010, ARQ NEURO-PSIQUIAT, V68, P263, DOI 10.1590/S0004-282X2010000200021; Desport JC, 1999, NEUROLOGY, V53, P1059, DOI 10.1212/WNL.53.5.1059; Dorst J, 2013, AMYOTROPH LAT SCL FR, V14, P533, DOI 10.3109/21678421.2013.823999; Dupuis L, 2008, NEUROLOGY, V70, P1004, DOI 10.1212/01.wnl.0000285080.70324.27; Dupuis L, 2004, P NATL ACAD SCI USA, V101, P11159, DOI 10.1073/pnas.0402026101; Dupuis L, 2011, LANCET NEUROL, V10, P75, DOI 10.1016/S1474-4422(10)70224-6; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Gallo V, 2013, NEUROLOGY, V80, P829, DOI 10.1212/WNL.0b013e3182840689; Genton L, 2011, CLIN NUTR, V30, P553, DOI 10.1016/j.clnu.2011.06.004; Greenwood DI, 2013, NUTR CLIN PRACT, V28, P392, DOI 10.1177/0884533613476554; Ichihara N, 2012, AMYOTROPH LATERAL SC, V13, P544, DOI 10.3109/17482968.2012.699968; Kasarskis EJ, 2011, AMYOTROPH LATERAL SC, V12, P17, DOI 10.3109/17482968.2010.515225; Kasarskis EJ, 1996, NEUROLOGY, V47, pS118, DOI 10.1212/WNL.47.4_Suppl_2.118S; Kasarskis EJ, 1996, AM J CLIN NUTR, V63, P130, DOI 10.1093/ajcn/63.1.130; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Mattson MP, 2007, NEUROMOL MED, V9, P17, DOI 10.1385/NMM:9:1:17; Miller RG, 2009, NEUROLOGY, V73, P1218, DOI 10.1212/WNL.0b013e3181bc0141; NAU KL, 1995, J NEUROL SCI, V129, P47, DOI 10.1016/0022-510X(95)00061-6; O'Reilly EJ, 2013, AMYOTROPH LAT SCL FR, V14, P205, DOI 10.3109/21678421.2012.735240; Otten J.J., 2006, DIETARY REFERENCE IN, DOI DOI 10.17226/11537; Paganoni S, 2011, MUSCLE NERVE, V44, P20, DOI 10.1002/mus.22114; Pedersen WA, 1999, BRAIN RES, V833, P117, DOI 10.1016/S0006-8993(99)01471-7; Pontes-Arruda A, 2006, CRIT CARE MED, V34, P2325, DOI 10.1097/01.CCM.0000234033.65657.B6; Reich-Slotky R, 2013, AMYOTROPH LAT SCL FR, V14, P212, DOI 10.3109/21678421.2013.770028; Shaw AS, 2006, AMYOTROPH LATERAL SC, V7, P16, DOI 10.1080/14660820510012013; Trumbo P, 2002, J AM DIET ASSOC, V102, P1621, DOI 10.1016/S0002-8223(02)90346-9	31	154	160	1	36	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 14	2014	383	9934					2065	2072		10.1016/S0140-6736(14)60222-1	http://dx.doi.org/10.1016/S0140-6736(14)60222-1			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI9VZ	24582471	Green Published, Green Accepted			2022-12-28	WOS:000337292400026
J	Ayers, JW; Althouse, BM; Dredze, M				Ayers, John W.; Althouse, Benjamin M.; Dredze, Mark			Could Behavioral Medicine Lead the Web Data Revolution?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Ayers, John W.] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92123 USA; [Althouse, Benjamin M.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Dredze, Mark] Johns Hopkins Univ, Human Language Technol Ctr Excellence, Baltimore, MD USA	California State University System; San Diego State University; The Santa Fe Institute; Johns Hopkins University	Ayers, JW (corresponding author), San Diego State Univ, Grad Sch Publ Hlth, 9245 Sky Pk Ct, San Diego, CA 92123 USA.	ayers.john.w@gmail.com		Dredze, Mark/0000-0002-0422-2474	NCI NIH HHS [R21 CA173299] Funding Source: Medline; PHS HHS [RCA173299A] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R21CA173299] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Althouse BM, 2014, AM J PREV MED, V46, P166, DOI 10.1016/j.amepre.2013.10.008; Ayers JW, 2014, JAMA INTERN MED, V174, P146, DOI 10.1001/jamainternmed.2013.11933; Ayers JW, 2014, PREV MED, V58, P81, DOI 10.1016/j.ypmed.2013.11.007; Ayers JW, 2013, AM J PREV MED, V44, P520, DOI 10.1016/j.amepre.2013.01.012; Ayers JW, 2011, AM J PREV MED, V40, P448, DOI 10.1016/j.amepre.2010.12.007; Chunara R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061373; Myung SK, 2009, ARCH INTERN MED, V169, P929, DOI 10.1001/archinternmed.2009.109; Olson DR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003256; Paul M. J., YOU ARE WHAT YOU TWE	9	85	86	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 9	2014	311	14					1399	1400		10.1001/jama.2014.1505	http://dx.doi.org/10.1001/jama.2014.1505			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE4EP	24577162	Green Accepted			2022-12-28	WOS:000333935000013
J	Akiyoshi, B; Gull, K				Akiyoshi, Bungo; Gull, Keith			Discovery of Unconventional Kinetochores in Kinetoplastids	CELL			English	Article							TRYPANOSOMA-BRUCEI; CELL-CYCLE; CENP-A; CENTROMERE; DNA; MINICHROMOSOMES; GENE; ARCHITECTURE; SEGREGATION; ALIGNMENT	The kinetochore is the macromolecular protein complex that directs chromosome segregation in eukaryotes. It has been widely assumed that the core kinetochore consists of proteins that are common to all eukaryotes. However, no conventional kinetochore components have been identified in any kinetoplastid genome, thus challenging this assumption of universality. Here, we report the identification of 19 kinetochore proteins (KKT1-19) in Trypanosoma brucei. The majority is conserved among kinetoplastids, but none of them has detectable homology to conventional kinetochore proteins. These proteins instead have a variety of features not found in conventional kinetochore proteins. We propose that kinetoplastids build kinetochores using a distinct set of proteins. These findings provide important insights into the longstanding problem of the position of the root of the eukaryotic tree of life.	[Akiyoshi, Bungo; Gull, Keith] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Akiyoshi, Bungo] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Oxford; University of Oxford	Akiyoshi, B (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	bungo.akiyoshi@bioch.ox.ac.uk		gull, keith/0000-0001-6954-9569; Akiyoshi, Bungo/0000-0001-6010-394X	EMBO; Human Frontier Science Program; Sir Henry Dale Fellowship; Wellcome Trust [098403/Z/12/Z]; Royal Society [098403/Z/12/Z]; Wellcome-Beit Prize Fellowship [098403/Z/12/A]	EMBO(European Molecular Biology Organization (EMBO)); Human Frontier Science Program(Human Frontier Science Program); Sir Henry Dale Fellowship; Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Wellcome-Beit Prize Fellowship	We thank Kim Nasmyth, Stuart Ferguson, Sue Biggins, and Hannah Long for comments on the manuscript. We also thank Vladimir Varga for discussion; Jonathan Higgins for advice on kinases; Takashi Sutani, Nicolai Siegel, and Mike Fiebig for advice on ChIP-seq; and the Central Proteomics Facility, Benjamin Thomas, and Gabriela Ridlova for mass spectrometry analysis. B. A. was supported by postdoctoral fellowships from the EMBO and Human Frontier Science Program and is currently supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (grant 098403/Z/12/Z), as well as a Wellcome-Beit Prize Fellowship (grant 098403/Z/12/A). Research in the Gull laboratory is supported by the Wellcome Trust. The authors declare no competing financial interests.	Akiyoshi B, 2010, NATURE, V468, P576, DOI 10.1038/nature09594; Allen JWA, 2008, FEBS LETT, V582, P2817, DOI 10.1016/j.febslet.2008.07.015; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Archer SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018425; Bastin P, 1996, MOL BIOCHEM PARASIT, V77, P235, DOI 10.1016/0166-6851(96)02598-4; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Biggins S, 2013, GENETICS, V194, P817, DOI 10.1534/genetics.112.145276; BRUN R, 1979, ACTA TROP, V36, P289; Buscaino A, 2010, CURR OPIN GENET DEV, V20, P118, DOI 10.1016/j.gde.2010.01.006; Cavalier-Smith T, 2013, EUR J PROTISTOL, V49, P115, DOI 10.1016/j.ejop.2012.06.001; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Daniels JP, 2010, MICROBIOL MOL BIOL R, V74, P552, DOI 10.1128/MMBR.00024-10; Drechsler H, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120140; Durand-Dubief M, 2007, MOL BIOCHEM PARASIT, V156, P144, DOI 10.1016/j.molbiopara.2007.07.016; Echeverry MC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-29; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Ersfeld K, 1997, SCIENCE, V276, P611, DOI 10.1126/science.276.5312.611; Ersfeld K, 2011, RES MICROBIOL, V162, P626, DOI 10.1016/j.resmic.2011.01.014; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Gull K, 1998, TRENDS MICROBIOL, V6, P319, DOI 10.1016/S0966-842X(98)01314-6; Hayden KE, 2013, MOL CELL BIOL, V33, P763, DOI 10.1128/MCB.01198-12; Hori T, 2013, J CELL BIOL, V200, P45, DOI 10.1083/jcb.201210106; Hori T, 2012, CHROMOSOME RES, V20, P547, DOI 10.1007/s10577-012-9289-9; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Katz LA, 2012, SYST BIOL, V61, P653, DOI 10.1093/sysbio/sys026; Kelly S, 2007, MOL BIOCHEM PARASIT, V154, P103, DOI 10.1016/j.molbiopara.2007.03.012; Kohl L, 1999, J EUKARYOT MICROBIOL, V46, P105, DOI 10.1111/j.1550-7408.1999.tb04592.x; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lowell JE, 2004, J CELL SCI, V117, P5937, DOI 10.1242/jcs.01515; Maddox PS, 2012, CURR OPIN GENET DEV, V22, P139, DOI 10.1016/j.gde.2011.11.005; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Meraldi P, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r23; Muller S, 2014, BBA-GENE REGUL MECH, V1839, P241, DOI 10.1016/j.bbagrm.2013.11.008; Nechemia-Arbely Y, 2012, EXP CELL RES, V318, P1353, DOI 10.1016/j.yexcr.2012.04.007; Nishino M, 2013, ELIFE, V2, DOI 10.7554/eLife.00712; Obado SO, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r37; Obado SO, 2005, GENOME RES, V15, P36, DOI 10.1101/gr.2895105; Ogbadoyi E, 2000, CHROMOSOMA, V108, P501, DOI 10.1007/s004120050402; Parsons M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-127; Ploubidou A, 1999, J CELL SCI, V112, P4641; Poon SK, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.110037; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reinhardt HC, 2013, NAT REV MOL CELL BIO, V14, P563, DOI 10.1038/nrm3640; Rogozin IB, 2009, GENOME BIOL EVOL, V1, P99, DOI 10.1093/gbe/evp011; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Siegel TN, 2008, MOL BIOCHEM PARASIT, V160, P171, DOI 10.1016/j.molbiopara.2008.04.004; Siegel T Nicolai, 2009, Genes Dev, V23, P1063, DOI 10.1101/gad.1790409; SLOOF P, 1983, NUCLEIC ACIDS RES, V11, P3889, DOI 10.1093/nar/11.12.3889; Stechmann A, 2002, SCIENCE, V297, P89, DOI 10.1126/science.1071196; Stuart K, 2008, J CLIN INVEST, V118, P1301, DOI 10.1172/JCI33945; SUZUKI M, 1989, EMBO J, V8, P797, DOI 10.1002/j.1460-2075.1989.tb03440.x; Talbert Paul B., 2009, P193, DOI 10.1007/978-0-387-69076-6_7; Trudgian DC, 2010, BIOINFORMATICS, V26, P1131, DOI 10.1093/bioinformatics/btq081; Tschudi C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-427; Unnikrishnan A, 2012, METHODS MOL BIOL, V833, P115, DOI 10.1007/978-1-61779-477-3_8; Walker G, 2011, PARASITOLOGY, V138, P1638, DOI 10.1017/S0031182010001708; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Westermann S, 2013, TRENDS CELL BIOL, V23, P260, DOI 10.1016/j.tcb.2013.01.010; Westhorpe FG, 2013, CURR OPIN CELL BIOL, V25, P334, DOI 10.1016/j.ceb.2013.02.001; Wickstead B, 2003, MOL BIOCHEM PARASIT, V132, P97, DOI 10.1016/j.molbiopara.2003.08.007; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; WOODWARD R, 1990, J CELL SCI, V95, P49	66	153	153	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 13	2014	156	6					1247	1258		10.1016/j.cell.2014.01.049	http://dx.doi.org/10.1016/j.cell.2014.01.049			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AD0ST	24582333	hybrid, Green Published			2022-12-28	WOS:000332945100014
J	Grant, PR; Grant, BR				Grant, Peter R.; Grant, B. Rosemary			EVOLUTIONARY BIOLOGY Speciation undone	NATURE			English	Editorial Material							HYBRIDIZATION; GALAPAGOS; REVERSAL	Hybridization can cause two species to fuse into a single population. New observations suggest that two species of Darwin's finches are hybridizing on a Galapagos island, and that a third one has disappeared through interbreeding.	[Grant, Peter R.; Grant, B. Rosemary] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08540 USA	Princeton University	Grant, PR (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08540 USA.	prgrant@princeton.edu; rgrant@princeton.edu	Grant, Peter/HIR-3733-2022					Bowman R.I., 1983, P237; Causton CE, 2006, ANN ENTOMOL SOC AM, V99, P121, DOI 10.1603/0013-8746(2006)099[0121:AITAIF]2.0.CO;2; Dobzhansky T., 1941, GENETICS ORIGIN SPEC; Grant P.R., 1999, RECOGNITION STATES L, V2; Grant P. R., 2008, WHY SPECIES MULTIPLY; Grant P. R., 40 YEARS EV IN PRESS; Grant PR, 2005, BIOL CONSERV, V122, P499, DOI 10.1016/j.biocon.2004.09.001; Kleindorfer S, 2014, AM NAT, V183, P325, DOI 10.1086/674899; Lack D., 1947, DARWINS FINCHES; McKinnon JS, 2012, NATURE, V482, P313, DOI 10.1038/482313a; Seehausen O, 2008, MOL ECOL, V17, P30, DOI 10.1111/j.1365-294X.2007.03529.x; Seehausen O, 2006, P ROY SOC B-BIOL SCI, V273, P1987, DOI 10.1098/rspb.2006.3539; Vonlanthen P, 2012, NATURE, V482, P357, DOI 10.1038/nature10824	13	14	17	0	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2014	507	7491					178	179		10.1038/507178b	http://dx.doi.org/10.1038/507178b			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC6RJ	24622197				2022-12-28	WOS:000332651800028
J	Coontz, R; Fahrenkamp-Uppenbrink, J; Lavine, M; Vinson, V				Coontz, Robert; Fahrenkamp-Uppenbrink, Julia; Lavine, Marc; Vinson, Valda			INTRODUCTION Going from Strength to Strength	SCIENCE			English	Editorial Material													Vinson, Valda/GVR-8232-2022						0	5	5	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2014	343	6175					1091	1091		10.1126/science.343.6175.1091	http://dx.doi.org/10.1126/science.343.6175.1091			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC2LB	24604190				2022-12-28	WOS:000332331500034
J	Iacobucci, G				Iacobucci, Gareth			Integration of services or empire building?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SOCIAL CARE; HEALTH		BMJ, London WC1H 9JR, England		Iacobucci, G (corresponding author), BMJ, London WC1H 9JR, England.	giacobucci@bmj.com						Hawkes N, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7318; Hawkes N, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6628; Hawkes N, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d8344; Iacobucci G, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5911; Iacobucci G, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f466; Newcastle Hospitals NHS Foundation Trust, BETT TOG; Roberts N., 2014, GP              0109	7	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 6	2014	348								g1854	10.1136/bmj.g1854	http://dx.doi.org/10.1136/bmj.g1854			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC6IP	24604166				2022-12-28	WOS:000332625700001
J	Jack, A				Jack, Andrew			HEALTH SPENDING DECISIONS Should healthcare be guaranteed for cancer but not diabetes?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Financial Times, London, England		Jack, A (corresponding author), Financial Times, London, England.	andrew.jack@ft.com		Jack, Andrew/0000-0001-9679-2898				Organisation for Economic Co-operation and Development (OECD), 2013, OUT POCK EXP HLTH; Pearson M., HLTH SYSTEMS COST EV; Solimano G, 2010, UNIVERSAL HLTH COVER; The Nuffield Trust, 2012, RAT HLTH CAR IS IT T	4	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2014	348								g1812	10.1136/bmj.g1812	http://dx.doi.org/10.1136/bmj.g1812			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC6HV	24594666				2022-12-28	WOS:000332623400008
J	Zingg, B; Hintiryan, H; Gou, L; Song, MY; Bay, M; Bienkowski, MS; Foster, NN; Yamashita, S; Bowman, I; Toga, AW; Dong, HW				Zingg, Brian; Hintiryan, Houri; Gou, Lin; Song, Monica Y.; Bay, Maxwell; Bienkowski, Michael S.; Foster, Nicholas N.; Yamashita, Seita; Bowman, Ian; Toga, Arthur W.; Dong, Hong-Wei			Neural Networks of the Mouse Neocortex	CELL			English	Article							INSULAR CORTEX; NERVOUS-SYSTEM; MOTOR CORTEX; STRUCTURAL CONNECTIVITY; OBJECT RECOGNITION; LIMBIC CONNECTIONS; CEREBRAL-CORTEX; BRAIN NETWORKS; RAT; CIRCUITS	Numerous studies have examined the neuronal inputs and outputs of many areas within the mammalian cerebral cortex, but how these areas are organized into neural networks that communicate across the entire cortex is unclear. Over 600 labeled neuronal pathways acquired from tracer injections placed across the entire mouse neocortex enabled us to generate a cortical connectivity atlas. A total of 240 intracortical connections were manually reconstructed within a common neuroanatomic framework, forming a cortico-cortical connectivity map that facilitates comparison of connections from different cortical targets. Connectivity matrices were generated to provide an overview of all intracortical connections and subnetwork clusterings. The connectivity matrices and cortical map revealed that the entire cortex is organized into four somatic sensorimotor, two medial, and two lateral subnetworks that display unique topologies and can interact through select cortical areas. Together, these data provide a resource that can be used to further investigate cortical networks and their corresponding functions.	[Zingg, Brian] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Los Angeles, CA 90032 USA; [Hintiryan, Houri; Gou, Lin; Song, Monica Y.; Bay, Maxwell; Bienkowski, Michael S.; Foster, Nicholas N.; Yamashita, Seita; Bowman, Ian; Toga, Arthur W.; Dong, Hong-Wei] Univ So Calif, Keck Sch Med, Inst Neuroimaging & Informat, Los Angeles, CA 90032 USA; [Toga, Arthur W.; Dong, Hong-Wei] Univ So Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA 90032 USA	University of Southern California; University of Southern California; University of Southern California	Dong, HW (corresponding author), Univ So Calif, Keck Sch Med, Inst Neuroimaging & Informat, Los Angeles, CA 90032 USA.	Hongwei.Dong@loni.usc.edu		Bienkowski, Michael/0000-0002-8231-8893; Song, Monica/0000-0002-3320-5550; Foster, Nicholas/0000-0003-1740-9788	NIH/NIMH [MH094360-01A1]; P41 Supplement [AWT 3P41RR013642-12S3]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094360] Funding Source: NIH RePORTER	NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); P41 Supplement; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors would like to thank Drs. Larry Swanson and Harvey Karten for advising this project, Daren Lee, Anand A. Joshi, Nikhil G. Sane, and Queenie Ng for the initial development of the iConnectome visualization tool and Betty W. Lee, Carlos Mena, Vaughan Greer, and Robert De La Cruz for their contributions to the website. We acknowledge Arleen Grewal, Annie Chen, Amy Hwang, and Hyojin Ryu for their contributions in image processing. This work was supported by NIH/NIMH, MH094360-01A1 (HWD) and P41 Supplement (AWT 3P41RR013642-12S3). The Mouse Connectome Project (MCP) was initiated by the authors while still at the University of California, Los Angeles (UCLA), but the entire program and project now fully reside at the University of Southern California (USC). This manuscript is dedicated to Dr. Edward (Ted) G. Jones, a devoted scientist, colleague, and beloved friend who will be greatly missed.	Aggleton JP, 2010, BEHAV NEUROSCI, V124, P55, DOI 10.1037/a0018320; ALLEN GV, 1991, J COMP NEUROL, V311, P1, DOI 10.1002/cne.903110102; Andrews-Hanna JR, 2010, NEURON, V65, P550, DOI 10.1016/j.neuron.2010.02.005; Behrens TEJ, 2012, CURR OPIN NEUROBIOL, V22, P144, DOI 10.1016/j.conb.2011.08.005; Bohland JW, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000334; Bota M, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00002; Brecht M, 2004, J COMP NEUROL, V479, P360, DOI 10.1002/cne.20306; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Bucci DJ, 2009, NEUROBIOL LEARN MEM, V91, P114, DOI 10.1016/j.nlm.2008.07.004; Carleton A, 2010, TRENDS NEUROSCI, V33, P326, DOI 10.1016/j.tins.2010.04.002; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; de Curtis M, 2004, PROG NEUROBIOL, V74, P101, DOI 10.1016/j.pneurobio.2004.08.005; Driver J, 2008, NEURON, V57, P11, DOI 10.1016/j.neuron.2007.12.013; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Feierstein CE, 2006, NEURON, V51, P495, DOI 10.1016/j.neuron.2006.06.032; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Gerdjikov TV, 2013, J NEUROSCI, V33, P14193, DOI 10.1523/JNEUROSCI.0337-13.2013; Hintiryan H, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00030; Honey CJ, 2007, P NATL ACAD SCI USA, V104, P10240, DOI 10.1073/pnas.0701519104; Jarrell TA, 2012, SCIENCE, V337, P437, DOI 10.1126/science.1221762; Jasmin L, 2004, J COMP NEUROL, V468, P425, DOI 10.1002/cne.10978; Jones E.G., 2007, THALAMUS, VVolume 1, P575; Jones EG, 2011, ANN NY ACAD SCI, V1225, pE147, DOI 10.1111/j.1749-6632.2011.06009.x; Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002; Maffei A, 2012, CURR OPIN NEUROBIOL, V22, P709, DOI 10.1016/j.conb.2012.04.001; Mao TY, 2011, NEURON, V72, P111, DOI 10.1016/j.neuron.2011.07.029; Markov NT, 2011, CEREB CORTEX, V21, P1254, DOI 10.1093/cercor/bhq201; Marx V, 2012, NATURE, V490, P293, DOI 10.1038/490293a; Osakada F, 2011, NEURON, V71, P617, DOI 10.1016/j.neuron.2011.07.005; Osten P, 2013, NAT METHODS, V10, P515, DOI [10.1038/NMETH.2477, 10.1038/nmeth.2477]; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Pollock JD, 2014, TRENDS NEUROSCI, V37, P106, DOI 10.1016/j.tins.2013.11.001; REEP RL, 1990, J COMP NEUROL, V294, P262, DOI 10.1002/cne.902940210; Saleem KS, 2008, J COMP NEUROL, V506, P659, DOI 10.1002/cne.21577; SAPER CB, 1982, J COMP NEUROL, V210, P163, DOI 10.1002/cne.902100207; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Sporns O., 2010, NETWORKS BRAIN; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Stein BE, 2008, NAT REV NEUROSCI, V9, P255, DOI 10.1038/nrn2331; Swanson LW, 2010, P NATL ACAD SCI USA, V107, P20610, DOI 10.1073/pnas.1015128107; Thompson RH, 2010, P NATL ACAD SCI USA, V107, P15235, DOI 10.1073/pnas.1009112107; Toga AW, 2012, NEUROSURGERY, V71, P1, DOI 10.1227/NEU.0b013e318258e9ff; Vann SD, 2009, NAT REV NEUROSCI, V10, P792, DOI 10.1038/nrn2733; Weible AP, 2013, BEHAV BRAIN RES, V245, P63, DOI 10.1016/j.bbr.2013.02.010; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Winters BD, 2008, NEUROSCI BIOBEHAV R, V32, P1055, DOI 10.1016/j.neubiorev.2008.04.004; Witter MP, 2007, PROG BRAIN RES, V163, P43, DOI 10.1016/S0079-6123(07)63003-9; Yamada Y, 2005, RESP PHYSIOL NEUROBI, V147, P177, DOI 10.1016/j.resp.2005.02.017; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004	49	418	421	5	72	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 27	2014	156	5					1096	1111		10.1016/j.cell.2014.02.023	http://dx.doi.org/10.1016/j.cell.2014.02.023			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AB9BK	24581503	Bronze, Green Accepted			2022-12-28	WOS:000332083900024
J	Shah, KB				Shah, Khanjan Baxi			Adverbs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Hosp Case Med Center, Dept Internal Med, Cleveland, OH USA	Case Western Reserve University	Shah, KB (corresponding author), Univ Hosp Case Med Center, Dept Internal Med, Cleveland, OH USA.	khanjan.shah@uhhospitals.org							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 26	2014	311	8					801	801		10.1001/jama.2014.912	http://dx.doi.org/10.1001/jama.2014.912			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB4XQ	24570241				2022-12-28	WOS:000331793700035
J	Guest, RV; Margocsy, D; Wigmore, SJ				Guest, Rachel V.; Margocsy, Daniel; Wigmore, Stephen J.			Govert Bidloo's liver: human symmetry reflected	LANCET			English	Editorial Material									[Guest, Rachel V.] Univ Edinburgh, MRC Ctr Regenerat Med, Edinburgh EH16 4UU, Midlothian, Scotland; [Margocsy, Daniel] CUNY, Dept Hist, Hunter Coll, New York, NY 10021 USA; [Wigmore, Stephen J.] Royal Infirm Edinburgh NHS Trust, MRC Ctr Inflammat Res, Edinburgh, Midlothian, Scotland; [Wigmore, Stephen J.] Royal Infirm Edinburgh NHS Trust, Scottish Liver Transplant Unit, Edinburgh, Midlothian, Scotland	University of Edinburgh; City University of New York (CUNY) System; Hunter College (CUNY); Royal Infirmary of Edinburgh; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh	Guest, RV (corresponding author), Univ Edinburgh, MRC Ctr Regenerat Med, Edinburgh EH16 4UU, Midlothian, Scotland.	rvguest@doctors.org.uk	Wigmore, Stephen/AAF-3562-2019	Wigmore, Stephen/0000-0002-3614-8002					0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 22	2014	383	9918					688	689		10.1016/S0140-6736(14)60248-8	http://dx.doi.org/10.1016/S0140-6736(14)60248-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB2WR	24567974				2022-12-28	WOS:000331653300015
J	Shetty, P				Shetty, Priya			Sulafa Ali: a pioneer of paediatric cardiology in Sudan	LANCET			English	Biographical-Item																			0	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 22	2014	383	9918					687	687		10.1016/S0140-6736(14)60247-6	http://dx.doi.org/10.1016/S0140-6736(14)60247-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB2WR	24560047				2022-12-28	WOS:000331653300014
J	Heymann, DL; Dar, OA				Heymann, David L.; Dar, Osman A.			Prevention is better than cure for emerging infectious diseases	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Heymann, David L.; Dar, Osman A.] Publ Hlth England, London SE1 8UG, England; [Heymann, David L.] London Sch Hyg & Trop Med, London WC1, England; [Heymann, David L.; Dar, Osman A.] Chatham House Ctr Global Hlth Secur, London, England	Public Health England; University of London; London School of Hygiene & Tropical Medicine	Heymann, DL (corresponding author), Publ Hlth England, London SE1 8UG, England.	david.heymann@phe.org.uk						American Veterinary Medical Association, 2008, ON HLTH NEW PROF IMP; [Anonymous], 2010, PEOPL PATH OUR PLAN, V1; Centers for Disease Control and Prevention, 2010, OP ON HLTH POL PERSP; Coker R, 2011, LANCET INFECT DIS, V11, P326, DOI 10.1016/S1473-3099(10)70312-1; Delgado C., 1999, 28 INT FOOD POL RES; Dixon S, 2002, BRIT MED J, V324, P232, DOI 10.1136/bmj.324.7331.232; Evidence and lessons from Latin America (ELLA), IMPR ENV MAN EXTR EN; Hall D, 2011, IMPLEMENTATION ONE H; Hancock J, 2008, ASSESSMENT LIKELY IM; Heymann DL, 2013, MICROBIOL SPECTR, V1, DOI 10.1128/microbiolspec.OH-0011-2012; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kakkar M, 2011, LANCET INFECT DIS, V11, P808, DOI 10.1016/S1473-3099(11)70298-5; Karesh WB, 2012, LANCET, V380, P1936, DOI 10.1016/S0140-6736(12)61678-X; Kruse H, 2004, EMERG INFECT DIS, V10, P2067, DOI 10.3201/eid1012.040707; Marsh, 2008, EC SOC IMP EM INF DI; One Health Global Network, WHATS IS ON HLTH; Public Health England, EMERGING INFECT; Reusken CBEM, 2013, LANCET INFECT DIS, V13, P859, DOI 10.1016/S1473-3099(13)70164-6; Rodier G, 2007, EMERG INFECT DIS, V13, P1447, DOI 10.3201/eid1310.070732; Thorns CJ, 2000, REV SCI TECH OIE, V19, P226, DOI 10.20506/rst.19.1.1219; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775; World Bank, 2012, PEOPL PATH OUR PLAN, V2; World Health Organization, GLOB AL RESP; World Organisation for Animal Health, ON WORLD ON HLTH	24	24	25	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 21	2014	348								g1499	10.1136/bmj.g1499	http://dx.doi.org/10.1136/bmj.g1499			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB9ZU	24563451	Green Accepted			2022-12-28	WOS:000332155100002
J	Ackerly, DC; Grabowski, DC				Ackerly, D. Clay; Grabowski, David C.			Post-Acute Care Reform - Beyond the ACA	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ackerly, D. Clay] Partners HealthCare, Boston, MA 02199 USA; [Ackerly, D. Clay] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Ackerly, D. Clay] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Ackerly, D. Clay; Grabowski, David C.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA	Partners Healthcare System; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Ackerly, DC (corresponding author), Partners HealthCare, Boston, MA 02199 USA.			Grabowski, David/0000-0003-2915-5770				Institute of Medicine, 2013, VAR HLTH CAR SPEND T; Jencks SF, 2011, NEW ENGL J MED, V364, P1582; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Lipsitz LA, 2013, JAMA-J AM MED ASSOC, V310, P1441, DOI 10.1001/jama.2013.254845; Medicare Payment Advisory Commission, 2013, MED POSTAC CAR REF; Mor V, 2010, HEALTH AFFAIR, V29, P57, DOI 10.1377/hlthaff.2009.0629	6	85	85	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 20	2014	370	8					689	691		10.1056/NEJMp1315350	http://dx.doi.org/10.1056/NEJMp1315350			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AB1DO	24552314				2022-12-28	WOS:000331531900002
J	Grefenstette, BW; Harrison, FA; Boggs, SE; Reynolds, SP; Fryer, CL; Madsen, KK; Wik, DR; Zoglauer, A; Ellinger, CI; Alexander, DM; An, H; Barret, D; Christensen, FE; Craig, WW; Forster, K; Giommi, P; Hailey, CJ; Hornstrup, A; Kaspi, VM; Kitaguchi, T; Koglin, JE; Mao, PH; Miyasaka, H; Mori, K; Perri, M; Pivovaroff, MJ; Puccetti, S; Rana, V; Stern, D; Westergaard, NJ; Zhang, WW				Grefenstette, B. W.; Harrison, F. A.; Boggs, S. E.; Reynolds, S. P.; Fryer, C. L.; Madsen, K. K.; Wik, D. R.; Zoglauer, A.; Ellinger, C. I.; Alexander, D. M.; An, H.; Barret, D.; Christensen, F. E.; Craig, W. W.; Forster, K.; Giommi, P.; Hailey, C. J.; Hornstrup, A.; Kaspi, V. M.; Kitaguchi, T.; Koglin, J. E.; Mao, P. H.; Miyasaka, H.; Mori, K.; Perri, M.; Pivovaroff, M. J.; Puccetti, S.; Rana, V.; Stern, D.; Westergaard, N. J.; Zhang, W. W.			Asymmetries in core-collapse supernovae from maps of radioactive Ti-44 in Cassiopeia A	NATURE			English	Article							A SUPERNOVA; 3-DIMENSIONAL STRUCTURE; REMNANT CASSIOPEIA; RAY; EXPLOSION; EJECTA; CAS; HYDRODYNAMICS; CONSTRAINTS; EVOLUTION	Asymmetry is required by most numerical simulations of stellar core-collapse explosions, but the form it takes differs significantly among models. The spatial distribution of radioactive Ti-44, synthesized in an exploding star near the boundary between material falling back onto the collapsing core and that ejected into the surrounding medium(1), directly probes the explosion asymmetries. Cassiopeia A is a young(2), nearby(3), core-collapse(4) remnant from which Ti-44 emission has previously been detected(5-8) but not imaged. Asymmetries in the explosion have been indirectly inferred from a high ratio of observed Ti-44 emission to estimated Ni-56 emission(9), from optical light echoes(10), and from jet-like features seen in the X-ray(11) and optical(12) ejecta. Here we report spatial maps and spectral properties of the Ti-44 in Cassiopeia A. This may explain the unexpected lack of correlation between the Ti-44 and iron X-ray emission, the latter being visible only in shock-heated material. The observed spatial distribution rules out symmetric explosions even with a high level of convective mixing, as well as highly asymmetric bipolar explosions resulting from a fast-rotating progenitor. Instead, these observations provide strong evidence for the development of low-mode convective instabilities in core-collapse supernovae.	[Grefenstette, B. W.; Harrison, F. A.; Madsen, K. K.; Forster, K.; Mao, P. H.; Miyasaka, H.; Rana, V.] CALTECH, Cahill Ctr Astrophys, Pasadena, CA 91125 USA; [Boggs, S. E.; Zoglauer, A.; Craig, W. W.] Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; [Reynolds, S. P.] N Carolina State Univ, Dept Phys, Raleigh, NC 27695 USA; [Fryer, C. L.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Wik, D. R.; Zhang, W. W.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Ellinger, C. I.] Univ Texas Arlington, Dept Phys, Arlington, TX 76019 USA; [Alexander, D. M.] Univ Durham, Dept Phys, Durham DH1 3LE, England; [An, H.; Kaspi, V. M.] McGill Univ, Dept Phys, Montreal, PQ H3A 2T8, Canada; [Barret, D.] Univ Toulouse, UPS OMP, IRAP, F-31028 Toulouse 4, France; [Barret, D.] CNRS, Inst Rech Astrophys & Planetol, F-31028 Toulouse 4, France; [Christensen, F. E.; Hornstrup, A.; Westergaard, N. J.] Tech Univ Denmark, Natl Space Inst, DTU Space, DK-2800 Lyngby, Denmark; [Craig, W. W.; Pivovaroff, M. J.] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Giommi, P.; Perri, M.; Puccetti, S.] Agenzia Spaziale Italiana, Sci Data Ctr, I-00133 Rome, Italy; [Hailey, C. J.; Mori, K.] Columbia Univ, Columbia Astrophys Lab, New York, NY 10027 USA; [Kitaguchi, T.] RIKEN, Nishina Ctr, Wako, Saitama 3510198, Japan; [Koglin, J. E.] SLAC Natl Accelerator Lab, Kavli Inst Particle Astrophys & Cosmol, Menlo Pk, CA 94025 USA; [Perri, M.] Osserv Astron Roma, INAF, I-00040 Monte Porzio Catone, Italy; [Stern, D.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	California Institute of Technology; University of California System; University of California Berkeley; University of North Carolina; North Carolina State University; United States Department of Energy (DOE); Los Alamos National Laboratory; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Texas System; University of Texas Arlington; Durham University; McGill University; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Technical University of Denmark; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Agenzia Spaziale Italiana (ASI); Columbia University; RIKEN; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Istituto Nazionale Astrofisica (INAF); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Grefenstette, BW (corresponding author), CALTECH, Cahill Ctr Astrophys, 1216 East Calif Blvd, Pasadena, CA 91125 USA.	bwgref@srl.caltech.edu; fiona@srl.caltech.edu	christensen, finn/AAB-8622-2020; Ellinger, Carola/AAQ-3079-2020; Boggs, Steven E/E-4170-2015; Barret, Didier/AAV-2771-2020; Mori, Kaya/ABH-2066-2021; Rana, Vikram/R-9180-2018; Alexander, David/K-5544-2019; Pivovaroff, Michael J/M-7998-2014; giommi, paolo/L-1006-2018	Ellinger, Carola/0000-0002-2689-8627; Boggs, Steven E/0000-0001-9567-4224; Alexander, David/0000-0002-5896-6313; Pivovaroff, Michael J/0000-0001-6780-6816; Perri, Matteo/0000-0003-3613-4409; Hornstrup, Allan/0000-0002-3363-0936; Puccetti, Simonetta/0000-0002-2734-7835; giommi, paolo/0000-0002-2265-5003; Stern, Daniel/0000-0003-2686-9241	NASA [NNG08FD60C]; NASA	NASA(National Aeronautics & Space Administration (NASA)); NASA(National Aeronautics & Space Administration (NASA))	This work was supported by NASA under grant no. NNG08FD60C, and made use of data from the Nuclear Spectroscopic Telescope Array (NuSTAR) mission, a project led by Caltech, managed by the Jet Propulsion Laboratory and funded by NASA. We thank the NuSTAR operations, software and calibration teams for support with execution and analysis of these observations.	Ahmad I, 2006, PHYS REV C, V74, DOI 10.1103/PhysRevC.74.065803; BAARS JWM, 1977, ASTRON ASTROPHYS, V61, P99; Blondin JM, 2003, ASTROPHYS J, V584, P971, DOI 10.1086/345812; Chevalier RA, 2003, ASTROPHYS J, V593, pL23, DOI 10.1086/377572; Ellinger C. I., 2013, PREPRINT; Fesen RA, 2006, ASTROPHYS J, V645, P283, DOI 10.1086/504254; Fryer CL, 2006, ASTROPHYS J, V643, P292, DOI 10.1086/501493; Fryer CL, 2000, ASTROPHYS J, V541, P1033, DOI 10.1086/309446; Georgakakis A, 2008, MON NOT R ASTRON SOC, V388, P1205, DOI [10.1111/j.1365-2966.2008.13423.x, 10.1111/j.1365-2966.2008.13423.X]; Gotthelf EV, 2001, ASTROPHYS J, V552, pL39, DOI 10.1086/320250; HACHISU I, 1990, ASTROPHYS J, V358, pL57, DOI 10.1086/185779; Hungerford AL, 2003, ASTROPHYS J, V594, P390, DOI 10.1086/376776; Hwang U, 2003, ASTROPHYS J, V597, P362, DOI 10.1086/378269; Hwang U, 2012, ASTROPHYS J, V746, DOI 10.1088/0004-637X/746/2/130; Isensee K, 2010, ASTROPHYS J, V725, P2059, DOI 10.1088/0004-637X/725/2/2059; IYUDIN AF, 1994, ASTRON ASTROPHYS, V284, pL1; Janka HT, 2012, ANNU REV NUCL PART S, V62, P407, DOI 10.1146/annurev-nucl-102711-094901; Krause O, 2008, SCIENCE, V320, P1195, DOI 10.1126/science.1155788; Laming JM, 2006, ASTROPHYS J, V644, P260, DOI 10.1086/503553; Laming JM, 2001, AIP CONF PROC, V598, P411, DOI 10.1063/1.1434031; LI HW, 1993, ASTROPHYS J, V419, P824, DOI 10.1086/173534; Magkotsios G, 2010, ASTROPHYS J SUPPL S, V191, P66, DOI 10.1088/0067-0049/191/1/66; Nagataki S, 1998, ASTROPHYS J, V492, pL45, DOI 10.1086/311089; NOMOTO K, 1995, PHYS REP, V256, P173, DOI 10.1016/0370-1573(94)00107-E; REED JE, 1995, ASTROPHYS J, V440, P706, DOI 10.1086/175308; Reichart DE, 2000, ASTROPHYS J, V537, P904, DOI 10.1086/309073; Renaud M, 2006, ASTROPHYS J, V647, pL41, DOI 10.1086/507300; Rest A, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/1/3; Rothschild RE, 2003, ASTROPHYS J, V582, P257, DOI 10.1086/344567; SHIGEYAMA T, 1994, ASTROPHYS J, V420, P341, DOI 10.1086/173564; Thorstensen JR, 2001, ASTRON J, V122, P297, DOI 10.1086/321138; Vink J, 2001, ASTROPHYS J, V560, pL79, DOI 10.1086/324172; Wheeler JC, 2010, NEW ASTRON REV, V54, P183, DOI 10.1016/j.newar.2010.09.033; Wongwathanarat A, 2010, ASTROPHYS J LETT, V725, pL106, DOI 10.1088/2041-8205/725/1/L106; WOOSLEY SE, 1995, ASTROPHYS J SUPPL S, V101, P181, DOI 10.1086/192237; WOOSLEY SE, 1993, ASTROPHYS J, V405, P273, DOI 10.1086/172359; Young PA, 2006, ASTROPHYS J, V640, P891, DOI 10.1086/500108	40	158	159	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 20	2014	506	7488					339	+		10.1038/nature12997	http://dx.doi.org/10.1038/nature12997			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB0JL	24553239	Green Accepted, Green Submitted			2022-12-28	WOS:000331477800035
J	Ji, LN				Ji, Linong			Sex disparity in the risk of diabetes-associated stroke	LANCET			English	Editorial Material							MELLITUS; POPULATION; INFARCTION; SURVIVAL		[Ji, Linong] Peking Univ Peoples Hosp, Dept Endocrinol & Metab, Beijing, Peoples R China; [Ji, Linong] Peking Univ Diabet Ctr, Beijing, Peoples R China	Peking University	Ji, LN (corresponding author), Peking Univ Peoples Hosp, Dept Endocrinol & Metab, Beijing, Peoples R China.	jiln@bjmu.edu.cn	Linong, Ji/AAB-6543-2020					Banerjee C, 2012, STROKE, V43, P1212, DOI 10.1161/STROKEAHA.111.641381; Bushnell C, 2014, STROKE, V45, P1545, DOI 10.1161/01.str.0000442009.06663.48; Davis TME, 1999, ARCH INTERN MED, V159, P1097, DOI 10.1001/archinte.159.10.1097; Eriksson M, 2012, CEREBROVASC DIS, V34, P153, DOI 10.1159/000339763; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Huxley R, 2006, BMJ-BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C; Hyvarinen M, 2009, DIABETES CARE, V32, P348, DOI 10.2337/dc08-1411; Idris I, 2006, INT J CLIN PRACT, V60, P48, DOI 10.1111/j.1368-5031.2006.00682.x; Peters SA, 2014, LANCET; Petty GW, 1998, NEUROLOGY, V50, P208, DOI 10.1212/WNL.50.1.208; Preiss D, 2013, STROKE, V44, P2590, DOI 10.1161/STROKEAHA.113.001177; Stevens R, 2004, DIABETES CARE, V27, P201, DOI 10.2337/diacare.27.1.201; Tuomilehto J, 1996, STROKE, V27, P210, DOI 10.1161/01.STR.27.2.210	13	1	2	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 7	2014	383	9933					1948	1950		10.1016/S0140-6736(14)60158-6	http://dx.doi.org/10.1016/S0140-6736(14)60158-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AI4PV	24613027				2022-12-28	WOS:000336848200005
J	Paz-Ares, L; Corral, J				Paz-Ares, Luis; Corral, Jesus			Treatment for early-stage lung cancer: what next?	LANCET			English	Editorial Material							ADJUVANT CHEMOTHERAPY; PREOPERATIVE CHEMOTHERAPY; TRIAL; SURGERY; PLACEBO		[Paz-Ares, Luis; Corral, Jesus] Hosp Univ Virgen del Rocio, Inst Biomed Sevilla IBIS, Med Oncol Serv, Seville 41013, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital	Paz-Ares, L (corresponding author), Hosp Univ Virgen del Rocio, Inst Biomed Sevilla IBIS, Med Oncol Serv, Seville 41013, Spain.	lpazares@hotmail.com	Paz-Ares, Luis/AAH-2750-2019					Auperin A, 2010, LANCET, V375, P1267, DOI 10.1016/S0140-6736(10)60059-1; Burdett S, 2006, J THORAC ONCOL, V1, P611; DeMatteo RP, 2009, LANCET, V373, P1097, DOI 10.1016/S0140-6736(09)60500-6; Felip E, 2010, J CLIN ONCOL, V28, P3138, DOI 10.1200/JCO.2009.27.6204; Goss GD, 2013, J CLIN ONCOL, V31, P3320, DOI 10.1200/JCO.2013.51.1816; Hamada C, 2009, J THORAC ONCOL, V4, P1511, DOI 10.1097/JTO.0b013e3181bbf1f2; IARC, LUNG CANC EST INC MO; NSCLC Meta-analyses Collaborative Group, 2014, LANCET; Pignon JP, 2008, J CLIN ONCOL, V26, P3552, DOI 10.1200/JCO.2007.13.9030; Rastogi P, 2008, J CLIN ONCOL, V26, P778, DOI 10.1200/JCO.2007.15.0235; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Westeel V, 2013, EUR J CANCER, V49, P2654, DOI 10.1016/j.ejca.2013.04.013; Yang X-N, 2013, ASCO ANN M CHIC IL U	14	6	8	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 3	2014	383	9928					1528	1530		10.1016/S0140-6736(14)60002-7	http://dx.doi.org/10.1016/S0140-6736(14)60002-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG5YO	24576775	hybrid			2022-12-28	WOS:000335495400007
J	Iinuma, R; Ke, YG; Jungmann, R; Schlichthaerle, T; Woehrstein, JB; Yin, P				Iinuma, Ryosuke; Ke, Yonggang; Jungmann, Ralf; Schlichthaerle, Thomas; Woehrstein, Johannes B.; Yin, Peng			Polyhedra Self-Assembled from DNA Tripods and Characterized with 3D DNA-PAINT	SCIENCE			English	Article							SINGLE-STRANDED-DNA; SUPERRESOLUTION MICROSCOPY; NANOSTRUCTURES; MOLECULE; ORIGAMI; BINDING; DESIGN; SHAPES	DNA self-assembly has produced diverse synthetic three-dimensional polyhedra. These structures typically have a molecular weight no greater than 5 megadaltons. We report a simple, general strategy for one-step self-assembly of wireframe DNA polyhedra that are more massive than most previous structures. A stiff three-arm-junction DNA origami tile motif with precisely controlled angles and arm lengths was used for hierarchical assembly of polyhedra. We experimentally constructed a tetrahedron (20 megadaltons), a triangular prism (30 megadaltons), a cube (40 megadaltons), a pentagonal prism (50 megadaltons), and a hexagonal prism (60 megadaltons) with edge widths of 100 nanometers. The structures were visualized by means of transmission electron microscopy and three-dimensional DNA-PAINT super-resolution fluorescent microscopy of single molecules in solution.	[Iinuma, Ryosuke; Ke, Yonggang; Jungmann, Ralf; Schlichthaerle, Thomas; Woehrstein, Johannes B.; Yin, Peng] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Ke, Yonggang] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Ke, Yonggang] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Jungmann, Ralf; Woehrstein, Johannes B.; Yin, Peng] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Yin, P (corresponding author), Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.	py@hms.harvard.edu	Jungmann, Ralf/A-6357-2015	Jungmann, Ralf/0000-0003-4607-3312; Schlichthaerle, Thomas/0000-0003-4444-2575	Office of Naval Research (ONR) [N000141110914]; ONR [N000141010827, N000141310593]; Army Research Office [W911NF1210238]; National Institutes of Health (NIH) [1DP2OD007292, 1R01EB018659, 5R21HD072481]; National Science Foundation (NSF) [CCF1054898, CCF1317291, CCF1162459, CMMI1333215]; JSR corporation; Wyss Institute for Biologically Inspired Engineering Faculty Startup Fund; Alexander von Humboldt Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD072481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB018659] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007292] Funding Source: NIH RePORTER	Office of Naval Research (ONR)(Office of Naval Research); ONR(Office of Naval Research); Army Research Office; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); JSR corporation(JSR Corporation); Wyss Institute for Biologically Inspired Engineering Faculty Startup Fund; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank S. Woo and W. Shih for discussions. This work is supported by an Office of Naval Research (ONR) Young Investigator Program Award (N000141110914), ONR grants (N000141010827 and N000141310593), an Army Research Office grant (W911NF1210238), a National Institutes of Health (NIH) Director's New Innovator Award (1DP2OD007292), a NIH Transformative Research Award (1R01EB018659), a NIH grant (5R21HD072481), a National Science Foundation (NSF) Faculty Early Career Development Award (CCF1054898), a NSF Expedition in Computing Award (CCF1317291), NSF grants (CCF1162459, CMMI1333215), a gift from JSR corporation, and a Wyss Institute for Biologically Inspired Engineering Faculty Startup Fund to P.Y. R. I. acknowledges support from JSR corporation. R.J. acknowledges support from the Alexander von Humboldt Foundation through a Feodor-Lynen Fellowship. R. I., Y.K., and R.J. contributed equally. R. I. and Y.K. designed the system, conducted the experiments, analyzed the data, and wrote the paper. R.J. designed and performed the super-resolution study, analyzed the data, and wrote the paper. T. S. and J.B.W. performed the super-resolution experiments and analyzed the data. P.Y. conceived, designed, and supervised the study; interpreted the data; and wrote the paper. All authors commented on and approved the manuscript.	Acuna GP, 2012, SCIENCE, V338, P506, DOI 10.1126/science.1228638; Aldaye FA, 2007, J AM CHEM SOC, V129, P13376, DOI 10.1021/ja075966q; Andersen ES, 2009, NATURE, V459, P73, DOI 10.1038/nature07971; Bhatia D, 2009, ANGEW CHEM INT EDIT, V48, P4134, DOI 10.1002/anie.200806000; CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0; Douglas SM, 2012, SCIENCE, V335, P831, DOI 10.1126/science.1214081; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Erben CM, 2007, J AM CHEM SOC, V129, P6992, DOI 10.1021/ja071493b; Fu JL, 2012, J AM CHEM SOC, V134, P5516, DOI 10.1021/ja300897h; Goodman RP, 2005, SCIENCE, V310, P1661, DOI 10.1126/science.1120367; Han DR, 2013, SCIENCE, V339, P1412, DOI 10.1126/science.1232252; He Y, 2008, NATURE, V452, P198, DOI 10.1038/nature06597; Hell SW, 2007, SCIENCE, V316, P1153, DOI 10.1126/science.1137395; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Jungmann R, 2014, NAT METHODS, V11, P313, DOI [10.1038/nmeth.2835, 10.1038/NMETH.2835]; Jungmann R, 2010, NANO LETT, V10, P4756, DOI 10.1021/nl103427w; KAO HP, 1994, BIOPHYS J, V67, P1291, DOI 10.1016/S0006-3495(94)80601-0; Ke YG, 2012, SCIENCE, V338, P1177, DOI 10.1126/science.1227268; Ke YG, 2009, NANO LETT, V9, P2445, DOI 10.1021/nl901165f; Kuzyk A, 2012, NATURE, V483, P311, DOI 10.1038/nature10889; Langecker M, 2012, SCIENCE, V338, P932, DOI 10.1126/science.1225624; Lin CX, 2012, NAT CHEM, V4, P832, DOI 10.1038/NCHEM.1451; Linko V, 2013, CURR OPIN BIOTECH, V24, P555, DOI 10.1016/j.copbio.2013.02.001; Nie Z, 2013, CHEM COMMUN, V49, P2807, DOI 10.1039/c3cc39177a; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Rothemund PWK, 2004, PLOS BIOL, V2, P2041, DOI 10.1371/journal.pbio.0020424; Schmied JJ, 2013, NANO LETT, V13, P781, DOI 10.1021/nl304492y; Sharonov A, 2006, P NATL ACAD SCI USA, V103, P18911, DOI 10.1073/pnas.0609643104; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307; Shtengel G, 2009, P NATL ACAD SCI USA, V106, P3125, DOI 10.1073/pnas.0813131106; Smith DM, 2011, J NUCLEIC ACIDS, V2011, DOI 10.4061/2011/360954; Wei B, 2012, NATURE, V485, P623, DOI 10.1038/nature11075; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Yang H, 2009, NAT CHEM, V1, P390, DOI [10.1038/NCHEM.290, 10.1038/nchem.290]; Zhang C, 2008, P NATL ACAD SCI USA, V105, P10665, DOI 10.1073/pnas.0803841105; Zhang C, 2009, J AM CHEM SOC, V131, P1413, DOI 10.1021/ja809666h; ZHANG YW, 1994, J AM CHEM SOC, V116, P1661, DOI 10.1021/ja00084a006; Zheng JP, 2009, NATURE, V461, P74, DOI 10.1038/nature08274; Zimmermann J, 2008, ANGEW CHEM INT EDIT, V47, P3626, DOI 10.1002/anie.200702682	39	249	268	15	471	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2014	344	6179					65	69		10.1126/science.1250944	http://dx.doi.org/10.1126/science.1250944			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE1RD	24625926	Green Accepted			2022-12-28	WOS:000333746100052
J	Steinbrook, R				Steinbrook, Robert			Public Disclosure of Medicare Payments to Individual Physicians	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA	Yale University	Steinbrook, R (corresponding author), Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St,1-456 SHM,POB 208008, New Haven, CT 06520 USA.	robert.steinbrook@yale.edu						[Anonymous], PHYSICIAN COMPARE; [Anonymous], DESCRIPTION OF THE C; [Anonymous], REPORT TO THE CONGRE; [Anonymous], 2013, REVIEWS OF CLINICIAN; [Anonymous], 2013, REQUEST FOR PUBLIC C; Blum J., CMS MODIFIES POLICY; Centers for Disease Control and Prevention, 2012, OV REF HLTH GUID MAL; Department of Health Education and Welfare, 1980, FED REGIST, V45, P79172; Ornstein C., 2014, SOME PREDICTIONS ON; FEDERAL REGISTER	10	8	8	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 2	2014	311	13					1285	1286		10.1001/jama.2014.1033	http://dx.doi.org/10.1001/jama.2014.1033			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE0HU	24535488				2022-12-28	WOS:000333645400006
J	Macho, AP; Schwessinger, B; Ntoukakis, V; Brutus, A; Segonzac, C; Roy, S; Kadota, Y; Oh, MH; Sklenar, J; Derbyshire, P; Lozano-Duran, R; Malinovsky, FG; Monaghan, J; Menke, FL; Huber, SC; He, SY; Zipfel, C				Macho, Alberto P.; Schwessinger, Benjamin; Ntoukakis, Vardis; Brutus, Alexandre; Segonzac, Cecile; Roy, Sonali; Kadota, Yasuhiro; Oh, Man-Ho; Sklenar, Jan; Derbyshire, Paul; Lozano-Duran, Rosa; Malinovsky, Frederikke Gro; Monaghan, Jacqueline; Menke, Frank L.; Huber, Steven C.; He, Sheng Yang; Zipfel, Cyril			A Bacterial Tyrosine Phosphatase Inhibits Plant Pattern Recognition Receptor Activation	SCIENCE			English	Article							IMMUNE RECEPTORS; INNATE IMMUNITY; KINASES; ARABIDOPSIS; PHOSPHORYLATION; PERCEPTION; EFFECTOR	Innate immunity relies on the perception of pathogen-associated molecular patterns (PAMPs) by pattern-recognition receptors (PRRs) located on the host cell's surface. Many plant PRRs are kinases. Here, we report that the Arabidopsis receptor kinase EF-TU RECEPTOR (EFR), which perceives the elf18 peptide derived from bacterial elongation factor Tu, is activated upon ligand binding by phosphorylation on its tyrosine residues. Phosphorylation of a single tyrosine residue, Y836, is required for activation of EFR and downstream immunity to the phytopathogenic bacterium Pseudomonas syringae. A tyrosine phosphatase, HopAO1, secreted by P. syringae, reduces EFR phosphorylation and prevents subsequent immune responses. Thus, host and pathogen compete to take control of PRR tyrosine phosphorylation used to initiate antibacterial immunity.	[Macho, Alberto P.; Schwessinger, Benjamin; Ntoukakis, Vardis; Segonzac, Cecile; Roy, Sonali; Kadota, Yasuhiro; Sklenar, Jan; Derbyshire, Paul; Lozano-Duran, Rosa; Malinovsky, Frederikke Gro; Monaghan, Jacqueline; Menke, Frank L.; Zipfel, Cyril] Sainsbury Lab, Norwich NR4 7UH, Norfolk, England; [Brutus, Alexandre; He, Sheng Yang] Michigan State Univ, Dept Energy Plant Res Lab, E Lansing, MI 48824 USA; [Oh, Man-Ho; Huber, Steven C.] Univ Illinois, USDA ARS, Urbana, IL 61801 USA; [Oh, Man-Ho; Huber, Steven C.] Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA; [Oh, Man-Ho] Chungnam Natl Univ, Dept Biol Sci, Coll Biol Sci & Biotechnol, Taejon 305764, South Korea; [He, Sheng Yang] Michigan State Univ, Howard Hughes Med Inst, E Lansing, MI 48824 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Michigan State University; United States Department of Agriculture (USDA); University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Chungnam National University; Howard Hughes Medical Institute; Michigan State University	Zipfel, C (corresponding author), Sainsbury Lab, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	cyril.zipfel@tsl.ac.uk	mailnovsky, frederikke gro/C-1959-2015; Kadota, Yasuhiro/AGJ-3017-2022; ZIPFEL, CYRIL/ABD-5076-2021; Kadota, Yasuhiro/A-9406-2011; Kadota, Yasuhiro/AAC-4545-2019; Roy, Sonali/I-1576-2019; Ntoukakis, Vardis/C-6296-2012; Schwessinger, Benjamin/R-5869-2018; Menke, Frank/F-2739-2014	mailnovsky, frederikke gro/0000-0002-9833-7968; Kadota, Yasuhiro/0000-0002-4782-1418; ZIPFEL, CYRIL/0000-0003-4935-8583; Kadota, Yasuhiro/0000-0002-4782-1418; Kadota, Yasuhiro/0000-0002-4782-1418; Roy, Sonali/0000-0002-8114-8300; Oh, Man-Ho/0000-0002-6524-3252; Ntoukakis, Vardis/0000-0003-0069-6004; Schwessinger, Benjamin/0000-0002-7194-2922; Segonzac, Cecile/0000-0002-5537-7556; Menke, Frank/0000-0003-2490-4824; Macho, Alberto P/0000-0001-9935-8026; He, Sheng Yang/0000-0003-1308-498X	United Kingdom Biotechnology and Biological Sciences Research Council; U.S. Department of Energy (the Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science) [DE-FG02-91ER20021]; U.S. National Institutes of Health [R01AI060761]; Gordon and Betty Moore Foundation [GBMF3037]; National Science Foundation [MCB-0742411, 0740211]; USDA-ARS; Federation of European Biochemical Societies (FEBS); KAKENHI [23580068]; Excellent Young Researcher Overseas Visit Program; Uehara memorial foundation; European Molecular Biology Organization; Fundacion Ramon Areces; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060761] Funding Source: NIH RePORTER; BBSRC [BB/G024944/1, BB/E017134/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E017134/1, BB/G024944/1] Funding Source: researchfish	United Kingdom Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); U.S. Department of Energy (the Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science)(United States Department of Energy (DOE)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Science Foundation(National Science Foundation (NSF)); USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Federation of European Biochemical Societies (FEBS); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Excellent Young Researcher Overseas Visit Program; Uehara memorial foundation(Uehara Memorial Foundation); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Fundacion Ramon Areces; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded by the Gatsby Charitable Foundation (C.Z.), the European Research Council (grant "PHOSPHinnATE") (C.Z.), grants BB/E024874/1 (ERA-PG "RLPRLKs") and BB/G024944/1 ERA-PG "Pathonet" from the United Kingdom Biotechnology and Biological Sciences Research Council (C.Z.), grants from U.S. Department of Energy (the Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science; DE-FG02-91ER20021 for infrastructural support to S.Y.H.), the U.S. National Institutes of Health R01AI060761 (S.Y.H.), the Gordon and Betty Moore Foundation GBMF3037 (S.Y.H.), and grants from the National Science Foundation (MCB-0742411 and 0740211) and USDA-ARS (S. C. H). A. P. M. was supported by a postdoctoral fellowship from the Federation of European Biochemical Societies (FEBS). Y.K. was supported by fellowships from KAKENHI (no. 23580068), the Excellent Young Researcher Overseas Visit Program, and the Uehara memorial foundation. B. S. and S. R. were/are part of the JIC/TSL rotation program. J.M. was supported by a long-term postdoctoral fellowship from the European Molecular Biology Organization. R.L-D. was supported by a postdoctoral fellowship from Fundacion Ramon Areces. We thank L. Stransfeld, K. Morehouse, the John Innes Centre horticultural service, and the TSL tissue culture service for technical assistance, and all members of the Zipfel laboratory for discussions and comments. A. P. M., B. S., V.N., A. B., S. C. H., S.Y.H., and C.Z. designed and conceived the experiments. A. P. M., B. S., V.N., A. B., C. S., S. R., Y.K., M.-H.O., R.L.-D., F. G. M., J.M., J.S., and F. L. M. performed the experiments. A. P. M. and C.Z. wrote the manuscript. All authors commented and agreed on the manuscript before submission.	Baltrus DA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002132; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Bretz JR, 2003, MOL MICROBIOL, V49, P389, DOI 10.1046/j.1365-2958.2003.03616.x; Dardick C, 2012, CURR OPIN PLANT BIOL, V15, P358, DOI 10.1016/j.pbi.2012.05.002; Dean P, 2011, FEMS MICROBIOL REV, V35, P1100, DOI 10.1111/j.1574-6976.2011.00271.x; Espinosa A, 2003, MOL MICROBIOL, V49, P377, DOI 10.1046/j.1365-2958.2003.03588.x; Feng F, 2012, CURR OPIN PLANT BIOL, V15, P469, DOI 10.1016/j.pbi.2012.03.004; Jaillais Y, 2011, GENE DEV, V25, P232, DOI 10.1101/gad.2001911; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Liebrand TWH, 2014, TRENDS PLANT SCI, V19, P123, DOI 10.1016/j.tplants.2013.10.003; Lin WW, 2014, P NATL ACAD SCI USA, V111, P3632, DOI 10.1073/pnas.1318817111; Lu DP, 2010, P NATL ACAD SCI USA, V107, P496, DOI 10.1073/pnas.0909705107; Oh MH, 2010, P NATL ACAD SCI USA, V107, P17827, DOI 10.1073/pnas.0915064107; Oh MH, 2009, P NATL ACAD SCI USA, V106, P658, DOI 10.1073/pnas.0810249106; Schwessinger B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002046; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Underwood W, 2007, PLANT J, V52, P658, DOI 10.1111/j.1365-313X.2007.03262.x; Zhang J, 2010, CELL HOST MICROBE, V7, P290, DOI 10.1016/j.chom.2010.03.007; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	19	106	115	1	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2014	343	6178					1509	1512		10.1126/science.1248849	http://dx.doi.org/10.1126/science.1248849			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7TZ	24625928				2022-12-28	WOS:000333471000047
J	Lee, JH; Daugharthy, ER; Scheiman, J; Kalhor, R; Yang, JL; Ferrante, TC; Terry, R; Jeanty, SSF; Li, C; Amamoto, R; Peters, DT; Turczyk, BM; Marblestone, AH; Inverso, SA; Bernard, A; Mali, P; Rios, X; Aach, J; Church, GM				Lee, Je Hyuk; Daugharthy, Evan R.; Scheiman, Jonathan; Kalhor, Reza; Yang, Joyce L.; Ferrante, Thomas C.; Terry, Richard; Jeanty, Sauveur S. F.; Li, Chao; Amamoto, Ryoji; Peters, Derek T.; Turczyk, Brian M.; Marblestone, Adam H.; Inverso, Samuel A.; Bernard, Amy; Mali, Prashant; Rios, Xavier; Aach, John; Church, George M.			Highly Multiplexed Subcellular RNA Sequencing in Situ	SCIENCE			English	Article							GENE-EXPRESSION; TRANSCRIPTS; REVEALS; TISSUE	Understanding the spatial organization of gene expression with single-nucleotide resolution requires localizing the sequences of expressed RNA transcripts within a cell in situ. Here, we describe fluorescent in situ RNA sequencing (FISSEQ), in which stably cross-linked complementary DNA (cDNA) amplicons are sequenced within a biological sample. Using 30-base reads from 8102 genes in situ, we examined RNA expression and localization in human primary fibroblasts with a simulated wound-healing assay. FISSEQ is compatible with tissue sections and whole-mount embryos and reduces the limitations of optical resolution and noisy signals on single-molecule detection. Our platform enables massively parallel detection of genetic elements, including gene transcripts and molecular barcodes, and can be used to investigate cellular phenotype, gene regulation, and environment in situ.	[Lee, Je Hyuk; Daugharthy, Evan R.; Scheiman, Jonathan; Ferrante, Thomas C.; Terry, Richard; Jeanty, Sauveur S. F.; Li, Chao; Turczyk, Brian M.; Marblestone, Adam H.; Inverso, Samuel A.; Church, George M.] Harvard Univ, Sch Med, Wyss Inst, Boston, MA 02115 USA; [Lee, Je Hyuk; Daugharthy, Evan R.; Scheiman, Jonathan; Kalhor, Reza; Yang, Joyce L.; Marblestone, Adam H.; Mali, Prashant; Rios, Xavier; Aach, John; Church, George M.] Harvard Univ, Dept Genet, Sch Med, Boston, MA 02115 USA; [Amamoto, Ryoji; Peters, Derek T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Boston, MA 02138 USA; [Daugharthy, Evan R.] Harvard Univ, Dept Syst Biol, Sch Med, Boston, MA 02115 USA; [Bernard, Amy] Allen Inst Brain Sci, Seattle, WA 98103 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard University; Harvard Medical School; Allen Institute for Brain Science	Lee, JH (corresponding author), Harvard Univ, Sch Med, Wyss Inst, Boston, MA 02115 USA.	jehyuklee@mac.com; gchurch@genetics.med.harvard.edu		Marblestone, Adam/0000-0001-9833-9931; Bernard, Amy/0000-0003-2540-1153; church, george/0000-0001-6232-9969	NIH Centers of Excellence in Genomic Sciences [P50 HG005550]; National Heart, Lung, and Blood Institute, NIH [RC2HL102815]; Allen Institute for Brain Science; National Institute of Mental Health, NIH [MH098977]; NIH [GM080177]; NSF [DGE1144152]; Hertz Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL102815] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG005550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753, T32GM080177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH098977] Funding Source: NIH RePORTER	NIH Centers of Excellence in Genomic Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Allen Institute for Brain Science; National Institute of Mental Health, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Hertz Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Data can be downloaded from http://arep.med.harvard.edu/FISSEQ_Science_2014/ and Gene Expression Omnibus (gene expression arrays: GSM313643, GSM313646, and GSM313657; RNA-seq: GSE54733). We thank S. Kosuri, K. Zhang, and M. Nilsson for discussions; A. DePace for Drosophila embryos; and I. Bachelet for antibody conjugation. Funded by NIH Centers of Excellence in Genomic Sciences grant P50 HG005550. J.H.L. and co-workers were funded by the National Heart, Lung, and Blood Institute, NIH, grant RC2HL102815; the Allen Institute for Brain Science, and the National Institute of Mental Health, NIH, grant MH098977. E.R.D. was funded by NIH grant GM080177 and NSF Graduate Research Fellowship Program grant DGE1144152. A.H.M. was funded by the Hertz Foundation. Potential conflicts of interests for G.M.C. are listed on http://arep.med.harvard.edu/gmc/tech.html. J.H.L., E.R.D., R.T., and G.M.C. are authors on a patent application from the Wyss Institute that covers the method of generating three-dimensional nucleic acid-containing matrix.	Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Itzkovitz S, 2011, NAT METHODS, V8, pS12, DOI [10.1038/NMETH.1573, 10.1038/nmeth.1573]; Ke RQ, 2013, NAT METHODS, V10, P857, DOI 10.1038/nmeth.2563; Kim JB, 2007, SCIENCE, V316, P1481, DOI 10.1126/science.1137325; Kornblihtt AR, 1996, FASEB J, V10, P248, DOI 10.1096/fasebj.10.2.8641558; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Lee JH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000718; Levsky JM, 2002, SCIENCE, V297, P836, DOI 10.1126/science.1072241; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; McAnulty RJ, 2007, INT J BIOCHEM CELL B, V39, P666, DOI 10.1016/j.biocel.2006.11.005; Mitra RD, 2003, P NATL ACAD SCI USA, V100, P5926, DOI 10.1073/pnas.0936399100; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Zeng HK, 2012, CELL, V149, P483, DOI 10.1016/j.cell.2012.02.052; Zhang K, 2009, NAT METHODS, V6, P613, DOI 10.1038/nmeth.1357	19	554	655	17	224	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2014	343	6177					1360	1363		10.1126/science.1250212	http://dx.doi.org/10.1126/science.1250212			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD3AI	24578530	Green Accepted			2022-12-28	WOS:000333108500039
J	Dewey, FE; Grove, ME; Pan, CP; Goldstein, BA; Bernstein, JA; Chaib, H; Merker, JD; Goldfeder, RL; Enns, GM; David, SP; Pakdaman, N; Ormond, KE; Caleshu, C; Kingham, K; Klein, TE; Whirl-Carrillo, M; Sakamoto, K; Wheeler, MT; Butte, AJ; Ford, JM; Boxer, L; Ioannidis, JPA; Yeung, AC; Altman, RB; Assimes, TL; Snyder, M; Ashley, EA; Quertermous, T				Dewey, Frederick E.; Grove, Megan E.; Pan, Cuiping; Goldstein, Benjamin A.; Bernstein, Jonathan A.; Chaib, Hassan; Merker, Jason D.; Goldfeder, Rachel L.; Enns, Gregory M.; David, Sean P.; Pakdaman, Neda; Ormond, Kelly E.; Caleshu, Colleen; Kingham, Kerry; Klein, Teri E.; Whirl-Carrillo, Michelle; Sakamoto, Kenneth; Wheeler, Matthew T.; Butte, Atul J.; Ford, James M.; Boxer, Linda; Ioannidis, John P. A.; Yeung, Alan C.; Altman, Russ B.; Assimes, Themistocles L.; Snyder, Michael; Ashley, Euan A.; Quertermous, Thomas			Clinical Interpretation and Implications of Whole-Genome Sequencing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMPLEMENTATION CONSORTIUM GUIDELINES; OF-FUNCTION VARIANTS; ACMG RECOMMENDATIONS; INCIDENTAL FINDINGS; EXOME; MUTATIONS; INSIGHTS; INDIVIDUALS; ASSOCIATION; STANDARDS	IMPORTANCE Whole-genome sequencing (WGS) is increasingly applied in clinical medicine and is expected to uncover clinically significant findings regardless of sequencing indication. OBJECTIVES To examine coverage and concordance of clinically relevant genetic variation provided by WGS technologies; to quantitate inherited disease risk and pharmacogenomic findings in WGS data and resources required for their discovery and interpretation; and to evaluate clinical action prompted by WGS findings. DESIGN, SETTING, AND PARTICIPANTS An exploratory study of 12 adult participants recruited at Stanford University Medical Center who underwent WGS between November 2011 and March 2012. A multidisciplinary team reviewed all potentially reportable genetic findings. Five physicians proposed initial clinical follow-up based on the genetic findings. MAIN OUTCOMES AND MEASURES Genome coverage and sequencing platform concordance in different categories of genetic disease risk, person-hours spent curating candidate disease-risk variants, interpretation agreement between trained curators and disease genetics databases, burden of inherited disease risk and pharmacogenomic findings, and burden and interrater agreement of proposed clinical follow-up. RESULTS Depending on sequencing platform, 10% to 19% of inherited disease genes were not covered to accepted standards for single nucleotide variant discovery. Genotype concordance was high for previously described single nucleotide genetic variants (99%-100%) but low for small insertion/deletion variants (53%-59%). Curation of 90 to 127 genetic variants in each participant required a median of 54 minutes (range, 5-223 minutes) per genetic variant, resulted in moderate classification agreement between professionals (Gross., 0.52; 95% CI, 0.40-0.64), and reclassified 69% of genetic variants cataloged as disease causing in mutation databases to variants of uncertain or lesser significance. Two to 6 personal disease-risk findings were discovered in each participant, including 1 frameshift deletion in the BRCA1 gene implicated in hereditary breast and ovarian cancer. Physician review of sequencing findings prompted consideration of a median of 1 to 3 initial diagnostic tests and referrals per participant, with fair interrater agreement about the suitability of WGS findings for clinical follow-up (Fleiss., 0.24; P < 001). CONCLUSIONS AND RELEVANCE In this exploratory study of 12 volunteer adults, the use of WGS was associated with incomplete coverage of inherited disease genes, low reproducibility of detection of genetic variation with the highest potential clinical effects, and uncertainty about clinically reportable findings. In certain cases, WGS will identify clinically actionable genetic variants warranting early medical intervention. These issues should be considered when determining the role of WGS in clinical medicine.	[Dewey, Frederick E.; Grove, Megan E.; Caleshu, Colleen; Wheeler, Matthew T.; Ashley, Euan A.; Quertermous, Thomas] Stanford Ctr Inherited Cardiovasc Dis, Stanford, CA USA; [Dewey, Frederick E.; Grove, Megan E.; Caleshu, Colleen; Wheeler, Matthew T.; Yeung, Alan C.; Assimes, Themistocles L.; Snyder, Michael; Ashley, Euan A.; Quertermous, Thomas] Stanford Cardiovasc Inst, Stanford, CA 94305 USA; [Dewey, Frederick E.; Grove, Megan E.; Caleshu, Colleen; Sakamoto, Kenneth; Wheeler, Matthew T.; Yeung, Alan C.; Assimes, Themistocles L.; Ashley, Euan A.; Quertermous, Thomas] Stanford Univ, Div Cardiovasc Med, Stanford, CA 94305 USA; [Dewey, Frederick E.; Grove, Megan E.; Pan, Cuiping; Chaib, Hassan; Wheeler, Matthew T.; Snyder, Michael; Ashley, Euan A.; Quertermous, Thomas] Stanford Ctr Genom & Personalized Med, Stanford, CA USA; [Pan, Cuiping; Chaib, Hassan; Ormond, Kelly E.; Klein, Teri E.; Whirl-Carrillo, Michelle; Altman, Russ B.; Snyder, Michael; Ashley, Euan A.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Goldstein, Benjamin A.; David, Sean P.; Pakdaman, Neda; Sakamoto, Kenneth; Boxer, Linda; Ioannidis, John P. A.; Altman, Russ B.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Bernstein, Jonathan A.; Enns, Gregory M.; Caleshu, Colleen; Butte, Atul J.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Merker, Jason D.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Goldfeder, Rachel L.] Stanford Univ, Biomed Informat Training Program, Stanford, CA 94305 USA; [Ormond, Kelly E.] Stanford Ctr Biomed Eth, Stanford, CA USA; [Kingham, Kerry; Ford, James M.] Stanford Univ, Div Med Oncol, Stanford, CA 94305 USA; [Butte, Atul J.; Ioannidis, John P. A.] Stanford Univ, Div Syst Med, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Stat, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Altman, Russ B.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University	Ashley, EA (corresponding author), Stanford Cardiovasc Inst, Falk CVRC, 300 Pasteur Dr, Stanford, CA 94305 USA.	euan@stanford.edu; tomq1@stanford.edu	Assimes, Themistocles Leonard/D-9696-2015; Ioannidis, John P. A./G-9836-2011; Ormond, Kelly E/I-5676-2019	Assimes, Themistocles Leonard/0000-0003-2349-0009; Ormond, Kelly E/0000-0002-1033-0818; Pan, Cuiping/0000-0002-8152-2489; Grove, Megan/0000-0002-7972-0005; Ford, James/0000-0002-2513-7025; Quertermous, Thomas/0000-0002-7645-9067; Altman, Russ/0000-0003-3859-2905; Whirl-Carrillo, Michelle/0000-0003-2414-9312; Snyder, Michael/0000-0003-0784-7987; David, Sean/0000-0002-4922-2603; Wheeler, Matthew/0000-0001-8721-3022; Klein, Teri/0000-0001-5527-6475	NHLBI [T32 HL094274-01A2]; NHGRI [P50 HG003389-05, U01 HG004267-03]; NIGMS [R24 GM61374]; NIH [R01 GM079719 9]; Director's New Innovator Award from the National Institutes of Health [DP2 OD004613, R01 HL113006, U01 HG007436, X01 HL115206, HL094274]; Breetwor Family Foundation; LeDucq Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113006, T32HL094274, R01HL087647] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003389, U01HG004267, U01HG007436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K25DK097279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079719, R24GM061374] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Director's New Innovator Award from the National Institutes of Health; Breetwor Family Foundation; LeDucq Foundation(Leducq Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported in part by grants NHLBI T32 HL094274-01A2 (Dr Dewey), NHGRI P50 HG003389-05 (Ms Ormond), NIGMS R24 GM61374 (Drs Klein, Whirl-Carrillo, and Altman), NIH R01 GM079719 9 (Dr Butte), NHGRI U01 HG004267-03 (Dr Snyder), and Director's New Innovator Award DP2 OD004613, R01 HL113006, U01 HG007436, X01 HL115206, and HL094274 from the National Institutes of Health and by a grant from the Breetwor Family Foundation (Dr Ashley) and a grant from the LeDucq Foundation (Dr Quertermous).	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Ashley EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7; Ball MP, 2012, P NATL ACAD SCI USA, V109, P11920, DOI 10.1073/pnas.1201904109; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Baudi F, 2001, Hum Mutat, V18, P163, DOI 10.1002/humu.1167; Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Berg JS, 2013, GENET MED, V15, P36, DOI 10.1038/gim.2012.112; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Couch FJ, 1997, NEW ENGL J MED, V336, P1409, DOI 10.1056/NEJM199705153362002; Crews KR, 2012, CLIN PHARMACOL THER, V91, P321, DOI 10.1038/clpt.2011.287; Daly MB, 2010, J NATL COMPR CANC NE, V8, P562, DOI 10.6004/jnccn.2010.0043; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; Dewey FE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002280; Dorschner MO, 2013, AM J HUM GENET, V93, P631, DOI 10.1016/j.ajhg.2013.08.006; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; FLEISS JL, 1971, PSYCHOL BULL, V76, P378, DOI 10.1037/h0031619; Gahl WA, 2012, GENET MED, V14, P51, DOI 10.1038/gim.0b013e318232a005; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; GROSS ST, 1986, BIOMETRICS, V42, P883, DOI 10.2307/2530702; Hudson G, 2006, HUM MOL GENET, V15, pR244, DOI 10.1093/hmg/ddl233; Johnson JA, 2011, CLIN PHARMACOL THER, V90, P625, DOI 10.1038/clpt.2011.185; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Johnston JJ, 2012, AM J HUM GENET, V91, P97, DOI 10.1016/j.ajhg.2012.05.021; Knowles JW, 2012, CIRC-CARDIOVASC GENE, V5, P368, DOI 10.1161/CIRCGENETICS.112.962746; Lam HYK, 2012, NAT BIOTECHNOL, V30, P78, DOI 10.1038/nbt.2065; Lu XF, 2012, NAT GENET, V44, P890, DOI 10.1038/ng.2337; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; MacArthur DG, 2010, HUM MOL GENET, V19, pR125, DOI 10.1093/hmg/ddq365; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Musunuru K, 2010, NEW ENGL J MED, V363, P2220, DOI 10.1056/NEJMoa1002926; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Quaresima B, 2008, CLIN CANCER RES, V14, P6797, DOI 10.1158/1078-0432.CCR-07-5208; Relling MV, 2013, CLIN PHARMACOL THER, V93, P324, DOI 10.1038/clpt.2013.4; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Riggs ER, 2013, HUM MUTAT, V34, P915, DOI 10.1002/humu.22306; Scott SA, 2011, CLIN PHARMACOL THER, V90, P328, DOI 10.1038/clpt.2011.132; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Whirl-Carrillo M, 2012, CLIN PHARMACOL THER, V92, P414, DOI 10.1038/clpt.2012.96; Wilke RA, 2012, CLIN PHARMACOL THER, V92, P112, DOI 10.1038/clpt.2012.57; Worthey EA, 2011, GENET MED, V13, P255, DOI 10.1097/GIM.0b013e3182088158; Xue YL, 2012, AM J HUM GENET, V91, P1022, DOI 10.1016/j.ajhg.2012.10.015	44	324	336	0	68	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2014	311	10					1035	1044		10.1001/jama.2014.1717	http://dx.doi.org/10.1001/jama.2014.1717			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC5QO	24618965	Green Accepted, Bronze			2022-12-28	WOS:000332575800021
J	Malicki, M; von Elm, E; Marusic, A				Malicki, Mario; von Elm, Erik; Marusic, Ana			Study Design, Publication Outcome, and Funding of Research Presented at International Congresses on Peer Review and Biomedical Publication	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Malicki, Mario; Marusic, Ana] Univ Split, Sch Med, Dept Res Biomed & Hlth, Split 21000, Croatia; [von Elm, Erik] Univ Lausanne Hosp, Inst Social & Prevent Med, Lausanne, Switzerland	University of Split; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Marusic, A (corresponding author), Univ Split, Sch Med, Dept Res Biomed & Hlth, Soltanska 2, Split 21000, Croatia.	ana.marusic@mefst.hr	Malički, Mario/E-8621-2016; Marusic, Ana/E-7683-2013	Malički, Mario/0000-0003-0698-1930; Marusic, Ana/0000-0001-6272-0917; von Elm, Erik/0000-0002-7412-0406				Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; DICKERSIN K, 1994, BMJ-BRIT MED J, V309, P1286, DOI 10.1136/bmj.309.6964.1286; DICKERSIN K, 1990, JAMA-J AM MED ASSOC, V263, P1385, DOI 10.1001/jama.263.10.1385; National Library of Medicine, MED SUBJ HEAD PEER R; Rennie D, 1991, PEER REV SCI PUBLISH; Scherer RW, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000005.pub3, 10.1002/14651858.MR000005.pub4]	6	9	9	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2014	311	10					1065	1067		10.1001/jama.2014.143	http://dx.doi.org/10.1001/jama.2014.143			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC5QO	24618970				2022-12-28	WOS:000332575800026
J	Nolan, JP; Pullinger, R				Nolan, Jerry P.; Pullinger, Rick			Hypovolaemic Shock	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material													Nolan, Jerry P./ABF-2561-2020	Nolan, Jerry/0000-0003-3141-3812				American College of Surgeons Committee on Trauma, 2008, ADVANCED TRAUMA LIFE; Finfer S, 2004, NEW ENGL J MED, V350, P2247; National Institute for Health and Clinical Excellence, 2004, PRE HOSPITAL INITIAT; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5	4	0	1	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 7	2014	348								g1139					13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC6JC	24609389				2022-12-28	WOS:000332627300002
J	Srinivasan, V; Pierik, AJ; Lill, R				Srinivasan, Vasundara; Pierik, Antonio J.; Lill, Roland			Crystal Structures of Nucleotide-Free and Glutathione-Bound Mitochondrial ABC Transporter Atm1	SCIENCE			English	Article							LINKED SIDEROBLASTIC ANEMIA; IRON-SULFUR PROTEINS; BINDING CASSETTE TRANSPORTER; P-GLYCOPROTEIN; BIOGENESIS; MUTATION; ATAXIA; METABOLISM; MATURATION; REQUIRES	The yeast mitochondrial ABC transporter Atm1, in concert with glutathione, functions in the export of a substrate required for cytosolic-nuclear iron-sulfur protein biogenesis and cellular iron regulation. Defects in the human ortholog ABCB7 cause the sideroblastic anemia XLSA/A. Here, we report the crystal structures of free and glutathione-bound Atm1 in inward-facing, open conformations at 3.06- and 3.38-angstrom resolution, respectively. The glutathione binding site includes a residue mutated in XLSA/A and is located close to the inner membrane surface in a large cavity. The two nucleotide-free adenosine 5'-triphosphate binding domains do not interact yet are kept in close vicinity through tight interaction of the two C-terminal alpha-helices of the Atm1 dimer. The resulting protein stabilization may be a common structural feature of all ABC exporters.	[Srinivasan, Vasundara; Pierik, Antonio J.; Lill, Roland] Univ Marburg, Inst Zytobiol, D-35032 Marburg, Germany; [Srinivasan, Vasundara; Lill, Roland] LOEWE Zentrum Synthet Mikrobiol SynMikro, D-35043 Marburg, Germany; [Lill, Roland] Max Planck Inst Terr Mikrobiol, D-35043 Marburg, Germany	Philipps University Marburg; Max Planck Society	Srinivasan, V (corresponding author), Univ Marburg, Inst Zytobiol, Robert Koch Str 6, D-35032 Marburg, Germany.	vasundara.srinivasan@staff.uni-marburg.de; lill@staff.uni-marburg.de	Pierik, Antonio J/G-1108-2010	Pierik, Antonio J/0000-0002-1509-6370; Lill, Roland/0000-0002-8345-6518	Deutsche Forschungsgemeinschaft [SFB 593, SFB 987, GRK 1216]; von Behring-Rontgen Stiftung; LOEWE program of state Hessen; Max-Planck Gesellschaft; Feldberg Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); von Behring-Rontgen Stiftung; LOEWE program of state Hessen; Max-Planck Gesellschaft(Max Planck Society); Feldberg Foundation	We thank U. Linne for mass spectrometry, S. Freibert for help with thermophoresis, M. Stumpfig and N. Herlerth for expert technical assistance, D. C. Rees for discussion, and the beamline staff for support at the X06SA beamline, Swiss Light Source, Paul Scherrer Institute, Villigen, Switzerland. R.L. acknowledges generous support from Deutsche Forschungsgemeinschaft (SFB 593, SFB 987, and GRK 1216), von Behring-Rontgen Stiftung, LOEWE program of state Hessen, Max-Planck Gesellschaft, and the Feldberg Foundation. Coordinates and structure factors have been deposited in the Protein Data Bank (PDB accession codes 4MYC and 4MYH).	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Allikmets R, 1999, HUM MOL GENET, V8, P743, DOI 10.1093/hmg/8.5.743; Bekri S, 2000, BLOOD, V96, P3256; Bernard DG, 2009, PLANT PHYSIOL, V151, P590, DOI 10.1104/pp.109.143651; Boultwood J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001970; Burke MA, 2007, TRANSL RES, V150, P73, DOI 10.1016/j.trsl.2007.03.002; Cavadini P, 2007, BLOOD, V109, P3552, DOI 10.1182/blood-2006-08-041632; D'Hooghe M, 2012, EUR J PAEDIATR NEURO, V16, P730, DOI 10.1016/j.ejpn.2012.02.003; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Gari K, 2012, SCIENCE, V337, P243, DOI 10.1126/science.1219664; Honisch U, 2003, J BACTERIOL, V185, P1895, DOI 10.1128/JB.185.6.1895-1902.2003; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; Kispal G, 2005, EMBO J, V24, P589, DOI 10.1038/sj.emboj.7600541; Kispal G, 1997, FEBS LETT, V418, P346, DOI 10.1016/S0014-5793(97)01414-2; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; Kuhnke G, 2006, MOL MEMBR BIOL, V23, P173, DOI 10.1080/09687860500473630; Kumar C, 2011, EMBO J, V30, P2044, DOI 10.1038/emboj.2011.105; Kushnir S, 2001, PLANT CELL, V13, P89, DOI 10.1105/tpc.13.1.89; Lange H, 2001, EMBO REP, V2, P715, DOI 10.1093/embo-reports/kve161; Lee JY, 2014, SCIENCE, V343, P1133, DOI 10.1126/science.1246489; LILL R, 2003, ABC PROTEINS BACTERI, P515; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Maguire A, 2001, BRIT J HAEMATOL, V115, P910, DOI 10.1046/j.1365-2141.2001.03015.x; Netz DJA, 2012, NAT CHEM BIOL, V8, P125, DOI 10.1038/nchembio.721; Nikpour M, 2013, LEUKEMIA, V27, P889, DOI 10.1038/leu.2012.298; Pellegrino MW, 2013, BBA-MOL CELL RES, V1833, P410, DOI 10.1016/j.bbamcr.2012.02.019; Philpott CC, 2012, BBA-MOL CELL RES, V1823, P1509, DOI 10.1016/j.bbamcr.2012.01.012; Pondarre C, 2006, HUM MOL GENET, V15, P953, DOI 10.1093/hmg/ddl012; Qi WB, 2012, J AM CHEM SOC, V134, P10745, DOI 10.1021/ja302186j; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Rutherford JC, 2005, J BIOL CHEM, V280, P10135, DOI 10.1074/jbc.M413731200; Schilke B, 1999, P NATL ACAD SCI USA, V96, P10206, DOI 10.1073/pnas.96.18.10206; Shintre CA, 2013, P NATL ACAD SCI USA, V110, P9710, DOI 10.1073/pnas.1217042110; Sipos K, 2002, J BIOL CHEM, V277, P26944, DOI 10.1074/jbc.M200677200; Stehling O, 2012, SCIENCE, V337, P195, DOI 10.1126/science.1219723; Teschner J, 2010, PLANT CELL, V22, P468, DOI 10.1105/tpc.109.068478; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Zutz A, 2009, BBA-BIOENERGETICS, V1787, P681, DOI 10.1016/j.bbabio.2009.02.009	39	145	148	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2014	343	6175					1137	1140		10.1126/science.1246729	http://dx.doi.org/10.1126/science.1246729			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2LB	24604199				2022-12-28	WOS:000332331500048
J	Bagci, T; Simonsen, A; Schmid, S; Villanueva, LG; Zeuthen, E; Appel, J; Taylor, JM; Sorensen, A; Usami, K; Schliesser, A; Polzik, ES				Bagci, T.; Simonsen, A.; Schmid, S.; Villanueva, L. G.; Zeuthen, E.; Appel, J.; Taylor, J. M.; Sorensen, A.; Usami, K.; Schliesser, A.; Polzik, E. S.			Optical detection of radio waves through a nanomechanical transducer	NATURE			English	Article							CAVITY OPTOMECHANICS; MICROWAVE; RESONATOR; STATE	Low-loss transmission and sensitive recovery of weak radio-frequency and microwave signals is a ubiquitous challenge, crucial in radio astronomy, medical imaging, navigation, and classical and quantum communication. Efficient up-conversion of radio-frequency signals to an optical carrier would enable their transmission through optical fibres instead of through copper wires, drastically reducing losses, and would give access to the set of established quantum optical techniques that are routinely used in quantum-limited signal detection. Research in cavity optomechanics(1,2) has shown that nanomechanical oscillators can couple strongly to either microwave(3-5) or optical fields(6,7). Here we demonstrate a room-temperature optoelectromechanical transducer with both these functionalities, following a recent proposal(8) using a high-quality nanomembrane. A voltage bias of less than 10 V is sufficient to induce strong coupling(4,6,7) between the voltage fluctuations in a radio-frequency resonance circuit and the membrane's displacement, which is simultaneously coupled to light reflected off its surface. The radio-frequency signals are detected as an optical phase shift with quantum-limited sensitivity. The corresponding half-wave voltage is in the microvolt range, orders of magnitude less than that of standard optical modulators. The noise of the transducer-beyond the measured 800 pV Hz(-1/2) Johnson noise of the resonant circuit-consists of the quantum noise of light and thermal fluctuations of the membrane, dominating the noise floor in potential applications in radio astronomy and nuclear magnetic imaging. Each of these contributions is inferred to be 60 pV Hz(-1/2) when balanced by choosing an electromechanical cooperativity of similar to 150 with an optical power of 1 mW. The noise temperature of the membrane is 300 K divided by the cooperativity. For the highest observed cooperativity of 6,800, this leads to a projected noise temperature of 40 mK and a sensitivity limit of 5 pV Hz(-1/2). Our approach to all-optical, ultralow-noise detection of classical electronic signals sets the stage for coherent up-conversion of low-frequency quantum signals to the optical domain(8-11).	[Bagci, T.; Simonsen, A.; Zeuthen, E.; Appel, J.; Sorensen, A.; Usami, K.; Schliesser, A.; Polzik, E. S.] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Schmid, S.; Villanueva, L. G.] Tech Univ Denmark, DTU Nanotech, Dept Micro & Nanotechnol, DK-2800 Lyngby, Denmark; [Taylor, J. M.] NIST, Joint Quantum Inst, College Pk, MD 20742 USA	University of Copenhagen; Niels Bohr Institute; Technical University of Denmark; National Institute of Standards & Technology (NIST) - USA	Polzik, ES (corresponding author), Univ Copenhagen, Niels Bohr Inst, Blegdamsvej 17, DK-2100 Copenhagen, Denmark.	albert.schliesser@nbi.dk; polzik@nbi.dk	Taylor, Jacob/O-1670-2019; Simonsen, Anders/AAE-6424-2019; Taylor, Jacob M/B-7826-2011; Koji, Usami/AAG-4803-2020; Sørensen, Anders Søndberg/L-1868-2013; Appel, Jürgen/E-9036-2012; Schmid, Silvan/E-5822-2010; Simonsen, Anders/C-8294-2019; Schliesser, Albert/C-5619-2014; Villanueva, Luis Guillermo/C-4904-2009; Polzik, Eugene/M-4724-2014	Taylor, Jacob/0000-0003-0493-5594; Simonsen, Anders/0000-0002-2521-5986; Taylor, Jacob M/0000-0003-0493-5594; Sørensen, Anders Søndberg/0000-0003-1337-9163; Appel, Jürgen/0000-0003-1315-3439; Schmid, Silvan/0000-0003-3778-7137; Simonsen, Anders/0000-0002-2521-5986; Schliesser, Albert/0000-0003-4317-5030; Villanueva, Luis Guillermo/0000-0003-3340-2930; Zeuthen, Emil/0000-0002-1206-6862; Polzik, Eugene/0000-0001-9859-6591	DARPA project QUASAR; European Union Seventh Framework Program through SIQS [600645]; European Union Seventh Framework Program through iQUOEMS [323924]; ERC grant QIOS [306576]; ERC grant INTERFACE [291038]	DARPA project QUASAR; European Union Seventh Framework Program through SIQS; European Union Seventh Framework Program through iQUOEMS; ERC grant QIOS; ERC grant INTERFACE	This work was supported by the DARPA project QUASAR, the European Union Seventh Framework Program through SIQS (grant no. 600645) and iQUOEMS (grant no. 323924), and the ERC grants QIOS (grant no. 306576) and INTERFACE (grant no. 291038). We would like to thank J. H. Muller for valuable discussions, A. Barg and A. Naesby for assistance with the interferometer, and L. Jorgensen for cleanroom support.	Andrews R. W., 2013, PREPRINT; Anetsberger G, 2009, NAT PHYS, V5, P909, DOI 10.1038/NPHYS1425; ASPELMEYER M, 2013, PREPRINT; Bochmann J, 2013, NAT PHYS, V9, P712, DOI [10.1038/NPHYS2748, 10.1038/nphys2748]; Devgan PS, 2010, IEEE PHOTONIC TECH L, V22, P152, DOI 10.1109/LPT.2009.2037154; Dong CH, 2012, SCIENCE, V338, P1609, DOI 10.1126/science.1228370; Faust T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1723; Groblacher S, 2009, NATURE, V460, P724, DOI 10.1038/nature08171; HOROWITZ P, 1989, ART ELECTRONICS, P428; Ilchenko VS, 2008, IEEE PHOTONIC TECH L, V20, P1600, DOI 10.1109/LPT.2008.928837; Jensen K, 2007, NANO LETT, V7, P3508, DOI 10.1021/nl0721113; Kippenberg TJ, 2008, SCIENCE, V321, P1172, DOI 10.1126/science.1156032; Kovacs H, 2005, PROG NUCL MAG RES SP, V46, P131, DOI 10.1016/j.pnmrs.2005.03.001; Kraus J.D., 1966, RADIO ASTRONOMY; Massel F, 2011, NATURE, V480, P351, DOI 10.1038/nature10628; O'Connell AD, 2010, NATURE, V464, P697, DOI 10.1038/nature08967; Palomaki TA, 2013, NATURE, V495, P210, DOI 10.1038/nature11915; Regal CA, 2011, J PHYS CONF SER, V264, DOI 10.1088/1742-6596/264/1/012025; Resmer F, 2010, J MAGN RESON, V203, P57, DOI 10.1016/j.jmr.2009.11.021; Safavi-Naeini AH, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/1/013017; Stannigel K, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.220501; Taylor JM, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.273601; Teufel JD, 2011, NATURE, V471, P204, DOI 10.1038/nature09898; Thompson JD, 2008, NATURE, V452, P72, DOI 10.1038/nature06715; Truitt PA, 2007, NANO LETT, V7, P120, DOI 10.1021/nl062278g; Unterreithmeier QP, 2009, NATURE, V458, P1001, DOI 10.1038/nature07932; Verhagen E, 2012, NATURE, V482, P63, DOI 10.1038/nature10787; Wang YD, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.153603; Weis S, 2010, SCIENCE, V330, P1520, DOI 10.1126/science.1195596; Yu PL, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.083603	30	312	323	9	241	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					81	85		10.1038/nature13029	http://dx.doi.org/10.1038/nature13029			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0ZQ	24598636	Green Submitted, Green Published			2022-12-28	WOS:000332224400046
J	Nozawa, RS; Gilbert, N				Nozawa, Ryu-Suke; Gilbert, Nick			Interphase Chromatin LINEd with RNA	CELL			English	Editorial Material							NUCLEAR MATRIX; X-CHROMOSOME; PROTEIN		[Nozawa, Ryu-Suke; Gilbert, Nick] Univ Edinburgh, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Gilbert, N (corresponding author), Univ Edinburgh, Inst Genet & Mol Med, MRC Human Genet Unit, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.	nick.gilbert@ed.ac.uk		Gilbert, Nick/0000-0003-0505-6081	Medical Research Council [MR/J00913X/1] Funding Source: Medline; MRC [MR/J00913X/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BEREZNEY R, 1974, BIOCHEM BIOPH RES CO, V60, P1410, DOI 10.1016/0006-291X(74)90355-6; Clemson CM, 2006, P NATL ACAD SCI USA, V103, P7688, DOI 10.1073/pnas.0601069103; Hall LL, 2014, CELL, V156, P907, DOI 10.1016/j.cell.2014.01.042; Hasegawa Y, 2010, DEV CELL, V19, P469, DOI 10.1016/j.devcel.2010.08.006; HOLMES DS, 1972, SCIENCE, V177, P72, DOI 10.1126/science.177.4043.72; Naughton C, 2010, MOL CELL, V40, P397, DOI 10.1016/j.molcel.2010.10.013; Nickerson JA, 2001, J CELL SCI, V114, P463; ROMIG H, 1992, EMBO J, V11, P3431, DOI 10.1002/j.1460-2075.1992.tb05422.x	8	3	3	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 27	2014	156	5					864	865		10.1016/j.cell.2014.02.005	http://dx.doi.org/10.1016/j.cell.2014.02.005			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AB9BK	24581484	Bronze			2022-12-28	WOS:000332083900002
J	Raychaudhuri, S; Loew, C; Korner, R; Pinkert, S; Theis, M; Hayer-Hartl, M; Buchholz, F; Hartl, FU				Raychaudhuri, Swasti; Loew, Christian; Koerner, Roman; Pinkert, Stefan; Theis, Mirko; Hayer-Hartl, Manajit; Buchholz, Frank; Hartl, F. Ulrich			Interplay of Acetyltransferase EP300 and the Proteasome System in Regulating Heat Shock Transcription Factor 1	CELL			English	Article							MOLECULAR CHAPERONES; CAENORHABDITIS-ELEGANS; PROTEIN STABILITY; IN-VIVO; STRESS; PROTEOSTASIS; ACTIVATION; GENE; HSF1; LOCALIZATION	When exposed to proteotoxic environmental conditions, mammalian cells activate the cytosolic stress response in order to restore protein homeostasis. A key feature of this response is the heat shock transcription factor 1 (HSF1)-dependent expression of molecular chaperones. Here, we describe the results of an RNA interference screen in HeLa cells to identify modulators of stress response induction and attenuation. The modulator proteins are localized in multiple cellular compartments, with chromatin modifiers and nuclear protein quality control playing a central regulatory role. We find that the acetyltransferase, EP300, controls the cellular level of activatable HSF1. This involves acetylation of HSF1 at multiple lysines not required for function and results in stabilization of HSF1 against proteasomal turnover. Acetylation of functionally critical lysines during stress serves to fine-tune HSF1 activation. Finally, the nuclear proteasome system functions in attenuating the stress response by degrading activated HSF1 in a manner linked with the clearance of misfolded proteins.	[Raychaudhuri, Swasti; Loew, Christian; Koerner, Roman; Pinkert, Stefan; Hayer-Hartl, Manajit; Hartl, F. Ulrich] Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany; [Theis, Mirko; Buchholz, Frank] Univ Hosp, D-01307 Dresden, Germany; [Theis, Mirko; Buchholz, Frank] Carl Gustav Carus Univ Technol, Fac Med, D-01307 Dresden, Germany	Max Planck Society; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden	Hartl, FU (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	uhartl@biochem.mpg.de	Hartl, F. Ulrich/Y-8206-2019; Buchholz, Frank/B-4700-2017; Raychaudhuri, Swasti/AAZ-2748-2020; Hayer-Hartl, Manajit/V-8078-2017; Körner, Roman/G-8565-2011	Buchholz, Frank/0000-0002-4577-3344; Hayer-Hartl, Manajit/0000-0001-8213-6742; Körner, Roman/0000-0001-9285-9290	EU; Human Frontier Science Program [HFSP RGP0048/2011]; Munich Cluster for Systems Neurology (SyNergy)	EU(European Commission); Human Frontier Science Program(Human Frontier Science Program); Munich Cluster for Systems Neurology (SyNergy)	The esiRNA interference screen reported in this study was performed at the High-Throughput Technology Development Studio (HT-TDS) at the Max Planck Institute of Molecular Cell Biology and Genetics in Dresden. We especially thank K. Korn and M. Bickle for their help with assay development and R. Zenke for assistance with cell cycle analysis. Expert technical assistance by V. Marcus is acknowledged. We thank M. Hipp, Y. Kim, and J. Verghese for critically reading the manuscript. Financial support from EU Framework 7 Integrated Project PROSPECTS, Human Frontier Science Program (HFSP RGP0048/2011), and the Munich Cluster for Systems Neurology (SyNergy) is acknowledged.	Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Batista-Nascimento L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015976; Ben-Zvi A, 2009, P NATL ACAD SCI USA, V106, P14914, DOI 10.1073/pnas.0902882106; Bharadwaj S, 1999, MOL CELL BIOL, V19, P8033; Biamonti G, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000695; Biamonti G, 2009, TRENDS BIOCHEM SCI, V34, P146, DOI 10.1016/j.tibs.2008.11.004; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Calamini B, 2012, NAT CHEM BIOL, V8, P185, DOI 10.1038/nchembio.763; Caron C, 2005, BIOESSAYS, V27, P408, DOI 10.1002/bies.20210; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Finka A, 2012, PLANT CELL, V24, P3333, DOI 10.1105/tpc.112.095844; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Geng H, 2012, J BIOL CHEM, V287, P35496, DOI 10.1074/jbc.M112.400697; Gidalevitz T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a009704; Guettouche Toumy, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-4; Guisbert E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003466; Gupta R, 2011, NAT METHODS, V8, P879, DOI [10.1038/NMETH.1697, 10.1038/nmeth.1697]; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hietakangas V, 2003, MOL CELL BIOL, V23, P2953, DOI 10.1128/MCB.23.8.2953-2968.2003; Kittler R, 2005, NAT METHODS, V2, P779, DOI 10.1038/nmeth1005-779; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Laemmle A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033433; Mendillo ML, 2012, CELL, V150, P549, DOI 10.1016/j.cell.2012.06.031; Mercier PA, 1999, J CELL SCI, V112, P2765; Morimoto RI, 2002, CELL, V110, P281, DOI 10.1016/S0092-8674(02)00860-7; Neef DW, 2011, NAT REV DRUG DISCOV, V10, P930, DOI 10.1038/nrd3453; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Park SH, 2013, CELL, V154, P134, DOI 10.1016/j.cell.2013.06.003; PELHAM HRB, 1984, EMBO J, V3, P3095, DOI 10.1002/j.1460-2075.1984.tb02264.x; PELHAM HRB, 1982, CELL, V30, P517, DOI 10.1016/0092-8674(82)90249-5; Petesch SJ, 2008, CELL, V134, P74, DOI 10.1016/j.cell.2008.05.029; Prahlad V, 2008, SCIENCE, V320, P811, DOI 10.1126/science.1156093; Raynes R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054364; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Russell SJ, 1999, J BIOL CHEM, V274, P21943, DOI 10.1074/jbc.274.31.21943; SAAD AH, 1992, P NATL ACAD SCI USA, V89, P9396, DOI 10.1073/pnas.89.20.9396; SARGE KD, 1993, MOL CELL BIOL, V13, P1392, DOI 10.1128/MCB.13.3.1392; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; van Oosten-Hawle P, 2013, CELL, V153, P1366, DOI 10.1016/j.cell.2013.05.015; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	42	99	102	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 27	2014	156	5					975	985		10.1016/j.cell.2014.01.055	http://dx.doi.org/10.1016/j.cell.2014.01.055			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AB9BK	24581496	Bronze			2022-12-28	WOS:000332083900015
J	Sturm, S; Kohler, F; Zatorski, J; Wagner, A; Harman, Z; Werth, G; Quint, W; Keitel, CH; Blaum, K				Sturm, S.; Koehler, F.; Zatorski, J.; Wagner, A.; Harman, Z.; Werth, G.; Quint, W.; Keitel, C. H.; Blaum, K.			High-precision measurement of the atomic mass of the electron	NATURE			English	Article							MAGNETIC-MOMENT; ION	The quest for the value of the electron's atomic mass has been the subject of continuing efforts over the past few decades(1-4). Among the seemingly fundamental constants that parameterize the Standard Model of physics(5) and which are thus responsible for its predictive power, the electron mass m(e) is prominent, being responsible for the structure and properties of atoms and molecules. It is closely linked to other fundamental constants, such as the Rydberg constant R-infinity and the fine-structure constant alpha (ref. 6). However, the low mass of the electron considerably complicates its precise determination. Here we combine a very precise measurement of the magnetic moment of a single electron bound to a carbon nucleus with a state-of-the-art calculation in the framework of bound-state quantum electrodynamics. The precision of the resulting value for the atomic mass of the electron surpasses the current literature value of the Committee on Data for Science and Technology (CODATA(6)) by a factor of 13. This result lays the foundation for future fundamental physics experiments(7,8) and precision tests of the Standard Model(9-11).	[Sturm, S.; Koehler, F.; Zatorski, J.; Wagner, A.; Harman, Z.; Keitel, C. H.; Blaum, K.] Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; [Koehler, F.; Quint, W.] GSI Helmholtzzentrum Schwerionenforschung, D-64291 Darmstadt, Germany; [Harman, Z.] ExtreMe Matter Inst EMMI, D-64291 Darmstadt, Germany; [Werth, G.] Johannes Gutenberg Univ Mainz, Inst Phys, D-55128 Mainz, Germany	Max Planck Society; Helmholtz Association; GSI Helmholtz-Center for Heavy Ion Research; Johannes Gutenberg University of Mainz	Sturm, S (corresponding author), Max Planck Inst Kernphys, Saupfercheckweg 1, D-69117 Heidelberg, Germany.	sven.sturm@mpi-hd.mpg.de	; Zatorski, Jacek/D-9966-2014	Sturm, Sven/0000-0002-0309-5311; Zatorski, Jacek/0000-0003-2424-9081	Max Planck Society; EU (ERC) [290870]; IMPRS-QD; GSI; Helmholtz Alliance [HA216/EMMI]	Max Planck Society(Max Planck SocietyFoundation CELLEX); EU (ERC)(European Research Council (ERC)European Commission); IMPRS-QD; GSI; Helmholtz Alliance	This work was supported by the Max Planck Society, the EU (ERC grant number 290870; MEFUCO), the IMPRS-QD, GSI and the Helmholtz Alliance HA216/EMMI.	Aoyama T, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.111807; Beier T, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.011603; Beier T, 2000, PHYS REP, V339, P80; Boehm C, 2008, PHYS LETT B, V661, P287, DOI 10.1016/j.physletb.2008.02.019; Bouchendira R, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.080801; Breit G, 1928, NATURE, V122, P649, DOI 10.1038/122649a0; BROWN LS, 1986, REV MOD PHYS, V58, P233, DOI 10.1103/RevModPhys.58.233; CORNELL EA, 1989, PHYS REV LETT, V63, P1674, DOI 10.1103/PhysRevLett.63.1674; Cottingham WN, 2007, INTRODUCTION TO THE STANDARD MODEL OF PARTICLE PHYSICS, 2ND EDITION, P1; DEHMELT H, 1986, P NATL ACAD SCI USA, V83, P2291, DOI 10.1073/pnas.83.8.2291; FARNHAM DL, 1995, PHYS REV LETT, V75, P3598, DOI 10.1103/PhysRevLett.75.3598; Gabrielse G, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.172501; GRAFF G, 1980, Z PHYS A-HADRON NUCL, V297, P35, DOI 10.1007/BF01414243; Haffner H, 2000, PHYS REV LETT, V85, P5308, DOI 10.1103/PhysRevLett.85.5308; Hanneke D, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.120801; Hori M, 2011, NATURE, V475, P484, DOI 10.1038/nature10260; KRAMIDA A., ATOMIC ENERGY LEVELS; Mohr PJ, 2012, REV MOD PHYS, V84, P1527, DOI 10.1103/RevModPhys.84.1527; Mount BJ, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.042513; Pachucki K, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.022108; Shabaev VM, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.253002; Shabaev VM, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.062104; Sturm S, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.030501; Sturm S, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.023002; Sturm S, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.143003; Verdu J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.093002; Yerokhin VA, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.052503	27	209	213	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2014	506	7489					467	470		10.1038/nature13026	http://dx.doi.org/10.1038/nature13026			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0DN	24553144	Green Submitted			2022-12-28	WOS:000332165100033
J	Cole, TB				Cole, Thomas B.			Untitled	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 19	2014	311	7					654	655		10.1001/jama.2013.279334	http://dx.doi.org/10.1001/jama.2013.279334			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA8ZO	24549530				2022-12-28	WOS:000331383700001
J	O'Dowd, A				O'Dowd, Adrian			BMJ AWARDS 2014 Clinical leadership team award	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												adrianodowd@hotmail.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2014	348								g2051	10.1136/bmj.g2051	http://dx.doi.org/10.1136/bmj.g2051			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD1ZL	24620363				2022-12-28	WOS:000333032100011
J	Sproat, R; Burgess, C; Lancaster, T; Martinez-Devesa, P				Sproat, Rhona; Burgess, Christopher; Lancaster, Tim; Martinez-Devesa, Pablo			10-MINUTE CONSULTATION Eustachian tube dysfunction in adults	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sproat, Rhona; Burgess, Christopher; Martinez-Devesa, Pablo] John Radcliffe Hosp, Dept Ear Nose & Throat, Oxford OX3 9DU, England; [Lancaster, Tim] Jericho Hlth Ctr Primary Care, Oxford, England	University of Oxford	Sproat, R (corresponding author), John Radcliffe Hosp, Dept Ear Nose & Throat, Oxford OX3 9DU, England.	rhonasproat@gmail.com		McCallum, Rhona/0000-0001-8938-655X				Gluth MB, 2011, ARCH OTOLARYNGOL, V137, P449, DOI 10.1001/archoto.2011.56; National Institute for Health and Clinical Excellence, 2011, BALL DIL EUST TUB IN; Park MS, 2012, YONSEI MED J, V53, P985, DOI [10.3349/ymj.2012.53.5.985, /10.3349/ymj.2012.53.5.985]; PERERA R, 2013, COCHRANE DB SYST REV, V31; Reh DD, 2012, INT FORUM ALLERGY RH, V2, P362, DOI 10.1002/alr.21054; Yu MC, 2002, SEMIN CANCER BIOL, V12, P421, DOI 10.1016/S1044579X02000858	6	5	6	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2014	348								g1647	10.1136/bmj.g1647	http://dx.doi.org/10.1136/bmj.g1647			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD1ZL	24618189				2022-12-28	WOS:000333032100003
J	Brody, H				Brody, Herb			VACCINES	NATURE			English	Editorial Material																			0	0	0	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					S1	S1		10.1038/507S1a	http://dx.doi.org/10.1038/507S1a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC0ZQ	24611166	Bronze			2022-12-28	WOS:000332224400001
J	Eisler, MC; Lee, MRF; Tarlton, JF; Martin, GB; Beddington, J; Dungait, JAJ; Greathead, H; Liu, JX; Mathew, S; Miller, H; Misselbrook, T; Murray, P; Vinod, VK; Van Saun, R; Winter, M				Eisler, Mark C.; Lee, Michael R. F.; Tarlton, John F.; Martin, Graeme B.; Beddington, John; Dungait, Jennifer A. J.; Greathead, Henry; Liu, Jianxin; Mathew, Stephen; Miller, Helen; Misselbrook, Tom; Murray, Phil; Vinod, Valil K.; Van Saun, Robert; Winter, Michael			Steps to sustainable livestock	NATURE			English	Editorial Material									[Eisler, Mark C.; Lee, Michael R. F.; Tarlton, John F.] Univ Bristol, Sch Vet Sci, Bristol BS8 1TH, Avon, England; [Martin, Graeme B.] Univ Western Australia, UWA Inst Agr, Perth, WA 6009, Australia	University of Bristol; University of Western Australia	Eisler, MC (corresponding author), Univ Bristol, Sch Vet Sci, Bristol BS8 1TH, Avon, England.	mark.eisler@bristol.ac.uk	Eisler, Mark/AAK-1119-2020; Misselbrook, Tom/N-2385-2014; Dungait, Jenni/F-1110-2013; Dungait, Jennifer/AAV-7301-2021; Martin, Graeme B/A-2618-2008; Murray, Phil/B-1246-2009	Eisler, Mark/0000-0001-6843-3345; Misselbrook, Tom/0000-0002-4594-3606; Dungait, Jenni/0000-0001-9074-4174; Martin, Graeme B/0000-0002-1905-7934; Lee, Michael/0000-0001-7451-5611; Tarlton, John/0000-0002-4886-6634; Murray, Phil/0000-0002-5526-8317	Biotechnology and Biological Sciences Research Council [BB/K001906/1] Funding Source: researchfish; The British Council [GII108] Funding Source: researchfish; BBSRC [BBS/E/C/00005190, BBS/E/C/00005198, BB/K001906/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); The British Council; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Bickell S. L., 2010, Updates on ruminant production and medicine. XXVI World Buiatrics Congress, Santiago, Chile, 14-18 November 2010, P317; Bocquier F, 2010, ANIMAL, V4, P1258, DOI 10.1017/S1751731110001023; FAO, 2002, WORLD AGR 2015 2030; Garnett T, 2009, ENVIRON SCI POLICY, V12, P491, DOI 10.1016/j.envsci.2009.01.006; Grace D., 2012, MAPPING POVERTY LIKE; Herrero M, 2010, SCIENCE, V327, P822, DOI 10.1126/science.1183725; Kenyon F, 2009, VET PARASITOL, V164, P3, DOI 10.1016/j.vetpar.2009.04.015; Lee MRF, 2009, ANIM FEED SCI TECH, V149, P250, DOI 10.1016/j.anifeedsci.2008.06.013; Otte J., 2012, LIVESTOCK SECTOR DEV; Smith J., 2013, Animal Frontiers, V3, P6, DOI 10.2527/af.2013-0002	10	200	207	8	168	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					32	34		10.1038/507032a	http://dx.doi.org/10.1038/507032a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0ZQ	24605375	Green Published, Bronze			2022-12-28	WOS:000332224400026
J	Karagoz, GE; Duarte, AMS; Akoury, E; Ippel, H; Biernat, J; Luengo, TM; Radli, M; Didenko, T; Nordhues, BA; Veprintsev, DB; Dickey, CA; Mandelkow, E; Zweckstetter, M; Boelens, R; Madl, T; Rudiger, SGD				Karagoz, G. Elif; Duarte, Afonso M. S.; Akoury, Elias; Ippel, Hans; Biernat, Jacek; Luengo, Tania Moran; Radli, Martina; Didenko, Tatiana; Nordhues, Bryce A.; Veprintsev, Dmitry B.; Dickey, Chad A.; Mandelkow, Eckhard; Zweckstetter, Markus; Boelens, Rolf; Madl, Tobias; Rudiger, Stefan G. D.			Hsp90-Tau Complex Reveals Molecular Basis for Specificity in Chaperone Action	CELL			English	Article							PAIRED HELICAL FILAMENTS; ESCHERICHIA-COLI HSP90; N-TERMINAL DOMAIN; X-RAY-SCATTERING; NMR-SPECTROSCOPY; TAU-PROTEIN; CRYSTAL-STRUCTURE; STRUCTURAL-ANALYSIS; INTRINSIC DISORDER; QUALITY-CONTROL	Protein folding in the cell relies on the orchestrated action of conserved families of molecular chaperones, the Hsp70 and Hsp90 systems. Hsp70 acts early and Hsp90 late in the folding path, yet the molecular basis of this timing is enigmatic, mainly because the substrate specificity of Hsp90 is poorly understood. Here, we obtained a structural model of Hsp90 in complex with its natural disease-associated substrate, the intrinsically disordered Tau protein. Hsp90 binds to a broad region in Tau that includes the aggregation-prone repeats. Complementarily, a 106-angstrom-long substrate-binding interface in Hsp90 enables many low-affinity contacts. This allows recognition of scattered hydrophobic residues in late folding intermediates that remain after early burial of the Hsp70 sites. Our model resolves the paradox of how Hsp90 specifically selects for late folding intermediates but also for some intrinsically disordered proteins-through the eyes of Hsp90 they look the same.	[Karagoz, G. Elif; Duarte, Afonso M. S.; Luengo, Tania Moran; Radli, Martina; Didenko, Tatiana; Rudiger, Stefan G. D.] Univ Utrecht, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Karagoz, G. Elif] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Karagoz, G. Elif] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Duarte, Afonso M. S.] Univ Nova Lisboa, Inst Tecnol Quim Biol Antonio Xavier, P-2780157 Oeiras, Portugal; [Akoury, Elias; Zweckstetter, Markus] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, D-37077 Gottingen, Germany; [Ippel, Hans; Boelens, Rolf; Madl, Tobias] Univ Utrecht, Bijvoet Ctr Biomol Res, Biomol NMR Spect, NL-3584 CH Utrecht, Netherlands; [Ippel, Hans] Maastricht Univ, Biochem Grp, CARIM Sch Cardiovasc Dis, NL-6229 ER Maastricht, Netherlands; [Biernat, Jacek; Mandelkow, Eckhard] DZNE, German Ctr Neurodegenerat Dis, D-53175 Bonn, Germany; [Nordhues, Bryce A.; Dickey, Chad A.] Univ S Florida, Hlth Byrd Alzheimers Inst, Dept Pharmaceut Sci, Tampa, FL 33613 USA; [Nordhues, Bryce A.; Dickey, Chad A.] Univ S Florida, Hlth Byrd Alzheimers Inst, Dept Mol Med, Tampa, FL 33613 USA; [Veprintsev, Dmitry B.] Paul Scherrer Inst, Lab Biomol Res, CH-5232 Villigen, Switzerland; [Veprintsev, Dmitry B.] Swiss Fed Inst Technol, Dept Biol, CH-8093 Zurich, Switzerland; [Mandelkow, Eckhard] CAESAR Res Ctr, D-53175 Bonn, Germany; [Zweckstetter, Markus] German Ctr Neurodegenerat Dis DZNE, D-37077 Gottingen, Germany; [Zweckstetter, Markus] Univ Med Ctr, Ctr Nanoscale Microscopy & Mol Physiol Brain CNMP, D-37073 Gottingen, Germany; [Madl, Tobias] Tech Univ Munich, Helmholtz Zentrum Munchen Neuherberg & Biomol NMR, Inst Struct Biol, D-85747 Garching, Germany; [Madl, Tobias] Graz Univ, Inst Chem, A-8010 Graz, Austria	Utrecht University; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Universidade Nova de Lisboa; Max Planck Society; Utrecht University; Maastricht University; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich; Center of Advanced European Studies & Research (CAESAR); Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Gottingen; Technical University of Munich; University of Graz	Madl, T (corresponding author), Univ Utrecht, Bijvoet Ctr Biomol Res, Biomol NMR Spect, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	t.madl@tum.de; s.g.d.rudiger@uu.nl	Madl, Tobias/B-1682-2012; Veprintsev, Dmitry B/H-2228-2012; Rüdiger, Stefan GD/G-4906-2012; Akoury, Elias/AAG-2881-2019; Boelens, Rolf/B-4702-2009; Ippel, Hans/D-6917-2016; Duarte, Afonso/G-3233-2010	Madl, Tobias/0000-0002-9725-5231; Veprintsev, Dmitry B/0000-0002-3583-5409; Rüdiger, Stefan GD/0000-0002-1807-2972; Akoury, Elias/0000-0001-5202-8935; Boelens, Rolf/0000-0002-6939-8913; Duarte, Afonso/0000-0003-2181-0187; Karagoz, Gulsun Elif/0000-0002-3392-2250; Zweckstetter, Markus/0000-0002-2536-6581	EU [25651, 317371, 608180]; Nederlands Organisation for Scientific Research NWO; Utrecht University; Fundacao para a Ciencia e a Tecnologia, Portugal [SFRH/BPD/78075/2011]; project ITRANS from the Marie Curie Actions [PCIG11-GA-2012-322346]; NWO-CW; European Union (EU) [261863]; German Research Foundation [ZW71/7-1]; National Insitutes of Health [NS073899]; Bavarian Ministry of Sciences, Research and the Arts (Bavarian Molecular Biosystems Research Network); Austrian Academy of Sciences (APART-fellowship); German Research Foundation (Emmy Noether program) [MA 5703/1-1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073899] Funding Source: NIH RePORTER	EU(European Commission); Nederlands Organisation for Scientific Research NWO; Utrecht University; Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); project ITRANS from the Marie Curie Actions; NWO-CW(Netherlands Organization for Scientific Research (NWO)); European Union (EU)(CGIAREuropean Commission); German Research Foundation(German Research Foundation (DFG)); National Insitutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bavarian Ministry of Sciences, Research and the Arts (Bavarian Molecular Biosystems Research Network); Austrian Academy of Sciences (APART-fellowship); German Research Foundation (Emmy Noether program)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to Ineke Braakman for continuous support. We thank Assaf Friedler, Sander van den Heuvel, and Paul van Bergen en Henegouwen for comments on the manuscript. S.G.D.R. was supported by Marie-Curie Actions of the 6th and 7th Framework programme of the EU (Excellence Grant "chaperoning cascades'' [No. 25651], Innovative Doctoral Programme "ManiFold" [No. 317371] and Initial Training Network "WntsApp" [No. 608180]), a VIDI career development grant by the Nederlands Organisation for Scientific Research NWO and a High Potential Grant of Utrecht University. A.M.S.D. was supported by Fundacao para a Ciencia e a Tecnologia, Portugal (SFRH/BPD/78075/2011) and by the project ITRANS from the Marie Curie Actions PCIG11-GA-2012-322346. R.B. was supported by NWO-CW for the 900 MHz NMR and the TCI cryoprobe. R.B., H.I., and T.M. were supported by the European Union (EU) project "BioNMR" (No. 261863). M.Z. was supported by the German Research Foundation (ZW71/7-1). C.A.D. was supported by the National Insitutes of Health (No. NS073899). T.M. was supported by the Bavarian Ministry of Sciences, Research and the Arts (Bavarian Molecular Biosystems Research Network), the Austrian Academy of Sciences (APART-fellowship), and the German Research Foundation (Emmy Noether program MA 5703/1-1). We are grateful to D. Svergun (EMBL Outstation at DESY, Hamburg) for providing access to SAXS measurements, and to the Leibniz Supercomputing Centre (LRZ; http://www.lrz.de) for providing computing time on the Linux Cluster.	Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Barghorn S, 2004, BIOCHEMISTRY-US, V43, P1694, DOI 10.1021/bi0357006; Blair LJ, 2013, J CLIN INVEST, V123, P4158, DOI 10.1172/JCI69003; Buckle AM, 1997, P NATL ACAD SCI USA, V94, P3571, DOI 10.1073/pnas.94.8.3571; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Daggett V, 2003, NAT REV MOL CELL BIO, V4, P497, DOI 10.1038/nrm1126; Daturpalli S., 2013, J MOL BIOL; DEKKER N, 1993, NATURE, V362, P852, DOI 10.1038/362852a0; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; Didenko T, 2012, BBA-MOL CELL RES, V1823, P636, DOI 10.1016/j.bbamcr.2011.11.009; Didenko T, 2011, PROTEIN ENG DES SEL, V24, P99, DOI 10.1093/protein/gzq091; Dollins DE, 2007, MOL CELL, V28, P41, DOI 10.1016/j.molcel.2007.08.024; Dou F, 2003, P NATL ACAD SCI USA, V100, P721, DOI 10.1073/pnas.242720499; Dunker AK, 2011, CURR OPIN STRUC BIOL, V21, P379, DOI 10.1016/j.sbi.2011.04.002; Echeverria PC, 2010, BBA-MOL CELL RES, V1803, P641, DOI 10.1016/j.bbamcr.2009.11.012; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Genest O, 2013, MOL CELL, V49, P464, DOI 10.1016/j.molcel.2012.11.017; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hagn F, 2011, NAT STRUCT MOL BIOL, V18, P1086, DOI 10.1038/nsmb.2114; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; JAKOB U, 1995, J BIOL CHEM, V270, P7288, DOI 10.1074/jbc.270.13.7288; Jinwal UK, 2013, FASEB J, V27, P1450, DOI 10.1096/fj.12-220889; Karagoz GE, 2011, P NATL ACAD SCI USA, V108, P580, DOI 10.1073/pnas.1011867108; Kemmer G, 2010, NAT PROTOC, V5, P267, DOI 10.1038/nprot.2009.182; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; Krukenberg KA, 2008, STRUCTURE, V16, P755, DOI 10.1016/j.str.2008.01.021; Krukenberg KA, 2009, PROTEIN SCI, V18, P1815, DOI 10.1002/pro.191; Luo WJ, 2007, P NATL ACAD SCI USA, V104, P9511, DOI 10.1073/pnas.0701055104; Mandelkow EM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006247; Mayer MP, 2010, MOL CELL, V39, P321, DOI 10.1016/j.molcel.2010.07.012; Meyer P, 2003, MOL CELL, V11, P647, DOI 10.1016/S1097-2765(03)00065-0; Miyata Y, 2011, FUTURE MED CHEM, V3, P1523, DOI [10.4155/FMC.11.88, 10.4155/fmc.11.88]; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; Mylonas E, 2008, BIOCHEMISTRY-US, V47, P10345, DOI 10.1021/bi800900d; Oddo S, 2004, NEURON, V43, P321, DOI 10.1016/j.neuron.2004.07.003; Park SJ, 2011, J MOL BIOL, V411, P158, DOI 10.1016/j.jmb.2011.05.030; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Prodromou C, 1997, NAT STRUCT BIOL, V4, P477, DOI 10.1038/nsb0697-477; Retzlaff M, 2010, MOL CELL, V37, P344, DOI 10.1016/j.molcel.2010.01.006; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Rudiger S, 1997, NAT STRUCT BIOL, V4, P342, DOI 10.1038/nsb0597-342; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Sarkar M, 2008, J NEUROSCI RES, V86, P2763, DOI 10.1002/jnr.21721; Sette M, 1997, EMBO J, V16, P1436, DOI 10.1093/emboj/16.6.1436; Shiau AK, 2006, CELL, V127, P329, DOI 10.1016/j.cell.2006.09.027; Shkumatov AV, 2011, PROTEINS, V79, P2122, DOI 10.1002/prot.23033; Street TO, 2011, MOL CELL, V42, P96, DOI 10.1016/j.molcel.2011.01.029; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Thompson AD, 2012, ACS CHEM BIOL, V7, P1677, DOI 10.1021/cb3002599; Tugarinov V, 2003, J AM CHEM SOC, V125, P10420, DOI 10.1021/ja030153x; Uversky VN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S7; Vaughan CK, 2006, MOL CELL, V23, P697, DOI 10.1016/j.molcel.2006.07.016; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wegele H, 2004, REV PHYSIOL BIOCH P, V151, P1, DOI 10.1007/s10254-003-0021-1; Weibezahn J, 2005, BIOL CHEM, V386, P739, DOI 10.1515/BC.2005.086; Wuthrich K, 2003, ANGEW CHEM INT EDIT, V42, P3340, DOI 10.1002/anie.200300595; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	64	190	191	0	66	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 27	2014	156	5					963	974		10.1016/j.cell.2014.01.037	http://dx.doi.org/10.1016/j.cell.2014.01.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AB9BK	24581495	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000332083900014
J	Ogden, CL; Carroll, MD; Kit, BK; Flegal, KM				Ogden, Cynthia L.; Carroll, Margaret D.; Kit, Brian K.; Flegal, Katherine M.			Prevalence of Childhood and Adult Obesity in the United States, 2011-2012	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; CHILDREN; TRENDS; ADOLESCENTS	IMPORTANCE More than one-third of adults and 17% of youth in the United States are obese, although the prevalence remained stable between 2003-2004 and 2009-2010. OBJECTIVE To provide the most recent national estimates of childhood obesity, analyze trends in childhood obesity between 2003 and 2012, and provide detailed obesity trend analyses among adults. DESIGN, SETTING, AND PARTICIPANTS Weight and height or recumbent length were measured in 9120 participants in the 2011-2012 nationally representative National Health and Nutrition Examination Survey. MAIN OUTCOMES AND MEASURES In infants and toddlers from birth to 2 years, high weight for recumbent length was defined as weight for length at or above the 95th percentile of the sex-specific Centers for Disease Control and Prevention (CDC) growth charts. In children and adolescents aged 2 to 19 years, obesity was defined as a body mass index (BMI) at or above the 95th percentile of the sex-specific CDC BMI-for-age growth charts. In adults, obesity was defined as a BMI greater than or equal to 30. Analyses of trends in high weight for recumbent length or obesity prevalence were conducted overall and separately by age across 5 periods (2003-2004, 2005-2006, 2007-2008, 2009-2010, and 2011-2012). RESULTS In 2011-2012, 8.1% (95% CI, 5.8%-11.1%) of infants and toddlers had high weight for recumbent length, and 16.9% (95% CI, 14.9%-19.2%) of 2- to 19-year-olds and 34.9% (95% CI, 32.0%-37.9%) of adults (age-adjusted) aged 20 years or older were obese. Overall, there was no significant change from 2003-2004 through 2011-2012 in high weight for recumbent length among infants and toddlers, obesity in 2- to 19-year-olds, or obesity in adults. Tests for an interaction between survey period and age found an interaction in children (P=.03) and women (P=.02). There was a significant decrease in obesity among 2- to 5-year-old children (from 13.9% to 8.4%; P=.03) and a significant increase in obesity among women aged 60 years and older (from 31.5% to 38.1%; P=.006). CONCLUSIONS AND RELEVANCE Overall, there have been no significant changes in obesity prevalence in youth or adults between 2003-2004 and 2011-2012. Obesity prevalence remains high and thus it is important to continue surveillance.	[Ogden, Cynthia L.; Carroll, Margaret D.; Kit, Brian K.; Flegal, Katherine M.] Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA; [Kit, Brian K.] US PHS, Rockville, MD USA	Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); United States Public Health Service	Ogden, CL (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, 3311 Toledo Rd,Room 4415, Hyattsville, MD 20782 USA.	cogden@cdc.gov	Flegal, Katherine M/A-4608-2013		Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Ahima RS, 2013, SCIENCE, V341, P856, DOI 10.1126/science.1241244; [Anonymous], NATIONAL HEALTH AND; [Anonymous], 2010, THE SURGEON GENERALS; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; BAUMGARTNER RN, 1995, OBES RES, V3, P73, DOI 10.1002/j.1550-8528.1995.tb00124.x; Bluher S, 2011, INT J PEDIATR OBES, V6, pE199, DOI 10.3109/17477166.2010.526305; CDC National Center for Health Statistics, 2011, NHANES RESPONSE RATE; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P1673; Chu NF, 2005, OBES REV, V6, P271, DOI 10.1111/j.1467-789X.2005.00175.x; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Eaton Danice K., 2012, Morbidity and Mortality Weekly Report, V61, P1; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Flegal KM, 2010, AM J CLIN NUTR, V91, P1020, DOI 10.3945/ajcn.2009.28589; Flegal KM, 2009, AM J CLIN NUTR, V89, P500, DOI 10.3945/ajcn.2008.26847; Food and Nutrition Service; USDA, 2007, SPECIAL SUPPLEMENTAL; Fryar CD, PREVALENCE OF OVERWE; Grummer-Strawn Laurence M., 2010, Morbidity and Mortality Weekly Report, V59, P1; Guo, 2002, VITAL HLTH STAT, V11, DOI DOI 10.1016/J.BBRC.2015.06.114; Iannotti RJ, 2013, PEDIATRICS, V132, P606, DOI 10.1542/peds.2013-1488; Institute of Medicine, 2012, ACCELERATING PROGRES; Khan Laura Kettel, 2009, Morbidity and Mortality Weekly Report, V58, P1; May AL, 2013, MMWR-MORBID MORTAL W, V62, P629; Ogden Cynthia L, 2013, NCHS Data Brief, P1; Ogden Cynthia L, 2012, NCHS Data Brief, P1; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Ogden Cynthia L, 2010, Natl Health Stat Report, P1; Olds T, 2011, INT J PEDIATR OBES, V6, P342, DOI 10.3109/17477166.2011.605895; Skinner CJ, 1989, ANALYSIS OF COMPLEX; Sperrin M, 2014, INT J OBESITY, V38, P818, DOI 10.1038/ijo.2013.161; Wen XZ, 2012, PEDIATRICS, V129, P823, DOI 10.1542/peds.2011-1833; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA; Wolter KM, 1985, INTRODUCTION TO VARI	32	5912	6000	14	622	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 26	2014	311	8					806	814		10.1001/jama.2014.732	http://dx.doi.org/10.1001/jama.2014.732			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB4XQ	24570244	Green Accepted, Bronze			2022-12-28	WOS:000331793700020
J	Conlin, S; Fenning, SJ; Weir, G; Raza, Z; Phelps, RG; Gifford, FJ				Conlin, Samantha; Fenning, Stephen J.; Weir, Graeme; Raza, Zahid; Phelps, Richard G.; Gifford, Fiona J.			Sudden, severe headache: an unexpected culprit	LANCET			English	Editorial Material							SUBCLAVIAN STEAL SYNDROME		[Conlin, Samantha; Fenning, Stephen J.; Phelps, Richard G.; Gifford, Fiona J.] Royal Infirm Edinburgh NHS Trust, Dept Renal Med, Edinburgh EH16 4SA, Midlothian, Scotland; [Weir, Graeme] Royal Infirm Edinburgh NHS Trust, Dept Radiol, Edinburgh EH16 4SA, Midlothian, Scotland; [Raza, Zahid] Royal Infirm Edinburgh NHS Trust, Dept Vasc Surg, Edinburgh EH16 4SA, Midlothian, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh	Gifford, FJ (corresponding author), Royal Infirm Edinburgh NHS Trust, Dept Renal Med, Edinburgh EH16 4SA, Midlothian, Scotland.	fionagiff@gmail.com		Downie, Samantha/0000-0002-3269-337X; Fenning, Stephen/0000-0001-9297-7393				Alcocer F, 2013, AM J CASE REP, V14, P58, DOI 10.12659/AJCR.883808; Chin HK, 2008, KAOHSIUNG J MED SCI, V24, P536, DOI 10.1016/S1607-551X(09)70013-0; HERRING M, 1977, AM SURGEON, V43, P220; MARSHALL WG, 1988, ANN THORAC SURG, V46, P93, DOI 10.1016/S0003-4975(10)65861-4; MOHR LL, 1986, J CARDIOVASC SURG, V27, P434	5	4	4	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 22	2014	383	9918					754	754		10.1016/S0140-6736(14)60083-0	http://dx.doi.org/10.1016/S0140-6736(14)60083-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB2WR	24560059				2022-12-28	WOS:000331653300037
J	Chinot, OL; Wick, W; Mason, W; Henriksson, R; Saran, F; Nishikawa, R; Carpentier, AF; Hoang-Xuan, K; Kavan, P; Cernea, D; Brandes, AA; Hilton, M; Abrey, L; Cloughesy, T				Chinot, Olivier L.; Wick, Wolfgang; Mason, Warren; Henriksson, Roger; Saran, Frank; Nishikawa, Ryo; Carpentier, Antoine F.; Hoang-Xuan, Khe; Kavan, Petr; Cernea, Dana; Brandes, Alba A.; Hilton, Magalie; Abrey, Lauren; Cloughesy, Timothy			Bevacizumab plus Radiotherapy-Temozolomide for Newly Diagnosed Glioblastoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; ENDOTHELIAL GROWTH-FACTOR; HIGH-GRADE GLIOMA; RESPONSE ASSESSMENT CRITERIA; PHASE-II TRIAL; RECURRENT GLIOBLASTOMA; CLINICAL-TRIALS; CONCOMITANT RADIOCHEMOTHERAPY; MALIGNANT GLIOMAS; MULTIFORME	BackgroundStandard therapy for newly diagnosed glioblastoma is radiotherapy plus temozolomide. In this phase 3 study, we evaluated the effect of the addition of bevacizumab to radiotherapy-temozolomide for the treatment of newly diagnosed glioblastoma. MethodsWe randomly assigned patients with supratentorial glioblastoma to receive intravenous bevacizumab (10 mg per kilogram of body weight every 2 weeks) or placebo, plus radiotherapy (2 Gy 5 days a week; maximum, 60 Gy) and oral temozolomide (75 mg per square meter of body-surface area per day) for 6 weeks. After a 28-day treatment break, maintenance bevacizumab (10 mg per kilogram intravenously every 2 weeks) or placebo, plus temozolomide (150 to 200 mg per square meter per day for 5 days), was continued for six 4-week cycles, followed by bevacizumab monotherapy (15 mg per kilogram intravenously every 3 weeks) or placebo until the disease progressed or unacceptable toxic effects developed. The coprimary end points were investigator-assessed progression-free survival and overall survival. ResultsA total of 458 patients were assigned to the bevacizumab group, and 463 patients to the placebo group. The median progression-free survival was longer in the bevacizumab group than in the placebo group (10.6 months vs. 6.2 months; stratified hazard ratio for progression or death, 0.64; 95% confidence interval [CI], 0.55 to 0.74; P<0.001). The benefit with respect to progression-free survival was observed across subgroups. Overall survival did not differ significantly between groups (stratified hazard ratio for death, 0.88; 95% CI, 0.76 to 1.02; P=0.10). The respective overall survival rates with bevacizumab and placebo were 72.4% and 66.3% at 1 year (P=0.049) and 33.9% and 30.1% at 2 years (P=0.24). Baseline health-related quality of life and performance status were maintained longer in the bevacizumab group, and the glucocorticoid requirement was lower. More patients in the bevacizumab group than in the placebo group had grade 3 or higher adverse events (66.8% vs. 51.3%) and grade 3 or higher adverse events often associated with bevacizumab (32.5% vs. 15.8%). ConclusionsThe addition of bevacizumab to radiotherapy-temozolomide did not improve survival in patients with glioblastoma. Improved progression-free survival and maintenance of baseline quality of life and performance status were observed with bevacizumab; however, the rate of adverse events was higher with bevacizumab than with placebo. (Funded by F. Hoffmann-La Roche; ClinicalTrials.gov number, NCT00943826.)	[Chinot, Olivier L.] Aix Marseille Univ, CHU Timone, AP HM, Serv Neurooncol, F-13005 Marseille, France; [Carpentier, Antoine F.] UFR Sante Med & Biol Humaine, Bobigny, France; [Carpentier, Antoine F.] Univ Paris 13, Hop Avicenne, AP HP, Serv Neurol, F-93430 Villetaneuse, France; [Hoang-Xuan, Khe] Univ Paris 06, Grp Hosp Pitie Salpetriere, AP HP, Paris, France; [Wick, Wolfgang] Univ Heidelberg Hosp, Dept Neurooncol, Heidelberg, Germany; [Wick, Wolfgang] German Canc Res Ctr, German Canc Consortium, Heidelberg, Germany; [Mason, Warren] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada; [Kavan, Petr] McGill Univ, Montreal, PQ, Canada; [Henriksson, Roger] Stockholm Gotland, Reg Canc Ctr, Stockholm, Sweden; [Henriksson, Roger] Umea Univ, Dept Radiat Sci & Oncol, Umea, Sweden; [Saran, Frank] Royal Marsden Natl Hlth Serv Fdn Trust, Sutton, Surrey, England; [Nishikawa, Ryo] Saitama Med Univ, Saitama, Japan; [Cernea, Dana] Oncol Inst Ion Chiricuta, Cluj Napoca, Romania; [Brandes, Alba A.] Azienda Unita Sanitaria Locale, Dept Med Oncol, Bologna, Italy; [Hilton, Magalie; Abrey, Lauren] F Hoffmann La Roche, Basel, Switzerland; [Cloughesy, Timothy] Univ Calif Los Angeles, Los Angeles, CA USA	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; McGill University; Umea University; Royal Marsden NHS Foundation Trust; Saitama Medical University; Oncology Institute Prof. Dr. Ion Chiricuta; Roche Holding; University of California System; University of California Los Angeles	Chinot, OL (corresponding author), Aix Marseille Univ, CHU Timone, AP HM, Serv Neurooncol, 264 Rue St Pierre, F-13005 Marseille, France.	olivier.chinot@ap-hm.fr	Cloughesy, Timothy Francis/AGV-1013-2022; Henriksson, Roger/AAI-8608-2020; Wick, Wolfgang/AAA-2545-2020; Hoang-Xuan, Khe/O-7527-2017; CHINOT, Olivier/M-9196-2018	Wick, Wolfgang/0000-0002-6171-634X; CHINOT, Olivier/0000-0001-6317-9691; Brandes, Alba/0000-0002-2503-9089; Carpentier, Antoine/0000-0003-2926-0060	F. Hoffmann-La Roche	F. Hoffmann-La Roche(Hoffmann-La Roche)	Supported by F. Hoffmann-La Roche.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; [Anonymous], TEMODAL SMPC PRODUCT; Armstrong TS, 2013, PRESENTED AT THE 201; BERKMAN RA, 1993, J CLIN INVEST, V91, P153, DOI 10.1172/JCI116165; Bosma I, 2007, NEURO-ONCOLOGY, V9, P53, DOI 10.1215/15228517-2006-012; Brada M, 2001, ANN ONCOL, V12, P259, DOI 10.1023/A:1008382516636; Brandes AA, 2008, NEURO-ONCOLOGY, V10, P361, DOI 10.1215/15228517-2008-008; Brandes AA, 2008, J CLIN ONCOL, V26, P2192, DOI 10.1200/JCO.2007.14.8163; Brandsma D, 2008, LANCET ONCOL, V9, P453, DOI 10.1016/S1470-2045(08)70125-6; Cancer Therapy Evaluation Program, 2006, COMMON TERMINOLOGY C; Chi AS, 2009, ONCOLOGIST, V14, P621, DOI 10.1634/theoncologist.2008-0272; Chinot OL, 2011, ADV THER, V28, P334, DOI 10.1007/s12325-011-0007-3; Chinot OL, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0347-2; Friedman HS, 2009, J CLIN ONCOL, V27, P4733, DOI 10.1200/JCO.2008.19.8721; Gilbert MR, 2014, NEW ENGL J MED, V370, P699, DOI 10.1056/NEJMoa1308573; Giovagnoli AR, 2005, J NEUROL NEUROSUR PS, V76, P562, DOI 10.1136/jnnp.2004.036186; Gutin PH, 2009, INT J RADIAT ONCOL, V75, P156, DOI 10.1016/j.ijrobp.2008.10.043; Henriksson R, 2013, PRESENTED AT THE 201; Henriksson R, 2011, J NEURO-ONCOL, V104, P639, DOI 10.1007/s11060-011-0565-x; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Klein M, 2001, J CLIN ONCOL, V19, P4037, DOI 10.1200/JCO.2001.19.20.4037; Kreisl TN, 2009, J CLIN ONCOL, V27, P740, DOI 10.1200/JCO.2008.16.3055; Lai A, 2011, J CLIN ONCOL, V29, P142, DOI 10.1200/JCO.2010.30.2729; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Macdonald DR, 2005, CANCER INVEST, V23, P138, DOI 10.1081/CNV-200050453; Meyers CA, 2003, NEURO-ONCOLOGY, V5, P89, DOI 10.1215/S1522851702000261; Mirimanoff RO, 2006, J CLIN ONCOL, V24, P2563, DOI 10.1200/JCO.2005.04.5963; Narayana A, 2012, J NEUROSURG, V116, P341, DOI 10.3171/2011.9.JNS11656; National Comprehensive Cancer Network, 2012, NCCN GUIDELINES CENT; Ohgaki Hiroko, 2009, V472, P323, DOI 10.1007/978-1-60327-492-0_14; Osoba D, 1996, QUAL LIFE RES, V5, P139, DOI 10.1007/BF00435979; Osoba D, 2000, J CLIN ONCOL, V18, P1481, DOI 10.1200/JCO.2000.18.7.1481; PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0; Stupp R, 2010, ANN ONCOL, V21, pv190, DOI 10.1093/annonc/mdq187; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2013, PRESENTED AT THE 201; Tabouret E, 2013, J NEURO-ONCOL, V114, P191, DOI 10.1007/s11060-013-1170-y; Taphoorn MJB, 2010, EUR J CANCER, V46, P1033, DOI 10.1016/j.ejca.2010.01.012; Vredenburgh JJ, 2007, J CLIN ONCOL, V25, P4722, DOI 10.1200/JCO.2007.12.2440; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541	40	1542	1585	3	162	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 20	2014	370	8					709	722		10.1056/NEJMoa1308345	http://dx.doi.org/10.1056/NEJMoa1308345			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB1DO	24552318	Green Published			2022-12-28	WOS:000331531900006
J	Lowenstern, JB; Evans, WC; Bergfeld, D; Hunt, AG				Lowenstern, J. B.; Evans, W. C.; Bergfeld, D.; Hunt, A. G.			Prodigious degassing of a billion years of accumulated radiogenic helium at Yellowstone	NATURE			English	Article							NOBLE-GASES; CONTINENTAL-CRUST; VOLCANIC SYSTEM; NATIONAL-PARK; CO2 EMISSIONS; TRANSPORT; FLUX; FLUIDS; BASIN; GROUNDWATER	Helium is used as a critical tracer throughout the Earth sciences, where its relatively simple isotopic systematics is used to trace degassing from the mantle, to date groundwater and to time the rise of continents(1). The hydrothermal system at Yellowstone National Park is famous for its high helium-3/helium-4 isotope ratio, commonly cited as evidence for a deep mantle source for the Yellowstone hotspot(2). However, much of the helium emitted from this region is actually radiogenic helium-4 produced within the crust by alpha-decay of uranium and thorium. Here we show, by combining gas emission rates with chemistry and isotopic analyses, that crustal helium-4 emission rates from Yellowstone exceed (by orders of magnitude) any conceivable rate of generation within the crust. It seems that helium has accumulated for (at least) many hundreds of millions of years in Archaean (more than 2.5 billion years old) cratonic rocks beneath Yellowstone, only to be liberated over the past two million years by intense crustal metamorphism induced by the Yellowstone hotspot. Our results demonstrate the extremes in variability of crustal helium efflux on geologic time-scales and imply crustal-scale open-system behaviour of helium in tectonically and magmatically active regions.	[Lowenstern, J. B.; Evans, W. C.; Bergfeld, D.] US Geol Survey, Menlo Pk, CA 94025 USA; [Hunt, A. G.] US Geol Survey, Denver, CO 80225 USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Lowenstern, JB (corresponding author), US Geol Survey, 345 Middlefield Rd, Menlo Pk, CA 94025 USA.	jlwnstrn@usgs.gov		Lowenstern, Jacob/0000-0003-0464-7779				Ballentine CJ, 2002, REV MINERAL GEOCHEM, V47, P539, DOI 10.2138/rmg.2002.47.13; Ballentine CJ, 2002, REV MINERAL GEOCHEM, V47, P481, DOI 10.2138/rmg.2002.47.12; Ballentine CJ, 2002, GEOCHIM COSMOCHIM AC, V66, P2483, DOI 10.1016/S0016-7037(02)00850-5; Bergfeld D, 2012, CHEM GEOL, V330, P233, DOI 10.1016/j.chemgeo.2012.09.001; Bergfeld D., 2011, 20115012 US GEOL SUR; Bindeman IN, 2008, J PETROL, V49, P163, DOI 10.1093/petrology/egm075; Chiodini G, 2012, GEOCHIM COSMOCHIM AC, V89, P265, DOI 10.1016/j.gca.2012.04.051; Chiodini G, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036347; Christiansen RL., 2001, QUATERNARY PLIOCENE; CRAIG H, 1978, GEOPHYS RES LETT, V5, P897, DOI 10.1029/GL005i011p00897; Dunai TJ, 2002, REV MINERAL GEOCHEM, V47, P371, DOI 10.2138/rmg.2002.47.10; Farley KA, 2002, REV MINERAL GEOCHEM, V47, P819, DOI 10.2138/rmg.2002.47.18; Graham DW, 2009, J VOLCANOL GEOTH RES, V188, P128, DOI 10.1016/j.jvolgeores.2008.12.004; HILDRETH W, 1991, J PETROL, V32, P63, DOI 10.1093/petrology/32.1.63; Holland G, 2013, NATURE, V497, P357, DOI 10.1038/nature12127; Ingebritsen SE, 2010, GEOFLUIDS, V10, P193, DOI 10.1111/j.1468-8123.2010.00278.x; KENNEDY BM, 1985, GEOCHIM COSMOCHIM AC, V49, P1251, DOI 10.1016/0016-7037(85)90014-6; Kennedy BM, 1997, SCIENCE, V278, P1278, DOI 10.1126/science.278.5341.1278; Lewicki JL, 2005, B VOLCANOL, V68, P76, DOI 10.1007/s00445-005-0423-9; Lippmann-Pipke J, 2011, CHEM GEOL, V283, P287, DOI 10.1016/j.chemgeo.2011.01.028; Lorenson T. D., 1993, FUTURE ENERGY GASES, P453; Lowenstern JB, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2011GC003835; Lowenstern JB, 2008, ELEMENTS, V4, P35, DOI 10.2113/GSELEMENTS.4.1.35; Mogk D.W., 2008, NW GEOLOGY, V37, P5; Mueller PA, 2006, CAN J EARTH SCI, V43, P1391, DOI 10.1139/E06-075; Peng XH, 1998, J GEOPHYS RES-SOL EA, V103, P7171, DOI 10.1029/97JB03615; RUDNICK RL, 1995, REV GEOPHYS, V33, P267, DOI 10.1029/95RG01302; SANO Y, 1986, NATURE, V323, P55, DOI 10.1038/323055a0; Sapienza G, 2005, CHEM GEOL, V219, P115, DOI 10.1016/j.chemgeo.2005.02.012; Smith RB, 2009, J VOLCANOL GEOTH RES, V188, P26, DOI 10.1016/j.jvolgeores.2009.08.020; TORGERSEN T, 1985, GEOCHIM COSMOCHIM AC, V49, P1211, DOI 10.1016/0016-7037(85)90011-0; Torgersen T, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002930; Vaughan RG, 2012, J VOLCANOL GEOTH RES, V233, P72, DOI 10.1016/j.jvolgeores.2012.04.022; Werner C, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000473; Werner C, 2008, J VOLCANOL GEOTH RES, V178, P751, DOI 10.1016/j.jvolgeores.2008.09.016; Werner C, 2000, J GEOPHYS RES-SOL EA, V105, P10831, DOI 10.1029/1999JB900331; Wieler R, 2002, REV MINERAL GEOCHEM, V47	37	55	55	4	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 20	2014	506	7488					355	+		10.1038/nature12992	http://dx.doi.org/10.1038/nature12992			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB0JL	24553240				2022-12-28	WOS:000331477800038
J	Wise, J				Wise, Jacqui			Patent wars: affordable medicines versus intellectual property rights	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INDIA; DRUG					jacquiyoung1@gmail.com						[Anonymous], 2013, BRAZILS PATENT REFOR; Arie S, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2949; Arie S, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2099; Arie S, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e6015; Bagcchi S, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1094; Bollyky T, 2013, WHY CHEMOTHERAPY COS; Global Intellectual Property Center, MEAS MOM; Light DW, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4348; Limb M, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5197; Medecins Sans Frontieres, 2013, TRANSP PARTN AGR; Office of the United States Trade Representative, 2013, 2013 SPEC 301 REP; UCL School of Pharmacy, PAT NEEDS MED INN GL; UCL School of Pharmacy, 2013, HLTH HLTH CAR IND NA	13	2	2	1	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2014	348								g1533	10.1136/bmj.g1533	http://dx.doi.org/10.1136/bmj.g1533			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB9ZG	24535664				2022-12-28	WOS:000332153700004
J	Peters, SAE; Huxley, RR; Woodward, M				Peters, Sanne A. E.; Huxley, Rachel R.; Woodward, Mark			Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775 385 individuals and 12 539 strokes	LANCET			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; SEX-DIFFERENCES; ISCHEMIC-STROKE; GENDER-DIFFERENCES; MELLITUS; HEALTH; POPULATION; DISPARITIES; MORTALITY	Background Diabetes mellitus is a major cause of death and disability worldwide and is a strong risk factor for stroke. Whether and to what extent the excess risk of stroke conferred by diabetes differs between the sexes is unknown. We did a systematic review and meta-analysis to estimate the relative effect of diabetes on stroke risk in women compared with men. Methods We systematically searched PubMed for reports of prospective, population-based cohort studies published between Jan 1, 1966, and Dec 16, 2013. Studies were selected if they reported sex-specific estimates of the relative risk (RR) for stroke associated with diabetes, and its associated variability. We pooled the sex-specific RRs and their ratio comparing women with men using random-effects meta-analysis with inverse-variance weighting. Findings Data from 64 cohort studies, representing 775 385 individuals and 12 539 fatal and non-fatal strokes, were included in the analysis. The pooled maximum-adjusted RR of stroke associated with diabetes was 2.28 (95% CI 1.93-2.69) in women and 1.83 (1.60-2.08) in men. Compared with men with diabetes, women with diabetes therefore had a greater risk of stroke-the pooled ratio of RRs was 1.27 (1.10-1.46; I-2=0%), with no evidence of publication bias. This sex differential was seen consistently across major predefined stroke, participant, and study subtypes. Interpretation The excess risk of stroke associated with diabetes is significantly higher in women than men, independent of sex differences in other major cardiovascular risk factors. These data add to the existing evidence that men and women experience diabetes-related diseases differently and suggest the need for further work to clarify the biological, behavioural, or social mechanisms involved.	[Peters, Sanne A. E.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Peters, Sanne A. E.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cardiovasc Epidemiol Unit, Cambridge, England; [Huxley, Rachel R.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Woodward, Mark] Univ Sydney, George Inst Global Hlth, Sydney, NSW 2006, Australia; [Woodward, Mark] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Woodward, Mark] Univ Oxford, George Inst Global Hlth, Nuffield Dept Populat Hlth, Oxford, England	Utrecht University; Utrecht University Medical Center; University of Cambridge; University of Queensland; George Institute for Global Health; University of Sydney; Johns Hopkins University; University of Oxford	Huxley, RR (corresponding author), Univ Queensland, Epidemiol & Biostat Div, Sch Populat Hlth, Herston, Qld 4006, Australia.	r.huxley@uq.edu.au	Huxley, Rachel R/C-7032-2013; Huxley, Rachel R/J-4638-2013; Woodward, Mark/D-8492-2015; Woodward, Mark/L-6817-2017	Huxley, Rachel R/0000-0002-2705-6616; Huxley, Rachel R/0000-0002-2705-6616; Peters, Sanne/0000-0003-0346-5412; Woodward, Mark/0000-0001-9800-5296	Niels Stensen fellowship; Australian National Health and Medical Research Council fellowship	Niels Stensen fellowship; Australian National Health and Medical Research Council fellowship(National Health and Medical Research Council (NHMRC) of Australia)	SAEP is supported by a Niels Stensen fellowship and MW by an Australian National Health and Medical Research Council fellowship. We thank Leon Simons and Shino Oba for contributing additional tabulated data from the Dubbo and the Takayama studies, respectively.	[Anonymous], 2011, LANCET, V378, P1826; [Anonymous], 1994, VITAL HEALTH STAT 1, V1, P1; BARRETTCONNOR E, 1988, AM J EPIDEMIOL, V128, P116, DOI 10.1093/oxfordjournals.aje.a114934; Cui RZ, 2011, STROKE, V42, P2611, DOI 10.1161/STROKEAHA.111.614313; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Doi Y, 2010, STROKE, V41, P203, DOI 10.1161/STROKEAHA.109.564708; Donahue RP, 2007, DIABETES CARE, V30, P354, DOI 10.2337/dc06-1772; Duggirala MK, 2005, J WOMENS HEALTH, V14, P418, DOI 10.1089/jwh.2005.14.418; EVANS RW, 1994, METABOLISM, V43, P1196, DOI 10.1016/0026-0495(94)90065-5; Ferrara A, 2008, DIABETES CARE, V31, P69, DOI 10.2337/dc07-1244; Franzini L, 2013, NUTR METAB CARDIOVAS, V23, P235, DOI 10.1016/j.numecd.2011.12.003; Garaulet M, 2000, EUR J ENDOCRINOL, V143, P657, DOI 10.1530/eje.0.1430657; Geer EB, 2009, GEND MED; Gobl CS, 2010, GENDER MED, V7, P593, DOI 10.1016/j.genm.2010.11.003; Gouni-Berthold I, 2008, DIABETES CARE, V31, P1389, DOI 10.2337/dc08-0194; Haffner SM, 1997, DIABETOLOGIA, V40, P711, DOI 10.1007/s001250050738; Hart CL, 2000, STROKE, V31, P1893, DOI 10.1161/01.STR.31.8.1893; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Howard BV, 1998, DIABETES CARE, V21, P1258, DOI 10.2337/diacare.21.8.1258; Hu G, 2005, DIABETOLOGIA, V48, P856, DOI 10.1007/s00125-005-1730-6; Huxley R, 2006, BMJ-BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C; Huxley RR, 2011, LANCET, V378, P1297, DOI 10.1016/S0140-6736(11)60781-2; Hyvarinen M, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-17; Iso H, 2004, DIABETOLOGIA, V47, P2137, DOI 10.1007/s00125-004-1587-0; Kramer HU, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-88; Leosdottir M, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-118; Mansfield MW, 1996, ARTERIOSCL THROM VAS, V16, P160, DOI 10.1161/01.ATV.16.1.160; Mendis S, 2011, GLOBAL ATLAS ON CARD; Myint PK, 2008, EUR J CARDIOV PREV R, V15, P663, DOI 10.1097/HJR.0b013e32830fe465; Najarian RM, 2006, ARCH INTERN MED, V166, P106, DOI 10.1001/archinte.166.1.106; Nilsson PM, 2004, SCAND J PRIM HEALTH, V22, P27, DOI 10.1080/02813430310003264; Oba S, 2008, J EPIDEMIOL, V18, P197, DOI 10.2188/jea.JE2008004; Ossei-Gerning N, 1998, THROMB HAEMOSTASIS, V79, P736, DOI 10.1055/s-0037-1615055; Penno G, 2013, J INTERN MED, V274, P176, DOI 10.1111/joim.12073; Rivellese AA, 2010, NUTR METAB CARDIOVAS, V20, P474, DOI 10.1016/j.numecd.2010.01.008; SIEVERS ML, 1992, DIABETES CARE, V15, P1541, DOI 10.2337/diacare.15.11.1541; Simons Leon A, 2009, Heart Lung Circ, V18, P330, DOI 10.1016/j.hlc.2009.05.001; Steinberg HO, 2000, CIRCULATION, V101, P2040, DOI 10.1161/01.CIR.101.17.2040; Tanizaki Y, 2000, STROKE, V31, P2616, DOI 10.1161/01.STR.31.11.2616; The ARIC Investigators, 1989, AM J EPIDEMIOL, V129, P687; Vaccaro O, 2008, ATHEROSCLEROSIS, V198, P396, DOI 10.1016/j.atherosclerosis.2007.10.026; WALDEN CE, 1984, NEW ENGL J MED, V311, P953, DOI 10.1056/NEJM198410113111505; Wannamethee SG, 2012, DIABETOLOGIA, V55, P80, DOI 10.1007/s00125-011-2284-4; Wexler DJ, 2005, DIABETES CARE, V28, P514, DOI 10.2337/diacare.28.3.514; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Winston GJ, 2009, DIABETES CARE, V32, P1467, DOI 10.2337/dc09-0260; Woodward M, 2006, INT J EPIDEMIOL, V35, P1412, DOI 10.1093/ije/dyl222; Woodward M, 2003, DIABETES CARE, V26, P360; Woodward M., 2013, EPIDEMIOLOGY STUDY D; Woodward M, 2007, HEART, V93, P172, DOI 10.1136/hrt.2006.108167	51	420	439	1	47	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 7	2014	383	9933					1973	1980		10.1016/S0140-6736(14)60040-4	http://dx.doi.org/10.1016/S0140-6736(14)60040-4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI4PV	24613026				2022-12-28	WOS:000336848200025
J	Hitti, FL; Siegelbaum, SA				Hitti, Frederick L.; Siegelbaum, Steven A.			The hippocampal CA2 region is essential for social memory	NATURE			English	Article							VASOPRESSIN 1B RECEPTOR; SYNAPTIC PLASTICITY; GENE-EXPRESSION; AREA CA2; NEURONS; CELLS; BRAIN; DORSAL; MICE; PROJECTION	The hippocampus is critical for encoding declarative memory, our repository of knowledge of who, what, where and when(1). Mnemonic information is processed in the hippocampus through several parallel routes involving distinct subregions. In the classic trisynaptic pathway, information proceeds from entorhinal cortex (EC) to dentate gyrus to CA3 and then to CA1, the main hippocampal output(2). Genetic lesions of EC(ref. 3) and hippocampal dentate gyrus (ref. 4), CA3 (ref. 5) and CA1 (ref. 6) regions have revealed their distinct functions in learning and memory. In contrast, little is known about the role of CA2, a relatively small area interposed between CA3 and CA1 that forms the nexus of a powerful disynaptic circuit linking EC input with CA1 output(7). Here we report a novel transgenic mouse line that enabled us to selectively examine the synaptic connections and behavioural role of the CA2 region in adult mice. Genetically targeted inactivation of CA2 pyramidal neurons caused a pronounced loss of social memory-the ability of an animal to remember a conspecific-with no change in sociability or several other hippocampus-dependent behaviours, including spatial and contextual memory. These behavioural and anatomical results thus reveal CA2 as a critical hub of sociocognitive memory processing.	[Hitti, Frederick L.; Siegelbaum, Steven A.] Columbia Univ, Coll Phys & Surg, Kavli Inst, Dept Neurosci, New York, NY 10032 USA; [Siegelbaum, Steven A.] Columbia Univ, Coll Phys & Surg, Howard Hughes Med Inst, Dept Pharmacol, New York, NY 10032 USA	Columbia University; Columbia University; Howard Hughes Medical Institute	Siegelbaum, SA (corresponding author), Columbia Univ, Coll Phys & Surg, Kavli Inst, Dept Neurosci, 1051 Riverside Dr, New York, NY 10032 USA.	sas8@columbia.edu	Core, Vector/CAF-4832-2022	Hitti, Frederick L/0000-0002-5308-9817	Ruth L. Kirschstein F30 National Research Service Award from the National Institute of Mental Health; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH098633] Funding Source: NIH RePORTER	Ruth L. Kirschstein F30 National Research Service Award from the National Institute of Mental Health; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank T. R. Reardon for providing the rabies virus; J. Kupferman and F. Lema for experimental assistance; and C. Denny, Z. Donaldson, R. Hen, J. Gordon, J. Basu and M. Russo for discussions and comments on the manuscript. This work was supported by a Ruth L. Kirschstein F30 National Research Service Award from the National Institute of Mental Health (F. L. H.) and the Howard Hughes Medical Institute (S.A.S.).	Benes FM, 1998, BIOL PSYCHIAT, V44, P88, DOI 10.1016/S0006-3223(98)00138-3; Bielsky IF, 2004, NEUROPSYCHOPHARMACOL, V29, P483, DOI 10.1038/sj.npp.1300360; BOULANGER LM, 1995, J NEUROSCI, V15, P1532; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Brennan PA, 2006, NATURE, V444, P308, DOI 10.1038/nature05404; Chevaleyre V, 2010, NEURON, V66, P560, DOI 10.1016/j.neuron.2010.04.013; Corkin S, 2002, NAT REV NEUROSCI, V3, P153, DOI 10.1038/nrn726; Cui ZZ, 2013, J COMP NEUROL, V521, P1844, DOI 10.1002/cne.23263; de No RL, 1934, J PSYCHOL NEUROL, V46, P113; DeVito LM, 2009, J NEUROSCI, V29, P2676, DOI 10.1523/JNEUROSCI.5488-08.2009; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Ferguson JN, 2000, NAT GENET, V25, P284, DOI 10.1038/77040; Franklin K., 2007, MOUSE BRAIN STEREOTA; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; Heintz N., 2003, GENSAT BRAIN ATLAS G; Hensler JG, 2006, NEUROSCI BIOBEHAV R, V30, P203, DOI 10.1016/j.neubiorev.2005.06.007; Jiao Y, 1999, J NEUROSCI METH, V93, P149, DOI 10.1016/S0165-0270(99)00142-9; Kogan JH, 2000, HIPPOCAMPUS, V10, P47, DOI 10.1002/(SICI)1098-1063(2000)10:1<47::AID-HIPO5>3.0.CO;2-6; Kohara K, 2014, NAT NEUROSCI, V17, P269, DOI 10.1038/nn.3614; Lee SE, 2010, P NATL ACAD SCI USA, V107, P16994, DOI 10.1073/pnas.1005362107; Lein E. S., 2007, ISH DATA ALLEN BRAIN; Lein ES, 2005, J COMP NEUROL, V485, P1, DOI 10.1002/cne.20426; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Meyer-Lindenberg A, 2011, NAT REV NEUROSCI, V12, P524, DOI 10.1038/nrn3044; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; Pan WX, 2004, PROG NEUROBIOL, V74, P127, DOI 10.1016/j.pneurobio.2004.09.003; Rasband W.S., 1997, IMAGE J; Rowland DC, 2013, J NEUROSCI, V33, P14889, DOI 10.1523/JNEUROSCI.1046-13.2013; Squire LR, 2011, ANNU REV NEUROSCI, V34, P259, DOI 10.1146/annurev-neuro-061010-113720; Stevenson EL, 2012, HORM BEHAV, V61, P277, DOI 10.1016/j.yhbeh.2011.11.009; Suh J, 2011, SCIENCE, V334, P1415, DOI 10.1126/science.1210125; Takeda K, 2001, HUM MOL GENET, V10, P477, DOI 10.1093/hmg/10.5.477; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; van Strien NM, 2009, NAT REV NEUROSCI, V10, P272, DOI 10.1038/nrn2614; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wall NR, 2013, NEURON, V79, P347, DOI 10.1016/j.neuron.2013.05.014; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Watabe-Uchida M, 2012, NEURON, V74, P858, DOI 10.1016/j.neuron.2012.03.017; Wersinger SR, 2002, MOL PSYCHIATR, V7, P975, DOI 10.1038/sj.mp.4001195; Wickersham IR, 2010, NAT PROTOC, V5, P595, DOI 10.1038/nprot.2009.248; Yamamoto M, 2003, J NEUROSCI, V23, P6759; Yang Mu, 2009, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0824s48; Young WS, 2006, NEUROSCIENCE, V143, P1031, DOI 10.1016/j.neuroscience.2006.08.040	45	464	468	10	134	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					88	+		10.1038/nature13028	http://dx.doi.org/10.1038/nature13028			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD9UL	24572357	Green Accepted			2022-12-28	WOS:000333609900048
J	Amorisco, NC; Evans, NW; van de Ven, G				Amorisco, N. C.; Evans, N. W.; van de Ven, G.			The remnant of a merger between two dwarf galaxies in Andromeda II	NATURE			English	Article							STELLAR TIDAL STREAM; SPHEROIDAL GALAXY; NGC 4449; HALO; M31; SAGITTARIUS; KINEMATICS; FOSSILS; STARS	Driven by gravity, massive structures like galaxies and clusters of galaxies are believed to grow continuously through hierarchical merging and accretion of smaller systems. Observational evidence of accretion events is provided by the coherent stellar streams crossing the outer haloes of massive galaxies, such as the Milky Way(1) or Andromeda(2). At similar mass scales, around 1011 solar masses in stars, further evidence of merging activity is also ample(3-5). Mergers of lower-mass galaxies are expected within the hierarchical process of galaxy formation(6), but have hitherto not been seen for galaxies with less than about 10(9) solar masses in stars(7,8). Here we report the kinematic detection of a stellar stream in one of the satellite galaxies of Andromeda, the dwarf spheroidal Andromeda II, which has a mass of only 10(7) solar masses in stars(9). The properties of the stream show that we are observing the remnant of a merger between two dwarf galaxies. This had a drastic influence on the dynamics of the remnant, which is now rotating around its projected major axis(10). The stellar stream in Andromeda II illustrates the scale-free character of the formation of galaxies, down to the lowest galactic mass scales.	[Amorisco, N. C.] Univ Copenhagen, Niels Bohr Inst, Dark Cosmol Ctr, DK-2100 Copenhagen, Denmark; [Evans, N. W.] Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; [van de Ven, G.] Max Planck Inst Astron, D-69117 Heidelberg, Germany	University of Copenhagen; Niels Bohr Institute; University of Cambridge; Max Planck Society	Amorisco, NC (corresponding author), Univ Copenhagen, Niels Bohr Inst, Dark Cosmol Ctr, Juliane Maries Vej 30, DK-2100 Copenhagen, Denmark.	amorisco@dark-cosmology.dk	van de Ven, Glenn/R-5189-2019	van de Ven, Glenn/0000-0003-4546-7731; Amorisco, Nicola C./0000-0002-3205-5335	Danish National Research Foundation; German Research Foundation [Sonderforschungsbereich SFB 881]; Science and Technology Facilities Council [ST/H00243X/1] Funding Source: researchfish	Danish National Research Foundation(Danmarks Grundforskningsfond); German Research Foundation(German Research Foundation (DFG)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank M. Irwin for discussions on the photometric properties of And II. The Dark Cosmology Centre is funded by the Danish National Research Foundation. This work was partly supported by Sonderforschungsbereich SFB 881 'The Milky Way System' (subproject A7) of the German Research Foundation.	Amorisco NC, 2012, ASTROPHYS J LETT, V756, DOI 10.1088/2041-8205/756/1/L2; Amorisco NC, 2011, MON NOT R ASTRON SOC, V411, P2118, DOI 10.1111/j.1365-2966.2010.17715.x; Belokurov V, 2006, ASTROPHYS J, V642, pL137, DOI 10.1086/504797; Belokurov V, 2014, MON NOT R ASTRON SOC, V437, P116, DOI 10.1093/mnras/stt1862; Chonis TS, 2011, ASTRON J, V142, DOI 10.1088/0004-6256/142/5/166; Coleman M, 2004, ASTRON J, V127, P832, DOI 10.1086/381298; Collins MLM, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/2/172; De Rijcke S, 2004, ASTRON ASTROPHYS, V426, P53, DOI 10.1051/0004-6361:20041205; Fakhouri O, 2010, MON NOT R ASTRON SOC, V406, P2267, DOI 10.1111/j.1365-2966.2010.16859.x; Ho N, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/2/124; Ibata R, 2001, NATURE, V412, P49, DOI 10.1038/35083506; Irwin M, 1995, MON NOT R ASTRON SOC, V277, P1354, DOI 10.1093/mnras/277.4.1354; Kleyna JT, 2003, ASTROPHYS J, V588, pL21, DOI 10.1086/375522; Koposov SE, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/2/146; Martinez-Delgado D, 2012, ASTROPHYS J LETT, V748, DOI 10.1088/2041-8205/748/2/L24; Martinez-Delgado D, 2009, ASTROPHYS J, V692, P955, DOI 10.1088/0004-637X/692/2/955; Martinez-Delgado D, 2008, ASTROPHYS J, V689, P184, DOI 10.1086/592555; McConnachie AW, 2008, ASTROPHYS J, V688, P1009, DOI 10.1086/591313; McConnachie AW, 2007, MON NOT R ASTRON SOC, V379, P379, DOI 10.1111/j.1365-2966.2007.11969.x; McConnachie AW, 2006, MON NOT R ASTRON SOC, V365, P1263, DOI 10.1111/j.1365-2966.2005.09806.x; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Palma C, 2003, ASTRON J, V125, P1352, DOI 10.1086/367594; Rich RM, 2012, NATURE, V482, P192, DOI 10.1038/nature10837; Sanchez-Salcedo FJ, 2010, MON NOT R ASTRON SOC, V407, P1135, DOI 10.1111/j.1365-2966.2010.16963.x; Shaya EJ, 2013, MON NOT R ASTRON SOC, V436, P2096, DOI 10.1093/mnras/stt1714; Tremaine S, 1981, STRUCTURE EVOLUTION, P67; Walker M., 2013, PLANETS STARS STELLA, V5, P1039; Walker MG, 2011, ASTROPHYS J, V742, DOI 10.1088/0004-637X/742/1/20; Watkins LL, 2013, MON NOT R ASTRON SOC, V430, P971, DOI 10.1093/mnras/sts634	29	79	79	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2014	507	7492					335	+		10.1038/nature12995	http://dx.doi.org/10.1038/nature12995			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD1YG	24572352	Green Submitted			2022-12-28	WOS:000333029000028
J	Godfray, HCJ				Godfray, H. Charles J.			Society, Where None Intrudes	SCIENCE			English	Editorial Material							APPARENT COMPETITION; DIVERSITY		Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	Godfray, HCJ (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	charles.godfray@zoo.ox.ac.uk						Coley PD, 2014, SCIENCE, V343, P35, DOI 10.1126/science.1248110; Condon MA, 2014, SCIENCE, V343, P1240, DOI 10.1126/science.1245007; Hamilton AJ, 2010, AM NAT, V176, P90, DOI 10.1086/652998; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; Hrcek J, 2013, OECOLOGIA, V173, P521, DOI 10.1007/s00442-013-2619-6; JEFFRIES MJ, 1984, BIOL J LINN SOC, V23, P269, DOI 10.1111/j.1095-8312.1984.tb00145.x; Kaartinen R, 2010, ECOL ENTOMOL, V35, P623, DOI 10.1111/j.1365-2311.2010.01224.x; MEMMOTT J, 1994, J ANIM ECOL, V63, P521, DOI 10.2307/5219; Morris RJ, 2004, NATURE, V428, P310, DOI 10.1038/nature02394; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105	10	1	1	1	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2014	343	6176					1213	1214		10.1126/science.1251275	http://dx.doi.org/10.1126/science.1251275			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC7RG	24626922				2022-12-28	WOS:000332728500027
J	Hashiguchi, BG; Konnick, MM; Bischof, SM; Gustafson, SJ; Devarajan, D; Gunsalus, N; Ess, DH; Periana, RA				Hashiguchi, Brian G.; Konnick, Michael M.; Bischof, Steven M.; Gustafson, Samantha J.; Devarajan, Deepa; Gunsalus, Niles; Ess, Daniel H.; Periana, Roy A.			Main-Group Compounds Selectively Oxidize Mixtures of Methane, Ethane, and Propane to Alcohol Esters	SCIENCE			English	Article							CATALYTIC CONVERSION; CHLORIDE COMPLEXES; ALKANE METATHESIS; CH-ACTIVATION; FUNCTIONALIZATION; DEHYDROGENATION; OXIDATION; HYDROCARBONS; REACTIVITY; COPPER	Much of the recent research on homogeneous alkane oxidation has focused on the use of transition metal catalysts. Here, we report that the electrophilic main-group cations thallium(III) and lead(IV) stoichiometrically oxidize methane, ethane, and propane, separately or as a one-pot mixture, to corresponding alcohol esters in trifluoroacetic acid solvent. Esters of methanol, ethanol, ethylene glycol, isopropanol, and propylene glycol are obtained with greater than 95% selectivity in concentrations up to 1.48 molar within 3 hours at 180 degrees C. Experiment and theory support a mechanism involving electrophilic carbon-hydrogen bond activation to generate metal alkyl intermediates. We posit that the comparatively high reactivity of these d(10) main-group cations relative to transition metals stems from facile alkane coordination at vacant sites, enabled by the overall lability of the ligand sphere and the absence of ligand field stabilization energies in systems with filled d-orbitals.	[Hashiguchi, Brian G.; Konnick, Michael M.; Bischof, Steven M.; Gunsalus, Niles; Periana, Roy A.] Scripps Res Inst, Dept Chem, Scripps Energy & Mat Ctr, Jupiter, FL 33458 USA; [Gustafson, Samantha J.; Devarajan, Deepa; Ess, Daniel H.] Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA	Scripps Research Institute; Brigham Young University	Hashiguchi, BG (corresponding author), Scripps Res Inst, Dept Chem, Scripps Energy & Mat Ctr, Jupiter, FL 33458 USA.	bhashigu@scripps.edu; dhe@chem.byu.edu; rperiana@scripps.edu		Bischof, Steven/0000-0003-2063-2630	Center for Catalytic Hydrocarbon Functionalization, an Energy Frontier Research Center; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC0001298]	Center for Catalytic Hydrocarbon Functionalization, an Energy Frontier Research Center; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	This work was supported as part of the Center for Catalytic Hydrocarbon Functionalization, an Energy Frontier Research Center Funded by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under award DE-SC0001298 (to R.A.P. and D.H.E). D.H.E. thanks the BYU Fulton Supercomputing Lab. We also thank S. Burt (BYU) for assistance with Tl NMR. Several provisional and one nonprovisional patents have been filed (applications PCT/US2014/018175, 61/768,715, 61/862,715, 61/862,723, and 61/862,731).	Ahlquist M, 2009, CHEM COMMUN, P2373, DOI 10.1039/b821854d; Ahrens S, 2006, ORGANOMETALLICS, V25, P5409, DOI 10.1021/om060577a; An ZJ, 2006, J AM CHEM SOC, V128, P16028, DOI 10.1021/ja0647912; Bard A. J., 1985, STANDARD POTENTIALS; Basolo F., 1967, MECH INORGANIC REACT, V2; BURK MJ, 1984, ORGANOMETALLICS, V3, P816, DOI 10.1021/om00083a034; BURK MJ, 1987, J AM CHEM SOC, V109, P8025, DOI 10.1021/ja00260a013; Chen HY, 2000, SCIENCE, V287, P1995, DOI 10.1126/science.287.5460.1995; Choi J, 2011, CHEM REV, V111, P1761, DOI 10.1021/cr1003503; Fujii T., 1968, U.S. patent, Patent No. 3399956; George D. L., 2011, PIPELINE GAS J, V238, P38; Goldman AS, 2006, SCIENCE, V312, P257, DOI 10.1126/science.1123787; GOLDSHLE.NF, 1972, RUSS J PHYS CH USSR, V46, P785; Haibach MC, 2012, ACCOUNTS CHEM RES, V45, P947, DOI 10.1021/ar3000713; Hammond C, 2012, ANGEW CHEM INT EDIT, V51, P5129, DOI 10.1002/anie.201108706; Hartwig JF, 2005, J AM CHEM SOC, V127, P2538, DOI 10.1021/ja045090c; Hartwig JF, 2012, ACCOUNTS CHEM RES, V45, P864, DOI 10.1021/ar200206a; Hashiguchi BG, 2012, ACCOUNTS CHEM RES, V45, P885, DOI 10.1021/ar200250r; HUTCHINGS GJ, 1989, CHEM SOC REV, V18, P251, DOI 10.1039/cs9891800251; Johnson R. A., 1980, U.S. patent, Patent No. 4192814; Johnson R. A., 1978, U.S. patent, Patent No. 4113756; Jones CJ, 2004, ANGEW CHEM INT EDIT, V43, P4626, DOI 10.1002/anie.200461055; KUROSAWA H, 1967, J ORGANOMET CHEM, V10, P211, DOI 10.1016/S0022-328X(00)93080-8; Muehlhofer M, 2002, ANGEW CHEM INT EDIT, V41, P1745, DOI 10.1002/1521-3773(20020517)41:10<1745::AID-ANIE1745>3.0.CO;2-E; Periana RA, 2003, SCIENCE, V301, P814, DOI 10.1126/science.1086466; Periana RA, 2002, CHEM COMMUN, P2376, DOI 10.1039/b205366g; Periana RA, 1998, SCIENCE, V280, P560, DOI 10.1126/science.280.5363.560; PERIANA RA, 1993, SCIENCE, V259, P340, DOI 10.1126/science.259.5093.340; Peterson R. G., 1973, HARD SOFT ACIDS BASE; Sen A, 1998, ACCOUNTS CHEM RES, V31, P550, DOI 10.1021/ar970290x; SHILOV AE, 1977, COORDIN CHEM REV, V24, P97, DOI 10.1016/S0010-8545(00)80336-7; STOLAROV IP, 1991, J CHEM SOC CHEM COMM, P938, DOI 10.1039/c39910000938; Strassner T, 2004, J ORGANOMET CHEM, V689, P1418, DOI 10.1016/j.jorganchem.2004.02.013; U. S. E. I. Administration, 2013, US CRUDE OIL NATURAL, V2011, P1; Vanelderen P, 2013, COORDIN CHEM REV, V257, P483, DOI 10.1016/j.ccr.2012.07.008; VARGAFTIK MN, 1990, J CHEM SOC CHEM COMM, P1049, DOI 10.1039/c39900001049	36	114	118	6	338	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2014	343	6176					1232	1237		10.1126/science.1249357	http://dx.doi.org/10.1126/science.1249357			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC7RG	24626925				2022-12-28	WOS:000332728500032
J	Jones, R				Jones, Robert			BECOMING A PHYSICIAN Caring for William	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A medical student working in a homeless shelter for mentally ill men finds himself thinking of William, a shelter resident, as one of his patients. But that's the last thing William wants to be, and the current health care system seems a long way from meeting his needs. Shaving William is something like performing surgery, and when the weather permits, the back porch becomes our operating room. Before each procedure, I drape him in standard fashion, with a nylon hairdresser's cape he scavenged from our neighbor's garage sale. Like any operation, the procedure itself is sequential and ritualistic. Pulling taut his wrinkles, we start with his neck and move upward, trimming even his ear hair and eyebrows. As I unplug the clippers, William lifts his hands to his face, manually inspecting my work. Most sensible 67-year-olds would be grateful just to have a free barber, but William remains ...	Univ Missouri, Sch Med, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Jones, R (corresponding author), Univ Missouri, Sch Med, Columbia, MO 65211 USA.			Jones, Robert/0000-0003-4833-6905					0	1	1	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 13	2014	370	11					993	995		10.1056/NEJMp1314190	http://dx.doi.org/10.1056/NEJMp1314190			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AC7ED	24620865				2022-12-28	WOS:000332689100006
J	Garman, EF				Garman, Elspeth F.			Developments in X-ray Crystallographic Structure Determination of Biological Macromolecules	SCIENCE			English	Review							PROTEIN CRYSTALS; ANOMALOUS DIFFRACTION; ROOM-TEMPERATURE; RADIATION-DAMAGE; SOFTWARE; REFINEMENT; COMPLEX; LASER	The three-dimensional structures of large biomolecules important in the function and mechanistic pathways of all living systems and viruses can be determined by x-ray diffraction from crystals of these molecules and their complexes. This area of crystallography is continually expanding and evolving, and the introduction of new methods that use the latest technology is allowing the elucidation of ever larger and more complex biological systems, which are now becoming tractable to structure solution. This review looks back at what has been achieved and forward at how current and future developments may allow technical challenges to be overcome.	Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Oxford	Garman, EF (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	elspeth.garman@bioch.ox.ac.uk		Garman, Elspeth/0000-0001-8329-5665				Adams PD, 2013, ANNU REV BIOPHYS, V42, P265, DOI 10.1146/annurev-biophys-083012-130253; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Arndt U., 1966, CAMBRIDGE MONOGRAPHS, P88; Axford D, 2012, ACTA CRYSTALLOGR D, V68, P592, DOI 10.1107/S0907444912006749; Barends TRM, 2014, NATURE, V505, P244, DOI 10.1038/nature12773; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bernal JD, 1934, NATURE, V133, P794, DOI 10.1038/133794b0; BLAKE CCF, 1965, NATURE, V206, P757, DOI 10.1038/206757a0; Bragg WL, 1913, P R SOC LOND A-CONTA, V89, P248, DOI 10.1098/rspa.1913.0083; Broennimann C, 2006, J SYNCHROTRON RADIAT, V13, P120, DOI 10.1107/S0909049505038665; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Chapman HN, 2011, NATURE, V470, P73, DOI 10.1038/nature09750; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Garman EF, 1997, J APPL CRYSTALLOGR, V30, P211, DOI 10.1107/S0021889897002677; Garman EF, 2010, ACTA CRYSTALLOGR D, V66, P339, DOI 10.1107/S0907444910008656; Gruner SM, 2012, INT TABLES CRYSTALLO, VF, P177; Haffke M, 2013, METHODS MOL BIOL, V1073, P131, DOI 10.1007/978-1-62703-625-2_11; Helliwell JR., 2012, INT TABLES CRYSTALLO, VF, P189; Hendrickson WA, 1997, METHOD ENZYMOL, V276, P494, DOI 10.1016/S0076-6879(97)76074-9; KENDREW JC, 1958, NATURE, V181, P662, DOI 10.1038/181662a0; Kern J, 2013, SCIENCE, V340, P491, DOI 10.1126/science.1234273; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Liu Q, 2012, SCIENCE, V336, P1033, DOI 10.1126/science.1218753; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGeehan J, 2009, J SYNCHROTRON RADIAT, V16, P163, DOI 10.1107/S0909049509001629; McNicholas S, 2011, ACTA CRYSTALLOGR D, V67, P386, DOI 10.1107/S0907444911007281; Miller RJD, 2014, SCIENCE, V343, P1108, DOI 10.1126/science.1248488; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Nave C, 2005, J SYNCHROTRON RADIAT, V12, P257, DOI 10.1107/S0909049505007132; Nishizawa T, 2013, SCIENCE, V341, P168, DOI 10.1126/science.1239002; Owen RL, 2006, P NATL ACAD SCI USA, V103, P4912, DOI 10.1073/pnas.0600973103; Owen RL, 2012, ACTA CRYSTALLOGR D, V68, P810, DOI 10.1107/S0907444912012553; Philipp HT, 2011, NUCL INSTRUM METH A, V649, P67, DOI 10.1016/j.nima.2010.11.189; Pozharski E, 2013, ACTA CRYSTALLOGR D, V69, P150, DOI 10.1107/S0907444912044423; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Redecke L, 2013, SCIENCE, V339, P227, DOI 10.1126/science.1229663; Rodriguez D, 2012, ACTA CRYSTALLOGR D, V68, P336, DOI 10.1107/S0907444911056071; Sanchez-Weatherby J, 2009, ACTA CRYSTALLOGR D, V65, P1237, DOI 10.1107/S0907444909037822; Seibert MM, 2011, NATURE, V470, P78, DOI 10.1038/nature09748; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Voorhees RM, 2009, NAT STRUCT MOL BIOL, V16, P528, DOI 10.1038/nsmb.1577; Warren AJ, 2013, ACTA CRYSTALLOGR D, V69, P1252, DOI 10.1107/S0907444913011359; Weierstall U, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3693040; Weik M, 2000, P NATL ACAD SCI USA, V97, P623, DOI 10.1073/pnas.97.2.623; White S., 2014, MEMBRANE PROTEINS KN; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zeldin OB, 2013, P NATL ACAD SCI USA, V110, P20551, DOI 10.1073/pnas.1315879110	49	90	93	1	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2014	343	6175					1102	1108		10.1126/science.1247829	http://dx.doi.org/10.1126/science.1247829			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2LB	24604194				2022-12-28	WOS:000332331500038
J	Tsay, YF				Tsay, Yi-Fang			PLANT SCIENCE How to switch affinity	NATURE			English	Editorial Material							NITRATE TRANSPORTER; CHL1		Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan	Academia Sinica - Taiwan	Tsay, YF (corresponding author), Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan.	yftsay@gate.sinica.edu.tw	Tsay, Yi-Fang/ABB-3662-2021	Tsay, Yi-Fang/0000-0003-4271-0687				Ho CH, 2009, CELL, V138, P1184, DOI 10.1016/j.cell.2009.07.004; Leran S, 2014, TRENDS PLANT SCI, V19, P5, DOI 10.1016/j.tplants.2013.08.008; Leturque A, 2009, AM J PHYSIOL-ENDOC M, V296, pE985, DOI 10.1152/ajpendo.00004.2009; Liu KH, 2003, EMBO J, V22, P1005, DOI 10.1093/emboj/cdg118; Sun J, 2014, NATURE, V507, P73, DOI 10.1038/nature13074; TSAY YF, 1993, CELL, V72, P705, DOI 10.1016/0092-8674(93)90399-B; Yan N, 2013, TRENDS BIOCHEM SCI, V38, P151, DOI 10.1016/j.tibs.2013.01.003	7	17	19	0	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					44	45		10.1038/nature13063	http://dx.doi.org/10.1038/nature13063			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0ZQ	24572361				2022-12-28	WOS:000332224400036
J	Grodzinsky, Y; Nelken, I				Grodzinsky, Yosef; Nelken, Israel			The Neural Code That Makes Us Human	SCIENCE			English	Editorial Material							BROCAS REGION; PERCEPTION; CORTEX		[Grodzinsky, Yosef] McGill Univ, Dept Linguist, Montreal, PQ H3A1A7, Canada; [Nelken, Israel] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Neurobiol, IL-91904 Jerusalem, Israel; [Grodzinsky, Yosef; Nelken, Israel] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, IL-91904 Jerusalem, Israel	McGill University; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Grodzinsky, Y (corresponding author), McGill Univ, Dept Linguist, 1085 Dr Penfield Ave, Montreal, PQ H3A1A7, Canada.	yosef.grodzinsky@mcgill.ca	Nelken, Israel/B-7753-2011	Nelken, Israel/0000-0002-6645-107X; Grodzinsky, Yosef/0000-0002-9912-7196				Chomsky N., 1969, THE SOUND PATTERN OF; Chomsky N., 1986, KNOWLEDGE OF LANGUAG; FADIGA L, 2006, BROCAS REGION; Friederici AD, 2006, CEREB CORTEX, V16, P1709, DOI 10.1093/cercor/bhj106; GESCHWIN.N, 1970, SCIENCE, V170, P940, DOI 10.1126/science.170.3961.940; Grodzinsky Y, 2008, TRENDS COGN SCI, V12, P474, DOI 10.1016/j.tics.2008.09.001; Heim Stefan, 2012, Front Evol Neurosci, V4, P4, DOI 10.3389/fnevo.2012.00004; Jakobson Roman, 1972, CHILD LANGUAGE APHAS, P14; LIBERMAN AM, 1967, PSYCHOL REV, V74, P431, DOI 10.1037/h0020279; LIBERMAN AM, 1985, COGNITION, V21, P1, DOI 10.1016/0010-0277(85)90021-6; Makuuchi M, 2013, CEREB CORTEX, V23, P694, DOI 10.1093/cercor/bhs058; Mesgarani N, 2014, SCIENCE, V343, P1006, DOI 10.1126/science.1245994; Steinschneider M, 1999, J NEUROPHYSIOL, V82, P2346, DOI 10.1152/jn.1999.82.5.2346; Trubetzkoy N., 1969, PRINCIPLES OF PHONOL; YOUNG ED, 1979, J ACOUST SOC AM, V66, P1381, DOI 10.1121/1.383532	15	7	7	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2014	343	6174					978	979		10.1126/science.1251495	http://dx.doi.org/10.1126/science.1251495			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2DZ	24578570				2022-12-28	WOS:000332309600029
J	Almand-Hunter, AE; Li, H; Cundiff, ST; Mootz, M; Kira, M; Koch, SW				Almand-Hunter, A. E.; Li, H.; Cundiff, S. T.; Mootz, M.; Kira, M.; Koch, S. W.			Quantum droplets of electrons and holes	NATURE			English	Article							PSEUDOGAP; LIQUID; SPECTROSCOPY; EXCITATION; PHASE; ORDER	Interacting many-body systems are characterized by stable configurations of objects-ranging from elementary particles to cosmological formations(1-3)-that also act as building blocks for more complicated structures. It is often possible to incorporate interactions in theoretical treatments of crystalline solids by introducing suitable quasiparticles that have an effective mass, spin or charge(4,5) which in turn affects the material's conductivity, optical response or phase transitions(2,6,7). Additional quasiparticle interactions may also create strongly correlated configurations yielding new macroscopic phenomena, such as the emergence of a Mott insulator(8), superconductivity or the pseudogap phase of high-temperature superconductors(9-11). In semiconductors, a conduction-band electron attracts a valence-band hole (electronic vacancy) to create a bound pair, known as an exciton(12,13), which is yet another quasiparticle. Two excitons may also bind together to give molecules, often referred to as biexcitons(14), and even polyexcitons may exist(15,16). In indirect-gap semiconductors such as germanium or silicon, a thermodynamic phase transition may produce electron-hole droplets whose diameter can approach the micrometre range(17,18). In direct-gap semiconductors such as gallium arsenide, the exciton lifetime is too short for such a thermodynamic process. Instead, different quasiparticle configurations are stabilized dominantly by many-body interactions, not by thermalization. The resulting non-equilibrium quantum kinetics is so complicated that stable aggregates containing three or more Coulomb-correlated electron-hole pairs remain mostly unexplored. Here we study such complex aggregates and identify a new stable configuration of charged particles that we call a quantum droplet. This configuration exists in a plasma and exhibits quantization owing to its small size. It is charge neutral and contains a small number of particles with a pair-correlation function that is characteristic of a liquid. We present experimental and theoretical evidence for the existence of quantum droplets in an electron-hole plasma created in a gallium arsenide quantum well by ultrashort optical pulses.	[Almand-Hunter, A. E.; Li, H.; Cundiff, S. T.] Univ Colorado, JILA, Boulder, CO 80309 USA; [Almand-Hunter, A. E.; Li, H.; Cundiff, S. T.] NIST, Boulder, CO 80309 USA; [Almand-Hunter, A. E.; Cundiff, S. T.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Mootz, M.; Kira, M.; Koch, S. W.] Univ Marburg, Dept Phys, D-35032 Marburg, Germany	University of Colorado System; University of Colorado Boulder; National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder; Philipps University Marburg	Kira, M (corresponding author), Univ Marburg, Dept Phys, Renthof 5, D-35032 Marburg, Germany.	mackillo.kira@physik.uni-marburg.de	Kira, Mackillo/G-5812-2015; Li, Hebin/A-8711-2009; Cundiff, Steven T/B-4974-2009	Li, Hebin/0000-0002-2126-4086; Cundiff, Steven T/0000-0002-7119-5197; Kira, Gervais M/0000-0001-6989-7336	Deutsche Forschungsgemeinschaft [KI 917/2-1]; NSF [1125844]; NIST; Alexander von Humboldt Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NSF(National Science Foundation (NSF)); NIST(National Institute of Standards & Technology (NIST) - USA); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	We thank R. Mirin at NIST-Boulder for growing the quantum well samples. The work at Philipps-University Marburg was supported by the Deutsche Forschungsgemeinschaft under grant KI 917/2-1, and the work at JILA was supported by the NSF under grant 1125844 and by NIST. S. T. C. acknowledges support from the Alexander von Humboldt Foundation.	BARKER JA, 1976, REV MOD PHYS, V48, P587, DOI 10.1103/RevModPhys.48.587; Cundiff ST, 2012, J OPT SOC AM B, V29, pA69, DOI 10.1364/JOSAB.29.000A69; Daou R, 2010, NATURE, V463, P519, DOI 10.1038/nature08716; Datta S., 1997, CAMBRIDGE STUDIES SE; Endres M, 2011, SCIENCE, V334, P200, DOI [10.1126/science.1209284, 10.1126/science.1210268]; Frenkel J, 1931, PHYS REV, V37, P17, DOI 10.1103/PhysRev.37.17; Hirschifelder JO, 1938, J CHEM PHYS, V6, P795, DOI 10.1063/1.1750173; Huber R, 2001, NATURE, V414, P286, DOI 10.1038/35104522; JEFFRIES CD, 1975, SCIENCE, V189, P955, DOI 10.1126/science.189.4207.955; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaindl RA, 2003, NATURE, V423, P734, DOI 10.1038/nature01676; Kanigel A, 2006, NAT PHYS, V2, P447, DOI 10.1038/nphys334; Khitrova G, 1999, REV MOD PHYS, V71, P1591, DOI 10.1103/RevModPhys.71.1591; KIM JC, 1994, PHYS REV B, V50, P15099, DOI 10.1103/PhysRevB.50.15099; Kira M, 2011, NAT PHYS, V7, P799, DOI 10.1038/nphys2091; Kittel C., 2004, INTRO SOLID STATE PH; Lissauer JJ, 1999, REV MOD PHYS, V71, P835, DOI 10.1103/RevModPhys.71.835; Mootz M, 2013, NEW J PHYS, V15, DOI 10.1088/1367-2630/15/9/093040; Oganessian YT, 1999, NATURE, V400, P242, DOI 10.1038/22281; Papon P., 2006, PHYS PHASE TRANSITIO; Sastry S, 2003, NAT MATER, V2, P739, DOI 10.1038/nmat994; Smith RP, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.247401; STEELE AG, 1987, PHYS REV LETT, V59, P2899, DOI 10.1103/PhysRevLett.59.2899; Suzuki T, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.057401; Turner DB, 2010, NATURE, V466, P1089, DOI 10.1038/nature09286; Vershinin M, 2004, SCIENCE, V303, P1995, DOI 10.1126/science.1093384; Wannier GH, 1937, PHYS REV, V52, P0191, DOI 10.1103/PhysRev.52.191	29	78	80	2	151	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2014	506	7489					471	475		10.1038/nature12994	http://dx.doi.org/10.1038/nature12994			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0DN	24572422				2022-12-28	WOS:000332165100034
J	Borges, R				Borges, Ricardo			PERSONAL VIEW We need a global system to help identify new uses for existing drugs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DOUBLE-BLIND		Univ La Laguna, Sch Med, Pharmacol Unit, E-38071 Tenerife, Spain	Universidad de la Laguna	Borges, R (corresponding author), Univ La Laguna, Sch Med, Pharmacol Unit, E-38071 Tenerife, Spain.	rborges@ull.es	Borges, Ricardo/N-3250-2014	Borges, Ricardo/0000-0003-3413-4392				[Anonymous], 2014, WHO PROGR INT DRUG M; BAUM J, 1969, ANN INTERN MED, V71, P202, DOI 10.7326/0003-4819-71-1-202; DELAY JEAN, 1955, JOUR CLIN AND EXPTL PSYCHOPATH AND QUART REV PSYCHIATRY AND NEUROL, V16, P104; EVANS W, 1973, PSYCHOSOMATICS, V14, P214; Frank S, 2010, NEUROPSYCH DIS TREAT, V6, P657, DOI 10.2147/NDT.S6430; Hazell L, 2013, DRUG SAFETY, V36, P199, DOI 10.1007/s40264-013-0021-2; KUHN R, 1958, AM J PSYCHIAT, V115, P459, DOI 10.1176/ajp.115.5.459; Muench Peter J, 2012, Del Med J, V84, P157; Parle J, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d8337; Scannell JW, 2012, NAT REV DRUG DISCOV, V11, P191, DOI 10.1038/nrd3681; Storey JR, 2001, HEADACHE, V41, P968, DOI 10.1046/j.1526-4610.2001.01190.x; US Food and Drug Administration, 2013, VAL RES DRUG DEV RAR; Webb DJ, 2012, BRIT J CLIN PHARMACO, V73, P948, DOI 10.1111/j.1365-2125.2012.04244.x	13	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 27	2014	348								g1806	10.1136/bmj.g1806	http://dx.doi.org/10.1136/bmj.g1806			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC0UF	24578516				2022-12-28	WOS:000332210200005
J	Murthy, A; Li, Y; Peng, I; Reichelt, M; Katakam, AK; Noubade, R; Roose-Girma, M; DeVoss, J; Diehl, L; Graham, RR; Campagne, MV				Murthy, Aditya; Li, Yun; Peng, Ivan; Reichelt, Mike; Katakam, Anand Kumar; Noubade, Rajkumar; Roose-Girma, Merone; DeVoss, Jason; Diehl, Lauri; Graham, Robert R.; Campagne, Menno van Lookeren			A Crohn's disease variant in Atg16l1 enhances its degradation by caspase 3	NATURE			English	Article							ENTEROCOLITICA INDUCES APOPTOSIS; HOST-MICROBE INTERACTIONS; AUTOPHAGY GENE ATG16L1; GLUCOSE DEPRIVATION; MACROPHAGES; MECHANISMS; CELLS; INFLAMMATION; COMMON; YOPP	Crohn's disease is a debilitating inflammatory bowel disease (IBD) that can involve the entire digestive tract. A single-nucleotide polymorphism (SNP) encoding a missense variant in the autophagy gene ATG16L1 (rs2241880, Thr300Ala) is strongly associated with the incidence of Crohn's disease. Numerous studies have demonstrated the effect of ATG16L1 deletion or deficiency; however, the molecular consequences of the Thr300Ala (T300A) variant remains unknown. Here we show that amino acids 296-299 constitute a caspase cleavage motif in ATG16L1 and that the T300A variant (T316A in mice) significantly increases ATG16L1 sensitization to caspase-3-mediated processing. We observed that death-receptor activation or starvation-induced metabolic stress in human and murine macrophages increased degradation of the T300A or T316A variants of ATG16L1, respectively, resulting in diminished autophagy. Knock-in mice harbouring the T316A variant showed defective clearance of the ileal pathogen Yersinia enterocolitica and an elevated inflammatory cytokine response. In turn, deletion of the caspase-3-encoding gene, Casp3, or elimination of the caspase cleavage site by site-directed mutagenesis rescued starvation-induced autophagy and pathogen clearance, respectively. These findings demonstrate that caspase 3 activation in the presence of a common risk allele leads to accelerated degradation of ATG16L1, placing cellular stress, apoptotic stimuli and impaired autophagy in a unified pathway that predisposes to Crohn's disease.	[Murthy, Aditya; Li, Yun; Peng, Ivan; Noubade, Rajkumar; DeVoss, Jason; Campagne, Menno van Lookeren] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Reichelt, Mike; Katakam, Anand Kumar; Diehl, Lauri] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Roose-Girma, Merone] Genentech Inc, Dept Mol Biol, San Francisco, CA 94080 USA; [Graham, Robert R.] Genentech Inc, ITGR Human Genet, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech	Campagne, MV (corresponding author), Genentech Inc, Dept Immunol, 1 DNA Way, San Francisco, CA 94080 USA.	menno@gene.com						Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Adolph TE, 2013, NATURE, V503, P272, DOI 10.1038/nature12599; Altman BJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008763; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Baxt LA, 2013, SCIENCE, V340, P697, DOI 10.1126/science.1235771; Bialik S, 1999, CIRC RES, V85, P403, DOI 10.1161/01.RES.85.5.403; Brown EM, 2013, NAT IMMUNOL, V14, P660, DOI 10.1038/ni.2611; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Caro-Maldonado A, 2010, CELL DEATH DIFFER, V17, P1335, DOI 10.1038/cdd.2010.21; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Conway KL, 2013, GASTROENTEROLOGY, V145, P1347, DOI 10.1053/j.gastro.2013.08.035; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; de la Calle C, 2011, AUTOPHAGY, V7, P1045, DOI 10.4161/auto.7.9.16252; Denecker G, 2001, J BIOL CHEM, V276, P19706, DOI 10.1074/jbc.M101573200; Doria A, 2013, NEW ENGL J MED, V368, P1845, DOI [10.1056/NEJMc1303158, 10.1056/NEJMra1205406]; Dube PH, 2001, P NATL ACAD SCI USA, V98, P10880, DOI 10.1073/pnas.191214498; Erfurth SE, 2004, INFECT IMMUN, V72, P7045, DOI 10.1128/IAI.72.12.7045-7054.2004; Fujita N, 2009, J BIOL CHEM, V284, P32602, DOI 10.1074/jbc.M109.037671; Gardet A, 2012, CURR OPIN IMMUNOL, V24, P522, DOI 10.1016/j.coi.2012.08.001; Grassl GA, 2008, GASTROENTEROLOGY, V134, P768, DOI 10.1053/j.gastro.2007.12.043; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Jost PJ, 2009, NATURE, V460, P1035, DOI 10.1038/nature08229; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kuballa P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003391; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Manolio TA, 2013, NAT REV GENET, V14, P549, DOI 10.1038/nrg3523; Marchiando AM, 2013, CELL HOST MICROBE, V14, P216, DOI 10.1016/j.chom.2013.07.013; McAlpine F, 2013, AUTOPHAGY, V9, P361, DOI 10.4161/auto.23066; McStay GP, 2008, CELL DEATH DIFFER, V15, P322, DOI 10.1038/sj.cdd.4402260; Messer JS, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002790; Mills SD, 1997, P NATL ACAD SCI USA, V94, P12638, DOI 10.1073/pnas.94.23.12638; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Prescott NJ, 2007, GASTROENTEROLOGY, V132, P1665, DOI 10.1053/j.gastro.2007.03.034; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Shi CS, 2012, NAT IMMUNOL, V13, P255, DOI 10.1038/ni.2215; Sorbara MT, 2013, IMMUNITY, V39, P858, DOI 10.1016/j.immuni.2013.10.013; Stennicke HR, 2000, BIOCHEM J, V350, P563, DOI 10.1042/0264-6021:3500563; Wang GG, 2006, NAT METHODS, V3, P287, DOI 10.1038/NMETH865	46	263	273	2	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2014	506	7489					456	+		10.1038/nature13044	http://dx.doi.org/10.1038/nature13044			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0DN	24553140				2022-12-28	WOS:000332165100031
J	Newton, K; Hildebrand, JM; Shen, ZR; Rodriguez, D; Alvarez-Diaz, S; Petersen, S; Shah, S; Dugger, DL; Huang, CZ; Auwerx, J; Vandenabeele, P; Green, DR; Ashkenazi, A; Dixit, VM; Kaiser, WJ; Strasser, A; Degterev, A; Silke, J				Newton, Kim; Hildebrand, Joanne M.; Shen, Zhirong; Rodriguez, Diego; Alvarez-Diaz, Silvia; Petersen, Sean; Shah, Saumil; Dugger, Debra L.; Huang, Chunzi; Auwerx, Johan; Vandenabeele, Peter; Green, Douglas R.; Ashkenazi, Avi; Dixit, Vishva M.; Kaiser, William J.; Strasser, Andreas; Degterev, Alexei; Silke, John			Is SIRT2 required for necroptosis?	NATURE			English	Letter							PROGRAMMED NECROSIS; TNF-ALPHA; INFLAMMATION; METABOLISM; APOPTOSIS		[Newton, Kim; Petersen, Sean; Dugger, Debra L.; Ashkenazi, Avi; Dixit, Vishva M.] Genentech Inc, San Francisco, CA 94080 USA; [Hildebrand, Joanne M.; Alvarez-Diaz, Silvia; Strasser, Andreas; Silke, John] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Hildebrand, Joanne M.; Alvarez-Diaz, Silvia; Strasser, Andreas; Silke, John] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3050, Australia; [Shen, Zhirong] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Rodriguez, Diego; Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Shah, Saumil; Degterev, Alexei] Tufts Univ, Dept Biochem, Boston, MA 02111 USA; [Huang, Chunzi; Kaiser, William J.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Auwerx, Johan] Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, CH-1015 Lausanne, Switzerland; [Vandenabeele, Peter] Univ Ghent VIB, Inflammat Res Ctr, Mol Signaling & Cell Death Unit, B-9052 Ghent, Belgium; [Vandenabeele, Peter] Univ Ghent, Dept Biomed Mol Biol, B-9052 Ghent, Belgium; [Vandenabeele, Peter] Univ Ghent, B-9052 Ghent, Belgium	Roche Holding; Genentech; Walter & Eliza Hall Institute; University of Melbourne; National Institute of Biological Sciences, Beijing; St Jude Children's Research Hospital; Tufts University; Emory University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Ghent University	Newton, K (corresponding author), Genentech Inc, San Francisco, CA 94080 USA.	silke@wehi.edu.au	Alvarez-Diaz, Silvia/P-4948-2018; Silke, John/B-7622-2008; Ashkenazi, Avi/ABG-2712-2020; Strasser, Andreas/C-7581-2013; Vandenabeele, Peter/C-8597-2009; Auwerx, Johan/ABE-9307-2021; Green, Douglas R/N-8083-2018; Vandenabeele, Peter/AAD-5793-2022; dixit, vishva m/A-4496-2012	Alvarez-Diaz, Silvia/0000-0002-8897-1893; Silke, John/0000-0002-7611-5774; Ashkenazi, Avi/0000-0002-6890-4589; Strasser, Andreas/0000-0002-5020-4891; Green, Douglas R/0000-0002-7332-1417; Vandenabeele, Peter/0000-0002-6669-8822; dixit, vishva m/0000-0001-6983-0326; Rodriguez, Diego/0000-0003-4771-0221; Auwerx, Johan/0000-0002-5065-5393; Hildebrand, Joanne/0000-0002-1456-2042	NATIONAL CANCER INSTITUTE [P30CA021765, R01CA169291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044828] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012198] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA169291, P30 CA021765] Funding Source: Medline; NIAID NIH HHS [R01 AI044828] Funding Source: Medline; NIH HHS [DP5 OD012198] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Beirowski B, 2011, P NATL ACAD SCI USA, V108, pE952, DOI 10.1073/pnas.1104969108; Bobrowska A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034805; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Duprez L, 2011, IMMUNITY, V35, P908, DOI 10.1016/j.immuni.2011.09.020; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Houtkooper RH, 2012, NAT REV MOL CELL BIO, V13, P225, DOI 10.1038/nrm3293; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; Narayan N, 2012, NATURE, V492, P199, DOI 10.1038/nature11700; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Piao XH, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003558; Sebastian C, 2012, J BIOL CHEM, V287, P42444, DOI 10.1074/jbc.R112.402768; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Welz PS, 2011, NATURE, V477, P330, DOI 10.1038/nature10273; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308	15	19	24	2	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2014	506	7489					E4	E6		10.1038/nature13024	http://dx.doi.org/10.1038/nature13024			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0DN	24572428	Green Accepted			2022-12-28	WOS:000332165100001
J	Starosta, AL; Wilson, DN				Starosta, Agata L.; Wilson, Daniel N.			Ribosome Rescue, Nearing the End	CELL			English	Editorial Material							MESSENGER-RNA; TRANSLATION		[Starosta, Agata L.; Wilson, Daniel N.] Univ Munich, Gene Ctr, Dept Biochem, D-81377 Munich, Germany; [Starosta, Agata L.; Wilson, Daniel N.] Univ Munich, Ctr Integrated Prot Sci Munich CiPSM, D-81377 Munich, Germany	University of Munich; University of Munich	Wilson, DN (corresponding author), Univ Munich, Gene Ctr, Dept Biochem, D-81377 Munich, Germany.	wilson@lmb.uni-muenchen.de	Wilson, Daniel/AAE-8504-2019; Starosta, Agata/D-9535-2017	Wilson, Daniel/0000-0003-3816-3828; Starosta, Agata/0000-0003-3915-5723				Becker T, 2011, NAT STRUCT MOL BIOL, V18, P715, DOI 10.1038/nsmb.2057; Dever TE, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013706; Franckenberg S, 2012, CURR OPIN STRUC BIOL, V22, P786, DOI 10.1016/j.sbi.2012.08.002; Gutierrez E, 2013, MOL CELL, V51, P35, DOI 10.1016/j.molcel.2013.04.021; Guydosh NR, 2014, CELL, V156, P950, DOI 10.1016/j.cell.2014.02.006; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Tsuboi T, 2012, MOL CELL, V46, P518, DOI 10.1016/j.molcel.2012.03.013; Ude S, 2013, SCIENCE, V339, P82, DOI 10.1126/science.1228985	9	1	1	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 27	2014	156	5					866	867		10.1016/j.cell.2014.02.028	http://dx.doi.org/10.1016/j.cell.2014.02.028			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AB9BK	24581485	Bronze			2022-12-28	WOS:000332083900003
J	Cheng, W; Li, WK				Cheng, Wei; Li, Weikai			Structural Insights into Ubiquinone Biosynthesis in Membranes	SCIENCE			English	Article							ESCHERICHIA-COLI; TRANSFERASE; PRENYLATION; MECHANISM; UBIAD1; ENZYME; ACID; GENE; CONSERVATION; EXPRESSION	Biosynthesis of ubiquinones requires the intramembrane UbiA enzyme, an archetypal member of a superfamily of prenyltransferases that generates lipophilic aromatic compounds. Mutations in eukaryotic superfamily members have been linked to cardiovascular degeneration and Parkinson's disease. To understand how quinones are produced within membranes, we report the crystal structures of an archaeal UbiA in its apo and substrate-bound states at 3.3 and 3.6 angstrom resolution, respectively. The structures reveal nine transmembrane helices and an extramembrane cap domain that surround a large central cavity containing the active site. To facilitate the catalysis inside membranes, UbiA has an unusual active site that opens laterally to the lipid bilayer. Our studies illuminate general mechanisms for substrate recognition and catalysis in the UbiA superfamily and rationalize disease-related mutations in humans.	[Cheng, Wei; Li, Weikai] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Li, WK (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.	liw@biochem.wustl.edu			National Heart, Lung, and Blood Institute [5R00HL097083]; American Society of Hematology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL121718, R00HL097083, K99HL097083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Society of Hematology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff at Advanced Photon Source beamline ID-24C (GM103403) for support with data collection; T. Lohman and A. Kozlov for assistance with ITC experiments; J. Janetka and Z. Han for aid with the HPLC analysis; J. Wang, F. Murphy, and J. Schuermann for help with structure analysis; S. Chen for mass spectrometry analysis of protein samples; N. Ke and J. Beckwith for generating the quinone-deficient strains; R. Zhang for help with the figures; and D. Fremont, J. Chai, T. Lohman, and T. Ellenberger for critical reading of the manuscript. W. L. is supported by a R00 grant 5R00HL097083 from the National Heart, Lung, and Blood Institute and a scholar award from the American Society of Hematology. The structure factors and coordinates were deposited in the Protein Data Bank (PDB accession code 4OD4 for the apo structure and accession code 4OD5 for the substrate-bound structure). The authors declare no conflicts of interest.	Bonitz T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027336; Brauer L, 2008, CHEMBIOCHEM, V9, P982, DOI 10.1002/cbic.200700575; Brauer L, 2004, J MOL MODEL, V10, P317, DOI 10.1007/s00894-004-0197-6; Forsgren M, 2004, BIOCHEM J, V382, P519, DOI 10.1042/BJ20040261; Fredericks WJ, 2013, J CELL BIOCHEM, V114, P2170, DOI 10.1002/jcb.24567; Hegarty JM, 2013, DEVELOPMENT, V140, P1713, DOI 10.1242/dev.093112; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hosfield DJ, 2004, J BIOL CHEM, V279, P8526, DOI 10.1074/jbc.C300511200; Jormakka M, 2008, NAT STRUCT MOL BIOL, V15, P730, DOI 10.1038/nsmb.1434; KALEN A, 1990, J BIOL CHEM, V265, P1158; Kellogg BA, 1997, CURR OPIN CHEM BIOL, V1, P570, DOI 10.1016/S1367-5931(97)80054-3; Kuzuyama T, 2005, NATURE, V435, P983, DOI 10.1038/nature03668; MELZER M, 1994, BBA-LIPID LIPID MET, V1212, P93, DOI 10.1016/0005-2760(94)90193-7; Metzger U, 2010, J MOL BIOL, V404, P611, DOI 10.1016/j.jmb.2010.09.067; Metzger U, 2009, P NATL ACAD SCI USA, V106, P14309, DOI 10.1073/pnas.0904897106; Mugoni V, 2013, CELL, V152, P504, DOI 10.1016/j.cell.2013.01.013; Nakagawa K, 2010, NATURE, V468, P117, DOI 10.1038/nature09464; Nickerson ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010760; Ohara K, 2009, BIOCHEM J, V421, P231, DOI 10.1042/BJ20081968; SUZUKI K, 1994, BIOSCI BIOTECH BIOCH, V58, P1814, DOI 10.1271/bbb.58.1814; SWIEZEWSKA E, 1993, J BIOL CHEM, V268, P1494; Vos M, 2012, SCIENCE, V336, P1306, DOI 10.1126/science.1218632; Wallrapp FH, 2013, P NATL ACAD SCI USA, V110, pE1196, DOI 10.1073/pnas.1300632110; Weiss JS, 2007, INVEST OPHTH VIS SCI, V48, P5007, DOI 10.1167/iovs.07-0845; Wessjohann L, 1996, ANGEW CHEM INT EDIT, V35, P1697, DOI 10.1002/anie.199616971; Yang Y, 2012, BIOCHEMISTRY-US, V51, P2606, DOI 10.1021/bi201800m; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; YOUNG IG, 1972, J BACTERIOL, V110, P18, DOI 10.1128/JB.110.1.18-25.1972	28	87	90	4	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 21	2014	343	6173					878	881		10.1126/science.1246774	http://dx.doi.org/10.1126/science.1246774			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB1LG	24558159	Green Accepted			2022-12-28	WOS:000331552600044
J	Handor, H; Daoudi, R				Handor, Hanan; Daoudi, Rajae			Hypertensive Retinopathy Associated with Preeclampsia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Handor, Hanan; Daoudi, Rajae] Univ Mohammed V Souissi, Rabat, Morocco	Mohammed V University in Rabat	Handor, H (corresponding author), Univ Mohammed V Souissi, Rabat, Morocco.	hhandor@yahoo.fr							0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 20	2014	370	8					752	752		10.1056/NEJMicm1306891	http://dx.doi.org/10.1056/NEJMicm1306891			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB1DO	24552322				2022-12-28	WOS:000331531900010
J	van Dongen, TMA; van der Heijden, GJMG; Venekamp, RP; Rovers, MM; Schilder, AGM				van Dongen, Thijs M. A.; van der Heijden, Geert J. M. G.; Venekamp, Roderick P.; Rovers, Maroeska M.; Schilder, Anne G. M.			A Trial of Treatment for Acute Otorrhea in Children with Tympanostomy Tubes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE OTITIS-MEDIA; TOPICAL CIPROFLOXACIN/DEXAMETHASONE; AMOXICILLIN/CLAVULANIC ACID; PEDIATRIC-PATIENTS; SUPERIOR; CIPROFLOXACIN; METAANALYSIS; ANTIBIOTICS; PARENTS; IMPACT	BackgroundRecent guidance for the management of acute otorrhea in children with tympanostomy tubes is based on limited evidence from trials comparing oral antibiotic agents with topical antibiotics. MethodsIn this open-label, pragmatic trial, we randomly assigned 230 children, 1 to 10 years of age, who had acute tympanostomy-tube otorrhea to receive hydrocortisone-bacitracin-colistin eardrops (76 children) or oral amoxicillin-clavulanate suspension (77) or to undergo initial observation (77). The primary outcome was the presence of otorrhea, as assessed otoscopically, 2 weeks after study-group assignment. Secondary outcomes were the duration of the initial otorrhea episode, the total number of days of otorrhea and the number of otorrhea recurrences during 6 months of follow-up, quality of life, complications, and treatment-related adverse events. ResultsAntibiotic-glucocorticoid eardrops were superior to oral antibiotics and initial observation for all outcomes. At 2 weeks, 5% of children treated with antibiotic-glucocorticoid eardrops had otorrhea, as compared with 44% of those treated with oral antibiotics (risk difference, -39 percentage points; 95% confidence interval [CI], -51 to -26) and 55% of those treated with initial observation (risk difference, -49 percentage points; 95% CI, -62 to -37). The median duration of the initial episode of otorrhea was 4 days for children treated with antibiotic-glucocorticoid eardrops versus 5 days for those treated with oral antibiotics (P<0.001) and 12 days for those who were assigned to initial observation (P<0.001). Treatment-related adverse events were mild, and no complications of otitis media, including local cellulitis, perichondritis, mastoiditis, and intracranial complications, were reported at 2 weeks. ConclusionsAntibiotic-glucocorticoid eardrops were more effective than oral antibiotics and initial observation in children with tympanostomy tubes who had uncomplicated acute otorrhea. (Funded by the Netherlands Organization for Health Research and Development; Netherlands Trial Register number, NTR1481.)	[van Dongen, Thijs M. A.; van der Heijden, Geert J. M. G.; Venekamp, Roderick P.; Rovers, Maroeska M.; Schilder, Anne G. M.] Julius Ctr Hlth Sci & Primary Care, Dept Epidemiol, Utrecht, Netherlands; [van der Heijden, Geert J. M. G.; Venekamp, Roderick P.; Schilder, Anne G. M.] Univ Med Ctr Utrecht, Dept Otorhinolaryngol, Div Surg Specialties, Utrecht, Netherlands; [van der Heijden, Geert J. M. G.] Univ Amsterdam, Acad Ctr Dent Amsterdam, Dept Social Dent, Amsterdam, Netherlands; [van der Heijden, Geert J. M. G.] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Rovers, Maroeska M.] Radboud Univ Nijmegen Med Ctr, Dept Operating Rooms, Nijmegen, Netherlands; [Rovers, Maroeska M.] Radboud Univ Nijmegen Med Ctr, Dept Hlth Evidence, Nijmegen, Netherlands; [Schilder, Anne G. M.] UCL, Ear Inst, London, England	Utrecht University; Utrecht University Medical Center; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Radboud University Nijmegen; Radboud University Nijmegen; University of London; University College London	van Dongen, TMA (corresponding author), Julius Ctr Hlth Sci & Primary Care, Dept Epidemiol, Utrecht, Netherlands.	t.m.a.vandongen@umcutrecht.nl	Rovers, Maroeska/F-2969-2014	Rovers, Maroeska/0000-0002-3095-170X; Venekamp, Roderick P/0000-0002-1446-9614; Schilder, Anne/0000-0002-5496-4580	Netherlands Organization for Health Research and Development Effects and Costs subprogram [170992502]; GlaxoSmithKline; National Institute for Health Research [NIHR-RP-011-045] Funding Source: researchfish	Netherlands Organization for Health Research and Development Effects and Costs subprogram; GlaxoSmithKline(GlaxoSmithKline); National Institute for Health Research(National Institute for Health Research (NIHR))	Supported by a grant (170992502) from the Netherlands Organization for Health Research and Development Effects and Costs subprogram.; Dr. Schilder reports receiving grant support through her institution from GlaxoSmithKline. No other potential conflict of interest relevant to this article was reported.	Ah-Tye C, 2001, PEDIATRICS, V107, P1251, DOI 10.1542/peds.107.6.1251; [Anonymous], 2012, EPISHEET; BALKANY TJ, 1983, AM J OTOL, V4, P288; Cullen K, 2006, NATIONAL HEALTH STAT, V11; Dohar J, 2006, PEDIATRICS, V118, pE561, DOI 10.1542/peds.2005-2033; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Easton J, 2003, DRUGS, V63, P311, DOI 10.2165/00003495-200363030-00005; Goldblatt EL, 1998, INT J PEDIATR OTORHI, V46, P91, DOI 10.1016/S0165-5876(98)00150-5; Heslop A, 2010, LARYNGOSCOPE, V120, P2516, DOI 10.1002/lary.21015; Hullmann SE, 2011, ARTHRIT CARE RES, V63, pS420, DOI 10.1002/acr.20637; Isaacson G, 2006, PEDIATRICS, V118, P1252, DOI 10.1542/peds.2006-0826; Kay DJ, 2001, OTOLARYNG HEAD NECK, V124, P374, DOI 10.1067/mhn.2001.113941; Moher D, 2012, J CLIN EPIDEMIOL, V65, P351, DOI 10.1016/j.jclinepi.2011.10.006; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Peters BM, 2012, CLIN MICROBIOL REV, V25, P193, DOI 10.1128/CMR.00013-11; Raat H, 2005, J EPIDEMIOL COMMUN H, V59, P75, DOI 10.1136/jech.2003.012914; Roland PS, 2003, LARYNGOSCOPE, V113, P2116, DOI 10.1097/00005537-200312000-00011; Rosenfeld RM, 2000, ARCH OTOLARYNGOL, V126, P585, DOI 10.1001/archotol.126.5.585; Rosenfeld RM, 1997, ARCH OTOLARYNGOL, V123, P1049; Rosenfeld RM, 2003, EVIDENCE BASED OTITI, V2nd, P227; Rovers MM, 2006, LANCET, V368, P1429, DOI 10.1016/S0140-6736(06)69606-2; Ruohola A, 2003, PEDIATRICS, V111, P1061, DOI 10.1542/peds.111.5.1061; Schulz KF, 2011, INT J SURG, V9, P672, DOI 10.1016/j.ijsu.2011.09.004; Scott IA, 2012, MED J AUSTRALIA, V196, P304, DOI 10.5694/mja11.10364; Tahtinen PA, 2011, NEW ENGL J MED, V364, P116, DOI 10.1056/NEJMoa1007174; U.S. National Library of Medicine, DAILY MED; Vaile L, 2006, COCHRANE DB SYST REV, V2; van Dongen TMA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069062; van Dongen TMA, 2012, PEDIATR INFECT DIS J, V31, P868, DOI 10.1097/INF.0b013e318258f100; Weber PC, 2004, OTOLARYNG HEAD NECK, V130, pS89, DOI 10.1016/j.otohns.2003.12.009	30	46	46	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 20	2014	370	8					723	733		10.1056/NEJMoa1301630	http://dx.doi.org/10.1056/NEJMoa1301630			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB1DO	24552319	Green Published, Bronze			2022-12-28	WOS:000331531900007
J	Chessman, AW				Chessman, Alexander W.			Review: Sumatriptan plus naproxen improves acute migraine more than placebo, sumatriptan, or naproxen	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Med Univ S Carolina, Charleston, SC 29425 USA	Medical University of South Carolina	Chessman, AW (corresponding author), Med Univ S Carolina, Charleston, SC 29425 USA.				Global Campaign against Headache, UK; International Headache Society, UK	Global Campaign against Headache, UK; International Headache Society, UK	Global Campaign against Headache, UK and International Headache Society, UK.	Derry CJ, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008615.pub2; Derry S., 2013, COCHRANE DATABASE SY; Derry S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008783.pub3; Kirthi V, 2013, COCHRANE DB SYST REV, V4; Law S, 2013, COCHRANE DB SYST REV, V10; Rabbie R, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008039.pub3	6	2	2	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 18	2014	160	4							JC8	10.7326/0003-4819-160-4-201402180-02008	http://dx.doi.org/10.7326/0003-4819-160-4-201402180-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC8RF	24534942				2022-12-28	WOS:000350635100007
J	Vanassche, T; Connolly, SJ; Eikelboom, JW				Vanassche, Thomas; Connolly, Stuart J.; Eikelboom, John W.			Review: New oral anticoagulants increase GI bleeding in venous thrombosis and ACS	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							WARFARIN		[Vanassche, Thomas; Connolly, Stuart J.; Eikelboom, John W.] McMaster Univ, Hamilton, ON, Canada	McMaster University	Vanassche, T (corresponding author), McMaster Univ, Hamilton, ON, Canada.		Eikelboom, John/AAG-6117-2019; Vanassche, Thomas/GQZ-9004-2022	Eikelboom, John/0000-0003-4126-1285; Vanassche, Thomas/0000-0002-7404-8918				Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Heitman SJ, 2013, GASTROENTEROLOGY, V145, P42, DOI 10.1053/j.gastro.2013.05.025; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Ruff CT, 2013, LANCET	5	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 18	2014	160	4							JC4	10.7326/0003-4819-160-4-201402180-02004	http://dx.doi.org/10.7326/0003-4819-160-4-201402180-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC8RF	24534938				2022-12-28	WOS:000350635100003
J	Sun, TJ; Lin, FH; Campbell, RL; Allingham, JS; Davies, PL				Sun, Tianjun; Lin, Feng-Hsu; Campbell, Robert L.; Allingham, John S.; Davies, Peter L.			An Antifreeze Protein Folds with an Interior Network of More Than 400 Semi-Clathrate Waters	SCIENCE			English	Article							MOLECULAR RECOGNITION; WINTER FLOUNDER; ICE; BINDING; RESOLUTION; HYDRATION; FISH	When polypeptide chains fold into a protein, hydrophobic groups are compacted in the center with exclusion of water. We report the crystal structure of an alanine-rich antifreeze protein that retains similar to 400 waters in its core. The putative ice-binding residues of this dimeric, four-helix bundle protein point inwards and coordinate the interior waters into two intersecting polypentagonal networks. The bundle makes minimal protein contacts between helices, but is stabilized by anchoring to the semi-clathrate water monolayers through backbone carbonyl groups in the protein interior. The ordered waters extend outwards to the protein surface and likely are involved in ice binding. This protein fold supports both the anchored-clathrate water mechanism of antifreeze protein adsorption to ice and the water-expulsion mechanism of protein folding.	[Sun, Tianjun; Lin, Feng-Hsu; Campbell, Robert L.; Allingham, John S.; Davies, Peter L.] Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Davies, PL (corresponding author), Queens Univ, Dept Biomed & Mol Sci, Kingston, ON K7L 3N6, Canada.	peter.davies@queensu.ca	Allingham, John/AAW-9262-2020	Campbell, Robert/0000-0002-5473-5876	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We are grateful to D. McLeod and K. Munro of the Protein Function Discovery Facility at Queen's University for mass spectrometry and intrinsic fluorescence analyses, respectively. We thank E. Lazo and V. Stojanoff of the X6A beamline at Brookhaven National Laboratories for help with x-ray data acquisition and processing. This research was funded by the Canadian Institutes of Health Research. P. L. D. holds the Canada Research Chair in Protein Engineering. J.S.A holds a Canada Research Chair (Tier 2) in Structural Biology and is an Ontario Early Researcher Award recipient. The coordinates and x-ray data for Maxi have been deposited with the PDB with accession code 4KE2.	Ahmad M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1258; Baardsnes J, 1999, FEBS LETT, V463, P87, DOI 10.1016/S0014-5793(99)01588-4; Bai JI, 2012, P NATL ACAD SCI USA, V109, P21240, DOI 10.1073/pnas.1213342110; Bai J, 2010, P NATL ACAD SCI USA, V107, P5718, DOI 10.1073/pnas.0906437107; BANNER DW, 1987, J MOL BIOL, V196, P657, DOI 10.1016/0022-2836(87)90039-8; Carugo O, 1999, ACTA CRYSTALLOGR D, V55, P479, DOI 10.1107/S0907444998012086; Garnham CP, 2011, P NATL ACAD SCI USA, V108, P7363, DOI 10.1073/pnas.1100429108; Garnham CP, 2010, BIOCHEMISTRY-US, V49, P9063, DOI 10.1021/bi100516e; Graham LA, 2008, BIOCHEMISTRY-US, V47, P2051, DOI 10.1021/bi7020316; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; KNIGHT CA, 1991, BIOPHYS J, V59, P409, DOI 10.1016/S0006-3495(91)82234-2; Koga K, 2000, NATURE, V408, P564, DOI 10.1038/35046035; Levy Y, 2006, ANNU REV BIOPH BIOM, V35, P389, DOI 10.1146/annurev.biophys.35.040405.102134; Marshall CB, 2005, J BIOL CHEM, V280, P17920, DOI 10.1074/jbc.M500622200; Marshall CB, 2004, NATURE, V429, P153, DOI 10.1038/429153a; Nutt DR, 2008, J AM CHEM SOC, V130, P13066, DOI 10.1021/ja8034027; Olijve LLC, 2013, RSC ADV, V3, P5903, DOI 10.1039/c3ra22729d; Rasaiah JC, 2008, ANNU REV PHYS CHEM, V59, P713, DOI 10.1146/annurev.physchem.59.032607.093815; SCHERAGA HA, 1962, J BIOL CHEM, V237, P2506; SICHERI F, 1995, NATURE, V375, P427, DOI 10.1038/375427a0; Tanford C., 2001, NATURES ROBOTS HIST, Vfirst; ten Wolde PR, 2002, P NATL ACAD SCI USA, V99, P6539, DOI 10.1073/pnas.052153299; Yang C, 2005, PROTEINS, V59, P266, DOI 10.1002/prot.20429; Young T, 2007, P NATL ACAD SCI USA, V104, P808, DOI 10.1073/pnas.0610202104	25	122	127	6	167	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 14	2014	343	6172					795	798		10.1126/science.1247407	http://dx.doi.org/10.1126/science.1247407			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB1NB	24531972				2022-12-28	WOS:000331557800046
J	Soria, R; Long, KS; Blair, WP; Godfrey, L; Kuntz, KD; Lenc, E; Stockdale, C; Winkler, PF				Soria, R.; Long, K. S.; Blair, W. P.; Godfrey, L.; Kuntz, K. D.; Lenc, E.; Stockdale, C.; Winkler, P. F.			Super-Eddington Mechanical Power of an Accreting Black Hole in M83	SCIENCE			English	Article							X-RAY SOURCES; HIGH-RESOLUTION RADIO; FE-II EMISSION; MICROQUASAR; JETS; SIMULATIONS; REMNANTS; DENSITY; BUBBLES; CHANDRA	Mass accretion onto black holes releases energy in the form of radiation and outflows. Although the radiative flux cannot substantially exceed the Eddington limit, at which the outgoing radiation pressure impedes the inflow of matter, it remains unclear whether the kinetic energy flux is bounded by this same limit. Here, we present the detection of a radio-optical structure, powered by outflows from a non-nuclear black hole. Its accretion disk properties indicate that this black hole is less than 100 solar masses. The optical-infrared line emission implies an average kinetic power of 3 x 10(40) erg second(-1), higher than the Eddington luminosity of the black hole. These results demonstrate kinetic power exceeding the Eddington limit over a sustained period, which implies greater ability to influence the evolution of the black hole's environment.	[Soria, R.] Curtin Univ, Int Ctr Radio Astron Res, Perth, WA 6845, Australia; [Long, K. S.; Blair, W. P.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Blair, W. P.; Kuntz, K. D.] Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; [Godfrey, L.] Netherlands Inst Radio Astron ASTRON, NL-7990 AA Dwingeloo, Netherlands; [Kuntz, K. D.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Lenc, E.] Univ Sydney, Sydney Inst Astron, Sch Phys, Sydney, NSW 2006, Australia; [Lenc, E.] ARC Ctr Excellence All Sky Astrophys CAASTRO, Sydney, NSW, Australia; [Stockdale, C.] Marquette Univ, Dept Phys, Milwaukee, WI 53201 USA; [Winkler, P. F.] Middlebury Coll, Dept Phys, Middlebury, VT 05753 USA	Curtin University; Space Telescope Science Institute; Johns Hopkins University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Sydney; Marquette University	Soria, R (corresponding author), Curtin Univ, Int Ctr Radio Astron Res, GPO Box U1987, Perth, WA 6845, Australia.	roberto.soria@icrar.org	Soria, Roberto/AAU-3154-2020	Soria, Roberto/0000-0002-4622-796X; Lenc, Emil/0000-0002-9994-1593	Australian Research Council [DP 120102393]; Space Telescope Science Institute [GO-12513-01]; NASA Wisconsin Space Grant Consortium; NSF [AST-0908566]; NASA by the Chandra X-ray Observatory Center [G01-12115]; NASA [NAS8-03060];  [CE110001020]	Australian Research Council(Australian Research Council); Space Telescope Science Institute(Space Telescope Science Institute); NASA Wisconsin Space Grant Consortium; NSF(National Science Foundation (NSF)); NASA by the Chandra X-ray Observatory Center; NASA(National Aeronautics & Space Administration (NASA)); 	We thank M. W. Pakull for his insightful lessons and comments on ULX bubbles, J. Miller-Jones and A. Moin for their help with the ATCA observations and data analysis, and P. P. Plucinsky for his helpful role in the Chandra study of M83. R. S. acknowledges an Australian Research Council's Discovery Projects funding scheme (project number DP 120102393). W. P. B. acknowledges Space Telescope Science Institute grant GO-12513-01 to Johns Hopkins University. C. S. acknowledges the NASA Wisconsin Space Grant Consortium research grant. P. F. W. acknowledges financial support from the NSF through grant AST-0908566. This work was supported by NASA through Chandra grant G01-12115, issued by the Chandra X-ray Observatory Center, which is operated by the Smithsonian Astrophysical Observatory for and on behalf of NASA under contract NAS8-03060. The Centre for All-sky Astrophysics (CAASTRO) is an Australian Research Council Centre of Excellence, funded by grant CE110001020.	Allen MG, 2008, ASTROPHYS J SUPPL S, V178, P20, DOI 10.1086/589652; Arnaud KA, 1996, ASTR SOC P, V101, P17; BARDEEN JM, 1972, ASTROPHYS J, V178, P347, DOI 10.1086/151796; Begelman MC, 2006, ASTROPHYS J, V643, P1065, DOI 10.1086/503093; Blair WP, 2013, ASTROPHYS J SUPPL S, V207, DOI 10.1088/0067-0049/207/2/40; Blair WP, 2012, ASTROPHYS J SUPPL S, V203, DOI 10.1088/0067-0049/203/1/8; Blundell KM, 2000, ASTRON J, V119, P1111, DOI 10.1086/301254; Corbel S, 2013, MON NOT R ASTRON SOC, V428, P2500, DOI 10.1093/mnras/sts215; Cseh D, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/1/17; Dopita MA, 2012, MON NOT R ASTRON SOC, V427, P956, DOI 10.1111/j.1365-2966.2012.21947.x; Dopita MA, 1996, ASTROPHYS J SUPPL S, V102, P161, DOI 10.1086/192255; Dopita MA, 2010, ASTROPHYS J, V710, P964, DOI 10.1088/0004-637X/710/2/964; Dubner GM, 1998, ASTRON J, V116, P1842, DOI 10.1086/300537; ELSTON R, 1987, ASTRON J, V94, P1633, DOI 10.1086/114594; Fabrika S., 2004, ASTROPHYS SPACE PHYS, V12, P1; Feng H, 2011, NEW ASTRON REV, V55, P166, DOI 10.1016/j.newar.2011.08.002; Gallo E, 2005, NATURE, V436, P819, DOI 10.1038/nature03879; Godfrey LEH, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/1/12; Guver T, 2009, MON NOT R ASTRON SOC, V400, P2050, DOI 10.1111/j.1365-2966.2009.15598.x; Kaiser CR, 1997, MON NOT R ASTRON SOC, V286, P215, DOI 10.1093/mnras/286.1.215; King AR, 2003, MON NOT R ASTRON SOC, V345, P657, DOI 10.1046/j.1365-8711.2003.06980.x; Krivosheyev YM, 2009, MON NOT R ASTRON SOC, V394, P1674, DOI 10.1111/j.1365-2966.2009.14452.x; Kubota A, 1998, PUBL ASTRON SOC JPN, V50, P667, DOI 10.1093/pasj/50.6.667; Lenc E., 2009, THESIS SWINBURNE U T; MARGON B, 1984, ANNU REV ASTRON ASTR, V22, P507; Marshall HL, 2002, ASTROPHYS J, V564, P941, DOI 10.1086/324398; McClintock J.E., 2006, BLACK HOLE BINARIES, V39, P157; Morel T, 2002, MON NOT R ASTRON SOC, V329, P398, DOI 10.1046/j.1365-8711.2002.05026.x; Ohsuga K, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/1/2; OLIVA E, 1989, ASTRON ASTROPHYS, V214, P307; Pakull M.W., 2006, POPULATIONS HIGH ENE, V230, P293, DOI [10.1017/S1743921306008489, DOI 10.1017/S1743921306008489]; Pakull M. W., 2002, P S NEW VIS XRAY UN; Pakull M. W., 2003, REV MEX ASTRON ASTR, V15, P197; Pakull MW, 2008, AIP CONF PROC, V1010, P303, DOI 10.1063/1.2945062; Pakull MW, 2010, NATURE, V466, P209, DOI 10.1038/nature09168; Poutanen J, 2007, MON NOT R ASTRON SOC, V377, P1187, DOI 10.1111/j.1365-2966.2007.11668.x; Punsly B, 2005, ASTROPHYS J, V623, pL9, DOI 10.1086/430140; Punsly B, 2007, MON NOT R ASTRON SOC, V374, pL10, DOI 10.1111/j.1745-3933.2006.00254.x; Punsly B, 2011, ASTROPHYS J LETT, V728, DOI 10.1088/2041-8205/728/1/L17; Reiter M, 2013, MON NOT R ASTRON SOC, V433, P2226, DOI 10.1093/mnras/stt889; Saha A, 2006, ASTROPHYS J SUPPL S, V165, P108, DOI 10.1086/503800; Shabala SS, 2013, ASTROPHYS J, V769, DOI 10.1088/0004-637X/769/2/129; SHAKURA NI, 1973, ASTRON ASTROPHYS, V24, P337; Shinn JH, 2013, ASTROPHYS J, V777, DOI 10.1088/0004-637X/777/1/45; Soria R, 2003, ASTRON ASTROPHYS, V410, P53, DOI 10.1051/0004-6361:20031074; Soria R, 2002, ASTRON ASTROPHYS, V384, P99, DOI 10.1051/0004-6361:20020026; Soria R, 2010, MON NOT R ASTRON SOC, V409, P541, DOI 10.1111/j.1365-2966.2010.17360.x; Sutton AD, 2013, MON NOT R ASTRON SOC, V435, P1758, DOI 10.1093/mnras/stt1419; THORNE KS, 1974, ASTROPHYS J, V191, P507, DOI 10.1086/152991; WEAVER R, 1977, ASTROPHYS J, V218, P377, DOI 10.1086/155692; Willott CJ, 1999, MON NOT R ASTRON SOC, V309, P1017, DOI 10.1046/j.1365-8711.1999.02907.x; ZEALEY WJ, 1980, MON NOT R ASTRON SOC, V192, P731, DOI 10.1093/mnras/192.4.731	53	38	38	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2014	343	6177					1330	1333		10.1126/science.1248759	http://dx.doi.org/10.1126/science.1248759			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD3AI	24578533	Green Submitted			2022-12-28	WOS:000333108500030
J	Barber, MD; Brubaker, L; Burgio, KL; Richter, HE; Nygaard, I; Weidner, AC; Menefee, SA; Lukacz, ES; Norton, P; Schaffer, J; Nguyen, JN; Borello-France, D; Goode, PS; Jakus-Waldman, S; Spino, C; Warren, LK; Gantz, MG; Meikle, SF				Barber, Matthew D.; Brubaker, Linda; Burgio, Kathryn L.; Richter, Holly E.; Nygaard, Ingrid; Weidner, Alison C.; Menefee, Shawn A.; Lukacz, Emily S.; Norton, Peggy; Schaffer, Joseph; Nguyen, John N.; Borello-France, Diane; Goode, Patricia S.; Jakus-Waldman, Sharon; Spino, Cathie; Warren, Lauren Klein; Gantz, Marie G.; Meikle, Susan F.		Eunice Kennedy Shriver Natl Inst C	Comparison of 2 Transvaginal Surgical Approaches and Perioperative Behavioral Therapy for Apical Vaginal Prolapse The OPTIMAL Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PELVIC ORGAN PROLAPSE; SACROSPINOUS LIGAMENT FIXATION; URGE URINARY-INCONTINENCE; CONSERVATIVE TREATMENT; STRESS-INCONTINENCE; CLINICAL-TRIALS; VAULT PROLAPSE; UNITED-STATES; WOMEN; SURGERY	IMPORTANCE More than 300 000 surgeries are performed annually in the United States for pelvic organ prolapse. Sacrospinous ligament fixation (SSLF) and uterosacral ligament suspension (ULS) are commonly performed transvaginal surgeries to correct apical prolapse. Little is known about their comparative efficacy and safety, and it is unknown whether perioperative behavioral therapy with pelvic floor muscle training (BPMT) improves outcomes of prolapse surgery. OBJECTIVE To compare outcomes between (1) SSLF and ULS and (2) perioperative BPMT and usual care in women undergoing surgery for vaginal prolapse and stress urinary incontinence. DESIGN, SETTING, AND PARTICIPANTS Multicenter, 2 x 2 factorial, randomized trial of 374 women undergoing surgery to treat both apical vaginal prolapse and stress urinary incontinence was conducted between 2008 and 2013 at 9 US medical centers. Two-year follow-up rate was 84.5%. INTERVENTIONS The surgical intervention was transvaginal surgery including midurethral sling with randomization to SSLF (n = 186) or ULS (n = 188); the behavioral intervention was randomization to receive perioperative BPMT (n = 186) or usual care (n = 188). MAIN OUTCOMES AND MEASURES The primary outcome for the surgical intervention (surgical success) was defined as (1) no apical descent greater than one-third into vaginal canal or anterior or posterior vaginal wall beyond the hymen (anatomic success), (2) no bothersome vaginal bulge symptoms, and (3) no re-treatment for prolapse at 2 years. For the behavioral intervention, primary outcome at 6 months was urinary symptom scores (Urinary Distress Inventory; range 0-300, higher scores worse), and primary outcomes at 2 years were prolapse symptom scores (Pelvic Organ Prolapse Distress Inventory; range 0-300, higher scores worse) and anatomic success. RESULTS At 2 years, surgical group was not significantly associated with surgical success rates (ULS, 59.2%[93/157] vs SSLF, 60.5%[92/152]; unadjusted difference, -1.3%; 95% CI, -12.2% to 9.6%; adjusted odds ratio [OR], 0.9; 95% CI, 0.6 to 1.5) or serious adverse event rates (ULS, 16.5%[31/188] vs SSLF, 16.7%[31/186]; unadjusted difference, -0.2%; 95% CI, -7.7% to 7.4%; adjusted OR, 0.9; 95% CI, 0.5 to 1.6). Perioperative BPMT was not associated with greater improvements in urinary scores at 6 months (adjusted treatment difference, -6.7; 95% CI, -19.7 to 6.2), prolapse scores at 24 months (adjusted treatment difference, -8.0; 95% CI, -22.1 to 6.1), or anatomic success at 24 months. CONCLUSIONS AND RELEVANCE Two years after vaginal surgery for prolapse and stress urinary incontinence, neither ULS nor SSLF was significantly superior to the other for anatomic, functional, or adverse event outcomes. Perioperative BPMT did not improve urinary symptoms at 6 months or prolapse outcomes at 2 years.	[Barber, Matthew D.] Cleveland Clin, Obstet Gynecol & Womens Hlth Inst, Cleveland, OH 44195 USA; [Brubaker, Linda] Loyola Univ, Dept Obstet & Gynecol, Stritch Sch Med, Chicago, IL 60611 USA; [Brubaker, Linda] Loyola Univ, Dept Urol, Stritch Sch Med, Chicago, IL 60611 USA; [Burgio, Kathryn L.; Goode, Patricia S.] Univ Alabama Birmingham, Div Gerontol Geriatr & Palliat Care, Birmingham, AL USA; [Burgio, Kathryn L.; Goode, Patricia S.] Dept Vet Affairs, Birmingham, AL USA; [Richter, Holly E.] Univ Alabama Birmingham, Dept Obstet & Gynecol, Birmingham, AL USA; [Nygaard, Ingrid; Norton, Peggy] Univ Utah, Med Ctr, Dept Obstet & Gynecol, Salt Lake City, UT 84132 USA; [Weidner, Alison C.] Duke Univ, Med Ctr, Dept Obstet & Gynecol, Durham, NC 27710 USA; [Menefee, Shawn A.] Kaiser Permanente So Calif, Dept Obstet & Gynecol, San Diego, CA USA; [Lukacz, Emily S.] Univ Calif San Diego Hlth Syst, Dept Reprod Med, San Diego, CA USA; [Schaffer, Joseph] Univ Texas SW Med Ctr Dallas, Dept Obstet & Gynecol, Dallas, TX 75390 USA; [Nguyen, John N.; Jakus-Waldman, Sharon] Kaiser Permanente So Calif, Dept Obstet & Gynecol, Downey, CA USA; [Borello-France, Diane] Duquesne Univ, Dept Phys Therapy, Pittsburgh, PA 15219 USA; [Spino, Cathie] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Warren, Lauren Klein; Gantz, Marie G.] RTI Int, Social Stat & Environm Sci, Res Triangle Pk, NC USA; [Meikle, Susan F.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD USA	Cleveland Clinic Foundation; Loyola University Chicago; Loyola University Chicago; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Utah System of Higher Education; University of Utah; Duke University; Kaiser Permanente; University of California System; University of California San Diego; University of Texas System; University of Texas Southwestern Medical Center Dallas; Kaiser Permanente; Duquesne University; University of Michigan System; University of Michigan; Research Triangle Institute; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Barber, MD (corresponding author), Cleveland Clin, Obstet Gynecol & Womens Hlth Inst, 9500 Euclid Ave,Desk A81, Cleveland, OH 44195 USA.	barberm2@ccf.org	Brubaker, Linda/J-5918-2019	Brubaker, Linda/0000-0002-8598-2589; Gantz, Marie/0000-0001-8528-0184; Warren, Lauren/0000-0002-0965-767X; Richter, Holly E/0000-0001-7741-5771	Eunice Kennedy Shriver National Institute of Child Health and Human Development [U01 HD041249, U10 HD041250, U10 HD041261, U10 HD041267, U10 HD054136, U10 HD054214, U10 HD054215, U01 HD069031, U10 HD054241]; National Institutes of Health Office of Research on Women's Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD041250, U10HD069006, U10HD054215, UG1HD041267, U01HD069031, U10HD041267, UG1HD054214, U10HD054241, U10HD054136, U10HD054214, U10HD041261] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD041249] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH Office of Research on Women's Health (ORWH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by grants U01 HD041249, U10 HD041250, U10 HD041261, U10 HD041267, U10 HD054136, U10 HD054214, U10 HD054215, U01 HD069031, and U10 HD054241 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development and the National Institutes of Health Office of Research on Women's Health.	Albo ME, 2007, NEW ENGL J MED, V356, P2143, DOI 10.1056/NEJMoa070416; Antosh DD, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.07.007; Barber MD, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.02.007; Barber MD, 2001, AM J OBSTET GYNECOL, V185, P1388, DOI 10.1067/mob.2001.118659; Barber MD, 2000, AM J OBSTET GYNECOL, V183, P1402, DOI 10.1067/mob.2000.111298; Barbera MD, 2009, CONTEMP CLIN TRIALS, V30, P178, DOI 10.1016/j.cct.2008.12.001; Berghmans LCM, 1998, BRIT J UROL, V82, P181; Berghmans LCM, 2000, BJU INT, V85, P254, DOI 10.1046/j.1464-410x.2000.00434.x; Boyles SH, 2003, AM J OBSTET GYNECOL, V188, P108, DOI 10.1067/mob.2003.101; Brown JS, 2002, AM J OBSTET GYNECOL, V186, P712, DOI 10.1067/mob.2002.121897; BROWN MB, 1992, CONTROL CLIN TRIALS, V13, P213, DOI 10.1016/0197-2456(92)90004-J; Bump RC, 1996, AM J OBSTET GYNECOL, V175, P10, DOI 10.1016/S0002-9378(96)70243-0; Burgio KL, 1998, JAMA-J AM MED ASSOC, V280, P1995, DOI 10.1001/jama.280.23.1995; Chen LY, 2006, OBSTET GYNECOL, V108, P324, DOI 10.1097/01.AOG.0000227786.69257.a8; DeLancey JO, 2001, OBSTET GYNECOL MANAG, V13; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Diwadkar GB, 2009, OBSTET GYNECOL, V113, P367, DOI 10.1097/AOG.0b013e318195888d; Dumoulin C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005654.pub2; Ellerkmann RM, 2001, AM J OBSTET GYNECOL, V185, P1332, DOI 10.1067/mob.2001.119078; FitzGerald MP, 2007, PHYS THER, V87, P1316, DOI 10.2522/ptj.20060073; Frawley HC, 2010, NEUROUROL URODYNAM, V29, P719, DOI 10.1002/nau.20828; Hagen S, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003882.pub4; Jarvis SK, 2005, AUST NZ J OBSTET GYN, V45, P300, DOI 10.1111/j.1479-828X.2005.00415.x; Lakeman MME, 2013, INT UROGYNECOL J, V24, P371, DOI 10.1007/s00192-012-1973-y; Maher C, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004014.pub5; Morgan DM, 2007, OBSTET GYNECOL, V109, P1424, DOI 10.1097/01.AOG.0000264066.89094.21; MORLEY GW, 1988, AM J OBSTET GYNECOL, V158, P872, DOI 10.1016/0002-9378(88)90088-9; Nygaard I, 2013, JAMA-J AM MED ASSOC, V309, P2016, DOI 10.1001/jama.2013.4919; Olsen AL, 1997, OBSTET GYNECOL, V89, P501, DOI 10.1016/S0029-7844(97)00058-6; Richter HE, 2010, NEW ENGL J MED, V362, P2066, DOI 10.1056/NEJMoa0912658; Roshanravan SM, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.08.061; SANDVIK H, 1993, J EPIDEMIOL COMMUN H, V47, P497, DOI 10.1136/jech.47.6.497; Shull BL, 2000, AM J OBSTET GYNECOL, V183, P1365, DOI 10.1067/mob.2000.110910; Shull BL, 1999, AM J OBSTET GYNECOL, V181, P6, DOI 10.1016/S0002-9378(99)70427-8; Sze EHM, 1997, OBSTET GYNECOL, V89, P466, DOI 10.1016/S0029-7844(96)00337-7; Toozs-Hobson P, 1998, BRIT J OBSTET GYNAEC, V105, P13, DOI 10.1111/j.1471-0528.1998.tb09343.x; US Food and Drug Administration, UROGYNECOLOGIC SURGI; Vakili B, 2005, AM J OBSTET GYNECOL, V192, P1592, DOI 10.1016/j.ajog.2004.11.022	38	249	266	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2014	311	10					1023	1034		10.1001/jama.2014.1719	http://dx.doi.org/10.1001/jama.2014.1719			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC5QO	24618964	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000332575800020
J	Cundy, T; Ackermann, E; Ryan, EA				Cundy, Tim; Ackermann, Evan; Ryan, Edmond A.			TOO MUCH MEDICINE Gestational diabetes: new criteria may triple the prevalence but effect on outcomes is unclear	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GLUCOSE-TOLERANCE; INTERNATIONAL ASSOCIATION; PREPREGNANCY OVERWEIGHT; RANDOMIZED-TRIAL; BIRTH-WEIGHT; PREGNANCY; MELLITUS; DIAGNOSIS; WOMEN; CLASSIFICATION		[Cundy, Tim] Univ Auckland, Dept Med, Fac Med & Hlth Sci, Auckland 1, New Zealand; [Ackermann, Evan] Condamine Med Ctr, Warwick, Qld, Australia; [Ackermann, Evan; Ryan, Edmond A.] Univ Alberta, Dept Med, Edmonton, AB T6G 2S2, Canada	University of Auckland; University of Alberta	Ryan, EA (corresponding author), Univ Alberta, Dept Med, Edmonton, AB T6G 2S2, Canada.	edmond.ryan@ualberta.ca		Cundy, Timothy/0000-0003-4890-9400				Balion CM, 2007, CLIN CHEM LAB MED, V45, P1180, DOI 10.1515/CCLM.2007.250; Black MH, 2013, DIABETES CARE, V36, P56, DOI 10.2337/dc12-0741; Buckley BS, 2012, DIABETIC MED, V29, P844, DOI 10.1111/j.1464-5491.2011.03541.x; CARRINGTON ER, 1957, OBSTET GYNECOL, V9, P664, DOI 10.1097/00006250-195706000-00008; Crowther CA, 2005, NEW ENGL J MED, V352, P2477, DOI 10.1056/NEJMoa042973; Cutchie WA, 2006, DIABETIC MED, V23, P460, DOI 10.1111/j.1464-5491.2006.01850.x; Falavigna M, 2012, DIABETES RES CLIN PR, V98, P396, DOI 10.1016/j.diabres.2012.09.002; Farrell T, 2002, DIABETIC MED, V19, P322, DOI 10.1046/j.1464-5491.2002.00700.x; Griffin ME, 2000, DIABETIC MED, V17, P26, DOI 10.1046/j.1464-5491.2000.00214.x; Grimes DA, 2012, OBSTET GYNECOL, V120, P920, DOI 10.1097/AOG.0b013e31826af61a; HARRIS M, 1979, DIABETES, V28, P1039; Horvath K, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1395; Landon MB, 2009, NEW ENGL J MED, V361, P1339, DOI 10.1056/NEJMoa0902430; Ludwig DS, 2010, LANCET, V376, P984, DOI 10.1016/S0140-6736(10)60751-9; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Mission JF, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.048; Naylor CD, 1996, JAMA-J AM MED ASSOC, V275, P1165, DOI 10.1001/jama.275.15.1165; NEIGER R, 1991, AM J OBSTET GYNECOL, V165, P787, DOI 10.1016/0002-9378(91)90418-Q; Pirkola J, 2010, J CLIN ENDOCR METAB, V95, P772, DOI 10.1210/jc.2009-1075; Quinlivan JA, 2011, AUST NZ J OBSTET GYN, V51, P141, DOI 10.1111/j.1479-828X.2010.01268.x; Ricart W, 2005, DIABETOLOGIA, V48, P1736, DOI 10.1007/s00125-005-1877-1; Ryan EA, 2011, DIABETOLOGIA, V54, P480, DOI 10.1007/s00125-010-2005-4; SPRATT IL, 1980, DIABETES CARE, V3, P499; Thompson D, 2013, CAN J DIABETES, V37, pS168, DOI 10.1016/j.jcjd.2013.01.044; THOMPSON DM, 1994, OBSTET GYNECOL, V83, P362; Vandorsten James P, 2013, NIH Consens State Sci Statements, V29, P1; Werner EF, 2012, DIABETES CARE, V35, P529, DOI 10.2337/dc11-1643; WHO Study Group, 2013, DIAGN CRIT CLASS HYP	29	91	91	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2014	348								g1567	10.1136/bmj.g1567	http://dx.doi.org/10.1136/bmj.g1567			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD1ZL	24618099				2022-12-28	WOS:000333032100001
J	Bald, T; Quast, T; Landsberg, J; Rogava, M; Glodde, N; Lopez-Ramos, D; Kohlmeyer, J; Riesenberg, S; van den Boorn-Konijnenberg, D; Homig-Holzel, C; Reuten, R; Schadow, B; Weighardt, H; Wenzel, D; Helfrich, I; Schadendorf, D; Bloch, W; Bianchi, ME; Lugassy, C; Barnhill, RL; Koch, M; Fleischmann, BK; Forster, I; Kastenmuller, W; Kolanus, W; Holzel, M; Gaffal, E; Tuting, T				Bald, Tobias; Quast, Thomas; Landsberg, Jennifer; Rogava, Meri; Glodde, Nicole; Lopez-Ramos, Dorys; Kohlmeyer, Judith; Riesenberg, Stefanie; van den Boorn-Konijnenberg, Debby; Hoemig-Hoelzel, Cornelia; Reuten, Raphael; Schadow, Benjamin; Weighardt, Heike; Wenzel, Daniela; Helfrich, Iris; Schadendorf, Dirk; Bloch, Wilhelm; Bianchi, Marco E.; Lugassy, Claire; Barnhill, Raymond L.; Koch, Manuel; Fleischmann, Bernd K.; Foerster, Irmgard; Kastenmueller, Wolfgang; Kolanus, Waldemar; Hoelzel, Michael; Gaffal, Evelyn; Tueting, Thomas			Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma	NATURE			English	Article							CIRCULATING TUMOR-CELLS; MALIGNANT-MELANOMA; CYTOKINE RELEASE; ANGIOGENESIS; NEUTROPHILS; EXPRESSION; PROTEIN; IMMUNE; STAGE; MOUSE	Intermittent intense ultraviolet (UV) exposure represents an important aetiological factor in the development of malignant melanoma(1). The ability of UV radiation to cause tumour-initiating DNA mutations in melanocytes is now firmly established(2), but how the microenvironmental effects of UV radiation(3,4) influence melanoma pathogenesis is not fully understood. Here we report that repetitive UV exposure of primary cutaneous melanomas in a genetically engineered mouse model(5) promotes metastatic progression, independent of its tumour-initiating effects. UV irradiation enhanced the expansion of tumour cells along abluminal blood vessel surfaces and increased the number of lung metastases. This effect depended on the recruitment and activation of neutrophils, initiated by the release of high mobility group box 1 (HMGB1) from UV-damaged epidermal keratinocytes and driven by Toll-like receptor 4 (TLR4). The UV-induced neutrophilic inflammatory response stimulated angiogenesis and promoted the ability of melanoma cells to migrate towards endothelial cells and use selective motility cues on their surfaces. Our results not only reveal how UV irradiation of epidermal keratinocytes is sensed by the innate immune system, but also show that the resulting inflammatory response catalyses reciprocal melanoma-endothelial cell interactions leading to perivascular invasion, a phenomenon originally described as angiotropism in human melanomas by histopathologists(6). Angiotropism represents a hitherto underappreciated mechanism of metastasis(7) that also increases the likelihood of intravasation and haematogenous dissemination. Consistent with our findings, ulcerated primary human melanomas with abundant neutrophils and reactive angiogenesis frequently show angiotropism and a high risk for metastases. Our work indicates that targeting the inflammation-induced phenotypic plasticity of melanoma cells and their association with endothelial cells represent rational strategies to specifically interfere with metastatic progression.	[Bald, Tobias; Landsberg, Jennifer; Rogava, Meri; Glodde, Nicole; Lopez-Ramos, Dorys; Kohlmeyer, Judith; Gaffal, Evelyn; Tueting, Thomas] Univ Bonn, Dept Dermatol & Allergy, Lab Expt Dermatol, D-53115 Bonn, Germany; [Quast, Thomas; Schadow, Benjamin; Weighardt, Heike; Foerster, Irmgard; Kolanus, Waldemar] Univ Bonn, Life & Med Sci Inst, D-53115 Bonn, Germany; [Riesenberg, Stefanie; van den Boorn-Konijnenberg, Debby; Hoemig-Hoelzel, Cornelia; Hoelzel, Michael] Univ Bonn, Dept Clin Chem & Clin Pharmacol, Unit RNA Biol, D-53105 Bonn, Germany; [Reuten, Raphael; Koch, Manuel] Univ Cologne, Inst Dent Res & Oral Musculoskeletal Biol, Fac Med, Ctr Biochem, D-50931 Cologne, Germany; [Wenzel, Daniela; Fleischmann, Bernd K.] Univ Bonn, Life & Brain Ctr, Inst Physiol 1, D-53105 Bonn, Germany; [Helfrich, Iris; Schadendorf, Dirk] Univ Hosp Essen, Dept Dermatol, D-45122 Essen, Germany; [Bloch, Wilhelm] German Sport Univ Cologne, Inst Cardiovasc Res & Sport Med, Dept Mol & Cellular Sport Med, D-50933 Cologne, Germany; [Bianchi, Marco E.] San Raffaele Univ & Sci Inst, Div Genet & Cell Biol, I-20132 Milan, Italy; [Lugassy, Claire; Barnhill, Raymond L.] Univ Calif Los Angeles, Med Ctr, Jonsson Comprehens Canc Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Kastenmueller, Wolfgang] Univ Bonn, Inst Mol Med & Expt Immunol, D-53105 Bonn, Germany	University of Bonn; University of Bonn; University of Bonn; University of Cologne; University of Bonn; University of Duisburg Essen; German Sport University Cologne; Vita-Salute San Raffaele University; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of Bonn	Holzel, M (corresponding author), Univ Bonn, Dept Clin Chem & Clin Pharmacol, Unit RNA Biol, D-53105 Bonn, Germany.	michael.hoelzel@ukb.uni-bonn.de; evelyn.gaffal@ukb.uni-bonn.de; thomas.tueting@ukb.uni-bonn.de	Bianchi, Marco Emilio/K-3417-2018; Schadendorf, Dirk/AAE-8206-2019; Reuten, Raphael/AAA-3235-2022; Landsberg, Jennifer/AAF-5113-2019; Bald, Tobias/H-9525-2018; Förster, Irmgard/P-8545-2016; Tüting, Thomas/AAJ-3610-2021; Landsberg, Jenny/AGI-0216-2022; Wenzel, Daniela/B-7613-2014; Koch, Manuel/AAG-9914-2021	Bianchi, Marco Emilio/0000-0002-5329-6445; Reuten, Raphael/0000-0002-9434-4108; Bald, Tobias/0000-0003-0061-235X; Förster, Irmgard/0000-0002-7644-5642; Tüting, Thomas/0000-0001-7146-0934; Landsberg, Jenny/0000-0001-8029-3883; Wenzel, Daniela/0000-0003-1100-6363; Koch, Manuel/0000-0002-2962-7814; Sirokay, Judith/0000-0003-3945-845X; Rogava, Meri/0000-0002-0314-5323	Deutsche Krebshilfe P9 in the Melanoma Research Network; DFG [SFB832, SFB704, HO 4281/2-1, SFB829, SFB829 Z2]; BONFOR; NRW junior research group; Jurgen Manchot Stiftung; AIRC	Deutsche Krebshilfe P9 in the Melanoma Research Network(Deutsche Krebshilfe); DFG(German Research Foundation (DFG)); BONFOR; NRW junior research group; Jurgen Manchot Stiftung; AIRC(Fondazione AIRC per la ricerca sul cancro)	We would like to thank the following individuals for their support: G. Merlino, M. Barbacid, A. Nagy, M. Gertsenstein and J. Takeda for generously providing genetically engineered mice; S. Bald, A. Sporleder, C. Lemke, T. Artz and P. Aymans for managing the mouse colony and performing tumour analyses. This research was funded in part by the following grants: Deutsche Krebshilfe P9 in the Melanoma Research Network and DFG A12 in the SFB832 as well as A22 in the SFB704 to T.T., BONFOR to J.L., J.K. and C.H.-H., DFG SFB832 core support and HO 4281/2-1 to M.H., DFG A7 in the SFB832 and A2 in the SFB829 to M.K., DFG A8 in the SFB704 to W. Ko., DFG A1 in the SFB704 to I.F., DFG SFB829 Z2 to W.B., NRW junior research group to D.W., Jurgen Manchot Stiftung to H.W. and AIRC to M.E.B. Additionally, the DFG supports I.F., W.Ka., W.Ko., M.H. and T.T. as members of the Excellence Cluster ImmunoSensation.	Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Barnhill R, 2002, J INVEST DERMATOL, V119, P705, DOI 10.1046/j.1523-1747.2002.01871.x; Barnhill RL, 2004, PATHOLOGY, V36, P485, DOI 10.1080/00313020412331282708; Bernard JJ, 2012, NAT MED, V18, P1286, DOI 10.1038/nm.2861; Bloch W, 2000, FASEB J, V14, P2373; Chang YM, 2009, INT J EPIDEMIOL, V38, P814, DOI 10.1093/ije/dyp166; Cools-Lartigue J, 2013, J CLIN INVEST, V123, P3446, DOI 10.1172/JCI67484; Dunning MJ, 2007, BIOINFORMATICS, V23, P2183, DOI 10.1093/bioinformatics/btm311; Eggermont AMM, 2012, EUR J CANCER, V48, P218, DOI 10.1016/j.ejca.2011.09.028; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Gaffal E, 2013, J IMMUNOL, V190, P4929, DOI 10.4049/jimmunol.1201777; Gaffal E, 2011, INT J CANCER, V129, P285, DOI 10.1002/ijc.25913; Gais P, 2012, J IMMUNOL, V188, P5833, DOI 10.4049/jimmunol.1200038; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Guo ZS, 2013, AM J CANCER RES, V3, P1; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Haass NK, 2005, J INVEST DERM SYMP P, V10, P153, DOI 10.1111/j.1087-0024.2005.200407.x; Hiratsuka S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2856; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Huh SJ, 2010, CANCER RES, V70, P6071, DOI 10.1158/0008-5472.CAN-09-4442; Jablonska J, 2010, J CLIN INVEST, V120, P1151, DOI 10.1172/JCI37223; Jensen TO, 2012, CANCER-AM CANCER SOC, V118, P2476, DOI 10.1002/cncr.26511; Kastenmuller W, 2012, CELL, V150, P1235, DOI 10.1016/j.cell.2012.07.021; Kholmanskikh O, 2010, INT J CANCER, V127, P1625, DOI 10.1002/ijc.25182; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Kirschmann DA, 2012, CLIN CANCER RES, V18, P2726, DOI 10.1158/1078-0432.CCR-11-3237; Kohlmeyer J, 2009, CANCER RES, V69, P6265, DOI 10.1158/0008-5472.CAN-09-0579; Landsberg J, 2012, NATURE, V490, P412, DOI 10.1038/nature11538; Lange SS, 2008, P NATL ACAD SCI USA, V105, P10320, DOI 10.1073/pnas.0803181105; Lin WM, 2008, CANCER RES, V68, P664, DOI 10.1158/0008-5472.CAN-07-2615; Lugassy C, 2013, PIGM CELL MELANOMA R, V26, P746, DOI 10.1111/pcmr.12120; Lugassy C, 2013, CANCER MICROENVIRON, V6, P19, DOI 10.1007/s12307-012-0128-5; Mittal D, 2010, EMBO J, V29, P2242, DOI 10.1038/emboj.2010.94; Mollica L, 2007, CHEM BIOL, V14, P431, DOI 10.1016/j.chembiol.2007.03.007; Nagy N, 2009, DEV BIOL, V330, P263, DOI 10.1016/j.ydbio.2009.03.025; Nicosia RF, 2009, J CELL MOL MED, V13, P4113, DOI 10.1111/j.1582-4934.2009.00891.x; Pflicke H, 2009, J EXP MED, V206, P2925, DOI 10.1084/jem.20091739; Schiraldi M, 2012, J EXP MED, V209, P551, DOI 10.1084/jem.20111739; Schmidt H, 2007, J CLIN ONCOL, V25, P1562, DOI 10.1200/JCO.2006.09.0274; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tarutani M, 1997, P NATL ACAD SCI USA, V94, P7400, DOI 10.1073/pnas.94.14.7400; TRONNIER M, 1995, J INVEST DERMATOL, V104, P475, DOI 10.1111/1523-1747.ep12605910; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Venereau E, 2012, J EXP MED, V209, P1519, DOI 10.1084/jem.20120189; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; Zaidi MR, 2011, NATURE, V469, P548, DOI 10.1038/nature09666	51	412	429	2	143	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					109	+		10.1038/nature13111	http://dx.doi.org/10.1038/nature13111			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0ZQ	24572365				2022-12-28	WOS:000332224400052
J	Bourzac, K				Bourzac, Katherine			INFECTIOUS DISEASE Beating the big three	NATURE			English	Editorial Material																			0	17	20	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					S4	S7		10.1038/507S4a	http://dx.doi.org/10.1038/507S4a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC0ZQ	24611168	Bronze			2022-12-28	WOS:000332224400003
J	Chen, F; Lam, CH; Tsui, OKC				Chen, Fei; Lam, Chi-Hang; Tsui, Ophelia K. C.			The Surface Mobility of Glasses	SCIENCE			English	Editorial Material							FILMS; DYNAMICS; POLYMERS		[Chen, Fei; Tsui, Ophelia K. C.] Boston Univ, Dept Phys, Boston, MA 02215 USA; [Lam, Chi-Hang] Hong Kong Polytech Univ, Dept Appl Phys, Hong Kong, Hong Kong, Peoples R China; [Tsui, Ophelia K. C.] Boston Univ, Div Mat Sci & Engn, Boston, MA 02215 USA	Boston University; Hong Kong Polytechnic University; Boston University	Chen, F (corresponding author), Boston Univ, Dept Phys, 590 Commonwealth Ave, Boston, MA 02215 USA.	c.h.lam@polyu.edu.hk; okctsui@bu.edu	Lam, Chi-Hang/A-4626-2009; CHEN, FEI/D-5037-2015	Lam, Chi-Hang/0000-0002-0476-1857; CHEN, FEI/0000-0002-0828-9211; Tsui, Ophelia K. C./0000-0001-5987-2733				Baschnagel J, 2005, J PHYS-CONDENS MAT, V17, pR851, DOI 10.1088/0953-8984/17/32/R02; Chai Y, 2014, SCIENCE, V343, P994, DOI 10.1126/science.1244845; Fakhraai Z, 2008, SCIENCE, V319, P600, DOI 10.1126/science.1151205; GOMER R, 1990, REP PROG PHYS, V53, P917, DOI 10.1088/0034-4885/53/7/002; Hamdorf M, 2000, J CHEM PHYS, V112, P4262, DOI 10.1063/1.481002; Hutcheson SA, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.076103; KEDDIE JL, 1994, EUROPHYS LETT, V27, P59, DOI 10.1209/0295-5075/27/1/011; Kim H, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.068302; Lam CH, 2012, LANGMUIR, V28, P10217, DOI 10.1021/la301884j; MULLINS WW, 1959, J APPL PHYS, V30, P77, DOI 10.1063/1.1734979; Paeng K, 2011, J AM CHEM SOC, V133, P8444, DOI 10.1021/ja2022834; Yang ZH, 2010, SCIENCE, V328, P1676, DOI 10.1126/science.1184394; Zhu L, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.256103	13	32	35	1	138	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2014	343	6174					975	976		10.1126/science.1248113	http://dx.doi.org/10.1126/science.1248113			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2DZ	24578568				2022-12-28	WOS:000332309600027
J	Buchwalter, A; Hetzer, MW				Buchwalter, Abigail; Hetzer, Martin W.			Nuclear Pores Set the Speed Limit for Mitosis	CELL			English	Editorial Material							SPINDLE-ASSEMBLY CHECKPOINT; CDC20; MAD2		[Buchwalter, Abigail; Hetzer, Martin W.] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA	Salk Institute	Hetzer, MW (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hetzer@salk.edu			NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM103084] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA014195] Funding Source: Medline; NIGMS NIH HHS [F32 GM103084] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Collin P, 2013, NAT CELL BIOL, V15, P1378, DOI 10.1038/ncb2855; Fraschini R, 2001, EMBO J, V20, P6648, DOI 10.1093/emboj/20.23.6648; Kohler A, 2010, MOL CELL, V38, P6, DOI 10.1016/j.molcel.2010.01.040; Lee SH, 2008, GENE DEV, V22, P2926, DOI 10.1101/gad.1677208; Maciejowski J, 2010, J CELL BIOL, V190, P89, DOI 10.1083/jcb.201001050; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Rodriguez-Bravo V, 2014, CELL, V156, P1017, DOI 10.1016/j.cell.2014.01.010; Schweizer N, 2013, J CELL BIOL, V203, P883, DOI 10.1083/jcb.201309076; Sironi L, 2002, EMBO J, V21, P2496, DOI 10.1093/emboj/21.10.2496	10	3	3	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 27	2014	156	5					868	869		10.1016/j.cell.2014.02.004	http://dx.doi.org/10.1016/j.cell.2014.02.004			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AB9BK	24581486	Bronze, Green Accepted			2022-12-28	WOS:000332083900004
J	Vadodaria, KC; Gage, FH				Vadodaria, Krishna C.; Gage, Fred H.			SnapShot: Adult Hippocampal Neurogenesis	CELL			English	Editorial Material							NEURONS		[Vadodaria, Krishna C.; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA	Salk Institute	Vadodaria, KC (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Vadodaria, Krishna C./H-1711-2017	Vadodaria, Krishna C./0000-0002-3455-0209				Aimone JB, 2010, TRENDS COGN SCI, V14, P325, DOI 10.1016/j.tics.2010.04.003; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Duan X, 2008, CURR OPIN NEUROBIOL, V18, P108, DOI 10.1016/j.conb.2008.04.001; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Gage F, 2008, COLD SPRING HARBOR M, V52; Kempermann G, 2011, EUR J NEUROSCI, V33, P1018, DOI 10.1111/j.1460-9568.2011.07599.x; Sahay A, 2011, NEURON, V70, P582, DOI 10.1016/j.neuron.2011.05.012; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002	8	35	36	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 27	2014	156	5								10.1016/j.cell.2014.02.029	http://dx.doi.org/10.1016/j.cell.2014.02.029			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CB3QY	24581504	Bronze			2022-12-28	WOS:000349544600001
J	Burton, K; Kendall, N				Burton, Kim; Kendall, Nicholas			ABC of Occupational and Environmental Medicine, 3rd Edition Musculoskeletal Disorders	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material														Burton, Kim/0000-0002-9462-2227				[Anonymous], INFORMATION AND ADVI; [Anonymous], INFORMATION BOOKLETS; Australian Acute Musculoskeletal Pain Guidelines Group, 2003, EVIDENCE BASED MANAG; Burton AK, 2008, MANAGEMENT OF UPPER; Carter JT, 2000, OCCUPATIONAL HEALTH; European Commission Research Directorate General, 2004, LOW BACK PAIN GUIDEL; FOM, 2009, UPPER LIMB DISORDERS; FOM, 2005, THE HEALTH AND WORK; Kendall NAS, 2009, ON BEHALF OF THE FLA; Waddell G, 2008, REPORT FOR THE VOCAT	10	5	5	3	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 21	2014	348								g1076	10.1136/bmj.g1076	http://dx.doi.org/10.1136/bmj.g1076			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB9ZU	24561301				2022-12-28	WOS:000332155100001
J	Kim, SYH; Miller, FG				Kim, Scott Y. H.; Miller, Franklin G.			Informed Consent for Pragmatic Trials - The Integrated Consent Model	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									[Kim, Scott Y. H.; Miller, Franklin G.] NIH, Dept Bioeth, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Kim, SYH (corresponding author), NIH, Dept Bioeth, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA.				CLINICAL CENTER [ZIACL010538] Funding Source: NIH RePORTER	CLINICAL CENTER		Berg JW, 2001, INFORM CONSENT LEGAL; Department of Health and Human Services, 2013, FED REGISTER, V78, P38343; Faden R, 2013, MED CARE, V51, pS53, DOI 10.1097/MLR.0b013e31829b1e4b; Faden RR, 2013, HASTINGS CENT REP, V43, pS16, DOI 10.1002/hast.134; Feudtner C, 2013, NEW ENGL J MED, V369, P892, DOI 10.1056/NEJMp1309322; Flory James, 2012, Am J Public Health, V102, pe8, DOI 10.2105/AJPH.2012.301036; Kass NE, 2013, HASTINGS CENT REP, V43, pS4, DOI 10.1002/hast.133; Kim S, 2009, NATURE, V457, P534, DOI 10.1038/457534a; Largent EA, 2011, HASTINGS CENT REP, V41, P37; Olsen L., 2007, LEARNING HEALTHCARE, DOI DOI 10.17226/; Tilburt JC, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1938; Truog RD, 1999, NEW ENGL J MED, V340, P804, DOI 10.1056/NEJM199903113401013; van Staa TP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e55	13	114	114	1	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 20	2014	370	8					769	772		10.1056/NEJMhle1312508	http://dx.doi.org/10.1056/NEJMhle1312508			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AB1DO	24552326				2022-12-28	WOS:000331531900014
J	Moyer, VA				Moyer, Virginia A.		US Preventive Serv Task Force	Primary Care Behavioral Interventions to Reduce Illicit Drug and Nonmedical Pharmaceutical Use in Children and Adolescents: US Preventive Services Task Force Recommendation Statement	ANNALS OF INTERNAL MEDICINE			English	Article							MOTHER-DAUGHTER PROGRAM; SUBSTANCE USE; OUTCOMES; GIRLS; COMPUTER; TRIAL	Description: Update of the 2008 U. S. Preventive Services Task Force (USPSTF) recommendation on screening for illicit drug use. Methods: The USPSTF reviewed the evidence on interventions to help adolescents who have never used drugs to remain abstinent and interventions to help adolescents who are using drugs but do not meet criteria for a substance use disorder to reduce or stop their use. Population: This recommendation applies to children and adolescents younger than age 18 years who have not been diagnosed with a substance use disorder. Recommendation: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of primary care-based behavioral interventions to prevent or reduce illicit drug or nonmedical pharmaceutical use in children and adolescents. (I statement)	[Moyer, Virginia A.; US Preventive Serv Task Force] US Prevent Serv Task ForceM, Rockville, MD 20850 USA		Moyer, VA (corresponding author), US Prevent Serv Task ForceM, Rockville, MD 20850 USA.		Phillips, William R./V-1065-2017	Phillips, William R./0000-0003-2802-4349				Fang L, 2013, PSYCHOL ADDICT BEHAV, V27, P788, DOI 10.1037/a0030925; Fang L, 2010, J ADOLESCENT HEALTH, V47, P529, DOI 10.1016/j.jadohealth.2010.03.011; Harris SK, 2012, PEDIATRICS, V129, P1072, DOI 10.1542/peds.2011-1624; Johnston L.D., 2013, MONITORING FUTURE NA; Patnode CD, 2014, AHRQ PUBLICATION, V106; Schinke SP, 2009, PREV MED, V49, P429, DOI 10.1016/j.ypmed.2009.08.001; Schinke SP, 2009, ADDICT BEHAV, V34, P1060, DOI 10.1016/j.addbeh.2009.06.007; Substance Abuse and Mental Health Services Administration, 2013, NSDUH SER H, VH-46; Substance Abuse and Mental Health Services Administration, NSDUH SER, VSMA, P13; US Preventive Services Task Force, 2008, SCREEN ILL DRUG US; Walton MA, 2013, DRUG ALCOHOL DEPEN, V132, P646, DOI 10.1016/j.drugalcdep.2013.04.020; Williams JF, 2011, PEDIATRICS, V128, pE1330, DOI 10.1542/peds.2011-1754	12	18	18	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 6	2014	160	9					634	U208		10.7326/M14-0334	http://dx.doi.org/10.7326/M14-0334			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AI0GO	24615535				2022-12-28	WOS:000336524400005
J	Beuschlein, F; Fassnacht, M; Assie, G; Calebiro, D; Stratakis, CA; Osswald, A; Ronchi, CL; Wieland, T; Sbiera, S; Faucz, FR; Schaak, K; Schmittfull, A; Schwarzmayr, T; Barreau, O; Vezzosi, D; Rizk-Rabin, M; Zabel, U; Szarek, E; Salpea, P; Forlino, A; Vetro, A; Zuffardi, O; Kisker, C; Diener, S; Meitinger, T; Lohse, MJ; Reincke, M; Bertherat, J; Strom, TM; Allolio, B				Beuschlein, Felix; Fassnacht, Martin; Assie, Guillaume; Calebiro, Davide; Stratakis, Constantine A.; Osswald, Andrea; Ronchi, Cristina L.; Wieland, Thomas; Sbiera, Silviu; Faucz, Fabio R.; Schaak, Katrin; Schmittfull, Anett; Schwarzmayr, Thomas; Barreau, Olivia; Vezzosi, Delphine; Rizk-Rabin, Marthe; Zabel, Ulrike; Szarek, Eva; Salpea, Paraskevi; Forlino, Antonella; Vetro, Annalisa; Zuffardi, Orsetta; Kisker, Caroline; Diener, Susanne; Meitinger, Thomas; Lohse, Martin J.; Reincke, Martin; Bertherat, Jerome; Strom, Tim M.; Allolio, Bruno			Constitutive Activation of PKA Catalytic Subunit in Adrenal Cushing's Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PROTEIN-KINASE-A; ADRENOCORTICAL TUMORS; REGULATORY SUBUNIT; SOMATIC MUTATIONS; CARNEY COMPLEX; GENE; HYPERPLASIA; EXPRESSION; MANAGEMENT; RECEPTOR	BackgroundCorticotropin-independent Cushing's syndrome is caused by tumors or hyperplasia of the adrenal cortex. The molecular pathogenesis of cortisol-producing adrenal adenomas is not well understood. MethodsWe performed exome sequencing of tumor-tissue specimens from 10 patients with cortisol-producing adrenal adenomas and evaluated recurrent mutations in candidate genes in an additional 171 patients with adrenocortical tumors. We also performed genomewide copy-number analysis in 35 patients with cortisol-secreting bilateral adrenal hyperplasias. We studied the effects of these genetic defects both clinically and in vitro. ResultsExome sequencing revealed somatic mutations in PRKACA, which encodes the catalytic subunit of cyclic AMP-dependent protein kinase (protein kinase A [PKA]), in 8 of 10 adenomas (c.617AC in 7 and c.595_596insCAC in 1). Overall, PRKACA somatic mutations were identified in 22 of 59 unilateral adenomas (37%) from patients with overt Cushing's syndrome; these mutations were not detectable in 40 patients with subclinical hypercortisolism or in 82 patients with other adrenal tumors. Among 35 patients with cortisol-producing hyperplasias, 5 (including 2 first-degree relatives) carried a germline copy-number gain (duplication) of the genomic region on chromosome 19 that includes PRKACA. In vitro studies showed impaired inhibition of both PKA catalytic subunit mutants by the PKA regulatory subunit, whereas cells from patients with germline chromosomal gains showed increased protein levels of the PKA catalytic subunit; in both instances, basal PKA activity was increased. ConclusionsGenetic alterations of the catalytic subunit of PKA were found to be associated with human disease. Germline duplications of this gene resulted in bilateral adrenal hyperplasias, whereas somatic PRKACA mutations resulted in unilateral cortisol-producing adrenal adenomas. (Funded by the European Commission Seventh Framework Program and others.) Corticotropin-independent Cushing's syndrome occurs with adrenocortical tumors or hyperplasia. The authors report that germline duplications of PRKACA lead to bilateral adrenal hyperplasia, whereas somatic mutations lead to unilateral cortisol-producing adrenal adenomas. Endogenous hypercortisolism, referred to as Cushing's syndrome, is associated with substantial morbidity and mortality.(1) When Cushing's syndrome is severe, patients have catabolic symptoms such as muscle weakness, skin fragility, osteoporosis, and severe metabolic sequelae.(2) Hypersecretion of cortisol can be driven by an excess of pituitary or ectopic corticotropin or can be due to adrenocortical tumors or hyperplasias with corticotropin-independent cortisol production. Adrenal adenomas are common, with a prevalence of at least 3% among persons older than 50 years of age.(3) Whereas only a subset of these tumors is associated with overt Cushing's syndrome, some degree of cortisol excess is present, ...	[Beuschlein, Felix; Fassnacht, Martin; Osswald, Andrea; Sbiera, Silviu; Schaak, Katrin; Reincke, Martin] Univ Munich, Med Klin & Poliklin IV, Munich, Germany; [Meitinger, Thomas; Strom, Tim M.] Tech Univ Munich, Inst Human Genet, D-80290 Munich, Germany; [Meitinger, Thomas; Strom, Tim M.] Munich Heart Alliance, Deutsch Zentrum Herz Kreislauf Forsch, Munich, Germany; [Fassnacht, Martin; Sbiera, Silviu; Allolio, Bruno] Univ Wurzburg, Dept Med 1, Endocrine & Diabet Unit, Univ Hosp, D-97070 Wurzburg, Germany; [Fassnacht, Martin; Lohse, Martin J.; Allolio, Bruno] Univ Wurzburg, Comprehens Heart Failure Ctr, D-97070 Wurzburg, Germany; [Calebiro, Davide; Zabel, Ulrike; Lohse, Martin J.] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97070 Wurzburg, Germany; [Calebiro, Davide; Kisker, Caroline; Lohse, Martin J.] Univ Wurzburg, Rudolf Virchow Ctr, D-97070 Wurzburg, Germany; [Calebiro, Davide; Kisker, Caroline; Lohse, Martin J.] Univ Wurzburg, Deutsch Forschungsgemeinschaft Res Ctr Expt Biome, D-97070 Wurzburg, Germany; [Ronchi, Cristina L.] Univ Wurzburg, Comprehens Canc Ctr Mainfranken, D-97070 Wurzburg, Germany; [Wieland, Thomas; Schmittfull, Anett; Schwarzmayr, Thomas; Diener, Susanne; Meitinger, Thomas; Strom, Tim M.] Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Assie, Guillaume; Barreau, Olivia; Vezzosi, Delphine; Rizk-Rabin, Marthe; Bertherat, Jerome] Univ Paris 05, Ctr Natl Rech Scientif, Unit Mixte Rech 8104, INSERM Unite 1016,Inst Cochin,Fac Med,Sorbonne Pa, Paris, France; [Assie, Guillaume; Barreau, Olivia; Bertherat, Jerome] Hop Cochin, Assistance Publique Hop Paris, Referral Ctr Rare Adrenal Dis, Dept Endocrinol, F-75674 Paris, France; [Stratakis, Constantine A.; Faucz, Fabio R.; Szarek, Eva; Salpea, Paraskevi] NICHHD, Sect Endocrinol & Genet, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20892 USA; [Forlino, Antonella; Zuffardi, Orsetta] Univ Pavia, Dipartimento Med Mol, I-27100 Pavia, Italy; [Vetro, Annalisa] Policlin San Matteo, Fdn Ist Ricovoro & Cura Carattere Sci, Biotechnol Res Lab, I-27100 Pavia, Italy	University of Munich; Technical University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Pavia; IRCCS Fondazione San Matteo	Fassnacht, M (corresponding author), Univ Hosp Wurzburg, Dept Med 1, Oberdurrbacherstr 6, D-97080 Wurzburg, Germany.	fassnacht_m@ukw.de	Sbiera, Silviu/E-8128-2019; Kisker, Caroline/T-1724-2019; Vetro, Annalisa/J-8203-2018; Fassnacht, Martin/N-9614-2019; Faucz, Fabio R/C-1607-2009; Forlino, Antonella/H-5385-2015; Stratakis, Constantine/AAP-4745-2020; vezzosi, delphine/G-2734-2017; Meitinger, Thomas/O-1318-2015; Lohse, Martin J/A-7160-2012; Rizk-Rabin, Marthe/A-1698-2018	Sbiera, Silviu/0000-0002-6271-5533; Vetro, Annalisa/0000-0003-2437-7526; Fassnacht, Martin/0000-0001-6170-6398; Forlino, Antonella/0000-0002-6385-1182; Lohse, Martin J/0000-0002-0599-3510; Faucz, Fabio/0000-0001-7959-9842; Meitinger, Thomas/0000-0002-8838-8403; zuffardi, orsetta/0000-0002-1466-4559; calebiro, davide/0000-0002-3811-1553; Beuschlein, Felix/0000-0001-7826-3984; Kisker, Caroline/0000-0002-0216-6026; Ronchi, Cristina/0000-0001-5020-2071; Rizk-Rabin, Marthe/0000-0003-1558-737X; BERTHERAT, Jerome/0000-0003-2551-3008; Assie, Guillaume/0000-0001-9590-0906	European Commission; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008920] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funded by the European Commission Seventh Framework Program and others.	Bertherat J, 2003, CANCER RES, V63, P5308; Beuschlein F, 2013, NAT GENET, V45, P440, DOI 10.1038/ng.2550; Bimpaki EI, 2009, EUR J ENDOCRINOL, V161, P153, DOI 10.1530/EJE-09-0027; Bonaglia MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002173; Bonnet S, 2011, J CLIN ENDOCR METAB, V96, pE419, DOI 10.1210/jc.2010-1885; Calebiro D, 2006, MOL ENDOCRINOL, V20, P3196, DOI 10.1210/me.2005-0493; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Carney JA, 2011, AM J SURG PATHOL, V35, P1311, DOI 10.1097/PAS.0b013e31821ec4ce; Collier LS, 2004, GENETICS, V167, P783, DOI 10.1534/genetics.103.024992; Das R, 2007, P NATL ACAD SCI USA, V104, P93, DOI 10.1073/pnas.0609033103; Fragoso MCBV, 2003, J CLIN ENDOCR METAB, V88, P2147, DOI 10.1210/jc.2002-021362; Grumbach MM, 2003, ANN INTERN MED, V138, P424, DOI 10.7326/0003-4819-138-5-200303040-00013; Herbst KJ, 2011, MOL CELL BIOL, V31, P4063, DOI 10.1128/MCB.05459-11; Horvath A, 2008, NEW ENGL J MED, V358, P750, DOI 10.1056/NEJMc0706182; Horvath A, 2006, NAT GENET, V38, P794, DOI 10.1038/ng1809; Horvath A, 2010, HUM MUTAT, V31, P369, DOI 10.1002/humu.21178; Hsiao HP, 2009, J CLIN ENDOCR METAB, V94, P2930, DOI 10.1210/jc.2009-0516; Kirschner LS, 2000, NAT GENET, V26, P89, DOI 10.1038/79238; Kirschner LS, 2005, CANCER RES, V65, P4506, DOI 10.1158/0008-5472.CAN-05-0580; Kobayashi H, 2000, ENDOCR J, V47, P461, DOI 10.1507/endocrj.47.461; LACROIX A, 1992, NEW ENGL J MED, V327, P974, DOI 10.1056/NEJM199210013271402; Lacroix A, 1999, NEW ENGL J MED, V341, P1577, DOI 10.1056/NEJM199911183412104; Lacroix A, 2010, CLIN ENDOCRINOL, V73, P1, DOI 10.1111/j.1365-2265.2009.03689.x; Lindholm J, 2001, J CLIN ENDOCR METAB, V86, P117, DOI 10.1210/jc.86.1.117; Louiset E, 2009, J CLIN ENDOCR METAB, V94, P2406, DOI 10.1210/jc.2009-0031; Mansmann G, 2004, ENDOCR REV, V25, P309, DOI 10.1210/er.2002-0031; Meoli E, 2008, CANCER RES, V68, P3133, DOI 10.1158/0008-5472.CAN-08-0064; Newell-Price J, 2006, LANCET, V367, P1605, DOI 10.1016/S0140-6736(06)68699-6; ORELLANA SA, 1992, P NATL ACAD SCI USA, V89, P4726, DOI 10.1073/pnas.89.10.4726; Ronchi CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073959; Ronchi CL, 2012, NEOPLASIA, V14, P206, DOI 10.1593/neo.111758; Stratakis CA, 2013, MOL CELL ENDOCRINOL, V371, P208, DOI 10.1016/j.mce.2013.01.015; Taylor SS, 2012, NAT REV MOL CELL BIO, V13, P646, DOI 10.1038/nrm3432; Terzolo M, 2012, CLIN ENDOCRINOL, V76, P12, DOI 10.1111/j.1365-2265.2011.04253.x; Vincent-Dejean C, 2008, EUR J ENDOCRINOL, V158, P829, DOI 10.1530/EJE-07-0819; Wilmot Roussel H, 2013, J CLIN ENDOCRINOL ME, V98, pE1109; Zhang P, 2012, SCIENCE, V335, P712, DOI 10.1126/science.1213979	37	265	273	2	45	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 13	2014	370	11					1019	1028		10.1056/NEJMoa1310359	http://dx.doi.org/10.1056/NEJMoa1310359			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC7ED	24571724	Green Accepted, Green Published			2022-12-28	WOS:000332689100009
J	Burgoine, T; Forouhi, NG; Griffin, SJ; Wareham, NJ; Monsivais, P				Burgoine, Thomas; Forouhi, Nita G.; Griffin, Simon J.; Wareham, Nicholas J.; Monsivais, Pablo			Associations between exposure to takeaway food outlets, takeaway food consumption, and body weight in Cambridgeshire, UK: population based, cross sectional study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ENERGY-INTAKE; MASS INDEX; HEART-RATE; ENVIRONMENT; ADULTS; NEIGHBORHOOD; DIETARY; RESTAURANTS; ESTABLISHMENTS; OBESITY	Objectives To examine the association between environmental exposure to takeaway food outlets, takeaway food consumption, and body weight, while accounting for home, work place, and commuting route environments. Design Population based, cross sectional study, using data on individual participants' diet and weight, and objective metrics of food environment exposure. Participants Working adults participating in the Fenland Study, Cambridgeshire, UK (n=5442, aged 29-62 years), who provided home and work addresses and commuting preferences. Takeaway food outlet exposure was derived using data from local authorities for individual environmental domains (at home, at work, and along commuting routes (the shortest route between home and work)), and for exposure in all three domains combined. Exposure was divided into quarters (Q); Q1 being the least exposed and Q4 being the most exposed. Main outcome measures Self reported consumption of takeaway type food (g/day; pizza, burgers, fried foods, and chips) using food frequency questionnaires, measured body mass index, and cut-offs for body mass index as defined by the World Health Organization. Results In multiple linear regression models, exposure to takeaway food outlets was positively associated with consumption of takeaway food. Among domains at home, at work, and along commuting routes, associations were strongest in work environments (Q4 v Q1; beta coefficient=5.3 g/day, 95% confidence interval 1.6 to 8.7; P<0.05), with evidence of a dose-response effect. Associations between exposure in all three domains combined and consumption were greater in magnitude across quarters of exposure (Q4 v Q1; 5.7 g/day, 2.6 to 8.8; P<0.001), with evidence of a dose-response effect. Combined exposure was especially strongly associated with increased body mass index (Q4 v Q1; body mass index 1.21, 0.68 to 1.74; P<0.001) and odds of obesity (Q4 v Q1; odds ratio 1.80, 1.28 to 2.53; P<0.05). There was no evidence of effect modification by sex. Conclusions Exposure to takeaway food outlets in home, work, and commuting environments combined was associated with marginally higher consumption of takeaway food, greater body mass index, and greater odds of obesity. Government strategies to promote healthier diets through planning restrictions for takeaway food could be most effective if focused around the workplace.	[Burgoine, Thomas; Forouhi, Nita G.; Griffin, Simon J.; Wareham, Nicholas J.; Monsivais, Pablo] Univ Cambridge, Sch Clin Med, Inst Metab Sci, MRC,UKCRC Ctr Diet & Act Res,Epidemiol Unit, Cambridge CB2 0QQ, England; [Griffin, Simon J.; Monsivais, Pablo] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England	University of Cambridge; University of Cambridge	Burgoine, T (corresponding author), Univ Cambridge, Sch Clin Med, Inst Metab Sci, MRC,UKCRC Ctr Diet & Act Res,Epidemiol Unit, Box 285,Cambridge Biomed Campus, Cambridge CB2 0QQ, England.	tb464@medschl.cam.ac.uk	Griffin, Simon/K-3106-2013	Griffin, Simon/0000-0002-2157-4797; Monsivais, Pablo/0000-0002-7088-6674; Forouhi, Nita/0000-0002-5041-248X	British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Medical Research Council; National Institute for Health Research; Wellcome Trust under the UK Clinical Research Collaboration; Core MRC Epidemiology Unit [MC_UU_12015/1, MC_UU_12015/5]; ESRC [ES/G007462/1] Funding Source: UKRI; MRC [MC_U106179474, MC_UP_A100_1003, MC_UU_12015/1, MR/K023187/1, MC_UU_12015/4, MC_UU_12015/5] Funding Source: UKRI; Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish; Medical Research Council [MC_UU_12015/1, MC_U106179474, MC_U106179471, MC_UU_12015/4, MC_UU_12015/5, MC_UP_A100_1003, MR/K023187/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10135] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust under the UK Clinical Research Collaboration(Wellcome Trust); Core MRC Epidemiology Unit(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was undertaken by the Centre for Diet and Activity Research, a UK Clinical Research Collaboration Public Health Research Centre of Excellence. Funding from the British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, National Institute for Health Research, and Wellcome Trust, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. Core MRC Epidemiology Unit support through programmes MC_UU_12015/1 and MC_UU_12015/5 is acknowledged. All authors remain independent from funders.	[Anonymous], 2012, NAT STAT FAM FOOD 20; Besson H, 2010, AM J CLIN NUTR, V91, P106, DOI 10.3945/ajcn.2009.28432; Black JL, 2010, HEALTH PLACE, V16, P489, DOI 10.1016/j.healthplace.2009.12.007; Block JP, 2011, AM J EPIDEMIOL, V174, P1108, DOI 10.1093/aje/kwr244; Bonsall P, 2007, REV POTENTIAL ROLE N; Boone-Heinonen J, 2011, ARCH INTERN MED, V171, P1162, DOI 10.1001/archinternmed.2011.283; Bowman SA, 2004, J AM COLL NUTR, V23, P163, DOI 10.1080/07315724.2004.10719357; Bowman SA, 2004, PEDIATRICS, V113, P112, DOI 10.1542/peds.113.1.112; Brage S, 2005, EUR J CLIN NUTR, V59, P561, DOI 10.1038/sj.ejcn.1602118; Brage S, 2004, J APPL PHYSIOL, V96, P343, DOI 10.1152/japplphysiol.00703.2003; Burgoine T, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-85; Burgoine T, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-2; Burgoine T, 2009, APPETITE, V53, P157, DOI 10.1016/j.appet.2009.05.012; Caspi CE, 2012, HEALTH PLACE, V18, P1172, DOI 10.1016/j.healthplace.2012.05.006; Cavill N, 2013, HLTH PEOPLE HLTH PLA; Chaix B, 2012, AM J PREV MED, V43, P440, DOI 10.1016/j.amepre.2012.06.026; Charreire H, 2010, PUBLIC HEALTH NUTR, V13, P1773, DOI 10.1017/S1368980010000753; Condon SK, 2013, BMJ-BRIT MED J, V346, pf2907; Cooper AJM, 2014, DIABETOLOGIA, V57, P73, DOI 10.1007/s00125-013-3069-8; Duffey KJ, 2009, J NUTR, V139, P2113, DOI 10.3945/jn.109.109520; Dumanovsky T., 2011, BRIT MED J, V26, P343; Duncan MJ, 2007, AM J PREV MED, V33, P51, DOI 10.1016/j.amepre.2007.02.042; Feng J, 2010, HEALTH PLACE, V16, P175, DOI 10.1016/j.healthplace.2009.09.008; Fleischhacker SE, 2011, OBES REV, V12, pe460, DOI 10.1111/j.1467-789X.2010.00715.x; Fraser LK, 2010, INT J ENV RES PUB HE, V7, P2290, DOI 10.3390/ijerph7052290; Giskes K, 2007, PUBLIC HEALTH NUTR, V10, P1005, DOI 10.1017/S1368980007665525; Harrison F, 2011, SOC SCI MED, V72, P1411, DOI 10.1016/j.socscimed.2011.02.023; Inagami S, 2007, SOC SCI MED, V65, P1779, DOI 10.1016/j.socscimed.2007.05.051; Jeffery RW, 2006, INT J BEHAV NUTR PHY, V3, P1; Kestens Y, 2010, HEALTH PLACE, V16, P1094, DOI 10.1016/j.healthplace.2010.06.016; Kirkpatrick SI, 2014, AM J PREV MED, V46, P94, DOI 10.1016/j.amepre.2013.08.015; Lachat C, 2012, OBES REV, V13, P329, DOI 10.1111/j.1467-789X.2011.00953.x; Lake AA, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-37; Lake AA, 2010, HEALTH PLACE, V16, P666, DOI 10.1016/j.healthplace.2010.02.004; Larsen K, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-16; Let's move campaign, 2010, AM MOV RAIS HLTH GEN; London Borough of Barking and Dagenham, 2010, SAT POINT A IN PRESS; Lovasi GS, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-10; Matthews SA, 2009, AM J PREV MED, V36, pS171, DOI 10.1016/j.amepre.2009.01.011; McPherson K, 2007, TACKLING OBESITIES F; Mitchell C, 2011, OBES REV, V12, P660, DOI 10.1111/j.1467-789X.2011.00872.x; Moore LV, 2009, AM J EPIDEMIOL, V170, P29, DOI 10.1093/aje/kwp090; Moudon Anne Vernez, 2006, J Phys Act Health, V3, pS99, DOI 10.1123/jpah.3.s1.s99; Panter J, 2007, TACKLING OBESITIES F; Panter JR, 2010, AM J PREV MED, V38, P268, DOI 10.1016/j.amepre.2009.10.040; Patterson R, 2013, BMJ OPEN, V2, P1; Pereira MA, 2005, LANCET, V365, P36, DOI 10.1016/S0140-6736(04)17663-0; Powell LM, 2012, AM J PREV MED, V43, P498, DOI 10.1016/j.amepre.2012.07.041; Rolfe ED, 2010, AM J CLIN NUTR, V92, P347, DOI 10.3945/ajcn.2010.29247; Rundle A, 2009, ENVIRON HEALTH PERSP, V117, P442, DOI 10.1289/ehp.11590; Seliske L, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-19; Smith D, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-70; Smith G, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-34; Smith KJ, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-29; Stark JH, 2013, J EPIDEMIOL COMMUN H, V67, P736, DOI 10.1136/jech-2013-202354; Swinburn B, 2002, Obes Rev, V3, P289; The London Food Board Chartered Institute of Environmental Health, 2012, TAK TOOLK TOOLS INT; The strategy Unit Cabinet Office, 2008, FOOD AN ISS; Timperio A, 2006, AM J PREV MED, V30, P45, DOI 10.1016/j.amepre.2005.08.047; Townshend T, 2009, HEALTH PLACE, V15, P909, DOI 10.1016/j.healthplace.2008.12.002; U.S. Department of Agriculture; Agricultural Research Service, 2011, USDA NAT NUTR DAT ST; Waltham Forest SPD, 2009, WALTH FOR SPD HOT FO; White E, 2008, PRINCIPLES EXPOSURE; White M., 2004, N09010 DO FOOD DESER; Willett WC, 2007, CANCER EPIDEM BIOMAR, V16, P182, DOI 10.1158/1055-9965.EPI-06-0843; Zenk SN, 2011, HEALTH PLACE, V17, P1150, DOI 10.1016/j.healthplace.2011.05.001	66	155	158	3	47	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 13	2014	348								g1464	10.1136/bmj.g1464	http://dx.doi.org/10.1136/bmj.g1464			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD1ZS	24625460	Green Published, hybrid			2022-12-28	WOS:000333032800001
J	Park, EP; Boulmay, BC				Park, E. Peter; Boulmay, Brian C.			Herpes Labialis and Facial- Nerve Paralysis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 65-year-old woman presented to the emergency department with odynophagia, facial edema, and perioral swelling with crusting blisters containing clear fluid. One week earlier, she had completed one cycle of treatment with rituximab and bendamustine for CLL. A 65-year-old woman presented to the emergency department with odynophagia, facial edema, and perioral swelling with crusting blisters containing clear fluid (Panel A). One week earlier, she had completed one cycle of treatment with rituximab and bendamustine for chronic lymphocytic leukemia. In the emergency department, treatment with intravenous acyclovir was started for a clinical diagnosis of herpes labialis. With therapy, the facial edema resolved; the blistered lesions developed an eschar (Panel B) that resolved within 2 weeks. Two days after she started treatment with acyclovir, isolated paralysis of the right side of the face developed, as manifested by the inability ...	[Park, E. Peter; Boulmay, Brian C.] Louisiana State Univ, Hlth Sci Ctr, New Orleans, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Park, EP (corresponding author), Louisiana State Univ, Hlth Sci Ctr, New Orleans, LA USA.	bboulm@lsuhsc.edu		Park, Earl Peter/0000-0003-3328-5703					0	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 13	2014	370	11					1048	1048		10.1056/NEJMicm1305786	http://dx.doi.org/10.1056/NEJMicm1305786			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC7ED	24620868				2022-12-28	WOS:000332689100012
J	Solomon, BD				Solomon, Benjamin D.			Incidentalomas in Genomics and Radiology	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RECOMMENDATIONS; EXOME	The often-drawn analogy between incidental findings in genomics and radiology may give nonexperts a false impression of our ability to efficiently interpret genetic or genomic findings and to understand how they might affect a person's health. The availability of new technologies has made high-throughput genomic sequencing increasingly prevalent in both research and clinical fields. Such sequencing includes targeted methods, such as exome sequencing, which focuses on the functionally important regions of known genes, as well as whole-genome sequencing. As the use of these methods grows, it is important to accurately describe both their potential and their inherent challenges. One controversial area involves the handling of the range of medical information found through genomic sequencing.(1),(2) This may include genetic or genomic data that are unrelated to the primary reason for conducting sequencing but may be medically ...	[Solomon, Benjamin D.] NHGRI, Med Genet Branch, Bethesda, MD 20892 USA; [Solomon, Benjamin D.] Inova Translat Med Inst, Falls Church, VA USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Solomon, BD (corresponding author), NHGRI, Med Genet Branch, Bethesda, MD 20892 USA.							Burke W, 2013, GENET MED, V15, P854, DOI 10.1038/gim.2013.113; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Orme NM, 2010, ARCH INTERN MED, V170, P1525, DOI 10.1001/archinternmed.2010.317; Piton A, 2013, AM J HUM GENET, V93, P368, DOI 10.1016/j.ajhg.2013.06.013	5	28	28	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 13	2014	370	11					988	990		10.1056/NEJMp1310471	http://dx.doi.org/10.1056/NEJMp1310471			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC7ED	24620864				2022-12-28	WOS:000332689100004
J	Miller, RJD				Miller, R. J. Dwayne			Femtosecond Crystallography with Ultrabright Electrons and X-rays: Capturing Chemistry in Action	SCIENCE			English	Review							NORMAL-MODE ANALYSIS; STRUCTURAL DYNAMICS; ULTRAFAST DIFFRACTION; CONFORMATIONAL-CHANGE; ATOMIC MOTIONS; TIME; PROTEIN; DIARYLETHENE; MYOGLOBIN; SOLIDS	With the recent advances in ultrabright electron and x-ray sources, it is now possible to extend crystallography to the femtosecond time domain to literally light up atomic motions involved in the primary processes governing structural transitions. This review chronicles the development of brighter and brighter electron and x-ray sources that have enabled atomic resolution to structural dynamics for increasingly complex systems. The primary focus is on achieving sufficient brightness using pump-probe protocols to resolve the far-from-equilibrium motions directing chemical processes that in general lead to irreversible changes in samples. Given the central importance of structural transitions to conceptualizing chemistry, this emerging field has the potential to significantly improve our understanding of chemistry and its connection to driving biological processes.	[Miller, R. J. Dwayne] Hamburg Ctr Ultrafast Imaging, Max Planck Inst Struct & Dynam Matter, Atomically Resolved Dynam Div, D-22761 Hamburg, Germany; [Miller, R. J. Dwayne] Univ Toronto, Dept Chem, Toronto, ON M5S 1H6, Canada; [Miller, R. J. Dwayne] Univ Toronto, Dept Phys, Toronto, ON M5S 1H6, Canada	Max Planck Society; University of Hamburg; University of Toronto; University of Toronto	Miller, RJD (corresponding author), Hamburg Ctr Ultrafast Imaging, Max Planck Inst Struct & Dynam Matter, Atomically Resolved Dynam Div, Luruper Chaussee 149, D-22761 Hamburg, Germany.							Aidelsburger M, 2010, P NATL ACAD SCI USA, V107, P19714, DOI 10.1073/pnas.1010165107; Aquila A, 2012, OPT EXPRESS, V20, P2706, DOI 10.1364/OE.20.002706; Armstrong MR, 2003, P NATL ACAD SCI USA, V100, P4990, DOI 10.1073/pnas.0936507100; Bahar I, 2005, CURR OPIN STRUC BIOL, V15, P586, DOI 10.1016/j.sbi.2005.08.007; Baum P, 2006, P NATL ACAD SCI USA, V103, P16105, DOI 10.1073/pnas.0607451103; Beaud P, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.174801; Boggio-Pasqua M, 2003, J PHYS CHEM A, V107, P11139, DOI 10.1021/jp036862e; Bourgeois D, 2006, P NATL ACAD SCI USA, V103, P4924, DOI 10.1073/pnas.0508880103; Cavalleri A, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.237401; Chin AH, 1999, PHYS REV LETT, V83, P336, DOI 10.1103/PhysRevLett.83.336; Collet E, 2003, SCIENCE, V300, P612, DOI 10.1126/science.1082001; Collet E, 2012, PHYS CHEM CHEM PHYS, V14, P6192, DOI 10.1039/c2cp23587k; Coppens P, 2010, ACTA CRYSTALLOGR A, V66, P179, DOI 10.1107/S0108767309055342; Coppens P, 2009, J SYNCHROTRON RADIAT, V16, P226, DOI 10.1107/S0909049508040892; Corkum PB, 2007, NAT PHYS, V3, P381, DOI 10.1038/nphys620; Delarue M, 2004, P NATL ACAD SCI USA, V101, P6957, DOI 10.1073/pnas.0400301101; Domcke W, 2012, ANNU REV PHYS CHEM, V63, P325, DOI 10.1146/annurev-physchem-032210-103522; Dudek RC, 2001, J PHYS CHEM A, V105, P4167, DOI 10.1021/jp010122t; Eichberger M, 2010, NATURE, V468, P799, DOI 10.1038/nature09539; Elsaesser T, 2010, ACTA CRYSTALLOGR A, V66, P168, DOI 10.1107/S0108767309048181; Emma P, 2010, NAT PHOTONICS, V4, P641, DOI [10.1038/NPHOTON.2010.176, 10.1038/nphoton.2010.176]; Erasmus N, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.167402; Ernstorfer R, 2009, SCIENCE, V323, P1033, DOI 10.1126/science.1162697; Fleming GR, 1986, CHEMICAL APPLICATION; Gao M, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4813313; Garman EF, 2014, SCIENCE, V343, P1102, DOI 10.1126/science.1247829; GENBERG L, 1991, SCIENCE, V251, P1051, DOI 10.1126/science.1998121; Han TRT, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.075145; Harb M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.155504; Hastings JB, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2372697; Hebeisen CT, 2008, OPT EXPRESS, V16, P3334, DOI 10.1364/OE.16.003334; Henderson R, 2004, Q REV BIOPHYS, V37, P3, DOI 10.1017/S0033583504003920; Howard JAK, 2014, SCIENCE, V343, P1098, DOI 10.1126/science.1247252; Ihee H, 2001, SCIENCE, V291, P458, DOI 10.1126/science.291.5503.458; Irie M, 2001, SCIENCE, V291, P1769, DOI 10.1126/science.291.5509.1769; ISCHENKO AA, 1983, APPL PHYS B-PHOTO, V32, P161, DOI 10.1007/BF00688823; Jean-Ruel H, 2013, J PHYS CHEM B, V117, P15894, DOI 10.1021/jp409245h; Jean-Ruel H, 2011, J PHYS CHEM A, V115, P13158, DOI 10.1021/jp205818h; Juve V, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.217401; King WE, 2005, J APPL PHYS, V97, DOI 10.1063/1.1927699; Kitao A, 1999, CURR OPIN STRUC BIOL, V9, P164, DOI 10.1016/S0959-440X(99)80023-2; Lin ZB, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.184113; Maguid S, 2008, GENE, V422, P7, DOI 10.1016/j.gene.2008.06.002; Miller RJD, 2014, ANNU REV PHYS CHEM, V65, P583, DOI 10.1146/annurev-physchem-040412-110117; Miller RJD, 2002, CAN J CHEM, V80, P1, DOI 10.1139/V01-199; MILLER RJD, 1994, ACCOUNTS CHEM RES, V27, P145, DOI 10.1021/ar00041a005; Mohr-Vorobeva E, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.036403; Muro'oka Y, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3602314; Musumeci P, 2010, J APPL PHYS, V108, DOI 10.1063/1.3520283; Redecke L, 2013, SCIENCE, V339, P227, DOI 10.1126/science.1229663; Rischel C, 1997, NATURE, V390, P490, DOI 10.1038/37317; Rose-Petruck C, 1999, NATURE, V398, P310, DOI 10.1038/18631; ROSENBAU.G, 1971, NATURE, V230, P434, DOI 10.1038/230434a0; Rousse A, 2001, NATURE, V410, P65, DOI 10.1038/35065045; SCHLICHTING I, 1990, NATURE, V345, P309, DOI 10.1038/345309a0; Schoenlein RW, 2000, SCIENCE, V287, P2237, DOI 10.1126/science.287.5461.2237; Schotte F, 2003, SCIENCE, V300, P1944, DOI 10.1126/science.1078797; Schotte F, 2012, P NATL ACAD SCI USA, V109, P19256, DOI 10.1073/pnas.1210938109; Sciaini G, 2011, REP PROG PHYS, V74, DOI 10.1088/0034-4885/74/9/096101; SENO Y, 1990, J MOL BIOL, V216, P111, DOI 10.1016/S0022-2836(05)80064-6; Siwick BJ, 2002, J APPL PHYS, V92, P1643, DOI 10.1063/1.1487437; Siwick BJ, 2003, SCIENCE, V302, P1382, DOI 10.1126/science.1090052; Spence JCH, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/10/102601; Srajer V, 1996, SCIENCE, V274, P1726, DOI 10.1126/science.274.5293.1726; Subramaniam S, 2002, PHILOS T ROY SOC A, V360, P859, DOI 10.1098/rsta.2001.0971; Tomov IV, 1999, J PHYS CHEM B, V103, P7081, DOI 10.1021/jp9908449; van Oudheusden T, 2007, J APPL PHYS, V102, DOI 10.1063/1.2801027; Veisz L, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/12/451; Williamson J. Charles, 1993, CHEM PHYS LETT, V209, P10; Williamson JC, 1997, NATURE, V386, P159, DOI 10.1038/386159a0; WILLIAMSON JC, 1992, CHEM PHYS LETT, V196, P529, DOI 10.1016/0009-2614(92)85988-M; Woerner M, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3469779; Wulff M, 1997, NUCL INSTRUM METH A, V398, P69, DOI 10.1016/S0168-9002(96)01226-0; Zarrine-Afsar A, 2012, ACTA CRYSTALLOGR D, V68, P321, DOI 10.1107/S0907444911055296; Zarrine-Afsar A, 2011, ANAL CHEM, V83, P767, DOI 10.1021/ac1021024	76	214	218	8	291	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2014	343	6175					1108	1116		10.1126/science.1248488	http://dx.doi.org/10.1126/science.1248488			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2LB	24604195				2022-12-28	WOS:000332331500039
J	Bill-Axelson, A; Holmberg, L; Garmo, H; Rider, JR; Taari, K; Busch, C; Nordling, S; Haggman, M; Andersson, SO; Spangberg, A; Andren, O; Palmgren, J; Steineck, G; Adami, HO; Johansson, JE				Bill-Axelson, Anna; Holmberg, Lars; Garmo, Hans; Rider, Jennifer R.; Taari, Kimmo; Busch, Christer; Nordling, Stig; Haggman, Michael; Andersson, Swen-Olof; Spangberg, Anders; Andren, Ove; Palmgren, Juni; Steineck, Gunnar; Adami, Hans-Olov; Johansson, Jan-Erik			Radical Prostatectomy or Watchful Waiting in Early Prostate Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; RANDOMIZED-TRIAL; SEXUAL FUNCTION; CLINICAL-TRIAL; OUTCOMES; RISK	BackgroundRadical prostatectomy reduces mortality among men with localized prostate cancer; however, important questions regarding long-term benefit remain. MethodsBetween 1989 and 1999, we randomly assigned 695 men with early prostate cancer to watchful waiting or radical prostatectomy and followed them through the end of 2012. The primary end points in the Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) were death from any cause, death from prostate cancer, and the risk of metastases. Secondary end points included the initiation of androgen-deprivation therapy. ResultsDuring 23.2 years of follow-up, 200 of 347 men in the surgery group and 247 of the 348 men in the watchful-waiting group died. Of the deaths, 63 in the surgery group and 99 in the watchful-waiting group were due to prostate cancer; the relative risk was 0.56 (95% confidence interval [CI], 0.41 to 0.77; P=0.001), and the absolute difference was 11.0 percentage points (95% CI, 4.5 to 17.5). The number needed to treat to prevent one death was 8. One man died after surgery in the radical-prostatectomy group. Androgen-deprivation therapy was used in fewer patients who underwent prostatectomy (a difference of 25.0 percentage points; 95% CI, 17.7 to 32.3). The benefit of surgery with respect to death from prostate cancer was largest in men younger than 65 years of age (relative risk, 0.45) and in those with intermediate-risk prostate cancer (relative risk, 0.38). However, radical prostatectomy was associated with a reduced risk of metastases among older men (relative risk, 0.68; P=0.04). ConclusionsExtended follow-up confirmed a substantial reduction in mortality after radical prostatectomy; the number needed to treat to prevent one death continued to decrease when the treatment was modified according to age at diagnosis and tumor risk. A large proportion of long-term survivors in the watchful-waiting group have not required any palliative treatment. (Funded by the Swedish Cancer Society and others.) The randomized Swedish trial of prostatectomy versus watchful waiting in disease detected mainly clinically (not by PSA screening) continues to show a benefit for early prostatectomy. The number of men younger than 65 needed to treat to prevent one death is now four. The Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4), a randomized trial of radical prostatectomy versus watchful waiting in men with localized prostate cancer diagnosed before the era of prostate-specific antigen (PSA) testing, showed a survival benefit of radical prostatectomy as compared with observation at 15 years of follow-up.(1) By contrast, the Prostate Cancer Intervention versus Observation Trial (PIVOT), initiated in the early era of PSA testing, showed that radical prostatectomy did not significantly reduce prostate cancer-specific or overall mortality after 12 years.(2) PSA screening profoundly changes the clinical domain of study. Among other considerations, the substantial additional lead time ...	[Bill-Axelson, Anna; Haggman, Michael] Univ Uppsala Hosp, Dept Surg Sci, S-75185 Uppsala, Sweden; [Busch, Christer] Univ Uppsala Hosp, Dept Immunol Genet & Pathol, S-75185 Uppsala, Sweden; [Holmberg, Lars; Garmo, Hans] Univ Uppsala Hosp, Reg Canc Ctr Uppsala Orebro, S-75185 Uppsala, Sweden; [Andersson, Swen-Olof; Andren, Ove; Johansson, Jan-Erik] Univ Orebro, Sch Hlth & Med Sci, SE-70182 Orebro, Sweden; [Andersson, Swen-Olof; Andren, Ove; Johansson, Jan-Erik] Orebro Univ Hosp, Dept Urol, Orebro, Sweden; [Spangberg, Anders] Linkoping Univ Hosp, Dept Urol, S-58185 Linkoping, Sweden; [Steineck, Gunnar] Karolinska Inst, Dept Pathol & Oncol, Div Clin Canc Epidemiol, Stockholm, Sweden; [Palmgren, Juni; Adami, Hans-Olov] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Steineck, Gunnar] Sahlgrens Acad, Div Clin Canc Epidemiol, Gothenburg, Sweden; [Holmberg, Lars; Garmo, Hans] Kings Coll London, Sch Med, Div Canc Studies, London WC2R 2LS, England; [Rider, Jennifer R.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA USA; [Rider, Jennifer R.] Harvard Univ, Sch Med, Boston, MA USA; [Rider, Jennifer R.; Adami, Hans-Olov] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Taari, Kimmo] Univ Helsinki, Cent Hosp, Dept Urol, Helsinki, Finland; [Nordling, Stig] Univ Helsinki, Dept Pathol, Helsinki, Finland	Uppsala University; Uppsala University Hospital; Orebro University; Orebro University; Linkoping University; Karolinska Institutet; Karolinska Institutet; University of Gothenburg; University of London; King's College London; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of Helsinki; Helsinki University Central Hospital; University of Helsinki	Bill-Axelson, A (corresponding author), Univ Uppsala Hosp, Dept Urol, S-75185 Uppsala, Sweden.	anna.bill.axelson@akademiska.se	Rider, Jennifer/T-1272-2019; Steineck, Gunnar/W-1515-2019	Rider, Jennifer/0000-0002-2637-6036; Steineck, Gunnar/0000-0002-0787-3969; Palmgren, Juni/0000-0002-9031-8615; Taari, Kimmo/0000-0002-0077-4896	Swedish Cancer Society [07 05 12, 09 05 12]; National Institutes of Health [1ROI CA 108746-O1A1]; Karolinska Institutet [2368/10-221]; Prostate Cancer Foundation; Percy Falk Foundation; NATIONAL CANCER INSTITUTE [R01CA108746] Funding Source: NIH RePORTER	Swedish Cancer Society(Swedish Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Karolinska Institutet(Karolinska Institutet); Prostate Cancer Foundation; Percy Falk Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by grants from the Swedish Cancer Society (07 05 12, to Dr. Johansson; and 09 05 12, to Dr. Bill-Axelson), the National Institutes of Health (1ROI CA 108746-O1A1, to Dr. Steineck), the Karolinska Institutet (distinguished professor award Dnr:2368/10-221, to Dr. Adami), and the Prostate Cancer Foundation and Percy Falk Foundation (both to Dr. Bill-Axelson).	Bill-Axelson A, 2008, J NATL CANCER I, V100, P1144, DOI 10.1093/jnci/djn255; Bill-Axelson A, 2013, EUR UROL, V64, P920, DOI 10.1016/j.eururo.2013.02.025; Bill-Axelson A, 2011, NEW ENGL J MED, V364, P1708, DOI 10.1056/NEJMoa1011967; BRENDLER CB, 1980, J UROLOGY, V124, P849, DOI 10.1016/S0022-5347(17)55696-7; Gleason DF, 1977, UROLOGIC PATHOLOGY P, P171; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Harmer MH, 1978, TNM CLASSIFICATION O; Holmberg L, 2002, NEW ENGL J MED, V347, P781, DOI 10.1056/NEJMoa012794; Horwich A, 2013, ANN ONCOL, V24, P1141, DOI 10.1093/annonc/mds624; Johansson E, 2011, LANCET ONCOL, V12, P891, DOI 10.1016/S1470-2045(11)70162-0; Johansson E, 2009, EUR UROL, V55, P422, DOI 10.1016/j.eururo.2008.08.054; Kalbfleisch J., 2002, THE STATISTICAL ANAL; Sanda MG, 2008, NEW ENGL J MED, V358, P1250, DOI 10.1056/NEJMoa074311; Stanford JL, 2000, JAMA-J AM MED ASSOC, V283, P354, DOI 10.1001/jama.283.3.354; Steineck G, 2002, NEW ENGL J MED, V347, P790, DOI 10.1056/NEJMoa021483; WALSH PC, 1983, PROSTATE, V4, P473, DOI 10.1002/pros.2990040506; Wilt TJ, 2012, NEW ENGL J MED, V367, P203, DOI 10.1056/NEJMoa1113162	17	658	675	1	58	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 6	2014	370	10					932	942		10.1056/NEJMoa1311593	http://dx.doi.org/10.1056/NEJMoa1311593			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC2EB	24597866	Bronze, Green Accepted			2022-12-28	WOS:000332309800010
J	Luksza, M; Lassig, M				Luksza, Marta; Laessig, Michael			A predictive fitness model for influenza	NATURE			English	Article							A VIRUS; EVOLUTIONARY DYNAMICS; LINKED GLYCOSYLATION; BENEFICIAL MUTATIONS; CLONAL INTERFERENCE; SEASONAL INFLUENZA; POSITIVE SELECTION; ASEXUAL EVOLUTION; RECEPTOR-BINDING; ANTIGENIC SITES	The seasonal human influenza A/H3N2 virus undergoes rapid evolution, which produces significant year-to-year sequence turnover in the population of circulating strains. Adaptive mutations respond to human immune challenge and occur primarily in antigenic epitopes, the antibody-binding domains of the viral surface protein haemagglutinin. Here we develop a fitness model for haemagglutinin that predicts the evolution of the viral population from one year to the next. Two factors are shown to determine the fitness of a strain: adaptive epitope changes and deleterious mutations outside the epitopes. We infer both fitness components for the strains circulating in a given year, using population-genetic data of all previous strains. From fitness and frequency of each strain, we predict the frequency of its descendent strains in the following year. This fitness model maps the adaptive history of influenza A and suggests a principled method for vaccine selection. Our results call for a more comprehensive epidemiology of influenza and other fast-evolving pathogens that integrates antigenic phenotypes with other viral functions coupled by genetic linkage.	[Luksza, Marta; Laessig, Michael] Univ Cologne, Inst Theoret Phys, D-50937 Cologne, Germany; [Luksza, Marta] Columbia Univ, Fairchild Ctr 607D, New York, NY 10027 USA	University of Cologne; Columbia University	Lassig, M (corresponding author), Univ Cologne, Inst Theoret Phys, Zulpicher Str 77, D-50937 Cologne, Germany.	lassig@thp.uni-koeln.de			Deutsche Forschungsgemeinschaft [SFB 680]; German Federal Ministry of Education and Research [0315893-Sybacol]; National Science Foundation [PHY05-51164]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); National Science Foundation(National Science Foundation (NSF))	We acknowledge discussions with B. D. Greenbaum, B. Grenfell, C. Illingworth, A. Levine, J. W. McCauley, V. Mustonen, S. Pompei and R. Rabadan. This work has been partially supported by Deutsche Forschungsgemeinschaft grant SFB 680 and by German Federal Ministry of Education and Research grant 0315893-Sybacol. Part of this work was performed at the Kavli Institute of Theoretical Physics (Santa Barbara), which has been supported by National Science Foundation grant PHY05-51164.	Ampofo W. K., 2010, INFLUENZA OTHER RESP, V6, P147; Andreasen V, 1997, J MATH BIOL, V35, P825, DOI 10.1007/s002850050079; Arinaminpathy N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015674; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Bhatt S, 2011, MOL BIOL EVOL, V28, P2443, DOI 10.1093/molbev/msr044; Blackburne BP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000058; Bloom JD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000349; Bogner P, 2006, NATURE, V442, P981, DOI 10.1038/442981a; Bush RM, 2000, P NATL ACAD SCI USA, V97, P6974, DOI 10.1073/pnas.97.13.6974; Bush RM, 1999, SCIENCE, V286, P1921, DOI 10.1126/science.286.5446.1921; Cui JK, 2009, P NATL ACAD SCI USA, V106, P13421, DOI 10.1073/pnas.0905818106; Desai MM, 2007, GENETICS, V176, P1759, DOI 10.1534/genetics.106.067678; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239; Gog JR, 2002, P NATL ACAD SCI USA, V99, P17209, DOI 10.1073/pnas.252512799; Gog JR, 2002, J MATH BIOL, V44, P169, DOI 10.1007/s002850100120; Good BH, 2012, P NATL ACAD SCI USA, V109, P4950, DOI 10.1073/pnas.1119910109; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Holmes EC, 2005, PLOS BIOL, V3, P1579, DOI 10.1371/journal.pbio.0030300; Huang JW, 2012, VACCINE, V30, P6327, DOI 10.1016/j.vaccine.2012.07.079; Illingworth CJR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003091; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Koelle K, 2010, J R SOC INTERFACE, V7, P1257, DOI 10.1098/rsif.2010.0007; Kryazhimskiy S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001301; Kryazhimskiy S, 2007, PLOS COMPUT BIOL, V3, P1513, DOI 10.1371/journal.pcbi.0030159; Lin YP, 2012, P NATL ACAD SCI USA, V109, P21474, DOI 10.1073/pnas.1218841110; Meyer AG, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0334; Minayev P, 2009, J R SOC INTERFACE, V6, P509, DOI 10.1098/rsif.2008.0333; Miralles R, 1999, SCIENCE, V285, P1745, DOI 10.1126/science.285.5434.1745; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Mustonen V, 2007, P NATL ACAD SCI USA, V104, P2277, DOI 10.1073/pnas.0607105104; Mustonen V, 2010, P NATL ACAD SCI USA, V107, P4248, DOI 10.1073/pnas.0907953107; Mustonen V, 2009, TRENDS GENET, V25, P111, DOI 10.1016/j.tig.2009.01.002; Myers JL, 2013, J VIROL, V87, P11168, DOI 10.1128/JVI.01414-13; Neher RA, 2013, P NATL ACAD SCI USA, V110, P437, DOI 10.1073/pnas.1213113110; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Plotkin JB, 2002, P NATL ACAD SCI USA, V99, P6263, DOI 10.1073/pnas.082110799; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Rasmussen DA, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002136; Rouzine IM, 2008, THEOR POPUL BIOL, V73, P24, DOI 10.1016/j.tpb.2007.10.004; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Schiffels S, 2011, GENETICS, V189, P1361, DOI 10.1534/genetics.111.132027; Schulze Irene T., 1997, Journal of Infectious Diseases, V176, pS24, DOI 10.1086/514170; Shih ACC, 2007, P NATL ACAD SCI USA, V104, P6283, DOI 10.1073/pnas.0701396104; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Strelkowa N, 2012, GENETICS, V192, P671, DOI 10.1534/genetics.112.143396; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Tria F, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/07/P07008; Tsimring LS, 1996, PHYS REV LETT, V76, P4440, DOI 10.1103/PhysRevLett.76.4440; WEIS W, 1988, NATURE, V333, P426, DOI 10.1038/333426a0; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; Wolf YI, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-34; Wylie CS, 2011, P NATL ACAD SCI USA, V108, P9916, DOI 10.1073/pnas.1017572108; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106	58	234	238	1	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					57	+		10.1038/nature13087	http://dx.doi.org/10.1038/nature13087			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0ZQ	24572367				2022-12-28	WOS:000332224400041
J	Sharifi, N				Sharifi, Nima			Steroid Receptors Aplenty in Prostate Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RESISTANCE; MUTATION	The up-regulation of glucocorticoid receptors in prostate cancers treated with enzalutamide, an androgen antagonist, may drive resistance to the drug. Cancer cells use diverse means to avoid being damaged by drugs. Often, the development of new treatment strategies in clinical oncology is made possible by discovering the mechanisms of drug resistance by tumors. However, the development of treatments that target such mechanisms is particularly challenging when an intact mechanism is required for a human to sustain life. A recent study by Arora and colleagues(1) suggests that a shift may occur in advanced prostate cancer from the expression of a steroid receptor that is not required for life to another that is and that this shift allows the cancer ...	Cleveland Clin, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Sharifi, N (corresponding author), Cleveland Clin, Cleveland, OH 44106 USA.							Arora VK, 2013, CELL, V155, P1309, DOI 10.1016/j.cell.2013.11.012; Chang KH, 2013, CELL, V154, P1074, DOI 10.1016/j.cell.2013.07.029; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; MARCELLI M, 1991, J CLIN INVEST, V87, P1123, DOI 10.1172/JCI115076; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506	5	27	28	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 6	2014	370	10					970	971		10.1056/NEJMcibr1315706	http://dx.doi.org/10.1056/NEJMcibr1315706			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC2EB	24597872				2022-12-28	WOS:000332309800016
J	Sillanpaa, MA; Hakonen, PJ				Sillanpaa, Mika A.; Hakonen, Pertti J.			OPTOMECHANICS Hardware for a quantum network	NATURE			English	Editorial Material							MICROWAVE		[Sillanpaa, Mika A.] Aalto Univ, Dept Appl Phys, FI-00076 Aalto, Finland; [Hakonen, Pertti J.] Aalto Univ, OV Lounasmaa Lab, FI-00076 Aalto, Finland	Aalto University; Aalto University	Sillanpaa, MA (corresponding author), Aalto Univ, Dept Appl Phys, FI-00076 Aalto, Finland.	mika.sillanpaa@aalto.fi	Hakonen, Pertti J/E-7688-2012; Sillanpaa, Mika/A-3554-2013	Hakonen, Pertti J/0000-0002-8247-4108; 				Andrews R. W., 2013, PREPRINT; ASPELMEYER M, 2013, PREPRINT; Bagci T, 2014, NATURE, V507, P81, DOI 10.1038/nature13029; Bochmann J, 2013, NAT PHYS, V9, P712, DOI [10.1038/NPHYS2748, 10.1038/nphys2748]; Devoret MH, 2013, SCIENCE, V339, P1169, DOI 10.1126/science.1231930; Massel F, 2011, NATURE, V480, P351, DOI 10.1038/nature10628	6	5	5	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					45	47		10.1038/507045a	http://dx.doi.org/10.1038/507045a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0ZQ	24598635				2022-12-28	WOS:000332224400037
J	Clement, A; DiNezio, P				Clement, Amy; DiNezio, Pedro			The Tropical Pacific Ocean-Back in the Driver's Seat?	SCIENCE			English	Editorial Material							EQUATORIAL PACIFIC; VARIABILITY; HIATUS		[Clement, Amy] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Miami, FL 33149 USA; [DiNezio, Pedro] Univ Hawaii Manoa, Sch Ocean & Earth Sci & Technol, Honolulu, HI 96822 USA	University of Miami; University of Hawaii System; University of Hawaii Manoa	Clement, A (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, 4600 Rickenbacker Causeway, Miami, FL 33149 USA.	aclement@rsmas.miami.edu						Ault TR, 2013, GEOPHYS RES LETT, V40, P3450, DOI 10.1002/grl.50647; Balmaseda MA, 2013, GEOPHYS RES LETT, V40, P1754, DOI 10.1002/grl.50382; Clement AC, 2009, SCIENCE, V325, P460, DOI 10.1126/science.1171255; Deser C, 2004, J CLIMATE, V17, P3109, DOI 10.1175/1520-0442(2004)017<3109:PICVLB>2.0.CO;2; Deser C, 2014, J CLIMATE, V27, P2271, DOI 10.1175/JCLI-D-13-00451.1; England M. H., 2014, CLIMATE CHANGE, P1758, DOI [10.1038/ nclimate2106, DOI 10.1038/NCLIMATE2106,1758]; Gu DF, 1997, SCIENCE, V275, P805, DOI 10.1126/science.275.5301.805; IPCC, 2013, CLIMATE CHANGE 2022; Kosaka Y, 2013, NATURE, V501, P403, DOI 10.1038/nature12534; Meehl GA, 2013, J CLIMATE, V26, P7298, DOI 10.1175/JCLI-D-12-00548.1; Okumura YM, 2013, J CLIMATE, V26, P9791, DOI 10.1175/JCLI-D-13-00448.1; Rosenfeld D, 2014, SCIENCE, V343, P379, DOI 10.1126/science.1247490; Solomon S, 2011, SCIENCE, V333, P866, DOI 10.1126/science.1206027; Trenberth KE, 2014, J CLIMATE, V27, P3129, DOI 10.1175/JCLI-D-13-00294.1; Trenberth KE, 2013, EARTHS FUTURE, V1, P19, DOI 10.1002/2013EF000165; Trenberth KE, 2009, CURR OPIN ENV SUST, V1, P19, DOI 10.1016/j.cosust.2009.06.001	16	30	31	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2014	343	6174					976	978		10.1126/science.1248115	http://dx.doi.org/10.1126/science.1248115			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2DZ	24578569				2022-12-28	WOS:000332309600028
J	Sorup, S; Benn, CS; Poulsen, A; Krause, TG; Aaby, P; Ravn, H				Sorup, Signe; Benn, Christine S.; Poulsen, Anja; Krause, Tyra G.; Aaby, Peter; Ravn, Henrik			Live Vaccine Against Measles, Mumps, and Rubella and the Risk of Hospital Admissions for Nontargeted Infections	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DIPHTHERIA-TETANUS-PERTUSSIS; FEMALE-MALE MORTALITY; RANDOMIZED-TRIAL; CHILDHOOD VACCINATION; DANISH; CHILDREN; DISEASE; BIRTH; IMMUNIZATION; SURVIVAL	IMPORTANCE In low-income countries, live measles vaccine reduces mortality from causes other than measles infection. Such nonspecific effects of vaccines might also be important for the health of children in high-income settings. OBJECTIVE To examine whether the live vaccine against measles, mumps, and rubella (MMR) is associated with lower rates of hospital admissions for infections among children in Denmark. DESIGN, SETTING, AND PARTICIPANTS Population-based cohort study of Danish children born 1997-2006 and followed up from ages 11 months to 2 years (last follow-up, August 31, 2008). Nationwide Danish registers provided data on vaccinations and hospital admissions. The recommended vaccination schedule was inactivated vaccine against diphtheria, tetanus, pertussis, polio, and Haemophilus influenzae type b (DTaP-IPV-Hib) administered at ages 3, 5, and 12 months and MMR at age 15 months. MAIN OUTCOMES AND MEASURES Incidence rate ratios (IRRs) of hospital admissions for any infection, comparing receipt of MMR vs DTaP-IPV-Hib as the most recent vaccine. Risks, risk difference, and number needed to vaccinate were calculated for receiving MMR on time. RESULTS The study included 495 987 children contributing with 56 889 hospital admissions for any type of infection during 509 427 person-years (rate, 11.2 per 100 person-years). Receiving the live MMR vaccine after the inactivated DTaP-IPV-Hib-vaccine was associated with a lower rate of hospital admissions for any infection. [GRAPHICS] The risk of admission for an infection between ages 16 months and 24 months was 4.6% (95% CI, 4.5%-4.7%) for receiving MMR on time and 5.1% (95% CI, 5.0%-5.2%) for not receiving MMR on time. The risk difference was 0.5 percentage point (95% CI, 0.4-0.6), and the number needed to vaccinate with MMR before age 16 months to prevent 1 infectious disease admission was 201 (95% CI, 159-272). CONCLUSIONS AND RELEVANCE In a cohort of Danish children, receipt of live MMR vs inactivated DTaP-IPV-Hib as the most recent vaccine was associated with a lower rate of hospital admissions for any infections. These findings require replication in other high-income populations.	[Sorup, Signe; Benn, Christine S.; Aaby, Peter; Ravn, Henrik] Statens Serum Inst, Bandim Hlth Project, Res Ctr Vitamins & Vaccines CVIVA, DK-2300 Copenhagen S, Denmark; [Benn, Christine S.] Univ Southern Denmark, Inst Clin Res, Odense, Denmark; [Benn, Christine S.] Odense Univ Hosp, DK-5000 Odense, Denmark; [Benn, Christine S.; Aaby, Peter; Ravn, Henrik] INDEPTH Network, Bandim Hlth Project, Bissau, Guinea Bissau; [Poulsen, Anja] Rigshosp, Child & Adolescent Clin, DK-2100 Copenhagen, Denmark; [Krause, Tyra G.] Statens Serum Inst, Dept Infect Dis Epidemiol, DK-2300 Copenhagen S, Denmark	Statens Serum Institut; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; Rigshospitalet; University of Copenhagen; Statens Serum Institut	Sorup, S (corresponding author), Statens Serum Inst, Bandim Hlth Project, CVIVA, Artillerivej 5, DK-2300 Copenhagen S, Denmark.	sgs@ssi.dk		Sorup, Signe/0000-0003-1942-683X; Aaby, Peter/0000-0001-8331-1389; Poulsen, Anja/0000-0002-9656-1552	Health Foundation [2009B132]; Rosalie Petersen Foundation; Novo Nordisk Foundation; European Research Council (ERC) [ERC-StG-243149]; Danish National Research Foundation (DNRF) [DNRF108]	Health Foundation; Rosalie Petersen Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Research Council (ERC)(European Research Council (ERC)European Commission); Danish National Research Foundation (DNRF)(Danmarks Grundforskningsfond)	This work was supported by the Health Foundation (2009B132 [Dr Sorup]); the Rosalie Petersen Foundation (Dr Sorup); and the Novo Nordisk Foundation (research professorship grant [Dr Aaby]). Dr Benn holds a European Research Council (ERC) Starting Grant (ERC-StG-243149). The Danish National Research Foundation (DNRF) supports the Research Center for Vitamins and Vaccines (DNRF108).	Aaby P, 2006, VACCINE, V24, P2764, DOI 10.1016/j.vaccine.2006.01.004; AABY P, 1995, BRIT MED J, V311, P481, DOI 10.1136/bmj.311.7003.481; Aaby P, 2003, PEDIATR INFECT DIS J, V22, P798, DOI 10.1097/01.inf.0000083821.33187.b5; Aaby P, 2003, LANCET, V361, P2183, DOI 10.1016/S0140-6736(03)13771-3; Aaby P, 2003, INT J EPIDEMIOL, V32, P106, DOI 10.1093/ije/dyg005; Aaby P, 2007, PEDIATR INFECT DIS J, V26, P247, DOI 10.1097/01.inf.0000256735.05098.01; Aaby P, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000761; Aaby P, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000707; Aaby P, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3769; Aaby P, 2011, J INFECT DIS, V204, P245, DOI 10.1093/infdis/jir240; Aaby P, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6495; Andersen JS, 2011, SCAND J PUBLIC HEALT, V39, P34, DOI 10.1177/1403494810394718; Andersen PK, 2002, STAT METHODS MED RES, V11, P91, DOI 10.1191/0962280202SM276ra; Austin PC, 2010, J CLIN EPIDEMIOL, V63, P46, DOI 10.1016/j.jclinepi.2009.03.012; Baadsgaard M, 2011, SCAND J PUBLIC HEALT, V39, P103, DOI 10.1177/1403494811405098; Benn CS, 2013, TRENDS IMMUNOL, V34, P431, DOI 10.1016/j.it.2013.04.004; Biering-Sorensen S, 2012, PEDIATR INFECT DIS J, V31, P306, DOI 10.1097/INF.0b013e3182458289; Carrillo-Santisteve P, 2012, CLIN MICROBIOL INFEC, V18, P50, DOI 10.1111/j.1469-0691.2012.03982.x; Cook R, 2007, STAT BIOL HEALTH, P161; Davis K, 2002, HEALTH POLICY, V59, P119, DOI 10.1016/S0168-8510(01)00202-0; Farrington CP, 2009, TROP MED INT HEALTH, V14, P977, DOI 10.1111/j.1365-3156.2009.02302.x; Frolich A, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-252; Garly ML, 2004, PEDIATR INFECT DIS J, V23, P1086, DOI 10.1097/01.inf.0000145700.77286.94; Hviid A, 2005, JAMA-J AM MED ASSOC, V294, P699, DOI 10.1001/jama.294.6.699; Jensen VM, 2011, SCAND J PUBLIC HEALT, V39, P91, DOI 10.1177/1403494810394715; Kamper-Jorgensen M, 2006, ARCH DIS CHILD, V91, P401, DOI 10.1136/adc.2005.085787; Kleinnijenhuis J, 2012, P NATL ACAD SCI USA, V109, P17537, DOI 10.1073/pnas.1202870109; Knudsen LB, 1998, DAN MED BULL, V45, P320; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Martins CL, 2014, J INFECT DIS, V209, P1731, DOI 10.1093/infdis/jit804; Mullooly JP, 2011, VACCINE, V29, P7611, DOI 10.1016/j.vaccine.2011.08.022; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Roth AE, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c671; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Shann F, 2010, ARCH DIS CHILD, V95, P662, DOI 10.1136/adc.2009.157537; Stowe J, 2009, VACCINE, V27, P1422, DOI 10.1016/j.vaccine.2008.12.038; VANBALEN H, 1981, LANCET, V1, P764; Wojcik OP, 2013, VACCINE, V31, P955, DOI 10.1016/j.vaccine.2012.11.100	38	114	114	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 26	2014	311	8					826	835		10.1001/jama.2014.470	http://dx.doi.org/10.1001/jama.2014.470			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB4XQ	24570246				2022-12-28	WOS:000331793700022
J	Bonini, F; Burle, B; Liegeois-Chauvel, C; Regis, J; Chauvel, P; Vidal, F				Bonini, Francesca; Burle, Boris; Liegeois-Chauvel, Catherine; Regis, Jean; Chauvel, Patrick; Vidal, Franck			Action Monitoring and Medial Frontal Cortex: Leading Role of Supplementary Motor Area	SCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; ERROR NEGATIVITY; ACTIVATION; RESPONSES; CONFLICT; FIELD	The capacity to evaluate the outcomes of our actions is fundamental for adapting and optimizing behavior and depends on an action-monitoring system that assesses ongoing actions and detects errors. The neuronal network underlying this executive function, classically attributed to the rostral cingulate zone, is poorly characterized in humans, owing to the limited number of direct neurophysiological data. Using intracerebral recordings, we show that the leading role is played by the supplementary motor area (SMA), which rapidly evaluates successful and erroneous actions. The rostral part of medial prefrontal cortex, driven by the SMA, was activated later and exclusively in the case of errors. This suggests a hierarchical organization of the different frontal regions involved in implementation of action monitoring and error processing.	[Bonini, Francesca; Burle, Boris; Liegeois-Chauvel, Catherine; Regis, Jean; Chauvel, Patrick; Vidal, Franck] Aix Marseille Univ, F-13385 Marseille, France; [Bonini, Francesca; Liegeois-Chauvel, Catherine; Regis, Jean; Chauvel, Patrick] INSERM, UMR 1106, Inst Neurosci Syst, F-13385 Marseille, France; [Bonini, Francesca; Burle, Boris; Vidal, Franck] CNRS, UMR 7291, Cognit Neurosci Lab, F-13331 Marseille, France; [Bonini, Francesca; Regis, Jean; Chauvel, Patrick] Timone Hosp, APHM, Pole Neurosci Clin, F-13005 Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Bonini, F (corresponding author), Aix Marseille Univ, F-13385 Marseille, France.	francesca.bonini@univ-amu.fr		BURLE, Boris/0000-0001-8179-9034; Liegeois Chauvel, Catherine/0000-0002-9612-9110; Chauvel, Patrick/0000-0003-2161-6077	European Research Council under the European Community [241077]; Ecole Doctorale Science de la Vie et de la Sante, Aix-Marseille Universite	European Research Council under the European Community(European Research Council (ERC)); Ecole Doctorale Science de la Vie et de la Sante, Aix-Marseille Universite	We thank P. Marquis for technical help in acquiring intracerebral recordings; D. Schon for critical discussion and reading the manuscript; and R. Hewett, M. Woodman, and J. Coull for English revision. B. B. was supported by the European Research Council under the European Community's Seventh Framework Program (FP7/2007-2013 Grant Agreement no. 241077). F. B. was supported by the Ecole Doctorale Science de la Vie et de la Sante, Aix-Marseille Universite. F. V. and B. B. designed the study. F. B. administered the Simon task and obtained intracerebral recordings. J. R. performed the surgical procedure and provided coordinates of intracerebral electrodes. F. B. analyzed data. B. B. and F. B. performed statistical analysis. F. V., B. B., F. B., P. C., and C. L.-C. interpreted data and discussed results. F. B. and F. V. wrote the manuscript. All authors commented on and edited the manuscript. The authors declare no conflict of interest.	Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Burle B, 2008, J COGNITIVE NEUROSCI, V20, P1637, DOI 10.1162/jocn.2008.20110; Chauvel PY, 1996, ADV NEUROL, V70, P199; COLES MGH, 1995, ACTA PSYCHOL, V90, P129, DOI 10.1016/0001-6918(95)00020-U; de Bruijn ERA, 2009, J NEUROSCI, V29, P12183, DOI 10.1523/JNEUROSCI.1751-09.2009; Debener S, 2005, J NEUROSCI, V25, P11730, DOI 10.1523/JNEUROSCI.3286-05.2005; Emeric EE, 2008, J NEUROPHYSIOL, V99, P759, DOI 10.1152/jn.00896.2006; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; Fitzgerald KD, 2005, BIOL PSYCHIAT, V57, P287, DOI 10.1016/j.biopsych.2004.10.038; Garavan H, 2002, NEUROIMAGE, V17, P1820, DOI 10.1006/nimg.2002.1326; Ham TE, 2013, CEREB CORTEX, V23, P703, DOI 10.1093/cercor/bhs056; Herrmann MJ, 2004, COGNITIVE BRAIN RES, V20, P294, DOI 10.1016/j.cogbrainres.2004.02.013; Hoffmann S, 2010, HUM BRAIN MAPP, V31, P1305, DOI 10.1002/hbm.20937; Kiehl KA, 2000, PSYCHOPHYSIOLOGY, V37, P216, DOI 10.1111/1469-8986.3720216; Kolling N, 2012, SCIENCE, V336, P95, DOI 10.1126/science.1216930; Luu P, 2003, PSYCHOL SCI, V14, P47, DOI 10.1111/1467-9280.01417; Nachev P, 2008, NAT REV NEUROSCI, V9, P856, DOI 10.1038/nrn2478; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Roger C, 2010, NEUROIMAGE, V51, P391, DOI 10.1016/j.neuroimage.2010.02.005; Scangos KW, 2013, J NEUROPHYSIOL, V109, P1928, DOI 10.1152/jn.00688.2012; Simon JR., 1990, ADV PSYCHOL, P31, DOI [10.1016/s0166-4115(08)61218-2, DOI 10.1016/S0166-4115(08)61218-2]; SMID HGOM, 1990, ACTA PSYCHOL, V74, P169, DOI 10.1016/0001-6918(90)90005-Z; Stuphorn V, 2000, NATURE, V408, P857, DOI 10.1038/35048576; van Veen V, 2002, J COGNITIVE NEUROSCI, V14, P593, DOI 10.1162/08989290260045837; Vidal F, 2000, BIOL PSYCHOL, V51, P109, DOI 10.1016/S0301-0511(99)00032-0	26	155	156	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 21	2014	343	6173					888	891		10.1126/science.1247412	http://dx.doi.org/10.1126/science.1247412			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB1LG	24558161				2022-12-28	WOS:000331552600047
J	Faden, RR; Beauchamp, TL; Kass, NE				Faden, Ruth R.; Beauchamp, Tom L.; Kass, Nancy E.			Informed Consent, Comparative Effectiveness, and Learning Health Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									[Faden, Ruth R.; Kass, Nancy E.] Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD 21218 USA; [Beauchamp, Tom L.] Georgetown Univ, Kennedy Inst Eth, Washington, DC 20057 USA	Johns Hopkins University; Georgetown University	Faden, RR (corresponding author), Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD 21218 USA.							Faden R, 2013, MED CARE, V51, pS53, DOI 10.1097/MLR.0b013e31829b1e4b; Faden RR, 2013, HASTINGS CENT REP, V43, pS16, DOI 10.1002/hast.134; Kass NE, 2013, HASTINGS CENT REP, V43, pS4, DOI 10.1002/hast.133; Morris MC, 2007, CRIT CARE MED, V35, P940, DOI 10.1097/01.CCM.0000257333.95528.B8; Truog RD, 1999, NEW ENGL J MED, V340, P804, DOI 10.1056/NEJM199903113401013	5	140	142	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 20	2014	370	8					766	768		10.1056/NEJMhle1313674	http://dx.doi.org/10.1056/NEJMhle1313674			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AB1DO	24552325				2022-12-28	WOS:000331531900013
J	Morillo, CA; Verma, A; Connolly, SJ; Kuck, KH; Nair, GM; Champagne, J; Sterns, LD; Beresh, H; Healey, JS; Natale, A				Morillo, Carlos A.; Verma, Atul; Connolly, Stuart J.; Kuck, Karl H.; Nair, Girish M.; Champagne, Jean; Sterns, Laurence D.; Beresh, Heather; Healey, Jeffrey S.; Natale, Andrea		RAAFT-2 Investigators	Radiofrequency Ablation vs Antiarrhythmic Drugs as First-Line Treatment of Paroxysmal Atrial Fibrillation (RAAFT-2) A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; PULMONARY VEIN ABLATION; CATHETER ABLATION; THERAPY; RECOMMENDATIONS; MULTICENTER; GUIDELINES	IMPORTANCE Atrial fibrillation (AF) is the most common rhythm disorder seen in clinical practice. Antiarrhythmic drugs are effective for reduction of recurrence in patients with symptomatic paroxysmal AF. Radiofrequency ablation is an accepted therapy in patients for whom antiarrhythmic drugs have failed; however, its role as a first-line therapy needs further investigation. OBJECTIVE To compare radiofrequency ablation with antiarrhythmic drugs (standard therapy) in treating patients with paroxysmal AF as a first-line therapy. DESIGN, SETTING, AND PATIENTS A randomized clinical trial involving 127 treatment-naive patients with paroxysmal AF were randomized at 16 centers in Europe and North America to received either antiarrhythmic therapy or ablation. The first patient was enrolled July 27, 2006; the last patient, January 29, 2010. The last follow-up was February 16, 2012. INTERVENTIONS Sixty-one patients in the antiarrhythmic drug group and 66 in the radiofrequency ablation group were followed up for 24 months. MAIN OUTCOMES AND MEASURES The time to the first documented atrial tachyarrhythmia of more than 30 seconds (symptomatic or asymptomatic AF, atrial flutter, or atrial tachycardia), detected by either scheduled or unscheduled electrocardiogram, Holter, transtelephonic monitor, or rhythm strip, was the primary outcome. Secondary outcomes included symptomatic recurrences of atrial tachyarrhythmias and quality of life measures assessed by the EQ-5D tool. RESULTS Forty-four patients (72.1%) in the antiarrhythmic group and in 36 patients (54.5%) in the ablation group experienced the primary efficacy outcome (hazard ratio [HR], 0.56 [95% CI, 0.35-0.90]; P = .02). For the secondary outcomes, 59% in the drug group and 47% in the ablation group experienced the first recurrence of symptomatic AF, atrial flutter, atrial tachycardia (HR, 0.56 [95% CI, 0.33-0.95]; P = .03). No deaths or strokes were reported in either group; 4 cases of cardiac tamponade were reported in the ablation group. In the standard treatment group, 26 patients (43%) underwent ablation after 1-year. Quality of life was moderately impaired at baseline in both groups and improved at the 1 year follow-up. However, improvement was not significantly different among groups. CONCLUSIONS AND RELEVANCE Among patients with paroxysmal AF without previous antiarrhythmic drug treatment, radiofrequency ablation compared with antiarrhythmic drugs resulted in a lower rate of recurrent atrial tachyarrhythmias at 2 years. However, recurrence was frequent in both groups.	[Morillo, Carlos A.; Connolly, Stuart J.; Beresh, Heather; Healey, Jeffrey S.] McMaster Univ, Populat Hlth Res Inst, Hamilton Hlth Sci, Hamilton, ON L8L 2X2, Canada; [Verma, Atul] Southlake Reg Hlth Ctr, Newmarket, ON, Canada; [Kuck, Karl H.] Asklepios Klin St Georg, Hamburg, Germany; [Nair, Girish M.] Ottawa Heart Inst, Ottawa, ON, Canada; [Champagne, Jean] Univ Laval, Quebec City, PQ, Canada; [Sterns, Laurence D.] Victoria Cardiac Arrhythmia Trials Inc, Victoria, BC, Canada; [Natale, Andrea] St Davids Med Ctr, Austin, TX USA	McMaster University; Population Health Research Institute; Southlake Regional Health Centre; Asklepios Klinik St. Georg; University of Ottawa; University of Ottawa Heart Institute; Laval University; Saint David's Medical Center	Morillo, CA (corresponding author), McMaster Univ, Populat Hlth Res Inst, David Braley Cardiac Vasc & Stroke Res Inst, Hamilton Hlth Sci, Room C-120,237 Barton St, Hamilton, ON L8L 2X2, Canada.	morillo@hhsc.ca	Gula, Lorne/G-3298-2011; Nair, Girish Madhavan/AFO-6160-2022	Nair, Girish Madhavan/0000-0002-3303-1490; Essebag, Vidal/0000-0003-0107-5197; Morillo, Carlos/0000-0002-8739-2099	Biosense Webster; Population Health Research Institute (PHRI); PHRI at McMaster University	Biosense Webster; Population Health Research Institute (PHRI); PHRI at McMaster University	This study was supported by an unrestricted research grant from Biosense Webster (Dr Morillo) and the Population Health Research Institute (PHRI), sponsored and supported by PHRI at McMaster University.	ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Calkins H, 2007, EUROPACE, V9, P335, DOI 10.1093/europace/eum120; Calkins H, 2009, CIRC-ARRHYTHMIA ELEC, V2, P349, DOI 10.1161/CIRCEP.108.824789; Camm AJ, 2012, EUR HEART J, V33, P2719, DOI 10.1093/eurheartj/ehs253; Cappato R, 2010, CIRC-ARRHYTHMIA ELEC, V3, P32, DOI 10.1161/CIRCEP.109.859116; Dagres N, 2009, J CARDIOVASC ELECTR, V20, P1014, DOI 10.1111/j.1540-8167.2009.01493.x; Dorian P, 2002, AM HEART J, V143, P984, DOI 10.1067/mhj.2002.122518; EuroQol Group, 2007, EQ 5D VAL SETS INV C, V2; Fuster V, 2006, J AM COLL CARDIOL, V48, P854, DOI 10.1016/j.jacc.2006.07.009; Gjesdal K, 2008, SCAND CARDIOVASC J, V42, P3, DOI 10.1080/14017430701798838; Ha ACT, 2013, J INTERV CARD ELECTR, V36, P177, DOI 10.1007/s10840-012-9721-2; Hindricks G, 2005, CIRCULATION, V112, P307, DOI 10.1161/CIRCULATIONAHA.104.518837; Jais P, 2009, CIRCULATION, V120, pE83, DOI 10.1161/CIRCULATIONAHA.109.192636; Jais P, 2008, CIRCULATION, V118, P2498, DOI 10.1161/CIRCULATIONAHA.108.772582; Nair GM, 2009, J CARDIOVASC ELECTR, V20, P138, DOI 10.1111/j.1540-8167.2008.01285.x; Nielsen JC, 2012, NEW ENGL J MED, V367, P1587, DOI 10.1056/NEJMoa1113566; Pappone C, 2006, J AM COLL CARDIOL, V48, P2340, DOI 10.1016/j.jacc.2006.08.037; Pappone C, 2011, CIRC-ARRHYTHMIA ELEC, V4, P808, DOI 10.1161/CIRCEP.111.966408; Singh SN, 2006, J AM COLL CARDIOL, V48, P721, DOI 10.1016/j.jacc.2006.03.051; Skanes AC, 2012, CAN J CARDIOL, V28, P125, DOI 10.1016/j.cjca.2012.01.021; Stabile G, 2006, EUR HEART J, V27, P216, DOI 10.1093/eurheartj/ehi583; Tamborero D, 2010, HEART RHYTHM, V7, P612, DOI 10.1016/j.hrthm.2010.01.021; Verma A, 2013, JAMA INTERN MED, V173, P149, DOI 10.1001/jamainternmed.2013.1561; Wang TJ, 2003, CIRCULATION, V107, P2920, DOI 10.1161/01.CIR.0000072767.89944.6E; Wazni OM, 2005, JAMA-J AM MED ASSOC, V293, P2634, DOI 10.1001/jama.293.21.2634; Wilber DJ, 2010, JAMA-J AM MED ASSOC, V303, P333, DOI 10.1001/jama.2009.2029; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	28	370	387	5	42	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 19	2014	311	7					692	699		10.1001/jama.2014.467	http://dx.doi.org/10.1001/jama.2014.467			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA8ZO	24549549	Bronze			2022-12-28	WOS:000331383700021
J	Saitz, R				Saitz, Richard			Gabapentin increased complete abstinence in alcohol-dependent patients seeking treatment	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Boston Univ, Boston, MA 02215 USA	Boston University	Saitz, R (corresponding author), Boston Univ, Boston, MA 02215 USA.			/0000-0002-2535-1427	National Institute on Alcohol Abuse and Alcoholism; Pfizer	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Pfizer(Pfizer)	National Institute on Alcohol Abuse and Alcoholism. Study drug was provided by Pfizer.	Nunes EV, 2014, JAMA INTERN MED, V174, P78, DOI 10.1001/jamainternmed.2013.11973; Rosner S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001867.pub3; Rosner S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004332.pub2	3	1	1	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 18	2014	160	4							JC10	10.7326/0003-4819-160-4-201402180-02010	http://dx.doi.org/10.7326/0003-4819-160-4-201402180-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC8RF	24534932				2022-12-28	WOS:000350635100009
J	Macnabb, J; Rowan, L; Heneghan, C; Onakpoya, I				Macnabb, Jasmine; Rowan, Lyndsay; Heneghan, Carl; Onakpoya, Igho			How England's emergency departments are being penalised	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Macnabb, Jasmine; Rowan, Lyndsay] Channel 4, Dispatches, London, England; [Heneghan, Carl; Onakpoya, Igho] Ctr Evidence Based Med, Oxford, England	University of Oxford	Heneghan, C (corresponding author), Ctr Evidence Based Med, Oxford, England.	carl.heneghan@phc.ox.ac.uk						[Anonymous], 2013, HLTH SERVICE J  0625; Monitor and NHS England's review of the marginal rate rule, 2013, MONITOR NHS ENGLANDS; Urrey A., 2013, BBC NEWS	3	6	6	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2014	348								g1604	10.1136/bmj.g1604	http://dx.doi.org/10.1136/bmj.g1604			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB9ZG	24535578				2022-12-28	WOS:000332153700011
J	Manno, D; Ker, K; Roberts, I				Manno, Daniela; Ker, Katharine; Roberts, Ian			How effective is tranexamic acid for acute gastrointestinal bleeding?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MANAGEMENT; TRACT; CONSENSUS		[Manno, Daniela; Ker, Katharine; Roberts, Ian] Univ London London Sch Hyg & Trop Med, Clin Trials Unit, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Manno, D (corresponding author), Univ London London Sch Hyg & Trop Med, Clin Trials Unit, Keppel St, London WC1E 7HT, England.	daniela.manno@lshtm.ac.uk		Manno, Daniela/0000-0002-7026-3581; Ker, Katharine/0000-0002-1514-5005	National Institute for Health Research [11/01/04] Funding Source: researchfish; Department of Health [11/01/04] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		Ali F, 2007, GUT, V56, P1, DOI 10.1136/gut.2006.117598; ALMOHANA JMA, 1993, LANCET, V341, P518, DOI 10.1016/0140-6736(93)90278-O; Bagnenko S F, 2011, Khirurgiia (Mosk), P42; BARER D, 1983, NEW ENGL J MED, V308, P1571, DOI 10.1056/NEJM198306303082606; Barkun AN, 2010, ANN INTERN MED, V152, P101, DOI 10.7326/0003-4819-152-2-201001190-00009; Barnert J, 2009, NAT REV GASTRO HEPAT, V6, P637, DOI 10.1038/nrgastro.2009.167; BERGQVIST D, 1980, UPSALA J MED SCI, V85, P173, DOI 10.3109/03009738009179185; BIGGS JC, 1976, GUT, V17, P729, DOI 10.1136/gut.17.9.729; British Society of Gastroenterology, 2007, UK COMP AUD UPP GAST; Brok J, 2008, J CLIN EPIDEMIOL, V61, P763, DOI 10.1016/j.jclinepi.2007.10.007; CORMACK F, 1973, LANCET, V1, P1207; Dworzynski K, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3412; ENGQVIST A, 1979, SCAND J GASTROENTERO, V14, P839, DOI 10.3109/00365527909181413; Gluud LL, 2012, COCHRANE DB SYST REV, V18; Hawkey GM, 2001, GUT, V49, P372, DOI 10.1136/gut.49.3.372; Hearnshaw SA, 2011, GUT, V60, P1327, DOI 10.1136/gut.2010.228437; Ker K, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3054; National Institute for Health and Care Excellence, 2012, MAN AC UPP GASTR BLE; POLLER L, 1973, BRIT J HAEMATOL, V24, P664; Roberts I, 2011, LANCET, V377, P1096, DOI 10.1016/S0140-6736(11)60278-X; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Sung JJY, 2011, GUT, V60, P1170, DOI 10.1136/gut.2010.230292; The CRASH-2 Collaborators, 2011, LANCET, V377; VONHOLSTEIN CCSS, 1987, BMJ-BRIT MED J, V294, P7, DOI 10.1136/bmj.294.6563.7	24	14	15	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2014	348								g1421	10.1136/bmj.g1421	http://dx.doi.org/10.1136/bmj.g1421			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB9ZG	24535627	Green Accepted			2022-12-28	WOS:000332153700002
J	Tomasson, G; Peloquin, C; Mohammad, A; Love, TJ; Zhang, YQ; Choi, HK; Merkel, PA				Tomasson, Gunnar; Peloquin, Christine; Mohammad, Aladdin; Love, Thorvardur J.; Zhang, Yuqing; Choi, Hyon K.; Merkel, Peter A.			Risk for Cardiovascular Disease Early and Late After a Diagnosis of Giant-Cell Arteritis	ANNALS OF INTERNAL MEDICINE			English	Article							TEMPORAL ARTERITIS; VISUAL-LOSS; CLASSIFICATION; MULTICENTER; PREDICTORS; CRITERIA; HAZARDS; WOMEN	Background: Involvement of large arteries is well-documented in giant-cell arteritis (GCA), but the risk for cardiovascular events is not well-understood. Objective: To evaluate the risks for incident myocardial infarction (MI), cerebrovascular accident (CVA), and peripheral vascular disease (PVD) in individuals with incident GCA in a general population context. Design: Observational cohort study. Setting: U. K. primary care database. Patients: 3408 patients with incident GCA and 17 027 age-and sex-matched reference participants without baseline cardiovascular disease (MI, CVA, or PVD). Measurements: Diagnoses of GCA, outcomes, and cardiovascular risk factors were identified from electronic medical records. One combined and 3 separate cohort analyses were conducted for the outcomes of MI, CVA, and PVD. The association of GCA with study outcomes is expressed with hazard ratios (HRs) with 95% CIs after adjustment for potential cardiovascular risk factors. Results: Among 3408 patients with GCA (73% female; mean age, 73 years), the incidence rates of MI, CVA, and PVD were 10.0, 8.0, and 4.2 events per 1000 person-years, respectively, versus 4.9, 6.3, and 2.0 events per 1000 person-years, respectively, among reference participants. The HRs were 1.70 (95% CI, 1.51 to 1.91) for the combined outcome, 2.06 (CI, 1.72 to 2.46) for MI, 1.28 (CI, 1.06 to 1.54) for CVA, and 2.13 (CI, 1.61 to 2.81) for PVD. The HRs were more pronounced in the first month after GCA diagnosis (combined HR, 4.92 [CI, 2.59 to 9.34]; HR for MI, 11.89 [CI, 2.40 to 59.00]; HR for CVA, 3.93 [CI, 1.76 to 8.79]; HR for PVD, 3.86 [CI, 0.78 to 19.17]). Limitation: Information on temporal arterial biopsies was not available, and there was a substantial amount of missing data on cardiovascular risk factors. Conclusion: Giant-cell arteritis is associated with increased risks for MI, CVA, and PVD.	Univ Iceland, IS-101 Reykjavik, Iceland; Boston Univ, Sch Med, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Boston, MA USA; Skane Univ Hosp, Lund, Sweden; Univ Penn, Sch Med, Philadelphia, PA 19104 USA	University of Iceland; Boston University; Boston University; Lund University; Skane University Hospital; University of Pennsylvania	Tomasson, G (corresponding author), Univ Iceland, Dept Publ Hlth Sci, IS-101 Reykjavik, Iceland.	gunnar.tomasson@gmail.com	Mohammad, Aladdin/AAV-7102-2020; Love, Thorvardur/M-2987-2015; Mohammad, Aladdin/T-2600-2019	Mohammad, Aladdin/0000-0002-7169-6936; Love, THorvardur Jon/0000-0002-2680-6120; Zhang, Yuqing/0000-0001-7954-1149	National Institute of Arthritis and Musculoskeletal and Skin Diseases; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR047785] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	National Institute of Arthritis and Musculoskeletal and Skin Diseases.	Agard C, 2008, ARTHRIT RHEUM-ARTHR, V59, P670, DOI 10.1002/art.23577; Duhaut P, 1998, ARTHRITIS RHEUM-US, V41, P1960, DOI 10.1002/1529-0131(199811)41:11<1960::AID-ART10>3.0.CO;2-X; Fang F, 2012, NEW ENGL J MED, V366, P1310, DOI 10.1056/NEJMoa1110307; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gonzalez-Gay MA, 1998, ARTHRITIS RHEUM, V41, P1497, DOI 10.1002/1529-0131(199808)41:8<1497::AID-ART22>3.0.CO;2-Z; Gonzalez-Gay MA, 2004, MEDICINE, V83, P342, DOI 10.1097/01.md.0000145369.25558.b5; Hernan MA, 2010, EPIDEMIOLOGY, V21, P13, DOI 10.1097/EDE.0b013e3181c1ea43; Hoffman GS, 2002, ARTHRITIS RHEUM, V46, P1309, DOI 10.1002/art.10262; HUNDER GG, 1990, ARTHRITIS RHEUM, V33, P1122; Larsson K, 2006, ANN RHEUM DIS, V65, P529, DOI 10.1136/ard.2005.039404; LIE JT, 1990, ARTHRITIS RHEUM-US, V33, P1074; Liozon E, 2001, AM J MED, V111, P211, DOI 10.1016/S0002-9343(01)00770-7; Loddenkemper T, 2007, J NEUROL NEUROSUR PS, V78, P1255, DOI 10.1136/jnnp.2006.113787; Manzi S, 1997, AM J EPIDEMIOL, V145, P408; Molloy ES, 2007, AM COLL RHEUM ANN SC; Nuenninghoff DM, 2003, ARTHRITIS RHEUM-US, V48, P3522, DOI 10.1002/art.11353; Ray JG, 2005, HEART, V91, P324, DOI 10.1136/hrt.2004.037481; Salvarani C, 2005, ARTHRIT RHEUM-ARTHR, V53, P293, DOI 10.1002/art.21075; Schafer JL., 1997, ANAL INCOMPLETE MULT, DOI 10.1201/9781439821862; Sholter DE, 2000, CAN J CARDIOL, V16, P505; Simon C, 2008, INNOVAIT, V1, P134, DOI DOI 10.1093/INNOVAIT/INN010; Solomon DH, 2003, CIRCULATION, V107, P1303, DOI 10.1161/01.CIR.0000054612.26458.B2; Stuart-Buttle C D, 1996, Proc AMIA Annu Fall Symp, P75; Suppiah R, 2011, ARTHRIT CARE RES, V63, P588, DOI 10.1002/acr.20433; Weijenberg MP, 1996, AM J EPIDEMIOL, V143, P151, DOI 10.1093/oxfordjournals.aje.a008724	25	108	110	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 21	2014	160	2					73	+		10.7326/M12-3046	http://dx.doi.org/10.7326/M12-3046			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	297SQ	24592492	Green Accepted			2022-12-28	WOS:000330275600013
J	Maher, K; Chamberlain, CP				Maher, K.; Chamberlain, C. P.			Hydrologic Regulation of Chemical Weathering and the Geologic Carbon Cycle	SCIENCE			English	Article							ATMOSPHERIC CO2; RESIDENCE TIME; EROSION RATES; LARGE RIVERS; CHEMISTRY; EVOLUTION; FEEDBACK; CLIMATE; FLUXES; ZONE	Earth's temperature is thought to be regulated by a negative feedback between atmospheric CO2 levels and chemical weathering of silicate rocks that operates over million-year time scales. To explain variations in the strength of the weathering feedback, we present a model for silicate weathering that regulates climatic and tectonic forcing through hydrologic processes and imposes a thermodynamic limit on weathering fluxes, based on the physical and chemical properties of river basins. Climate regulation by silicate weathering is thus strongest when global topography is elevated, similar to the situation today, and lowest when global topography is more subdued, allowing planetary temperatures to vary depending on the global distribution of topography and mountain belts, even in the absence of appreciable changes in CO2 degassing rates.	[Maher, K.] Stanford Univ, Dept Geol & Environm Sci, Stanford, CA 94305 USA; [Chamberlain, C. P.] Stanford Univ, Dept Environm Earth Syst Sci, Stanford, CA 94305 USA	Stanford University; Stanford University	Maher, K (corresponding author), Stanford Univ, Dept Geol & Environm Sci, Stanford, CA 94305 USA.	kmaher@stanford.edu	Maher, Kate/B-3489-2010	Maher, Kate/0000-0002-5982-6064	U.S. NSF [EAR-1254156]	U.S. NSF(National Science Foundation (NSF))	The paper benefitted greatly from the reviews provided by several anonymous reviewers. This work was supported by the U.S. NSF (EAR-1254156 to K. M.). Data used in this study come from previously published studies, and the details of the model are provided in the supplementary materials.	BERNER RA, 1983, AM J SCI, V283, P641, DOI 10.2475/ajs.283.7.641; Berner RA, 1997, GEOLOGY, V25, P955, DOI 10.1130/0091-7613(1997)025<0955:TNFMBA>2.3.CO;2; Berner RA, 2001, AM J SCI, V301, P182, DOI 10.2475/ajs.301.2.182; BLUTH GJS, 1994, GEOCHIM COSMOCHIM AC, V58, P2341, DOI 10.1016/0016-7037(94)90015-9; Boucher D.F., 1959, CHEM ENG PROG, V55, P55; Bouchez J, 2012, CHEM GEOL, V332, P166, DOI 10.1016/j.chemgeo.2012.09.032; Brantley SL, 2011, ANNU REV EARTH PL SC, V39, P387, DOI 10.1146/annurev-earth-040809-152321; Edmond JM, 1997, TECTONIC UPLIFT CLIM, P329, DOI [DOI 10.1007/978-1-4615-5935-1_14, 10.1007/978-1-4615-5935-1_14]; Ferrier KL, 2008, EARTH PLANET SC LETT, V272, P591, DOI 10.1016/j.epsl.2008.05.024; Gaillardet J, 1999, CHEM GEOL, V159, P3, DOI 10.1016/S0009-2541(99)00031-5; Godsey SE, 2009, HYDROL PROCESS, V23, P1844, DOI 10.1002/hyp.7315; Hilley GE, 2010, EARTH PLANET SC LETT, V293, P191, DOI 10.1016/j.epsl.2010.01.008; Kump L. R., 1997, TECTONIC UPLIFT CLIM, P399, DOI [DOI 10.1007/978-1-4615-5935-1, DOI 10.1007/978-1-4615-5935-1_18]; Kump LR, 2000, ANNU REV EARTH PL SC, V28, P611, DOI 10.1146/annurev.earth.28.1.611; Li GJ, 2013, GEOCHIM COSMOCHIM AC, V103, P11, DOI 10.1016/j.gca.2012.10.014; Maher K, 2011, EARTH PLANET SC LETT, V312, P48, DOI 10.1016/j.epsl.2011.09.040; Manabe S, 2004, CLIMATIC CHANGE, V64, P59, DOI 10.1023/B:CLIM.0000024674.37725.ca; McCauley S. E., 1997, GLOBAL TECTONICS CLI, P427; Montgomery DR, 2002, EARTH PLANET SC LETT, V201, P481, DOI 10.1016/S0012-821X(02)00725-2; Pagani M, 2009, NATURE, V460, P85, DOI 10.1038/nature08133; RAYMO ME, 1992, NATURE, V359, P117, DOI 10.1038/359117a0; STALLARD RF, 1983, J GEOPHYS RES-OCEANS, V88, P9671, DOI 10.1029/JC088iC14p09671; WALKER JCG, 1981, J GEOPHYS RES-OCEANS, V86, P9776, DOI 10.1029/JC086iC10p09776; West AJ, 2012, GEOLOGY, V40, P811, DOI 10.1130/G33041.1; West AJ, 2002, GEOLOGY, V30, P355; Willenbring JK, 2010, NATURE, V465, P211, DOI 10.1038/nature09044; Willett SD, 1999, J GEOPHYS RES-SOL EA, V104, P28957, DOI 10.1029/1999JB900248; Yoo K, 2008, GEOLOGY, V36, P35, DOI 10.1130/G24285A.1	29	332	350	24	375	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2014	343	6178					1502	1504		10.1126/science.1250770	http://dx.doi.org/10.1126/science.1250770			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7TZ	24625927				2022-12-28	WOS:000333471000045
J	Murray, TH				Murray, Thomas H.			Stirring the Simmering "Designer Baby" Pot	SCIENCE			English	Editorial Material							PREIMPLANTATION GENETIC DIAGNOSIS; POLICY		[Murray, Thomas H.] Hastings Ctr, Garrison, NY USA; [Murray, Thomas H.] Natl Univ Singapore, Ctr Biomed Eth, Singapore 117597, Singapore	National University of Singapore	Murray, TH (corresponding author), Hastings Ctr, Garrison, NY USA.	murrayt@thehastingscenter.org						Baruch S, 2008, FERTIL STERIL, V89, P1053, DOI 10.1016/j.fertnstert.2007.05.048; Bianchi DW, 2014, NEW ENGL J MED, V370, P799, DOI 10.1056/NEJMoa1311037; Committee on Ethics American College of Obstetricians and Gynecologists, 2007, Obstet Gynecol, V109, P475; Ethics Comm Amer Soc Reprod Med, 2001, FERTIL STERIL, V75, P861; Ethics Committee of the American Society for Reproduc- tive Medicine, 2013, FERTIL STERIL, V100, P54; Fallat ME, 2013, PEDIATRICS, V131, P620, DOI 10.1542/peds.2012-3680; Glover Jonathan, 2007, CHOOSING CHILDREN GE; Gregg A. R., 2013, J AM COLL MED GENET, V15, P395; Hudson KL, 2006, FERTIL STERIL, V85, P1638, DOI 10.1016/j.fertnstert.2006.01.014; Human Fertilisation and Embryology Authority, 2003, SEX SELECTION OPTION; Kitzman JO, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004323; Murray T. H., 1996, THE WORTH OF A CHILD; Robertson JA, 2003, J MED ETHICS, V29, P213, DOI 10.1136/jme.29.4.213; STEINBOCK B, 1994, HASTINGS CENT REP, V24, P15; Wojcick A., 2013, U.S. Patent, Patent No. [8,543,339, 8543339]	15	7	8	1	162	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2014	343	6176					1208	1210		10.1126/science.1248080	http://dx.doi.org/10.1126/science.1248080			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC7RG	24626919				2022-12-28	WOS:000332728500024
J	Kafsack, BFC; Rovira-Graells, N; Clark, TG; Bancells, C; Crowley, VM; Campino, SG; Williams, AE; Drought, LG; Kwiatkowski, DP; Baker, DA; Cortes, A; Llinas, M				Kafsack, Bjoern F. C.; Rovira-Graells, Nuria; Clark, Taane G.; Bancells, Cristina; Crowley, Valerie M.; Campino, Susana G.; Williams, April E.; Drought, Laura G.; Kwiatkowski, Dominic P.; Baker, David A.; Cortes, Alfred; Llinas, Manuel			A transcriptional switch underlies commitment to sexual development in malaria parasites	NATURE			English	Article							PLASMODIUM-FALCIPARUM GAMETOCYTES; PROTEIN; GENES; EXPRESSION; TRANSMISSION; REGION	The life cycles of many parasites involve transitions between disparate host species, requiring these parasites to go through multiple developmental stages adapted to each of these specialized niches. Transmission of malaria parasites (Plasmodium spp.) from humans to the mosquito vector requires differentiation from asexual stages replicating within red blood cells into non-dividing male and female gametocytes. Although gametocytes were first described in 1880, our understanding of the molecular mechanisms involved in commitment to gametocyte formation is extremely limited, and disrupting this critical developmental transition remains a long-standing goal(1). Here we show that expression levels of the DNA-binding protein PfAP2-G correlate strongly with levels of gametocyte formation. Using independent forward and reverse genetics approaches, we demonstrate that PfAP2-G function is essential for parasite sexual differentiation. By combining genome-wide PfAP2-G cognate motif occurrence with global transcriptional changes resulting from PfAP2-G ablation, we identify early gametocyte genes as probable targets of PfAP2-G and show that their regulation by PfAP2-G is critical for their wild-type level expression. In the asexual blood-stage parasites pfap2-g appears to be among a set of epigenetically silenced loci(2,3) prone to spontaneous activation(4). Stochastic activation presents a simple mechanism for a low baseline of gametocyte production. Overall, these findings identify PfAP2-G as a master regulator of sexual-stage development in malaria parasites and mark the first discovery of a transcriptional switch controlling a differentiation decision in protozoan parasites.	[Kafsack, Bjoern F. C.; Crowley, Valerie M.; Llinas, Manuel] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Rovira-Graells, Nuria; Bancells, Cristina; Cortes, Alfred] Hosp Clin Univ Barcelona, CRESIB, Barcelona Ctr Int Hlth Res, Barcelona 08036, Catalonia, Spain; [Rovira-Graells, Nuria; Crowley, Valerie M.; Cortes, Alfred] IRB, Barcelona 08028, Catalonia, Spain; [Clark, Taane G.; Drought, Laura G.; Baker, David A.] Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London WC1E 7HT, England; [Clark, Taane G.] Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1E 7HT, England; [Campino, Susana G.; Kwiatkowski, Dominic P.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Williams, April E.; Llinas, Manuel] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Kwiatkowski, Dominic P.] Wellcome Trust Sanger Ctr Human Genet, Oxford OX37BN, England; [Cortes, Alfred] Catalan Inst Res & Adv Studies ICREA, Barcelona 08010, Spain	Princeton University; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Wellcome Trust Sanger Institute; Princeton University; University of Oxford; Wellcome Centre for Human Genetics; ICREA	Llinas, M (corresponding author), Penn State Univ, Dept Mol Biol, State Coll, PA 16802 USA.	manuel@psu.edu	Clark, Taane G./AAM-2570-2020; Closas, Alfred Cortes/I-8134-2015; Campino, Susana/AAM-2577-2020	Clark, Taane G./0000-0001-8985-9265; Closas, Alfred Cortes/0000-0003-0730-6582; Campino, Susana/0000-0003-1403-6138; Williams, April/0000-0001-9281-8528; Baker, David/0000-0002-5490-8933; Kafsack, Bjorn F.C./0000-0003-0089-1096; Kwiatkowski, Dominic/0000-0002-5023-0176; Bancells, Cristina/0000-0003-4819-218X; Crowley, Valerie/0000-0002-2593-1130	National Institutes of Health (NIH) [R01 AI076276]; Centre for Quantitative Biology [P50GM071508]; Howard Hughes Medical Institute fellowship of the Damon Runyon Cancer Research Foundation; Wellcome Trust [094752, 098051, 090532/Z/09/Z]; European Commission [223044]; Biotechnology and Biological Sciences Research Council CASE PhD studentship; Spanish Ministry of Science and Innovation [SAF2010-20111]; IRB Barcelona; Medical Research Council UK [J005398, G0600230]; Catalan Government fellowship [2011-BP-B 00060]; MRC [G0600230, G0600718] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [971922] Funding Source: researchfish; Medical Research Council [G0600230, G0600718] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076276] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007388, P50GM071508] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centre for Quantitative Biology; Howard Hughes Medical Institute fellowship of the Damon Runyon Cancer Research Foundation; Wellcome Trust(Wellcome Trust); European Commission(European CommissionEuropean Commission Joint Research Centre); Biotechnology and Biological Sciences Research Council CASE PhD studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); IRB Barcelona; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Catalan Government fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ICREA(ICREA)	We would like to thank C. Klein, T. Campbell and A. Schieler for technical assistance and are grateful to O. Billker, C. Flueck, J. Kelly, C. Sutherland, A. Vaidya and A. Waters for discussion and reading of the manuscript. We would also like to thank P. Alano for providing P. falciparum clone F12, C. Taylor for providing the P. falciparum GNP-A4 clone, E. Thompson for isolating P. falciparum DNA for whole genome analysis, Z. Gorvett for assistance with confirming single nucleotide polymorphisms in gametocyte non-producing clones, M. Duraisingh for the ddFKBP tagging construct pJDD145, C. Ben Mamoun for the anti-PP2c antibody and D. Goldberg for Shld1. M. L. is funded by National Institutes of Health (NIH) grant R01 AI076276 with support from the Centre for Quantitative Biology (P50GM071508). B. F. C. K. was supported by a Howard Hughes Medical Institute fellowship of the Damon Runyon Cancer Research Foundation. D. A. B. is funded by Wellcome Trust grant ref. 094752 and European Commission FP7 'MALSIG' (ref. 223044). L. G. D. is supported by a Biotechnology and Biological Sciences Research Council CASE PhD studentship with Pfizer as the Industrial partner. A. C. is funded by the Spanish Ministry of Science and Innovation grant SAF2010-20111. V. M. C. was supported by a fellowship from IRB Barcelona. T. G. C. is supported by the Medical Research Council UK (J005398). D. P. K. and S. G. C. are supported through the Wellcome Trust (098051; 090532/Z/09/Z) and the Medical Research Council UK (G0600230). C. B. is supported by the Catalan Government fellowship 2011-BP-B 00060 (AGAUR, Catalonia, Spain).	ALANO P, 1995, EXP PARASITOL, V81, P227, DOI 10.1006/expr.1995.1112; Alano P, 2007, MOL MICROBIOL, V66, P291, DOI 10.1111/j.1365-2958.2007.05904.x; Armstrong CM, 2007, NAT METHODS, V4, P1007, DOI 10.1038/nmeth1132; Avraham I, 2012, P NATL ACAD SCI USA, V109, pE3678, DOI 10.1073/pnas.1214572109; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; BRUCE MC, 1990, PARASITOLOGY, V100, P191, DOI 10.1017/S0031182000061199; Calderwood MS, 2003, J BIOL CHEM, V278, P34125, DOI 10.1074/jbc.M213065200; Campbell TL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001165; Cortes A, 2004, BLOOD, V104, P2961, DOI 10.1182/blood-2004-06-2136; Cortes A, 2007, PLOS PATHOG, V3, P1023, DOI 10.1371/journal.ppat.0030107; Cortes A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002943; Crowley VM, 2011, MOL MICROBIOL, V80, P391, DOI 10.1111/j.1365-2958.2011.07574.x; DAY KP, 1993, P NATL ACAD SCI USA, V90, P8292, DOI 10.1073/pnas.90.17.8292; Dixon MWA, 2008, TRENDS PARASITOL, V24, P168, DOI 10.1016/j.pt.2008.01.004; Eksi S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002964; Farrell A, 2012, SCIENCE, V335, P218, DOI 10.1126/science.1210829; Fivelman QL, 2007, MOL BIOCHEM PARASIT, V154, P119, DOI 10.1016/j.molbiopara.2007.04.008; Flueck C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000569; Guizetti J, 2013, CELL MICROBIOL, V15, P718, DOI 10.1111/cmi.12115; Ikadai H, 2013, P NATL ACAD SCI USA, V110, pE1676, DOI 10.1073/pnas.1217712110; Iwanaga S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047557; Jiang LB, 2010, P NATL ACAD SCI USA, V107, P2224, DOI 10.1073/pnas.0913396107; Kafsack BFC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-187; Lopez-Rubio JJ, 2009, CELL HOST MICROBE, V5, P179, DOI 10.1016/j.chom.2008.12.012; Maier AG, 2006, MOL BIOCHEM PARASIT, V150, P118, DOI 10.1016/j.molbiopara.2006.06.014; Manske M, 2012, NATURE, V487, P375, DOI 10.1038/nature11174; Me ' nard R., 2013, METHOD MOL BIOL, V923, P3; Painter HJ, 2011, MOL BIOCHEM PARASIT, V176, P1, DOI 10.1016/j.molbiopara.2010.11.014; Perez-Toledo K, 2009, NUCLEIC ACIDS RES, V37, P2596, DOI 10.1093/nar/gkp115; Pradel G, 2007, PARASITOLOGY, V134, P1911, DOI 10.1017/S0031182007003381; Robinson T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023204; Rovira-Graells N, 2012, GENOME RES, V22, P925, DOI 10.1101/gr.129692.111; Silvestrini F, 2010, MOL CELL PROTEOMICS, V9, P1437, DOI 10.1074/mcp.M900479-MCP200; Straimer J, 2012, NAT METHODS, V9, P993, DOI [10.1038/NMETH.2143, 10.1038/nmeth.2143]; Taylor C. J., 2007, THESIS U LONDON; Taylor CJ, 2008, MOL MICROBIOL, V69, P110, DOI 10.1111/j.1365-2958.2008.06267.x; WALLIKER D, 1987, SCIENCE, V236, P1661, DOI 10.1126/science.3299700; Wells TNC, 2009, NAT REV DRUG DISCOV, V8, P879, DOI 10.1038/nrd2972; Yuda M, 2010, MOL MICROBIOL, V75, P854, DOI 10.1111/j.1365-2958.2009.07005.x; Yuda M, 2009, MOL MICROBIOL, V71, P1402, DOI 10.1111/j.1365-2958.2009.06609.x	40	281	281	2	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2014	507	7491					248	+		10.1038/nature12920	http://dx.doi.org/10.1038/nature12920			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC6RJ	24572369	Green Accepted			2022-12-28	WOS:000332651800042
J	Scully, T				Scully, Tony			THE AGE OF VACCINES	NATURE			English	Editorial Material																			0	9	9	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					S2	S3		10.1038/507S2a	http://dx.doi.org/10.1038/507S2a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC0ZQ	24611167	Bronze			2022-12-28	WOS:000332224400002
J	Wasio, NA; Quardokus, RC; Forrest, RP; Lent, CS; Corcelli, SA; Christie, JA; Henderson, KW; Kandel, SA				Wasio, Natalie A.; Quardokus, Rebecca C.; Forrest, Ryan P.; Lent, Craig S.; Corcelli, Steven A.; Christie, John A.; Henderson, Kenneth W.; Kandel, S. Alex			Self-assembly of hydrogen-bonded two-dimensional quasicrystals	NATURE			English	Article							VAN-DER-WAALS; ACID; MOLECULES; ENERGIES; SURFACE; ORDER; MODEL	The process of molecular self-assembly on solid surfaces is essentially one of crystallization in two dimensions, and the structures that result depend on the interplay between intermolecular forces and the interaction between adsorbates and the underlying substrate(1). Because a single hydrogen bond typically has an energy between 15 and 35 kilojoules per mole, hydrogen bonding can be a strong driver of molecular assembly; this is apparent from the dominant role of hydrogen bonding in nucleic-acid base pairing, as well as in the secondary structure of proteins. Carboxylic acid functional groups, which provide two hydrogen bonds, are particularly promising and reliable in creating and maintaining surface order, and self-assembled monolayers of benzoic acids produce structure that depends on the number and relative placement of carboxylic acid groups(2-6). Here we use scanning tunnelling microscopy to study self-assembled monolayers of ferrocenecarboxylic acid (FcCOOH), and find that, rather than producing dimeric or linear structures typical of carboxylic acids, FcCOOH forms highly unusual cyclic hydrogen-bonded pentamers, which combine with simultaneously formed FcCOOH dimers to form two-dimensional quasicrystallites that exhibit local five-fold symmetry and maintain translational and rotational order (without periodicity) for distances of more than 400 angstroms.	[Wasio, Natalie A.; Quardokus, Rebecca C.; Forrest, Ryan P.; Corcelli, Steven A.; Christie, John A.; Henderson, Kenneth W.; Kandel, S. Alex] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Lent, Craig S.] Univ Notre Dame, Dept Elect Engn, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame	Kandel, SA (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA.	skandel@nd.edu	Corcelli, Steven/AAT-9394-2021	Lent, Craig/0000-0002-0026-516X	US National Science Foundation [NSF CHE-1124762]; Center for Research Computing at the University of Notre Dame	US National Science Foundation(National Science Foundation (NSF)); Center for Research Computing at the University of Notre Dame	This work was supported by the US National Science Foundation under grant NSF CHE-1124762. The authors acknowledge high-performance computing resources and support from the Center for Research Computing at the University of Notre Dame.	BAUER K, 1989, Z PHYS B CON MAT, V75, P385, DOI 10.1007/BF01321826; Bauert T, 2009, J AM CHEM SOC, V131, P3460, DOI 10.1021/ja8101083; Bell W, 1996, ACTA CRYSTALLOGR C, V52, P1928, DOI 10.1107/S0108270196006233; Beyer T, 2000, J PHYS CHEM B, V104, P2647, DOI 10.1021/jp9941413; BOYS SF, 1970, MOL PHYS, V19, P553, DOI 10.1080/00268977000101561; Clair S, 2004, J PHYS CHEM B, V108, P14585, DOI 10.1021/jp049501n; COTTON FA, 1985, ACTA CRYSTALLOGR C, V41, P686, DOI 10.1107/S010827018500511X; Ecija D, 2013, P NATL ACAD SCI USA, V110, P6678, DOI 10.1073/pnas.1222713110; Fischer S, 2011, P NATL ACAD SCI USA, V108, P1810, DOI 10.1073/pnas.1008695108; Fuhr JD, 2013, J PHYS CHEM C, V117, P1287, DOI 10.1021/jp305455v; Gierer M, 1998, PHYS REV B, V57, P7628, DOI 10.1103/PhysRevB.57.7628; Guillermet O, 2009, ANGEW CHEM INT EDIT, V48, P1970, DOI 10.1002/anie.200805689; Hayashida K, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.195502; Heininger C, 2009, LANGMUIR, V25, P968, DOI 10.1021/la803055p; Ireta J, 2004, J PHYS CHEM A, V108, P5692, DOI 10.1021/jp0377073; IUCr, 1992, ACTA CRYSTALLOGR A, V48, P922, DOI 10.1107/S0108768192099828; Lackinger M, 2009, LANGMUIR, V25, P11307, DOI 10.1021/la900785f; LEVINE D, 1984, PHYS REV LETT, V53, P2477, DOI 10.1103/PhysRevLett.53.2477; LEVINE D, 1986, PHYS REV B, V34, P596, DOI 10.1103/PhysRevB.34.596; Nishio M, 2011, PHYS CHEM CHEM PHYS, V13, P13873, DOI 10.1039/c1cp20404a; Penrose R., 1978, EUREKA, V39, P16; Quardokus RC, 2013, PHYS CHEM CHEM PHYS, V15, P6973, DOI 10.1039/c3cp50225b; Reichert M, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.214202; Sanders R, 1996, J ORGANOMET CHEM, V512, P219, DOI 10.1016/0022-328X(95)05914-B; Shao Y, 2006, PHYS CHEM CHEM PHYS, V8, P3172, DOI 10.1039/b517914a; SHECHTMAN D, 1984, PHYS REV LETT, V53, P1951, DOI 10.1103/PhysRevLett.53.1951; Smerdon JA, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.075407; Smith RK, 2004, PROG SURF SCI, V75, P1, DOI 10.1016/j.progsurf.2003.12.001; Steiner T, 1998, CHEM COMMUN, P891, DOI 10.1039/a708099i; Talapin DV, 2009, NATURE, V461, P964, DOI 10.1038/nature08439; Thanthiriwatte KS, 2011, J CHEM THEORY COMPUT, V7, P88, DOI 10.1021/ct100469b; Tsuzuki S, 2001, J CHEM PHYS, V114, P3949, DOI 10.1063/1.1344891; Vargas R, 2000, J AM CHEM SOC, V122, P4750, DOI 10.1021/ja993600a; Xiao CH, 2012, NATURE, V487, P349, DOI 10.1038/nature11230; Ye YC, 2007, J PHYS CHEM C, V111, P10138, DOI 10.1021/jp072726o; Zeng XB, 2004, NATURE, V428, P157, DOI 10.1038/nature02368; Zhong DY, 2010, ACS NANO, V4, P1997, DOI 10.1021/nn100116y	37	159	162	8	383	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					86	+		10.1038/nature12993	http://dx.doi.org/10.1038/nature12993			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0ZQ	24598637				2022-12-28	WOS:000332224400047
J	Carrero, JJ; Evans, M; Szummer, K; Spaak, J; Lindhagen, L; Edfors, R; Stenvinkel, P; Jacobson, SH; Jernberg, T				Carrero, Juan Jesus; Evans, Marie; Szummer, Karolina; Spaak, Jonas; Lindhagen, Lars; Edfors, Robert; Stenvinkel, Peter; Jacobson, Stefan H.; Jernberg, Tomas			Warfarin, Kidney Dysfunction, and Outcomes Following Acute Myocardial Infarction in Patients With Atrial Fibrillation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GLOMERULAR-FILTRATION-RATE; HEMODIALYSIS-PATIENTS; DIALYSIS PATIENTS; RENAL-DISEASE; RISK-FACTORS; ANTICOAGULATION; STROKE; PREVENTION; EQUATION; THROMBOEMBOLISM	IMPORTANCE Conflicting evidence exists regarding the association between warfarin treatment, death, and ischemic stroke incidence in patients with advanced chronic kidney disease (CKD) and atrial fibrillation. OBJECTIVE To study outcomes associated with warfarin treatment in relation to kidney function among patients with established cardiovascular disease and atrial fibrillation. DESIGN, SETTING, AND PARTICIPANTS Observational, prospective, multicenter cohort study from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART) registry (2003-2010), which includes all Swedish hospitals that provide care for acute cardiac diseases. Participants included consecutive survivors of an acute myocardial infarction (MI) with atrial fibrillation and known serum creatinine (N = 24 317), including 21.8% who were prescribed warfarin at discharge. Chronic kidney disease stages were classified according to estimated glomerular filtration rate (eGFR). MAIN OUTCOMES AND MEASURES (1) Composite end point analysis of death, readmission due to MI, or ischemic stroke; (2) bleeding (composite of readmission due to hemorrhagic stroke, gastrointestinal bleeding, bleeding causing anemia, and others); or (3) the aggregate of these 2 outcomes within 1 year from discharge date. RESULTS A total of 5292 patients (21.8%) were treated with warfarin at discharge, and 51.7% had manifest CKD (eGFR <60 mL/min/1.73 m(2) [eGFR(<60)]). Compared with no warfarin use, warfarin was associated with a lower risk of the first composite outcome (n = 9002 events) in each CKD stratum for event rates per 100 person-years: eGFR(>60) event rate, 28.0 for warfarin vs 36.1 for no warfarin; adjusted hazard ratio (HR), 0.73 (95% CI, 0.65 to 0.81); eGFR(>30-60): event rate, 48.5 for warfarin vs 63.8 for no warfarin; HR, 0.73 (95% CI, 0.66 to 0.80); eGFR(>15-30): event rate, 84.3 for warfarin vs 110.1 for no warfarin; HR, 0.84 (95% CI, 0.70-1.02); eGFR(<= 15): event rate, 83.2 for warfarin vs 128.3 for no warfarin; HR, 0.57 (95% CI, 0.37-0.86). The risk of bleeding (n = 1202 events) was not significantly higher in patients treated with warfarin in any CKD stratum for event rates per 100 person-years: eGFR(>60) event rate, 5.0 for warfarin vs 4.8 for no warfarin; HR, 1.10 (95% CI, 0.86-1.41); eGFR(>30-60) event rate, 6.8 forwarfarin vs 6.3 for no warfarin; HR, 1.04 (95% CI, 0.81-1.33); eGFR(>15-30) event rate, 9.3 forwarfarin vs 10.4 for nowarfarin; HR, 0.82 (95% CI, 0.48-1.39); eGFR(<= 15) event rate, 9.1 forwarfarin vs 13.5 for nowarfarin; HR, 0.52 (95% CI, 0.16-1.65). Warfarin use in each CKD stratum was associated with lower hazards of the aggregate outcome (n = 9592 events) for event rates per 100 person-years: eGFR(>60) event rate, 32.1 for warfarin vs 40.0 for no warfarin; HR, 0.76 (95% CI, 0.69-0.84); eGFR(>30-60) event rate, 53.6 forwarfarin vs 69.0 for nowarfarin; HR, 0.75 (95% CI, 0.68-0.82); eGFR(>15-30) event rate, 90.2 forwarfarin vs 117.7 for nowarfarin; HR, 0.82 (95% CI, 0.68-0.99); eGFR(<= 15) event rate, 86.2 forwarfarin vs 138.2 for nowarfarin; HR, 0.55 (95% CI, 0.37-0.83). CONCLUSIONS AND RELEVANCE Warfarin treatment was associated with a lower 1-year risk for the composite outcome of death, MI, and ischemic stroke without a higher risk of bleeding in consecutive acute MI patients with atrial fibrillation. This association was not related to the severity of concurrent CKD.	[Carrero, Juan Jesus] Karolinska Inst, Ctr Mol Med, S-14186 Stockholm, Sweden; [Carrero, Juan Jesus; Evans, Marie; Stenvinkel, Peter] Karolinska Inst, Div Renal Med, S-14186 Stockholm, Sweden; [Szummer, Karolina; Edfors, Robert; Jernberg, Tomas] Karolinska Inst, Div Cardiol, S-14186 Stockholm, Sweden; [Spaak, Jonas; Jacobson, Stefan H.] Karolinska Inst, Danderyd Univ Hosp, Dept Clin Sci, S-14186 Stockholm, Sweden; [Lindhagen, Lars] Uppsala Clin Res Ctr, Uppsala, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Danderyds Hospital; Karolinska Institutet; Uppsala University	Carrero, JJ (corresponding author), Karolinska Inst, Div Renal Med, K56, S-14186 Stockholm, Sweden.	juan.jesus.carrero@ki.se	Edfors, Robert Lars/GQQ-1419-2022	Evans, Marie/0000-0001-8650-5795; Stenvinkel, Peter/0000-0002-8785-4820; Carrero, Juan Jesus/0000-0003-4763-2024; Jernberg, Tomas/0000-0003-1695-379X; Edfors, Robert/0000-0003-2377-436X	Swedish Foundation for Strategic Research	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	This work was supported by a grant from the Swedish Foundation for Strategic Research.	Bansal N, 2013, CIRCULATION, V127, P569, DOI 10.1161/CIRCULATIONAHA.112.123992; Camm AJ, 2012, EUR HEART J, V33, P2719, DOI 10.1093/eurheartj/ehs253; Chan KE, 2009, J AM SOC NEPHROL, V20, P2223, DOI 10.1681/ASN.2009030319; Chan KE, 2009, J AM SOC NEPHROL, V20, P872, DOI 10.1681/ASN.2008080824; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Elliott MJ, 2007, AM J KIDNEY DIS, V50, P433, DOI 10.1053/j.ajkd.2007.06.017; Fine A, 2002, KIDNEY INT, V61, P2210, DOI 10.1046/j.1523-1755.2002.00375.x; Go AS, 2009, CIRCULATION, V119, P1363, DOI 10.1161/CIRCULATIONAHA.108.816082; Guo S., 2009, PROPENSITY SCORE ANA, V12; Hart RG, 2011, CLIN J AM SOC NEPHRO, V6, P2599, DOI 10.2215/CJN.02400311; Herzog CA, 2011, KIDNEY INT, V80, P572, DOI 10.1038/ki.2011.223; Holden RM, 2008, CLIN J AM SOC NEPHRO, V3, P105, DOI 10.2215/CJN.01810407; ISEKI K, 1993, KIDNEY INT, V44, P1086, DOI 10.1038/ki.1993.352; James MT, 2010, LANCET, V375, P1296, DOI 10.1016/S0140-6736(09)62004-3; Jernberg T, 2010, HEART, V96, P1617, DOI 10.1136/hrt.2010.198804; Journal of the International Society of Nephrology, J INT SOC NEPHROLOGY; Knoll F, 2012, NEPHROL DIAL TRANSPL, V27, P332, DOI 10.1093/ndt/gfr341; Koos R, 2005, AM J CARDIOL, V96, P747, DOI 10.1016/j.amjcard.2005.05.014; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Limdi NA, 2010, AM J KIDNEY DIS, V56, P823, DOI 10.1053/j.ajkd.2010.05.023; Limdi NA, 2009, J AM SOC NEPHROL, V20, P912, DOI 10.1681/ASN.2008070802; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Nelson SE, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.002097; Olesen JB, 2012, NEW ENGL J MED, V367, P625, DOI 10.1056/NEJMoa1105594; Piccini JP, 2013, CIRCULATION, V127, P224, DOI 10.1161/CIRCULATIONAHA.112.107128; Skali H, 2011, AM HEART J, V162, P548, DOI 10.1016/j.ahj.2011.06.006; Wallentin L, 2010, LANCET, V376, P975, DOI 10.1016/S0140-6736(10)61194-4; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Wieloch M, 2011, EUR HEART J, V32, P2282, DOI 10.1093/eurheartj/ehr134; Winkelmayer WC, 2011, CLIN J AM SOC NEPHRO, V6, P2662, DOI 10.2215/CJN.04550511; Wizemann V, 2010, KIDNEY INT, V77, P1098, DOI 10.1038/ki.2009.477; Yang JY, 2012, J AM SOC NEPHROL, V23, P495, DOI 10.1681/ASN.2011070658	34	108	114	1	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2014	311	9					919	928		10.1001/jama.2014.1334	http://dx.doi.org/10.1001/jama.2014.1334			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC0FS	24595776	Bronze			2022-12-28	WOS:000332170800020
J	Zarin, DA; Tse, T; Menikoff, J				Zarin, Deborah A.; Tse, Tony; Menikoff, Jerry			Federal Human Research Oversight of Clinical Trials in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Zarin, Deborah A.; Tse, Tony] NIH, Natl Lib Med, Bethesda, MD 20894 USA; [Menikoff, Jerry] US Dept HHS, Off Human Res Protect, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Zarin, DA (corresponding author), NIH, 8600 Rockville Pike,Bldg 38A,Room 07N719, Bethesda, MD 20894 USA.	dzarin@mail.nih.gov		Tse, Tony/0000-0002-9906-6864	NATIONAL LIBRARY OF MEDICINE [ZIALM008926] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 LM999999] Funding Source: Medline	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Califf RM, 2006, CLIN TRIALS, V3, P496, DOI 10.1177/1740774506073173; ClinicalTrials.gov, CLINICALTRIALS GOV P; Gunsalus CK., 2001, ETHICAL AND POLICY I, VII; National Bioethics Advisory Commission, 2001, REPORT AND RECOMMEND	4	6	7	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2014	311	9					960	961		10.1001/jama.2013.284306	http://dx.doi.org/10.1001/jama.2013.284306			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC0FS	24595782	Green Accepted, Bronze			2022-12-28	WOS:000332170800026
J	Martino, MM; Briquez, PS; Guc, E; Tortelli, F; Kilarski, WW; Metzger, S; Rice, JJ; Kuhn, GA; Muller, R; Swartz, MA; Hubbell, JA				Martino, Mikael M.; Briquez, Priscilla S.; Guc, Esra; Tortelli, Federico; Kilarski, Witold W.; Metzger, Stephanie; Rice, Jeffrey J.; Kuhn, Gisela A.; Muller, Ralph; Swartz, Melody A.; Hubbell, Jeffrey A.			Growth Factors Engineered for Super-Affinity to the Extracellular Matrix Enhance Tissue Healing	SCIENCE			English	Article							FACTOR-BINDING; REPAIR; ANGIOGENESIS	Growth factors (GFs) are critical in tissue repair, but their translation to clinical use has been modest. Physiologically, GF interactions with extracellular matrix (ECM) components facilitate localized and spatially regulated signaling; therefore, we reasoned that the lack of ECM binding in their clinically used forms could underlie the limited translation. We discovered that a domain in placenta growth factor-2 (PlGF-2(123-144)) binds exceptionally strongly and promiscuously to ECM proteins. By fusing this domain to the GFs vascular endothelial growth factor-A, platelet-derived growth factor-BB, and bone morphogenetic protein-2, we generated engineered GF variants with super-affinity to the ECM. These ECM super-affinity GFs induced repair in rodent models of chronic wounds and bone defects that was greatly enhanced as compared to treatment with the wild-type GFs, demonstrating that this approach may be useful in several regenerative medicine applications.	[Martino, Mikael M.; Briquez, Priscilla S.; Guc, Esra; Tortelli, Federico; Kilarski, Witold W.; Metzger, Stephanie; Rice, Jeffrey J.; Swartz, Melody A.; Hubbell, Jeffrey A.] Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, CH-1015 Lausanne, Switzerland; [Martino, Mikael M.; Briquez, Priscilla S.; Guc, Esra; Tortelli, Federico; Kilarski, Witold W.; Metzger, Stephanie; Rice, Jeffrey J.; Swartz, Melody A.; Hubbell, Jeffrey A.] Ecole Polytech Fed Lausanne, Sch Engn, CH-1015 Lausanne, Switzerland; [Martino, Mikael M.] Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Rice, Jeffrey J.] Tennessee Technol Univ, Dept Chem Engn, Cookeville, TN 38505 USA; [Kuhn, Gisela A.; Muller, Ralph] Swiss Fed Inst Technol, Inst Biomech, CH-8093 Zurich, Switzerland; [Swartz, Melody A.] Ecole Polytech Fed Lausanne, Sch Life Sci, Swiss Inst Expt Canc Res, CH-1015 Lausanne, Switzerland; [Swartz, Melody A.; Hubbell, Jeffrey A.] Ecole Polytech Fed Lausanne, Sch Basic Sci, Inst Chem Sci & Engn, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Osaka University; Tennessee Technological University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Hubbell, JA (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Inst Bioengn, CH-1015 Lausanne, Switzerland.	jeffrey.hubbell@epfl.ch	Swartz, Melody A./F-9563-2011; Hubbell, Jeffrey A/A-9266-2008; Kilarski, Witold/AAA-1843-2019; Kilarski, Witold W./G-8673-2012; Müller, Ralph/A-1198-2008; Martino, Mikaël M/N-9345-2013	Hubbell, Jeffrey A/0000-0003-0276-5456; Kilarski, Witold W./0000-0003-0734-4749; Müller, Ralph/0000-0002-5811-7725; Martino, Mikaël M/0000-0002-5012-4605; Briquez, Priscilla/0000-0002-4680-9636	European Community; Swiss National Science Foundation; Fondation Bertarelli	European Community(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Fondation Bertarelli	The Protein Expression, Proteomics, and Histology Core Facilities of the Ecole Polytechnique Federale de Lausanne and M. Pasquier, X. Quaglia, and C. Dessibourg provided technical assistance. Funding was from the European Community's Seventh Framework Programme in the project Angioscaff, the Swiss National Science Foundation, and the Fondation Bertarelli. J.A.H., M. M. M., and P. S. B. are named as inventors on a patent application filed by the Ecole Polytechnique Federale de Lausanne that covers the technology described in this paper.	[Anonymous], 2008, SAF WARN BEC REGR; Chan RK, 2006, J BURN CARE RES, V27, P202, DOI 10.1097/01.BCR.0000202898.11277.58; De Falco S, 2012, EXP MOL MED, V44, P1, DOI 10.3858/emm.2012.44.1.025; De Laporte L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062076; Ferrara N, 2010, MOL BIOL CELL, V21, P687, DOI 10.1091/mbc.E09-07-0590; Food and Drug Administration, 2010, EX SUMM P050036 MEDT; Galiano RD, 2004, AM J PATHOL, V164, P1935, DOI 10.1016/S0002-9440(10)63754-6; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Herbert SP, 2011, NAT REV MOL CELL BIO, V12, P551, DOI 10.1038/nrm3176; Kilarski WW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057135; Lo KWH, 2012, ADV DRUG DELIVER REV, V64, P1277, DOI 10.1016/j.addr.2012.03.014; Ponte AL, 2007, STEM CELLS, V25, P1737, DOI 10.1634/stemcells.2007-0054; Macri L, 2007, ADV DRUG DELIVER REV, V59, P1366, DOI 10.1016/j.addr.2007.08.015; Martino MM, 2013, P NATL ACAD SCI USA, V110, P4563, DOI 10.1073/pnas.1221602110; Martino MM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002614; Martino MM, 2010, FASEB J, V24, P4711, DOI 10.1096/fj.09-151282; Rice JJ, 2013, ADV HEALTHC MATER, V2, P57, DOI 10.1002/adhm.201200197; Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029; Schmoekel HG, 2005, BIOTECHNOL BIOENG, V89, P253, DOI 10.1002/bit.20168; Schultz GS, 2011, WOUND REPAIR REGEN, V19, P134, DOI 10.1111/j.1524-475X.2011.00673.x; Simons M, 2003, NAT REV DRUG DISCOV, V2, P863, DOI 10.1038/nrd1226; Solchaga LA, 2012, J TISSUE ENG, V3, DOI 10.1177/2041731412442668; Spicer PP, 2012, NAT PROTOC, V7, P1918, DOI 10.1038/nprot.2012.113; Sullivan SR, 2004, PLAST RECONSTR SURG, V113, P953, DOI 10.1097/01.PRS.0000105044.03230.F4; Woo EJ, 2012, SPINE J, V12, P894, DOI 10.1016/j.spinee.2012.09.052	25	312	325	8	260	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 21	2014	343	6173					885	888		10.1126/science.1247663	http://dx.doi.org/10.1126/science.1247663			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB1LG	24558160				2022-12-28	WOS:000331552600046
J	McCartney, M				McCartney, Margaret			Care.data: why are Scotland and Wales doing it differently?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358	Medical Research Council [MR/K006525/1] Funding Source: Medline; MRC [MR/K006525/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		[Anonymous], 2021, BBC NEWS 0412; BBC, 2014, BBC; Department for Health Social Services and Public Safety Health and Social Care, INF BETT CAR NO IR; Lewis G., 2014, BETTER INFORM MEANS; Scottish Primary Care Information Resource, FREQ ASK QUEST	5	6	6	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 20	2014	348								g1702	10.1136/bmj.g1702	http://dx.doi.org/10.1136/bmj.g1702			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB9ZO	24556069				2022-12-28	WOS:000332154500007
J	Aiken, LH; Sloane, DM; Bruyneel, L; Van den Heede, K; Griffiths, P; Busse, R; Diomidous, M; Kinnunen, J; Kozka, M; Lesaffre, E; McHugh, MD; Moreno-Casbas, MT; Rafferty, AM; Schwendimann, R; Scott, PA; Tishelman, C; van Achterberg, T; Sermeus, W				Aiken, Linda H.; Sloane, Douglas M.; Bruyneel, Luk; Van den Heede, Koen; Griffiths, Peter; Busse, Reinhard; Diomidous, Marianna; Kinnunen, Juha; Kozka, Maria; Lesaffre, Emmanuel; McHugh, Matthew D.; Moreno-Casbas, M. T.; Rafferty, Anne Marie; Schwendimann, Rene; Scott, P. Anne; Tishelman, Carol; van Achterberg, Theo; Sermeus, Walter		RN4CAST Consortium	Nurse staffing and education and hospital mortality in nine European countries: a retrospective observational study	LANCET			English	Article							PATIENT OUTCOMES; ADMINISTRATIVE DATA; UNITED-STATES; CARE; QUALITY; HEALTH; AUSTERITY; CRISIS; SYSTEM; RATES	Background Austerity measures and health-system redesign to minimise hospital expenditures risk adversely affecting patient outcomes. The RN4CAST study was designed to inform decision making about nursing, one of the largest components of hospital operating expenses. We aimed to assess whether differences in patient to nurse ratios and nurses' educational qualifications in nine of the 12 RN4CAST countries with similar patient discharge data were associated with variation in hospital mortality after common surgical procedures. Methods For this observational study, we obtained discharge data for 422 730 patients aged 50 years or older who underwent common surgeries in 300 hospitals in nine European countries. Administrative data were coded with a standard protocol (variants of the ninth or tenth versions of the International Classification of Diseases) to estimate 30 day in-hospital mortality by use of risk adjustment measures including age, sex, admission type, 43 dummy variables suggesting surgery type, and 17 dummy variables suggesting comorbidities present at admission. Surveys of 26 516 nurses practising in study hospitals were used to measure nurse staffing and nurse education. We used generalised estimating equations to assess the effects of nursing factors on the likelihood of surgical patients dying within 30 days of admission, before and after adjusting for other hospital and patient characteristics. Findings An increase in a nurses' workload by one patient increased the likelihood of an inpatient dying within 30 days of admission by 7% (odds ratio 1.068, 95% CI 1.031-1.106), and every 10% increase in bachelor's degree nurses was associated with a decrease in this likelihood by 7% (0.929, 0.886-0.973). These associations imply that patients in hospitals in which 60% of nurses had bachelor's degrees and nurses cared for an average of six patients would have almost 30% lower mortality than patients in hospitals in which only 30% of nurses had bachelor's degrees and nurses cared for an average of eight patients. Interpretation Nurse staffing cuts to save money might adversely affect patient outcomes. An increased emphasis on bachelor's education for nurses could reduce preventable hospital deaths.	[Aiken, Linda H.; Sloane, Douglas M.; McHugh, Matthew D.] Univ Penn, Sch Nursing, Ctr Hlth Outcomes & Policy Res, Philadelphia, PA 19104 USA; [Bruyneel, Luk; Van den Heede, Koen; Sermeus, Walter] Catholic Univ Louvain, Ctr Hlth Serv & Nursing Res, B-3000 Louvain, Belgium; [Griffiths, Peter] Univ Southampton, Fac Hlth Sci, Southampton, Hants, England; [Busse, Reinhard] Berlin Univ Technol, WHO Collaborating Ctr Hlth Syst Res & Management, Dept Hlth Care Management, Berlin, Germany; [Diomidous, Marianna] Univ Athens, Fac Nursing, Athens, Greece; [Kinnunen, Juha] Univ Eastern Finland, Dept Hlth Policy & Management, Kuopio, Finland; [Kozka, Maria] Jagiellonian Univ, Coll Med, Fac Hlth Sci, Inst Nursing & Midwifery, Krakow, Poland; [Lesaffre, Emmanuel] Katholieke Univ Leuven, Leuven Biostat & Stat Bioinformat Ctr, Louvain, Belgium; [Moreno-Casbas, M. T.] Inst Hlth Carlos III, Nursing & Healthcare Res Unit, Madrid, Spain; [Rafferty, Anne Marie] Kings Coll London, Florence Nightingale Sch Nursing & Midwifery, London WC2R 2LS, England; [Schwendimann, Rene] Inst Nursing Sci, Basel, Switzerland; [Scott, P. Anne] Dublin City Univ, Sch Nursing & Human Sci, Dublin 9, Ireland; [Tishelman, Carol] Karolinska Inst, Dept Learning Informat Management & Eth, Med Management Ctr, Stockholm, Sweden; [van Achterberg, Theo] Radboud Univ Nijmegen, Med Ctr, IQ Healthcare, Sci Inst Qual Healthcare, Nijmegen, Netherlands	University of Pennsylvania; Universite Catholique Louvain; University of Southampton; Technical University of Berlin; National & Kapodistrian University of Athens; University of Eastern Finland; Jagiellonian University; Collegium Medicum Jagiellonian University; KU Leuven; University of London; King's College London; Dublin City University; Karolinska Institutet; Radboud University Nijmegen	Aiken, LH (corresponding author), Univ Penn, Sch Nursing, Ctr Hlth Outcomes & Policy Res, Philadelphia, PA 19104 USA.	laiken@nursing.upenn.edu	Sermeus, Walter/J-4290-2017; Heinen, Maud/L-4361-2015; Staines, Anthony/AFQ-7565-2022; Bruyneel, Luk/V-6022-2019; Moreno-Casbas, Teresa/X-6721-2019; Lindqvist, Rikard/AAZ-9034-2020; Tishelman, Carol/AAB-8936-2020; Moreno-Casbas, Teresa/S-2075-2016; Mantas, John/AAF-9997-2019; Scott, P Anne/N-3400-2019; Griffiths, Peter/D-4016-2009; Achterberg, M./H-8006-2014; Brzostek, Tomasz/T-9357-2018	Sermeus, Walter/0000-0002-5915-1845; Heinen, Maud/0000-0001-7536-1327; Staines, Anthony/0000-0001-9161-1357; Bruyneel, Luk/0000-0003-1209-692X; Moreno-Casbas, Teresa/0000-0001-9061-4628; Lindqvist, Rikard/0000-0002-1913-8523; Tishelman, Carol/0000-0003-4161-0342; Moreno-Casbas, Teresa/0000-0001-9061-4628; Scott, P Anne/0000-0002-5790-8066; Griffiths, Peter/0000-0003-2439-2857; Blumel, Miriam/0000-0002-8452-4666; van Achterberg, Theo/0000-0003-0111-6622; Gonzalez-Maria, Esther/0000-0002-0212-1872; Gomez-Garcia, Teresa/0000-0001-8871-8161; Brzostek, Tomasz/0000-0001-6838-2090; Van den Heede, Koen/0000-0003-2947-7219	European Union's Seventh Framework Programme; National Institute of Nursing Research; National Institutes of Health; Norwegian Nurses Organisation; Norwegian Knowledge Centre for the Health Services; Swedish Association of Health Professionals; Stockholm County Council; Karolinska Institutet; Committee for Health and Caring Sciences; Strategic Research Program in Care Sciences at Karolinska Institutet, Spanish Ministry of Science and Innovation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD044964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR004513] Funding Source: NIH RePORTER	European Union's Seventh Framework Programme; National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Norwegian Nurses Organisation; Norwegian Knowledge Centre for the Health Services; Swedish Association of Health Professionals; Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Committee for Health and Caring Sciences; Strategic Research Program in Care Sciences at Karolinska Institutet, Spanish Ministry of Science and Innovation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	Funding European Union's Seventh Framework Programme, National Institute of Nursing Research, National Institutes of Health, the Norwegian Nurses Organisation and the Norwegian Knowledge Centre for the Health Services, Swedish Association of Health Professionals, the regional agreement on medical training and clinical research between Stockholm County Council and Karolinska Institutet, Committee for Health and Caring Sciences and Strategic Research Program in Care Sciences at Karolinska Institutet, Spanish Ministry of Science and Innovation.	Aiken LH, 2003, JAMA-J AM MED ASSOC, V290, P1617, DOI 10.1001/jama.290.12.1617; Aiken LH, 2013, INT J NURS STUD, V50, P143, DOI 10.1016/j.ijnurstu.2012.11.009; Aiken LH, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1717; Aiken LH, 2011, MED CARE, V49, P1047, DOI 10.1097/MLR.0b013e3182330b6e; Aiken LH, 2010, HEALTH SERV RES, V45, P904, DOI 10.1111/j.1475-6773.2010.01114.x; Aylin P, 2007, BMJ-BRIT MED J, V334, P1044, DOI 10.1136/bmj.39168.496366.55; Blegen MA, 2013, J NURS ADMIN, V43, P89, DOI 10.1097/NNA.0b013e31827f2028; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Dall TM, 2009, MED CARE, V47, P97, DOI 10.1097/MLR.0b013e3181844da8; Estabrooks CA, 2005, NURS RES, V54, P74; European Parliament, REC PROF QUAL ADM CO; Francis R., 2013, REP MIDST NHS FDN TR; Institute of Medicine (IOm), 2011, FUT NURS LEAD CHANG; Jarman B, 1999, BMJ-BRIT MED J, V318, P1515, DOI 10.1136/bmj.318.7197.1515; Kane RL, 2007, MED CARE, V45, P1195, DOI 10.1097/MLR.0b013e3181468ca3; Karanikolos M, 2013, LANCET, V381, P1323, DOI 10.1016/S0140-6736(13)60102-6; Keogh B, 2013, REV QUALITY CARE TRE; Kutney-Lee A, 2013, HEALTH AFFAIR, V32, P579, DOI 10.1377/hlthaff.2012.0504; Legido-Quigley H, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2363; McHugh MD, 2013, HEALTH AFFAIR, V32, P1740, DOI 10.1377/hlthaff.2013.0613; Needleman J, 2006, HEALTH AFFAIR, V25, P204, DOI 10.1377/hlthaff.25.1.204; Pearse RM, 2012, LANCET, V380, P1059, DOI 10.1016/S0140-6736(12)61148-9; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Quentin W, 2013, HEALTH AFFAIR, V32, P713, DOI 10.1377/hlthaff.2012.0876; Rafferty AM, 2007, INT J NURS STUD, V44, P175, DOI 10.1016/j.ijnurstu.2006.08.003; Rechel B., 2009, INVESTING HOSP FUTUR; Schubert M, 2012, INT J QUAL HEALTH C, V24, P230, DOI 10.1093/intqhc/mzs009; Sermeus W, 2011, BMC NURS, V10, DOI 10.1186/1472-6955-10-6; Silber JH, 2000, ANESTHESIOLOGY, V93, P152, DOI 10.1097/00000542-200007000-00026; Thomas S, 2012, LANCET, V380, P1056, DOI 10.1016/S0140-6736(12)61599-2; Van den Heede K, 2009, INT J NURS STUD, V46, P796, DOI 10.1016/j.ijnurstu.2008.12.018; Zabalegui A, 2006, J NURS SCHOLARSHIP, V38, P114, DOI 10.1111/j.1547-5069.2006.00087.x	32	1088	1127	11	249	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 24	2014	383	9931					1824	1830		10.1016/S0140-6736(13)62631-8	http://dx.doi.org/10.1016/S0140-6736(13)62631-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH6US	24581683	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000336267800029
J	Patnode, CD; O'Connor, E; Rowland, M; Burda, BU; Perdue, LA; Whitlock, EP				Patnode, Carrie D.; O'Connor, Elizabeth; Rowland, Maya; Burda, Brittany U.; Perdue, Leslie A.; Whitlock, Evelyn P.			Primary Care Behavioral Interventions to Prevent or Reduce Illicit Drug Use and Nonmedical Pharmaceutical Use in Children and Adolescents: A Systematic Evidence Review for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							SUBSTANCE USE; YOUNG-PEOPLE; COMPUTER; OUTCOMES; SCHOOL; TEENS	Background: Drug use among youths is associated with negative health and social consequences. Even infrequent use increases the risk for serious adverse events by increasing risk-taking behaviors in intoxicated or impaired persons. Purpose: To systematically review the benefits and harms of primary care-relevant interventions designed to prevent or reduce illicit drug use or the nonmedical use of prescription drugs among youths. Data Sources: PubMed, PsycINFO, and the Cochrane Central Register of Controlled Trials through 4 June 2013; MEDLINE through 31 August 2013; and manual searches of reference lists and gray literature. Study Selection: Two investigators independently reviewed 2253 abstracts and 144 full-text articles. English-language trials of primary care-relevant behavioral interventions that reported drug use, health outcomes, or harms were included. Data Extraction: One investigator abstracted data from good- and fair-quality trials into prespecified evidence tables, and a second investigator checked these data. Data Synthesis: Six trials were included, 4 of which examined the effect of the intervention on a health or social outcome. One trial found no effect of the intervention on marijuana-related consequences or driving under the influence of marijuana; 3 trials generally found no reduction in depressed mood at 12 or 24 months. Four of the 5 trials assessing self-reported marijuana use found statistically significant differences favoring the intervention group participants (such as a between-group difference of 0.10 to 0.17 use occasions in the past month). Three trials also reported positive outcomes in nonmedical prescription drug use occasions. Limitations: The body of evidence was small, and there were heterogeneous measures of outcomes of limited clinical applicability. Trials primarily included adolescents with little or no substance use. Conclusion: Evidence is inadequate on the benefits of primary care-relevant behavioral interventions in reducing self-reported illicit and pharmaceutical drug use among adolescents.	[Patnode, Carrie D.; O'Connor, Elizabeth; Rowland, Maya; Burda, Brittany U.; Perdue, Leslie A.; Whitlock, Evelyn P.] Kaiser Permanente Northwest, Portland, OR USA	Kaiser Permanente	Patnode, CD (corresponding author), Kaiser Permanente Ctr Hlth Res, 3800 North Interstate Ave, Portland, OR 97227 USA.				Agency for Healthcare Research and Quality	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Agency for Healthcare Research and Quality.	[Anonymous], 2008, US PREV SERV TASK FO; Barnett E, 2012, ADDICT BEHAV, V37, P1325, DOI 10.1016/j.addbeh.2012.07.001; Becker SJ, 2008, J CONSULT CLIN PSYCH, V76, P531, DOI 10.1037/0022-006X.76.4.531; Belani Hrishikesh, 2012, Morbidity and Mortality Weekly Report, V61, P1; Carney T, 2012, SUBST ABUSE TREAT PR, V7, DOI 10.1186/1747-597X-7-25; Committee on Substance Abuse, 2011, SUBST US SCREEN BRIE; Eaton Danice K., 2012, Morbidity and Mortality Weekly Report, V61, P1; Fang L, 2013, PSYCHOL ADDICT BEHAV, V27, P788, DOI 10.1037/a0030925; Fang L, 2010, J ADOLESCENT HEALTH, V47, P529, DOI 10.1016/j.jadohealth.2010.03.011; Gates S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005030.pub2; Harris SK, 2012, PEDIATRICS, V129, P1072, DOI 10.1542/peds.2011-1624; Hays S. P., 2003, J PRIM PREV, V24, P125, DOI [10.1023/A:1025940311556, DOI 10.1023/A:1025940311556]; Ioannidis JPA, 2012, J PSYCHOSOM RES, V73, P408, DOI 10.1016/j.jpsychores.2012.09.014; Jackson C, 2012, ADDICTION, V107, P733, DOI 10.1111/j.1360-0443.2011.03751.x; Jensen CD, 2011, J CONSULT CLIN PSYCH, V79, P433, DOI 10.1037/a0023992; Knight JR, 1999, ARCH PEDIAT ADOL MED, V153, P591; Mayberry ML, 2009, J YOUTH ADOLESCENCE, V38, P1038, DOI 10.1007/s10964-009-9425-9; Mitchell SG, 2013, J SUBST ABUSE TREAT, V44, P463, DOI 10.1016/j.jsat.2012.11.005; Polen MR, 2008, SCREENING PRIMARY CA; Rhee Hyekyun, 2008, J Pediatr Nurs, V23, P439, DOI 10.1016/j.pedn.2008.01.079; Schinke SP, 2009, PREV MED, V49, P429, DOI 10.1016/j.ypmed.2009.08.001; Schinke SP, 2009, ADDICT BEHAV, V34, P1060, DOI 10.1016/j.addbeh.2009.06.007; Substance Abuse and Mental Health Services Administration, 2013, RES 2012 NAT SURV DR; Substance Abuse and Mental Health Services Administration, 2012, SCREEN BRIEF INT REF; U. S. Preventive Services Task Force, 2008, SCREEN ILL DRUG US U; Vuckovic N, 2003, PREV MED, V37, P209, DOI 10.1016/S0091-7435(03)00115-4; Walton MA, 2013, DRUG ALCOHOL DEPEN, V132, P646, DOI 10.1016/j.drugalcdep.2013.04.020	27	23	23	0	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 6	2014	160	9					612	U161		10.7326/M13-2064	http://dx.doi.org/10.7326/M13-2064			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AI0GO	24615613				2022-12-28	WOS:000336524400004
J	Watson, JD				Watson, James D.			Type 2 diabetes as a redox disease	LANCET			English	Article							EXERCISE; METFORMIN; PATHWAY; INSULIN; CANCER; HEALTH		Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Watson, JD (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	berejka@cshl.edu						Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Bolen S, 2007, ANN INTERN MED, V147, P386, DOI 10.7326/0003-4819-147-6-200709180-00178; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Gomez-Cabrera MC, 2012, AM J PHYSIOL-ENDOC M, V302, pE476, DOI 10.1152/ajpendo.00567.2011; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; GERSTER H, 1989, J AM COLL NUTR, V8, P636; Gliemann L, 2013, J PHYSIOL-LONDON, V591, P5047, DOI 10.1113/jphysiol.2013.258061; Gomes EC, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/756132; Gupta A, 2011, NEUROPHARMACOLOGY, V60, P910, DOI 10.1016/j.neuropharm.2011.01.033; Hirsch HA, 2013, P NATL ACAD SCI USA, V110, P972, DOI 10.1073/pnas.1221055110; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Koenner AC, 2009, PHYSIOL BEHAV, V97, P632, DOI 10.1016/j.physbeh.2009.03.027; Li JJ, 2012, PHARMACOL BIOCHEM BE, V101, P564, DOI 10.1016/j.pbb.2012.03.002; Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Nardai G, 2005, BIOCHEM BIOPH RES CO, V334, P787, DOI 10.1016/j.bbrc.2005.06.172; Petersen AC, 2012, ACTA PHYSIOL, V204, P382, DOI 10.1111/j.1748-1716.2011.02344.x; Pollak MN, 2012, CANCER DISCOV, V2, P778, DOI 10.1158/2159-8290.CD-12-0263; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106; Ron D, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013177; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Schoenmakers E, 2010, J CLIN INVEST, V120, P4220, DOI 10.1172/JCI43653; Sevier CS, 2008, BBA-MOL CELL RES, V1783, P549, DOI 10.1016/j.bbamcr.2007.12.011; Shackelford DB, 2013, CANCER CELL, V23, P143, DOI 10.1016/j.ccr.2012.12.008; Sharma Morali D, 2008, Endocr Pract, V14, P373; Sharoff CG, 2010, AM J PHYSIOL-ENDOC M, V298, pE815, DOI 10.1152/ajpendo.00517.2009; Smith JC, 2013, J ALZHEIMERS DIS, V37, P197, DOI 10.3233/JAD-130467; TIIDUS PM, 1995, SPORTS MED, V20, P12, DOI 10.2165/00007256-199520010-00002; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Zhao WQ, 2004, EUR J PHARMACOL, V490, P71, DOI 10.1016/j.ejphar.2004.02.045	32	136	150	4	72	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2014	383	9919					841	843		10.1016/S0140-6736(13)62365-X	http://dx.doi.org/10.1016/S0140-6736(13)62365-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC3EV	24581668				2022-12-28	WOS:000332398700031
J	Li, RC; Liu, LD; Mo, ZJ; Wang, XY; Xia, JL; Liang, ZL; Zhang, Y; Li, YP; Mao, QY; Wang, JJ; Jiang, L; Dong, CH; Che, YC; Huang, T; Jiang, ZW; Xie, ZP; Wang, LC; Liao, Y; Liang, Y; Nong, Y; Liu, JS; Zhao, HL; Na, RX; Guo, L; Pu, J; Yang, EX; Sun, L; Cui, PF; Shi, HJ; Wang, JZ; Li, QH				Li, Rongcheng; Liu, Longding; Mo, Zhaojun; Wang, Xuanyi; Xia, Jielai; Liang, Zhenglun; Zhang, Ying; Li, Yanping; Mao, Qunying; Wang, Jingjing; Jiang, Li; Dong, Chenghong; Che, Yanchun; Huang, Teng; Jiang, Zhiwei; Xie, Zhongping; Wang, Lichun; Liao, Yun; Liang, Yan; Nong, Yi; Liu, Jiansheng; Zhao, Hongling; Na, Ruixiong; Guo, Lei; Pu, Jing; Yang, Erxia; Sun, Le; Cui, Pingfang; Shi, Haijing; Wang, Junzhi; Li, Qihan			An Inactivated Enterovirus 71 Vaccine in Healthy Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHINA; INFECTION; EPIDEMIC; OUTBREAK; FUYANG; TAIWAN	BackgroundEnterovirus 71 (EV71) is a major cause of hand, foot, and mouth disease in children and may be fatal. A vaccine against EV71 is needed. MethodsWe conducted a randomized, double-blind, placebo-controlled phase 3 trial involving healthy children 6 to 71 months of age in Guangxi Zhuang Autonomous Region, China. Two doses of an inactivated EV71 vaccine or placebo were administered intramuscularly, with a 4-week interval between doses, and children were monitored for up to 11 months. The primary end point was protection against hand, foot, and mouth disease caused by EV71. ResultsA total of 12,000 children were randomly assigned to receive vaccine or placebo. Serum neutralizing antibodies were assessed in 549 children who received the vaccine. The seroconversion rate was 100% 4 weeks after the two vaccinations, with a geometric mean titer of 170.6. Over the course of two epidemic seasons, the vaccine efficacy was 97.4% (95% confidence interval [CI], 92.9 to 99.0) according to the intention-to-treat analysis and 97.3% (95% CI, 92.6 to 99.0) according to the per-protocol analysis. Adverse events, such as fever (which occurred in 41.6% of the participants who received vaccine vs. 35.2% of those who received placebo), were significantly more common in the week after vaccination among children who received the vaccine than among those who received placebo. ConclusionsThe inactivated EV71 vaccine elicited EV71-specific immune responses and protection against EV71-associated hand, foot, and mouth disease. (Funded by the National Basic Research Program and others; ClinicalTrials.gov number, NCT01569581.) Enterovirus 71 (EV71), a cause of hand, foot, and mouth disease, may be associated with poliomyelitis-like paralysis. In this report from China, a vaccine was shown to significantly decrease EV71-associated illness in children. Epidemics of hand, foot, and mouth disease in children have emerged recently in Asia and have been caused primarily by enterovirus 71 (EV71) and coxsackievirus A16,(1) which typically show two peak epidemic incidences each year, in May and October.(2)-(5) An important clinical concern regarding hand, foot, and mouth disease is central nervous system injury, which occurs during the disease course in some severe cases and may result in a poor outcome.(6)-(11) Infection with the EV71 C4 genotype accounts for 40.1 to 55.4% of cases of hand, foot, and mouth disease, with considerable associated mortality, including thousands of deaths ...	[Li, Rongcheng; Mo, Zhaojun; Li, Yanping; Huang, Teng; Nong, Yi] Guangxi Prov Ctr Dis Control & Prevent, Nanning, Peoples R China; [Liu, Longding; Zhang, Ying; Wang, Jingjing; Jiang, Li; Dong, Chenghong; Che, Yanchun; Xie, Zhongping; Wang, Lichun; Liao, Yun; Liang, Yan; Liu, Jiansheng; Zhao, Hongling; Na, Ruixiong; Guo, Lei; Pu, Jing; Yang, Erxia; Sun, Le; Cui, Pingfang; Shi, Haijing; Li, Qihan] Chinese Acad Med Sci, Inst Med Biol, Yunnan Key Lab Vaccine Res & Dev Severe Infect Di, Kunming 650118, Yunnan, Peoples R China; [Liu, Longding; Zhang, Ying; Wang, Jingjing; Jiang, Li; Dong, Chenghong; Che, Yanchun; Xie, Zhongping; Wang, Lichun; Liao, Yun; Liang, Yan; Liu, Jiansheng; Zhao, Hongling; Na, Ruixiong; Guo, Lei; Pu, Jing; Yang, Erxia; Sun, Le; Cui, Pingfang; Shi, Haijing; Li, Qihan] Peking Union Med Coll, Kunming 650118, Yunnan, Peoples R China; [Wang, Xuanyi] Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol, Ministries Educ, Shanghai 200433, Peoples R China; [Wang, Xuanyi] Fudan Univ, Shanghai Med Coll, Minist Hlth, Shanghai 200433, Peoples R China; [Wang, Xuanyi] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Xia, Jielai; Jiang, Zhiwei] Fourth Mil Med Univ, Dept Hlth Stat, Xian 710032, Peoples R China; [Liang, Zhenglun; Mao, Qunying; Wang, Junzhi] Natl Inst Food, Beijing 100050, Peoples R China; [Liang, Zhenglun; Mao, Qunying; Wang, Junzhi] Natl Inst Drug Control, Beijing 100050, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; Yunnan Key Laboratory of Vaccine Research & Development on Severe Infectious Diseases; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Fudan University; Fudan University; Fudan University; Air Force Military Medical University	Li, QH (corresponding author), Chinese Acad Med Sci, Inst Med Biol, 935 Jiaoling Rd, Kunming 650118, Yunnan, Peoples R China.	wangjz@nicpbp.org.cn; liqihan@imbcams.com.cn	li, yan/GTI-4638-2022; Guo, Lei/AEU-0178-2022	Guo, Lei/0000-0003-1733-1802	National Basic Research Program	National Basic Research Program(National Basic Research Program of China)	Funded by the National Basic Research Program and others; ClinicalTrials.gov number, NCT01569581.	Dong CH, 2011, VACCINE, V29, P6269, DOI 10.1016/j.vaccine.2011.06.044; Ge-xin X, 2012, JI BING JIAN CE, V27, P932; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hu MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038978; Huang Xue-yong, 2012, Zhonghua Yu Fang Yi Xue Za Zhi, V46, P883; Jian-jun M, 2012, OCCUPATION HLTH, V28, P2276; Liang ZL, 2011, VACCINE, V29, P9668, DOI 10.1016/j.vaccine.2011.10.018; Liu LD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054451; Ma HL, 2010, PEDIATR INFECT DIS J, V29, P524, DOI 10.1097/INF.0b013e3181cdd178; Ma Shao-hui, 2009, Virologica Sinica, V24, P162, DOI 10.1007/s12250-009-3033-4; Modlin F., 2005, MANDELL DOUGLAS BENN, P2148; Sun LM, 2011, JPN J INFECT DIS, V64, P13; Tan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025662; Wang SM, 1999, CLIN INFECT DIS, V29, P184, DOI 10.1086/520149; Wu D, 2011, ARCH VIROL, V156, P945, DOI 10.1007/s00705-011-0929-8; Yi M, 2011, JI BING JIAN CE, V26, P611; Zhang Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059086, 10.1371/journal.pone.0056341]; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94	18	256	335	6	90	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 27	2014	370	9					829	837		10.1056/NEJMoa1303224	http://dx.doi.org/10.1056/NEJMoa1303224			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB8AR	24571755				2022-12-28	WOS:000332013000008
J	Mori, M; Triboulet, R; Mohseni, M; Schlegelmilch, K; Shrestha, K; Camargo, FD; Gregory, RI				Mori, Masaki; Triboulet, Robinson; Mohseni, Morvarid; Schlegelmilch, Karin; Shrestha, Kriti; Camargo, Fernando D.; Gregory, Richard I.			Hippo Signaling Regulates Microprocessor and Links Cell-Density-Dependent miRNA Biogenesis to Cancer	CELL			English	Article							MICRORNA BIOGENESIS; YAP PATHWAY; POSTTRANSCRIPTIONAL REGULATION; TRANSCRIPTIONAL COACTIVATOR; CONTACT INHIBITION; TUMOR-SUPPRESSOR; GROWTH-CONTROL; ALPHA-CATENIN; SIZE-CONTROL; ORGAN SIZE	Global downregulation of microRNAs (miRNAs) is commonly observed in human cancers and can have a causative role in tumorigenesis. The mechanisms responsible for this phenomenon remain poorly understood. Here, we show that YAP, the downstream target of the tumor-suppressive Hippo-signaling pathway regulates miRNA biogenesis in a cell-density-dependent manner. At low cell density, nuclear YAP binds and sequesters p72 (DDX17), a regulatory component of the miRNA-processing machinery. At high cell density, Hippo-mediated cytoplasmic retention of YAP facilitates p72 association with Microprocessor and binding to a specific sequence motif in pri-miRNAs. Inactivation of the Hippo pathway or expression of constitutively active YAP causes widespread miRNA suppression in cells and tumors and a corresponding posttranscriptional induction of MYC expression. Thus, the Hippo pathway links contact-inhibition regulation to miRNA biogenesis and may be responsible for the widespread miRNA repression observed in cancer.	[Mori, Masaki; Triboulet, Robinson; Mohseni, Morvarid; Schlegelmilch, Karin; Shrestha, Kriti; Camargo, Fernando D.; Gregory, Richard I.] Boston Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Mori, Masaki; Mohseni, Morvarid; Schlegelmilch, Karin; Shrestha, Kriti; Camargo, Fernando D.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Mori, Masaki; Triboulet, Robinson; Gregory, Richard I.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Mori, Masaki; Triboulet, Robinson; Gregory, Richard I.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Mori, Masaki; Triboulet, Robinson; Mohseni, Morvarid; Schlegelmilch, Karin; Shrestha, Kriti; Camargo, Fernando D.; Gregory, Richard I.] Harvard Stem Cell Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University	Camargo, FD (corresponding author), Boston Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA.	fernando.camargo@childrens.harvard.edu; rgregory@enders.tch.harvard.edu		Mori, Masaki/0000-0001-7632-3875; camargo, fernando/0000-0002-5630-5909; Schlegelmilch, Karin/0000-0003-3173-0914	Japan Heart Foundation/Bayer Yakuhin Research Grant Abroad; Simeon Burt Wolbach Fellowship from Boston Children's Hospital; US National Institute of General Medical Sciences (NIGMS) [R01GM086386]; Stand Up to Cancer-AACR initiative; NIH [R01 CA131426]; Department of Defense [DOD W81XWH-09]; NATIONAL CANCER INSTITUTE [R01CA131426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR064036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086386] Funding Source: NIH RePORTER	Japan Heart Foundation/Bayer Yakuhin Research Grant Abroad; Simeon Burt Wolbach Fellowship from Boston Children's Hospital; US National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Stand Up to Cancer-AACR initiative; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Thanks to Ralf Janknecht for HA-p72 plasmid, Tyler Jacks for pRL MYC 3'UTR plasmid, Kun-Liang Guan for YAP S94A and S94A/5SA plasmids, and Dae-Sik Lim for Lats1/2 knockout MEFs. M.M is supported by Japan Heart Foundation/Bayer Yakuhin Research Grant Abroad. R.T. was supported by a Simeon Burt Wolbach Fellowship from Boston Children's Hospital. R.I.G is supported by a grant from the US National Institute of General Medical Sciences (NIGMS) (R01GM086386). F.D.C is supported by awards from Stand Up to Cancer-AACR initiative, NIH grant R01 CA131426, and Department of Defense (DOD W81XWH-09). F.D.C. is a Pew Scholar in the Biomedical Sciences.	Auyeung VC, 2013, CELL, V152, P844, DOI 10.1016/j.cell.2013.01.031; Barry ER, 2013, NATURE, V493, P106, DOI 10.1038/nature11693; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Benhamouche S, 2010, GENE DEV, V24, P1718, DOI 10.1101/gad.1938710; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Choudhury NR, 2013, GENE DEV, V27, P24, DOI 10.1101/gad.199190.112; Christoffersen NR, 2010, CELL DEATH DIFFER, V17, P236, DOI 10.1038/cdd.2009.109; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Fukuda T, 2007, NAT CELL BIOL, V9, P604, DOI 10.1038/ncb1577; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Halder G, 2012, NAT REV MOL CELL BIO, V13, P591, DOI 10.1038/nrm3416; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hill DA, 2009, SCIENCE, V325, P965, DOI 10.1126/science.1174334; Hong SG, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003706; Hwang HW, 2009, P NATL ACAD SCI USA, V106, P7016, DOI 10.1073/pnas.0811523106; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kawai S, 2012, J CELL BIOL, V197, P201, DOI 10.1083/jcb.201110008; Kim M, 2013, EMBO J, V32, P1543, DOI 10.1038/emboj.2013.102; Kim NG, 2011, P NATL ACAD SCI USA, V108, P11930, DOI 10.1073/pnas.1103345108; Kim YK, 2012, MOL CELL, V46, P893, DOI 10.1016/j.molcel.2012.05.036; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Lee EJ, 2008, RNA, V14, P35, DOI 10.1261/rna.804508; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Maillot G, 2009, CANCER RES, V69, P8332, DOI 10.1158/0008-5472.CAN-09-2206; Melo SA, 2010, CANCER CELL, V18, P303, DOI 10.1016/j.ccr.2010.09.007; Melo SA, 2009, NAT GENET, V41, P365, DOI 10.1038/ng.317; Mooney SM, 2010, BIOCHEMISTRY-US, V49, P1, DOI 10.1021/bi901263m; Morlando M, 2012, EMBO J, V31, P4502, DOI 10.1038/emboj.2012.319; Newman MA, 2010, GENE DEV, V24, P1086, DOI 10.1101/gad.1919710; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Paroo Z, 2009, CELL, V139, P112, DOI 10.1016/j.cell.2009.06.044; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Ramos A, 2012, TRENDS CELL BIOL, V22, P339, DOI 10.1016/j.tcb.2012.04.006; Sakamoto S, 2009, MOL CELL BIOL, V29, P3754, DOI 10.1128/MCB.01836-08; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Shen J, 2013, NATURE, V497, P383, DOI 10.1038/nature12080; Silvis MR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001823; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Tsutsui M, 2008, BIOCHEM BIOPH RES CO, V372, P856, DOI 10.1016/j.bbrc.2008.05.141; Wada KI, 2011, DEVELOPMENT, V138, P3907, DOI 10.1242/dev.070987; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Yi R, 2009, P NATL ACAD SCI USA, V106, P498, DOI 10.1073/pnas.0810766105; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zeng Y, 2005, EMBO J, V24, P138, DOI 10.1038/sj.emboj.7600491; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210	59	264	267	1	77	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 27	2014	156	5					893	906		10.1016/j.cell.2013.12.043	http://dx.doi.org/10.1016/j.cell.2013.12.043			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AB9BK	24581491	Green Accepted, Bronze			2022-12-28	WOS:000332083900009
J	Buckley, NA; Dawson, AH; Isbister, GK				Buckley, Nicholas A.; Dawson, Andrew H.; Isbister, Geoffrey K.			PRACTICE POINTER Serotonin syndrome	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DRUG-INTERACTIONS; REUPTAKE INHIBITORS; MONOAMINE-OXIDASE; TOXICITY; CITALOPRAM; DIAGNOSIS		[Buckley, Nicholas A.; Dawson, Andrew H.; Isbister, Geoffrey K.] NSW Poisons Informat Ctr, Sydney, NSW, Australia; [Buckley, Nicholas A.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Dawson, Andrew H.] Royal Prince Alfred Hosp, Dept Clin Toxicol, Sydney, NSW, Australia; [Isbister, Geoffrey K.] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW 2300, Australia	University of Sydney; University of Sydney; University of Newcastle	Buckley, NA (corresponding author), NSW Poisons Informat Ctr, Sydney, NSW, Australia.	nbuckley@hypertox.com	Isbister, Geoffrey K/G-8052-2015; Braitberg, George/H-4099-2015; Dawson, Andrew H/U-8041-2019; Whyte, Ian/A-1621-2010; Buckley, Nicholas A/D-4030-2012	Isbister, Geoffrey K/0000-0003-1519-7419; Dawson, Andrew H/0000-0002-8047-397X; Whyte, Ian/0000-0001-7693-3948; Buckley, Nicholas A/0000-0002-6326-4711				Buckley NA, 2013, HYPERTOX ASSESSMENT; Clarke SED, 2011, J NEURAL TRANSM, V118, P1031, DOI 10.1007/s00702-010-0537-x; Dunkley EJC, 2003, QJM-INT J MED, V96, P635, DOI 10.1093/qjmed/hcg109; Evans RW, 2010, HEADACHE, V50, P1089, DOI 10.1111/j.1526-4610.2010.01691.x; Gillman PK, 2007, BRIT J PHARMACOL, V151, P737, DOI 10.1038/sj.bjp.0707253; Gillman PK, 2006, BIOL PSYCHIAT, V59, P1046, DOI 10.1016/j.biopsych.2005.11.016; Gillman PK, 2011, J PSYCHOPHARMACOL, V25, P429, DOI 10.1177/0269881109359098; Gillman PK, 2009, AM J EMERG MED, V27, P509, DOI 10.1016/j.ajem.2009.03.001; Gillman PK, 2005, BRIT J ANAESTH, V95, P434, DOI 10.1093/bja/aei210; Isbister GK, 2007, MED J AUSTRALIA, V187, P361, DOI 10.5694/j.1326-5377.2007.tb01282.x; Isbister GK, 2004, J TOXICOL-CLIN TOXIC, V42, P277, DOI 10.1081/CLT-120037428; Isbister GK, 2005, CLIN NEUROPHARMACOL, V28, P205, DOI 10.1097/01.wnf.0000177642.89888.85; Isbister GK, 2003, BRIT J CLIN PHARMACO, V56, P441, DOI 10.1046/j.1365-2125.2003.01895.x; Karunatilake H, 2006, ANN PHARMACOTHER, V40, P155, DOI 10.1345/aph.1E671; Krishnamoorthy S, 2010, BASIC CLIN PHARMACOL, V107, P830, DOI 10.1111/j.1742-7843.2010.00586.x; Liechti ME, 2000, J PSYCHOPHARMACOL, V14, P269, DOI 10.1177/026988110001400313; NEUVONEN PJ, 1993, LANCET, V342, P1419, DOI 10.1016/0140-6736(93)92774-N; Porcelli S, 2011, J PSYCHIATR NEUROSCI, V36, P87, DOI 10.1503/jpn.100059; Ramsey TD, 2013, ANN PHARMACOTHER, V47, P543, DOI 10.1345/aph.1R604; STERNBACH H, 1991, AM J PSYCHIAT, V148, P705	20	89	91	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 19	2014	348								g1626	10.1136/bmj.g1626	http://dx.doi.org/10.1136/bmj.g1626			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB9ZL	24554467				2022-12-28	WOS:000332154200022
J	Rashid, MA				Rashid, Mohammed Ahmed			Consultations in primary care should be held standing up	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PHYSICAL-ACTIVITY; DISEASE; PERCEPTION; TIME		Univ Cambridge, Strangeways Res Lab, Dept Publ Hlth & Primary Care, Primary Care Unit, Cambridge CB1 8RN, England	University of Cambridge	Rashid, MA (corresponding author), Univ Cambridge, Strangeways Res Lab, Dept Publ Hlth & Primary Care, Primary Care Unit, Cambridge CB1 8RN, England.							Aboulghate A, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X653624; Chau JY, 2010, PREV MED, V51, P352, DOI 10.1016/j.ypmed.2010.08.012; Freeman G, 2010, CONTINUITY CARE PATI; Johnson RL, 2008, ANN EMERG MED, V51, P188, DOI 10.1016/j.annemergmed.2007.04.024; Kay MP, 2004, MED J AUSTRALIA, V181, P368, DOI 10.5694/j.1326-5377.2004.tb06329.x; Marteau TM, 2012, SCIENCE, V337, P1492, DOI 10.1126/science.1226918; MORRIS JN, 1958, BMJ-BRIT MED J, V2, P1485, DOI 10.1136/bmj.2.5111.1485; Silverman J, 2013, COMMUNICATION, P41; Strasser F, 2005, J PAIN SYMPTOM MANAG, V29, P489, DOI 10.1016/j.jpainsymman.2004.08.011; Swayden KJ, 2012, PATIENT EDUC COUNS, V86, P166, DOI 10.1016/j.pec.2011.05.024; Thompson PD, 2003, CIRCULATION, V107, P3109, DOI 10.1161/01.CIR.0000075572.40158.77; van der Ploeg HP, 2012, ARCH INTERN MED, V172, P494, DOI 10.1001/archinternmed.2011.2174	12	3	3	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 18	2014	348								g1558	10.1136/bmj.g1558	http://dx.doi.org/10.1136/bmj.g1558			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB9ZI	24550239				2022-12-28	WOS:000332153900009
J	Omatsu, Y; Seike, M; Sugiyama, T; Kume, T; Nagasawa, T				Omatsu, Yoshiki; Seike, Masanari; Sugiyama, Tatsuki; Kume, Tsutomu; Nagasawa, Takashi			Foxc1 is a critical regulator of haematopoietic stem/progenitor cell niche formation	NATURE			English	Article							BONE-MARROW NICHE; STEM-CELLS; PROGENITORS; MAINTENANCE; MICE; DISTINCT; MUSCLE; MICROENVIRONMENT; DIFFERENTIATION; REPOPULATION	Haematopoietic stem and progenitor cells are maintained by special microenvironments known as niches in bone marrow(1-6). Many studies have identified diverse candidate cells that constitute niches for haematopoietic stem cells in the marrow, including osteoblasts(7-10), endothelial cells(11-14), Schwann cells(15), alpha-smooth muscle actin-expressing macrophages(16) and mesenchymal progenitors such as CXC chemokine ligand (CXCL) 12-abundant reticular (CAR) cells(17,18), stem cell factor-expressing cells(13), nestin-expressing cells(19) and platelet-derived growth factor receptor-alpha (PDGFR-alpha)(+)Sca-1(+)CD45(-)Ter119(-) (P alpha S) cells(20). However, the molecular basis of the formation of the niches remains unclear. Here we find that the transcription factor Foxc1 is preferentially expressed in the adipo-osteogenic progenitor CAR cells essential for haematopoietic stem and progenitor cell maintenance in vivo(5,13,18) in the developing and adult bone marrow. When Foxc1 was deleted in all marrow mesenchymal cells or CAR cells, from embryogenesis onwards, osteoblasts appeared normal, but haematopoietic stem and progenitor cells were markedly reduced and marrow cavities were occupied by adipocytes (yellow adipose marrow) with reduced CAR cells. Inducible deletion of Foxc1 in adult mice depleted haematopoietic stem and progenitor cells and reduced CXCL12 and stem cell factor expression in CAR cells but did not induce a change to yellow marrow. These data suggest a role for Foxc1 in inhibiting adipogenic processes in CAR progenitors. Foxc1 might also promote CAR cell development, upregulating CXCL12 and stem cell factor expression. This study identifies Foxc1 as a specific transcriptional regulator essential for development and maintenance of the mesenchymal niches for haematopoietic stem and progenitor cells.	[Omatsu, Yoshiki; Seike, Masanari; Sugiyama, Tatsuki; Nagasawa, Takashi] Kyoto Univ, Dept Immunobiol & Hematol, Inst Frontier Med Sci, Kyoto 6068501, Japan; [Omatsu, Yoshiki; Seike, Masanari; Sugiyama, Tatsuki; Nagasawa, Takashi] Japan Sci & Technol Agcy JST, CREST, Sakyo Ku, Kyoto 6068507, Japan; [Kume, Tsutomu] Northwestern Univ, Feinberg Cardiovasc Res Inst, Feinberg Sch Med, Chicago, IL 60611 USA	Kyoto University; Northwestern University; Feinberg School of Medicine	Nagasawa, T (corresponding author), Kyoto Univ, Dept Immunobiol & Hematol, Inst Frontier Med Sci, Kyoto 6068501, Japan.	tnagasa@frontier.kyoto-u.ac.jp		Nagasawa, Takashi/0000-0002-1085-0960; Sugiyama, Tatsuki/0000-0002-9349-0824; Omatsu, Yoshiki/0000-0002-6212-0441	JST, CREST; Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI	JST, CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI	We appreciate the technical assistance provided by K. Kawaguchi and G. Kondoh, and thank I. Sasagawa for secretarial assistance. This research was supported by JST, CREST and the Ministry of Education, Culture, Sports, Science and Technology (MEXT)/Japan Society for the Promotion of Science (JSPS) KAKENHI.	Ara T, 2003, IMMUNITY, V19, P257, DOI 10.1016/S1074-7613(03)00201-2; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Bianco P, 2011, BLOOD, V117, P5281, DOI 10.1182/blood-2011-01-315069; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chan CKF, 2009, NATURE, V457, P490, DOI 10.1038/nature07547; DeFalco J, 2001, SCIENCE, V291, P2608, DOI 10.1126/science.1056602; Ding L, 2013, NATURE, V495, P231, DOI 10.1038/nature11885; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Ehninger A, 2011, J EXP MED, V208, P421, DOI 10.1084/jem.20110132; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; HARRISON DE, 1993, EXP HEMATOL, V21, P206; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; KODAMA H, 1994, EXP HEMATOL, V22, P979; Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741; Kume T, 1998, CELL, V93, P985, DOI 10.1016/S0092-8674(00)81204-0; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Ludin A, 2012, NAT IMMUNOL, V13, P1072, DOI 10.1038/ni.2408; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mercier FE, 2012, NAT REV IMMUNOL, V12, P49, DOI 10.1038/nri3132; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nagasawa T, 2011, TRENDS IMMUNOL, V32, P315, DOI 10.1016/j.it.2011.03.009; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Sasman A, 2012, GENESIS, V50, P766, DOI 10.1002/dvg.22036; Sugimura R, 2012, CELL, V150, P351, DOI 10.1016/j.cell.2012.05.041; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	40	157	161	2	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 24	2014	508	7497					536	+		10.1038/nature13071	http://dx.doi.org/10.1038/nature13071			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AF5GI	24590069				2022-12-28	WOS:000334741600039
J	Spencer, JA; Ferraro, F; Roussakis, E; Klein, A; Wu, JW; Runnels, JM; Zaher, W; Mortensen, LJ; Alt, C; Turcotte, R; Yusuf, R; Cote, D; Vinogradov, SA; Scadden, DT; Lin, CP				Spencer, Joel A.; Ferraro, Francesca; Roussakis, Emmanuel; Klein, Alyssa; Wu, Juwell; Runnels, Judith M.; Zaher, Walid; Mortensen, Luke J.; Alt, Clemens; Turcotte, Raphael; Yusuf, Rushdia; Cote, Daniel; Vinogradov, Sergei A.; Scadden, David T.; Lin, Charles P.			Direct measurement of local oxygen concentration in the bone marrow of live animals	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; MODELING PO(2) DISTRIBUTIONS; PROGENITOR CELLS; NICHE; MICROSCOPY; PHOSPHORESCENCE; COMPARTMENT; GRADIENTS; TRACKING; HYPOXIA	Characterization of how the microenvironment, or niche, regulates stem cell activity is central to understanding stem cell biology and to developing strategies for the therapeutic manipulation of stem cells(1). Low oxygen tension (hypoxia) is commonly thought to be a shared niche characteristic in maintaining quiescence in multiple stem cell types(2-4). However, support for the existence of a hypoxic niche has largely come from indirect evidence such as proteomic analysis(5), expression of hypoxia inducible factor-1 alpha (Hif-1 alpha) and related genes(6), and staining with surrogate hypoxic markers (for example, pimonidazole)(6-8). Here we perform direct in vivo measurements of local oxygen tension (p(O2)) in the bone marrow of live mice. Using two-photon phosphorescence lifetime microscopy, we determined the absolute p(O2) of the bone marrow to be quite low (<32 mm Hg) despite very high vascular density. We further uncovered heterogeneities in local p(O2), with the lowest p(O2) (similar to 9.9 mm Hg, or 1.3%) found in deeper peri-sinusoidal regions. The endosteal region, by contrast, is less hypoxic as it is perfused with small arteries that are often positive for the marker nestin. These p(O2) values change markedly after radiation and chemotherapy, pointing to the role of stress in altering the stem cell metabolic microenvironment.	[Spencer, Joel A.; Roussakis, Emmanuel; Wu, Juwell; Runnels, Judith M.; Zaher, Walid; Mortensen, Luke J.; Alt, Clemens; Turcotte, Raphael; Lin, Charles P.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wellman Ctr Photomed, Boston, MA 02114 USA; [Spencer, Joel A.; Wu, Juwell; Runnels, Judith M.; Zaher, Walid; Mortensen, Luke J.; Alt, Clemens; Turcotte, Raphael; Lin, Charles P.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Spencer, Joel A.] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [Ferraro, Francesca; Klein, Alyssa; Yusuf, Rushdia; Scadden, David T.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Regenerat Med, Boston, MA 02114 USA; [Ferraro, Francesca; Klein, Alyssa; Yusuf, Rushdia; Scadden, David T.; Lin, Charles P.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Ferraro, Francesca; Klein, Alyssa; Yusuf, Rushdia; Scadden, David T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Roussakis, Emmanuel; Vinogradov, Sergei A.] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Zaher, Walid] King Saud Univ, Coll Med, Dept Anat, Stem Cell Unit, Riyadh 11461, Saudi Arabia; [Turcotte, Raphael] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Cote, Daniel] Univ Laval, Dept Phys Genie Phys & Opt, Quebec City, PQ G1J 2G3, Canada; [Cote, Daniel] Univ Laval, Ctr Rech, Inst Univ Sante Mentale Quebec, Quebec City, PQ G1J 2G3, Canada	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Tufts University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard University; University of Pennsylvania; King Saud University; Boston University; Laval University; Laval University	Lin, CP (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Wellman Ctr Photomed, Boston, MA 02114 USA.	charles_lin@hms.harvard.edu	Mortensen, Luke/N-2640-2018; Spencer, Joel/GLT-9687-2022	Mortensen, Luke/0000-0002-4331-4099; Spencer, Joel/0000-0002-4013-8763; Turcotte, Raphael/0000-0002-2257-4190; , Emmanouil/0000-0002-2824-2840	US National Institutes of Health [HL097748, EB017274, HL097794, HL096372, EB014703]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097748, U01HL100402, R03HL096372, R01HL097794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB017274, R01EB014703] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank S. Sakadzic for helpful discussion on setting up the 2PLM experiment. This work was supported by the US National Institutes of Health grant HL097748, EB017274 (to C. P. L.), HL097794, HL096372 and EB014703 (to D.T.S.).	Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chow DC, 2001, BIOPHYS J, V81, P675, DOI 10.1016/S0006-3495(01)75732-3; Chow DC, 2001, BIOPHYS J, V81, P685, DOI 10.1016/S0006-3495(01)75733-5; Dewhirst MW, 1999, BRIT J CANCER, V79, P1717, DOI 10.1038/sj.bjc.6690273; Esipova TV, 2011, ANAL CHEM, V83, P8756, DOI 10.1021/ac2022234; Finikova OS, 2008, CHEMPHYSCHEM, V9, P1673, DOI 10.1002/cphc.200800296; Kazmi SMS, 2013, BIOMED OPT EXPRESS, V4, P1061, DOI 10.1364/BOE.4.001061; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Lebedev AY, 2009, ACS APPL MATER INTER, V1, P1292, DOI 10.1021/am9001698; Lebedev AY, 2008, J PORPHYR PHTHALOCYA, V12, P1261, DOI 10.1142/S1088424608000649; Lecoq J, 2011, NAT MED, V17, P893, DOI 10.1038/nm.2394; Lee KE, 2012, CURR OPIN CELL BIOL, V24, P232, DOI 10.1016/j.ceb.2012.01.005; LICHTMAN MA, 1981, EXP HEMATOL, V9, P391; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Lymperi S, 2010, ANN NY ACAD SCI, V1192, P12, DOI 10.1111/j.1749-6632.2009.05223.x; Mazo IB, 2002, BLOOD, V99, P4182, DOI 10.1182/blood.V99.11.4182; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Nombela-Arrieta C, 2013, NAT CELL BIOL, V15, P533, DOI 10.1038/ncb2730; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Sakadzic S, 2010, NAT METHODS, V7, P755, DOI 10.1038/nmeth.1490; Sinks LE, 2010, J PHYS CHEM B, V114, P14373, DOI 10.1021/jp100353v; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Unwin RD, 2006, BLOOD, V107, P4687, DOI 10.1182/blood-2005-12-4995; VANDERKOOI JM, 1987, J BIOL CHEM, V262, P5476; Veilleux I, 2008, IEEE J SEL TOP QUANT, V14, P10, DOI 10.1109/JSTQE.2007.912751; Wang LD, 2011, NAT REV MOL CELL BIO, V12, P643, DOI 10.1038/nrm3184	32	698	717	10	214	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 10	2014	508	7495					269	+		10.1038/nature13034	http://dx.doi.org/10.1038/nature13034			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE4UK	24590072	Green Accepted, Green Submitted			2022-12-28	WOS:000333979900049
J	Meusch, D; Gatsogiannis, C; Efremov, RG; Lang, AE; Hofnagel, O; Vetter, IR; Aktories, K; Raunser, S				Meusch, Dominic; Gatsogiannis, Christos; Efremov, Rouslan G.; Lang, Alexander E.; Hofnagel, Oliver; Vetter, Ingrid R.; Aktories, Klaus; Raunser, Stefan			Mechanism of Tc toxin action revealed in molecular detail	NATURE			English	Article							ANTHRAX TOXIN; CRYSTAL-STRUCTURE; PROTEIN TRANSLOCATION; COMPLEX; PHOTORHABDUS; REFINEMENT; SYSTEM; MODEL; PREDICTION; QUALITY	Tripartite Tc toxin complexes of bacterial pathogens perforate the host membrane and translocate toxic enzymes into the host cell, including in humans. The underlying mechanism is complex but poorly understood. Here we report the first, to our knowledge, high-resolution structures of a TcA subunit in its prepore and pore state and of a complete 1.7 megadalton Tc complex. The structures reveal that, in addition to a translocation channel, TcA forms four receptor-binding sites and a neuraminidase-like region, which are important for its host specificity. pH-induced opening of the shell releases an entropic spring that drives the injection of the TcA channel into the membrane. Binding of TcB/TcC to TcA opens a gate formed by a six-bladed beta-propeller and results in a continuous protein translocation channel, whose architecture and properties suggest a novel mode of protein unfolding and translocation. Our results allow us to understand key steps of infections involving Tc toxins at the molecular level.	[Meusch, Dominic; Gatsogiannis, Christos; Efremov, Rouslan G.; Hofnagel, Oliver; Raunser, Stefan] Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44227 Dortmund, Germany; [Lang, Alexander E.; Aktories, Klaus] Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, D-79104 Freiburg, Germany; [Vetter, Ingrid R.] Max Planck Inst Mol Physiol, Dept Mechanist Cell Biol, D-44227 Dortmund, Germany; [Aktories, Klaus] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany; [Raunser, Stefan] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany	Max Planck Society; University of Freiburg; Max Planck Society; University of Freiburg; Free University of Berlin	Raunser, S (corresponding author), Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44227 Dortmund, Germany.	stefan.raunser@mpi-dortmund.mpg.de	Aktories, Klaus/CAJ-5682-2022; Raunser, Stefan/AHE-1573-2022; Efremov, Rouslan/P-9085-2015; Gatsogiannis, Christos/K-1012-2018	Aktories, Klaus/0000-0002-5397-0436; Efremov, Rouslan/0000-0001-7516-8658; Gatsogiannis, Christos/0000-0002-4922-4545; Raunser, Stefan/0000-0001-9373-3016	Deutsche Forschungsgemeinschaft [RA 1781/1-1, AK 6/22-1]; Max Planck Society	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck Society)	We are grateful to R. S. Goody for continuous support and for useful comments on the manuscript. We thank V. Pfaumann for cloning, C. Schwan and S. Bergbrede for technical support and the Raunser laboratory for selecting particles. We thank the staff of beamline X10SA at the Paul Scherrer Institute, the X-ray communities at the Max Planck Institute (MPI) Dortmund and the MPI Heidelberg for help with data collection. This work was supported by the Deutsche Forschungsgemeinschaft, grants RA 1781/1-1 (to S. R.) and AK 6/22-1 (to K. A.), and by the Max Planck Society (to S.R.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anger AM, 2013, NATURE, V497, P80, DOI 10.1038/nature12104; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAKER D, 1993, ACTA CRYSTALLOGR D, V49, P429, DOI 10.1107/S0907444993004032; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BLAUSTEIN RO, 1989, P NATL ACAD SCI USA, V86, P2209, DOI 10.1073/pnas.86.7.2209; Bravo A, 2008, TRENDS BIOTECHNOL, V26, P573, DOI 10.1016/j.tibtech.2008.06.005; Brown MJ, 2011, J BIOL CHEM, V286, P23189, DOI 10.1074/jbc.M111.231167; Busby JN, 2013, NATURE, V501, P547, DOI 10.1038/nature12465; CHOE S, 1992, NATURE, V357, P216, DOI 10.1038/357216a0; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ERICKSON HP, 1994, P NATL ACAD SCI USA, V91, P10114, DOI 10.1073/pnas.91.21.10114; Evans P.R., 1997, JOINT CCP4 ESF EACBM, V33, P22; Feld GK, 2012, PROTEIN SCI, V21, P606, DOI 10.1002/pro.2052; Fernandez JJ, 2008, J STRUCT BIOL, V164, P170, DOI 10.1016/j.jsb.2008.05.010; ffrench-Constant RH, 2000, CELL MOL LIFE SCI, V57, P828, DOI 10.1007/s000180050044; Ffrench-Constant RH, 2007, TRENDS PARASITOL, V23, P514, DOI 10.1016/j.pt.2007.08.021; FLORY PJ, 1956, J AM CHEM SOC, V78, P5222, DOI 10.1021/ja01601a025; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Gatsogiannis C, 2013, BIOPHYS J, V104, p352A, DOI 10.1016/j.bpj.2013.06.003; Gatsogiannis C, 2013, NATURE, V495, P520, DOI 10.1038/nature11987; Hares MC, 2008, MICROBIOL-SGM, V154, P3503, DOI 10.1099/mic.0.2008/018440-0; HARPAZ Y, 1994, STRUCTURE, V2, P641, DOI 10.1016/S0969-2126(00)00065-4; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Humphries MJ, 2000, BIOCHEM SOC T, V28, P311, DOI 10.1042/0300-5127:0280311; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; Jones DT, 2005, PROTEINS, V61, P143, DOI 10.1002/prot.20731; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Koenig T, 2008, J PROTEOME RES, V7, P3708, DOI 10.1021/pr700859x; Krantz BA, 2005, SCIENCE, V309, P777, DOI 10.1126/science.1113380; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Landsberg MJ, 2011, P NATL ACAD SCI USA, V108, P20544, DOI 10.1073/pnas.1111155108; Lang AE, 2010, SCIENCE, V327, P1139, DOI 10.1126/science.1184557; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; Lee SC, 2007, J MOL BIOL, V366, P1558, DOI 10.1016/j.jmb.2006.12.057; Lemkul JA, 2010, J PHYS CHEM B, V114, P1652, DOI 10.1021/jp9110794; Lesieur C, 1997, MOL MEMBR BIOL, V14, P45, DOI 10.3109/09687689709068435; Li ZL, 2008, J MOL BIOL, V377, P715, DOI 10.1016/j.jmb.2007.12.005; Ludtke SJ, 2010, METHODS MOL BIOL, V673, P157, DOI 10.1007/978-1-60761-842-3_9; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murphy JR, 2011, TOXINS, V3, P294, DOI 10.3390/toxins3030294; Noy A., 2007, HDB MOL FORCE SPECTR; Pellegrini-Calace M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000440; Perez A., 2007, BIOPHYS J; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Raunser S, 2009, P NATL ACAD SCI USA, V106, P3160, DOI 10.1073/pnas.0810563106; Sheets JJ, 2011, J BIOL CHEM, V286, P22742, DOI 10.1074/jbc.M111.227009; Sotomayor M, 2007, SCIENCE, V316, P1144, DOI 10.1126/science.1137591; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; VARGHESE JN, 1983, NATURE, V303, P35, DOI 10.1038/303035a0; Walshaw J, 2001, J MOL BIOL, V307, P1427, DOI 10.1006/jmbi.2001.4545; Wang Z, 2012, BIOPOLYMERS, V97, P687, DOI 10.1002/bip.22046; Waterfield NR, 2001, TRENDS MICROBIOL, V9, P185, DOI 10.1016/S0966-842X(01)01978-3; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728; Zhang B, 1999, BIOPHYS J, V77, P1306, DOI 10.1016/S0006-3495(99)76980-8; Zhang ZQ, 1998, J AM SOC MASS SPECTR, V9, P225, DOI 10.1016/S1044-0305(97)00284-5	68	99	102	3	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 3	2014	508	7494					61	+		10.1038/nature13015	http://dx.doi.org/10.1038/nature13015			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD9UL	24572368				2022-12-28	WOS:000333609900042
J	Napolitano, LM; Angus, DC; Uyeki, TM				Napolitano, Lena M.; Angus, Derek C.; Uyeki, Timothy M.			Critically Ill Patients With Influenza A(H1N1)pdm09 Virus Infection in 2014	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							UNITED-STATES		[Napolitano, Lena M.] Univ Michigan Hosp, Univ Michigan Hlth Syst, Dept Surg Surg Crit Care & Trauma, Ann Arbor, MI 48109 USA; [Angus, Derek C.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA; [Angus, Derek C.] UPMC Hlth Syst, CRISMA Ctr, Dept Crit Care Med, Pittsburgh, PA USA; [Uyeki, Timothy M.] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Centers for Disease Control & Prevention - USA	Napolitano, LM (corresponding author), Univ Michigan, Dept Surg, 1500 E Med Ctr Dr,1C340A UH, Ann Arbor, MI 48109 USA.	lenan@umich.edu	Angus, Derek C/E-9671-2012; Napolitano, Lena/AAZ-8651-2021		Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Arriola CS, 2014, MMWR-MORBID MORTAL W, V63, P148; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Beaute J, 2012, EURO SURVEILL, V17; CDC, ANT MED SUMM CLIN; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Hui DS, 2013, ANTIVIR RES, V98, P410, DOI 10.1016/j.antiviral.2013.03.019; Louie JK, 2012, CLIN INFECT DIS, V55, P1198, DOI 10.1093/cid/cis636; Masclans JR, 2013, CLIN MICROBIOL INFEC, V19, P249, DOI 10.1111/j.1469-0691.2012.03797.x; Pham T, 2013, AM J RESP CRIT CARE, V187, P276, DOI 10.1164/rccm.201205-0815OC; Rice TW, 2012, CRIT CARE MED, V40, P1487, DOI 10.1097/CCM.0b013e3182416f23	10	19	19	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 2	2014	311	13					1289	1290		10.1001/jama.2014.2116	http://dx.doi.org/10.1001/jama.2014.2116			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE0HU	24566924	Green Accepted			2022-12-28	WOS:000333645400008
J	Simon, P; Gogotsi, Y; Dunn, B				Simon, Patrice; Gogotsi, Yury; Dunn, Bruce			Where Do Batteries End and Supercapacitors Begin?	SCIENCE			English	Editorial Material							ELECTROCHEMICAL ENERGY-STORAGE; INTERCALATION; ELECTRODE; MNO2		[Simon, Patrice] Univ Toulouse 3, CNRS, CIRIMAT, UMR 5085, F-31062 Toulouse, France; [Simon, Patrice] CNRS, FR 3459, RS2E, F-31062 Toulouse, France; [Gogotsi, Yury] Drexel Univ, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA; [Gogotsi, Yury] Drexel Univ, AJ Drexel Nanomat Inst, Philadelphia, PA 19104 USA; [Dunn, Bruce] Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90095 USA; [Dunn, Bruce] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Drexel University; Drexel University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Simon, P (corresponding author), Univ Toulouse 3, CNRS, CIRIMAT, UMR 5085, 118 Route Narbonne, F-31062 Toulouse, France.	simon@chimie.ups-tlse.fr; gogotsi@drexel.edu; bdunn@ucla.edu	Gogotsi, Yury/B-2167-2008; SIMON, Patrice/N-6777-2016	Gogotsi, Yury/0000-0001-9423-4032; SIMON, Patrice/0000-0002-0461-8268				Arico AS, 2005, NAT MATER, V4, P366, DOI 10.1038/nmat1368; Augustyn V, 2013, NAT MATER, V12, P518, DOI [10.1038/nmat3601, 10.1038/NMAT3601]; Beguin F., 2013, SUPERCAPACITORS MAT; Boisset A, 2013, J PHYS CHEM C, V117, P7408, DOI 10.1021/jp3118488; Come J, 2011, J ELECTROCHEM SOC, V158, pA1090, DOI 10.1149/1.3619791; CONWAY BE, 1991, J ELECTROCHEM SOC, V138, P1539, DOI 10.1149/1.2085829; Conway BE, 2013, ELECTROCHEMICAL SUPE; Gogotsi Y, 2011, SCIENCE, V334, P917, DOI 10.1126/science.1213003; Lindstrom H, 1997, J PHYS CHEM B, V101, P7717, DOI 10.1021/jp970490q; Miller JR, 2008, SCIENCE, V321, P651, DOI 10.1126/science.1158736; Okubo M, 2007, J AM CHEM SOC, V129, P7444, DOI 10.1021/ja0681927; Sathiya M, 2011, J AM CHEM SOC, V133, P16291, DOI 10.1021/ja207285b; Shimizu W, 2013, J POWER SOURCES, V241, P572, DOI 10.1016/j.jpowsour.2013.05.003; Simon P, 2013, ACCOUNTS CHEM RES, V46, P1094, DOI 10.1021/ar200306b	14	3899	3982	94	1307	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2014	343	6176					1210	1211		10.1126/science.1249625	http://dx.doi.org/10.1126/science.1249625			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC7RG	24626920	Green Submitted			2022-12-28	WOS:000332728500025
J	Zhao, J; Deng, QM; Bachmatiuk, A; Sandeep, G; Popov, A; Eckert, J; Rummeli, MH				Zhao, Jiong; Deng, Qingming; Bachmatiuk, Alicja; Sandeep, Gorantla; Popov, Alexey; Eckert, Juergen; Ruemmeli, Mark H.			Free-Standing Single-Atom-Thick Iron Membranes Suspended in Graphene Pores	SCIENCE			English	Article							FE FILMS; ANISOTROPY; STABILITY; DYNAMICS	The excess of surface dangling bonds makes the formation of free-standing two-dimensional (2D) metals unstable and hence difficult to achieve. To date, only a few reports have demonstrated 2D metal formation over substrates. Here, we show a free-standing crystalline single-atom-thick layer of iron (Fe) using in situ low-voltage aberration-corrected transmission electron microscopy and supporting image simulations. First-principles calculations confirm enhanced magnetic properties for single-atom-thick 2D Fe membranes. This work could pave the way for new 2D structures to be formed in graphene membranes.	[Zhao, Jiong; Bachmatiuk, Alicja; Sandeep, Gorantla; Eckert, Juergen] Leibniz Inst Festkorper & Werkstoffforsch Dresden, Inst Complex Mat, D-01171 Dresden, Germany; [Deng, Qingming; Popov, Alexey] IFW Dresden, Inst Solid State Res, D-01171 Dresden, Germany; [Zhao, Jiong; Bachmatiuk, Alicja; Ruemmeli, Mark H.] Inst for Basic Sci, IBS Ctr Integrated Nanostruct Phys, Taejon 305701, South Korea; [Bachmatiuk, Alicja] Polish Acad Sci, Ctr Polymer & Carbon Mat, PL-41819 Zabrze, Poland; [Eckert, Juergen] Tech Univ Dresden, Inst Mat Sci, D-01062 Dresden, Germany; [Ruemmeli, Mark H.] Sungkyunkwan Univ, Dept Phys, Dept Energy Sci, Suwon 440746, South Korea	Leibniz Institute for Solid State & Materials Research Dresden; Technische Universitat Dresden; Institute for Integrative Nanosciences (IIN); Leibniz Institute for Solid State & Materials Research Dresden; Institute for Basic Science - Korea (IBS); Polish Academy of Sciences; Centre of Polymer & Carbon Materials of the Polish Academy of Sciences; Technische Universitat Dresden; Sungkyunkwan University (SKKU)	Rummeli, MH (corresponding author), Inst for Basic Sci, IBS Ctr Integrated Nanostruct Phys, Taejon 305701, South Korea.	mark@rummeli.com	Gorantla, Sandeep/A-6293-2009; Eckert, Jurgen/U-8328-2019; Zhao, Jiong/P-5735-2017; Popov, Alexey/A-9937-2011; Deng, Qingming/C-3775-2016	Gorantla, Sandeep/0000-0002-8498-3651; Eckert, Jurgen/0000-0003-4112-3181; Zhao, Jiong/0000-0002-7411-0734; Popov, Alexey/0000-0002-7596-0378; Deng, Qingming/0000-0002-5293-0256; Rummeli, Mark Hermann/0000-0003-3736-6439	Deutscher Akademischer Austausch Dienst DAAD Foundation; Deutsche Forschungsgemeinschaft [RU 1540/8-1]; DFG [PO 1602/1-1]; Institute of Basic Science (IBS) Korea	Deutscher Akademischer Austausch Dienst DAAD Foundation(Deutscher Akademischer Austausch Dienst (DAAD)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Institute of Basic Science (IBS) Korea	J.Z. thanks the Deutscher Akademischer Austausch Dienst DAAD Foundation, and S.G. thanks the Deutsche Forschungsgemeinschaft (RU 1540/8-1). thanks the DFG (project PO 1602/1-1 to A.P.). This work was supported by the Institute of Basic Science (IBS) Korea. We also thank Y.-h. Luo (East China University of Science and Technology) for providing us with the Dmol3 code. We thank S. Melkhanova and J. Pang for the fabrication of the CVD-grown graphene. We thank the IFW Dresden for granting as use of their microscopy facilities.	Borrnert F, 2013, J MICROSC-OXFORD, V249, P87, DOI 10.1111/j.1365-2818.2012.03684.x; Cretu O, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.196102; Dai BY, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1539; GAY JG, 1986, PHYS REV LETT, V56, P2728, DOI 10.1103/PhysRevLett.56.2728; Girit CO, 2009, SCIENCE, V323, P1705, DOI 10.1126/science.1166999; Grimvall G, 2012, REV MOD PHYS, V84, P945, DOI 10.1103/RevModPhys.84.945; Izquierdo J, 2000, PHYS REV B, V61, P13639, DOI 10.1103/PhysRevB.61.13639; Jin CH, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.195505; Komsa HP, 2012, J PHYS CHEM LETT, V3, P3652, DOI 10.1021/jz301673x; Krasheninnikov AV, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.126807; Lagos MJ, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.055501; Lehnert A, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.094409; Li J., 2005, HDB MAT MODELING; Lin YC, 2011, ACS NANO, V5, P2362, DOI 10.1021/nn200105j; Lorenz R, 1996, PHYS REV B, V54, P15937, DOI 10.1103/PhysRevB.54.15937; LU WC, 1993, PHYS REV B, V48, P18159, DOI 10.1103/PhysRevB.48.18159; Matsuda Y, 2010, J PHYS CHEM C, V114, P17845, DOI 10.1021/jp806437y; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Ohnishi H, 1998, NATURE, V395, P780, DOI 10.1038/27399; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Qian D, 2001, PHYS REV LETT, V87, part. no., DOI 10.1103/PhysRevLett.87.227204; Robertson AW, 2013, NANO LETT, V13, P1468, DOI 10.1021/nl304495v; Stankov S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.185501; Wang HT, 2012, SCI REP-UK, V2, DOI 10.1038/srep00995; Wedler G, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.236101; WUTTIG M, 1993, SURF SCI, V282, P237, DOI 10.1016/0039-6028(93)90929-E	26	224	230	27	599	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2014	343	6176					1228	1232		10.1126/science.1245273	http://dx.doi.org/10.1126/science.1245273			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC7RG	24626924				2022-12-28	WOS:000332728500031
J	Al-Mudhaffar, M; Hormbrey, P				Al-Mudhaffar, Munawar; Hormbrey, Philip			Abdominal Trauma	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		*AM COLL SURG COMM, 2004, ADV TRAUM LIF SUPP C	1	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 12	2014	348								g1140	10.1136/bmj.g1140	http://dx.doi.org/10.1136/bmj.g1140			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD1ZP	24622776				2022-12-28	WOS:000333032500001
J	Brousse, V; Makani, J; Rees, DC				Brousse, Valentine; Makani, Julie; Rees, David C.			Management of sickle cell disease in the community	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RISK-FACTORS; HOSPITAL ADMISSIONS; ANEMIA; CHILDREN; HEMOGLOBIN; PAIN; HYDROXYUREA; PREVENTION; STROKE; COHORT		[Brousse, Valentine] Hop Univ Necker Enfants Malad, APHP, Reference Ctr Sickle Cell Dis, Dept Pediat, Paris, France; [Makani, Julie] Muhimbili Univ Hlth & Allied Sci, Dept Haematol & Blood Transfus, Dar Es Salaam, Tanzania; [Makani, Julie] Nuffield Dept Med, Oxford, England; [Rees, David C.] Kings Coll Hosp NHS Fdn Trust, Kings Hlth Partners, Dept Paediat Haematol, London SE5 9RS, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Muhimbili University of Health & Allied Sciences; University of Oxford; King's College Hospital NHS Foundation Trust; University of London; King's College London	Rees, DC (corresponding author), Kings Coll Hosp NHS Fdn Trust, Kings Hlth Partners, Dept Paediat Haematol, London SE5 9RS, England.	david.rees2@nhs.net	Makani, Julie/E-8525-2017; Rees, David/B-6789-2011	Makani, Julie/0000-0002-4801-6250; Rees, David/0000-0003-3647-1050	Stroke Association [TSA2012/06] Funding Source: researchfish; Wellcome Trust [093727] Funding Source: Medline	Stroke Association; Wellcome Trust(Wellcome TrustEuropean Commission)		Adams RJ, 1998, NEW ENGL J MED, V339, P5, DOI 10.1056/NEJM199807023390102; Anie KA, 2012, COCHRANE DB SYST REV, V2; Bain BJ, 2009, J CLIN PATHOL, V62, P53, DOI 10.1136/jcp.2008.060624; Ballas SK, 2012, BLOOD, V120, P3647, DOI 10.1182/blood-2012-04-383430; Ballas SK, 2009, J NATL MED ASSOC, V101, P1046, DOI 10.1016/S0027-9684(15)31072-5; BARRETTCONNOR E, 1971, MEDICINE, V50, P97, DOI 10.1097/00005792-197103000-00002; Bhatia M, 2008, BONE MARROW TRANSPL, V41, P109, DOI 10.1038/sj.bmt.1705943; Brousse V, 2012, BRIT J HAEMATOL, V156, P643, DOI 10.1111/j.1365-2141.2011.08999.x; BROWN AK, 1994, ARCH PEDIAT ADOL MED, V148, P796, DOI 10.1001/archpedi.1994.02170080026005; CHARACHE S, 1992, BLOOD, V79, P2555; Day TG, 2011, J PEDIAT HEMATOL ONC, V33, P491, DOI 10.1097/MPH.0b013e31822543f4; de Montalembert M, 2014, BRIT J HAEMATOL, V164, P630, DOI 10.1111/bjh.12700; de Montalembert M, 2011, AM J HEMATOL, V86, P72, DOI 10.1002/ajh.21865; DeBaun MR, 2012, BLOOD, V119, P4587, DOI 10.1182/blood-2011-02-272682; Downes SM, 2005, OPHTHALMOLOGY, V112, P1869, DOI 10.1016/j.ophtha.2005.05.026; Field JJ, 2008, UROLOGY, V72, P81, DOI 10.1016/j.urology.2008.02.006; FIGUEROA TE, 1995, J UROLOGY, V153, P1987, DOI 10.1016/S0022-5347(01)67386-5; FLEMING AF, 1979, ANN TROP MED PARASIT, V73, P161, DOI 10.1080/00034983.1979.11687243; Fullerton HJ, 2004, BLOOD, V104, P336, DOI 10.1182/blood-2004-02-0636; GASTON MH, 1986, NEW ENGL J MED, V314, P1593, DOI 10.1056/NEJM198606193142501; GILL FM, 1995, BLOOD, V86, P776, DOI 10.1182/blood.V86.2.776.bloodjournal862776; Gillis VL, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4063; Haddad LB, 2012, CONTRACEPTION, V85, P527, DOI 10.1016/j.contraception.2011.10.008; Hamideh D, 2013, PEDIATR BLOOD CANCER, V60, P1482, DOI 10.1002/pbc.24557; Hebbel RP, 2011, AM J HEMATOL, V86, P123, DOI 10.1002/ajh.21952; Howard J, 2012, BEST PRACT RES CL OB, V26, P25, DOI 10.1016/j.bpobgyn.2011.10.001; Huang E, 2013, NEPHROL DIAL TRANSPL, V28, P1039, DOI 10.1093/ndt/gfs585; JOHN AB, 1984, BRIT MED J, V288, P1567, DOI 10.1136/bmj.288.6430.1567; Jones S, 2005, BRIT J HAEMATOL, V131, P530, DOI 10.1111/j.1365-2141.2005.05799.x; Knight-Madden J, 2014, PAEDIATR RESPIR REV, V15, P13, DOI 10.1016/j.prrv.2013.10.005; Leveziel N, 2011, MEDICINE, V90, P372, DOI 10.1097/MD.0b013e3182364cba; Makani J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014699; Makani J, 2010, BLOOD, V115, P215, DOI 10.1182/blood-2009-07-233528; Makani J, 2009, BRIT J HAEMATOL, V145, P529, DOI 10.1111/j.1365-2141.2009.07660.x; Minniti Caterina P, 2010, Am J Hematol, V85, P831, DOI 10.1002/ajh.21838; Niscola P, 2009, PAIN MED, V10, P470, DOI 10.1111/j.1526-4637.2009.00601.x; Ohene-Frempong K, 1998, BLOOD, V91, P288; Parent F, 2011, NEW ENGL J MED, V365, P44, DOI 10.1056/NEJMoa1005565; PATTISON JR, 1981, LANCET, V1, P664; Piel FB, 2013, LANCET, V381, P142, DOI 10.1016/S0140-6736(12)61229-X; PLATT OS, 1991, NEW ENGL J MED, V325, P11, DOI 10.1056/NEJM199107043250103; Porter J, 2013, HEMATOL-AM SOC HEMAT, P447, DOI 10.1182/asheducation-2013.1.447; Rees DC, 2011, HAEMATOL-HEMATOL J, V96, P488, DOI 10.3324/haematol.2011.041988; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Ryan K, 2010, BRIT J HAEMATOL, V149, P35, DOI 10.1111/j.1365-2141.2009.08054.x; Sasongko TH, 2013, COCHRANE DB SYST REV, V3; Scheinman JI, 2009, NAT CLIN PRACT NEPHR, V5, P78, DOI 10.1038/ncpneph1008; Smith JA, 1996, OBSTET GYNECOL, V87, P199, DOI 10.1016/0029-7844(95)00367-3; Streetly A, 2010, J CLIN PATHOL, V63, P626, DOI 10.1136/jcp.2010.077560; Switzer JA, 2006, LANCET NEUROL, V5, P501, DOI 10.1016/S1474-4422(06)70469-0; Thuret I, 2010, J CLIN PATHOL, V63, P548, DOI 10.1136/jcp.2009.068874; Vichinsky EP, 2000, NEW ENGL J MED, V342, P1855, DOI 10.1056/NEJM200006223422502; Villers MS, 2008, AM J OBSTET GYNECOL, V1992, pE1; Ware RE, 2010, BLOOD, V115, P5300, DOI 10.1182/blood-2009-04-146852; Ware RE, 2010, J PEDIATR-US, V156, P66, DOI 10.1016/j.jpeds.2009.06.060; Williams TN, 2009, LANCET, V374, P1364, DOI 10.1016/S0140-6736(09)61374-X	56	38	40	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 10	2014	348								g1765	10.1136/bmj.g1765	http://dx.doi.org/10.1136/bmj.g1765			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD1ZH	24613806	Green Accepted			2022-12-28	WOS:000333031700007
J	Gronewold, AD; Stow, CA				Gronewold, Andrew D.; Stow, Craig A.			Water Loss from the Great Lakes	SCIENCE			English	Editorial Material							SUPERIOR		[Gronewold, Andrew D.; Stow, Craig A.] NOAA, Great Lakes Environm Res Lab, Ann Arbor, MI 48105 USA	National Oceanic Atmospheric Admin (NOAA) - USA	Gronewold, AD (corresponding author), NOAA, Great Lakes Environm Res Lab, 2205 Commonwealth Blvd, Ann Arbor, MI 48105 USA.	drew.gronewold@noaa.gov	Stow, Craig/AAG-8109-2020	Gronewold, Andrew/0000-0002-3576-2529; Stow, Craig/0000-0001-6171-7855				[Anonymous], 2013, INT JOINT COMM ADV G; [Anonymous], 2009, CLIMATE CHANGE IMPAC, DOI DOI 10.1111/j.1365-2664.2010.01827.x; Assel RA, 2004, B AM METEOROL SOC, V85, P1143, DOI 10.1175/BAMS-85-8-1143; Gronewold AD, 2013, CLIMATIC CHANGE, V120, P697, DOI 10.1007/s10584-013-0840-2; Heinmiller BT, 2007, GOVERNANCE, V20, P655, DOI 10.1111/j.1468-0491.2007.00376.x; Holman KD, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050468; Laird NF, 2002, J HYDROMETEOROL, V3, P3, DOI 10.1175/1525-7541(2002)003<0003:VOSALH>2.0.CO;2; Lamon EC, 2010, J GREAT LAKES RES, V36, P172, DOI 10.1016/j.jglr.2009.11.009; Meteorological Service of Canada (MSC), MET SERV CAN MSC DLY; NOAA NCDC, SURF LAND DAIL COOP; NOAA NCDC, INT SURF DAT DAT SET; QUINN FH, 1985, J GREAT LAKES RES, V11, P400, DOI 10.1016/S0380-1330(85)71784-4; Sherwood S, 2014, SCIENCE, V343, P737, DOI 10.1126/science.1247620; Spence C, 2013, J HYDROMETEOROL, V14, P1647, DOI 10.1175/JHM-D-12-0170.1; Willis JK, 2012, SCIENCE, V336, P550, DOI 10.1126/science.1220366	15	78	78	2	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2014	343	6175					1084	1085		10.1126/science.1249978	http://dx.doi.org/10.1126/science.1249978			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2LB	24604186				2022-12-28	WOS:000332331500030
J	Dover, C				Dover, Caroline			PERSONAL VIEW Spurious syndromes: we create disease by giving every illness a name	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TROCHANTERIC PAIN SYNDROME; DIAGNOSIS; BURSITIS		Royal Shrewsbury Hosp, Oswestry Shrewsbury Sch Surg, Shrewsbury SY3 8XQ, Salop, England		Dover, C (corresponding author), Royal Shrewsbury Hosp, Oswestry Shrewsbury Sch Surg, Shrewsbury SY3 8XQ, Salop, England.							Alvarez-Nemegyei J, 2004, JCR-J CLIN RHEUMATOL, V10, P123, DOI 10.1097/01.rhu.0000129089.57719.16; [Anonymous], 2013, CAMBRIDGE DICT ONLIN; Asher R, 1972, TALKING SENSE PITMAN; Bird PA, 2001, ARTHRITIS RHEUM, V44, P2138, DOI 10.1002/1529-0131(200109)44:9<2138::AID-ART367>3.0.CO;2-M; Blank E, 2012, ORTHOPEDICS, V35, pE1022, DOI 10.3928/01477447-20120621-14; Geraci A, 2011, TMJ, V61, P74; Helman C G, 1981, J R Coll Gen Pract, V31, P548; KARPINSKI MRK, 1985, J BONE JOINT SURG BR, V67, P762; LEONARD MH, 1958, JAMA-J AM MED ASSOC, V168, P175, DOI 10.1001/jama.1958.63000020003007a; Romano TJ, 2006, J MUSCULOSKELET PAIN, V14, P65; Sayegh Fares, 2004, Acta Orthop Belg, V70, P423; Stegemann H, 1923, ARCH KLIN CHIR, V125, P718; Strauss EJ, 2010, SPORTS MED ARTHROSC, V18, P113, DOI 10.1097/JSA.0b013e3181e0b2ff; Tibor LM, 2008, ARTHROSCOPY, V24, P1407, DOI 10.1016/j.arthro.2008.06.019; Williams BS, 2009, ANESTH ANALG, V108, P1662, DOI 10.1213/ane.0b013e31819d6562	15	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2014	348								g1828	10.1136/bmj.g1828	http://dx.doi.org/10.1136/bmj.g1828			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC6HV	24594759				2022-12-28	WOS:000332623400009
J	Wright, AA; Zhang, BH; Keating, NL; Weeks, JC; Prigerson, HG				Wright, Alexi A.; Zhang, Baohui; Keating, Nancy L.; Weeks, Jane C.; Prigerson, Holly G.			Associations between palliative chemotherapy and adult cancer patients' end of life care and place of death: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CELL LUNG-CANCER; OF-LIFE; MEDICARE BENEFICIARIES; TREATMENT PREFERENCES; PROPENSITY SCORE; MENTAL-HEALTH; HOSPICE CARE; NEAR-DEATH; DISCUSSIONS; QUALITY	Objectives To determine whether the receipt of chemotherapy among terminally ill cancer patients months before death was associated with patients' subsequent intensive medical care and place of death. Design Secondary analysis of a prospective, multi-institution, longitudinal study of patients with advanced cancer. Setting Eight outpatient oncology clinics in the United States. Participants 386 adult patients with metastatic cancers refractory to at least one chemotherapy regimen, whom physicians identified as terminally ill at study enrollment and who subsequently died. Main outcome measures Primary outcomes: intensive medical care (cardiopulmonary resuscitation, mechanical ventilation, or both) in the last week of life and patients' place of death (for example, intensive care unit). Secondary outcomes: survival, late hospice referrals (<= 1 week before death), and dying in preferred place of death. Results 216 (56%) of 386 terminally ill cancer patients were receiving palliative chemotherapy at study enrollment, a median of 4.0 months before death. After propensity score weighted adjustment, use of chemotherapy at enrollment was associated with higher rates of cardiopulmonary resuscitation, mechanical ventilation, or both in the last week of life (14% v 2%; adjusted risk difference 10.5%, 95% confidence interval 5.0% to 15.5%) and late hospice referrals (54% v 37%; 13.6%, 3.6% to 23.6%) but no difference in survival (hazard ratio 1.11, 95% confidence interval 0.90 to 1.38). Patients receiving palliative chemotherapy were more likely to die in an intensive care unit (11% v 2%; adjusted risk difference 6.1%, 1.1% to 11.1%) and less likely to die at home (47% v 66%; -10.8%, -1.0% to -20.6%), compared with those who were not. Patients receiving palliative chemotherapy were also less likely to die in their preferred place, compared with those who were not (65% v 80%; adjusted risk difference -9.4%, -0.8% to -18.1%). Conclusions The use of chemotherapy in terminally ill cancer patients in the last months of life was associated with an increased risk of undergoing cardiopulmonary resuscitation, mechanical ventilation or both and of dying in an intensive care unit. Future research should determine the mechanisms by which palliative chemotherapy affects end of life outcomes and patients' attainment of their goals.	[Wright, Alexi A.; Weeks, Jane C.] Harvard Univ, Sch Med, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA 02215 USA; [Zhang, Baohui; Prigerson, Holly G.] Weill Cornell Med Coll, Ctr End Of Life Res, New York, NY 10065 USA; [Keating, Nancy L.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Cornell University; Harvard University; Harvard Medical School	Prigerson, HG (corresponding author), Weill Cornell Med Coll, Ctr End Of Life Res, New York, NY 10065 USA.	hgp2001@med.cornell.edu	Wright, Alexi/T-5793-2019; Prigerson, Holly/GWV-3283-2022; Keating, Nancy L/I-9968-2019; Prigerson, Holly/L-3800-2019	Keating, Nancy L/0000-0002-8274-4681; Prigerson, Holly/0000-0002-7075-4268	National Institute of Mental Health [MH63892]; National Cancer Institute [CA 106370, CA 156732, 1K07 CA166210, 1R01 CA164021]; American Cancer Society [MRSG-13-013]; Conquer Cancer Foundation of American Society for Clinical Oncology Career Development Award; NATIONAL CANCER INSTITUTE [K07CA166210, R01CA106370, R01CA164021, U54CA156732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063892] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Conquer Cancer Foundation of American Society for Clinical Oncology Career Development Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	HGP has received research grants MH63892 from the National Institute of Mental Health and CA 106370 and CA 156732 from the National Cancer Institute; AAW has received research grants 1K07 CA166210 from the National Cancer Institute and MRSG-13-013 from the American Cancer Society and a Conquer Cancer Foundation of American Society for Clinical Oncology Career Development Award; NLK received research grant 1R01 CA164021 from the National Cancer Institute. The funding organizations had no role in the design and conduct of the study; collection, analysis, or preparation of the data; or preparation, review, or approval of the manuscript. Any opinions, findings, and conclusions expressed in this material are those of the authors and do not necessarily reflect those of the American Cancer Society, the American Society of Clinical Oncology, or the Conquer Cancer Foundation.	Alonso-Babarro A, 2011, J CLIN ONCOL, V29, P1159, DOI 10.1200/JCO.2010.31.6752; Anders CK, 2009, CANCER INVEST, V27, P13, DOI 10.1080/07357900802484944; Bach PB, 2004, JAMA-J AM MED ASSOC, V292, P2765, DOI 10.1001/jama.292.22.2765; Braga S, 2011, ANN ONCOL, V22, P2345, DOI 10.1093/annonc/mdr416; Buiting HM, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1933; Carlson MDA, 2010, J CLIN ONCOL, V28, P4371, DOI 10.1200/JCO.2009.26.1818; Carlson MDA, 2012, HEALTH AFFAIR, V31, P2690, DOI 10.1377/hlthaff.2012.0286; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; Cavalli-Bjorkman N, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001248; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; de Haes H, 2003, PATIENT EDUC COUNS, V50, P43, DOI 10.1016/S0738-3991(03)00079-X; Donovan KA, 2002, GYNECOL ONCOL, V86, P200, DOI 10.1006/gyno.2002.6748; Earle CC, 2006, J CLIN ONCOL, V24, P838, DOI 10.1200/JCO.2005.03.9388; Earle CC, 2004, J CLIN ONCOL, V22, P315, DOI 10.1200/JCO.2004.08.136; Earle CC, 2008, J CLIN ONCOL, V26, P3860, DOI 10.1200/JCO.2007.15.8253; Emanuel EJ, 2003, ANN INTERN MED, V138, P639, DOI 10.7326/0003-4819-138-8-200304150-00011; Fried TR, 2002, J GERONTOL B-PSYCHOL, V57, pS348, DOI 10.1093/geronb/57.6.S348; Gomes B, 2006, BMJ-BRIT MED J, V332, P515, DOI 10.1136/bmj.38740.614954.55; Greer JA, 2012, J CLIN ONCOL, V30, P394, DOI 10.1200/JCO.2011.35.7996; Harrington SE, 2008, JAMA-J AM MED ASSOC, V299, P2667, DOI 10.1001/jama.299.22.2667; Helft PR, 2005, J CLIN ONCOL, V23, P3146, DOI 10.1200/JCO.2005.07.003; Huskamp HA, 2009, ARCH INTERN MED, V169, P954, DOI 10.1001/archinternmed.2009.127; Jeurkar N, 2012, J CLIN ONCOL, V30, P2783, DOI 10.1200/JCO.2011.41.5711; KARNOFSKY DA, 1968, CANCER-AM CANCER SOC, V22, P730, DOI 10.1002/1097-0142(196810)22:4<730::AID-CNCR2820220407>3.0.CO;2-H; Keating NL, 2010, CANCER-AM CANCER SOC, V116, P998, DOI 10.1002/cncr.24761; Kelley AS, 2013, HEALTH AFFAIR, V32, P552, DOI 10.1377/hlthaff.2012.0851; LAVORI PW, 1995, STAT MED, V14, P1913, DOI 10.1002/sim.4780141707; Li F, 2013, STAT MED, V32, P3373, DOI 10.1002/sim.5786; Mack JW, 2009, CANCER-AM CANCER SOC, V115, P3302, DOI 10.1002/cncr.24360; Matsuyama R, 2006, J CLIN ONCOL, V24, P3490, DOI 10.1200/JCO.2005.03.6236; Morden NE, 2012, HEALTH AFFAIR, V31, P786, DOI 10.1377/hlthaff.2011.0650; Pargament KI, 2000, J CLIN PSYCHOL, V56, P519, DOI 10.1002/(SICI)1097-4679(200004)56:4<519::AID-JCLP6>3.0.CO;2-1; PRIGERSON HG, 1992, J HEALTH SOC BEHAV, V33, P378, DOI 10.2307/2137315; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Saito AM, 2011, BMC PALLIAT CARE, V10, DOI 10.1186/1472-684X-10-14; Schnipper LE, 2012, J CLIN ONCOL, V30, P1715, DOI 10.1200/JCO.2012.42.8375; Silvestri G, 1998, BRIT MED J, V317, P771, DOI 10.1136/bmj.317.7161.771; SLEVIN ML, 1990, BRIT MED J, V300, P1458, DOI 10.1136/bmj.300.6737.1458; Sulmasy DP, 2010, CANCER-AM CANCER SOC, V116, P3702, DOI 10.1002/cncr.25201; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Teno JM, 2004, JAMA-J AM MED ASSOC, V291, P88, DOI 10.1001/jama.291.1.88; Teno JM, 2013, JAMA-J AM MED ASSOC, V309, P470, DOI 10.1001/jama.2012.207624; Teno JM, 2012, J PAIN SYMPTOM MANAG, V43, P732, DOI 10.1016/j.jpainsymman.2011.05.012; Weeks JC, 2012, NEW ENGL J MED, V367, P1616, DOI 10.1056/NEJMoa1204410; Weeks JC, 1998, JAMA-J AM MED ASSOC, V279, P1709, DOI 10.1001/jama.279.21.1709; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665; Wright AA, 2007, NEW ENGL J MED, V357, P324, DOI 10.1056/NEJMp078074; Wright AA, 2010, J CLIN ONCOL, V28, P4457, DOI 10.1200/JCO.2009.26.3863	48	194	194	2	33	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 4	2014	348								g1219	10.1136/bmj.g1219	http://dx.doi.org/10.1136/bmj.g1219			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AC6HV	24594868	Green Published, hybrid			2022-12-28	WOS:000332623400001
J	Boyce, N; Marsh, J; Quarini, C				Boyce, Niall; Marsh, Joan; Quarini, Catherine			The Lancet Psychiatry: a call for papers	LANCET			English	Editorial Material									[Boyce, Niall; Marsh, Joan; Quarini, Catherine] Lancet Psychiat, London NW1 7BY, England		Boyce, N (corresponding author), Lancet Psychiat, London NW1 7BY, England.	niall.boyce@lancet.com		Marsh, Joan/0000-0002-3494-9324					0	0	0	1	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2014	383	9919					767	767		10.1016/S0140-6736(14)60228-2	http://dx.doi.org/10.1016/S0140-6736(14)60228-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC3EV	24581656	Bronze			2022-12-28	WOS:000332398700009
J	Watts, G				Watts, Geoff			James Watson: thinking outside the genome	LANCET			English	Biographical-Item																		WATSON JP, PUBLICATION LIST	1	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2014	383	9919					775	775		10.1016/S0140-6736(14)60393-7	http://dx.doi.org/10.1016/S0140-6736(14)60393-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC3EV	24581658				2022-12-28	WOS:000332398700013
J	Beaty, NB; Ahn, E				Beaty, Narlin Bennet; Ahn, Edward			Adamantinomatous Craniopharyngioma Containing Teeth	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 4-month-old term male infant presented with increasing head circumference on routine pediatric visits. MRI of the brain revealed a heterogeneous, enhancing suprasellar mass (4.1 cm by 4.0 cm by 3.5 cm) on T1-weighted images. A 4-month-old term male infant presented with increasing head circumference on routine pediatric visits. Magnetic resonance imaging (MRI) of the brain revealed a heterogeneous, enhancing suprasellar mass (4.1 cm by 4.0 cm by 3.5 cm) on T-1-weighted images after the administration of contrast material (Panel A). Multiple structures along the right periphery of the mass showed characteristics similar to those of teeth in the mandible (arrows). The patient underwent tumor resection through a right pterional approach; multiple fully formed teeth were seen in the tumor mass (Panel B). On pathological examination, an adamantinomatous craniopharyngioma was identified, which is ...	[Beaty, Narlin Bennet] Univ Maryland, Baltimore, MD 21201 USA; [Ahn, Edward] Johns Hopkins Childrens Ctr, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Johns Hopkins Medicine	Beaty, NB (corresponding author), Univ Maryland, Baltimore, MD 21201 USA.	nbeaty@smail.umaryland.edu							0	10	10	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 27	2014	370	9					860	860		10.1056/NEJMicm1308260	http://dx.doi.org/10.1056/NEJMicm1308260			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB8AR	24571758				2022-12-28	WOS:000332013000011
J	Bianchi, DW; Parker, RL; Wentworth, J; Madankumar, R; Saffer, C; Das, AF; Craig, JA; Chudova, DI; Devers, PL; Jones, KW; Oliver, K; Rava, RP; Sehnert, AJ				Bianchi, Diana W.; Parker, R. Lamar; Wentworth, Jeffrey; Madankumar, Rajeevi; Saffer, Craig; Das, Anita F.; Craig, Joseph A.; Chudova, Darya I.; Devers, Patricia L.; Jones, Keith W.; Oliver, Kelly; Rava, Richard P.; Sehnert, Amy J.		CARE Study Grp	DNA Sequencing versus Standard Prenatal Aneuploidy Screening	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CELL-FREE DNA; FREE FETAL DNA; MATERNAL BLOOD; TRISOMIES 21; 1ST-TRIMESTER; TRISOMY-21; EXPERIENCE; POSITION; SOCIETY; LIMITS	BackgroundIn high-risk pregnant women, noninvasive prenatal testing with the use of massively parallel sequencing of maternal plasma cell-free DNA (cfDNA testing) accurately detects fetal autosomal aneuploidy. Its performance in low-risk women is unclear. MethodsAt 21 centers in the United States, we collected blood samples from women with singleton pregnancies who were undergoing standard aneuploidy screening (serum biochemical assays with or without nuchal translucency measurement). We performed massively parallel sequencing in a blinded fashion to determine the chromosome dosage for each sample. The primary end point was a comparison of the false positive rates of detection of fetal trisomies 21 and 18 with the use of standard screening and cfDNA testing. Birth outcomes or karyotypes were the reference standard. ResultsThe primary series included 1914 women (mean age, 29.6 years) with an eligible sample, a singleton fetus without aneuploidy, results from cfDNA testing, and a risk classification based on standard screening. For trisomies 21 and 18, the false positive rates with cfDNA testing were significantly lower than those with standard screening (0.3% vs. 3.6% for trisomy 21, P<0.001; and 0.2% vs. 0.6% for trisomy 18, P=0.03). The use of cfDNA testing detected all cases of aneuploidy (5 for trisomy 21, 2 for trisomy 18, and 1 for trisomy 13; negative predictive value, 100% [95% confidence interval, 99.8 to 100]). The positive predictive values for cfDNA testing versus standard screening were 45.5% versus 4.2% for trisomy 21 and 40.0% versus 8.3% for trisomy 18. ConclusionsIn a general obstetrical population, prenatal testing with the use of cfDNA had significantly lower false positive rates and higher positive predictive values for detection of trisomies 21 and 18 than standard screening. (Funded by Illumina; ClinicalTrials.gov number, NCT01663350.) Sequencing of fetal DNA in maternal blood to detect trisomies had a significantly lower false positive rate than the standard method of biochemical assay and measurement of nuchal translucency in women at low risk for carrying an affected child. Noninvasive prenatal testing performed with the use of massively parallel sequencing of cell-free DNA (cfDNA testing) in maternal plasma came into use in clinical prenatal care in the United States in late 2011. This transition occurred after multiple clinical validation studies all showed high sensitivities, specificities, and negative predictive values for detection of the most common autosomal aneuploidies.(1)-(9) Plasma samples for the validation studies were either acquired retrospectively from populations with known karyotypes or collected prospectively from high-risk populations to ensure an adequate enrichment of aneuploid fetal samples for testing. The results of these studies were sufficiently robust to ...	[Bianchi, Diana W.] Tufts Med Ctr, Mother Infant Res Inst, Boston, MA 02111 USA; [Bianchi, Diana W.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Parker, R. Lamar] Lyndhurst Clin Res, Winston Salem, NC USA; [Wentworth, Jeffrey] Grp Women, Norfolk, VA USA; [Madankumar, Rajeevi] North Shore LIJ Hlth Syst, Long Isl Jewish Med Ctr, New Hyde Pk, NY USA; [Saffer, Craig] West Coast OB GYN, San Diego, CA USA; [Das, Anita F.] InClin, San Mateo, CA USA; [Chudova, Darya I.; Devers, Patricia L.; Jones, Keith W.; Oliver, Kelly; Rava, Richard P.; Sehnert, Amy J.] Illumina, Redwood City, CA USA; [Craig, Joseph A.] Colorado Permanente Med Grp, Denver, CO USA	Tufts Medical Center; Tufts University; Northwell Health; Illumina; Permanente Medical Groups	Bianchi, DW (corresponding author), Tufts Med Ctr, Mother Infant Res Inst, 800 Washington St,Box 394, Boston, MA 02111 USA.	dbianchi@tuftsmedicalcenter.org			Illumina	Illumina	Funded by Illumina; ClinicalTrials.gov number, NCT01663350.	American College of Obstetricians and Gynecologists Committee on Genetics, 2012, Obstet Gynecol, V120, P1532, DOI 10.1097/01.AOG.0000423819.85283.f4; Benn P, 2013, PRENATAL DIAG, V33, P622, DOI 10.1002/pd.4139; Bianchi DW, 2012, OBSTET GYNECOL, V119, P890, DOI 10.1097/AOG.0b013e31824fb482; Chiu RWK, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7401; Choi H, 2013, PRENATAL DIAG, V33, P198, DOI 10.1002/pd.4024; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Dan S, 2012, PRENATAL DIAG, V32, P1225, DOI 10.1002/pd.4002; Devers PL, 2013, J GENET COUNS, V22, P291, DOI 10.1007/s10897-012-9564-0; Ehrich M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.060; Fairbrother G, 2013, PRENATAL DIAG, V33, P580, DOI 10.1002/pd.4092; Futch T, 2013, PRENATAL DIAG, V33, P569, DOI 10.1002/pd.4123; Gil MM, 2013, ULTRASOUND OBST GYN, V42, P34, DOI 10.1002/uog.12504; Hall AL, 2013, GENET MED, V15, P729, DOI 10.1038/gim.2013.26; Lutgendorf MA, 2013, GENET MED; Malone FD, 2005, NEW ENGL J MED, V353, P2001, DOI 10.1056/NEJMoa043693; Morain S, 2013, NEW ENGL J MED, V369, P499, DOI 10.1056/NEJMp1304843; Nicolaides KH, 2013, ULTRASOUND OBST GYN, V42, P41, DOI 10.1002/uog.12511; Norton ME, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.05.021; Palomaki GE, 2012, GENET MED, V14, P296, DOI 10.1038/gim.2011.73; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Rava RP, 2014, CLIN CHEM, V60, P243, DOI 10.1373/clinchem.2013.207951; Sehnert AJ, 2011, CLIN CHEM, V57, P1042, DOI 10.1373/clinchem.2011.165910; Song YJ, 2013, PRENATAL DIAG, V33, P700, DOI 10.1002/pd.4160; Sparks AB, 2012, PRENATAL DIAG, V32, P3, DOI 10.1002/pd.2922; Wang E, 2013, PRENATAL DIAG, V33, P662, DOI 10.1002/pd.4119; Wang YL, 2013, PRENATAL DIAG, V33, P1207, DOI 10.1002/pd.4212	26	429	478	4	81	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 27	2014	370	9					799	808		10.1056/NEJMoa1311037	http://dx.doi.org/10.1056/NEJMoa1311037			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB8AR	24571752				2022-12-28	WOS:000332013000005
J	Duffy, T				Duffy, Thomas			Crystallography's journey to the deep Earth	NATURE			English	Editorial Material							POST-PEROVSKITE PHASE; MGSIO3		Princeton Univ, Princeton, NJ 08544 USA	Princeton University	Duffy, T (corresponding author), Princeton Univ, Princeton, NJ 08544 USA.	duffy@princeton.edu	Duffy, Thomas S/C-9140-2017	Duffy, Thomas S/0000-0002-5357-1259				Deguen R., 2012, EARTH PLANET SC LETT, V333-334, P211; Dubrovinsky L, 2010, HIGH PRESSURE RES, V30, P620, DOI 10.1080/08957959.2010.534092; Dubrovinsky L, 2013, HIGH PRESSURE RES, V33, P451, DOI 10.1080/08957959.2013.835896; Hirose K., 2007, POSTPEROVSKITE LAST; Mao WL, 2013, REV MINERAL GEOCHEM, V75, P423, DOI 10.2138/rmg.2013.75.13; Murakami M, 2004, SCIENCE, V304, P855, DOI 10.1126/science.1095932; Nisr C, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB008401; Oganov AR, 2004, NATURE, V430, P445, DOI 10.1038/nature02701; Tateno S, 2010, SCIENCE, V330, P359, DOI 10.1126/science.1194662; Zhang L, 2013, P NATL ACAD SCI USA, V110, P6292, DOI 10.1073/pnas.1304402110	10	10	12	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2014	506	7489					427	429		10.1038/506427a	http://dx.doi.org/10.1038/506427a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0DN	24579100	Bronze			2022-12-28	WOS:000332165100015
J	Dan, B; Fonteyne, C; de Clety, SC				Dan, Bernard; Fonteyne, Christine; de Clety, Stephan Clement			Self-requested euthanasia for children in Belgium	LANCET			English	Editorial Material							OF-LIFE PRACTICES; END; NETHERLANDS; LAW		[Dan, Bernard; Fonteyne, Christine] Univ Libre Bruxelles, Hop Univ Enfants Reine Fabiola, B-1020 Brussels, Belgium; [de Clety, Stephan Clement] Catholic Univ Louvain, Clin Univ St Luc, B-1200 Brussels, Belgium	Universite Libre de Bruxelles; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Dan, B (corresponding author), Univ Libre Bruxelles, Hop Univ Enfants Reine Fabiola, B-1020 Brussels, Belgium.	bernard.dan@ulb.ac.be		Dan, Bernard/0000-0002-2051-9876				[Anonymous], 2002, MONITEUR BELGE, V2141, P28515; Bilsen J, 2009, NEW ENGL J MED, V361, P1119, DOI 10.1056/NEJMc0904292; Cohen J, 2014, INT J PUBLIC HEALTH, V59, P143, DOI 10.1007/s00038-013-0461-6; Commission Federale de Controle et d'Evaluation de l'Euthanasie, 2013, RAPP CHAMBR LEG 2004; de Haan Jurriaan, 2002, Med Law Rev, V10, P57, DOI 10.1093/medlaw/10.1.57; Feudtner C., 2011, TXB INTERDISCIPLINAR, P7; Leners JC, 2013, EUR GERIATR MED, V4, pS38; Onwuteaka-Philipsen BD, 2012, LANCET, V380, P908, DOI 10.1016/S0140-6736(12)61034-4; Pousset G, 2010, ARCH PEDIAT ADOL MED, V164, P547, DOI 10.1001/archpediatrics.2010.59; Ronen GM, 2013, HAND CLINIC, V111, P107, DOI 10.1016/B978-0-444-52891-9.00011-7; Schneider CE, 1998, PRACTICE AUTONOMY PA; Smets T, 2010, MED CARE, V48, P187, DOI 10.1097/MLR.0b013e3181bd4dde; Steck N, 2013, MED CARE, V51, P938, DOI 10.1097/MLR.0b013e3182a0f427; van der Heide A, 2007, NEW ENGL J MED, V356, P1957, DOI 10.1056/NEJMsa071143; VANDERBURG W, 1991, ETHICS, V102, P42, DOI 10.1086/293369; Verhagen E, 2005, NEW ENGL J MED, V352, P959, DOI 10.1056/NEJMp058026; Vincent JL, 2014, J CRIT CARE, V29, P174, DOI 10.1016/j.jcrc.2013.08.025	17	23	24	1	31	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 22	2014	383	9918					671	672		10.1016/S0140-6736(14)60110-0	http://dx.doi.org/10.1016/S0140-6736(14)60110-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AB2WR	24560045				2022-12-28	WOS:000331653300004
J	Skupski, DW				Skupski, Daniel W.			Twin-to-twin transfusion syndrome: knowing our boundaries	LANCET			English	Editorial Material							ALUMINUM-GARNET LASER; PLACENTAL VASCULATURE; FETOSCOPY		Cornell Univ, Weill Med Coll, New York, NY 10021 USA	Cornell University	Skupski, DW (corresponding author), Cornell Univ, Weill Med Coll, New York, NY 10021 USA.	dwskupsk@med.cornell.edu						DELIA JE, 1985, AM J OBSTET GYNECOL, V151, P1126, DOI 10.1016/0002-9378(85)90395-3; DELIA JE, 1989, AM J OBSTET GYNECOL, V160, P485, DOI 10.1016/0002-9378(89)90477-8; FREDA VJ, 1967, NEW ENGL J MED, V277, P1022, DOI 10.1056/NEJM196711092771908; LILEY AW, 1963, BRIT MED J, P1107, DOI 10.1136/bmj.2.5365.1107; Mari G, 2000, NEW ENGL J MED, V342, P9, DOI 10.1056/NEJM200001063420102; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Senat MV, 2004, NEW ENGL J MED, V351, P136, DOI 10.1056/NEJMoa032597; Skupski DW, 2013, TWIN TWIN TRANSFUSIO; Slaghekke F, 2014, LANCET; Woods R, 2008, B WORLD HEALTH ORGAN, V86, P460, DOI 10.2471/BLT.07.043471	10	0	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 21	2014	383	9935					2108	2109		10.1016/S0140-6736(13)62698-7	http://dx.doi.org/10.1016/S0140-6736(13)62698-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ7VG	24613025				2022-12-28	WOS:000337906600008
J	Simon, JR; Stier, EA				Simon, Jeremy R.; Stier, Elizabeth A.			If a Man Needs a Gynecologist, Will He Be Able to Find One?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Columbia Univ, New York, NY USA; [Stier, Elizabeth A.] Boston Univ, Med Ctr, Boston, MA 02118 USA	Columbia University; Boston University	Stier, EA (corresponding author), Boston Univ, Med Ctr, 85 East Concord St,6th Floor, Boston, MA 02118 USA.	elstier@bu.edu		Stier, Elizabeth/0000-0003-3526-0032	NATIONAL CANCER INSTITUTE [U01CA121947] Funding Source: NIH RePORTER; NCI NIH HHS [U01 CA121947] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		American Medical Association, 2012, COD MED ETH CURR OP; Eisenberg ML, 2009, UROLOGY, V74, P1020, DOI 10.1016/j.urology.2009.06.042; Grady D, 2013, NY TIMES, pD1; Grady D, 2013, NY TIMES, pA14; Grady D, NY TIMES, pA20; Grady D, 2013, NY TIMES, pA18; Grady D, 2013, NY TIMES, pA17; Shiels MS, 2012, JNCI-J NATL CANCER I, V104, P1591, DOI 10.1093/jnci/djs371	8	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 15	2014	160	8					570	+		10.7326/M13-2990	http://dx.doi.org/10.7326/M13-2990			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AG0ZE	24567231	Green Accepted			2022-12-28	WOS:000335143700009
J	Merin, O; Kreiss, Y; Lin, G; Pras, E; Dagan, D				Merin, Ofer; Kreiss, Yitshak; Lin, Guy; Pras, Elon; Dagan, David			Collaboration in Response to Disaster - Typhoon Yolanda and an Integrative Model	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								An Israeli medical relief team that usually deploys a freestanding, self-sufficient field hospital found in the Philippines that when a local facility is partly functional, there are important short- and long-term benefits to full integration with the local units. The powerful typhoon that struck the Philippines on November 8, 2013, was the strongest in local history, causing massive destruction and affecting 25 million people.(1) More than 5000 people were confirmed dead, 22,000 were still reported missing when our team arrived in the country, and many others had lost their homes. The damage to the infrastructure left many areas without running water and electricity and caused total devastation in others. Some hospitals were shut down altogether, and some continued to work at partial capacity, leaving many of the injured without access to medical assistance. Various countries and relief organizations responded ...	[Merin, Ofer; Kreiss, Yitshak; Lin, Guy; Pras, Elon; Dagan, David] Israel Def Forces Med Corps Field Hosp, Tel Hashomer, Israel; [Merin, Ofer] Hebrew Univ Jerusalem, Shaare Zedek Med Ctr, Dept Cardiac Surg, Trauma Unit, Jerusalem, Israel; [Kreiss, Yitshak] Hebrew Univ Jerusalem, Dept Mil Med, Jerusalem, Israel; [Lin, Guy] Tel Aviv Univ, Sackler Sch Med, Meir Med Ctr, Trauma Unit, Kefar Sava, Israel; [Pras, Elon] Chaim Sheba Med Ctr, Danek Gertner Inst Human Genet, Ramat Gan, Israel	Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center	Merin, O (corresponding author), Israel Def Forces Med Corps Field Hosp, Tel Hashomer, Israel.							[Anonymous], 2013, B WHO, V91, P900; [Anonymous], WHO PAHO GUID US FOR; World Health Organization, WHO SUPP PHIL GOV AR	3	20	21	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 27	2014	370	13					1183	1184		10.1056/NEJMp1315960	http://dx.doi.org/10.1056/NEJMp1315960			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AD7EW	24552287				2022-12-28	WOS:000333426000004
J	Werner, SC; Ody, A; Poulet, F				Werner, Stephanie C.; Ody, Anouck; Poulet, Francois			The Source Crater of Martian Shergottite Meteorites	SCIENCE			English	Article							MARS; AGE; CONUNDRUM; LAUNCH	Absolute ages for planetary surfaces are often inferred by crater densities and only indirectly constrained by the ages of meteorites. We show that the <5 million-year-old and 55-km-wide Mojave Crater on Mars is the ejection source for the meteorites classified as shergottites. Shergottites and this crater are linked by their coinciding meteorite ejection ages and the crater formation age and by mineralogical constraints. Because Mojave formed on 4.3 billion-year-old terrain, the original crystallization ages of shergottites are old, as inferred by Pb-Pb isotope ratios, and the much-quoted shergottite ages of <600 million years are due to resetting. Thus, the cratering-based age determination method for Mars is now calibrated in situ, and it shifts the absolute age of the oldest terrains on Mars backward by 200 million years.	[Werner, Stephanie C.] Univ Oslo, Ctr Earth Evolut & Dynam, Sem Saelandsvei 24, N-0371 Oslo, Norway; [Ody, Anouck] Univ Lyon 1, CNRS, ENS Lyon, Lab Geol Lyon Terre, F-69622 Villeurbanne, France; [Poulet, Francois] Univ Paris Sud, Univ Paris 11, Inst Astrophys Spatiale, F-91405 Orsay, France	University of Oslo; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay	Werner, SC (corresponding author), Univ Oslo, Ctr Earth Evolut & Dynam, Sem Saelandsvei 24, N-0371 Oslo, Norway.	stephanie.werner@geo.uio.no	Werner, Stephanie C/A-6438-2012	Werner, Stephanie C/0000-0001-5704-0909	Norwegian Research Council through a Centre of Excellence; European Research Council (ERC) under the European Union [267631]; ERC under the European Union [280168]	Norwegian Research Council through a Centre of Excellence(Research Council of Norway); European Research Council (ERC) under the European Union(European Research Council (ERC)); ERC under the European Union	S.C.W. is supported by the Norwegian Research Council through a Centre of Excellence grant to the Centre for Earth Evolution and Dynamics and partially by the European Research Council (ERC) under the European Union's Seventh Framework Program (FP7/2007-2013)/ERC Grant agreement no. 267631 (Beyond Plate Tectonics). A.O. is supported by the ERC under the European Union's Seventh Framework Program (FP7/2007-2013)/ERC Grant agreement no. 280168 (e-Mars). Image and spectral data are available through the PDS (Planetary Data System) Geosciences Mars Orbital Data Explorer (http://ode.rsl.wustl.edu/mars/). The spectral data (SNC spectra) are described in the supplementary materials and are available on the RELAB (Reflectance Experiment Laboratory) spectral database (www.planetary.brown.edu/relabdata/).	Artemieva N, 2004, ICARUS, V171, P84, DOI 10.1016/j.icarus.2004.05.003; Bouvier A, 2005, EARTH PLANET SC LETT, V240, P221, DOI 10.1016/j.epsl.2005.09.007; Bouvier A., 2013, LUNAR PLANET SCI C, VXLIV; Bouvier A, 2008, EARTH PLANET SC LETT, V266, P105, DOI 10.1016/j.epsl.2007.11.006; Bouvier A, 2009, EARTH PLANET SC LETT, V280, P285, DOI 10.1016/j.epsl.2009.01.042; Brennecka G. A., 2013, LUNAR PLANET SCI C, VXLIV; Daubar IJ, 2013, ICARUS, V225, P506, DOI 10.1016/j.icarus.2013.04.009; Debaille V, 2007, NATURE, V450, P525, DOI 10.1038/nature06317; Dyar M., 2004, RELAB SPECTRUM DD MD; El Goresy A, 2013, GEOCHIM COSMOCHIM AC, V101, P233, DOI 10.1016/j.gca.2012.10.002; Goddard K., 2012, LUNAR PLANET SCI C, VXLIII; Hartmann WK, 2010, ICARUS, V208, P621, DOI 10.1016/j.icarus.2010.03.030; Herzog G.F., 2013, TREATISE GEOCHEMISTR, V1, P419; Ivanov B.A., 2007, TREATISE GEOPHYS, V10, P207, DOI DOI 10.1016/B978-044452748-6.00158-9; Ivanov BA, 2001, SPACE SCI REV, V96, P87, DOI 10.1023/A:1011941121102; Kerr RA, 2004, SCIENCE, V304, P196; Lapen TJ, 2010, SCIENCE, V328, P347, DOI 10.1126/science.1185395; Malin MC, 2006, SCIENCE, V314, P1573, DOI 10.1126/science.1135156; McFadden LA, 2005, METEORIT PLANET SCI, V40, P151, DOI 10.1111/j.1945-5100.2005.tb00372.x; Meyer C., 2003, JSC PUB, V27672; Moser DE, 2013, NATURE, V499, P454, DOI 10.1038/nature12341; Nyquist LE, 2001, SPACE SCI REV, V96, P105, DOI 10.1023/A:1011993105172; Rochette P, 2005, METEORIT PLANET SCI, V40, P529, DOI 10.1111/j.1945-5100.2005.tb00961.x; TANAKA KL, 1986, J GEOPHYS RES-SOLID, V91, pE139, DOI 10.1029/JB091iB13p0E139; Tornabene LL, 2012, ICARUS, V220, P348, DOI 10.1016/j.icarus.2012.05.022; Tornabene LL, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002600; Williams R. M., 2004, LUNAR PLANET SCI C, VXXXV; Williams RME, 2008, ICARUS, V198, P365, DOI 10.1016/j.icarus.2008.07.013; Zahnle K., 2004, UNIQUE ORIGIN MOJAVE	29	62	62	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 21	2014	343	6177					1343	1346		10.1126/science.1247282	http://dx.doi.org/10.1126/science.1247282			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD3AI	24603150				2022-12-28	WOS:000333108500034
J	Haeusler, AR; Donnelly, CJ; Periz, G; Simko, EAJ; Shaw, PG; Kim, MS; Maragakis, NJ; Troncoso, JC; Pandey, A; Sattler, R; Rothstein, JD; Wang, J				Haeusler, Aaron R.; Donnelly, Christopher J.; Periz, Goran; Simko, Eric A. J.; Shaw, Patrick G.; Kim, Min-Sik; Maragakis, Nicholas J.; Troncoso, Juan C.; Pandey, Akhilesh; Sattler, Rita; Rothstein, Jeffrey D.; Wang, Jiou			C9orf72 nucleotide repeat structures initiate molecular cascades of disease	NATURE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; RNA G-QUADRUPLEX; FRONTOTEMPORAL DEMENTIA; HEXANUCLEOTIDE REPEAT; GGGGCC REPEAT; DNA REPEATS; EXPANSION; PROTEIN; ALS; ACIDS	A hexanucleotide repeat expansion (HRE), (GGGGCC)(n), inC9orf72 is the most common genetic cause of the neurodegenerative diseases amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). Here we identify a molecular mechanism by which structural polymorphism of the HRE leads to ALS/FTD pathology and defects. The HRE forms DNA and RNA G-quadruplexes with distinct structures and promotes RNA-DNA hybrids (R-loops). The structural polymorphism causes a repeat-length-dependent accumulation of transcripts aborted in the HRE region. These transcribed repeats bind to ribonucleoproteins in a conformation-dependent manner. Specifically, nucleolin, an essential nucleolar protein, preferentially binds the HRE G-quadruplex, and patient cells show evidence of nucleolar stress. Our results demonstrate that distinct C9orf72 HRE structural polymorphism at both DNA and RNA levels initiates molecular cascades leading to ALS/FTD pathologies, and provide the basis for a mechanistic model for repeat-associated neurodegenerative diseases.	[Haeusler, Aaron R.; Periz, Goran; Simko, Eric A. J.; Wang, Jiou] Johns Hopkins Univ, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA; [Haeusler, Aaron R.; Periz, Goran; Simko, Eric A. J.; Rothstein, Jeffrey D.; Wang, Jiou] Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21205 USA; [Donnelly, Christopher J.; Maragakis, Nicholas J.; Sattler, Rita; Rothstein, Jeffrey D.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21205 USA; [Donnelly, Christopher J.; Sattler, Rita; Rothstein, Jeffrey D.] Johns Hopkins Univ, Brain Sci Inst, Baltimore, MD 21205 USA; [Shaw, Patrick G.; Kim, Min-Sik; Pandey, Akhilesh] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Troncoso, Juan C.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Wang, J (corresponding author), Johns Hopkins Univ, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA.	jiouw@jhmi.edu	Donnelly, Christopher/AGI-7461-2022; Kim, Min-Sik/M-3488-2016; Kim, Min-Sik/N-5010-2018	Kim, Min-Sik/0000-0001-7317-5360; Kim, Min-Sik/0000-0001-7317-5360; Haeusler, Aaron/0000-0001-5566-3707; Simko, Eric/0000-0001-8617-8608; Donnelly, Christopher/0000-0002-2383-9015	National Institutes of Health [NS07432, NS085207]; Robert Packard Center for ALS Research at Johns Hopkins; Muscular Dystrophy Association; Target ALS; ALS Association; Johns Hopkins Alzheimer's Disease Research Center NIH [P50AG05146]; National Cancer Institute [5T32CA009110-36]; Maryland Stem Cell Research Fund; Judith & Jean Pape Adams Charitable Foundation; Samuel I. Newhouse Foundation; NATIONAL CANCER INSTITUTE [T32CA009110] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS074324, R01NS085207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005146] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Packard Center for ALS Research at Johns Hopkins; Muscular Dystrophy Association(Muscular Dystrophy Association); Target ALS; ALS Association; Johns Hopkins Alzheimer's Disease Research Center NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Maryland Stem Cell Research Fund; Judith & Jean Pape Adams Charitable Foundation; Samuel I. Newhouse Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank B.J. Traynor for the information on the ALS patient cells, M. DeJesus-Hernandez and R. Rademakers for the genotyping PCR protocols on patient cells, P.J. Tienari for providing additional fibroblast/iPS cell lines, M.J. Matunis for the hnRNP F/H antibody, R. S. Nirujogi for his assistance with the SILAC LC-MS analysis, T. K. Chakravarty for his assistance with transfection of HEK293T cells, the S. Balasubramanian laboratory for generously providing the BG4 plasmid, P. L. Steinwald for purification and assistance in the validation of the BG4 protein, R. M. Powers for assistance in the staining and quantification of P bodies in iPS neurons, and O. Pletnikova for processing human tissues. This work was supported by National Institutes of Health grants NS07432 (J.W.) and NS085207 (R. S. and J.D.R.), the Robert Packard Center for ALS Research at Johns Hopkins and the Muscular Dystrophy Association (J.W.), Target ALS (J.D.R.), the ALS Association (J.W.), the Johns Hopkins Alzheimer's Disease Research Center NIH P50AG05146 (J.C.T.), National Cancer Institute training grant 5T32CA009110-36 (A. R. H. and E.A.J.S.), Maryland Stem Cell Research Fund (C.J.D.), Judith & Jean Pape Adams Charitable Foundation (R. S.), and the Samuel I. Newhouse Foundation (J.C.T.). We thank P. A. Coulumbe, V. C. Culotta, M. J. Matunis, P. S. Miller, B. A. Learn and members of the J. Wang laboratory for manuscript advice and discussions.	Abdelmohsen K, 2012, RNA BIOL, V9, P799, DOI 10.4161/rna.19718; Almeida S, 2013, ACTA NEUROPATHOL, V126, P385, DOI 10.1007/s00401-013-1149-y; Ash PEA, 2013, NEURON, V77, P639, DOI 10.1016/j.neuron.2013.02.004; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Fratta P, 2012, SCI REP-UK, V2, DOI 10.1038/srep01016; GELLERT M, 1962, P NATL ACAD SCI USA, V48, P2013, DOI 10.1073/pnas.48.12.2013; Hazel P, 2004, J AM CHEM SOC, V126, P16405, DOI 10.1021/ja045154j; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Hetman M, 2012, TRENDS NEUROSCI, V35, P305, DOI 10.1016/j.tins.2012.01.002; Hsu RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016417; Huppert JL, 2008, CHEM SOC REV, V37, P1375, DOI 10.1039/b702491f; Iioka H, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1316; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Kohli MA, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.10.003; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; La Spada AR, 2010, NAT REV GENET, V11, P247, DOI 10.1038/nrg2748; Lagier-Tourenne C, 2013, P NATL ACAD SCI USA, V110, pE4530, DOI 10.1073/pnas.1318835110; Li HB, 2013, BIOSENS BIOELECTRON, V50, P180, DOI 10.1016/j.bios.2013.06.041; Majounie E, 2012, LANCET NEUROL, V11, P323, DOI 10.1016/S1474-4422(12)70043-1; Majounie E, 2012, NEW ENGL J MED, V366, P283, DOI 10.1056/NEJMc1113592; MATUNIS MJ, 1994, NUCLEIC ACIDS RES, V22, P1059, DOI 10.1093/nar/22.6.1059; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Moss DJH, 2014, NEUROLOGY, V82, P292, DOI 10.1212/WNL.0000000000000061; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Rademakers R, 2012, NAT REV NEUROL, V8, P423, DOI 10.1038/nrneurol.2012.117; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Reddy K, 2013, J BIOL CHEM, V288, P9860, DOI 10.1074/jbc.C113.452532; Reddy K, 2011, NUCLEIC ACIDS RES, V39, P1749, DOI 10.1093/nar/gkq935; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Richard GF, 2008, MICROBIOL MOL BIOL R, V72, P686, DOI 10.1128/MMBR.00011-08; Rollinson S., 2012, NEUROBIOL AGING, V33; Rutherford NJ, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.07.005; Sareen D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007529; Sun D, 2010, METHODS MOL BIOL, V608, P65, DOI 10.1007/978-1-59745-363-9_5; Tsoi H, 2012, P NATL ACAD SCI USA, V109, P13428, DOI 10.1073/pnas.1204089109; Uemura M, 2012, ONCOGENE, V31, P1254, DOI 10.1038/onc.2011.319; Van Langenhove T, 2012, ANN MED, V44, P817, DOI 10.3109/07853890.2012.665471; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Xu ZH, 2013, P NATL ACAD SCI USA, V110, P7778, DOI 10.1073/pnas.1219643110; Zu T., 2013, P NATL ACAD SCI US	46	615	627	5	176	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2014	507	7491					195	+		10.1038/nature13124	http://dx.doi.org/10.1038/nature13124			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC6RJ	24598541	Green Accepted			2022-12-28	WOS:000332651800031
J	DeCamp, M; Sugarman, J; Berkowitz, S				DeCamp, Matthew; Sugarman, Jeremy; Berkowitz, Scott			Shared Savings in Accountable Care Organizations How to Determine Fair Distributions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[DeCamp, Matthew; Sugarman, Jeremy] Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD 21205 USA; [DeCamp, Matthew; Sugarman, Jeremy] Johns Hopkins Univ, Div Gen Internal Med, Baltimore, MD 21205 USA; [Berkowitz, Scott] Johns Hopkins Univ, Sch Med, Div Cardiol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	DeCamp, M (corresponding author), Johns Hopkins Univ, Berman Inst Bioeth, 1809 Ashland Ave, Baltimore, MD 21205 USA.	mdecamp1@jhmi.edu	DeCamp, Matthew/N-6028-2014	Sugarman, Jeremy/0000-0001-7022-8332; DeCamp, Matthew/0000-0002-9371-8729				[Anonymous], ACO TOOLKIT; Biller-Andorno N, 2013, NEW ENGL J MED, V368, P980, DOI 10.1056/NEJMp1300373; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Centers for Medicare & Medicaid Services, 2011, FED REGIST, V76, P67802; Siddiqui M, 2014, J GEN INTERN MED, V29, P832, DOI 10.1007/s11606-013-2733-5; Sinaiko AD, 2010, NEW ENGL J MED, V363, P2583, DOI 10.1056/NEJMp1011927; Toussaint J, 2013, JAMA-J AM MED ASSOC, V310, P1341, DOI 10.1001/jama.2013.279149	7	8	8	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2014	311	10					1011	1012		10.1001/jama.2014.498	http://dx.doi.org/10.1001/jama.2014.498			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC5QO	24618958				2022-12-28	WOS:000332575800014
J	Mannix, R				Mannix, Rebekah			What Would You Do, Doctor?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CHILD; IF		Boston Childrens Hosp, Dept Med, Div Emergency Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital	Mannix, R (corresponding author), Boston Childrens Hosp, Dept Med, Div Emergency Med, Boston, MA 02115 USA.	rebekah.mannix@childrens.harvard.edu	Mannix, Rebekah/AAD-8702-2020	Mannix, Rebekah/0000-0003-3608-2792				Gutgesell HP, 2002, AM J CARDIOL, V89, P856, DOI 10.1016/S0002-9149(02)02199-9; OKEN D, 1961, JAMA-J AM MED ASSOC, V175, P1120, DOI 10.1001/jama.1961.03040130004002; Ross LF, 2003, J CLIN ETHIC, V14, P59; Ruddick W, 2003, J CLIN ETHIC, V14, P68; Truog RD, 1999, PEDIATRICS, V103, P153, DOI 10.1542/peds.103.1.153	5	2	2	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2014	311	9					911	912		10.1001/jama.2014.910	http://dx.doi.org/10.1001/jama.2014.910			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AC0FS	24595772				2022-12-28	WOS:000332170800016
J	Potter, CJ				Potter, Christopher J.			Stop the Biting: Targeting a Mosquito's Sense of Smell	CELL			English	Review							OLFACTION; NEURONS; SKIN; DEET	Mosquitoes are a great threat to human health. Fortunately, they have a weakness: they utilize their sense of smell to target a human host. Recent studies examine the effectiveness of protecting humans from attack by ablating or odorant targeting mosquito olfactory receptors. The results are both promising and alarming.	Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Potter, CJ (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	cpotter@jhmi.edu	Potter, Christopher John/H-5884-2019	Potter, Christopher John/0000-0002-5223-8112				Boyle SM, 2013, ELIFE, V2, DOI 10.7554/eLife.01120; Carey AF, 2011, P NATL ACAD SCI USA, V108, P12987, DOI 10.1073/pnas.1103472108; DeGennaro M, 2013, NATURE, V498, P487, DOI 10.1038/nature12206; Dekker T, 2005, J EXP BIOL, V208, P2963, DOI 10.1242/jeb.01736; Kain P, 2013, NATURE, V502, P507, DOI 10.1038/nature12594; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; McMeniman CJ, 2014, CELL, V156, P1060, DOI 10.1016/j.cell.2013.12.044; Silbering AF, 2011, J NEUROSCI, V31, P13357, DOI 10.1523/JNEUROSCI.2360-11.2011; Tauxe GM, 2013, CELL, V155, P1365, DOI 10.1016/j.cell.2013.11.013; Turner SL, 2011, NATURE, V474, P87, DOI 10.1038/nature10081; World health organization, 2013, WORLD HLTH STAT 2013	12	37	40	3	57	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 27	2014	156	5					878	881		10.1016/j.cell.2014.02.003	http://dx.doi.org/10.1016/j.cell.2014.02.003			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AB9BK	24581489	Bronze			2022-12-28	WOS:000332083900007
J	Zamudio, JR; Kelly, TJ; Sharp, PA				Zamudio, Jesse R.; Kelly, Timothy J.; Sharp, Phillip A.			Argonaute-Bound Small RNAs from Promoter-Proximal RNA Polymerase II	CELL			English	Article							LARGE GENE LISTS; MICRORNA PRECURSORS; TRANSCRIPTION; EXPRESSION; INTERFERENCE; DROSOPHILA; SIRNAS; CELLS; DNA; TERMINATION	Argonaute (Ago) proteins mediate posttranscriptional gene repression by binding guide miRNAs to regulate targeted RNAs. To confidently assess Ago-bound small RNAs, we adapted a mouse embryonic stem cell system to express a single epitope-tagged Ago protein family member in an inducible manner. Here, we report the small RNA profile of Ago-deficient cells and show that Ago-dependent stability is a common feature of mammalian miRNAs. Using this criteria and immunopurification, we identified an Ago-dependent class of noncanonical miRNAs derived from protein-coding gene promoters, which we name transcriptional start site miRNAs (TSS-miRNAs). A subset of promoter-proximal RNA polymerase II (RNAPII) complexes produces hairpin RNAs that are processed in a DiGeorge syndrome critical region gene 8 (Dgcr8)/Drosha-independent but Dicer-dependent manner. TSS-miRNA activity is detectable from endogenous levels and following overexpression of mRNA constructs. Finally, we present evidence of differential expression and conservation in humans, suggesting important roles in gene regulation.	[Zamudio, Jesse R.; Kelly, Timothy J.; Sharp, Phillip A.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Sharp, Phillip A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Sharp, PA (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	sharppa@mit.edu			United States Public Health Service grants from the NIH [RO1 GM34277]; NCI [PO1-CA42063]; Institute Support (core) grant from the NCI [P30-CA14051]; NIH NSRA [F32CA139902, F32GM101872]; NATIONAL CANCER INSTITUTE [P30CA014051, P01CA042063, F32CA139902, R01CA133404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034277, F32GM101872] Funding Source: NIH RePORTER	United States Public Health Service grants from the NIH; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Institute Support (core) grant from the NCI; NIH NSRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Blelloch and X. Wang for cells and the Swanson Biotechnology Center at the Koch Institute and the MIT BioMicro Center for sequencing support. This work was supported by United States Public Health Service grants RO1 GM34277 from the NIH, PO1-CA42063 from the NCI (to P.A.S.), and partially by Koch Institute Support (core) grant P30-CA14051 from the NCI. J.R.Z. and T.J.K. were supported by NIH NSRA F32CA139902 and F32GM101872, respectively. The content of the project described is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. The authors wish to dedicate this paper to the memory of MIT Police Officer Sean Collier for his caring service to the MIT community and for his sacrifice.	Adelman K, 2012, NAT REV GENET, V13, P720, DOI 10.1038/nrg3293; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Berezikov E, 2011, GENOME RES, V21, P203, DOI 10.1101/gr.116657.110; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Brannan K, 2012, MOL CELL, V46, P311, DOI 10.1016/j.molcel.2012.03.006; Chen PY, 2008, RNA, V14, P263, DOI 10.1261/rna.789808; Chong MMW, 2010, GENE DEV, V24, P1951, DOI 10.1101/gad.1953310; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Eulalio A, 2008, NAT STRUCT MOL BIOL, V15, P346, DOI 10.1038/nsmb.1405; FARNHAM PJ, 1981, NUCLEIC ACIDS RES, V9, P563, DOI 10.1093/nar/9.3.563; Flynn RA, 2011, P NATL ACAD SCI USA, V108, P10460, DOI 10.1073/pnas.1106630108; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; HOFACKER IL, 2009, CURR PROTOC BIOINFOR, pCH12, DOI DOI 10.1002/0471250953.BI1202S26; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Janowski BA, 2005, NAT CHEM BIOL, V1, P216, DOI 10.1038/nchembio725; Kanhere A, 2010, MOL CELL, V38, P675, DOI 10.1016/j.molcel.2010.03.019; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Ladewig E, 2012, GENOME RES, V22, P1634, DOI 10.1101/gr.133553.111; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lima WF, 2012, CELL, V150, P883, DOI 10.1016/j.cell.2012.08.014; Liphardt J, 2001, SCIENCE, V292, P733, DOI 10.1126/science.1058498; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Meunier J, 2013, GENOME RES, V23, P34, DOI 10.1101/gr.140269.112; Min IM, 2011, GENE DEV, V25, P742, DOI 10.1101/gad.2005511; Mukherji S, 2011, NAT GENET, V43, P854, DOI 10.1038/ng.905; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; O'Carroll D, 2007, GENE DEV, V21, P1999, DOI 10.1101/gad.1565607; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Okamura K, 2013, GENE DEV, V27, P778, DOI 10.1101/gad.211698.112; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Rudel S, 2011, NUCLEIC ACIDS RES, V39, P2330, DOI 10.1093/nar/gkq1032; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Shin KJ, 2006, P NATL ACAD SCI USA, V103, P13759, DOI 10.1073/pnas.0606179103; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Su H, 2009, GENE DEV, V23, P304, DOI 10.1101/gad.1749809; Valen E, 2011, NAT STRUCT MOL BIOL, V18, P1075, DOI 10.1038/nsmb.2091; Wilson RC, 2013, ANNU REV BIOPHYS, V42, P217, DOI 10.1146/annurev-biophys-083012-130404; Winter J, 2011, RNA BIOL, V8, P1149, DOI 10.4161/rna.8.6.17665	52	80	84	2	65	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 27	2014	156	5					920	934		10.1016/j.cell.2014.01.041	http://dx.doi.org/10.1016/j.cell.2014.01.041			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AB9BK	24581493	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000332083900011
J	Saini, SD; Vijan, S; Schoenfeld, P; Powell, AA; Moser, S; Kerr, EA				Saini, Sameer D.; Vijan, Sandeep; Schoenfeld, Philip; Powell, Adam A.; Moser, Stephanie; Kerr, Eve A.			Role of quality measurement in inappropriate use of screening for colorectal cancer: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							COMORBIDITY INDEX; HEALTH-CARE; VETERANS; PERFORMANCE; MANAGEMENT; AGE; RECOMMENDATIONS; VALIDATION; GUIDELINES; PHYSICIANS	Objective To examine whether the age based quality measure for screening for colorectal cancer is associated with overuse of screening in patients aged 70-75 in poor health and underuse in those aged over age 75 in good health. Design Retrospective cohort study utilizing electronic data from the Veterans Affairs (VA) Health Care System, the largest integrated healthcare system in the United States. Setting VA Health Care System. Participants Veterans aged >= 50 due for repeat average risk colorectal cancer screening at a primary care visit in fiscal year 2010. Main outcome measures Completion of colonoscopy, sigmoidoscopy, or fecal occult blood testing within 24 months of the 2010 visit. Results 399 067 veterans met inclusion/exclusion criteria (mean age 67, 97% men). Of these, 38% had electronically documented screening within 24 months. In multivariable log binomial regression adjusted for Charlson comorbidity index, sex, and number of primary care visits, screening decreased markedly after the age of 75 (the age cut off used by the quality measure) (adjusted relative risk 0.35, 95% confidence interval 0.30 to 0.40). A veteran who was aged 75 and unhealthy (in whom life expectancy might be limited and screening more likely to result in net burden or harm) was significantly more likely to undergo screening than a veteran aged 76 and healthy (unadjusted relative risk 1.64, 1.36 to 1.97). Conclusions Specification of a quality measure can have important implications for clinical care. Future quality measures should focus on individual risk/benefit to ensure that patients who are likely to benefit from a service receive it (regardless of age), and that those who are likely to incur harm are spared unnecessary and costly care.	[Saini, Sameer D.; Vijan, Sandeep; Schoenfeld, Philip; Moser, Stephanie; Kerr, Eve A.] VA Ann Arbor Healthcare Syst, Vet Affairs Ctr Clin Management Res, Ann Arbor, MI 48105 USA; [Saini, Sameer D.; Vijan, Sandeep; Schoenfeld, Philip; Kerr, Eve A.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Powell, Adam A.] VA Minneapolis Hlth Care Syst, Vet Affairs Ctr Chron Dis Outcomes Res, Minneapolis, MN 55417 USA; [Powell, Adam A.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; University of Minnesota System; University of Minnesota Twin Cities	Saini, SD (corresponding author), VA Ann Arbor Healthcare Syst, Vet Affairs Ctr Clin Management Res, 2215 Fuller Rd, Ann Arbor, MI 48105 USA.	sdsaini@umich.edu	Saini, Sameer/C-7249-2015		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK084208] Funding Source: NIH RePORTER; NIDDK NIH HHS [K24 DK084208] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Asch SM, 2004, ANN INTERN MED, V141, P938, DOI 10.7326/0003-4819-141-12-200412210-00010; Beard AJ, 2013, CIRC-CARDIOVASC QUAL, V6, P66, DOI 10.1161/CIRCOUTCOMES.112.966697; Calonge N, 2008, ANN INTERN MED, V149, P627, DOI 10.7326/0003-4819-149-9-200811040-00243; Cassel CK, 2012, JAMA-J AM MED ASSOC, V307, P1801, DOI 10.1001/jama.2012.476; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cho H, 2013, ANN INTERN MED, V159, P667, DOI 10.7326/0003-4819-159-10-201311190-00005; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Fisher DA, 2005, AM J GASTROENTEROL, V100, P2526, DOI 10.1111/j.1572-0241.2005.00322.x; Fisher DA, 2010, DIGEST DIS SCI, V55, P1721, DOI 10.1007/s10620-010-1200-y; Gross C, 2011, TLS-TIMES LIT SUPPL, P26; Kerr E, 2007, BMJ-BRIT MED J, V335, P971, DOI 10.1136/bmj.39358.498889.94; Kerr EA, 2013, JAMA-J AM MED ASSOC, V310, P137, DOI 10.1001/jama.2013.6828; Kerr EA, 2012, ARCH INTERN MED, V172, P938, DOI 10.1001/archinternmed.2012.2253; Keyhani S, 2007, AM J PUBLIC HEALTH, V97, P2179, DOI 10.2105/AJPH.2007.114934; Kistler CE, 2011, ARCH INTERN MED, V171, P1344, DOI 10.1001/archinternmed.2011.206; Lee SJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8441; Long MD, 2012, DIGEST DIS SCI, V57, P288, DOI 10.1007/s10620-011-1895-4; NHS Information Centre, EXT NHS BOW CANC SCR; Petersen LA, 2010, HEALTH SERV RES, V45, P762, DOI 10.1111/j.1475-6773.2010.01107.x; Powell AA, 2012, J GEN INTERN MED, V27, P405, DOI 10.1007/s11606-011-1906-3; Qaseem A, 2012, ANN INTERN MED, V156, P378, DOI 10.7326/0003-4819-156-5-201203060-00010; Sheffield KM, 2013, JAMA INTERN MED, P1; Shellnut JK, 2010, DIS COLON RECTUM, V53, P5, DOI 10.1007/DCR.0b013e3181bc01d1; Sohn Min-Woong, 2006, Popul Health Metr, V4, P7, DOI 10.1186/1478-7954-4-7; Walter LC, 2004, JAMA-J AM MED ASSOC, V291, P2466, DOI 10.1001/jama.291.20.2466; Walter LC, 2001, JAMA-J AM MED ASSOC, V285, P2750, DOI 10.1001/jama.285.21.2750; Walter LC, 2009, ANN INTERN MED, V150, P465, DOI 10.7326/0003-4819-150-7-200904070-00006; Zauber AG, 2010, DIS COLON RECTUM, V53, P1453, DOI 10.1007/DCR.0b013e3181ecfb3f	29	38	38	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 26	2014	348								g1247	10.1136/bmj.g1247	http://dx.doi.org/10.1136/bmj.g1247			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC0UC	24574474	Green Published, hybrid			2022-12-28	WOS:000332209900002
J	DeBakey, ME; Schroeder, GF; Ochsner, A				DeBakey, Michael E.; Schroeder, George F.; Ochsner, Alton			Significance of Phlebography in Phlebothrombosis (Reprinted from JAMA, vol 123, pgs 738-744, 1943)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																			0	0	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 19	2014	311	7					741	741		10.1001/jama.2013.279341	http://dx.doi.org/10.1001/jama.2013.279341			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA8ZO	24549564				2022-12-28	WOS:000331383700035
J	Owens, PL; Barrett, ML; Raetzman, S; Maggard-Gibbons, M; Steiner, CA				Owens, Pamela L.; Barrett, Marguerite L.; Raetzman, Susan; Maggard-Gibbons, Melinda; Steiner, Claudia A.			Surgical Site Infections Following Ambulatory Surgery Procedures	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							WOUND INFECTIONS; HAND SURGERY; SAME-DAY; IDENTIFICATION; CARE; COMPLICATIONS; RISK	IMPORTANCE Surgical site infections can result in substantial morbidity following inpatient surgery. Little is known about serious infections following ambulatory surgery. OBJECTIVE To determine the incidence of clinically significant surgical site infections (CS-SSIs) following low-to moderate-risk ambulatory surgery in patients with low risk for surgical complications. DESIGN, SETTING, AND PARTICIPANTS Retrospective analysis of ambulatory surgical procedures complicated by CS-SSIs that require a postsurgical acute care visit (defined as subsequent hospitalization or ambulatory surgical visit for infection) using the 2010 Healthcare Cost and Utilization Project State Ambulatory Surgery and State Inpatient Databases for 8 geographically dispersed states (California, Florida, Georgia, Hawaii, Missouri, Nebraska, New York, and Tennessee) representing one-third of the US population. Index cases included 284 098 ambulatory surgical procedures (general surgery, orthopedic, neurosurgical, gynecologic, and urologic) in adult patients with low surgical risk (defined as not seen in past 30 days in acute care, length of stay less than 2 days, no other surgery on the same day, and discharged home and no infection coded on the same day). MAIN OUTCOMES AND MEASURES Rates of 14- and 30-day postsurgical acute care visits for CS-SSIs following ambulatory surgery. RESULTS Postsurgical acute care visits for CS-SSIs occurred in 3.09 (95% CI, 2.89-3.30) per 1000 ambulatory surgical procedures at 14 days and 4.84 (95% CI, 4.59-5.10) per 1000 at 30 days. Two-thirds (63.7%) of all visits for CS-SSI occurred within 14 days of the surgery; of those visits, 93.2%(95% CI, 91.3%-94.7%) involved treatment in the inpatient setting. All-cause inpatient or outpatient postsurgical visits, including those for CS-SSIs, following ambulatory surgery occurred in 19.99 (95% CI, 19.48-20.51) per 1000 ambulatory surgical procedures at 14 days and 33.62 (95% CI, 32.96-34.29) per 1000 at 30 days. CONCLUSIONS AND RELEVANCE Among patients in 8 states undergoing ambulatory surgery, rates of postsurgical visits for CS-SSIs were low relative to all causes; however, they may represent a substantial number of adverse outcomes in aggregate. Thus, these serious infections merit quality improvement efforts to minimize their occurrence.	[Owens, Pamela L.; Steiner, Claudia A.] Agcy Healthcare Res & Qual, Ctr Delivery Org & Markets, Rockville, MD 20850 USA; [Barrett, Marguerite L.] ML Barrett Inc, Del Mar, CA USA; [Raetzman, Susan] Truven Hlth Analyt, Bethesda, MD USA; [Maggard-Gibbons, Melinda] RAND Corp, Los Angeles, CA USA; [Maggard-Gibbons, Melinda] Univ Calif Los Angeles, Dept Surg, Los Angeles, CA 90024 USA	Agency for Healthcare Research & Quality; RAND Corporation; University of California System; University of California Los Angeles	Steiner, CA (corresponding author), Agcy Healthcare Res & Qual, 540 Gaither Rd, Rockville, MD 20850 USA.	claudia.steiner@ahrq.hhs.gov			Agency for Healthcare Research and Quality (AHRQ) [HHSA-290-2013-00002-C]	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This study was funded by the Agency for Healthcare Research and Quality (AHRQ) under a contract to Truven Health Analytics to develop and support the Healthcare Cost and Utilization Project (HCUP) (contract HHSA-290-2013-00002-C).	Agency for Healthcare Research and Quality (AHRQ), 2009, OV HEALTHC COST UT P; Agency for Healthcare Research and Quality (AHRQ), HEALTHC COST UT PROJ; Alkhoury F, 2012, J PEDIATR SURG, V47, P313, DOI 10.1016/j.jpedsurg.2011.11.024; American College of Surgeons National Surgical Quality Improvement Program (ACSNSQIP), BUS CAS; American Hospital Association, 2010, ANN SURV DAT 2010; Amici JM, 2005, BRIT J DERMATOL, V153, P967, DOI 10.1111/j.1365-2133.2005.06861.x; AUDRY G, 1994, EUR J PEDIATR SURG, V4, P87, DOI 10.1055/s-2008-1066074; Brebbia Giovanna, 2006, Surg Infect (Larchmt), V7 Suppl 2, pS121; Broex ECJ, 2009, J HOSP INFECT, V72, P193, DOI 10.1016/j.jhin.2009.03.020; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Bykowski MR, 2011, J HAND SURG-AM, V36A, P1741, DOI 10.1016/j.jhsa.2011.08.005; Calderwood MS, 2012, INFECT CONT HOSP EP, V33, P40, DOI 10.1086/663207; Centers for Disease Control and Prevention, OUTBR PAT NOT OUTP S; Davis JM, 2011, SURG INFECT, V12, P429, DOI 10.1089/sur.2011.020; de Lissovoy G, 2009, AM J INFECT CONTROL, V37, P387, DOI 10.1016/j.ajic.2008.12.010; Department of Health and Human Services (DHHS), NAT ACT PLAN PREV HE; Engbaek J, 2006, ACTA ANAESTH SCAND, V50, P911, DOI 10.1111/j.1399-6576.2006.01090.x; Fallaize RC, 2008, ANN ROY COLL SURG, V90, P464, DOI 10.1308/003588408X300975; Grogaard B, 2001, Ambul Surg, V9, P109, DOI 10.1016/S0966-6532(01)00106-8; Hashemi K, 2004, ANN ROY COLL SURG, V86, P449, DOI 10.1308/147870804687; Hirsemann S, 2005, AM J INFECT CONTROL, V33, P6, DOI 10.1016/j.ajic.2004.09.006; HOLMES J, 1994, J HOSP INFECT, V28, P153, DOI 10.1016/0195-6701(94)90142-2; Hwa K, 2013, JAMA SURG, V148, P823, DOI 10.1001/jamasurg.2013.2672; Kozak LJ, 1999, HEALTH CARE FINANC R, V21, P31; Lawthers AG, 2000, MED CARE, V38, P785, DOI 10.1097/00005650-200008000-00003; Magill SS, 2012, INFECT CONT HOSP EP, V33, P283, DOI 10.1086/664048; Manian FA, 1998, INFECT CONT HOSP EP, V19, P17; Minatti WR, 2002, AMBUL SURG, V10, P17; Miner AL, 2004, EMERG INFECT DIS, V10, P1931, DOI 10.3201/eid1011.040784; Mlangeni D, 2005, AM J INFECT CONTROL, V33, P11, DOI 10.1016/j.ajic.2004.09.004; National Center for Health Statistics Centers for Disease Control and Prevention (CDC), 2013, HHLTH US 2012 SPEC F; Rosbe KW, 2000, ARCH OTOLARYNGOL, V126, P718, DOI 10.1001/archotol.126.6.718; Sands K, 1999, J INFECT DIS, V179, P434, DOI 10.1086/314586; Schaefer MK, 2010, JAMA-J AM MED ASSOC, V303, P2273, DOI 10.1001/jama.2010.744; US Government Accountability Office (GAO), 2012, PAT SAF HHS HAS TAK; Vilar-Compte D, 2001, AM J INFECT CONTROL, V29, P99, DOI 10.1067/mic.2001.112241	36	65	65	2	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 19	2014	311	7					709	716		10.1001/jama.2014.4	http://dx.doi.org/10.1001/jama.2014.4			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA8ZO	24549551	Bronze			2022-12-28	WOS:000331383700023
J	Address, RRF				Address, Rabbi Richard F.			Medicine: a partnership of trust and faith	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												rfaddress@gmail.com						Friedman DM., 2013, COMMUNICATION; George Washington Institute for Spirituality and Health, EX SPIR ASS TOOL; Grose C. R, 2013, CHRISTIAN CENTURY, P13; Heschel AJ., 1972, INSECURITY FREEDOM, P28; Pew Research Center, 2013, VIEWS END OF LIF MED	5	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2014	348								g1452	10.1136/bmj.g1452	http://dx.doi.org/10.1136/bmj.g1452			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB9ZG	24534014				2022-12-28	WOS:000332153700003
J	Suh, E; Daugherty, CK; Wroblewski, K; Lee, H; Kigin, ML; Rasinski, KA; Ford, JS; Tonorezos, ES; Nathan, PC; Oeffinger, KC; Henderson, TO				Suh, Eugene; Daugherty, Christopher K.; Wroblewski, Kristen; Lee, Hannah; Kigin, Mackenzie L.; Rasinski, Kenneth A.; Ford, Jennifer S.; Tonorezos, Emily S.; Nathan, Paul C.; Oeffinger, Kevin C.; Henderson, Tara O.			General Internists' Preferences and Knowledge About the Care of Adult Survivors of Childhood Cancer A Cross-sectional Survey	ANNALS OF INTERNAL MEDICINE			English	Article							LONG-TERM SURVIVORS; HEALTH-INSURANCE COVERAGE; FOLLOW-UP CARE; 5-YEAR SURVIVORS; PHYSICIAN PREFERENCES; ADOLESCENT CANCER; AMERICAN-SOCIETY; CHEST RADIATION; LATE MORTALITY; BREAST-CANCER	Background: Adult childhood cancer survivors (CCSs) are at high risk for illness and premature death. Little is known about the physicians who provide their routine medical care. Objective: To determine general internists' self-reported attitudes and knowledge about the care of CCSs. Design: Cross-sectional survey. Setting: Mailed survey delivered between September 2011 and August 2012. Participants: Random sample of 2000 U.S. general internists. Measurements: Care preferences, comfort levels with caring for CCSs (7-point Likert scale: 1 = very uncomfortable, 7 = very comfortable), familiarity with available surveillance guidelines (7-point Likert scale: 1 = very unfamiliar, 7 = very familiar), and concordance with Children's Oncology Group Long-Term Follow-Up Guidelines in response to a clinical vignette. Results: The response rate was 61.6% (1110 of 1801). More than half the internists (51.1%) reported caring for at least 1 CCS; 72.0% of these internists never received a treatment summary. On average, internists were "somewhat uncomfortable" caring for survivors of Hodgkin lymphoma, acute lymphoblastic leukemia, and osteosarcoma. Internists reported being "somewhat unfamiliar" with available surveillance guidelines. In response to a clinical vignette about a young adult survivor of Hodgkin lymphoma, 90.6% of respondents did not appropriately recommend yearly breast cancer surveillance, 85.1% did not appropriately recommended cardiac surveillance, and 23.6% did not appropriately recommend yearly thyroid surveillance. Access to surveillance guidelines and treatment summaries were identified as the most useful resources for caring for CCSs. Limitation: Findings, based on self-report, may not reflect actual clinical practice. Conclusion: Although most general internists report involvement in the care of CCSs, many seem unfamiliar with available surveillance guidelines and would prefer to follow patients in collaboration with a cancer center.	Univ Chicago, Med Comer Childrens Hosp, Chicago, IL 60637 USA; Univ Chicago, Chicago, IL 60637 USA; Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; Hosp Sick Children, Toronto, ON M5G 1X8, Canada	University of Chicago; University of Chicago; Memorial Sloan Kettering Cancer Center; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Henderson, TO (corresponding author), Univ Chicago, Med Comer Childrens Hosp, 5841 South Maryland Ave,MC 4060, Chicago, IL 60637 USA.	thenderson@peds.bsd.uchicago.edu	Nathan, Paul/GRR-2377-2022	Nathan, Paul/0000-0003-0334-0871	National Cancer Institute; NATIONAL CANCER INSTITUTE [K05CA160724, K07CA134935] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Cancer Institute.	American College of Surgeons Commission on Cancer, 2013, CANC PROGR STAND 201; Armstrong GT, 2009, J CLIN ONCOL, V27, P2328, DOI 10.1200/JCO.2008.21.1425; Brinkman TM, 2012, J CLIN ONCOL, V30; Children's Oncology Group, 2008, LONG TERM FOLL UP GU; Daugherty CK, 2008, J CLIN ONCOL, V26, P5988, DOI 10.1200/JCO.2008.17.2221; Del Giudice ME, 2009, J CLIN ONCOL, V27, P3338, DOI 10.1200/JCO.2008.20.4883; Freyer DR, 2010, J CLIN ONCOL, V28, P4810, DOI 10.1200/JCO.2009.23.4278; Friedman DL, 2010, JNCI-J NATL CANCER I, V102, P1083, DOI 10.1093/jnci/djq238; Friedman DL, 2002, PEDIATR CLIN N AM, V49, P1083, DOI 10.1016/S0031-3955(02)00032-9; Geenen MM, 2007, JAMA-J AM MED ASSOC, V297, P2705, DOI 10.1001/jama.297.24.2705; Greenlee RT, 2000, CA-CANCER J CLIN, V50, P7, DOI 10.3322/canjclin.50.1.7; Helft PR, 2003, J CLIN ONCOL, V21, P942, DOI 10.1200/JCO.2003.08.007; Henderson TO, 2010, PEDIATRICS, V126, P129, DOI 10.1542/peds.2009-2802; Henderson TO, 2010, ANN INTERN MED, V152, P444, DOI 10.7326/0003-4819-152-7-201004060-00009; Henderson TO, 2010, J CLIN ONCOL, V28, P878, DOI 10.1200/JCO.2009.25.6107; Hewitt M, 2006, CANC PATIENT CANC SU, DOI DOI 10.17226/11613; Ishida Y, 2012, JPN J CLIN ONCOL, V42, P513, DOI 10.1093/jjco/hys038; Kadan-Lottick NS, 2002, JAMA-J AM MED ASSOC, V287, P1832, DOI 10.1001/jama.287.14.1832; Kirchhoff AC, 2010, MED CARE, V48, P1015, DOI 10.1097/MLR.0b013e3181eaf880; Kremer LCM, 2006, TIJDSCHRIFT KINDERGE, V6, P214; Kremer LCM, 2013, PEDIATR BLOOD CANCER, V60, P543, DOI 10.1002/pbc.24445; Landier W, 2004, J CLIN ONCOL, V22, P4979, DOI 10.1200/JCO.2004.11.032; Lawrence RE, 2011, CONTRACEPTION, V84, P259, DOI 10.1016/j.contraception.2010.12.002; Mariotto AB, 2009, CANCER EPIDEM BIOMAR, V18, P1033, DOI 10.1158/1055-9965.EPI-08-0988; McCabe MS, 2013, J CLIN ONCOL, V31, P631, DOI 10.1200/JCO.2012.46.6854; Meadows AT, 2009, J CLIN ONCOL, V27, P2356, DOI 10.1200/JCO.2008.21.1920; Mertens AC, 2004, HEALTH POLICY, V69, P169, DOI 10.1016/j.healthpol.2003.12.008; Mertens AC, 2001, J CLIN ONCOL, V19, P3163, DOI 10.1200/JCO.2001.19.13.3163; Nathan PC, 2008, J CLIN ONCOL, V26, P4401, DOI 10.1200/JCO.2008.16.9607; Nathan PC, 2013, J CANCER SURVIV, V7, P275, DOI 10.1007/s11764-013-0271-0; Nathan PC, 2010, ANN INTERN MED, V153, P442, DOI 10.7326/0003-4819-153-7-201010050-00007; Oeffinger KC, 2006, PEDIATR BLOOD CANCER, V46, P135, DOI 10.1002/pbc.20614; Oeffinger KC, 2004, ANN FAM MED, V2, P61, DOI 10.1370/afm.26; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Oeffinger KC, 2011, PEDIATR BLOOD CANCER, V56, P818, DOI 10.1002/pbc.22696; Oeffinger KC, 2009, JAMA-J AM MED ASSOC, V301, P404, DOI 10.1001/jama.2008.1039; Park ER, 2012, J CANCER SURVIV, V6, P251, DOI 10.1007/s11764-012-0225-y; Park ER, 2005, J CLIN ONCOL, V23, P9187, DOI 10.1200/JCO.2005.01.7418; Potosky AL, 2011, J GEN INTERN MED, V26, P1403, DOI 10.1007/s11606-011-1808-4; Rebholz CE, 2011, J CLIN ONCOL, V29, P4181, DOI 10.1200/JCO.2011.36.5619; Reulen RC, 2011, JAMA-J AM MED ASSOC, V305, P2311, DOI 10.1001/jama.2011.747; Robison LL, 2002, MED PEDIATR ONCOL, V38, P229, DOI 10.1002/mpo.1316; Salz T, 2012, CA-CANCER J CLIN; Saslow D, 2007, CA-CANCER J CLIN, V57, P75, DOI 10.3322/canjclin.57.2.75; Scottish Intercollegiate Guidelines Network (SIGN), 2013, SIGN 132 LONG TERM F; Simone J.V., 2003, CHILDHOOD CANC SURVI; SKINNER R, 2005, THERAPY BASED LONG T; Spain PD, 2012, J ONCOL PRACT, V8, P196, DOI 10.1200/JOP.2011.000345; USDHHS, 2008, PHYS WORKFORCE PROJE; Yoon JD, 2010, ACAD MED, V85, P1475, DOI 10.1097/ACM.0b013e3181eabacc; Zebrack BJ, 2004, CANCER-AM CANCER SOC, V100, P843, DOI 10.1002/cncr.20033; Zeltzer LK, 2008, CANCER EPIDEM BIOMAR, V17, P435, DOI 10.1158/1055-9965.EPI-07-2541	52	121	121	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 7	2014	160	1					11	+		10.7326/M13-1941	http://dx.doi.org/10.7326/M13-1941			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	297IS	24573662	Green Accepted			2022-12-28	WOS:000330249700002
J	Kocher, R; Roberts, B				Kocher, Robert; Roberts, Bryan			The Calculus of Cures	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kocher, Robert; Roberts, Bryan] Venrock, Palo Alto, CA 94304 USA; [Kocher, Robert] Univ So Calif, Leonard D Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA USA	University of Southern California	Kocher, R (corresponding author), Venrock, Palo Alto, CA 94304 USA.							Duijnhoven RG, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001407; Food and Drug Administration, NEW DRUGS FDA CDERS; Kantarjian HM, 2013, J CLIN ONCOL, V31, P3600, DOI 10.1200/JCO.2013.49.1845; Morgan S, 2011, HEALTH POLICY, V100, P4, DOI 10.1016/j.healthpol.2010.12.002	4	19	20	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 17	2014	370	16					1473	1475		10.1056/NEJMp1400868	http://dx.doi.org/10.1056/NEJMp1400868			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AF3HE	24571723				2022-12-28	WOS:000334601600002
J	Wen, H; Li, YY; Xi, YX; Jiang, SM; Stratton, S; Peng, DN; Tanaka, K; Ren, YF; Xia, Z; Wu, J; Li, B; Barton, MC; Li, W; Li, HT; Shi, XB				Wen, Hong; Li, Yuanyuan; Xi, Yuanxin; Jiang, Shiming; Stratton, Sabrina; Peng, Danni; Tanaka, Kaori; Ren, Yongfeng; Xia, Zheng; Wu, Jun; Li, Bing; Barton, Michelle C.; Li, Wei; Li, Haitao; Shi, Xiaobing			ZMYND11 links histone H3.3K36me3 to transcription elongation and tumour suppression	NATURE			English	Article							ADENOVIRUS E1A-ASSOCIATED PROTEIN; HIGH-AFFINITY BINDING; PWWP DOMAIN; LYSINE 36; PLANT HOMEODOMAIN; H3; RECOGNITION; BS69; METHYLATION; MUTATIONS	Recognition of modified histones by 'reader' proteins plays a critical role in the regulation of chromatin(1). H3K36 trimethylation (H3K36me3) is deposited onto the nucleosomes in the transcribed regions after RNA polymerase II elongation. In yeast, this mark in turn recruits epigenetic regulators to reset the chromatin to a relatively repressive state, thus suppressing cryptic transcription(2). However, much less is known about the role of H3K36me3 in transcription regulation in mammals. This is further complicated by the transcription-coupled incorporation of the histone variant H3.3 in gene bodies(3). Here we show that the candidate tumour suppressor ZMYND11 specifically recognizes H3K36me3 on H3.3 (H3.3K36me3) and regulates RNA polymerase II elongation. Structural studies show that in addition to the trimethyl-lysine binding by an aromatic cage within the PWWP domain, the H3.3-dependent recognition is mediated by the encapsulation of the H3.3-specific 'Ser 31' residue in a composite pocket formed by the tandem bromo-PWWP domains of ZMYND11. Chromatin immunoprecipitation followed by sequencing shows a genome-wide co-localization of ZMYND11 with H3K36me3 and H3.3 in gene bodies, and its occupancy requires the pre-deposition of H3.3K36me3. Although ZMYND11 is associated with highly expressed genes, it functions as an unconventional transcription corepressor by modulating RNA polymerase II at the elongation stage. ZMYND11 is critical for the repression of a transcriptional program that is essential for tumour cell growth; low expression levels of ZMYND11 in breast cancer patients correlate with worse prognosis. Consistently, overexpression of ZMYND11 suppresses cancer cell growth in vitro and tumour formation in mice. Together, this study identifies ZMYND11 as an H3.3-specific reader of H3K36me3 that links the histone-variant-mediated transcription elongation control to tumour suppression.	[Wen, Hong; Jiang, Shiming; Stratton, Sabrina; Peng, Danni; Tanaka, Kaori; Barton, Michelle C.; Shi, Xiaobing] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Wen, Hong; Barton, Michelle C.; Shi, Xiaobing] Univ Texas MD Anderson Canc Ctr, Ctr Canc Epigenet, Ctr Genet & Genom, Houston, TX 77030 USA; [Wen, Hong; Barton, Michelle C.; Shi, Xiaobing] Univ Texas MD Anderson Canc Ctr, Ctr Stem Cell & Dev Biol, Houston, TX 77030 USA; [Li, Yuanyuan; Ren, Yongfeng; Li, Haitao] Tsinghua Univ, Sch Life Sci, Struct Biol Ctr, MOE Key Lab Prot Sci, Beijing 100084, Peoples R China; [Li, Yuanyuan; Ren, Yongfeng; Li, Haitao] Tsinghua Univ, Sch Med, Dept Basic Med Sci, Beijing 100084, Peoples R China; [Xi, Yuanxin; Xia, Zheng; Li, Wei] Baylor Coll Med, Dept Mol & Cellular Biol, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Wu, Jun; Li, Bing] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Barton, Michelle C.; Shi, Xiaobing] Univ Texas Houston, Grad Sch Biomed Sci, Genes & Dev Grad Program, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Tsinghua University; Tsinghua University; Baylor College of Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Health Science Center Houston	Shi, XB (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	hwen@mdanderson.org; WL1@bcm.edu; lht@tsinghua.edu.cn; xbshi@mdanderson.org	Li, Haitao/B-2668-2012; Xia, Zheng/AAC-5360-2022; Xia, Zheng/F-6561-2014	Li, Haitao/0000-0001-6741-293X; Xia, Zheng/0000-0003-3364-8324; Xia, Zheng/0000-0003-3364-8324; Wen, Hong/0000-0001-8739-4572; Shi, Xiaobing/0000-0001-5242-8189; Li, Wei/0000-0001-9931-5990; Barton, Michelle/0000-0002-4042-1374	American Cancer Society [RSG-13-290-01-TBE]; National institutes of Health (NIH)/MDACC [CCSG CA016672]; Major State Basic Research Development Program in China [2011CB965300]; Program for New Century Excellent Talents in University; China Postdoctoral Science Foundation [2012M510413]; Kimmel Scholar Award;  [CPRITRP110471];  [Welch G1719];  [NIH R01HG007538];  [NIH R01GM090077];  [Welch I1713]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090077] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National institutes of Health (NIH)/MDACC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Major State Basic Research Development Program in China(National Basic Research Program of China); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Kimmel Scholar Award; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Lipsick, Y. Shi, P. Chi, C. D. Allis, D. J. Patel, S. R. Dent, J. Tyler, M. Galko, T. Westbrook, M. Lee, T. Yao and E. Guccione for comments and reagents. We thank the staff at beamlines 1W2B of the Beijing Synchrotron Radiation Facility and BL17U of the Shanghai Synchrotron Radiation Facility for their assistance in data collection. We thank J. Munch for editing the manuscript. This work was supported by grants to X. S. (CPRITRP110471, Welch G1719, American Cancer Society RSG-13-290-01-TBE, and National institutes of Health (NIH)/MDACC CCSG CA016672), H. L. (The Major State Basic Research Development Program in China, 2011CB965300 and Program for New Century Excellent Talents in University), W. L. (CPRITRP110471, NIH R01HG007538), B. L. (NIH R01GM090077, Welch I1713), Y. L. (China Postdoctoral Science Foundation, 2012M510413) and H. W. (MD Anderson IRG, Center for Cancer Epigenetics pilot grant). W. L. is a recipient of a Duncan Scholar Award and X. S. is a recipient of a Kimmel Scholar Award.	Abmayr Susan M, 2006, Curr Protoc Pharmacol, VChapter 12, DOI [10.1002/0471142727.mb1201s75, 10.1002/0471141755.ph1203s35]; Akue-Gedu R, 2009, J MED CHEM, V52, P6369, DOI 10.1021/jm901018f; Ansieau S, 2003, PATHOL BIOL, V51, P397, DOI 10.1016/S0369-8114(03)00019-1; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bjerke L, 2013, CANCER DISCOV, V3, P512, DOI 10.1158/2159-8290.CD-12-0426; Boettiger AN, 2009, SCIENCE, V325, P471, DOI 10.1126/science.1173976; Danko CG, 2013, MOL CELL, V50, P212, DOI 10.1016/j.molcel.2013.02.015; Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Eidahl JO, 2013, NUCLEIC ACIDS RES, V41, P3924, DOI 10.1093/nar/gkt074; Elsaesser SJ, 2010, CURR OPIN GENET DEV, V20, P110, DOI 10.1016/j.gde.2010.01.003; Eswaran J, 2009, P NATL ACAD SCI USA, V106, P20198, DOI 10.1073/pnas.0901989106; Fish PV, 2012, J MED CHEM, V55, P9831, DOI 10.1021/jm3010515; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; HATEBOER G, 1995, EMBO J, V14, P3159, DOI 10.1002/j.1460-2075.1995.tb07318.x; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Kessler JD, 2012, SCIENCE, V335, P348, DOI 10.1126/science.1212728; Kuo AJ, 2011, MOL CELL, V44, P609, DOI 10.1016/j.molcel.2011.08.042; Ladendorff NE, 2001, ONCOGENE, V20, P125, DOI 10.1038/sj.onc.1204048; Lewis PW, 2013, SCIENCE, V340, P857, DOI 10.1126/science.1232245; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Li YY, 2012, ACTA BIOCH BIOPH SIN, V44, P28, DOI 10.1093/abbs/gmr117; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luo ZJ, 2012, NAT REV MOL CELL BIO, V13, P543, DOI 10.1038/nrm3417; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Naar AM, 2001, ANNU REV BIOCHEM, V70, P475, DOI 10.1146/annurev.biochem.70.1.475; Nechaev S, 2008, CELL CYCLE, V7, P1539, DOI 10.4161/cc.7.11.6006; Qiu C, 2002, NAT STRUCT BIOL, V9, P217, DOI 10.1038/nsb759; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Ray-Gallet D, 2011, MOL CELL, V44, P928, DOI 10.1016/j.molcel.2011.12.006; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Sturm D, 2012, CANCER CELL, V22, P425, DOI 10.1016/j.ccr.2012.08.024; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; van Nuland R, 2013, EPIGENET CHROMATIN, V6, DOI 10.1186/1756-8935-6-12; Venkatesh S, 2012, NATURE, V489, P452, DOI 10.1038/nature11326; Vezzoli A, 2010, NAT STRUCT MOL BIOL, V17, P617, DOI 10.1038/nsmb.1797; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wei G, 2003, ANTICANCER RES, V23, P2173; Wen H, 2010, J BIOL CHEM, V285, P9322, DOI 10.1074/jbc.C109.097667; Wu H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018919; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	49	202	212	1	102	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 10	2014	508	7495					263	+		10.1038/nature13045	http://dx.doi.org/10.1038/nature13045			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE4UK	24590075	Green Accepted			2022-12-28	WOS:000333979900048
J	Keppler, H				Keppler, Hans			GEOLOGY Earth's deep water reservoir	NATURE			English	Editorial Material							TRANSITION ZONE; RINGWOODITE; MANTLE; CONDUCTIVITY; WADSLEYITE; SPINEL	A tiny sample of a mineral included in a diamond confirms predictions from high-pressure laboratory experiments that a water reservoir comparable in size to all the oceans combined is hidden deep in Earth's mantle.	Univ Bayreuth, Bayer Geoinst, D-95440 Bayreuth, Germany	University of Bayreuth	Keppler, H (corresponding author), Univ Bayreuth, Bayer Geoinst, POB 101251, D-95440 Bayreuth, Germany.	hans.keppler@uni-bayreuth.de						BINNS RA, 1969, NATURE, V221, P943, DOI 10.1038/221943a0; Bolfan-Casanova N, 2000, EARTH PLANET SC LETT, V182, P209, DOI 10.1016/S0012-821X(00)00244-2; Frost DJ, 2007, EARTH PLANET SC LETT, V256, P182, DOI 10.1016/j.epsl.2007.01.023; Huang XG, 2005, NATURE, V434, P746, DOI 10.1038/nature03426; Kelley SP, 2000, SCIENCE, V289, P609, DOI 10.1126/science.289.5479.609; Kohlstedt DL, 1996, CONTRIB MINERAL PETR, V123, P345, DOI 10.1007/s004100050161; Major A., 1966, EARTH PLANET SC LETT, V1, P241, DOI [10.1016/0012-821X(66)90077-X, DOI 10.1016/0012-821X(66)90077-X]; Pearson DG, 2014, NATURE, V507, P221, DOI 10.1038/nature13080; RINGWOOD AE, 1959, AM MINERAL, V44, P659; SMYTH JR, 1987, AM MINERAL, V72, P1051; Yoshino T, 2008, NATURE, V451, P326, DOI 10.1038/nature06427	11	6	8	1	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2014	507	7491					174	175		10.1038/507174a	http://dx.doi.org/10.1038/507174a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC6RJ	24622195				2022-12-28	WOS:000332651800025
J	Reis, RC; Reynolds, MT; Miller, JM; Walton, DJ				Reis, R. C.; Reynolds, M. T.; Miller, J. M.; Walton, D. J.			Reflection from the strong gravity regime in a lensed quasar at redshift z=0.658	NATURE			English	Article							XMM-NEWTON VIEW; X-RAY; BLACK-HOLE; EMISSION-LINES; PG QUASARS; CHANDRA; EVOLUTION; RADIO; MODEL; DISK	The co-evolution of a supermassive black hole with its host galaxy1 through cosmic time is encoded in its spin(2-4). At z > 2, supermassive black holes are thought to grow mostly by merger-driven accretion leading to high spin. It is not known, however, whether below z approximate to 1 these black holes continue to grow by coherent accretion or in a chaotic manner(5), though clear differences are predicted(3,4) in their spin evolution. An established method(6) of measuring the spin of black holes is through the study of relativistic reflection features(7) from the inner accretion disk. Owing to their greater distances from Earth, there has hitherto been no significant detection of relativistic reflection features in a moderate-redshift quasar. Here we report an analysis of archival X-ray data together with a deep observation of a gravitationally lensed quasar at z = 0.658. The emission originates within three or fewer gravitational radii from the black hole, implying a spin parameter (a measure of how fast the black hole is rotating) of a = 0.87(-0.15)(0. 08) at the 3 sigma confidence level and a > 0.66 at the 5 sigma level. The high spin found here is indicative of growth by coherent accretion for this black hole, and suggests that black-hole growth at 0.5 <= z <= 1 occurs principally by coherent rather than chaotic accretion episodes.	[Reis, R. C.; Reynolds, M. T.; Miller, J. M.] Univ Michigan, Dept Astron, Ann Arbor, MI 48109 USA; [Walton, D. J.] CALTECH, Cahill Ctr Astron & Astrophys, Pasadena, CA 91125 USA	University of Michigan System; University of Michigan; California Institute of Technology	Reis, RC (corresponding author), Univ Michigan, Dept Astron, Ann Arbor, MI 48109 USA.	rdosreis@umich.edu		Miller, Jon/0000-0003-2869-7682	Michigan Society of Fellows; NASA [PF1-120087]	Michigan Society of Fellows; NASA(National Aeronautics & Space Administration (NASA))	R.C.R. thanks the Michigan Society of Fellows and NASA for support through the Einstein Fellowship Program, grant number PF1-120087. We thank the ESA XMM-Newton Project Scientist N. Schartel and the XMM-Newton planning team for carrying out the DDT observation. The scientific results reported in this article are based on data obtained from the Chandra Data Archive.	ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; BALUCINSKACHURCH M, 1992, ASTROPHYS J, V400, P699, DOI 10.1086/172032; Berti E, 2008, ASTROPHYS J, V684, P822, DOI 10.1086/590379; Chartas G, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/2/137; Chartas G, 2009, ASTROPHYS J, V693, P174, DOI 10.1088/0004-637X/693/1/174; Crummy J, 2006, MON NOT R ASTRON SOC, V365, P1067, DOI 10.1111/j.1365-2966.2005.09844.x; Dai X, 2010, ASTROPHYS J, V709, P278, DOI 10.1088/0004-637X/709/1/278; Dauser T, 2010, MON NOT R ASTRON SOC, V409, P1534, DOI 10.1111/j.1365-2966.2010.17393.x; Davis JE, 2001, ASTROPHYS J, V562, P575, DOI 10.1086/323488; Fabian AC, 2009, NATURE, V459, P540, DOI 10.1038/nature08007; Falcke H, 2000, ASTRON ASTROPHYS, V362, P113; Fanidakis N, 2011, MON NOT R ASTRON SOC, V410, P53, DOI 10.1111/j.1365-2966.2010.17427.x; Fruscione A., 2006, SPIE C SER, V6270; Gebhardt K, 2000, ASTROPHYS J, V539, pL13, DOI 10.1086/312840; Gilli R, 2007, ASTRON ASTROPHYS, V463, P79, DOI 10.1051/0004-6361:20066334; Green PJ, 2009, ASTROPHYS J, V690, P644, DOI 10.1088/0004-637X/690/1/644; HAARDT F, 1991, ASTROPHYS J, V380, pL51, DOI 10.1086/186171; Jimenez-Bailon E, 2005, ASTRON ASTROPHYS, V435, P449, DOI 10.1051/0004-6361:20041623; King AR, 2006, MON NOT R ASTRON SOC, V373, pL90, DOI 10.1111/j.1745-3933.2006.00249.x; Miller JM, 2007, ANNU REV ASTRON ASTR, V45, P441, DOI 10.1146/annurev.astro.45.051806.110555; Miller JM, 2010, ASTROPHYS J, V724, P1441, DOI 10.1088/0004-637X/724/2/1441; Piconcelli E, 2005, ASTRON ASTROPHYS, V432, P15, DOI 10.1051/0004-6361:20041621; Pooley D, 2007, ASTROPHYS J, V661, P19, DOI 10.1086/512115; Porquet D, 2004, ASTRON ASTROPHYS, V422, P85, DOI 10.1051/0004-6361:20047108; Reis RC, 2013, ASTROPHYS J LETT, V769, DOI 10.1088/2041-8205/769/1/L7; Reynolds C. S., SPACE SCI REV; Reynolds CS, 2008, ASTROPHYS J, V675, P1048, DOI 10.1086/527344; Risaliti G, 2013, NATURE, V494, P449, DOI 10.1038/nature11938; ROSS RR, 1993, MON NOT R ASTRON SOC, V261, P74, DOI 10.1093/mnras/261.1.74; Russell HR, 2010, MON NOT R ASTRON SOC, V402, P1561, DOI 10.1111/j.1365-2966.2009.16027.x; Schmoll S, 2009, ASTROPHYS J, V703, P2171, DOI 10.1088/0004-637X/703/2/2171; Sluse D, 2012, ASTRON ASTROPHYS, V544, DOI 10.1051/0004-6361/201219125; Sluse D, 2003, ASTRON ASTROPHYS, V406, pL43, DOI 10.1051/0004-6361:20030904; TANAKA Y, 1995, NATURE, V375, P659, DOI 10.1038/375659a0; Tewes M, 2013, ASTRON ASTROPHYS, V556, DOI 10.1051/0004-6361/201220352; Tsunemi H, 2001, ASTROPHYS J, V554, P496, DOI 10.1086/321338; Volonteri M, 2013, ASTROPHYS J, V775, DOI 10.1088/0004-637X/775/2/94; Walton DJ, 2013, MON NOT R ASTRON SOC, V428, P2901, DOI 10.1093/mnras/sts227; Walton DJ, 2012, MON NOT R ASTRON SOC, V422, P2510, DOI 10.1111/j.1365-2966.2012.20809.x; Wang JF, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/1/75	41	40	40	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2014	507	7491					207	+		10.1038/nature13031	http://dx.doi.org/10.1038/nature13031			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC6RJ	24598545	Green Submitted			2022-12-28	WOS:000332651800033
J	Singer, AJ; Talan, DA				Singer, Adam J.; Talan, David A.			Management of Skin Abscesses in the Era of Methicillin-Resistant Staphylococcus aureus	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SOFT-TISSUE INFECTIONS; EMERGENCY-DEPARTMENT; CUTANEOUS ABSCESSES; PEDIATRIC SKIN; UNITED-STATES; INCISION; DRAINAGE; ULTRASOUND; CHILDREN; TRIAL	The incidence of abscesses is increasing, and community-acquired methicillin-resistant Staphylococcus aureus (MRSA) has become common. This review explains the role of ultrasonography and provides guidance on the management of skin abscesses and the use of antibiotics. Abscesses are one of the most common skin conditions managed by general practitioners and emergency physicians. The incidence of skin abscesses has increased,(1)-(5) and this increase has coincided with the emergence of community-associated methicillin-resistant Staphylococcus aureus (MRSA). In many parts of the world, MRSA infections are now the most common cause of skin abscesses.(6) Community-associated MRSA has also been found to cause severe infections including necrotizing pneumonia, necrotizing fasciitis, purpura fulminans, and severe sepsis in nonimmunocompromised hosts; however, its apparently increased virulence as compared with that of health care-associated strains and methicillin-susceptible S. aureus is incompletely understood. ...	[Singer, Adam J.] SUNY Stony Brook, Dept Emergency Med, Stony Brook, NY 11794 USA; [Talan, David A.] Olive View UCLA Med Ctr, Div Infect Dis, Dept Emergency Med, Sylmar, CA 91342 USA; [Talan, David A.] Olive View UCLA Med Ctr, Div Infect Dis, Dept Med, Sylmar, CA 91342 USA; [Talan, David A.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Singer, AJ (corresponding author), SUNY Stony Brook, Dept Emergency Med, HSC L4-080, Stony Brook, NY 11794 USA.	singer@stonybrook.edu	Singer, Adam/ABG-4506-2021					[Anonymous], 1999, MMWR-MORBID MORTAL W, V48, P48; Baumann BM, 2011, WEST J EMERG MED, V12, P159; Bobrow BJ, 1997, ANN EMERG MED, V29, P404, DOI 10.1016/S0196-0644(97)70354-8; Cheng AG, 2011, TRENDS MICROBIOL, V19, P225, DOI 10.1016/j.tim.2011.01.007; Diep BA, 2008, ANN INTERN MED, V148, P249, DOI 10.7326/0003-4819-148-4-200802190-00204; Duong M, 2010, ANN EMERG MED, V55, P401, DOI 10.1016/j.annemergmed.2009.03.014; Fitch MT, 2007, NEW ENGL J MED, V357, pE20, DOI 10.1056/NEJMvcm071319; Fritz SA, 2012, ARCH PEDIAT ADOL MED, V166, P551, DOI 10.1001/archpediatrics.2011.900; Fritz SA, 2012, CLIN INFECT DIS, V54, P743, DOI 10.1093/cid/cir919; Gaspari RJ, 2011, ANN EMERG MED, V57, P483, DOI 10.1016/j.annemergmed.2010.11.021; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Hammond SP, 2008, NEW ENGL J MED, V359, pE20, DOI 10.1056/NEJMclde0806337; Han LL, 2007, J CLIN MICROBIOL, V45, P1350, DOI 10.1128/JCM.02274-06; Hersh AL, 2008, ARCH INTERN MED, V168, P1585, DOI 10.1001/archinte.168.14.1585; Iverson K, 2012, AM J EMERG MED, V30, P1347, DOI 10.1016/j.ajem.2011.09.020; Kessler DO, 2012, PEDIATR EMERG CARE, V28, P514, DOI 10.1097/PEC.0b013e3182587b20; Lee MC, 2004, PEDIATR INFECT DIS J, V23, P123, DOI 10.1097/01.inf.0000109288.06912.21; Liu C, 2011, CLIN INFECT DIS, V53, P319, DOI [10.1093/cid/cir353, 10.1093/cid/ciq146]; Marin JR, 2013, ACAD EMERG MED, V20, P545, DOI 10.1111/acem.12148; Marin JR, 2010, PEDIATRICS, V126, P925, DOI 10.1542/peds.2010-1039; May L, 2012, AM J EMERG MED, V30, P302, DOI 10.1016/j.ajem.2010.11.033; McNamara WF, 2011, J PEDIATR SURG, V46, P502, DOI 10.1016/j.jpedsurg.2010.08.019; Miller LG, 2005, NEW ENGL J MED, V352, P1445, DOI 10.1056/NEJMoa042683; Miller LG, 2012, CLIN INFECT DIS, V54, P752, DOI 10.1093/cid/cir922; Miller LG, 2012, ANTIMICROB AGENTS CH, V56, P1084, DOI 10.1128/AAC.01608-10; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Moran GJ, 2012, CLIN INFECT DIS, V54, P1126, DOI 10.1093/cid/cis022; Niska Richard, 2010, Natl Health Stat Report, P1; O'Malley GF, 2009, ACAD EMERG MED, V16, P470, DOI 10.1111/j.1553-2712.2009.00409.x; Olderog CK, 2012, J EMERG MED, V43, P605, DOI 10.1016/j.jemermed.2011.09.037; Pallin DJ, 2013, CLIN INFECT DIS, V56, P1754, DOI 10.1093/cid/cit122; Pallin DJ, 2009, CLIN INFECT DIS, V49, P901, DOI 10.1086/605434; Qualls ML, 2012, CLIN INFECT DIS, V55, P103, DOI 10.1093/cid/cis342; Rajendran PM, 2007, ANTIMICROB AGENTS CH, V51, P4044, DOI 10.1128/AAC.00377-07; Schmitz GR, 2010, ANN EMERG MED, V56, P283, DOI 10.1016/j.annemergmed.2010.03.002; Singer AJ, 2013, ACAD EMERG MED, V20, P27, DOI 10.1111/acem.12053; Singer AJ, 2011, AM J EMERG MED, V29, P361, DOI 10.1016/j.ajem.2009.10.004; Singer AJ, 1999, ANN EMERG MED, V33, P652, DOI 10.1016/S0196-0644(99)70194-0; Szumowski JD, 2007, ANTIMICROB AGENTS CH, V51, P423, DOI 10.1128/AAC.01244-06; Taira BR, 2009, AM J EMERG MED, V27, P289, DOI 10.1016/j.ajem.2008.02.027; Talan DA, 2011, CLIN INFECT DIS, V53, P144, DOI 10.1093/cid/cir308; Talan DA, 2010, ANN EMERG MED, V55, P412, DOI 10.1016/j.annemergmed.2010.02.024; Tayal VS, 2006, ACAD EMERG MED, V13, P384, DOI 10.1197/j.aem.2005.11.074; Tsoraides SS, 2010, J PEDIATR SURG, V45, P606, DOI 10.1016/j.jpedsurg.2009.06.013; Wilson W, 2007, J AM DENT ASSOC, V138, P739, DOI 10.1161/CIRCULATIONAHA.106.183095	46	100	102	2	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 13	2014	370	11					1039	1047		10.1056/NEJMra1212788	http://dx.doi.org/10.1056/NEJMra1212788			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC7ED	24620867				2022-12-28	WOS:000332689100011
J	Griffing, G				Griffing, George			Frank's Sign	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 59-year-old man with long-standing hypertension presented with exertional chest pain. The patient was noted to have bilateral Frank's sign, a diagonal crease that runs across the earlobe at a 45-degree angle and may be a predictor of coronary artery disease. A 59-year-old man with long-standing hypertension presented with exertional chest pain. An electrocardiogram and cardiac stress testing were unremarkable. Coronary angiography, however, revealed substantial stenosis, and two stents were placed. The patient's recovery was uneventful, and he has returned to the clinic with no further chest pain. The patient was noted to have bilateral Frank's sign, which is a diagonal crease in the earlobe that runs backward from the tragus at a 45-degree angle across the lobule to the rear edge of the auricle and may be a predictor of coronary artery disease. Frank's sign is thought to indicate premature ...	St Louis Univ, St Louis, MO 63103 USA	Saint Louis University	Griffing, G (corresponding author), St Louis Univ, St Louis, MO 63103 USA.	george.griffing@gmail.com							0	11	11	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 6	2014	370	10					E15	E15		10.1056/NEJMicm1213868	http://dx.doi.org/10.1056/NEJMicm1213868			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC2EB	24597888				2022-12-28	WOS:000332309800002
J	Elias, WJ; Shah, BB				Elias, W. Jeffrey; Shah, Binit B.			Tremor	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							DEEP BRAIN-STIMULATION; QUALITY STANDARDS SUBCOMMITTEE; POSITRON-EMISSION-TOMOGRAPHY; RANDOMIZED CONTROLLED-TRIAL; GAMMA-KNIFE THALAMOTOMY; ADULT MOVEMENT-DISORDER; PARKINSONS-DISEASE; THALAMIC-STIMULATION; INITIAL TREATMENT; AMERICAN-ACADEMY	Tremor, defined as a rhythmic and involuntary movement of any body part, is the most prevalent movement disorder, affecting millions of people in the United States. All adults have varying degrees of physiological tremor so it is imperative to distinguish physiological tremor from pathological tremor types. Tremor is not inherently dangerous, but it can cause significant disability at home and in the workplace. Common tremors like essential tremor and Parkinson disease tremor can be recognized by most clinicians at the early stages for the initiation of disease-specific medical therapies. Less common tremors, such as those induced by drugs or brain lesions, are also important to recognize because they may be more refractory to medical therapies and may require earlier referral to a neurological specialist. In patients with the most progressive and severe tremors that are resistant to medical therapies, surgical interventions are available and typically target deep brain regions with stimulation or lesioning. This Grand Rounds review describes the evaluation and evidence-based management of the most common tremors, essential tremor and Parkinson disease tremor.	[Elias, W. Jeffrey] Univ Virginia, Dept Neurol Surg, Charlottesville, VA 22908 USA; [Shah, Binit B.] Univ Virginia, Dept Neurol, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Elias, WJ (corresponding author), Univ Virginia, Dept Neurol Surg, POB 800212, Charlottesville, VA 22908 USA.	wje4r@virginia.edu			Insightec Ltd; Focused Ultrasound Foundation	Insightec Ltd; Focused Ultrasound Foundation	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Drs Elias and Shah received focused ultrasound research funding from Insightec Ltd and the Focused Ultrasound Foundation.	Alves G, 2006, MOVEMENT DISORD, V21, P1123, DOI 10.1002/mds.20897; Anderson VC, 2009, NEUROSCI LETT, V462, P166, DOI 10.1016/j.neulet.2009.07.003; BAIN PG, 1994, BRAIN, V117, P805, DOI 10.1093/brain/117.4.805; Bartels AL, 2009, CORTEX, V45, P915, DOI 10.1016/j.cortex.2008.11.010; Benamer HTS, 2003, MOVEMENT DISORD, V18, P977, DOI 10.1002/mds.10482; Berg D, 2000, J NEUROL NEUROSUR PS, V69, P780, DOI 10.1136/jnnp.69.6.780; Bove M, 2006, MOVEMENT DISORD, V21, P192, DOI 10.1002/mds.20696; Brin MF, 1998, MOVEMENT DISORD, V13, P55; Brodkey JA, 2004, J NEUROSURG, V101, P43, DOI 10.3171/jns.2004.101.1.0043; Bucy PC, 1939, ARCH NEURO PSYCHIATR, V41, P721, DOI 10.1001/archneurpsyc.1939.02270160077007; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; deRijk MC, 1995, NEUROLOGY, V45, P2143, DOI 10.1212/WNL.45.12.2143; Deuschl G, 2000, J NEUROL, V247, P33, DOI 10.1007/PL00007781; Deuschl G, 1998, MOVEMENT DISORD, V13, P2, DOI 10.1002/mds.870131303; Diaz NL, 2010, PARKINSONISM RELAT D, V16, P604, DOI 10.1016/j.parkreldis.2010.07.011; EIDELBERG D, 1995, NEUROLOGY, V45, P1995, DOI 10.1212/WNL.45.11.1995; Elias WJ, 2013, NEW ENGL J MED, V369, P640, DOI 10.1056/NEJMoa1300962; Fahn S, 2004, NEW ENGL J MED, V351, P2498; Fasano A, 2013, J NEUROL NEUROSURG P; Hallett SF, 2006, PSYCHOGENIC MOVEMENT, P35; Holloway R, 2000, JAMA-J AM MED ASSOC, V284, P1931, DOI 10.1001/jama.284.15.1931; Holloway RG, 2004, ARCH NEUROL-CHICAGO, V61, P1044; HUGHES AJ, 1993, ARCH NEUROL-CHICAGO, V50, P140, DOI 10.1001/archneur.1993.00540020018011; JANKOVIC J, 1990, NEUROLOGY, V40, P1529, DOI 10.1212/WNL.40.10.1529; JENKINS IH, 1993, ANN NEUROL, V34, P82, DOI 10.1002/ana.410340115; KOLLER W, 1989, NEUROLOGY, V39, P1094, DOI 10.1212/WNL.39.8.1094; KOLLER WC, 1989, NEUROLOGY, V39, P1587, DOI 10.1212/WNL.39.12.1587; Kooshkabadi A, 2013, J NEUROSURG, V118, P713, DOI 10.3171/2013.1.JNS121111; Lombardi WJ, 2001, NEUROLOGY, V57, P785, DOI 10.1212/WNL.57.5.785; Lorenz D, 2006, MOVEMENT DISORD, V21, P1114, DOI 10.1002/mds.20884; Louis ED, 2000, ARCH NEUROL-CHICAGO, V57, P1194, DOI 10.1001/archneur.57.8.1194; Louis ED, 2002, NEUROSCI LETT, V333, P17, DOI 10.1016/S0304-3940(02)00966-7; Louis ED, 1998, MOVEMENT DISORD, V13, P5, DOI 10.1002/mds.870130105; Louis ED, 2001, MOVEMENT DISORD, V16, P914, DOI 10.1002/mds.1184; Louis ED, 2010, MOVEMENT DISORD, V25, P534, DOI 10.1002/mds.22838; Nicoletti G, 2010, NEUROLOGY, V74, P988, DOI 10.1212/WNL.0b013e3181d5a460; Pahwa R, 2001, MOVEMENT DISORD, V16, P140, DOI 10.1002/1531-8257(200101)16:1<140::AID-MDS1025>3.0.CO;2-T; PARDO B, 1993, MOVEMENT DISORD, V8, P278, DOI 10.1002/mds.870080305; Parisi SL, 2006, ARCH PHYS MED REHAB, V87, P1357, DOI 10.1016/j.apmr.2006.07.255; Raethjen J, 2000, CLIN NEUROPHYSIOL, V111, P1825, DOI 10.1016/S1388-2457(00)00384-9; Rajput A, 2004, NEUROLOGY, V62, P932, DOI 10.1212/01.WNL.0000115145.18830.1A; Rajput AH, 2012, PARKINSONISM RELAT D, V18, P626, DOI 10.1016/j.parkreldis.2012.01.013; Rajput AH, 2009, NEUROLOGY, V73, P206, DOI 10.1212/WNL.0b013e3181ae7af1; RIEDERER P, 1976, J NEURAL TRANSM, V38, P277, DOI 10.1007/BF01249445; Rodriguez-Oroz MC, 2005, BRAIN, V128, P2240, DOI 10.1093/brain/awh571; Schelosky L, 1991, Behav Neurol, V4, P103, DOI 10.3233/BEN-1991-4206; Schneier FR, 2001, J CLIN PSYCHIAT, V62, P367, DOI 10.4088/JCP.v62n0511; Schuurman PR, 2000, NEW ENGL J MED, V342, P461, DOI 10.1056/NEJM200002173420703; Shah BS, 2013, PARKINSONS DIS IMPRO; Shahed J, 2007, PARKINSONISM RELAT D, V13, P67, DOI 10.1016/j.parkreldis.2006.05.033; Shill HA, 2008, NEUROLOGY, V70, P1452, DOI 10.1212/01.wnl.0000310425.76205.02; SHOULSON I, 1989, ARCH NEUROL-CHICAGO, V46, P1052, DOI 10.1001/archneur.1989.00520460028009; Stolze H, 2001, BRAIN, V124, P2278, DOI 10.1093/brain/124.11.2278; Tanner CM, 2001, NEUROLOGY, V57, P1389, DOI 10.1212/WNL.57.8.1389; Tasker RR, 1998, SURG NEUROL, V49, P145, DOI 10.1016/S0090-3019(97)00459-X; Woods SP, 2008, COGN BEHAV NEUROL, V21, P28, DOI 10.1097/WNN.0b013e3181684414; Young RF, 2010, J NEUROSURG, V112, P1311, DOI 10.3171/2009.10.JNS09332; Yu M, 2012, EUR J NEUROL, V19, P625, DOI 10.1111/j.1468-1331.2011.03598.x; Zesiewicz TA, 2011, NEUROLOGY, V77, P1752, DOI 10.1212/WNL.0b013e318236f0fd; Zesiewicz TA, 2005, NEUROLOGY, V64, P2008, DOI 10.1212/01.WNL.0000163769.28552.CD	60	84	89	1	19	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2014	311	9					948	954		10.1001/jama.2014.1397	http://dx.doi.org/10.1001/jama.2014.1397			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC0FS	24595779				2022-12-28	WOS:000332170800023
J	Bhattacharya, S				Bhattacharya, Shaoni			Disease detectives	NATURE			English	News Item							SEQUENCES; OUTBREAK; HIV-1											de Oliveira T, 2006, NATURE, V444, P836, DOI 10.1038/444836a; Gonzalez-Candelas F, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-76; Hanczaruk M, 2014, EMERG INFECT DIS, V20, P322, DOI 10.3201/eid2002.120921; Scaduto DI, 2010, P NATL ACAD SCI USA, V107, P21242, DOI 10.1073/pnas.1015673107; 2004, NATURE, V430, P277; 2008, NATURE, V454, P672	6	6	6	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2014	506	7489					424	426		10.1038/506424a	http://dx.doi.org/10.1038/506424a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0DN	24572408	Bronze			2022-12-28	WOS:000332165100014
J	Rodriguez-Bravo, V; Maciejowski, J; Corona, J; Buch, HK; Collin, P; Kanemaki, MT; Shah, JV; Jallepalli, PV				Rodriguez-Bravo, Veronica; Maciejowski, John; Corona, Jennifer; Buch, Hakon Kirkeby; Collin, Philippe; Kanemaki, Masato T.; Shah, Jagesh V.; Jallepalli, Prasad V.			Nuclear Pores Protect Genome Integrity by Assembling a Premitotic and Mad1-Dependent Anaphase Inhibitor	CELL			English	Article							CHROMOSOME SEGREGATION ERRORS; MITOTIC SPINDLE CHECKPOINT; AURORA-B; GENE-REGULATION; KINETOCHORE PROTEINS; PROMOTING COMPLEX; SOMATIC-CELLS; CORE COMPLEX; IN-VIVO; CENP-E	The spindle assembly checkpoint (SAC) delays anaphase until all chromosomes are bioriented on the mitotic spindle. Under current models, unattached kinetochores transduce the SAC by catalyzing the intramitotic production of a diffusible inhibitor of APC/C Cdc20 (the anaphase-promoting complex/cyclosome and its coactivator Cdc20, a large ubiquitin ligase). Here we show that nuclear pore complexes (NPCs) in interphase cells also function as scaffolds for anaphase-inhibitory signaling. This role is mediated by Mad1-Mad2 complexes tethered to the nuclear basket, which activate soluble Mad2 as a binding partner and inhibitor of Cdc20 in the cytoplasm. Displacing Mad1-Mad2 from nuclear pores accelerated anaphase onset, prevented effective correction of merotelic errors, and increased the threshold of kinetochore-dependent signaling needed to halt mitosis in response to spindle poisons. A heterologous Mad1-NPC tether restored Cdc20 inhibitor production and normal M phase control. We conclude that nuclear pores and kinetochores both emit "wait anaphase" signals that preserve genome integrity.	[Rodriguez-Bravo, Veronica; Maciejowski, John; Corona, Jennifer; Jallepalli, Prasad V.] Mem Sloan Kettering Canc Ctr, Jr Grad Sch Biomed Sci, Mol Biol Program, New York, NY 10065 USA; [Buch, Hakon Kirkeby] Swiss Fed Inst Technol Zurich, CH-8093 Zurich, Switzerland; [Collin, Philippe] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; [Collin, Philippe] Univ Cambridge, Dept Zool, Cambridge CB2 1QN, England; [Kanemaki, Masato T.] SOKENDAI, ROIS, Natl Inst Genet, Ctr Frontier Res, Mishima, Shizuoka 4118540, Japan; [Kanemaki, Masato T.] SOKENDAI, Dept Genet, Mishima, Shizuoka 4118540, Japan; [Buch, Hakon Kirkeby; Shah, Jagesh V.] Harvard Univ, Dept Syst Biol, Sch Med, Boston, MA 02115 USA	Memorial Sloan Kettering Cancer Center; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Cambridge; University of Cambridge; Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Harvard University; Harvard Medical School	Jallepalli, PV (corresponding author), Mem Sloan Kettering Canc Ctr, Jr Grad Sch Biomed Sci, Mol Biol Program, New York, NY 10065 USA.	jallepap@mskcc.org	Kanemaki, Masato/Q-3246-2019	Kanemaki, Masato/0000-0002-7657-1649; Rodriguez-Bravo, Veronica/0000-0002-7363-3672; Maciejowski, John/0000-0001-8134-9308	BBSRC; NIH [R01GM077238, R01GM094972]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077238, R01GM094972] Funding Source: NIH RePORTER	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Gray, J. Hanover, A. Musacchio, and E. Nigg for generous gifts of reagents, M. Leversha (MSKCC Cytogenetics Core) for performing FISH, and A. North (Bio-Imaging Resource Center, Rockefeller University) and K. Manova (MSKCC Molecular Cytology Core) for help with confocal imaging. We are grateful to F. Cubizolles for help in preparing the Venus-Mad2 targeting construct and E. Foley for assistance with live-cell imaging. P.C. was funded via a BBSRC project grant. This work was supported by NIH grants R01GM077238 to J.V.S. and R01GM094972 to P.V.J.	Arnaoutov A, 2005, NAT CELL BIOL, V7, P626, DOI 10.1038/ncb1263; Bakhoum SF, 2009, NAT CELL BIOL, V11, P27, DOI 10.1038/ncb1809; Bapteste E, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r85; Berdougo E, 2009, METHODS MOL BIOL, V545, P21, DOI 10.1007/978-1-60327-993-2_2; Cairo LV, 2013, MOL CELL, V49, P109, DOI 10.1016/j.molcel.2012.10.017; Campbell MS, 2001, J CELL SCI, V114, P953; Capelson M, 2009, EMBO REP, V10, P697, DOI 10.1038/embor.2009.147; Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310; Chow KH, 2012, NAT REV CANCER, V12, P196, DOI 10.1038/nrc3219; Cimini D, 2008, BBA-REV CANCER, V1786, P32, DOI 10.1016/j.bbcan.2008.05.003; Cimini D, 2006, CURR BIOL, V16, P1711, DOI 10.1016/j.cub.2006.07.022; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; Collin P, 2013, NAT CELL BIOL, V15, P1378, DOI 10.1038/ncb2855; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; De Antoni A, 2005, CURR BIOL, V15, P214, DOI 10.1016/j.cub.2005.01.038; DeGrasse JA, 2009, MOL CELL PROTEOMICS, V8, P2119, DOI 10.1074/mcp.M900038-MCP200; Dick AE, 2013, NAT CELL BIOL, V15, P1370, DOI 10.1038/ncb2842; Dieckmann R., 2005, PROTEOMICS PROTOCOLS, P79; Dieppois G, 2010, J CELL SCI, V123, P1989, DOI 10.1242/jcs.053694; Ding DF, 2012, PLANT MOL BIOL, V79, P203, DOI 10.1007/s11103-012-9903-4; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Fahrenkrog B, 2002, J STRUCT BIOL, V140, P254, DOI 10.1016/S1047-8477(02)00524-5; Fang GW, 2002, MOL BIOL CELL, V13, P755, DOI 10.1091/mbc.01-09-0437; Fava LL, 2011, EMBO J, V30, P3322, DOI 10.1038/emboj.2011.239; Foley EA, 2013, NAT REV MOL CELL BIO, V14, P25, DOI 10.1038/nrm3494; Fraschini R, 2001, EMBO J, V20, P6648, DOI 10.1093/emboj/20.23.6648; Gascoigne KE, 2013, J CELL BIOL, V201, P23, DOI 10.1083/jcb.201301006; Gregan J, 2011, TRENDS CELL BIOL, V21, P374, DOI 10.1016/j.tcb.2011.01.003; Hase ME, 2003, MOL BIOL CELL, V14, P1923, DOI 10.1091/mbc.E02-09-0620; Hetzer MW, 2009, DEV CELL, V17, P606, DOI 10.1016/j.devcel.2009.10.007; Hewitt L, 2010, J CELL BIOL, V190, P25, DOI 10.1083/jcb.201002133; Iouk T, 2002, J CELL BIOL, V159, P807, DOI 10.1083/jcb.200205068; Jallepalli PV, 2001, CELL, V105, P445, DOI 10.1016/S0092-8674(01)00340-3; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Jones MJK, 2012, DEV CELL, V23, P908, DOI 10.1016/j.devcel.2012.10.010; Joseph J, 2004, CURR BIOL, V14, P611, DOI 10.1016/j.cub.2004.03.031; Kim SJ, 2012, P NATL ACAD SCI USA, V109, P6549, DOI 10.1073/pnas.1118210109; Kohler A, 2010, MOL CELL, V38, P6, DOI 10.1016/j.molcel.2010.01.040; Krull S, 2004, MOL BIOL CELL, V15, P4261, DOI 10.1091/mbc.E04-03-0165; Kusano A, 2001, DEV CELL, V1, P351, DOI 10.1016/S1534-5807(01)00042-9; Kwiatkowski N, 2010, NAT CHEM BIOL, V6, P359, DOI 10.1038/nchembio.345; Larracuente AM, 2012, GENETICS, V192, P33, DOI 10.1534/genetics.112.141390; Lee SH, 2008, GENE DEV, V22, P2926, DOI 10.1101/gad.1677208; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lince-Faria M, 2009, J CELL BIOL, V184, P647, DOI 10.1083/jcb.200811012; Liu ST, 2003, MOL BIOL CELL, V14, P1638, DOI 10.1091/mbc.02-05-0074; Luo XL, 2002, MOL CELL, V9, P59, DOI 10.1016/S1097-2765(01)00435-X; Maciejowski J, 2010, J CELL BIOL, V190, P89, DOI 10.1083/jcb.201001050; Maldonado M, 2011, NAT CELL BIOL, V13, P475, DOI 10.1038/ncb2223; Malureanu LA, 2009, DEV CELL, V16, P118, DOI 10.1016/j.devcel.2008.11.004; Meraldi P, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r23; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nakano H, 2010, J BIOL CHEM, V285, P10841, DOI 10.1074/jbc.M110.105890; Nijenhuis W, 2013, J CELL BIOL, V201, P217, DOI 10.1083/jcb.201210033; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Phadnis N, 2012, MOL BIOL EVOL, V29, P1429, DOI 10.1093/molbev/msr306; Pines J, 2011, NAT REV MOL CELL BIO, V12, P427, DOI 10.1038/nrm3132; Poddar A, 2005, EUKARYOT CELL, V4, P867, DOI 10.1128/EC.4.5.867-878.2005; Salmon ED, 2005, PHILOS T R SOC B, V360, P553, DOI 10.1098/rstb.2004.1610; Samereier M., 2011, CELL BIOL; Santaguida S, 2011, EMBO J, V30, P1508, DOI 10.1038/emboj.2011.70; Santaguida S, 2010, J CELL BIOL, V190, P73, DOI 10.1083/jcb.201001036; Saurin AT, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1319; Scherl A, 2002, MOL BIOL CELL, V13, P4100, DOI 10.1091/mbc.E02-05-0271; Schweizer N, 2013, J CELL BIOL, V203, P883, DOI 10.1083/jcb.201309076; Shah JV, 2004, CURR BIOL, V14, P942, DOI 10.1016/j.cub.2004.05.046; Sironi L, 2002, EMBO J, V21, P2496, DOI 10.1093/emboj/21.10.2496; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Strambio-De-Castillia C, 2010, NAT REV MOL CELL BIO, V11, P490, DOI 10.1038/nrm2928; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Tracy C, 2010, GENETICS, V184, P1067, DOI 10.1534/genetics.109.113522; Vink M, 2006, CURR BIOL, V16, P755, DOI 10.1016/j.cub.2006.03.057; Vleugel M, 2012, DEV CELL, V23, P239, DOI 10.1016/j.devcel.2012.06.013; Walther TC, 2001, EMBO J, V20, P5703, DOI 10.1093/emboj/20.20.5703; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Yu HT, 2006, J CELL BIOL, V173, P153, DOI 10.1083/jcb.200601172; Zeng X, 2010, CANCER CELL, V18, P382, DOI 10.1016/j.ccr.2010.08.010; Zuccolo M, 2007, EMBO J, V26, P1853, DOI 10.1038/sj.emboj.7601642	80	103	106	1	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 27	2014	156	5					1017	1031		10.1016/j.cell.2014.01.010	http://dx.doi.org/10.1016/j.cell.2014.01.010			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AB9BK	24581499	Green Accepted, Bronze			2022-12-28	WOS:000332083900018
J	Bunn, HF				Bunn, H. Franklin			BASIC IMPLICATIONS OF CLINICAL OBSERVATIONS Vitamin B-12 and Pernicious Anemia - The Dawn of Molecular Medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Bunn, HF (corresponding author), Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02115 USA.							Addison T., 1855, CONSTITUTIONAL LOCAL, P1; Cabot RC, 1908, MODERN MED, V4, P612; Castle WB, 1929, AM J MED SCI, V178, P748, DOI 10.1097/00000441-192912000-00002; Castle WB, 1980, BLOOD PURE ELOQUENT, P284; Corner G.W., 1963, GH WHIPPLE HIS FRIEN; Kaptan K, 2000, ARCH INTERN MED, V160, P1349, DOI 10.1001/archinte.160.9.1349; Minot GR, 1926, J AMER MED ASSOC, V87, P470, DOI 10.1001/jama.1926.02680070016005; Minot GR, 1928, AM J MED SCI, V175, P581, DOI 10.1097/00000441-192805000-00001; Rackemann F. M., 1956, INQUISITIVE PHYS LIF; Toh BH, 2012, CLIN REV ALLERG IMMU, V42, P269, DOI 10.1007/s12016-010-8218-y	10	20	20	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 20	2014	370	8					773	776		10.1056/NEJMcibr1315544	http://dx.doi.org/10.1056/NEJMcibr1315544			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB1DO	24552327				2022-12-28	WOS:000331531900015
J	Wells, PS; Forgie, MA; Rodger, MA				Wells, Philip S.; Forgie, Melissa A.; Rodger, Marc A.			Treatment of Venous Thromboembolism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							DEEP-VEIN THROMBOSIS; MOLECULAR-WEIGHT HEPARIN; ACUTE PULMONARY-EMBOLISM; INTENSITY WARFARIN THERAPY; VENA-CAVA FILTERS; OUTPATIENT TREATMENT; 1ST EPISODE; LONG-TERM; ANTICOAGULANT TREATMENT; COST-EFFECTIVENESS	IMPORTANCE Venous thromboembolism (VTE), comprising deep vein thrombosis (DVT) and pulmonary embolism (PE), is a common, potentially lethal condition with acute morbidity. OBJECTIVE To review the etiology of VTE and the 3 phases of VTE treatment: acute (first 5-10 days), long-term (from end of acute treatment to 3-6 months), and extended (beyond 3-6 months). EVIDENCE REVIEW Cochrane reviews, meta-analyses, and randomized controlled trials, as well as other clinical trials for topics not covered by the former, were reviewed. Literature searches using broad terms were used to find meta-analyses published in the last 15 years. The ninth edition of the American College of Chest Physicians Antithrombotic Therapy Guidelines was used to supplement the literature search. Guidelines from specialty organizations were consulted when relevant. The Canadian Agency for Drugs and Technologies in Health was searched for relevant cost-effectiveness studies. We also searched our own literature database of 8386 articles for relevant research. FINDINGS Low-molecular-weight heparin (LMWH) along with with vitamin K antagonists and the benefits and proven safety of ambulation have allowed for outpatient management of most cases of DVT in the acute phase. Development of new oral anticoagulants further simplifies acute-phase treatment and 2 oral agents can be used as monotherapy, avoiding the need for LMWH. Patients with PE can also be treated in the acute phase as outpatients, a decision dependent on prognosis and severity of PE. Thrombolysis is best reserved for severe VTE; inferior vena cava filters, ideally the retrievable variety, should be used when anticoagulation is contraindicated. In general, DVT and PE patients require 3 months of treatment with anticoagulants, with options including LMWH, vitamin K antagonists, or direct factor Xa or direct factor IIa inhibitors. After this time, decisions for further treatment are based on balancing the risk of VTE recurrence, determined by etiology of the VTE (transient risk factors, unprovoked or malignancy associated), against the risk of major hemorrhage from treatment. Better prediction tools for major hemorrhage are needed. Experience with new oral anticoagulants as acute, long-term, and extended therapy options is limited as yet, but as a class they appear to be safe and effective for all phases of treatment. CONCLUSIONS AND RELEVANCE The mainstay of VTE treatment is anticoagulation, while interventions such as thrombolysis and inferior vena cava filters are reserved for limited circumstances. Multiple therapeutic modes and options exist for VTE treatment with small but nonetheless important differential effects to consider. Anticoagulants will probably always increase bleeding risk, necessitating tailored treatment strategies that must incorporate etiology, risk, benefit, cost, and patient preference. Although great progress has been made, further study to understand individual patient risks is needed to make ideal treatment decisions.	[Wells, Philip S.; Forgie, Melissa A.] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Wells, Philip S.; Forgie, Melissa A.; Rodger, Marc A.] Ottawa Hosp, Ottawa Hosp Res Inst, Ottawa, ON, Canada; [Forgie, Melissa A.] Univ Ottawa, Ottawa, ON, Canada; [Rodger, Marc A.] Univ Ottawa, Dept Med, Div Hematol, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa	Wells, PS (corresponding author), 501 Smyth Rd,POB 206, Ottawa, ON K1H 8L6, Canada.	pwells@toh.on.ca		Rodger, Marc/0000-0001-8166-3487				Agnelli G, 2013, NEW ENGL J MED, V369, P799, DOI 10.1056/NEJMoa1302507; Agnelli G, 2013, NEW ENGL J MED, V368, P699, DOI 10.1056/NEJMoa1207541; Agterof MJ, 2010, J THROMB HAEMOST, V8, P1235, DOI 10.1111/j.1538-7836.2010.03831.x; Aujesky D, 2006, EUR HEART J, V27, P476, DOI 10.1093/eurheartj/ehi588; Aujesky D, 2005, AM J RESP CRIT CARE, V172, P1041, DOI 10.1164/rccm.200506-862OC; Aujesky D, 2005, CHEST, V128, P1601, DOI 10.1378/chest.128.3.1601; Aujesky D, 2011, LANCET, V378, P41, DOI 10.1016/S0140-6736(11)60824-6; Baglin T, 2003, LANCET, V362, P523, DOI 10.1016/S0140-6736(03)14111-6; BARRITT DW, 1960, LANCET, V1, P1309; Bates Shannon M, 2012, Chest, V141, pe691S, DOI 10.1378/chest.11-2300; Bauersachs R, 2010, NEW ENGL J MED, V363, P2499, DOI 10.1056/NEJMoa1007903; Beyth RJ, 1998, AM J MED, V105, P91, DOI 10.1016/S0002-9343(98)00198-3; Blondon M, 2012, CHEST, V142, P697, DOI 10.1378/chest.11-2694; Bourjeily G, 2010, LANCET, V375, P500, DOI 10.1016/S0140-6736(09)60996-X; Boutitie F, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3036; BRANDJES DPM, 1992, NEW ENGL J MED, V327, P1485, DOI 10.1056/NEJM199211193272103; Brown A, 2007, CADTH TECHNOLOGY REP, V72, P1; Buller HR, 2013, NEW ENGL J MED, V369, P1406, DOI 10.1056/NEJMoa1306638; Buller HR, 2012, NEW ENGL J MED, V366, P1287, DOI 10.1056/NEJMoa1113572; Carrier M, 2011, J THROMB HAEMOST, V9, P1119, DOI 10.1111/j.1538-7836.2011.04254.x; Carrier M, 2010, ANN INTERN MED, V152, P578, DOI 10.7326/0003-4819-152-9-201005040-00008; Castellucci LA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5133; Cosmi B, 2010, BLOOD, V115, P481, DOI 10.1182/blood-2009-08-237354; Crowther MA, 2003, NEW ENGL J MED, V349, P1133, DOI 10.1056/NEJMoa035241; Decousus H, 2005, CIRCULATION, V112, P416, DOI 10.1161/CIRCULATIONHA.104.512834; Douketis J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d813; Dowlatshahi D, 2012, STROKE, V43, P1812, DOI 10.1161/STROKEAHA.112.652065; Eckman MH, 2009, ANN INTERN MED, V150, P73, DOI 10.7326/0003-4819-150-2-200901200-00005; Eichinger S, 2010, CIRCULATION, V121, P1630, DOI 10.1161/CIRCULATIONAHA.109.925214; Enden T, 2012, LANCET, V379, P31, DOI 10.1016/S0140-6736(11)61753-4; Erkens PMG, 2010, J THROMB HAEMOST, V8, P2412, DOI 10.1111/j.1538-7836.2010.04041.x; Erkens PMG, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001100.pub3; Finazzi G, 2005, J THROMB HAEMOST, V3, P848, DOI 10.1111/j.1538-7836.2005.01340.x; Forgie MA, 2001, THROMB HAEMOST, V86; Furie B, 2013, NEW ENGL J MED, V369, P2345, DOI 10.1056/NEJMe1313682; Garcia D, 2013, BLOOD, V122, P817, DOI 10.1182/blood-2013-04-496257; Gauthier K, 2013, J THROMB HAEMOST, V11, P200, DOI 10.1111/jth.12048; Heit JA, 1999, ARCH INTERN MED, V159, P445, DOI 10.1001/archinte.159.5.445; Heneghan C, 2010, BMC CARDIOVASC DISOR, V10, DOI 10.1186/1471-2261-10-18; Hogg K, 2013, JAMA INTERN MED, V173, P1067, DOI 10.1001/jamainternmed.2013.563; Holbrook A, 2012, CHEST, V141, pE152S, DOI 10.1378/chest.11-2295; Holley AB, 2010, THROMBOSIS, V2010; Hull RD, 2011, AM J MED, V124, P756, DOI 10.1016/j.amjmed.2011.02.033; Iorio A, 2010, ARCH INTERN MED, V170, P1710, DOI 10.1001/archinternmed.2010.367; Kahn SR, 2004, ARCH INTERN MED, V164, P17, DOI 10.1001/archinte.164.1.17; Kahn SR, 2008, THROMB RES, V122, P763, DOI 10.1016/j.thromres.2007.10.011; Kahn SR, 2014, LANCET, V383, P880, DOI 10.1016/S0140-6736(13)61902-9; Kearon C, 2003, NEW ENGL J MED, V349, P631, DOI 10.1056/NEJMoa035422; Kearon C, 1999, NEW ENGL J MED, V340, P901, DOI 10.1056/NEJM199903253401201; Kearon Clive, 2012, Chest, V141, pe419S, DOI 10.1378/chest.11-2301; Kimmel SE, 2013, NEW ENGL J MED, V369, P2283, DOI 10.1056/NEJMoa1310669; Konstantinides S, 2002, NEW ENGL J MED, V347, P1143, DOI 10.1056/NEJMoa021274; Konstantinides S, 2013, AM COLL CARD ANN SCI; Kovacs MJ, 2010, J THROMB HAEMOST, V8, P2406, DOI 10.1111/j.1538-7836.2010.03981.x; Kovacs MJ, 2003, ANN INTERN MED, V138, P714, DOI 10.7326/0003-4819-138-9-200305060-00007; Krahn M, 2008, JAMA-J AM MED ASSOC, V300, P436, DOI 10.1001/jama.300.4.436; Locadia M, 2004, THROMB HAEMOSTASIS, V92, P1336, DOI 10.1160/TH04-02-0075; Louzada ML, 2012, CIRCULATION, V126, P448, DOI 10.1161/CIRCULATIONAHA.111.051920; Louzada ML, 2009, THROMB RES, V123, P837, DOI 10.1016/j.thromres.2008.09.002; Masuda EM, 2010, DM-DIS MON, V56, P601, DOI 10.1016/j.disamonth.2010.06.011; Monkman K, 2009, THROMB RES, V124, P275, DOI 10.1016/j.thromres.2008.12.001; Murugappan M, 2008, AM J RESP CRIT CARE, V177, pA182; Nieto JA, 2010, J THROMB HAEMOST, V8, P1216, DOI 10.1111/j.1538-7836.2010.03852.x; Otero R, 2010, THROMB RES, V126, pE1, DOI 10.1016/j.thromres.2009.09.026; OTHIENO R, 2007, COCHRANE DB SYST REV, V3; Pengo V, 2004, NEW ENGL J MED, V350, P2257, DOI 10.1056/NEJMoa032274; Pirmohamed M, 2013, NEW ENGL J MED, V369, P2294, DOI 10.1056/NEJMoa1311386; Prandoni P, 2002, BLOOD, V100, P3484, DOI 10.1182/blood-2002-01-0108; Prins MH, 2013, THROMB J, V11, DOI 10.1186/1477-9560-11-21; Ray CE, 2008, CARDIOVASC INTER RAD, V31, P316, DOI 10.1007/s00270-007-9244-x; Ray J G, 1999, Obstet Gynecol Surv, V54, P265, DOI 10.1097/00006254-199904000-00023; Ridker PM, 2003, NEW ENGL J MED, V348, P1425, DOI 10.1056/NEJMoa035029; Rodger M, 1998, CAN MED ASSOC J, V159, P931; Rodger MA, 2003, THROMB RES, V112, P13, DOI 10.1016/j.thromres.2003.09.027; Rodger MA, 2008, CAN MED ASSOC J, V179, P417, DOI 10.1503/cmaj.080493; Romualdi E, 2013, J THROMB HAEMOST, V11, P270, DOI 10.1111/jth.12085; Schulman S, 1998, AM J MED, V104, P332, DOI 10.1016/S0002-9343(98)00060-6; Schulman S, 1997, NEW ENGL J MED, V336, P393, DOI 10.1056/NEJM199702063360601; Schulman S, 2013, NEW ENGL J MED, V368, P709, DOI 10.1056/NEJMoa1113697; Schulman S, 2009, NEW ENGL J MED, V361, P2342, DOI 10.1056/NEJMoa0906598; Southworth MR, 2013, NEW ENGL J MED, V368, P1272, DOI 10.1056/NEJMp1302834; Squizzato A, 2012, J THROMB HAEMOST, V10, P1276, DOI 10.1111/j.1538-7836.2012.04739.x; Squizzato A, 2009, EUR RESPIR J, V33, P1148, DOI 10.1183/09031936.00133608; Stein PD, 2012, AM J MED, V125, P478, DOI 10.1016/j.amjmed.2011.05.025; Streiff MB, 2000, BLOOD, V95, P3669; Tagalakis V, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2013.02.024; Tosetto A, 2012, J THROMB HAEMOST, V10, P1019, DOI 10.1111/j.1538-7836.2012.04735.x; van Dongen CJ, 2005, COCHRANE DB SYST REV, V3; Van Dongen CJJ, 2005, J THROMB HAEMOST, V3, P939; van Walraven C, 2006, CHEST, V129, P1155, DOI 10.1378/chest.129.5.1155; Watson LI, 2004, COCHRANE DB SYST REV, V4; Wells Philip S, 2007, Open Med, V1, pe131; Wicki J, 2000, THROMB HAEMOSTASIS, V84, P548, DOI 10.1055/s-0037-1614065; Zondag W, 2011, J THROMB HAEMOST, V9, P1500, DOI 10.1111/j.1538-7836.2011.04388.x	94	137	149	0	40	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 19	2014	311	7					717	728		10.1001/jama.2014.65	http://dx.doi.org/10.1001/jama.2014.65			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA8ZO	24549552				2022-12-28	WOS:000331383700024
J	Sumego, M; Bronson, DL				Sumego, Marianne; Bronson, David L.			Review: In type 1 or type 2 diabetes, group medical visits improve HbA(1c) levels compared with usual care	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Sumego, Marianne; Bronson, David L.] Cleveland Clin, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Sumego, M (corresponding author), Cleveland Clin, Cleveland, OH 44106 USA.							Noffsinger EB, 2008, GROUP PRACTICE J FEB, P23	1	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 18	2014	160	4							JC6	10.7326/0003-4819-160-4-201402180-02006	http://dx.doi.org/10.7326/0003-4819-160-4-201402180-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC8RF	24534940				2022-12-28	WOS:000350635100005
J	Brette, F; Machado, B; Cros, C; Incardona, JP; Scholz, NL; Block, BA				Brette, Fabien; Machado, Ben; Cros, Caroline; Incardona, John P.; Scholz, Nathaniel L.; Block, Barbara A.			Crude Oil Impairs Cardiac Excitation-Contraction Coupling in Fish	SCIENCE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; HERRING CLUPEA-PALLASI; ATLANTIC BLUEFIN TUNA; VENTRICULAR MYOCYTES; EMBRYOS; MORTALITY; EXPOSURE; SENSITIVITY; PLASTICITY; ZEBRAFISH	Crude oil is known to disrupt cardiac function in fish embryos. Large oil spills, such as the Deepwater Horizon (DWH) disaster that occurred in 2010 in the Gulf of Mexico, could severely affect fish at impacted spawning sites. The physiological mechanisms underlying such potential cardiotoxic effects remain unclear. Here, we show that crude oil samples collected from the DWH spill prolonged the action potential of isolated cardiomyocytes from juvenile bluefin and yellowfin tunas, through the blocking of the delayed rectifier potassium current (I-Kr). Crude oil exposure also decreased calcium current (I-Ca) and calcium cycling, which disrupted excitation-contraction coupling in cardiomyocytes. Our findings demonstrate a cardiotoxic mechanism by which crude oil affects the regulation of cellular excitability, with implications for life-threatening arrhythmias in vertebrates.	[Brette, Fabien; Machado, Ben; Cros, Caroline; Block, Barbara A.] Stanford Univ, Hopkins Marine Stn, Dept Biol, Pacific Grove, CA 93950 USA; [Incardona, John P.; Scholz, Nathaniel L.] NOAA, NW Fisheries Sci Ctr, Seattle, WA 98112 USA	Stanford University; National Oceanic Atmospheric Admin (NOAA) - USA	Block, BA (corresponding author), Stanford Univ, Hopkins Marine Stn, Dept Biol, Pacific Grove, CA 93950 USA.	bblock@stanford.edu	Scholz, Nathaniel L/L-1642-2013; Brette, Fabien/A-2603-2009	Scholz, Nathaniel L/0000-0001-6207-0272; Brette, Fabien/0000-0002-5406-4531	Monterey Bay Aquarium Foundation; Stanford University	Monterey Bay Aquarium Foundation; Stanford University(Stanford University)	We thank D. Bers and K. Ginsburg of University of California, Davis; R. Kochevar of Stanford University; and R. Ricker of NOAA for constructive advice on an earlier draft of the manuscript. We are also grateful to C. Farwell, A. Norton, and E. Estess of the Monterey Bay Aquarium, along with husbandry teams for maintenance of bluefin and yellowfin tunas and handling of oil experiments within Tuna Research and Conservation Center; the Government of Mexico for permitting the collection of tunas in their waters; T. Dunn and the crew of the F/V Shogun; and H. Shiels, G. Galli, and S. Thompson for experimental help during preliminary studies of PAH compounds. This work was funded as a contributing study to the DWH-MC252 incident Natural Resource Damage Assessment. Additional funds were provided by the Monterey Bay Aquarium Foundation and Stanford University. All experiments with crude oil were approved by Stanford University Institutional Animal Care and Use Committee procedures. All data necessary to understand this manuscript are presented in the main text or supplementary materials.	Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Blank JM, 2004, J EXP BIOL, V207, P881, DOI 10.1242/jeb.00820; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Bostrom CE, 2002, ENVIRON HEALTH PERSP, V110, P451, DOI 10.1289/ehp.02110s3451; Brette F, 2006, PROG BIOPHYS MOL BIO, V91, P1, DOI 10.1016/j.pbiomolbio.2005.01.001; Brette F, 2006, BIOPHYS J, V90, P381, DOI 10.1529/biophysj.105.069013; Brette F, 2008, BIOCHEM BIOPH RES CO, V374, P143, DOI 10.1016/j.bbrc.2008.06.109; CANNELL MB, 1995, SCIENCE, V268, P1045, DOI 10.1126/science.7754384; Carls MG, 2009, HUM ECOL RISK ASSESS, V15, P1084, DOI 10.1080/10807030903304708; Carls MG, 1999, ENVIRON TOXICOL CHEM, V18, P481, DOI 10.1002/etc.5620180317; Diercks AR, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045046; Galli GLJ, 2009, AM J PHYSIOL-REG I, V297, pR502, DOI 10.1152/ajpregu.90810.2008; Heintz RA, 1999, ENVIRON TOXICOL CHEM, V18, P494, DOI 10.1002/etc.5620180318; Hicken CE, 2011, P NATL ACAD SCI USA, V108, P7086, DOI 10.1073/pnas.1019031108; Hondeghem LM, 2001, CIRCULATION, V103, P2004; Incardona JP, 2012, P NATL ACAD SCI USA, V109, pE51, DOI 10.1073/pnas.1108884109; Incardona JP, 2011, J EXPO SCI ENV EPID, V21, P3, DOI 10.1038/jes.2010.51; Incardona JP, 2009, ENVIRON SCI TECHNOL, V43, P201, DOI 10.1021/es802270t; Incardona JP, 2005, ENVIRON HEALTH PERSP, V113, P1755, DOI 10.1289/ehp.8230; Incardona JP, 2004, TOXICOL APPL PHARM, V196, P191, DOI 10.1016/j.taap.2003.11.026; Jung JH, 2013, CHEMOSPHERE, V91, P1146, DOI 10.1016/j.chemosphere.2013.01.019; Kannankeril P, 2010, PHARMACOL REV, V62, P760, DOI 10.1124/pr.110.003723; Neilson JD, 2008, CAN J FISH AQUAT SCI, V65, P1523, DOI 10.1139/F08-127; Nerbonne JM, 2005, PHYSIOL REV, V85, P1205, DOI 10.1152/physrev.00002.2005; Peterson CH, 2003, SCIENCE, V302, P2082, DOI 10.1126/science.1084282; Rooker JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034180; Shiels HA, 2011, P ROY SOC B-BIOL SCI, V278, P18, DOI 10.1098/rspb.2010.1274; Shiels HA, 1999, J EXP BIOL, V202, P881; Shiels HA, 2005, AM J PHYSIOL-REG I, V288, pR1756, DOI 10.1152/ajpregu.00510.2004; STEGEMAN JJ, 1991, ENVIRON HEALTH PERSP, V90, P101, DOI 10.2307/3430851; Tie H, 2000, BRIT J PHARMACOL, V130, P1967, DOI 10.1038/sj.bjp.0703470; Vornanen M, 2002, COMP BIOCHEM PHYS A, V132, P827, DOI 10.1016/S1095-6433(02)00051-X	32	204	205	4	206	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 14	2014	343	6172					772	776		10.1126/science.1242747	http://dx.doi.org/10.1126/science.1242747			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB1NB	24531969				2022-12-28	WOS:000331557800040
J	Leening, MJG; Vedder, MM; Witteman, JCM; Pencina, MJ; Steyerberg, EW				Leening, Maarten J. G.; Vedder, Moniek M.; Witteman, Jacqueline C. M.; Pencina, Michael J.; Steyerberg, Ewout W.			Net Reclassification Improvement: Computation, Interpretation, and Controversies	ANNALS OF INTERNAL MEDICINE			English	Article							CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; CARDIOVASCULAR RISK PREDICTION; PENCINA,M.J. ET-AL.; COMMON GENETIC-VARIANTS; INTIMA-MEDIA THICKNESS; CHRONIC KIDNEY-DISEASE; BODY-MASS INDEX; ROC CURVE; ABDOMINAL ADIPOSITY	The net reclassification improvement (NRI) is an increasingly popular measure for evaluating improvements in risk predictions. This article details a review of 67 publications in high-impact general clinical journals that considered the NRI. Incomplete reporting of NRI methods, incorrect calculation, and common misinterpretations were found. To aid improved applications of the NRI, the article elaborates on several aspects of the computation and interpretation in various settings. Limitations and controversies are discussed, including the effect of miscalibration of prediction models, the use of the continuous NRI and "clinical NRI," and the relation with decision analytic measures. A systematic approach toward presenting NRI analysis is proposed: Detail and motivate the methods used for computation of the NRI, use clinically meaningful risk cutoffs for the category-based NRI, report both NRI components, address issues of calibration, and do not interpret the overall NRI as a percentage of the study population reclassified. Promising NRI findings need to be followed with decision analytic or formal cost-effectiveness evaluations.	Erasmus MC Univ Med Ctr Rotterdam, NL-3000 CA Rotterdam, Netherlands; Duke Univ, Durham, NC USA	Erasmus University Rotterdam; Erasmus MC; Duke University	Leening, MJG (corresponding author), Erasmus MC Univ Med Ctr Rotterdam, Dept Epidemiol, POB 2040, NL-3000 CA Rotterdam, Netherlands.	m.leening@erasmusmc.nl			Netherlands Organisation for Health Research and Development (ZonMw); Netherlands Organisation for Scientific Research (NWO) [80-82500-98-10208, 918-76-619]; Center for Translational Molecular Medicine (PCMM project grant)	Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Center for Translational Molecular Medicine (PCMM project grant)	By the Netherlands Organisation for Health Research and Development (ZonMw) and the Netherlands Organisation for Scientific Research (NWO) (ZonMw HTA grant 80-82500-98-10208; Vici grant 918-76-619) and the Center for Translational Molecular Medicine (PCMM project grant). The funding sources had no role in the design or conduct of the study; the collection, management, analysis, or interpretation of the data; or the preparation, review, or approval of the manuscript.	Adabag AS, 2008, JAMA-J AM MED ASSOC, V300, P2022, DOI 10.1001/jama.2008.553; Auer R, 2012, JAMA-J AM MED ASSOC, V307, P1497, DOI 10.1001/jama.2012.434; Austin PC, 2013, STAT MED, V32, P661, DOI 10.1002/sim.5598; Bates SM, 2012, CHEST, V141, pE351S, DOI 10.1378/chest.11-2299; Breteler MMB, 2011, JAMA-J AM MED ASSOC, V305, P304, DOI 10.1001/jama.2010.2017; Brindle P, 2003, BMJ-BRIT MED J, V327, P1267, DOI 10.1136/bmj.327.7426.1267; Buckley DI, 2009, ANN INTERN MED, V151, P483, DOI 10.7326/0003-4819-151-7-200910060-00009; Cai TX, 2011, BIOSTATISTICS, V12, P597, DOI 10.1093/biostatistics/kxr001; Chou R, 2011, ANN INTERN MED, V155, P375, DOI 10.7326/0003-4819-155-6-201109200-00006; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cook NR, 2008, STAT MED, V27, P191, DOI 10.1002/sim.2987; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Cook NR, 2006, ANN INTERN MED, V145, P21, DOI 10.7326/0003-4819-145-1-200607040-00128; Cook NR, 2012, CIRCULATION, V125, P1748, DOI 10.1161/CIRCULATIONAHA.111.075929; Cook NR, 2012, STAT MED, V31, P93, DOI 10.1002/sim.4209; Cook NR, 2011, BIOMETRICAL J, V53, P237, DOI 10.1002/bimj.201000078; Cook NR, 2009, JAMA-J AM MED ASSOC, V302, P2089, DOI 10.1001/jama.2009.1636; Cook NR, 2009, ANN INTERN MED, V150, P795, DOI 10.7326/0003-4819-150-11-200906020-00007; Cornelis MC, 2009, ANN INTERN MED, V150, P541, DOI 10.7326/0003-4819-150-8-200904210-00008; COX DR, 1958, BIOMETRIKA, V45, P562, DOI 10.1093/biomet/45.3-4.562; de Boer IH, 2012, ANN INTERN MED, V156, P627, DOI 10.7326/0003-4819-156-9-201205010-00004; de Lemos JA, 2010, JAMA-J AM MED ASSOC, V304, P2503, DOI 10.1001/jama.2010.1768; deFilippi CR, 2010, JAMA-J AM MED ASSOC, V304, P2494, DOI 10.1001/jama.2010.1708; Den Ruijter HM, 2012, JAMA-J AM MED ASSOC, V308, P796, DOI 10.1001/jama.2012.9630; Devereaux PJ, 2012, JAMA-J AM MED ASSOC, V307, P2295, DOI 10.1001/jama.2012.5502; Di Angelantonio E, 2012, JAMA-J AM MED ASSOC, V307, P2499, DOI 10.1001/jama.2012.6571; Eddy DM, 2011, ANN INTERN MED, V154, P627, DOI 10.7326/0003-4819-154-9-201105030-00008; Farooq V, 2013, LANCET, V381, P639, DOI 10.1016/S0140-6736(13)60108-7; Fonarow GC, 2012, JAMA-J AM MED ASSOC, V308, P257, DOI 10.1001/jama.2012.7870; Ganna A, 2012, AM J EPIDEMIOL, V175, P715, DOI 10.1093/aje/kwr374; Greenland P, 2010, J AM COLL CARDIOL, V56, pE50, DOI 10.1016/j.jacc.2010.09.001; Greenland S, 2008, STAT MED, V27, P199, DOI 10.1002/sim.2995; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Gulati A, 2013, JAMA-J AM MED ASSOC, V309, P896, DOI 10.1001/jama.2013.1363; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Helfand M, 2009, ANN INTERN MED, V151, P496, DOI 10.7326/0003-4819-151-7-200910060-00010; Hense HW, 2003, EUR HEART J, V24, P937, DOI 10.1016/S0195-668X(03)00081-2; Hilden J, 2013, STAT MED; Hingorani AD, 2009, JAMA-J AM MED ASSOC, V302, P2144, DOI 10.1001/jama.2009.1698; Hlatky MA, 2012, ANN INTERN MED, V156, P468, DOI 10.7326/0003-4819-156-6-201203200-00013; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Janes H, 2008, ANN INTERN MED, V149, P751, DOI 10.7326/0003-4819-149-10-200811180-00009; Janssens ACJW, 2011, ANN INTERN MED, V154, P421, DOI 10.7326/0003-4819-154-6-201103150-00008; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; Kaptoge S, 2012, NEW ENGL J MED, V367, P1310, DOI 10.1056/NEJMoa1107477; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Kavousi M, 2012, JAMA-J AM MED ASSOC, V308, P2561, DOI 10.1001/jama.2012.25786; Kavousi M, 2012, ANN INTERN MED, V156, P438, DOI 10.7326/0003-4819-156-6-201203200-00006; Keller T, 2011, JAMA-J AM MED ASSOC, V306, P2684, DOI 10.1001/jama.2011.1896; Kengne AP, 2012, NEW ENGL J MED, V379, P312; Kim WR, 2008, NEW ENGL J MED, V359, P1018, DOI 10.1056/NEJMoa0801209; Kivimaki M, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-7-201104050-00003; Koller MT, 2007, AM HEART J, V154, P87, DOI 10.1016/j.ahj.2007.03.022; Koller MT, 2012, ANN INTERN MED, V157, P389, DOI 10.7326/0003-4819-157-6-201209180-00002; Kramer AA, 2007, CRIT CARE MED, V35, P2052, DOI 10.1097/01.CCM.0000275267.64078.B0; Leening MJG, 2013, JAMA-J AM MED ASSOC, V309, P2547, DOI 10.1001/jama.2013.6470; Leening MJG, 2013, EUR J EPIDEMIOL, V28, P21, DOI 10.1007/s10654-012-9759-6; Lilford R J, 2001, Health Technol Assess, V5, P1; Localio AR, 2012, ANN INTERN MED, V157, P294, DOI 10.7326/0003-4819-157-4-201208210-00014; Lubitz SA, 2010, JAMA-J AM MED ASSOC, V304, P2263, DOI 10.1001/jama.2010.1690; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Martinez ME, 2012, ANN INTERN MED, V157, P856, DOI 10.7326/0003-4819-157-12-201212180-00005; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; McEvoy JW, 2010, JAMA-J AM MED ASSOC, V304, P741, DOI 10.1001/jama.2010.1143; McGeechan K, 2008, ARCH INTERN MED, V168, P2304, DOI 10.1001/archinte.168.21.2304; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Melander O, 2009, JAMA-J AM MED ASSOC, V302, P2090; Melander O, 2009, JAMA-J AM MED ASSOC, V302, P49, DOI 10.1001/jama.2009.943; Merry AHH, 2012, EUR J PREV CARDIOL, V19, P840, DOI 10.1177/1741826711410256; Mihaescu R, 2010, AM J EPIDEMIOL, V172, P353, DOI 10.1093/aje/kwq122; Mosca L, 2011, J AM COLL CARDIOL, V57, P1404, DOI [10.1016/j.jacc.2011.02.005, 10.1161/CIR.0b013e31820faaf8]; Muhlenbruch K, 2013, EUR J EPIDEMIOL, V28, P25, DOI 10.1007/s10654-012-9744-0; Munshi NC, 2011, BLOOD, V117, P4696, DOI 10.1182/blood-2010-10-300970; Omland T, 2009, NEW ENGL J MED, V361, P2538, DOI 10.1056/NEJMoa0805299; Palomaki GE, 2010, JAMA-J AM MED ASSOC, V303, P648, DOI 10.1001/jama.2010.118; Paynter NP, 2013, MED DECIS MAKING, V33, P154, DOI 10.1177/0272989X12461856; Paynter NP, 2010, JAMA-J AM MED ASSOC, V303, P631, DOI 10.1001/jama.2010.119; Paynter NP, 2009, ANN INTERN MED, V150, P65, DOI 10.7326/0003-4819-150-2-200901200-00003; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pencina MJ, 2012, AM J EPIDEMIOL, V176, P473, DOI 10.1093/aje/kws207; Pencina MJ, 2012, STAT MED, V31, P101, DOI 10.1002/sim.4348; Pencina MJ, 2010, CLIN CHEM LAB MED, V48, P1703, DOI 10.1515/CCLM.2010.340; Pencina MJ, 2011, STAT MED, V30, P11, DOI 10.1002/sim.4085; Pencina MJ, 2009, CIRCULATION, V119, P3078, DOI 10.1161/CIRCULATIONAHA.108.816694; Pepe MS, 2008, STAT MED, V27, P173, DOI 10.1002/sim.2991; Pepe MS, 2011, INT J EPIDEMIOL, V40, P1106, DOI 10.1093/ije/dyr083; Pepe MS, 2011, AM J EPIDEMIOL, V173, P1327, DOI 10.1093/aje/kwr013; Pepe MS, 2013, STAT MED, V32, P1467, DOI 10.1002/sim.5727; Pepe MS, 2012, CLIN CHEM, V58, P1242, DOI 10.1373/clinchem.2012.186007; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Peralta CA, 2011, JAMA-J AM MED ASSOC, V305, P1545, DOI 10.1001/jama.2011.468; Perk Joep, 2012, Atherosclerosis, V223, P1, DOI [10.1016/j.atherosclerosis.2012.05.007, 10.1007/s12529-012-9242-5, 10.1093/eurheartj/ehs092]; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Pletcher MJ, 2010, JAMA-J AM MED ASSOC, V303, P835, DOI 10.1001/jama.2010.188; Polak JF, 2011, NEW ENGL J MED, V365, P213, DOI 10.1056/NEJMoa1012592; Polonsky TS, 2010, JAMA-J AM MED ASSOC, V303, P1610, DOI 10.1001/jama.2010.461; Ripatti S, 2010, LANCET, V376, P1393, DOI 10.1016/S0140-6736(10)61267-6; Rosenberg S, 2010, ANN INTERN MED, V153, P425, DOI 10.7326/0003-4819-153-7-201010050-00005; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Schelbert EB, 2012, JAMA-J AM MED ASSOC, V308, P890, DOI 10.1001/2012.jama.11089; Schnabel RB, 2009, LANCET, V373, P739, DOI 10.1016/S0140-6736(09)60443-8; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Siontis GCM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3318; Steyerberg EW, 2009, CLIN PREDICTION MODE, DOI 10.1007/978-0-387-77244-8; Steyerberg EW, 2010, ANN INTERN MED, V152, P195, DOI 10.7326/0003-4819-152-3-201002020-00019; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Takahara M, 2013, EUR J EPIDEMIOL, V28, P607, DOI 10.1007/s10654-013-9824-9; Tammemagi MC, 2013, NEW ENGL J MED, V368, P728, DOI 10.1056/NEJMoa1211776; Tangri N, 2011, JAMA-J AM MED ASSOC, V305, P1553, DOI 10.1001/jama.2011.451; Tzoulaki I, 2011, INT J EPIDEMIOL, V40, P1094, DOI 10.1093/ije/dyr013; Tzoulaki I, 2009, JAMA-J AM MED ASSOC, V302, P2345, DOI 10.1001/jama.2009.1757; Van Calster B, 2013, MED DECIS MAKING, V33, P490, DOI 10.1177/0272989X12470757; Vergouwe Y, 2010, AM J EPIDEMIOL, V172, P971, DOI 10.1093/aje/kwq223; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Vickers AJ, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-13; Vickers AJ, 2009, STAT MED, V28, P525, DOI 10.1002/sim.3087; Visvanathan K, 2009, J CLIN ONCOL, V27, P3235, DOI 10.1200/JCO.2008.20.5179; Wacholder S, 2010, NEW ENGL J MED, V362, P986, DOI 10.1056/NEJMoa0907727; Wilson PWF, 2009, JAMA-J AM MED ASSOC, V302, P2369, DOI 10.1001/jama.2009.1765; Wormser D, 2011, LANCET, V378, P228, DOI 10.1016/S0140-6736(11)61122-7; Wormser D, 2011, LANCET, V377, P1085, DOI 10.1016/S0140-6736(11)60105-0; Worth LJ, 2011, INTERN MED J, V41, P82, DOI 10.1111/j.1445-5994.2010.02339.x; Yeboah J, 2012, JAMA-J AM MED ASSOC, V308, P788, DOI 10.1001/jama.2012.9624; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064; Zoungas S, 2010, NEW ENGL J MED, V363, P1410, DOI 10.1056/NEJMoa1003795	127	358	362	1	52	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 21	2014	160	2					122	+		10.7326/M13-1522	http://dx.doi.org/10.7326/M13-1522			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	297SQ	24592497				2022-12-28	WOS:000330275600018
J	Wilson, JF; Cotton, D; Taichman, D; Williams, S				Wilson, Jennifer Fisher; Cotton, Deborah; Taichman, Darren; Williams, Sankey			Stable Ischemic Heart Disease	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ASSOCIATION TASK-FORCE; CARDIOVASCULAR NURSES ASSOCIATION/SOCIETY; CLINICAL-PRACTICE GUIDELINE; AMERICAN-COLLEGE; MYOCARDIAL-INFARCTION; PHYSICIANS/AMERICAN COLLEGE; HYPERCHOLESTEROLEMIC MEN; PRIMARY PREVENTION; MEDICAL THERAPY; INDIVIDUAL DATA						Wilson, Jennifer/Q-3623-2019					Agodoa L, 2007, J HYPERTENS, V25, P951; ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; Anderson JL, 2013, CIRCULATION, V127, pE663, DOI 10.1161/CIR.0b013e31828478ac; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Braunwald E, 1994, UNSTABLE ANGINA DIAG; Brown BG, 2001, NEW ENGL J MED, V345, P1583, DOI 10.1056/NEJMoa011090; Brunner EJ, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002128.pub2; Chaitman BR, 2004, JAMA-J AM MED ASSOC, V291, P309, DOI 10.1001/jama.291.3.309; Chen JT, 2005, PHARMACOTHERAPY, V25, P171, DOI 10.1592/phco.25.2.171.56942; Collins R, 1994, TXB HYPERTENSION; De Bruyne B, 2012, NEW ENGL J MED, V367, P991, DOI 10.1056/NEJMoa1205361; de Diego C, 2009, EUR HEART J, V30, P209, DOI 10.1093/eurheartj/ehn498; DIAMOND GA, 1979, NEW ENGL J MED, V300, P1350, DOI 10.1056/NEJM197906143002402; Farkouh ME, 2012, NEW ENGL J MED, V367, P2375, DOI 10.1056/NEJMoa1211585; Fihn SD, 2012, CIRCULATION, V126, pE354, DOI 10.1161/CIR.0b013e318277d6a0; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Fortmann SP, 2013, ANN INTERN MED, V159, P824, DOI 10.7326/0003-4819-159-12-201312170-00729; Goldberg AC, 2006, AM J CARDIOL, V97, P376, DOI 10.1016/j.amjcard.2005.08.056; Hachamovitch R, 1997, AM J CARDIOL, V80, P426, DOI 10.1016/S0002-9149(97)00390-1; Hallikainen MA, 2000, J NUTR, V130, P767, DOI 10.1093/jn/130.4.767; Heidenreich PA, 1999, JAMA-J AM MED ASSOC, V281, P1927, DOI 10.1001/jama.281.20.1927; KOTTKE TE, 1988, JAMA-J AM MED ASSOC, V259, P2882, DOI 10.1001/jama.1988.03720190050031; Kumar A, 2009, MAYO CLIN PROC, V84, P917, DOI 10.1016/S0025-6196(11)60509-0; Leizorovicz A, 2002, AM HEART J, V143, P301, DOI 10.1067/mhj.2002.120768; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; MARK DB, 1987, ANN INTERN MED, V106, P793, DOI 10.7326/0003-4819-106-6-793; Nguyen TT, 1999, MAYO CLIN PROC, V74, P1198, DOI 10.4065/74.12.1198; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; PRYOR DB, 1991, AM J MED, V90, P553; Qaseem A, 2012, ANN INTERN MED, V157, P729, DOI 10.7326/0003-4819-157-10-201211200-00010; Qaseem A, 2012, ANN INTERN MED, V157, P735, DOI 10.7326/0003-4819-157-10-201211200-00011; Rousseau MF, 2005, AM J CARDIOL, V95, P311, DOI 10.1016/j.amjcard.2004.09.025; Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; Tanguay JF, 2003, J AM COLL CARDIOL, V41, p404A; TAYLOR CB, 1990, ANN INTERN MED, V113, P118, DOI 10.7326/0003-4819-113-2-118; Tepper David, 1999, Congest Heart Fail, V5, P184; *US DEP HHS, 1989, DHHS PUBLICATION; Wilkins J, 2013, CIRCULATION, V127; Wolff T, 2009, ANN INTERN MED, V150, P405, DOI 10.7326/0003-4819-150-6-200903170-00009; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; YUSUF S, 1992, LANCET, V340, P1173, DOI 10.1016/0140-6736(92)92889-N; Yusuf S, 2000, NEW ENGL J MED, V342, P145	43	4	4	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 7	2014	160	1							ITC1	10.7326/0003-4819-160-1-201401070-01001	http://dx.doi.org/10.7326/0003-4819-160-1-201401070-01001			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW3QL	24573669				2022-12-28	WOS:000364906700001
J	Khan, AG; Whidby, J; Miller, MT; Scarborough, H; Zatorski, AV; Cygan, A; Price, AA; Yost, SA; Bohannon, CD; Jacob, J; Grakoui, A; Marcotrigiano, J				Khan, Abdul Ghafoor; Whidby, Jillian; Miller, Matthew T.; Scarborough, Hannah; Zatorski, Alexandra V.; Cygan, Alicja; Price, Aryn A.; Yost, Samantha A.; Bohannon, Caitlin D.; Jacob, Joshy; Grakoui, Arash; Marcotrigiano, Joseph			Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2	NATURE			English	Article							E2; SCATTERING; SEQUENCE; PROTEIN; FUSION; NEUTRALIZATION; INVOLVEMENT; EXPRESSION; RESOLUTION; REGION-1	Hepatitis C virus (HCV) is a significant public health concern with approximately 160 million people infected worldwide(1). HCV infection often results in chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. No vaccine is available and current therapies are effective against some, but not all, genotypes. HCV is an enveloped virus with two surface glycoproteins (E1 and E2). E2 binds to the host cell through interactions with scavenger receptor class B type I (SR-BI) and CD81, and serves as a target for neutralizing antibodies(2-4). Little is known about the molecular mechanism that mediates cell entry and membrane fusion, although E2 is predicted to be a class II viral fusion protein. Here we describe the structure of the E2 core domain in complex with an antigen-binding fragment (Fab) at 2.4 angstrom resolution. The E2 core has a compact, globular domain structure, consisting mostly of beta-strands and random coil with two small alpha-helices. The strands are arranged in two, perpendicular sheets (A and B), which are held together by an extensive hydrophobic core and disulphide bonds. Sheet A has an IgG-like fold that is commonly found in viral and cellular proteins, whereas sheet B represents a novel fold. Solution-based studies demonstrate that the full-length E2 ectodomain has a similar globular architecture and does not undergo significant conformational or oligomeric rearrangements on exposure to low pH. Thus, the IgG-like fold is the only feature that E2 shares with class II membrane fusion proteins. These results provide unprecedented insights into HCV entry and will assist in developing an HCV vaccine and new inhibitors.	[Khan, Abdul Ghafoor; Whidby, Jillian; Miller, Matthew T.; Zatorski, Alexandra V.; Cygan, Alicja; Yost, Samantha A.; Marcotrigiano, Joseph] Rutgers State Univ, Dept Chem & Chem Biol, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Scarborough, Hannah; Price, Aryn A.; Bohannon, Caitlin D.; Jacob, Joshy; Grakoui, Arash] Emory Univ, Div Microbiol & Immunol, Emory Vaccine Ctr, Sch Med, Atlanta, GA 30322 USA; [Grakoui, Arash] Emory Univ, Div Infect Dis, Dept Med, Sch Med, Atlanta, GA 30322 USA	Rutgers State University New Brunswick; Emory University; Emory University	Marcotrigiano, J (corresponding author), Rutgers State Univ, Dept Chem & Chem Biol, Ctr Adv Biotechnol & Med, 679 Hoes Lane West, Piscataway, NJ 08854 USA.	arash.grakoui@emory.edu; jmarco@cabm.rutgers.edu	Marcotrigiano, Joseph/K-6697-2016; Cheng, Yushao/E-6256-2011; Khan, Abdul/P-1569-2016	Marcotrigiano, Joseph/0000-0003-0346-3353; Khan, Abdul/0000-0001-8600-8254; Marcotrigiano, Joseph/0000-0001-7670-7836; Yost, Samantha/0000-0002-8286-2530	US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-98CH10886]; Yerkes Research Center Base Grant [RR-00165]; NIH [P50 GM103368, R01 AI080659, AI070101, DK083356]; New Jersey Commission on Cancer Research [DFHS13CRP001]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080659, T32AI007403, R56AI070101, R01AI070101, T32AI007610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083356] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM111244, P50GM103368] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER; Alberta Innovates [201201140] Funding Source: researchfish	US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Yerkes Research Center Base Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New Jersey Commission on Cancer Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alberta Innovates	We acknowledge access to the X25 beamline at NSLS and thank the NSLS staff. NSLS is supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-98CH10886. We thank J. Tainer and J. Perry for their support and access to SIBYLS beamline at the Advanced Light Source, Lawrence Berkeley National Laboratory. We thank E. Arnold, J. Bonanno, S. K. Burley, J. Chiu, D. Comoletti, E. Elrod, F. Jiang, S. Khare, P. Lobel, A. Shatkin, A. Stock, J. Shires and A. Thanou for providing helpful comments and assistance. Special thanks to C. M. Rice for providing J6 HCV clone and support. This work was supported by a Yerkes Research Center Base Grant RR-00165 (A. G.) and NIH grants P50 GM103368 (J. M.), R01 AI080659 (J. M.) AI070101 (A. G.) and DK083356 (A. G.). A. G. K. was supported by a grant from the New Jersey Commission on Cancer Research (DFHS13CRP001).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Deng L, 2013, P NATL ACAD SCI USA, V110, P7418, DOI 10.1073/pnas.1305306110; Drummer HE, 2004, J BIOL CHEM, V279, P30066, DOI 10.1074/jbc.M405098200; El Omari K, 2013, CELL REP, V3, P30, DOI 10.1016/j.celrep.2012.12.001; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Forns X, 2000, P NATL ACAD SCI USA, V97, P13318, DOI 10.1073/pnas.230453597; Helle F, 2010, J VIROL, V84, P11905, DOI 10.1128/JVI.01548-10; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Keck ZY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002653; Keck ZY, 2005, J VIROL, V79, P13199, DOI 10.1128/JVI.79.21.13199-13208.2005; Kong L, 2013, SCIENCE, V342, P1090, DOI 10.1126/science.1243876; Kong L, 2012, J VIROL, V86, P13085, DOI 10.1128/JVI.01939-12; Kong L, 2012, P NATL ACAD SCI USA, V109, P9499, DOI 10.1073/pnas.1202924109; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krey T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000762; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Lavillette D, 2007, J VIROL, V81, P8752, DOI 10.1128/JVI.02642-06; Li HF, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-89; Li Y, 2013, P NATL ACAD SCI USA, V110, P6805, DOI 10.1073/pnas.1300524110; Lindenbach B., 2011, FIELDS VIROLOGY, V5th ed., P1101; Mateu G, 2008, VIROLOGY, V376, P397, DOI 10.1016/j.virol.2008.03.027; Michalak JP, 1997, J GEN VIROL, V78, P2299, DOI 10.1099/0022-1317-78-9-2299; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nielsen SS, 2012, J APPL CRYSTALLOGR, V45, P213, DOI 10.1107/S0021889812000957; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Rothwang KB, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-46; Sautto G, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/450963; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Sharma S, 2009, PROTEINS, V76, P882, DOI 10.1002/prot.22394; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Tiller T, 2009, J IMMUNOL METHODS, V350, P183, DOI 10.1016/j.jim.2009.08.009; Vaney MC, 2011, CELL MICROBIOL, V13, P1451, DOI 10.1111/j.1462-5822.2011.01653.x; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wahid A, 2013, J VIRAL HEPATITIS, V20, P369, DOI 10.1111/jvh.12094; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Whidby J, 2009, J VIROL, V83, P11078, DOI 10.1128/JVI.00800-09; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; Zhang KYJ, 1997, METHOD ENZYMOL, V277, P53, DOI 10.1016/S0076-6879(97)77006-X	43	209	214	1	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 15	2014	509	7500					381	+		10.1038/nature13117	http://dx.doi.org/10.1038/nature13117			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AH4TM	24553139	Green Accepted			2022-12-28	WOS:000336121200043
J	Chopra, V; McMahon, LF				Chopra, Vineet; McMahon, Laurence F., Jr.			Redesigning Hospital Alarms for Patient Safety Alarmed and Potentially Dangerous	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Chopra, Vineet] Ann Arbor VA Med Ctr, Patient Safety Enhancement Program, Ctr Clin Management Res, Ann Arbor, MI USA; [Chopra, Vineet; McMahon, Laurence F., Jr.] Univ Michigan Hlth Syst, Dept Internal Med, Ann Arbor, MI 48109 USA; [McMahon, Laurence F., Jr.] Univ Michigan, Sch Publ Hlth, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Chopra, V (corresponding author), Univ Michigan Hlth Syst, Dept Internal Med, 2800 Plymouth Rd,Bldg 16,Room 430W, Ann Arbor, MI 48109 USA.	vineetc@med.umich.edu		Chopra, Vineet/0000-0001-8670-9376	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS022835] Funding Source: NIH RePORTER; AHRQ HHS [K08 HS022835] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Keller JP, 2012, J ELECTROCARDIOL, V45, P588, DOI 10.1016/j.jelectrocard.2012.08.050; Kowalczyk L., MGH DEATH SPURS REVI; Kowlaczyk L., ALARM FATIGUE A FACT; Siebig S, 2010, CRIT CARE MED, V38, P451, DOI 10.1097/CCM.0b013e3181cb0888; Sun LH, TOO MUCH NOISE FROM; The Joint Commission, THE JOINT COMMISSION	6	30	30	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 26	2014	311	12					1199	1200		10.1001/jama.2014.710	http://dx.doi.org/10.1001/jama.2014.710			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD6CE	24590296				2022-12-28	WOS:000333340500019
J	Adelman, RD; Tmanova, LL; Delgado, D; Dion, S; Lachs, MS				Adelman, Ronald D.; Tmanova, Lyubov L.; Delgado, Diana; Dion, Sarah; Lachs, Mark S.			Caregiver Burden A Clinical Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							FAMILY CAREGIVERS; HEALTH BEHAVIORS; OLDER PATIENT; DEMENTIA; INTERVENTIONS; PEOPLE; DEPRESSION; METAANALYSIS; PREDICTORS; PHYSICIANS	IMPORTANCE Caregiver burden may result from providing care for patients with chronic illness. It can occur in any of the 43.5 million individuals providing support to midlife and older adults. Caregiver burden is frequently overlooked by clinicians. OBJECTIVES To outline the epidemiology of caregiver burden; to provide strategies to diagnose, assess, and intervene for caregiver burden in clinical practice; and to evaluate evidence on interventions intended to avert or mitigate caregiver burden and related caregiver distress. EVIDENCE Cohort studies examining the relation between demographic and social risk factors and adverse outcomes of caregiver burden were reviewed. Review of recent meta-analyses to summarize the effectiveness of caregiver burden interventions were identified by searching Ovid MEDLINE, AgeLine, and the Cochrane Library. RESULTS Risk factors for caregiver burden include female sex, low educational attainment, residence with the care recipient, higher number of hours spent caregiving, depression, social isolation, financial stress, and lack of choice in being a caregiver. Practical assessment strategies for caregiver burden exist to evaluate caregivers, their care recipients, and the care recipient's overall caregiving needs. A variety of psychosocial and pharmacological interventions have shown mild to modest efficacy in mitigating caregiver burden and associated manifestations of caregiver distress in high-quality meta-analyses. Psychosocial interventions include support groups or psychoeducational interventions for caregivers of dementia patients (effect size, 0.09-0.23). Pharmacologic interventions include use of anticholinergics or antipsychotic medications for dementia or dementia-related behaviors in the care recipient (effect size, 0.18-0.27). Many studies showed improvements in caregiver burden-associated symptoms (eg, mood, coping, self-efficacy) even when caregiver burden itself was minimally improved. CONCLUSIONS AND RELEVANCE Physicians have a responsibility to recognize caregiver burden. Caregiver assessment and intervention should be tailored to the individual circumstances and contexts in which caregiver burden occurs.	[Adelman, Ronald D.; Dion, Sarah; Lachs, Mark S.] Cornell Univ, Weill Cornell Med Coll, Div Geriatr & Palliat Med, New York, NY 10065 USA; [Adelman, Ronald D.; Tmanova, Lyubov L.; Delgado, Diana; Dion, Sarah; Lachs, Mark S.] Cornell Univ, Weill Cornell Med Coll, Samuel J Wood Lib, CV Starr Biomed Sci Informat Ctr, New York, NY 10065 USA	Cornell University; Cornell University	Adelman, RD (corresponding author), Cornell Univ, Weill Cornell Med Coll, Div Geriatr & Palliat Med, 1300 York Ave, New York, NY 10065 USA.	rdadelma@med.cornell.edu	Tmanova, L/AGH-4573-2022	Delgado, Diana/0000-0002-6290-3497	SCAN Foundation; National Institute on Aging (NIA) [K24AGO22399]; NIA [ROIAG14299]	SCAN Foundation; National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Care of the Aging Patient series is made possible by funding from The SCAN Foundation. Dr Lachs reports being a recipient of a National Institute on Aging (NIA) mentoring award in patient-oriented research (K24AGO22399) and other NIA support (ROIAG14299).	Adelman RD, 2000, CLIN GERIATR MED, V16, P1, DOI 10.1016/S0749-0690(05)70004-5; Aldrich N., CDC SEEKS PROTECT HL; Arno PS, 1999, HEALTH AFFAIR, V18, P182, DOI 10.1377/hlthaff.18.2.182; Beach SR, 2005, J AM GERIATR SOC, V53, P255, DOI 10.1111/j.1532-5415.2005.53111.x; Bevans M, 2012, JAMA-J AM MED ASSOC, V307, P398, DOI 10.1001/jama.2012.29; Brodaty H, 2003, J AM GERIATR SOC, V51, P657, DOI 10.1034/j.1600-0579.2003.00210.x; Burton LC, 1997, PREV MED, V26, P162, DOI 10.1006/pmed.1996.0129; Cameron JI, 2002, CANCER-AM CANCER SOC, V94, P521, DOI 10.1002/cncr.10212; Capistrant BD, 2012, J EPIDEMIOL COMMUN H, V66, P951, DOI 10.1136/jech-2011-200040; Chien LY, 2011, INT J GERIATR PSYCH, V26, P1089, DOI 10.1002/gps.2660; Cohen CA, 2000, CAN FAM PHYSICIAN, V46, P376; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Collins LG, 2011, AM FAM PHYSICIAN, V83, P1309; Demiris G, 2010, J PALLIAT MED, V13, P1005, DOI 10.1089/jpm.2010.0022; Family Caregiver Alliance, NAT CONS REP CAR ASS; Family Caregiver Alliance, CAR COUNT TOOL TOOLK; Family Caregiver Alliance, CAR ASS PRINC GUID S; FREDMAN L, 1993, JAMA-J AM MED ASSOC, V270, P1426, DOI 10.1001/jama.1993.03510120048027; GALLAGHER D, 1989, GERONTOLOGIST, V29, P449, DOI 10.1093/geront/29.4.449; Gallicchio L, 2002, INT J GERIATR PSYCH, V17, P154, DOI 10.1002/gps.538; Gillick MR, 2013, JAMA-J AM MED ASSOC, V310, P575, DOI 10.1001/jama.2013.7310; Gitlin LN, 2003, PSYCHOL AGING, V18, P361, DOI 10.1037/0882-7974.18.3.361; GREENE MG, 1994, J AM GERIATR SOC, V42, P413, DOI 10.1111/j.1532-5415.1994.tb07490.x; Hauser JM, 2004, CLIN GERIATR MED, V20, P671, DOI 10.1016/j.cger.2004.07.003; Hoffman GJ, 2012, GERONTOLOGIST, V52, P219, DOI 10.1093/geront/gns003; Hurd MD, 2013, NEW ENGL J MED, V368, P1326, DOI 10.1056/NEJMsa1204629; Institute of Medicine, 2008, RET AG AM BUILD HLTH; Kim H, 2012, J ADV NURS, V68, P846, DOI 10.1111/j.1365-2648.2011.05787.x; Levine C, 1999, ANN INTERN MED, V130, P148, DOI 10.7326/0003-4819-130-2-199901190-00010; Levine C, 2010, HEALTH AFFAIR, V29, P116, DOI 10.1377/hlthaff.2009.0520; Lilly MB, 2012, HEALTH SOC CARE COMM, V20, P103, DOI 10.1111/j.1365-2524.2011.01025.x; Lingler JH, 2005, J AM GERIATR SOC, V53, P983, DOI 10.1111/j.1532-5415.2005.53313.x; Monin JK, 2009, PSYCHOL AGING, V24, P681, DOI 10.1037/a0016355; National Alliance for Caregiving and AARP, CAR US 2009; Northouse L, 2012, J CLIN ONCOL, V30, P1227, DOI 10.1200/JCO.2011.39.5798; Northouse LL, 2010, CA-CANCER J CLIN, V60, P317, DOI 10.3322/caac.20081; Ornstein K, 2013, J PALLIAT MED, V16, P1048, DOI 10.1089/jpm.2012.0546; Parks SM, 2000, AM FAM PHYSICIAN, V62, P2613; Pinquart M, 2006, INT PSYCHOGERIATR, V18, P577, DOI 10.1017/S1041610206003462; Rodakowski J, 2012, ARCH PHYS MED REHAB, V93, P2229, DOI 10.1016/j.apmr.2012.07.004; Salmon JR, 2005, J PAIN SYMPTOM MANAG, V29, P121, DOI 10.1016/j.jpainsymman.2004.12.008; Schoenmakers B, 2009, FAM PRACT, V26, P279, DOI 10.1093/fampra/cmp024; Schoenmakers B, 2009, SCAND J PRIM HEALTH, V27, P31, DOI 10.1080/02813430802588907; Schulz R, 1997, ANN BEHAV MED, V19, P110, DOI 10.1007/BF02883327; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; Schulz R, 2007, GERONTOLOGIST, V47, P4, DOI 10.1093/geront/47.1.4; Schulz R, 2012, AGING MENT HEALTH, V16, P712, DOI 10.1080/13607863.2011.651439; SILLIMAN RA, 1989, J GEN INTERN MED, V4, P237, DOI 10.1007/BF02599531; Tarlow BJ, 2004, RES AGING, V26, P429, DOI 10.1177/0164027504264493; Thompson Carl A, 2007, BMC Geriatr, V7, P18, DOI 10.1186/1471-2318-7-18; Van't Leven N, 2013, INT PSYCHOGERIATR, V25, P1581, DOI 10.1017/S1041610213000860; Vernooij-Dassen M, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005318.pub2; Vincent C, 2009, CEREBROVASC DIS, V27, P456, DOI 10.1159/000210092; ZARIT SH, 1986, GERONTOLOGIST, V26, P260, DOI 10.1093/geront/26.3.260; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649	55	955	985	29	401	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2014	311	10					1052	1059		10.1001/jama.2014.304	http://dx.doi.org/10.1001/jama.2014.304			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AC5QO	24618967				2022-12-28	WOS:000332575800023
J	Gunawardane, ND; Laumann, A				Gunawardane, Nilanthi D.; Laumann, Anne			An Immunocompromised Patient With Recent-Onset Skin Lesions Ecthyma and perianal streptococcal disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INFECTIONS; DERMATITIS		[Gunawardane, Nilanthi D.; Laumann, Anne] Northwestern Univ, Feinberg Sch Med, Dept Dermatol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Laumann, A (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Dermatol, 676 N St Clair,Ste 1600, Chicago, IL 60611 USA.	a-laumann@northwestern.edu						Herbst RA, 2000, J AM ACAD DERMATOL, V42, P885, DOI 10.1016/S0190-9622(00)90263-9; Lehman R, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1517; Matz H, 2005, CLIN DERMATOL, V23, P503, DOI 10.1016/j.clindermatol.2005.01.007; Neri I, 1996, BRIT J DERMATOL, V135, P796; PASS BJ, 1954, JAMA-J AM MED ASSOC, V155, P1153, DOI 10.1001/jama.1954.73690310003007b; Tognetti L, 2012, J EUR ACAD DERMATOL, V26, P931, DOI 10.1111/j.1468-3083.2011.04416.x; Tschachler E, 2007, J Dtsch Dermatol Ges, V5, P527, DOI 10.1111/j.1610-0387.2007.06287.x	7	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2014	311	9					957	958		10.1001/jama.2013.284992	http://dx.doi.org/10.1001/jama.2013.284992			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC0FS	24595781				2022-12-28	WOS:000332170800025
J	Mooney, PD; Hadjivassiliou, M; Sanders, DS				Mooney, Peter D.; Hadjivassiliou, Marios; Sanders, David S.			Coeliac disease	BMJ-BRITISH MEDICAL JOURNAL			English	Review							GLUTEN-FREE DIET; T-CELL LYMPHOMA; QUALITY-OF-LIFE; PRIMARY-CARE; SENSITIVE ENTEROPATHY; CLINICAL-FEATURES; CHANGING FACE; BONE MASS; RISK; MALIGNANCY		[Mooney, Peter D.; Sanders, David S.] Royal Hallamshire Hosp, Reg Gastrointestinal & Liver Unit, Sheffield S10 2JF, S Yorkshire, England; [Hadjivassiliou, Marios] Royal Hallamshire Hosp, Dept Neurol, Sheffield S10 2JF, S Yorkshire, England	University of Sheffield; University of Sheffield	Mooney, PD (corresponding author), Royal Hallamshire Hosp, Reg Gastrointestinal & Liver Unit, Glossop Rd, Sheffield S10 2JF, S Yorkshire, England.	peter.mooney@sth.nhs.uk						Aziz I, 2010, ALIMENT PHARM THER, V32, P1392, DOI 10.1111/j.1365-2036.2010.04477.x; Barratt SM, 2011, J GASTROINTEST LIVER, V20, P241; Barratt SM, 2011, EUR J GASTROEN HEPAT, V23, P159, DOI 10.1097/MEG.0b013e328342a547; Berti I, 2006, DIGEST LIVER DIS, V38, P461, DOI 10.1016/j.dld.2005.12.007; Biagi F, 2009, BRIT J NUTR, V102, P882, DOI 10.1017/S0007114509301579; Bianchi ML, 2008, OSTEOPOROSIS INT, V19, P1705, DOI 10.1007/s00198-008-0624-0; Biesiekierski JR, 2011, AM J GASTROENTEROL, V106, P508, DOI 10.1038/ajg.2010.487; Biesiekierski JR, 2011, AM J GASTROENTEROL, V106, P15; Card TR, 2004, ALIMENT PHARM THER, V20, P769, DOI 10.1111/j.1365-2036.2004.02177.x; Carroccio A, 2012, AM J GASTROENTEROL, V107, P1898, DOI 10.1038/ajg.2012.236; Catassi C, 2010, ANN MED, V42, P530, DOI 10.3109/07853890.2010.514285; Ciclitira P, 2010, MANAGEMENT ADULTS CO; COOPER BT, 1982, DIGESTION, V23, P89, DOI 10.1159/000198692; Corazza GR, 1996, BONE, V18, P525, DOI 10.1016/8756-3282(96)00071-3; DAVIDSON LSP, 1950, BMJ-BRIT MED J, V1, P1157, DOI 10.1136/bmj.1.4663.1157; Esteve M, 2006, GUT, V55, P1739, DOI 10.1136/gut.2006.095299; Evans KE, 2011, AM J GASTROENTEROL, V106, P1837, DOI 10.1038/ajg.2011.171; Fasano A, 2003, ARCH INTERN MED, V163, P286, DOI 10.1001/archinte.163.3.286; Fasano A, 2001, GASTROENTEROLOGY, V120, P636, DOI 10.1053/gast.2001.22123; Ford AC, 2009, ARCH INTERN MED, V169, P651, DOI 10.1001/archinternmed.2009.22; Gale J, 2000, J CLIN ONCOL, V18, P795, DOI 10.1200/JCO.2000.18.4.795; GOUGH KR, 1962, GUT, V3, P232, DOI 10.1136/gut.3.3.232; Green PHR, 2003, AM J MED, V115, P191, DOI 10.1016/S0002-9343(03)00302-4; Hadithi M, 2007, ANN INTERN MED, V147, P294, DOI 10.7326/0003-4819-147-5-200709040-00003; Hadjivassiliou M, 2010, LANCET NEUROL, V9, P318, DOI 10.1016/S1474-4422(09)70290-X; Hall NJ, 2009, ALIMENT PHARM THER, V30, P315, DOI 10.1111/j.1365-2036.2009.04053.x; Hallert C, 1999, NUTRITION, V15, P795; HARRIS OD, 1967, AM J MED, V42, P899, DOI 10.1016/0002-9343(67)90071-X; Hin H, 1999, BMJ-BRIT MED J, V318, P164, DOI 10.1136/bmj.318.7177.164; HOLMES GKT, 1976, GUT, V17, P612, DOI 10.1136/gut.17.8.612; HOLMES GKT, 1989, GUT, V30, P333, DOI 10.1136/gut.30.3.333; Hopper AD, 2008, CLIN GASTROENTEROL H, V6, P314, DOI 10.1016/j.cgh.2007.12.008; Hopper AD, 2007, BMJ-BRIT MED J, V334, P729, DOI 10.1136/bmj.39133.668681.BE; Husby S, 2012, J PEDIATR GASTR NUTR, V54, P136, DOI 10.1097/MPG.0b013e31821a23d0; Kane EV, 2011, CANCER CAUSE CONTROL, V22, P1435, DOI 10.1007/s10552-011-9818-4; Kaukinen K, 2002, EUR J GASTROEN HEPAT, V14, P311, DOI 10.1097/00042737-200203000-00017; Kochhar R, 2012, DIGEST LIVER DIS, V44, P530, DOI 10.1016/j.dld.2012.01.004; Korponay-Szabo IR, 2007, BMJ-BRIT MED J, V335, P1244, DOI 10.1136/bmj.39405.472975.80; Lebwohl B, 2013, ANN INTERN MED, V159, P169, DOI 10.7326/0003-4819-159-3-201308060-00006; Leffler D, 2013, GUT, V62, P996, DOI 10.1136/gutjnl-2012-302196; Leffler DA, 2010, AM J GASTROENTEROL, V105, P2520, DOI 10.1038/ajg.2010.276; Lewis NR, 2006, ALIMENT PHARM THER, V24, P47, DOI 10.1111/j.1365-2036.2006.02967.x; Lewis NR, 2009, ALIMENT PHARM THER, V31, P73, DOI 10.1111/j.1365-2036.2009.04110.x; Logan RFA, 2009, GUT, V58, P618, DOI 10.1136/gut.2008.161182; Lohi S, 2007, ALIMENT PHARM THERAP, V26, P1217, DOI 10.1111/j.1365-2036.2007.03502.x; Ludvigsson JF, 2008, GUT, V57, P1074, DOI 10.1136/gut.2007.133868; Ludvigsson JF, 2013, AM J GASTROENTEROL, V108, P818, DOI 10.1038/ajg.2013.60; Ludvigsson JF, 2013, GUT, V62, P43, DOI 10.1136/gutjnl-2011-301346; McGowan KE, 2009, PEDIATRICS, V124, P1572, DOI 10.1542/peds.2008-2373; Meyer D, 2001, AM J GASTROENTEROL, V96, P112; Mooney PD, 2014, DIGEST LIVER DIS, V46, P32, DOI 10.1016/j.dld.2013.08.127; Mooney Peter D, 2013, Expert Opin Med Diagn, V7, P645, DOI 10.1517/17530059.2013.836179; Mustalahti K, 2010, ANN MED, V42, P587, DOI 10.3109/07853890.2010.505931; Naiyer AJ, 2009, J CLIN GASTROENTEROL, V43, P225, DOI 10.1097/MCG.0b013e31816200e5; National Institute for Health and Clinical Excellence, 2009, COEL DIS REC ASS COE; Novakovic BJ, 2006, ONCOL REP, V16, P191; Oberhuber G, 1999, EUR J GASTROEN HEPAT, V11, P1185, DOI 10.1097/00042737-199910000-00019; Olen O, 2011, DIGEST LIVER DIS, V43, P862, DOI 10.1016/j.dld.2011.07.012; Passananti V, 2012, DIGEST LIVER DIS, V44, P379, DOI 10.1016/j.dld.2011.12.012; Rosinach M, 2012, DIGEST LIVER DIS, V44, P643, DOI 10.1016/j.dld.2012.03.006; Rubio-Tapia A, 2008, CLIN GASTROENTEROL H, V6, P983, DOI 10.1016/j.cgh.2008.04.008; Rubio-Tapia A, 2013, AM J GASTROENTEROL, V108, P656, DOI 10.1038/ajg.2013.79; Rubio-Tapia A, 2010, GUT, V59, P547, DOI 10.1136/gut.2009.195131; Rubio-Tapia A, 2009, GASTROENTEROLOGY, V137, P88, DOI 10.1053/j.gastro.2009.03.059; Sainsbury A, 2011, ALIMENT PHARM THER, V34, P33, DOI 10.1111/j.1365-2036.2011.04685.x; Sainsbury A, 2013, CLIN GASTROENTEROL H, V11, P359, DOI 10.1016/j.cgh.2012.11.033; Sanders DS, 2002, POSTGRAD MED J, V78, P31, DOI 10.1136/pmj.78.915.31; Sharkey LM, 2013, ALIMENT PHARM THER, V38, P1278, DOI 10.1111/apt.12510; Silano M, 2008, DIGEST DIS SCI, V53, P972, DOI 10.1007/s10620-007-9952-8; van der Windt DAWM, 2010, JAMA-J AM MED ASSOC, V303, P1738, DOI 10.1001/jama.2010.549; van Heel DA, 2006, GUT, V55, P1037, DOI 10.1136/gut.2005.075119; Wang XQ, 2011, J PEDIATR GASTR NUTR, V53, P368, DOI 10.1097/MPG.0b013e31822a0128; West J, 2004, BRIT MED J, V329, P716, DOI 10.1136/bmj.38169.486701.7C	73	39	40	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 3	2014	348								g1561	10.1136/bmj.g1561	http://dx.doi.org/10.1136/bmj.g1561			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC6HK	24589518				2022-12-28	WOS:000332622000001
J	Lerner, J; Tirole, J				Lerner, Josh; Tirole, Jean			A Better Route to Tech Standards	SCIENCE			English	Editorial Material									[Lerner, Josh] Harvard Univ, Sch Business, Boston, MA 02163 USA; [Tirole, Jean] Toulouse Sch Econ, F-31000 Toulouse, France; [Tirole, Jean] Inst Adv Study Toulouse, F-31000 Toulouse, France	Harvard University; Universite de Toulouse; Universite Toulouse 1 Capitole; Toulouse School of Economics	Lerner, J (corresponding author), Harvard Univ, Sch Business, Boston, MA 02163 USA.	josh@hbs.edu						Barnett T. O., 2006, BUSINESS REV LETT VI; Contreras Jorge L., 2013, JURIMETRICS, V53, P163; Lemley Mark A., 2018, BERKELEY TECH L J, V28, P1135; Lerner J., 2013, 19664 NAT BUR EC RES; MAJORAS D, 2005, STANDARDIZATION LAW; National Academy of Sciences, 2013, PAT CHALL STAND SETT	6	13	14	0	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2014	343	6174					972	973		10.1126/science.1246439	http://dx.doi.org/10.1126/science.1246439			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC2DZ	24578566				2022-12-28	WOS:000332309600025
J	D'Acremont, V; Kilowoko, M; Kyungu, E; Philipina, S; Sangu, W; Kahama-Maro, J; Lengeler, C; Cherpillod, P; Kaiser, L; Genton, B				D'Acremont, Valerie; Kilowoko, Mary; Kyungu, Esther; Philipina, Sister; Sangu, Willy; Kahama-Maro, Judith; Lengeler, Christian; Cherpillod, Pascal; Kaiser, Laurent; Genton, Blaise			Beyond Malaria - Causes of Fever in Outpatient Tanzanian Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RAPID DIAGNOSTIC-TESTS; DAR-ES-SALAAM; PLASMODIUM-FALCIPARUM; CLINICAL PRESENTATION; CASE-MANAGEMENT; INFECTIONS; INFANTS; BACTEREMIA; PNEUMONIA; EPIDEMIOLOGY	BackgroundAs the incidence of malaria diminishes, a better understanding of nonmalarial fever is important for effective management of illness in children. In this study, we explored the spectrum of causes of fever in African children. MethodsWe recruited children younger than 10 years of age with a temperature of 38 degrees C or higher at two outpatient clinics one rural and one urban in Tanzania. Medical histories were obtained and clinical examinations conducted by means of systematic procedures. Blood and nasopharyngeal specimens were collected to perform rapid diagnostic tests, serologic tests, culture, and molecular tests for potential pathogens causing acute fever. Final diagnoses were determined with the use of algorithms and a set of prespecified criteria. ResultsAnalyses of data derived from clinical presentation and from 25,743 laboratory investigations yielded 1232 diagnoses. Of 1005 children (22.6% of whom had multiple diagnoses), 62.2% had an acute respiratory infection; 5.0% of these infections were radiologically confirmed pneumonia. A systemic bacterial, viral, or parasitic infection other than malaria or typhoid fever was found in 13.3% of children, nasopharyngeal viral infection (without respiratory symptoms or signs) in 11.9%, malaria in 10.5%, gastroenteritis in 10.3%, urinary tract infection in 5.9%, typhoid fever in 3.7%, skin or mucosal infection in 1.5%, and meningitis in 0.2%. The cause of fever was undetermined in 3.2% of the children. A total of 70.5% of the children had viral disease, 22.0% had bacterial disease, and 10.9% had parasitic disease. ConclusionsThese results provide a description of the numerous causes of fever in African children in two representative settings. Evidence of a viral process was found more commonly than evidence of a bacterial or parasitic process. (Funded by the Swiss National Science Foundation and others.) As malaria is controlled in regions of sub-Saharan Africa, the causes of febrile illness are changing. In this report on febrile children in Tanzania, a broad array of possible pathogens are identified and stratified by presenting syndrome. With malaria transmission declining in many parts of Africa,(1),(2) there is increasing awareness that most acute febrile episodes are due to other infectious diseases some of which are life-threatening that must be identified and treated appropriately.(3),(4) World Health Organization (WHO) guidelines recommend malaria testing for all patients with febrile illness in areas where malaria is endemic.(5) The advent of point-of-care rapid diagnostic tests for malaria presents health care providers with a new and daunting challenge: the need to determine the causes of febrile illness and the appropriate course of action when treating children who test negative ...	[D'Acremont, Valerie; Kahama-Maro, Judith; Lengeler, Christian; Genton, Blaise] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [D'Acremont, Valerie; Kahama-Maro, Judith; Lengeler, Christian; Genton, Blaise] Univ Basel, Basel, Switzerland; [D'Acremont, Valerie; Genton, Blaise] Univ Lausanne, Dept Ambulatory Care & Community Med, Lausanne, Switzerland; [Genton, Blaise] Univ Lausanne Hosp, Infect Dis Serv, Lausanne, Switzerland; [Cherpillod, Pascal; Kaiser, Laurent] Univ Geneva, Univ Hosp Geneva, Virol Lab, Div Infect Dis, Geneva, Switzerland; [Cherpillod, Pascal; Kaiser, Laurent] Univ Geneva, Univ Hosp Geneva, Div Lab Med, Geneva, Switzerland; [Cherpillod, Pascal; Kaiser, Laurent] Univ Geneva, Fac Med, Geneva, Switzerland; [D'Acremont, Valerie; Kahama-Maro, Judith] Dar Es Salaam City Council, City Med Off Hlth, Dar Es Salaam, Tanzania; [Kilowoko, Mary; Sangu, Willy] Amana Hosp, Dar Es Salaam, Tanzania; [Genton, Blaise] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Genton, Blaise] Ifakara Hlth Inst, Ifakara, Tanzania; [Kyungu, Esther; Philipina, Sister] St Francis Hosp, Ifakara, Tanzania	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva; University of Geneva; University of Geneva; Ifakara Health Institute; Ifakara Health Institute	D'Acremont, V (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.	valerie.dacremont@unibas.ch	Boillat-Blanco, Noémie/GLT-5579-2022		Swiss National Science Foundation [3270B0-109696, IZ70Z0-124023, 32003B_127160]; Commission for International Medicine of the University Hospital of Geneva; Bill and Melinda Gates Foundation; Swiss National Science Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Commission for International Medicine of the University Hospital of Geneva; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Funded by the Swiss National Science Foundation and others.	Abdullahi O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030787; Alba S, 2013, INT J EPIDEMIOL; [Anonymous], 2005, HOSP CAR CHILDR GUID; Baiden F, 2011, TROP MED INT HEALTH, V16, P142, DOI 10.1111/j.1365-3156.2010.02692.x; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Berkley JA, 2010, JAMA-J AM MED ASSOC, V303, P2051, DOI 10.1001/jama.2010.675; Brent AJ, 2006, LANCET, V367, P482, DOI 10.1016/S0140-6736(06)68180-4; Brodzinski H, 2009, PEDIATR EMERG CARE, V25, P352, DOI 10.1097/PEC.0b013e3181a3497e; Calvo Rey C, 2005, An Pediatr (Barc), V63, P22; Cevey-Macherel M, 2009, EUR J PEDIATR, V168, P1429, DOI 10.1007/s00431-009-0943-y; Crump JA, 2011, TROP MED INT HEALTH, V16, P830, DOI 10.1111/j.1365-3156.2011.02774.x; D'Acremont V, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-107; D'Acremont V, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-240; d'Acremont V, 2010, CLIN INFECT DIS, V51, P506, DOI 10.1086/655688; English M, 2008, PLOS MED, V5, P1665, DOI 10.1371/journal.pmed.0050241; Feikin DR, 2013, PEDIATR INFECT DIS J, V32, pE14, DOI 10.1097/INF.0b013e31826fd39b; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Hamer DH, 2012, PATHOG GLOB HEALTH, V106, P32, DOI 10.1179/1364859411Y.0000000042; Hazir T, 2011, CLIN INFECT DIS, V52, P293, DOI 10.1093/cid/ciq142; Kwambana BA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-175; Lubell Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017439; Madhi SA, 2006, J INFECT DIS, V193, P1236, DOI 10.1086/503053; Makani J, 2003, QJM-INT J MED, V96, P355, DOI 10.1093/qjmed/hcg059; Mosha JF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008707; Msellem MI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000070; Mtove G, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-320; Peltola V, 2008, J CLIN VIROL, V43, P411, DOI 10.1016/j.jcv.2008.08.014; Perkins MD, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S5; Punjabi NH, 2012, AM J TROP MED HYG, V86, P46, DOI 10.4269/ajtmh.2012.10-0497; Reyburn H, 2004, BMJ-BRIT MED J, V329, P1212, DOI 10.1136/bmj.38251.658229.55; Selvaraju SB, 2011, J CLIN VIROL, V51, P126, DOI 10.1016/j.jcv.2011.02.014; Senn N, 2012, CLIN INFECT DIS, V54, P644, DOI 10.1093/cid/cir901; Stalkup JR, 2002, DERMATOL CLIN, V20, P217, DOI 10.1016/S0733-8635(01)00009-2; Wang SJ, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-28; World Health Organization, 2005, EM TRIAG ASS TREATM	35	278	281	3	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 27	2014	370	9					809	817		10.1056/NEJMoa1214482	http://dx.doi.org/10.1056/NEJMoa1214482			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB8AR	24571753	Bronze, Green Published			2022-12-28	WOS:000332013000006
J	Hall, LL; Carone, DM; Gomez, AV; Kolpa, HJ; Byron, M; Mehta, N; Fackelmayer, FO; Lawrence, JB				Hall, Lisa L.; Carone, Dawn M.; Gomez, Alvin V.; Kolpa, Heather J.; Byron, Meg; Mehta, Nitish; Fackelmayer, Frank O.; Lawrence, Jeanne B.			Stable C0T-1 Repeat RNA Is Abundant and Is Associated with Euchromatic Interphase Chromosomes	CELL			English	Article							HUMAN XIST GENE; X-CHROMOSOME; NONCODING RNA; MESSENGER-RNA; NUCLEAR-RNA; TRANSCRIPTION; INACTIVATION; DNA; ORGANIZATION; TRANSPORT	Recent studies recognize a vast diversity of noncoding RNAs with largely unknown functions, but few have examined interspersed repeat sequences, which constitute almost half our genome. RNA hybridization in situ using C0T-1 (highly repeated) DNA probes detects surprisingly abundant euchromatin-associated RNA comprised predominantly of repeat sequences (C0T-1 RNA), including LINE-1. C0T-1-hybridizing RNA strictly localizes to the interphase chromosome territory in cis and remains stably associated with the chromosome territory following prolonged transcriptional inhibition. The C0T-1 RNA territory resists mechanical disruption and fractionates with the nonchromatin scaffold but can be experimentally released. Loss of repeat-rich, stable nuclear RNAs from euchromatin corresponds to aberrant chromatin distribution and condensation. C0T-1 RNA has several properties similar to XIST chromosomal RNA but is excluded from chromatin condensed by XIST. These findings impact two "black boxes" of genome science: the poorly understood diversity of noncoding RNA and the unexplained abundance of repetitive elements.	[Hall, Lisa L.; Carone, Dawn M.; Gomez, Alvin V.; Kolpa, Heather J.; Byron, Meg; Mehta, Nitish; Lawrence, Jeanne B.] Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA 01655 USA; [Fackelmayer, Frank O.] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Dept Biomed Res, Lab Epigenet & Chromosome Biol, Ioannina 45110, Greece	University of Massachusetts System; University of Massachusetts Worcester; Foundation for Research & Technology - Hellas (FORTH)	Lawrence, JB (corresponding author), Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA 01655 USA.	jeanne.lawrence@umassmed.edu		Lawrence, Jeanne/0000-0001-6572-3128; Carone, Dawn/0000-0002-4362-6690	NIH [GM053234, GM107604, S10RR027897]; NIH/NCI NRSA [1F32CA154086]; NATIONAL CANCER INSTITUTE [F32CA154086] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107604, R01GM053234] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCI NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grant GM053234 and GM107604 to J.B.L. D.M.C. is supported by NIH/NCI NRSA 1F32CA154086. We wish to thank John Moran for the gift of L1 ORF1 and ORF2 plasmids and Laurie Lizotte for general technical assistance. A special thanks to Jeff Nickerson for helpful discussion of EM results and to Lara Strittmatter from the UMMS Electron Microscopy core for the EM fixation and analysis. The EM Core facility is supported by NIH award S10RR027897.	Aalto AP, 2012, CURR OPIN CELL BIOL, V24, P333, DOI 10.1016/j.ceb.2012.03.006; Bensaude O, 2011, TRANSCR-AUSTIN, V2, P103, DOI 10.4161/trns.2.3.16172; BRITTEN RJ, 1968, SCIENCE, V161, P529, DOI 10.1126/science.161.3841.529; BRITTEN RJ, 1971, Q REV BIOL, V46, P111, DOI 10.1086/406830; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; BYNUM JW, 1980, BIOCHIM BIOPHYS ACTA, V607, P304, DOI 10.1016/0005-2787(80)90083-0; Byron Meg, 2013, Curr Protoc Hum Genet, VChapter 4, DOI 10.1002/0471142905.hg0415s76; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; CHEN TL, 1989, CHROMOSOMA, V98, P309, DOI 10.1007/BF00292382; Chow JC, 2010, CELL, V141, P956, DOI 10.1016/j.cell.2010.04.042; Clark MB, 2012, GENOME RES, V22, P885, DOI 10.1101/gr.131037.111; Clemson CM, 2006, P NATL ACAD SCI USA, V103, P7688, DOI 10.1073/pnas.0601069103; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; de Koning APJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002384; Espinoza CA, 2004, NAT STRUCT MOL BIOL, V11, P822, DOI 10.1038/nsmb812; FACKELMAYER FO, 1994, EUR J BIOCHEM, V221, P749, DOI 10.1111/j.1432-1033.1994.tb18788.x; FEDOROFF N, 1977, CELL, V10, P597, DOI 10.1016/0092-8674(77)90092-7; FEY EG, 1986, J CELL SCI, P99; Gardner EJ, 2012, GENE DEV, V26, P2550, DOI 10.1101/gad.202184.112; Geisler S, 2013, NAT REV MOL CELL BIO, V14, P699, DOI 10.1038/nrm3679; Goodier JL, 2008, CELL, V135, P23, DOI 10.1016/j.cell.2008.09.022; Hadjiargyrou M, 2013, INT J MOL SCI, V14, P13307, DOI 10.3390/ijms140713307; Hall LL, 2010, COLD SH Q B, V75, P345, DOI 10.1101/sqb.2010.75.030; Hall LL, 2006, ANAT REC PART A, V288A, P664, DOI 10.1002/ar.a.20336; Hall LL, 2009, J CELL BIOL, V186, P491, DOI 10.1083/jcb.200811143; Hall LL, 2002, P NATL ACAD SCI USA, V99, P8677, DOI 10.1073/pnas.132468999; Jiang J, 2013, NATURE, V500, P296, DOI 10.1038/nature12394; Johnson C, 2000, J CELL BIOL, V150, P417, DOI 10.1083/jcb.150.3.417; JOHNSON CV, 1991, METHOD CELL BIOL, V35, P73; Kapusta A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003470; KORENBERG JR, 1988, CELL, V53, P391, DOI 10.1016/0092-8674(88)90159-6; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LAWRENCE JB, 1989, CELL, V57, P493, DOI 10.1016/0092-8674(89)90924-0; Lyon MF, 1998, CYTOGENET CELL GENET, V80, P133, DOI 10.1159/000014969; Mariner PD, 2008, MOL CELL, V29, P499, DOI 10.1016/j.molcel.2007.12.013; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; NICKERSON JA, 1989, P NATL ACAD SCI USA, V86, P177, DOI 10.1073/pnas.86.1.177; Nickerson JA, 2001, J CELL SCI, V114, P463; Santoni FA, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-111; Schubert T, 2012, MOL CELL, V48, P434, DOI 10.1016/j.molcel.2012.08.021; Smith KP, 2007, J CELL BIOL, V178, P951, DOI 10.1083/jcb.200706048; Tam R, 2004, J CELL BIOL, V167, P269, DOI 10.1083/jcb.200403128; Tam R., 2002, FISH PRACTICAL APPRO, P93; Venters BJ, 2013, NATURE, V502, P53, DOI 10.1038/nature12535; Wutz A, 2011, NAT REV GENET, V12, P542, DOI 10.1038/nrg3035	45	113	114	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 27	2014	156	5					907	919		10.1016/j.cell.2014.01.042	http://dx.doi.org/10.1016/j.cell.2014.01.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AB9BK	24581492	Green Accepted, Bronze			2022-12-28	WOS:000332083900010
J	Pencheva, N; Buss, CG; Posada, J; Merghoub, T; Tavazoie, SF				Pencheva, Nora; Buss, Colin G.; Posada, Jessica; Merghoub, Taha; Tavazoie, Sohail F.			Broad-Spectrum Therapeutic Suppression of Metastatic Melanoma through Nuclear Hormone Receptor Activation	CELL			English	Article							BREAST-CANCER METASTASIS; INHIBITOR; SURVIVAL; LXR; RESISTANCE; GENE	Melanoma metastasis is a devastating outcome lacking an effective preventative therapeutic. We provide pharmacologic, molecular, and genetic evidence establishing the liver-X nuclear hormone receptor (LXR) as a therapeutic target in melanoma. Oral administration of multiple LXR agonists suppressed melanoma invasion, angiogenesis, tumor progression, and metastasis. Molecular and genetic experiments revealed these effects to be mediated by LXR beta, which elicits these outcomes through transcriptional induction of tumoral and stromal apolipoprotein-E (ApoE). LXR beta agonism robustly suppressed tumor growth and metastasis across a diverse mutational spectrum of melanoma lines. LXR beta targeting significantly prolonged animal survival, suppressed the progression of established metastases, and inhibited brain metastatic colonization. Importantly, LXR beta activation displayed melanoma-suppressive cooperativity with the frontline regimens dacarbazine, B-Raf inhibition, and the anti-CTLA-4 antibody and robustly inhibited melanomas that had acquired resistance to B-Raf inhibition or dacarbazine. We present a promising therapeutic approach that uniquely acts by transcriptionally activating a metastasis suppressor gene.	[Pencheva, Nora; Buss, Colin G.; Posada, Jessica; Tavazoie, Sohail F.] Rockefeller Univ, Lab Syst Canc Biol, New York, NY 10065 USA; [Merghoub, Taha] Mem Sloan Kettering Canc Ctr, Dept Immunol, New York, NY 10065 USA	Rockefeller University; Memorial Sloan Kettering Cancer Center	Tavazoie, SF (corresponding author), Rockefeller Univ, Lab Syst Canc Biol, New York, NY 10065 USA.	stavazoie@mail.rockefeller.edu	Merghoub, Taha/ABD-8362-2021; Buss, Colin/I-5326-2014	Buss, Colin/0000-0001-7771-1685	Rita Allen foundation; Melanoma Research Alliance; Melanoma Research Foundation; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Rita Allen foundation; Melanoma Research Alliance; Melanoma Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to the members of our laboratory who thoughtfully contributed to past drafts of this manuscript. We thank Masoud Tavazoie, Siavash Kurdistani, Richard Carvajal, Charles Rice, and Fred Cross for providing insightful comments on previous manuscript versions. We thank Marija Drobnjak, Jordana Ray-Kirton, and Umesh Bhanot for greatly assisting with clinical sample processing and procurement. We are grateful to David Mangelsdorf for developing the LXRa and LXR beta-null mice and making them available through the Jackson Laboratory. ApoE-null mice were generously provided by Jan Breslow. The B-Raf<SUP>V600E/+</SUP>; Pten<SUP>-/-</SUP>; CDKN2A<SUP>-/-</SUP> primary mouse melanoma cells were kindly provided by Marcus Bosenberg, and the SK-Mel-239 parental and vemurafenib-resistant cell lines were a generous gift from Poulikos Poulikakos. We express gratitude to Marcus Bosenberg's, Martin McMahon's, and David Dankort's groups for making the Tyr::CreER; B-Raf<SUP>V600E/+</SUP>; Pten<SUP>lox/+</SUP> mouse model available through the Jackson Laboratory. S.F.T. was supported by the Rita Allen foundation and is a DOD Era of Hope Scholar. N.P. is an Anderson Cancer Center fellow. This work was partly funded by the Melanoma Research Alliance and the Melanoma Research Foundation. S.F.T. is a cofounder and shareholder of Rgenix and is a member of its scientific advisory board.	APFEL R, 1994, MOL CELL BIOL, V14, P7025, DOI 10.1128/MCB.14.10.7025; Bhatia S, 2009, ONCOLOGY-NY, V23, P488; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Collins JL, 2002, J MED CHEM, V45, P1963, DOI 10.1021/jm0255116; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Deblois G, 2013, NAT REV CANCER, V13, P27, DOI 10.1038/nrc3396; Groot PHE, 2005, J LIPID RES, V46, P2182, DOI 10.1194/jlr.M500116-JLR200; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Holbeck S, 2010, MOL ENDOCRINOL, V24, P1287, DOI 10.1210/me.2010-0040; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; Lucas R., 2006, ENV BURDEN DIS SERIE; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Nelson ER, 2013, SCIENCE, V342, P1094, DOI 10.1126/science.1241908; O'Hare T, 2005, CANCER RES, V65, P4500, DOI 10.1158/0008-5472.CAN-05-0259; Pencheva N, 2012, CELL, V151, P1068, DOI 10.1016/j.cell.2012.10.028; Png KJ, 2012, NATURE, V481, P190, DOI 10.1038/nature10661; Poulikakos PI, 2011, NATURE, V480, P387, DOI 10.1038/nature10662; Prahallad A, 2012, NATURE, V483, P100, DOI 10.1038/nature10868; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Shi HB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1727; SONG C, 1994, P NATL ACAD SCI USA, V91, P10809, DOI 10.1073/pnas.91.23.10809; Sosman JA, 2012, NEW ENGL J MED, V366, P707, DOI 10.1056/NEJMoa1112302; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Tavazoie SF, 2008, NATURE, V451, P147, DOI 10.1038/nature06487; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; van Elsas A, 1999, J EXP MED, V190, P355, DOI 10.1084/jem.190.3.355; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Yang H, 2010, CANCER RES, V70, P5518, DOI 10.1158/0008-5472.CAN-10-0646	35	117	128	2	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 27	2014	156	5					986	1001		10.1016/j.cell.2014.01.038	http://dx.doi.org/10.1016/j.cell.2014.01.038			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AB9BK	24581497	Bronze			2022-12-28	WOS:000332083900016
J	Valiente, M; Obenauf, AC; Jin, X; Chen, Q; Zhang, XHF; Lee, DJ; Chaft, JE; Kris, MG; Huse, JT; Brogi, E; Massague, J				Valiente, Manuel; Obenauf, Anna C.; Jin, Xin; Chen, Qing; Zhang, Xiang H. -F.; Lee, Derek J.; Chaft, Jamie E.; Kris, Mark G.; Huse, Jason T.; Brogi, Edi; Massague, Joan			Serpins Promote Cancer Cell Survival and Vascular Co-Option in Brain Metastasis	CELL			English	Article							ADHESION MOLECULE L1; PLASMINOGEN-ACTIVATOR INHIBITOR-1; BREAST-CANCER; FAS LIGAND; EXPRESSION; SYSTEM; ADENOCARCINOMA; SUPERFAMILY; PROGRESSION; INDUCTION	Brain metastasis is an ominous complication of cancer, yet most cancer cells that infiltrate the brain die of unknown causes. Here, we identify plasmin from the reactive brain stroma as a defense against metastatic invasion, and plasminogen activator (PA) inhibitory serpins in cancer cells as a shield against this defense. Plasmin suppresses brain metastasis in two ways: by converting membrane-bound astrocytic FasL into a paracrine death signal for cancer cells, and by inactivating the axon pathfinding molecule L1CAM, which metastatic cells express for spreading along brain capillaries and for metastatic outgrowth. Brain metastatic cells from lung cancer and breast cancer express high levels of anti-PA serpins, including neuroserpin and serpin B2, to prevent plasmin generation and its metastasis-suppressive effects. By protecting cancer cells from death signals and fostering vascular co-option, anti-PA serpins provide a unifying mechanism for the initiation of brain metastasis in lung and breast cancers.	[Valiente, Manuel; Obenauf, Anna C.; Jin, Xin; Chen, Qing; Zhang, Xiang H. -F.; Lee, Derek J.; Massague, Joan] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Chaft, Jamie E.; Kris, Mark G.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Huse, Jason T.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Huse, Jason T.; Massague, Joan] Mem Sloan Kettering Canc Ctr, Brain Tumor Ctr, New York, NY 10065 USA; [Brogi, Edi] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Massague, Joan] Mem Sloan Kettering Canc Ctr, Metastasis Res Ctr, New York, NY 10065 USA; [Massague, Joan] Howard Hughes Med Inst, Chevy Chase, MD 21205 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA.	j-massague@ski.mskcc.org	Valiente, Manuel/J-9523-2014	Valiente, Manuel/0000-0002-0647-7542; Kris, Mark/0000-0002-7317-5341; Obenauf, Anna/0000-0002-9556-5914; Massague, Joan/0000-0001-9324-8408; Chaft, Jamie/0000-0002-5838-9982; Zhang, Xiang/0000-0002-5674-8670	NIH [P01-CA129243, U54-163167]; DOD [W81XWH-12-0074]; Alan and Sandra Gerry Metastasis Research Initiative; FWF, Austrian Science Fund [J3013]; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE [P01CA129243, U54CA163167, P30CA008748] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [J 3013] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); Alan and Sandra Gerry Metastasis Research Initiative; FWF, Austrian Science Fund(Austrian Science Fund (FWF)); Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank A. Boire, P. Bos, L. DeAngelis, E. Holland, and J. Posner for helpful input; the Brain Tumor Center for tumor samples; Marija Drobnjak for establishing the tissue microarray from lung cancer brain metastasis; T. Jacks for cell lines; and A. Thorburn for reagents. This work was supported by NIH grants P01-CA129243 and U54-163167, DOD Innovator award W81XWH-12-0074, and the Alan and Sandra Gerry Metastasis Research Initiative (J.M.). M.V. is a Hope Funds for Cancer Research postdoctoral fellow. A.C.O. is an Erwin Schrodinger Fellowship awardee (J3013, FWF, Austrian Science Fund). X.H.-F.Z. is a McNair Scholar and the recipient of a grant from the Breast Cancer Research Foundation. J.M. is an investigator of the Howard Hughes Medical Institute.	Adhami F, 2008, AM J PATHOL, V172, P1704, DOI 10.2353/ajpath.2008.070979; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bajou K, 2008, CANCER CELL, V14, P324, DOI 10.1016/j.ccr.2008.08.012; Baldini E, 2009, INT J ANDROL, V32, P123, DOI 10.1111/j.1365-2605.2007.00823.x; Beer R, 2000, J CEREBR BLOOD F MET, V20, P669, DOI 10.1097/00004647-200004000-00004; Benarroch EE, 2007, NEUROLOGY, V69, P799, DOI 10.1212/01.wnl.0000269668.08747.78; Berger DH, 2002, WORLD J SURG, V26, P767, DOI 10.1007/s00268-002-4050-8; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Carbonell WS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005857; Castellani V, 2002, EMBO J, V21, P6348, DOI 10.1093/emboj/cdf645; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chen ZL, 1997, CELL, V91, P917, DOI 10.1016/S0092-8674(00)80483-3; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4961; Choi C, 2004, BRAIN RES REV, V44, P65, DOI 10.1016/j.brainresrev.2003.08.007; Doberstein K, 2011, CARCINOGENESIS, V32, P262, DOI 10.1093/carcin/bgq249; Donier E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040674; Donnem T, 2013, CANCER MED-US, V2, P427, DOI 10.1002/cam4.105; Fang H, 2012, JNCI-J NATL CANCER I, V104, P1470, DOI 10.1093/jnci/djs377; FELD R, 1984, J CLIN ONCOL, V2, P1352, DOI 10.1200/JCO.1984.2.12.1352; Felding-Habermann B, 1997, J CELL BIOL, V139, P1567, DOI 10.1083/jcb.139.6.1567; FOEKENS JA, 1995, J NATL CANCER I, V87, P751, DOI 10.1093/jnci/87.10.751; Francia G, 2011, NAT REV CANCER, V11, P135, DOI 10.1038/nrc3001; Fujimoto S, 2008, J CEREBR BLOOD F MET, V28, P506, DOI 10.1038/sj.jcbfm.9600547; Ganesh BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018305; Gavrilovic IT, 2005, J NEURO-ONCOL, V75, P5, DOI 10.1007/s11060-004-8093-6; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Gutierrez-Fernandez A, 2009, J NEUROSCI, V29, P12393, DOI 10.1523/JNEUROSCI.3553-09.2009; Harbeck N, 1999, BREAST CANCER RES TR, V54, P147, DOI 10.1023/A:1006118828278; Heyn C, 2006, MAGN RESON MED, V56, P1001, DOI 10.1002/mrm.21029; Irving JA, 2000, GENOME RES, V10, P1845, DOI 10.1101/gr.GR-1478R; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Karrison TG, 1999, JNCI-J NATL CANCER I, V91, P80, DOI 10.1093/jnci/91.1.80; Kienast Y, 2010, NAT MED, V16, P116, DOI 10.1038/nm.2072; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Kulahin N, 2008, MOL CELL NEUROSCI, V37, P528, DOI 10.1016/j.mcn.2007.12.001; Law RHP, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-216; Leenders WPJ, 2004, CLIN CANCER RES, V10, P6222, DOI 10.1158/1078-0432.CCR-04-0823; Li B, 2013, ONCOGENE, V32, P2952, DOI 10.1038/onc.2012.313; Lin QT, 2010, NEOPLASIA, V12, P748, DOI 10.1593/neo.10602; Lorger M, 2010, AM J PATHOL, V176, P2958, DOI 10.2353/ajpath.2010.090838; Maher Elizabeth A, 2009, Cancer Res, V69, P6015, DOI 10.1158/0008-5472.CAN-08-4347; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; McMahon B, 2007, PATHOPHYSIOL HAEMO T, V36, P184, DOI 10.1159/000175156; Mechtersheimer S, 2001, J CELL BIOL, V155, P661, DOI 10.1083/jcb.200101099; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Nayeem N, 1999, J CELL SCI, V112, P4739; Nguyen DX, 2009, CELL, V138, P51, DOI 10.1016/j.cell.2009.04.030; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Polleux F, 2002, SCI STKE, V136, P19; Schafer MKE, 2010, CELL MOL LIFE SCI, V67, P2425, DOI 10.1007/s00018-010-0339-1; Schroder C, 2009, ONCOL REP, V22, P1109, DOI 10.3892/or_00000543; Seike T, 2011, CLIN EXP METASTAS, V28, P13, DOI 10.1007/s10585-010-9354-8; Silletti S, 2000, J CELL BIOL, V149, P1485, DOI 10.1083/jcb.149.7.1485; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Takehara S, 2009, J MOL BIOL, V388, P11, DOI 10.1016/j.jmb.2009.03.007; Teesalu T, 2001, AM J PATHOL, V159, P2227, DOI 10.1016/S0002-9440(10)63073-8; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Vanharanta S, 2013, CANCER CELL, V24, P410, DOI 10.1016/j.ccr.2013.09.007; Voura EB, 2001, MOL BIOL CELL, V12, P2699, DOI 10.1091/mbc.12.9.2699; Wang X, 2013, EUR J IMMUNOL, V43, P115, DOI 10.1002/eji.201242679; Wiencken-Barger AE, 2004, CEREB CORTEX, V14, P121, DOI 10.1093/cercor/bhg110; Winslow MM, 2011, NATURE, V473, P101, DOI 10.1038/nature09881; Yepes M, 2000, BLOOD, V96, P569	64	476	490	5	89	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 27	2014	156	5					1002	1016		10.1016/j.cell.2014.01.040	http://dx.doi.org/10.1016/j.cell.2014.01.040			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AB9BK	24581498	Bronze, Green Accepted			2022-12-28	WOS:000332083900017
J	Blair, HT				Blair, H. T.			Charting the Islands of Memory	SCIENCE			English	Editorial Material							ENTORHINAL CORTEX; OSCILLATORY INTERFERENCE; SPATIAL PERIODICITY; THETA OSCILLATIONS; GRID CELLS; HIPPOCAMPUS; MODEL; MAP		[Blair, H. T.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; [Blair, H. T.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Blair, HT (corresponding author), Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA.	blairlab@gmail.com		Blair, Hugh/0000-0001-8256-5109				ALONSO A, 1993, J NEUROPHYSIOL, V70, P128, DOI 10.1152/jn.1993.70.1.128; Brandon MP, 2011, SCIENCE, V332, P595, DOI 10.1126/science.1201652; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hartley T, 2000, HIPPOCAMPUS, V10, P369, DOI 10.1002/1098-1063(2000)10:4<369::AID-HIPO3>3.0.CO;2-0; Kitamura T, 2014, SCIENCE, V343, P896, DOI 10.1126/science.1244634; Koenig J, 2011, SCIENCE, V332, P592, DOI 10.1126/science.1201685; Mizuseki K, 2009, NEURON, V64, P267, DOI 10.1016/j.neuron.2009.08.037; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Ray S, 2014, SCIENCE, V343, P891, DOI 10.1126/science.1243028; Solstad T, 2006, HIPPOCAMPUS, V16, P1026, DOI 10.1002/hipo.20244; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; Suh J, 2011, SCIENCE, V334, P1415, DOI 10.1126/science.1210125; Welday AC, 2011, J NEUROSCI, V31, P16157, DOI 10.1523/JNEUROSCI.0712-11.2011	15	0	0	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 21	2014	343	6173					846	847		10.1126/science.1251252	http://dx.doi.org/10.1126/science.1251252			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB1LG	24558150				2022-12-28	WOS:000331552600033
J	Denman, M				Denman, Michael			In patients with early rheumatoid arthritis, fish oil reduced failure of treatment with DMARDs	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Northwick Pk Hosp & Clin Res Ctr, Harrow, England	Imperial College London	Denman, M (corresponding author), Northwick Pk Hosp & Clin Res Ctr, Harrow, England.				National Health Medical Research Council of Australia; Royal Adelaide Hospital Research Committee	National Health Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Royal Adelaide Hospital Research Committee	National Health Medical Research Council of Australia and Royal Adelaide Hospital Research Committee.	Berglin E, 2013, SCAND J RHEUMATOL, V42, P362, DOI 10.3109/03009742.2013.776103; van Venrooij WJ, 2011, NAT REV RHEUMATOL, V7, P391, DOI 10.1038/nrrheum.2011.76	2	1	1	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 18	2014	160	4							JC11	10.7326/0003-4819-160-4-201402180-02011	http://dx.doi.org/10.7326/0003-4819-160-4-201402180-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC8RF	24534933				2022-12-28	WOS:000350635100010
J	Earley, A; Persson, R; Garlitski, AC; Balk, EM; Uhlig, K				Earley, Amy; Persson, Rebecca; Garlitski, Ann C.; Balk, Ethan M.; Uhlig, Katrin			Effectiveness of Implantable Cardioverter Defibrillators for Primary Prevention of Sudden Cardiac Death in Subgroups	ANNALS OF INTERNAL MEDICINE			English	Review							LEFT-VENTRICULAR DYSFUNCTION; ASSOCIATION TASK-FORCE; ADVANCED HEART-FAILURE; 2002 GUIDELINE UPDATE; IMPROVED SURVIVAL; CORONARY REVASCULARIZATION; DILATED CARDIOMYOPATHY; ANTIARRHYTHMIA DEVICES; MYOCARDIAL-INFARCTION; AMERICAN-COLLEGE	Background: Previous systematic reviews of implantable cardioverter defibrillators (ICDs) used for primary prevention of sudden cardiac death (SCD) concluded that ICDs are less effective in women and the elderly. Purpose: To examine ICD effectiveness for primary prevention of SCD across subgroups by sex, age, New York Heart Association class, left ventricular ejection fraction, heart failure, left bundle branch block, QRS interval, time since myocardial infarction, blood urea nitrogen level, and diabetes. Data Sources: MEDLINE and the Cochrane Central Register of Controlled Trials through 3 September 2013 with no language restriction. Study Selection: Researchers screened articles for studies comparing ICD versus no ICD for primary prevention. Data Extraction: Data were extracted about study design, patients, interventions, mortality and SCD outcomes, subgroup characteristics, and subgroup effects. Quality of subgroup analyses was determined by consensus. Relative odds ratios comparing subgroup effects were calculated, and random-effects model meta-analyses were conducted on these ratios. Data Synthesis: Meta-analysis of 14 studies showed a decrease in deaths and SCDs due to ICD treatment. Ten studies provided subgroup analyses. Nine studies compared ICD versus no ICD, whereas one compared cardiac resynchronization therapy plus a defibrillator versus no ICD. Within-study interaction tests and across-study meta-analyses yielded weak evidence that did not show differences for all-cause mortality in subgroups by sex, age, and QRS interval. The evidence was indeterminate for other evaluated subgroups because of a paucity of data. Limitation: Many subgroup analyses were underpowered, which may have resulted in false-negative findings. Conclusion: Weak evidence fails to show differences for all-cause mortality in subgroups of sex, age, and QRS interval. Evidence is indeterminate for all-cause mortality in the other subgroups and for SCD.	[Earley, Amy; Persson, Rebecca; Garlitski, Ann C.; Balk, Ethan M.; Uhlig, Katrin] Tufts Med Ctr, Ctr Clin Evidence Synth, Inst Clin Res & Hlth Policy Study, Boston, MA 02111 USA	Tufts Medical Center	Uhlig, K (corresponding author), Tufts Med Ctr, 800 Washington St,Box 391, Boston, MA 02111 USA.	kuhlig@tuftsmedicalcenter.org	Persson, Rebecca/W-2603-2019; Balk, Ethan/AAJ-2547-2020		Agency for Healthcare Research and Quality [290 2007 10055 I]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By the Agency for Healthcare Research and Quality to the Tufts Evidence-Based Practice Center (contract no. 290 2007 10055 I).	Al-Khatib SM, 2008, J CARDIOVASC ELECTR, V19, P1059, DOI 10.1111/j.1540-8167.2008.01191.x; Al-Khatib SM, 2013, JAMA-J AM MED ASSOC, V309, P55, DOI 10.1001/jama.2012.157182; Bansch D, 2002, CIRCULATION, V105, P1453, DOI 10.1161/01.CIR.0000012350.99718.AD; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Barsheshet A, 2011, HEART RHYTHM, V8, P212, DOI 10.1016/j.hrthm.2010.10.035; Berenbom LD, 2005, ANN NONINVAS ELECTRO, V10, P429, DOI 10.1111/j.1542-474X.2005.00063.x; Bigger JT, 1997, NEW ENGL J MED, V337, P1569, DOI 10.1056/NEJM199711273372201; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Brockwell SE, 2001, STAT MED, V20, P825, DOI 10.1002/sim.650; Brookes S T, 2001, Health Technol Assess, V5, P1; Buxton AE, 2000, NEW ENGL J MED, V342, P1937, DOI 10.1056/NEJM200006293422602; Chan PS, 2009, CIRC-CARDIOVASC QUAL, V2, P16, DOI 10.1161/CIRCOUTCOMES.108.807123; Chen CY, 2013, J AM COLL CARDIOL, V61, P2142, DOI 10.1016/j.jacc.2013.02.043; Epstein AE, 2008, CIRCULATION, V117, P2820, DOI 10.1161/CIRCUALTIONAHA.108.189741; Fonarow GC, 2000, AM J CARDIOL, V85, P981, DOI 10.1016/S0002-9149(99)00914-5; Ghanbari H, 2009, ARCH INTERN MED, V169, P1500, DOI 10.1001/archinternmed.2009.255; Goldenberg I, 2006, J AM COLL CARDIOL, V47, P1811, DOI 10.1016/j.jacc.2005.12.048; Goldenberg I, 2006, AM J CARDIOL, V98, P485, DOI 10.1016/j.amjcard.2006.03.025; Goldenberg I, 2007, CLIN GERIATR MED, V23, P205, DOI 10.1016/j.cger.2006.08.010; Gregoratos G, 2002, J AM COLL CARDIOL, V40, P1703, DOI 10.1016/S0735-1097(02)02528-7; Hernandez AF, 2010, CIRC-HEART FAIL, V3, P7, DOI 10.1161/CIRCHEARTFAILURE.109.884395; Hoffmeister JM, 2012, J INTERV CARD ELECTR, V35, P227, DOI 10.1007/s10840-012-9711-4; Hohnloser SH, 2004, NEW ENGL J MED, V351, P2481, DOI 10.1056/NEJMoa041489; Huang DT, 2007, J CARDIOVASC ELECTR, V18, P833, DOI 10.1111/j.1540-8167.2007.00857.x; Kadish A, 2004, NEW ENGL J MED, V350, P2151, DOI 10.1056/NEJMoa033088; Masoudi FA, 2012, CIRC-CARDIOVASC QUAL, V5, pE78, DOI 10.1161/CIRCOUTCOMES.112.965368; Mezu U, 2011, AM J CARDIOL, V108, P718, DOI 10.1016/j.amjcard.2011.04.022; Mitchell JE, 2008, AM HEART J, V155, P501, DOI 10.1016/j.ahj.2007.10.022; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Namerow PB, 1999, PACE, V22, P1305, DOI 10.1111/j.1540-8159.1999.tb00623.x; Nanthakumar K, 2004, J AM COLL CARDIOL, V44, P2166, DOI 10.1016/j.jacc.2004.08.054; Noyes K, 2007, MED CARE, V45, P377, DOI 10.1097/01.mlr.0000257142.12600.c1; Piccini JP, 2011, HEART RHYTHM, V8, P393, DOI 10.1016/j.hrthm.2010.11.033; Russo AM, 2008, J CARDIOVASC ELECTR, V19, P720, DOI 10.1111/j.1540-8167.2008.01129.x; Santangeli P, 2011, ANN INTERN MED, V154, DOI 10.7326/0003-4819-154-7-201104050-00014; Santangeli P, 2010, ANN INTERN MED, V153, P592, DOI 10.7326/0003-4819-153-9-201011020-00009; Santangeli P, 2010, HEART RHYTHM, V7, P876, DOI 10.1016/j.hrthm.2010.03.042; Steinbeck G, 2009, NEW ENGL J MED, V361, P1427, DOI 10.1056/NEJMoa0901889; Strickberger SA, 2003, J AM COLL CARDIOL, V41, P1707, DOI 10.1016/S0735-1097(03)00297-3; Sun X, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c117; Tsai V, 2011, CIRC-CARDIOVASC QUAL, V4, P549, DOI 10.1161/CIRCOUTCOMES.110.959205; Uhlig K, 2013, Assessment on implantable defibrillators and the evidence for primary prevention of sudden cardiac death; Wallace BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-55; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; Wilber DJ, 2004, CIRCULATION, V109, P1082, DOI 10.1161/01.CIR.0000121328.12536.07; Zareba W, 2005, AM J CARDIOL, V95, P1487, DOI 10.1016/j.amjcard.2005.02.021	47	27	27	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 21	2014	160	2					111	+		10.7326/M13-1787	http://dx.doi.org/10.7326/M13-1787			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	297SQ	24592496				2022-12-28	WOS:000330275600017
J	Dent, WRF; Wyatt, MC; Roberge, A; Augereau, JC; Casassus, S; Corder, S; Greaves, JS; de Gregorio-Monsalvo, I; Hales, A; Jackson, AP; Hughes, AM; Lagrange, AM; Matthews, B; Wilner, D				Dent, W. R. F.; Wyatt, M. C.; Roberge, A.; Augereau, J-C; Casassus, S.; Corder, S.; Greaves, J. S.; de Gregorio-Monsalvo, I.; Hales, A.; Jackson, A. P.; Hughes, A. Meredith; Lagrange, A-M; Matthews, B.; Wilner, D.			Molecular Gas Clumps from the Destruction of Icy Bodies in the beta Pictoris Debris Disk	SCIENCE			English	Article							CIRCUMSTELLAR DISK; COLLISIONS; DUST; CO; VEGA; MYR	Many stars are surrounded by disks of dusty debris formed in the collisions of asteroids, comets, and dwarf planets, but is gas also released in such events? Observations at submillimeter wavelengths of the archetypal debris disk around beta Pictoris show that 0.3% of a Moon mass of carbon monoxide orbits in its debris belt. The gas distribution is highly asymmetric, with 30% found in a single clump 85 astronomical units from the star, in a plane closely aligned with the orbit of the inner planet, beta Pictoris b. This gas clump delineates a region of enhanced collisions, either from a mean motion resonance with an unseen giant planet or from the remnants of a collision of Mars-mass planets.	[Dent, W. R. F.; Corder, S.; de Gregorio-Monsalvo, I.; Hales, A.] Atacama Large Millimeter Submillimeter Array ALMA, Santiago Cent Off, Santiago, Chile; [Wyatt, M. C.; Jackson, A. P.] Univ Cambridge, Inst Astron, Cambridge CB3 0HA, England; [Roberge, A.] NASA, Exoplanets & Stellar Astrophys Lab, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Augereau, J-C; Lagrange, A-M] Univ Grenoble 1, CNRS, Inst Planetol & Astrophys Grenoble, Inst Natl Sci Univers,UMR 5274, F-38041 Grenoble, France; [Casassus, S.] Univ Chile, Dept Astron, Santiago, Chile; [Greaves, J. S.] Univ St Andrews, Dept Astron, St Andrews, Fife, Scotland; [de Gregorio-Monsalvo, I.] European So Observ, D-85748 Garching, Germany; [Jackson, A. P.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Hughes, A. Meredith] Wesleyan Univ, Dept Astron, Van Vleck Observ, Middletown, CT 06459 USA; [Matthews, B.] Natl Res Council Canada, Herzberg Astron Program, Victoria, BC V9E 2E7, Canada; [Matthews, B.] Natl Res Council Canada, Astrophys Program, Victoria, BC V9E 2E7, Canada; [Matthews, B.] Univ Victoria, Dept Phys & Astron, Victoria, BC V8P 5C2, Canada; [Wilner, D.] Smithsonian Astrophys Observ, Cambridge, MA 02138 USA	University of Cambridge; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Planetologie et d'Astrophysique de Grenoble (IPAG); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universidad de Chile; University of St Andrews; European Southern Observatory; Arizona State University; Arizona State University-Tempe; Wesleyan University; National Research Council Canada; National Research Council Canada; University of Victoria; Harvard University; Smithsonian Institution	Dent, WRF (corresponding author), Atacama Large Millimeter Submillimeter Array ALMA, Santiago Cent Off, Alonso de Cordova 3107,Casilla 763 0355, Santiago, Chile.	wdent@alma.cl	Roberge, Aki/D-2782-2012; Casassus, Simon/I-8609-2016; Jackson, Alan P./ABD-3887-2020	Roberge, Aki/0000-0002-2989-3725; Jackson, Alan P./0000-0003-4393-9520; de Gregorio-Monsalvo, Itziar/0000-0003-4518-407X	Millenium Nucleus (Chilean Ministry of Economy) [P10-022-F]; Goddard Center for Astrobiology, part of the NASA Astrobiology Institute; European Union through European Research Council [279973]; Ministerio de Ciencia e Innovacion (Spain) [AYA2011-30228-C03]; Science and Technology Facilities Council; French National Research Agency (ANR) [ANR-2010 BLAN-0505-01]; Science and Technology Facilities Council [ST/I505599/1, ST/J001651/1] Funding Source: researchfish; STFC [ST/I505599/1, ST/J001651/1] Funding Source: UKRI	Millenium Nucleus (Chilean Ministry of Economy); Goddard Center for Astrobiology, part of the NASA Astrobiology Institute; European Union through European Research Council; Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); French National Research Agency (ANR)(French National Research Agency (ANR)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This paper makes use of the following ALMA data: ADS/JAO. ALMA#2011.0.00087. S. ALMA is a partnership of ESO (representing its member states), NSF (USA), and National Institute of Natural Sciences (Japan), together with National Research Council (Canada) and National Science Council and Academia Sinica Institute of Astronomy and Astrophysics (Taiwan), in cooperation with the Republic of Chile. The Joint ALMA Observatory is operated by ESO, Associated Universities, Inc./National Radio Astronomy Observatory and National Astronomical Observatory of Japan. Partial financial support for S. Casassus, M. C. W. and A. H. was provided by Millenium Nucleus P10-022-F (Chilean Ministry of Economy). A. R. acknowledges support by the Goddard Center for Astrobiology, part of the NASA Astrobiology Institute. M. C. W. was supported by the European Union through European Research Council grant number 279973, I.d. G.-M. acknowledges support from Ministerio de Ciencia e Innovacion (Spain) grant number AYA2011-30228-C03 (including European Funds for Economic and Regional Development), A.P.J. was supported by a Science and Technology Facilities Council postgraduate studentship, and J.-C.A. acknowledges the French National Research Agency (ANR) for support through contract number ANR-2010 BLAN-0505-01 (EXOZODI).	Augereau JC, 2001, ASTRON ASTROPHYS, V370, P447, DOI 10.1051/0004-6361:20010199; Binks AS, 2014, MON NOT R ASTRON SOC, V438, pL11, DOI 10.1093/mnrasl/slt141; Brandeker A, 2004, ASTRON ASTROPHYS, V413, P681, DOI 10.1051/0004-6361:20034326; Chauvin G, 2012, ASTRON ASTROPHYS, V542, DOI 10.1051/0004-6361/201118346; Collings MP, 2003, ASTROPHYS J, V583, P1058, DOI 10.1086/345389; Dent WRF, 2000, MON NOT R ASTRON SOC, V314, P702, DOI 10.1046/j.1365-8711.2000.03331.x; Fernandez R, 2006, ASTROPHYS J, V643, P509, DOI 10.1086/500788; Golimowski DA, 2006, ASTRON J, V131, P3109, DOI 10.1086/503801; Grigorieva A, 2007, ASTRON ASTROPHYS, V475, P755, DOI 10.1051/0004-6361:20077686; Jackson AP, 2012, MON NOT R ASTRON SOC, V425, P657, DOI 10.1111/j.1365-2966.2012.21546.x; Kamp I, 2000, ASTRON ASTROPHYS, V353, P276; Li D, 2012, ASTROPHYS J, V759, DOI 10.1088/0004-637X/759/2/81; Oberg KI, 2011, ASTROPHYS J, V740, DOI 10.1088/0004-637X/740/2/109; Riviere-Marichalar P, 2012, ASTRON ASTROPHYS, V546, DOI 10.1051/0004-6361/201219745; Roberge A, 2000, ASTROPHYS J, V538, P904, DOI 10.1086/309157; Roberge A, 2006, NATURE, V441, P724, DOI 10.1038/nature04832; SMITH BA, 1984, SCIENCE, V226, P1421, DOI 10.1126/science.226.4681.1421; Stewart ST, 2012, ASTROPHYS J, V751, DOI 10.1088/0004-637X/751/1/32; Telesco CM, 2005, NATURE, V433, P133, DOI 10.1038/nature03255; TIELENS AGGM, 1994, ASTROPHYS J, V431, P321, DOI 10.1086/174488; van Leeuwen F, 2007, ASTRON ASTROPHYS, V474, P653, DOI 10.1051/0004-6361:20078357; VIDALMADJAR A, 1994, ASTRON ASTROPHYS, V290, P245; Visser R, 2009, ASTRON ASTROPHYS, V503, P323, DOI 10.1051/0004-6361/200912129; Wyatt MC, 2003, ASTROPHYS J, V598, P1321, DOI 10.1086/379064; Wyatt MC, 2006, ASTROPHYS J, V639, P1153, DOI 10.1086/499487; Xie JW, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/2/114; Zuckerman B, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/2/77	28	141	141	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2014	343	6178					1490	1492		10.1126/science.1248726	http://dx.doi.org/10.1126/science.1248726			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7TZ	24603151	Green Submitted			2022-12-28	WOS:000333471000041
J	Han, YC; Donovan, J; Rath, S; Whitney, G; Chitrakar, A; Korennykh, A				Han, Yuchen; Donovan, Jesse; Rath, Sneha; Whitney, Gena; Chitrakar, Alisha; Korennykh, Alexei			Structure of Human RNase L Reveals the Basis for Regulated RNA Decay in the IFN Response	SCIENCE			English	Article							UNFOLDED PROTEIN RESPONSE; DOUBLE-STRANDED-RNA; RIBONUCLEASE-L; CLEAVAGE; KINASE; IRE1; ACTIVATION; ENZYME; VIRUS; MICE	One of the hallmark mechanisms activated by type I interferons (IFNs) in human tissues involves cleavage of intracellular RNA by the kinase homology endoribonuclease RNase L. We report 2.8 and 2.1 angstrom crystal structures of human RNase L in complexes with synthetic and natural ligands and a fragment of an RNA substrate. RNase L forms a crossed homodimer stabilized by ankyrin (ANK) and kinase homology (KH) domains, which positions two kinase extension nuclease (KEN) domains for asymmetric RNA recognition. One KEN protomer recognizes an identity nucleotide (U), whereas the other protomer cleaves RNA between nucleotides +1 and +2. The coordinated action of the ANK, KH, and KEN domains thereby provides regulated, sequence-specific cleavage of viral and host RNA targets by RNase L.	[Han, Yuchen; Donovan, Jesse; Rath, Sneha; Whitney, Gena; Chitrakar, Alisha; Korennykh, Alexei] Princeton Univ, Dept Mol Biol, Schultz Lab 216, Princeton, NJ 08540 USA	Princeton University	Korennykh, A (corresponding author), Princeton Univ, Dept Mol Biol, Schultz Lab 216, Princeton, NJ 08540 USA.	akorenny@princeton.edu	Han, Yu/GZA-9220-2022; Rath, Sneha/AAC-4493-2019	Rath, Sneha/0000-0001-8839-1285	Princeton University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110161, T32GM007388, P41GM111244] Funding Source: NIH RePORTER	Princeton University(Princeton University); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. Hughson (Princeton University) and A. Korostelev (University of Massachusetts, Worcester) for reading the manuscript and making valuable suggestions. We thank the staff of Brookhaven National Laboratory for providing access to a synchrotron x-ray source. We are grateful to our colleagues at the Department of Molecular Biology for stimulating discussions and an excellent research environment. We thank Princeton University for supporting and funding our work. Coordinates have been deposited to the Protein Data Bank with accession codes 4OAU and 4OAU. Author contributions: Y.H., J.D., and A.K. determined the structures of RNase L. S.R. carried out biochemical studies of model RNA substrates. G.W. and A.C. carried out studies in HeLa cells Y.H. and A.K. wrote the manuscript A.K. supervised the work.	Carroll SS, 1996, J BIOL CHEM, V271, P4988; Chakrabarti A, 2011, J INTERF CYTOK RES, V31, P49, DOI 10.1089/jir.2010.0120; Dong BH, 1999, NUCLEIC ACIDS RES, V27, P439, DOI 10.1093/nar/27.2.439; Donovan J, 2013, P NATL ACAD SCI USA, V110, P1652, DOI 10.1073/pnas.1218528110; Han YC, 2012, CELL REP, V2, P902, DOI 10.1016/j.celrep.2012.09.004; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Huang H, 2014, MOL CELL, V53, P221, DOI 10.1016/j.molcel.2013.12.025; Hur KY, 2012, J EXP MED, V209, P307, DOI 10.1084/jem.20111298; Iordanov MS, 2000, MOL CELL BIOL, V20, P617, DOI 10.1128/MCB.20.2.617-627.2000; Kimmig P, 2012, ELIFE, V1, DOI 10.7554/eLife.00048; Korennykh AV, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-47; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Lee KPK, 2008, CELL, V132, P89, DOI 10.1016/j.cell.2007.10.057; Lin RJ, 2009, J IMMUNOL, V183, P8035, DOI 10.4049/jimmunol.0902728; So JS, 2012, CELL METAB, V16, P487, DOI 10.1016/j.cmet.2012.09.004; Tanaka N, 2004, EMBO J, V23, P3929, DOI 10.1038/sj.emboj.7600420; Turowec JP, 2010, METHOD ENZYMOL, V484, P471, DOI [10.1016/S0076-6879(10)84023-6, 10.1016/B978-0-12-381298-8.00023-X]; Upton JP, 2012, SCIENCE, V338, P818, DOI 10.1126/science.1226191; Washenberger CL, 2007, VIRUS RES, V130, P85, DOI 10.1016/j.virusres.2007.05.020; WRESCHNER DH, 1981, NATURE, V289, P414, DOI 10.1038/289414a0	20	102	104	5	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2014	343	6176					1244	1248		10.1126/science.1249845	http://dx.doi.org/10.1126/science.1249845			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC7RG	24578532	Green Accepted			2022-12-28	WOS:000332728500035
J	Held, I				Held, Isaac			Simplicity Amid Complexity	SCIENCE			English	Editorial Material							CLIMATE; LATITUDE; FUTURE		NOAA, Geophys Fluid Dynam Lab, Princeton, NJ 08540 USA	National Oceanic Atmospheric Admin (NOAA) - USA	Held, I (corresponding author), NOAA, Geophys Fluid Dynam Lab, Forrestal Campus, Princeton, NJ 08540 USA.	isaac.held@noaa.gov						Abbot DS, 2009, J ATMOS SCI, V66, P519, DOI 10.1175/2008JAS2840.1; Clement A, 2014, SCIENCE, V343, P976, DOI 10.1126/science.1248115; Garfinkel CI, 2013, J CLIMATE, V26, P2077, DOI 10.1175/JCLI-D-12-00301.1; Hegerl G, 2014, SCIENCE, V343, P844, DOI 10.1126/science.1249368; Held IM, 2005, B AM METEOROL SOC, V86, P1609, DOI 10.1175/BAMS-86-11-1609; Nisbet EG, 2014, SCIENCE, V343, P493, DOI 10.1126/science.1247828; Rosenfeld D, 2014, SCIENCE, V343, P379, DOI 10.1126/science.1247490; Sherwood S, 2014, SCIENCE, V343, P737, DOI 10.1126/science.1247620; Sherwood SC, 2014, NATURE, V505, P37, DOI 10.1038/nature12829; Son SW, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014271; Thompson DWJ, 2002, SCIENCE, V296, P895, DOI 10.1126/science.1069270; Vecchi GA, 2014, SCIENCE, V343, P618, DOI 10.1126/science.1247759	12	27	28	1	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2014	343	6176					1206	1207		10.1126/science.1248447	http://dx.doi.org/10.1126/science.1248447			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC7RG	24626917				2022-12-28	WOS:000332728500022
J	Keenan, TF; Hollinger, DY; Bohrer, G; Dragoni, D; Munger, JW; Schmid, HP; Richardson, AD				Keenan, Trevor F.; Hollinger, David Y.; Bohrer, Gil; Dragoni, Danilo; Munger, J. William; Schmid, Hans Peter; Richardson, Andrew D.			Air pollution and forest water use reply	NATURE			English	Letter							CARBON-DIOXIDE		[Keenan, Trevor F.] Macquarie Univ, Dept Biol Sci, N Ryde, NSW 2109, Australia; [Hollinger, David Y.] US Forest Serv, USDA, No Res Stn, Durham, NH 03824 USA; [Bohrer, Gil] Ohio State Univ, Dept Civil Environm & Geodet Engn, Columbus, OH 43210 USA; [Dragoni, Danilo] Indiana Univ, Dept Geog, Bloomington, IN 47405 USA; [Munger, J. William] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Munger, J. William] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA; [Schmid, Hans Peter] Karlsruhe Inst Technol, IMK IFU, Inst Meteorol & Climate Res, D-82467 Garmisch Partenkirchen, Germany; [Richardson, Andrew D.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Macquarie University; United States Department of Agriculture (USDA); United States Forest Service; University System of Ohio; Ohio State University; Indiana University System; Indiana University Bloomington; Harvard University; Harvard University; Helmholtz Association; Karlsruhe Institute of Technology; Harvard University	Keenan, TF (corresponding author), Macquarie Univ, Dept Biol Sci, N Ryde, NSW 2109, Australia.	trevor.keenan@mq.edu.au	Bohrer, Gil/A-9731-2008; Schmid, Hans Peter/AAP-4450-2021; Schmid, Hans Peter E/I-1224-2012; Hollinger, David Y/G-7185-2012; Keenan, Trevor/AAY-7786-2020; Munger, J William/H-4502-2013; Richardson, Andrew/F-5691-2011; Keenan, Trevor F./B-2744-2010	Bohrer, Gil/0000-0002-9209-9540; Schmid, Hans Peter/0000-0001-9076-4466; Schmid, Hans Peter E/0000-0001-9076-4466; Keenan, Trevor/0000-0002-3347-0258; Munger, J William/0000-0002-1042-8452; Richardson, Andrew/0000-0002-0148-6714; Keenan, Trevor F./0000-0002-3347-0258				Cooper OR, 2010, NATURE, V463, P344, DOI 10.1038/nature08708; Cooper OR, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD018261; Holmes CD, 2014, NATURE, V507, pE1, DOI 10.1038/nature13113; Keenan TF, 2013, NATURE, V499, P324, DOI 10.1038/nature12291; Lombardozzi D, 2013, BIOGEOSCIENCES, V10, P6815, DOI 10.5194/bg-10-6815-2013; Medlyn B, 2013, NATURE, V499, P287, DOI 10.1038/nature12411; Parrish DD, 2012, ATMOS CHEM PHYS, V12, P11485, DOI 10.5194/acp-12-11485-2012	7	3	4	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2014	507	7491					E2	E3		10.1038/nature13114	http://dx.doi.org/10.1038/nature13114			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC6RJ	24622207				2022-12-28	WOS:000332651800002
J	Taylor, JP				Taylor, J. Paul			NEURODEGENERATIVE DISEASES G-quadruplex poses quadruple threat	NATURE			English	Editorial Material							AMYOTROPHIC-LATERAL-SCLEROSIS; RNA-BINDING PROTEINS; HEXANUCLEOTIDE REPEAT; C9ORF72; EXPANSION; DISORDERS; FOCI; ALS	Multiplication of repetitive DNA sequences is often the cause of neurodegenerative diseases. A four-stranded structure has been found to form in one such expansion in the gene C9orf72, altering gene function in four ways. SEE ARTICLE P.195	St Jude Childrens Res Hosp, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Taylor, JP (corresponding author), St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA.	jpaul.taylor@stjude.org	Taylor, J. Paul/N-2482-2018	Taylor, J. Paul/0000-0002-5794-0349				Abdelmohsen K, 2012, RNA BIOL, V9, P799, DOI 10.4161/rna.19718; Aguilera A, 2012, MOL CELL, V46, P115, DOI 10.1016/j.molcel.2012.04.009; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Ciura S, 2013, ANN NEUROL, V74, P180, DOI 10.1002/ana.23946; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Echeverria GV, 2012, BRAIN RES, V1462, P100, DOI 10.1016/j.brainres.2012.02.030; Fratta P, 2012, SCI REP-UK, V2, DOI 10.1038/srep01016; Gijselinck I, 2012, LANCET NEUROL, V11, P54, DOI 10.1016/S1474-4422(11)70261-7; Haeusler AR, 2014, NATURE, V507, P195, DOI 10.1038/nature13124; Lagier-Tourenne C, 2013, P NATL ACAD SCI USA, V110, pE4530, DOI 10.1073/pnas.1318835110; Lee YB, 2013, CELL REP, V5, P1178, DOI 10.1016/j.celrep.2013.10.049; Mori K, 2013, ACTA NEUROPATHOL, V125, P413, DOI 10.1007/s00401-013-1088-7; Reddy K, 2013, J BIOL CHEM, V288, P9860, DOI 10.1074/jbc.C113.452532; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Sareen D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007529; Therrien M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083450; Xi ZR, 2013, AM J HUM GENET, V92, P981, DOI 10.1016/j.ajhg.2013.04.017; Xu ZH, 2013, P NATL ACAD SCI USA, V110, P7778, DOI 10.1073/pnas.1219643110	19	25	27	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2014	507	7491					175	177		10.1038/nature13067	http://dx.doi.org/10.1038/nature13067			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC6RJ	24598546				2022-12-28	WOS:000332651800026
J	Borovsky, JE				Borovsky, Joseph E.			Feedback of the Magnetosphere	SCIENCE			English	Editorial Material							MAGNETOPAUSE; PLASMASPHERE		Ctr Space Plasma Phys, Space Sci Inst, Boulder, CO 80301 USA		Borovsky, JE (corresponding author), Ctr Space Plasma Phys, Space Sci Inst, Boulder, CO 80301 USA.	jborovsky@space-science.org						Valdivia JA, 2013, ADV SPACE RES, V51, P1934, DOI 10.1016/j.asr.2012.04.004; Birn J., 2007, RECONNECTION MAGNETI; Borovsky JE, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2005JA011397; Cassak PA, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2795630; CHAPPELL CR, 1971, J GEOPHYS RES, V76, P7632, DOI 10.1029/JA076i031p07632; Goldstein J, 2006, SPACE SCI REV, V124, P203, DOI 10.1007/s11214-006-9105-y; GONZALEZ WD, 1974, J GEOPHYS RES, V79, P4186, DOI 10.1029/JA079i028p04186; Luo A. C. J., 2010, DYNAMICAL SYSTEMS DI; Space Studies Board, 2008, SEV SPAC WEATH EV UN; Su YJ, 2000, J GEOPHYS RES-SPACE, V105, P7591, DOI 10.1029/1999JA000266; Vassiliadis D, 2006, REV GEOPHYS, V44, DOI 10.1029/2004RG000161; Walsh BM, 2014, SCIENCE, V343, P1122, DOI 10.1126/science.1247212; Walsh BM, 2013, J GEOPHYS RES-SPACE, V118, P4844, DOI 10.1002/jgra.50458	13	11	11	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2014	343	6175					1086	1087		10.1126/science.1250590	http://dx.doi.org/10.1126/science.1250590			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2LB	24604187				2022-12-28	WOS:000332331500031
J	Elkan, PN; Pierce, SB; Segel, R; Walsh, T; Barash, J; Padeh, S; Zlotogorski, A; Berkun, Y; Press, JJ; Mukamel, M; Voth, I; Hashkes, PJ; Harel, L; Hoffer, V; Ling, E; Yalcinkaya, F; Kasapcopur, O; Lee, MK; Klevit, RE; Renbaum, P; Weinberg-Shukron, A; Sener, EF; Schormair, B; Zeligson, S; Marek-Yagel, D; Strom, TM; Shohat, M; Singer, A; Rubinow, A; Pras, E; Winkelmann, J; Tekin, M; Anikster, Y; King, MC; Levy-Lahad, E				Elkan, Paulina Navon; Pierce, Sarah B.; Segel, Reeval; Walsh, Tom; Barash, Judith; Padeh, Shai; Zlotogorski, Abraham; Berkun, Yackov; Press, Joseph J.; Mukamel, Masha; Voth, Isabel; Hashkes, Philip J.; Harel, Liora; Hoffer, Vered; Ling, Eduard; Yalcinkaya, Fatos; Kasapcopur, Ozgur; Lee, Ming K.; Klevit, Rachel E.; Renbaum, Paul; Weinberg-Shukron, Ariella; Sener, Elif F.; Schormair, Barbara; Zeligson, Sharon; Marek-Yagel, Dina; Strom, Tim M.; Shohat, Mordechai; Singer, Amihood; Rubinow, Alan; Pras, Elon; Winkelmann, Juliane; Tekin, Mustafa; Anikster, Yair; King, Mary-Claire; Levy-Lahad, Ephrat			Mutant Adenosine Deaminase 2 in a Polyarteritis Nodosa Vasculopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GRANULOMATOSIS; CLASSIFICATION; CRITERIA; MICE	BackgroundPolyarteritis nodosa is a systemic necrotizing vasculitis with a pathogenesis that is poorly understood. We identified six families with multiple cases of systemic and cutaneous polyarteritis nodosa, consistent with autosomal recessive inheritance. In most cases, onset of the disease occurred during childhood. MethodsWe carried out exome sequencing in persons from multiply affected families of Georgian Jewish or German ancestry. We performed targeted sequencing in additional family members and in unrelated affected persons, 3 of Georgian Jewish ancestry and 14 of Turkish ancestry. Mutations were assessed by testing their effect on enzymatic activity in serum specimens from patients, analysis of protein structure, expression in mammalian cells, and biophysical analysis of purified protein. ResultsIn all the families, vasculitis was caused by recessive mutations in CECR1, the gene encoding adenosine deaminase 2 (ADA2). All the Georgian Jewish patients were homozygous for a mutation encoding a Gly47Arg substitution, the German patients were compound heterozygous for Arg169Gln and Pro251Leu mutations, and one Turkish patient was compound heterozygous for Gly47Val and Trp264Ser mutations. In the endogamous Georgian Jewish population, the Gly47Arg carrier frequency was 0.102, which is consistent with the high prevalence of disease. The other mutations either were found in only one family member or patient or were extremely rare. ADA2 activity was significantly reduced in serum specimens from patients. Expression in human embryonic kidney 293T cells revealed low amounts of mutant secreted protein. ConclusionsRecessive loss-of-function mutations of ADA2, a growth factor that is the major extracellular adenosine deaminase, can cause polyarteritis nodosa vasculopathy with highly varied clinical expression. (Funded by the Shaare Zedek Medical Center and others.) Adenosine deaminase 2 (ADA2) is a protein with at least two functions. It is a growth factor affecting leukocytes and endothelial cells and an enzyme that influences purine metabolism. This study shows that mutant ADA2 causes polyarteritis nodosa. Polyarteritis nodosa, first described in 1866,(1) is a systemic necrotizing vasculitis that affects medium and small muscular arteries.(2),(3) The ensuing tissue ischemia can affect any organ, including the skin, musculoskeletal system, kidneys, gastrointestinal tract, and the cardiovascular and nervous systems. Polyarteritis nodosa is usually diagnosed in middle age or later but can appear in childhood.(2),(4),(5) The diagnosis remains challenging despite classification criteria for adults(6) and children,(7) because polyarteritis nodosa frequently presents with nonspecific constitutional symptoms, and organ involvement and disease severity are highly varied. Polyarteritis nodosa is most often primary, but in adults it may be associated ...	[Elkan, Paulina Navon; Hashkes, Philip J.] Shaare Zedek Med Ctr, Pediat Rheumatol Unit, IL-91031 Jerusalem, Israel; [Segel, Reeval; Renbaum, Paul; Weinberg-Shukron, Ariella; Zeligson, Sharon; Levy-Lahad, Ephrat] Shaare Zedek Med Ctr, Inst Med Genet, IL-91031 Jerusalem, Israel; [Segel, Reeval; Zlotogorski, Abraham; Berkun, Yackov; Hashkes, Philip J.; Weinberg-Shukron, Ariella; Levy-Lahad, Ephrat] Hebrew Univ Jerusalem, Hadassah Med Ctr, Fac Med, Jerusalem, Israel; [Rubinow, Alan] Hadassah Hebrew Univ Med Ctr, Dept Dermatol, Jerusalem, Israel; [Zlotogorski, Abraham] Hadassah Hebrew Univ Med Ctr, Ctr Genet Dis Skin & Hair, Jerusalem, Israel; [Berkun, Yackov] Hadassah Hebrew Univ Med Ctr, Dept Pediat, Mt Scopus, Israel; [Barash, Judith] Kaplan Med Ctr, Pediat Day Care, Rehovot, Israel; [Padeh, Shai] Edmond & Lily Safra Childrens Hosp, Dept Pediat, Tel Hashomer, Israel; [Marek-Yagel, Dina; Anikster, Yair] Edmond & Lily Safra Childrens Hosp, Metab Dis Unit, Tel Hashomer, Israel; [Pras, Elon] Chaim Sheba Med Ctr, Danek Gertner Inst Human Genet, IL-52621 Tel Hashomer, Israel; [Padeh, Shai; Press, Joseph J.; Harel, Liora; Hoffer, Vered; Shohat, Mordechai; Pras, Elon; Anikster, Yair] Tel Aviv Univ, Sackler Fac Med, Ramat Aviv, Israel; [Press, Joseph J.; Mukamel, Masha; Harel, Liora] Schneider Childrens Med Ctr Israel, Petah Tiqwa, Israel; [Hoffer, Vered] Schneider Childrens Med Ctr Israel, Dept Pediat B, Petah Tiqwa, Israel; [Shohat, Mordechai] Rabin Med Ctr, Raphael Recanati Med Genet Inst, Petah Tiqwa, Israel; [Ling, Eduard] Soroka Univ Med Ctr, Pediat Rheumatol Unit, Beer Sheva, Israel; [Ling, Eduard] Soroka Univ Med Ctr, Dept Pediat B, Beer Sheva, Israel; [Singer, Amihood] Barzilai Govt Hosp, Genet Unit, Ashqelon, Israel; [Pierce, Sarah B.; Walsh, Tom; Lee, Ming K.; King, Mary-Claire] Univ Washington, Dept Med & Genome Sci, Seattle, WA 98195 USA; [Klevit, Rachel E.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Voth, Isabel; Winkelmann, Juliane] Tech Univ Munich, Dept Neurol, D-80290 Munich, Germany; [Schormair, Barbara; Strom, Tim M.] Tech Univ Munich, Inst Human Genet, D-80290 Munich, Germany; [Winkelmann, Juliane] Munich Cluster Syst Neurol, Munich, Germany; [Schormair, Barbara; Strom, Tim M.; Winkelmann, Juliane] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Yalcinkaya, Fatos; Tekin, Mustafa] Ankara Univ, Div Pediat Genet, Sch Med, TR-06100 Ankara, Turkey; [Kasapcopur, Ozgur] Istanbul Univ, Dept Pediat, Istanbul, Turkey; [Sener, Elif F.] Erciyes Univ, Dept Med Genet, Kayseri, Turkey; [Sener, Elif F.; Tekin, Mustafa] Univ Miami, Miller Sch Med, Hussman Inst Human Genom, Miami, FL 33136 USA; [Winkelmann, Juliane] Stanford Univ, Dept Neurol & Neurosci, Palo Alto, CA 94304 USA; [Winkelmann, Juliane] Stanford Univ, Ctr Sleep & Sleep Sci, Palo Alto, CA 94304 USA	Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Kaplan Medical Center; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Barzilai Medical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Ankara University; Istanbul University; Erciyes University; University of Miami; Stanford University	Levy-Lahad, E (corresponding author), Shaare Zedek Med Ctr, Inst Med Genet, POB 3235, IL-91031 Jerusalem, Israel.	lahad@szmc.org.il	Levy-Lahad, Ephrat/F-2186-2018; Tekin, Mustafa/ABG-7627-2020; Klevit, Rachel/AAI-7038-2021; Berkun, Yackov/A-1694-2009; Segel, Reeval/AAT-1498-2020; Kasapcopur, Ozgur/A-8888-2018; Yalcinkaya, Fatma Fatos/AAI-7277-2020; Sener, Elif Funda/AAL-8916-2021	Levy-Lahad, Ephrat/0000-0002-2637-1921; Klevit, Rachel/0000-0002-3476-969X; Berkun, Yackov/0000-0001-9823-4750; Kasapcopur, Ozgur/0000-0002-1125-7720; Winkelmann, Juliane/0000-0003-2667-9691; Pierce, Sarah/0000-0001-6739-7135; Walsh, Tom/0000-0002-8875-0310; Tekin, Mustafa/0000-0002-3525-7960; King, Mary-Claire/0000-0001-9426-1743	Shaare Zedek Medical Center; Technical University of Munich; Adler Cathedra for Pediatrics	Shaare Zedek Medical Center; Technical University of Munich; Adler Cathedra for Pediatrics	Supported by Shaare Zedek Medical Center, with a gift from David and Anita Fuld and with equipment donated by the Legacy Heritage Fund to the Medical Genetics Institute at Shaare Zedek Medical Center, Jerusalem, Israel (to Dr. Levy-Lahad); by unrestricted gifts to the King Laboratory at the University of Washington, Seattle (to Dr. King); by the Adler Cathedra for Pediatrics (to Dr. Shohat); and by a scholarship from the Technical University of Munich (to Dr. Schormair).	Dillon MJ, 2010, PEDIATR NEPHROL, V25, P1641, DOI 10.1007/s00467-009-1336-1; Footz TK, 2001, GENOME RES, V11, P1053, DOI 10.1101/gr.154901; Gaspar HB, 2009, BLOOD, V114, P3524, DOI 10.1182/blood-2009-06-189209; Giehl KA, 2012, AM J HUM GENET, V91, P754, DOI 10.1016/j.ajhg.2012.08.024; Guillevin L, 2005, MEDICINE, V84, P313, DOI 10.1097/01.md.0000180792.80212.5e; Gulati Shuchi, 2012, BMJ Case Rep, V2012, DOI 10.1136/bcr-2012-007123; Guo DC, 2008, NAT GENET, V40, P255, DOI 10.1038/ng0208-255c; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Jennette JC, 1997, NEW ENGL J MED, V337, P1512, DOI 10.1056/NEJM199711203372106; Karmouty-Quintana H, 2013, J MOL MED, V91, P173, DOI 10.1007/s00109-013-0997-1; Kussmaul A, 1866, DTSCH ARCH KLIN MED, P484; LIGHTFOOT RW, 1990, ARTHRITIS RHEUM, V33, P1088; Mahr A, 2004, ARTHRIT RHEUM-ARTHR, V51, P92, DOI 10.1002/art.20077; Milewicz DM, 2010, GENET MED, V12, P196, DOI 10.1097/GIM.0b013e3181cdd687; Navon-Elkan P, 2000, ANN RHEUM DIS S746, V59, P746; Ozen S, 2010, ANN RHEUM DIS, V69, P798, DOI 10.1136/ard.2009.116657; Riazi AM, 2005, TRANSGENIC RES, V14, P333, DOI 10.1007/s11248-005-1174-2; Sauer AV, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00265; SUSTER S, 1986, AM J DERMATOPATH, V8, P386, DOI 10.1097/00000372-198610000-00004; UCSC Genome Browser, DBSNP137; Walsh T, 2010, AM J HUM GENET, V87, P90, DOI 10.1016/j.ajhg.2010.05.010; Watts R, 2010, RHEUMATOLOGY, P1523; Weiss PF, 2012, PEDIATR CLIN N AM, V59, P407, DOI 10.1016/j.pcl.2012.03.013; Zavialov AV, 2010, J LEUKOCYTE BIOL, V88, P279, DOI 10.1189/jlb.1109764; Zavialov AV, 2010, J BIOL CHEM, V285, P12367, DOI 10.1074/jbc.M109.083527	25	399	408	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 6	2014	370	10					921	931		10.1056/NEJMoa1307362	http://dx.doi.org/10.1056/NEJMoa1307362			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC2EB	24552285				2022-12-28	WOS:000332309800009
J	Harper, L				Harper, Luke			We should start to quantify the environmental impact of different treatments	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Hosp St Denis La Reunion, Dept Pediat Surg, St Denis, Reunion, France	CHU Reunion	Harper, L (corresponding author), Univ Hosp St Denis La Reunion, Dept Pediat Surg, St Denis, Reunion, France.	harper_luke@hotmail.com						[Anonymous], 2013, LANCET, V382, P1154, DOI 10.1016/S0140-6736(13)62046-2; [Anonymous], 2013, LANCET, V381, P700, DOI 10.1016/S0140-6736(13)60564-4; Holmes D, 2013, LANCET DIABETES ENDO, V1, P93, DOI 10.1016/S2213-8587(13)70057-3; Huijbregts MAJ, 2008, ECOL ECON, V64, P798, DOI 10.1016/j.ecolecon.2007.04.017; Van der Vorst G, 2011, ENVIRON SCI TECHNOL, V45, P3040, DOI 10.1021/es1015907	5	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 6	2014	348								g1997	10.1136/bmj.g1997	http://dx.doi.org/10.1136/bmj.g1997			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC6IP	24603961				2022-12-28	WOS:000332625700008
J	Livio, M; Silk, J				Livio, Mario; Silk, Joe			Broaden the search for dark matter	NATURE			English	Editorial Material									[Livio, Mario] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Silk, Joe] Univ Paris 06, Inst Astrophys, Paris, France; [Silk, Joe] Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; [Silk, Joe] Univ Oxford, Beecroft Inst Particle Astrophys & Cosmol, Oxford OX1 2JD, England	Space Telescope Science Institute; UDICE-French Research Universities; Sorbonne Universite; Johns Hopkins University; University of Oxford	Livio, M (corresponding author), Space Telescope Sci Inst, 3700 San Martin Dr, Baltimore, MD 21218 USA.	mlivio@stsci.edu						Aalseth C, 2014, PREPRINT; Aguilar M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.141102; Bernabei R, 2013, EUR PHYS J C, V73, DOI 10.1140/epjc/s10052-013-2648-7; Bertone G, 2005, PHYS REP, V405, P279, DOI 10.1016/j.physrep.2004.08.031; Bertone G, 2010, NATURE, V468, P389, DOI 10.1038/nature09509; GOODMAN MW, 1985, PHYS REV D, V31, P3059, DOI 10.1103/PhysRevD.31.3059; Lockyer N, 2013, NATURE, V504, P367, DOI 10.1038/504367a; LUX Collaboration, 2013, PREPRINT; SILK J, 1984, PHYS REV LETT, V53, P624, DOI 10.1103/PhysRevLett.53.624; Viel M, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.043502	10	6	6	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					29	31		10.1038/507029a	http://dx.doi.org/10.1038/507029a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0ZQ	24605374	Bronze, Green Submitted			2022-12-28	WOS:000332224400025
J	Tebas, P; Stein, D; Tang, WW; Frank, I; Wang, SQ; Lee, G; Spratt, SK; Surosky, RT; Giedlin, MA; Nichol, G; Holmes, MC; Gregory, PD; Ando, DG; Kalos, M; Collman, RG; Binder-Scholl, G; Plesa, G; Hwang, WT; Levine, BL; June, CH				Tebas, Pablo; Stein, David; Tang, Winson W.; Frank, Ian; Wang, Shelley Q.; Lee, Gary; Spratt, S. Kaye; Surosky, Richard T.; Giedlin, Martin A.; Nichol, Geoff; Holmes, Michael C.; Gregory, Philip D.; Ando, Dale G.; Kalos, Michael; Collman, Ronald G.; Binder-Scholl, Gwendolyn; Plesa, Gabriela; Hwang, Wei-Ting; Levine, Bruce L.; June, Carl H.			Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RESISTANCE; RECEPTOR; HETEROZYGOSITY; INDIVIDUALS; CORECEPTOR; BINDING	BackgroundCCR5 is the major coreceptor for human immunodeficiency virus (HIV). We investigated whether site-specific modification of the gene (gene editing) in this case, the infusion of autologous CD4 T cells in which the CCR5 gene was rendered permanently dysfunctional by a zinc-finger nuclease (ZFN) is safe. MethodsWe enrolled 12 patients in an open-label, nonrandomized, uncontrolled study of a single dose of ZFN-modified autologous CD4 T cells. The patients had chronic aviremic HIV infection while they were receiving highly active antiretroviral therapy. Six of them underwent an interruption in antiretroviral treatment 4 weeks after the infusion of 10 billion autologous CD4 T cells, 11 to 28% of which were genetically modified with the ZFN. The primary outcome was safety as assessed by treatment-related adverse events. Secondary outcomes included measures of immune reconstitution and HIV resistance. ResultsOne serious adverse event was associated with infusion of the ZFN-modified autologous CD4 T cells and was attributed to a transfusion reaction. The median CD4 T-cell count was 1517 per cubic millimeter at week 1, a significant increase from the preinfusion count of 448 per cubic millimeter (P<0.001). The median concentration of CCR5-modified CD4 T cells at 1 week was 250 cells per cubic millimeter. This constituted 8.8% of circulating peripheral-blood mononuclear cells and 13.9% of circulating CD4 T cells. Modified cells had an estimated mean half-life of 48 weeks. During treatment interruption and the resultant viremia, the decline in circulating CCR5-modified cells (-1.81 cells per day) was significantly less than the decline in unmodified cells (-7.25 cells per day) (P=0.02). HIV RNA became undetectable in one of four patients who could be evaluated. The blood level of HIV DNA decreased in most patients. ConclusionsCCR5-modified autologous CD4 T-cell infusions are safe within the limits of this study. (Funded by the National Institute of Allergy and Infectious Diseases and others; ClinicalTrials.gov number, NCT00842634.) In this small study, investigators genetically disrupted the HIV receptor CCR5 in CD4 T cells of aviremic persons who were infected with HIV. After reinfusion and during viremia, the modified cells declined at a significantly slower rate than did the unmodified cells. The ability to make site-specific modifications to (or edit) the human genome has been an objective in medicine since the recognition of the gene as the basic unit of heredity.(1),(2) The challenge of genome editing is the ability to generate a single double-strand break at a specific point in the DNA molecule. Numerous agents, including meganucleases, oligonucleotides that form DNA triplexes, and peptide nucleic acids, have been tested and shown to be limited by inefficiency.(3)-(5) Another class of reagents, the zinc-finger nucleases (ZFNs), have proved versatile for genome editing, and the use of ZFNs is now well established ...	[Tebas, Pablo; Frank, Ian; Kalos, Michael; Collman, Ronald G.; Binder-Scholl, Gwendolyn; Plesa, Gabriela; Hwang, Wei-Ting; Levine, Bruce L.; June, Carl H.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Stein, David] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Tang, Winson W.; Wang, Shelley Q.; Lee, Gary; Spratt, S. Kaye; Surosky, Richard T.; Giedlin, Martin A.; Nichol, Geoff; Holmes, Michael C.; Gregory, Philip D.; Ando, Dale G.] Sangamo BioSci, Richmond, CA USA	University of Pennsylvania; Pennsylvania Medicine; Yeshiva University; Albert Einstein College of Medicine; Sangamo Therapeutics, Inc.	Tebas, P (corresponding author), Dept Med, Div Infect Dis, 502 Johnson Pavil,3610 Hamilton Walk, Philadelphia, PA 19104 USA.	pablo.tebas@uphs.upenn.edu; cjune@exchange.upenn.edu	Stein, David/CAA-3481-2022; Stein, David/AAE-9835-2022	Collman, Ronald/0000-0002-0508-3701; Gregory, Philip/0000-0001-9249-2468; Tebas, Pablo/0000-0001-5345-7942	National Institute of Allergy and Infectious Diseases [U19 AI066290]; Penn Center for AIDS Research [P30 AIO45008]; Penn Clinical Trials Unit [AIO69534]; Sangamo BioSciences; NATIONAL CANCER INSTITUTE [P30CA016520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI066290, P30AI045008, UM1AI069534] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Penn Center for AIDS Research; Penn Clinical Trials Unit; Sangamo BioSciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported in part by a grant from the National Institute of Allergy and Infectious Diseases (U19 AI066290), the Penn Center for AIDS Research (P30 AIO45008), the Penn Clinical Trials Unit (AIO69534), and Sangamo BioSciences.	Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Allers K, 2011, BLOOD, V117, P2791, DOI 10.1182/blood-2010-09-309591; Ashworth J, 2006, NATURE, V441, P656, DOI 10.1038/nature04818; Benner SA, 2005, NAT REV GENET, V6, P533, DOI 10.1038/nrg1637; Bitinaite J, 1998, P NATL ACAD SCI USA, V95, P10570, DOI 10.1073/pnas.95.18.10570; Carroll D, 2011, GENETICS, V188, P773, DOI 10.1534/genetics.111.131433; Chin JY, 2009, MOL CARCINOGEN, V48, P389, DOI 10.1002/mc.20501; Cohen OJ, 1997, J CLIN INVEST, V100, P1581, DOI 10.1172/JCI119682; Deeks SG, 2010, NAT BIOTECHNOL, V28, P807, DOI 10.1038/nbt0810-807; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; DiGiusto DL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000931; Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549; EugenOlsen J, 1997, AIDS, V11, P305, DOI 10.1097/00002030-199703110-00007; Gulick RM, 2008, NEW ENGL J MED, V359, P1429, DOI 10.1056/NEJMoa0803152; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Igoucheva O, 2004, CURR MOL MED, V4, P445, DOI 10.2174/1566524043360465; Kim KH, 2006, BIOCHEMISTRY-US, V45, P314, DOI 10.1021/bi051379a; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; Mitsuyasu RT, 2009, NAT MED, V15, P285, DOI 10.1038/nm.1932; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Riddell SR, 1996, NAT MED, V2, P216, DOI 10.1038/nm0296-216; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; SCHERER S, 1979, P NATL ACAD SCI USA, V76, P4951, DOI 10.1073/pnas.76.10.4951; Shimizu S, 2010, BLOOD, V115, P1534, DOI 10.1182/blood-2009-04-215855; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842	28	942	1039	7	333	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 6	2014	370	10					901	910		10.1056/NEJMoa1300662	http://dx.doi.org/10.1056/NEJMoa1300662			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC2EB	24597865	Green Accepted			2022-12-28	WOS:000332309800007
J	Kovats, S; Depledge, M; Haines, A; Fleming, LE; Wilkinson, P; Shonkoff, SB; Scovronick, N				Kovats, Sari; Depledge, Michael; Haines, Andy; Fleming, Lora E.; Wilkinson, Paul; Shonkoff, Seth B.; Scovronick, Noah			The health implications of fracking	LANCET			English	Editorial Material							DRINKING-WATER WELLS; SHALE; QUALITY		[Kovats, Sari; Haines, Andy; Wilkinson, Paul; Scovronick, Noah] Univ London London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1E 7HT, England; [Depledge, Michael] Univ Exeter, European Ctr Environm & Human Hlth, Sch Med, Exeter, Devon, England; [Fleming, Lora E.] Univ Exeter, European Ctr Environm & Human Hlth, Sch Med, Truro, England; [Shonkoff, Seth B.] Hth Energy, Oakland, CA USA; [Shonkoff, Seth B.] Univ Calif Berkeley, Berkeley, CA 94720 USA	University of London; London School of Hygiene & Tropical Medicine; University of Exeter; University of Exeter; University of California System; University of California Berkeley	Kovats, S (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, Keppel St, London WC1E 7HT, England.	sari.kovats@lshtm.ac.uk	Fleming, Lora E/ABH-1310-2021	Fleming, Lora E/0000-0003-1076-9967; Wilkinson, Paul/0000-0001-7456-259X; Depledge, Michael/0000-0002-7216-0439; Haines, Andy/0000-0002-8053-4605; Kovats, Sari/0000-0002-4823-8099; Scovronick, Noah/0000-0003-1410-3337				Broderick J, 2012, HAS US SHALE GAS RED; Brufatto C., 2003, OILFIELD REV, V15, P62; Esswein EJ, 2013, J OCCUP ENVIRON HYG, V10, P347, DOI 10.1080/15459624.2013.788352; Fontenot BE, 2013, ENVIRON SCI TECHNOL, V47, P10032, DOI 10.1021/es4011724; HM Government, 2012, GOV RESP ROYAL AC EN; Jackson RB, 2013, P NATL ACAD SCI USA, V110, P11250, DOI 10.1073/pnas.1221635110; Kassotis CD, 2014, ENDOCRINOLOGY, V155, P897, DOI 10.1210/en.2013-1697; McKenzie LM, 2012, SCI TOTAL ENVIRON, V424, P79, DOI 10.1016/j.scitotenv.2012.02.018; Petron G, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016360; Roy AA, 2014, J AIR WASTE MANAGE, V64, P19, DOI 10.1080/10962247.2013.826151; Royal Society and Royal Academy of Engineering, 2012, SHALE GAS EXTRACTION; Screen Australia, 2013, REV INT GAM AND MULT; Warner NR, 2013, ENVIRON SCI TECHNOL, V47, P11849, DOI 10.1021/es402165b	13	47	50	0	215	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2014	383	9919					757	758		10.1016/S0140-6736(13)62700-2	http://dx.doi.org/10.1016/S0140-6736(13)62700-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AC3EV	24581655				2022-12-28	WOS:000332398700004
J	Daumke, O; Roux, A; Haucke, V				Daumke, Oliver; Roux, Aurelien; Haucke, Volker			BAR Domain Scaffolds in Dynamin-Mediated Membrane Fission	CELL			English	Review							SYNAPTIC VESICLE ENDOCYTOSIS; CLATHRIN-COATED PITS; CRYSTAL-STRUCTURE; NERVE-TERMINALS; STRUCTURAL INSIGHTS; CONTAINING PROTEINS; SORTING NEXIN-9; SH3 DOMAIN; CURVATURE; ENDOPHILIN	Biological membranes undergo constant remodeling by membrane fission and fusion to change their shape and to exchange material between subcellular compartments. During clathrin-mediated endocytosis, the dynamic assembly and disassembly of protein scaffolds comprising members of the bin-amphiphysin-rvs (BAR) domain protein superfamily constrain the membrane into distinct shapes as the pathway progresses toward fission by the GTPase dynamin. In this Review, we discuss how BAR domain protein assembly and disassembly are controlled in space and time and which structural and biochemical features allow the tight regulation of their shape and function to enable dynamin-mediated membrane fission.	[Haucke, Volker] Leibniz Inst Mol Pharmakol FMP, D-13125 Berlin, Germany; [Haucke, Volker] Charite, D-10117 Berlin, Germany; [Daumke, Oliver] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Roux, Aurelien] Univ Geneva, Dept Biochem, CH-1211 Geneva 4, Switzerland; [Roux, Aurelien] Swiss Natl Ctr Competence Res, Programme Chem Biol, CH-1211 Geneva, Switzerland; [Daumke, Oliver] Free Univ Berlin, Inst Chem & Biochem, D-14195 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Geneva; Free University of Berlin	Daumke, O (corresponding author), Univ Geneva, Dept Biochem, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.	oliver.daumke@mdc-berlin.de; aurelien.roux@unige.ch; haucke@fmp-berlin.de	Roux, Aurelien R/G-9541-2013; Roux, Aurelien/AAU-1262-2021	Roux, Aurelien R/0000-0002-6088-0711; Haucke, Volker/0000-0003-3119-6993	Deutsche Forschungsgemeinschaft [SFB958/A01, SFB958/A12, SFB740/C07]; Career Development Awards from "The Human Frontier Science Program Organization" [CDA-00007/2009-C, CDA-0061-08]; Swiss National Fund for Research [31003A_130520]; European Research Council (ERC) [311536]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Career Development Awards from "The Human Frontier Science Program Organization"; Swiss National Fund for Research(Swiss National Science Foundation (SNSF)); European Research Council (ERC)(European Research Council (ERC))	Work in the authors' laboratories is supported by grants from the Deutsche Forschungsgemeinschaft (SFB958/A01, A07 to V.H. and SFB958/A12, SFB740/C07 both to O.D.), Career Development Awards from "The Human Frontier Science Program Organization" to O.D. (CDA-00007/2009-C) and to A.R. (CDA-0061-08) and by the Swiss National Fund for Research (grant No 31003A_130520) as well as the European Research Council (ERC Starting Grant No 311536, 2011 call) to A.R.	Aguet F, 2013, DEV CELL, V26, P279, DOI 10.1016/j.devcel.2013.06.019; Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Bhatia VK, 2009, EMBO J, V28, P3303, DOI 10.1038/emboj.2009.261; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Boucrot E, 2012, CELL, V149, P124, DOI 10.1016/j.cell.2012.01.047; Chang-Ileto B, 2011, DEV CELL, V20, P206, DOI 10.1016/j.devcel.2010.12.008; Chappie JS, 2011, CELL, V147, P209, DOI 10.1016/j.cell.2011.09.003; CHEN MS, 1991, NATURE, V351, P583, DOI 10.1038/351583a0; Cocucci E, 2012, CELL, V150, P495, DOI 10.1016/j.cell.2012.05.047; Cullen PJ, 2012, NAT CELL BIOL, V14, P29, DOI 10.1038/ncb2374; Danino D, 2004, J STRUCT BIOL, V147, P259, DOI 10.1016/j.jsb.2004.04.005; David C, 1996, P NATL ACAD SCI USA, V93, P331, DOI 10.1073/pnas.93.1.331; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dittman J, 2009, ANNU REV CELL DEV BI, V25, P133, DOI 10.1146/annurev.cellbio.042308.113302; Faelber K, 2012, STRUCTURE, V20, P1621, DOI 10.1016/j.str.2012.08.028; Faelber K, 2011, NATURE, V477, P556, DOI 10.1038/nature10369; Farsad K, 2003, NEUROPHARMACOLOGY, V45, P787, DOI 10.1016/S0028-3908(03)00306-X; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Ford MGJ, 2011, NATURE, V477, P561, DOI 10.1038/nature10441; Frohlich C, 2013, EMBO J, V32, P1280, DOI 10.1038/emboj.2013.74; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; Gehart H, 2012, DEV CELL, V23, P756, DOI 10.1016/j.devcel.2012.07.019; Henne WM, 2007, STRUCTURE, V15, P839, DOI 10.1016/j.str.2007.05.002; Henne WM, 2010, SCIENCE, V328, P1281, DOI 10.1126/science.1188462; HINSHAW JE, 1995, NATURE, V374, P190, DOI 10.1038/374190a0; Karotki L, 2011, J CELL BIOL, V195, P889, DOI 10.1083/jcb.201104040; Kinosita K, 2000, PHILOS T R SOC B, V355, P473, DOI 10.1098/rstb.2000.0589; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Koh TW, 2007, J CELL BIOL, V178, P309, DOI 10.1083/jcb.200701030; Kononenko NL, 2013, ELIFE, V2, DOI 10.7554/eLife.01233; Kozlov MM, 2010, TRENDS BIOCHEM SCI, V35, P699, DOI 10.1016/j.tibs.2010.06.003; Krauss M, 2006, P NATL ACAD SCI USA, V103, P11934, DOI 10.1073/pnas.0510306103; Lee M, 2013, NUCLEIC ACIDS RES, V41, P7023, DOI 10.1093/nar/gkt425; Liu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000204; Liu YW, 2011, P NATL ACAD SCI USA, V108, pE234, DOI 10.1073/pnas.1102710108; Lundmark R, 2003, J BIOL CHEM, V278, P46772, DOI 10.1074/jbc.M307334200; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Mears JA, 2007, STRUCTURE, V15, P1190, DOI 10.1016/j.str.2007.08.012; Mears JA, 2011, NAT STRUCT MOL BIOL, V18, P20, DOI 10.1038/nsmb.1949; Meinecke M, 2013, J BIOL CHEM, V288, P6651, DOI 10.1074/jbc.M112.444869; Milosevic I, 2011, NEURON, V72, P587, DOI 10.1016/j.neuron.2011.08.029; Mim C, 2012, TRENDS BIOCHEM SCI, V37, P526, DOI 10.1016/j.tibs.2012.09.001; Mim C, 2012, CELL, V149, P137, DOI 10.1016/j.cell.2012.01.048; Morlot S, 2012, CELL, V151, P619, DOI 10.1016/j.cell.2012.09.017; Neumann S, 2013, J BIOL CHEM, V288, P25119, DOI 10.1074/jbc.M113.490474; Owen DJ, 1998, EMBO J, V17, P5273, DOI 10.1093/emboj/17.18.5273; Pechstein A, 2010, P NATL ACAD SCI USA, V107, P4206, DOI 10.1073/pnas.0911073107; Perera RM, 2006, P NATL ACAD SCI USA, V103, P19332, DOI 10.1073/pnas.0609795104; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Posor Y, 2013, NATURE, V499, P233, DOI 10.1038/nature12360; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Pylypenko O, 2007, EMBO J, V26, P4788, DOI 10.1038/sj.emboj.7601889; Qualmann B, 2011, EMBO J, V30, P3501, DOI 10.1038/emboj.2011.266; Raimondi A, 2011, NEURON, V70, P1100, DOI 10.1016/j.neuron.2011.04.031; Ramachandran R, 2009, MOL BIOL CELL, V20, P4630, DOI 10.1091/mbc.E09-08-0683; Rao YJ, 2010, P NATL ACAD SCI USA, V107, P8213, DOI 10.1073/pnas.1003478107; Ringstad N, 1999, NEURON, V24, P143, DOI 10.1016/S0896-6273(00)80828-4; Romer W, 2010, CELL, V140, P540, DOI 10.1016/j.cell.2010.01.010; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Roux A, 2010, P NATL ACAD SCI USA, V107, P4141, DOI 10.1073/pnas.0913734107; Saheki Y, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005645; Schmid SL, 2011, ANNU REV CELL DEV BI, V27, P79, DOI 10.1146/annurev-cellbio-100109-104016; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Shnyrova AV, 2013, SCIENCE, V339, P1433, DOI 10.1126/science.1233920; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; Soulet F, 2005, MOL BIOL CELL, V16, P2058, DOI 10.1091/mbc.E04-11-1016; Sundborger A, 2011, J CELL SCI, V124, P133, DOI 10.1242/jcs.072686; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Taylor MJ, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001302; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Thieman JR, 2009, J BIOL CHEM, V284, P13924, DOI 10.1074/jbc.M901017200; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Vazquez FX, 2013, BIOPHYS J, V104, P396, DOI 10.1016/j.bpj.2012.12.009; Watanabe S, 2013, NATURE, V504, P242, DOI 10.1038/nature12809; Watanabe S, 2013, ELIFE, V2, DOI 10.7554/eLife.00723; Wu M, 2010, NAT CELL BIOL, V12, P902, DOI 10.1038/ncb2094; Yao LH, 2013, J NEUROSCI, V33, P15793, DOI 10.1523/JNEUROSCI.2171-13.2013; Yarar D, 2007, DEV CELL, V13, P43, DOI 10.1016/j.devcel.2007.04.014; Yoshida Y, 2004, EMBO J, V23, P3483, DOI 10.1038/sj.emboj.7600355; Zhao HX, 2013, CELL REP, V4, P1213, DOI 10.1016/j.celrep.2013.08.024	89	131	134	2	105	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 27	2014	156	5					882	892		10.1016/j.cell.2014.02.017	http://dx.doi.org/10.1016/j.cell.2014.02.017			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AB9BK	24581490	Bronze, Green Published			2022-12-28	WOS:000332083900008
J	Fathi, AT; Dec, GW; Richter, JM; Chen, YB; Schwartzenberg, SS; Holmvang, G; Hasserjian, RP				Fathi, Amir T.; Dec, G. William, Jr.; Richter, James M.; Chen, Yi-Bin; Schwartzenberg, Shmuel S.; Holmvang, Godtfred; Hasserjian, Robert P.			Case 7-2014: A 27-Year-Old Man with Diarrhea, Fatigue, and Eosinophilia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IDIOPATHIC-HYPEREOSINOPHILIC-SYNDROME; BONE-MARROW-TRANSPLANTATION; IMATINIB MESYLATE; SYSTEMIC MASTOCYTOSIS; BLOOD EOSINOPHILIA; DRESS SYNDROME; DISORDERS; THERAPY; FUSION; GENE	A 27-year-old man was admitted to the hospital because of diarrhea, fatigue, and eosinophilia. He had a history of ulcerative colitis, controlled with mesalamine. Examination revealed splenomegaly. Diagnostic procedures were performed. Presentation of CaseDr. Tilak Sundaresan (Medicine): A 27-year-old man was admitted to this hospital because of diarrhea, fatigue, and eosinophilia. The patient had been in good health until 2 weeks before admission, when fatigue developed. Eleven days before presentation, he had moved to the United States from Indonesia. After his arrival, he had bloating and nonbloody, loose bowel movements, without fever, chills, vomiting, cramping, or abdominal pain. One week later, the diarrhea persisted and his exercise tolerance sharply decreased. The day before admission, he was seen at his local health center. Testing included a complete blood count (Table 1) ...	[Fathi, Amir T.; Dec, G. William, Jr.; Richter, James M.; Chen, Yi-Bin; Schwartzenberg, Shmuel S.; Holmvang, Godtfred] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA 02130 USA; [Hasserjian, Robert P.] Harvard Univ, Sch Med, Dept Pathol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Fathi, Amir T.; Dec, G. William, Jr.; Richter, James M.; Chen, Yi-Bin; Schwartzenberg, Shmuel S.; Holmvang, Godtfred] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Hasserjian, Robert P.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Fathi, AT (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med, Boston, MA 02130 USA.				Genzyme; Seattle Genetics; Concert Pharmaceuticals; Agios Pharmaceuticals; Teva Pharmaceuticals; Policy Analysis; Otsuka Pharmaceuticals; Bayer/Onyx; Sanofi; Incyte; Amgen	Genzyme(Sanofi-AventisGenzyme Corporation); Seattle Genetics; Concert Pharmaceuticals; Agios Pharmaceuticals; Teva Pharmaceuticals(Teva Pharmaceutical Industries); Policy Analysis; Otsuka Pharmaceuticals(Otsuka Pharmaceutical); Bayer/Onyx(Bayer AG); Sanofi; Incyte; Amgen(Amgen)	Dr. Fathi reports receiving consulting fees for serving on the advisory boards of Genzyme, Seattle Genetics, Concert Pharmaceuticals, Agios Pharmaceuticals, and Teva Pharmaceuticals; Dr. Richter, consulting fees from Policy Analysis; Dr. Chen, consulting fees from Seattle Genetics and Otsuka Pharmaceuticals and grant funding from Seattle Genetics, Otsuka Pharmaceuticals, and Bayer/Onyx; and Dr. Hasserjian, consulting fees from Sanofi, Incyte, and Amgen. No other potential conflict of interest relevant to this article was reported.	Apperley JF, 2002, NEW ENGL J MED, V347, P481, DOI 10.1056/NEJMoa020150; ARCHIMBAUD E, 1988, AM J HEMATOL, V27, P302, DOI 10.1002/ajh.2830270414; Atanes A, 1996, SCAND J RHEUMATOL, V25, P183, DOI 10.3109/03009749609080013; Balian A, 2001, J HEPATOL, V34, P355, DOI 10.1016/S0168-8278(00)00091-X; Baumgartner C, 2008, EXP HEMATOL, V36, P1244, DOI 10.1016/j.exphem.2008.04.017; Beishuizen A, 1999, LANCET, V353, P1675, DOI 10.1016/S0140-6736(99)01346-X; BENFIELD GFA, 1986, POSTGRAD MED J, V62, P1101, DOI 10.1136/pgmj.62.734.1101; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; Butterfield JH, 2005, ACTA HAEMATOL-BASEL, V114, P26, DOI 10.1159/000085560; BUTTERFIELD JH, 1994, J ALLERGY CLIN IMMUN, V94, P1318, DOI 10.1016/0091-6749(94)90348-4; Butterfield JH, 2009, LEUKEMIA RES, V33, P1127, DOI 10.1016/j.leukres.2008.12.001; Cacoub P, 2011, AM J MED, V124, P588, DOI 10.1016/j.amjmed.2011.01.017; Chun W, 2004, CIRCULATION, V110, pE19, DOI 10.1161/01.CIR.0000135586.94417.3C; CHUSID MJ, 1975, MEDICINE, V54, P1, DOI 10.1097/00005792-197501000-00001; CHUSID MJ, 1975, AM J MED, V59, P297, DOI 10.1016/0002-9343(75)90368-X; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; David M, 2007, BLOOD, V109, P61, DOI 10.1182/blood-2006-05-024828; Erben P, 2010, HAEMATOL-HEMATOL J, V95, P738, DOI 10.3324/haematol.2009.016345; EstevaLorenzo FJ, 1996, AM J HEMATOL, V51, P164, DOI 10.1002/(SICI)1096-8652(199602)51:2<164::AID-AJH12>3.0.CO;2-I; Farahi N, 2012, BLOOD, V120, P4068, DOI 10.1182/blood-2012-07-443424; FAUCI AS, 1982, ANN INTERN MED, V97, P78, DOI 10.7326/0003-4819-97-1-78; Fukushima K, 2009, J BIOL CHEM, V284, P7719, DOI 10.1074/jbc.M807489200; Ganeva M, 2008, INT J DERMATOL, V47, P853, DOI 10.1111/j.1365-4632.2008.03637.x; GILL GV, 1989, ANN TROP MED PARASIT, V83, P249, DOI 10.1080/00034983.1989.11812339; Ginsberg Fredric, 2005, Heart Fail Clin, V1, P419, DOI 10.1016/j.hfc.2005.06.013; Gotlib J, 2011, AM J HEMATOL, V86, P678, DOI 10.1002/ajh.22062; Gotlib J, 2010, CURR OPIN HEMATOL, V17, P117, DOI 10.1097/MOH.0b013e3283366c70; Grau Rafael G, 2008, Curr Rheumatol Rep, V10, P453; GRIMALDI JC, 1989, BLOOD, V73, P2081; Helbig G, 2009, HAEMATOL-HEMATOL J, V94, P1236, DOI 10.3324/haematol.2008.005447; KAPLAN MH, 1991, AM J MED, V91, P300, DOI 10.1016/0002-9343(91)90132-H; Klion AD, 2003, BLOOD, V101, P4660, DOI 10.1182/blood-2003-01-0006; Lammel V, 2012, LUNG CANCER, V76, P493, DOI 10.1016/j.lungcan.2012.02.014; LIBMAN MD, 1993, CLIN INFECT DIS, V17, P353, DOI 10.1093/clinids/17.3.353; Macdonald D, 2002, ACTA HAEMATOL-BASEL, V107, P101, DOI 10.1159/000046639; Meltzer E, 2008, AM J TROP MED HYG, V78, P702, DOI 10.4269/ajtmh.2008.78.702; Morice AH, 1997, LANCET, V350, P1105, DOI 10.1016/S0140-6736(05)70471-2; NAVARROROMAN L, 1994, AM J SURG PATHOL, V18, P347, DOI 10.1097/00000478-199404000-00003; Noh G, 2010, ALLERGY ASTHMA PROC, V31, pE18, DOI 10.2500/aap.2010.31.3312; NUTMAN TB, 1987, J INFECT DIS, V155, P309, DOI 10.1093/infdis/155.2.309; Ogbogu PU, 2009, J ALLERGY CLIN IMMUN, V124, P1319, DOI 10.1016/j.jaci.2009.09.022; Pardanani A, 2003, BLOOD, V102, P3093, DOI 10.1182/blood-2003-05-1627; Pardanani A, 2003, BLOOD, V101, P3391, DOI 10.1182/blood-2002-10-3103; PARRILLO JE, 1978, ANN INTERN MED, V89, P167, DOI 10.7326/0003-4819-89-2-167; Plotz S, 2003, NEW ENGL J MED, V349, P2334, DOI 10.1056/NEJMoa031261; Popovici C, 1999, BLOOD, V93, P1381, DOI 10.1182/blood.V93.4.1381.404k30_1381_1389; Renston JP, 2000, MAYO CLIN PROC, V75, P586, DOI 10.4065/75.6.586; Sadrzadeh H, 2011, DISCOV MED, V12, P481; SAMOSZUK M, 1990, BLOOD, V75, P13; SIGMUND DA, 1995, BONE MARROW TRANSPL, V15, P647; Skiest DJ, 1997, AM J MED, V102, P449, DOI 10.1016/S0002-9343(97)00048-X; Tefferi A, 2010, MAYO CLIN PROC, V85, P158, DOI 10.4065/mcp.2009.0503; Terrier B, 2007, AM J GASTROENTEROL, V102, P1132, DOI 10.1111/j.1572-0241.2007.01180_9.x; Ueno NT, 2002, BRIT J HAEMATOL, V119, P131, DOI 10.1046/j.1365-2141.2002.03771.x; Valent P, 2012, EXPERT REV HEMATOL, V5, P157, DOI [10.1586/EHM.11.81, 10.1586/ehm.11.81]; Verstovsek S, 2006, LEUKEMIA RES, V30, P1499, DOI 10.1016/j.leukres.2006.03.012; Verstovsek S, 2009, CLIN CANCER RES, V15, P368, DOI 10.1158/1078-0432.CCR-08-1302; WELLER PF, 1994, BLOOD, V83, P2759, DOI 10.1182/blood.V83.10.2759.2759; WELLER PF, 1992, MED CLIN N AM, V76, P1413, DOI 10.1016/S0025-7125(16)30294-2; Xiao S, 1998, NAT GENET, V18, P84, DOI 10.1038/ng0198-84	60	9	9	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 27	2014	370	9					861	872		10.1056/NEJMcpc1302331	http://dx.doi.org/10.1056/NEJMcpc1302331			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB8AR	24571759				2022-12-28	WOS:000332013000012
J	McGloin, D				McGloin, David			APPLIED PHYSICS Optical trapping for space mirrors	NATURE			English	Editorial Material									Univ Dundee, Div Phys, Dundee DD1 4HN, Scotland	University of Dundee	McGloin, D (corresponding author), Univ Dundee, Div Phys, Dundee DD1 4HN, Scotland.	d.mcgloin@dundee.ac.uk	McGloin, David/J-6167-2018	McGloin, David/0000-0002-0075-4481				BURNS MM, 1990, SCIENCE, V249, P749, DOI 10.1126/science.249.4970.749; Grzegorczyk TM, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.023902; Labeyrie A, 2010, ASTR SOC P, V430, P239; LABEYRIE A, 1979, ASTRON ASTROPHYS, V77, pL1	4	0	0	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2014	506	7489					437	438		10.1038/506437a	http://dx.doi.org/10.1038/506437a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0DN	24572418				2022-12-28	WOS:000332165100024
J	Tewari, KS; Sill, MW; Long, HJ; Penson, RT; Huang, H; Ramondetta, LM; Landrum, LM; Oaknin, A; Reid, TJ; Leitao, MM; Michael, HE; Monk, BJ				Tewari, Krishnansu S.; Sill, Michael W.; Long, Harry J., III; Penson, Richard T.; Huang, Helen; Ramondetta, Lois M.; Landrum, Lisa M.; Oaknin, Ana; Reid, Thomas J.; Leitao, Mario M.; Michael, Helen E.; Monk, Bradley J.			Improved Survival with Bevacizumab in Advanced Cervical Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GYNECOLOGIC-ONCOLOGY-GROUP; SQUAMOUS-CELL CARCINOMA; ENDOTHELIAL GROWTH-FACTOR; RANDOMIZED-TRIAL; UTERINE CERVIX; PHASE-II; CISPLATIN; RECURRENT; PERSISTENT; TOPOTECAN	BackgroundVascular endothelial growth factor (VEGF) promotes angiogenesis, a mediator of disease progression in cervical cancer. Bevacizumab, a humanized anti-VEGF monoclonal antibody, has single-agent activity in previously treated, recurrent disease. Most patients in whom recurrent cervical cancer develops have previously received cisplatin with radiation therapy, which reduces the effectiveness of cisplatin at the time of recurrence. We evaluated the effectiveness of bevacizumab and nonplatinum combination chemotherapy in patients with recurrent, persistent, or metastatic cervical cancer. MethodsUsing a 2-by-2 factorial design, we randomly assigned 452 patients to chemotherapy with or without bevacizumab at a dose of 15 mg per kilogram of body weight. Chemotherapy consisted of cisplatin at a dose of 50 mg per square meter of body-surface area, plus paclitaxel at a dose of 135 or 175 mg per square meter or topotecan at a dose of 0.75 mg per square meter on days 1 to 3, plus paclitaxel at a dose of 175 mg per square meter on day 1. Cycles were repeated every 21 days until disease progression, the development of unacceptable toxic effects, or a complete response was documented. The primary end point was overall survival; a reduction of 30% in the hazard ratio for death was considered clinically important. ResultsGroups were well balanced with respect to age, histologic findings, performance status, previous use or nonuse of a radiosensitizing platinum agent, and disease status. Topotecan-paclitaxel was not superior to cisplatin-paclitaxel (hazard ratio for death, 1.20). With the data for the two chemotherapy regimens combined, the addition of bevacizumab to chemotherapy was associated with increased overall survival (17.0 months vs. 13.3 months; hazard ratio for death, 0.71; 98% confidence interval, 0.54 to 0.95; P=0.004 in a one-sided test) and higher response rates (48% vs. 36%, P=0.008). Bevacizumab, as compared with chemotherapy alone, was associated with an increased incidence of hypertension of grade 2 or higher (25% vs. 2%), thromboembolic events of grade 3 or higher (8% vs. 1%), and gastrointestinal fistulas of grade 3 or higher (3% vs. 0%). ConclusionsThe addition of bevacizumab to combination chemotherapy in patients with recurrent, persistent, or metastatic cervical cancer was associated with an improvement of 3.7 months in median overall survival. (Funded by the National Cancer Institute; GOG 240 ClinicalTrials.gov number, NCT00803062.)	[Tewari, Krishnansu S.] Univ Calif Irvine, Med Ctr, Orange, CA 92868 USA; [Sill, Michael W.; Huang, Helen] SUNY Buffalo, Roswell Pk Canc Inst, Buffalo, NY 14260 USA; [Long, Harry J., III] Mayo Clin, Rochester, MN USA; [Penson, Richard T.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Ramondetta, Lois M.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Landrum, Lisa M.] Univ Oklahoma, Oklahoma City, OK USA; [Oaknin, Ana] Vall dHebron Univ Hosp, Barcelona, Spain; [Reid, Thomas J.] Univ Cincinnati, Coll Med, Womens Canc Ctr Kettering, Kettering, OH USA; [Leitao, Mario M.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Michael, Helen E.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Monk, Bradley J.] Univ Arizona, Ctr Canc, Phoenix, AZ USA; [Monk, Bradley J.] Creighton Univ, St Josephs Hosp & Med Ctr, Phoenix, AZ USA	University of California System; University of California Irvine; Roswell Park Cancer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Mayo Clinic; Harvard University; Massachusetts General Hospital; University of Texas System; UTMD Anderson Cancer Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Hospital Universitari Vall d'Hebron; University System of Ohio; University of Cincinnati; Memorial Sloan Kettering Cancer Center; Indiana University System; Indiana University Bloomington; University of Arizona; Creighton University; St. Joseph's Hospital and Medical Center	Tewari, KS (corresponding author), Univ Calif Irvine, Med Ctr, Div Gynecol Oncol, 101 City Dr S,Bldg 56, Orange, CA 92868 USA.	ktewari@uci.edu			NATIONAL CANCER INSTITUTE [U10CA180858, P30CA016672, U10CA037517] Funding Source: NIH RePORTER; NCI NIH HHS [U10 CA180858, UG1 CA233329, U10 CA037517, P30 CA016672] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 2011, COMM TERM CRIT ADV E; Bahadori HR, 2001, CANCER CHEMOTH PHARM, V48, P188, DOI 10.1007/s002800100327; Bloss JD, 2002, J CLIN ONCOL, V20, P1832, DOI 10.1200/JCO.2002.07.045; Bodily JM, 2011, CANCER RES, V71, P1187, DOI 10.1158/0008-5472.CAN-10-2626; BONOMI P, 1985, J CLIN ONCOL, V3, P1079, DOI 10.1200/JCO.1985.3.8.1079; Cancer Therapy Evaluation Program, 2006, COMM TERM CRIT ADV E; Cella D, 1997, MANUAL FUNCTIONAL AS; Clere N, 2007, EXP CELL RES, V313, P3239, DOI 10.1016/j.yexcr.2007.06.029; COX DR, 1972, J R STAT SOC B, V34, P187; Diggle P., 1993, ANAL LONGITUDINAL DA; Ferrara N, 2004, NAT REV DRUG DISCOV, V3, P391, DOI 10.1038/nrd1381; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Long HJ, 2005, J CLIN ONCOL, V23, P4626, DOI 10.1200/JCO.2005.10.021; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; MCGUIRE WP, 1989, J CLIN ONCOL, V7, P1462, DOI 10.1200/JCO.1989.7.10.1462; Monk BJ, 2007, J CLIN ONCOL, V25, P2952, DOI 10.1200/JCO.2007.10.8324; Monk BJ, 2010, J CLIN ONCOL, V28, P3562, DOI 10.1200/JCO.2009.26.9571; Monk BJ, 2009, J CLIN ONCOL, V27, P4649, DOI 10.1200/JCO.2009.21.8909; Monk BJ, 2009, J CLIN ONCOL, V27, P1069, DOI 10.1200/JCO.2008.18.9043; Moore DH, 2010, GYNECOL ONCOL, V116, P44, DOI 10.1016/j.ygyno.2009.09.006; Moore DH, 2004, J CLIN ONCOL, V22, P3113, DOI 10.1200/JCO.2004.04.170; No JH, 2009, ANN NY ACAD SCI, V1171, P105, DOI 10.1111/j.1749-6632.2009.04891.x; Omura GA, 1997, J CLIN ONCOL, V15, P165, DOI 10.1200/JCO.1997.15.1.165; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Tang XD, 2007, CLIN CANCER RES, V13, P2568, DOI 10.1158/1078-0432.CCR-06-2704; Tewari Krishnansu S, 2005, Curr Oncol Rep, V7, P419, DOI 10.1007/s11912-005-0007-z; Tewari KS, 2009, ONKOLOGIE, V32, P552, DOI 10.1159/000232385; Tewari KS, 2009, SEMIN ONCOL, V36, P170, DOI 10.1053/j.seminoncol.2008.12.008; Tewari Krishnansu Sujata, 2010, Clin Adv Hematol Oncol, V8, P108; Tewari KS, 2000, GYNECOL ONCOL, V77, P137, DOI 10.1006/gyno.2000.5729; Tewari KS, 2012, CLIN GYNECOLOGIC ONC; Tewari KS., 2011, CLIN OVARIAN CANC, V4, P90; Tewari KS., 2010, AM J HEMATOL ONCOL, V9, P31; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; THIGPEN JT, 1989, GYNECOL ONCOL, V32, P198, DOI 10.1016/S0090-8258(89)80033-2; Tiersten AD, 2004, GYNECOL ONCOL, V92, P635, DOI 10.1016/j.ygyno.2003.11.019; WIEAND S, 1994, STAT MED, V13, P1453, DOI 10.1002/sim.4780131321	38	858	915	4	95	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 20	2014	370	8					734	743		10.1056/NEJMoa1309748	http://dx.doi.org/10.1056/NEJMoa1309748			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB1DO	24552320	Green Accepted, Green Published			2022-12-28	WOS:000331531900008
J	Gologorsky, D				Gologorsky, Daniel			On Vision and Perception	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Anne Bates Leach Eye Hosp, Bascom Palmer Eye Inst, Dept Ophthalmol, Miami, FL 33136 USA	Bascom Palmer Eye Institute	Gologorsky, D (corresponding author), Anne Bates Leach Eye Hosp, Bascom Palmer Eye Inst, Dept Ophthalmol, Miami, FL 33136 USA.	dg255@cornell.edu							0	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 19	2014	311	7					675	676		10.1001/jama.2013.286180	http://dx.doi.org/10.1001/jama.2013.286180			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA8ZO	24549544				2022-12-28	WOS:000331383700016
J	Granwehr, B				Granwehr, Bruno			Review: Influenza vaccination reduces cardiovascular events in adults	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Granwehr, B (corresponding author), Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA.		Granwehr, Bruno/S-3997-2019	Granwehr, Bruno/0000-0002-5143-6416				Grohskopf LA, 2013, MMWR RECOMM REP, V62, P1; Hung IFN, 2010, CLIN INFECT DIS, V51, P1007, DOI 10.1086/656587	2	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 18	2014	160	4							JC2	10.7326/0003-4819-160-4-201402180-02002	http://dx.doi.org/10.7326/0003-4819-160-4-201402180-02002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC8RF	24534936				2022-12-28	WOS:000350635100001
J	Vlad, D; Kierzkowski, D; Rast, MI; Vuolo, F; Dello Ioio, R; Galinha, C; Gan, XC; Hajheidari, M; Hay, A; Smith, RS; Huijser, P; Bailey, CD; Tsiantis, M				Vlad, Daniela; Kierzkowski, Daniel; Rast, Madlen I.; Vuolo, Francesco; Dello Ioio, Raffaele; Galinha, Carla; Gan, Xiangchao; Hajheidari, Mohsen; Hay, Angela; Smith, Richard S.; Huijser, Peter; Bailey, C. Donovan; Tsiantis, Miltos			Leaf Shape Evolution Through Duplication, Regulatory Diversification, and Loss of a Homeobox Gene	SCIENCE			English	Article							RELATIVE CARDAMINE-HIRSUTA; ARABIDOPSIS-THALIANA; MORPHOGENESIS; PATTERNS; FRAMEWORK; MERISTEM; GROWTH; LEAVES	In this work, we investigate morphological differences between Arabidopsis thaliana, which has simple leaves, and its relative Cardamine hirsuta, which has dissected leaves comprising distinct leaflets. With the use of genetics, interspecific gene transfers, and time-lapse imaging, we show that leaflet development requires the REDUCED COMPLEXITY (RCO) homeodomain protein. RCO functions specifically in leaves, where it sculpts developing leaflets by repressing growth at their flanks. RCO evolved in the Brassicaceae family through gene duplication and was lost in A. thaliana, contributing to leaf simplification in this species. Species-specific RCO action with respect to its paralog results from its distinct gene expression pattern in the leaf base. Thus, regulatory evolution coupled with gene duplication and loss generated leaf shape diversity by modifying local growth patterns during organogenesis.	[Vlad, Daniela; Galinha, Carla; Tsiantis, Miltos] Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England; [Kierzkowski, Daniel; Rast, Madlen I.; Vuolo, Francesco; Dello Ioio, Raffaele; Gan, Xiangchao; Hajheidari, Mohsen; Hay, Angela; Smith, Richard S.; Huijser, Peter; Tsiantis, Miltos] Max Planck Inst Plant Breeding Res, Dept Comparat Dev & Genet, D-50829 Cologne, Germany; [Galinha, Carla] Oxford Brookes Univ, Fac Hlth & Life Sci, Dept Biol & Med Sci, Oxford OX3 0BP, England; [Bailey, C. Donovan] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA	University of Oxford; Max Planck Society; Oxford Brookes University; New Mexico State University	Tsiantis, M (corresponding author), Univ Oxford, Dept Plant Sci, S Parks Rd, Oxford OX1 3RB, England.	tsiantis@mpipz.mpg.de	dello ioio, raffaele/P-6254-2015	dello ioio, raffaele/0000-0001-8679-9412; Gan, Xiangchao/0000-0001-6398-5191	Biotechnology and Biological Sciences Research Council [BB/H011455/1, BB/H006974/1]; Deutsche Forschungsgemeinschaft [TS 229/1-1, SFB 680]; Gatsby Charitable Foundation; Human Frontier Science Program [RGP0047/2010]; Max Planck Society; NSF Plant Genome Research Mid-Career Investigator Award [1238731]; Cluster of Excellence on Plant Sciences; BBSRC [BB/H011455/1, BB/H006974/1] Funding Source: UKRI; Division Of Integrative Organismal Systems [1238731] Funding Source: National Science Foundation	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Gatsby Charitable Foundation; Human Frontier Science Program(Human Frontier Science Program); Max Planck Society(Max Planck SocietyFoundation CELLEX); NSF Plant Genome Research Mid-Career Investigator Award; Cluster of Excellence on Plant Sciences; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank A. Hudson, G. Coupland, Y. Eshed, and N. Gompel for critical comments on the manuscript; P. Sarchet and S. Broholm for mutant screening and providing the mapping cross; I. A. Al-Shehbaz for helpful discussions on leaf shape in Aethionema; S. Hake, M. Aida, G. Coupland, S. Sampson, and D. Wagner for materials; and R. Berndtgen, S. Hohmann, E. Rabbinowitsch, J. Baker, and Z. Lewis for technical assistance. This work was supported by Biotechnology and Biological Sciences Research Council grants BB/H011455/1 (M. T.) and BB/H006974/1 (M. T. and A. H.), Deutsche Forschungsgemeinschaft 'Adaptomics' grant TS 229/1-1 (M. T. and A. H.) and grant SFB 680 (M. T.), the Gatsby Charitable Foundation (M. T.), Human Frontier Science Program grant RGP0047/2010 (M. T.), a core grant from the Max Planck Society (M. T.), and NSF Plant Genome Research Mid-Career Investigator Award 1238731 (C. D. B.). M. T. also acknowledges support of the Cluster of Excellence on Plant Sciences. The data reported in this paper are tabulated in the supplementary materials. Sequences have been submitted to GenBank for archiving under the following accession numbers: ChLMI1, KF939590; RCO, KF939591; and LMI1-like3, KF939592.	Bailey CD, 2006, MOL BIOL EVOL, V23, P2142, DOI 10.1093/molbev/msl087; Barkoulas M, 2008, NAT GENET, V40, P1136, DOI 10.1038/ng.189; Beilstein MA, 2010, P NATL ACAD SCI USA, V107, P18724, DOI 10.1073/pnas.0909766107; Berger Y, 2009, DEVELOPMENT, V136, P823, DOI 10.1242/dev.031625; Bilsborough GD, 2011, P NATL ACAD SCI USA, V108, P3424, DOI 10.1073/pnas.1015162108; Blein T, 2008, SCIENCE, V322, P1835, DOI 10.1126/science.1166168; Couvreur TLP, 2010, MOL BIOL EVOL, V27, P55, DOI 10.1093/molbev/msp202; Efroni I, 2010, PLANT CELL, V22, P1019, DOI 10.1105/tpc.109.073601; Floyd SK, 2010, J PLANT RES, V123, P43, DOI 10.1007/s10265-009-0256-2; Freeling M, 2009, ANNU REV PLANT BIOL, V60, P433, DOI 10.1146/annurev.arplant.043008.092122; Hake S, 2002, NAT GENET, V31, P121, DOI 10.1038/ng0602-121; Hay A, 2006, NAT GENET, V38, P942, DOI 10.1038/ng1835; Hofer J, 2009, PLANT CELL, V21, P420, DOI 10.1105/tpc.108.064071; Kierzkowski D, 2012, SCIENCE, V335, P1096, DOI 10.1126/science.1213100; Koenig D, 2009, DEVELOPMENT, V136, P2997, DOI 10.1242/dev.033811; Kuchen EE, 2012, SCIENCE, V335, P1092, DOI 10.1126/science.1214678; Ohno S., 1970, EVOLUTION GENE DUPLI; Ori N, 2007, NAT GENET, V39, P787, DOI 10.1038/ng2036; Piazza P, 2010, CURR BIOL, V20, P2223, DOI 10.1016/j.cub.2010.11.037; Prud'homme B, 2007, P NATL ACAD SCI USA, V104, P8605, DOI 10.1073/pnas.0700488104; Saddic LA, 2006, DEVELOPMENT, V133, P1673, DOI 10.1242/dev.02331; Stern DL, 2009, SCIENCE, V323, P746, DOI 10.1126/science.1158997; Whaley WG, 1942, AM J BOT, V29, P195, DOI 10.2307/2437668	23	189	197	6	152	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 14	2014	343	6172					780	783		10.1126/science.1248384	http://dx.doi.org/10.1126/science.1248384			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB1NB	24531971				2022-12-28	WOS:000331557800042
J	Block, SD; Billings, JA				Block, Susan D.; Billings, J. Andrew			A need for scalable outpatient palliative care interventions	LANCET			English	Editorial Material							CELL LUNG-CANCER; WORKFORCE SHORTAGE		[Block, Susan D.] Dana Farber Canc Inst, Dept Psychosocial Oncol & Palliat Care, Boston, MA 02215 USA; [Block, Susan D.] Brigham & Womens Hosp, Boston, MA 02215 USA; [Block, Susan D.; Billings, J. Andrew] Harvard Univ, Sch Med, Ctr Palliat Care, Boston, MA USA; [Billings, J. Andrew] Massachusetts Gen Hosp, Cambridge Hlth Alliance, Boston, MA 02114 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Cambridge Health Alliance; Massachusetts General Hospital	Block, SD (corresponding author), Dana Farber Canc Inst, Dept Psychosocial Oncol & Palliat Care, Boston, MA 02215 USA.	sblock@partners.org						Higginson IJ, 2010, CANCER J, V16, P423, DOI 10.1097/PPO.0b013e3181f684e5; Jacobsen J, 2011, J PALLIAT MED, V14, P459, DOI 10.1089/jpm.2010.0382; Lupu D, 2010, J PAIN SYMPTOM MANAG, V40, P899, DOI 10.1016/j.jpainsymman.2010.07.004; Maison D, 2010, J PAIN SYMPTOM MANAG, V40, P912, DOI 10.1016/j.jpainsymman.2010.09.011; Rabow M, 2013, J PALLIAT MED, V16, P1540, DOI 10.1089/jpm.2013.0153; Smith TJ, 2012, J CLIN ONCOL, V30, P880, DOI 10.1200/JCO.2011.38.5161; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Zimmermann C, 2014, LANCET	8	37	37	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 17	2014	383	9930					1699	1700		10.1016/S0140-6736(13)62676-8	http://dx.doi.org/10.1016/S0140-6736(13)62676-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH6UO	24559580				2022-12-28	WOS:000336267300006
J	Cho, TA; Chi, AS; Schaefer, PW; Louis, DN				Cho, Tracey A.; Chi, Andrew S.; Schaefer, Pamela W.; Louis, David N.			Case 8-2014: A 29-Year- Old Man with Headache, Vomiting, and Diplopia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DIFFUSE LEPTOMENINGEAL GLIOMATOSIS; GLIOBLASTOMA-MULTIFORME; TUBERCULOUS MENINGITIS; TEMOZOLOMIDE	A 29-year-old man was admitted to the hospital because of headache, vomiting, photophobia, diplopia, and stiff neck. He was born in Southeast Asia. Brain imaging showed diffuse leptomeningeal enhancement. Cultures were sterile. A diagnostic procedure was performed. Presentation of CaseDr. Xuemei Cai (Neurology): A 29-year-old man was admitted to this hospital because of headache, vomiting, and diplopia. The patient had been well until 3 weeks before admission, when headaches, blurred vision, nausea, and vomiting developed, followed by anorexia and weight loss (7.3 kg). Evaluation at a student health center, including computed tomography (CT) of the brain, reportedly revealed no abnormalities. Three days before admission, photophobia, diplopia, neck stiffness, tremulousness of the left hand, and somnolence developed. On the day of admission, the patient became mute. Earlier that day, magnetic resonance imaging (MRI) of the brain and ...	[Cho, Tracey A.; Chi, Andrew S.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Schaefer, Pamela W.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Louis, David N.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Cho, Tracey A.; Chi, Andrew S.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Schaefer, Pamela W.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Louis, David N.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Cho, TA (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.		Schaefer, Pamela/AAA-1323-2019; Cho, Tracey/O-8645-2018	Cho, Tracey/0000-0002-6208-1489				ANDERSON NE, 1987, Q J MED, V63, P283; ATWOOD WJ, 1993, CLIN MICROBIOL REV, V6, P339, DOI 10.1128/CMR.6.4.339-366.1993; Beauchesne P, 1998, J NEURO-ONCOL, V37, P161, DOI 10.1023/A:1005888319228; Burger PC, 2001, J NEUROPATH EXP NEUR, V60, P1099, DOI 10.1093/jnen/60.11.1099; COOPER IS, 1951, J NEUROPATH EXP NEUR, V10, P16; Franceschi E, 2005, J NEURO-ONCOL, V73, P261, DOI 10.1007/s11060-004-5672-5; Gleissner B, 2006, LANCET NEUROL, V5, P443, DOI 10.1016/S1474-4422(06)70443-4; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hildebrand J, 2003, J NEUROL, V250, P653, DOI 10.1007/s00415-003-1101-5; HSIEH FY, 1992, NEURORADIOLOGY, V34, P197, DOI 10.1007/BF00596334; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Straathof CSM, 1999, J NEUROL, V246, P810, DOI 10.1007/s004150050459; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; TANNER DC, 1994, J CLIN MICROBIOL, V32, P1680, DOI 10.1128/JCM.32.7.1680-1684.1994; Thwaites GE, 2004, J CLIN MICROBIOL, V42, P378, DOI 10.1128/JCM.42.1.378-379.2004; Tortosa A, 2000, NEUROPATH APPL NEURO, V26, P544, DOI 10.1046/j.0305-1846.2000.00290.x; Yomo S, 2007, J NEURO-ONCOL, V81, P209, DOI 10.1007/s11060-006-9219-9	17	2	2	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 13	2014	370	11					1049	1059		10.1056/NEJMcpc1214216	http://dx.doi.org/10.1056/NEJMcpc1214216			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC7ED	24620869				2022-12-28	WOS:000332689100013
J	Kunte, K; Zhang, W; Tenger-Trolander, A; Palmer, DH; Martin, A; Reed, RD; Mullen, SP; Kronforst, MR				Kunte, K.; Zhang, W.; Tenger-Trolander, A.; Palmer, D. H.; Martin, A.; Reed, R. D.; Mullen, S. P.; Kronforst, M. R.			doublesex is a mimicry supergene	NATURE			English	Article							TIGER SWALLOWTAIL BUTTERFLIES; DNA-SEQUENCING DATA; SEXUAL-DIMORPHISM; EVOLUTION; GENETICS; GENOME; DROSOPHILA; POLYMORPHISMS; ADAPTATION; SPECIATION	One of the most striking examples of sexual dimorphism is sex-limited mimicry in butterflies, a phenomenon in which one sex-usually the female-mimics a toxic model species, whereas the other sex displays a different wing pattern(1). Sex-limited mimicry is phylogenetically widespread in the swallowtail butterfly genus Papilio, in which it is often associated with female mimetic polymorphism(1-3). In multiple polymorphic species, the entire wing pattern phenotype is controlled by a single Mendelian 'supergene'(4). Although theoretical work has explored the evolutionary dynamics of supergene mimicry(5-9), there are almost no empirical data that address the critical issue of what a mimicry supergene actually is at a functional level. Using an integrative approach combining genetic and association mapping, transcriptome and genome sequencing, and gene expression analyses, we show that a single gene, doublesex, controls supergene mimicry in Papilio polytes. This is in contrast to the long-held view that supergenes are likely to be controlled by a tightly linked cluster of loci(4). Analysis of gene expression and DNA sequence variation indicates that isoform expression differences contribute to the functional differences between dsx mimicry alleles, and protein sequence evolution may also have a role. Our results combine elements from different hypotheses for the identity of supergenes, showing that a single gene can switch the entire wing pattern among mimicry phenotypes but may require multiple, tightly linked mutations to do so.	[Kunte, K.] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bengaluru 560065, Karnataka, India; [Zhang, W.; Tenger-Trolander, A.; Kronforst, M. R.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Palmer, D. H.; Kronforst, M. R.] Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA; [Martin, A.; Reed, R. D.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA; [Mullen, S. P.] Boston Univ, Dept Biol, Boston, MA 02215 USA	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); University of Chicago; University of Chicago; Cornell University; Boston University	Kronforst, MR (corresponding author), Univ Chicago, Dept Ecol & Evolut, 940 E 57th St, Chicago, IL 60637 USA.	krushnamegh@ncbs.res.in; mkronforst@uchicago.edu	Zhang, Wei/AAV-6724-2021; Tenger-Trolander, Ayse/L-2413-2014; Zhang, Wei/P-1532-2015	Zhang, Wei/0000-0002-6644-7046; Reed, Robert/0000-0002-6065-6728; Kunte, Krushnamegh/0000-0002-3860-6118; Martin, Arnaud/0000-0002-5980-2249; Tenger-Trolander, Ayse/0000-0001-8319-0273	National Science Foundation [DEB-1316037]; Division Of Environmental Biology [1020136] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank W. Wang for sharing genome sequence data, C. Robinett for providing the Dsx-DM monoclonal antibody, and E. Westerman, S. Nallu, M. Zhang, G. Garcia and N. Pierce for assistance and discussion. This project was funded by National Science Foundation grant DEB-1316037 to M.R.K.	Bates H.W., 1862, T LINN SOC LOND, V23, P495; Benjamini Y, 2001, ANN STAT, V29, P1165; BURTIS KC, 1989, CELL, V56, P997, DOI 10.1016/0092-8674(89)90633-8; Charlesworth B, 2010, ELEMENTS EVOLUTIONAR; CHARLESWORTH D, 1975, J THEOR BIOL, V55, P305, DOI 10.1016/S0022-5193(75)80082-8; Charlesworth D, 2011, CURR BIOL, V21, pR846, DOI 10.1016/j.cub.2011.09.004; Cho S, 2007, GENETICS, V177, P1733, DOI 10.1534/genetics.107.078980; Clark R, 2008, P R SOC B, V275, P1181, DOI 10.1098/rspb.2007.1762; CLARKE C. A., 1960, HEREDITY, V14, P175, DOI 10.1038/hdy.1960.15; CLARKE CA, 1972, PHILOS T ROY SOC B, V263, P431, DOI 10.1098/rstb.1972.0006; CLARKE CA, 1968, PHILOS T ROY SOC B, V254, P37, DOI 10.1098/rstb.1968.0013; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Fisher R.A., 1930, GENETICAL THEORY NAT; FORD EB, 1953, ADV GENET, V5, P43, DOI 10.1016/S0065-2660(08)60405-8; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hoffmann AA, 2004, TRENDS ECOL EVOL, V19, P482, DOI 10.1016/j.tree.2004.06.013; HUDSON RR, 1987, GENETICS, V116, P153; Joron M, 1998, TRENDS ECOL EVOL, V13, P461, DOI 10.1016/S0169-5347(98)01483-9; Joron M, 2011, NATURE, V477, P203, DOI 10.1038/nature10341; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kijimoto T, 2012, P NATL ACAD SCI USA, V109, P20526, DOI 10.1073/pnas.1118589109; Kopp A, 2012, TRENDS GENET, V28, P175, DOI 10.1016/j.tig.2012.02.002; Kunte K, 2009, ANIM BEHAV, V78, P1029, DOI 10.1016/j.anbehav.2009.08.013; Kunte K, 2009, EVOLUTION, V63, P2707, DOI 10.1111/j.1558-5646.2009.00752.x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Larracuente AM, 2012, GENETICS, V192, P33, DOI 10.1534/genetics.112.141390; Loehlin DW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000821; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Mallet J, 1999, ANNU REV ECOL SYST, V30, P201, DOI 10.1146/annurev.ecolsys.30.1.201; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mellert DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051489; NIJHOUT HF, 1994, BIOSCIENCE, V44, P148, DOI 10.2307/1312251; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Scriber JM, 1996, EVOLUTION, V50, P222, DOI 10.1111/j.1558-5646.1996.tb04487.x; SHEPPARD PM, 1959, COLD SPRING HARB SYM, V24, P131, DOI 10.1101/SQB.1959.024.01.013; Takayama S, 2005, ANNU REV PLANT BIOL, V56, P467, DOI 10.1146/annurev.arplant.56.032604.144249; Tanaka K, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001131; TURNER JRG, 1984, BIOL BUTTERFLIES, P141; Williams TM, 2008, CELL, V134, P610, DOI 10.1016/j.cell.2008.06.052; Williams TM, 2009, NAT REV GENET, V10, P797, DOI 10.1038/nrg2687; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zhang W, 2013, GENOME BIOL EVOL, V5, P1233, DOI 10.1093/gbe/evt090	44	213	216	5	190	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2014	507	7491					229	+		10.1038/nature13112	http://dx.doi.org/10.1038/nature13112			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC6RJ	24598547				2022-12-28	WOS:000332651800038
J	Gomes, B; Calanzani, N; Higginson, IJ				Gomes, Barbara; Calanzani, Natalia; Higginson, Irene J.			Benefits and Costs of Home Palliative Care Compared With Usual Care for Patients With Advanced Illness and Their Family Caregivers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								CLINICAL QUESTION Are home palliative care services associated with benefits to patients with advanced illness and family caregivers, and are they cost-effective? BOTTOM LINE Compared with usual care, home palliative care is associated with increased odds of dying at home and fewer symptoms for patients with advanced illness. It is not associated with changes in caregiver grief. Cost-effectiveness is inconclusive.	[Gomes, Barbara; Calanzani, Natalia; Higginson, Irene J.] Kings Coll London, Cicely Saunders Inst, Dept Palliat Care Policy & Rehabil, London SE5 9PJ, England	University of London; King's College London	Gomes, B (corresponding author), Kings Coll London, Cicely Saunders Inst, Dept Palliat Care Policy & Rehabil, Bessemer Rd, London SE5 9PJ, England.	barbara.gomes@kcl.ac.uk	Calanzani, Natalia/AAK-2007-2020; Higginson, Irene Julie/C-7309-2012	Calanzani, Natalia/0000-0002-5068-2543; Gomes, Barbara/0000-0001-8149-1806; Higginson, Irene Julie/0000-0002-3687-1313	Cicely Saunders International; Calouste Gulbenkian Foundation; MRC [G0802654] Funding Source: UKRI; Medical Research Council [G0802654] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10209] Funding Source: researchfish	Cicely Saunders International; Calouste Gulbenkian Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by Cicely Saunders International and the Calouste Gulbenkian Foundation.	Abernethy AP, 2013, J PAIN SYMPTOM MANAG, V45, P488, DOI 10.1016/j.jpainsymman.2012.02.024; Cohen J, 2010, J CLIN ONCOL, V28, P2267, DOI 10.1200/JCO.2009.23.2850; Gomes B., 2011, LIVING AGEING DYING, P3; Gomes B, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-7; Gomes B, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD007760.pub2, 10.1590/1516-3180.20161341T2]; National Institute for Health and Care Excellence, 2004, IMPR SUPP PALL CAR A	6	37	37	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2014	311	10					1060	1061		10.1001/jama.2014.553	http://dx.doi.org/10.1001/jama.2014.553			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC5QO	24618968				2022-12-28	WOS:000332575800024
J	Smith, JM				Smith, Jeanette M.			Ninth Avenue Elevated	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2014	311	10					994	1001		10.1001/jama.2013.279376	http://dx.doi.org/10.1001/jama.2013.279376			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC5QO	24618944				2022-12-28	WOS:000332575800001
J	Geersing, GJ; Zuithoff, NPA; Kearon, C; Anderson, DR; ten Cate-Hoek, AJ; Elf, JL; Bates, SM; Hoes, AW; Kraaijenhagen, RA; Oudega, R; Schutgens, REG; Stevens, SM; Woller, SC; Wells, PS; Moons, KGM				Geersing, G. J.; Zuithoff, N. P. A.; Kearon, C.; Anderson, D. R.; ten Cate-Hoek, A. J.; Elf, J. L.; Bates, S. M.; Hoes, A. W.; Kraaijenhagen, R. A.; Oudega, R.; Schutgens, R. E. G.; Stevens, S. M.; Woller, S. C.; Wells, P. S.; Moons, K. G. M.			Exclusion of deep vein thrombosis using the Wells rule in clinically important subgroups: individual patient data meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							D-DIMER; VENOUS THROMBOSIS; PRIMARY-CARE; EMERGENCY-DEPARTMENT; PULMONARY-EMBOLISM; OLDER PATIENTS; MISSING DATA; MANAGEMENT; PROBABILITY; DIAGNOSIS	Objective To assess the accuracy of the Wells rule for excluding deep vein thrombosis and whether this accuracy applies to different subgroups of patients. Design Meta-analysis of individual patient data. Data sources Authors of 13 studies (n=10 002) provided their datasets, and these individual patient data were merged into one dataset. Eligibility criteria Studies were eligible if they enrolled consecutive outpatients with suspected deep vein thrombosis, scored all variables of the Wells rule, and performed an appropriate reference standard. Main outcome measures Multilevel logistic regression models, including an interaction term for each subgroup, were used to estimate differences in predicted probabilities of deep vein thrombosis by the Wells rule. In addition, D-dimer testing was added to assess differences in the ability to exclude deep vein thrombosis using an unlikely score on the Wells rule combined with a negative D-dimer test result. Results Overall, increasing scores on the Wells rule were associated with an increasing probability of having deep vein thrombosis. Estimated probabilities were almost twofold higher in patients with cancer, in patients with suspected recurrent events, and (to a lesser extent) in males. An unlikely score on the Wells rule (<= 1) combined with a negative D-dimer test result was associated with an extremely low probability of deep vein thrombosis (1.2%, 95% confidence interval 0.7% to 1.8%). This combination occurred in 29% (95% confidence interval 20% to 40%) of patients. These findings were consistent in subgroups defined by type of D-dimer assay (quantitative or qualitative), sex, and care setting (primary or hospital care). For patients with cancer, the combination of an unlikely score on the Wells rule and a negative D-dimer test result occurred in only 9% of patients and was associated with a 2.2% probability of deep vein thrombosis being present. In patients with suspected recurrent events, only the modified Wells rule (adding one point for the previous event) is safe. Conclusion Combined with a negative D-dimer test result (both quantitative and qualitative), deep vein thrombosis can be excluded in patients with an unlikely score on the Wells rule. This finding is true for both sexes, as well as for patients presenting in primary and hospital care. In patients with cancer, the combination is neither safe nor efficient. For patients with suspected recurrent disease, one extra point should be added to the rule to enable a safe exclusion.	[Geersing, G. J.; Zuithoff, N. P. A.; Hoes, A. W.; Oudega, R.; Moons, K. G. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3584 CG Utrecht, Netherlands; [Kearon, C.; Bates, S. M.] McMaster Univ, Dept Med, Div Haematol & Thromboembolism, Hamilton, ON, Canada; [Anderson, D. R.] Dalhousie Univ, Dept Med, Div Haematol, Halifax, NS, Canada; [ten Cate-Hoek, A. J.] Maastricht Univ, Med Ctr, Dept Internal Med, Maastricht, Netherlands; [Elf, J. L.] Skane Univ Hosp, Vasc Ctr, Malmo, Sweden; [Kraaijenhagen, R. A.] Univ Amsterdam, Acad Med Ctr, Dept Med, NL-1105 AZ Amsterdam, Netherlands; [Schutgens, R. E. G.] Univ Med Ctr Utrecht, Van Creveld Clin, NL-3584 CG Utrecht, Netherlands; [Stevens, S. M.; Woller, S. C.] Intermt Med Ctr, Thrombosis Clin, Murray, UT USA; [Wells, P. S.] Univ Ottawa, Dept Med, Ottawa Hosp, Ottawa, ON, Canada	Utrecht University; Utrecht University Medical Center; McMaster University; Dalhousie University; Maastricht University; Lund University; Skane University Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; Intermountain Healthcare; Intermountain Medical Center; University of Ottawa; Ottawa Hospital Research Institute	Geersing, GJ (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Univ Weg 100, NL-3584 CG Utrecht, Netherlands.	g.j.geersing@umcutrecht.nl	Geersing, Geert-Jan/AAY-1119-2021; Woller, Scott C./AAV-6187-2021	Woller, Scott C./0000-0002-2522-2705; Schutgens, Roger/0000-0002-2762-6033; Anderson, David/0000-0003-0845-1722				Abo-Zaid G, 2013, J CLIN EPIDEMIOL, V66, P865, DOI 10.1016/j.jclinepi.2012.12.017; Anderson DR, 2003, J THROMB HAEMOST, V1, P645, DOI 10.1046/j.1538-7836.2003.00131.x; Anderson DR, 2000, J EMERG MED, V19, P225, DOI 10.1016/S0736-4679(00)00225-0; Andreou ER, 2008, J THROMB HAEMOST, V6, P1713, DOI 10.1111/j.1538-7836.2008.03110.x; Austin PC, 2001, CAN J PUBLIC HEALTH, V92, P150, DOI 10.1007/BF03404950; Bates SM, 2012, CHEST, V141, pE351S, DOI 10.1378/chest.11-2299; Bates SM, 2003, ANN INTERN MED, V138, P787, DOI 10.7326/0003-4819-138-10-200305200-00006; Buller HR, 2009, ANN INTERN MED, V150, P229, DOI 10.7326/0003-4819-150-4-200902170-00003; Debray TPA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060650; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Douma RA, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c1475; Elf JL, 2009, THROMB RES, V123, P612, DOI 10.1016/j.thromres.2008.04.007; Fancher TL, 2004, BMJ-BRIT MED J, V329, P821, DOI 10.1136/bmj.38226.719803.EB; Geersing GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2990; Geersing GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032844; Greenland S, 2000, INT J EPIDEMIOL, V29, P158, DOI 10.1093/ije/29.1.158; Greenland S, 2000, BIOMETRICS, V56, P915, DOI 10.1111/j.0006-341X.2000.00915.x; Groenwold RHH, 2012, AM J EPIDEMIOL, V175, P210, DOI 10.1093/aje/kwr302; Kearon C, 2005, ANN INTERN MED, V142, P490, DOI 10.7326/0003-4819-142-7-200504050-00007; Kearon C, 2001, ANN INTERN MED, V135, P108, DOI 10.7326/0003-4819-135-2-200107170-00011; Koopman L, 2008, AM J EPIDEMIOL, V167, P540, DOI 10.1093/aje/kwm341; Kraaijenhagen RA, 2002, ARCH INTERN MED, V162, P907, DOI 10.1001/archinte.162.8.907; Le Gal G, 2004, J THROMB HAEMOST, V2, P1244, DOI 10.1111/j.1538-7836.2004.00795.x; Lee A, 2008, THROMB RES, V123, pS50, DOI 10.1016/j.thromres.2008.08.017; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Marcucci M, 2013, J CLIN EPIDEMIOL, V66, P415, DOI 10.1016/j.jclinepi.2012.08.007; Oudega R, 2005, THROMB HAEMOSTASIS, V94, P200, DOI 10.1160/TH04-12-0829; Oudega R, 2005, ANN INTERN MED, V143, P100, DOI 10.7326/0003-4819-143-2-200507190-00008; Palareti G, 2006, NEW ENGL J MED, V355, P1780, DOI 10.1056/NEJMoa054444; Reilly BM, 2009, ANN INTERN MED, V150, P270, DOI 10.7326/0003-4819-150-4-200902170-00008; Riley RD, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d549; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schouten HJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2492; Schutgens REG, 2005, HAEMATOLOGICA, V90, P214; Schutgens REG, 2003, CIRCULATION, V107, P593, DOI 10.1161/01.CIR.0000045670.12988.1E; Stevens SM, 2004, ANN INTERN MED, V140, P985, DOI 10.7326/0003-4819-140-12-200406150-00007; Ten Cate-Hoek AJ, 2005, J THROMB HAEMOST, V3, P2465, DOI 10.1111/j.1538-7836.2005.01556.x; Toll DB, 2008, FAM PRACT, V25, P3, DOI 10.1093/fampra/cmm075; Toll DB, 2006, J FAM PRACTICE, V55, P613; Urbach DR, 2005, J CLIN EPIDEMIOL, V58, P391, DOI 10.1016/j.jclinepi.2004.12.001; van der Velde EF, 2011, ANN FAM MED, V9, P31, DOI 10.1370/afm.1198; Wells PS, 2003, NEW ENGL J MED, V349, P1227, DOI 10.1056/NEJMoa023153; Wells PS, 2006, JAMA-J AM MED ASSOC, V295, P199, DOI 10.1001/jama.295.2.199	43	115	123	2	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 10	2014	348								g1340	10.1136/bmj.g1340	http://dx.doi.org/10.1136/bmj.g1340			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD1ZH	24615063	Green Published, hybrid			2022-12-28	WOS:000333031700001
J	Chang, WC; Guo, YS; Wang, C; Butch, SE; Rosenzweig, AC; Boal, AK; Krebs, C; Bollinger, JM				Chang, Wei-chen; Guo, Yisong; Wang, Chen; Butch, Susan E.; Rosenzweig, Amy C.; Boal, Amie K.; Krebs, Carsten; Bollinger, J. Martin, Jr.			Mechanism of the C5 Stereoinversion Reaction in the Biosynthesis of Carbapenem Antibiotics	SCIENCE			English	Article							BETA-LACTAM ANTIBIOTICS; KETOGLUTARATE DIOXYGENASE TAUD; NONHEME IRON OXYGENASES; SPIN FE(IV) COMPLEX; ESCHERICHIA-COLI; SYNTHASE CARC; ALIPHATIC HALOGENASE; ENZYMES; SUBSTRATE; EPIMERIZATION	The bicyclic beta-lactam/2-pyrrolidine precursor to all carbapenem antibiotics is biosynthesized by attachment of a carboxymethylene unit to C5 of L-proline followed by beta-lactam ring closure. Carbapenem synthase (CarC), an Fe(II) and 2-(oxo)glutarate (Fe/2OG)-dependent oxygenase, then inverts the C5 configuration. Here we report the structure of CarC in complex with its substrate and biophysical dissection of its reaction to reveal the stereoinversion mechanism. An Fe(IV)-oxo intermediate abstracts the hydrogen (H center dot) from C5, and tyrosine 165, a residue not visualized in the published structures of CarC lacking bound substrate, donates H center dot to the opposite face of the resultant radical. The reaction oxidizes the Fe(II) cofactor to Fe(III), limiting wild-type CarC to one turnover, but substitution of the H center dot-donating tyrosine disables stereoinversion and confers to CarC the capacity for catalytic substrate oxidation.	[Chang, Wei-chen; Guo, Yisong; Butch, Susan E.; Boal, Amie K.; Krebs, Carsten; Bollinger, J. Martin, Jr.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Wang, Chen; Boal, Amie K.; Krebs, Carsten; Bollinger, J. Martin, Jr.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Rosenzweig, Amy C.; Boal, Amie K.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Rosenzweig, Amy C.; Boal, Amie K.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Northwestern University; Northwestern University	Chang, WC (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.	oscarntu@gmail.com; akb20@psu.edu; ckrebs@psu.edu; jmb21@psu.edu	Krebs, Carsten/D-4773-2009; Guo, Yisong/C-7785-2009; Bollinger, Joseph/C-1425-2016	Krebs, Carsten/0000-0002-3302-7053; Guo, Yisong/0000-0002-4132-3565; CHANG, WEI-CHEN/0000-0002-2341-9846	National Institutes of Health [GM 058518, GM 100011, GM 069657]; U.S. DOE [DE-AC02-06CH11357]; Michigan Economic Development Corporation; Michigan Technology Tri-Corridor [085P1000817]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069657, R00GM100011, K99GM100011, R01GM058518] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. DOE(United States Department of Energy (DOE)); Michigan Economic Development Corporation; Michigan Technology Tri-Corridor; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Atomic coordinates and structure factors have been deposited in the Protein Data Bank with accession code 4OJ8. This work was supported by grants from the National Institutes of Health (GM 058518 to A.C.R., GM 100011 to A.K.B., and GM 069657 to C.K. and J.M.B.). Use of the Advanced Photon Source, an Office of Science User Facility operated for the U.S. Department of Energy (DOE) Office of Science by Argonne National Laboratory, was supported by the U.S. DOE under Contract no. DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor (grant 085P1000817). We thank E. Y. Tamanaha for assistance in the kinetic analysis.	[Anonymous], 2013, NATURE, V495, P141; Avenoza A, 2003, J ORG CHEM, V68, P2889, DOI 10.1021/jo026804+; Bodner MJ, 2010, J AM CHEM SOC, V132, P12, DOI 10.1021/ja907320n; Bollinger JM, 2005, EUR J INORG CHEM, P4245, DOI 10.1002/ejic.200500476; Bollinger JM, 2006, J INORG BIOCHEM, V100, P586, DOI 10.1016/j.jinorgbio.2006.01.022; BOLLINGER JM, 1995, METHOD ENZYMOL, V258, P278; Borowski T, 2006, J COMPUT CHEM, V27, P740, DOI 10.1002/jcc.20384; Bradley JS, 1999, INT J ANTIMICROB AG, V11, P93, DOI 10.1016/S0924-8579(98)00094-6; BYCROFT BW, 1989, J CHEM SOC CHEM COMM, P423, DOI 10.1039/c39890000423; Clifton IJ, 2003, J BIOL CHEM, V278, P20843, DOI 10.1074/jbc.M213054200; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Coulthurst SJ, 2005, NAT REV MICROBIOL, V3, P295, DOI 10.1038/nrmicro1128; Demain AL, 1999, ANTON LEEUW INT J G, V75, P5, DOI 10.1023/A:1001738823146; Elander RP, 2003, APPL MICROBIOL BIOT, V61, P385, DOI 10.1007/s00253-003-1274-y; Galonic DP, 2007, NAT CHEM BIOL, V3, P113, DOI 10.1038/nchembio856; Gerratana B, 2004, BIOCHEMISTRY-US, V43, P15936, DOI 10.1021/bi0483662; Gerratana B, 2003, BIOCHEMISTRY-US, V42, P7836, DOI 10.1021/bi034361d; GROVES JT, 1985, J CHEM EDUC, V62, P928, DOI 10.1021/ed062p928; Hamed RB, 2013, NAT PROD REP, V30, P21, DOI 10.1039/c2np20065a; Hamed RB, 2012, J AM CHEM SOC, V134, P471, DOI 10.1021/ja208318d; Hamed RB, 2011, NAT CHEM, V3, P365, DOI [10.1038/NCHEM.1011, 10.1038/nchem.1011]; Hamed RB, 2010, CHEM COMMUN, V46, P1413, DOI 10.1039/b924519g; Hamed RB, 2009, CHEMBIOCHEM, V10, P246, DOI 10.1002/cbic.200800652; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Hoffart LM, 2006, P NATL ACAD SCI USA, V103, P14738, DOI 10.1073/pnas.0604005103; KAHAN JS, 1979, J ANTIBIOT, V32, P1; Krebs C, 2007, ACCOUNTS CHEM RES, V40, P484, DOI 10.1021/ar700066p; Li RF, 2000, J AM CHEM SOC, V122, P9296, DOI 10.1021/ja001723l; Matthews ML, 2009, P NATL ACAD SCI USA, V106, P17723, DOI 10.1073/pnas.0909649106; Matthews ML, 2009, BIOCHEMISTRY-US, V48, P4331, DOI 10.1021/bi900109z; McCusker KP, 2009, P NATL ACAD SCI USA, V106, P19791, DOI 10.1073/pnas.0910660106; McGowan S. J., 1996, MOL MICROBIOL, V22, P415; Nangia A., 1996, J CHEM SOC P1, V2, P943; PARKER WL, 1982, J ANTIBIOT, V35, P653, DOI 10.7164/antibiotics.35.653; PFAENDLER HR, 1981, J AM CHEM SOC, V103, P4526, DOI 10.1021/ja00405a039; Phelan RM, 2013, J AM CHEM SOC, V135, P7496, DOI 10.1021/ja311078s; Phelan RM, 2012, ACS CHEM BIOL, V7, P835, DOI 10.1021/cb200504g; Price JC, 2003, BIOCHEMISTRY-US, V42, P7497, DOI 10.1021/bi030011f; Sleeman MC, 2004, CHEMBIOCHEM, V5, P879, DOI 10.1002/cbic.200300908; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; Stapon A, 2003, J AM CHEM SOC, V125, P8486, DOI 10.1021/ja034248a; Topf M, 2004, J AM CHEM SOC, V126, P9932, DOI 10.1021/ja047899v; WOODWARD RB, 1980, PHILOS T ROY SOC B, V289, P239, DOI 10.1098/rstb.1980.0042; Zhou J, 2001, J AM CHEM SOC, V123, P7388, DOI 10.1021/ja004025+	44	77	77	0	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2014	343	6175					1140	1144		10.1126/science.1248000	http://dx.doi.org/10.1126/science.1248000			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2LB	24604200	Green Accepted			2022-12-28	WOS:000332331500049
J	Salmeron, M				Salmeron, Miquel			CO Meets CO, One at a Time	SCIENCE			English	Editorial Material							SCANNING TUNNELING MICROSCOPE; ATOMIC-FORCE MICROSCOPY		Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Salmeron, M (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA.	mbsalmeron@lbl.gov						BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; BINNIG G, 1982, APPL PHYS LETT, V40, P178, DOI 10.1063/1.92999; EIGLER DM, 1991, NATURE, V352, P600, DOI 10.1038/352600a0; EIGLER DM, 1990, NATURE, V344, P524, DOI 10.1038/344524a0; Gross L, 2009, SCIENCE, V325, P1110, DOI 10.1126/science.1176210; Sugimoto Y, 2007, NATURE, V446, P64, DOI 10.1038/nature05530; Weymouth AJ, 2014, SCIENCE, V343, P1120, DOI 10.1126/science.1249502	7	3	3	1	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2014	343	6175					1083	1084		10.1126/science.1251251	http://dx.doi.org/10.1126/science.1251251			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2LB	24604185				2022-12-28	WOS:000332331500029
J	Jurecic, A				Jurecic, Ann			The art of medicine Life writing in the genomic age	LANCET			English	Editorial Material									Rutgers State Univ, Dept English, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick	Jurecic, A (corresponding author), Rutgers State Univ, Dept English, New Brunswick, NJ 08901 USA.	ann.jurecic@rutgers.edu							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 1	2014	383	9919					776	777		10.1016/S0140-6736(14)60394-9	http://dx.doi.org/10.1016/S0140-6736(14)60394-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	AC3EV	24592454				2022-12-28	WOS:000332398700014
J	Chai, Y; Salez, T; McGraw, JD; Benzaquen, M; Dalnoki-Veress, K; Raphael, E; Forrest, JA				Chai, Y.; Salez, T.; McGraw, J. D.; Benzaquen, M.; Dalnoki-Veress, K.; Raphael, E.; Forrest, J. A.			A Direct Quantitative Measure of Surface Mobility in a Glassy Polymer	SCIENCE			English	Article							TRANSITION; DYNAMICS; BEHAVIOR; FILMS; FLOW	Thin polymer films have striking dynamical properties that differ from their bulk counterparts. With the simple geometry of a stepped polymer film on a substrate, we probe mobility above and below the glass transition temperature T-g. Above T-g the entire film flows, whereas below T-g only the near-surface region responds to the excess interfacial energy. An analytical thin-film model for flow limited to the free surface region shows excellent agreement with sub-T-g data. The system transitions from whole-film flow to surface localized flow over a narrow temperature region near the bulk T-g. The experiments and model provide a measure of surface mobility in a simple geometry where confinement and substrate effects are negligible. This fine control of the glassy rheology is of key interest to nanolithography among numerous other applications.	[Chai, Y.; Forrest, J. A.] Univ Waterloo, Dept Phys & Astron, Waterloo, ON N2L 3G1, Canada; [Chai, Y.; Forrest, J. A.] Univ Waterloo, Guelph Waterloo Phys Inst, Waterloo, ON N2L 3G1, Canada; [Forrest, J. A.] Perimeter Inst Theoret Phys, Waterloo, ON N2L 2Y5, Canada; [Salez, T.; Benzaquen, M.; Dalnoki-Veress, K.; Raphael, E.] Ecole Super Phys & Chim Ind Ville Paris, Lab Physicochim Theor, UMR CNRS Gulliver 7083, Paris, France; [McGraw, J. D.; Dalnoki-Veress, K.] McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada	University of Waterloo; University of Guelph; University of Waterloo; Guelph - Waterloo Physics Institute; Perimeter Institute for Theoretical Physics; UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); McMaster University	Forrest, JA (corresponding author), Univ Waterloo, Dept Phys & Astron, Waterloo, ON N2L 3G1, Canada.	jforrest@uwaterloo.ca	Raphaël, Elie/K-4043-2012; Salez, Thomas/N-8039-2016; Dalnoki-Veress, Kari/A-3668-2012	Raphaël, Elie/0000-0003-0007-4790; Salez, Thomas/0000-0001-6111-8721; Dalnoki-Veress, Kari/0000-0002-0885-6634; McGraw, Joshua D./0000-0003-4925-5496; /0000-0002-9751-7625; Chai, Yu/0000-0001-6085-4321	Ecole Normale Superieure of Paris; Fondation Langlois; Chaire Total-ESPCI ParisTech; Natural Sciences and Engineering Research Council of Canada	Ecole Normale Superieure of Paris; Fondation Langlois; Chaire Total-ESPCI ParisTech; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The authors acknowledge the Ecole Normale Superieure of Paris, the Fondation Langlois, the Chaire Total-ESPCI ParisTech, as well as the Natural Sciences and Engineering Research Council of Canada, for financial support. We also thank O. Baumchen for interesting discussions.	Alcoutlabi M, 2005, J PHYS-CONDENS MAT, V17, pR461, DOI 10.1088/0953-8984/17/15/R01; ANDERSON PW, 1995, SCIENCE, V268, P1154, DOI 10.1126/science.268.5214.1154; Blossey, 2012, THIN LIQUID FILMS DE; Buck E, 2004, MACROMOLECULES, V37, P8647, DOI 10.1021/ma049595z; Daley CR, 2012, SOFT MATTER, V8, P2206, DOI 10.1039/c2sm06826e; Ediger MD, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4747326; Fakhraai Z, 2008, SCIENCE, V319, P600, DOI 10.1126/science.1151205; Forrest JA, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4818989; Forrest JA, 2000, PHYS REV E, V61, pR53, DOI 10.1103/PhysRevE.61.R53; Forrest JA, 2002, EUR PHYS J E, V8, P261, DOI 10.1140/epje/i2002-10005-5; Forrest JA, 2001, ADV COLLOID INTERFAC, V94, P167, DOI 10.1016/S0001-8686(01)00060-4; Ge S, 2000, PHYS REV LETT, V85, P2340, DOI 10.1103/PhysRevLett.85.2340; Ilton M, 2009, MACROMOLECULES, V42, P6851, DOI 10.1021/ma901057b; Kerle T, 2001, MACROMOLECULES, V34, P3484, DOI 10.1021/ma0020335; Majeste JC, 1998, RHEOL ACTA, V37, P486, DOI 10.1007/s003970050135; Malshe R, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3573903; Mattsson J, 2000, PHYS REV E, V62, P5187, DOI 10.1103/PhysRevE.62.5187; McGraw JD, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.128303; MULLINS WW, 1959, J APPL PHYS, V30, P77, DOI 10.1063/1.1734979; Papaleo RM, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.094203; Qi D, 2011, EUR PHYS J E, V34, DOI 10.1140/epje/i2011-11056-1; Qi D, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.096101; Qi D., 2009, THESIS U WATERLOO ON; Rognin E, 2012, J VAC SCI TECHNOL B, V30, DOI 10.1116/1.3664088; Rognin E, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.041805; Salez T, 2012, EUR PHYS J E, V35, DOI 10.1140/epje/i2012-12114-x; Salez T, 2012, PHYS FLUIDS, V24, DOI 10.1063/1.4763569; STILLWAGON LE, 1988, J APPL PHYS, V63, P5251, DOI 10.1063/1.340388; Teichroeb JH, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.016104; Teisseire J, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3535614; WU S, 1970, J PHYS CHEM-US, V74, P632, DOI 10.1021/j100698a026; Yang ZH, 2010, SCIENCE, V328, P1676, DOI 10.1126/science.1184394; Zhu L, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.256103	33	170	172	4	234	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2014	343	6174					994	999		10.1126/science.1244845	http://dx.doi.org/10.1126/science.1244845			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2DZ	24578574	Green Submitted			2022-12-28	WOS:000332309600038
J	Versteeg, R				Versteeg, Rogier			CANCER Tumours outside the mutation box	NATURE			English	Editorial Material							NEUROBLASTOMA; ONCOGENE		Univ Amsterdam, Acad Med Ctr, Dept Oncogen, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Versteeg, R (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Oncogen, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	r.versteeg@amc.uva.nl	Versteeg, Rogier/AAQ-1765-2020	Versteeg, Rogier/0000-0001-7172-0388				Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Lee RS, 2012, J CLIN INVEST, V122, P2983, DOI 10.1172/JCI64400; Mack SC, 2014, NATURE, V506, P445, DOI 10.1038/nature13108; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Parker M, 2014, NATURE, V506, P451, DOI 10.1038/nature13109; Plass C, 2013, NAT REV GENET, V14, P765, DOI 10.1038/nrg3554; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; REDDY EP, 1982, NATURE, V300, P149, DOI 10.1038/300149a0; Sausen M, 2013, NAT GENET, V45, P12, DOI 10.1038/ng.2493; TABIN CJ, 1982, NATURE, V300, P143, DOI 10.1038/300143a0; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Witt H, 2011, CANCER CELL, V20, P143, DOI 10.1016/j.ccr.2011.07.007	13	48	50	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2014	506	7489					438	439		10.1038/nature13061	http://dx.doi.org/10.1038/nature13061			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0DN	24553138				2022-12-28	WOS:000332165100025
J	Mody, L; Juthani-Mehta, M				Mody, Lona; Juthani-Mehta, Manisha			Urinary Tract Infections in Older Women A Clinical Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							SULFAMETHOXAZOLE-INDUCED HYPERKALEMIA; NURSING-HOME RESIDENTS; TRIMETHOPRIM-SULFAMETHOXAZOLE; ASYMPTOMATIC BACTERIURIA; ANTIBIOTIC-THERAPY; ESCHERICHIA-COLI; ANTIMICROBIAL TREATMENT; AMERICA GUIDELINES; DISEASES-SOCIETY; DOUBLE-BLIND	IMPORTANCE Asymptomatic bacteriuria and symptomatic urinary tract infections (UTIs) in older women are commonly encountered in outpatient practice. OBJECTIVE To review management of asymptomatic bacteriuria and symptomatic UTI and review prevention of recurrent UTIs in older community-dwelling women. EVIDENCE REVIEW A search of Ovid (Medline, PsycINFO, Embase) for English-language human studies conducted among adults aged 65 years and older and published in peer-reviewed journals from 1946 to November 20, 2013. RESULTS The clinical spectrum of UTIs ranges from asymptomatic bacteriuria, to symptomatic and recurrent UTIs, to sepsis associated with UTI requiring hospitalization. Recent evidence helps differentiate asymptomatic bacteriuria from symptomatic UTI. Asymptomatic bacteriuria is transient in older women, often resolves without any treatment, and is not associated with morbidity or mortality. The diagnosis of symptomatic UTI is made when a patient has both clinical features and laboratory evidence of a urinary infection. Absent other causes, patients presenting with any 2 of the following meet the clinical diagnostic criteria for symptomatic UTI: fever, worsened urinary urgency or frequency, acute dysuria, suprapubic tenderness, or costovertebral angle pain or tenderness. A positive urine culture (>= 10(5) CFU/mL) with no more than 2 uropathogens and pyuria confirms the diagnosis of UTI. Risk factors for recurrent symptomatic UTI include diabetes, functional disability, recent sexual intercourse, prior history of urogynecologic surgery, urinary retention, and urinary incontinence. Testing for UTI is easily performed in the clinic using dipstick tests. When there is a low pretest probability of UTI, a negative dipstick result for leukocyte esterase and nitrites excludes infection. Antibiotics are selected by identifying the uropathogen, knowing local resistance rates, and considering adverse effect profiles. Chronic suppressive antibiotics for 6 to 12 months and vaginal estrogen therapy effectively reduce symptomatic UTI episodes and should be considered in patients with recurrent UTIs. CONCLUSIONS AND RELEVANCE Establishing a diagnosis of symptomatic UTI in older women requires careful clinical evaluation with possible laboratory assessment using urinalysis and urine culture. Asymptomatic bacteriuria should be differentiated from symptomatic UTI. Asymptomatic bacteriuria in older women should not be treated.	[Mody, Lona] Univ Michigan, Div Geriatr, Ann Arbor, MI 48185 USA; [Mody, Lona] Univ Michigan, Div Palliat Care Med, Ann Arbor, MI 48185 USA; [Mody, Lona] Vet Affairs Ann Arbor Healthcare Syst, Geriatr Res Educ & Clin Ctr, Ann Arbor, MI USA; [Juthani-Mehta, Manisha] Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06510 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; Yale University	Mody, L (corresponding author), Univ Michigan, Div Geriatr, 2215 Fuller Dr, Ann Arbor, MI 48185 USA.	lonamody@umich.edu			National Institute on Aging (NIA) [R01 AG032298, R01 AG41780, R18 HS019979]; University of Michigan Claude D. Pepper Older Americans Independence Center [P30 AG024824]; NIA [5K23A028691, 1R01AG041153]; Yale Claude D. Pepper Older Americans Independence Center [P30 AG021342]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R18HS019979] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032298, R01AG041153, R01AG041780, P30AG024824, P30AG021342] Funding Source: NIH RePORTER	National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); University of Michigan Claude D. Pepper Older Americans Independence Center; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Yale Claude D. Pepper Older Americans Independence Center; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr Mody is supported by the National Institute on Aging (NIA) (R01 AG032298, R01 AG41780, R18 HS019979) and University of Michigan Claude D. Pepper Older Americans Independence Center (P30 AG024824). Dr Juthani-Mehta is supported by the NIA (5K23A028691, 1R01AG041153) and the Yale Claude D. Pepper Older Americans Independence Center (P30 AG021342).	ABRUTYN E, 1994, ANN INTERN MED, V120, P827, DOI 10.7326/0003-4819-120-10-199405150-00003; Albert X, 2004, COCHRANE DB SYST REV, V3, DOI [10.1002/14651858.CD001209.pub2, DOI 10.1002/14651858.CD001209.PUB2]; [Anonymous], 2012, MED LETT DRUGS THER, V54, P57; Antoniou T, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5228; Antoniou T, 2010, ARCH INTERN MED, V170, P1045, DOI 10.1001/archinternmed.2010.142; AVORN J, 1994, JAMA-J AM MED ASSOC, V271, P751, DOI 10.1001/jama.271.10.751; Bains A, 2009, CAN PHARM J, V142, P248, DOI 10.3821/1913-701X-142.5.248; Bazaz R, 2010, J ANTIMICROB CHEMOTH, V65, P1510, DOI 10.1093/jac/dkq152; Bent S, 2002, JAMA-J AM MED ASSOC, V287, P2701, DOI 10.1001/jama.287.20.2701; BOSCIA JA, 1986, AM J MED, V81, P979, DOI 10.1016/0002-9343(86)90391-8; BOSCIA JA, 1987, JAMA-J AM MED ASSOC, V257, P1067, DOI 10.1001/jama.257.8.1067; Brumfitt W, 1998, J ANTIMICROB CHEMOTH, V42, P363, DOI 10.1093/jac/42.3.363; Christiaens TCM, 2002, BRIT J GEN PRACT, V52, P729; Czaja CA, 2009, J INFECT DIS, V200, P528, DOI 10.1086/600385; D'Agata E, 2013, J AM GERIATR SOC, V61, P62, DOI 10.1111/jgs.12070; Deville Walter L J M, 2004, BMC Urol, V4, P4, DOI 10.1186/1471-2490-4-4; Ducharme James, 2007, CJEM, V9, P87; Elstad EA, 2011, J CLIN NURS, V20, P156, DOI 10.1111/j.1365-2702.2010.03493.x; Epp A, 2010, J OBSTET GYNAECOL CA, V32, P1082, DOI 10.1016/S1701-2163(16)34717-X; Eriksson I, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-73; FERRARO G, 1990, CHEMOTHERAPY, V36, P46, DOI 10.1159/000238817; Ferry SA, 2007, SCAND J PRIM HEALTH, V25, P49, DOI 10.1080/02813430601183074; Fischer HD, 2010, ARCH INTERN MED, V170, P617, DOI 10.1001/archinternmed.2010.37; Foxman B, 2003, DM-DIS MON, V49, P53, DOI 10.1067/mda.2003.7; Gorter KJ, 2010, FAM PRACT, V27, P379, DOI 10.1093/fampra/cmq026; Gupta K, 2011, CLIN INFECT DIS, V52, pE103, DOI [10.1093/cid/ciq257, 10.1093/cid/cir102]; Hu KK, 2004, ARCH INTERN MED, V164, P989, DOI 10.1001/archinte.164.9.989; HURLBUT TA, 1991, AM J CLIN PATHOL, V96, P582, DOI 10.1093/ajcp/96.5.582; Iravani A, 1999, J ANTIMICROB CHEMOTH, V43, P67, DOI 10.1093/jac/43.suppl_1.67; Jackson SL, 2004, AM J MED, V117, P903, DOI 10.1016/j.amjmed.2004.07.045; Jepson RG, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001321.pub4; Juthani-Mehta M, 2009, J AM GERIATR SOC, V57, P963, DOI 10.1111/j.1532-5415.2009.02227.x; Kallen AJ, 2006, ARCH INTERN MED, V166, P635, DOI 10.1001/archinte.166.6.635; Kavatha D, 2003, ANTIMICROB AGENTS CH, V47, P897, DOI 10.1128/AAC.47.3.897-900.2003; Kaye D, 1989, Trans Am Clin Climatol Assoc, V100, P155; Knottnerus BJ, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-71; LABOVITZ E, 1974, ANTIMICROB AGENTS CH, V6, P465, DOI 10.1128/AAC.6.4.465; LACHS MS, 1992, ANN INTERN MED, V117, P135, DOI 10.7326/0003-4819-117-2-135; Lifshitz E, 2000, ARCH INTERN MED, V160, P2537, DOI 10.1001/archinte.160.16.2537; Linhares I, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-19; Litman HJ, 2007, UROLOGY, V70, P916, DOI 10.1016/j.urology.2007.06.1117; Litwin MS, 2005, J UROLOGY, V173, P933, DOI 10.1097/01.ju.0000152365.43125.3b; Lutters M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001535.pub2; Matthews SJ, 2011, AM J GERIATR PHARMAC, V9, P286, DOI 10.1016/j.amjopharm.2011.07.002; Mazzulli T, 2012, CAN J UROL, V19, P42; McKinnell JA, 2011, MAYO CLIN PROC, V86, P480, DOI 10.4065/mcp.2010.0800; Medina-Bombardo D, 2003, FAM PRACT, V20, P103, DOI 10.1093/fampra/20.2.103; Meier S, 2011, INFECTION, V39, P333, DOI 10.1007/s15010-011-0132-6; MONANE M, 1995, J AM GERIATR SOC, V43, P618, DOI 10.1111/j.1532-5415.1995.tb07194.x; Moore EE, 2008, J GEN INTERN MED, V23, P595, DOI 10.1007/s11606-008-0535-y; Moore EE, 2008, OBSTET GYNECOL, V111, P317, DOI 10.1097/AOG.0b013e318160d64a; Nicolle LE, 2009, CLIN GERIATR MED, V25, P423, DOI 10.1016/j.cger.2009.04.005; Nicolle LE, 2005, CLIN INFECT DIS, V40, P643, DOI 10.1086/427507; Nicolle LE, 2002, AM J MED, V113, p35S; Nygaard I, 2008, JAMA-J AM MED ASSOC, V300, P1311, DOI 10.1001/jama.300.11.1311; Oplinger M, 2013, ANN PHARMACOTHER, V47, P106, DOI 10.1345/aph.1R352; Ouslander JG, 1996, J AM GERIATR SOC, V44, P420, DOI 10.1111/j.1532-5415.1996.tb06414.x; Perrotta C, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005131.pub2; Raz R, 2000, CLIN INFECT DIS, V30, P152, DOI 10.1086/313596; Renko M, 2011, DIABETES CARE, V34, P230, DOI 10.2337/dc10-0421; Rodriguez-Bano J, 2008, ARCH INTERN MED, V168, P1897, DOI 10.1001/archinte.168.17.1897; SHEINFELD J, 1989, NEW ENGL J MED, V320, P773, DOI 10.1056/NEJM198903233201205; Simel DL, 2009, RATIONAL CLIN EXAMIN; Sobel JD, 2010, MANDELL DOUGLAS BENN, P957; STAMEY TA, 1977, NEW ENGL J MED, V296, P780, DOI 10.1056/NEJM197704072961403; STAMM WE, 1980, ANN INTERN MED, V92, P770, DOI 10.7326/0003-4819-92-6-770; STAPLETON A, 1995, J INFECT DIS, V171, P717, DOI 10.1093/infdis/171.3.717; Stein GE, 1999, CLIN THER, V21, P1864, DOI 10.1016/S0149-2918(00)86734-X; Swami SK, 2012, MAYO CLIN PROC, V87, P753, DOI 10.1016/j.mayocp.2012.02.025; Taur Y, 2007, CLIN INFECT DIS, V44, P769, DOI 10.1086/511866; Vogel T, 2004, CAN MED ASSOC J, V170, P469; Wang CH, 2012, ARCH INTERN MED, V172, P988, DOI 10.1001/archinternmed.2012.3004; Warren JW, 1999, CLIN INFECT DIS, V29, P745, DOI 10.1086/520427; Zafenello F, J BIOMED BIOTECHNOL, DOI [10.1155/2010/321082, DOI 10.1155/2010/321082]; Zhanel GG, 2005, INT J ANTIMICROB AG, V26, P380, DOI 10.1016/j.ijantimicag.2005.08.003	75	175	190	0	52	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 26	2014	311	8					844	854		10.1001/jama.2014.303	http://dx.doi.org/10.1001/jama.2014.303			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB4XQ	24570248	Green Accepted			2022-12-28	WOS:000331793700024
J	Smith, JM				Smith, Jeanette M.			February Thaw Charles Burchfield	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 26	2014	311	8					780	781		10.1001/jama.2013.279348	http://dx.doi.org/10.1001/jama.2013.279348			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB4XQ	24570225				2022-12-28	WOS:000331793700001
J	Kentikelenis, A; Karanikolos, M; Reeves, A; McKee, M; Stuckler, D				Kentikelenis, Alexander; Karanikolos, Marina; Reeves, Aaron; McKee, Martin; Stuckler, David			Greece's health crisis: from austerity to denialism	LANCET			English	Article							FINANCIAL CRISIS; ECONOMIC-CRISIS; POLICY; CARE; DEPRESSION; MORTALITY; SYSTEM; ERA	Greece's economic crisis has deepened since it was bailed out by the international community in 2010. The country underwent the sixth consecutive year of economic contraction in 2013, with its economy shrinking by 20% between 2008 and 2012, and anaemic or no growth projected for 2014. Unemployment has more than tripled, from 7.7% in 2008 to 24.3% in 2012, and long-term unemployment reached 14.4%. We review the background to the crisis, assess how austerity measures have affected the health of the Greek population and their access to public health services, and examine the political response to the mounting evidence of a Greek public health tragedy.	[Kentikelenis, Alexander] Univ Cambridge, Dept Sociol, Cambridge, England; [Kentikelenis, Alexander] Univ Cambridge, Kings Coll, Cambridge, England; [Karanikolos, Marina; McKee, Martin; Stuckler, David] London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, London WC1, England; [Karanikolos, Marina; McKee, Martin] European Observ Hlth Syst & Policies, London, England; [Reeves, Aaron; Stuckler, David] Univ Oxford, Dept Sociol, Oxford, England	University of Cambridge; University of Cambridge; University of London; London School of Hygiene & Tropical Medicine; European Observatory on Health Systems & Policies; University of Oxford	Kentikelenis, A (corresponding author), Kings Coll 562, Cambridge CB2 1ST, England.	aek37@cam.ac.uk	McKee, Marc D/E-2187-2011; Mckee, Martin/E-6673-2018	McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683; Reeves, Aaron/0000-0001-9114-965X; Karanikolos, Marina/0000-0002-3824-8226; Stuckler, David/0000-0002-1288-8401; Kentikelenis, Alexander/0000-0002-1543-4595	Greek Ministry of Education (IKY); Onassis Foundation; Wellcome Trust [100709/Z/12/Z]	Greek Ministry of Education (IKY); Onassis Foundation; Wellcome Trust(Wellcome TrustEuropean Commission)	AK acknowledges financial support from the Greek Ministry of Education (IKY) and the Onassis Foundation. DS is funded by a Wellcome Trust Investigator Award 100709/Z/12/Z. The European Union Statistics on Income and Living Conditions data were provided by Eurostat, which has no responsibility for the results and conclusions of this study. We thank Sanjay Basu for his comments.	Anagnostopoulos DC, 2013, EUR CHILD ADOLES PSY, V22, P131, DOI 10.1007/s00787-013-0377-y; [Anonymous], 2013, LANCET, V382, P102, DOI 10.1016/S0140-6736(13)61547-0; Badawi Z, 2013, GREECE IN SICKNESS D; Balzli B., 2010, SPIEGEL ONLINE  0408; Bonovas S, 2012, J PREV MED HYG, V53; Bruckner TA, 2008, ACCIDENT ANAL PREV, V40, P1797, DOI 10.1016/j.aap.2008.07.011; Daley Suzanne, 2013, NY TIMES; Danis K, 2011, EUROSURVEILLANCE, V16, P2; Davaki K, 2005, J HEALTH POLIT POLIC, V30, P143, DOI 10.1215/03616878-30-1-2-143; Diethelm P, 2009, EUR J PUBLIC HEALTH, V19, P2, DOI 10.1093/eurpub/ckn139; Durkheim Emile, 2006, SUICIDE; ECDC, 2012, RISK ASS HIV GREEC; Economou C, 2010, HLTH SYST TRANSIT, V12, pxv; Economou C, IMPACT FINA IN PRESS; Economou Charalambos, 2010, Health Syst Transit, V12, P1; Economou M, 2013, J AFFECT DISORDERS, V145, P308, DOI 10.1016/j.jad.2012.08.008; Economou M, 2011, LANCET, V378, P1459, DOI 10.1016/S0140-6736(11)61638-3; EKTEPN, 2010, ANN REP STAT DRUGS A; European Centre for Disease Prevention and Control/World Health Organization Regional Office for Europe, 2013, HIV AIDS SURV EUR 20; European Commission, 2013, EUR DAT; European Commission, 2012, EUROPEAN EC OCCASION, V2012, P123; European Commission, 2010, 72 EUR COMM, P29; European Commission, 2013, EUROPEAN EC OCCASION, P148; Eurostat, 2013, CROSS SECT EUR UN ST; Fotiou A, HIV OUTBREAK INJECTI; Greer SL, 2013, LANCET, V381, P1135, DOI 10.1016/S0140-6736(12)62083-2; Hyphantis T, 2013, J PSYCHOSOM RES, V74, P530, DOI 10.1016/j.jpsychores.2013.03.010; IMF, 2013, WORLD EC FIN SURV WO; IMF, 2013, GREEC EX POST EV EXC; Karamanlis K., 2008, COMMUNICATION; Karamanoli E, 2011, LANCET, V378, P303, DOI 10.1016/S0140-6736(11)61152-5; Kelland K., 2012, REUTERS; Kentikelenis A, 2012, EUR J PUBLIC HEALTH, V22, P4, DOI 10.1093/eurpub/ckr190; Kentikelenis A, 2011, LANCET, V378, P1457, DOI 10.1016/S0140-6736(11)61556-0; Kopsini C., 2013, KATHIMERINI ATH 1008; Labropoulou E, 2013, SICK MAN EUROPE LIFE; Legido-Quigley H, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2363; Liaropoulos L, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7988; Loverdos A., 2011, WHO WORLD C SOC DET; Malkoutzis N, 2013, KATHIMERINI ATH 0530; Mantzouranis G, 2012, ELEGEIA PRIMARY HLTH, V24, P27; Matsaganis M., 2012, AUEB WORKING PAPER S, V1231, P1; Matsaganis M, 2012, CRIT SOC POLICY, V32, P406, DOI 10.1177/0261018312444417; Medecins du Monde, 2013, ACC HEALTHC EUR TIM; Ministry of Health, 2013, STAT MIN ADM REF DEV; Mossialos E, 2005, HEALTH ECON, V14, pS151, DOI 10.1002/hec.1033; Mossialos E, 2005, WEST EUR POLIT, V28, P420, DOI 10.1080/01402380500060460; Nolte E, 2000, J EPIDEMIOL COMMUN H, V54, P84, DOI 10.1136/jech.54.2.84; OECD, 2013, JOINT M CHEM COMM WO; Polyzos N, 2012, LANCET, V379, P1000, DOI 10.1016/S0140-6736(12)60421-8; Rauch B, 2011, GER ECON REV, V12, P243, DOI 10.1111/j.1468-0475.2011.00542.x; Reeves A, 2013, J ROY SOC MED, V106, P432, DOI 10.1177/0141076813501101; Schwartz N. D, 2010, NY TIMES; Simou E, 2013, ASS BIRTH RATES SELE; Spala G., 2013, EPIDEMIOLOGICAL DATA; Stuckler D., 2013, BODY EC AUSTERITY KI; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7; Sukkar E, 2013, GUARDIAN; Telloglou T., 2011, COMMUNICATION; Tripsa T, 2013, HELLENIC J NURSING S, V4, p27 39; Tsiantou V, 2009, J CLIN PHARM THER, V34, P547, DOI 10.1111/j.1365-2710.2009.01037.x; Tsiligianni I, 2013, RURAL REMOTE HEALTH, V13; UNAIDS, 2013, UNAIDS URG GREEK AUT; UNICEF, 2013, REP SIT CHILDR GREEC; United Nations Committee on the Rights of the Child, 2012, CRCCGRCCO23 UN COMM; WHO Regional Office for Europe, 2013, EUR HLTH ALL DAT; WHO Regional Office for Europe, 2013, WHO GREEC SIGN AGR S	67	244	248	0	44	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 22	2014	383	9918					748	753		10.1016/S0140-6736(13)62291-6	http://dx.doi.org/10.1016/S0140-6736(13)62291-6			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AB2WR	24560058				2022-12-28	WOS:000331653300036
J	Sedgwick, P; Hoope, C				Sedgwick, Philip; Hoope, Carwyn			Placebo controlled trials	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sedgwick, Philip; Hoope, Carwyn] Univ London, Ctr Med & Healthcare Educ, London, England	St Georges University London; University of London	Sedgwick, P (corresponding author), Univ London, Ctr Med & Healthcare Educ, London, England.	p.sedgwick@sgul.ac.uk	Hooper, Carwyn/AAM-1819-2021; Sedgwick, Philip/C-6997-2019	Sedgwick, Philip/0000-0001-8859-2175; Hooper, Carwyn/0000-0001-5147-3842				Fagerstrom K, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6549; Sedgwick P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5420; Sedgwick P, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7951	3	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 21	2014	348								g1635	10.1136/bmj.g1635	http://dx.doi.org/10.1136/bmj.g1635			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB9ZU	24563452				2022-12-28	WOS:000332155100003
J	Lyons, TW; Reinhard, CT; Planavsky, NJ				Lyons, Timothy W.; Reinhard, Christopher T.; Planavsky, Noah J.			The rise of oxygen in Earth's early ocean and atmosphere	NATURE			English	Review							MASS-INDEPENDENT FRACTIONATION; CARBON-ISOTOPE EXCURSION; ORGANIC-CARBON; IRON-FORMATION; FERRUGINOUS CONDITIONS; MCARTHUR BASIN; SULFATE LEVELS; EARLY HISTORY; NEW-MODEL; OXIDATION	The rapid increase of carbon dioxide concentration in Earth's modern atmosphere is a matter of major concern. But for the atmosphere of roughly two-and-half billion years ago, interest centres on a different gas: free oxygen (O-2) spawned by early biological production. The initial increase of O-2 in the atmosphere, its delayed build-up in the ocean, its increase to near-modern levels in the sea and air two billion years later, and its cause-and-effect relationship with life are among the most compelling stories in Earth's history.	[Lyons, Timothy W.; Reinhard, Christopher T.; Planavsky, Noah J.] Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA; [Reinhard, Christopher T.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Reinhard, Christopher T.] Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA; [Planavsky, Noah J.] Yale Univ, Dept Geol & Geophys, New Haven, CT 06511 USA	University of California System; University of California Riverside; California Institute of Technology; University System of Georgia; Georgia Institute of Technology; Yale University	Lyons, TW (corresponding author), Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA.	timothy.lyons@ucr.edu			NSF-EAR; NASA Exobiology Program; NASA Astrobiology Institute; Agouron Institute; O. K. Earl Postdoctoral Fellowship in Geological and Planetary Sciences at the California Institute of Technology; NSF-EAR-PDF; Directorate For Geosciences [1338299, 1144317] Funding Source: National Science Foundation	NSF-EAR(National Science Foundation (NSF)); NASA Exobiology Program(National Aeronautics & Space Administration (NASA)); NASA Astrobiology Institute; Agouron Institute(Pfizer); O. K. Earl Postdoctoral Fellowship in Geological and Planetary Sciences at the California Institute of Technology; NSF-EAR-PDF; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding from NSF-EAR, the NASA Exobiology Program, the NASA Astrobiology Institute, and the Agouron Institute supported this work. C. T. R. acknowledges support from an O. K. Earl Postdoctoral Fellowship in Geological and Planetary Sciences at the California Institute of Technology. N.J.P. acknowledges support from NSF-EAR-PDF. Comments and criticism from A. Bekker, D. Erwin, I. Halevy and D. Johnston improved the manuscript. A. Bekker was helpful in discussions about the GOE and suggested the acronym 'GOT'.	Algeo TJ, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2004PA001112; Anbar AD, 2002, SCIENCE, V297, P1137, DOI 10.1126/science.1069651; Anbar AD, 2007, SCIENCE, V317, P1903, DOI 10.1126/science.1140325; [Anonymous], [No title captured]; Arnold GL, 2004, SCIENCE, V304, P87, DOI 10.1126/science.1091785; Baldwin GJ, 2013, PRECAMBRIAN RES, V230, P168, DOI 10.1016/j.precamres.2013.02.011; Bekker A, 2004, NATURE, V427, P117, DOI 10.1038/nature02260; Bekker A, 2012, EARTH PLANET SC LETT, V317, P295, DOI 10.1016/j.epsl.2011.12.012; Bekker A, 2010, ECON GEOL, V105, P467, DOI 10.2113/gsecongeo.105.3.467; Bergman NM, 2004, AM J SCI, V304, P397, DOI 10.2475/ajs.304.5.397; Berner R.A., 2004, PHANEROZOIC CARBON C; BERNER RA, 1989, AM J SCI, V289, P333, DOI 10.2475/ajs.289.4.333; Bosak T, 2013, ANNU REV EARTH PL SC, V41, P21, DOI 10.1146/annurev-earth-042711-105327; Boyle RA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2511; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; Brocks JJ, 2011, GEOCHIM COSMOCHIM AC, V75, P3196, DOI 10.1016/j.gca.2011.03.014; Butterfield NJ, 2009, GEOBIOLOGY, V7, P1, DOI 10.1111/j.1472-4669.2009.00188.x; CAIRNSSMITH AG, 1978, NATURE, V276, P807, DOI 10.1038/276807a0; Canfield DE, 2005, ANNU REV EARTH PL SC, V33, P1, DOI 10.1146/annurev.earth.33.092203.122711; Canfield DE, 1998, NATURE, V396, P450, DOI 10.1038/24839; Canfield DE, 2007, SCIENCE, V315, P92, DOI 10.1126/science.1135013; Canfield DE, 2008, SCIENCE, V321, P949, DOI 10.1126/science.1154499; Canil D, 2002, EARTH PLANET SC LETT, V195, P75, DOI 10.1016/S0012-821X(01)00582-9; Catling DC, 2001, SCIENCE, V293, P839, DOI 10.1126/science.1061976; Claire M. W., 2006, GEOBIOLOGY, V4, P239; Clement BG, 2009, GEOCHIM COSMOCHIM AC, V73, P1878, DOI 10.1016/j.gca.2008.12.023; Crowe SA, 2008, P NATL ACAD SCI USA, V105, P15938, DOI 10.1073/pnas.0805313105; Crowe SA, 2013, NATURE, V501, P535, DOI 10.1038/nature12426; Dupont CL, 2010, P NATL ACAD SCI USA, V107, P10567, DOI 10.1073/pnas.0912491107; Erwin DH, 2011, SCIENCE, V334, P1091, DOI 10.1126/science.1206375; Evans DA, 1997, NATURE, V386, P262, DOI 10.1038/386262a0; Farquhar J, 2000, SCIENCE, V289, P756, DOI 10.1126/science.289.5480.756; Farquhar J, 2011, PHOTOSYNTH RES, V107, P11, DOI 10.1007/s11120-010-9594-0; Fike DA, 2006, NATURE, V444, P744, DOI 10.1038/nature05345; Frei R, 2009, NATURE, V461, P250, DOI 10.1038/nature08266; French K. L., 2013, GOLDSCHM 2013 C; Gaillard F, 2011, NATURE, V478, P229, DOI 10.1038/nature10460; Glass JB, 2009, GEOBIOLOGY, V7, P100, DOI 10.1111/j.1472-4669.2009.00190.x; Goldblatt C, 2006, NATURE, V443, P683, DOI 10.1038/nature05169; GOUGH DO, 1981, SOL PHYS, V74, P21, DOI 10.1007/BF00151270; Grotzinger JP, 2011, NAT GEOSCI, V4, P285, DOI [10.1038/ngeo1138, 10.1038/NGEO1138]; Guo QJ, 2009, GEOLOGY, V37, P399, DOI 10.1130/G25423A.1; Habicht KS, 2002, SCIENCE, V298, P2372, DOI 10.1126/science.1078265; Halevy I, 2010, SCIENCE, V329, P204, DOI 10.1126/science.1190298; Haqq-Misra JD, 2008, ASTROBIOLOGY, V8, P1127, DOI 10.1089/ast.2007.0197; Hayes JM, 2006, PHILOS T R SOC B, V361, P931, DOI 10.1098/rstb.2006.1840; Holland HD, 2002, GEOCHIM COSMOCHIM AC, V66, P3811, DOI 10.1016/S0016-7037(02)00950-X; Holland HD, 2006, PHILOS T R SOC B, V361, P903, DOI 10.1098/rstb.2006.1838; Jamieson JW, 2013, NAT GEOSCI, V6, P61, DOI [10.1038/ngeo1647, 10.1038/NGEO1647]; Johnston DT, 2009, P NATL ACAD SCI USA, V106, P16925, DOI 10.1073/pnas.0909248106; Karhu JA, 1996, GEOLOGY, V24, P867, DOI 10.1130/0091-7613(1996)024<0867:CIATRO>2.3.CO;2; Kasting J.F., 1992, PROTEROZOIC BIOSPHER, P1185; Kendall B, 2009, GEOCHIM COSMOCHIM AC, V73, P2534, DOI 10.1016/j.gca.2009.02.013; Kharecha P, 2005, GEOBIOLOGY, V3, P53, DOI 10.1111/j.1472-4669.2005.00049.x; Kirschvink JL, 2008, PHILOS T R SOC B, V363, P2755, DOI 10.1098/rstb.2008.0024; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Konhauser KO, 2002, GEOLOGY, V30, P1079, DOI 10.1130/0091-7613(2002)030<1079:CBHFTP>2.0.CO;2; Konhauser KO, 2011, NATURE, V478, P369, DOI 10.1038/nature10511; Konhauser KO, 2009, NATURE, V458, P750, DOI 10.1038/nature07858; Kump LR, 2008, NATURE, V451, P277, DOI 10.1038/nature06587; Kump LR, 2007, NATURE, V448, P1033, DOI 10.1038/nature06058; Kump LR, 2005, EARTH PLANET SC LETT, V235, P654, DOI 10.1016/j.epsl.2005.04.040; Li ZXA, 2004, EARTH PLANET SC LETT, V228, P483, DOI 10.1016/j.epsl.2004.10.006; LOGAN GA, 1995, NATURE, V376, P53, DOI 10.1038/376053a0; Love GD, 2009, NATURE, V457, P718, DOI 10.1038/nature07673; Lyons T. W., 2012, FUNDAMENTALS GEOBIOL, P371; Lyons TW, 2009, ANNU REV EARTH PL SC, V37, P507, DOI 10.1146/annurev.earth.36.031207.124233; Maloof AC, 2010, NAT GEOSCI, V3, P653, DOI 10.1038/NGEO934; Messie M, 2009, PROG OCEANOGR, V83, P151, DOI 10.1016/j.pocean.2009.07.018; Och LM, 2012, EARTH-SCI REV, V110, P26, DOI 10.1016/j.earscirev.2011.09.004; Ohmoto H, 2006, NATURE, V442, P908, DOI 10.1038/nature05044; Overmann J, 1996, LIMNOL OCEANOGR, V41, P147, DOI 10.4319/lo.1996.41.1.0147; Partin CA, 2013, EARTH PLANET SC LETT, V369, P284, DOI 10.1016/j.epsl.2013.03.031; Pavlov AA, 2002, ASTROBIOLOGY, V2, P27, DOI 10.1089/153110702753621321; Pavlov AA, 2000, J GEOPHYS RES-PLANET, V105, P11981, DOI 10.1029/1999JE001134; Planavsky NJ, 2012, P NATL ACAD SCI USA, V109, P18300, DOI 10.1073/pnas.1120387109; Planavsky NJ, 2011, NATURE, V477, P448, DOI 10.1038/nature10327; Planavsky NJ, 2010, NATURE, V467, P1088, DOI 10.1038/nature09485; Poulton SW, 2011, ELEMENTS, V7, P107, DOI 10.2113/gselements.7.2.107; Poulton SW, 2010, NAT GEOSCI, V3, P486, DOI 10.1038/NGEO889; Rasmussen B, 2008, NATURE, V455, P1101, DOI 10.1038/nature07381; Reinhard CT, 2013, NATURE, V497, P100, DOI 10.1038/nature12021; Reinhard CT, 2013, P NATL ACAD SCI USA, V110, P5357, DOI 10.1073/pnas.1208622110; Reinhard CT, 2009, SCIENCE, V326, P713, DOI 10.1126/science.1176711; Rosing MT, 2004, EARTH PLANET SC LETT, V217, P237, DOI 10.1016/S0012-821X(03)00609-5; Rye R, 1998, AM J SCI, V298, P621, DOI 10.2475/ajs.298.8.621; Sahoo SK, 2012, NATURE, V489, P546, DOI 10.1038/nature11445; Sarmiento JL, 1988, GLOBAL BIOGEOCHEM CY, V2, P115, DOI 10.1029/GB002i002p00115; Schroeder S, 2008, TERRA NOVA, V20, P108, DOI 10.1111/j.1365-3121.2008.00795.x; Scott C, 2008, NATURE, V452, P456, DOI 10.1038/nature06811; Shen YN, 2002, AM J SCI, V302, P81, DOI 10.2475/ajs.302.2.81; Slack JF, 2007, EARTH PLANET SC LETT, V255, P243, DOI 10.1016/j.epsl.2006.12.018; Sperling EA, 2013, P NATL ACAD SCI USA, V110, P13446, DOI 10.1073/pnas.1312778110; Swanson-Hysell NL, 2010, SCIENCE, V328, P608, DOI 10.1126/science.1184508; Swart PK, 2012, GEOLOGY, V40, P87, DOI 10.1130/G32538.1; Thunell RC, 2000, LIMNOL OCEANOGR, V45, P300, DOI 10.4319/lo.2000.45.2.0300; Trail D, 2011, NATURE, V480, P79, DOI 10.1038/nature10655; TROMP TK, 1995, GEOCHIM COSMOCHIM AC, V59, P1259, DOI 10.1016/0016-7037(95)00042-X; Waldbauer JR, 2011, P NATL ACAD SCI USA, V108, P13409, DOI 10.1073/pnas.1104160108; Zahnle K., 2006, GEOBIOLOGY, V4, P271, DOI 10.1111/j.1472-4669.2006.00085.x; Zahnle K. J., CHEM GEOL IN PRESS; ZBINDEN EA, 1988, PRECAMBRIAN RES, V42, P141, DOI 10.1016/0301-9268(88)90014-9; Zerkle AL, 2012, NAT GEOSCI, V5, P359, DOI [10.1038/NGEO1425, 10.1038/ngeo1425]	104	1380	1454	53	945	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 20	2014	506	7488					307	315		10.1038/nature13068	http://dx.doi.org/10.1038/nature13068			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB0JL	24553238				2022-12-28	WOS:000331477800030
J	Yager, PH; Luginbuhl, LM; Dekker, JP				Yager, Phoebe H.; Luginbuhl, Lynn M.; Dekker, John P.			Case 6-2014: A 35-Day-Old Boy with Fever, Vomiting, Mottled Skin, and Severe Anemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NEW-YORK-STATE; EXCHANGE-TRANSFUSION; HUMAN BABESIOSIS; CONGENITAL BABESIOSIS; NEW-JERSEY; INFECTIONS; MALARIA; SEPSIS; INFANT; TICKS		[Yager, Phoebe H.; Luginbuhl, Lynn M.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Dekker, John P.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Yager, Phoebe H.; Luginbuhl, Lynn M.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Dekker, John P.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Yager, PH (corresponding author), Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA.							Adelson ME, 2004, J CLIN MICROBIOL, V42, P2799, DOI 10.1128/JCM.42.6.2799-2801.2004; Aderinboye O, 2010, PEDIATR INFECT DIS J, V29, P188, DOI 10.1097/INF.0b013e3181c3c971; [Anonymous], 2010, BAB SURV MASS 2010; Bizzarro MJ, 2005, PEDIATRICS, V116, P595, DOI 10.1542/peds.2005-0552; Dorman SE, 2000, TRANSFUSION, V40, P375, DOI 10.1046/j.1537-2995.2000.40030375.x; ESERNIOJENSSEN D, 1987, J PEDIATR-US, V110, P570, DOI 10.1016/S0022-3476(87)80552-8; Feigin RD., 2009, FEIGIN CHERRYS TXB P, V6th ed.; Fortunov RM, 2006, PEDIATRICS, V118, P874, DOI 10.1542/peds.2006-0884; Fox LAM, 2006, PEDIATR INFECT DIS J, V25, P169, DOI 10.1097/01.inf.0000195438.09628.b0; Greenhow TL, 2012, PEDIATRICS, V129, pE590, DOI 10.1542/peds.2011-1546; Hatcher JC, 2001, CLIN INFECT DIS, V32, P1117, DOI 10.1086/319742; Joseph JT, 2011, EMERG INFECT DIS, V17, P843, DOI 10.3201/eid1705.101334; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; MELDRUM SC, 1992, CLIN INFECT DIS, V15, P1019, DOI 10.1093/clind/15.6.1019; MILLER KD, 1989, NEW ENGL J MED, V321, P65, DOI 10.1056/NEJM198907133210201; New DL, 1997, J PEDIATR-US, V131, P163, DOI 10.1016/S0022-3476(97)70143-4; Pickering LK, 2009, RED BOOK 2009 REPORT; Powell VI, 2002, TRANSFUS MED REV, V16, P239, DOI 10.1053/tmrv.2002.33437; Sethi S, 2009, EMERG INFECT DIS, V15, P788, DOI 10.3201/eid1505.070808; Tokarz R, 2010, VECTOR-BORNE ZOONOT, V10, P217, DOI 10.1089/vbz.2009.0036; Vannier E, 2009, INTERDISCIP PERSPECT; Vannier E, 2008, INFECT DIS CLIN N AM, V22, P469, DOI 10.1016/j.idc.2008.03.010; White DJ, 1998, ARCH INTERN MED, V158, P2149, DOI 10.1001/archinte.158.19.2149	23	15	16	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 20	2014	370	8					753	762		10.1056/NEJMcpc1208155	http://dx.doi.org/10.1056/NEJMcpc1208155			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB1DO	24552323				2022-12-28	WOS:000331531900011
J	Jaitin, DA; Kenigsberg, E; Keren-Shaul, H; Elefant, N; Paul, F; Zaretsky, I; Mildner, A; Cohen, N; Jung, S; Tanay, A; Amit, I				Jaitin, Diego Adhemar; Kenigsberg, Ephraim; Keren-Shaul, Hadas; Elefant, Naama; Paul, Franziska; Zaretsky, Irina; Mildner, Alexander; Cohen, Nadav; Jung, Steffen; Tanay, Amos; Amit, Ido			Massively Parallel Single-Cell RNA-Seq for Marker-Free Decomposition of Tissues into Cell Types	SCIENCE			English	Article							GENE-EXPRESSION; DENDRITIC CELLS; HETEROGENEITY; RESPONSES; IMMUNE	In multicellular organisms, biological function emerges when heterogeneous cell types form complex organs. Nevertheless, dissection of tissues into mixtures of cellular subpopulations is currently challenging. We introduce an automated massively parallel single-cell RNA sequencing (RNA-seq) approach for analyzing in vivo transcriptional states in thousands of single cells. Combined with unsupervised classification algorithms, this facilitates ab initio cell-type characterization of splenic tissues. Modeling single-cell transcriptional states in dendritic cells and additional hematopoietic cell types uncovers rich cell-type heterogeneity and gene-modules activity in steady state and after pathogen activation. Cellular diversity is thereby approached through inference of variable and dynamic pathway activity rather than a fixed preprogrammed cell-type hierarchy. These data demonstrate single-cell RNA-seq as an effective tool for comprehensive cellular decomposition of complex tissues.	[Jaitin, Diego Adhemar; Keren-Shaul, Hadas; Elefant, Naama; Paul, Franziska; Zaretsky, Irina; Mildner, Alexander; Jung, Steffen; Amit, Ido] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Kenigsberg, Ephraim; Cohen, Nadav; Tanay, Amos] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Kenigsberg, Ephraim; Cohen, Nadav; Tanay, Amos] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science	Tanay, A (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel.	amos.tanay@weizmann.ac.il; ido.amit@weizmann.ac.il	Jung, Steffen/K-1409-2012; mildner, alexander/AFK-2161-2022; mildner, alexander/AAF-9451-2022; mildner, alexander/GQA-3761-2022; Mildner, Alexander/ABG-6122-2020; Kenigsberg, Ephraim/AAM-5690-2020	Jung, Steffen/0000-0003-4290-5716; mildner, alexander/0000-0002-2019-8427; mildner, alexander/0000-0002-2019-8427; mildner, alexander/0000-0002-2019-8427; Paul, Franziska/0000-0003-0344-6764	European Research Council; Israel Science Foundation [1782/11, 1050/12]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); Israel Science Foundation(Israel Science Foundation); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Research was supported by the European Research Council and Israel Science Foundation (1782/11, 1050/12) grants to I. A. and A. T. RNA-seq data are deposited in Gene Expression Omnibus, accession no. GSE54006.	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Bar-On L, 2010, P NATL ACAD SCI USA, V107, P14745, DOI 10.1073/pnas.1001562107; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bradford BM, 2011, IMMUNOBIOLOGY, V216, P1228, DOI 10.1016/j.imbio.2011.08.006; Deng QL, 2014, SCIENCE, V343, P193, DOI 10.1126/science.1245316; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Geissmann F, 2010, NAT REV IMMUNOL, V10, P453, DOI 10.1038/nri2784; Germain RN, 2012, NAT IMMUNOL, V13, P902, DOI 10.1038/ni.2404; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Hume DA, 2011, J LEUKOCYTE BIOL, V89, P525, DOI 10.1189/jlb.0810472; Islam S, 2014, NAT METHODS, V11, P163, DOI [10.1038/nmeth.2772, 10.1038/NMETH.2772]; Islam S, 2012, NAT PROTOC, V7, P813, DOI 10.1038/nprot.2012.022; NUSSENZWEIG MC, 1982, P NATL ACAD SCI-BIOL, V79, P161, DOI 10.1073/pnas.79.1.161; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Sasagawa Y, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r31; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; Tang FC, 2011, NAT METHODS, V8, pS6, DOI [10.1038/NMETH.1557, 10.1038/nmeth.1557]; Wu AR, 2014, NAT METHODS, V11, P41, DOI 10.1038/nmeth.2694	21	1030	1086	11	236	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 14	2014	343	6172					776	779		10.1126/science.1247651	http://dx.doi.org/10.1126/science.1247651			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB1NB	24531970	Green Accepted			2022-12-28	WOS:000331557800041
J	Wilhelm, EE; Oster, E; Shoulson, I				Wilhelm, Erin E.; Oster, Emily; Shoulson, Ira			Approaches and Costs for Sharing Clinical Research Data	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ACCESS		[Wilhelm, Erin E.; Shoulson, Ira] Georgetown Univ, Dept Physiol & Pharmacol, Program Regulatory Sci & Med, Washington, DC 20007 USA; [Oster, Emily] Univ Chicago, Booth Sch Business, Chicago, IL 60637 USA; [Shoulson, Ira] Georgetown Univ, Program Regulatory Sci & Med, Dept Neurol, Washington, DC 20007 USA; [Shoulson, Ira] Georgetown Univ, Program Regulatory Sci & Med, Dept Pharmacol, Washington, DC 20007 USA; [Shoulson, Ira] Georgetown Univ, Program Regulatory Sci & Med, Dept Human Sci, Washington, DC 20007 USA	Georgetown University; University of Chicago; Georgetown University; Georgetown University; Georgetown University	Shoulson, I (corresponding author), Georgetown Univ, Dept Physiol & Pharmacol, Program Regulatory Sci & Med, 2115 Wisconsin Ave NW,Ste 603, Washington, DC 20007 USA.	is267@georgetown.edu			FDA HHS [FD U01004319] Funding Source: Medline; FOOD AND DRUG ADMINISTRATION [U01FD004319] Funding Source: NIH RePORTER	FDA HHS; FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services)		Berman F, 2013, SCIENCE, V341, P616, DOI 10.1126/science.1241625; National Database for Autism Research (NDAR), NDAR DATA DISTRIBUTI; Ross JS, 2013, JAMA-J AM MED ASSOC, V309, P1355, DOI 10.1001/jama.2013.1299; Spertus JA, 2012, CIRC-CARDIOVASC QUAL, V5, P143, DOI 10.1161/CIRCOUTCOMES.112.965814	4	20	20	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 26	2014	311	12					1201	1202		10.1001/jama.2014.850	http://dx.doi.org/10.1001/jama.2014.850			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD6CE	24556937				2022-12-28	WOS:000333340500020
J	Gulland, A				Gulland, Anne			BMJ AWARDS 2014 Karen Woo Surgical Team Award: making a difference in the UK and abroad	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												annecgulland@yahoo.co.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 10	2014	348								g1995	10.1136/bmj.g1995	http://dx.doi.org/10.1136/bmj.g1995			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD1ZH	24615856				2022-12-28	WOS:000333031700020
J	Rosenberg, SM; Queitsch, C				Rosenberg, Susan M.; Queitsch, Christine			Combating Evolution to Fight Disease	SCIENCE			English	Editorial Material							DNA BREAKS; CANCER; MUTATION; GENOMES; REPAIR		[Rosenberg, Susan M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Rosenberg, Susan M.] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Rosenberg, Susan M.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Rosenberg, Susan M.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Queitsch, Christine] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Washington; University of Washington Seattle	Rosenberg, SM (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	smr@bcm.edu		Rosenberg, Susan M./0000-0003-1444-473X	NCI NIH HHS [R01 CA085777, DP1 CA174424, R01-CA85777, DP1-CA174424] Funding Source: Medline; NIGMS NIH HHS [R35 GM122598, R01 GM053158, R01-GM53158] Funding Source: Medline; NIH HHS [DP2 OD008371, DP2-OD008371] Funding Source: Medline; NATIONAL CANCER INSTITUTE [DP1CA174424, R01CA085777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM122598, R01GM053158] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008371] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Al Mamun AM, 2012, SCIENCE, V338, P1344, DOI 10.1126/science.1226683; Bindra RS, 2007, CANCER METAST REV, V26, P249, DOI 10.1007/s10555-007-9061-3; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Cowen LE, 2013, CURR OPIN MICROBIOL, V16, P377, DOI 10.1016/j.mib.2013.03.005; De S, 2011, NAT BIOTECHNOL, V29, P1103, DOI 10.1038/nbt.2030; Fudenberg G, 2011, NAT BIOTECHNOL, V29, P1109, DOI 10.1038/nbt.2049; Girirajan S, 2011, ANNU REV GENET, V45, P203, DOI 10.1146/annurev-genet-102209-163544; Gordon AJE, 2009, PLOS BIOL, V7, P364, DOI 10.1371/journal.pbio.1000044; Gutierrez A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2607; Lindquist S, 2009, COLD SH Q B, V74, P103, DOI 10.1101/sqb.2009.74.043; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Roberts SA, 2012, MOL CELL, V46, P424, DOI 10.1016/j.molcel.2012.03.030; Santagata S, 2013, SCIENCE, V341, P250, DOI 10.1126/science.1238303; Shee C, 2012, CELL REP, V2, P714, DOI 10.1016/j.celrep.2012.08.033; Shor E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003680	15	33	34	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2014	343	6175					1088	1089		10.1126/science.1247472	http://dx.doi.org/10.1126/science.1247472			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2LB	24604189	Green Accepted			2022-12-28	WOS:000332331500033
J	Willett, SD; McCoy, SW; Perron, JT; Goren, L; Chen, CY				Willett, Sean D.; McCoy, Scott W.; Perron, J. Taylor; Goren, Liran; Chen, Chia-Yu			Dynamic Reorganization of River Basins	SCIENCE			English	Article							LANDSCAPE EVOLUTION; DRAINAGE PATTERNS; EROSION; CAPTURE; UPLIFT; MODEL; REARRANGEMENT; ESCARPMENT; TOPOGRAPHY; TECTONICS	River networks evolve as migrating drainage divides reshape river basins and change network topology by capture of river channels. We demonstrate that a characteristic metric of river network geometry gauges the horizontal motion of drainage divides. Assessing this metric throughout a landscape maps the dynamic states of entire river networks, revealing diverse conditions: Drainage divides in the Loess Plateau of China appear stationary; the young topography of Taiwan has migrating divides driving adjustment of major basins; and rivers draining the ancient landscape of the southeastern United States are reorganizing in response to escarpment retreat and coastal advance. The ability to measure the dynamic reorganization of river basins presents opportunities to examine landscape-scale interactions among tectonics, erosion, and ecology.	[Willett, Sean D.; McCoy, Scott W.; Goren, Liran; Chen, Chia-Yu] Swiss Fed Inst Technol, Inst Geol, CH-8092 Zurich, Switzerland; [McCoy, Scott W.; Perron, J. Taylor] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA	Swiss Federal Institutes of Technology Domain; ETH Zurich; Massachusetts Institute of Technology (MIT)	Willett, SD (corresponding author), Swiss Fed Inst Technol, Inst Geol, CH-8092 Zurich, Switzerland.	swillett@erdw.ethz.ch	Willett, Sean D/B-1716-2008	Chen, Chia-Yu/0000-0002-3837-5858; Goren, Liran/0000-0002-4704-5009	Canadian Institute for Advanced Research (CIFAR); CIFAR postdoctoral fellowship; U.S. National Science Foundation [EAR-0951672]; Swiss National Research Foundation; Division Of Earth Sciences [0951672] Funding Source: National Science Foundation	Canadian Institute for Advanced Research (CIFAR)(Canadian Institute for Advanced Research (CIFAR)); CIFAR postdoctoral fellowship; U.S. National Science Foundation(National Science Foundation (NSF)); Swiss National Research Foundation(Swiss National Science Foundation (SNSF)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	S.D.W., S.W.M., and J.T.P. thank the Canadian Institute for Advanced Research (CIFAR) for research support and members of the Earth System Evolution Program of CIFAR for discussions. S.W.M. was supported by a CIFAR postdoctoral fellowship and by the U.S. National Science Foundation through award EAR-0951672 to J.T.P. C.-Y.C. was supported by the Swiss National Research Foundation. Data are archived in the supplementary materials.	Bishop P, 1995, PROG PHYS GEOG, V19, P449, DOI 10.1177/030913339501900402; Bonnet S, 2009, NAT GEOSCI, V2, P766, DOI 10.1038/NGEO666; Brocard G, 2012, AM J SCI, V312, P449, DOI 10.2475/05.2012.01; Castelltort S, 2012, NAT GEOSCI, V5, P744, DOI [10.1038/ngeo1582, 10.1038/NGEO1582]; Clark MK, 2004, TECTONICS, V23, DOI 10.1029/2002TC001402; D W M, 1889, Science, V13, P108; Dadson SJ, 2003, NATURE, V426, P648, DOI 10.1038/nature02150; Davis W.M., 1903, GEOLSOCPHILABULL, V3, P213; Davis W. M., 1899, GEOGR J, V14, P481, DOI [10.2307/1774538, DOI 10.2307/1774538]; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Ferrier KL, 2013, NATURE, V496, P206, DOI 10.1038/nature11982; Goren L, 2014, EARTH SURF PROC LAND, V39, P522, DOI 10.1002/esp.3514; Hack J.T., 1957, STUDIES LONGITUDINAL, V294, P45; Hancock GS, 2002, GEOL SOC AM BULL, V114, P1131; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; Hovius N, 1996, BASIN RES, V8, P29, DOI 10.1111/j.1365-2117.1996.tb00113.x; HOWARD AD, 1965, AM J SCI, V263, P302, DOI 10.2475/ajs.263.4.302; HOWARD AD, 1990, WATER RESOUR RES, V26, P2107, DOI 10.1029/WR026i009p02107; HOWARD AD, 1994, J GEOPHYS RES-SOL EA, V99, P13971, DOI 10.1029/94JB00744; HOWARD AD, 1971, GEOL SOC AM BULL, V82, P1355, DOI 10.1130/0016-7606(1971)82[1355:SMOSC]2.0.CO;2; Johnson DW, 1907, SCIENCE, V25, P428, DOI 10.1126/science.25.637.428-a; Kirby E, 2012, J STRUCT GEOL, V44, P54, DOI 10.1016/j.jsg.2012.07.009; Matmon A, 2003, GEOLOGY, V31, P155, DOI 10.1130/0091-7613(2003)031<0155:TASURO>2.0.CO;2; MONTGOMERY DR, 1988, NATURE, V336, P232, DOI 10.1038/336232a0; Mudd SM, 2014, J GEOPHYS RES-EARTH, V119, P138, DOI 10.1002/2013JF002981; Nicholson S. W., 2005, PRELIMINARY INTEGRAT; Pelletier JD, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020802; Perron JT, 2013, EARTH SURF PROC LAND, V38, P570, DOI 10.1002/esp.3302; Perron JT, 2012, NATURE, V492, P100, DOI 10.1038/nature11672; Perron JT, 2009, NATURE, V460, P502, DOI 10.1038/nature08174; PITMAN WC, 1972, GEOL SOC AM BULL, V83, P619, DOI 10.1130/0016-7606(1972)83[619:SSITNA]2.0.CO;2; Portenga E, 2011, GSA TODAY, V21, P4, DOI DOI 10.1130/G111A.1; Prince PS, 2013, EARTH SURF PROC LAND, V38, P1685, DOI 10.1002/esp.3406; Prince PS, 2011, GEOLOGY, V39, P823, DOI 10.1130/G32008.1; Pritchard D, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040928; Reiners PW, 2006, ANNU REV EARTH PL SC, V34, P419, DOI 10.1146/annurev.earth.34.031405.125202; Rigon R, 1996, WATER RESOUR RES, V32, P3367, DOI 10.1029/96WR02397; Rodriguez Iturbe I., 2001, FRACTAL RIVER BASINS, P564; Roering JJ, 1999, WATER RESOUR RES, V35, P853, DOI 10.1029/1998WR900090; Rowley DB, 2013, SCIENCE, V340, P1560, DOI 10.1126/science.1229180; Royden L, 2013, J GEOPHYS RES-EARTH, V118, P497, DOI 10.1002/jgrf.20031; Seidl MA, 1996, BASIN RES, V8, P301, DOI 10.1046/j.1365-2117.1996.00266.x; SEPKOSKI JJ, 1974, SYST ZOOL, V23, P165, DOI 10.2307/2412130; Spotila JA, 2004, BASIN RES, V16, P41, DOI 10.1111/j.1365-2117.2003.00219.x; Sullivan C. L., 2008, THESIS U VERMONT; Suppe J, 1981, MEMOIR GEOL SOC CHIN, V4, P67; Tucker GE, 1997, WATER RESOUR RES, V33, P2031, DOI 10.1029/97WR00409; Waters JM, 2001, EVOLUTION, V55, P1844; Whipple KX, 2001, AM J SCI, V301, P313, DOI 10.2475/ajs.301.4-5.313; Willett SD, 2001, AM J SCI, V301, P455, DOI 10.2475/ajs.301.4-5.455; Xiong LY, 2014, GEOMORPHOLOGY, V209, P18, DOI 10.1016/j.geomorph.2013.12.009; Yan M. J., 2014, RESTORATION DEV DEGR; Zemlak TS, 2008, MOL ECOL, V17, P5049, DOI 10.1111/j.1365-294X.2008.03987.x	53	367	384	17	291	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2014	343	6175					1117	+	1248765	10.1126/science.1248765	http://dx.doi.org/10.1126/science.1248765			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2LB	24604204				2022-12-28	WOS:000332331500040
J	Little, P; Moore, M; Kelly, J; Williamson, I; Leydon, G; McDermott, L; Mullee, M; Stuart, B				Little, Paul; Moore, Michael; Kelly, Jo; Williamson, Ian; Leydon, Geraldine; McDermott, Lisa; Mullee, Mark; Stuart, Beth		PIPS Investigators	Delayed antibiotic prescribing strategies for respiratory tract infections in primary care: pragmatic, factorial, randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SORE THROAT; COMPLICATIONS; RESISTANCE; COUGH	Objective To estimate the effectiveness of different strategies involving delayed antibiotic prescription for acute respiratory tract infections. Design Open, pragmatic, parallel group, factorial, randomised controlled trial. Setting Primary care in the United Kingdom. Patients 889 patients aged 3 years and over with acute respiratory tract infection, recruited between 3 March 2010 and 28 March 2012 by 53 health professionals in 25 practices. Interventions Patients judged not to need immediate antibiotics were randomised to undergo four strategies of delayed prescription: recontact for a prescription, post-dated prescription, collection of the prescription, and be given the prescription (patient led). During the trial, a strategy of no antibiotic prescription was added as another randomised comparison. Analysis was intention to treat. Main outcome measures Mean symptom severity (0-6 scale) at days 2-4 (primary outcome), antibiotic use, and patients' beliefs in the effectiveness of antibiotic use. Secondary analysis included comparison with immediate use of antibiotics. Results Mean symptom severity had minimal differences between the strategies involving no prescription and delayed prescription (recontact, post-date, collection, patient led; 1.62, 1.60, 1.82, 1.68, 1.75, respectively; likelihood ratio test x(2) 2.61, P=0.625). Duration of symptoms rated moderately bad or worse also did not differ between no prescription and delayed prescription strategies combined (median 3 days v 4 days; 4.29, P=0.368). There were modest and non-significant differences in patients very satisfied with the consultation between the randomised groups (79%, 74%, 80%, 88%, 89%, respectively; likelihood ratio test x(2) 2.38, P=0.667), belief in antibiotics (71%, 74%, 73%, 72%, 66%; 1.62, P=0.805), or antibiotic use (26%, 37%, 37%, 33%, 39%; 4.96, P=0.292). By contrast, most patients given immediate antibiotics used antibiotics (97%) and strongly believed in them (93%), but with no benefit for symptom severity (score 1.76) or duration (median 4 days). Conclusion Strategies of no prescription or delayed antibiotic prescription result in fewer than 40% of patients using antibiotics, and are associated with less strong beliefs in antibiotics, and similar symptomatic outcomes to immediate prescription. If clear advice is given to patients, there is probably little to choose between the different strategies of delayed prescription.	[Little, Paul; Moore, Michael; Kelly, Jo; Williamson, Ian; Leydon, Geraldine; McDermott, Lisa; Mullee, Mark; Stuart, Beth; PIPS Investigators] Univ Southampton, Aldermoor Hlth Ctr, Southampton SO16 5ST, Hants, England	University of Southampton	Little, P (corresponding author), Univ Southampton, Aldermoor Hlth Ctr, Southampton SO16 5ST, Hants, England.	p.little@soton.ac.uk	Moore, Michael/C-3447-2011	Moore, Michael/0000-0002-5127-4509; Little, Paul/0000-0003-3664-1873; Leydon, Geraldine Marie/0000-0001-5986-3300; Stuart, Beth/0000-0001-5432-7437	National Institute for Health Research under its Programme Grants for Applied Research programme [RP-PG-0407-10098]; National Institute for Health Research [RP-PG-0407-10098] Funding Source: researchfish	National Institute for Health Research under its Programme Grants for Applied Research programme; National Institute for Health Research(National Institute for Health Research (NIHR))	This article presents independent research funded by the National Institute for Health Research under its Programme Grants for Applied Research programme (grant reference no RP-PG-0407-10098). The National Institute for Health Research did not interfere in the research, nor have input into the analysis, interpretation, or writing of the paper.	Arnold SR, 2005, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003539.PUB2; Arroll B, 2003, BRIT J GEN PRACT, V53, P871; Butler CC, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2242; Cornford CS, 1998, BRIT J GEN PRACT, V48, P1751; Costelloe C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2096; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; House of Lords, 1998, 7 HOUS LORDS; Kai J, 1996, BRIT MED J, V313, P987; Little P, 2001, BMJ-BRIT MED J, V322, P336, DOI 10.1136/bmj.322.7282.336; Little P, 2005, JAMA-J AM MED ASSOC, V293, P3029, DOI 10.1001/jama.293.24.3029; Little P, 1997, BRIT MED J, V315, P350; Little P, 1997, BMJ-BRIT MED J, V314, P722, DOI 10.1136/bmj.314.7082.722; Little P, 2014, LANCET INFECT DIS, V14, P213, DOI 10.1016/S1473-3099(13)70294-9; Little P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6867; Little P, 2013, LANCET INFECT DIS, V13, P123, DOI 10.1016/S1473-3099(12)70300-6; Nice, 2011, PRESCR ANT SELF LIM; *SMAC, 1998, STAND MED ADV COMM S; Spurling G, 2010, COCHRANE DB SYST REV, V3; Watson L, 2001, FAM PRACT, V18, P553, DOI 10.1093/fampra/18.5.553; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	20	88	89	1	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2014	348								g1606	10.1136/bmj.g1606	http://dx.doi.org/10.1136/bmj.g1606			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC6IM	24603565	hybrid, Green Accepted, Green Published			2022-12-28	WOS:000332625300002
J	Mahony, C				Mahony, Chris			Primary care team of the year: saving money and improving care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												chris.mahony@cjmedia.biz							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 3	2014	348								g1753	10.1136/bmj.g1753	http://dx.doi.org/10.1136/bmj.g1753			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC6HK	24589482	Green Published			2022-12-28	WOS:000332622000004
J	McMinn, PC				McMinn, Peter C.			Enterovirus Vaccines for an Emerging Cause of Brain-Stem Encephalitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Human enterovirus 71 (EV71), which can cause brain-stem encephalitis, has caused approximately 2000 deaths in the past decade. New vaccines represent an exciting development in the global response to the emergence of EV71 as a cause of severe neurologic disease. Hand, foot, and mouth disease is a common childhood exanthem caused by enteroviruses that belong to the human enterovirus A species of the family Picornaviridae most commonly, human enterovirus 71 (EV71) and coxsackievirus A16. Although the clinical signs of hand, foot, and mouth disease associated with various enteroviruses are indistinguishable, EV71 epidemics are a cause for public health concern because they place young children (<5 years of age) at increased risk for severe neurologic disease.(1) EV71 was first identified in the United States in 1969.(1) Despite causing epidemics of severe neurologic disease in Bulgaria in 1975 and in Hungary ...	Univ Sydney, Sydney Med Sch, Infect Dis & Immunol Dept, Sydney, NSW 2006, Australia	University of Sydney	McMinn, PC (corresponding author), Univ Sydney, Sydney Med Sch, Infect Dis & Immunol Dept, Sydney, NSW 2006, Australia.							Chou AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079783; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; World Health Organization (WHO): Western Pacific Region, 2011, GUID CLIN MAN PUBL H; Zhu FC, 2013, LANCET, V381, P2024, DOI 10.1016/S0140-6736(13)61049-1	5	22	25	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 27	2014	370	9					792	794		10.1056/NEJMp1400601	http://dx.doi.org/10.1056/NEJMp1400601			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB8AR	24571750				2022-12-28	WOS:000332013000003
J	Sooriakumaran, P; Nyberg, T; Akre, O; Haendler, L; Heus, I; Olsson, M; Carlsson, S; Roobol, MJ; Steineck, G; Wiklund, P				Sooriakumaran, Prasanna; Nyberg, Tommy; Akre, Olof; Haendler, Leif; Heus, Inge; Olsson, Mats; Carlsson, Stefan; Roobol, Monique J.; Steineck, Gunnar; Wiklund, Peter			Comparative effectiveness of radical prostatectomy and radiotherapy in prostate cancer: observational study of mortality outcomes	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ANDROGEN-DEPRIVATION THERAPY; EVALUATING STATISTICAL ADJUSTMENTS; BEAM RADIATION-THERAPY; CURATIVE INTENT; RISK; SURVIVAL; REGISTER; SWEDEN; DEATH; MEN	Objective To compare the survival outcomes of patients treated with surgery or radiotherapy for prostate cancer. Design Observational study. Setting Sweden, 1996-2010. Participants 34 515 men primarily treated for prostate cancer with surgery (n=21 533) or radiotherapy (n=12 982). Patients were categorised by risk group (low, intermediate, high, and metastatic), age, and Charlson comorbidity score. Main outcome measures Cumulative incidence of mortality from prostate cancer and other causes. Competing risks regression hazard ratios for radiotherapy versus surgery were computed without adjustment and after propensity score and traditional (multivariable) adjustments, as well as after propensity score matching. Several sensitivity analyses were performed. Results Prostate cancer mortality became a larger proportion of overall mortality as risk group increased for both the surgery and the radiotherapy cohorts. Among patients with non-metastatic prostate cancer the adjusted subdistribution hazard ratio for prostate cancer mortality favoured surgery (1.76, 95% confidence interval 1.49 to 2.08, for radiotherapy v prostatectomy), whereas there was no discernible difference in treatment effect among men with metastatic disease. Subgroup analyses indicated more clear benefits of surgery among younger and fitter men with intermediate and high risk disease. Sensitivity analyses confirmed the main findings. Conclusions This large observational study with follow-up to 15 years suggests that for most men with non-metastatic prostate cancer, surgery leads to better survival than does radiotherapy. Younger men and those with less comorbidity who have intermediate or high risk localised prostate cancer might have a greater benefit from surgery.	[Sooriakumaran, Prasanna; Haendler, Leif; Olsson, Mats; Carlsson, Stefan; Wiklund, Peter] Karolinska Univ Hosp, Dept Urol, Stockholm, Sweden; [Sooriakumaran, Prasanna] Univ Oxford, Nuffield Dept Surg Sci, Surg Intervent Trials Unit, Oxford, England; [Nyberg, Tommy; Steineck, Gunnar] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Akre, Olof] Karolinska Inst, Dept Med Solna, Clin Epidemiol Unit, Stockholm, Sweden; [Heus, Inge; Roobol, Monique J.] Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Steineck, Gunnar] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Div Clin Canc Epidemiol,Dept Oncol, Gothenburg, Sweden	Karolinska Institutet; Karolinska University Hospital; University of Oxford; Karolinska Institutet; Karolinska Institutet; Erasmus University Rotterdam; Erasmus MC; University of Gothenburg	Wiklund, P (corresponding author), Karolinska Univ Hosp, Dept Urol, Stockholm, Sweden.	peter.wiklund@karolinska.se	Steineck, Gunnar/W-1515-2019; Nyberg, Tommy/AGG-2330-2022	Steineck, Gunnar/0000-0002-0787-3969; Nyberg, Tommy/0000-0002-9436-0626; Wiklund, Peter/0000-0001-6497-4697				Abdollah F, 2012, INT J UROL, V19, P836, DOI 10.1111/j.1442-2042.2012.03052.x; Abdollah F, 2011, EUR UROL, V59, P88, DOI 10.1016/j.eururo.2010.10.003; Berglund A, 2011, J UROLOGY, V185, P833, DOI 10.1016/j.juro.2010.10.061; Bill-Axelson A, 2011, NEW ENGL J MED, V364, P1708, DOI 10.1056/NEJMoa1011967; Boorjian SA, 2012, EUR UROL, V61, P664, DOI 10.1016/j.eururo.2011.11.053; Boorjian SA, 2011, CANCER-AM CANCER SOC, V117, P2883, DOI 10.1002/cncr.25900; Bostrom PJ, 2007, EUR UROL, V52, P973, DOI 10.1016/j.eururo.2007.07.002; Cooperberg MR, 2010, CANCER-AM CANCER SOC, V116, P5226, DOI 10.1002/cncr.25456; D'Amico AV, 1998, JAMA-J AM MED ASSOC, V280, P969, DOI 10.1001/jama.280.11.969; Fall K, 2008, SCAND J UROL NEPHROL, V42, P352, DOI 10.1080/00365590802078583; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fouad MN, 2004, J CLIN EPIDEMIOL, V57, P721, DOI 10.1016/j.jclinepi.2003.11.009; Grimm P, 2012, BJU INT, V109, P22, DOI 10.1111/j.1464-410X.2011.10827.x; Hadley J, 2010, JNCI-J NATL CANCER I, V102, P1780, DOI 10.1093/jnci/djq393; Hagel E, 2009, SCAND J UROL NEPHROL, V43, P342, DOI 10.3109/00365590903024577; Heidenreich A, 2014, EUR UROL, V65, P124, DOI 10.1016/j.eururo.2013.09.046; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Keating NL, 2010, J NATL CANCER I, V102, P39, DOI 10.1093/jnci/djp404; Kibel AS, 2012, J UROLOGY, V187, P1259, DOI 10.1016/j.juro.2011.11.084; Ladjevardi S, 2013, BJU INT, V111, P381, DOI 10.1111/j.1464-410X.2012.11320.x; Lane JA, 2010, EUR J CANCER, V46, P3095, DOI 10.1016/j.ejca.2010.09.016; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; Makarov DV, 2007, UROLOGY, V69, P1095, DOI 10.1016/j.urology.2007.03.042; Nepple KG, 2013, EUR UROL, V64, P372, DOI 10.1016/j.eururo.2013.03.005; Nguyen PL, 2011, JAMA-J AM MED ASSOC, V306, P2359, DOI 10.1001/jama.2011.1745; Okajima K, 2013, INT J CLIN ONCOL, V18, P1078, DOI 10.1007/s10147-012-0496-3; Pound CR, 1999, JAMA-J AM MED ASSOC, V281, P1591, DOI 10.1001/jama.281.17.1591; Trinh QD, 2012, EUR UROL, V61, P679, DOI 10.1016/j.eururo.2011.12.027; Stattin P, 2010, JNCI-J NATL CANCER I, V102, P950, DOI 10.1093/jnci/djq154; Van Hemelrijck M, 2013, INT J EPIDEMIOL, V42, P956, DOI 10.1093/ije/dys068; Vickers A, 2012, EUR UROL, V62, P204, DOI 10.1016/j.eururo.2012.04.024; Vickers AJ, 2011, J NATL CANCER I, V103, P1134, DOI 10.1093/jnci/djr208; Wilt TJ, 2012, NEW ENGL J MED, V367, P203, DOI 10.1056/NEJMoa1113162; Zelefsky MJ, 2010, J CLIN ONCOL, V28, P1508, DOI 10.1200/JCO.2009.22.2265	34	152	154	0	29	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 27	2014	348								g1502	10.1136/bmj.g1502	http://dx.doi.org/10.1136/bmj.g1502			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC0UF	24574496	Green Published, hybrid			2022-12-28	WOS:000332210200001
J	Zhu, FC; Xu, WB; Xia, JL; Liang, ZL; Liu, Y; Zhang, XF; Tan, XJ; Wang, L; Mao, QY; Wu, JY; Hu, YM; Ji, TJ; Song, LF; Liang, Q; Zhang, BM; Gao, Q; Li, JX; Wang, SY; Hu, YS; Gu, SR; Zhang, JH; Yao, GH; Gu, JX; Wang, XS; Zhou, YC; Chen, CB; Zhang, ML; Cao, MQ; Wang, JZ; Wang, H; Wang, N				Zhu, Fengcai; Xu, Wenbo; Xia, Jielai; Liang, Zhenglun; Liu, Yan; Zhang, Xuefeng; Tan, Xiaojuan; Wang, Ling; Mao, Qunying; Wu, Junyu; Hu, Yuemei; Ji, Tianjiao; Song, Lifei; Liang, Qi; Zhang, Baomin; Gao, Qiang; Li, Jingxin; Wang, Shenyu; Hu, Yuansheng; Gu, Shanru; Zhang, Jianhua; Yao, Genhong; Gu, Jianxiang; Wang, Xushan; Zhou, Yuchun; Chen, Changbiao; Zhang, Minglei; Cao, Minquan; Wang, Junzhi; Wang, Hua; Wang, Nan			Efficacy, Safety, and Immunogenicity of an Enterovirus 71 Vaccine in China	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MOUTH-DISEASE; INACTIVATED VACCINE; DOUBLE-BLIND; PHASE-I; EPIDEMIC; FOOT; HAND; INFECTION; OUTBREAK; CHILDREN	BackgroundEnterovirus 71 (EV71) is one of the major causative agents of outbreaks of hand, foot, and mouth disease or herpangina worldwide. This phase 3 trial was designed to evaluate the efficacy, safety, and immunogenicity of an EV71 vaccine. MethodsWe conducted a randomized, double-blind, placebo-controlled, multicenter trial in which 10,007 healthy infants and young children (6 to 35 months of age) were randomly assigned in a 1:1 ratio to receive two intramuscular doses of either EV71 vaccine or placebo, 28 days apart. The surveillance period was 12 months. The primary end point was the occurrence of EV71-associated hand, foot, and mouth disease or herpangina. ResultsDuring the 12-month surveillance period, EV71-associated disease was identified in 0.3% of vaccine recipients (13 of 5041 children) and 2.1% of placebo recipients (106 of 5028 children) in the intention-to-treat cohort. The vaccine efficacy against EV71-associated hand, foot, and mouth disease or herpangina was 94.8% (95% confidence interval [CI], 87.2 to 97.9; P<0.001) in this cohort. Vaccine efficacies against EV71-associated hospitalization (0 cases vs. 24 cases) and hand, foot, and mouth disease with neurologic complications (0 cases vs. 8 cases) were both 100% (95% CI, 83.7 to 100 and 42.6 to 100, respectively). Serious adverse events occurred in 111 of 5044 children in the vaccine group (2.2%) and 131 of 5033 children in the placebo group (2.6%). In the immunogenicity subgroup (1291 children), an anti-EV71 immune response was elicited by the two-dose vaccine series in 98.8% of participants at day 56. An anti-EV71 neutralizing antibody titer of 1:16 was associated with protection against EV71-associated hand, foot, and mouth disease or herpangina. ConclusionsThe EV71 vaccine provided protection against EV71-associated hand, foot, and mouth disease or herpangina in infants and young children. (Funded by Sinovac Biotech; ClinicalTrials.gov number, NCT01507857.) Enterovirus 71 (EV71) is an important cause of hand, foot, and mouth disease, especially in China. In this phase 3 trial involving 10,077 infants and children in China, an EV71 vaccine provided protection against EV71-associated disease. Enterovirus 71 (EV71), an enterovirus that is not associated with poliomyelitis, was one of the major causative agents of outbreaks of hand, foot, and mouth disease or herpangina in Europe,(1)-(3) Australia,(4),(5) and Japan(6),(7) between 1972 and 1988, and it has been implicated in a series of outbreaks across the Asia-Pacific region since the 1990s.(8)-(11) The largest Asia-Pacific epidemic occurred in China in 2008, when approximately 490,000 infections and 126 deaths in infants and young children were reported.(12) The vast majority of severe cases and fatal cases occurred in children younger than 3 years of age. EV71 ...	[Zhu, Fengcai; Zhang, Xuefeng; Hu, Yuemei; Liang, Qi; Wang, Shenyu; Wang, Hua] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Xu, Wenbo; Ji, Tianjiao; Zhang, Baomin] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control, Beijing, Peoples R China; [Xu, Wenbo; Tan, Xiaojuan; Ji, Tianjiao; Zhang, Baomin] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Prevent, Beijing, Peoples R China; [Liang, Zhenglun; Mao, Qunying; Wang, Junzhi] Natl Inst Food, Beijing, Peoples R China; [Liang, Zhenglun; Mao, Qunying; Wang, Junzhi] Natl Inst Drug Control, Beijing, Peoples R China; [Liu, Yan; Wu, Junyu; Song, Lifei; Gao, Qiang; Hu, Yuansheng; Wang, Nan] Sinovac Biotech, Beijing, Peoples R China; [Xia, Jielai; Wang, Ling] Fourth Mil Med Univ, Xian 710032, Peoples R China; [Gu, Shanru; Gu, Jianxiang; Chen, Changbiao] Sheyang Cty Ctr Dis Control & Prevent, Yancheng City, Peoples R China; [Zhang, Jianhua; Wang, Xushan; Zhang, Minglei] Ganyu Cty Ctr Dis Control & Prevent, Lianyungang, Peoples R China; [Yao, Genhong; Zhou, Yuchun; Cao, Minquan] Taixing Cty Ctr Dis Control & Prevent, Taizhou City, Peoples R China	Jiangsu Provincial Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Air Force Military Medical University	Wang, N (corresponding author), Sinovac Biotech, 39 Shangdi Western Rd, Beijing, Peoples R China.	wangjz@nicpbp.org.cn; hua@jscdc.cn; wangnan@sinovac.com	Hu, Yue/HGE-1673-2022; ji, tianjiao/HCH-4631-2022; Wang, Shenyu/GVU-9078-2022	Wang, Shenyu/0000-0002-3328-3671	Sinovac Biotech	Sinovac Biotech	Funded by Sinovac Biotech; ClinicalTrials.gov number, NCT01507857.	Bek EJ, 2011, VACCINE, V29, P4829, DOI 10.1016/j.vaccine.2011.04.070; BLOMBERG J, 1974, LANCET, V2, P112; Chan LG, 2000, CLIN INFECT DIS, V31, P678, DOI 10.1086/314032; Cheng A, 2013, VACCINE, V31, P2471, DOI 10.1016/j.vaccine.2013.03.015; Chou AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034834; Dong CH, 2011, VACCINE, V29, P6269, DOI 10.1016/j.vaccine.2011.06.044; GILBERT GL, 1988, PEDIATR INFECT DIS J, V7, P484, DOI 10.1097/00006454-198807000-00007; HAGIWARA A, 1978, INTERVIROLOGY, V9, P60, DOI 10.1159/000148922; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Jeong EJ, 2010, ARCH VIROL, V155, P1707, DOI 10.1007/s00705-010-0755-4; Jiao QJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027646; KENNETT ML, 1974, B WORLD HEALTH ORGAN, V51, P609; Li YP, 2014, J INFECT DIS, V209, P46, DOI 10.1093/infdis/jit429; Li YP, 2012, VACCINE, V30, P3295, DOI 10.1016/j.vaccine.2012.03.010; Liang ZL, 2013, FRONT MED-PRC, V7, P111, DOI 10.1007/s11684-012-0237-z; Liu CC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020005, 10.1371/journal.pone.0021464]; NAGY G, 1982, ARCH VIROL, V71, P217, DOI 10.1007/BF01314873; SHINDAROV LM, 1979, J HYG EPID MICROB IM, V23, P284; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Sun LM, 2011, JPN J INFECT DIS, V64, P13; TAGAYA I, 1975, JPN J MED SCI BIOL, V28, P231, DOI 10.7883/yoken1952.28.231; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632; Yi LN, 2011, CRIT REV MICROBIOL, V37, P313, DOI 10.3109/1040841X.2011.580723; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhu FC, 2012, PEDIATR INFECT DIS J, V31, P1158, DOI 10.1097/INF.0b013e31826eba74	26	294	383	4	116	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 27	2014	370	9					818	828		10.1056/NEJMoa1304923	http://dx.doi.org/10.1056/NEJMoa1304923			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB8AR	24571754				2022-12-28	WOS:000332013000007
J	Loxterkamp, D				Loxterkamp, David			LETTER FROM NEW ENGLAND No mission without the marginalized: the scope of family medicine	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Seaport Community Hlth Ctr, Belfast, ME 04915 USA		Loxterkamp, D (corresponding author), Seaport Community Hlth Ctr, Belfast, ME 04915 USA.	david.loxterkamp@gmail.com							0	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 26	2014	348								g1707	10.1136/bmj.g1707	http://dx.doi.org/10.1136/bmj.g1707			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC0UC	24574478				2022-12-28	WOS:000332209900008
J	Palese, A; Watson, R				Palese, Alvisa; Watson, Roger			Nurse staffing and education in Europe: if not now, when?	LANCET			English	Editorial Material									[Palese, Alvisa] Univ Udine, Dept Clin & Biol Sci, I-33100 Udine, Italy; [Watson, Roger] Univ Hull, Fac Hlth & Social Care, Kingston Upon Hull HU6 7RX, N Humberside, England	University of Udine; University of Hull	Palese, A (corresponding author), Univ Udine, Dept Clin & Biol Sci, I-33100 Udine, Italy.	alvisa.palese@uniud.it	Watson, Roger/A-2969-2009; Palese, Alvisa/J-9427-2015	Watson, Roger/0000-0001-8040-7625; Palese, Alvisa/0000-0002-3508-844X				Aiken LH, 2003, JAMA-J AM MED ASSOC, V290, P1617, DOI 10.1001/jama.290.12.1617; Aiken LH, 2014, LANCET; Bar-Yosef S., 1981, IMPACT GOVT FINANCIA; Buchan J, 2008, J CLIN NURS, V17, P3262, DOI 10.1111/j.1365-2702.2008.02636.x; Commission of the European Communities, 2008, GREEN PAP EUR WORKF; Dean Erin, 2014, Nurs Stand, V28, P10, DOI 10.7748/ns2014.01.28.21.10.s4; Diya L, 2012, J ADV NURS, V68, P1073, DOI 10.1111/j.1365-2648.2011.05812.x; Rafferty AM, 2007, INT J NURS STUD, V44, P175, DOI 10.1016/j.ijnurstu.2006.08.003; Sermeus W, 2011, BMC NURS, V10, DOI 10.1186/1472-6955-10-6; Vassiliou A., 2010, FOCUS HIGHER ED EURO; Wray J, 2013, J ADV NURS, V69, P497, DOI 10.1111/jan.12031	11	12	12	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 24	2014	383	9931					1789	1790		10.1016/S0140-6736(14)60188-4	http://dx.doi.org/10.1016/S0140-6736(14)60188-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AH6US	24581681				2022-12-28	WOS:000336267800007
J	Crowley, MJ; McCrory, DC; Chatterjee, R; Gierisch, JM; Myers, ER; Schmit, KM; Coeytaux, RR; Correll, CU; Kendrick, AS; Sanders, GD				Crowley, Matthew J.; McCrory, Douglas C.; Chatterjee, Ranee; Gierisch, Jennifer M.; Myers, Evan R.; Schmit, Kristine M.; Coeytaux, Remy R.; Correll, Christoph U.; Kendrick, Amy S.; Sanders, Gillian D.			Prioritization of Research Addressing Antipsychotics for Adolescents and Young Adults With Bipolar Disorder	ANNALS OF INTERNAL MEDICINE			English	Article							LONGITUDINAL COURSE; SPECTRUM DISORDERS; NATIONAL TRENDS; I DISORDER; CHILDREN; DIVALPROEX; MANIA; SCHIZOPHRENIA; RISPERIDONE; DIAGNOSIS	Despite a paucity of high-quality evidence about benefits and harms, antipsychotic medication use among adolescents and young adults with bipolar disorder is increasing. The Patient-Centered Outcomes Research Institute tasked the Duke Evidence Synthesis Group with creating a prioritized agenda for research in this area that would incorporate the perspectives of relevant stakeholders. We identified a list of potential evidence gaps by reviewing existing literature and engaged a diverse group of 9 stakeholders to expand and refine this list. Using a forced-ranking prioritization method, stakeholders prioritized 10 of 23 potential evidence gaps as the (m)ost pressing for future research. These evidence gaps relate to 3 areas: the comparative effectiveness of intervention strategies, the effect of antipsychotics on patient-centered outcomes, and the influence of various patient characteristics on antipsychotic effectiveness. In addition to presenting these findings, we suggest appropriate study designs for addressing the stakeholder-prioritized research questions.	Duke Clin Res Inst, Durham Vet Affairs Med Ctr, Durham, NC 27705 USA; Duke Univ, Sch Med, Durham, NC USA; Hofstra North Shore Long Isl Jewish Sch Med, Hempstead, NY USA	Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; Hofstra University	Sanders, GD (corresponding author), Duke Clin Res Inst, 2400 Pratt St, Durham, NC 27705 USA.	gillian.sanders@duke.edu	Correll, Christoph/D-3530-2011; Correll, Christoph U/AAY-3179-2021; Gierisch, Jennifer/GLU-1269-2022	Correll, Christoph/0000-0002-7254-5646; Kendrick, Amy/0000-0001-8769-1702; Gierisch, Jennifer/0000-0002-5057-4964	PCORI	PCORI(Patient-Centered Outcomes Research Institute - PCORI)	By a contract from PCORI	Abou-Setta A, 2012, COMP EFFECTIVENESS R; Agency for Healthcare Research and Quality, 2012, ANT MED CHILDR TEENS; Axelson D, 2003, J CHILD ADOL PSYCHOP, V13, P463, DOI 10.1089/104454603322724850; Axelson D, 2012, J CLIN PSYCHIAT, V73, P1342, DOI 10.4088/JCP.12m07674; Birmaher B, 2006, ARCH GEN PSYCHIAT, V63, P175, DOI 10.1001/archpsyc.63.2.175; Birmaher B, 2007, AM J PSYCHIAT, V164, P537, DOI 10.1176/appi.ajp.164.4.537; Birmaher B, 2009, AM J PSYCHIAT, V166, P795, DOI 10.1176/appi.ajp.2009.08101569; Blader JC, 2007, BIOL PSYCHIAT, V62, P107, DOI 10.1016/j.biopsych.2006.11.006; Chang SM, 2012, ANN INTERN MED, V157, P439, DOI 10.7326/0003-4819-157-6-201209180-00515; Christian R., 2012, 13 AG HEALTHC RES QU; Correll CU, 2008, J AM ACAD CHILD PSY, V47, P9, DOI 10.1097/chi.0b013e31815b5cb1; Correll CU, 2010, BIPOLAR DISORD, V12, P116, DOI 10.1111/j.1399-5618.2010.00798.x; DelBello MP, 2007, AM J PSYCHIAT, V164, P582, DOI 10.1176/appi.ajp.164.4.582; Delbello MP, 2006, J AM ACAD CHILD PSY, V45, P305, DOI 10.1097/01.chi.0000194567.63289.97; Freedman R, 2013, AM J PSYCHIAT, V170, P1, DOI 10.1176/appi.ajp.2012.12091189; Geller B, 2008, ARCH GEN PSYCHIAT, V65, P1125, DOI 10.1001/archpsyc.65.10.1125; Geller B, 2012, ARCH GEN PSYCHIAT, V69, P515, DOI 10.1001/archgenpsychiatry.2011.1508; Gierisch JM, 2014, ANN INTERN MED, V160, P484, DOI 10.7326/M13-2548; Ip S, 2013, AHRQ PUBLICATION, V13-EHC007-EF; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Leibenluft E, 2011, AM J PSYCHIAT, V168, P129, DOI 10.1176/appi.ajp.2010.10050766; Moreno C, 2007, ARCH GEN PSYCHIAT, V64, P1032, DOI 10.1001/archpsyc.64.9.1032; Olfson M, 2012, ARCH GEN PSYCHIAT, V69, P1247, DOI 10.1001/archgenpsychiatry.2012.647; Pavuluri MN, 2010, BIPOLAR DISORD, V12, P593, DOI 10.1111/j.1399-5618.2010.00850.x; Perlis RH, 2004, BIOL PSYCHIAT, V55, P875, DOI 10.1016/j.biopsych.2004.01.022; Van Meter AR, 2011, J CLIN PSYCHIAT, V72, P1250, DOI 10.4088/JCP.10m06290; Youngstrom E, 2005, BIPOLAR DISORD, V7, P507, DOI 10.1111/j.1399-5618.2005.00269.x	27	1	1	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 1	2014	160	7					492	+		10.7326/M13-2549	http://dx.doi.org/10.7326/M13-2549			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AE6IL	24567115				2022-12-28	WOS:000334093800007
J	Shen, P; Roch, T; Lampropoulou, V; O'Connor, RA; Stervbo, U; Hilgenberg, E; Ries, S; Dang, VD; Jaimes, Y; Daridon, C; Li, R; Jouneau, L; Boudinot, P; Wilantri, S; Sakwa, I; Miyazaki, Y; Leech, MD; McPherson, RC; Wirtz, S; Neurath, M; Hoehlig, K; Meinl, E; Grutzkau, A; Grun, JR; Horn, K; Kuhl, AA; Dorner, T; Bar-Or, A; Kaufmann, SHE; Anderton, SM; Fillatreau, S				Shen, Ping; Roch, Toralf; Lampropoulou, Vicky; O'Connor, Richard A.; Stervbo, Ulrik; Hilgenberg, Ellen; Ries, Stefanie; Van Duc Dang; Jaimes, Yarua; Daridon, Capucine; Li, Rui; Jouneau, Luc; Boudinot, Pierre; Wilantri, Siska; Sakwa, Imme; Miyazaki, Yusei; Leech, Melanie D.; McPherson, Rhoanne C.; Wirtz, Stefan; Neurath, Markus; Hoehlig, Kai; Meinl, Edgar; Gruetzkau, Andreas; Gruen, Joachim R.; Horn, Katharina; Kuehl, Anja A.; Doerner, Thomas; Bar-Or, Amit; Kaufmann, Stefan H. E.; Anderton, Stephen M.; Fillatreau, Simon			IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases	NATURE			English	Article							T-CELLS; SALMONELLA-TYPHIMURIUM; ULCERATIVE-COLITIS; DEPLETION; RITUXIMAB; CYTOKINE; ACTIVATION; EXPRESSION; PREVENTION; ARTHRITIS	B lymphocytes have critical roles as positive and negative regulators of immunity. Their inhibitory function has been associated primarily with interleukin 10 (IL-10) because B-cell-derived IL-10 can protect against autoimmune disease and increase susceptibility to pathogens(1,2). Here we identify IL-35-producing B cells as key players in the negative regulation of immunity. Mice in which only B cells did not express IL-35 lost their ability to recover from the T-cell mediated demyelinating autoimmune disease experimental autoimmune encephalomyelitis (EAE). In contrast, these mice displayed a markedly improved resistance to infection with the intracellular bacterial pathogen Salmonella enterica serovar Typhimurium as shown by their superior containment of the bacterial growth and their prolonged survival after primary infection, and upon secondary challenge, compared to control mice. The increased immunity found in mice lacking IL-35 production by B cells was associated with a higher activation of macrophages and inflammatory T cells, as well as an increased function of B cells as antigen-presenting cells (APCs). During Salmonella infection, IL-35- and IL-10-producing B cells corresponded to two largely distinct sets of surface-IgM1 CD138(hi)TACI(+)CXCR4(+)CD1d(int)Tim1(int) plasma cells expressing the transcription factor Blimp1 (also known as Prdm1). During EAE, CD138(+) plasma cells were also the main source of B-cell-derived IL-35 and IL-10. Collectively, our data show the importance of IL-35 producing B cells in regulation of immunity and highlight IL-35 production by B cells as a potential therapeutic target for autoimmune and infectious diseases. This study reveals the central role of activated B cells, particularly plasma cells, and their production of cytokines in the regulation of immune responses in health and disease.	[Shen, Ping; Roch, Toralf; Lampropoulou, Vicky; Stervbo, Ulrik; Hilgenberg, Ellen; Ries, Stefanie; Van Duc Dang; Jaimes, Yarua; Daridon, Capucine; Wilantri, Siska; Sakwa, Imme; Hoehlig, Kai; Gruetzkau, Andreas; Gruen, Joachim R.; Horn, Katharina; Doerner, Thomas; Fillatreau, Simon] Deutsch Rheuma Forschungszentrum, Charite Pl 1, D-10117 Berlin, Germany; [O'Connor, Richard A.; Leech, Melanie D.; McPherson, Rhoanne C.; Anderton, Stephen M.] Univ Edinburgh, Ctr Inflammat Res, Edinburgh EH16 4TJ, Midlothian, Scotland; [O'Connor, Richard A.; Leech, Melanie D.; McPherson, Rhoanne C.; Anderton, Stephen M.] Univ Edinburgh, Ctr Multiple Sclerosis Res, Queens Med Res Inst, Edinburgh EH16 4TJ, Midlothian, Scotland; [Daridon, Capucine; Doerner, Thomas] Charite, Dept Med Rheumatol & Clin Immunol, CC12, D-10117 Berlin, Germany; [Li, Rui; Miyazaki, Yusei; Bar-Or, Amit] McGill Univ, Montreal Neurol Inst & Hosp, Neuroimmunol Unit, Montreal, PQ H3A 2B4, Canada; [Jouneau, Luc; Boudinot, Pierre] INRA, Virol & Immunol Mol, F-78352 Jouy En Josas, France; [Wirtz, Stefan; Neurath, Markus] Univ Erlangen Nurnberg, Med Clin 1, D-91054 Erlangen, Germany; [Meinl, Edgar] Univ Munich, Inst Klin Neuroimmunol Klinikum, D-81377 Munich, Germany; [Kuehl, Anja A.] Res Ctr ImmunoSci, D-12203 Berlin, Germany; [Kaufmann, Stefan H. E.] Max Planck Inst Infect Biol, Dept Immunol, D-10117 Berlin, Germany	Deutsches Rheuma-Forschungszentrum (DRFZ); University of Edinburgh; University of Edinburgh; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; McGill University; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Erlangen Nuremberg; University of Munich; Max Planck Society	Fillatreau, S (corresponding author), Deutsch Rheuma Forschungszentrum, Charite Pl 1, D-10117 Berlin, Germany.	fillatreau@drfz.de	Stervbo, Ulrik/AAV-1561-2020; Jouneau, Luc/AAC-4711-2020; Bar-Or, Amit/AIC-1416-2022; boudinot, pierre/L-4246-2016; Li, Rui/O-7397-2016; Roch, Toralf/AAQ-7480-2021; Kaufmann, Stefan HE/I-5454-2014	Stervbo, Ulrik/0000-0002-2831-8868; Li, Rui/0000-0002-7210-8358; Fillatreau, Simon/0000-0002-7730-9917; Meinl, Edgar/0000-0002-2570-6785; boudinot, pierre/0000-0002-7490-9677; Roch, Toralf/0000-0003-2948-8700; Shen, Ping/0000-0003-3046-3818; Dang, Van Duc/0000-0002-0403-6479; Kaufmann, Stefan HE/0000-0001-9866-8268; Kuhl, Anja/0000-0003-2293-5387; O'Connor, Richard/0000-0001-7100-0233; Wirtz, Stefan/0000-0001-6936-7431; Grun, Joachim R./0000-0002-2875-3691	Deutsche Forschungsgemeinschaft [SFB-650, TRR-36, TRR-130, FI-1238/02, Do491/7-2, Do491/8-2]; Hertie Stiftung; Merieux Institute; INRA; CIHR/MSSC New Emerging Team grant in Clinical Autoimmunity; UK Medical Research Council; Wellcome Trust; Clinical Competence Network for Multiple Sclerosis;  [SFB-TR128]; MRC [G0801924, G0901697, G1100084] Funding Source: UKRI; Medical Research Council [G0801924, G0901697, G1100084] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hertie Stiftung(Austrian Science Fund (FWF)); Merieux Institute; INRA; CIHR/MSSC New Emerging Team grant in Clinical Autoimmunity; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Clinical Competence Network for Multiple Sclerosis; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank H. Schliemann, H. Ruebsamen, M. Spadaro and D. Jenne for assistance and support. We thank M. Loehning for providing IL-12 p40-deficient mice, and S. Akira for providing TLR2- and TLR4-deficient mice. We thank O. Neyrolles for help with some of the in vivo experiments. We thank E. Schott for help with the AST/ALT measurements. S. F. is supported by grants from the Deutsche Forschungsgemeinschaft (SFB-650, TRR-36, TRR-130, FI-1238/02), Hertie Stiftung, and an advanced grant from the Merieux Institute. C. D and T. D. are supported by the Deutsche Forschungsgemeinschaft (SFB-650, Do491/7-2, 8-2). P. B. and L.J. are supported by INRA. A.B.-O. is supported by a CIHR/MSSC New Emerging Team grant in Clinical Autoimmunity. Work in S.M.A.'s laboratory was supported by grants from the UK Medical Research Council and the Wellcome Trust. E. M. is supported by the Clinical Competence Network for Multiple Sclerosis and SFB-TR128.	Barr TA, 2012, J EXP MED, V209, P1001, DOI 10.1084/jem.20111675; Benedetti L, 2007, ARCH NEUROL-CHICAGO, V64, P1531, DOI 10.1001/archneur.64.10.1531; Bettini M, 2012, DIABETES, V61, P1519, DOI 10.2337/db11-0784; Biesen R, 2008, ARTHRITIS RHEUM-US, V58, P1136, DOI 10.1002/art.23404; Brentano F, 2009, ANN RHEUM DIS, V68, P143, DOI 10.1136/ard.2007.082081; Chan YH, 2009, J IMMUNOL, V183, P7039, DOI 10.4049/jimmunol.0901543; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Dass S, 2007, ARTHRITIS RHEUM, V56, P2715, DOI 10.1002/art.22811; Devergne O, 1997, P NATL ACAD SCI USA, V94, P12041, DOI 10.1073/pnas.94.22.12041; Duddy M, 2007, J IMMUNOL, V178, P6092, DOI 10.4049/jimmunol.178.10.6092; El Fassi D, 2008, GUT, V57, P714, DOI 10.1136/gut.2007.138305; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Fillatreau S, 2008, NAT REV IMMUNOL, V8, P391, DOI 10.1038/nri2315; Fillatreau S, 2011, IMMUNOL REV, V240, P52, DOI 10.1111/j.1600-065X.2010.00991.x; Goetz M, 2007, INFLAMM BOWEL DIS, V13, P1365, DOI 10.1002/ibd.20215; Hoehlig K, 2012, EUR J IMMUNOL, V42, P1164, DOI 10.1002/eji.201142242; Jagannathan M, 2010, DIABETOLOGIA, V53, P1461, DOI 10.1007/s00125-010-1730-z; KUCHROO VK, 1993, J IMMUNOL, V151, P4371; Lampropoulou V, 2008, J IMMUNOL, V180, P4763, DOI 10.4049/jimmunol.180.7.4763; Mauri C, 2003, J EXP MED, V197, P489, DOI 10.1084/jem.20021293; McGeachy MJ, 2005, J IMMUNOL, V175, P3025, DOI 10.4049/jimmunol.175.5.3025; Mittrucker HW, 2000, J LEUKOCYTE BIOL, V67, P457, DOI 10.1002/jlb.67.4.457; Mizoguchi A, 2002, IMMUNITY, V16, P219, DOI 10.1016/S1074-7613(02)00274-1; Neves P, 2010, IMMUNITY, V33, P777, DOI 10.1016/j.immuni.2010.10.016; Niedbala W, 2007, EUR J IMMUNOL, V37, P3021, DOI 10.1002/eji.200737810; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Su Y, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00154; Villarino A, 2003, IMMUNITY, V19, P645, DOI 10.1016/S1074-7613(03)00300-5; Weber MS, 2010, ANN NEUROL, V68, P369, DOI 10.1002/ana.22081; Wilson MS, 2010, EUR J IMMUNOL, V40, P1682, DOI 10.1002/eji.200939721	31	689	751	5	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 20	2014	507	7492					366	+		10.1038/nature12979	http://dx.doi.org/10.1038/nature12979			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD1YG	24572363	Green Accepted			2022-12-28	WOS:000333029000036
J	Nilsen, TW				Nilsen, Timothy W.			Internal mRNA Methylation Finally Finds Functions	SCIENCE			English	Editorial Material									Case Western Reserve Univ, Sch Med, Ctr RNA Mol Biol, Cleveland, OH 44106 USA	Case Western Reserve University	Nilsen, TW (corresponding author), Case Western Reserve Univ, Sch Med, Ctr RNA Mol Biol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	twn@case.edu						Bokar JA, 1997, RNA, V3, P1233; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Fustin JM, 2013, CELL, V155, P793, DOI 10.1016/j.cell.2013.10.026; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015	7	59	61	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2014	343	6176					1207	1208		10.1126/science.1249340	http://dx.doi.org/10.1126/science.1249340			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC7RG	24626918				2022-12-28	WOS:000332728500023
J	Kasenda, B; von Elm, E; You, J; Blumle, A; Tomonaga, Y; Saccilotto, R; Amstutz, A; Bengough, T; Meerpohl, JJ; Stegert, M; Tikkinen, KAO; Neumann, I; Carrasco-Labra, A; Faulhaber, M; Mulla, SM; Mertz, D; Akl, EA; Bassler, D; Busse, JW; Ferreira-Gonzalez, I; Lamontagne, F; Nordmann, A; Gloy, V; Raatz, H; Moja, L; Rosenthal, R; Ebrahim, S; Schandelmaier, S; Xin, S; Vandvik, PO; Johnston, BC; Walter, MA; Burnand, B; Schwenkglenks, M; Hemkens, LG; Bucher, HC; Guyatt, GH; Briel, M				Kasenda, Benjamin; von Elm, Erik; You, John; Bluemle, Anette; Tomonaga, Yuki; Saccilotto, Ramon; Amstutz, Alain; Bengough, Theresa; Meerpohl, Joerg J.; Stegert, Mihaela; Tikkinen, Kari A. O.; Neumann, Ignacio; Carrasco-Labra, Alonso; Faulhaber, Markus; Mulla, Sohail M.; Mertz, Dominik; Akl, Elie A.; Bassler, Dirk; Busse, Jason W.; Ferreira-Gonzalez, Ignacio; Lamontagne, Francois; Nordmann, Alain; Gloy, Viktoria; Raatz, Heike; Moja, Lorenzo; Rosenthal, Rachel; Ebrahim, Shanil; Schandelmaier, Stefan; Xin, Sun; Vandvik, Per O.; Johnston, Bradley C.; Walter, Martin A.; Burnand, Bernard; Schwenkglenks, Matthias; Hemkens, Lars G.; Bucher, Heiner C.; Guyatt, Gordon H.; Briel, Matthias			Prevalence, Characteristics, and Publication of Discontinued Randomized Trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL-TRIALS; PRIMARY-CARE; RECRUITMENT; COMMITTEE; FATE; BIAS	IMPORTANCE The discontinuation of randomized clinical trials (RCTs) raises ethical concerns and often wastes scarce research resources. The epidemiology of discontinued RCTs, however, remains unclear. OBJECTIVES To determine the prevalence, characteristics, and publication history of discontinued RCTs and to investigate factors associated with RCT discontinuation due to poor recruitment and with nonpublication. DESIGN AND SETTING Retrospective cohort of RCTs based on archived protocols approved by 6 research ethics committees in Switzerland, Germany, and Canada between 2000 and 2003. We recorded trial characteristics and planned recruitment from included protocols. Last follow-up of RCTs was April 27, 2013. MAIN OUTCOMES AND MEASURES Completion status, reported reasons for discontinuation, and publication status of RCTs as determined by correspondence with the research ethics committees, literature searches, and investigator surveys. RESULTS After a median follow-up of 11.6 years (range, 8.8-12.6 years), 253 of 1017 included RCTs were discontinued (24.9% [95% CI, 22.3%-27.6%]). Only 96 of 253 discontinuations (37.9% [95% CI, 32.0%-44.3%]) were reported to ethics committees. The most frequent reason for discontinuation was poor recruitment (101/1017; 9.9%[95% CI, 8.2%-12.0%]). In multivariable analysis, industry sponsorship vs investigator sponsorship (8.4% vs 26.5%; odds ratio [OR], 0.25 [95% CI, 0.15-0.43]; P < .001) and a larger planned sample size in increments of 100 (-0.7%; OR, 0.96 [95% CI, 0.92-1.00]; P = .04) were associated with lower rates of discontinuation due to poor recruitment. Discontinued trials were more likely to remain unpublished than completed trials (55.1% vs 33.6%; OR, 3.19 [95% CI, 2.29-4.43]; P < .001). CONCLUSIONS AND RELEVANCE In this sample of trials based on RCT protocols from 6 research ethics committees, discontinuation was common, with poor recruitment being the most frequently reported reason. Greater efforts are needed to ensure the reporting of trial discontinuation to research ethics committees and the publication of results of discontinued trials.	[Kasenda, Benjamin; Saccilotto, Ramon; Amstutz, Alain; Stegert, Mihaela; Nordmann, Alain; Gloy, Viktoria; Raatz, Heike; Schandelmaier, Stefan; Hemkens, Lars G.; Bucher, Heiner C.; Briel, Matthias] Univ Basel Hosp, Basel Inst Clin Epidemiol & Biostat, CH-4031 Basel, Switzerland; [von Elm, Erik; Bengough, Theresa; Burnand, Bernard] Univ Lausanne Hosp, Inst Social & Prevent Med IUMSP, Cochrane Switzerland, Lausanne, Switzerland; [You, John; Tikkinen, Kari A. O.; Neumann, Ignacio; Carrasco-Labra, Alonso; Faulhaber, Markus; Mulla, Sohail M.; Mertz, Dominik; Akl, Elie A.; Busse, Jason W.; Ebrahim, Shanil; Xin, Sun; Johnston, Bradley C.; Guyatt, Gordon H.; Briel, Matthias] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Bluemle, Anette; Meerpohl, Joerg J.] Univ Freiburg, Med Ctr, German Cochrane Ctr, Inst Med Biometry & Med Informat, Freiburg, Germany; [Tomonaga, Yuki; Schwenkglenks, Matthias] Univ Zurich, Inst Social & Prevent Med, CH-8006 Zurich, Switzerland; [Bassler, Dirk] Univ Childrens Hosp, Dept Neonatol, Ctr Pediat Clin Studies, Tubingen, Germany; [Ferreira-Gonzalez, Ignacio] Vall dHebron Hosp, Dept Cardiol, Epidemiol Unit, Barcelona, Spain; [Ferreira-Gonzalez, Ignacio] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; [Lamontagne, Francois] Univ Sherbrooke, Ctr Rech Clin Etienne Le Bel, Sherbrooke, PQ J1K 2R1, Canada; [Lamontagne, Francois] Univ Sherbrooke, Dept Med, Sherbrooke, PQ J1K 2R1, Canada; [Moja, Lorenzo] IRCCS Orthoped Inst Galeazzi, Milan, Italy; [Rosenthal, Rachel] Univ Basel Hosp, Dept Surg, CH-4031 Basel, Switzerland; [Vandvik, Per O.] Innlandet Hosp Trust, Div Gjovik, Dept Med, Oppland, Norway; [Johnston, Bradley C.] Hosp Sick Children, Dept Anesthesia & Pain Med, Toronto, ON M5G 1X8, Canada; [Gloy, Viktoria; Walter, Martin A.] Univ Hosp Bern, Inst Nucl Med, CH-3010 Bern, Switzerland; [You, John] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Tikkinen, Kari A. O.] Univ Helsinki, Dept Urol, Helsinki Univ Cent Hosp, Helsinki, Finland; [Neumann, Ignacio] Pontificia Univ Catolica Chile, Dept Internal Med, Santiago, Chile; [Faulhaber, Markus] McMaster Univ, Dept Family Med, Hamilton, ON L8S 4L8, Canada; [Akl, Elie A.] Amer Univ Beirut, Dept Internal Med, Beirut, Lebanon; [Akl, Elie A.] SUNY Buffalo, Dept Med, Buffalo, NY 14260 USA; [Busse, Jason W.; Ebrahim, Shanil] McMaster Univ, Dept Anesthesia, Hamilton, ON, Canada; [Ebrahim, Shanil] Stanford Univ, Stanford Prevent Res Ctr, Stanford, CA 94305 USA; [Schandelmaier, Stefan] Univ Basel Hosp, Acad Swiss Insurance Med, CH-4031 Basel, Switzerland; [Xin, Sun] Sichuan Univ, West China Hosp, Chinese Evidence Based Med Ctr, Chengdu 610064, Peoples R China; [Johnston, Bradley C.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Carrasco-Labra, Alonso] Univ Chile, Fac Dent, Evidence Based Dent Unit, Santiago, Chile; [Mertz, Dominik] McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON, Canada; [Busse, Jason W.] McMaster Univ, Michael G DeGroote Inst Pain Res & Care, Hamilton, ON, Canada	University of Basel; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); McMaster University; University of Freiburg; University of Zurich; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; University of Hamburg; University Medical Center Hamburg-Eppendorf; Hospital Universitari Vall d'Hebron; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Sherbrooke; University of Sherbrooke; University of Basel; Innlandet Hospital Trust; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Bern; University Hospital of Bern; McMaster University; University of Helsinki; Helsinki University Central Hospital; Pontificia Universidad Catolica de Chile; McMaster University; American University of Beirut; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; McMaster University; Stanford University; University of Basel; Sichuan University; University of Toronto; Universidad de Chile; McMaster University; McMaster University	Briel, M (corresponding author), Univ Basel Hosp, Basel Inst Clin Epidemiol & Biostat, Hebelstr 10, CH-4031 Basel, Switzerland.	matthias.briel@usb.ch	Akl, Elie/K-5269-2019; Amstutz, Alain/Y-7039-2019; Hemkens, Lars G./AAB-2653-2020; Akl, Elie A/R-2079-2016; Neumann, Ignacio/ABB-5013-2020; Busse, Jason/CAH-3696-2022; Briel, Matthias/AAT-9284-2021; Carrasco-Labra, Alonso/ABF-9555-2020; Meerpohl, Joerg J/J-4224-2013; Schandelmaier, Stefan/GLV-3722-2022; Ferreira-Gonzalez, Ignacio/K-9939-2017; Walter, Martin A/B-5203-2017; Amstutz, Alain/P-7810-2018; Moja, Pasquale Lorenzo/CAH-0318-2022; Kasenda, Benjamin/AAF-4184-2019; Tikkinen, Kari/L-3632-2018	Amstutz, Alain/0000-0003-1716-993X; Hemkens, Lars G./0000-0002-3444-1432; Akl, Elie A/0000-0002-3444-8618; Busse, Jason/0000-0002-0178-8712; Carrasco-Labra, Alonso/0000-0003-3546-3526; Meerpohl, Joerg J/0000-0002-1333-5403; Schandelmaier, Stefan/0000-0002-8429-0337; Walter, Martin A/0000-0001-6487-5349; Amstutz, Alain/0000-0003-1716-993X; Moja, Pasquale Lorenzo/0000-0001-6680-6507; Kasenda, Benjamin/0000-0003-0110-8585; Lamontagne, Francois/0000-0002-0360-3427; Blumle, Anette/0000-0003-2877-1029; Tikkinen, Kari/0000-0002-1389-8214; Briel, Matthias/0000-0002-2070-5230; von Elm, Erik/0000-0002-7412-0406; Bassler, Dirk/0000-0003-2358-4419; Schwenkglenks, Matthias/0000-0001-7217-1173	Swiss National Science Foundation [320030_133540/1]; German Research Foundation [EL 544/1-2]; Brocher Foundation; Reseach Early Career Award from Hamilton Health Sciences; Finnish Cultural Foundation; Finnish Medical Foundation; Hamilton Health Sciences Foundation; New Investigator Award from the Canadian Institutes of Health Research; Canadian Chiropractic Research Foundation; Santesuisse; Gottfried and Julia Bangerter-Rhyner-Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); German Research Foundation(German Research Foundation (DFG)); Brocher Foundation; Reseach Early Career Award from Hamilton Health Sciences; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Finnish Medical Foundation; Hamilton Health Sciences Foundation; New Investigator Award from the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Chiropractic Research Foundation; Santesuisse; Gottfried and Julia Bangerter-Rhyner-Foundation	This study was funded by the Swiss National Science Foundation (grant 320030_133540/1) and the German Research Foundation (grant EL 544/1-2). During study preparation, Dr von Elm was supported by the Brocher Foundation. Dr You is supported by a Reseach Early Career Award from Hamilton Health Sciences. Dr Tikkinen is funded by unrestricted grants from the Finnish Cultural Foundation and the Finnish Medical Foundation. Dr Mertz is a recipient of a Research Early Career Award from Hamilton Health Sciences Foundation (Jack Hirsh Fellowship). Dr Busse is funded by a New Investigator Award from the Canadian Institutes of Health Research and Canadian Chiropractic Research Foundation. Drs Nordmann, Gloy, Raatz, Hemkens, Bucher, and Briel are supported by Santesuisse and the Gottfried and Julia Bangerter-Rhyner-Foundation.	[Anonymous], 1996, INTERNATIONAL CONFER; Barnard KD, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-63; Bassler D, 2010, JAMA-J AM MED ASSOC, V303, P1180, DOI 10.1001/jama.2010.310; Bower P, 2007, FAM PRACT, V24, P601, DOI 10.1093/fampra/cmm051; Campbell MK, 2007, HEALTH TECHNOL ASSES, V11; Damen L, 2012, J MED ETHICS, V38, P413, DOI 10.1136/medethics-2011-100020; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; Decullier E, 2005, BMJ-BRIT MED J, V331, P19, DOI 10.1136/bmj.38488.385995.8F; Dwan K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066844; EASTERBROOK PJ, 1992, J ROY SOC MED, V85, P71; Fletcher B, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000496; Kasenda B, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-131; Kenward MG, 2007, STAT METHODS MED RES, V16, P199, DOI 10.1177/0962280206075304; Kooistra BW, 2011, J CLIN EPIDEMIOL, V64, P537, DOI 10.1016/j.jclinepi.2010.05.002; McDonald AM, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-9; Pich J, 2003, LANCET, V361, P1015, DOI 10.1016/S0140-6736(03)12799-7; Schroen AT, 2010, CLIN TRIALS, V7, P312, DOI 10.1177/1740774510374973; Stern JM, 1997, BMJ-BRIT MED J, V315, P640, DOI 10.1136/bmj.315.7109.640; Toerien M, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-52; Treweek S, 2010, COCHRANE DATABASE SY; von Elm E, 2008, SWISS MED WKLY, V138, P197, DOI 2008/13/smw-12027; Wilson S, 2000, BMJ-BRIT MED J, V321, P24, DOI 10.1136/bmj.321.7252.24	22	206	209	2	41	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 12	2014	311	10					1045	1051		10.1001/jama.2014.1361	http://dx.doi.org/10.1001/jama.2014.1361			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC5QO	24618966	Green Published			2022-12-28	WOS:000332575800022
J	Coffelt, SB; de Visser, KE				Coffelt, Seth B.; de Visser, Karin E.			CANCER Inflammation lights the way to metastasis	NATURE			English	Editorial Material							LUNG METASTASIS; MELANOMA; IPILIMUMAB; CELLS		[Coffelt, Seth B.; de Visser, Karin E.] Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	Coffelt, SB (corresponding author), Netherlands Canc Inst, Div Immunol, NL-1066 CX Amsterdam, Netherlands.	k.d.visser@nki.nl	Coffelt, Seth/O-9929-2019	Coffelt, Seth/0000-0003-2257-2862; de Visser, Karin/0000-0002-0293-868X				Bald T, 2014, NATURE, V507, P109, DOI 10.1038/nature13111; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Couzin-Frankel J, 2013, SCIENCE, V342, P1432, DOI 10.1126/science.342.6165.1432; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Huh SJ, 2010, CANCER RES, V70, P6071, DOI 10.1158/0008-5472.CAN-09-4442; Kowanetz M, 2010, P NATL ACAD SCI USA, V107, P21248, DOI 10.1073/pnas.1015855107; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Robbins PF, 2013, NAT MED, V19, P747, DOI 10.1038/nm.3161; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369	10	88	93	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					48	49		10.1038/nature13062	http://dx.doi.org/10.1038/nature13062			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0ZQ	24572360				2022-12-28	WOS:000332224400039
J	Stohr, K				Stoehr, Klaus			PERSPECTIVE Ill prepared for a pandemic	NATURE			English	Editorial Material							INFLUENZA		[Stoehr, Klaus] Novartis Vaccines & Diagnost, Policy, Cambridge, MA 02139 USA	Novartis	Stohr, K (corresponding author), Novartis Vaccines & Diagnost, Policy, Cambridge, MA 02139 USA.	klaus.stohr@novartis.com						Collin N, 2009, VACCINE, V27, P5184, DOI 10.1016/j.vaccine.2009.06.034; Dormitzer PR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006368; Palache A, 2011, VACCINE, V29, P9459, DOI 10.1016/j.vaccine.2011.10.030; Settembre EC, 2014, HUM VACC IMMUNOTHER, V10, P600, DOI 10.4161/hv.27600	4	10	10	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					S20	S21		10.1038/507S20a	http://dx.doi.org/10.1038/507S20a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC0ZQ	24611175	Bronze			2022-12-28	WOS:000332224400010
J	Kaspari, M; Weiser, MD				Kaspari, Michael; Weiser, Michael D.			Meet the New Boss, Same as the Old Boss	SCIENCE			English	Editorial Material									[Kaspari, Michael; Weiser, Michael D.] Univ Oklahoma, Dept Biol, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Kaspari, M (corresponding author), Univ Oklahoma, Dept Biol, Norman, OK 73019 USA.	mkaspari@ou.edu	Weiser, Michael/E-6215-2011	Weiser, Michael/0000-0001-9080-0834; Kaspari, Michael/0000-0002-9717-5768				BHATKAR A, 1972, Environmental Entomology, V1, P274; CHAO L, 1981, P NATL ACAD SCI-BIOL, V78, P6324, DOI 10.1073/pnas.78.10.6324; Cooling M, 2012, BIOL LETTERS, V8, P430, DOI 10.1098/rsbl.2011.1014; Feener DH, 2008, ECOLOGY, V89, P1824, DOI 10.1890/07-0659.1; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; LeBrun EG, 2014, SCIENCE, V343, P1014, DOI 10.1126/science.1245833; LeBrun EG, 2013, BIOL INVASIONS, V15, P2429, DOI 10.1007/s10530-013-0463-6; ORIANS GH, 1974, AM NAT, V108, P581, DOI 10.1086/282937; Simberloff D, 2013, INVASIVE SPECIES WHA; Tschinkel WR, 2006, FIRE ANTS	10	1	1	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2014	343	6174					974	975		10.1126/science.1251272	http://dx.doi.org/10.1126/science.1251272			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2DZ	24578567				2022-12-28	WOS:000332309600026
J	Kempermann, G				Kempermann, Gerd			Off the Beaten Track: New Neurons in the Adult Human Striatum	CELL			English	Editorial Material							NEUROGENESIS; SURVIVAL		[Kempermann, Gerd] Tech Univ Dresden, German Ctr Neurodegenerat Dis DZNE Dresden, D-01307 Dresden, Germany; [Kempermann, Gerd] Tech Univ Dresden, CRTD, D-01307 Dresden, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technische Universitat Dresden; Technische Universitat Dresden	Kempermann, G (corresponding author), Tech Univ Dresden, German Ctr Neurodegenerat Dis DZNE Dresden, Fetscherstr 105, D-01307 Dresden, Germany.	gerd.kempermann@dzne.de	Kempermann, Gerd/F-5416-2010	Kempermann, Gerd/0000-0002-5304-4061				Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bergmann O, 2012, NEURON, V74, P634, DOI 10.1016/j.neuron.2012.03.030; Bhardwaj RD, 2006, P NATL ACAD SCI USA, V103, P12564, DOI 10.1073/pnas.0605177103; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Ernst A, 2014, CELL, V156, P1072, DOI 10.1016/j.cell.2014.01.044; Glass R, 2005, J NEUROSCI, V25, P2637, DOI 10.1523/JNEUROSCI.5118-04.2005; Kempermann G, 2012, NAT REV NEUROSCI, V13, P727, DOI 10.1038/nrn3319; Patzke N, 2015, BRAIN STRUCT FUNCT, V220, P361, DOI 10.1007/s00429-013-0660-1; Spalding KL, 2013, CELL, V153, P1219, DOI 10.1016/j.cell.2013.05.002	9	12	12	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 27	2014	156	5					870	871		10.1016/j.cell.2014.02.027	http://dx.doi.org/10.1016/j.cell.2014.02.027			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AB9BK	24581487	Bronze			2022-12-28	WOS:000332083900005
J	McFiggans, G				McFiggans, Gordon			ATMOSPHERIC SCIENCE Involatile particles from rapid oxidation	NATURE			English	Editorial Material							AEROSOLS		Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester M13 9PL, Lancs, England	University of Manchester	McFiggans, G (corresponding author), Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester M13 9PL, Lancs, England.	g.mcfiggans@manchester.ac.uk	McFiggans, Gordon B/B-8689-2011	McFiggans, Gordon B/0000-0002-3423-7896				Donahue NM, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048115; Donahue NM, 2013, FARADAY DISCUSS, V165, P91, DOI 10.1039/c3fd00046j; Ehn M, 2014, NATURE, V506, P476, DOI 10.1038/nature13032; Hallquist M, 2009, ATMOS CHEM PHYS, V9, P5155, DOI 10.5194/acp-9-5155-2009; Jimenez JL, 2009, SCIENCE, V326, P1525, DOI 10.1126/science.1180353; Kulmala M, 2004, ATMOS CHEM PHYS, V4, P557, DOI 10.5194/acp-4-557-2004; Kulmala M, 2004, J AEROSOL SCI, V35, P143, DOI 10.1016/j.jaerosci.2003.10.003; Kulmala M, 2013, SCIENCE, V339, P943, DOI 10.1126/science.1227385; Mentel TF, 2013, ATMOS CHEM PHYS, V13, P8755, DOI 10.5194/acp-13-8755-2013; Paasonen P, 2013, NAT GEOSCI, V6, P438, DOI [10.1038/NGEO1800, 10.1038/ngeo1800]; Spracklen DV, 2011, ATMOS CHEM PHYS, V11, P12109, DOI 10.5194/acp-11-12109-2011; Topping D, 2013, NAT GEOSCI, V6, P443, DOI [10.1038/NGEO1809, 10.1038/ngeo1809]	12	9	9	1	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2014	506	7489					442	443		10.1038/506442a	http://dx.doi.org/10.1038/506442a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0DN	24572421				2022-12-28	WOS:000332165100028
J	McMeniman, CJ; Corfas, RA; Matthews, BJ; Ritchie, SA; Vosshall, LB				McMeniman, Conor J.; Corfas, Roman A.; Matthews, Benjamin J.; Ritchie, Scott A.; Vosshall, Leslie B.			Multimodal Integration of Carbon Dioxide and Other Sensory Cues Drives Mosquito Attraction to Humans	CELL			English	Article							AEDES-AEGYPTI; CHEMOSENSORY RECEPTORS; MAXILLARY PALP; RESPONSES; NEURONS; DIPTERA; SKIN; ACTIVATION; DROSOPHILA; CULICIDAE	Multiple sensory cues emanating from humans are thought to guide blood-feeding female mosquitoes to a host. To determine the relative contribution of carbon dioxide (CO2) detection to mosquito host-seeking behavior, we mutated the AaegGr3 gene, a subunit of the heteromeric CO2 receptor in Aedes aegypti mosquitoes. Gr3 mutants lack electrophysiological and behavioral responses to CO2. These mutants also fail to show CO2-evoked responses to heat and lactic acid, a human-derived attractant, suggesting that CO2 can gate responses to other sensory stimuli. Whereas attraction of Gr3 mutants to live humans in a large semi-field environment was only slightly impaired, responses to an animal host were greatly reduced in a spatial-scale-dependent manner. Synergistic integration of heat and odor cues likely drive host-seeking behavior in the absence of CO2 detection. We reveal a networked series of interactions by which multimodal integration of CO2, human odor, and heat orchestrates mosquito attraction to humans.	[McMeniman, Conor J.; Corfas, Roman A.; Matthews, Benjamin J.; Vosshall, Leslie B.] Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10065 USA; [Ritchie, Scott A.] James Cook Univ, Sch Publ Hlth Trop Med & Rehabilitat Sci, Cairns, Qld 4870, Australia; [Vosshall, Leslie B.] Howard Hughes Med Inst, Chevy Chase, MD USA	Rockefeller University; James Cook University; Howard Hughes Medical Institute	Vosshall, LB (corresponding author), Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10065 USA.	leslie.vosshall@rockefeller.edu		McMeniman, Conor/0000-0001-8502-8712; Vosshall, Leslie/0000-0002-6060-8099; Corfas, Roman/0000-0002-3096-6813; Matthews, Benjamin/0000-0002-8697-699X	Marie-Josee and Henry Kravis Postdoctoral Fellowship; Human Frontier Science Program Long-Term Postdoctoral Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066699] Funding Source: NIH RePORTER	Marie-Josee and Henry Kravis Postdoctoral Fellowship; Human Frontier Science Program Long-Term Postdoctoral Fellowship(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Matthew DeGennaro, Jeff Liesch, Carolyn McBride, and other members of the Vosshall Lab for helpful discussions and comments on the manuscript; Deborah Beck, Allison Goff, Emma Mullen, Jason Pitts, Laura Seeholzer, and Sarah Yeoh-Wang for expert technical assistance; Lindsay Bellani for collaborating to establish the membrane-feeding assay; and Scott Dewell for bioinformatic support. At James Cook University, Jessica Dickie, Chris Paton, and Michael Townsend provided valuable support with Australian importation, regulatory inspections, and mosquito rearing, and Mark Pearson facilitated sample processing. Zach Adelman of Virginia Tech University provided plasmids. C.J.M. was supported by a Marie-Josee and Henry Kravis Postdoctoral Fellowship and a Human Frontier Science Program Long-Term Postdoctoral Fellowship. B.J.M. is a Jane Coffin Childs Postdoctoral Fellow. L.B.V. is an Investigator of the Howard Hughes Medical Institute.	ACREE F, 1968, SCIENCE, V161, P1346, DOI 10.1126/science.161.3848.1346; Anton S, 2003, ARTHROPOD STRUCT DEV, V32, P319, DOI 10.1016/j.asd.2003.09.002; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Bohbot J, 2007, INSECT MOL BIOL, V16, P525, DOI 10.1111/j.1365-2583.2007.00748.x; BURGESS L, 1959, NATURE, V184, P1968, DOI 10.1038/1841968a0; Campbell R, 2008, PHILOS T R SOC B, V363, P1001, DOI 10.1098/rstb.2007.2155; Dekker T, 2005, J EXP BIOL, V208, P2963, DOI 10.1242/jeb.01736; Dekker T, 2011, J EXP BIOL, V214, P3480, DOI 10.1242/jeb.055186; EIRAS AE, 1991, B ENTOMOL RES, V81, P151, DOI 10.1017/S0007485300051221; Erdelyan CNG, 2012, INSECT MOL BIOL, V21, P119, DOI 10.1111/j.1365-2583.2011.01120.x; Gallagher M, 2008, BRIT J DERMATOL, V159, P780, DOI 10.1111/j.1365-2133.2008.08748.x; Geier M, 1999, J EXP BIOL, V202, P1639; Gibson G, 1999, MED VET ENTOMOL, V13, P2, DOI 10.1046/j.1365-2915.1999.00163.x; GILLIES MT, 1980, B ENTOMOL RES, V70, P525, DOI 10.1017/S0007485300007811; GRANT AJ, 1995, J COMP PHYSIOL A, V177, P389, DOI 10.1007/BF00187475; HEALY TP, 1995, MED VET ENTOMOL, V9, P331, DOI 10.1111/j.1365-2915.1995.tb00143.x; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Keller A, 2013, BMC EAR NOSE THROAT, V13, DOI 10.1186/1472-6815-13-8; Kennedy JS, 1940, P ZOOL SOC LOND A-GE, V109, P221, DOI 10.1111/j.1096-3642.1940.tb00831.x; Krober T, 2010, J AM MOSQUITO CONTR, V26, P381, DOI 10.2987/10-6044.1; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; LEWIS HE, 1969, LANCET, V1, P1273; Lu T, 2007, CURR BIOL, V17, P1533, DOI 10.1016/j.cub.2007.07.062; Maekawa E, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-10; MCIVER SB, 1972, CAN J ZOOLOG, V50, P571, DOI 10.1139/z72-078; Pellegrino Maurizio, 2010, J Vis Exp, P1, DOI 10.3791/1725; Ritchie Scott A, 2011, PLoS Negl Trop Dis, V5, pe988, DOI 10.1371/journal.pntd.0000988; Robertson HM, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.1901; Ruta V, 2010, NATURE, V468, P686, DOI 10.1038/nature09554; Small DM, 2012, PHYSIOL BEHAV, V107, P540, DOI 10.1016/j.physbeh.2012.04.011; Smallegange RC, 2011, TRENDS PARASITOL, V27, P143, DOI 10.1016/j.pt.2010.12.009; SNOW WF, 1970, B ENTOMOL RES, V60, P43, DOI 10.1017/S0007485300034131; Spitzen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062995; Tauxe GM, 2013, CELL, V155, P1365, DOI 10.1016/j.cell.2013.11.013; TRPIS M, 1973, B WORLD HEALTH ORGAN, V48, P623; Turner SL, 2011, NATURE, V474, P87, DOI 10.1038/nature10081; Woke P.A., 1937, LINN J PARASITOL, V23, P310	40	241	251	6	89	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 27	2014	156	5					1060	1071		10.1016/j.cell.2013.12.044	http://dx.doi.org/10.1016/j.cell.2013.12.044			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AB9BK	24581501	Green Accepted, Bronze			2022-12-28	WOS:000332083900021
J	Parker, M; Mohankumar, KM; Punchihewa, C; Weinlich, R; Dalton, JD; Li, YJ; Lee, R; Tatevossian, RG; Phoenix, TN; Thiruvenkatam, R; White, E; Tang, B; Orisme, W; Gupta, K; Rusch, M; Chen, X; Li, YX; Nagahawhatte, P; Hedlund, E; Finkelstein, D; Wu, G; Shurtleff, S; Easton, J; Boggs, K; Yergeau, D; Vadodaria, B; Mulder, HL; Becksford, J; Gupta, P; Huether, R; Ma, J; Song, GC; Gajjar, A; Merchant, T; Boop, F; Smith, AA; Ding, L; Lu, C; Ochoa, K; Zhao, D; Fulton, RS; Fulton, LL; Mardis, ER; Wilson, RK; Downing, JR; Green, DR; Zhang, JH; Ellison, DW; Gilbertson, RJ				Parker, Matthew; Mohankumar, Kumarasamypet M.; Punchihewa, Chandanamali; Weinlich, Ricardo; Dalton, James D.; Li, Yongjin; Lee, Ryan; Tatevossian, Ruth G.; Phoenix, Timothy N.; Thiruvenkatam, Radhika; White, Elsie; Tang, Bo; Orisme, Wilda; Gupta, Kirti; Rusch, Michael; Chen, Xiang; Li, Yuxin; Nagahawhatte, Panduka; Hedlund, Erin; Finkelstein, David; Wu, Gang; Shurtleff, Sheila; Easton, John; Boggs, Kristy; Yergeau, Donald; Vadodaria, Bhavin; Mulder, Heather L.; Becksford, Jared; Gupta, Pankaj; Huether, Robert; Ma, Jing; Song, Guangchun; Gajjar, Amar; Merchant, Thomas; Boop, Frederick; Smith, Amy A.; Ding, Li; Lu, Charles; Ochoa, Kerri; Zhao, David; Fulton, Robert S.; Fulton, Lucinda L.; Mardis, Elaine R.; Wilson, Richard K.; Downing, James R.; Green, Douglas R.; Zhang, Jinghui; Ellison, David W.; Gilbertson, Richard J.			C11orf95-RELA fusions drive oncogenic NF-kappa B signalling in ependymoma	NATURE			English	Article							DISTINCT SUBGROUPS; CANCER GENOMES; CYCLIN D1; P65; MUTATIONS; PHOSPHORYLATION; ASSOCIATION; SUBUNIT; DISEASE; COMPLEX	Members of the nuclear factor-kappa B (NF-kappa B) family of transcriptional regulators are central mediators of the cellular inflammatory response. Although constitutive NF-kappa B signalling is present in most human tumours, mutations in pathway members are rare, complicating efforts to understand and block aberrant NF-kappa B activity in cancer. Here we show that more than two-thirds of supratentorial ependymomas contain oncogenic fusions between RELA, the principal effector of canonical NF-kappa B signalling, and an uncharacterized gene, C11orf95. In each case, C11orf95-RELA fusions resulted from chromothripsis involving chromosome 11q13.1. C11orf95-RELA fusion proteins translocated spontaneously to the nucleus to activate NF-kappa B target genes, and rapidly transformed neural stem cells-the cell of origin of ependymoma-to form these tumours in mice. Our data identify a highly recurrent genetic alteration of RELA in human cancer, and the C11orf95-RELA fusion protein as a potential therapeutic target in supratentorial ependymoma.	[Parker, Matthew; Dalton, James D.; Li, Yongjin; Tatevossian, Ruth G.; Tang, Bo; Orisme, Wilda; Boggs, Kristy; Yergeau, Donald; Vadodaria, Bhavin; Mulder, Heather L.; Ma, Jing; Song, Guangchun; Gajjar, Amar; Ding, Li; Lu, Charles; Ochoa, Kerri; Zhao, David; Fulton, Robert S.; Fulton, Lucinda L.; Mardis, Elaine R.; Wilson, Richard K.; Downing, James R.; Zhang, Jinghui; Ellison, David W.; Gilbertson, Richard J.] Washington Univ, St Jude Childrens Res Hosp, Pediat Canc Genome Project, Memphis, TN 38105 USA; [Parker, Matthew; Li, Yongjin; Rusch, Michael; Chen, Xiang; Li, Yuxin; Nagahawhatte, Panduka; Hedlund, Erin; Finkelstein, David; Wu, Gang; Gupta, Pankaj; Zhao, David; Zhang, Jinghui] St Jude Childrens Res Hosp, Dept Computat Biol & Bioinformat, Memphis, TN 38105 USA; [Mohankumar, Kumarasamypet M.; Phoenix, Timothy N.; Thiruvenkatam, Radhika; White, Elsie; Gilbertson, Richard J.] St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Punchihewa, Chandanamali; Dalton, James D.; Lee, Ryan; Tatevossian, Ruth G.; Tang, Bo; Orisme, Wilda; Gupta, Kirti; Shurtleff, Sheila; Easton, John; Becksford, Jared; Downing, James R.; Ellison, David W.] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA; [Weinlich, Ricardo; Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Li, Yuxin; Huether, Robert] St Jude Childrens Res Hosp, Memphis, TN 38105 USA; [Gajjar, Amar] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Merchant, Thomas] St Jude Childrens Res Hosp, Dept Radiol Sci, Memphis, TN 38105 USA; [Boop, Frederick] St Jude Childrens Res Hosp, Dept Surg, Memphis, TN 38105 USA; [Smith, Amy A.] MD Anderson Canc Ctr Orlando, Orlando, FL 32806 USA; [Ding, Li; Lu, Charles; Ochoa, Kerri; Fulton, Robert S.; Fulton, Lucinda L.; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Sch Med St Louis, Genome Inst, St Louis, MO 63108 USA; [Ding, Li; Ochoa, Kerri; Fulton, Lucinda L.; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Sch Med St Louis, Dept Genet, St Louis, MO 63108 USA; [Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Sch Med St Louis, Siteman Canc Ctr, St Louis, MO 63108 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Texas System; UTMD Anderson Cancer Center; Saint Louis University; Washington University (WUSTL); Saint Louis University; Washington University (WUSTL); Saint Louis University; Siteman Cancer Center; Washington University (WUSTL)	Gilbertson, RJ (corresponding author), Washington Univ, St Jude Childrens Res Hosp, Pediat Canc Genome Project, Memphis, TN 38105 USA.	Jinghui.Zhang@stjude.org; David.Ellison@stjude.org; Richard.Gilbertson@stjude.org	Lee, Ryan/HCI-5836-2022; Huether, Robert/E-9638-2012; Mardis, Elaine/W-2202-2019; Wilson, Richard K./AAF-4139-2019; Zhang, Jing/GWZ-7332-2022; Downing, James R./N-8102-2018; LI, YONGJIN/E-1688-2011; Weinlich, Ricardo/AAW-3154-2020; Merchant, Thomas E/N-3344-2018; Tatevossian, Ruth G./G-6377-2016; Li, Yuxin/K-9197-2016; Green, Douglas R/N-8083-2018; Gilbertson, Richard James/ABE-1346-2021; Gajjar, Amar/N-8059-2018; Chen, Xiang/N-2524-2018; Lien, Brian/AAI-7882-2020; Rusch, Michael/AAG-1998-2019; Ellison, David/N-4806-2018; Weinlich, Ricardo/S-7495-2016; Wu, Gang/M-8012-2014	Huether, Robert/0000-0001-7077-7470; Wilson, Richard K./0000-0002-1992-1358; Weinlich, Ricardo/0000-0001-6822-7330; Merchant, Thomas E/0000-0002-0412-6255; Tatevossian, Ruth G./0000-0002-1653-3026; Green, Douglas R/0000-0002-7332-1417; Gilbertson, Richard James/0000-0001-7539-9472; Chen, Xiang/0000-0002-2499-8261; Rusch, Michael/0000-0002-5363-1848; Wu, Gang/0000-0002-1678-5864; Easton, John/0000-0003-4503-6608; Lee, Ryan/0000-0002-2517-9559; KM, Mohankumar/0000-0001-9407-1800; Li, Yuxin/0000-0001-9739-9860; Parker, Matthew/0000-0003-2999-3870	St. Jude Children's Research Hospital, Washington University Pediatric Cancer Genome Project; National Institutes of Health [R01CA129541, P01CA96832, P30CA021765]; Collaborative Ependymoma Research Network (CERN); American Lebanese Syrian Associated Charities (ALSAC); NATIONAL CANCER INSTITUTE [R01CA129541, P01CA096832, P30CA021765] Funding Source: NIH RePORTER	St. Jude Children's Research Hospital, Washington University Pediatric Cancer Genome Project; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Collaborative Ependymoma Research Network (CERN); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported as part of the St. Jude Children's Research Hospital, Washington University Pediatric Cancer Genome Project. This work was supported by grants from the National Institutes of Health (R01CA129541, P01CA96832 and P30CA021765 to R.J.G), the Collaborative Ependymoma Research Network (CERN), and by the American Lebanese Syrian Associated Charities (ALSAC). We are grateful to S. Temple for the gift of reagents and the staff of the Hartwell Center for Bioinformatics and Biotechnology, Animal Imaging Center, and Flow Cytometry and Cell Sorting Shared Resource at St. Jude Children's Research Hospital for technical assistance.	Atkinson JM, 2011, CANCER CELL, V20, P384, DOI 10.1016/j.ccr.2011.08.013; Baud V, 2009, NAT REV DRUG DISCOV, V8, P33, DOI 10.1038/nrd2781; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; Chen LF, 2004, NAT REV MOL CELL BIO, V5, P392, DOI 10.1038/nrm1368; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Godfraind C, 2012, ACTA NEUROPATHOL, V124, P247, DOI 10.1007/s00401-012-0981-9; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; HANSEN SK, 1994, MOL CELL BIOL, V14, P2593, DOI 10.1128/MCB.14.4.2593; Hinz M, 1999, MOL CELL BIOL, V19, P2690; Johnson RA, 2010, NATURE, V466, P632, DOI 10.1038/nature09173; Kiefel H, 2012, CARCINOGENESIS, V33, P1919, DOI 10.1093/carcin/bgs220; Kiefel H, 2011, TRENDS MOL MED, V17, P178, DOI 10.1016/j.molmed.2010.11.005; Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215; Korbel JO, 2013, CELL, V152, P1226, DOI 10.1016/j.cell.2013.02.023; Merchant TE, 2009, LANCET ONCOL, V10, P258, DOI 10.1016/S1470-2045(08)70342-5; Modena P, 2006, J CLIN ONCOL, V24, P5223, DOI 10.1200/JCO.2006.06.3701; NOLAN GP, 1991, CELL, V64, P961, DOI 10.1016/0092-8674(91)90320-X; Okazaki T, 2003, BIOCHEM BIOPH RES CO, V300, P807, DOI 10.1016/S0006-291X(02)02932-7; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Puget S, 2009, J CLIN ONCOL, V27, P1884, DOI 10.1200/JCO.2007.15.4195; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Wang JM, 2011, NAT METHODS, V8, P652, DOI [10.1038/nmeth.1628, 10.1038/NMETH.1628]; Witt H, 2011, CANCER CELL, V20, P143, DOI 10.1016/j.ccr.2011.07.007; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	28	407	422	1	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2014	506	7489					451	+		10.1038/nature13109	http://dx.doi.org/10.1038/nature13109			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0DN	24553141	Green Accepted			2022-12-28	WOS:000332165100030
J	Wlodarska, M; Thaiss, CA; Nowarski, R; Henao-Mejia, J; Zhang, JP; Brown, EM; Frankel, G; Levy, M; Katz, MN; Philbrick, WM; Elinav, E; Finlay, BB; Flavell, RA				Wlodarska, Marta; Thaiss, Christoph A.; Nowarski, Roni; Henao-Mejia, Jorge; Zhang, Jian-Ping; Brown, Eric M.; Frankel, Gad; Levy, Maayan; Katz, Meirav N.; Philbrick, William M.; Elinav, Eran; Finlay, B. Brett; Flavell, Richard A.			NLRP6 Inflammasome Orchestrates the Colonic Host-Microbial Interface by Regulating Goblet Cell Mucus Secretion	CELL			English	Article							INTESTINAL INFLAMMATION; CITROBACTER-RODENTIUM; ADAPTIVE IMMUNITY; LIVER-DISEASE; MUCIN; INFECTION; AUTOPHAGY; MICE; CASPASE-1; PROTEINS	Mucusproduction by goblet cells of the large intestine serves as a crucial antimicrobial protective mechanism at the interface between the eukaryotic and prokaryotic cells of the mammalian intestinal ecosystem. However, the regulatory pathways involved in goblet cell-induced mucus secretion remain largely unknown. Here, we demonstrate that the NLRP6 inflammasome, a recently described regulator of colonic microbiota composition and biogeographical distribution, is a critical orchestrator of goblet cell mucin granule exocytosis. NLRP6 deficiency leads to defective autophagy in goblet cells and abrogated mucus secretion into the large intestinal lumen. Consequently, NLRP6 inflammasome-deficient mice are unable to clear enteric pathogens from the mucosal surface, rendering them highly susceptible to persistent infection. This study identifies an innate immune regulatory pathway governing goblet cell mucus secretion, linking nonhematopoietic inflammasome signaling to autophagy and highlighting the goblet cell as a critical innate immune player in the control of intestinal host-microbial mutualism.	[Wlodarska, Marta; Brown, Eric M.; Finlay, B. Brett] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada; [Wlodarska, Marta; Brown, Eric M.; Finlay, B. Brett] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z4, Canada; [Thaiss, Christoph A.; Levy, Maayan; Katz, Meirav N.; Elinav, Eran] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Nowarski, Roni; Henao-Mejia, Jorge; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Zhang, Jian-Ping; Philbrick, William M.] Yale Univ, Sch Med, Ctr Endocrinol & Metab, New Haven, CT 06520 USA; [Frankel, Gad] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, MRC Ctr Mol Bacteriol & Infect, London SW7 2AZ, England; [Katz, Meirav N.] Tel Aviv Univ, Sackler Fac Med, Tel Aviv Sourasky Med Ctr, Res Ctr Digest Tract & Liver Dis, IL-64239 Tel Aviv, Israel; [Finlay, B. Brett] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z4, Canada; [Flavell, Richard A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	University of British Columbia; University of British Columbia; Weizmann Institute of Science; Yale University; Yale University; Imperial College London; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; University of British Columbia; Howard Hughes Medical Institute	Elinav, E (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	eran.elinav@weizmann.ac.il; bfinlay@interchange.ubc.ca; richard.flavell@yale.edu	Elinav, Eran/ABE-8881-2020	Elinav, Eran/0000-0002-5775-2110	Weizmann Institute; Department of Veterinary Resources; Canadian Institutes of Health Research (CIHR); Charles Best Canada graduate scholarship; Boehringer Ingelheim Fonds PhD Fellowship; Friends of Tel Aviv Sourasky Medical Center Foundation; Yael and Rami Ungar, Israel; Abisch Frenkel Foundation for the Promotion of Life Sciences; Gurwin Family Fund for Scientific Research; Leona M. and Harry B. Helmsley Charitable Trust; Crown Endowment Fund for Immunological Research; Estate of Jack Gitlitz; Estate of Lydia Hershkovich; European Research Council; Kenneth Rainin Foundation; German-Israel Binational Foundation; Israel Science Foundation; Minerva Foundation; Alon Foundation; CIHR; US Department of Defense; Blavatnik Family Foundation; MRC [MR/J006874/1] Funding Source: UKRI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735] Funding Source: NIH RePORTER	Weizmann Institute; Department of Veterinary Resources; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Charles Best Canada graduate scholarship; Boehringer Ingelheim Fonds PhD Fellowship(Boehringer Ingelheim); Friends of Tel Aviv Sourasky Medical Center Foundation; Yael and Rami Ungar, Israel; Abisch Frenkel Foundation for the Promotion of Life Sciences; Gurwin Family Fund for Scientific Research; Leona M. and Harry B. Helmsley Charitable Trust; Crown Endowment Fund for Immunological Research; Estate of Jack Gitlitz; Estate of Lydia Hershkovich; European Research Council(European Research Council (ERC)European Commission); Kenneth Rainin Foundation; German-Israel Binational Foundation; Israel Science Foundation(Israel Science Foundation); Minerva Foundation; Alon Foundation; CIHR(Canadian Institutes of Health Research (CIHR)); US Department of Defense(United States Department of Defense); Blavatnik Family Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the members of the Elinav, Finlay, and Flavell labs and Zamir Halpern, Tel Aviv Sourasky Medical Center, for fruitful scientific discussions. We thank Akiko Iwasaki, Yale University School of Medicine, for kindly providing LC3 reporter mice. We thank the Weizmann Institute management and Alon Harmelin, director of the Department of Veterinary Resources, for providing financial and infrastructural support. We thank M. Graham and X. Liu, CCMI EM Core Facility, Yale School of Medicine. M.W. is supported through the Canadian Institutes of Health Research (CIHR) doctoral award-Frederick Banting and Charles Best Canada graduate scholarship. C.A.T. is the recipient of a Boehringer Ingelheim Fonds PhD Fellowship. M.N.K. was supported by a travel grant from the Friends of Tel Aviv Sourasky Medical Center Foundation. E.E. is supported by Yael and Rami Ungar, Israel, Abisch Frenkel Foundation for the Promotion of Life Sciences, the Gurwin Family Fund for Scientific Research, Leona M. and Harry B. Helmsley Charitable Trust, Crown Endowment Fund for Immunological Research, Estate of Jack Gitlitz, Estate of Lydia Hershkovich, grants funded by the European Research Council, the Kenneth Rainin Foundation, the German-Israel Binational Foundation, the Israel Science Foundation, the Minerva Foundation, and the Alon Foundation scholar award. B.B.F. is supported by operating grants from CIHR and is the UBC Peter Wall Distinguished Professor. R.A.F. is supported by grants from the US Department of Defense and the Blavatnik Family Foundation and is a Howard Hughes Medical Institute (HHMI) investigator.	Ambort D, 2012, P NATL ACAD SCI USA, V109, P5645, DOI 10.1073/pnas.1120269109; Anand PK, 2012, NATURE, V488, P389, DOI 10.1038/nature11250; Artis D, 2004, P NATL ACAD SCI USA, V101, P13596, DOI 10.1073/pnas.0404034101; Bergstrom KSB, 2008, INFECT IMMUN, V76, P796, DOI 10.1128/IAI.00093-07; Bergstrom KSB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000902; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Chen GY, 2011, J IMMUNOL, V186, P7187, DOI 10.4049/jimmunol.1100412; DeSelm CJ, 2011, DEV CELL, V21, P966, DOI 10.1016/j.devcel.2011.08.016; Elinav E, 2013, MUCOSAL IMMUNOL, V6, P4, DOI 10.1038/mi.2012.115; Elinav Eran, 2013, Methods Mol Biol, V1040, P185, DOI 10.1007/978-1-62703-523-1_14; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Elinav E, 2011, IMMUNITY, V34, P665, DOI 10.1016/j.immuni.2011.05.007; FORSTNER G, 1995, ANNU REV PHYSIOL, V57, P585, DOI 10.1146/annurev.ph.57.030195.003101; Gill N, 2011, CELL MICROBIOL, V13, P660, DOI 10.1111/j.1462-5822.2011.01578.x; Grenier JM, 2002, FEBS LETT, V530, P73, DOI 10.1016/S0014-5793(02)03416-6; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Henao-Mejia J, 2013, J AUTOIMMUN, V46, P66, DOI 10.1016/j.jaut.2013.07.001; Henao-Mejia J, 2013, ADV IMMUNOL, V117, P73, DOI 10.1016/B978-0-12-410524-9.00003-7; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hu B, 2013, P NATL ACAD SCI USA, V110, P9862, DOI 10.1073/pnas.1307575110; Inoue J, 2012, ARCH BIOCHEM BIOPHYS, V521, P95, DOI 10.1016/j.abb.2012.03.019; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kamada N, 2012, SCIENCE, V336, P1325, DOI 10.1126/science.1222195; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Leverkoehne I, 2002, J HISTOCHEM CYTOCHEM, V50, P829, DOI 10.1177/002215540205000609; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Lupp C, 2007, CELL HOST MICROBE, V2, P204, DOI 10.1016/j.chom.2007.08.002; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Nair MG, 2008, J IMMUNOL, V181, P4709, DOI 10.4049/jimmunol.181.7.4709; Normand S, 2011, P NATL ACAD SCI USA, V108, P9601, DOI 10.1073/pnas.1100981108; Patel KK, 2013, EMBO J, V32, P3130, DOI 10.1038/emboj.2013.233; Rodriguez-Pineiro AM, 2012, J PROTEOME RES, V11, P1879, DOI 10.1021/pr2010988; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Songhet P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022459; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Stienstra R, 2010, CELL METAB, V12, P593, DOI 10.1016/j.cmet.2010.11.011; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Takeda K, 1998, IMMUNITY, V8, P383, DOI 10.1016/S1074-7613(00)80543-9; TYTGAT KMAJ, 1994, GASTROENTEROLOGY, V107, P1352, DOI 10.1016/0016-5085(94)90537-1; Ushio H, 2011, J ALLERGY CLIN IMMUN, V127, P1267, DOI 10.1016/j.jaci.2010.12.1078; van der Sluis M, 2008, LAB INVEST, V88, P634, DOI 10.1038/labinvest.2008.28; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Wiles S, 2006, INFECT IMMUN, V74, P5391, DOI 10.1128/IAI.00848-06; Wysolmerski JJ, 1998, DEVELOPMENT, V125, P1285	44	452	477	7	120	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 27	2014	156	5					1045	1059		10.1016/j.cell.2014.01.026	http://dx.doi.org/10.1016/j.cell.2014.01.026			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AB9BK	24581500	Bronze, Green Accepted			2022-12-28	WOS:000332083900020
J	Lovett-Barron, M; Kaifosh, P; Kheirbek, MA; Danielson, N; Zaremba, JD; Reardon, TR; Turi, GF; Hen, RN; Zemelman, BV; Losonczy, A				Lovett-Barron, Matthew; Kaifosh, Patrick; Kheirbek, Mazen A.; Danielson, Nathan; Zaremba, Jeffrey D.; Reardon, Thomas R.; Turi, Gergely F.; Hen, Rene; Zemelman, Boris V.; Losonczy, Attila			Dendritic Inhibition in the Hippocampus Supports Fear Learning	SCIENCE			English	Article							DORSAL HIPPOCAMPUS; PLACE CELLS; CELLULAR RESOLUTION; SYNAPTIC PLASTICITY; SENSORY MODULATION; NEURONAL-ACTIVITY; NEURAL ACTIVITY; TOOTH-PULP; CA1; AMYGDALA	Fear memories guide adaptive behavior in contexts associated with aversive events. The hippocampus forms a neural representation of the context that predicts aversive events. Representations of context incorporate multisensory features of the environment, but must somehow exclude sensory features of the aversive event itself. We investigated this selectivity using cell type-specific imaging and inactivation in hippocampal area CA1 of behaving mice. Aversive stimuli activated CA1 dendrite-targeting interneurons via cholinergic input, leading to inhibition of pyramidal cell distal dendrites receiving aversive sensory excitation from the entorhinal cortex. Inactivating dendrite-targeting interneurons during aversive stimuli increased CA1 pyramidal cell population responses and prevented fear learning. We propose subcortical activation of dendritic inhibition as a mechanism for exclusion of aversive stimuli from hippocampal contextual representations during fear learning.	[Lovett-Barron, Matthew; Kaifosh, Patrick; Danielson, Nathan; Zaremba, Jeffrey D.; Reardon, Thomas R.; Hen, Rene; Losonczy, Attila] Columbia Univ, Doctoral Program Neurobiol & Behav, New York, NY 10027 USA; [Lovett-Barron, Matthew; Kaifosh, Patrick; Kheirbek, Mazen A.; Danielson, Nathan; Zaremba, Jeffrey D.; Reardon, Thomas R.; Turi, Gergely F.; Hen, Rene; Losonczy, Attila] Columbia Univ, Dept Neurosci, New York, NY USA; [Kheirbek, Mazen A.; Hen, Rene] New York State Psychiat Inst & Hosp, Div Integrat Neurosci, New York, NY 10032 USA; [Zemelman, Boris V.] Univ Texas Austin, Ctr Learning & Memory, Austin, TX 78712 USA; [Losonczy, Attila] Columbia Univ, Kavli Inst Brain Sci, New York, NY USA	Columbia University; Columbia University; New York State Psychiatry Institute; University of Texas System; University of Texas Austin; Columbia University	Losonczy, A (corresponding author), Columbia Univ, Doctoral Program Neurobiol & Behav, New York, NY 10027 USA.	al2856@columbia.edu	Turi, Gergely/E-7631-2013; Kheirbek, Mazen A/J-3656-2015; Turi, Gergely/G-5054-2019	Kheirbek, Mazen A/0000-0001-9157-7363; Turi, Gergely/0000-0001-5651-9459; Zemelman, Boris/0000-0003-2463-4887; Zaremba, Jeffrey/0000-0001-6531-5474; Danielson, Nathan/0000-0002-5946-872X; Kaifosh, Patrick/0000-0002-1470-5701; Lovett-Barron, Matthew/0000-0003-1425-5277	Canadian Natural Sciences and Engineering Research Council; NIMH [K01MH099371]; Sackler Institute; NARSAD; NIH [R37 MH068542]; NIA [R01 AG043688]; New York State Stem Cell Science; Hope for Depression Research Foundation; Human Frontier Science Program; Searle Scholars Program; McKnight Memory and Cognitive Disorders Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH099371, R37MH068542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG043688] Funding Source: NIH RePORTER	Canadian Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Sackler Institute; NARSAD(NARSAD); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); New York State Stem Cell Science; Hope for Depression Research Foundation; Human Frontier Science Program(Human Frontier Science Program); Searle Scholars Program; McKnight Memory and Cognitive Disorders Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Sternson and P. Lee for proving PSEM<SUP>89</SUP>, A. Castro for programming assistance, E. Balough and M. Cloidt for scoring freezing, R. Field for preparing brain slices, J. Tsai for assistance with histology, T. Machado for assistance with ChAT-cre mice, W. Fischler for assistance with odor stimuli, and C. Lacefield for assistance with behavioral apparatus. M.L.-B. was supported by an Canadian Natural Sciences and Engineering Research Council postgraduate scholarship. P. K. is an Howard Hughes Medical Institute International Predoctoral Fellow. M. A. K. is supported by NIMH K01MH099371, the Sackler Institute, and a NARSAD Young Investigator Award. R. H. is supported by NIH R37 MH068542, NIA R01 AG043688, New York State Stem Cell Science, and the Hope for Depression Research Foundation. B.V.Z. is supported by the Human Frontier Science Program. A. L. is supported by the Searle Scholars Program, the Human Frontier Science Program, and the McKnight Memory and Cognitive Disorders Award.	Ahmed OJ, 2009, TRENDS NEUROSCI, V32, P329, DOI 10.1016/j.tins.2009.01.009; Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Anagnostaras SG, 2001, HIPPOCAMPUS, V11, P8; Bargmann CI, 2012, BIOESSAYS, V34, P458, DOI 10.1002/bies.201100185; BOUTON ME, 1980, ANIM LEARN BEHAV, V8, P429, DOI 10.3758/BF03199629; BRANKACK J, 1986, BRAIN RES, V378, P303, DOI 10.1016/0006-8993(86)90933-9; Burwell RD, 1998, J COMP NEUROL, V398, P179, DOI 10.1002/(SICI)1096-9861(19980824)398:2<179::AID-CNE3>3.0.CO;2-Y; Calandreau L, 2007, LEARN MEMORY, V14, P422, DOI 10.1101/lm.531407; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Dasari S, 2011, J NEUROPHYSIOL, V105, P779, DOI 10.1152/jn.00686.2010; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Dudman JT, 2007, NEURON, V56, P866, DOI 10.1016/j.neuron.2007.10.020; FANSELOW MS, 1993, J EXP PSYCHOL ANIM B, V19, P121, DOI 10.1037/0097-7403.19.2.121; Fanselow MS, 2005, ANNU REV PSYCHOL, V56, P207, DOI 10.1146/annurev.psych.56.091103.070213; FANSELOW MS, 1986, LEARN MOTIV, V17, P16, DOI 10.1016/0023-9690(86)90018-4; FANSELOW MS, 1990, ANIM LEARN BEHAV, V18, P264, DOI 10.3758/BF03205285; Frankland PW, 2004, HIPPOCAMPUS, V14, P557, DOI 10.1002/hipo.10208; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Funahashi M, 1999, BRAIN RES, V827, P215, DOI 10.1016/S0006-8993(99)01250-0; Gale GD, 2001, HIPPOCAMPUS, V11, P371, DOI 10.1002/hipo.1051.abs; Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854; Goshen I, 2011, CELL, V147, P678, DOI 10.1016/j.cell.2011.09.033; Hargreaves EL, 2005, SCIENCE, V308, P1792, DOI 10.1126/science.1110449; Harris KD, 2001, NEURON, V32, P141, DOI 10.1016/S0896-6273(01)00447-0; Hasselmo ME, 2006, CURR OPIN NEUROBIOL, V16, P710, DOI 10.1016/j.conb.2006.09.002; HERRERAS O, 1988, BRAIN RES, V461, P303, DOI 10.1016/0006-8993(88)90260-0; HERRERAS O, 1988, BRAIN RES, V461, P290, DOI 10.1016/0006-8993(88)90259-4; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Kaifosh P, 2013, NAT NEUROSCI, V16, P1182, DOI 10.1038/nn.3482; Kesner RP, 2007, LEARN MEMORY, V14, P771, DOI 10.1101/lm.688207; Khanna S, 1997, NEUROSCIENCE, V77, P713, DOI 10.1016/S0306-4522(96)00456-3; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Klausberger T, 2008, SCIENCE, V321, P53, DOI 10.1126/science.1149381; Lanuza E, 2004, NEUROSCIENCE, V125, P305, DOI 10.1016/j.neuroscience.2003.12.034; Lawrence JJ, 2006, J PHYSIOL-LONDON, V570, P595, DOI 10.1113/jphysiol.2005.100875; Leao RN, 2012, NAT NEUROSCI, V15, P1524, DOI 10.1038/nn.3235; Letzkus JJ, 2011, NATURE, V480, P331, DOI 10.1038/nature10674; Losonczy A, 2010, NAT NEUROSCI, V13, P967, DOI 10.1038/nn.2597; Lovett-Barron M, 2012, NAT NEUROSCI, V15, P423, DOI 10.1038/nn.3024; Magnus CJ, 2011, SCIENCE, V333, P1292, DOI 10.1126/science.1206606; MAHONEY WJ, 1976, ANIM LEARN BEHAV, V4, P357, DOI 10.3758/BF03214421; MAREN S, 1995, J NEUROSCI, V15, P7548; Maren S, 1997, NEUROBIOL LEARN MEM, V67, P142, DOI 10.1006/nlme.1996.3752; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Melzer S, 2012, SCIENCE, V335, P1506, DOI 10.1126/science.1217139; MILLER SW, 1977, PHYSIOL BEHAV, V18, P141; Moita MAP, 2004, J NEUROSCI, V24, P7015, DOI 10.1523/JNEUROSCI.5492-03.2004; Murray AJ, 2011, NAT NEUROSCI, V14, P297, DOI 10.1038/nn.2751; Palmer L, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00026; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; ROMANSKI LM, 1993, CEREB CORTEX, V3, P515, DOI 10.1093/cercor/3.6.515; Royer S, 2012, NAT NEUROSCI, V15, P769, DOI 10.1038/nn.3077; Rudy JW, 2004, NEUROSCI BIOBEHAV R, V28, P675, DOI 10.1016/j.neubiorev.2004.09.004; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Takahashi H, 2009, NEURON, V62, P102, DOI 10.1016/j.neuron.2009.03.007; Vinogradova OS, 2001, HIPPOCAMPUS, V11, P578, DOI 10.1002/hipo.1073; Widmer H, 2006, HIPPOCAMPUS, V16, P617, DOI 10.1002/hipo.20191; Xu W, 2012, NEURON, V73, P990, DOI 10.1016/j.neuron.2011.12.036; YOUNG SL, 1994, BEHAV NEUROSCI, V108, P19, DOI 10.1037/0735-7044.108.1.19; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhang SJ, 2013, SCIENCE, V340, P44, DOI 10.1126/science.1232627; Zheng F, 2001, NEUROSCIENCE, V103, P985, DOI 10.1016/S0306-4522(01)00006-9	63	288	288	6	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 21	2014	343	6173					857	863		10.1126/science.1247485	http://dx.doi.org/10.1126/science.1247485			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB1LG	24558155	Green Accepted			2022-12-28	WOS:000331552600039
J	Payne, JL; Wagner, A				Payne, Joshua L.; Wagner, Andreas			The Robustness and Evolvability of Transcription Factor Binding Sites	SCIENCE			English	Article							EVOLUTION; SELECTION; ENHANCER; REVEALS	Robustness, the maintenance of a character in the presence of genetic change, can help preserve adaptive traits but also may hinder evolvability, the ability to bring forth novel adaptations. We used genotype networks to analyze the binding site repertoires of 193 transcription factors from mice and yeast, providing empirical evidence that robustness and evolvability need not be conflicting properties. Network vertices represent binding sites where two sites are connected if they differ in a single nucleotide. We show that the binding sites of larger genotype networks are not only more robust, but the sequences adjacent to such networks can also bind more transcription factors, thus demonstrating that robustness can facilitate evolvability.	[Payne, Joshua L.; Wagner, Andreas] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Payne, Joshua L.; Wagner, Andreas] Swiss Inst Bioinformat, Lausanne, Switzerland; [Wagner, Andreas] Santa Fe Inst, Santa Fe, NM 87501 USA	University of Zurich; Swiss Institute of Bioinformatics; The Santa Fe Institute	Wagner, A (corresponding author), Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland.	andreas.wagner@ieu.uzh.ch		Payne, Joshua/0000-0002-2978-8423	International Research Fellowship Program of the NSF; Swiss National Science Foundation [315230-129708]; University Priority Research Program in Evolutionary Biology at the University of Zurich	International Research Fellowship Program of the NSF; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); University Priority Research Program in Evolutionary Biology at the University of Zurich	We thank A. Barve, D. Pechenick, J. Aguilar-Rodriguez, K. Sprouffske, and D. Urbach for discussions. J. L. P. acknowledges support from the International Research Fellowship Program of the NSF. A. W. acknowledges support through Swiss National Science Foundation grant 315230-129708 and the University Priority Research Program in Evolutionary Biology at the University of Zurich. Database S1 is available as supplementary material on Science Online.	Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Ciliberti S, 2007, P NATL ACAD SCI USA, V104, P13591, DOI 10.1073/pnas.0705396104; Cotterell J, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.74; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Guerreiro I, 2013, P NATL ACAD SCI USA, V110, P10682, DOI 10.1073/pnas.1300592110; Guet CC, 2002, SCIENCE, V296, P1466, DOI 10.1126/science.1067407; Ihmels J, 2005, SCIENCE, V309, P938, DOI 10.1126/science.1113833; Kimura-Yoshida C, 2007, P NATL ACAD SCI USA, V104, P5919, DOI 10.1073/pnas.0607779104; Kwasnieski JC, 2012, P NATL ACAD SCI USA, V109, P19498, DOI 10.1073/pnas.1210678109; Ludwig MZ, 2000, NATURE, V403, P564, DOI 10.1038/35000615; Maerkl SJ, 2007, SCIENCE, V315, P233, DOI 10.1126/science.1131007; Patwardhan RP, 2012, NAT BIOTECHNOL, V30, P265, DOI 10.1038/nbt.2136; Schaerli Y, 2013, MOL BIOSYST, V9, P1559, DOI 10.1039/c2mb25483b; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; SCHUSTER P, 1994, P ROY SOC B-BIOL SCI, V255, P279, DOI 10.1098/rspb.1994.0040; Stewart AJ, 2012, GENETICS, V192, P973, DOI 10.1534/genetics.112.143370; Tuch BB, 2008, PLOS BIOL, V6, P352, DOI 10.1371/journal.pbio.0060038; Wagner A, 2008, P ROY SOC B-BIOL SCI, V275, P91, DOI 10.1098/rspb.2007.1137; Wagner A, 2012, P ROY SOC B-BIOL SCI, V279, P1249, DOI 10.1098/rspb.2011.2293; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108	22	95	95	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 21	2014	343	6173					875	877		10.1126/science.1249046	http://dx.doi.org/10.1126/science.1249046			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB1LG	24558158				2022-12-28	WOS:000331552600043
J	Hanauer, DA; Zheng, K; Singer, DC; Gebremariam, A; Davis, MM				Hanauer, David A.; Zheng, Kai; Singer, Dianne C.; Gebremariam, Achamyeleh; Davis, Matthew M.			Public Awareness, Perception, and Use of Online Physician Rating Sites	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Hanauer, David A.] Univ Michigan, Sch Med, Dept Pediat, Ann Arbor, MI 48109 USA; [Zheng, Kai] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Singer, Dianne C.; Gebremariam, Achamyeleh] Univ Michigan Hlth Syst, Child Hlth Evaluat & Res Unit, Ann Arbor, MI USA; [Davis, Matthew M.] Univ Michigan, Inst Healthcare Policy & Innovat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Hanauer, DA (corresponding author), Univ Michigan, Sch Med, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	hanauer@med.umich.edu						Emmert M, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2702; Galizzi MM, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001493; Gao GG, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.2003; Lagu T, 2010, J GEN INTERN MED, V25, P942, DOI 10.1007/s11606-010-1383-0; Lopez A, 2012, J GEN INTERN MED, V27, P685, DOI 10.1007/s11606-011-1958-4; The Kaiser Family Foundation, 2008 UPD CONS VIEWS	6	233	233	1	28	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 19	2014	311	7					734	735		10.1001/jama.2013.283194	http://dx.doi.org/10.1001/jama.2013.283194			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AA8ZO	24549555	Bronze			2022-12-28	WOS:000331383700027
J	Thien, F				Thien, Francis			Review: Spacers and nebulizers for delivery of beta(2)-agonists do not differ for clinical outcomes in acute asthma	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							INHALED ALBUTEROL; MEDICATION		[Thien, Francis] Monash Univ, Melbourne, Vic 3004, Australia; [Thien, Francis] Eastern Hlth, Melbourne, Vic, Australia	Monash University	Thien, F (corresponding author), Monash Univ, Melbourne, Vic 3004, Australia.				Garfield Weston Foundation, UK; Canadian Institutes of Health Research	Garfield Weston Foundation, UK; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Garfield Weston Foundation, UK and Canadian Institutes of Health Research.	Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Blake K, 2008, CHEST, V134, P981, DOI 10.1378/chest.07-2991; Mazhar SHR, 2008, BRIT J CLIN PHARMACO, V65, P334, DOI 10.1111/j.1365-2125.2007.03036.x; Rottier BL, 2013, PAEDIATR RESPIR REV, V14, P112, DOI 10.1016/j.prrv.2013.02.013; Salyer JW, 2008, RESP CARE, V53, P338; Selroos O, 1996, CLIN IMMUNOTHER, V6, P273, DOI 10.1007/BF03259089	6	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 18	2014	160	4							JC9	10.7326/0003-4819-160-4-201402180-02009	http://dx.doi.org/10.7326/0003-4819-160-4-201402180-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC8RF	24534943				2022-12-28	WOS:000350635100008
J	Licht, SD; Winther, JF; Gudmundsdottir, T; Holmqvist, AS; Bonnesen, TG; Asdahl, PH; Tryggvadottir, L; Anderson, H; Wesenberg, F; Malila, N; Holm, K; Hasle, H; Olsen, JH				Licht, Sofie de Fine; Winther, Jeanette Falck; Gudmundsdottir, Thorgerdur; Holmqvist, Anna Sallfors; Bonnesen, Trine Gade; Asdahl, Peter Haubjerg; Tryggvadottir, Laufey; Anderson, Harald; Wesenberg, Finn; Malila, Nea; Holm, Kirsten; Hasle, Henrik; Olsen, Jorgen Helge		ALiCCS Study Grp	Hospital contacts for endocrine disorders in Adult Life after Childhood Cancer in Scandinavia (ALiCCS): a population-based cohort study	LANCET			English	Article							SURVIVORS; RADIATION; MENARCHE; THERAPY; TUMORS	Background The pattern of endocrine disorders in long-term survivors of childhood cancer has not been investigated comprehensively. Here, we aimed to assess the lifetime risk of these disorders in Nordic survivors of childhood cancer. Methods From the national cancer registries of Denmark, Finland, Iceland, Norway, and Sweden, we identified 31 723 1-year survivors of childhood cancer, notified since the start of registration in the 1940s and 1950s. From the national population registries, we randomly selected a comparison cohort of people matched by age, sex, and country. Study participants were linked to the national hospital registries, and observed numbers of first-time hospital contacts for endocrine disorders in survivors of childhood cancer were compared with the expected numbers derived from the population comparison cohort. We calculated the absolute excess risks attributable to status as a childhood cancer survivor and standardised hospitalisation rate ratios (SHRRs). Findings Of the childhood cancer survivors, 3292 had contact with a hospital for an endocrine disorder, yielding a SHRR of 4.8 (95% CI 4.6-5.0); the highest risks were in survivors of leukaemia (SHRR 7.3 [ 95% CI 6.7-7.9]), CNS tumours (6.6 [6.2-7.0]), and Hodgkin's lymphoma (6.2 [5.6-7.0]). The absolute excess risk for endocrine disorders was roughly 1000 per 100 000 person-years before 20 years of age, and 400 per 100 000 person-years during the remaining lifetime. For children with cancer diagnosed at 5-9 years of age, the cumulative risk for endocrine disorders was highest, and reached 43% at the age of 60 years. Diagnoses of pituitary hypofunction (SHRR 88.0), hypothyroidism (9.9), and testicular and ovarian dysfunction (42.5 and 4.7, respectively) together constituted 61% (655 of 1078) of all excess disease-induced and treatment-induced endocrine disorders in survivors of childhood cancer. Interpretation A cumulative risk for endocrine disorders at 60 years of age of above 40% in survivors of childhood cancer emphasises the importance of minimisation of damaging treatment, intensification of secondary prevention, and targeting of survivor follow-up throughout life. Since most long-term childhood cancer survivors are not followed in a specialised late-effect clinic, they are a growing challenge for the primary care physician and medical specialists working outside the late-effect area.	[Licht, Sofie de Fine; Winther, Jeanette Falck; Gudmundsdottir, Thorgerdur; Olsen, Jorgen Helge] Danish Canc Soc, Res Ctr, DK-2100 Copenhagen, Denmark; [Holmqvist, Anna Sallfors] Skane Univ Hosp, Div Paediat Oncol & Haematol, Lund, Sweden; [Holmqvist, Anna Sallfors] Lund Univ, Dept Clin Sci, Lund, Sweden; [Anderson, Harald] Lund Univ, Dept Canc Epidemiol, Lund, Sweden; [Bonnesen, Trine Gade; Asdahl, Peter Haubjerg; Hasle, Henrik] Aarhus Univ Hosp, Dept Paediat, DK-8000 Aarhus, Denmark; [Tryggvadottir, Laufey] Iceland Canc Registry, Reykjavik, Iceland; [Tryggvadottir, Laufey] Univ Iceland, Fac Med, Reykjavik, Iceland; [Wesenberg, Finn] Oslo Univ Hosp, Dept Paediat, Oslo, Norway; [Wesenberg, Finn] Univ Oslo, Fac Med, Oslo, Norway; [Wesenberg, Finn] Norwegian Canc Registry, Oslo, Norway; [Malila, Nea] Finnish Canc Registry, FIN-00170 Helsinki, Finland; [Holm, Kirsten] Hilleroed Hosp, Dept Paediat, Hillerod, Denmark	Danish Cancer Society; Lund University; Skane University Hospital; Lund University; Lund University; Aarhus University; University of Iceland; University of Oslo; University of Oslo; Finnish Cancer Registry; University of Copenhagen	Licht, SD (corresponding author), Danish Canc Soc, Res Ctr, Survivorship Unit, Strandboulevarden 49, DK-2100 Copenhagen, Denmark.	sofielie@cancer.dk	Winther, Jeanette Falck/AAS-2754-2020	Winther, Jeanette Falck/0000-0002-3440-5108; Hasle, Henrik/0000-0003-3976-9231; de Fine Licht, Sofie/0000-0001-7855-4706; Tryggvadottir, Laufey/0000-0001-8067-9030; Olsen, Jorgen Helge/0000-0001-9633-5662; Asdahl, Peter Haubjerg/0000-0002-5604-8578	Danish Council for Strategic Research [09-066899]	Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	This study was funded by grant 09-066899 from the Danish Council for Strategic Research. We thank Andrea Bautz for her contribution to data management, Lasse Wegener Lund for helpful comments, and the ALiCCS board (Jorgen H Olsen, Finn Wesenberg, Catherine Rechnitzer, Kirsi Jahnukainen, Lars Hjorth, and Nea Malila), three of whom were coauthors, for their valuable help and guidance.	Armstrong GT, 2009, CANCER, V115, P2562, DOI 10.1002/cncr.24294; BIRCH JM, 1987, INT J CANCER, V40, P620, DOI 10.1002/ijc.2910400508; Brabant G, 2012, INT J CANCER, V130, P1145, DOI 10.1002/ijc.26086; BROWN PD, 1995, ACTA PAEDIATR, V84, P316, DOI 10.1111/j.1651-2227.1995.tb13636.x; Chow EJ, 2008, PEDIATR BLOOD CANCER, V50, P854, DOI 10.1002/pbc.21316; CONSTINE LS, 1993, NEW ENGL J MED, V328, P87, DOI 10.1056/NEJM199301143280203; Gatta G, 2009, EUR J CANCER, V45, P992, DOI 10.1016/j.ejca.2008.11.042; Gjerstorff ML, 2011, SCAND J PUBLIC HEALT, V39, P42, DOI 10.1177/1403494810393562; Green DM, 2009, J CLIN ONCOL, V27, P2374, DOI 10.1200/JCO.2008.21.1839; Gurney JG, 2003, CANCER-AM CANCER SOC, V97, P663, DOI 10.1002/cncr.11095; HORNING SJ, 1981, NEW ENGL J MED, V304, P1377, DOI 10.1056/NEJM198106043042301; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Meacham Lillian, 2003, Curr Probl Pediatr Adolesc Health Care, V33, P217, DOI 10.1016/S1538-5442(03)00053-1; Nandagopal R, 2008, HORM RES, V69, P65, DOI 10.1159/000111809; Oberfield SE, 1996, ARCH PEDIAT ADOL MED, V150, P589, DOI 10.1001/archpedi.1996.02170310023003; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Punyko JA, 2005, PEDIATR BLOOD CANCER, V44, P643, DOI 10.1002/pbc.20310; Robison LL, 2009, J CLIN ONCOL, V27, P2308, DOI 10.1200/JCO.2009.22.3339; Robison LL, 2002, MED PEDIATR ONCOL, V38, P229, DOI 10.1002/mpo.1316; SHALET SM, 1976, CANCER, V37, P1144, DOI 10.1002/1097-0142(197602)37:2+<1144::AID-CNCR2820370824>3.0.CO;2-U; Sigurdardottir LG, 2012, ACTA ONCOL, V51, P880, DOI 10.3109/0284186X.2012.698751; Sklar C, 2000, J CLIN ENDOCR METAB, V85, P3227, DOI 10.1210/jc.85.9.3227; Teinturier C, 1998, BONE MARROW TRANSPL, V22, P989, DOI 10.1038/sj.bmt.1701483; Tulinius H, 1992, APMIS Suppl, V31, P1	25	54	55	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 7	2014	383	9933					1981	1989		10.1016/S0140-6736(13)62564-7	http://dx.doi.org/10.1016/S0140-6736(13)62564-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI4PV	24556022				2022-12-28	WOS:000336848200026
J	Levin, M; Burgner, D				Levin, Michael; Burgner, David			Treatment of Kawasaki disease with anti-TNF antibodies	LANCET			English	Editorial Material							GAMMA		[Levin, Michael] Univ London Imperial Coll Sci Technol & Med, Fac Med, Paediat Sect, London W2 1PG, England; [Burgner, David] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Burgner, David] Univ Melbourne, Melbourne, Vic 3010, Australia; [Burgner, David] Monash Childrens Hosp, Melbourne, Vic, Australia	Imperial College London; Murdoch Children's Research Institute; University of Melbourne	Levin, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Paediat Sect, London W2 1PG, England.	m.levin@imperial.ac.uk		Burgner, David/0000-0002-8304-4302; Levin, Michael/0000-0003-2767-6919	National Institute for Health Research [NF-SI-0611-10230] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Burns JC, 2008, J PEDIATR-US, V153, P833, DOI 10.1016/j.jpeds.2008.06.011; Eleftheriou D, 2014, ARCH DIS CHILD, V99, P74, DOI 10.1136/archdischild-2012-302841; Hirono K, 2009, PEDIATR RES, V65, P696, DOI 10.1203/01.pdr.0000352115.41382.65; Kobayashi T, 2006, CIRCULATION, V113, P2606, DOI 10.1161/CIRCULATIONAHA.105.592865; Kobayashi T, 2012, LANCET, V379, P1613, DOI 10.1016/S0140-6736(11)61930-2; MATSUBARA T, 1990, CLIN IMMUNOL IMMUNOP, V56, P29, DOI 10.1016/0090-1229(90)90166-N; NEWBURGER JW, 1991, NEW ENGL J MED, V324, P1633, DOI 10.1056/NEJM199106063242305; Rodo X, 2011, SCI REP-UK, V1, DOI 10.1038/srep00152; Sleeper LA, 2011, J PEDIATR-US, V158, P831, DOI 10.1016/j.jpeds.2010.10.031; Suda K, 2011, CIRCULATION, V123, P1836, DOI 10.1161/CIRCULATIONAHA.110.978213; Takahashi K, 2011, CLIN EXP IMMUNOL, V164, P20, DOI 10.1111/j.1365-2249.2011.04361.x; Tremoulet AH, 2014, LANCET; Uehara R, 2008, PEDIATR INFECT DIS J, V27, P155, DOI 10.1097/INF.0b013e31815922b5	13	6	8	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 17	2014	383	9930					1700	1703		10.1016/S0140-6736(14)60131-8	http://dx.doi.org/10.1016/S0140-6736(14)60131-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH6UO	24572998				2022-12-28	WOS:000336267300007
J	Peisley, A; Wu, B; Xu, H; Chen, ZJJ; Hur, S				Peisley, Alys; Wu, Bin; Xu, Hui; Chen, Zhijian J.; Hur, Sun			Structural basis for ubiquitin-mediated antiviral signal activation by RIG-I	NATURE			English	Article							RNA RECOGNITION; PROTEIN; OLIGOMERIZATION; SEQUENCE; REVEALS; COMPLEX; SENSORS; MAVS	Ubiquitin (Ub) has important roles in a wide range of intracellular signalling pathways. In the conventional view, ubiquitin alters the signalling activity of the target protein through covalent modification, but accumulating evidence points to the emerging role of noncovalent interaction between ubiquitin and the target. In the innate immune signalling pathway of a viral RNA sensor, RIG-I, both covalent and non-covalent interactions with K63-linked ubiquitin chains (K63-Ub(n)) were shown to occur in its signalling domain, a tandem caspase activation and recruitment domain (hereafter referred to as 2CARD)(1,2). Non-covalent binding of K63-Ub(n) to 2CARD induces its tetramer formation, a requirement for downstream signal activation(3). Here we report the crystal structure of the tetramer of human RIG-I 2CARD bound by three chains of K63-Ub(2). 2CARD assembles into a helical tetramer resembling a 'lock-washer', in which the tetrameric surface serves as a signalling platform for recruitment and activation of the downstream signalling molecule, MAVS. Ubiquitin chains are bound along the outer rim of the helical trajectory, bridging adjacent subunits of 2CARD and stabilizing the 2CARD tetramer. The combination of structural and functional analyses reveals that binding avidity dictates the K63-linkage and chain-length specificity of 2CARD, and that covalent ubiquitin conjugation of 2CARD further stabilizes the Ub-2CARD interaction and thus the 2CARD tetramer. Our work provides unique insights into the novel types of ubiquitin-mediated signal-activation mechanism, and previously unexpected synergism between the covalent and non-covalent ubiquitin interaction modes.	[Peisley, Alys; Wu, Bin; Hur, Sun] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Peisley, Alys; Wu, Bin; Hur, Sun] Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Xu, Hui; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Chen, Zhijian J.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute	Hur, S (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	Sun.Hur@childrens.harvard.edu	Chen, Zhijian/C-6039-2012; Wu, Bin/C-4715-2015	Chen, Zhijian/0000-0002-8475-8251; Wu, Bin/0000-0002-0883-8006; Peisley, Alys/0000-0002-8999-5440	GSK; Welch Foundation [I-1389]; NIH [R01-GM63692]; Pew Scholarship; BCH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063692] Funding Source: NIH RePORTER	GSK(GlaxoSmithKline); Welch Foundation(The Welch Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholarship; BCH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Meigs at ALS BL 8.3.1 for data collection, and H. Wu and M. Eck for comments on the manuscript. This work was supported by GSK fellowship (B. W.), The Welch Foundation (I-1389; Z.J.C.), NIH (R01-GM63692; Z.J.C), Pew Scholarship (S. H.) and Career Development Award from BCH (S. H.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andreani J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002677; Antos JM, 2009, J AM CHEM SOC, V131, P10800, DOI 10.1021/ja902681k; Braberg H, 2012, BIOINFORMATICS, V28, P2072, DOI 10.1093/bioinformatics/bts302; Caffrey DR, 2004, PROTEIN SCI, V13, P190, DOI 10.1110/ps.03323604; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dong KC, 2011, STRUCTURE, V19, P1053, DOI 10.1016/j.str.2011.06.010; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferrao R, 2012, CURR OPIN STRUC BIOL, V22, P241, DOI 10.1016/j.sbi.2012.02.006; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Jiang FG, 2011, NATURE, V479, P423, DOI 10.1038/nature10537; Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kato H, 2011, IMMUNOL REV, V243, P91, DOI 10.1111/j.1600-065X.2011.01052.x; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Luo DH, 2011, CELL, V147, P409, DOI 10.1016/j.cell.2011.09.023; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Park HH, 2007, CELL, V128, P533, DOI 10.1016/j.cell.2007.01.019; Patel JR, 2013, EMBO REP, V14, P780, DOI 10.1038/embor.2013.102; Peisley A, 2013, MOL CELL, V51, P573, DOI 10.1016/j.molcel.2013.07.024; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Wang LW, 2010, NAT STRUCT MOL BIOL, V17, P1324, DOI 10.1038/nsmb.1920; Wu B, 2013, CELL, V152, P276, DOI 10.1016/j.cell.2012.11.048; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029	30	231	234	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 1	2014	509	7498					110	+		10.1038/nature13140	http://dx.doi.org/10.1038/nature13140			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG1TM	24590070	Green Accepted			2022-12-28	WOS:000335199100049
J	McCay, AS; Elliott, EC; Walden, M				McCay, Amy S.; Elliott, Elizabeth C.; Walden, Marlene			PICC Placement in the Neonate	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Long-term vascular access is often required in neonatal patients for the delivery of life-sustaining medications and nutrition. This video demonstrates the placement of a peripherally inserted central catheter (PICC) in a neonate. Long-term vascular access is often required in neonatal patients for the delivery of life-sustaining medications and nutrition. This video demonstrates the placement of a peripherally inserted central catheter (PICC) in a neonate.	[McCay, Amy S.; Elliott, Elizabeth C.; Walden, Marlene] Texas Childrens Hosp, Houston, TX 77030 USA	Baylor College of Medicine	McCay, AS (corresponding author), Texas Childrens Hosp, 6621 Fannin St, Houston, TX 77030 USA.	asmccay@comcast.net						Amer Acad Pediat, 2007, PEDIATRICS, V119, P425, DOI 10.1542/peds.2006-2277; Amer Acad Pediat, 2006, PEDIATRICS, V118, P2231, DOI 10.1542/peds.2006-2277; Coit Alison Kirse, 2005, J Perinatol, V25, P674, DOI 10.1038/sj.jp.7211363; Intravenous Nurses Society, 1997, J INTRAVEN NURS, V20, P175; Nadroo A M, 2001, J Perinatol, V21, P465; Nowlen TT, 2002, PEDIATRICS, V110, P137, DOI 10.1542/peds.110.1.137; Pettit J, 2007, PERIPHERALLY INSERTE; Rothschild JM., 2001, MAKING HEALTHCARE SA, P245; Sengupta A, 2010, PEDIATRICS, V125, P648, DOI 10.1542/peds.2009-2559; Trotter CW, 2009, NEONATAL NETW, V28, P179, DOI 10.1891/0730-0832.28.3.179	10	22	22	2	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 13	2014	370	11							e17	10.1056/NEJMvcm1101914	http://dx.doi.org/10.1056/NEJMvcm1101914			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC7ED	24620893				2022-12-28	WOS:000332689100001
J	Olveczky, BP				Oelveczky, Bence P.			NEUROSCIENCE Ordered randomness in fly love songs	NATURE			English	Editorial Material							DROSOPHILA-MELANOGASTER; COURTSHIP BEHAVIOR	A systematic and painstaking analysis reveals that much of the complexity and variability of the courtship song of male fruit flies can be accounted for by simple rules that relate sensory experience to motor output. SEE LETTER P.233	Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University	Olveczky, BP (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	olveczky@fas.harvard.edu		Olveczky, Bence/0000-0003-2499-2705				Censi A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002891; Coen P, 2014, NATURE, V507, P233, DOI 10.1038/nature13131; Destexhe A, 2012, SPR SER COMPUT NEURO, V8, P1, DOI 10.1007/978-0-387-79020-6; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; HALL JC, 1978, BEHAV GENET, V8, P125, DOI 10.1007/BF01066870; Katz Y, 2011, P NATL ACAD SCI USA, V108, P18720, DOI 10.1073/pnas.1107583108; Rideout EJ, 2010, NAT NEUROSCI, V13, P458, DOI 10.1038/nn.2515; SPIETH HT, 1974, ANNU REV ENTOMOL, V19, P385, DOI 10.1146/annurev.en.19.010174.002125; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Trott AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046025; Yu JY, 2010, CURR BIOL, V20, P1602, DOI 10.1016/j.cub.2010.08.025	11	1	1	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2014	507	7491					177	178		10.1038/nature13208	http://dx.doi.org/10.1038/nature13208			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC6RJ	24598540				2022-12-28	WOS:000332651800027
J	Pearson, DG; Brenker, FE; Nestola, F; McNeill, J; Nasdala, L; Hutchison, MT; Matveev, S; Mather, K; Silversmit, G; Schmitz, S; Vekemans, B; Vincze, L				Pearson, D. G.; Brenker, F. E.; Nestola, F.; McNeill, J.; Nasdala, L.; Hutchison, M. T.; Matveev, S.; Mather, K.; Silversmit, G.; Schmitz, S.; Vekemans, B.; Vincze, L.			Hydrous mantle transition zone indicated by ringwoodite included within diamond	NATURE			English	Article							MINERAL INCLUSIONS; ELECTRICAL-CONDUCTIVITY; WATER-CONTENT; WADSLEYITE; PRESSURE; OLIVINE; PHASE; IRON; GAMMA-MG2SIO4; SPECTROSCOPY	The ultimate origin of water in the Earth's hydrosphere is in the deep Earth-the mantle. Theory(1) and experiments(2-4) have shown that although the water storage capacity of olivine-dominated shallow mantle is limited, the Earth's transition zone, at depths between 410 and 660 kilometres, could be a major repository for water, owing to the ability of the higher-pressure polymorphs of olivine-wadsleyite and ringwoodite-to host enough water to comprise up to around 2.5 per cent of their weight. A hydrous transition zone may have a key role in terrestrial magmatism and plate tectonics(5-7), yet despite experimental demonstration of the water-bearing capacity of these phases, geophysical probes such as electrical conductivity have provided conflicting results(8-10), and the issue of whether the transition zone contains abundant water remains highly controversial(11). Here we report X-ray diffraction, Raman and infrared spectroscopic data that provide, to our knowledge, the first evidence for the terrestrial occurrence of any higher-pressure polymorph of olivine: we find ringwoodite included in a diamond from Juina, Brazil. The water-rich nature of this inclusion, indicated by infrared absorption, along with the preservation of the ringwoodite, is direct evidence that, at least locally, the transition zone is hydrous, to about 1 weight per cent. The finding also indicates that some kimberlites must have their primary sources in this deep mantle region.	[Pearson, D. G.; Matveev, S.] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada; [Brenker, F. E.; Schmitz, S.] Goethe Univ Frankfurt, Geosci Inst Mineral, D-60438 Frankfurt, Germany; [Nestola, F.] Univ Padua, Dipartimento Geosci, I-35137 Padua, Italy; [McNeill, J.; Mather, K.] Univ Durham, Dept Earth Sci, Durham DH1 3LE, England; [Nasdala, L.] Univ Vienna, Inst Mineral & Kristallog, A-1090 Vienna, Austria; [Hutchison, M. T.] Trigon GeoServ Ltd, Las Vegas, NV 89146 USA; [Silversmit, G.; Vekemans, B.; Vincze, L.] Univ Ghent, Dept Analyt Chem, B-9000 Ghent, Belgium	University of Alberta; Goethe University Frankfurt; University of Padua; Durham University; University of Vienna; Ghent University	Pearson, DG (corresponding author), Univ Alberta, Dept Earth & Atmospher Sci, 1-26 Earth Sci Bldg, Edmonton, AB T6G 2E3, Canada.	gdpearso@ualberta.ca	nestola, fabrizio/K-2798-2015; Pearson, Graham/AAN-5507-2020; Nestola, Fabrizio/AAZ-6783-2021; Vincze, Laszlo/AAP-3914-2020	nestola, fabrizio/0000-0002-4875-5125; Nestola, Fabrizio/0000-0002-4875-5125; Silversmit, Geert/0000-0003-1104-1839; Brenker, Frank Erich/0000-0002-9735-8206	CERC; ERC [307322]; Alfred P. Sloan Foundation	CERC; ERC(European Research Council (ERC)European Commission); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	D.G.P. acknowledges CERC funding for this study. F.N. is supported by ERC Starting Grant 307322. Support from the Alfred P. Sloan Foundation's Deep Carbon Observatory project created this research partnership. We thank T. Stachel for comments on the manuscript plus access to the FTIR instrument at the De Beers Laboratory of Diamond Research at the University of Alberta, and we thank J. Harris for discussions. Sample JUc29 was provided by Trigon GeoServices Ltd.	Agee CB, 1998, REV MINERAL, V37, P165; Baonza VG, 2003, J RAMAN SPECTROSC, V34, P264, DOI 10.1002/jrs.998; Bercovici D, 2003, NATURE, V425, P39, DOI 10.1038/nature01918; Blanchard M, 2009, AM MINERAL, V94, P83, DOI 10.2138/am.2009.3020; Bolfan-Casanova N, 2005, MINERAL MAG, V69, P229, DOI 10.1180/0026461056930248; Bolfan-Casanova N, 2000, EARTH PLANET SC LETT, V182, P209, DOI 10.1016/S0012-821X(00)00244-2; Brenker FE, 2005, EARTH PLANET SC LETT, V236, P579, DOI 10.1016/j.epsl.2005.05.021; Brenker FE, 2007, EARTH PLANET SC LETT, V260, P1, DOI 10.1016/j.epsl.2007.02.038; Bulanova GP, 2010, CONTRIB MINERAL PETR, V160, P489, DOI 10.1007/s00410-010-0490-6; Chen JH, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014429; Chen M, 2004, P NATL ACAD SCI USA, V101, P15033, DOI 10.1073/pnas.0405048101; Feng L, 2011, AM MINERAL, V96, P1480, DOI 10.2138/am.2011.3679; FINGER LW, 1993, PHYS CHEM MINER, V19, P361; FUJINO K, 1981, ACTA CRYSTALLOGR B, V37, P513, DOI 10.1107/S0567740881003506; GRIMSDITCH MH, 1978, PHYS REV B, V18, P901, DOI 10.1103/PhysRevB.18.901; Harris J, 1997, NATURE, V387, P486, DOI 10.1038/387486a0; Harte B, 2010, MINERAL MAG, V74, P189, DOI 10.1180/minmag.2010.074.2.189; Harte B., 1994, MINERAL MAG A, V58A, P384, DOI DOI 10.1180/MINMAG.1994.58A.1.201; Harte B., 1999, MANTLE PETROLOGY FIE, P125; Hayman PC, 2005, CONTRIB MINERAL PETR, V149, P430, DOI 10.1007/s00410-005-0657-8; Huang XG, 2005, NATURE, V434, P746, DOI 10.1038/nature03426; Hutchison M. T., 1999, P 7 INT KIMB C, P372; Hutchison MT, 2001, CONTRIB MINERAL PETR, V142, P119, DOI 10.1007/s004100100279; Jacobsen SD, 2004, PHYS EARTH PLANET IN, V143, P47, DOI 10.1016/j.pepi.2003.07.019; Kelbert A, 2009, NATURE, V460, P1003, DOI 10.1038/nature08257; Keppler H, 2006, REV MINERAL GEOCHEM, V62, P193, DOI 10.2138/rmg.2006.62.9; Khan A, 2012, EARTH PLANET SC LETT, V317, P27, DOI 10.1016/j.epsl.2011.11.031; Kleppe AK, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015276; Kleppe AK, 2002, PHYS CHEM MINER, V29, P473, DOI 10.1007/s00269-002-0255-5; Koch-Muller M, 2010, AM MINERAL, V95, P770, DOI 10.2138/am.2010.3358; Kohlstedt DL, 1996, CONTRIB MINERAL PETR, V123, P345, DOI 10.1007/s004100050161; Libowitzky E, 1996, PHYS CHEM MINER, V23, P319, DOI 10.1007/BF00199497; Liu L, 2002, PHYS CHEM MINER, V29, P181, DOI 10.1007/s00269-001-0219-1; Matveev S, 2007, GEOCHIM COSMOCHIM AC, V71, P5528, DOI 10.1016/j.gca.2007.08.016; Nasdala L, 2003, EUR J MINERAL, V15, P931, DOI 10.1127/0935-1221/2003/0015-0931; Ringwood A.E., 1970, PHYS EARTH PLANET IN, V3, P89, DOI DOI 10.1016/0031-9201(70)90046-4; Silversmit G, 2009, J PHYS CONF SER, V190, DOI 10.1088/1742-6596/190/1/012036; Smyth JR, 2003, AM MINERAL, V88, P1402; SMYTH JR, 1987, AM MINERAL, V72, P1051; Stachel T, 2005, ELEMENTS, V1, P73, DOI 10.2113/gselements.1.2.73; Stachel T, 2000, CONTRIB MINERAL PETR, V140, P16, DOI 10.1007/s004100000174; Tappert R, 2005, EUR J MINERAL, V17, P423, DOI 10.1127/0935-1221/2005/0017-0423; Xu YS, 1998, SCIENCE, V280, P1415, DOI 10.1126/science.280.5368.1415; YAMANAKA T, 1986, PHYS CHEM MINER, V13, P227, DOI 10.1007/BF00308273; Ye Y, 2012, AM MINERAL, V97, P573, DOI 10.2138/am.2012.4010; Yoshino T, 2008, NATURE, V451, P326, DOI 10.1038/nature06427	47	479	519	20	412	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2014	507	7491					221	+		10.1038/nature13080	http://dx.doi.org/10.1038/nature13080			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC6RJ	24622201	Green Published			2022-12-28	WOS:000332651800036
J	Lourdes, LS; Daily, KC				Lourdes, Laura S.; Daily, Karen C.			Common variable immunodeficiency syndrome in an adult	LANCET			English	Editorial Material									[Lourdes, Laura S.] Univ Florida, Dept Med, Gainesville, FL USA; [Daily, Karen C.] Univ Florida, Dept Med, Div Hematol & Oncol, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Lourdes, LS (corresponding author), 1600 SW Archer Rd,POB 100277, Gainesville, FL 32610 USA.	laura.lourdes@medicine.ufl.edu						Borish L, 2011, J ALLERGY CLIN IMMUN, V127, P541, DOI 10.1016/j.jaci.2010.11.004; Cunningham-Rundles C., 2012, HEMATOLOGY, V1, P301; Park MA, 2008, LANCET, V372, P489, DOI 10.1016/S0140-6736(08)61199-X; Raeiszadeh M, 2006, CLIN EXP IMMUNOL, V146, P234, DOI 10.1111/j.1365-2249.2006.03209.x; Salzer U, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4032	5	1	1	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 8	2014	383	9920					926	926		10.1016/S0140-6736(14)60415-3	http://dx.doi.org/10.1016/S0140-6736(14)60415-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC3FC	24607101				2022-12-28	WOS:000332399500033
J	Schmitz, RJ				Schmitz, Robert J.			The Secret Garden-Epigenetic Alleles Underlie Complex Traits	SCIENCE			English	Editorial Material							ARABIDOPSIS-THALIANA; DNA METHYLATION; MISSING HERITABILITY; PATTERNS		Univ Georgia, Dept Genet, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Schmitz, RJ (corresponding author), Univ Georgia, Dept Genet, Athens, GA 30602 USA.	schmitz@uga.edu	Schmitz, Robert/AAY-7659-2020	Schmitz, Robert/0000-0001-7538-6663				Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Becker C, 2011, NATURE, V480, P245, DOI 10.1038/nature10555; Colome-Tatche M, 2012, P NATL ACAD SCI USA, V109, P16240, DOI 10.1073/pnas.1212955109; Cortijo S, 2014, SCIENCE, V343, P1145, DOI 10.1126/science.1248127; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Johannes F, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000530; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Reinders J, 2009, GENE DEV, V23, P939, DOI 10.1101/gad.524609; Roux F, 2011, GENETICS, V188, P1015, DOI 10.1534/genetics.111.128744; Schmitz RJ, 2013, NATURE, V495, P193, DOI 10.1038/nature11968; Schmitz RJ, 2012, TRENDS PLANT SCI, V17, P149, DOI 10.1016/j.tplants.2012.01.001; Schmitz RJ, 2011, SCIENCE, V334, P369, DOI 10.1126/science.1212959; Seisenberger S, 2013, CURR OPIN CELL BIOL, V25, P281, DOI 10.1016/j.ceb.2013.02.013; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832	14	18	19	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2014	343	6175					1082	1083		10.1126/science.1251864	http://dx.doi.org/10.1126/science.1251864			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2LB	24604184				2022-12-28	WOS:000332331500028
J	Siraj, AS; Santos-Vega, M; Bouma, MJ; Yadeta, D; Carrascal, DR; Pascual, M				Siraj, A. S.; Santos-Vega, M.; Bouma, M. J.; Yadeta, D.; Ruiz Carrascal, D.; Pascual, M.			Altitudinal Changes in Malaria Incidence in Highlands of Ethiopia and Colombia	SCIENCE			English	Article							CLIMATE-CHANGE; AFRICAN HIGHLANDS; TEMPERATURE; RESURGENCE; TRANSMISSION; ASSOCIATION; EPIDEMICS; RISK; AIR	The impact of global warming on insect-borne diseases and on highland malaria in particular remains controversial. Temperature is known to influence transmission intensity through its effects on the population growth of the mosquito vector and on pathogen development within the vector. Spatiotemporal data at a regional scale in highlands of Colombia and Ethiopia supplied an opportunity to examine how the spatial distribution of the disease changes with the interannual variability of temperature. We provide evidence for an increase in the altitude of malaria distribution in warmer years, which implies that climate change will, without mitigation, result in an increase of the malaria burden in the densely populated highlands of Africa and South America.	[Siraj, A. S.] Univ Denver, Dept Geog & Environm, Denver, CO 80208 USA; [Santos-Vega, M.; Pascual, M.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Bouma, M. J.] Univ London, London Sch Hyg & Trop Med, London WC1 E7HT, England; [Yadeta, D.] Oromia Reg Hlth Bur, Addis Ababa, Ethiopia; [Ruiz Carrascal, D.] Columbia Univ City New York, Int Res Inst Climate & Soc, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Ruiz Carrascal, D.] Escuela Ingn Antioquia, Envigado, Antioquia, Colombia; [Pascual, M.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	University of Denver; University of Michigan System; University of Michigan; University of London; London School of Hygiene & Tropical Medicine; Columbia University; Howard Hughes Medical Institute	Pascual, M (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, 2019 Kraus Nat Sci Bldg,830 North Univ, Ann Arbor, MI 48109 USA.	pascual@umich.edu		Siraj, Amir/0000-0002-9275-0380; Ruiz-Carrascal, Daniel/0000-0003-0987-5017	WHO (Roll Back Malaria/WHO)	WHO (Roll Back Malaria/WHO)	We thank the Colombian National Institute of Health and the Oromia Health Bureau (Ethiopia) for supplying the malaria data reported for the Antioquia and Debre Zeit regions respectively; we also thank the Colombian Institute for Hydrology and Meteorology and the Ethiopian National Meteorological Agency for providing climate data, and the Colombian Statistical Institute and the Ethiopian Central Statistics Agency for cartographic and demographic information. We express our sincere thanks to A. Mekuria, A. Yeshiwondem, D. Dengela, A. Hailemariam, A. Woyessa, S. Chibsa, and the field and laboratory health workers in Ethiopia for their active involvement in the data collection and to the World Health Organization (WHO) Office for Ethiopia, Ministry of Health, and Center for National Health Development in Ethiopia for their technical support during the data collection. We are indebted to A. Nega Tulu for sharing the malaria data of Debre Zeit before 1993. We are also grateful to K. Ebi and R. Santiago Nicholls for their support in obtaining the pre-1990 malaria data for Anori, Colombia. The Ethiopian malaria data entry and Global Positioning System data collection were funded by a grant from WHO (Roll Back Malaria/WHO). M. P. is an investigator of the Howard Hughes Medical Institute. Data from this study can be found at the Dryad Repository (doi:10.5061/dryad.dp78p).	Abeku TA, 2003, ACTA TROP, V87, P331, DOI 10.1016/S0001-706X(03)00123-2; Alonso D, 2011, P ROY SOC B-BIOL SCI, V278, P1661, DOI 10.1098/rspb.2010.2020; [Anonymous], 2009, WORLD MAL REP 2009; Barry R. G., 1992, MOUNTAIN WEATHER CLI, P206; Bouma MJ, 2011, TRENDS PARASITOL, V27, P421, DOI 10.1016/j.pt.2011.07.003; Bouma MJ, 1997, JAMA-J AM MED ASSOC, V278, P1772, DOI 10.1001/jama.278.21.1772; Bouma MJ, 2003, T ROY SOC TROP MED H, V97, P133, DOI 10.1016/S0035-9203(03)90099-X; BOUMA MJ, 1994, LANCET, V343, P1440, DOI 10.1016/S0140-6736(94)92569-0; Bradley RS, 2006, SCIENCE, V312, P1755, DOI 10.1126/science.1128087; Chaves LF, 2010, Q REV BIOL, V85, P27, DOI 10.1086/650284; Cox J., 1999, MAPPING MALARIA RISK; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; DE ZULUETA J, 1961, East Afr Med J, V38, P1; Gething PW, 2010, NATURE, V465, P342, DOI 10.1038/nature09098; Hay SI, 2002, TRENDS PARASITOL, V18, P530, DOI 10.1016/S1471-4922(02)02374-7; Hay SI, 2002, NATURE, V415, P905, DOI 10.1038/415905a; Hirsch A, 1883, HDB GEOGRAPHICAL HIS, VI; LAVERAN A, 1893, PALUDISM; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Lindblade KA, 2000, TROP MED INT HEALTH, V5, P263, DOI 10.1046/j.1365-3156.2000.00551.x; Lindsay SW, 1998, B WORLD HEALTH ORGAN, V76, P33; Lindsay SW, 1996, ANN TROP MED PARASIT, V90, P573, DOI 10.1080/00034983.1996.11813087; LOEVINSOHN ME, 1994, LANCET, V343, P714, DOI 10.1016/S0140-6736(94)91586-5; McCarthy J.J., 2001, CLIMATE CHANGE 2001; Molineaux L., 1988, P913; Omumbo JA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-12; Otten M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-14; Pascual M, 2006, P NATL ACAD SCI USA, V103, P5829, DOI 10.1073/pnas.0508929103; Pascual M, 2009, ECOLOGY, V90, P906, DOI 10.1890/08-0730.1; Patz JA, 2006, P NATL ACAD SCI USA, V103, P5635, DOI 10.1073/pnas.0601493103; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Poveda G, 2001, ENVIRON HEALTH PERSP, V109, P489, DOI 10.2307/3454707; PRICE MF, 1994, MOUNTAIN ENV CHANGIN, P431; Ruiz D, 2012, CLIMATIC CHANGE, V112, P717, DOI 10.1007/s10584-011-0228-0; Shanks GD, 2005, EMERG INFECT DIS, V11, P1425, DOI 10.3201/eid1109.041131; Stern DI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024524; Tulu AN, 1996, T ROY SOC TROP MED H, V90, P556, DOI 10.1016/S0035-9203(96)90322-3; Zhou G, 2004, P NATL ACAD SCI USA, V101, P2375, DOI 10.1073/pnas.0308714100	38	184	187	6	164	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2014	343	6175					1154	1158		10.1126/science.1244325	http://dx.doi.org/10.1126/science.1244325			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2LB	24604201				2022-12-28	WOS:000332331500053
J	Artenstein, AW; Poland, GA				Artenstein, Andrew W.; Poland, Gregory A.			PERSPECTIVE Elimination round	NATURE			English	Editorial Material									[Artenstein, Andrew W.] Tufts Univ, Sch Med, Dept Med, Baystate Hlth, Springfield, MA 01199 USA; [Poland, Gregory A.] Mayo Clin, Vaccine Res Grp, Rochester, MN USA	Tufts University; Mayo Clinic	Artenstein, AW (corresponding author), Tufts Univ, Sch Med, Dept Med, Baystate Hlth, Springfield, MA 01199 USA.	artenstein@baystatehealth.org						Daugla DM, 2014, LANCET, V383, P40, DOI 10.1016/S0140-6736(13)61612-8; LaForce FM, 2007, VACCINE, V25, pA97, DOI 10.1016/j.vaccine.2007.04.049; Luo HM, 2013, NEW ENGL J MED, V369, P1981, DOI 10.1056/NEJMoa1303368; Mundel T, 2013, NEW ENGL J MED, V369, P2045, DOI 10.1056/NEJMe1311591; WHO, 2013, AL GLOB RESP GAR IMP	5	2	2	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					S16	S16		10.1038/507S16a	http://dx.doi.org/10.1038/507S16a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC0ZQ	24611173	Bronze			2022-12-28	WOS:000332224400008
J	Crisp, N; Chen, L				Crisp, Nigel; Chen, Lincoln			Global Supply of Health Professionals	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							WORKFORCE; EDUCATION	The world's need for and supply of health professionals are in flux. This article reviews the supply in relation to the demand for physicians and nurses around the world. There is a global crisis of severe shortages and marked maldistribution of health professionals that is exacerbated by three great global transitions demographic changes, epidemiologic shifts, and redistribution of the disability burden. Each of these transitions exerts a powerful force for change in health care systems, the roles of health professionals, and the design of health professional education.(1)-(5) Every country will have to respond to these global pressures for change. There are many other reasons that it is important to think globally about the education and role of health professionals.(6) The knowledge base of the profession is global ...	[Crisp, Nigel] House Lords, London SW1A 0PW, England; [Chen, Lincoln] China Med Board, Cambridge, MA USA		Crisp, N (corresponding author), House Lords, Parliament Sq, London SW1A 0PW, England.			Galbraith, Kirsten/0000-0003-1703-8307; Crisp, Nigel/0000-0002-9452-095X				Africa All-Party Parliamentary Group, 2012, NEW ROLES BETTER TEA; [Anonymous], 2012, PROGR REP 2012; [Anonymous], 2002, EXTERNAL EVALUATION; [Anonymous], 2004, HUM RES HLTH OV CRIS; Belatchew M., 2011, RETAINING COMMUNITY; Bjorkman M, 2009, Q J ECON, V124, P735, DOI 10.1162/qjec.2009.124.2.735; Buerhaus PI, 2009, HEALTH AFFAIR, V28, pW657, DOI 10.1377/hlthaff.28.4.w657; Canadian Institute for Health Information, CAN HLTH CAR PROV; Chen LC, 2005, NEW ENGL J MED, V353, P1850, DOI 10.1056/NEJMe058188; Chen LC, 2010, B WORLD HEALTH ORGAN, V88, P323, DOI 10.2471/BLT.10.078477; Crisp LN, 2011, INFECT DIS CLIN N AM, V25, P359, DOI 10.1016/j.idc.2011.02.010; Crisp N., 2010, TURNING WORLD UPSIDE, P107; Crisp N, 2008, SCALING SAVING LIVES; Frenk J, 2010, LANCET, V376, P1923, DOI 10.1016/S0140-6736(10)61854-5; Goodman DC, 2008, NEW ENGL J MED, V358, P1658, DOI 10.1056/NEJMp0800319; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Henry J., 2011, TOTAL NURSE PRACTITI; Henry J., 2010, PHYS ASSISTANTS PRIM; Horton R, 2005, LANCET, V366, P1514, DOI 10.1016/S0140-6736(05)67454-5; Hyde P, 2004, HUM RELAT, V57, P1407, DOI 10.1177/0018726704049415; Institute for Health Metrics and Evaluation, SEARCH GBD DAT; Kanchanachitra C, 2011, LANCET, V377, P769, DOI 10.1016/S0140-6736(10)62035-1; Lewin T., 2012, NY TIMES; Mullan F, 2005, NEW ENGL J MED, V353, P1810, DOI 10.1056/NEJMsa050004; Mullan F, 2011, LANCET, V377, P1113, DOI 10.1016/S0140-6736(10)61961-7; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Pereira C, 1996, BRIT J OBSTET GYNAEC, V103, P508, DOI 10.1111/j.1471-0528.1996.tb09797.x; Reichenbach L, 2011, RES MONOGRAPH SERIES, V49; Sachs J, WE ARE ALREADY APPL; Savedoff WD, 2012, LANCET, V380, P924, DOI 10.1016/S0140-6736(12)61083-6; Standing H, 2008, SOC SCI MED, V66, P2096, DOI 10.1016/j.socscimed.2008.01.046; Tulchinsky TH, 2011, PUBLIC HEALTH REV, V33, P7, DOI 10.1007/BF03391617; World Health Organization, 2013, UN TRUTH NO HLTH WOR; World Health Organization, 2018, WHO GLOB HLTH WORKF; World Health Organization (WHO), 2006, WORLD HLTH REP 2006	35	212	222	1	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 6	2014	370	10					950	957		10.1056/NEJMra1111610	http://dx.doi.org/10.1056/NEJMra1111610			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AC2EB	24597868				2022-12-28	WOS:000332309800012
J	Cole, TB				Cole, Thomas B.			Slaughterhouse Ruins at Aledo Gertrude Abercrombie	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2014	311	9					884	885		10.1001/jama.2013.279362	http://dx.doi.org/10.1001/jama.2013.279362			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC0FS	24595760				2022-12-28	WOS:000332170800001
J	Stevens, MJ				Stevens, Mark J.			How Shape Affects Microtubule and Nanoparticle Assembly	SCIENCE			English	Editorial Material							DNA; CONDENSATION		Sandia Natl Labs, Ctr Integrated Nanotechnol, Albuquerque, NM 87185 USA	United States Department of Energy (DOE); Sandia National Laboratories	Stevens, MJ (corresponding author), Sandia Natl Labs, Ctr Integrated Nanotechnol, POB 5800, Albuquerque, NM 87185 USA.	msteve@sandia.gov						Bloomfield VA, 1997, BIOPOLYMERS, V44, P269, DOI 10.1002/(SICI)1097-0282(1997)44:3<269::AID-BIP6>3.0.CO;2-T; Cheng SF, 2014, SOFT MATTER, V10, P510, DOI 10.1039/c3sm52631c; Groschel AH, 2013, NATURE, V503, P247, DOI 10.1038/nature12610; Hess H, 2011, ANNU REV BIOMED ENG, V13, P429, DOI 10.1146/annurev-bioeng-071910-124644; Hunyadi V, 2007, BIOL CELL, V99, P117, DOI 10.1042/BC20060059; Lodish H., 2007, MOL CELL BIOL; Ojeda-Lopez MA, 2014, NAT MATER, V13, P195, DOI 10.1038/nmat3858; Rovigatti L, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.168302; Stevens MJ, 1999, PHYS REV LETT, V82, P101, DOI 10.1103/PhysRevLett.82.101; Stevens MJ, 2001, BIOPHYS J, V80, P130, DOI 10.1016/S0006-3495(01)76000-6; Tang JX, 1997, BIOCHEMISTRY-US, V36, P12600, DOI 10.1021/bi9711386; VanBuren V, 2005, BIOPHYS J, V89, P2911, DOI 10.1529/biophysj.105.060913; WIDOM J, 1980, J MOL BIOL, V144, P431, DOI 10.1016/0022-2836(80)90330-7	13	11	11	1	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2014	343	6174					981	982		10.1126/science.1250827	http://dx.doi.org/10.1126/science.1250827			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2DZ	24578572				2022-12-28	WOS:000332309600031
J	Guydosh, NR; Green, R				Guydosh, Nicholas R.; Green, Rachel			Dom34 Rescues Ribosomes in 3 ' Untranslated Regions	CELL			English	Article							UNFOLDED PROTEIN RESPONSE; MESSENGER-RNA DECAY; NO-GO DECAY; QUALITY-CONTROL PATHWAYS; IN-VIVO; TRANSLATIONAL ATTENUATION; SACCHAROMYCES-CEREVISIAE; SUBUNIT DISSOCIATION; NASCENT PEPTIDES; YEAST DOM34	Ribosomes that stall before completing peptide synthesis must be recycled and returned to the cytoplasmic pool. The protein Dom34 and cofactors Hbs1 and Rli1 can dissociate stalled ribosomes in vitro, but the identity of targets in the cell is unknown. Here, we extend ribosome profiling methodology to reveal a high-resolution molecular characterization of Dom34 function in vivo. Dom34 removes stalled ribosomes from truncated mRNAs, but, in contrast, does not generally dissociate ribosomes on coding sequences known to trigger stalling, such as polyproline. We also show that Dom34 targets arrested ribosomes near the ends of 3' UTRs. These ribosomes appear to gain access to the 3' UTR via a mechanism that does not require decoding of the mRNA. These results suggest that ribosomes frequently enter downstream noncoding regions and that Dom34 carries out the important task of rescuing them.	[Guydosh, Nicholas R.; Green, Rachel] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Green, R (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	ragreen@jhmi.edu	Guydosh, Nicholas/AFQ-5807-2022	Guydosh, Nicholas/0000-0001-7116-326X	NIH; HHMI; Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM059425, R01GM059425] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Allen Buskirk and Kristin Smith-Koutmou for comments on the manuscript; Nick Ingolia, Gloria Brar, and Jonathan Weissman for protocols and helpful discussions about ribosome profiling; Toshi Inada for thoughtful discussions; Roy Parker for wild-type, dom34 Delta, and hbs1 Delta yeast strains; Peter Walter for informative discussions about HAC1; Mick Tuite for advice on creating the suppressor tRNA strain; Alan Hinnebusch for advice on use of 3-AT; Pavan Vaidyanathan for advice on performing the runoff experiment; Grace Yeo for preliminary calculations of reading frame and help with choosing rRNA subtraction oligos; and Carla Connelly for assistance with tetrad dissection. The work was supported by the NIH and HHMI (R.G.) and the Damon Runyon Cancer Research Foundation (N.R.G.).	Adham IM, 2003, MOL CELL BIOL, V23, P1470, DOI 10.1128/MCB.23.4.1470-1476.2003; Amrani N, 2004, NATURE, V432, P112, DOI 10.1038/nature03060; Anderson JSJ, 1998, EMBO J, V17, P1497, DOI 10.1093/emboj/17.5.1497; Aragon T, 2009, NATURE, V457, P736, DOI 10.1038/nature07641; Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Balagopal V, 2011, RNA, V17, P835, DOI 10.1261/rna.2677311; Barthelme D, 2011, P NATL ACAD SCI USA, V108, P3228, DOI 10.1073/pnas.1015953108; Becker T, 2012, NATURE, V482, P501, DOI 10.1038/nature10829; Ben-Shem A, 2011, SCIENCE, V334, P1524, DOI 10.1126/science.1212642; Bhattacharya A, 2010, MOL CELL BIOL, V30, P5562, DOI 10.1128/MCB.00618-10; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Brar GA, 2012, SCIENCE, V335, P552, DOI 10.1126/science.1215110; Chartrand P, 2002, MOL CELL, V10, P1319, DOI 10.1016/S1097-2765(02)00694-9; Chen LM, 2010, NAT STRUCT MOL BIOL, V17, P1233, DOI 10.1038/nsmb.1922; Cole SE, 2009, MOL CELL, V34, P440, DOI 10.1016/j.molcel.2009.04.017; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Davis L, 1998, GENETICS, V149, P45; Dever TE, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013706; Dinman JD, 2012, WIRES RNA, V3, P661, DOI 10.1002/wrna.1126; Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530; Dunn JG, 2013, ELIFE, V2, DOI 10.7554/eLife.01179; Fernandez-Ricaud L, 2007, NUCLEIC ACIDS RES, V35, pD463, DOI 10.1093/nar/gkl1029; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Gandhi R, 2008, J BIOL CHEM, V283, P32218, DOI 10.1074/jbc.M803785200; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Graille M, 2008, J BIOL CHEM, V283, P7145, DOI 10.1074/jbc.M708224200; Gutierrez E, 2013, MOL CELL, V51, P35, DOI 10.1016/j.molcel.2013.04.021; Guttman M, 2013, CELL, V154, P240, DOI 10.1016/j.cell.2013.06.009; Harigaya Y, 2012, P NATL ACAD SCI USA, V109, P11764, DOI 10.1073/pnas.1119741109; Hinnebusch AG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011544; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Janosi L, 1998, EMBO J, V17, P1141, DOI 10.1093/emboj/17.4.1141; KLOPOTOW.T, 1965, ARCH BIOCHEM BIOPHYS, V112, P562, DOI 10.1016/0003-9861(65)90096-2; Kurian L, 2011, NATURE, V477, P490, DOI 10.1038/nature10393; Kuroha K, 2010, EMBO REP, V11, P956, DOI 10.1038/embor.2010.169; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu BT, 2013, MOL CELL, V49, P453, DOI 10.1016/j.molcel.2012.12.001; Menzel S, 2007, BLOOD, V110, P3624, DOI 10.1182/blood-2007-05-093419; Moore SD, 2007, ANNU REV BIOCHEM, V76, P101, DOI 10.1146/annurev.biochem.75.103004.142733; Mori T, 2010, MOL BIOL CELL, V21, P3722, DOI 10.1091/mbc.E10-08-0693; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Ozsolak F, 2010, CELL, V143, P1018, DOI 10.1016/j.cell.2010.11.020; PHILPOTT CC, 1993, J BIOL CHEM, V268, P17655; PIERCE MK, 1987, MUTAT RES, V182, P65, DOI 10.1016/0165-1161(87)90055-0; Pisareva VP, 2011, EMBO J, V30, P1804, DOI 10.1038/emboj.2011.93; Serio TR, 1999, ANNU REV CELL DEV BI, V15, P661, DOI 10.1146/annurev.cellbio.15.1.661; Shao S, 2013, MOL CELL, V50, P637, DOI 10.1016/j.molcel.2013.04.015; Shoemaker CJ, 2011, P NATL ACAD SCI USA, V108, pE1392, DOI 10.1073/pnas.1113956108; Shoemaker CJ, 2010, SCIENCE, V330, P369, DOI 10.1126/science.1192430; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; Skabkin MA, 2013, MOL CELL, V51, P249, DOI 10.1016/j.molcel.2013.05.026; Strunk BS, 2011, SCIENCE, V333, P1449, DOI 10.1126/science.1208245; Tsuboi T, 2012, MOL CELL, V46, P518, DOI 10.1016/j.molcel.2012.03.013; Ude S, 2013, SCIENCE, V339, P82, DOI 10.1126/science.1228985; van den Elzen AMG, 2014, EMBO J, V33, P265, DOI 10.1002/embj.201386123; van den Elzen AMG, 2010, NAT STRUCT MOL BIOL, V17, P1446, DOI 10.1038/nsmb.1963; Wang Z, 1997, MOL CELL BIOL, V17, P4904, DOI 10.1128/MCB.17.9.4904; WOLIN SL, 1988, EMBO J, V7, P3559, DOI 10.1002/j.1460-2075.1988.tb03233.x; Woolstenhulme CJ, 2013, P NATL ACAD SCI USA, V110, pE878, DOI 10.1073/pnas.1219536110; Yanagitani K, 2011, SCIENCE, V331, P586, DOI 10.1126/science.1197142; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554	64	232	234	3	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 27	2014	156	5					950	962		10.1016/j.cell.2014.02.006	http://dx.doi.org/10.1016/j.cell.2014.02.006			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	AB9BK	24581494	Green Accepted, Bronze			2022-12-28	WOS:000332083900013
J	Ehrlich, S; Calafat, AM; Humblet, O; Smith, T; Hauser, R				Ehrlich, Shelley; Calafat, Antonia M.; Humblet, Olivier; Smith, Thomas; Hauser, Russ			Handling of Thermal Receipts as a Source of Exposure to Bisphenol A	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Ehrlich, Shelley; Smith, Thomas; Hauser, Russ] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Calafat, Antonia M.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Humblet, Olivier] Univ Calif San Francisco, San Francisco, CA 94143 USA	Harvard University; Harvard T.H. Chan School of Public Health; Centers for Disease Control & Prevention - USA; University of California System; University of California San Francisco	Ehrlich, S (corresponding author), Univ Cincinnati, Coll Med, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	shelley.ehrlich@cchmc.org	Calafat, Antonia/B-8076-2012; Ehrlich, Shelley/L-6991-2015; Calafat, Antonia/N-1183-2019; Calafat, Antonia/GOP-1115-2022	Calafat, Antonia/0000-0002-9796-7482	Intramural CDC HHS [CC999999] Funding Source: Medline; NIOSH CDC HHS [T42 OH008416, 2 T42 OH008416-05] Funding Source: Medline; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [T42OH008416] Funding Source: NIH RePORTER	Intramural CDC HHS; NIOSH CDC HHS; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))		Biedermann S, 2010, ANAL BIOANAL CHEM, V398, P571, DOI 10.1007/s00216-010-3936-9; Braun JM, 2011, PEDIATRICS, V128, P873, DOI 10.1542/peds.2011-1335; Braun JM, 2011, ENVIRON HEALTH PERSP, V119, P131, DOI 10.1289/ehp.1002366; Carwile JL, 2011, JAMA-J AM MED ASSOC, V306, P2218, DOI 10.1001/jama.2011.1721; Centers for Disease Control and Prevention, 2013, 4 CDCP; Ehrlich S, 2012, HUM REPROD, V27, P3583, DOI 10.1093/humrep/des328	6	116	117	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 26	2014	311	8					859	860		10.1001/jama.2013.283735	http://dx.doi.org/10.1001/jama.2013.283735			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB4XQ	24570250	Green Accepted			2022-12-28	WOS:000331793700027
J	Tobisu, M; Chatani, N				Tobisu, Mamoru; Chatani, Naoto			Remote Control by Steric Effects	SCIENCE			English	Editorial Material							ACTIVATION; ARENES; BONDS		[Tobisu, Mamoru] Osaka Univ, Grad Sch Engn, Ctr Atom & Mol Technol, Suita, Osaka 5650871, Japan; [Chatani, Naoto] Osaka Univ, Dept Appl Chem, Fac Engn, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Tobisu, M (corresponding author), Osaka Univ, Grad Sch Engn, Ctr Atom & Mol Technol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	tobisu@chem.eng.osaka-u.ac.jp; chatani@chem.eng.osaka-u.ac.jp	Chatani, Naoto/J-6812-2016; Tobisu, mamoru/J-6813-2016					Cheng W, 2014, SCIENCE, V343, P878, DOI 10.1126/science.1246774; Ezbiansky K, 1998, ORGANOMETALLICS, V17, P1455, DOI 10.1021/om980037g; Kuhl N, 2012, ANGEW CHEM INT EDIT, V51, P10236, DOI 10.1002/anie.201203269; Leow D, 2012, NATURE, V486, P518, DOI 10.1038/nature11158; Lyons TW, 2010, CHEM REV, V110, P1147, DOI 10.1021/cr900184e; Mkhalid IAI, 2010, CHEM REV, V110, P890, DOI 10.1021/cr900206p; MURAI S, 1993, NATURE, V366, P529, DOI 10.1038/366529a0; Murata M, 2007, CHEM LETT, V36, P910, DOI 10.1246/cl.2007.910; Rouquet G, 2013, ANGEW CHEM INT EDIT, V52, P11726, DOI 10.1002/anie.201301451; SNIECKUS V, 1990, CHEM REV, V90, P879, DOI 10.1021/cr00104a001	10	48	47	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 21	2014	343	6173					850	851		10.1126/science.1250335	http://dx.doi.org/10.1126/science.1250335			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB1LG	24558153				2022-12-28	WOS:000331552600036
J	Cox, AG; Goessling, W				Cox, Andrew G.; Goessling, Wolfram			REGENERATIVE BIOLOGY Take the brakes off for liver repair	NATURE			English	Editorial Material							ANGIOCRINE SIGNALS; ANGIOPOIETIN-2		[Cox, Andrew G.; Goessling, Wolfram] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Cox, Andrew G.; Goessling, Wolfram] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Gastroenterol, Boston, MA 02115 USA; [Goessling, Wolfram] Dana Farber Canc Inst, Boston, MA USA; [Goessling, Wolfram] Harvard Stem Cell Inst, Cambridge, MA USA; [Goessling, Wolfram] Broad Inst MIT & Harvard, Cambridge, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Cox, AG (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA.	wgoessling@partners.org		Goessling, Wolfram/0000-0001-9972-1569; Cox, Andrew/0000-0003-4189-9422	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090311] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK090311] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Cox AG, 2014, CELL REP, V6, P56, DOI 10.1016/j.celrep.2013.12.007; Daly C, 2006, P NATL ACAD SCI USA, V103, P15491, DOI 10.1073/pnas.0607538103; Ding BS, 2014, NATURE, V505, P97, DOI 10.1038/nature12681; Ding BS, 2011, CELL, V147, P539, DOI 10.1016/j.cell.2011.10.003; Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493; FISHER B, 1971, SCIENCE, V171, P575, DOI 10.1126/science.171.3971.575; Hadem J, 2012, CRIT CARE MED, V40, P1499, DOI 10.1097/CCM.0b013e318241e34e; Hu JH, 2014, SCIENCE, V343, P416, DOI 10.1126/science.1244880; Kobayashi H, 2010, NAT CELL BIOL, V12, P1046, DOI 10.1038/ncb2108; North TE, 2010, P NATL ACAD SCI USA, V107, P17315, DOI 10.1073/pnas.1008209107; Panigrahy D, 2013, P NATL ACAD SCI USA, V110, P13528, DOI 10.1073/pnas.1311565110	11	1	3	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 20	2014	506	7488					299	300		10.1038/506299a	http://dx.doi.org/10.1038/506299a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AB0JL	24553235				2022-12-28	WOS:000331477800024
J	Masoodi, NA				Masoodi, Nasseer A.			In women with stress urinary incontinence, initial surgery was more effective than physiotherapy	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Villages Hlth Syst, Villages, FL 32159 USA		Masoodi, NA (corresponding author), Villages Hlth Syst, Villages, FL 32159 USA.			Masoodi, Nasseer/0000-0001-8559-1759	ZonMw; Netherlands Organization for Health Research and Development	ZonMw(Netherlands Organization for Health Research and Development); Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development)	ZonMw, the Netherlands Organization for Health Research and Development.	Burgio KL, 2013, CURR UROL REP, V14, P457, DOI 10.1007/s11934-013-0358-1; Fan HL, 2013, AUST NZ J OBSTET GYN, V53, P298, DOI 10.1111/ajo.12075	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 18	2014	160	4							JC7	10.7326/0003-4819-160-4-201402180-02007	http://dx.doi.org/10.7326/0003-4819-160-4-201402180-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CC8RF	24534941				2022-12-28	WOS:000350635100006
J	Jones, SS; Rudin, RS; Perry, T; Shekelle, PG				Jones, Spencer S.; Rudin, Robert S.; Perry, Tanja; Shekelle, Paul G.			Health Information Technology: An Updated Systematic Review With a Focus on Meaningful Use	ANNALS OF INTERNAL MEDICINE			English	Review							CLINICAL DECISION-SUPPORT; PROVIDER ORDER ENTRY; CARE; MANAGEMENT; EFFICIENCY; IMPROVE; QUALITY; IMPACT; BENEFITS; COSTS	Background: Incentives offered by the U.S. government have spurred marked increases in use of health information technology (IT). Purpose: To update previous reviews and examine recent evidence that relates health IT functionalities prescribed in meaningful use regulations to key aspects of health care. Data Sources: English-language articles in PubMed from January 2010 to August 2013. Study Selection: 236 studies, including pre-post and time-series designs and clinical trials that related the use of health IT to quality, safety, or efficiency. Data Extraction: Two independent reviewers extracted data on functionality, study outcomes, and context. Data Synthesis: Fifty-seven percent of the 236 studies evaluated clinical decision support and computerized provider order entry, whereas other meaningful use functionalities were rarely evaluated. Fifty-six percent of studies reported uniformly positive results, and an additional 21% reported mixed-positive effects. Reporting of context and implementation details was poor, and 61% of studies did not report any contextual details beyond basic information. Limitation: Potential for publication bias, and evaluated health IT systems and outcomes were heterogeneous and incompletely described. Conclusion: Strong evidence supports the use of clinical decision support and computerized provider order entry. However, insufficient reporting of implementation and context of use makes it impossible to determine why some health IT implementations are successful and others are not. The most important improvement that can be made in health IT evaluations is increased reporting of the effects of implementation and context.	RAND Corp, Santa Monica, CA USA; Soutern Calif Evidence Based Practice Ctr, Santa Monica, CA USA; Harvard Univ, Sch Med, Boston, MA USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Greater Los Angeles Vet Affairs Healthcare Syst, Los Angeles, CA USA; Vanguard Hlth Syst, Nashville, TN USA	RAND Corporation; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Jones, SS (corresponding author), RAND Hlth, Southern Calif Evidence Based Practice Ctr, 1776 Main St, Santa Monica, CA 90401 USA.	spencer.jones@vanguardhealth.com		Jones, Spencer/0000-0003-0358-6273	Office of the National Coordinator	Office of the National Coordinator	Office of the National Coordinator.	Bell DS, 2012, INT J MED INFORM, V81, pE74, DOI 10.1016/j.ijmedinf.2012.07.012; Bell LM, 2010, PEDIATRICS, V125, pE770, DOI 10.1542/peds.2009-1385; Bennett KJ, 2010, FAM MED, V42, P338; Bernstein JA, 2010, JT COMM J QUAL PATIE, V36, P72, DOI 10.1016/S1553-7250(10)36013-2; Blumenthal D, 2010, NEW ENGL J MED, V363, P501, DOI 10.1056/NEJMp1006114; Buntin MB, 2011, HEALTH AFFAIR, V30, P464, DOI 10.1377/hlthaff.2011.0178; Centers for Medicare & Medicaid Services (CMS) HHS, 2010, Fed Regist, V75, P44313; Chaudhry B, 2006, ANN INTERN MED, V144, P742, DOI 10.7326/0003-4819-144-10-200605160-00125; Chen AR, 2011, J ONCOL PRACT, V7, P218, DOI 10.1200/JOP.2011.000344; Dalal SR, 2013, MED DECIS MAKING, V33, P343, DOI 10.1177/0272989X12457243; Duffy William J, 2010, Nurs Adm Q, V34, pE1, DOI 10.1097/NAQ.0b013e3181c95ec4; Evidence Partners, 2011, DISTILLERSR; Fernando TJ, 2012, ACAD EMERG MED, V19, P102, DOI 10.1111/j.1553-2712.2011.01249.x; Furukawa MF, 2011, MED CARE RES REV, V68, P75, DOI 10.1177/1077558710372108; Galanter WL, 2010, AM J HEALTH-SYST PH, V67, P1265, DOI 10.2146/ajhp090575; Georgiou A, 2011, ARCH PATHOL LAB MED, V135, P495, DOI 10.1043/2010-0286-SO.1; Goldzweig CL, 2009, HEALTH AFFAIR, V28, pW282, DOI 10.1377/hlthaff.28.2.w282; Harman JS, 2012, J GEN INTERN MED, V27, P962, DOI 10.1007/s11606-012-2001-0; Hemens BJ, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-89; Hyman D, 2012, PEDIATRICS, V130, pE211, DOI 10.1542/peds.2011-2984; Jha A, 2012, WRONG QUESTION ELECT; Mathematica Policy Research Harvard School of Public Health Robert Wood Johnson Foundation, 2013, HLTH INF TECHN US 20; Nieuwlaat R, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-90; Radley DC, 2013, J AM MED INFORM ASSN, V20, P470, DOI 10.1136/amiajnl-2012-001241; Refuerzo JS, 2011, AM J PERINAT, V28, P253, DOI 10.1055/s-0030-1268717; Roshanov PS, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-88; Roshanov PS, 2011, IMPLEMENT SCI, V6, DOI [10.1186/1748-5908-6-92, 10.1186/1748-5908-6-88]; Ryan AM, 2013, HEALTH AFFAIR, V32, P53, DOI 10.1377/hlthaff.2012.0742; Sahota N, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-91; Schwann NM, 2011, ANESTH ANALG, V113, P869, DOI 10.1213/ANE.0b013e318227b511; Shamliyan TA, 2008, HEALTH SERV RES, V43, P32, DOI 10.1111/j.1475-6773.2007.00751.x; Shekelle PG, 2011, ANN INTERN MED, V154, P693, DOI 10.7326/0003-4819-154-10-201105170-00011; Shekelle PG, 2010, AHRQ PUBLICATION; Souza NM, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-87; Spalding SC, 2011, AM J EMERG MED, V29, P207, DOI 10.1016/j.ajem.2009.10.007; Talmon J, 2009, INT J MED INFORM, V78, P1, DOI 10.1016/j.ijmedinf.2008.09.002; Terrell KM, 2010, ANN EMERG MED, V56, P623, DOI 10.1016/j.annemergmed.2010.03.025; Wang HY, 2012, INT J CLIN PHARM TH, V50, P375, DOI 10.5414/CP201678	38	256	257	2	67	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 7	2014	160	1					48	+		10.7326/M13-1531	http://dx.doi.org/10.7326/M13-1531			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	297IS	24573664				2022-12-28	WOS:000330249700006
J	Slaghekke, F; Lopriore, E; Lewi, L; Middeldorp, JM; van Zwet, EW; Weingertner, AS; Klumper, FJ; DeKoninck, P; Devlieger, R; Kilby, MD; Rustico, MA; Deprest, J; Favre, R; Oepkes, D				Slaghekke, Femke; Lopriore, Enrico; Lewi, Liesbeth; Middeldorp, Johanna M.; van Zwet, Erik W.; Weingertner, Anne-Sophie; Klumper, Frans J.; DeKoninck, Philip; Devlieger, Roland; Kilby, Mark D.; Rustico, Maria Angela; Deprest, Jan; Favre, Romain; Oepkes, Dick			Fetoscopic laser coagulation of the vascular equator versus selective coagulation for twin-to-twin transfusion syndrome: an open-label randomised controlled trial	LANCET			English	Article							CEREBRAL INJURY; SURGERY; ANASTOMOSES; AMNIOREDUCTION; COMPLICATIONS; MANAGEMENT; FETAL	Background Monochorionic twin pregnancies complicated by twin-to-twin transfusion syndrome are typically treated with fetoscopic laser coagulation. Postoperative complications can occur due to residual vascular anastomoses on the placenta. We aimed to assess the efficacy and safety of a novel surgery technique that uses laser coagulation of the entire vascular equator (Solomon technique). Methods We undertook an open-label, international, multicentre, randomised controlled trial at five European tertiary referral centres. Women with twin-to-twin transfusion syndrome were randomly assigned by online randomisation (1: 1) with permuted blocks to the Solomon technique or standard laser coagulation. The primary outcome was a composite of incidence of twin anaemia polycythaemia sequence, recurrence of twin-to-twin transfusion syndrome, perinatal mortality, or severe neonatal morbidity. Analyses were by intention to treat, with results expressed as odds ratios (ORs) and 95% CIs. This trial is registered with the Dutch Trial Registry, number NTR1245. Findings Between March 11, 2008, and July 12, 2012, 274 women were randomly assigned to either the Solomon group (n= 139) or the standard treatment group (n= 135). The primary outcome occurred in 94 (34%) of 274 fetuses in the Solomon group versus 133 (49%) of 270 in the standard treatment group (OR 0.54; 95% CI 0.35-0.82). The Solomon technique was associated with a reduction in twin anaemia polycythaemia sequence (3% vs 16% for the standard treatment; OR 0.16, 95% CI 0.05-0.49) and recurrence of twin-to-twin transfusion syndrome (1% vs 7%; 0.21, 0.04-0.98). Perinatal mortality and severe neonatal morbidity did not differ significantly between the two groups. Outside of the common and well-known complications of twin-to-twin transfusion syndrome and its treatment, no serious adverse events occurred. Interpretation Fetoscopic laser coagulation of the entire vascular equator reduces postoperative fetal morbidity in severe twin-to-twin transfusion syndrome. We recommend that fetoscopic surgeons consider adopting this strategy for treatment of women with twin-to-twin transfusion syndrome.	[Slaghekke, Femke; Middeldorp, Johanna M.; Klumper, Frans J.] Leiden Univ, Med Ctr, Dept Obstet, NL-2300 RC Leiden, Netherlands; [Lopriore, Enrico] Leiden Univ, Med Ctr, Dept Pediat, NL-2300 RC Leiden, Netherlands; [van Zwet, Erik W.] Leiden Univ, Med Ctr, Dept Med Stat, NL-2300 RC Leiden, Netherlands; [Lewi, Liesbeth; DeKoninck, Philip; Devlieger, Roland; Deprest, Jan] Katholieke Univ Leuven, Univ Hosp, Dept Obstet, Louvain, Belgium; [Weingertner, Anne-Sophie; Favre, Romain] Univ Hosp Strasbourg, Dept Obstet, Strasbourg, France; [Kilby, Mark D.] Birmingham Womens Fdn Trust, Fetal Med Ctr, Birmingham, W Midlands, England; [Kilby, Mark D.] Univ Birmingham, Birmingham, W Midlands, England; [Rustico, Maria Angela] Childrens Hosp Vittore Buzzi, Dept Obstet, Fetal Therapy Unit, Milan, Italy	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; KU Leuven; CHU Strasbourg; University of Birmingham	Oepkes, D (corresponding author), Leiden Univ, Med Ctr, Dept Obstet, Div Fetal Med, K6,Albinusdreef 2,Postbox 9600, NL-2300 RC Leiden, Netherlands.	d.oepkes@lumc.nl	Lopriore, Enrico/ABE-3576-2021; Devlieger, Roland/AAS-9181-2020; DeKoninck, Philip/ACQ-3838-2022; FRCPI, Mark D Kilby MB BS DSc MD FRCOG/AAW-9704-2020; DeKoninck, Philip/X-5356-2019; Lewi, Liesbeth/A-1454-2015	Lopriore, Enrico/0000-0002-3513-5066; Devlieger, Roland/0000-0001-7837-4684; FRCPI, Mark D Kilby MB BS DSc MD FRCOG/0000-0001-9987-4223; Lewi, Liesbeth/0000-0002-9884-5778; Deprest, Jan/0000-0002-4920-945X	Netherlands Organization for the Health Research and Development [ZonMw 92003545]	Netherlands Organization for the Health Research and Development(Netherlands Organization for Health Research and Development)	Netherlands Organization for the Health Research and Development (ZonMw 92003545).	Baschat AA, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.05.034; Baud D, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.11.027; Berghella V, 2001, J REPROD MED, V46, P480; Chmait RH, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.02.001; Hack KE, 2008, BJOG-INT J OBSTET GY, V115, P58, DOI 10.1111/j.1471-0528.2007.01556.x; Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047; Lewi L, 2006, AM J OBSTET GYNECOL, V194, P790, DOI 10.1016/j.ajog.2005.08.062; Lewi L, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.03.050; Lopriore E, 2007, PLACENTA, V28, P204, DOI 10.1016/j.placenta.2006.03.005; Lopriore E, 2005, J PEDIATR-US, V147, P597, DOI 10.1016/j.jpeds.2005.06.004; Lopriore E, 2011, JOVE-J VIS EXP, DOI 10.3791/3208; Morris RK, 2010, BJOG-INT J OBSTET GY, V117, P1350, DOI 10.1111/j.1471-0528.2010.02680.x; Quintero R A, 1999, J Perinatol, V19, P550, DOI 10.1038/sj.jp.7200292; Roberts D, 2008, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002073.pub2, 10.1002/14651858.CD002073.pub3]; Robyr R, 2006, AM J OBSTET GYNECOL, V194, P796, DOI 10.1016/j.ajog.2005.08.069; Rossi AC, 2011, OBSTET GYNECOL, V118, P1145, DOI 10.1097/AOG.0b013e318231827f; Ruano R, 2013, ULTRASOUND OBST GYN, V42, P434, DOI 10.1002/uog.12492; Rustico MA, 2012, FETAL DIAGN THER, V31, P170, DOI 10.1159/000336227; Senat MV, 2004, NEW ENGL J MED, V351, P136, DOI 10.1056/NEJMoa032597; Simpson LL, 2013, AM J OBSTET GYNECOL, V208, P3, DOI 10.1016/j.ajog.2012.10.880; Skupski DW, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.018; Slaghekke F, 2010, FETAL DIAGN THER, V27, P181, DOI 10.1159/000304512; Spruijt M, 2012, OBSTET GYNECOL, V120, P15, DOI 10.1097/AOG.0b013e31825b9841; Valsky DV, 2012, FETAL DIAGN THER, V31, P30, DOI 10.1159/000330369; van Klink JMM, 2013, FETAL DIAGN THER, V33, P81, DOI 10.1159/000341814	25	197	212	1	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 21	2014	383	9935					2144	2151		10.1016/S0140-6736(13)62419-8	http://dx.doi.org/10.1016/S0140-6736(13)62419-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AJ7VG	24613024				2022-12-28	WOS:000337906600029
J	Oeffinger, KC; Sklar, CA				Oeffinger, Kevin C.; Sklar, Charles A.			Childhood cancer, endocrine disorders, and cohort studies	LANCET			English	Editorial Material							LONG-TERM SURVIVORS; DIABETES-MELLITUS; RADIATION-THERAPY; RISK		[Oeffinger, Kevin C.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Sklar, Charles A.] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Oeffinger, KC (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA.	oeffingk@mskcc.org			NATIONAL CANCER INSTITUTE [K05CA160724] Funding Source: NIH RePORTER; NCI NIH HHS [K05 CA160724] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		de Fine Licht S, 2014, LANCET; de Vathaire F, 2012, LANCET ONCOL, V13, P1002, DOI 10.1016/S1470-2045(12)70323-6; FUKS Z, 1976, CANCER-AM CANCER SOC, V37, P1152, DOI 10.1002/1097-0142(197602)37:2+<1152::AID-CNCR2820370826>3.0.CO;2-T; Geenen MM, 2007, JAMA-J AM MED ASSOC, V297, P2705, DOI 10.1001/jama.297.24.2705; Kremer LCM, 2013, PEDIATR BLOOD CANCER, V60, P543, DOI 10.1002/pbc.24445; LUSHBAUGH CC, 1976, CANCER, V37, P1111, DOI 10.1002/1097-0142(197602)37:2+<1111::AID-CNCR2820370821>3.0.CO;2-E; Meacham LR, 2009, ARCH INTERN MED, V169, P1381, DOI 10.1001/archinternmed.2009.209; Oeffinger KC, 2007, JAMA-J AM MED ASSOC, V297, P2762, DOI 10.1001/jama.297.24.2762; Oeffinger KC, 2012, LANCET ONCOL, V13, P961, DOI 10.1016/S1470-2045(12)70340-6; SHALET SM, 1976, CANCER, V37, P1144, DOI 10.1002/1097-0142(197602)37:2+<1144::AID-CNCR2820370824>3.0.CO;2-U	10	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 7	2014	383	9933					1950	1952		10.1016/S0140-6736(14)60114-8	http://dx.doi.org/10.1016/S0140-6736(14)60114-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AI4PV	24556021	Green Accepted			2022-12-28	WOS:000336848200006
J	Olsen, Y; Sharfstein, JM				Olsen, Yngvild; Sharfstein, Joshua M.			Confronting the Stigma of Opioid Use Disorder- and Its Treatment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Olsen, Yngvild] Inst Behav Resources Inc, Baltimore, MD 21218 USA; [Sharfstein, Joshua M.] Maryland Dept Hlth & Mental Hyg, Baltimore, MD USA	Maryland Department of Health & Mental Hygiene	Olsen, Y (corresponding author), Inst Behav Resources Inc, 2104 Maryland Ave, Baltimore, MD 21218 USA.	yngvild.olsen@gmail.com						Carrieri MP, 2006, CLIN INFECT DIS, V43, pS197, DOI 10.1086/508184; Centers for Disease Control and Prevention, DRUG OVERDOSE IN THE; Gibson A, 2008, ADDICTION, V103, P462, DOI 10.1111/j.1360-0443.2007.02090.x; Legal Action Center, 2011, LEGALITY OF DENYING; National Institute on Drug Abuse, 2012, MEDICATION ASSISTED; Schwartz RP, 2013, AM J PUBLIC HEALTH, V103, P917, DOI 10.2105/AJPH.2012.301049; White, 2011, NARCOTICS ANONYMOUS; White W, 2009, LONG TERM STRATEGIES	8	185	189	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 9	2014	311	14					1393	1394		10.1001/jama.2014.2147	http://dx.doi.org/10.1001/jama.2014.2147			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AE4EP	24577059				2022-12-28	WOS:000333935000010
J	Cranmer, HH; Biddinger, PD				Cranmer, Hilarie H.; Biddinger, Paul D.			Typhoon Haiyan and the Professionalization of Disaster Response	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								When international medical response teams landed in the Philippines after Typhoon Haiyan, they had to act as professional humanitarian responders. Medical responders to disasters can help best when they are well prepared and function as part of a coordinated effort. When international medical response teams landed in the Philippines last November in the days and weeks after Super Typhoon Haiyan hit, it was immediately apparent that they needed to act as professional humanitarian responders. The top priority was not that they deploy their medical skills but that they support the plans that were already in place. Although there were posters directing foreign medical response teams to register with the Philippine government, the trucks loaded with bags of rice from the World Food Program being delivered to the Department of Social Welfare and Development should have tipped off the response teams ...	[Cranmer, Hilarie H.; Biddinger, Paul D.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Cranmer, Hilarie H.] Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA; [Biddinger, Paul D.] Harvard Univ, Sch Publ Hlth, Div Policy Translat & Leadership Dev, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Cranmer, HH (corresponding author), Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA.							Burkle Jr FM, 2012, HDB PANDEMIC MASS CA, P72; Global Health Cluster (GHC), 2010, COORDINATION REGISTR; Johnson K, 2013, DISASTER MED PUBLIC, V7, P369, DOI 10.1017/dmp.2013.10; Leaning J, 2013, NEW ENGL J MED, V369, P1836, DOI 10.1056/NEJMra1109877	4	15	16	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 27	2014	370	13					1185	1187		10.1056/NEJMp1401820	http://dx.doi.org/10.1056/NEJMp1401820			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AD7EW	24552286				2022-12-28	WOS:000333426000005
J	Lazer, D; Kennedy, R; King, G; Vespignani, A				Lazer, David; Kennedy, Ryan; King, Gary; Vespignani, Alessandro			The Parable of Google Flu: Traps in Big Data Analysis	SCIENCE			English	Editorial Material							INFLUENZA; SURVEILLANCE; BEHAVIOR		[Lazer, David; Kennedy, Ryan] Northeastern Univ, Lazer Lab, Boston, MA 02115 USA; [Lazer, David] Harvard Univ, Harvard Kennedy Sch, Cambridge, MA 02138 USA; [Kennedy, Ryan; King, Gary; Vespignani, Alessandro] Harvard Univ, Inst Quantitat Social Sci, Cambridge, MA 02138 USA; [Kennedy, Ryan] Univ Houston, Houston, TX 77204 USA; [Vespignani, Alessandro] Northeastern Univ, Lab Modeling Biol & Sociotech Syst, Boston, MA 02115 USA; [Vespignani, Alessandro] Inst Sci Interchange Fdn, Turin, Italy	Northeastern University; Harvard University; Harvard University; University of Houston System; University of Houston; Northeastern University	Lazer, D (corresponding author), Northeastern Univ, Lazer Lab, Boston, MA 02115 USA.	d.lazer@neu.edu		Vespignani, Alessandro/0000-0003-3419-4205				[Anonymous], ORG LISTS REL SEARCH; [Anonymous], IMPR HLTH SEARCH BEC; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Berinsky AJ, 2012, POLIT ANAL, V20, P351, DOI 10.1093/pan/mpr057; Bollen J, 2011, J COMPUT SCI-NETH, V2, P1, DOI 10.1016/j.jocs.2010.12.007; Boyd DA, 2012, ARAB AND JEWISH WOMEN IN KENTUCKY: STORIES OF ACCOMMODATION AND AUDACITY, P15; Butler D, 2013, NATURE, V494, P155, DOI 10.1038/494155a; Chao DL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000656; Ciulla F, 2012, EPJ DATA SCI, V1, DOI 10.1140/epjds8; Cook S, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0023610, 10.1371/journal.pone.0025407]; Copeland P., 2013, INT SOC NEGL TROP DI, V2013, P3; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Goel S, 2010, P NATL ACAD SCI USA, V107, P17486, DOI 10.1073/pnas.1005962107; Hall IM, 2007, EPIDEMIOL INFECT, V135, P372, DOI 10.1017/S0950268806007084; Hannak A., 2013, P 22 INT C WORLD WID, P527, DOI [https://doi.org/10.1145/2488388.2488435, 10.1145/2488388.2488435]; KING G, 1995, PS POLITICAL SCI POL, V0028; King G, 2011, SCIENCE, V331, P719, DOI 10.1126/science.1197872; Lazarus R, 2001, BMC PUBLIC HEALTH, V1, DOI 10.1186/1471-2458-1-9; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; McAfee A, 2012, HARVARD BUS REV, V90, P60; Metaxas P., 2011, 2011 IEEE 3 INT C PR, P165, DOI [10.1109/PASSAT/SocialCom.2011.98, DOI 10.1109/PASSAT/SOCIALCOM.2011.98]; Mustafaraj E., 2010, P WEB SCI10 RAL NC 2; Nsoesie EO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067164; Olson DR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003256; Ong JBS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010036; Ortiz JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018687; Ratkiewicz J., 2011, ICWSM, P297; Shaman J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3837; Shaman J, 2012, P NATL ACAD SCI USA, V109, P20425, DOI 10.1073/pnas.1208772109; Thompson WW, 2006, J INFECT DIS, V194, pS82, DOI 10.1086/507558; Tumasjan A., 2010, P 4 INT AAAI C WEBLO, V4, P178, DOI DOI 10.1074/JBC.M501708200; Vespignani A, 2009, SCIENCE, V325, P425, DOI 10.1126/science.1171990; Viboud C, 2003, AM J EPIDEMIOL, V158, P996, DOI 10.1093/aje/kwg239; Voosen P., 2013, CHRONICLE HIGHER ED	35	1230	1285	27	830	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2014	343	6176					1203	1205		10.1126/science.1248506	http://dx.doi.org/10.1126/science.1248506			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC7RG	24626916	Green Submitted			2022-12-28	WOS:000332728500021
J	Dai, S; Fei, Z; Ma, Q; Rodin, AS; Wagner, M; McLeod, AS; Liu, MK; Gannett, W; Regan, W; Watanabe, K; Taniguchi, T; Thiemens, M; Dominguez, G; Neto, AHC; Zettl, A; Keilmann, F; Jarillo-Herrero, P; Fogler, MM; Basov, DN				Dai, S.; Fei, Z.; Ma, Q.; Rodin, A. S.; Wagner, M.; McLeod, A. S.; Liu, M. K.; Gannett, W.; Regan, W.; Watanabe, K.; Taniguchi, T.; Thiemens, M.; Dominguez, G.; Castro Neto, A. H.; Zettl, A.; Keilmann, F.; Jarillo-Herrero, P.; Fogler, M. M.; Basov, D. N.			Tunable Phonon Polaritons in Atomically Thin van der Waals Crystals of Boron Nitride	SCIENCE			English	Article							NEAR-FIELD MICROSCOPY; SPECTROSCOPY; PLASMONS	van der Waals heterostructures assembled from atomically thin crystalline layers of diverse two-dimensional solids are emerging as a new paradigm in the physics of materials. We used infrared nanoimaging to study the properties of surface phonon polaritons in a representative van der Waals crystal, hexagonal boron nitride. We launched, detected, and imaged the polaritonic waves in real space and altered their wavelength by varying the number of crystal layers in our specimens. The measured dispersion of polaritonic waves was shown to be governed by the crystal thickness according to a scaling law that persists down to a few atomic layers. Our results are likely to hold true in other polar van der Waals crystals and may lead to new functionalities.	[Dai, S.; Fei, Z.; Wagner, M.; McLeod, A. S.; Liu, M. K.; Fogler, M. M.; Basov, D. N.] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Ma, Q.; Jarillo-Herrero, P.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Rodin, A. S.; Castro Neto, A. H.] Boston Univ, Dept Phys, Boston, MA 02215 USA; [Gannett, W.; Regan, W.; Zettl, A.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Gannett, W.; Regan, W.; Zettl, A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Watanabe, K.; Taniguchi, T.] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan; [Thiemens, M.; Dominguez, G.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Dominguez, G.] Calif State Univ, Dept Phys, San Marcos, CA 92096 USA; [Castro Neto, A. H.] Natl Univ Singapore, Graphene Res Ctr, Singapore 117546, Singapore; [Castro Neto, A. H.] Natl Univ Singapore, Dept Phys, Singapore 117546, Singapore; [Zettl, A.] Univ Calif Berkeley, Kavli Energy NanoSci Inst, Berkeley, CA 94720 USA; [Zettl, A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Keilmann, F.] Univ Munich, D-80539 Munich, Germany; [Keilmann, F.] Ctr Nanosci, D-80539 Munich, Germany	University of California System; University of California San Diego; Massachusetts Institute of Technology (MIT); Boston University; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; National Institute for Materials Science; University of California System; University of California San Diego; California State University System; California State University San Marcos; National University of Singapore; National University of Singapore; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Munich; University of Munich	Basov, DN (corresponding author), Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA.	dbasov@physics.ucsd.edu	Zettl, Alex K/O-4925-2016; TANIGUCHI, Takashi/H-2718-2011; Castro Neto, Antonio/C-8363-2014; Fogler, Michael M/O-4610-2017; WATANABE, Kenji/H-2825-2011; Fei, Zhe/E-6475-2015; Jarillo-Herrero, Pablo/E-3755-2013	Zettl, Alex K/0000-0001-6330-136X; Castro Neto, Antonio/0000-0003-0613-4010; Fogler, Michael M/0000-0001-8239-7221; WATANABE, Kenji/0000-0003-3701-8119; Fei, Zhe/0000-0002-7940-5566; Jarillo-Herrero, Pablo/0000-0001-8217-8213; Rodin, Aleksandr/0000-0001-5321-7690; Liu, Mengkun/0000-0002-3512-9133; Regan, William/0000-0003-0143-9827	U.S. Department of Energy-Office of Basic Energy Sciences (DOE-BES); Office of Naval Research (ONR) [MURI N00014-09-1-1063]; DOE [DE-FG02-08ER46512]; Air Force Office of Scientific Research (AFOSR) [FA9550-11-1-0225]; National Research Foundation [R-144-000-295-281]; NASA; Office of Energy Research, BES, Materials Sciences and Engineering Division, of the U.S. DOE [DE-AC02- 05CH11231]	U.S. Department of Energy-Office of Basic Energy Sciences (DOE-BES)(United States Department of Energy (DOE)); Office of Naval Research (ONR)(Office of Naval Research); DOE(United States Department of Energy (DOE)); Air Force Office of Scientific Research (AFOSR)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); National Research Foundation; NASA(National Aeronautics & Space Administration (NASA)); Office of Energy Research, BES, Materials Sciences and Engineering Division, of the U.S. DOE(United States Department of Energy (DOE))	Work at UCSD was supported by U.S. Department of Energy-Office of Basic Energy Sciences (DOE-BES). The development of nano-FTIR at UCSD is supported by Office of Naval Research (ONR), DOE, Air Force Office of Scientific Research (AFOSR), and NSF. M.M.F. is supported by ONR. P.J.-H. acknowledges support from AFOSR grant number FA9550-11-1-0225. A.S.R. acknowledges DOE grant DE-FG02-08ER46512 and ONR grant MURI N00014-09-1-1063. M.T. and G.D. are supported by NASA. A.H.C.N. acknowledges a National Research Foundation-Competitive Research Programme award (R-144-000-295-281). A.Z., W.G., and W.R. acknowledge support from the Director, Office of Energy Research, BES, Materials Sciences and Engineering Division, of the U.S. DOE under contract no. DE-AC02- 05CH11231, which provided for preparation and characterization of the BN, and from the ONR, which provided for substrate transfer technique. F.K. is a cofounder of Neaspec, producer of the s-SNOM apparatus used in this study.	Atkin JM, 2012, ADV PHYS, V61, P745, DOI 10.1080/00018732.2012.737982; Britnell L, 2013, SCIENCE, V340, P1311, DOI 10.1126/science.1235547; Butler SZ, 2013, ACS NANO, V7, P2898, DOI 10.1021/nn400280c; Chen JN, 2012, NATURE, V487, P77, DOI 10.1038/nature11254; De Wilde Y, 2006, NATURE, V444, P740, DOI 10.1038/nature05265; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; Fei Z, 2012, NATURE, V487, P82, DOI 10.1038/nature11253; Fei Z, 2011, NANO LETT, V11, P4701, DOI 10.1021/nl202362d; Feurer T, 2003, SCIENCE, V299, P374, DOI 10.1126/science.1078726; GEICK R, 1966, PHYS REV, V146, P543, DOI 10.1103/PhysRev.146.543; Geim AK, 2013, NATURE, V499, P419, DOI 10.1038/nature12385; Hillenbrand R, 2002, NATURE, V418, P159, DOI 10.1038/nature00899; Huber A, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2032595; Keilmann F, 2012, J INFRARED MILLIM TE, V33, P479, DOI 10.1007/s10762-012-9894-x; Kimura T, 2000, ANNU REV MATER SCI, V30, P451, DOI 10.1146/annurev.matsci.30.1.451; Mak KF, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.136805; Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102; Novotny L., 2012, PRINCIPLES NANOOPTIC; Poddubny A, 2013, NAT PHOTONICS, V7, P948, DOI [10.1038/NPHOTON.2013.243, 10.1038/nphoton.2013.243]; Qi XL, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1057; Renger J, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.075410; Schuller JA, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.107401; Shen S, 2009, NANO LETT, V9, P2909, DOI 10.1021/nl901208v; Shvets G, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.035109; Splendiani A, 2010, NANO LETT, V10, P1271, DOI 10.1021/nl903868w; Stanley R, 2012, NAT PHOTONICS, V6, P409, DOI 10.1038/nphoton.2012.161; Taubner T, 2006, SCIENCE, V313, P1595, DOI 10.1126/science.1131025; Xu XJG, 2013, J PHYS CHEM A, V117, P3348, DOI 10.1021/jp4008784; Zhang LM, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.075419	29	728	739	39	607	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2014	343	6175					1125	1129		10.1126/science.1246833	http://dx.doi.org/10.1126/science.1246833			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2LB	24604197	Green Submitted			2022-12-28	WOS:000332331500045
J	Gregersen, PK				Gregersen, Peter K.			A Genomic Road Map for Complex Human Disease	SCIENCE			English	Editorial Material									North Shore LIJ Hlth Syst, Feinstein Inst Med Res, Robert S Boas Ctr Genom & Human Genet, Manhasset, NY 11030 USA	Northwell Health	Gregersen, PK (corresponding author), North Shore LIJ Hlth Syst, Feinstein Inst Med Res, Robert S Boas Ctr Genom & Human Genet, 350 Community Dr, Manhasset, NY 11030 USA.	peterg@nshs.edu						Al-Daccak R, 2004, CURR OPIN IMMUNOL, V16, P108, DOI 10.1016/j.coi.2003.11.006; Dendrou CA, 2009, NAT GENET, V41, P1011, DOI 10.1038/ng.434; Fairfax BP, 2014, SCIENCE, V343, P1118, DOI 10.1126/science.1246949; Gregersen PK, 2012, CURR OPIN IMMUNOL, V24, P538, DOI 10.1016/j.coi.2012.09.003; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kim SJ, 2013, J CLIN INVEST, V123, P823, DOI 10.1172/JCI64712; Lee MN, 2014, SCIENCE, V343, P1119, DOI 10.1126/science.1246980; Liu XG, 2011, NAT IMMUNOL, V12, P416, DOI 10.1038/ni.2015; Shrivastav M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00319	9	4	4	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2014	343	6175					1087	1088		10.1126/science.1251426	http://dx.doi.org/10.1126/science.1251426			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2LB	24604188				2022-12-28	WOS:000332331500032
J	Walsh, BM; Foster, JC; Erickson, PJ; Sibeck, DG				Walsh, B. M.; Foster, J. C.; Erickson, P. J.; Sibeck, D. G.			Simultaneous Ground- and Space-Based Observations of the Plasmaspheric Plume and Reconnection	SCIENCE			English	Article							MAGNETOPAUSE	Magnetic reconnection is the primary process through which energy couples from the solar wind into Earth's magnetosphere and ionosphere. Conditions both in the incident solar wind and in the magnetosphere are important in determining the efficiency of this energy transfer. In particular, the cold, dense plasmaspheric plume can substantially impact the coupling in the dayside reconnection region. Using ground-based total electron content (TEC) maps and measurements from the THEMIS spacecraft, we investigated simultaneous ionosphere and magnetosphere observations of the plasmaspheric plume and its involvement in an unsteady magnetic reconnection process. The observations show the full circulation pattern of the plasmaspheric plume and validate the connection between signatures of variability in the dense plume and reconnection at the magnetopause as measured in situ and through TEC measurements in the ionosphere.	[Walsh, B. M.; Sibeck, D. G.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Walsh, B. M.] Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; [Foster, J. C.; Erickson, P. J.] MIT, Haystack Observ, Westford, MA 01886 USA	National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of California System; University of California Berkeley; Massachusetts Institute of Technology (MIT)	Walsh, BM (corresponding author), NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA.	brian.walsh@nasa.gov	Erickson, Philip J/N-6853-2018; Walsh, Brian/C-4899-2016	Erickson, Philip J/0000-0002-0031-9324; Walsh, Brian/0000-0001-7426-5413	NSF [AGS-1136827, AGS-1242204]; NASA [NAS5-02099]; Directorate For Geosciences [1242204] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Supported by NSF grant AGS-1136827. We acknowledge NASA contract NAS5-02099 and instrument teams for use of the data from the THEMIS Mission, specifically the ESA, EFI, and FGM teams. Work at MIT Haystack Observatory was supported by NSF Cooperative Agreement AGS-1242204.	Angelopoulos V, 2008, SPACE SCI REV, V141, P453, DOI 10.1007/s11214-008-9378-4; Birn J, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2888491; Borovsky JE, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026519; Borovsky JE, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2772619; Borovsky JE, 2013, J GEOPHYS RES-SPACE, V118, P5695, DOI 10.1002/jgra.50527; Cassak PA, 2007, PHYS PLASMAS, V14, DOI 10.1063/1.2795630; CHAPPELL CR, 1970, J GEOPHYS RES, V75, P50, DOI 10.1029/JA075i001p00050; CHAPPELL CR, 1971, J GEOPHYS RES, V76, P7632, DOI 10.1029/JA076i031p07632; Foster JC, 2005, J GEOPHYS RES-SPACE, V110, DOI 10.1029/2004JA010928; Foster JC, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020082; Foster JC, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015067; FOSTER JC, 1993, J GEOPHYS RES-SPACE, V98, P1675, DOI 10.1029/92JA02032; LABELLEHAMER AL, 1995, J GEOPHYS RES-SPACE, V100, P11875, DOI 10.1029/95JA00969; LEE LC, 1985, GEOPHYS RES LETT, V12, P105, DOI 10.1029/GL012i002p00105; LOCKWOOD M, 1992, GEOPHYS RES LETT, V19, P1731, DOI 10.1029/92GL01993; Newell PT, 2002, ANN GEOPHYS-GERMANY, V20, P1039, DOI 10.5194/angeo-20-1039-2002; PASCHMANN G, 1986, J GEOPHYS RES, V91, P1099, DOI 10.1029/JA091iA10p11099; RUSSELL CT, 1978, SPACE SCI REV, V22, P681, DOI 10.1007/BF00212619; Shue JH, 1997, J GEOPHYS RES-SPACE, V102, P9497, DOI 10.1029/97JA00196; Walsh BM, 2013, J GEOPHYS RES-SPACE, V118, P4844, DOI 10.1002/jgra.50458; Zhang QH, 2013, SCIENCE, V339, P1597, DOI 10.1126/science.1231487	21	80	80	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2014	343	6175					1122	1125		10.1126/science.1247212	http://dx.doi.org/10.1126/science.1247212			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2LB	24604196	Green Published			2022-12-28	WOS:000332331500044
J	Zhou, Q; Yang, D; Ombrello, AK; Zavialov, AV; Toro, C; Zavialov, AV; Stone, DL; Chae, JJ; Rosenzweig, SD; Bishop, K; Barron, KS; Kuehn, HS; Hoffmann, P; Negro, A; Tsai, WXL; Cowen, EW; Pei, W; Milner, JD; Silvin, C; Heller, T; Chin, DT; Patronas, NJ; Barber, JS; Lee, CCR; Wood, GM; Ling, A; Kelly, SJ; Kleiner, DE; Mullikin, JC; Ganson, NJ; Kong, HH; Hambleton, S; Candotti, F; Quezado, MM; Calvo, KR; Alao, H; Barham, BK; Jones, A; Meschia, JF; Worrall, BB; Kasner, SE; Rich, SS; Goldbach-Mansky, R; Abinun, M; Chalom, E; Gotte, AC; Punaro, M; Pascual, V; Verbsky, JW; Torgerson, TR; Singer, NG; Gershon, TR; Ozen, S; Karadag, O; Fleisher, TA; Remmers, EF; Burgess, SM; Moir, SL; Gadina, M; Sood, R; Hershfield, MS; Boehm, M; Kastner, DL; Aksentijevich, I				Zhou, Qing; Yang, Dan; Ombrello, Amanda K.; Zavialov, Andrey V.; Toro, Camilo; Zavialov, Anton V.; Stone, Deborah L.; Chae, Jae Jin; Rosenzweig, Sergio D.; Bishop, Kevin; Barron, Karyl S.; Kuehn, Hye Sun; Hoffmann, Patrycja; Negro, Alejandra; Tsai, Wanxia L.; Cowen, Edward W.; Pei, Wuhong; Milner, Joshua D.; Silvin, Christopher; Heller, Theo; Chin, David T.; Patronas, Nicholas J.; Barber, John S.; Lee, Chyi-Chia R.; Wood, Geryl M.; Ling, Alexander; Kelly, Susan J.; Kleiner, David E.; Mullikin, James C.; Ganson, Nancy J.; Kong, Heidi H.; Hambleton, Sophie; Candotti, Fabio; Quezado, Martha M.; Calvo, Katherine R.; Alao, Hawwa; Barham, Beverly K.; Jones, Anne; Meschia, James F.; Worrall, Bradford B.; Kasner, Scott E.; Rich, Stephen S.; Goldbach-Mansky, Raphaela; Abinun, Mario; Chalom, Elizabeth; Gotte, Alisa C.; Punaro, Marilynn; Pascual, Virginia; Verbsky, James W.; Torgerson, Troy R.; Singer, Nora G.; Gershon, Timothy R.; Ozen, Seza; Karadag, Omer; Fleisher, Thomas A.; Remmers, Elaine F.; Burgess, Shawn M.; Moir, Susan L.; Gadina, Massimo; Sood, Raman; Hershfield, Michael S.; Boehm, Manfred; Kastner, Daniel L.; Aksentijevich, Ivona			Early- Onset Stroke and Vasculopathy Associated with Mutations in ADA2	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AICARDI-GOUTIERES SYNDROME; ADENOSINE-DEAMINASE 2; GROWTH-FACTOR; MACROPHAGES; MONOCYTES	BackgroundWe observed a syndrome of intermittent fevers, early-onset lacunar strokes and other neurovascular manifestations, livedoid rash, hepatosplenomegaly, and systemic vasculopathy in three unrelated patients. We suspected a genetic cause because the disorder presented in early childhood. MethodsWe performed whole-exome sequencing in the initial three patients and their unaffected parents and candidate-gene sequencing in three patients with a similar phenotype, as well as two young siblings with polyarteritis nodosa and one patient with small-vessel vasculitis. Enzyme assays, immunoblotting, immunohistochemical testing, flow cytometry, and cytokine profiling were performed on samples from the patients. To study protein function, we used morpholino-mediated knockdowns in zebrafish and short hairpin RNA knockdowns in U937 cells cultured with human dermal endothelial cells. ResultsAll nine patients carried recessively inherited mutations in CECR1 (cat eye syndrome chromosome region, candidate 1), encoding adenosine deaminase 2 (ADA2), that were predicted to be deleterious; these mutations were rare or absent in healthy controls. Six patients were compound heterozygous for eight CECR1 mutations, whereas the three patients with polyarteritis nodosa or small-vessel vasculitis were homozygous for the p.Gly47Arg mutation. Patients had a marked reduction in the levels of ADA2 and ADA2-specific enzyme activity in the blood. Skin, liver, and brain biopsies revealed vasculopathic changes characterized by compromised endothelial integrity, endothelial cellular activation, and inflammation. Knockdown of a zebrafish ADA2 homologue caused intracranial hemorrhages and neutropenia phenotypes that were prevented by coinjection with nonmutated (but not with mutated) human CECR1. Monocytes from patients induced damage in cocultured endothelial-cell layers. ConclusionsLoss-of-function mutations in CECR1 were associated with a spectrum of vascular and inflammatory phenotypes, ranging from early-onset recurrent stroke to systemic vasculopathy or vasculitis. (Funded by the National Institutes of Health Intramural Research Programs and others.) Adenosine deaminase 2 (ADA2) is an enzyme involved in purine metabolism and a growth factor that influences the development of endothelial cells and leukocytes. This study shows that defects in ADA2 cause recurrent fevers, vascular pathologic features, and mild immunodeficiency. Patients with autoinflammatory disease sometimes present with clinical findings that encompass multiple organ systems.(1) Three unrelated children presented to the National Institutes of Health (NIH) Clinical Center with intermittent fevers, recurrent lacunar strokes, elevated levels of acute-phase reactants, livedoid rash, hepatosplenomegaly, and hypogammaglobulinemia. Collectively, these findings do not easily fit with any of the known inherited autoinflammatory diseases. Hereditary or acquired vascular disorders can have protean manifestations yet be caused by mutations in a single gene. Diseases such as the Aicardi-Goutieres syndrome,(2),(3) polypoidal choroidal vasculopathy,(4) sickle cell anemia,(5) livedoid vasculopathy,(6) and the small-vessel vasculitides(7),(8) are examples of systemic ...	[Zhou, Qing; Ombrello, Amanda K.; Toro, Camilo; Stone, Deborah L.; Chae, Jae Jin; Bishop, Kevin; Hoffmann, Patrycja; Pei, Wuhong; Silvin, Christopher; Chin, David T.; Wood, Geryl M.; Mullikin, James C.; Candotti, Fabio; Barham, Beverly K.; Jones, Anne; Remmers, Elaine F.; Burgess, Shawn M.; Sood, Raman; Kastner, Daniel L.; Aksentijevich, Ivona] NHGRI, Bethesda, MD 20892 USA; [Yang, Dan; Negro, Alejandra; Boehm, Manfred] NHLBI, Bethesda, MD 20892 USA; [Rosenzweig, Sergio D.; Barron, Karyl S.; Milner, Joshua D.; Barber, John S.; Moir, Susan L.] NIAID, Bethesda, MD 20892 USA; [Kuehn, Hye Sun; Patronas, Nicholas J.; Ling, Alexander; Calvo, Katherine R.; Fleisher, Thomas A.] NIH, Ctr Clin, Bethesda, MD 20892 USA; [Tsai, Wanxia L.; Goldbach-Mansky, Raphaela; Gadina, Massimo] NIAMSD, Bethesda, MD 20892 USA; [Cowen, Edward W.; Lee, Chyi-Chia R.; Kleiner, David E.; Kong, Heidi H.; Quezado, Martha M.] NCI, Bethesda, MD 20892 USA; [Heller, Theo; Alao, Hawwa] NIDDK, Bethesda, MD 20892 USA; [Zavialov, Andrey V.; Zavialov, Anton V.] Univ Turku, Turku, Finland; [Kelly, Susan J.; Ganson, Nancy J.; Hershfield, Michael S.] Duke Univ Med Ctr, Durham, NC USA; [Gershon, Timothy R.] Univ N Carolina Neurosci Ctr, Chapel Hill, NC USA; [Hambleton, Sophie; Abinun, Mario] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Meschia, James F.] Mayo Clin Florida, Jacksonville, FL USA; [Worrall, Bradford B.; Rich, Stephen S.] Univ Virginia, Charlottesville, VA USA; [Kasner, Scott E.] Univ Penn, Philadelphia, PA 19104 USA; [Chalom, Elizabeth] Barnabas Hlth, W Orange, NJ USA; [Gotte, Alisa C.; Punaro, Marilynn] Texas Scottish Rite Hosp Crippled Children, Dallas, TX USA; [Pascual, Virginia] Baylor Inst Immunol Res, Dallas, TX USA; [Verbsky, James W.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Torgerson, Troy R.] Univ Washington, Seattle, WA 98195 USA; [Torgerson, Troy R.] Seattle Childrens Res Inst, Seattle, WA 98195 USA; [Singer, Nora G.] Metro Hlth Med Ctr, Cleveland, OH USA; [Singer, Nora G.] Case Western Reserve Univ, Sch Med, Cleveland, OH USA; [Ozen, Seza; Karadag, Omer] Hacettepe Univ, Fac Med, TR-06100 Ankara, Turkey	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Turku; Duke University; University of North Carolina; University of North Carolina Chapel Hill; Newcastle University - UK; Mayo Clinic; University of Virginia; University of Pennsylvania; Texas Scottish Rite Hospital for Children; Baylor Scott & White Health; Medical College of Wisconsin; University of Washington; University of Washington Seattle; Seattle Children's Hospital; MetroHealth System; Case Western Reserve University; Hacettepe University	Aksentijevich, I (corresponding author), NHGRI, NIH, Bldg 10, Bethesda, MD 20892 USA.	askentii@exchange.nih.gov; askentii@exchange.nih.gov	Gadina, Massimo/R-4195-2019; Kong, Heidi H/L-4856-2018; Karadag, Omer/I-9042-2013; Karadag, Omer/AAR-4219-2020; Pascual, Virginia/ABD-3099-2020; Aksentijevich, Ivona/AAF-1335-2019; Zavialov, Anton V./C-7664-2015; Karadag, Omer/AAD-5448-2019; Moir, Susan/AAC-3676-2020; Gershon, Timothy/H-5398-2019; Goldbach-Mansky, Raphaela/N-5917-2017; OZEN, SEZA/I-9096-2013; Lee, Chyi-Chia Richard/AAO-1149-2020; Kleiner, David E/N-2770-2013; Meschia, James/GPP-1636-2022; Yu, Xiaomin/I-6407-2016; Lee, Chyi-Chia/I-1938-2013	Kong, Heidi H/0000-0003-4424-064X; Karadag, Omer/0000-0002-3443-3117; Karadag, Omer/0000-0002-3443-3117; Zavialov, Anton V./0000-0001-6191-5931; Gershon, Timothy/0000-0001-7034-6400; Kleiner, David E/0000-0003-3442-4453; Meschia, James/0000-0002-4475-8142; Zavialov, Andrey/0000-0001-6420-0368; Calvo, Katherine/0000-0002-0771-4191; Candotti, Fabio/0000-0001-6399-6042; Heller, Theo/0000-0002-2643-6289; Lee, Chyi-Chia/0000-0002-5306-7781; Remmers, Elaine F/0000-0002-9522-1249; Rich, Stephen/0000-0003-3872-7793; Ombrello, Amanda/0000-0001-5563-9416; Dichgans, Martin/0000-0002-0654-387X; Singer, Nora/0000-0001-7041-723X	National Institutes of Health (NIH) Intramural Research Programs; National Human Genome Research Institute; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Heart, Lung, and Blood Institute (NHLBI); National Institute of Allergy and Infectious Diseases; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; Undiagnosed Diseases Program of the Common Fund of the Office of the Director of the NIH; NIH Clinical Center; Sigma Tau Pharmaceuticals; Finnish Academy; The Sir Jules Thorn Charitable Trust [12JTA] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [ZICBC010687, ZIDBC011317] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006077, ZIAHL006079] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200372, ZIAHG200392, ZIBHG000196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000825, ZIAAI001183, ZIAAI001122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZICAR041181, ZIHAR041173, ZIDAR041180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075008] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL010304, ZIACL090025, ZIACL010346] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Intramural Research Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Undiagnosed Diseases Program of the Common Fund of the Office of the Director of the NIH; NIH Clinical Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sigma Tau Pharmaceuticals; Finnish Academy(Academy of Finland); The Sir Jules Thorn Charitable Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); CLINICAL CENTER	Supported by the National Institutes of Health (NIH) Intramural Research Programs, including the Intramural Research Programs of the National Human Genome Research Institute, the National Institute of Arthritis and Musculoskeletal and Skin Diseases, the National Heart, Lung, and Blood Institute (NHLBI), the National Institute of Allergy and Infectious Diseases, the National Institute of Diabetes and Digestive and Kidney Diseases, the National Cancer Institute, the Undiagnosed Diseases Program of the Common Fund of the Office of the Director of the NIH, and the NIH Clinical Center; and by grants from Sigma Tau Pharmaceuticals (to Dr. Hershfield) and the Finnish Academy (to Drs. Andrey and Anton Zavialov).	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Butler MG, 2011, METHOD CELL BIOL, V105, P137, DOI 10.1016/B978-0-12-381320-6.00006-0; Cassani B, 2008, BLOOD, V111, P4209, DOI 10.1182/blood-2007-05-092429; Chen CJ, 2013, NEW ENGL J MED, V368, P1260, DOI 10.1056/NEJMc1300259; Crow YJ, 2009, HUM MOL GENET, V18, pR130, DOI 10.1093/hmg/ddp293; du Moulin M, 2011, P NATL ACAD SCI USA, V108, pE232, DOI 10.1073/pnas.1104699108; Elkan PN, 2014, NEW ENGL J MED, V370, P921, DOI 10.1056/NEJMoa1307362; Federico A, 2012, J NEUROL SCI, V322, P25, DOI 10.1016/j.jns.2012.07.041; Frances C, 1999, MEDICINE, V78, P209, DOI 10.1097/00005792-199907000-00001; Hershfield M., 2004, IMMUNOLOGIC DISORDER, P480; Iijima R, 2008, J BIOL CHEM, V283, P2255, DOI 10.1074/jbc.M709279200; Kastner DL, 2010, CELL, V140, P784, DOI 10.1016/j.cell.2010.03.002; Kato Gregory J, 2009, Am J Hematol, V84, P618, DOI 10.1002/ajh.21475; Khenifer S, 2010, CLIN EXP DERMATOL, V35, P693, DOI 10.1111/j.1365-2230.2009.03732.x; Lima LH, 2010, OPHTHALMOLOGY, V117, P1567, DOI 10.1016/j.ophtha.2009.12.018; Maier SA, 2001, GENE, V280, P27, DOI 10.1016/S0378-1119(01)00762-4; Meschia James F, 2002, BMC Med Genet, V3, P1, DOI 10.1186/1471-2350-3-1; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Rey-Giraud F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042656; Rost NS, 2010, NEUROLOGY, V75, P1670, DOI 10.1212/WNL.0b013e3181fc279a; Talarico R, 2012, CLIN EXP RHEUMATOL, V30, pS130; Wardlaw JM, 2013, LANCET NEUROL, V12, P483, DOI 10.1016/S1474-4422(13)70060-7; Woollard KJ, 2010, NAT REV CARDIOL, V7, P77, DOI 10.1038/nrcardio.2009.228; Zavialov AV, 2010, J LEUKOCYTE BIOL, V88, P279, DOI 10.1189/jlb.1109764; Zavialov AV, 2010, J BIOL CHEM, V285, P12367, DOI 10.1074/jbc.M109.083527	25	476	493	5	70	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 6	2014	370	10					911	920		10.1056/NEJMoa1307361	http://dx.doi.org/10.1056/NEJMoa1307361			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC2EB	24552284	Green Published, Green Accepted			2022-12-28	WOS:000332309800008
J	Mack, SC; Witt, H; Piro, RM; Gu, L; Zuyderduyn, S; Stutz, AM; Wang, X; Gallo, M; Garzia, L; Zayne, K; Zhang, X; Ramaswamy, V; Jager, N; Jones, DTW; Sill, M; Pugh, TJ; Ryzhova, M; Wani, KM; Shih, DJH; Head, R; Remke, M; Bailey, SD; Zichner, T; Faria, CC; Barszczyk, M; Stark, S; Seker-Cin, H; Hutter, S; Johann, P; Bender, S; Hovestadt, V; Tzaridis, T; Dubuc, AM; Northcott, PA; Peacock, J; Bertrand, KC; Agnihotri, S; Cavalli, FMG; Clarke, I; Nethery-Brokx, K; Creasy, CL; Verma, SK; Koster, J; Wu, X; Yao, Y; Milde, T; Sin-Chan, P; Zuccaro, J; Lau, L; Pereira, S; Castelo-Branco, P; Hirst, M; Marra, MA; Roberts, SS; Fults, D; Massimi, L; Cho, YJ; Van Meter, T; Grajkowska, W; Lach, B; Kulozik, AE; von Deimling, A; Witt, O; Scherer, SW; Fan, X; Muraszko, KM; Kool, M; Pomeroy, SL; Gupta, N; Phillips, J; Huang, A; Tabori, U; Hawkins, C; Malkin, D; Kongkham, PN; Weiss, WA; Jabado, N; Rutka, JT; Bouffet, E; Korbel, JO; Lupien, M; Aldape, KD; Bader, GD; Eils, R; Lichter, P; Dirks, PB; Pfister, SM; Korshunov, A; Taylor, MD				Mack, S. C.; Witt, H.; Piro, R. M.; Gu, L.; Zuyderduyn, S.; Stuetz, A. M.; Wang, X.; Gallo, M.; Garzia, L.; Zayne, K.; Zhang, X.; Ramaswamy, V.; Jaeger, N.; Jones, D. T. W.; Sill, M.; Pugh, T. J.; Ryzhova, M.; Wani, K. M.; Shih, D. J. H.; Head, R.; Remke, M.; Bailey, S. D.; Zichner, T.; Faria, C. C.; Barszczyk, M.; Stark, S.; Seker-Cin, H.; Hutter, S.; Johann, P.; Bender, S.; Hovestadt, V.; Tzaridis, T.; Dubuc, A. M.; Northcott, P. A.; Peacock, J.; Bertrand, K. C.; Agnihotri, S.; Cavalli, F. M. G.; Clarke, I.; Nethery-Brokx, K.; Creasy, C. L.; Verma, S. K.; Koster, J.; Wu, X.; Yao, Y.; Milde, T.; Sin-Chan, P.; Zuccaro, J.; Lau, L.; Pereira, S.; Castelo-Branco, P.; Hirst, M.; Marra, M. A.; Roberts, S. S.; Fults, D.; Massimi, L.; Cho, Y. J.; Van Meter, T.; Grajkowska, W.; Lach, B.; Kulozik, A. E.; von Deimling, A.; Witt, O.; Scherer, S. W.; Fan, X.; Muraszko, K. M.; Kool, M.; Pomeroy, S. L.; Gupta, N.; Phillips, J.; Huang, A.; Tabori, U.; Hawkins, C.; Malkin, D.; Kongkham, P. N.; Weiss, W. A.; Jabado, N.; Rutka, J. T.; Bouffet, E.; Korbel, J. O.; Lupien, M.; Aldape, K. D.; Bader, G. D.; Eils, R.; Lichter, P.; Dirks, P. B.; Pfister, S. M.; Korshunov, A.; Taylor, M. D.			Epigenomic alterations define lethal CIMP-positive ependymomas of infancy	NATURE			English	Article							ISLAND METHYLATOR PHENOTYPE; GENE-EXPRESSION SIGNATURE; DRIVER MUTATIONS; GENOMIC COMPLEXITY; DISTINCT SUBGROUPS; CANCER; LANDSCAPE; STRATEGY; SUBTYPE	Ependymomas are common childhood brain tumours that occur throughout the nervous system, but are most common in the paediatric hindbrain. Current standard therapy comprises surgery and radiation, but not cytotoxic chemotherapy as it does not further increase survival. Whole-genome and whole-exome sequencing of 47 hindbrain ependymomas reveals an extremely low mutation rate, and zero significant recurrent somatic single nucleotide variants. Although devoid of recurrent single nucleotide variants and focal copy number aberrations, poor-prognosis hindbrain ependymomas exhibit a CpG island methylator phenotype. Transcriptional silencing driven by CpG methylation converges exclusively on targets of the Polycomb repressive complex 2 which represses expression of differentiation genes through trimethylation of H3K27. CpG island methylator phenotype-positive hindbrain ependymomas are responsive to clinical drugs that target either DNA or H3K27 methylation both in vitro and in vivo. We conclude that epigenetic modifiers are the first rational therapeutic candidates for this deadly malignancy, which is epigenetically deregulated but genetically bland.	[Mack, S. C.; Wang, X.; Gallo, M.; Garzia, L.; Zayne, K.; Ramaswamy, V.; Shih, D. J. H.; Head, R.; Remke, M.; Faria, C. C.; Barszczyk, M.; Dubuc, A. M.; Peacock, J.; Bertrand, K. C.; Agnihotri, S.; Cavalli, F. M. G.; Clarke, I.; Nethery-Brokx, K.; Wu, X.; Yao, Y.; Sin-Chan, P.; Zuccaro, J.; Lau, L.; Pereira, S.; Castelo-Branco, P.; Scherer, S. W.; Huang, A.; Tabori, U.; Hawkins, C.; Kongkham, P. N.; Rutka, J. T.; Dirks, P. B.; Taylor, M. D.] Hosp Sick Children, Dev & Stem Cell Biol Program, Arthur & Sonia Labatt Brain Tumour Res Ctr, Toronto, ON M5G 1L7, Canada; [Mack, S. C.; Wang, X.; Ramaswamy, V.; Shih, D. J. H.; Remke, M.; Barszczyk, M.; Dubuc, A. M.; Peacock, J.; Bertrand, K. C.; Yao, Y.; Hawkins, C.; Kongkham, P. N.; Rutka, J. T.; Dirks, P. B.; Taylor, M. D.] Univ Toronto, Toronto, ON M5S 1A8, Canada; [Mack, S. C.; Kongkham, P. N.; Rutka, J. T.; Dirks, P. B.; Taylor, M. D.] Univ Toronto, Div Neurosurg, Toronto, ON M5S 1A8, Canada; [Witt, H.; Jones, D. T. W.; Ryzhova, M.; Stark, S.; Seker-Cin, H.; Hutter, S.; Johann, P.; Bender, S.; Tzaridis, T.; Northcott, P. A.; Kool, M.; Pfister, S. M.] German Canc Res Ctr, Div Pediat Neurooncol, D-69120 Heidelberg, Germany; [Witt, H.; Milde, T.; Kulozik, A. E.; Witt, O.; Pfister, S. M.] Heidelberg Univ, Dept Pediat Oncol Hematol & Immunol, D-69120 Heidelberg, Germany; [Witt, H.; Piro, R. M.; Gu, L.; Stuetz, A. M.; Jaeger, N.; Jones, D. T. W.; Sill, M.; Ryzhova, M.; Zichner, T.; Stark, S.; Seker-Cin, H.; Hutter, S.; Johann, P.; Bender, S.; Hovestadt, V.; Tzaridis, T.; Northcott, P. A.; Milde, T.; Kulozik, A. E.; von Deimling, A.; Witt, O.; Kool, M.; Eils, R.; Lichter, P.; Pfister, S. M.; Korshunov, A.] German Canc Consortium DKTK, D-69120 Heidelberg, Germany; [Piro, R. M.; Hovestadt, V.; Lichter, P.] German Canc Res Ctr, Div Mol Genet, D-69120 Heidelberg, Germany; [Gu, L.; Jaeger, N.; Eils, R.] German Canc Res Ctr, Div Theoret Bioinformat, D-69120 Heidelberg, Germany; [Zuyderduyn, S.; Bader, G. D.] Univ Toronto, Donnelly Ctr, Banting & Best Dept Med Res, Dept Mol Genet, Toronto, ON M4N 1X8, Canada; [Stuetz, A. M.; Zichner, T.; Korbel, J. O.] European Mol Biol, Genome Biol, D-69117 Heidelberg, Germany; [Zhang, X.] Dartmouth Med Sch, Norris Cotton Canc Ctr, Dept Genet, Lebanon, NH 03756 USA; [Sill, M.] German Canc Res Ctr, Div Bioinformat, D-69120 Heidelberg, Germany; [Pugh, T. J.; Pomeroy, S. L.] Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Neurol,MIT, Boston, MA 02115 USA; [Wani, K. M.; Aldape, K. D.] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Bailey, S. D.; Lupien, M.] Univ Hlth Network, Princess Margaret Canc Ctr, Ontario Canc Inst, Toronto, ON M5G 1L7, Canada; [Bailey, S. D.; Lupien, M.] Ontario Inst Canc Res, Toronto, ON M5G 1L7, Canada; [Creasy, C. L.; Verma, S. K.] GlaxoSmithKline, Canc Epigenet Discovery Performance Unit, Collegeville, PA 19426 USA; [Koster, J.] Acad Med Ctr, Dept Oncogen, NL-1105 Amsterdam, Netherlands; [Milde, T.; Witt, O.] German Canc Res Ctr, CCU Pediat Oncol, D-69120 Heidelberg, Germany; [Hirst, M.] Univ British Columbia, Dept Microbiol & Immunol, Ctr High Throughput Biol, Vancouver, BC V6T 1Z4, Canada; [Hirst, M.; Marra, M. A.] BC Canc Agcy, Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada; [Marra, M. A.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6H 3N1, Canada; [Roberts, S. S.] Uniformed Serv Univ Hlth Sci, Dept Pediat, Bethesda, MD 20814 USA; [Roberts, S. S.] Uniformed Serv Univ Hlth Sci, Natl Capital Consortium, Bethesda, MD 20814 USA; [Fults, D.] Univ Utah, Sch Med, Dept Neurosurg, Salt Lake City, UT 84132 USA; [Massimi, L.] Univ Cattolica Sacro Cuore, Sch Med, Gemelli Hosp, I-00168 Rome, Italy; [Cho, Y. J.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Van Meter, T.] Virginia Commonwealth, Dept Pediat, Richmond, VA 23298 USA; [Grajkowska, W.] Univ Warsaw, Dept Pathol, Childrens Mem Hlth Inst, PL-04730 Warsaw, Poland; [Lach, B.] McMaster Univ, Hamilton Gen Hosp, Div Anat Pathol, Dept Pathol & Mol Med, Hamilton, ON L8S 4K1, Canada; [von Deimling, A.] Heidelberg Univ, Inst Pathol, Dept Neuropathol, D-69120 Heidelberg, Germany; [Fan, X.; Korshunov, A.] Univ Michigan Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Fan, X.; Muraszko, K. M.] Univ Michigan, Sch Med, Dept Neurosurg, Ann Arbor, MI 48109 USA; [Gupta, N.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA; [Phillips, J.; Weiss, W. A.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Phillips, J.; Weiss, W. A.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94158 USA; [Phillips, J.; Weiss, W. A.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94158 USA; [Huang, A.; Tabori, U.; Bouffet, E.] Hosp Sick Children, Dept Neurooncol, Toronto, ON M5G 1X8, Canada; [Malkin, D.] Hosp Sick Children, Dept Haematol & Oncol, Toronto, ON M5G 1X8, Canada; [Jabado, N.] McGill Univ, Dept Pediat, Montreal, PQ H3Z 2Z3, Canada; [Jabado, N.] McGill Univ, Dept Human Genet, Montreal, PQ H3Z 2Z3, Canada; [Jabado, N.] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ H3Z 2Z3, Canada; [Lupien, M.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1X8, Canada; [Dirks, P. B.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Korshunov, A.] German Canc Res Ctr, CCU Neuropathol, D-69120 Heidelberg, Germany	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Toronto; Dartmouth College; Norris Cotton Cancer Center; Helmholtz Association; German Cancer Research Center (DKFZ); Harvard University; Boston Children's Hospital; Harvard Medical School; Massachusetts Institute of Technology (MIT); University of Texas System; UTMD Anderson Cancer Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; GlaxoSmithKline; Helmholtz Association; German Cancer Research Center (DKFZ); University of British Columbia; British Columbia Cancer Agency; University of British Columbia; Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA; Utah System of Higher Education; University of Utah; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Stanford University; Virginia Commonwealth University; Children's Memorial Health Institute; University of Warsaw; McMaster University; Ruprecht Karls University Heidelberg; University of Michigan System; University of Michigan; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McGill University; McGill University; McGill University; University of Toronto; University of Toronto; Helmholtz Association; German Cancer Research Center (DKFZ)	Korshunov, A (corresponding author), German Canc Consortium DKTK, D-69120 Heidelberg, Germany.	Andrey.Korshunov@med.uni-heidelberg.de; mdtaylor@sickkids.ca	Jabado, Nada/AAN-4026-2020; Bader, Gary/C-1176-2009; von Deimling, Andreas/F-7774-2013; Pereira, Sergio L/B-1984-2010; Piro, Rosario M./AAT-6937-2020; Eils, Roland/B-6121-2009; Marra, Marco A/B-5987-2008; Bouffet, Eric/AAB-8999-2020; Jones, David T. W./Z-1963-2019; Kool, Marcel/H-2541-2013; Wang, Xin/U-7221-2017; Wang, Xin/O-8779-2019; Johann, Pascal David/AAT-9368-2021; Jones, David TW/G-9588-2013; Northcott, Paul A/N-4022-2018; Kulozik, Andreas/AAO-2432-2020; Koster, Jan/C-5934-2008; Pugh, Trevor/Y-2535-2019; Milde, Till/L-7755-2015; Scherer, Stephen W./B-3785-2013; Ryzhova, Marina/G-4178-2014; Hirst, Martin/B-7684-2016; Hawkins, Cynthia/M-2571-2019; Korbel, Jan O/G-6470-2012; Shih, David J H/H-3186-2011; Shih, David J. H./AAE-8726-2019; Malkin, David/AAW-8715-2021; Milde, Till/AAR-4528-2021; Pfister, Stefan M/F-6860-2013; Witt, Hendrik/L-7810-2015	Bader, Gary/0000-0003-0185-8861; von Deimling, Andreas/0000-0002-5863-540X; Pereira, Sergio L/0000-0002-2796-5625; Piro, Rosario M./0000-0002-3066-7397; Eils, Roland/0000-0002-0034-4036; Marra, Marco A/0000-0001-7146-7175; Wang, Xin/0000-0001-6292-3087; Wang, Xin/0000-0001-6292-3087; Jones, David TW/0000-0002-2036-5141; Northcott, Paul A/0000-0002-1220-5252; Koster, Jan/0000-0002-0890-7585; Pugh, Trevor/0000-0002-8073-5888; Scherer, Stephen W./0000-0002-8326-1999; Ryzhova, Marina/0000-0001-7206-6365; Korbel, Jan O/0000-0002-2798-3794; Shih, David J H/0000-0002-9802-4937; Shih, David J. H./0000-0002-9802-4937; Milde, Till/0000-0002-7267-1052; Pfister, Stefan M/0000-0002-5447-5322; Jaeger, Natalie/0000-0002-9589-7580; Wang, Xin/0000-0001-8783-4080; Faria, Claudia/0000-0003-1259-9922; Kongkham, Paul/0000-0002-1047-9305; Ramaswamy, Vijay/0000-0002-6557-895X; Weiss, William/0000-0003-2230-9132; Grajkowska, Wieslawa/0000-0001-8318-5781; Castelo-Branco, Pedro/0000-0002-3453-3978; Remke, Marc/0000-0002-9404-9993; Zichner, Thomas/0000-0001-9848-7598; Hovestadt, Volker/0000-0002-3480-6649; Sill, Martin/0000-0001-7616-7665; Gallo, Marco/0000-0002-8451-8207; Mack, Stephen C./0000-0001-9620-4742; Korshunov, Andrey/0000-0002-5257-3623; Stuetz, Adrian/0000-0001-7650-3470; Tzaridis, Theophilos/0000-0001-9651-1144; Taylor, Michael/0000-0001-7009-3466; Tabori, Uri/0000-0002-5019-2683; Lupien, Mathieu/0000-0003-0929-9478; Cavalli, Florence M. G./0000-0002-4409-9642	Canadian Institutes of Health Research (CIHR); Garron Family Chair in Childhood Cancer Research; Cure Search Foundation; Younger Foundation; National Institutes of Health [R01CA148699, R01CA159859]; Pediatric Brain Tumor Foundation; Canadian Cancer Society; Terry Fox Research Institute; Brainchild; CIHR; Ontario Institute for Cancer Research through the Government of Ontario; Cure Search for Children's Cancer; PedBrain Tumor Project; German Cancer Aid [109252]; German Federal Ministry of Education and Research (BMBF) [01KU1201A, MedSys 0315416C, NGFNplus 01GS0883]; Sander Foundation; DKTK (Molecular Diagnostics of Pediatric Malignancies); NATIONAL CANCER INSTITUTE [P50CA097257, R01CA121941, R01CA159859, P30CA016672, R01CA148621, R01CA148699, R01CA163737] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Garron Family Chair in Childhood Cancer Research; Cure Search Foundation; Younger Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pediatric Brain Tumor Foundation; Canadian Cancer Society(Canadian Cancer Society (CCS)); Terry Fox Research Institute; Brainchild; CIHR(Canadian Institutes of Health Research (CIHR)); Ontario Institute for Cancer Research through the Government of Ontario; Cure Search for Children's Cancer; PedBrain Tumor Project; German Cancer Aid(Deutsche Krebshilfe); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Sander Foundation; DKTK (Molecular Diagnostics of Pediatric Malignancies); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	M.D.T. holds a Canadian Institutes of Health Research (CIHR) Clinician-Scientist Phase II Award, was a Sontag Foundation Distinguished Scholar, and is supported by The Garron Family Chair in Childhood Cancer Research. M. D. T. is supported by grants from the Cure Search Foundation, The Younger Foundation, the National Institutes of Health (R01CA148699 and R01CA159859), The Pediatric Brain Tumor Foundation, The Canadian Cancer Society, The Terry Fox Research Institute, and Brainchild. S. M., K. M. W. and A. D. are supported by Vanier Scholarships from CIHR. S. M. would like to thank K. Mack, R. Mack, S. Mack and K. Bertrand for their support of this project. This study was conducted with the support of the Ontario Institute for Cancer Research through funding provided by the Government of Ontario. This work was also supported by a Program Project Grant from the Terry Fox Research Institute, and a Grand Challenge Award from Cure Search for Children's Cancer. Additionally, this work was supported by the PedBrain Tumor Project contributing to the International Cancer Genome Consortium, funded by German Cancer Aid (109252) and by the German Federal Ministry of Education and Research (BMBF, grants 01KU1201A, MedSys 0315416C and NGFN<SUP>plus</SUP> 01GS0883). This study was supported by grants from the Sander Foundation and DKTK (Molecular Diagnostics of Pediatric Malignancies). For technical support and expertise of next-generation sequencing efforts we thank the DKFZ Genomics and Proteomics Core Facility, The EMBL Genomics Core Facility, and The Centre for Applied Genomics (Toronto). We thank S. Archer for technical writing and C. Smith for artwork. We thank A. Wittmann, L. Sieber and L. Linke for clinical assistance.	Atkinson JM, 2011, CANCER CELL, V20, P384, DOI 10.1016/j.ccr.2011.08.013; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Bouffet E, 1999, CHILD NERV SYST, V15, P563, DOI 10.1007/s003810050544; Bouffet E, 2012, INT J RADIAT ONCOL, V83, P1541, DOI 10.1016/j.ijrobp.2011.10.039; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Dees ND, 2012, GENOME RES, V22, P1589, DOI 10.1101/gr.134635.111; Down TA, 2008, NAT BIOTECHNOL, V26, P779, DOI 10.1038/nbt1414; Fang F, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001875; Gallo M, 2013, CANCER RES, V73, P417, DOI 10.1158/0008-5472.CAN-12-1881; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Johnson RA, 2010, NATURE, V466, P632, DOI 10.1038/nature09173; Jones DTW, 2012, NATURE, V488, P100, DOI 10.1038/nature11284; Kantarjian H, 2006, CANCER-AM CANCER SOC, V106, P1794, DOI 10.1002/cncr.21792; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee RS, 2012, J CLIN INVEST, V122, P2983, DOI 10.1172/JCI64400; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; Merchant TE, 2009, LANCET ONCOL, V10, P258, DOI 10.1016/S1470-2045(08)70342-5; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Northcott PA, 2012, NATURE, V488, P49, DOI 10.1038/nature11327; Northcott PA, 2009, NAT GENET, V41, P465, DOI 10.1038/ng.336; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Peifer M, 2012, NAT GENET, V44, P1104, DOI 10.1038/ng.2396; Pugh TJ, 2013, NAT GENET, V45, P279, DOI 10.1038/ng.2529; Pugh TJ, 2012, NATURE, V488, P106, DOI 10.1038/nature11329; Robinson G, 2012, NATURE, V488, P43, DOI 10.1038/nature11213; Roman-Gomez J, 2005, J CLIN ONCOL, V23, P7043, DOI 10.1200/JCO.2005.01.4944; Sausen M, 2013, NAT GENET, V45, P12, DOI 10.1038/ng.2493; Schwartzentruber J, 2012, NATURE, V482, P226, DOI [10.1038/nature10833, 10.1007/s13311-012-0137-6]; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Wani K, 2012, ACTA NEUROPATHOL, V123, P727, DOI 10.1007/s00401-012-0941-4; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Witt H, 2011, CANCER CELL, V20, P143, DOI 10.1016/j.ccr.2011.07.007; Wu G, 2012, NAT GENET, V44, P251, DOI 10.1038/ng.1102; Zhang JH, 2012, NATURE, V481, P329, DOI 10.1038/nature10733; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725; Zouridis H, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004504	50	407	415	0	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2014	506	7489					445	+		10.1038/nature13108	http://dx.doi.org/10.1038/nature13108			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0DN	24553142	Green Accepted			2022-12-28	WOS:000332165100029
J	Moran, M				Moran, Mary			WHO plans for neglected diseases are wrong	NATURE			English	Editorial Material									Policy Cures, Sydney, NSW, Australia		Moran, M (corresponding author), Policy Cures, Sydney, NSW, Australia.	mmoran@policycures.org						2014, NATURE, V505, P142	1	2	2	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 20	2014	506	7488					267	267		10.1038/506267a	http://dx.doi.org/10.1038/506267a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB0JL	24553204	Bronze			2022-12-28	WOS:000331477800004
J	Jerven, M				Jerven, Morten			Poor numbers and what to do about them	LANCET			English	Editorial Material									Simon Fraser Univ, Sch Int Studies, Vancouver, BC V6B 5K3, Canada	Simon Fraser University	Jerven, M (corresponding author), Simon Fraser Univ, Sch Int Studies, Vancouver, BC V6B 5K3, Canada.	mjerven@sfu.ca		Jerven, Morten/0000-0002-7302-3575					0	3	3	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 15	2014	383	9917					594	595		10.1016/S0140-6736(14)60209-9	http://dx.doi.org/10.1016/S0140-6736(14)60209-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AA5KP	24551888	Bronze			2022-12-28	WOS:000331137700017
J	Anglemyer, A; Horvath, T; Rutherford, G				Anglemyer, Andrew; Horvath, Tara; Rutherford, George			The Accessibility of Firearms and Risk for Suicide and Homicide Victimization Among Household Members	ANNALS OF INTERNAL MEDICINE			English	Review							UNITED-STATES; VIOLENT DEATH; ADOLESCENT SUICIDE; YOUTH SUICIDE; GENDER-GAP; GUN; ACCESS; MORTALITY; FATALITIES; RATES	Background: Research suggests that access to firearms in the home increases the risk for violent death. Purpose: To understand current estimates of the association between firearm availability and suicide or homicide. Data Sources: PubMed, EMBASE, the Cochrane Central Register of Controlled Trials, and Web of Science were searched without limitations and a gray-literature search was performed on 23 August 2013. Study Selection: All study types that assessed firearm access and outcomes between participants with and without firearm access. There were no restrictions on age, sex, or country. Data Extraction: Two authors independently extracted data into a standardized, prepiloted data extraction form. Data Synthesis: Odds ratios (ORs) and 95% CIs were calculated, although published adjusted estimates were preferentially used. Summary effects were estimated using random-and fixed-effects models. Potential methodological reasons for differences in effects through subgroup analyses were explored. Data were pooled from 15 observational studies that assessed the odds of suicide or homicide, yielding pooled ORs of 3.24 (95% CI, 2.41 to 4.40) and 1.94 (CI, 1.44 to 2.93), respectively. When only studies that used interviews to determine firearm accessibility were considered, the pooled OR for suicide was 3.14 (CI, 2.29 to 4.43). Limitations: Firearm accessibility was determined by survey interviews in most studies; misclassification of accessibility may have occurred. Heterogeneous populations of varying risks were synthesized to estimate pooled odds of death. Conclusion: Access to firearms is associated with risk for completed suicide and being the victim of homicide.	[Anglemyer, Andrew; Horvath, Tara; Rutherford, George] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Anglemyer, A (corresponding author), Univ Calif San Francisco, UCSF Box 1224,50 Beale St,Suite 1200, San Francisco, CA 94143 USA.	Andrew.Anglemyer@ucsf.edu		Horvath, Hacsi/0000-0001-7569-3524; Anglemyer, Andrew/0000-0002-9091-496X				ALPHEY RS, 1974, ROY SOC HEALTH J, V94, P97, DOI 10.1177/146642407409400304; Andres AR, 2011, HEALTH POLICY, V101, P95, DOI 10.1016/j.healthpol.2010.10.005; Azrael D, 2004, SUICIDE LIFE-THREAT, V34, P36, DOI 10.1521/suli.34.1.36.27771; Bailey JE, 1997, ARCH INTERN MED, V157, P777, DOI 10.1001/archinte.157.7.777; Beautrais AL, 1996, AUST NZ J PSYCHIAT, V30, P741, DOI 10.3109/00048679609065040; BEAVER BL, 1990, J PEDIATR SURG, V25, P97, DOI 10.1016/S0022-3468(05)80171-X; Betz ME, 2011, SUICIDE LIFE-THREAT, V41, P384, DOI 10.1111/j.1943-278X.2011.00036.x; Branas CC, 2004, AM J PUBLIC HEALTH, V94, P1750, DOI 10.2105/AJPH.94.10.1750; Branas CC, 2009, AM J PUBLIC HEALTH, V99, P2034, DOI 10.2105/AJPH.2008.143099; Brent DA, 2003, AM BEHAV SCI, V46, P1192, DOI 10.1177/0002764202250662; Brent DA, 1999, J AM ACAD CHILD PSY, V38, P1497, DOI 10.1097/00004583-199912000-00010; BRENT DA, 1991, JAMA-J AM MED ASSOC, V266, P2989, DOI 10.1001/jama.266.21.2989; BRENT DA, 1993, AM J DIS CHILD, V147, P1066, DOI 10.1001/archpedi.1993.02160340052013; BRENT DA, 1993, J AM ACAD CHILD PSY, V32, P494, DOI 10.1097/00004583-199305000-00002; Bretsky PM, 1996, ANN EMERG MED, V28, P176, DOI 10.1016/S0196-0644(96)70059-8; BROWNING CH, 1976, JAMA-J AM MED ASSOC, V236, P2198, DOI 10.1001/jama.236.19.2198; Callanan VJ, 2012, SOC PSYCH PSYCH EPID, V47, P857, DOI 10.1007/s00127-011-0393-5; Campbell BT, 2004, J PEDIATR SURG, V39, P1874, DOI 10.1016/j.jpedsurg.2004.08.004; Caron J, 2008, SUICIDE LIFE-THREAT, V38, P195, DOI 10.1521/suli.2008.38.2.195; Carr BG, 2012, J TRAUMA ACUTE CARE, V73, P1006, DOI 10.1097/TA.0b013e318265d10a; Centers for Disease Control and Prevention, 2013, INJ PREV CONTR DAT S; Cherry D, 1998, ANN EMERG MED, V32, P51, DOI 10.1016/S0196-0644(98)70099-X; Christoffel K K, 1988, Pediatr Emerg Care, V4, P32, DOI 10.1097/00006565-198803000-00011; Conwell Y, 2002, AM J GERIAT PSYCHIAT, V10, P407, DOI 10.1176/appi.ajgp.10.4.407; Coyne-Beasley T, 2005, PEDIATRICS, V115, pE662, DOI 10.1542/peds.2004-2259; Cummings P, 1997, AM J PUBLIC HEALTH, V87, P974, DOI 10.2105/AJPH.87.6.974; Cummings P, 1998, JAMA-J AM MED ASSOC, V280, P471, DOI 10.1001/jama.280.5.471; Dahlberg LL, 2004, AM J EPIDEMIOL, V160, P929, DOI 10.1093/aje/kwh309; FLANDERS WD, 1989, J CLIN EPIDEMIOL, V42, P395, DOI 10.1016/0895-4356(89)90127-3; Fleegler EW, 2013, JAMA INTERN MED, V173, DOI [10.1001/jamainternmed.2013.9957, 10.1001/jamainternmed.2013.1286]; Fraga AMA, 2010, EUR J EPIDEMIOL, V25, P211, DOI 10.1007/s10654-009-9420-1; Gardner HG, 2012, PEDIATRICS, V130, pE1416, DOI 10.1542/peds.2012-2481; Grassel KM, 2003, INJ PREV, V9, P48, DOI 10.1136/ip.9.1.48; Grossman DC, 2005, JAMA-J AM MED ASSOC, V293, P707, DOI 10.1001/jama.293.6.707; Grossman DC, 1999, ARCH PEDIAT ADOL MED, V153, P875, DOI 10.1001/archpedi.153.8.875; Guolo A, 2012, J STAT SOFTW, V50, P1; Hepburn L, 2006, J TRAUMA, V61, P423, DOI 10.1097/01.ta.0000226396.51850.fc; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Ismach RB, 2003, ANN EMERG MED, V41, P10, DOI 10.1067/mem.2003.7; Johnson RM, 2010, SUICIDE LIFE-THREAT, V40, P609, DOI 10.1521/suli.2010.40.6.609; Kaplan MS, 2009, J TRAUMA, V67, P503, DOI 10.1097/TA.0b013e3181b36521; Karch Debra L., 2012, Morbidity and Mortality Weekly Report, V61, P1; KELLERMANN AL, 1992, NEW ENGL J MED, V327, P467, DOI 10.1056/NEJM199208133270705; Kellermann AL, 1998, NEW ENGL J MED, V339, P928, DOI 10.1056/NEJM199809243391320; KELLERMANN AL, 1986, NEW ENGL J MED, V314, P1557, DOI 10.1056/NEJM198606123142406; KELLERMANN AL, 1993, NEW ENGL J MED, V329, P1084, DOI 10.1056/NEJM199310073291506; KLECK G, 1992, NEW ENGL J MED, V327, P1878; Klein SD, 2010, SWISS MED WKLY, V140, DOI 10.4414/smw.2010.13102; Krug EG, 1998, INT J EPIDEMIOL, V27, P214, DOI 10.1093/ije/27.2.214; Kung HC, 2005, ANN EPIDEMIOL, V15, P614, DOI 10.1016/j.annepidem.2004.09.011; Kung HC, 2003, SOC PSYCH PSYCH EPID, V38, P419, DOI 10.1007/s00127-003-0656-x; Ladapo JA, 2013, JAMA-J AM MED ASSOC, V310, P532, DOI 10.1001/jama.2013.119355; Large MM, 2010, MED J AUSTRALIA, V192, P432, DOI 10.5694/j.1326-5377.2010.tb03580.x; Li G, 1997, Inj Prev, V3, P115, DOI 10.1136/ip.3.2.115; Li GH, 1996, ARCH PEDIAT ADOL MED, V150, P1160, DOI 10.1001/archpedi.1996.02170360050008; LITAKER D, 1994, NEW ENGL J MED, V330, P365; Ludwig J, 1998, AM J PUBLIC HEALTH, V88, P1715, DOI 10.2105/AJPH.88.11.1715; LUO M, 2013, NEW YORK TIMES 0928, pA1; Mahon MJ, 2005, AM J PSYCHIAT, V162, P1688, DOI 10.1176/appi.ajp.162.9.1688; MARTIN JR, 1991, ANN EMERG MED, V20, P58, DOI 10.1016/S0196-0644(05)81120-5; Miller M, 2002, J URBAN HEALTH, V79, P26, DOI 10.1093/jurban/79.1.26; Miller M, 2009, INJURY PREV, V15, P183, DOI 10.1136/ip.2008.021352; Miller M, 2007, J TRAUMA, V62, P1029, DOI 10.1097/01.ta.0000198214.24056.40; Miller M, 2007, SOC SCI MED, V64, P656, DOI 10.1016/j.socscimed.2006.09.024; Molina DK, 2008, AM J FOREN MED PATH, V29, P281, DOI 10.1097/PAF.0b013e31818480a4; MORROW PL, 1986, AM J PUBLIC HEALTH, V76, P1120, DOI 10.2105/AJPH.76.9.1120; Murnan J, 2004, J SCHOOL HEALTH, V74, P335, DOI 10.1111/j.1746-1561.2004.tb06624.x; Nance ML, 2010, PEDIATRICS, V125, P1112, DOI 10.1542/peds.2009-3219; Rausch TK, 1998, PEDIATR EMERG CARE, V14, P388, DOI 10.1097/00006565-199812000-00002; Richardson EG, 2011, J TRAUMA, V70, P238, DOI 10.1097/TA.0b013e3181dbaddf; Ruback RB, 2011, J INTERPERS VIOLENCE, V26, P2111, DOI 10.1177/0886260510372948; Rucker G, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-79; RUSHFORTH NB, 1974, AM J EPIDEMIOL, V100, P499, DOI 10.1093/oxfordjournals.aje.a112062; SACKS JJ, 1994, JAMA-J AM MED ASSOC, V272, P847, DOI 10.1001/jama.1994.03520110025011; SALTZMAN LE, 1992, JAMA-J AM MED ASSOC, V267, P3043, DOI 10.1001/jama.267.22.3043; Sauaia A, 2013, JAMA-J AM MED ASSOC, V309, P1683, DOI 10.1001/jama.2013.3354; Schwartz AJ, 2011, SUICIDE LIFE-THREAT, V41, P353, DOI 10.1111/j.1943-278X.2011.00034.x; Senger C, 2011, J PEDIATR SURG, V46, P927, DOI 10.1016/j.jpedsurg.2011.02.032; Shah S, 2000, J ADOLESCENT HEALTH, V26, P157, DOI 10.1016/S1054-139X(99)00064-6; Sillito CL, 2011, J FAM VIOLENCE, V26, P285, DOI 10.1007/s10896-011-9364-6; Sing RF, 1997, J TRAUMA, V43, P825, DOI 10.1097/00005373-199711000-00015; Smith TW, 2007, PUBL ATT REG FIR; Svenson JE, 1996, ARCH PEDIAT ADOL MED, V150, P583, DOI 10.1001/archpedi.1996.02170310017002; Thornton A, 2000, J CLIN EPIDEMIOL, V53, P207, DOI 10.1016/S0895-4356(99)00161-4; Uzun I, 2009, J FORENSIC SCI, V54, P1097, DOI 10.1111/j.1556-4029.2009.01115.x; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1029, DOI 10.1093/oxfordjournals.aje.a116397; Webster DW, 2000, PEDIATRICS, V106, P1466, DOI 10.1542/peds.106.6.1466; Wellford C. F., 2004, FIREARMS VIOLENCE CR; Wells G, 2003, 11 CHCHR C EV HLTH C; Wells G., 2013, NEWCASTLE OTTAWA SCA; Wiebe DJ, 2003, ACCIDENT ANAL PREV, V35, P711, DOI 10.1016/S0001-4575(02)00049-0; Wiebe DJ, 2003, ANN EMERG MED, V41, P771, DOI 10.1067/mem.2003.187; Wiebe DJ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-199; Wintemute GJ, 2011, INJURY PREV, V17, P422, DOI 10.1136/ip.2010.031443; Wintemute GJ, 1999, NEW ENGL J MED, V341, P1583, DOI 10.1056/NEJM199911183412106	95	319	320	3	55	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 21	2014	160	2					101	+		10.7326/M13-1301	http://dx.doi.org/10.7326/M13-1301			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	297SQ	24592495				2022-12-28	WOS:000330275600016
J	Fitzpatrick, MC; Hampson, K; Cleaveland, S; Mzimbiri, I; Lankester, F; Lembo, T; Meyers, LA; Paltiel, D; Galvani, AP				Fitzpatrick, Meagan C.; Hampson, Katie; Cleaveland, Sarah; Mzimbiri, Imam; Lankester, Felix; Lembo, Tiziana; Meyers, Lauren A.; Paltiel, David; Galvani, Alison P.			Cost-Effectiveness of Canine Vaccination to Prevent Human Rabies in Rural Tanzania	ANNALS OF INTERNAL MEDICINE			English	Article							POSTEXPOSURE PROPHYLAXIS; TRANSMISSION DYNAMICS; DOG-POPULATION; STRATEGIES; AFRICA; ELIMINATION; ECONOMICS; COVERAGE; DISEASE	Background: The annual mortality rate of human rabies in rural Africa is 3.6 deaths per 100 000 persons. Rabies can be prevented with prompt postexposure prophylaxis, but this is costly and often inaccessible in rural Africa. Because 99% of human exposures occur through rabid dogs, canine vaccination also prevents transmission of rabies to humans. Objective: To evaluate the cost-effectiveness of rabies control through annual canine vaccination campaigns in rural sub-Saharan Africa. Design: We model transmission dynamics in dogs and wildlife and assess empirical uncertainty in the biological variables to make probability-based evaluations of cost-effectiveness. Data Sources: Epidemiologic variables from a contact-tracing study and literature and cost data from ongoing vaccination campaigns. Target Population: Two districts of rural Tanzania: Ngorongoro and Serengeti. Time Horizon: 10 years. Perspective: Health policymaker. Intervention: Vaccination coverage ranging from 0% to 95% in increments of 5%. Outcome Measures: Life-years for health outcomes and 2010 U.S. dollars for economic outcomes. Results of Base-Case Analysis: Annual canine vaccination campaigns were very cost-effective in both districts compared with no canine vaccination. In Serengeti, annual campaigns with as much as 70% coverage were cost-saving. Results of Sensitivity Analysis: Across a wide range of variable assumptions and levels of societal willingness to pay for life-years, the optimal vaccination coverage for Serengeti was 70%. In Ngorongoro, although optimal coverage depended on willingness to pay, vaccination campaigns were always cost-effective and lifesaving and therefore preferred. Limitation: Canine vaccination was very cost-effective in both districts, but there was greater uncertainty about the optimal coverage in Ngorongoro. Conclusion: Annual canine rabies vaccination campaigns conferred extraordinary value and dramatically reduced the health burden of rabies.	Sch Publ Hlth, New Haven, CT USA; Yale Univ, New Haven, CT 06520 USA; Univ Glasgow, Boyd Orr Ctr Populat & Ecosyst Hlth, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; Univ Glasgow, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; Lincoln Pk Zoo, Serengeti Hlth Initiat, Chicago, IL USA; [Lankester, Felix] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA; Univ Texas Austin, Austin, TX 78712 USA; Santa Fe Inst, Santa Fe, NM 87501 USA	Yale University; University of Glasgow; University of Glasgow; Washington State University; University of Texas System; University of Texas Austin; The Santa Fe Institute	Fitzpatrick, MC (corresponding author), Yale Univ, Sch Publ Hlth, 60 Coll St, New Haven, CT 06520 USA.	meagan.fitzpatrick@yale.edu	Fitzpatrick, Meagan C/K-5083-2012	Fitzpatrick, Meagan C/0000-0002-5248-2668; Paltiel, A. David/0000-0002-4861-3290; Hampson, Katie/0000-0001-5392-6884; Lankester, Felix/0000-0002-0802-0693; Cleaveland, Sarah/0000-0002-0456-0959; Meyers, Lauren/0000-0002-5828-8874	National Institutes of Health; National Institute of General Medical Sciences [U01 GM087719]; National Institute of Allergy and Infectious Diseases, Multidisciplinary Parasitology Training Program [T32AI007404]; Lindsay Fellowship for Research in Africa; Wellcome Trust; National Institute on Drug Abuse [R01 DA015612]; National Science Foundation and National Institutes of Health [DEB0225453, DEB0513994]; Lincoln Park Zoo; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM087719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015612, R37DA015612] Funding Source: NIH RePORTER; Medical Research Council [G0901135] Funding Source: researchfish; MRC [G0901135] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Allergy and Infectious Diseases, Multidisciplinary Parasitology Training Program; Lindsay Fellowship for Research in Africa; Wellcome Trust(Wellcome TrustEuropean Commission); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Science Foundation and National Institutes of Health; Lincoln Park Zoo; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	By the National Institute of General Medical Sciences (U01 GM087719, Models of Infectious Disease Agent Study) and the Miriam Burnett Trust (Ms. Fitzpatrick and Dr. Galvani). Ms. Fitzpatrick also received support from the National Institute of Allergy and Infectious Diseases, Multidisciplinary Parasitology Training Program (T32AI007404), and Lindsay Fellowship for Research in Africa. Support for Dr. Hampson was provided by the Wellcome Trust. Dr. Paltiel received support from the National Institute on Drug Abuse (R01 DA015612). Vaccination campaigns were conducted and field data were generated with the support of the National Science Foundation and National Institutes of Health (DEB0225453 and DEB0513994), the Wellcome Trust, and Lincoln Park Zoo.	[Anonymous], 2001, NATL BURDEN DIS STUD; [Anonymous], 2011, TANZ GLOB HLTH IN ST; Beyer HL, 2012, VACCINE, V30, P1014, DOI 10.1016/j.vaccine.2011.12.052; BOGEL K, 1990, B WORLD HEALTH ORGAN, V68, P281; Brainerd E., 2001, DEATH MARKET; Braithwaite RS, 2008, MED CARE, V46, P349, DOI 10.1097/MLR.0b013e31815c31a7; Briggs AH, 2002, MED DECIS MAKING, V22, P290, DOI 10.1177/027298902400448867; BROOKS R, 1990, VET REC, V127, P592; Cleaveland S, 2002, B WORLD HEALTH ORGAN, V80, P304; Cliquet F, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001535; Coleman PG, 1996, VACCINE, V14, P185, DOI 10.1016/0264-410X(95)00197-9; Davlin SL, 2012, VACCINE, V30, P3492, DOI 10.1016/j.vaccine.2012.03.069; Fitzpatrick MC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001796; Hampson K, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000339; Hampson K, 2007, P NATL ACAD SCI USA, V104, P7717, DOI 10.1073/pnas.0609122104; Hampson K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000982; Hampson K, 2009, PLOS BIOL, V7, P462, DOI 10.1371/journal.pbio.1000053; Hemachudha T, 2002, LANCET NEUROL, V1, P101, DOI 10.1016/S1474-4422(02)00041-8; Kaare M, 2009, VACCINE, V27, P152, DOI 10.1016/j.vaccine.2008.09.054; Kayali U, 2003, B WORLD HEALTH ORGAN, V81, P739; Kitala PM, 2002, EPIDEMIOL INFECT, V129, P215, DOI 10.1017/S0950268802006957; Knobel DL, 2005, B WORLD HEALTH ORGAN, V83, P360; Laurenson MK, 2005, CONSERVATION AND DEVELOPMENT INTERVENTIONS AT THE WILDLIFE/LIVESTOCK INTERFACE, P141; Lembo T, 2008, J APPL ECOL, V45, P1246, DOI 10.1111/j.1365-2664.2008.01468.x; Lembo T, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000626; McNeil Donald G., 2009, NEW YORK TIMES; Meltzer MI, 1998, PHARMACOECONOMICS, V14, P481, DOI 10.2165/00019053-199814050-00003; Minke JM, 2009, VET MICROBIOL, V133, P283, DOI 10.1016/j.vetmic.2008.06.024; Quiambao BP, 2005, VACCINE, V23, P1709, DOI 10.1016/j.vaccine.2004.09.027; Randall DA, 2006, BIOL CONSERV, V131, P151, DOI 10.1016/j.biocon.2006.04.004; Schneider MC, 2007, CAD SAUDE PUBLICA, V23, P2049, DOI 10.1590/S0102-311X2007000900013; Shim E, 2009, VACCINE, V27, P7167, DOI 10.1016/j.vaccine.2009.09.027; Stinnett AA, 1998, MED DECIS MAKING, V18, pS68, DOI 10.1177/0272989X98018002S09; WHO, 2005, WHO TECH REP SER, V931, P1; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO Rabies vaccines, 2007, WEEKLY EPIDEMIOLOGIC, V82, P425; World health organization, 2010, CHOOS INT AR COST EF; Zinsstag J, 2009, P NATL ACAD SCI USA, V106, P14996, DOI 10.1073/pnas.0904740106	38	64	64	0	36	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 21	2014	160	2					91	+		10.7326/M13-0542	http://dx.doi.org/10.7326/M13-0542			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	297SQ	24592494	Green Accepted			2022-12-28	WOS:000330275600015
J	Al-Chalabi, A				Al-Chalabi, Ammar			High-calorie diets in amyotrophic lateral sclerosis	LANCET			English	Editorial Material							DOUBLE-BLIND; TRIAL; DEXPRAMIPEXOLE; LITHIUM; PLACEBO		Kings Coll London, Inst Psychiat, London SE5 8AF, England	University of London; King's College London	Al-Chalabi, A (corresponding author), Kings Coll London, Inst Psychiat, London SE5 8AF, England.	ammar.al-chalabi@kcl.ac.uk	Al-Chalabi, Ammar/E-5361-2010	Al-Chalabi, Ammar/0000-0002-4924-7712	Medical Research Council [MR/L501529/1] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Allen C, 2013, LANCET NEUROL, V12, P339, DOI [10.1016/S1474-4422(13)70037-1, 10.1016/S1474-4422(13)700374]; Bouteloup C, 2009, J NEUROL, V256, P1236, DOI 10.1007/s00415-009-5100-z; Cudkowicz ME, 2013, LANCET NEUROL, V12, P1059, DOI 10.1016/S1474-4422(13)70221-7; Dupuis L, 2008, NEUROLOGY, V70, P1004, DOI 10.1212/01.wnl.0000285080.70324.27; Dupuis L, 2004, P NATL ACAD SCI USA, V101, P11159, DOI 10.1073/pnas.0402026101; Fang F, 2008, BRAIN, V131, P2729, DOI 10.1093/brain/awn161; Fornai F, 2008, P NATL ACAD SCI USA, V105, P2052, DOI 10.1073/pnas.0708022105; Johnston CA, 2006, J NEUROL, V253, P1642, DOI 10.1007/s00415-006-0195-y; Kasarskis EJ, 1996, AM J CLIN NUTR, V63, P130, DOI 10.1093/ajcn/63.1.130; Maessen M, 2010, J NEUROL, V257, P1192, DOI 10.1007/s00415-010-5474-y; Marin B, 2011, J NEUROL NEUROSUR PS, V82, P628, DOI 10.1136/jnnp.2010.211474; Rudnicki SA, 2013, AMYOTROPH LAT SCL FR, V14, P44, DOI 10.3109/17482968.2012.723723; Wicks P, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g368; Wills AM, 2014, LANCET	14	3	3	1	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 14	2014	383	9934					2028	2030		10.1016/S0140-6736(14)60270-1	http://dx.doi.org/10.1016/S0140-6736(14)60270-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AI9VZ	24582470				2022-12-28	WOS:000337292400009
J	Brown, K				Brown, Katherine			The UK chancellor should resist industry lobbying to scrap annual rise in alcohol duty	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Inst Alcohol Studies, London SW1H 0QS, England		Brown, K (corresponding author), Inst Alcohol Studies, London SW1H 0QS, England.	kbrown@ias.org.uk		Severi, Katherine/0000-0002-4282-0272				Curtis L, 2013, UNIT COSTS HLTH SOCI; Gornall J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7646; Health and Social Care Information Centre, 2013, STAT ALC ENGL 2013; Health and Social Care Information Centre, 2012, STAT ALC ENGL 2012; Holmes J, 2014, LANCET, V383, P1655, DOI 10.1016/S0140-6736(13)62417-4; Home Office, 2012, GOV ALC STRAT; Office for National Statistics, 2012, DRINK HAB AD GREAT B	7	3	3	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 13	2014	348								g2060	10.1136/bmj.g2060	http://dx.doi.org/10.1136/bmj.g2060			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD1ZS	24622487				2022-12-28	WOS:000333032800003
J	Elwyn, G				Elwyn, Glyn			PATIENT POWER "Patientgate"-digital recordings change everything	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Dartmouth Ctr Hlth Care Delivery Sci, Hanover, NH 03755 USA	Dartmouth College	Elwyn, G (corresponding author), Dartmouth Ctr Hlth Care Delivery Sci, Hanover, NH 03755 USA.	glynelwyn@gmail.com	Elwyn, Glyn/B-4798-2009; Elwyn, G./L-4292-2015	Elwyn, Glyn/0000-0002-0917-6286; 				ENGEL GL, 1977, SCIENCE, V196, P129, DOI 10.1126/science.847460; Guyatt Gordon, 2004, ACP J Club, V140, pA11; Sackett DL, 1991, CLIN EPIDEMIOLOGY BA, V2nd; Thomas CM, 2013, J NURS ED PRACT, V4, P210, DOI [10.5430/jnep.v4n2p210, DOI 10.5430/JNEP.V4N2P210]; Vox F., REUTERS; WEED LL, 1968, NEW ENGL J MED, V278, P652, DOI 10.1056/NEJM196803212781204	6	18	18	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2014	348								g2078	10.1136/bmj.g2078	http://dx.doi.org/10.1136/bmj.g2078			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD1ZL	24620357				2022-12-28	WOS:000333032100014
J	Horton, R; Beaglehole, R; Bonita, R; Raeburn, J; Mckee, M; Wall, S				Horton, Richard; Beaglehole, Robert; Bonita, Ruth; Raeburn, John; Mckee, Martin; Wall, Stig			From public to planetary health: a manifesto	LANCET			English	Editorial Material									[Horton, Richard] The Lancet, London NW1 7BY, England; [Beaglehole, Robert; Bonita, Ruth] Univ Auckland, Auckland 1, New Zealand; [Raeburn, John] AUT Univ, Dept Publ Hlth, Auckland, New Zealand; [Mckee, Martin] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1, England; [Wall, Stig] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden	University of Auckland; Auckland University of Technology; University of London; London School of Hygiene & Tropical Medicine; Umea University	Horton, R (corresponding author), The Lancet, London NW1 7BY, England.		McKee, Marc D/E-2187-2011; Mckee, Martin/E-6673-2018	McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683					0	161	165	1	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 8	2014	383	9920					847	847		10.1016/S0140-6736(14)60409-8	http://dx.doi.org/10.1016/S0140-6736(14)60409-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AC3FC	24607088				2022-12-28	WOS:000332399500004
J	Vickers, AJ; Linde, K				Vickers, Andrew J.; Linde, Klaus			Acupuncture for Chronic Pain	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							OSTEOARTHRITIS	CLINICAL QUESTION Is acupuncture associated with reduced pain outcomes for patients with chronic pain compared with sham-acupuncture (placebo) or no-acupuncture control? BOTTOM LINE Acupuncture is associated with improved pain outcomes compared with sham-acupuncture and no-acupuncture control, with response rates of approximately 30% for no acupuncture, 42.5% for sham acupuncture, and 50% for acupuncture.	[Vickers, Andrew J.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Linde, Klaus] Tech Univ Munich, D-80290 Munich, Germany	Memorial Sloan Kettering Cancer Center; Technical University of Munich	Vickers, AJ (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, 307 E 63rd St,Second Floor, New York, NY 10021 USA.	vickersa@mskcc.org		Linde, Klaus/0000-0002-2902-970X; Vickers, Andrew/0000-0003-1525-6503	NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT004189] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [R01AT006794] Funding Source: NIH RePORTER; NCCIH NIH HHS [R01 AT006794, R21 AT004189I, R21 AT004189] Funding Source: Medline; NCI NIH HHS [P30 CA008748] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		American Academy of Orthopaedic Surgeons, TREATMENT OF OSTEOAR; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Conaghan PG, 2008, BRIT MED J, V336, P502, DOI 10.1136/bmj.39490.608009.AD; Ezzo J, 2001, ARTHRITIS RHEUM, V44, P819, DOI 10.1002/1529-0131(200104)44:4<819::AID-ANR138>3.0.CO;2-P; Furlan AD, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001351.pub2; National Institute for Health and Clinical Excellence, HEADACHES; Vickers AJ, 2012, ARCH INTERN MED, V172, P1444, DOI 10.1001/archinternmed.2012.3654	7	132	142	113	328	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 5	2014	311	9					955	956		10.1001/jama.2013.285478	http://dx.doi.org/10.1001/jama.2013.285478			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC0FS	24595780	Green Accepted			2022-12-28	WOS:000332170800024
J	Schmidt, D; Schachter, SC				Schmidt, Dieter; Schachter, Steven C.			Drug treatment of epilepsy in adults	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CONTROLLED-RELEASE CARBAMAZEPINE; CHILDHOOD-ONSET EPILEPSY; SEIZURE-FREE PATIENTS; LONG-TERM OUTCOMES; ANTIEPILEPTIC DRUGS; DOUBLE-BLIND; ILAE-COMMISSION; PSYCHIATRIC COMORBIDITY; MANAGEMENT ISSUES; ENZYME-INDUCTION	Epilepsy is a serious, potentially life shortening brain disorder, the symptoms of which can be successfully treated in most patients with one or more antiepileptic drug. About two in three adults with new onset epilepsy will achieve lasting seizure remission on or off these drugs, although around half will experience mild to moderately severe adverse effects. Patients with epilepsy, especially the 20-30% whose seizures are not fully controlled with available drugs (drug resistant epilepsy), have a significantly increased risk of death, as well as psychiatric and somatic comorbidities, and adverse effects from antiepileptic drugs. Newer drugs have brought more treatment options, and some such as levetiracetam cause fewer drug interactions and less hypersensitivity than older ones. However, they do not reduce the prevalence of drug resistant epilepsy or prevent the development of epilepsy in patients at high risk, such as those with a traumatic brain injury. The development of antiepileptic drugs urgently needs to be revitalized so that we can discover more effective antiseizure drugs for the treatment of drug resistant epilepsy, including catastrophic forms. Antiepileptogenic agents to prevent epilepsy before the first seizure in at risk patients and disease modifying agents to control ongoing severe epilepsy associated with progressive underlying disease are also needed.	[Schmidt, Dieter] Epilepsy Res Grp, D-14163 Berlin, Germany; [Schachter, Steven C.] Massachusetts Gen Hosp, Dept Neurol, Beth Israel Deaconess Med Ctr, Boston, MA 02114 USA; [Schachter, Steven C.] Harvard Univ, Sch Med, Boston, MA USA	Epilepsy Research Group; Harvard University; Beth Israel Deaconess Medical Center; Massachusetts General Hospital; Harvard University; Harvard Medical School	Schmidt, D (corresponding author), Epilepsy Res Grp, Goethestr 5, D-14163 Berlin, Germany.	dbschmidt@t-online.de			Eisai; Sun; UCB; Viropharma	Eisai(Eisai Co Ltd); Sun; UCB(UCB Pharma SA); Viropharma	We have read and understood the BMJ Group policy on declaration of interests and declare the following interests: DS has received hospitality and consulting fees in the past two years from Eisai, Sun, UCB, and Viropharma. None of the companies has had any input to the manuscript. SCS: none declared.	Abou-Khalil Bassel, 2012, Handb Clin Neurol, V108, P723, DOI 10.1016/B978-0-444-52899-5.00024-1; Adab N, 2006, CNS DRUGS, V20, P791, DOI 10.2165/00023210-200620100-00001; [Anonymous], 2010, LANCET NEUROL, V9, P941, DOI 10.1016/S1474-4422(10)70226-X; BANCAUD J, 1981, EPILEPSIA, V22, P489, DOI 10.1111/j.1528-1157.1981.tb06159.x; Battino D, 2013, EPILEPSIA, V54, P1621, DOI 10.1111/epi.12302; Baulac M, 2012, LANCET NEUROL, V11, P579, DOI 10.1016/S1474-4422(12)70105-9; Baulac M, 2010, EPILEPSY RES, V91, P10, DOI 10.1016/j.eplepsyres.2010.05.008; Beghi E, 2003, EPILEPSY RES, V57, P1, DOI 10.1016/j.eplepsyres.2003.09.007; Benedetti MS, 2000, FUND CLIN PHARMACOL, V14, P301, DOI 10.1111/j.1472-8206.2000.tb00411.x; Berg AT, 2010, EPILEPSIA, V51, P676, DOI 10.1111/j.1528-1167.2010.02522.x; BERG AT, 1994, NEUROLOGY, V44, P601, DOI 10.1212/WNL.44.4.601; Beyenburg S, 2010, EPILEPSIA, V51, P7, DOI 10.1111/j.1528-1167.2009.02299.x; Bialer M, 2010, NAT REV DRUG DISCOV, V9, P68, DOI 10.1038/nrd2997; Birbeck GL, 2002, EPILEPSIA, V43, P535, DOI 10.1046/j.1528-1157.2002.32201.x; Bonnett LJ, 2011, J NEUROL NEUROSUR PS, V82, P1328, DOI 10.1136/jnnp.2010.222885; Braun KPJ, CURR OPIN N IN PRESS; Brodie MJ, 2007, NEUROLOGY, V68, P402, DOI 10.1212/01.wnl.0000252941.50833.4a; Brodie MJ, 2012, NEUROLOGY, V78, P1548, DOI 10.1212/WNL.0b013e3182563b19; Brodie MJ, 2013, EPILEPSIA, V54, P11, DOI 10.1111/j.1528-1167.2012.03671.x; Brodie MJ, 2012, EPILEPSIA, V53, P40, DOI 10.1111/epi.12027; Bulacio JC, 2012, EPILEPSIA, V53, P1722, DOI 10.1111/j.1528-1167.2012.03633.x; Carbone LD, 2010, J BONE MINER RES, V25, P873, DOI 10.1359/jbmr.091027; CHADWICK D, 1991, LANCET, V337, P1175; Cheung YK, 2013, EPILEPSIA, V54, P1307, DOI 10.1111/epi.12217; Cockerell OC, 1997, EPILEPSIA, V38, P31, DOI 10.1111/j.1528-1157.1997.tb01075.x; Costa J, 2011, EPILEPSIA, V52, P1280, DOI 10.1111/j.1528-1167.2011.03047.x; de Boer HM, 2013, CURR OPIN NEUROL, V26, P219, DOI 10.1097/WCO.0b013e32835f2037; Deckers CLP, 2001, EPILEPSIA, V42, P1387, DOI 10.1046/j.1528-1157.2001.30800.x; Edelvik A, 2013, NEUROLOGY, V81, P1244, DOI 10.1212/WNL.0b013e3182a6ca7b; Ekstein D, 2010, PHARMACEUTICALS, V3, P1426, DOI 10.3390/ph3051426; Engel J, 2013, CURR OPIN NEUROL, V26, P186, DOI 10.1097/WCO.0b013e32835ee5b8; European Medicines Agency, BUCC 2 5 MG OR SOL S; Faught E, 2008, NEUROLOGY, V71, P1572, DOI 10.1212/01.wnl.0000319693.10338.b9; Faught E, 2011, EPILEPSY CURR, V11, P75, DOI 10.5698/1535-7511-11.3.75; Fazel S, 2013, LANCET, V382, P1646, DOI 10.1016/S0140-6736(13)60899-5; Fisher RS, EPILEPSIA; French JA, 2013, EPILEPSIA, V54, P3, DOI 10.1111/epi.12294; Friedman D, 2012, LANCET NEUROL, V11, P827, DOI 10.1016/S1474-4422(12)70177-1; Gaitatzis A, 2013, CNS DRUGS, V27, P435, DOI 10.1007/s40263-013-0063-0; Gaitatzis A, 2012, EPILEPSIA, V53, P1282, DOI 10.1111/j.1528-1167.2012.03528.x; Glauser T, 2013, EPILEPSIA, V54, P551, DOI 10.1111/epi.12074; Greenberg MK, 1996, NEUROLOGY, V47, P600; Guerrini R, 2012, DRUG SAFETY, V35, P519, DOI 10.2165/11630700-000000000-00000; Halford JJ, 2011, EPILEPSIA, V52, P816, DOI 10.1111/j.1528-1167.2010.02960.x; Harden CL, 2009, EPILEPSIA, V50, P1237, DOI 10.1111/j.1528-1167.2009.02129.x; Harden CL, 2009, EPILEPSIA, V50, P1247, DOI 10.1111/j.1528-1167.2009.02130.x; Hauser WA, 1998, NEW ENGL J MED, V338, P429, DOI 10.1056/NEJM199802123380704; HAUSER WA, 1992, EPILEPSY RES, P25; Hirtz D, 2007, NEUROLOGY, V68, P326, DOI 10.1212/01.wnl.0000252807.38124.a3; Hirtz D, 2003, NEUROLOGY, V60, P166, DOI 10.1212/01.WNL.0000033622.27961.B6; Hitiris N, 2007, EPILEPSY RES, V75, P192, DOI 10.1016/j.eplepsyres.2007.06.003; Illing PT, 2013, CURR OPIN IMMUNOL, V25, P81, DOI 10.1016/j.coi.2012.10.002; Jentink J, 2010, NEW ENGL J MED, V362, P2185, DOI 10.1056/NEJMoa0907328; Kanner AM, 2013, EPILEPSIA, V54, P3, DOI 10.1111/epi.12100; Kanner AM, 2013, CURR OPIN NEUROL, V26, P208, DOI 10.1097/WCO.0b013e32835ee579; Karceski S, 2005, EPILEPSY BEHAV, V7, pS1, DOI 10.1016/j.yebeh.2005.06.001; Kim LG, 2006, LANCET NEUROL, V5, P317, DOI 10.1016/S1474-4422(06)70383-0; Kim SH, 2007, EPILEPSY BEHAV, V10, P291, DOI 10.1016/j.yebeh.2006.11.007; Kwan P, 2000, NEW ENGL J MED, V342, P314, DOI 10.1056/NEJM200002033420503; Kwan P, 2011, NEW ENGL J MED, V365, P919, DOI 10.1056/NEJMra1004418; Kwan P, 2010, EPILEPSIA, V51, P1069, DOI 10.1111/j.1528-1167.2009.02397.x; Lazzari AA, 2013, EPILEPSIA; Loeb JA, 2011, NEUROSCI LETT, V497, P205, DOI 10.1016/j.neulet.2011.02.041; Loscher W, 2006, EPILEPSIA, V47, P1253, DOI 10.1111/j.1528-1167.2006.00607.x; Loscher W, 2013, NAT REV DRUG DISCOV, V12, P757, DOI 10.1038/nrd4126; Loscher W, 2012, NAT REV NEUROL, V8, P661, DOI 10.1038/nrneurol.2012.222; Loscher W, 2011, EPILEPSIA, V52, P657, DOI 10.1111/j.1528-1167.2011.03024.x; Loscher W, 2010, PHARMACOL REV, V62, P668, DOI 10.1124/pr.110.003046; Loscher W, 2009, EPILEPSIA, V50, P1, DOI 10.1111/j.1528-1167.2008.01716.x; Lossius R, 2010, ACTA NEUROL SCAND, V122, P67, DOI 10.1111/j.1600-0404.2010.01379.x; Margineanu DG, 2013, EPILEPSY BEHAV; Marson A, 2005, LANCET, V365, P2007, DOI 10.1016/S0140-6736(05)66694-9; Marson AG, 2007, HEALTH TECHNOL ASSES, V11, pIX; Marson AG, 2007, LANCET, V369, P1016, DOI 10.1016/S0140-6736(07)60461-9; Marson AG, 2007, LANCET, V369, P1000, DOI 10.1016/S0140-6736(07)60460-7; Marson AG, 2008, EPILEPSIA, V49, P3, DOI 10.1111/j.1528-1167.2008.01920.x; MATTSON RH, 1985, NEW ENGL J MED, V313, P145, DOI 10.1056/NEJM198507183130303; McIntyre J, 2005, LANCET, V366, P205, DOI 10.1016/S0140-6736(05)66909-7; Meador KJ, 2013, JAMA-J AM MED ASSOC, V309, P1730, DOI 10.1001/jama.2013.4001; Meador KJ, 2013, LANCET NEUROL, V12, P244, DOI 10.1016/S1474-4422(12)70323-X; Meyer AC, 2010, B WORLD HEALTH ORGAN, V88, P260, DOI 10.2471/BLT.09.064147; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Najm I, 2013, EPILEPSIA, V54, P772, DOI 10.1111/epi.12152; Ngugi AK, 2010, EPILEPSIA, V51, P883, DOI 10.1111/j.1528-1167.2009.02481.x; Noe KH, 2011, CURR TREAT OPTION NE, V13, P371, DOI 10.1007/s11940-011-0127-8; Pack A, 2008, SEIZURE-EUR J EPILEP, V17, P181, DOI 10.1016/j.seizure.2007.11.020; Patsalos PN, 2008, EPILEPSIA, V49, P1239, DOI 10.1111/j.1528-1167.2008.01561.x; Patsalos PN, 2003, LANCET NEUROL, V2, P347, DOI 10.1016/S1474-4422(03)00409-5; Perucca E, 2007, LANCET NEUROL, V6, P793, DOI 10.1016/S1474-4422(07)70215-6; Perucca E, 2012, EPILEPTIC DISORD, V14, P124, DOI 10.1684/epd.2012.0511; Perucca E, 2011, LANCET NEUROL, V10, P446, DOI 10.1016/S1474-4422(11)70047-3; Picot MC, 2008, EPILEPSIA, V49, P1230, DOI 10.1111/j.1528-1167.2008.01579.x; Pirie DA, 2013, EUR J OBSTET GYNECOL; Pitkanen A, 2013, EPILEPSIA, V54, P35, DOI 10.1111/epi.12297; Privitera MD, 2003, ACTA NEUROL SCAND, V107, P165, DOI 10.1034/j.1600-0404.2003.00093.x; Ramsay RE, 2008, EPILEPSIA, V49, P1180, DOI 10.1111/j.1528-1167.2008.01584.x; Reisinger TL, 2013, EPILEPSY BEHAV, V29, P13, DOI 10.1016/j.yebeh.2013.06.026; ROBERTSON MM, 1985, J AFFECT DISORDERS, V9, P127, DOI 10.1016/0165-0327(85)90091-6; Rogawski MA, 2004, NAT REV NEUROSCI, V5, P553, DOI 10.1038/nrn1430; Rowan AJ, 2005, NEUROLOGY, V64, P1868, DOI 10.1212/01.WNL.0000167384.68207.3E; Ryvlin P, 2011, LANCET NEUROL, V10, P961, DOI 10.1016/S1474-4422(11)70193-4; Schachter SC, EPILEPSIA IN PRESS; Schachter SC, 2008, INT ENCY PUBLIC HLTH, V5, P674; Schiller Y, 2008, NEUROLOGY, V70, P54, DOI 10.1212/01.wnl.0000286959.22040.6e; Schmidt D, 2005, ACTA NEUROL SCAND, V111, P291, DOI 10.1111/j.1600-0404.2005.00408.x; Schmidt D, 2004, EPILEPSY RES, V60, P187, DOI 10.1016/j.eplepsyres.2004.07.004; Schmidt D, 2005, EPILEPSIA, V46, P858, DOI 10.1111/j.1528-1167.2005.54904.x; Schmidt D, 2004, EPILEPSIA, V45, P179, DOI 10.1111/j.0013-9580.2004.37803.x; Schmidt D, 2002, EPILEPSY RES, V52, P61, DOI 10.1016/S0920-1211(02)00186-9; Schmidt D, 2013, EPILEPSY BEHAV, V27, P393, DOI 10.1016/j.yebeh.2013.01.015; Schmidt D, 2012, EPILEPTIC DISORD, V14, P105, DOI 10.1684/epd.2012.0512; Schmidt D, 2009, EPILEPSY BEHAV, V15, P56, DOI 10.1016/j.yebeh.2009.02.030; Schmidt D, 2009, EPILEPSY CURR, V9, P47, DOI 10.1111/j.1535-7511.2008.01289.x; SHORVON SD, 2008, EPILEPSIA, V49, P2177; Shorvon S, 2012, BRAIN, V135, P2314, DOI 10.1093/brain/aws091; Shorvon S, 2011, CURR OPIN NEUROL, V24, P165, DOI 10.1097/WCO.0b013e3283446f31; Silbergleit R, 2011, EPILEPSIA, V52, P45, DOI 10.1111/j.1528-1167.2011.03235.x; Sillanp M, 2009, BRAIN, V132, P989, DOI 10.1093/brain/awn357; Sillanpaa M, 2006, BRAIN, V129, P617, DOI 10.1093/brain/awh726; Sillanpaa M, 2012, BRAIN, V135, P2256, DOI 10.1093/brain/aws062; Sillanpaa M, 2010, NEW ENGL J MED, V363, P2522, DOI 10.1056/NEJMoa0911610; Tejada J, 2013, EPILEPSY BEHAV, V26, P212, DOI 10.1016/j.yebeh.2012.09.029; Tellez-Zenteno JF, 2007, EPILEPSIA, V48, P2336; Tellez-Zenteno JF, 2007, BRAIN, V130, P334, DOI 10.1093/brain/awl316; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Thurman DJ, 2011, EPILEPSIA, V52, P2, DOI 10.1111/j.1528-1167.2011.03121.x; Tomson T, 2012, LANCET NEUROL, V11, P803, DOI 10.1016/S1474-4422(12)70103-5; Tomson T, 2011, LANCET NEUROL, V10, P609, DOI 10.1016/S1474-4422(11)70107-7; Trinka E, 2013, J NEUROL NEUROSUR PS, V84, P1138, DOI 10.1136/jnnp-2011-300376; Vestergaard P, 2004, EPILEPSIA, V45, P1330, DOI 10.1111/j.0013-9580.2004.18804.x; Wiebe S, 2012, NAT REV NEUROL, V8, P669, DOI 10.1038/nrneurol.2012.181; World Health Organization (WHO), 2006, DIS CONTR PRIOR REL; Wyszynski DF, 2005, NEUROLOGY, V64, P961, DOI 10.1212/01.WNL.0000154516.43630.C5; Zeng TF, 2012, EPILEPSY RES, V101, P14, DOI 10.1016/j.eplepsyres.2012.02.013	134	174	182	4	44	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 28	2014	348								g2546	10.1136/bmj.g254	http://dx.doi.org/10.1136/bmj.g254			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC0UX	24583319				2022-12-28	WOS:000332212100008
J	Barry, CE				Barry, Clifton E.			TUBERCULOSIS Drug discovery goes au naturel	NATURE			English	Editorial Material							EFFLUX		NIAID, TB Res Sect, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Barry, CE (corresponding author), NIAID, TB Res Sect, 9000 Rockville Pike, Bethesda, MD 20892 USA.	cbarry@niaid.nih.gov	Barry, Clifton E/ABE-7992-2020; Barry, III, Clifton/H-3839-2012	Barry, Clifton E/0000-0002-2927-270X; Barry, III, Clifton/0000-0002-2927-270X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000693] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA AI000693-20] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Balganesh M, 2012, ANTIMICROB AGENTS CH, V56, P2643, DOI 10.1128/AAC.06003-11; Borovinskaya MA, 2007, ACS CHEM BIOL, V2, P545, DOI 10.1021/cb700100n; Fox W, 1999, INT J TUBERC LUNG D, V3, pS231; Lee RE, 2014, NAT MED, V20, P152, DOI 10.1038/nm.3458; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; SENSI P, 1983, REV INFECT DIS, V5, pS402	6	6	6	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2014	506	7489					436	437		10.1038/506436a	http://dx.doi.org/10.1038/506436a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0DN	24572417	Green Accepted			2022-12-28	WOS:000332165100023
J	Lewis, SL				Lewis, Simon L.			Scientist-versus-activist debates mislead the public	NATURE			English	Editorial Material									[Lewis, Simon L.] UCL, London WC1E 6BT, England; [Lewis, Simon L.] Univ Leeds, Leeds LS2 9JT, W Yorkshire, England	University of London; University College London; University of Leeds	Lewis, SL (corresponding author), UCL, London WC1E 6BT, England.	s.l.lewis@leeds.ac.uk		Lewis, Simon/0000-0002-8066-6851				2010, NATURE, V468, P7	1	1	1	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2014	506	7489					409	409		10.1038/506409a	http://dx.doi.org/10.1038/506409a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC0DN	24572388	Bronze			2022-12-28	WOS:000332165100005
J	Arie, S				Arie, Sophie			GENETIC TESTING Routine testing for women with ovarian cancer	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												sophiearie@fmail.co.uk						Cancer Research UK, OV CANC KEY FACTS; *NAT CANC I, 2013, BRCA1 BRCA2 CANC RIS; National Institute for Health and Care Excellence (NICE), 2013, FAM BREAST CANC CLAS; Pal T, 2005, CANCER-AM CANCER SOC, V104, P2807, DOI 10.1002/cncr.21536; Wise J, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5664	5	2	2	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 26	2014	348								g1200	10.1136/bmj.g1200	http://dx.doi.org/10.1136/bmj.g1200			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC0UC	24574473				2022-12-28	WOS:000332209900001
J	Hegerl, G; Stott, P				Hegerl, Gabi; Stott, Peter			From Past to Future Warming	SCIENCE			English	Editorial Material									[Hegerl, Gabi] Univ Edinburgh, Sch Geosci, Edinburgh EH9 3JW, Midlothian, Scotland; [Stott, Peter] Hadley Ctr, Met Off, Exeter EX1 3PB, Devon, England	University of Edinburgh; Met Office - UK; Hadley Centre	Hegerl, G (corresponding author), Univ Edinburgh, Sch Geosci, Edinburgh EH9 3JW, Midlothian, Scotland.	gabi.hegerl@ed.ac.uk	; Stott, Peter/N-1228-2016	Hegerl, Gabriele/0000-0002-4159-1295; Stott, Peter/0000-0003-4853-7686	Natural Environment Research Council [NE/H003533/1] Funding Source: researchfish; NERC [NE/H003533/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Bindoff N. L., 2013, CLIM CHANG 2013 PHYS, DOI 10.1017/CBO9781107415324.022; Booth BBB, 2012, NATURE, V484, P228, DOI 10.1038/nature10946; Dole R, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046582; Hegerl G, 2011, WIRES CLIM CHANGE, V2, P570, DOI 10.1002/wcc.121; Lewis SC, 2013, GEOPHYS RES LETT, V40, P3705, DOI 10.1002/grl.50673; Mahlstein I, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/3/034009; Masato G, 2013, J CLIMATE, V26, P7044, DOI 10.1175/JCLI-D-12-00466.1; Otto FEL, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050422; Ribes A, 2013, CLIM DYNAM, V41, P2837, DOI 10.1007/s00382-013-1736-6; Rosenfeld D, 2014, SCIENCE, V343, P379, DOI 10.1126/science.1247490; Stott PA, 2004, NATURE, V432, P610, DOI 10.1038/nature03089; Stott P, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/014024	12	14	15	2	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 21	2014	343	6173					844	845		10.1126/science.1249368	http://dx.doi.org/10.1126/science.1249368			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB1LG	24558148				2022-12-28	WOS:000331552600031
J	Gilbert, MR; Dignam, JJ; Armstrong, TS; Wefel, JS; Blumenthal, DT; Vogelbaum, MA; Colman, H; Chakravarti, A; Pugh, S; Won, M; Jeraj, R; Brown, PD; Jaeckle, KA; Schiff, D; Stieber, VW; Brachman, DG; Werner-Wasik, M; Tremont-Lukats, IW; Sulman, EP; Aldape, KD; Curran, WJ; Mehta, MP				Gilbert, Mark R.; Dignam, James J.; Armstrong, Terri S.; Wefel, Jeffrey S.; Blumenthal, Deborah T.; Vogelbaum, Michael A.; Colman, Howard; Chakravarti, Arnab; Pugh, Stephanie; Won, Minhee; Jeraj, Robert; Brown, Paul D.; Jaeckle, Kurt A.; Schiff, David; Stieber, Volker W.; Brachman, David G.; Werner-Wasik, Maria; Tremont-Lukats, Ivo W.; Sulman, Erik P.; Aldape, Kenneth D.; Curran, Walter J., Jr.; Mehta, Minesh P.			A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RECURRENT GLIOBLASTOMA; ADJUVANT TEMOZOLOMIDE; RADIATION-THERAPY; PHASE-III; RESPONSE CRITERIA; CLINICAL-TRIALS; COMBINATION; VALIDATION; MULTIFORME; GLIOMA	BackgroundConcurrent treatment with temozolomide and radiotherapy followed by maintenance temozolomide is the standard of care for patients with newly diagnosed glioblastoma. Bevacizumab, a humanized monoclonal antibody against vascular endothelial growth factor A, is currently approved for recurrent glioblastoma. Whether the addition of bevacizumab would improve survival among patients with newly diagnosed glioblastoma is not known. MethodsIn this randomized, double-blind, placebo-controlled trial, we treated adults who had centrally confirmed glioblastoma with radiotherapy (60 Gy) and daily temozolomide. Treatment with bevacizumab or placebo began during week 4 of radiotherapy and was continued for up to 12 cycles of maintenance chemotherapy. At disease progression, the assigned treatment was revealed, and bevacizumab therapy could be initiated or continued. The trial was designed to detect a 25% reduction in the risk of death and a 30% reduction in the risk of progression or death, the two coprimary end points, with the addition of bevacizumab. ResultsA total of 978 patients were registered, and 637 underwent randomization. There was no significant difference in the duration of overall survival between the bevacizumab group and the placebo group (median, 15.7 and 16.1 months, respectively; hazard ratio for death in the bevacizumab group, 1.13). Progression-free survival was longer in the bevacizumab group (10.7 months vs. 7.3 months; hazard ratio for progression or death, 0.79). There were modest increases in rates of hypertension, thromboembolic events, intestinal perforation, and neutropenia in the bevacizumab group. Over time, an increased symptom burden, a worse quality of life, and a decline in neurocognitive function were more frequent in the bevacizumab group. ConclusionsFirst-line use of bevacizumab did not improve overall survival in patients with newly diagnosed glioblastoma. Progression-free survival was prolonged but did not reach the prespecified improvement target. (Funded by the National Cancer Institute; ClinicalTrials.gov number, NCT00884741.)	[Gilbert, Mark R.; Armstrong, Terri S.; Wefel, Jeffrey S.; Brown, Paul D.; Tremont-Lukats, Ivo W.; Sulman, Erik P.; Aldape, Kenneth D.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Armstrong, Terri S.] Univ Texas Hlth Sci Ctr Houston, Sch Nursing, Houston, TX 77030 USA; [Dignam, James J.; Pugh, Stephanie; Won, Minhee] Amer Coll Radiol, Philadelphia, PA USA; [Werner-Wasik, Maria] Thomas Jefferson Univ, Philadelphia, PA 19107 USA; [Dignam, James J.] Univ Chicago, Chicago, IL 60637 USA; [Blumenthal, Deborah T.] Tel Aviv Med Ctr & Sch Med, Tel Aviv, Israel; [Vogelbaum, Michael A.] Cleveland Clin, Cleveland, OH USA; [Colman, Howard] Univ Utah, Salt Lake City, UT USA; [Chakravarti, Arnab] Ohio State Univ, Columbus, OH 43210 USA; [Jeraj, Robert] Univ Wisconsin, Madison, WI 53706 USA; [Jaeckle, Kurt A.] Mayo Clin, Jacksonville, FL 32224 USA; [Schiff, David] Univ Virginia, Charlottesville, VA USA; [Stieber, Volker W.] Southeast Canc Control Consortium, Winston Salem, NC USA; [Brachman, David G.] Barrow Neurol Inst, Phoenix, AZ 85013 USA; [Curran, Walter J., Jr.] Emory Univ, Atlanta, GA 30322 USA; [Mehta, Minesh P.] Univ Maryland, Baltimore, MD 21201 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; American College of Radiology; Jefferson University; University of Chicago; Tel Aviv University; Sackler Faculty of Medicine; Cleveland Clinic Foundation; Utah System of Higher Education; University of Utah; University System of Ohio; Ohio State University; University of Wisconsin System; University of Wisconsin Madison; Mayo Clinic; University of Virginia; Barrow Neurological Institute; Emory University; University System of Maryland; University of Maryland Baltimore	Gilbert, MR (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, 1515 Holcombe Blvd,Unit 431, Houston, TX 77030 USA.		Colman, Howard/L-5433-2019; Gilbert, Mark R/J-7494-2016; Mehta, Minesh P./AAB-8915-2019; Lukats, Ivo W Tremont/B-8249-2013; Armstrong, Terri S/J-6871-2016	Gilbert, Mark R/0000-0003-2556-9722; Mehta, Minesh P./0000-0002-4812-5713; Lukats, Ivo W Tremont/0000-0001-8086-0200; Armstrong, Terri/0000-0002-2414-0492; Stieber, Volker/0000-0001-9785-8588; Sulman, Erik/0000-0003-4933-9120	National Cancer Institute [U10 CA21661, U10 CA37422]; Genentech; NATIONAL CANCER INSTITUTE [ZIDBC011642, U10CA037422, P30CA056036, P30CA016672, U10CA021661] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Genentech(Roche HoldingGenentech); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Supported by grants (U10 CA21661 and U10 CA37422) from the National Cancer Institute and by an unrestricted educational grant from Genentech.	Armstrong TS, 2006, J NEURO-ONCOL, V80, P27, DOI 10.1007/s11060-006-9135-z; Armstrong TS, 2013, J CLIN ONCOL, V31, P4076, DOI 10.1200/JCO.2013.49.6067; Batchelor TT, 2013, J CLIN ONCOL, V31, P3212, DOI 10.1200/JCO.2012.47.2464; Chinot OL, 2014, NEW ENGL J MED, V370, P709, DOI 10.1056/NEJMoa1308345; Colman H, 2010, NEURO-ONCOLOGY, V12, P49, DOI 10.1093/neuonc/nop007; COX DR, 1972, J R STAT SOC B, V34, P187; Ferrara N, 2005, BIOCHEM BIOPH RES CO, V333, P328, DOI 10.1016/j.bbrc.2005.05.132; Friedman HS, 2009, J CLIN ONCOL, V27, P4733, DOI 10.1200/JCO.2008.19.8721; GRAMBSCH P, 1994, STAT MED, V13, P1619, DOI 10.1002/sim.4780131603; Jain RK, 2007, NAT REV NEUROSCI, V8, P610, DOI 10.1038/nrn2175; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kreisl TN, 2009, J CLIN ONCOL, V27, P740, DOI 10.1200/JCO.2008.16.3055; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Lai A, 2011, J CLIN ONCOL, V29, P142, DOI 10.1200/JCO.2010.30.2729; Lee EQ, 2012, NEURO-ONCOLOGY, V14, P1511, DOI 10.1093/neuonc/nos264; Lund EL, 1998, ACTA NEUROL SCAND, V97, P52; MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277, DOI 10.1200/JCO.1990.8.7.1277; Mackenzie F, 2012, DEVELOPMENT, V139, P1371, DOI 10.1242/dev.072348; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; MULLER HG, 1994, BIOMETRICS, V50, P61, DOI 10.2307/2533197; Osoba D, 1996, QUAL LIFE RES, V5, P139, DOI 10.1007/BF00435979; Sanghera P, 2010, CAN J NEUROL SCI, V37, P36, DOI 10.1017/S0317167100009628; Sorensen AG, 2008, NAT CLIN PRACT ONCOL, V5, P634, DOI 10.1038/ncponc1204; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Vlassenbroeck I, 2008, J MOL DIAGN, V10, P332, DOI 10.2353/jmoldx.2008.070169; Vredenburgh JJ, 2011, CLIN CANCER RES, V17, P4119, DOI 10.1158/1078-0432.CCR-11-0120; Wefel JS, 2011, NEURO-ONCOLOGY, V13, P660, DOI 10.1093/neuonc/nor024; ZELEN M, 1974, J CHRON DIS, V27, P365, DOI 10.1016/0021-9681(74)90015-0	30	1658	1695	12	201	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 20	2014	370	8					699	708		10.1056/NEJMoa1308573	http://dx.doi.org/10.1056/NEJMoa1308573			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB1DO	24552317	Green Published, Green Accepted			2022-12-28	WOS:000331531900005
J	Snowdon, C				Snowdon, Christopher			ALCOHOL AND PUBLIC HEALTH Costs of minimum alcohol pricing would outweigh benefits	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Inst Econ Affairs, London, England		Snowdon, C (corresponding author), Inst Econ Affairs, London, England.	csnowdon@iea.org.uk			MRC [G1000043] Funding Source: UKRI; Medical Research Council [G1000043] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Gornall J, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7531	1	3	3	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 19	2014	348								g1572	10.1136/bmj.g1572	http://dx.doi.org/10.1136/bmj.g1572			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB9ZL	24554178				2022-12-28	WOS:000332154200014
J	Noor, AM; Kinyoki, DK; Mundia, CW; Kabaria, CW; Mutua, JW; Alegana, VA; Fall, IS; Snow, RW				Noor, Abdisalan M.; Kinyoki, Damaris K.; Mundia, Clara W.; Kabaria, Caroline W.; Mutua, Jonesmus W.; Alegana, Victor A.; Fall, Ibrahima Soce; Snow, Robert W.			The changing risk of Plasmodium falciparum malaria infection in Africa: 2000-10: a spatial and temporal analysis of transmission intensity	LANCET			English	Article							MORTALITY	Background Over a decade ago, the Roll Back Malaria Partnership was launched, and since then there has been unprecedented investment in malaria control. We examined the change in malaria transmission intensity during the period 2000-10 in Africa. Methods We assembled a geocoded and community Plasmodium falciparum parasite rate standardised to the age group 2-10 years (PfP R2-10) database from across 49 endemic countries and territories in Africa from surveys undertaken since 1980. The data were used within a Bayesian space-time geostatistical framework to predict PfP R2-10 in 2000 and 2010 at a 1 x 1 km spatial resolution. Population distribution maps at the same spatial resolution were used to compute populations at risk by endemicity class and estimate population-adjusted PfP R2-10 (P A PfP R2-10) for each of the 44 countries for which predictions were possible for each year. Findings Between 2000 and 2010, the population in hyperendemic (>50% to 75% PfP R2-10) or holoendemic (>75% PfP R2-10) areas decreased from 218.6 million (34.4%) of 635.7 million to 183.5 million (22.5%) of 815.7 million across 44 malaria-endemic countries. 280.1 million (34.3%) people lived in areas of mesoendemic transmission (>10% to 50% PfP R2-10) in 2010 compared with 178.6 million (28.1%) in 2000. Population in areas of unstable or very low transmission (<5% PfP R2-10) increased from 131.7 million people (20.7%) in 2000 to 219.0 million (26.8%) in 2010. An estimated 217.6 million people, or 26.7% of the 2010 population, lived in areas where transmission had reduced by at least one PfP R2-10 endemicity class. 40 countries showed a reduction in national mean P A PfP R2-10. Only ten countries contributed 87.1% of the population living in areas of hyperendemic or holoendemic transmission in 2010. Interpretation Substantial reductions in malaria transmission have been achieved in endemic countries in Africa over the period 2000-10. However, 57% of the population in 2010 continued to live in areas where transmission remains moderate to intense and global support to sustain and accelerate the reduction of transmission must remain a priority.	[Noor, Abdisalan M.; Kinyoki, Damaris K.; Mundia, Clara W.; Kabaria, Caroline W.; Mutua, Jonesmus W.; Alegana, Victor A.; Snow, Robert W.] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Malaria Publ Hlth Dept, POB 43640-00100, Nairobi, Kenya; [Noor, Abdisalan M.; Snow, Robert W.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford, England; [Fall, Ibrahima Soce] WHO, Reg Off Africa, Brazzaville, Rep Congo	Kenya Medical Research Institute; University of Oxford; World Health Organization	Noor, AM (corresponding author), Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Malaria Publ Hlth Dept, POB 43640-00100, Nairobi, Kenya.	anoor@kemri-wellcome.org	Alegana, Victor/P-6579-2019; Snow, Robert William/AFR-1436-2022; Kinyoki, Damaris/AAH-1633-2020	Alegana, Victor/0000-0001-5177-9227; Snow, Robert William/0000-0003-3725-6088; Kabaria, Caroline/0000-0002-5641-5243	Wellcome Trust	Wellcome Trust(Wellcome Trust)	Wellcome Trust.	[Anonymous], MAL SIT ROOM; [Anonymous], 2012, ADV PARASIT, DOI DOI 10.1016/B978-0-12-394303-3.00010-4; [Anonymous], LEAPS REGRESSION SUB; [Anonymous], GLOB MAL ACT PLAN; [Anonymous], MILL DEV GOALS; Cameletti M, 2013, ASTA-ADV STAT ANAL, V97, P109, DOI 10.1007/s10182-012-0196-3; Cibulskis RE, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001142; Cohen JM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-213; Diggle PJ, 2007, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-48536-2; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Griffin JT, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000324; Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000290; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Linard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031743; MACDONALD G, 1964, B WORLD HEALTH ORGAN, V31, P365; METSELAAR D., 1959, Tropical and Geographical Medicine, V11, P157; Miller A., 2002, SUBSET SELECTION REG, DOI DOI 10.1201/9781420035933; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Nabarro DN, 1998, SCIENCE, V280, P2067, DOI 10.1126/science.280.5372.2067; Okell LC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-327; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Smith DL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-131; Smith DL, 2009, TRENDS PARASITOL, V25, P511, DOI 10.1016/j.pt.2009.08.002; Snow RW, 2010, LANCET, V376, P137, DOI 10.1016/S0140-6736(10)60577-6; Snow RW, 1999, B WORLD HEALTH ORGAN, V77, P624; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; WHO, 2012, WORLD MALARIA REPORT 2012, P1	27	176	178	0	40	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 17	2014	383	9930					1739	1747		10.1016/S0140-6736(13)62566-0	http://dx.doi.org/10.1016/S0140-6736(13)62566-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AH6UO	24559537	Green Published, hybrid			2022-12-28	WOS:000336267300027
J	Wu, HX; Wang, C; Gregory, KJ; Han, GW; Cho, HP; Xia, Y; Niswender, CM; Katritch, V; Meiler, J; Cherezov, V; Conn, PJ; Stevens, RC				Wu, Huixian; Wang, Chong; Gregory, Karen J.; Han, Gye Won; Cho, Hyekyung P.; Xia, Yan; Niswender, Colleen M.; Katritch, Vsevolod; Meiler, Jens; Cherezov, Vadim; Conn, P. Jeffrey; Stevens, Raymond C.			Structure of a Class C GPCR Metabotropic Glutamate Receptor 1 Bound to an Allosteric Modulator	SCIENCE			English	Article							PROTEIN-COUPLED RECEPTOR; PHARMACOLOGICAL CHARACTERIZATION; NONCOMPETITIVE ANTAGONISTS; BINDING POCKETS; SMALL-MOLECULE; DISCOVERY; ACTIVATION; EXPRESSION; DIVERSITY; AFFINITY	The excitatory neurotransmitter glutamate induces modulatory actions via the metabotropic glutamate receptors (mGlus), which are class C G protein-coupled receptors (GPCRs). We determined the structure of the human mGlu(1) receptor seven-transmembrane (7TM) domain bound to a negative allosteric modulator, FITM, at a resolution of 2.8 angstroms. The modulator binding site partially overlaps with the orthosteric binding sites of class A GPCRs but is more restricted than most other GPCRs. We observed a parallel 7TM dimer mediated by cholesterols, which suggests that signaling initiated by glutamate's interaction with the extracellular domain might be mediated via 7TM interactions within the full-length receptor dimer. A combination of crystallography, structure-activity relationships, mutagenesis, and full-length dimer modeling provides insights about the allosteric modulation and activation mechanism of class C GPCRs.	[Wu, Huixian; Wang, Chong; Han, Gye Won; Katritch, Vsevolod; Cherezov, Vadim; Stevens, Raymond C.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Gregory, Karen J.; Cho, Hyekyung P.; Niswender, Colleen M.; Conn, P. Jeffrey] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Gregory, Karen J.; Cho, Hyekyung P.; Niswender, Colleen M.; Conn, P. Jeffrey] Vanderbilt Univ, Med Ctr, Vanderbilt Ctr Neurosci Drug Discovery, Nashville, TN 37232 USA; [Gregory, Karen J.] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia; [Xia, Yan; Meiler, Jens] Vanderbilt Univ, Med Ctr, Ctr Struct Biol, Nashville, TN 37232 USA; [Xia, Yan; Meiler, Jens] Vanderbilt Univ, Med Ctr, Dept Chem, Nashville, TN 37232 USA; [Xia, Yan; Meiler, Jens] Vanderbilt Univ, Med Ctr, Inst Chem Biol, Nashville, TN 37232 USA	Scripps Research Institute; Vanderbilt University; Vanderbilt University; Monash University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Stevens, RC (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.	stevens@scripps.edu	Stevens, Raymond/K-7272-2015; Katritch, Vsevolod/Q-8357-2016; Han, Gye Won/GLQ-8673-2022; Cherezov, Vadim/L-9812-2013; Han, Gye Won/GLT-1531-2022; Katritch, Vsevolod/Y-2721-2019; Han, Gye Won/GLQ-8724-2022; Wu, Huixian/N-6353-2014	Stevens, Raymond/0000-0002-4522-8725; Katritch, Vsevolod/0000-0003-3883-4505; Cherezov, Vadim/0000-0002-5265-3914; Han, Gye Won/0000-0003-4107-835X; Wu, Huixian/0000-0003-1357-9747; Meiler, Jens/0000-0001-8945-193X; Gregory, Karen/0000-0002-3833-2137	National Institute of General Medical Sciences (NIGMS) [U54 GM094618]; NIH [P50 GM073197, R01 NS031373, R01 MH062646, R21 NS078262, R01 MH090192, R01 GM080403, R01 GM099842, R01 DK097376]; International Rett Syndrome Foundation; NHMRC (Australia); NARSAD; NSF [CHE 1305874]; National Cancer Institute [Y1-CO-1020]; NIGMS [Y1-GM-1104]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080403, R01GM099842, P50GM073197, U54GM094618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062646, R01MH090192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS031373, R21NS078262, R01NS031373] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Rett Syndrome Foundation; NHMRC (Australia)(National Health and Medical Research Council (NHMRC) of Australia); NARSAD(NARSAD); NSF(National Science Foundation (NSF)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by National Institute of General Medical Sciences (NIGMS) PSI: Biology grant U54 GM094618 for biological studies and structure production (target GPCR-68) (V. K., V. C., and R. C. S.); NIH Common Fund in Structural Biology grant P50 GM073197 for technology development (V. C. and R. C. S.); NIH grants R01 NS031373 (P.J.C.), R01 MH062646 (P.J.C.), and R21 NS078262 (C.M.N.); a basic research grant from the International Rett Syndrome Foundation (C.M.N.); an NHMRC (Australia) Overseas Biomedical postdoctoral fellowship (K.J.G.); and a NARSAD Maltz Young Investigator award (K.J.G.). Work in the Meiler laboratory on computational modeling of membrane proteins and their ligand interactions is supported by NIH grants R01 MH090192, R01 GM080403, R01 GM099842, and R01 DK097376 and by NSF grant CHE 1305874. We thank K. Emmitte and P. Garcia for the synthesis of RO0711401 and FITM; J. Velasquez for help on molecular biology; T. Trinh and M. Chu for help on baculovirus expression; K. Kadyshevskaya for assistance with figure preparation; A. Walker for assistance with manuscript preparation; Q. Xu for help on SHARP density modification; and J. Smith, R. Fischetti, and N. Sanishvili for assistance in development and use of the minibeam and beamtime at GM/CA-CAT beamline 23-ID at the Advanced Photon Source, which is supported by National Cancer Institute grant Y1-CO-1020 and NIGMS grant Y1-GM-1104. Coordinates and structure factors have been deposited in the Protein Data Bank under accession code 4OR2.	Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Chen Y, 2008, MOL PHARMACOL, V73, P909, DOI 10.1124/mol.107.040097; Dolen G, 2010, PHARMACOL THERAPEUT, V127, P78, DOI 10.1016/j.pharmthera.2010.02.008; Doumazane E, 2013, P NATL ACAD SCI USA, V110, pE1416, DOI 10.1073/pnas.1215615110; Eroglu C, 2003, P NATL ACAD SCI USA, V100, P10219, DOI 10.1073/pnas.1737042100; Fukuda J, 2009, NEUROPHARMACOLOGY, V57, P438, DOI 10.1016/j.neuropharm.2009.06.017; Gregory KJ, 2013, MOL PHARMACOL, V83, P991, DOI 10.1124/mol.112.083949; Gregory KJ, 2012, MOL PHARMACOL, V82, P860, DOI 10.1124/mol.112.080531; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; HOUAMED KM, 1991, SCIENCE, V252, P1318, DOI 10.1126/science.1656524; Huang SL, 2011, P NATL ACAD SCI USA, V108, P15480, DOI 10.1073/pnas.1107775108; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kniazeff J, 2011, PHARMACOL THERAPEUT, V130, P9, DOI 10.1016/j.pharmthera.2011.01.006; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Litschig S, 1999, MOL PHARMACOL, V55, P453; Malherbe P, 2003, MOL PHARMACOL, V64, P823, DOI 10.1124/mol.64.4.823; Malherbe P, 2006, J NEUROCHEM, V98, P601, DOI 10.1111/j.1471-4159.2006.03886.x; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; Meiler J, 2006, PROTEINS, V65, P538, DOI 10.1002/prot.21086; Molck C, 2012, MOL PHARMACOL, V82, P929, DOI 10.1124/mol.112.078808; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Pagano A, 2000, J BIOL CHEM, V275, P33750, DOI 10.1074/jbc.M006230200; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Satoh A, 2009, BIOORG MED CHEM LETT, V19, P5464, DOI 10.1016/j.bmcl.2009.07.097; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Surin A, 2007, NEUROPHARMACOLOGY, V52, P744, DOI 10.1016/j.neuropharm.2006.09.018; Suzuki G, 2007, J PHARMACOL EXP THER, V321, P1144, DOI 10.1124/jpet.106.116574; Wang C, 2013, NATURE, V497, P338, DOI 10.1038/nature12167; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Xu F, 2011, SCIENCE, V332, P322, DOI 10.1126/science.1202793	34	404	416	6	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 4	2014	344	6179					58	64		10.1126/science.1249489	http://dx.doi.org/10.1126/science.1249489			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AE1RD	24603153	Green Accepted			2022-12-28	WOS:000333746100051
J	Nicoli, TK; Makitie, A				Nicoli, Taija Kristina; Makitie, Antti			Frontal Sinusitis Causing Epidural Abscess and Puffy Tumor	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A previously healthy 13-year-old boy presented to the otorhinolaryngology clinic with soft, well-demarcated, painless swelling of the forehead. He had no definite symptoms of sinusitis but had had a headache and fluctuating fever for 3 weeks. A previously healthy 13-year-old boy presented to the otorhinolaryngology clinic with soft, well-demarcated, painless swelling of the forehead (Panel A, arrow). He had no definite symptoms of sinusitis but had had a headache and fluctuating fever for 3 weeks. He had no neurologic deficit or abnormality on physical examination. A blood chemical profile showed a C-reactive protein level of 29 mg per liter and a white-cell count of 11,900 per cubic millimeter. Computed tomography revealed unilateral opacification of the left frontal and ethmoid sinuses (Panel B, white and green arrows, respectively) as well as defects in the frontal bone (Panel ...	[Nicoli, Taija Kristina; Makitie, Antti] Univ Helsinki, Cent Hosp, Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital	Nicoli, TK (corresponding author), Univ Helsinki, Cent Hosp, Helsinki, Finland.	taija.nicoli@helsinki.fi							0	7	7	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 13	2014	370	11							e18	10.1056/NEJMicm1307740	http://dx.doi.org/10.1056/NEJMicm1307740			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC7ED	24620894				2022-12-28	WOS:000332689100002
J	Risaliti, G				Risaliti, Guido			ASTROPHYSICS Cosmic lens reveals spinning black hole	NATURE			English	Editorial Material							RAY; DISK	The power of a cosmic lens to magnify and split the light from a distant, mass-accreting giant black hole into four components has allowed researchers to measure the black hole's spin.	[Risaliti, Guido] INAF Osservatorio Astrofis Arcetri, I-50125 Florence, Italy; [Risaliti, Guido] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA	Istituto Nazionale Astrofisica (INAF); Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution	Risaliti, G (corresponding author), INAF Osservatorio Astrofis Arcetri, I-50125 Florence, Italy.	risaliti@arcetri.astro.it		Risaliti, Guido/0000-0002-3556-977X				Brenneman LW, 2006, ASTROPHYS J, V652, P1028, DOI 10.1086/508146; Dauser T, 2010, MON NOT R ASTRON SOC, V409, P1534, DOI 10.1111/j.1365-2966.2010.17393.x; Dovciak M, 2004, ASTROPHYS J SUPPL S, V153, P205, DOI 10.1086/421115; FABIAN AC, 1989, MON NOT R ASTRON SOC, V238, P729, DOI 10.1093/mnras/238.3.729; Miller L, 2008, ASTRON ASTROPHYS, V483, P437, DOI 10.1051/0004-6361:200809590; Reis RC, 2014, NATURE, V507, P207, DOI 10.1038/nature13031; Risaliti G, 2013, NATURE, V494, P449, DOI 10.1038/nature11938; Volonteri M, 2005, ASTROPHYS J, V620, P69, DOI 10.1086/426858; Walton DJ, 2013, MON NOT R ASTRON SOC, V428, P2901, DOI 10.1093/mnras/sts227	10	0	0	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 13	2014	507	7491					173	174		10.1038/nature13209	http://dx.doi.org/10.1038/nature13209			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC6RJ	24598542				2022-12-28	WOS:000332651800024
J	Havard, J				Havard, John			PERSONAL VIEW It's time to change the catheter: this ubiquitous but flawed medical device is letting patients down	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							URINARY-TRACT-INFECTION; TERM CATHETERIZATION; NURSING-HOMES; COMPLICATIONS; PREVALENCE; MORBIDITY; BLADDER; SILVER		Saxmundham Hlth, Saxmundham IP17 1DY, Suffolk, England		Havard, J (corresponding author), Saxmundham Hlth, Saxmundham IP17 1DY, Suffolk, England.	john.havard@gp-d83053.nhs.uk						Darouiche RO, 2001, CLIN INFECT DIS, V33, P1567, DOI 10.1086/323130; Feneley RCL, 2012, BJU INT, V109, P1746, DOI 10.1111/j.1464-410X.2011.10753.x; Guggenbichler JP, 1999, INFECTION, V27, pS16, DOI 10.1007/BF02561612; Hooton TM, 2010, CLIN INFECT DIS, V50, P625, DOI 10.1086/650482; Johnson JR, 1999, ANTIMICROB AGENTS CH, V43, P2990, DOI 10.1128/AAC.43.12.2990; KohlerOckmore J, 1996, BRIT J UROL, V77, P347, DOI 10.1046/j.1464-410X.1996.09074.x; Kunin C., 1997, DETECTION PREVENTION; KUNIN CM, 1992, AM J EPIDEMIOL, V135, P291; Leuck AM, 2012, J UROLOGY, V187, P1662, DOI 10.1016/j.juro.2011.12.113; Pickard R, 2012, LANCET, V380, P1927, DOI 10.1016/S0140-6736(12)61380-4; STICKLER DJ, 1994, J HOSP INFECT, V28, P177, DOI 10.1016/0195-6701(94)90101-5; WARREN JW, 1989, ARCH INTERN MED, V149, P1535, DOI 10.1001/archinte.149.7.1535; Wilde MH, 2010, J WOUND OSTOMY CONT, V37, P301, DOI 10.1097/WON.0b013e3181d73ac4	13	3	4	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2014	348								g1932	10.1136/bmj.g1932	http://dx.doi.org/10.1136/bmj.g1932			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD1ZL	24620353				2022-12-28	WOS:000333032100008
J	Acuna, V; Datry, T; Marshall, J; Barcelo, D; Dahm, CN; Ginebreda, A; McGregor, G; Sabater, S; Tockner, K; Palmer, MA				Acuna, V.; Datry, T.; Marshall, J.; Barcelo, D.; Dahm, C. N.; Ginebreda, A.; McGregor, G.; Sabater, S.; Tockner, K.; Palmer, M. A.			Why Should We Care About Temporary Waterways?	SCIENCE			English	Editorial Material							RIVER; CONNECTIVITY; VALUES		[Acuna, V.; Barcelo, D.; Sabater, S.] Catalan Inst Water Res, Girona 17003, Spain; [Datry, T.] Natl Res Inst Sci & Technol Environm & Agr IRSTEA, F-69626 Villeurbanne, France; [Marshall, J.; McGregor, G.] Queensland Dept Sci Informat Technol Innovat & Ar, Brisbane, Qld 4001, Australia; [Marshall, J.] Griffith Univ, Australian Rivers Inst, Nathan, Qld 4111, Australia; [Barcelo, D.; Ginebreda, A.] Spanish Council Sci Res IDAEA CSIC, Inst Environm Assessment & Water Res, Dept Environm Chem, Water & Soil Qual Res Grp, Barcelona 08034, Spain; [Dahm, C. N.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Sabater, S.] Univ Girona, Inst Aquat Ecol, Girona 17071, Spain; [Tockner, K.] Free Univ Berlin, Inst Biol, D-14195 Berlin, Germany; [Tockner, K.] Leibniz Inst Freshwater Ecol & Inland Fisheries, D-12587 Berlin, Germany; [Palmer, M. A.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Palmer, M. A.] Natl Socioenvironm Synth Ctr, Annapolis, MD 21401 USA	Institut Catala de Recerca de l'Aigua (ICRA); AgroParisTech; INRAE; Griffith University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Diagnostico Ambiental y Estudios del Agua (IDAEA); University of New Mexico; Universitat de Girona; Free University of Berlin; Leibniz Institut fur Gewasserokologie und Binnenfischerei (IGB); University System of Maryland; University of Maryland College Park	Palmer, MA (corresponding author), Univ Maryland, Dept Entomol, College Pk, MD 20742 USA.	mpalmer@umd.edu	Sabater, Sergi/A-7549-2008; Acuña, Vicenç/L-6608-2014; Tockner, Klement/G-9265-2011; BARCELO, DAMIA/O-4558-2016; Palmer, Margaret A/F-9648-2013	Sabater, Sergi/0000-0003-3730-0261; Acuña, Vicenç/0000-0002-4485-6703; BARCELO, DAMIA/0000-0002-8873-0491; Palmer, Margaret A/0000-0003-1468-7993; Tockner, Klement/0000-0002-0038-8151; Ginebreda, Antonio/0000-0003-4714-2850; Marshall, Jonathan/0000-0002-7177-4543; McGregor, Glenn/0000-0002-0084-4356	Direct For Biological Sciences [1052875, 1639145] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Acuna V, 2010, GLOBAL CHANGE BIOL, V16, P2638, DOI 10.1111/j.1365-2486.2010.02170.x; [Anonymous], 2000, OFFICIAL J EUROPEA L, V327, P1; Barma D., 2012, HYDROLOGICAL MODELLI, P93; Burke T., 2012, WATER ACT 2007 BASIN, P245; Datry T, 2014, BIOSCIENCE, V64, P229, DOI 10.1093/biosci/bit027; Doyle MW, 2011, ENVIRON SCI TECHNOL, V45, P354, DOI 10.1021/es101273f; Elmore AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074819; EPA, 2013, EC AN PROP REV DEF W; Fonseca J.E., 2013, MERGING SCI MANAGEME, P119; Fritz KM, 2013, J AM WATER RESOUR AS, V49, P867, DOI 10.1111/jawr.12040; Jaeger KL, 2012, RIVER RES APPL, V28, P1843, DOI 10.1002/rra.1554; Julian JP, 2012, GEOMORPHOLOGY, V177, P194, DOI 10.1016/j.geomorph.2012.07.029; Lang M, 2012, WETLANDS, V32, P461, DOI 10.1007/s13157-012-0279-7; Larned ST, 2010, FRESHWATER BIOL, V55, P717, DOI 10.1111/j.1365-2427.2009.02322.x; Lindberg TT, 2011, P NATL ACAD SCI USA, V108, P20929, DOI 10.1073/pnas.1112381108; Munne A, 2004, ENVIRON MANAGE, V34, P711, DOI 10.1007/s00267-003-0098-y; Munoz I., 2012, LLO BREGAT STORY POL, P93; Nikolaidis NP, 2013, WATER POLICY, V15, P830, DOI 10.2166/wp.2013.158; Raymond PA, 2013, NATURE, V503, P355, DOI 10.1038/nature12760; Snelder TH, 2013, HYDROL EARTH SYST SC, V17, P2685, DOI 10.5194/hess-17-2685-2013; Steward AL, 2012, FRONT ECOL ENVIRON, V10, P202, DOI 10.1890/110136; Wigington PJ, 2006, FRONT ECOL ENVIRON, V4, P513, DOI 10.1890/1540-9295(2006)4[513:CSDOIS]2.0.CO;2	22	220	221	2	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2014	343	6175					1080	1081		10.1126/science.1246666	http://dx.doi.org/10.1126/science.1246666			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2LB	24604183				2022-12-28	WOS:000332331500027
J	Galaasen, EV; Ninnemann, US; Irvali, N; Kleiven, HF; Rosenthal, Y; Kissel, C; Hodell, DA				Galaasen, Eirik Vinje; Ninnemann, Ulysses S.; Irvali, Nil; Kleiven, Helga (Kikki) F.; Rosenthal, Yair; Kissel, Catherine; Hodell, David A.			Rapid Reductions in North Atlantic Deep Water During the Peak of the Last Interglacial Period	SCIENCE			English	Article							CLIMATE; VARIABILITY; CIRCULATION; SURFACE; SEA; STABILITY; GREENLAND; EVENT; RATES	Deep ocean circulation has been considered relatively stable during interglacial periods, yet little is known about its behavior on submillennial time scales. Using a subcentennially resolved epibenthic foraminiferal delta C-13 record, we show that the influence of North Atlantic Deep Water (NADW) was strong at the onset of the last interglacial period and was then interrupted by several prominent centennial-scale reductions. These NADW transients occurred during periods of increased ice rafting and southward expansions of polar water influence, suggesting that a buoyancy threshold for convective instability was triggered by freshwater and circum-Arctic cryosphere changes. The deep Atlantic chemical changes were similar in magnitude to those associated with glaciations, implying that the canonical view of a relatively stable interglacial circulation may not hold for conditions warmer and fresher than at present.	[Galaasen, Eirik Vinje; Ninnemann, Ulysses S.; Kleiven, Helga (Kikki) F.] Univ Bergen, Dept Earth Sci, N-5007 Bergen, Norway; [Galaasen, Eirik Vinje; Ninnemann, Ulysses S.; Irvali, Nil; Kleiven, Helga (Kikki) F.] Bjerknes Ctr Climate Res, N-5007 Bergen, Norway; [Ninnemann, Ulysses S.; Irvali, Nil; Kleiven, Helga (Kikki) F.] Uni Res, Uni Climate, Bergen, Norway; [Rosenthal, Yair] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08903 USA; [Rosenthal, Yair] Rutgers State Univ, Dept Earth & Planetary Sci, New Brunswick, NJ 08903 USA; [Kissel, Catherine] CEA CNRS UVSQ, Inst Pierre Simon Laplace, Lab Sci Climat & Environm, Gif Sur Yvette, France; [Hodell, David A.] Univ Cambridge, Dept Earth Sci, Godwin Lab Paleoclimate Res, Cambridge CB2 3EQ, England	University of Bergen; Bjerknes Centre for Climate Research; Rutgers State University New Brunswick; Rutgers State University New Brunswick; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); University of Cambridge	Galaasen, EV (corresponding author), Univ Bergen, Dept Earth Sci, Allegaten 41, N-5007 Bergen, Norway.	eirik.galaasen@geo.uib.no	Irvalı, Nil/ABC-2468-2021; Catherine, Kissel/AAH-1647-2019	Irvalı, Nil/0000-0001-5723-5781; Catherine, Kissel/0000-0002-2572-2742; Hodell, David/0000-0001-8537-1588; Galaasen, Eirik Vinje/0000-0002-6851-9066	Meltzer Fund (University of Bergen); North Atlantic Ocean-Climate Variability in a Warmer World (NOCWARM) project (Research Council of Norway); Natural Environment Research Council [NE/H014292/1] Funding Source: researchfish; NERC [NE/H014292/1] Funding Source: UKRI	Meltzer Fund (University of Bergen); North Atlantic Ocean-Climate Variability in a Warmer World (NOCWARM) project (Research Council of Norway); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the crew, chief scientist (C. Laj), and scientific party of the R/V Marion Dufresne; the Institut Polaire Emile Victorfrom the International Marine Global Changes (IMAGES) P.I.C.A.S.S.O. coring cruise; J. Wright for help locating MIS 5e in MD03-2664; two anonymous reviewers for their insightful and constructive comments; and D. I. Blindheim, O. Hansen, and R. Soraas from the Bjerknes Centre for Climate Research for technical assistance. This study was funded by the Meltzer Fund (University of Bergen) and the North Atlantic Ocean-Climate Variability in a Warmer World (NOCWARM) project (Research Council of Norway) and contributes to EU-FP7 IP Past4Future. The data reported in this paper are tabulated in the supplementary materials.	Adkins JF, 1997, NATURE, V390, P154, DOI 10.1038/36540; Bauch HA, 2013, QUATERNARY SCI REV, V63, P1, DOI 10.1016/j.quascirev.2012.11.023; Colville EJ, 2011, SCIENCE, V333, P620, DOI 10.1126/science.1204673; Curry WB, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001021; Dahl-Jensen D, 2013, NATURE, V493, P489, DOI 10.1038/nature11789; de Vernal A, 2008, SCIENCE, V320, P1622, DOI 10.1126/science.1153929; Dickson R, 1996, PROG OCEANOGR, V38, P241, DOI 10.1016/S0079-6611(97)00002-5; DICKSON RR, 1994, J GEOPHYS RES-OCEANS, V99, P12319, DOI 10.1029/94JC00530; Fronval T, 1998, QUATERNARY SCI REV, V17, P963, DOI 10.1016/S0277-3791(98)00038-9; Govin A, 2012, CLIM PAST, V8, P483, DOI 10.5194/cp-8-483-2012; Hall IR, 1998, EARTH PLANET SC LETT, V164, P15, DOI 10.1016/S0012-821X(98)00209-X; Hall J. M., 2004, PALEOCEANOGRAPHY, V19; Hodell DA, 2009, EARTH PLANET SC LETT, V288, P10, DOI 10.1016/j.epsl.2009.08.040; Hofmann M, 2009, P NATL ACAD SCI USA, V106, P20584, DOI 10.1073/pnas.0909146106; IPCC, 2013, CLIMATE CHANGE 2022; Irvali N, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2011PA002244; Keigwin LD, 1999, PALEOCEANOGRAPHY, V14, P164, DOI 10.1029/1998PA900026; Key RM, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002247; Kissel C, 2013, EARTH PLANET SC LETT, V369, P248, DOI 10.1016/j.epsl.2013.03.042; Kleiven HF, 2008, SCIENCE, V319, P60, DOI 10.1126/science.1148924; Levermann A, 2005, CLIM DYNAM, V24, P347, DOI 10.1007/s00382-004-0505-y; MCMANUS JF, 1994, NATURE, V371, P326, DOI 10.1038/371326a0; Nicholl JAL, 2012, NAT GEOSCI, V5, P901, DOI [10.1038/ngeo1622, 10.1038/NGEO1622]; Ninnemann US, 2002, EARTH PLANET SC LETT, V201, P383, DOI 10.1016/S0012-821X(02)00708-2; Ninnemann US, 1999, GEOPH MONOG SERIES, V112, P99; Olsen A, 2010, SCIENCE, V330, P658, DOI 10.1126/science.1193769; Oppo DW, 2003, NATURE, V422, P277, DOI 10.1038/422277b; Oppo DW, 1997, PALEOCEANOGRAPHY, V12, P51, DOI 10.1029/96PA03133; Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808; Rohling EJ, 2005, NATURE, V434, P975, DOI 10.1038/nature03421; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Shanahan TM, 2009, SCIENCE, V324, P377, DOI 10.1126/science.1166352; STOCKER TF, 1991, NATURE, V351, P729, DOI 10.1038/351729a0; Stocker TF, 1997, NATURE, V388, P862, DOI 10.1038/42224; Vellinga M, 2002, CLIMATIC CHANGE, V54, P251, DOI 10.1023/A:1016168827653	35	82	85	0	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2014	343	6175					1129	1132		10.1126/science.1248667	http://dx.doi.org/10.1126/science.1248667			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2LB	24557839				2022-12-28	WOS:000332331500046
J	Bould, MD; Hladkowicz, ES; Pigford, AAE; Ufholz, LA; Postonogova, T; Shin, E; Boet, S				Bould, M. Dylan; Hladkowicz, Emily S.; Pigford, Ashlee-Ann E.; Ufholz, Lee-Anne; Postonogova, Tatyana; Shin, Eunkyung; Boet, Sylvain			References that anyone can edit: review of Wikipedia citations in peer reviewed health science literature	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MEDICAL-STUDENTS; INTERNET; INFORMATION; RESIDENTS; RESOURCE; QUALITY; GOOGLE	Objectives To examine indexed health science journals to evaluate the prevalence of Wikipedia citations, identify the journals that publish articles with Wikipedia citations, and determine how Wikipedia is being cited. Design Bibliometric analysis. Study selection Publications in the English language that included citations to Wikipedia were retrieved using the online databases Scopus and Web of Science. Data sources To identify health science journals, results were refined using Ulrich's database, selecting for citations from journals indexed in Medline, PubMed, or Embase. Using Thomson Reuters Journal Citation Reports, 2011 impact factors were collected for all journals included in the search. Data extraction Resulting citations were thematically coded, and descriptive statistics were calculated. Results 1433 full text articles from 1008 journals indexed in Medline, PubMed, or Embase with 2049 Wikipedia citations were accessed. The frequency of Wikipedia citations has increased over time; most citations occurred after December 2010. More than half of the citations were coded as definitions (n= 648; 31.6%) or descriptions (n= 482; 23.5%). Citations were not limited to journals with a low or no impact factor; the search found Wikipedia citations in many journals with high impact factors. Conclusions Many publications are citing information from a tertiary source that can be edited by anyone, although permanent, evidence based sources are available. We encourage journal editors and reviewers to use caution when publishing articles that cite Wikipedia.	[Bould, M. Dylan] Univ Ottawa, Childrens Hosp Eastern Ontario, Dept Anesthesiol, Ottawa, ON K1H 8L1, Canada; [Hladkowicz, Emily S.; Pigford, Ashlee-Ann E.] Ottawa Hosp Res Inst, Dept Anesthesiol, Ottawa, ON, Canada; [Ufholz, Lee-Anne] Univ Ottawa, Hlth Sci Lib, Ottawa, ON K1H 8L1, Canada; [Postonogova, Tatyana] St Michaels Hosp, Li Ka Shing Knowledge Inst, Allan Waters Family Simulat Ctr, Toronto, ON M5B 1W8, Canada; [Shin, Eunkyung] Univ Toronto, Dept Surg, St Michaels Hosp, Toronto, ON, Canada; [Boet, Sylvain] Univ Toronto, Dept Anesthesiol, St Michaels Hosp, Toronto, ON, Canada	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Bould, MD (corresponding author), Univ Ottawa, Childrens Hosp Eastern Ontario, Dept Anesthesiol, 401 Smyth Rd, Ottawa, ON K1H 8L1, Canada.	dbould@cheo.on.ca	boet, sylvain/C-3983-2011	boet, sylvain/0000-0002-1679-818X; Bould, Dylan/0000-0003-1675-466X	Children's Hospital of Eastern Ontario Department of Anesthesiology, University of Ottawa; Ottawa Hospital Department of Anesthesiology, University of Ottawa	Children's Hospital of Eastern Ontario Department of Anesthesiology, University of Ottawa; Ottawa Hospital Department of Anesthesiology, University of Ottawa	The study was funded by the Children's Hospital of Eastern Ontario Department of Anesthesiology, University of Ottawa, and the Ottawa Hospital Department of Anesthesiology, University of Ottawa. The funding sources had no role in the study design; the collection, analysis, and interpretation of data; or the writing of the article and the decision to submit it for publication.	Allahwala UK, 2013, MED TEACH, V35, P337, DOI 10.3109/0142159X.2012.737064; [Anonymous], 2009, ABC NEWS; Callis KL, 2009, TRENDS ECOL EVOL, V24, P177, DOI 10.1016/j.tree.2009.01.003; Chakraborti CK, 2011, INDIAN J PHARMACOL, V43, P113, DOI 10.4103/0253-7613.77335; Chesney T., 2006, 1 MONDAY, V11; Czarnecka-Kujawa K, 2008, GASTROENTEROLOGY, V134, pA325; Duran-Nelson A, 2013, ACAD MED, V88, P788, DOI 10.1097/ACM.0b013e31828ffdb7; GARFIELD E, 1994, CURR CONTENTS, V20, P3; Giles J, 2005, NATURE, V438, P900, DOI 10.1038/438900a; Giles J, 2006, NATURE, V443, P493, DOI 10.1038/443493a; Haigh CA, 2011, NURS EDUC TODAY, V31, P135, DOI 10.1016/j.nedt.2010.05.004; Heilman J, 2013, B WORLD HEALTH ORGAN, V91, P8, DOI 10.2471/BLT.13.030113; Heilman JM, 2011, J MED INTERNET RES, V13, P153, DOI 10.2196/jmir.1589; Hughes B, 2009, INT J MED INFORM, V78, P645, DOI 10.1016/j.ijmedinf.2009.04.008; International Committee of Medical Journal Editors, 2013, REC COND REP ED PUBL; Judd T, 2011, BRIT J EDUC TECHNOL, V42, P351, DOI 10.1111/j.1467-8535.2009.01019.x; Kleeman J., 2007, NZ HERALD; Knapp M.M., 2008, THEATRE HIST STUD, V28, P36; Leithner A, 2010, J AM MED INFORM ASSN, V17, P373, DOI 10.1136/jamia.2010.004507; Martin L., 2006, GUARDIAN; Matava CT, 2013, BMC MED EDUC, V13, DOI 10.1186/1472-6920-13-59; Metcalfe D, 2011, J ROY SOC MED, V104, P488, DOI 10.1258/jrsm.2011.110227; Mostyn A, 2013, BMC MED EDUC, V13, DOI 10.1186/1472-6920-13-12; Nielsen F.A., 2007, 1 MONDAY, V12, DOI [10.5210/fm.v12i8.1997, DOI 10.5210/FM.V12I8.1997]; Okoli C., 2012, SSRN ELECT J, DOI DOI 10.2139/SSRN.2021326; Park T. K., 2011, 1 MONDAY, V16; Peoples LF, 2009, YALE J LAW TECHNOLOG, P12; Prytherch R. J., 2005, HARRODS LIB GLOSSARY; Rajagopalan MS, 2011, J ONCOL PRACT, V7, P319, DOI 10.1200/JOP.2010.000209; Reavley NJ, 2012, PSYCHOL MED, V42, P1753, DOI 10.1017/S003329171100287X; Reuters Thomson., 2014, 2013 J CIT REP; Richardson CG, 2013, CHRON DIS INJ CAN, V33, P123; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Thomas GR, 2013, SEMIN DIALYSIS, V26, P159, DOI 10.1111/sdi.12059; van der Marel S, 2009, INFLAMM BOWEL DIS, V15, P1891, DOI 10.1002/ibd.20976; Waters NL, 2007, COMMUN ACM, V50, P15, DOI 10.1145/1284621.1284635; Wikipedia, 2013, WIK PLAIN SIMPL GUID; Wikipedia, 2013, WIK CIT WIK	38	26	27	1	27	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 5	2014	348								g1585	10.1136/bmj.g1585	http://dx.doi.org/10.1136/bmj.g1585			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AC6IM	24603564	Green Published, hybrid			2022-12-28	WOS:000332625300001
J	Ladizinski, B; Sankey, C				Ladizinski, Barry; Sankey, Christopher			Vanishing Lung Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 41-year-old man with a smoking history of 30 pack-years presented with chronic chest pain, dyspnea, and cough. Physical examination revealed cachexia, with decreased apical breath sounds and hyperresonance to percussion in both lungs. A 41-year-old man with a smoking history of 30 pack-years presented with chronic chest pain, dyspnea, and cough. His vital signs were normal, and laboratory studies were unremarkable, including his level of (1)-antitrypsin, which was normal. Physical examination revealed cachexia, with decreased apical breath sounds and hyperresonance to percussion in both lungs. Chest radiography showed extensive bullous lung disease in the apex and upper lobes of both lungs (Panel A, arrows; Panel B), which was suggestive of vanishing lung syndrome; air-liquid levels were seen in the left lung (Panels A, B, and C, asterisk). Computed tomography of the ...	[Ladizinski, Barry] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA; [Sankey, Christopher] Yale Univ, New Haven, CT USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Yale University	Ladizinski, B (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD 21205 USA.		Sankey, Chris/AAX-3972-2021	Sankey, Chris/0000-0002-7327-7460					0	6	6	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 27	2014	370	9					E14	E14		10.1056/NEJMicm1305898	http://dx.doi.org/10.1056/NEJMicm1305898			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB8AR	24571779				2022-12-28	WOS:000332013000001
J	Mohamed, M; Fernando, R; Arora, A				Mohamed, Muhajir; Fernando, Ruchira; Arora, Anurag			CASE REPORT Airway obstruction after the development of Hashimoto's thyroiditis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LYMPHOMA; DISEASE; GLAND		[Mohamed, Muhajir; Arora, Anurag] Launceston Gen Hosp, Dept Med, Launceston, Tas 7250, Australia; [Mohamed, Muhajir] Univ Tasmania, Launceston Clin Sch, Launceston, Tas 7250, Australia; [Fernando, Ruchira] Launceston Gen Hosp, Dept Pathol, Launceston, Tas 7250, Australia	University of Tasmania	Mohamed, M (corresponding author), Launceston Gen Hosp, Dept Med, Launceston, Tas 7250, Australia.	muhajirbm@yahoo.com						Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; DiBiase SJ, 2004, AM J CLIN ONCOL-CANC, V27, P178, DOI 10.1097/01.coc.0000054891.30422.B5; Friedberg J, 2012, UPTODATE; Kakudo K, 2012, ENDOCR J, V59, P273, DOI 10.1507/endocrj.EJ11-0309; Klyachkin ML, 1998, AM SURGEON, V64, P234; Lee JK, 2011, INDIAN J OTOLARYNGOL, V63, P387, DOI 10.1007/s12070-011-0223-9; MARIOTTI S, 1990, J CLIN ENDOCR METAB, V71, P661, DOI 10.1210/jcem-71-3-661; Pedersen RK, 1996, HISTOPATHOLOGY, V28, P25, DOI 10.1046/j.1365-2559.1996.268311.x; Ross DS, 2013, UPTODATE; Stein SA, 2013, J CLIN ENDOCR METAB, V98, P3131, DOI 10.1210/jc.2013-1428; Van den Bruel A, 2002, THYROID, V12, P169, DOI 10.1089/105072502753522419; Walsh S, 2013, ONCOLOGIST, V18, P994, DOI 10.1634/theoncologist.2013-0036; Wood K, 2004, EJSO-EUR J SURG ONC, V30, P583, DOI 10.1016/j.ejso.2004.03.012; Zhang L, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-610	14	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 24	2014	348								g1643	10.1136/bmj.g1643	http://dx.doi.org/10.1136/bmj.g1643			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC0TP	24565961				2022-12-28	WOS:000332208400009
J	Mortha, A; Chudnovskiy, A; Hashimoto, D; Bogunovic, M; Spencer, SP; Belkaid, Y; Merad, M				Mortha, Arthur; Chudnovskiy, Aleksey; Hashimoto, Daigo; Bogunovic, Milena; Spencer, Sean P.; Belkaid, Yasmine; Merad, Miriam			Microbiota-Dependent Crosstalk Between Macrophages and ILC3 Promotes Intestinal Homeostasis	SCIENCE			English	Article							COLONY-STIMULATING FACTOR; ROR-GAMMA-T; DENDRITIC-CELL; GM-CSF; STEADY-STATE; COMMENSAL MICROFLORA; T(H)17 CELLS; DIFFERENTIATION; SUBSETS; LYMPH	The intestinal microbiota and tissue-resident myeloid cells promote immune responses that maintain intestinal homeostasis in the host. However, the cellular cues that translate microbial signals into intestinal homeostasis remain unclear. Here, we show that deficient granulocyte-macrophage colony-stimulating factor (GM-CSF) production altered mononuclear phagocyte effector functions and led to reduced regulatory T cell (T-reg) numbers and impaired oral tolerance. We observed that ROR gamma t(+) innate lymphoid cells (ILCs) are the primary source of GM-CSF in the gut and that ILC-driven GM-CSF production was dependent on the ability of macrophages to sense microbial signals and produce interleukin-1 beta. Our findings reveal that commensal microbes promote a crosstalk between innate myeloid and lymphoid cells that leads to immune homeostasis in the intestine.	[Mortha, Arthur; Chudnovskiy, Aleksey; Hashimoto, Daigo; Bogunovic, Milena; Merad, Miriam] Dept Oncol Sci, New York, NY 10029 USA; [Mortha, Arthur; Chudnovskiy, Aleksey; Hashimoto, Daigo; Bogunovic, Milena; Merad, Miriam] Tisch Canc Inst, New York, NY 10029 USA; [Mortha, Arthur; Chudnovskiy, Aleksey; Hashimoto, Daigo; Bogunovic, Milena; Merad, Miriam] Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA; [Spencer, Sean P.; Belkaid, Yasmine] NIAID, Program Barrier Immun & Repair, Mucosal Immunol Sect, Lab Parasit Dis, Bethesda, MD 20892 USA	Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Merad, M (corresponding author), Dept Oncol Sci, 1470 Madison Ave, New York, NY 10029 USA.	miriam.merad@mssm.edu	Mortha, Arthur/ABE-6250-2020; Hashimoto, Daigo/O-1013-2013	Hashimoto, Daigo/0000-0001-9489-9704; Mortha, Arthur/0000-0003-2673-0485; Spencer, Sean/0000-0002-7328-5399; Belkaid, Yasmine/0000-0001-9962-3571	NIH [R01 CA154947A, R01 CA173861, U01 AI095611]; German Research Foundation (DFG) [MO2380/1-1]; Division of Intramural Research of the National Institute of Allergy and Infectious Diseases; NATIONAL CANCER INSTITUTE [R01CA154947, R01CA173861] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001115, ZIAAI001133, ZIAAI001132, U01AI095611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK094708] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation (DFG)(German Research Foundation (DFG)); Division of Intramural Research of the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the Merad laboratory for helpful discussions and input. We are grateful to W.-H. Kwan and W. van der Touw for assistance with the T<INF>reg</INF> induction assay. We thank R. Huq and L. O'Rourke at the Icahn School of Medicine at Mount Sinai Microscopy Shared Resource Facility for their training, helpful advice, and support with microscopy imaging. We are grateful to C. Berin and A. Belen Blazquez for support with the oral tolerance and DTH models. We thank J. Ochando and the Flow Cytometry facility for technical support and assistance with cell sorting. The data presented in this paper are tabulated in the main paper and in the supporting materials. M. M. is funded by NIH grants R01 CA154947A, R01 CA173861, and U01 AI095611. A. M. is funded by the German Research Foundation (DFG) grant MO2380/1-1. Y.B. was supported by the Division of Intramural Research of the National Institute of Allergy and Infectious Diseases.	Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bogunovic M, 2012, IMMUNOL RES, V54, P37, DOI 10.1007/s12026-012-8323-5; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Cerovic V, 2013, MUCOSAL IMMUNOL, V6, P104, DOI 10.1038/mi.2012.53; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Crellin NK, 2010, IMMUNITY, V33, P752, DOI 10.1016/j.immuni.2010.10.012; Denning TL, 2007, NAT IMMUNOL, V8, P1086, DOI 10.1038/ni1511; Denning TL, 2011, J IMMUNOL, V187, P733, DOI 10.4049/jimmunol.1002701; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Egea L, 2013, J IMMUNOL, V190, P1702, DOI 10.4049/jimmunol.1202368; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Enzler T, 2007, BLOOD, V110, P954, DOI 10.1182/blood-2006-08-043786; Fukuzawa H, 2003, BIOCHEM BIOPH RES CO, V312, P897, DOI 10.1016/j.bbrc.2003.11.009; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Goldstein JI, 2011, GASTROENTEROLOGY, V141, P208, DOI 10.1053/j.gastro.2011.03.060; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Griseri T, 2012, IMMUNITY, V37, P1116, DOI 10.1016/j.immuni.2012.08.025; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Han XN, 2009, GASTROENTEROLOGY, V136, P1261, DOI 10.1053/j.gastro.2008.12.046; Hanash AM, 2012, IMMUNITY, V37, P339, DOI 10.1016/j.immuni.2012.05.028; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; Hashimoto D, 2011, J EXP MED, V208, P1069, DOI 10.1084/jem.20101709; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hoshi N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2113; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jakubzick C, 2008, J EXP MED, V205, P2839, DOI 10.1084/jem.20081430; Jinushi M, 2008, IMMUNOL REV, V222, P287, DOI 10.1111/j.1600-065X.2008.00618.x; Jinushi M, 2007, J CLIN INVEST, V117, P1902, DOI 10.1172/JCI30966; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Korzenik JR, 2005, NEW ENGL J MED, V352, P2193, DOI 10.1056/NEJMoa041109; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Naik SH, 2006, NAT IMMUNOL, V7, P663, DOI 10.1038/ni1340; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Reynders A, 2011, EMBO J, V30, P2934, DOI 10.1038/emboj.2011.201; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Shaw MH, 2012, J EXP MED, V209, P251, DOI 10.1084/jem.20111703; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Tamoutounour S, 2012, EUR J IMMUNOL, V42, P3150, DOI 10.1002/eji.201242847; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Vremec D, 1997, EUR J IMMUNOL, V27, P40, DOI 10.1002/eji.1830270107; Zhan YF, 2012, MOL IMMUNOL, V52, P30, DOI 10.1016/j.molimm.2012.04.009	58	523	556	10	148	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 28	2014	343	6178					1477	+	1249288	10.1126/science.1249288	http://dx.doi.org/10.1126/science.1249288			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AD7TZ	24625929	Green Accepted			2022-12-28	WOS:000333471000038
J	Shlomai, A; Rice, CM				Shlomai, Amir; Rice, Charles M.			Getting Rid of a Persistent Troublemaker to Cure Hepatitis	SCIENCE			English	Editorial Material							B-VIRUS REPLICATION; HBV INFECTION; INHIBITION; INTERFERON		[Shlomai, Amir; Rice, Charles M.] Rockefeller Univ, Lab Virol & Infect Dis, Ctr Study Hepatitis C, New York, NY 10065 USA	Rockefeller University	Shlomai, A (corresponding author), Rockefeller Univ, Lab Virol & Infect Dis, Ctr Study Hepatitis C, 1230 York Ave, New York, NY 10065 USA.	ricec@mail.rockefeller.edu		Shlomai, Amir/0000-0001-7437-9381				Belloni L, 2012, J CLIN INVEST, V122, P529, DOI 10.1172/JCI58847; Bonvin M, 2006, HEPATOLOGY, V43, P1364, DOI 10.1002/hep.21187; Dusheiko G, 2013, LIVER INT, V33, P137, DOI 10.1111/liv.12078; Guidotti LG, 1999, SCIENCE, V284, P825, DOI 10.1126/science.284.5415.825; Janssen HLA, 2005, LANCET, V365, P123, DOI 10.1016/S0140-6736(05)17701-0; Liu J, 2010, GASTROENTEROLOGY, V139, P474, DOI 10.1053/j.gastro.2010.04.048; Lucifora J, 2014, SCIENCE, V343, P1221, DOI 10.1126/science.1243462; Makowska Z, 2011, HEPATOLOGY, V53, P1154, DOI 10.1002/hep.24189; Suspene R, 2005, P NATL ACAD SCI USA, V102, P8321, DOI 10.1073/pnas.0408223102; Turelli P, 2004, SCIENCE, V303, P1829, DOI 10.1126/science.1092066; Zhang TW, 2013, HUM MOL GENET, V22, P1262, DOI 10.1093/hmg/dds513	11	12	12	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 14	2014	343	6176					1212	1213		10.1126/science.1252186	http://dx.doi.org/10.1126/science.1252186			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC7RG	24626921				2022-12-28	WOS:000332728500026
J	Spence, D				Spence, Des			FROM THE FRONTLINE Bad medicine: NICE's traffic light system for febrile children	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INFECTIONS; ENGLAND; DISEASE					destwo@yahoo.co.uk						[Anonymous], 2013, FEVERISH ILLNESS CHI; Collins S, 2013, CLIN INFECT DIS, V57, P1715, DOI 10.1093/cid/cit579; Craig JC, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1594; De S, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f866; Gill PJ, 2013, ARCH DIS CHILD, V98, P328, DOI 10.1136/archdischild-2012-302383; Health Protection Scotland, MEN INF; Roggen I, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002712; Spinks A, 2013, ANTIBIOTICS PEOPLE S; Van den Bruel A, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6144; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823	10	2	2	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2014	348								g2056	10.1136/bmj.g2056	http://dx.doi.org/10.1136/bmj.g2056			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD1ZL	24618116				2022-12-28	WOS:000333032100012
J	Teale, EA; Iliffe, S; Young, JB				Teale, Elizabeth A.; Iliffe, Steve; Young, John B.			EASILY MISSED? Subdural haematoma in the elderly	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INTRACRANIAL HEMORRHAGE; ATRIAL-FIBRILLATION; ANTICOAGULATION; RISK; DIAGNOSIS; WARFARIN; ASPIRIN; THERAPY		[Teale, Elizabeth A.; Young, John B.] Leeds Inst Hlth Sci, Acad Unit Elderly Care & Rehabil, Bradford BD9 6RJ, W Yorkshire, England; [Iliffe, Steve] UCL, Dept Primary Care & Populat Hlth, London NW3 2PF, England	University of London; University College London	Teale, EA (corresponding author), Leeds Inst Hlth Sci, Acad Unit Elderly Care & Rehabil, Bradford BD9 6RJ, W Yorkshire, England.	Elizabeth.Teale@bthft.nhs.uk	Iliffe, Steve/L-8379-2019	young, john/0000-0003-4085-9306; Iliffe, Stephen/0000-0003-2806-3997				Adhiyaman V, 2002, POSTGRAD MED J, V78, P71, DOI 10.1136/pmj.78.916.71; Asghar M, 2002, J ROY SOC MED, V95, P290, DOI 10.1258/jrsm.95.6.290; Aspegren OP, 2013, CLIN NEUROL NEUROSUR, V115, P981, DOI 10.1016/j.clineuro.2012.10.008; BLACK DW, 1984, BRIT J PSYCHIAT, V145, P200, DOI 10.1192/bjp.145.2.200; Bostantjopoulou S, 2009, J CLIN NEUROSCI, V16, P458, DOI 10.1016/j.jocn.2008.03.016; Connolly BJ, 2013, J STROKE CEREBROVASC, V22, P444, DOI 10.1016/j.jstrokecerebrovasdis.2013.01.007; Crandon IW, 2007, W INDIAN MED J, V56, P547; DAVENPORT RJ, 1994, BRIT MED J, V309, P792, DOI 10.1136/bmj.309.6957.792; Ducruet AF, 2012, NEUROSURG REV, V35, P155, DOI 10.1007/s10143-011-0349-y; Gelabert-Gonzalez M, 2005, CLIN NEUROL NEUROSUR, V107, P223, DOI 10.1016/j.clineuro.2004.09.015; Guptha S H, 2001, Age Ageing, V30, P172, DOI 10.1093/ageing/30.2.172; Hart RG, 2012, STROKE, V43, P1511, DOI 10.1161/STROKEAHA.112.650614; Henderson MJ, 2000, POSTGRAD MED J, V76, P585, DOI 10.1136/pmj.76.899.585; HYLEK EM, 1994, ANN INTERN MED, V120, P897, DOI 10.7326/0003-4819-120-11-199406010-00001; Ishikawa E, 2002, J NEUROSURG, V96, P680, DOI 10.3171/jns.2002.96.4.0680; Jeffree RL, 2009, J CLIN NEUROSCI, V16, P882, DOI 10.1016/j.jocn.2008.10.004; Jones S, 1999, AGE AGEING, V28, P519, DOI 10.1093/ageing/28.6.519; Karibe Hiroshi, 2011, No Shinkei Geka, V39, P1149; Liliang PC, 2002, INJURY, V33, P345, DOI 10.1016/S0020-1383(02)00020-7; Mant J, 2007, LANCET, V370, P493, DOI 10.1016/S0140-6736(07)61233-1; Medical Protection Society, 2003, UK CASEBOOK, V11, P10; Medical Protection Society, 2010, CASEBOOK, V18, P17; ROZZELLE CJ, 1995, J AM GERIATR SOC, V43, P240, DOI 10.1111/j.1532-5415.1995.tb07329.x; Rust T, 2006, J CLIN NEUROSCI, V13, P823, DOI 10.1016/j.jocn.2004.12.013; Sadrolhefazi A, 2000, NEUROSURG CLIN N AM, V11, P455, DOI 10.1016/S1042-3680(18)30108-6; Singh TB, 2013, ASEAN J PSYCHIATR, V14, P175; SNOEY ER, 1994, ANN EMERG MED, V23, P1127, DOI 10.1016/S0196-0644(94)70115-6; VELASCO J, 1995, SOUTHERN MED J, V88, P977, DOI 10.1097/00007611-199509000-00019	28	6	6	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2014	348								g1682	10.1136/bmj.g1682	http://dx.doi.org/10.1136/bmj.g1682			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AD1ZL	24620354				2022-12-28	WOS:000333032100004
J	Howard, JAK; Probert, MR				Howard, Judith A. K.; Probert, Michael R.			Cutting-Edge Techniques Used for the Structural Investigation of Single Crystals	SCIENCE			English	Review							X-RAY-DIFFRACTION; SPIN-CROSSOVER; HIGH-PRESSURE; DIFFRACTOMETER; CRYSTALLOGRAPHY; SPECTROSCOPY; COMPLEXES; DESIGN; POWDER; GROWTH	X-ray crystallography has become the leading technique for studying the structure of matter at the atomic and molecular level. Today it underpins all sciences and is widely applied in industry. It is essential in the development of new materials. The technique is very powerful, and the range of materials that can be studied expands as new technologies evolve and are applied in innovative ways to structure solution. It is now possible to record vast amounts of diffraction data in seconds electronically, whereas it took days and months by photographic methods 30 to 40 years ago. Single crystals can be created in various ways; they can be produced from compounds that are liquids or gases at room temperature, and complete molecular structures can be presented within minutes. This short review presents recent developments that are appropriate to the single-crystal x-ray studies of chemical and materials sciences.	[Howard, Judith A. K.] Univ Durham, Dept Chem, Durham DH1 3LE, England; [Probert, Michael R.] Newcastle Univ, Sch Chem, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Durham University; Newcastle University - UK	Howard, JAK (corresponding author), Univ Durham, Dept Chem, South Rd, Durham DH1 3LE, England.	j.a.k.howard@durham.ac.uk	Probert, Michael/G-5899-2014	Probert, Michael/0000-0002-2412-7917				Ababei R, 2013, J AM CHEM SOC, V135, P14840, DOI 10.1021/ja407570n; Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; Anderson KM, 2011, CRYST GROWTH DES, V11, P820, DOI 10.1021/cg101464j; Bader R. F. W., 1990, ATOMS IN MOLECULES A; Benet-Buchholz J, 1998, CHEM COMMUN, P2003, DOI 10.1039/a804842h; Betteridge PW, 2003, J APPL CRYSTALLOGR, V36, P1487, DOI 10.1107/S0021889803021800; Boll R, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.061402; Bowes KF, 2006, CHEM COMMUN, P2448, DOI 10.1039/b604039j; Bragg WL, 1914, P CAMB PHILOS SOC, V17, P43; Brayshaw S. K., 2011, CHEMISTRY, V17, P4385; BRODALLA D, 1985, J APPL CRYSTALLOGR, V18, P316, DOI 10.1107/S002188988501038X; Broennimann C, 2006, J SYNCHROTRON RADIAT, V13, P120, DOI 10.1107/S0909049505038665; Carbonera C, 2006, DALTON T, P3058, DOI 10.1039/b601366j; Cole JM, 2008, ACTA CRYSTALLOGR A, V64, P259, DOI 10.1107/S0108767307065324; Coppens P., 1997, X RAY CHARGE DENSITY; Coppens P, 2013, PHYS SCRIPTA, V87, DOI 10.1088/0031-8949/87/04/048104; COSIER J, 1986, J APPL CRYSTALLOGR, V19, P105, DOI 10.1107/S0021889886089835; Dawson A, 2004, J APPL CRYSTALLOGR, V37, P410, DOI 10.1107/S0021889804007149; Dolomanov OV, 2009, J APPL CRYSTALLOGR, V42, P339, DOI 10.1107/S0021889808042726; Farrell AR, 2013, CRYSTENGCOMM, V15, P3423, DOI 10.1039/c3ce00042g; Faulmann C, 2013, EUR J INORG CHEM, P1058, DOI 10.1002/ejic.201201328; Forsyth V. T., 2001, NEUTRON NEWS, V12, P20; Fromme P, 2011, CURR OPIN STRUC BIOL, V21, P509, DOI 10.1016/j.sbi.2011.06.001; Giacovazzo C., 2011, FUNDAMENTALS OF CRYS; Goeta AE, 2004, CHEM SOC REV, V33, P490, DOI 10.1039/b312763j; Goeta AE, 1999, ACTA CRYSTALLOGR C, V55, P1243, DOI 10.1107/S0108270199005648; Guerin L, 2004, CHEM PHYS, V299, P163, DOI 10.1016/j.chemphys.2003.10.002; HANSEN NK, 1978, ACTA CRYSTALLOGR A, V34, P909, DOI 10.1107/S0567739478001886; Harada J, 2001, J CHEM EDUC, V78, P607, DOI 10.1021/ed078p607; Harada J, 2008, J AM CHEM SOC, V130, P7085, DOI 10.1021/ja800353u; Ishikawa T, 2012, NAT PHOTONICS, V6, P540, DOI 10.1038/nphoton.2012.141; JAMIESON JC, 1959, REV SCI INSTRUM, V30, P1016, DOI 10.1063/1.1716408; Jiang H, 2013, MRS BULL, V38, P28, DOI 10.1557/mrs.2012.308; Katrusiak A, 2008, ACTA CRYSTALLOGR A, V64, P135, DOI 10.1107/S0108767307061181; Kern J, 2013, SCIENCE, V340, P491, DOI 10.1126/science.1234273; Kim CD, 2002, ACTA CRYSTALLOGR A, V58, P133, DOI 10.1107/S0108767301017986; Kovalevsky AY, 2002, J AM CHEM SOC, V124, P9241, DOI 10.1021/ja026045c; Kuz'mina LG, 2011, CRYSTALLOGR REP+, V56, P611, DOI 10.1134/S1063774511040110; Lee KKM, 2004, PHYS EARTH PLANET IN, V143, P241, DOI 10.1016/j.pepi.2003.06.002; Mahon MF, 2008, CRYSTENGCOMM, V10, P573, DOI 10.1039/b715941b; Moffat K, 2001, CHEM REV, V101, P1569, DOI 10.1021/cr990039q; Moggach SA, 2008, J APPL CRYSTALLOGR, V41, P249, DOI 10.1107/S0021889808000514; Ngan TW, 2007, INORG CHEM, V46, P1144, DOI 10.1021/ic061359c; Oszlanyi G, 2004, ACTA CRYSTALLOGR A, V60, P134, DOI 10.1107/S0108767303027569; Palatinus L, 2007, J APPL CRYSTALLOGR, V40, P786, DOI 10.1107/S0021889807029238; Petricek V., 2006, JANA2006 THE CRYSTAL; Pohl E, 2004, J SYNCHROTRON RADIAT, V11, P372, DOI 10.1107/S090904950401516X; Price SL, 2014, CHEM SOC REV, V43, P2098, DOI 10.1039/c3cs60279f; Probert MR, 2010, J APPL CRYSTALLOGR, V43, P1415, DOI 10.1107/S0021889810041282; Quevedo W, 2012, J APPL PHYS, V112, DOI 10.1063/1.4764918; Renz F, 2000, ANGEW CHEM INT EDIT, V39, P3699, DOI 10.1002/1521-3773(20001016)39:20<3699::AID-ANIE3699>3.0.CO;2-Z; Ridout J, 2013, CRYST GROWTH DES, V13, P1943, DOI 10.1021/cg301773h; ROSENBAU.G, 1971, NATURE, V230, P434, DOI 10.1038/230434a0; Rowsell JLC, 2005, SCIENCE, V309, P1350, DOI 10.1126/science.1113247; Schneider CJ, 2013, EUR J INORG CHEM, P850, DOI 10.1002/ejic.201201075; SCHUSTER M, 1995, J PHYS D APPL PHYS, V28, pA270, DOI 10.1088/0022-3727/28/4A/053; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Spencer EC, 2006, CHEM COMMUN, P278, DOI 10.1039/b511941c; Techert S, 2001, PHYS REV LETT, V86, P2030, DOI 10.1103/PhysRevLett.86.2030; Thalladi VR, 1998, J AM CHEM SOC, V120, P8702, DOI 10.1021/ja981198e; Thomson RI, 2013, MATER CHEM PHYS, V139, P34, DOI 10.1016/j.matchemphys.2012.11.031; Trincao J, 2013, BIOCHEM SOC T, V41, P1260, DOI 10.1042/BST20130125; Trueblood, 2010, CRYSTAL STRUCTURE AN; Warren JE, 2009, J APPL CRYSTALLOGR, V42, P457, DOI 10.1107/S0021889809010036; Wilson CC, 1997, J APPL CRYSTALLOGR, V30, P184, DOI 10.1107/S0021889896010886; Yufit DS, 2012, CRYSTENGCOMM, V14, P8222, DOI 10.1039/c2ce26191j; Yufit DS, 2005, J APPL CRYSTALLOGR, V38, P583, DOI 10.1107/S0021889805011258; Zhang JJ, 2013, ADV MATER, V25, P378, DOI 10.1002/adma.201201521	68	29	29	4	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2014	343	6175					1098	1102		10.1126/science.1247252	http://dx.doi.org/10.1126/science.1247252			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2LB	24604193				2022-12-28	WOS:000332331500037
J	Lee, MN; Ye, C; Villani, AC; Raj, T; Li, WB; Eisenhaure, TM; Imboywa, SH; Chipendo, PI; Ran, FA; Slowikowski, K; Ward, LD; Raddassi, K; McCabe, C; Lee, MH; Frohlich, IY; Hafler, DA; Kellis, M; Raychaudhuri, S; Zhang, F; Stranger, BE; Benoist, CO; De Jager, PL; Regev, A; Hacohen, N				Lee, Mark N.; Ye, Chun; Villani, Alexandra-Chloe; Raj, Towfique; Li, Weibo; Eisenhaure, Thomas M.; Imboywa, Selina H.; Chipendo, Portia I.; Ran, F. Ann; Slowikowski, Kamil; Ward, Lucas D.; Raddassi, Khadir; McCabe, Cristin; Lee, Michelle H.; Frohlich, Irene Y.; Hafler, David A.; Kellis, Manolis; Raychaudhuri, Soumya; Zhang, Feng; Stranger, Barbara E.; Benoist, Christophe O.; De Jager, Philip L.; Regev, Aviv; Hacohen, Nir			Common Genetic Variants Modulate Pathogen-Sensing Responses in Human Dendritic Cells	SCIENCE			English	Article							PATTERN-RECOGNITION RECEPTORS; MYCOBACTERIUM-TUBERCULOSIS INFECTION; GENOME-WIDE ASSOCIATION; TOLL-LIKE RECEPTORS; INNATE IMMUNITY; EXPRESSION; LOCI; ARCHITECTURE; RESISTANCE; INFLUENZA	Little is known about how human genetic variation affects the responses to environmental stimuli in the context of complex diseases. Experimental and computational approaches were applied to determine the effects of genetic variation on the induction of pathogen-responsive genes in human dendritic cells. We identified 121 common genetic variants associated in cis with variation in expression responses to Escherichia coli lipopolysaccharide, influenza, or interferon-beta (IFN-beta). We localized and validated causal variants to binding sites of pathogen-activated STAT ( signal transducer and activator of transcription) and IRF (IFN-regulatory factor) transcription factors. We also identified a common variant in IRF7 that is associated in trans with type I IFN induction in response to influenza infection. Our results reveal common alleles that explain interindividual variation in pathogen sensing and provide functional annotation for genetic variants that alter susceptibility to inflammatory diseases.	[Lee, Mark N.; Ye, Chun; Villani, Alexandra-Chloe; Raj, Towfique; Li, Weibo; Eisenhaure, Thomas M.; Ran, F. Ann; Ward, Lucas D.; McCabe, Cristin; Kellis, Manolis; Raychaudhuri, Soumya; De Jager, Philip L.; Regev, Aviv; Hacohen, Nir] Broad Inst Massachusetts Inst Technol MIT & Harva, Cambridge, MA 02142 USA; [Lee, Mark N.; Villani, Alexandra-Chloe; Raj, Towfique; Imboywa, Selina H.; Chipendo, Portia I.; Lee, Michelle H.; Frohlich, Irene Y.; Raychaudhuri, Soumya; Benoist, Christophe O.; De Jager, Philip L.; Hacohen, Nir] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Lee, Mark N.; Li, Weibo; Eisenhaure, Thomas M.; Hacohen, Nir] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA; [Raj, Towfique; McCabe, Cristin; De Jager, Philip L.] Brigham & Womens Hosp, Dept Neurol, Program Translat NeuroPsychiat Genom, Boston, MA 02115 USA; [Ran, F. Ann] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Ran, F. Ann] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Ran, F. Ann; Zhang, Feng] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Ran, F. Ann; Hafler, David A.; Zhang, Feng] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Slowikowski, Kamil] Harvard Univ, Grad Sch Arts & Sci, Cambridge, MA 02138 USA; [Ward, Lucas D.; Kellis, Manolis] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Raddassi, Khadir] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06511 USA; [Raychaudhuri, Soumya] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Raychaudhuri, Soumya] Brigham & Womens Hosp, Dept Med, Div Rheumatol, Boston, MA 02115 USA; [Raychaudhuri, Soumya] Univ Manchester, Manchester Acad Hlth Sci Ctr, Musculoskeletal Res Grp, Arthrit Res UK Epidemiol Unit, Manchester M13 9NT, Lancs, England; [Stranger, Barbara E.] Univ Chicago, Med Genet Sect, Chicago, IL 60637 USA; [Stranger, Barbara E.] Univ Chicago, Inst Genom & Syst Biol, Chicago, IL 60637 USA; [Regev, Aviv] MIT, Dept Biol, Cambridge, MA 02139 USA; [Regev, Aviv] Howard Hughes Med Inst, Chevy Chase, MD USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Yale University; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; University of Manchester; University of Chicago; University of Chicago; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute	Regev, A (corresponding author), Broad Inst Massachusetts Inst Technol MIT & Harva, Cambridge, MA 02142 USA.	aregev@broad.mit.edu; nhacohen@partners.org	Raj, Towfique/ABD-7620-2021; Chipendo, Portia/B-5457-2018; Kellis, Manolis/ABE-7385-2020; Slowikowski, Kamil/K-3728-2016; Macrae, Rhiannon/AAX-1536-2020; Ye, Chun/AAK-4868-2021	Kellis, Manolis/0000-0001-7113-9630; Slowikowski, Kamil/0000-0002-2843-6370; Ye, Chun/0000-0001-6560-3783; Raychaudhuri, Soumya/0000-0002-1901-8265; Stranger, Barbara/0000-0001-9021-7331; Ward, Lucas/0000-0002-8017-809X; Lee, Mark/0000-0002-9576-9589	National Institute of General Medical Sciences, NIH [RC2 GM093080]; National Institute of Allergy and Infectious Diseases [U19 AI082630]; NIH [DP2 OD002230, DP1 CA174427, R01 HG004037, DP1 MH100706, R01 DK097768, T32 GM007753, F32 AG043267, T32 HG002295]; National Human Genome Research Institute [P50 HG006193]; Howard Hughes Medical Institute; Keck Foundation; McKnight Foundation; Merkin Foundation; Vallee Foundation; Damon Runyon Foundation; Searle Scholars Foundation; Klingenstein Foundation; Simons Foundation; Direct For Biological Sciences [0644282] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [DP1CA174427] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002295, R01HG004037, P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091568, U19AI082630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097768, P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC2GM093080, T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH100706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG043267] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002230] Funding Source: NIH RePORTER	National Institute of General Medical Sciences, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Keck Foundation(W.M. Keck Foundation); McKnight Foundation; Merkin Foundation; Vallee Foundation; Damon Runyon Foundation; Searle Scholars Foundation; Klingenstein Foundation(Klingenstein Philanthropies); Simons Foundation; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank all study participants in the PhenoGenetic project for their contributions. We are grateful to Q. Sievers and C. Wu for advice about preparing primary cells and V. Agarwala and D. A. Landau for valuable discussions. This work was supported by the National Institute of General Medical Sciences, NIH, grant RC2 GM093080 (C.O.B. and N.H.); the National Institute of Allergy and Infectious Diseases grant U19 AI082630 and NIH Director's New Innovator Award DP2 OD002230 (N.H.); the National Human Genome Research Institute grant P50 HG006193, NIH Director's Pioneer Award DP1 CA174427, and Howard Hughes Medical Institute (A.R.); and NIH grant R01 HG004037 (M.K.). F.Z. is supported by an NIH Director's Pioneer Award (DP1 MH100706), an NIH Transformative R01 grant (R01 DK097768), the Keck, McKnight, Merkin, Vallee, Damon Runyon, Searle Scholars, Klingenstein, and Simons Foundations, Bob Metcalfe, and Jane Pauley. M.N.L. is supported by the NIH Medical Scientist Training Program fellowship (T32 GM007753). T.R. is supported by NIH fellowship F32 AG043267. K.S. is supported by NIH grant T32 HG002295. Gene expression data are deposited in National Center for Biotechnology Information's Gene Expression Omnibus under accession no. GSE53166.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Barreiro LB, 2012, P NATL ACAD SCI USA, V109, P1204, DOI 10.1073/pnas.1115761109; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Civelek M, 2014, NAT REV GENET, V15, P34, DOI 10.1038/nrg3575; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Divangahi M, 2008, J IMMUNOL, V181, P7157, DOI 10.4049/jimmunol.181.10.7157; Donner Y, 2012, NAT METHODS, V9, P1120, DOI [10.1038/NMETH.2207, 10.1038/nmeth.2207]; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921; Gat-Viks I, 2013, NAT BIOTECHNOL, V31, P342, DOI 10.1038/nbt.2519; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Han B, 2011, AM J HUM GENET, V88, P586, DOI 10.1016/j.ajhg.2011.04.014; Harley JB, 2008, NAT GENET, V40, P204, DOI 10.1038/ng.81; Hindorff LA, CATALOG PUBLISHED GE; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Hu XL, 2011, AM J HUM GENET, V89, P496, DOI 10.1016/j.ajhg.2011.09.002; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kasowski M, 2010, SCIENCE, V328, P232, DOI 10.1126/science.1183621; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Li Y, 2006, PLOS GENET, V2, P2155, DOI 10.1371/journal.pgen.0020222; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Orozco LD, 2012, CELL, V151, P658, DOI 10.1016/j.cell.2012.08.043; Pascual V, 2010, ANNU REV IMMUNOL, V28, P535, DOI 10.1146/annurev-immunol-030409-101221; Rai E, 2011, SEMIN IMMUNOL, V23, P67, DOI 10.1016/j.smim.2011.01.015; Romanoski CE, 2010, AM J HUM GENET, V86, P399, DOI 10.1016/j.ajhg.2010.02.002; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Smirnov DA, 2009, NATURE, V459, P587, DOI 10.1038/nature07940; Smith EN, 2008, PLOS BIOL, V6, P810, DOI 10.1371/journal.pbio.0060083; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Stower H, 2013, NAT REV GENET, V14, DOI 10.1038/nrg3622; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thomas D, 2010, NAT REV GENET, V11, P259, DOI 10.1038/nrg2764; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753	44	275	277	0	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 7	2014	343	6175					1119	+	1246980	10.1126/science.1246980	http://dx.doi.org/10.1126/science.1246980			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2LB	24604203	Green Accepted, Green Submitted			2022-12-28	WOS:000332331500042
J	Colak, D; Zaninovic, N; Cohen, MS; Rosenwaks, Z; Yang, WY; Gerhardt, J; Disney, MD; Jaffrey, SR				Colak, Dilek; Zaninovic, Nikica; Cohen, Michael S.; Rosenwaks, Zev; Yang, Wang-Yong; Gerhardt, Jeannine; Disney, Matthew D.; Jaffrey, Samie R.			Promoter-Bound Trinucleotide Repeat mRNA Drives Epigenetic Silencing in Fragile X Syndrome	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; FULL MUTATION; NONCODING RNAS; FMR1 LOCUS; IN-VITRO; EXPRESSION; LONG; METHYLATION; GENE; INSTABILITY	Epigenetic gene silencing is seen in several repeat-expansion diseases. In fragile X syndrome, the most common genetic form of mental retardation, a CGG trinucleotide-repeat expansion adjacent to the fragile X mental retardation 1 (FMR1) gene promoter results in its epigenetic silencing. Here, we show that FMR1 silencing is mediated by the FMR1 mRNA. The FMR1 mRNA contains the transcribed CGG-repeat tract as part of the 5' untranslated region, which hybridizes to the complementary CGG-repeat portion of the FMR1 gene to form an RNA . DNA duplex. Disrupting the interaction of the mRNA with the CGG-repeat portion of the FMR1 gene prevents promoter silencing. Thus, our data link trinucleotide-repeat expansion to a form of RNA-directed gene silencing mediated by direct interactions of the trinucleotide-repeat RNA and DNA.	[Colak, Dilek; Cohen, Michael S.; Jaffrey, Samie R.] Cornell Univ, Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA; [Zaninovic, Nikica; Rosenwaks, Zev] Cornell Univ, Weill Cornell Med Coll, Ctr Reprod Med & Infertil, New York, NY 10065 USA; [Yang, Wang-Yong; Disney, Matthew D.] Scripps Florida, Scripps Res Inst, Dept Chem, Jupiter, FL 33458 USA; [Gerhardt, Jeannine] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA	Cornell University; Cornell University; Scripps Research Institute; State University System of Florida; University of Florida; Yeshiva University; Albert Einstein College of Medicine	Jaffrey, SR (corresponding author), Cornell Univ, Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA.	srj2003@med.cornell.edu		Jaffrey, Samie/0000-0003-3615-6958; Disney, Matthew/0000-0001-8486-1796	Tri-Institutional Stem Cell Initiative (Tri-I SCI) [2008-019]; New York Stem Cell Foundation-Druckenmiller Fellowship; Life Sciences Research Foundation Fellowship; Tri-I SCI postdoctoral fellowship; FRAXA postdoctoral fellowship; NIH [R01 MH80420, R01 GM079235]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080420] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056306, R21NS087859] Funding Source: NIH RePORTER	Tri-Institutional Stem Cell Initiative (Tri-I SCI); New York Stem Cell Foundation-Druckenmiller Fellowship; Life Sciences Research Foundation Fellowship; Tri-I SCI postdoctoral fellowship; FRAXA postdoctoral fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Jaffrey lab for helpful comments and suggestions, E. Ferretti for assistance with chromatin immunoprecipitation, Q. Zhan for help with hESC cultures, S. L. Nolin and C. Dobkin for PCR on premutation lines. hESC lines are available from N.Z. and Z.R. (Weill Cornell Medical College hESC lines, nizanin@med.cornell.edu, zrosenw@med.cornell.edu) and S.R.J. (SI-214 hESC line, srj2003@med.cornell.edu), subject to approval by the Embryonic Stem Cell Research Oversight Committee (ESCRO) of Weill Cornell Medical College. M. D. D. previously consulted for SMaRT (Small Molecule Approach to Targeting RNA) Therapeutics. A patent (U. S. Patent and Trademark Office application no. 61/694,977) was filed on 30 August 2012 by the Scripps Research Institute governing composition and use of 1f and 1a. This work was supported by the Tri-Institutional Stem Cell Initiative (Tri-I SCI) grant 2008-019 (S.R.J., N.Z., and Z.R.), New York Stem Cell Foundation-Druckenmiller Fellowship (D. C.), Life Sciences Research Foundation Fellowship and Tri-I SCI postdoctoral fellowship (M. S. C.), and a FRAXA postdoctoral fellowship (W.-Y.Y.). Portions of this project not involving non-NIH registry stem cells were supported by NIH R01 MH80420 (S.R.J.) and NIH R01 GM079235 (M.D.D.).	Alisch RS, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-18; Belotserkovskii BP, 2010, P NATL ACAD SCI USA, V107, P12816, DOI 10.1073/pnas.1007580107; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Brouwer JR, 2007, EXP CELL RES, V313, P244, DOI 10.1016/j.yexcr.2006.10.002; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Coffee B, 2002, AM J HUM GENET, V71, P923, DOI 10.1086/342931; Disney MD, 2012, ACS CHEM BIOL, V7, P1711, DOI 10.1021/cb300135h; Eiges R, 2007, CELL STEM CELL, V1, P568, DOI 10.1016/j.stem.2007.09.001; Evans-Galea MV, 2013, TRENDS MOL MED, V19, P655, DOI 10.1016/j.molmed.2013.07.007; FENG Y, 1995, AM J HUM GENET, V56, P106; Gerhardt J, 2014, MOL CELL, V53, P19, DOI 10.1016/j.molcel.2013.10.029; GRABCZYK E, 1995, J BIOL CHEM, V270, P1791, DOI 10.1074/jbc.270.4.1791; Guil S, 2012, NAT STRUCT MOL BIOL, V19, P1068, DOI 10.1038/nsmb.2428; Handa V, 2003, NUCLEIC ACIDS RES, V31, P6243, DOI 10.1093/nar/gkg818; Jin P, 2004, NAT CELL BIOL, V6, P1048, DOI 10.1038/ncb1104-1048; Ladd PD, 2007, HUM MOL GENET, V16, P3174, DOI 10.1093/hmg/ddm293; Lee JT, 2012, SCIENCE, V338, P1435, DOI 10.1126/science.1231776; Mackintosh SG, 2006, NUCLEIC ACIDS RES, V34, P4154, DOI 10.1093/nar/gkl501; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; Sandberg G, 1997, NUCLEIC ACIDS RES, V25, P2883, DOI 10.1093/nar/25.14.2883; Simon MD, 2011, P NATL ACAD SCI USA, V108, P20497, DOI 10.1073/pnas.1113536108; USDIN K, 1995, NUCLEIC ACIDS RES, V23, P4202, DOI 10.1093/nar/23.20.4202; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Verlinsky Y, 2005, REPROD BIOMED ONLINE, V10, P105, DOI 10.1016/S1472-6483(10)60810-3; Willemsen R, 2002, HUM GENET, V110, P601, DOI 10.1007/s00439-002-0723-5; Wu JQ, 2010, P NATL ACAD SCI USA, V107, P5254, DOI 10.1073/pnas.0914114107; Xi ZR, 2013, AM J HUM GENET, V92, P981, DOI 10.1016/j.ajhg.2013.04.017	27	207	211	1	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 28	2014	343	6174					1002	1005		10.1126/science.1245831	http://dx.doi.org/10.1126/science.1245831			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC2DZ	24578575	Green Accepted			2022-12-28	WOS:000332309600040
J	Coia, JE; Leanord, AT; Reilly, J				Coia, John E.; Leanord, Alistair T.; Reilly, Jacqui			Screening for meticillin resistant Staphylococcus aureus (MRSA): who, when, and how?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; DECOLONIZATION; ERADICATION; PREVENTION; MUPIROCIN		[Coia, John E.] Glasgow Royal Infirm, Dept Clin Microbiol, Glasgow G4 0SF, Lanark, Scotland; [Leanord, Alistair T.; Reilly, Jacqui] NHS Natl Serv Scotland, Glasgow G2 6QE, Lanark, Scotland; [Reilly, Jacqui] Glasgow Caledonian Univ, Glasgow G4 0BA, Lanark, Scotland	University of Glasgow; NHS National Services Scotland; Glasgow Caledonian University	Coia, JE (corresponding author), Glasgow Royal Infirm, Dept Clin Microbiol, Glasgow G4 0SF, Lanark, Scotland.	john.coia@ggc.scot.nhs.uk	Coia, John/AAP-5379-2020	Coia, John/0000-0002-4966-8453; Reilly, Jacqui/0000-0003-2946-6720				Ammerlaan HSM, 2009, CLIN INFECT DIS, V48, P922, DOI 10.1086/597291; Coia JE, 2006, J HOSP INFECT, V63, pS1, DOI 10.1016/j.jhin.2006.01.001; Cooper B S, 2003, Health Technol Assess, V7, P1; Currie K, 2012, J HOSP INFECT, V80, P140, DOI 10.1016/j.jhin.2011.11.015; Gilpin DP, 2010, J HOSP INFECT, V75, P93, DOI 10.1016/j.jhin.2009.11.025; Harbarth S, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.04.042; Health Protection Scotland National Services Scotland, 2011, FIN REP, V1; Matheson A, 2012, INFECT CONT HOSP EP, V33, P803, DOI 10.1086/666639; Mody L, 2003, CLIN INFECT DIS, V37, P1467, DOI 10.1086/379325; MULLIGAN ME, 1993, AM J MED, V94, P313, DOI 10.1016/0002-9343(93)90063-U; Ritchie K, 2007, CLIN COST EFFECTIVEN; Robicsek A, 2009, CLIN INFECT DIS, V48, P910, DOI 10.1086/597296; Shenoy ES, 2013, CLIN INFECT DIS, V57, P176, DOI 10.1093/cid/cit206; Simor AE, 2007, CLIN INFECT DIS, V44, P178, DOI 10.1086/510392; Xue Yifan, 2012, JBI Libr Syst Rev, V10, P3487	15	11	14	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 27	2014	348								g1697	10.1136/bmj.g1697	http://dx.doi.org/10.1136/bmj.g1697			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC0UF	24578514				2022-12-28	WOS:000332210200002
J	Myers, EG				Myers, Edmund G.			FUNDAMENTAL CONSTANTS The teamwork of precision	NATURE			English	Editorial Material							PENNING TRAP; ELECTRON		Florida State Univ, Dept Phys, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Myers, EG (corresponding author), Florida State Univ, Dept Phys, Tallahassee, FL 32306 USA.	myers@nucmar.physics.fsu.edu			Direct For Mathematical & Physical Scien [0968889] Funding Source: National Science Foundation	Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		Aoyama T, 2012, PROG THEOR EXP PHYS, V2012, DOI 10.1093/ptep/pts030; Bouchendira R, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.080801; Bradley MP, 1999, PHYS REV LETT, V83, P4510, DOI 10.1103/PhysRevLett.83.4510; BROWN LS, 1986, REV MOD PHYS, V58, P233, DOI 10.1103/RevModPhys.58.233; Gabrielse G, 2013, PHYS TODAY, V66, P64, DOI 10.1063/PT.3.2223; Haffner H, 2000, PHYS REV LETT, V85, P5308, DOI 10.1103/PhysRevLett.85.5308; Hanneke D, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.120801; Mohr PJ, 2012, REV MOD PHYS, V84, P1527, DOI 10.1103/RevModPhys.84.1527; Mount BJ, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.042513; Pachucki K, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.022108; Sturm S, 2014, NATURE, V506, P467, DOI 10.1038/nature13026; VANDYCK RS, 1987, PHYS REV LETT, V59, P26, DOI 10.1103/PhysRevLett.59.26; Wicht A, 2002, PHYS SCRIPTA, VT102, P82, DOI 10.1238/Physica.Topical.102a00082	13	0	0	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 27	2014	506	7489					440	441		10.1038/nature13059	http://dx.doi.org/10.1038/nature13059			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC0DN	24553143				2022-12-28	WOS:000332165100026
J	Spence, D				Spence, Des			Lost in translation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 25	2014	348								g1749	10.1136/bmj.g1749	http://dx.doi.org/10.1136/bmj.g1749			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC0TW	24569546				2022-12-28	WOS:000332209200013
J	Meyer, A; Huete-Perez, JA				Meyer, Axel; Huete-Perez, Jorge A.			Nicaragua Canal could wreak environmental ruin	NATURE			English	Editorial Material									[Huete-Perez, Jorge A.] Univ Ctr Amer, Ctr Mol Biol, Managua, Nicaragua; [Huete-Perez, Jorge A.] Nicaraguan Acad Sci, Managua, Nicaragua; [Meyer, Axel] Univ Konstanz, Constance, Germany	University of Konstanz	Meyer, A (corresponding author), Univ Konstanz, Constance, Germany.	axel.meyer@uni-konstanz.de; jorgehuete@uca-cbm.org	Huete-Perez, Jorge/AAJ-9840-2021; Meyer, Axel/C-9826-2009	Meyer, Axel/0000-0002-0888-8193; Huete-Perez, Jorge A./0000-0001-5259-8428				Barluenga M, 2006, NATURE, V439, P719, DOI 10.1038/nature04325; Comision de Trabajo del Gran Canal, 2006, INT CAN NIC PROJ PRO; Corbett JJ, 2007, ENVIRON SCI TECHNOL, V41, P8512, DOI 10.1021/es071686z; Elmer KR, 2010, PHILOS T R SOC B, V365, P1763, DOI 10.1098/rstb.2009.0271; Jordan Christopher A., 2010, Tapir Conservation, V19, P11; Klytchnikova I.I, 2013, POLICY INVESTMENT PR; MCKAYE KR, 1995, BIOSCIENCE, V45, P406, DOI 10.2307/1312721; Verones F, 2013, ENVIRON SCI TECHNOL, V47, P9799, DOI 10.1021/es400266v; Wilber C.G., 1983, TURBIDITY AQUATIC EN	9	23	26	0	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 20	2014	506	7488					287	289		10.1038/506287a	http://dx.doi.org/10.1038/506287a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AB0JL	24558657	Green Submitted, Bronze			2022-12-28	WOS:000331477800014
J	Latham, NK; Harris, BA; Bean, JF; Heeren, T; Goodyear, C; Zawacki, S; Heislein, DM; Mustafa, J; Pardasaney, P; Giorgetti, M; Holt, N; Goehring, L; Jette, AM				Latham, Nancy K.; Harris, Bette Ann; Bean, Jonathan F.; Heeren, Timothy; Goodyear, Christine; Zawacki, Stacey; Heislein, Diane M.; Mustafa, Jabed; Pardasaney, Poonam; Giorgetti, Marie; Holt, Nicole; Goehring, Lori; Jette, Alan M.			Effect of a Home-Based Exercise Program on Functional Recovery Following Rehabilitation After Hip Fracture A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LOWER-EXTREMITY FUNCTION; OUTPATIENT REHABILITATION; PHYSICAL FUNCTION; MORTALITY; BALANCE; RELIABILITY; VELOCITY; EFFICACY; SCALE; RISK	IMPORTANCE For many older people, long-term functional limitations persist after a hip fracture. The efficacy of a home exercise program with minimal supervision after formal hip fracture rehabilitation ends has not been established. OBJECTIVE To determine whether a home exercise program with minimal contact with a physical therapist improved function after formal hip fracture rehabilitation ended. DESIGN, SETTING, AND PARTICIPANTS Randomized clinical trial conducted from September 2008 to October 2012 in the homes of 232 functionally limited older adults who had completed traditional rehabilitation after a hip fracture. INTERVENTIONS The intervention group (n = 120) received functionally oriented exercises (such as standing from a chair, climbing a step) taught by a physical therapist and performed independently by the participants in their homes for 6 months. The attention control group (n = 112) received in-home and telephone-based cardiovascular nutrition education. MAIN OUTCOMES AND MEASURES Physical function assessed at baseline, 6 months (ie, at completion of the intervention), and 9 months by blinded assessors. The primary outcome was change in function at 6 months measured by the Short Physical Performance Battery (SPPB; range 0-12, higher score indicates better function) and the Activity Measure for Post-Acute Care (AM-PAC) mobility and daily activity (range, 23-85 and 9-101, higher score indicates better function). RESULTS Among the 232 randomized patients, 195 were followed up at 6 months and included in the primary analysis. The intervention group (n=100) showed significant improvement relative to the control group (n=95) in functional mobility (mean SPPB scores for intervention group: 6.2 [SD, 2.7] at baseline, 7.2 [SD, 3] at 6 months; control group: 6.0 [SD, 2.8] at baseline, 6.2 [SD, 3] at 6 months; and between-group differences: 0.8 [95% CI, 0.4 to 1.2], P < .001; mean AM-PAC mobility scores for intervention group: 56.2 [SD, 7.3] at baseline, 58.1 [SD, 7.9] at 6 months; control group: 56 [SD, 7.1] at baseline, 56.6 [SD, 8.1] at 6 months; and between-group difference, 1.3 [95% CI, 0.2 to 2.4], P = .03; and mean AM-PAC daily activity scores for intervention group: 57.4 [SD, 13.7] at baseline, 61.3 [SD, 15.7] at 6 months; control group: 58.2 [SD, 15.2] at baseline, 58.6 [SD, 15.3] at 6 months; and between-group difference, 3.5 [95% CI, 0.9 to 6.0], P = .03). In multiple imputation analyses, between-group differences remained significant for SPPB and AM-PAC daily activity, but not for mobility. Significant between-group differences persisted at 9 months for all functional measures with and without imputation. CONCLUSIONS AND RELEVANCE Among patients who had completed standard rehabilitation after hip fracture, the use of a home-based functionally oriented exercise program resulted in modest improvement in physical function at 6 months after randomization. The clinical importance of these findings remains to be determined.	[Latham, Nancy K.; Heeren, Timothy; Zawacki, Stacey; Heislein, Diane M.; Mustafa, Jabed; Goehring, Lori; Jette, Alan M.] Boston Univ, Boston, MA 02118 USA; [Harris, Bette Ann; Giorgetti, Marie] MGH Inst Hlth Profess, Boston, MA USA; [Bean, Jonathan F.] Harvard Univ, Sch Med, Boston, MA USA; [Bean, Jonathan F.; Holt, Nicole] Spaulding Cambridge Outpatient Ctr, Cambridge, MA USA; [Goodyear, Christine] Spaulding Rehabil Network, Boston, MA USA; [Pardasaney, Poonam] RTI Int, Boston, MA USA	Boston University; Harvard University; Harvard Medical School; Research Triangle Institute	Latham, NK (corresponding author), Boston Univ, Sch Publ Hlth, Hlth & Disabil Res Inst, 715 Albany St,5TW, Boston, MA 02118 USA.	nlatham@bu.edu	Bean, Jonathan F/F-5798-2017	Bean, Jonathan F/0000-0001-8385-8210	National Institute of Nursing Research [5R01NR010815]; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR010815] Funding Source: NIH RePORTER	National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This study was funded by grant 5R01NR010815 from the National Institute of Nursing Research. All Thera-Band products were donated by Thera-Band.	Akamigbo A, 2012, MANDATED REPORT IMPR; Auais MA, 2012, PHYS THER, V92, P1437, DOI 10.2522/ptj.20110274; Bean JF, 2004, J AM GERIATR SOC, V52, P799, DOI 10.1111/j.1532-5415.2004.52222.x; BERG K, 1995, SCAND J REHABIL MED, V27, P27; BERG KO, 1992, CAN J PUBLIC HEALTH, V83, pS7; BERG KO, 1992, ARCH PHYS MED REHAB, V73, P1073; Binder EF, 2004, JAMA-J AM MED ASSOC, V292, P837, DOI 10.1001/jama.292.7.837; Braithwaite RS, 2003, J AM GERIATR SOC, V51, P364, DOI 10.1046/j.1532-5415.2003.51110.x; Brauer CA, 2009, JAMA-J AM MED ASSOC, V302, P1573, DOI 10.1001/jama.2009.1462; Chandra A, 2013, HEALTH AFFAIR, V32, P864, DOI 10.1377/hlthaff.2012.1262; Fransen M, 2002, J AM GERIATR SOC, V50, P685, DOI 10.1046/j.1532-5415.2002.50163.x; Fritz JM, 2011, PHYS THER, V91, P330, DOI 10.2522/ptj.20090290; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Haley SM, 2004, MED CARE, V42, P49, DOI 10.1097/01.mlr.0000103520.43902.6c; Handoll HHG, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001704.pub4; Hill KD, 1996, ARCH PHYS MED REHAB, V77, P1025, DOI 10.1016/S0003-9993(96)90063-5; Jette AM, 2007, PHYS THER, V87, P385, DOI 10.2522/ptj.20060121; Jette AM, 1999, AM J PUBLIC HEALTH, V89, P66, DOI 10.2105/AJPH.89.1.66; Jette AM, 1996, J AM GERIATR SOC, V44, P644, DOI 10.1111/j.1532-5415.1996.tb01825.x; Kammerlander C, 2011, ARCH ORTHOP TRAUM SU, V131, P1435, DOI 10.1007/s00402-011-1313-6; Kwon S, 2009, J NUTR HEALTH AGING, V13, P538, DOI 10.1007/s12603-009-0104-z; Latham NK, 2008, ARCH PHYS MED REHAB, V89, P2146, DOI 10.1016/j.apmr.2008.04.016; Latham NK, 2008, ARCH PHYS MED REHAB, V89, P807, DOI 10.1016/j.apmr.2008.02.010; Lord SR, 2003, PHYS THER, V83, P237, DOI 10.1093/ptj/83.3.237; Magaziner J, 2000, J GERONTOL A-BIOL, V55, pM498, DOI 10.1093/gerona/55.9.M498; Orwig DL, 2011, ARCH INTERN MED, V171, P323, DOI 10.1001/archinternmed.2011.15; Resnick B, 2000, NURS RES, V49, P154, DOI 10.1097/00006199-200005000-00007; Resnick B, 2000, J GERONTOL B-PSYCHOL, V55, pS352, DOI 10.1093/geronb/55.6.S352; Sherrington C, 2004, ARCH PHYS MED REHAB, V85, P710, DOI 10.1016/S0003-9993(03)00620-8; Sherrington C, 1997, ARCH PHYS MED REHAB, V78, P208, DOI 10.1016/S0003-9993(97)90265-3; Stevens JA, 2013, OSTEOPOROSIS INT, V24, P2725, DOI 10.1007/s00198-013-2375-9; TINETTI ME, 1990, J GERONTOL, V45, pP239, DOI 10.1093/geronj/45.6.P239; US Department of Health and Human Services and US Department of Agriculture, 2005, DIET GUID AM	34	122	123	0	39	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 19	2014	311	7					700	708		10.1001/jama.2014.469	http://dx.doi.org/10.1001/jama.2014.469			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	AA8ZO	24549550	Green Accepted			2022-12-28	WOS:000331383700022
J	Hoffmann, TC; Glasziou, PP; Boutron, I; Milne, R; Perera, R; Moher, D; Altman, DG; Barbour, V; Macdonald, H; Johnston, M; Lamb, SE; Dixon-Woods, M; McCulloch, P; Wyatt, JC; Chan, AW; Michie, S				Hoffmann, Tammy C.; Glasziou, Paul P.; Boutron, Isabelle; Milne, Ruairidh; Perera, Rafael; Moher, David; Altman, Douglas G.; Barbour, Virginia; Macdonald, Helen; Johnston, Marie; Lamb, Sarah E.; Dixon-Woods, Mary; McCulloch, Peter; Wyatt, Jeremy C.; Chan, An-Wen; Michie, Susan			Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIALS; NONPHARMACOLOGICAL INTERVENTIONS; TREATMENT FIDELITY; CONSORT STATEMENT; MEDICAL JOURNALS; BEHAVIOR-CHANGE; IMPLEMENTATION; EXPLANATION; MICHIGAN; IMPACT	Without a complete published description of interventions, clinicians and patients cannot reliably implement interventions that are shown to be useful, and other researchers cannot replicate or build on research findings. The quality of description of interventions in publications, however, is remarkably poor. To improve the completeness of reporting, and ultimately the replicability, of interventions, an international group of experts and stakeholders developed the Template for Intervention Description and Replication (TIDieR) checklist and guide. The process involved a literature review for relevant checklists and research, a Delphi survey of an international panel of experts to guide item selection, and a face to face panel meeting. The resultant 12 item TIDieR checklist (brief name, why, what (materials), what (procedure), who provided, how, where, when and how much, tailoring, modifications, how well (planned), how well (actual)) is an extension of the CONSORT 2010 statement (item 5) and the SPIRIT 2013 statement (item 11). While the emphasis of the checklist is on trials, the guidance is intended to apply across all evaluative study designs. This paper presents the TIDieR checklist and guide, with an explanation and elaboration for each item, and examples of good reporting. The TIDieR checklist and guide should improve the reporting of interventions and make it easier for authors to structure accounts of their interventions, reviewers and editors to assess the descriptions, and readers to use the information.	[Hoffmann, Tammy C.; Glasziou, Paul P.] Bond Univ, Fac Hlth Sci & Med, Ctr Res Evidence Based Practice, Southport, Qld 4229, Australia; [Boutron, Isabelle] Univ Paris 05, Sorbonne Paris Cite, INSERM, U738, Paris, France; [Milne, Ruairidh] Univ Southampton, Wessex Inst, Southampton, Hants, England; [Perera, Rafael] Univ Oxford, Dept Primary Care Hlth Sci, Oxford OX1 2JD, England; [Moher, David] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford OX1 2JD, England; [Barbour, Virginia] PLOS, Brisbane, Qld, Australia; [Macdonald, Helen] BMJ, London, England; [Johnston, Marie] Univ Aberdeen, Inst Appl Hlth Sci, Aberdeen, Scotland; [Lamb, Sarah E.] Univ Oxford, Botnar Res Ctr, Nuffield Dept Orthopaed Rheumatol & Musculoskel S, Oxford, England; [Dixon-Woods, Mary] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [McCulloch, Peter] Univ Oxford, Nuffield Dept Surg Sci, Oxford, England; [Wyatt, Jeremy C.] Univ Leeds, Leeds Inst Hlth Sci, Leeds, W Yorkshire, England; [Chan, An-Wen] Univ Toronto, Womens Coll Res Inst, Toronto, ON, Canada; [Michie, Susan] UCL, Dept Clin Educ & Hlth Psychol, Ctr Outcomes Res & Effectiveness, London, England	Bond University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Southampton; University of Oxford; University of Ottawa; Ottawa Hospital Research Institute; University of Oxford; University of Aberdeen; University of Oxford; University of Leicester; University of Oxford; University of Leeds; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of London; University College London	Hoffmann, TC (corresponding author), Bond Univ, Fac Hlth Sci & Med, Ctr Res Evidence Based Practice, Southport, Qld 4229, Australia.	thoffmann@bond.edu.au	Moher, David/I-3408-2019; Glasziou, Paul/A-7832-2008; Wyatt, Jeremy/F-8160-2010; Hoffmann, Tammy/E-8029-2010; Michie, Susan/A-1745-2010	Moher, David/0000-0003-2434-4206; Glasziou, Paul/0000-0001-7564-073X; Wyatt, Jeremy/0000-0001-7008-1473; Hoffmann, Tammy/0000-0001-5210-8548; Michie, Susan/0000-0003-0063-6378; Dixon-Woods, Mary/0000-0002-5915-0041; Perera, Rafael/0000-0003-2418-2091; Boutron, Isabelle/0000-0002-5263-6241; Voigt-Radloff, Sebastian/0000-0003-2745-3328; Lamb, Sarah/0000-0003-4349-7195; Milne, Ruairidh/0000-0002-5117-4380; Barbour, Virginia/0000-0002-2358-2440; McCulloch, Peter/0000-0002-3210-8273	NIHR; National Health and Medical Research Council of Australia (NHMRC)/Primary Health Care Research Evaluation and Development Career Development Fellowship [1033038]; Australian Department of Health and Ageing; NHMRC Australia Fellowship [527500]; Cancer Research UK [C5529]; Wellcome Trust [WT097899MA]; Cancer Research UK [16895] Funding Source: researchfish; Medical Research Council [G0901474, MR/J004871/1] Funding Source: researchfish; Wellcome Trust [097899/A/11/Z] Funding Source: researchfish; MRC [G0901474, MR/J004871/1] Funding Source: UKRI	NIHR(National Institute for Health Research (NIHR)); National Health and Medical Research Council of Australia (NHMRC)/Primary Health Care Research Evaluation and Development Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); NHMRC Australia Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome Trust); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	There was no explicit funding for the development of this checklist and guide. The consensus meeting in March 2013 was partially funded by a NIHR Senior Investigator Award held by PPG. TCH is supported by a National Health and Medical Research Council of Australia (NHMRC)/Primary Health Care Research Evaluation and Development Career Development Fellowship (1033038) with funding provided by the Australian Department of Health and Ageing. PPG is supported by a NHMRC Australia Fellowship (527500). DGA is supported by a programme grant from Cancer Research UK (C5529). MDW is supported by a Wellcome Trust Senior Investigator award (WT097899MA).	Bellg AJ, 2004, HEALTH PSYCHOL, V23, P443, DOI 10.1037/0278-6133.23.5.443; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Carroll C, 2007, IMPLEMENT SCI, V2, DOI 10.1186/1748-5908-2-40; Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Chan AW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7586; Craig Peter, 2008, BMJ, V337, pa1655, DOI 10.1136/bmj.a1655; de Bruin M, 2009, HEALTH PSYCHOL, V28, P668, DOI 10.1037/a0015989; Dixon-Woods M, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-70; Dixon-Woods M, 2011, MILBANK Q, V89, P167, DOI 10.1111/j.1468-0009.2011.00625.x; Duff JM, 2010, JNCI-J NATL CANCER I, V102, P702, DOI 10.1093/jnci/djq117; Gagnier JJ, 2006, ANN INTERN MED, V144, P364, DOI 10.7326/0003-4819-144-5-200603070-00013; Glasziou P, 2008, BMJ-BRIT MED J, V336, P1472, DOI 10.1136/bmj.39590.732037.47; Glasziou P, 2014, LANCET, V383, P267, DOI 10.1016/S0140-6736(13)62228-X; Hardeman W, 2008, PSYCHOL HEALTH, V23, P11, DOI 10.1080/08870440701615948; Hoffmann T, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-20; Hoffmann TC, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f3755; Hopewell S, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e4178; MacPherson Hugh, 2010, J Evid Based Med, V3, P140, DOI 10.1111/j.1756-5391.2010.01086.x; McCleary N, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-146; Michie S, 2013, HEALTH PSYCHOL REV, V7, P1, DOI 10.1080/17437199.2011.649445; Michie S, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-40; Moher D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000217; Murphy E., 1998, HEALTH TECHNOL ASSES, V2, pI, DOI [DOI 10.3310/HTA2030, 10.3310/hta2030]; Schroter S, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001978; Schulz K.F., 2010, BMJ-BRIT MED J, V340, pe332; Spillane V, 2007, J ADV NURS, V60, P343, DOI 10.1111/j.1365-2648.2007.04386.x; Thorpe KE, 2009, J CLIN EPIDEMIOL, V62, P464, DOI [10.1503/cmaj.090523, 10.1016/j.jclinepi.2008.12.011]; Turner L, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-60; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X	29	3837	3852	10	81	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 6	2014	348								g1687	10.1136/bmj.g1687	http://dx.doi.org/10.1136/bmj.g1687			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AC6IP	26824401	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000332625700011
J	Zakrzewska, JM; Linskey, ME				Zakrzewska, Joanna M.; Linskey, Mark E.			Trigeminal neuralgia	BMJ-BRITISH MEDICAL JOURNAL			English	Review							MICROVASCULAR DECOMPRESSION; MULTIPLE-SCLEROSIS; FACIAL-PAIN; STEREOTACTIC RADIOSURGERY; CLINICAL-EVALUATION; EVOKED-POTENTIALS; FOLLOW-UP; DIAGNOSIS; SURGERY; QUALITY		[Zakrzewska, Joanna M.] UCLH NHS Fdn Trust, Eastman Dent Hosp, Facial Pain Unit, London WC1X 8LD, England; [Linskey, Mark E.] Univ Calif Irvine, Dept Surg, Orange, CA 92668 USA	University College London Hospitals NHS Foundation Trust; University of London; University College London; University of California System; University of California Irvine	Zakrzewska, JM (corresponding author), UCLH NHS Fdn Trust, Eastman Dent Hosp, Facial Pain Unit, London WC1X 8LD, England.	j.zakrzewska@ucl.ac.uk	Zakrzewska, Joanna M./AAC-7378-2020	Zakrzewska, Joanna M./0000-0001-7805-5851				Akram H, 2013, NEUROSURG FOCUS, V35, DOI 10.3171/2013.6.FOCUS13213; Barker FG, 1996, NEW ENGL J MED, V334, P1077, DOI 10.1056/NEJM199604253341701; Blatow M, 2009, HUM BRAIN MAPP, V30, P3495, DOI 10.1002/hbm.20773; BRISMAN R, 1987, ARCH NEUROL-CHICAGO, V44, P379, DOI 10.1001/archneur.1987.00520160021008; BULLITT E, 1986, J NEUROSURG, V64, P865, DOI 10.3171/jns.1986.64.6.0865; BURCHIEL KJ, 1988, J NEUROSURG, V69, P35, DOI 10.3171/jns.1988.69.1.0035; CALVIN WH, 1982, EXP NEUROL, V75, P755, DOI 10.1016/0014-4886(82)90040-1; CHENG TMW, 1993, NEUROLOGY, V43, P2298, DOI 10.1212/WNL.43.11.2298; Cheshire WP, 2001, J PAIN SYMPTOM MANAG, V21, P506, DOI 10.1016/S0885-3924(01)00269-X; Cruccu G, 2008, EUR J NEUROL, V15, P1013, DOI 10.1111/j.1468-1331.2008.02185.x; Cruccu G, 2009, PAIN, V143, P186, DOI 10.1016/j.pain.2008.12.026; Devor M, 2002, CLIN J PAIN, V18, P4, DOI 10.1097/00002508-200201000-00002; El Otmani H, 2008, REV NEUROL-FRANCE, V164, P384, DOI 10.1016/j.neurol.2007.10.010; FROMM GH, 1984, ANN NEUROL, V15, P240, DOI 10.1002/ana.410150306; GARDNER WJ, 1962, J NEUROSURG, V19, P947, DOI 10.3171/jns.1962.19.11.0947; Gass A, 1997, NEUROLOGY, V49, P1142, DOI 10.1212/WNL.49.4.1142; Gronseth G, 2008, NEUROLOGY, V71, P1183, DOI 10.1212/01.wnl.0000326598.83183.04; HAKANSON S, 1981, NEUROSURGERY, V9, P638, DOI 10.1227/00006123-198112000-00005; Hall GC, 2006, PAIN, V122, P156, DOI 10.1016/j.pain.2006.01.030; HAMLYN PJ, 1992, J NEUROSURG, V76, P948, DOI 10.3171/jns.1992.76.6.0948; Hodaie M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032745; JENSEN TS, 1982, ACTA NEUROL SCAND, V65, P182; Kalkanis SN, 2003, NEUROSURGERY, V52, P1251, DOI 10.1227/01.NEU.0000065129.25359.EE; Kanai A, 2006, BRIT J ANAESTH, V97, P559, DOI 10.1093/bja/ael180; KATUSIC S, 1990, ANN NEUROL, V27, P89, DOI 10.1002/ana.410270114; Koopman JSHA, 2009, PAIN, V147, P122, DOI 10.1016/j.pain.2009.08.023; Lee JYK, 2010, J NEUROSURG, V113, P516, DOI 10.3171/2010.1.JNS09669; LEE KH, 1991, NEUROLOGY, V41, P657, DOI 10.1212/WNL.41.5.657; Lemos L, 2008, CLIN J PAIN, V24, P64, DOI 10.1097/AJP.0b013e318158011a; Limonadi FM, 2006, STEREOT FUNCT NEUROS, V84, P212, DOI 10.1159/000095167; Linskey ME, 2008, J NEUROSURG, V109, P160, DOI 10.3171/JNS/2008/109/12/S25; Liu Y, 2013, EUR J RADIOL, V82, P783, DOI 10.1016/j.ejrad.2012.11.027; Lopez BC, 2004, NEUROSURGERY, V54, P973, DOI 10.1227/01.NEU.0000114867.98896.F0; Lopez BC, 2004, J NEUROL NEUROSUR PS, V75, P1019, DOI 10.1136/jnnp.2003.018564; MacDonald BK, 2000, BRAIN, V123, P665, DOI 10.1093/brain/123.4.665; MELZACK R, 1986, PAIN, V27, P297, DOI 10.1016/0304-3959(86)90157-0; Moisset X, 2011, EUR J PAIN, V15, P124, DOI 10.1016/j.ejpain.2010.06.006; Mueller D, 2011, CEPHALALGIA, V31, P1542, DOI 10.1177/0333102411424619; MULLAN S, 1983, J NEUROSURG, V59, P1007, DOI 10.3171/jns.1983.59.6.1007; National Health and Medical Research Council, 2013, EAT HLTH AUSTR DIET, P1; NICE, 2013, NAT I HLTH CAR EXC 2, P1; Obermann M, 2008, CEPHALALGIA, V28, P174, DOI 10.1111/j.1468-2982.2007.01483.x; Obermann M, 2007, NEUROLOGY, V69, P835, DOI 10.1212/01.wnl.0000269670.30045.6b; Pan SL, 2011, CEPHALALGIA, V31, P937, DOI 10.1177/0333102411405225; PATY DW, 1988, NEUROLOGY, V38, P180, DOI 10.1212/WNL.38.2.180; Pollock BE, 2010, NEUROSURGERY, V67, P633, DOI 10.1227/01.NEU.0000377861.14650.98; Sato J, 2004, ORAL SURG ORAL MED O, V97, P18, DOI 10.1016/j.tripleo.2003.08.003; Simms HN, 2011, J NEUROSURG, V115, P210, DOI 10.3171/2011.4.JNS101843; Sindou M, 2002, ACTA NEUROCHIR, V144, P1, DOI 10.1007/s701-002-8269-4; Spatz AL, 2007, PAIN, V131, P302, DOI 10.1016/j.pain.2007.02.009; SWEET WH, 1974, J NEUROSURG, V40, P143, DOI 10.3171/jns.1974.40.2.0143; Tatli M, 2008, ACTA NEUROCHIR, V150, P243, DOI 10.1007/s00701-007-1488-3; Tolle Thomas, 2006, Pain Pract, V6, P153, DOI 10.1111/j.1533-2500.2006.00079.x; Torelli P, 2004, CEPHALALGIA, V24, P29, DOI 10.1111/j.1468-2982.2004.00633.x; Wiffen P. J., 2011, COCHRANE DB SYST REV, V2; Wiffen PJ, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD005452, 10.1002/14651858.CD005451]; Young RF, 1998, STEREOT FUNCT NEUROS, V70, P192, DOI 10.1159/000056422; Zakrzewska J.M., 2006, INSIGHTS FACTS STORI, p403 xviii; Zakrzewska JM, 1997, PAIN, V73, P223, DOI 10.1016/S0304-3959(97)00104-8; Zakrzewska JM, 2002, CLIN J PAIN, V18, P14, DOI 10.1097/00002508-200201000-00003; Zakrzewska JM, 1995, TRIGEMINAL NEURALGIA, P76; Zakrzewska Joanna M, 2009, BMJ Clin Evid, V2009; Zakrzewska JM, 2012, CURR OPIN NEUROL, V25, P296, DOI 10.1097/WCO.0b013e328352c465; Zakrzewska JM, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007312.pub2; Zakrzewska JM, 2009, EUR J PAIN, V13, P486, DOI 10.1016/j.ejpain.2008.06.001; Zeng QS, 2013, J CLIN NEUROSCI, V20, P107, DOI 10.1016/j.jocn.2012.01.046; Zhang J, 2013, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858.CD004029.PUB4	67	113	121	2	41	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 17	2014	348								g474	10.1136/bmj.g474	http://dx.doi.org/10.1136/bmj.g474			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	AB9ZG	25299564				2022-12-28	WOS:000332153700014
J	Savage, N				Savage, Neil			LOGISTICS Keeping cool	NATURE			English	Editorial Material																			0	30	31	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 6	2014	507	7490					S8	S9		10.1038/507S8a	http://dx.doi.org/10.1038/507S8a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AC0ZQ	24611169	Bronze			2022-12-28	WOS:000332224400004
